Citrus Sinensis ID: 039168
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 536 | 2.2.26 [Sep-21-2011] | |||||||
| Q8GYA4 | 669 | Cysteine-rich receptor-li | yes | no | 0.977 | 0.783 | 0.438 | 1e-130 | |
| O65468 | 676 | Cysteine-rich receptor-li | no | no | 0.979 | 0.776 | 0.428 | 1e-130 | |
| Q8GWJ7 | 645 | Cysteine-rich receptor-li | no | no | 0.988 | 0.821 | 0.438 | 1e-127 | |
| Q9C5S9 | 674 | Cysteine-rich receptor-li | no | no | 0.983 | 0.781 | 0.414 | 1e-126 | |
| Q9M0X5 | 675 | Cysteine-rich receptor-li | no | no | 0.927 | 0.736 | 0.435 | 1e-126 | |
| Q8W4G6 | 627 | Cysteine-rich receptor-li | no | no | 0.932 | 0.797 | 0.425 | 1e-124 | |
| Q9C5S8 | 659 | Cysteine-rich receptor-li | no | no | 0.981 | 0.798 | 0.422 | 1e-123 | |
| Q8L7G3 | 659 | Cysteine-rich receptor-li | no | no | 0.975 | 0.793 | 0.429 | 1e-122 | |
| O65479 | 666 | Putative cysteine-rich re | no | no | 0.988 | 0.795 | 0.417 | 1e-121 | |
| Q9LDQ3 | 669 | Putative cysteine-rich re | no | no | 0.966 | 0.774 | 0.402 | 1e-117 |
| >sp|Q8GYA4|CRK10_ARATH Cysteine-rich receptor-like protein kinase 10 OS=Arabidopsis thaliana GN=CRK10 PE=1 SV=3 | Back alignment and function desciption |
|---|
Score = 467 bits (1201), Expect = e-130, Method: Compositional matrix adjust.
Identities = 258/589 (43%), Positives = 365/589 (61%), Gaps = 65/589 (11%)
Query: 2 GLYLCKFDITFQSCQRCIATAVKAVMKKCNGTRKAIIWYRECMVRYSDKSLPIMDTSTVL 61
GL+ C+ D++ + C+RC++ AV + +C ++A ++Y EC++RYS+++ I+ T
Sbjct: 92 GLFNCRGDVSTEVCRRCVSFAVNDTLTRCPNQKEATLYYDECVLRYSNQN--ILSTLITT 149
Query: 62 CMYIVRNFSVPRNVTRILAQSFNDVIAMPSLSSFR----NATK--GTNISNINRLETFG- 114
I+ N RNVT +D++ +P+L+ N++K GT +N L++F
Sbjct: 150 GGVILVN---TRNVTSNQLDLLSDLV-LPTLNQAATVALNSSKKFGTRKNNFTALQSFYG 205
Query: 115 --QCIPVLSVDDCRDCLNNTIRWIQKCFDPPGTGFGRILFPSCIMGFELHPYSKVPAVGA 172
QC P L+ DC CL I I P RI+ PSC +E++ + AV
Sbjct: 206 LVQCTPDLTRQDCSRCLQLVINQI-----PTDRIGARIINPSCTSRYEIYAFYTESAVPP 260
Query: 173 LAPSS--------APGRIGNHYSYDILRGGEQQAESQEFPLFPLG--------------- 209
P AP R G + +L LF G
Sbjct: 261 PPPPPSISTPPVSAPPRSGKDGNSKVLVIAIVVPIIVAVLLFIAGYCFLTRRARKSYYTP 320
Query: 210 -------------LALE------ATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSR 250
L L+ AT+ F + NK+GQGGFG VYKGTL+DG +AVKRLS+
Sbjct: 321 SAFAGDDITTADSLQLDYRTIQTATDDFVESNKIGQGGFGEVYKGTLSDGTEVAVKRLSK 380
Query: 251 TSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSV 310
+SGQG EFKNEV L+AKLQH+NLVRLLG CL+G+E +L+YEY+PNKSLD LFD +
Sbjct: 381 SSGQGEVEFKNEVVLVAKLQHRNLVRLLGFCLDGEERVLVYEYVPNKSLDYFLFDPAKKG 440
Query: 311 QLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGG 370
QLDW RR II G+ARGILYLH+DSRL IIHRDLKASN+LLD DMNPKI+DFG ARIFG
Sbjct: 441 QLDWTRRYKIIGGVARGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGMARIFGL 500
Query: 371 NQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQT 430
+Q + NT+ I GTYGYM+PEYAM G +S+KSDV+SFGVL+LEIISG+KN+ FY ++
Sbjct: 501 DQTEENTSRIVGTYGYMSPEYAMHGQYSMKSDVYSFGVLVLEIISGKKNSSFYQTDGAHD 560
Query: 431 LLTYTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLA 490
L++Y W LW G +EL+DP + ++C +E+++ +HIGLLCVQ+DPA+RPT+S++V+ML
Sbjct: 561 LVSYAWGLWSNGRPLELVDPAIVENCQRNEVVRCVHIGLLCVQEDPAERPTLSTIVLMLT 620
Query: 491 SDSMTIPQPTEPA-FSVGRVVANSGHLLSSAK--VGSVNNVTVSDVSPR 536
S+++T+P P +P F R+ + +++K +GSV++ +++D+ PR
Sbjct: 621 SNTVTLPVPRQPGLFFQSRIGKDPLDTDTTSKSLLGSVDDASITDIHPR 669
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: - |
| >sp|O65468|CRK8_ARATH Cysteine-rich receptor-like protein kinase 8 OS=Arabidopsis thaliana GN=CRK8 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 466 bits (1198), Expect = e-130, Method: Compositional matrix adjust.
Identities = 255/595 (42%), Positives = 355/595 (59%), Gaps = 70/595 (11%)
Query: 2 GLYLCKFDITFQSCQRCIATAVKAVMKKCNGTRKAIIWYRECMVRYSDKSLPIMDTSTVL 61
GL+LC+ D++ + C C+A +V + +C R+A+ +Y EC++RYS K+ + T T
Sbjct: 92 GLFLCRGDLSPEVCSNCVAFSVNESLTRCPNQREAVFYYEECILRYSHKNF--LSTVTYE 149
Query: 62 CMYIVRNFSVPRNVTRILAQ----------SFNDVIAMPSLSSFRNATKGTNISNINRLE 111
I+RN P N++ I Q + N + SS + +T T ++++ L
Sbjct: 150 GELIMRN---PNNISSIQNQRDQFIDLVQSNMNQAANEAANSSRKFSTIKTELTSLQTLY 206
Query: 112 TFGQCIPVLSVDDCRDCLNNTIRWIQKCFDPPGTGFGRILFPSCIMGFELHPYSKVPAVG 171
QC P L+ DC CL ++I + F R +PSC +EL+ + A+G
Sbjct: 207 GLVQCTPDLARQDCFSCLTSSINRMMPLFRIGA----RQFWPSCNSRYELYAFYNETAIG 262
Query: 172 ALAPS-------------SAPGRIGN-----------------------------HYSYD 189
+P S PG+ GN ++D
Sbjct: 263 TPSPPPLFPGSTPPLTSPSIPGKSGNSTVLVVAIVVLAVLLFIALVGYCFLAQRTKKTFD 322
Query: 190 ILRG---GEQQAESQEFPLFPLGLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVK 246
G+ A + L ATN F++ NK+G+GGFG VYKGT ++GK +AVK
Sbjct: 323 TASASEVGDDMATADSLQL-DYRTIQTATNDFAESNKIGRGGFGEVYKGTFSNGKEVAVK 381
Query: 247 RLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDA 306
RLS+ S QG EFK EV ++AKLQH+NLVRLLG L+G+E +L+YEYMPNKSLD LFD
Sbjct: 382 RLSKNSRQGEAEFKTEVVVVAKLQHRNLVRLLGFSLQGEERILVYEYMPNKSLDCLLFDP 441
Query: 307 TRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTAR 366
T+ QLDW +R +II GIARGILYLH+DSRL IIHRDLKASN+LLD D+NPKI+DFG AR
Sbjct: 442 TKQTQLDWMQRYNIIGGIARGILYLHQDSRLTIIHRDLKASNILLDADINPKIADFGMAR 501
Query: 367 IFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSE 426
IFG +Q Q NT+ I GTYGYMAPEYAM G FS+KSDV+SFGVL+LEIISGRKN+ F S+
Sbjct: 502 IFGLDQTQDNTSRIVGTYGYMAPEYAMHGQFSMKSDVYSFGVLVLEIISGRKNSSFDESD 561
Query: 427 HGQTLLTYTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVV 486
Q LLT+TW+LW A++L+DP++ +C E+++ IHIGLLCVQ+DPA RPT+S+V
Sbjct: 562 GAQDLLTHTWRLWTNRTALDLVDPLIANNCQNSEVVRCIHIGLLCVQEDPAKRPTISTVF 621
Query: 487 VMLASDSMTIPQPTEPAF-----SVGRVVANSGHLLSSAKVGSVNNVTVSDVSPR 536
+ML S+++T+P P +P F V + + + S+++ ++D+ PR
Sbjct: 622 MMLTSNTVTLPVPRQPGFFIQSSPVKDPTDSDQSTTTKSTPASIDDELITDLYPR 676
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8GWJ7|CRK19_ARATH Cysteine-rich receptor-like protein kinase 19 OS=Arabidopsis thaliana GN=CRK19 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 457 bits (1175), Expect = e-127, Method: Compositional matrix adjust.
Identities = 251/572 (43%), Positives = 347/572 (60%), Gaps = 42/572 (7%)
Query: 2 GLYLCKFDITFQSCQRCIATAVKAVMKKCNGTRKAIIWYRECMVRYSDKSL-PIMDTSTV 60
GL+LC+ D++ + C+ C+ AV + +C ++ + +Y +C++RYS++++ ++T
Sbjct: 79 GLFLCRVDVSSEVCRSCVTFAVNETLTRCPKDKEGVFYYEQCLLRYSNRNIVATLNTDGG 138
Query: 61 LCMYIVRN-FSVPRNVTRILAQSFNDVIAMPSLSSFRN-ATKGTNISNINRLETFGQCIP 118
+ M RN SV ++ R L + ++ A+ + SF+ A + +++ L +C P
Sbjct: 139 MFMQSARNPLSVKQDQFRDLVLTPMNLAAVEAARSFKKWAVRKIDLNASQSLYGMVRCTP 198
Query: 119 VLSVDDCRDCLNNTIRWIQKCFDPPGTGFGRILFPSCIMGFELHPYSKVPAVGALAPSSA 178
L DC DCL I Q +D G GRIL PSC ++ + + VG SS
Sbjct: 199 DLREQDCLDCLKIGIN--QVTYDKIG---GRILLPSCASRYDNYAFYNESNVGTPQDSSP 253
Query: 179 -PGRIGNHYSYDI------------------LRGGEQQAESQEFPL-------------- 205
PG+ GN I +R ++ +++ P+
Sbjct: 254 RPGKGGNSSVIIIAVVVPITVLFLLLVAVFSVRAKNKRTLNEKEPVAEDGNDITTAGSLQ 313
Query: 206 FPLGLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNL 265
F ATN F NKLGQGGFG VYKGTL+ G +AVKRLS+TSGQG KEF+NEV +
Sbjct: 314 FDFKAIEAATNCFLPINKLGQGGFGEVYKGTLSSGLQVAVKRLSKTSGQGEKEFENEVVV 373
Query: 266 IAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIA 325
+AKLQH+NLV+LLG CLEG+E +L+YE++PNKSLD LFD+T ++LDW RR II GIA
Sbjct: 374 VAKLQHRNLVKLLGYCLEGEEKILVYEFVPNKSLDHFLFDSTMKMKLDWTRRYKIIGGIA 433
Query: 326 RGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYG 385
RGILYLH+DSRL IIHRDLKA N+LLDDDMNPKI+DFG ARIFG +Q +A T + GTYG
Sbjct: 434 RGILYLHQDSRLTIIHRDLKAGNILLDDDMNPKIADFGMARIFGMDQTEAMTRRVVGTYG 493
Query: 386 YMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFY-FSEHGQTLLTYTWKLWCEGHA 444
YM+PEYAM G FS+KSDV+SFGVL+LEIISG KN+ Y E L+TYTW+LW G
Sbjct: 494 YMSPEYAMYGQFSMKSDVYSFGVLVLEIISGMKNSSLYQMDESVGNLVTYTWRLWSNGSP 553
Query: 445 VELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSMTIPQPTEPAF 504
EL+DP + E+ + IHI LLCVQ+D DRPTMSS+V ML + + + +P P F
Sbjct: 554 SELVDPSFGDNYQTSEITRCIHIALLCVQEDAEDRPTMSSIVQMLTTSLIALAEPRPPGF 613
Query: 505 SVGRVVANSGHLLSSAKVGSVNNVTVSDVSPR 536
+G + S+ SV+ +++ V+PR
Sbjct: 614 FFRSKQEQAGPSIDSSTHCSVDEASITRVTPR 645
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9C5S9|CRK6_ARATH Cysteine-rich receptor-like protein kinase 6 OS=Arabidopsis thaliana GN=CRK6 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 453 bits (1166), Expect = e-126, Method: Compositional matrix adjust.
Identities = 249/601 (41%), Positives = 360/601 (59%), Gaps = 74/601 (12%)
Query: 2 GLYLCKFDITFQSCQRCIATAVKAVMKKCNGTRKAIIWYRECMVRYSDKSLPIMDTS-TV 60
GL+LC+ D++ + C+ C+A +V + C R+A+ +Y +C++RYS K+ I+ T+ T
Sbjct: 82 GLFLCRGDVSPEVCRNCVAFSVNQTLNLCPKVREAVFYYEQCILRYSHKN--ILSTAITN 139
Query: 61 LCMYIVRNFSV--PRN-----VTRILAQSFNDVIAMPSLSSFRNATKGTNISNINRLETF 113
+I+ N + P T ++ + ++ + SS + T T ++ L
Sbjct: 140 EGEFILSNTNTISPNQKQIDGFTSFVSSTMSEAAGKAANSSRKLYTVNTELTAYQNLYGL 199
Query: 114 GQCIPVLSVDDCRDCLNNTIRWIQKCFDPPGTGFGRILFPSCIMGFELHPYSKVPAVGA- 172
QC P L+ DC CL ++I + G R+ +PSC +EL+P+ A+
Sbjct: 200 LQCTPDLTRADCLSCLQSSINGM--ALSRIG---ARLYWPSCTARYELYPFYNESAIETP 254
Query: 173 --------------------LAPSSAPGRIGN---------------------------- 184
++ SS PG+ GN
Sbjct: 255 PLPPPPPPPPPRESLVSTPPISSSSLPGKSGNSTVLVVAVVVLAVLLFIALVGYCFLAKK 314
Query: 185 -HYSYDILRG---GEQQAESQEFPLFPLGLALEATNHFSDENKLGQGGFGPVYKGTLADG 240
++D G+ A + L + ATN F++ NK+G+GGFG VYKGT ++G
Sbjct: 315 KKKTFDTASASEVGDDMATADSLQLDYRTIQ-TATNDFAESNKIGRGGFGEVYKGTFSNG 373
Query: 241 KAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLD 300
K +AVKRLS+ S QG EFK EV ++AKLQH+NLVRLLG L+G+E +L+YEYMPNKSLD
Sbjct: 374 KEVAVKRLSKNSRQGEAEFKTEVVVVAKLQHRNLVRLLGFSLQGEERILVYEYMPNKSLD 433
Query: 301 VHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKIS 360
LFD T+ +QLDW +R +II GIARGILYLH+DSRL IIHRDLKASN+LLD D+NPKI+
Sbjct: 434 CLLFDPTKQIQLDWMQRYNIIGGIARGILYLHQDSRLTIIHRDLKASNILLDADINPKIA 493
Query: 361 DFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNN 420
DFG ARIFG +Q Q NT+ I GTYGYMAPEYAM G FS+KSDV+SFGVL+LEIISGRKN+
Sbjct: 494 DFGMARIFGLDQTQDNTSRIVGTYGYMAPEYAMHGQFSMKSDVYSFGVLVLEIISGRKNS 553
Query: 421 GFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRP 480
F S+ Q LLT+ W+LW A++L+DP++ ++C E+++ IHIGLLCVQ+DPA RP
Sbjct: 554 SFGESDGAQDLLTHAWRLWTNKKALDLVDPLIAENCQNSEVVRCIHIGLLCVQEDPAKRP 613
Query: 481 TMSSVVVMLASDSMTIPQPTEPAF-----SVGRVVANSGHLLSSAKVGSVNNVTVSDVSP 535
+S+V +ML S+++T+P P +P F +V + + + + S+++ +++D+ P
Sbjct: 614 AISTVFMMLTSNTVTLPVPRQPGFFIQCRAVKDPLDSDQSTTTKSFPASIDDESITDLYP 673
Query: 536 R 536
R
Sbjct: 674 R 674
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9M0X5|CRK25_ARATH Cysteine-rich receptor-like protein kinase 25 OS=Arabidopsis thaliana GN=CRK25 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 451 bits (1160), Expect = e-126, Method: Compositional matrix adjust.
Identities = 243/558 (43%), Positives = 334/558 (59%), Gaps = 61/558 (10%)
Query: 1 FGLYLCKFDITFQSCQRCIATAVKAVMKKCNGTRKAIIWYRECMVRYSDKSLPIMDTSTV 60
+G++LC+ D++ + C+ C+A A +++C + A+IWY ECMVRYS++S I+ +
Sbjct: 83 YGVFLCRGDVSAEICRDCVAFAANETLQRCPREKVAVIWYDECMVRYSNQS--IVGQMRI 140
Query: 61 LCMYIVRNFSVPRNVTRILAQSFN--------DVIAMPSLSSFRNATKGTNISNINRLET 112
+ N +N+T FN DV +LSS + AT+ N + + +
Sbjct: 141 RPGVFLTN---KQNITENQVSRFNESLPALLIDVAVKAALSSRKFATEKANFTVFQTIYS 197
Query: 113 FGQCIPVLSVDDCRDCLNNTIRWIQKCFDPPGTGFGRILFPSCIMGFELHPY-------- 164
QC P L+ DC CL I ++ +C D G GR++ PSC +EL+P+
Sbjct: 198 LVQCTPDLTNQDCESCLRQVINYLPRCCDR-SVG-GRVIAPSCSFRYELYPFYNETIAAA 255
Query: 165 -------SKVPA------------------VGALA-PSSA------------PGRIGNHY 186
S V A V A+A P S R N
Sbjct: 256 PMAPPPSSTVTAPPLNIPSEKGKGKNLTVIVTAIAVPVSVCVLLLGAMCWLLARRRNNKL 315
Query: 187 SYDILRGGEQQAESQEFPLFPLGLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVK 246
S + E S E F ATN FS+ NKLG GGFG VYKG L G+ +A+K
Sbjct: 316 SAETEDLDEDGITSTETLQFQFSAIEAATNKFSESNKLGHGGFGEVYKGQLITGETVAIK 375
Query: 247 RLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDA 306
RLS+ S QG +EFKNEV+++AKLQH+NL +LLG CL+G+E +L+YE++PNKSLD LFD
Sbjct: 376 RLSQGSTQGAEEFKNEVDVVAKLQHRNLAKLLGYCLDGEEKILVYEFVPNKSLDYFLFDN 435
Query: 307 TRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTAR 366
+ LDW+RR II GIARGILYLH DSRL IIHRDLKASN+LLD DM+PKISDFG AR
Sbjct: 436 EKRRVLDWQRRYKIIEGIARGILYLHRDSRLTIIHRDLKASNILLDADMHPKISDFGMAR 495
Query: 367 IFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSE 426
IFG +Q QANT I GTYGYM+PEYA+ G +S+KSDV+SFGVL+LE+I+G+KN+ FY +
Sbjct: 496 IFGVDQTQANTKRIVGTYGYMSPEYAIHGKYSVKSDVYSFGVLVLELITGKKNSSFYEED 555
Query: 427 HGQTLLTYTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVV 486
L+TY WKLW E +EL+D ++ + +E+++ IHI LLCVQ+D ++RP+M ++
Sbjct: 556 GLGDLVTYVWKLWVENSPLELVDEAMRGNFQTNEVIRCIHIALLCVQEDSSERPSMDDIL 615
Query: 487 VMLASDSMTIPQPTEPAF 504
VM+ S ++T+P P F
Sbjct: 616 VMMNSFTVTLPIPKRSGF 633
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8W4G6|CRK15_ARATH Cysteine-rich receptor-like protein kinase 15 OS=Arabidopsis thaliana GN=CRK15 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 446 bits (1146), Expect = e-124, Method: Compositional matrix adjust.
Identities = 235/552 (42%), Positives = 331/552 (59%), Gaps = 52/552 (9%)
Query: 2 GLYLCKFDITFQSCQRCIATAVKAVMKKCNGTRKAIIWYRECMVRYSDKSLPIMDTSTVL 61
GL+LC+ D++ C+ C+A ++ + +C RK++ +Y ECM+RYSD+++
Sbjct: 79 GLFLCRGDVSPAVCRNCVAFSINDTLVQCPSERKSVFYYDECMLRYSDQNILSTLAYDGA 138
Query: 62 CMYIVRNFSVPRN----VTRILAQSFNDVIAMPSLSSFRNATKGTNISNINRLETFGQCI 117
+ + N S+ +N ++ + N + S + T + + L QC
Sbjct: 139 WIRMNGNISIDQNQMNRFKDFVSSTMNQAAVKAASSPRKFYTVKATWTALQTLYGLVQCT 198
Query: 118 PVLSVDDCRDCLNNTIRWIQKCFDPPGTGFGRILFPSCIMGFELHPYSKVPAVGALAPS- 176
P L+ DC CL ++I+ + P GR L+ SC +EL + V
Sbjct: 199 PDLTRQDCFSCLESSIKLM-----PLYKTGGRTLYSSCNSRYELFAFYNETTVRTQQAPP 253
Query: 177 ----------SAPGRIGNHYSYDILR--------------------GGEQQAESQEFPLF 206
++P G ++ ++L + S P F
Sbjct: 254 PLPPSSTPLVTSPSLPGKSWNSNVLVVAIVLTILVAALLLIAGYCFAKRVKNSSDNAPAF 313
Query: 207 ------PLGLALE------ATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQ 254
L L+ ATN FS+ NK+GQGGFG VYKGT ++G +AVKRLS++SGQ
Sbjct: 314 DGDDITTESLQLDYRMIRAATNKFSENNKIGQGGFGEVYKGTFSNGTEVAVKRLSKSSGQ 373
Query: 255 GLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDW 314
G EFKNEV ++AKLQH+NLVRLLG + G E +L+YEYMPNKSLD LFD + QLDW
Sbjct: 374 GDTEFKNEVVVVAKLQHRNLVRLLGFSIGGGERILVYEYMPNKSLDYFLFDPAKQNQLDW 433
Query: 315 KRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQ 374
RR +I GIARGILYLH+DSRL IIHRDLKASN+LLD DMNPK++DFG ARIFG +Q Q
Sbjct: 434 TRRYKVIGGIARGILYLHQDSRLTIIHRDLKASNILLDADMNPKLADFGLARIFGMDQTQ 493
Query: 375 ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTY 434
NT+ I GT+GYMAPEYA+ G FS+KSDV+SFGVL+LEIISG+KNN FY ++ L+T+
Sbjct: 494 ENTSRIVGTFGYMAPEYAIHGQFSVKSDVYSFGVLVLEIISGKKNNSFYETDGAHDLVTH 553
Query: 435 TWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSM 494
W+LW G A++L+DP++ +C E+++ IHI LLCVQ+DPA+RP +S++ +ML S+++
Sbjct: 554 AWRLWSNGTALDLVDPIIIDNCQKSEVVRCIHICLLCVQEDPAERPILSTIFMMLTSNTV 613
Query: 495 TIPQPTEPAFSV 506
T+P P +P F V
Sbjct: 614 TLPVPLQPGFPV 625
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9C5S8|CRK5_ARATH Cysteine-rich receptor-like protein kinase 5 OS=Arabidopsis thaliana GN=CRK5 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 442 bits (1136), Expect = e-123, Method: Compositional matrix adjust.
Identities = 249/589 (42%), Positives = 349/589 (59%), Gaps = 63/589 (10%)
Query: 1 FGLYLCKFDITFQSCQRCIATAVKAVMKKCNGTRKAIIWYRECMVRYSDKSLPIMDTSTV 60
FGLYLCK D++ +SC+ C+ A K +C G ++ +I Y ECM+ YSD+++ MDT T
Sbjct: 81 FGLYLCKGDLSPESCRECVIFAAKDTRSRCPGGKEFLIQYDECMLGYSDRNI-FMDTVTT 139
Query: 61 LCMYIVRNFSVPRNVTRILAQSFNDVI---------AMPSLSSFRNATKGTNISNINRLE 111
+ + VT + FND + + +S + A K ++ S+ L
Sbjct: 140 TTIITWNT----QKVTADQSDRFNDAVLSLMKKSAEEAANSTSKKFAVKKSDFSSSQSLY 195
Query: 112 TFGQCIPVLSVDDCRDCLNNTIRWIQKCFDPPGTGFGRILFPSCIMGFELHPYSKVPAVG 171
QCIP L+ +DC CL +I+ + F+ G GR L PSC +E++P+ K G
Sbjct: 196 ASVQCIPDLTSEDCVMCLQQSIKELY--FNKVG---GRFLVPSCNSRYEVYPFYKETIEG 250
Query: 172 AL--------------APSSAPGRIGNH---------------------YSYDILRGGEQ 196
+ PS PG+ N +S+ + ++
Sbjct: 251 TVLPPPVSAPPLPLVSTPSFPPGKGKNSTVIIIAIVVPVAISVLICVAVFSFHASKRAKK 310
Query: 197 QAESQEFP--------LFPLGLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRL 248
++ E F + AT+ FS NKLGQGGFG VYKGTL +G +AVKRL
Sbjct: 311 TYDTPEEDDITTAGSLQFDFKVIEAATDKFSMCNKLGQGGFGQVYKGTLPNGVQVAVKRL 370
Query: 249 SRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATR 308
S+TSGQG KEFKNEV ++AKLQH+NLV+LLG CLE +E +L+YE++ NKSLD LFD+
Sbjct: 371 SKTSGQGEKEFKNEVVVVAKLQHRNLVKLLGFCLEREEKILVYEFVSNKSLDYFLFDSRM 430
Query: 309 SVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIF 368
QLDW R II GIARGILYLH+DSRL IIHRDLKA N+LLD DMNPK++DFG ARIF
Sbjct: 431 QSQLDWTTRYKIIGGIARGILYLHQDSRLTIIHRDLKAGNILLDADMNPKVADFGMARIF 490
Query: 369 GGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHG 428
+Q +A+T + GTYGYM+PEYAM G FS+KSDV+SFGVL+LEIISGRKN+ Y +
Sbjct: 491 EIDQTEAHTRRVVGTYGYMSPEYAMYGQFSMKSDVYSFGVLVLEIISGRKNSSLYQMDAS 550
Query: 429 -QTLLTYTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 487
L+TYTW+LW +G ++L+D + S +E+++ IHI LLCVQ+D +RPTMS++V
Sbjct: 551 FGNLVTYTWRLWSDGSPLDLVDSSFRDSYQRNEIIRCIHIALLCVQEDTENRPTMSAIVQ 610
Query: 488 MLASDSMTIPQPTEPAFSVGRVVANSGHLLSSAKVGSVNNVTVSDVSPR 536
ML + S+ + P P F +G + + + S++ +++ ++PR
Sbjct: 611 MLTTSSIALAVPQPPGFFFRSNHEQAGPSMDKSSLCSIDAASITILAPR 659
|
Involved in multiple distinct defense responses. May function as a disease resistance (R) protein. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8L7G3|CRK7_ARATH Cysteine-rich receptor-like protein kinase 7 OS=Arabidopsis thaliana GN=CRK7 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 439 bits (1129), Expect = e-122, Method: Compositional matrix adjust.
Identities = 254/591 (42%), Positives = 356/591 (60%), Gaps = 68/591 (11%)
Query: 2 GLYLCKFDITFQSCQRCIATAVKAVMKKCNGTRKAIIWYRECMVRYSDKSLPIMDTS-TV 60
GL+LC+ D++ + C+ C+ AV +C R+A+ +Y EC++RYS K+ I+ T+ T
Sbjct: 81 GLFLCRGDVSPEVCRNCVTFAVNNTFSRCPNQREAVFYYEECILRYSHKN--ILSTAITN 138
Query: 61 LCMYIVRNFSVPRNVTRILAQ--SFNDVI----AMPSLSSFRNATKGTNI-SNINRLETF 113
+I+RN P +++ I Q F +++ ++ + N K + I + + L+TF
Sbjct: 139 EGEFILRN---PNHISPIQNQINQFTNLVLSNMNQIAIEAADNPRKFSTIKTELTALQTF 195
Query: 114 G---QCIPVLSVDDCRDCLNNTIRWIQKCFDPPGTGFG-RILFPSCIMGFELHPYSKVPA 169
QC P LS +C +CL ++I + P + G R +PSC +EL+ + A
Sbjct: 196 YGLVQCTPDLSRQNCMNCLTSSINRM------PFSRIGARQFWPSCNSRYELYDFYNETA 249
Query: 170 VGA-------LAPSSAPGRIGNH---------------------YSYDILRGGEQQA--- 198
+G LA S + GN Y + R +
Sbjct: 250 IGTPPPPLPPLASPSLSDKSGNSNVVVVAVVVPIIVAVLIFIAGYCFFAKRAKKTYGTTP 309
Query: 199 ---ESQEFPLFPLGLALEA----TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRT 251
E + + L L A TN FS+ NK+G+GGFG VYKGT ++G +AVKRLS+T
Sbjct: 310 ALDEDDKTTIESLQLDYRAIQAATNDFSENNKIGRGGFGDVYKGTFSNGTEVAVKRLSKT 369
Query: 252 SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQ 311
S QG EFKNEV ++A L+HKNLVR+LG +E +E +L+YEY+ NKSLD LFD + Q
Sbjct: 370 SEQGDTEFKNEVVVVANLRHKNLVRILGFSIEREERILVYEYVENKSLDNFLFDPAKKGQ 429
Query: 312 LDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGN 371
L W +R II GIARGILYLH+DSRL IIHRDLKASN+LLD DMNPKI+DFG ARIFG +
Sbjct: 430 LYWTQRYHIIGGIARGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGMARIFGMD 489
Query: 372 QNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTL 431
Q Q NT+ I GTYGYM+PEYAM G FS+KSDV+SFGVL+LEIISGRKNN F ++ Q L
Sbjct: 490 QTQQNTSRIVGTYGYMSPEYAMRGQFSMKSDVYSFGVLVLEIISGRKNNSFIETDDAQDL 549
Query: 432 LTYTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 491
+T+ W+LW G A++L+DP + SC E+++ HIGLLCVQ+DP RP MS++ VML S
Sbjct: 550 VTHAWRLWRNGTALDLVDPFIADSCRKSEVVRCTHIGLLCVQEDPVKRPAMSTISVMLTS 609
Query: 492 DSMTIPQPTEPAFSV------GRVVANSGHLLSSAKVGSVNNVTVSDVSPR 536
++M +P P +P F V R+ ++ S V S+++ ++SD+ PR
Sbjct: 610 NTMALPAPQQPGFFVRSRPGTNRLDSDQSTTNKSVTV-SIDDKSMSDLDPR 659
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|O65479|CRK20_ARATH Putative cysteine-rich receptor-like protein kinase 20 OS=Arabidopsis thaliana GN=CRK20 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 436 bits (1122), Expect = e-121, Method: Compositional matrix adjust.
Identities = 247/591 (41%), Positives = 344/591 (58%), Gaps = 61/591 (10%)
Query: 2 GLYLCKFDITFQSCQRCIATAVKAVMKKCNGTRKAIIWYRECMVRYSDKS-LPIMDTSTV 60
GL+LC+ +++ + C+ CIA +V + +C R+A+ +Y +CM+RYS+++ L ++T
Sbjct: 81 GLFLCRGNVSPEVCRSCIALSVNESLSRCPNEREAVFYYEQCMLRYSNRNILSTLNTDGG 140
Query: 61 LCMYIVRN-FSVPRNVTRILAQSFNDVIAMPSLSSF-RNATKGTNISNINRLETFGQCIP 118
+ M RN SV ++ R L + ++ A+ + S R A +++ + L QC P
Sbjct: 141 VFMQNARNPISVKQDRFRDLVLNPMNLAAIEAARSIKRFAVTKFDLNALQSLYGMVQCTP 200
Query: 119 VLSVDDCRDCLNNTIRWIQKCFDPPGTGFGRILFPSCIMGFELHPYSKVPAVGALAPSSA 178
L+ DC DCL +I Q +D G GR PSC ++ + + VG SS
Sbjct: 201 DLTEQDCLDCLQQSIN--QVTYDKIG---GRTFLPSCTSRYDNYEFYNEFNVGTPQDSSP 255
Query: 179 -PGRIGNH------------------YSYDILRGGEQQAESQEFPLFPLGLA-------- 211
PG+ GN ++ +R +++ PLF +
Sbjct: 256 RPGKGGNSSVIVIAVVVPITVLFLLFVAFFSVRRAKRKKTIGAIPLFKVKRKETEVTEPP 315
Query: 212 ----------------------LEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLS 249
+ AT+ F NKLGQGGFG VYKGT G +AVKRLS
Sbjct: 316 AETTDGDDITTAGSLQFDFKAIVAATDIFLPINKLGQGGFGEVYKGTFPSGVQVAVKRLS 375
Query: 250 RTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRS 309
+ SGQG KEF+NEV ++AKLQH+NLV+LLG CLEG+E +L+YE++PNKSLD LFD T
Sbjct: 376 KNSGQGEKEFENEVVVVAKLQHRNLVKLLGYCLEGEEKILVYEFVPNKSLDYFLFDPTMQ 435
Query: 310 VQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFG 369
QLDW RR II GIARGILYLH+DSRL IIHRDLKA N+LLD DMNPK++DFG ARIFG
Sbjct: 436 GQLDWSRRYKIIGGIARGILYLHQDSRLTIIHRDLKAGNILLDADMNPKVADFGMARIFG 495
Query: 370 GNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHG- 428
+Q +ANT + GTYGYMAPEYAM G FS+KSDV+SFGVL+LEI+SG KN+ +
Sbjct: 496 MDQTEANTRRVVGTYGYMAPEYAMYGKFSMKSDVYSFGVLVLEIVSGMKNSSLDQMDGSI 555
Query: 429 QTLLTYTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488
L+TYTW+LW G EL+DP + E+ + IHI LLCVQ+D DRPTMS++V M
Sbjct: 556 SNLVTYTWRLWSNGSPSELVDPSFGDNYQTSEITRCIHIALLCVQEDANDRPTMSAIVQM 615
Query: 489 LASDSMTIPQPTEPAF---SVGRVVANSGHLLSSAKVGSVNNVTVSDVSPR 536
L + S+ + P P F S + + ++ + S++ +++ V+PR
Sbjct: 616 LTTSSIALAVPRPPGFFLRSKQEQAERACPSMDTSDLFSIDEASITSVAPR 666
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LDQ3|CRK35_ARATH Putative cysteine-rich receptor-like protein kinase 35 OS=Arabidopsis thaliana GN=CRK35 PE=3 SV=3 | Back alignment and function description |
|---|
Score = 421 bits (1081), Expect = e-117, Method: Compositional matrix adjust.
Identities = 238/592 (40%), Positives = 328/592 (55%), Gaps = 74/592 (12%)
Query: 13 QSCQRCIATAVKAVMKKCNGTRKAIIWYRECMVRYSDKSLP----------------IMD 56
++C CI A + + C A W CMVRYS+ S I D
Sbjct: 84 ETCSDCIKGASDKISESCPNKTDAYTWPDCCMVRYSNVSFSGSLVMEPSETLYHTGDIED 143
Query: 57 TSTVLCMYIVRNFSVPRNVTRILAQSFNDVIAMPSLSSFRNATKGTNISNINRLETFGQC 116
T T L ++ + + R + + S A + +++ + QC
Sbjct: 144 TGTNLTVF---DRIWEELMLRTITAASLSSSNGSSFGQKYFAAEVASLTTFQTMYAMMQC 200
Query: 117 IPVLSVDDCRDCLNNTIRWIQKCFDPPGTGFGRILFPSCIMGFELHPYSKV--------- 167
P +S DC CL ++ + C G G ++ PSC + ++L+PY+
Sbjct: 201 TPDVSSKDCEFCLKTSVGDYESCCR--GKQGGAVIRPSCFVRWDLYPYAGAFENVTFPPP 258
Query: 168 --------------PAVGALAPSSAPG-----------------------RIGNHYSYDI 190
P V A ++ G R Y
Sbjct: 259 PPQSLPQPPVSLIPPPVSDRANTTIKGIIVAIVVPIIVILVSLVVLLVVCRRKKSYKTTE 318
Query: 191 LRGGEQQAESQEFPLFPLGLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSR 250
++ ++ + F AT+ FSD N +G+GGFG VY+G L+ G +AVKRLS+
Sbjct: 319 VQATDEITTTHSLQ-FSFKTIEAATDKFSDSNMIGRGGFGEVYRGKLSSGPEVAVKRLSK 377
Query: 251 TSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSV 310
TSGQG +EFKNE L++KLQHKNLVRLLG CLEG+E +L+YE++PNKSLD LFD +
Sbjct: 378 TSGQGAEEFKNEAVLVSKLQHKNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLFDPAKQG 437
Query: 311 QLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGG 370
+LDW RR +II GIARGILYLH+DSRL IIHRDLKASN+LLD DMNPKI+DFG ARIFG
Sbjct: 438 ELDWTRRYNIIGGIARGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGMARIFGV 497
Query: 371 NQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFY-FSEHGQ 429
+Q+QANT IAGT+GYM+PEYAM G FS+KSDV+SFGVL+LEIISG+KN+ FY + G
Sbjct: 498 DQSQANTRRIAGTFGYMSPEYAMRGHFSMKSDVYSFGVLVLEIISGKKNSSFYNIDDSGS 557
Query: 430 TLLTYTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 489
L+T+ W+LW G +EL+DP + +S E + IHI LLCVQ+DPADRP + ++++ML
Sbjct: 558 NLVTHAWRLWRNGSPLELVDPTIGESYQSSEATRCIHIALLCVQEDPADRPLLPAIIMML 617
Query: 490 ASDSMTIPQPTEPAFSV-GRVVANSG----HLLSSAKVGSVNNVTVSDVSPR 536
S + T+ P P F + GR + G S + GS+N+ ++++ PR
Sbjct: 618 TSSTTTLHVPRAPGFCLSGRDLEQDGVEYTESTSRSIPGSINDASITEFYPR 669
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 536 | ||||||
| 224076400 | 666 | predicted protein [Populus trichocarpa] | 0.992 | 0.798 | 0.529 | 1e-161 | |
| 147776074 | 815 | hypothetical protein VITISV_005300 [Viti | 0.992 | 0.652 | 0.507 | 1e-159 | |
| 359477817 | 670 | PREDICTED: cysteine-rich receptor-like p | 0.992 | 0.794 | 0.507 | 1e-159 | |
| 356510387 | 647 | PREDICTED: cysteine-rich receptor-like p | 0.990 | 0.820 | 0.466 | 1e-145 | |
| 358346648 | 573 | Cysteine-rich receptor-like protein kina | 0.992 | 0.928 | 0.495 | 1e-145 | |
| 358346817 | 626 | Cysteine-rich receptor-like protein kina | 0.992 | 0.849 | 0.493 | 1e-144 | |
| 356546303 | 662 | PREDICTED: cysteine-rich receptor-like p | 0.994 | 0.805 | 0.474 | 1e-143 | |
| 356575783 | 619 | PREDICTED: cysteine-rich receptor-like p | 0.981 | 0.849 | 0.490 | 1e-143 | |
| 356554943 | 670 | PREDICTED: cysteine-rich receptor-like p | 0.990 | 0.792 | 0.472 | 1e-143 | |
| 356554939 | 662 | PREDICTED: cysteine-rich receptor-like p | 0.975 | 0.790 | 0.471 | 1e-141 |
| >gi|224076400|ref|XP_002304937.1| predicted protein [Populus trichocarpa] gi|222847901|gb|EEE85448.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 573 bits (1478), Expect = e-161, Method: Compositional matrix adjust.
Identities = 309/584 (52%), Positives = 386/584 (66%), Gaps = 52/584 (8%)
Query: 1 FGLYLCKFDITFQSCQRCIATAVK-AVMKKCNGTRKAIIWYRECMVRYSDKSL-PIMDTS 58
+GL+ C+ D++ CQ C+A A K V ++C + A IWY EC +RYS+K + M+
Sbjct: 87 YGLFFCRGDLSTDVCQNCVANATKDIVQRRCPTQKVAFIWYDECFLRYSNKIMFSTMERD 146
Query: 59 TVLCMYIVRNFSVPRNVTRILAQSF----NDVIAMPSLSSFRNATKGTNISNINRLETFG 114
++ N +V + R L + N MP+ + ATK N + + L
Sbjct: 147 PNYTLWNPENVAVHADFNRELLNTIFTAVNRAANMPAGAKKFRATKA-NYTTEHYLYVLV 205
Query: 115 QCIPVLSVDDCRDCLNNTIRWIQKCFDPPGTGFGRILFPSCIMGFELHPYSKVPAV--GA 172
QC P LS DC CL ++ C + G RILFPSCI+ FE + V A
Sbjct: 206 QCTPDLSSGDCEQCLLAAYSGLEICCNEKRGG--RILFPSCIVNFETYINYNETYVESAA 263
Query: 173 LAPSSAPGR------------------IG------------NHYSYDILRGGEQ------ 196
LAPS P IG + ++Y + R ++
Sbjct: 264 LAPSPVPQEKHFCYAGDKGSSKKTWIIIGATLSTIVGVLLLSSFAYTMWRRKKRDDCSNE 323
Query: 197 ----QAESQEFPLFPLGLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTS 252
+ +SQ+ L L + L+ATN +S+ENKLGQGGFGPVYKG + DGK IAVKRLSRTS
Sbjct: 324 IMYGEVKSQDSFLIQLDIVLKATNQYSNENKLGQGGFGPVYKGVMEDGKEIAVKRLSRTS 383
Query: 253 GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQL 312
GQGL+EF NEVNLIA+LQH+NLV+LLGCCLE E LL+YEYMPNKSLDV LFD+ VQL
Sbjct: 384 GQGLREFMNEVNLIARLQHRNLVKLLGCCLEKNEKLLVYEYMPNKSLDVFLFDSAMRVQL 443
Query: 313 DWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQ 372
DW+RRLSIINGIARG+LYLHEDSRL+IIHRDLKASN+LLD +MNPKISDFG ARIFGGN
Sbjct: 444 DWQRRLSIINGIARGLLYLHEDSRLRIIHRDLKASNILLDYEMNPKISDFGMARIFGGNH 503
Query: 373 NQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLL 432
++ANTN I GTYGYMAPEYAM G+ S+KSDVFSFGVL+LEIISG++N GF+ SE G++LL
Sbjct: 504 SEANTNRIVGTYGYMAPEYAMEGLSSVKSDVFSFGVLMLEIISGKRNGGFHLSEEGKSLL 563
Query: 433 TYTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492
+TWKLW EG +EL+D +L++S E+LK IHIGLLCVQ+DP DRPTMSSVVVMLA D
Sbjct: 564 NFTWKLWSEGKGLELMDSLLEKSSVATEVLKCIHIGLLCVQEDPVDRPTMSSVVVMLAGD 623
Query: 493 SMTIPQPTEPAFSVGRVVANSGHLLSSAKVGSVNNVTVSDVSPR 536
+ IP PT+PAFSVGR+VA S+ +V SVN VT+S+V PR
Sbjct: 624 NFKIPIPTKPAFSVGRIVAEET-TSSNQRVSSVNKVTLSNVLPR 666
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147776074|emb|CAN65425.1| hypothetical protein VITISV_005300 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 568 bits (1465), Expect = e-159, Method: Compositional matrix adjust.
Identities = 302/595 (50%), Positives = 378/595 (63%), Gaps = 63/595 (10%)
Query: 1 FGLYLCKFDITFQSCQRCIATAVKAVMKKCNGTRKAIIWYRECMVRYSDKS-LPIMDTST 59
+GL+LC+ D++ CQ CI A +++ C ++AIIWY EC +RYS++S ++
Sbjct: 225 YGLFLCRPDVSKHICQSCIDAATLKIVQVCQHKKEAIIWYNECFLRYSNRSFFSNLEMKP 284
Query: 60 VLCMYIVRNFSVPRNVTRILAQSFNDVIAMPSLSSFRNATKGTNISNINRLETFGQCIPV 119
L M+ +N S P + L + F ++ A + S A +SN L QC
Sbjct: 285 TLYMWNRQNASAPDKFDQKLGEMFQNLTAKATSSDGMYAIGQVEVSNFLNLYGIVQCTRD 344
Query: 120 LSVDDCRDCLNNTIRWIQKCFDPPGTGFGRILFPSCIMGFELHPYSKV--PAVGALAPSS 177
L + CR CL+ + +I + G GR+L PSC + +E++P++ V P V A PSS
Sbjct: 345 LRMSYCRQCLDEVVGYIPNFME--GKEGGRVLAPSCYIRYEIYPFAAVEDPIVEAQVPSS 402
Query: 178 AP--GRIGNHYS------------------YDILR----------------------GGE 195
GR G Y ++R GG
Sbjct: 403 ISPRGRKGRKTKWIATGTSLSGIVVVAFCVYYVIRRRKGADPEEKESKGDLCLLDLGGGR 462
Query: 196 QQAE--------------SQEFPLFPLGLALEATNHFSDENKLGQGGFGPVYKGTLADGK 241
AE S+EFP+ + EAT HFS++NKLG+GGFGPVYKGTL+DGK
Sbjct: 463 LDAEDYSSETLQGDMLAKSKEFPVIGFDIVYEATQHFSNDNKLGEGGFGPVYKGTLSDGK 522
Query: 242 AIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDV 301
IAVKRLSRTSGQGL+EFKNEV LIAKLQH+NLVRLLGCCLEG ELLLIYEYMPNKSLD
Sbjct: 523 EIAVKRLSRTSGQGLQEFKNEVILIAKLQHRNLVRLLGCCLEGNELLLIYEYMPNKSLDF 582
Query: 302 HLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISD 361
LFD+TR ++LDWK R SIINGIARGI YLHEDSRL+IIHRDLK SN+LLD DMNPKISD
Sbjct: 583 FLFDSTRGLELDWKTRFSIINGIARGISYLHEDSRLRIIHRDLKPSNILLDGDMNPKISD 642
Query: 362 FGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNG 421
FG ARIF G++N NT I G+YGYMAPEYAM G++S KSDVFSFGV+LLEII+GRKN G
Sbjct: 643 FGLARIFAGSENGTNTAKIVGSYGYMAPEYAMEGLYSNKSDVFSFGVVLLEIITGRKNAG 702
Query: 422 FYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPT 481
F+ S G +LL+Y W+LW EG +EL+DP+L SC PDE L+ HIGLLCVQ+D DRPT
Sbjct: 703 FHLSGMGLSLLSYAWQLWNEGKGLELMDPLLGDSCCPDEFLRCYHIGLLCVQEDAFDRPT 762
Query: 482 MSSVVVMLASDSMTIPQPTEPAFSVGRVVANSGHLLSSAKVGSVNNVTVSDVSPR 536
MSSV++ML S+S+++ QP PAFSVGR N ++S SVN +T S PR
Sbjct: 763 MSSVIIMLRSESLSLRQPERPAFSVGRFANN--QEIASGSSSSVNGLTASTAVPR 815
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359477817|ref|XP_003632027.1| PREDICTED: cysteine-rich receptor-like protein kinase 25-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 566 bits (1459), Expect = e-159, Method: Compositional matrix adjust.
Identities = 302/595 (50%), Positives = 377/595 (63%), Gaps = 63/595 (10%)
Query: 1 FGLYLCKFDITFQSCQRCIATAVKAVMKKCNGTRKAIIWYRECMVRYSDKS-LPIMDTST 59
+GL+LC+ D++ CQ CI A +++ C ++AIIWY EC +RYS++S ++
Sbjct: 80 YGLFLCRPDVSKHICQSCIDAATLKIVQVCQHKKEAIIWYNECFLRYSNRSFFSNLEMKP 139
Query: 60 VLCMYIVRNFSVPRNVTRILAQSFNDVIAMPSLSSFRNATKGTNISNINRLETFGQCIPV 119
L M+ +N S P + L + F ++ A + S A +SN L QC
Sbjct: 140 TLYMWNTQNASAPDKFDQKLGEMFQNLTAQATSSDDMYAIGQVEVSNFLNLYGIVQCTRD 199
Query: 120 LSVDDCRDCLNNTIRWIQKCFDPPGTGFGRILFPSCIMGFELHPYSKV--PAVGALAPSS 177
L + CR CL+ + +I + G GR+L PSC + +E++P++ V P V A PSS
Sbjct: 200 LRMSYCRRCLDEVVGYIPNFME--GKQGGRVLAPSCYIRYEVYPFAAVEDPVVEAQVPSS 257
Query: 178 AP--GRIGNHYS------------------YDILR----------------------GGE 195
GR G Y ++R GG
Sbjct: 258 ISPRGRKGRKTKWIATGTSLSGIVVVAFCVYYVIRRRKGADPEEKESKGDLCLLDLGGGR 317
Query: 196 QQAE--------------SQEFPLFPLGLALEATNHFSDENKLGQGGFGPVYKGTLADGK 241
AE S+EFP+ + EAT HFS++NKLG+GGFGPVYKGTL+DGK
Sbjct: 318 LDAEDYSSETLQGDMLAKSKEFPVIGFDIVYEATQHFSNDNKLGEGGFGPVYKGTLSDGK 377
Query: 242 AIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDV 301
IAVKRLS TSGQGL+EFKNEV LIAKLQH+NLVRLLGCCLEG ELLLIYEYMPNKSLD
Sbjct: 378 EIAVKRLSSTSGQGLQEFKNEVILIAKLQHRNLVRLLGCCLEGNELLLIYEYMPNKSLDF 437
Query: 302 HLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISD 361
LFD+TR ++LDWK R SIINGIARGI YLHEDSRL+IIHRDLK SN+LLD DMNPKISD
Sbjct: 438 FLFDSTRGLELDWKTRFSIINGIARGISYLHEDSRLRIIHRDLKPSNILLDGDMNPKISD 497
Query: 362 FGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNG 421
FG ARIF G++N NT I G+YGYMAPEYAM G++S KSDVFSFGV+LLEII+GRKN G
Sbjct: 498 FGLARIFAGSENGTNTAKIVGSYGYMAPEYAMEGLYSNKSDVFSFGVVLLEIITGRKNAG 557
Query: 422 FYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPT 481
F+ S G +LL+Y W+LW EG +EL+DP+L SC PDE L+ HIGLLCVQ+D DRPT
Sbjct: 558 FHLSGMGLSLLSYAWQLWNEGKGLELMDPLLGDSCCPDEFLRCYHIGLLCVQEDAFDRPT 617
Query: 482 MSSVVVMLASDSMTIPQPTEPAFSVGRVVANSGHLLSSAKVGSVNNVTVSDVSPR 536
MSSV++ML S+S+T+ QP PAFSVGR N ++S SVN +T S PR
Sbjct: 618 MSSVIIMLRSESLTLRQPERPAFSVGRFANN--QEIASGSSSSVNGLTASTTVPR 670
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356510387|ref|XP_003523920.1| PREDICTED: cysteine-rich receptor-like protein kinase 10-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 521 bits (1343), Expect = e-145, Method: Compositional matrix adjust.
Identities = 272/583 (46%), Positives = 362/583 (62%), Gaps = 52/583 (8%)
Query: 1 FGLYLCKFDITFQSCQRCIATAVKAVMKKCNGTRKAIIWYRECMVRYSDKSL--PIMDTS 58
+GLYLC+ D+ C C+ + + + C T AI+WY C++RYS+++ + T
Sbjct: 70 YGLYLCRGDVNTSLCHSCVQNSSILLKQHCPNTASAILWYPFCLLRYSNQNFFGNLTLTP 129
Query: 59 TVLCMYIVRNFSVPRNVTRILAQSFNDVIAMPSLSSFRNATKGTNISNINRLETFGQCIP 118
+ +NF+ N +I M S T NI+ R + QC
Sbjct: 130 RIPMFDATQNFTSAGEFDSDARVLMNGLIQMGSEEPLMFGTHMFNINGTQRRYGWVQCSR 189
Query: 119 VLSVDDCRDCLNNTIRWIQKCFDPPGTGFGRILFPSCIMGFELHPYSKVPAVGALAPSSA 178
++ ++CR CL+N + ++ C + R+ PSCI+ +E P+ G P+
Sbjct: 190 DITTEECRTCLSNMLEDVENCCEEKKVW--RVFSPSCIVMYETQPFF---LNGTSEPTPQ 244
Query: 179 PGRIGNH------------------------YSYDILRGGEQQAESQE------------ 202
G++ Y + L+ + + QE
Sbjct: 245 QDEDGDNRRWLIIVIISVSGVVVVALLSISTYYFWCLKWKKDKQAIQEDGLNSMFSQDQT 304
Query: 203 ---------FPLFPLGLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSG 253
P+ PL L++TN+FSDE+KLG+GGFGPVYKG L DG+ IAVKRLS+TS
Sbjct: 305 DKEESMNADLPMMPLSTILKSTNNFSDEHKLGKGGFGPVYKGVLPDGRQIAVKRLSKTSV 364
Query: 254 QGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLD 313
QG++EFKNEV LIAKLQH+NLVRLL CC+E E LL+YE+MPN SLD HLFD + L+
Sbjct: 365 QGVEEFKNEVILIAKLQHRNLVRLLACCIEQNEKLLVYEFMPNSSLDFHLFDMEKGEHLE 424
Query: 314 WKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQN 373
WK RL+IINGIA+G+LYLHEDSRL++IHRDLKASN+LLD +MNPKISDFG AR FGG+Q
Sbjct: 425 WKNRLNIINGIAKGLLYLHEDSRLRVIHRDLKASNILLDHEMNPKISDFGLARTFGGDQK 484
Query: 374 QANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLT 433
QANT + GTYGYMAPEYAM G+FS+KSDVFSFGVLLLEIISG++++ FY S+ GQ+LL
Sbjct: 485 QANTIRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKRSSKFYLSDQGQSLLI 544
Query: 434 YTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDS 493
Y W LWCE +EL+DP++++SC E+LK +HIGLLCVQ+D ADRP MSSVV MLASD+
Sbjct: 545 YAWNLWCERKGLELMDPIIEKSCVRSEVLKCMHIGLLCVQEDAADRPKMSSVVHMLASDT 604
Query: 494 MTIPQPTEPAFSVGRVVANSGHLLSSAKVGSVNNVTVSDVSPR 536
+++ PT PAFSVGR V +++ SVN TVS+V PR
Sbjct: 605 VSLSVPTRPAFSVGRAVTERECSSNTSMHYSVNEATVSEVIPR 647
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|358346648|ref|XP_003637378.1| Cysteine-rich receptor-like protein kinase [Medicago truncatula] gi|355503313|gb|AES84516.1| Cysteine-rich receptor-like protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 520 bits (1339), Expect = e-145, Method: Compositional matrix adjust.
Identities = 272/549 (49%), Positives = 362/549 (65%), Gaps = 17/549 (3%)
Query: 1 FGLYLCKFDITFQSCQRCIATAVKAVMKKCNGTRKAIIWYRECMVRYSDKSL-PIMDTST 59
+GLY C+ D+T CQ C++TA +++ C A+IWY C++RYS+ + + T+
Sbjct: 29 YGLYDCRGDVTGSFCQFCVSTAASDILQHCPNRASAVIWYNFCILRYSNHNFFGNLTTNP 88
Query: 60 VLCMYIVRNFSVPRNVTRILAQSFNDVIAMPSLSSFR-NATKGTNISNINRLETFGQCIP 118
M +N + P+ + + + +I+ +L + + + +S + QC
Sbjct: 89 SWQMLGSKNITNPQELDKG-EDNMQSLISEATLETNKLYGMREFTLSPTEKRYGLVQCSR 147
Query: 119 VLSVDDCRDCLNNTIRWIQKCFDPPGTGFG-RILFPSCIMGFELHPYSKV-----PAVGA 172
LS C CL + + KC GT G +++ PSC+M ++ + K+ P +
Sbjct: 148 DLSDKQCNQCLEAMLDKVPKCC---GTKIGWQVVAPSCLMKYDDFMFYKLIFQTSPPLPN 204
Query: 173 LAPSSAPGRIGN--HYSYDILRGGEQQAE---SQEFPLFPLGLALEATNHFSDENKLGQG 227
A + GR + I + G Q E + + P+ PL ++TN+FS+ KLG+G
Sbjct: 205 SALAGEQGRSNGLPSKTTPISQHGHIQGEDTYNADLPIIPLIWIRQSTNNFSEFCKLGEG 264
Query: 228 GFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQEL 287
GFGPVYKG L DG +A+KRLS TSGQG +EFKNEV IAKLQH+NLVRLLGCC+E E
Sbjct: 265 GFGPVYKGNLVDGTEVAIKRLSITSGQGSEEFKNEVIFIAKLQHRNLVRLLGCCIEDNEK 324
Query: 288 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKAS 347
LL+YEYMPN SLD HLFD + LDWK RL+IINGIA+G+LYLHEDSRL++IHRDLKAS
Sbjct: 325 LLVYEYMPNSSLDFHLFDEEKRKLLDWKLRLNIINGIAKGLLYLHEDSRLRVIHRDLKAS 384
Query: 348 NVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFG 407
NVLLD +MNPKISDFG AR F +Q Q NT + GTYGYMAPEYAM G++S+KSDVFSFG
Sbjct: 385 NVLLDQEMNPKISDFGLARAFEKDQCQENTRRVVGTYGYMAPEYAMEGLYSVKSDVFSFG 444
Query: 408 VLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHI 467
VLLLEII GR+N GFY +EHGQ+LL Y+W LWCE ++EL+DP+LK + +E++K IHI
Sbjct: 445 VLLLEIICGRRNGGFYLAEHGQSLLVYSWNLWCEDKSLELLDPILKNTYTTNEVIKCIHI 504
Query: 468 GLLCVQQDPADRPTMSSVVVMLASDSMTIPQPTEPAFSVGRVVANSGHLLSSAKVGSVNN 527
GLLCVQ+D DRPTMS+VVVMLASD+MT+P P PAFSVGR V ++ SVN
Sbjct: 505 GLLCVQEDAVDRPTMSNVVVMLASDTMTLPNPNHPAFSVGRKVVEGESTSKASNDPSVNE 564
Query: 528 VTVSDVSPR 536
VTV+++ PR
Sbjct: 565 VTVTNILPR 573
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|358346817|ref|XP_003637461.1| Cysteine-rich receptor-like protein kinase [Medicago truncatula] gi|355503396|gb|AES84599.1| Cysteine-rich receptor-like protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 520 bits (1338), Expect = e-144, Method: Compositional matrix adjust.
Identities = 271/549 (49%), Positives = 362/549 (65%), Gaps = 17/549 (3%)
Query: 1 FGLYLCKFDITFQSCQRCIATAVKAVMKKCNGTRKAIIWYRECMVRYSDKSL-PIMDTST 59
+GLY C+ D+T CQ C++TA +++ C A+IWY C++RYS+ + + T+
Sbjct: 82 YGLYDCRGDVTGSFCQFCVSTAASDILQHCPNRASAVIWYNFCILRYSNHNFFGNLTTNP 141
Query: 60 VLCMYIVRNFSVPRNVTRILAQSFNDVIAMPSLSSFR-NATKGTNISNINRLETFGQCIP 118
M +N + P+ + + + +I+ +L + + + +S + QC
Sbjct: 142 SWQMLGSKNITNPQELDKG-EDNMQSLISEATLETNKLYGMREFTLSPTEKRYGLVQCSR 200
Query: 119 VLSVDDCRDCLNNTIRWIQKCFDPPGTGFG-RILFPSCIMGFELHPYSKV-----PAVGA 172
LS C CL + + KC GT G +++ PSC++ ++ + K+ P +
Sbjct: 201 DLSDKQCNQCLEAMLDKVPKCC---GTKIGWQVVAPSCLIKYDDFMFYKLIFQTSPPLPN 257
Query: 173 LAPSSAPGRIGN--HYSYDILRGGEQQAE---SQEFPLFPLGLALEATNHFSDENKLGQG 227
A + GR + I + G Q E + + P+ PL ++TN+FS+ KLG+G
Sbjct: 258 SALAGEQGRSNGLPSKTTPISQHGHIQGEDTYNADLPIIPLIWIRQSTNNFSEFCKLGEG 317
Query: 228 GFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQEL 287
GFGPVYKG L DG +A+KRLS TSGQG +EFKNEV IAKLQH+NLVRLLGCC+E E
Sbjct: 318 GFGPVYKGNLVDGTEVAIKRLSITSGQGSEEFKNEVIFIAKLQHRNLVRLLGCCIEDNEK 377
Query: 288 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKAS 347
LL+YEYMPN SLD HLFD + LDWK RL+IINGIA+G+LYLHEDSRL++IHRDLKAS
Sbjct: 378 LLVYEYMPNSSLDFHLFDEEKRKLLDWKLRLNIINGIAKGLLYLHEDSRLRVIHRDLKAS 437
Query: 348 NVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFG 407
NVLLD +MNPKISDFG AR F +Q Q NT + GTYGYMAPEYAM G++S+KSDVFSFG
Sbjct: 438 NVLLDQEMNPKISDFGLARAFEKDQCQENTRRVVGTYGYMAPEYAMEGLYSVKSDVFSFG 497
Query: 408 VLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHI 467
VLLLEII GR+N GFY +EHGQ+LL Y+W LWCE ++EL+DP+LK + +E++K IHI
Sbjct: 498 VLLLEIICGRRNGGFYLAEHGQSLLVYSWNLWCEDKSLELLDPILKNTYTTNEVIKCIHI 557
Query: 468 GLLCVQQDPADRPTMSSVVVMLASDSMTIPQPTEPAFSVGRVVANSGHLLSSAKVGSVNN 527
GLLCVQ+D DRPTMS+VVVMLASD+MT+P P PAFSVGR V ++ SVN
Sbjct: 558 GLLCVQEDAVDRPTMSNVVVMLASDTMTLPNPNHPAFSVGRKVVEGESTSKASNDPSVNE 617
Query: 528 VTVSDVSPR 536
VTV+++ PR
Sbjct: 618 VTVTNILPR 626
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356546303|ref|XP_003541568.1| PREDICTED: cysteine-rich receptor-like protein kinase 10-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 515 bits (1326), Expect = e-143, Method: Compositional matrix adjust.
Identities = 273/575 (47%), Positives = 369/575 (64%), Gaps = 42/575 (7%)
Query: 1 FGLYLCKFDITFQSCQRCIATAVKAVMKKCNGTRKAIIWYRECMVRYSDKSLPIMDTSTV 60
+GLY C+ D+ CQ C++TA + V+++C AI+ Y C++RYS+++ + +
Sbjct: 91 YGLYNCRGDVVGYFCQFCVSTASREVLQRCPNRVSAIVLYDFCILRYSNENF-FGNVTVY 149
Query: 61 LCMYIV--RNFSVPRNVTRILAQSFNDVIAMPSLSSFRNATKGTNISNINRLETFGQCIP 118
+ V +N S + + L + ++ G N+S+ + QC
Sbjct: 150 PSWHAVQSKNVSSKEEIQKGLDFMRGLIRKATVETNLLYYMDGFNLSSTQKRYGLVQCSR 209
Query: 119 VLSVDDCRDCLNNTIRWIQKCFDPPGTGFGRILFPSCIMGFELHPY-------------- 164
L+ D CR+CL + + KC + G+ ++L SC++ ++ + +
Sbjct: 210 DLTSDGCRECLEAMLAQVPKCCEQ-NLGW-QVLAASCLIKYDDYIFYLFRTQASDTQTAK 267
Query: 165 ----SK--------VPAVGALAPSS--------APGRIGNHYSYDILRGGEQQAESQ--- 201
SK + +GALA + L+ Q E
Sbjct: 268 KRGASKSRIILIIGLSVLGALALLCFSVYCFWFRKRSRRGRGKGNFLKQYNVQTEETLNV 327
Query: 202 EFPLFPLGLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKN 261
+ P PL L++T++FS+ +KLG+GGFGPVYKGTL DG+ IAVKRLS+ SGQG +EFKN
Sbjct: 328 DLPTIPLITILKSTDNFSEASKLGEGGFGPVYKGTLPDGRQIAVKRLSQASGQGSEEFKN 387
Query: 262 EVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSII 321
EV IAKLQH NLVRLL CCLEG+E +L+YEY+ N SLD HLFD + QLDW RLSII
Sbjct: 388 EVMFIAKLQHCNLVRLLACCLEGKEKILVYEYLSNASLDFHLFDERKKRQLDWNLRLSII 447
Query: 322 NGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIA 381
NGIA+G+LYLHEDSRLK+IHRDLKASN+LLDD+MNPKISDFG AR F QNQANTN +
Sbjct: 448 NGIAKGLLYLHEDSRLKVIHRDLKASNILLDDEMNPKISDFGLARAFEKGQNQANTNRVM 507
Query: 382 GTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCE 441
GTYGYM+PEYAM G+FS+KSDVFS+GVL+LEII G+KN+GFY SE GQ+L Y WK+WC
Sbjct: 508 GTYGYMSPEYAMEGLFSVKSDVFSYGVLVLEIICGKKNSGFYLSECGQSLTLYAWKIWCA 567
Query: 442 GHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSMTIPQPTE 501
G ++EL+DPVL++SC E++K IHIGLLCVQ+D ADRPTMS+VVVMLASD M++P+P +
Sbjct: 568 GKSLELMDPVLEKSCIESEVMKCIHIGLLCVQEDAADRPTMSTVVVMLASDKMSLPEPNQ 627
Query: 502 PAFSVGRVVANSGHLLSSAKVGSVNNVTVSDVSPR 536
PAFSVGR+ S+K S+N+VTV+++ PR
Sbjct: 628 PAFSVGRMTLEGASTSKSSKNLSINDVTVTNILPR 662
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356575783|ref|XP_003556016.1| PREDICTED: cysteine-rich receptor-like protein kinase 25-like isoform 4 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 515 bits (1326), Expect = e-143, Method: Compositional matrix adjust.
Identities = 268/546 (49%), Positives = 361/546 (66%), Gaps = 20/546 (3%)
Query: 1 FGLYLCKFDITFQSCQRCIATAVKAVMK--KCNGTRKAIIWYRECMVRYSDKSL-PIMDT 57
+GL++C+ D+ FQ C +C+ A + + +C+ +++A+IWY ECMVRYS++S +DT
Sbjct: 84 YGLFMCRGDVPFQLCGQCVINATQKLSSDLQCSLSKQAVIWYDECMVRYSNRSFFSTVDT 143
Query: 58 STVLCMYIVRNFSVPRNVTRILAQSFNDVIAMPSLSSFRNATKGTNISNINRLETFGQCI 117
+ + N S N R++ + N+ ++ + + ATK NIS L QC
Sbjct: 144 RPAIGLLNSANISNQANFMRLMFDTMNETADEAAIGAKKYATKQANISGFQTLYCLVQCT 203
Query: 118 PVLSVDDCRDCLNNTIRWIQKCFDPPGTGFGRILFPSCIMGFELHPYSKVPAVGALAPSS 177
P LS CR CL++ I + C + G GRIL PSC + ++L+P+ + + P+S
Sbjct: 204 PDLSTQGCRSCLSDAIGLLPWCCE--GKQGGRILNPSCNVRYDLYPFYRTNV--SAPPAS 259
Query: 178 APGRIGNHYSYDILRGGEQQAESQEFPLFPLGLALEATNHFSDENKLGQGGFGPVYKGTL 237
P ++ G E + + E F AT+ FSD NKLG+GGFG VYKG L
Sbjct: 260 VPPTDSSN------SGAETEISAVESLRFDFSTIEAATDKFSDANKLGEGGFGEVYKGLL 313
Query: 238 ADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNK 297
G+ +AVKRLS+ SGQG EFKNEV ++AKLQHKNLVRLLG CLEG+E +L+YE++ NK
Sbjct: 314 PSGQEVAVKRLSKNSGQGGTEFKNEVEVVAKLQHKNLVRLLGFCLEGEEKILVYEFVANK 373
Query: 298 SLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNP 357
SLD LFD + LDW RR I+ GIARGI YLHEDSRLKIIHRDLKASNVLLD DMNP
Sbjct: 374 SLDYILFDPEKQKSLDWTRRYKIVEGIARGIQYLHEDSRLKIIHRDLKASNVLLDGDMNP 433
Query: 358 KISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGR 417
KISDFG ARIFG +Q QANTN I GTYGYM+PEYAM G +S KSDV+SFGVL+LEIISG+
Sbjct: 434 KISDFGMARIFGVDQTQANTNRIVGTYGYMSPEYAMHGEYSAKSDVYSFGVLILEIISGK 493
Query: 418 KNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPA 477
+N+ FY ++ + LL+Y WKLW + +EL+D L++S +E+++ IHIGLLCVQ+DP
Sbjct: 494 RNSSFYETDVAEDLLSYAWKLWKDEAPLELMDQSLRESYTRNEVIRCIHIGLLCVQEDPI 553
Query: 478 DRPTMSSVVVMLASDSMTIPQPTEPAFSV-GRVVANSGHLL------SSAKVGSVNNVTV 530
DRPTM+SVV+ML S S+T+ P +PAF + R N L +++ SVN+++V
Sbjct: 554 DRPTMASVVLMLDSYSVTLQVPNQPAFYINSRTEPNMPKGLKIDQSTTNSTSKSVNDMSV 613
Query: 531 SDVSPR 536
S+V PR
Sbjct: 614 SEVDPR 619
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356554943|ref|XP_003545800.1| PREDICTED: cysteine-rich receptor-like protein kinase 10-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 514 bits (1325), Expect = e-143, Method: Compositional matrix adjust.
Identities = 276/584 (47%), Positives = 371/584 (63%), Gaps = 53/584 (9%)
Query: 1 FGLYLCKFDITFQSCQRCIATAVKAVMKKCNGTRKAIIWYRECMVRYSDKSLPIMDTSTV 60
+GLY C+ DI CQ C++TA + V+++C AI+WY C++RYS+++ + +
Sbjct: 92 YGLYDCRGDIVGYFCQFCVSTASREVLQRCPNRVSAIVWYDFCILRYSNENF-FGNVTVY 150
Query: 61 LCMYIVRN--FSVPRNVTRILAQSFNDVIAMPSLSSFRNATKGTNISNINRLETFGQCIP 118
+ VR S + + L + ++ G N+S+ R QC
Sbjct: 151 PSWHAVRPKIVSSKEEIQKGLDFMRGLIRKATVETNLLYFMDGFNLSSTQRRYGLVQCSR 210
Query: 119 VLSVDDCRDCLNNTIRWIQKCFDPPGTGFGRILFPSCIMGFELHPY-------------- 164
L+ D CR+CL + + KC + G+ ++L SC++ ++ + +
Sbjct: 211 DLTNDGCRECLEAMLAHVPKCCEQ-NLGW-QVLAASCLIKYDDYIFYLFRTQASDTQTAK 268
Query: 165 ----SK--------VPAVGALA-----------------PSSAPGRIGN---HYSYDILR 192
SK + +GA+A GRI + SY ++
Sbjct: 269 QRGASKSRIILIIGLSVLGAVALLCFSVYCFWFRKRTRRGRGKDGRIPDTIHQSSYHNVQ 328
Query: 193 GGEQQAESQEFPLFPLGLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTS 252
++ + + P PL L++T++FS+ +KLG+GG+GPVYKG L DG+ IAVKRLS+ S
Sbjct: 329 --TEETLNTDLPTIPLITILKSTDNFSEASKLGEGGYGPVYKGILPDGRQIAVKRLSQAS 386
Query: 253 GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQL 312
GQG +EFKNEV IAKLQH+NLVRLL CCLEG E +L+YEY+ N SLD HLFD + QL
Sbjct: 387 GQGSEEFKNEVMFIAKLQHRNLVRLLACCLEGHEKILVYEYLSNASLDFHLFDERKKRQL 446
Query: 313 DWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQ 372
DW RLSIINGIA+G+LYLHEDSRLK+IHRDLKASN+LLDD+MNPKISDFG AR F Q
Sbjct: 447 DWNLRLSIINGIAKGLLYLHEDSRLKVIHRDLKASNILLDDEMNPKISDFGLARAFEKGQ 506
Query: 373 NQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLL 432
NQANT + GTYGYM+PEYAM G+FS+KSDVFS+GVL+LEII G+KN+GFY SE GQ+L
Sbjct: 507 NQANTKRVMGTYGYMSPEYAMEGLFSVKSDVFSYGVLVLEIICGKKNSGFYLSECGQSLT 566
Query: 433 TYTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492
Y WKLWC G +EL+DPVL++SC E++K IHIGLLCVQ+D ADRPTMS+VVVMLASD
Sbjct: 567 LYAWKLWCAGKCLELLDPVLEESCIESEVVKCIHIGLLCVQEDAADRPTMSTVVVMLASD 626
Query: 493 SMTIPQPTEPAFSVGRVVANSGHLLSSAKVGSVNNVTVSDVSPR 536
M +P+P +PAFSVGR+ S+K S+N+VTVS++ PR
Sbjct: 627 KMPLPKPNQPAFSVGRMTLEDASTSKSSKNLSINDVTVSNILPR 670
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356554939|ref|XP_003545798.1| PREDICTED: cysteine-rich receptor-like protein kinase 10-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 509 bits (1310), Expect = e-141, Method: Compositional matrix adjust.
Identities = 277/588 (47%), Positives = 356/588 (60%), Gaps = 65/588 (11%)
Query: 1 FGLYLCKFDITFQSCQRCIATAVKAVMKKCNGTRKAIIWYRECMVRYS----------DK 50
+GLY C+ D+ CQ C++TA + ++++C A IWY CM++YS D
Sbjct: 88 YGLYDCRGDVVGYFCQFCVSTAAREILQRCPNRVSAFIWYDFCMLKYSNENFFGNVTVDP 147
Query: 51 SLPIMDTSTVLCMY-IVRNFSVPRNVTRILAQSFNDVIAMPSLSSFRNATKGTNISNINR 109
S ++ T V I + R++ R N + M G N+S+ R
Sbjct: 148 SWHVVGTKDVSSAEEIQKGEDFMRSLIRKATLVTNQLYYM----------GGFNLSSSQR 197
Query: 110 LETFGQCIPVLSVDDCRDCLNNTIRWIQKCFDPPGTGFGRILFPSCIMGFELHPY----- 164
QC L+ D CR CL + I KC + F SC+M ++ +
Sbjct: 198 RYGLVQCSRDLTNDGCRQCLETMLAQISKCCEKKLGWFAGS--ASCLMKYDDSMFYLFHN 255
Query: 165 --SKVP-----------------------------AVGALAPSSAPGRIGNHYSYDILRG 193
S VP +V S P + G + +
Sbjct: 256 QSSTVPEAYRKIGIKMSKILIISFSVIGSITLLCFSVYCFWCRSRPRKDG-LIPHTVRLS 314
Query: 194 GEQQAESQE-----FPLFPLGLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRL 248
Q +++E P PL ++T++FS+ +KLG+GG+GPVYKG L DG+ IAVKRL
Sbjct: 315 SYQNVQTEETLNPDLPTIPLITIQQSTDNFSEASKLGEGGYGPVYKGILPDGRQIAVKRL 374
Query: 249 SRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATR 308
S+ SGQG +EFKNEV IAKLQH+NLVRLL CCLE E +L+YEY+ N SL+ HLFD +
Sbjct: 375 SQASGQGSEEFKNEVMFIAKLQHRNLVRLLACCLEENEKILVYEYLSNASLNFHLFDDEK 434
Query: 309 SVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIF 368
QLDWK RLSIINGIARGILYLHEDSRL++IHRDLKASNVLLD DMNPKISDFG AR F
Sbjct: 435 KKQLDWKLRLSIINGIARGILYLHEDSRLRVIHRDLKASNVLLDHDMNPKISDFGLARAF 494
Query: 369 GGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHG 428
Q QANTN + GTYGYMAPEYAM G+FS+KSDVFSFGVL+LEII G+KN+GFY SE G
Sbjct: 495 SKGQKQANTNRVMGTYGYMAPEYAMEGLFSVKSDVFSFGVLVLEIICGKKNSGFYLSECG 554
Query: 429 QTLLTYTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488
Q LL Y WK+WC G +EL+DPVL++SC E++K IHIGLLCVQ+D ADRP MS+VVVM
Sbjct: 555 QGLLLYAWKIWCAGKFLELLDPVLEESCIESEVVKCIHIGLLCVQEDAADRPNMSTVVVM 614
Query: 489 LASDSMTIPQPTEPAFSVGRVVANSGHLLSSAKVGSVNNVTVSDVSPR 536
LASD+M +P+P PAFSVGR+ S+ S+N++T+S++ PR
Sbjct: 615 LASDTMVLPKPNRPAFSVGRMALGDASTSKSSNKHSINDITISNILPR 662
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 536 | ||||||
| TAIR|locus:2121676 | 669 | CRK10 "cysteine-rich RLK (RECE | 0.602 | 0.482 | 0.567 | 9.7e-118 | |
| TAIR|locus:2121651 | 676 | CRK8 "cysteine-rich RLK (RECEP | 0.546 | 0.433 | 0.617 | 7.7e-116 | |
| TAIR|locus:2121686 | 645 | CRK19 "cysteine-rich RLK (RECE | 0.608 | 0.505 | 0.564 | 7.8e-114 | |
| TAIR|locus:2115728 | 675 | CRK25 "cysteine-rich RLK (RECE | 0.548 | 0.435 | 0.566 | 3.4e-113 | |
| TAIR|locus:2121636 | 659 | CRK7 "cysteine-rich RLK (RECEP | 0.602 | 0.490 | 0.567 | 7e-113 | |
| TAIR|locus:2123111 | 669 | CRK34 "cysteine-rich RLK (RECE | 0.602 | 0.482 | 0.556 | 2.1e-107 | |
| TAIR|locus:2077147 | 676 | CRK4 "cysteine-rich RLK (RECEP | 0.608 | 0.482 | 0.541 | 8.2e-106 | |
| TAIR|locus:2121626 | 830 | CRK23 "cysteine-rich RLK (RECE | 0.617 | 0.398 | 0.534 | 2.2e-105 | |
| TAIR|locus:2018546 | 843 | RK1 "receptor kinase 1" [Arabi | 0.638 | 0.405 | 0.574 | 1.8e-101 | |
| TAIR|locus:2141201 | 679 | CRK29 "cysteine-rich RLK (RECE | 0.597 | 0.471 | 0.542 | 5.9e-101 |
| TAIR|locus:2121676 CRK10 "cysteine-rich RLK (RECEPTOR-like protein kinase) 10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 983 (351.1 bits), Expect = 9.7e-118, Sum P(2) = 9.7e-118
Identities = 185/326 (56%), Positives = 246/326 (75%)
Query: 214 ATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKN 273
AT+ F + NK+GQGGFG VYKGTL+DG +AVKRLS++SGQG EFKNEV L+AKLQH+N
Sbjct: 344 ATDDFVESNKIGQGGFGEVYKGTLSDGTEVAVKRLSKSSGQGEVEFKNEVVLVAKLQHRN 403
Query: 274 LVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHE 333
LVR +YEY+PNKSLD LFD + QLDW RR II G+ARGILYLH+
Sbjct: 404 LVRLLGFCLDGEERVLVYEYVPNKSLDYFLFDPAKKGQLDWTRRYKIIGGVARGILYLHQ 463
Query: 334 DSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAM 393
DSRL IIHRDLKASN+LLD DMNPKI+DFG ARIFG +Q + NT+ I GTYGYM+PEYAM
Sbjct: 464 DSRLTIIHRDLKASNILLDADMNPKIADFGMARIFGLDQTEENTSRIVGTYGYMSPEYAM 523
Query: 394 GGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLK 453
G +S+KSDV+SFGVL+LEIISG+KN+ FY ++ L++Y W LW G +EL+DP +
Sbjct: 524 HGQYSMKSDVYSFGVLVLEIISGKKNSSFYQTDGAHDLVSYAWGLWSNGRPLELVDPAIV 583
Query: 454 QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSMTIPQPTEPA-FSVGRVVAN 512
++C +E+++ +HIGLLCVQ+DPA+RPT+S++V+ML S+++T+P P +P F R+ +
Sbjct: 584 ENCQRNEVVRCVHIGLLCVQEDPAERPTLSTIVLMLTSNTVTLPVPRQPGLFFQSRIGKD 643
Query: 513 --SGHLLSSAKVGSVNNVTVSDVSPR 536
S + +GSV++ +++D+ PR
Sbjct: 644 PLDTDTTSKSLLGSVDDASITDIHPR 669
|
|
| TAIR|locus:2121651 CRK8 "cysteine-rich RLK (RECEPTOR-like protein kinase) 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 957 (341.9 bits), Expect = 7.7e-116, Sum P(2) = 7.7e-116
Identities = 181/293 (61%), Positives = 228/293 (77%)
Query: 214 ATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKN 273
ATN F++ NK+G+GGFG VYKGT ++GK +AVKRLS+ S QG EFK EV ++AKLQH+N
Sbjct: 349 ATNDFAESNKIGRGGFGEVYKGTFSNGKEVAVKRLSKNSRQGEAEFKTEVVVVAKLQHRN 408
Query: 274 LVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHE 333
LVR +YEYMPNKSLD LFD T+ QLDW +R +II GIARGILYLH+
Sbjct: 409 LVRLLGFSLQGEERILVYEYMPNKSLDCLLFDPTKQTQLDWMQRYNIIGGIARGILYLHQ 468
Query: 334 DSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAM 393
DSRL IIHRDLKASN+LLD D+NPKI+DFG ARIFG +Q Q NT+ I GTYGYMAPEYAM
Sbjct: 469 DSRLTIIHRDLKASNILLDADINPKIADFGMARIFGLDQTQDNTSRIVGTYGYMAPEYAM 528
Query: 394 GGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLK 453
G FS+KSDV+SFGVL+LEIISGRKN+ F S+ Q LLT+TW+LW A++L+DP++
Sbjct: 529 HGQFSMKSDVYSFGVLVLEIISGRKNSSFDESDGAQDLLTHTWRLWTNRTALDLVDPLIA 588
Query: 454 QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSMTIPQPTEPAFSV 506
+C E+++ IHIGLLCVQ+DPA RPT+S+V +ML S+++T+P P +P F +
Sbjct: 589 NNCQNSEVVRCIHIGLLCVQEDPAKRPTISTVFMMLTSNTVTLPVPRQPGFFI 641
|
|
| TAIR|locus:2121686 CRK19 "cysteine-rich RLK (RECEPTOR-like protein kinase) 19" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 924 (330.3 bits), Expect = 7.8e-114, Sum P(2) = 7.8e-114
Identities = 185/328 (56%), Positives = 231/328 (70%)
Query: 211 ALEA-TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKL 269
A+EA TN F NKLGQGGFG VYKGTL+ G +AVKRLS+TSGQG KEF+NEV ++AKL
Sbjct: 318 AIEAATNCFLPINKLGQGGFGEVYKGTLSSGLQVAVKRLSKTSGQGEKEFENEVVVVAKL 377
Query: 270 QHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGIL 329
QH+NLV+ +YE++PNKSLD LFD+T ++LDW RR II GIARGIL
Sbjct: 378 QHRNLVKLLGYCLEGEEKILVYEFVPNKSLDHFLFDSTMKMKLDWTRRYKIIGGIARGIL 437
Query: 330 YLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAP 389
YLH+DSRL IIHRDLKA N+LLDDDMNPKI+DFG ARIFG +Q +A T + GTYGYM+P
Sbjct: 438 YLHQDSRLTIIHRDLKAGNILLDDDMNPKIADFGMARIFGMDQTEAMTRRVVGTYGYMSP 497
Query: 390 EYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFY-FSEHGQTLLTYTWKLWCEGHAVELI 448
EYAM G FS+KSDV+SFGVL+LEIISG KN+ Y E L+TYTW+LW G EL+
Sbjct: 498 EYAMYGQFSMKSDVYSFGVLVLEIISGMKNSSLYQMDESVGNLVTYTWRLWSNGSPSELV 557
Query: 449 DPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSMTIPQPTEPAFSVGR 508
DP + E+ + IHI LLCVQ+D DRPTMSS+V ML + + + +P P F
Sbjct: 558 DPSFGDNYQTSEITRCIHIALLCVQEDAEDRPTMSSIVQMLTTSLIALAEPRPPGFFFRS 617
Query: 509 VVANSGHLLSSAKVGSVNNVTVSDVSPR 536
+G + S+ SV+ +++ V+PR
Sbjct: 618 KQEQAGPSIDSSTHCSVDEASITRVTPR 645
|
|
| TAIR|locus:2115728 CRK25 "cysteine-rich RLK (RECEPTOR-like protein kinase) 25" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 876 (313.4 bits), Expect = 3.4e-113, Sum P(2) = 3.4e-113
Identities = 167/295 (56%), Positives = 218/295 (73%)
Query: 211 ALEA-TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKL 269
A+EA TN FS+ NKLG GGFG VYKG L G+ +A+KRLS+ S QG +EFKNEV+++AKL
Sbjct: 339 AIEAATNKFSESNKLGHGGFGEVYKGQLITGETVAIKRLSQGSTQGAEEFKNEVDVVAKL 398
Query: 270 QHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGIL 329
QH+NL + +YE++PNKSLD LFD + LDW+RR II GIARGIL
Sbjct: 399 QHRNLAKLLGYCLDGEEKILVYEFVPNKSLDYFLFDNEKRRVLDWQRRYKIIEGIARGIL 458
Query: 330 YLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAP 389
YLH DSRL IIHRDLKASN+LLD DM+PKISDFG ARIFG +Q QANT I GTYGYM+P
Sbjct: 459 YLHRDSRLTIIHRDLKASNILLDADMHPKISDFGMARIFGVDQTQANTKRIVGTYGYMSP 518
Query: 390 EYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELID 449
EYA+ G +S+KSDV+SFGVL+LE+I+G+KN+ FY + L+TY WKLW E +EL+D
Sbjct: 519 EYAIHGKYSVKSDVYSFGVLVLELITGKKNSSFYEEDGLGDLVTYVWKLWVENSPLELVD 578
Query: 450 PVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSMTIPQPTEPAF 504
++ + +E+++ IHI LLCVQ+D ++RP+M ++VM+ S ++T+P P F
Sbjct: 579 EAMRGNFQTNEVIRCIHIALLCVQEDSSERPSMDDILVMMNSFTVTLPIPKRSGF 633
|
|
| TAIR|locus:2121636 CRK7 "cysteine-rich RLK (RECEPTOR-like protein kinase) 7" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 937 (334.9 bits), Expect = 7.0e-113, Sum P(2) = 7.0e-113
Identities = 186/328 (56%), Positives = 236/328 (71%)
Query: 214 ATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKN 273
ATN FS+ NK+G+GGFG VYKGT ++G +AVKRLS+TS QG EFKNEV ++A L+HKN
Sbjct: 332 ATNDFSENNKIGRGGFGDVYKGTFSNGTEVAVKRLSKTSEQGDTEFKNEVVVVANLRHKN 391
Query: 274 LVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHE 333
LVR +YEY+ NKSLD LFD + QL W +R II GIARGILYLH+
Sbjct: 392 LVRILGFSIEREERILVYEYVENKSLDNFLFDPAKKGQLYWTQRYHIIGGIARGILYLHQ 451
Query: 334 DSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAM 393
DSRL IIHRDLKASN+LLD DMNPKI+DFG ARIFG +Q Q NT+ I GTYGYM+PEYAM
Sbjct: 452 DSRLTIIHRDLKASNILLDADMNPKIADFGMARIFGMDQTQQNTSRIVGTYGYMSPEYAM 511
Query: 394 GGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLK 453
G FS+KSDV+SFGVL+LEIISGRKNN F ++ Q L+T+ W+LW G A++L+DP +
Sbjct: 512 RGQFSMKSDVYSFGVLVLEIISGRKNNSFIETDDAQDLVTHAWRLWRNGTALDLVDPFIA 571
Query: 454 QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSMTIPQPTEPAFSV-GRVVAN 512
SC E+++ HIGLLCVQ+DP RP MS++ VML S++M +P P +P F V R N
Sbjct: 572 DSCRKSEVVRCTHIGLLCVQEDPVKRPAMSTISVMLTSNTMALPAPQQPGFFVRSRPGTN 631
Query: 513 ---SGHLLSSAKVG-SVNNVTVSDVSPR 536
S ++ V S+++ ++SD+ PR
Sbjct: 632 RLDSDQSTTNKSVTVSIDDKSMSDLDPR 659
|
|
| TAIR|locus:2123111 CRK34 "cysteine-rich RLK (RECEPTOR-like protein kinase) 34" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 943 (337.0 bits), Expect = 2.1e-107, Sum P(2) = 2.1e-107
Identities = 183/329 (55%), Positives = 240/329 (72%)
Query: 214 ATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKN 273
AT+ FSD N +G+GGFG VY+G L+ G +AVKRLS+TSGQG +EFKNE L++KLQHKN
Sbjct: 341 ATDKFSDSNMIGRGGFGEVYRGKLSSGPEVAVKRLSKTSGQGAEEFKNEAVLVSKLQHKN 400
Query: 274 LVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHE 333
LVR +YE++PNKSLD LFD + +LDW RR +II GIARGILYLH+
Sbjct: 401 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLFDPAKQGELDWTRRYNIIGGIARGILYLHQ 460
Query: 334 DSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAM 393
DSRL IIHRDLKASN+LLD DMNPKI+DFG ARIFG +Q+QANT IAGT+GYM+PEYAM
Sbjct: 461 DSRLTIIHRDLKASNILLDADMNPKIADFGMARIFGVDQSQANTRRIAGTFGYMSPEYAM 520
Query: 394 GGIFSIKSDVFSFGVLLLEIISGRKNNGFY-FSEHGQTLLTYTWKLWCEGHAVELIDPVL 452
G FS+KSDV+SFGVL+LEIISG+KN+ FY + G L+T+ W+LW G +EL+DP +
Sbjct: 521 RGHFSMKSDVYSFGVLVLEIISGKKNSSFYNIDDSGSNLVTHAWRLWRNGSPLELVDPTI 580
Query: 453 KQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSMTIPQPTEPAFSV-GRVVA 511
+S E + IHI LLCVQ+DPADRP + ++++ML S + T+ P P F + GR +
Sbjct: 581 GESYQSSEATRCIHIALLCVQEDPADRPLLPAIIMMLTSSTTTLHVPRAPGFCLSGRDLE 640
Query: 512 NSG--HLLSSAKV--GSVNNVTVSDVSPR 536
G + S+++ GS+N+ ++++ PR
Sbjct: 641 QDGVEYTESTSRSIPGSINDASITEFYPR 669
|
|
| TAIR|locus:2077147 CRK4 "cysteine-rich RLK (RECEPTOR-like protein kinase) 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 892 (319.1 bits), Expect = 8.2e-106, Sum P(2) = 8.2e-106
Identities = 181/334 (54%), Positives = 234/334 (70%)
Query: 211 ALEA-TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKL 269
A+EA TN F + NKLGQGGFG VYKG G +AVKRLS+TSGQG +EF NEV ++AKL
Sbjct: 343 AIEAATNKFCETNKLGQGGFGEVYKGIFPSGVQVAVKRLSKTSGQGEREFANEVIVVAKL 402
Query: 270 QHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGIL 329
QH+NLVR +YE++PNKSLD +FD+T LDW RR II GIARGIL
Sbjct: 403 QHRNLVRLLGFCLERDERILVYEFVPNKSLDYFIFDSTMQSLLDWTRRYKIIGGIARGIL 462
Query: 330 YLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAP 389
YLH+DSRL IIHRDLKA N+LL DDMN KI+DFG ARIFG +Q +ANT I GTYGYM+P
Sbjct: 463 YLHQDSRLTIIHRDLKAGNILLGDDMNAKIADFGMARIFGMDQTEANTRRIVGTYGYMSP 522
Query: 390 EYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSE--HGQTLLTYTWKLWCEGHAVEL 447
EYAM G FS+KSDV+SFGVL+LEIISG+KN+ Y + L+TYTW+LW G +EL
Sbjct: 523 EYAMYGQFSMKSDVYSFGVLVLEIISGKKNSNVYQMDGTSAGNLVTYTWRLWSNGSPLEL 582
Query: 448 IDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSMTIPQPTEPAF--- 504
+DP + + +E+ + IHI LLCVQ++ DRPTMS++V ML + S+ + P P F
Sbjct: 583 VDPSFRDNYRINEVSRCIHIALLCVQEEAEDRPTMSAIVQMLTTSSIALAVPQRPGFFFR 642
Query: 505 -SVGRVVANSGHL-LSSAKVGSVNNVTVSDVSPR 536
S V L ++++ + SV++ ++++V+PR
Sbjct: 643 SSKHEQVGLVDRLSINTSALCSVDDASITNVTPR 676
|
|
| TAIR|locus:2121626 CRK23 "cysteine-rich RLK (RECEPTOR-like protein kinase) 23" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 898 (321.2 bits), Expect = 2.2e-105, Sum P(2) = 2.2e-105
Identities = 179/335 (53%), Positives = 228/335 (68%)
Query: 206 FPLGLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNL 265
F + ATN+F NKLGQGGFG VYKGT G +AVKRLS+TSGQG +EF+NEV +
Sbjct: 496 FDFKAIVAATNNFLPINKLGQGGFGEVYKGTFPSGVQVAVKRLSKTSGQGEREFENEVVV 555
Query: 266 IAKLQHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIA 325
+AKLQH+NLVR +YE++ NKSLD LFD T QLDW RR II GIA
Sbjct: 556 VAKLQHRNLVRLLGYCLEGEEKILVYEFVHNKSLDYFLFDTTMKRQLDWTRRYKIIGGIA 615
Query: 326 RGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYG 385
RGILYLH+DSRL IIHRDLKA N+LLD DMNPK++DFG ARIFG +Q +ANT + GTYG
Sbjct: 616 RGILYLHQDSRLTIIHRDLKAGNILLDADMNPKVADFGMARIFGMDQTEANTRRVVGTYG 675
Query: 386 YMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFY-FSEHGQTLLTYTWKLWCEGHA 444
YMAPEYAM G FS+KSDV+SFGVL+ EIISG KN+ Y + L+TYTW+LW G
Sbjct: 676 YMAPEYAMYGQFSMKSDVYSFGVLVFEIISGMKNSSLYQMDDSVSNLVTYTWRLWSNGSQ 735
Query: 445 VELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSMTIPQPTEPAF 504
++L+DP + ++ + IHI LLCVQ+D DRP MS++V ML + S+ + P +P F
Sbjct: 736 LDLVDPSFGDNYQTHDITRCIHIALLCVQEDVDDRPNMSAIVQMLTTSSIVLAVPKQPGF 795
Query: 505 SV-GR--VVANSGHLLSSAKVGSVNNVTVSDVSPR 536
GR V G + + S+++ +++ V+PR
Sbjct: 796 FFRGRHEQVGEVGSSVDRLALCSIDDASITSVAPR 830
|
|
| TAIR|locus:2018546 RK1 "receptor kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 980 (350.0 bits), Expect = 1.8e-101, Sum P(2) = 1.8e-101
Identities = 200/348 (57%), Positives = 242/348 (69%)
Query: 195 EQQAESQEFPLFPLGLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQ 254
E+++E E PL L ATN+FS++NKLGQGGFG VYKG L DGK IAVKRLS+ S Q
Sbjct: 496 EKKSEYLELPLLELEALATATNNFSNDNKLGQGGFGIVYKGRLLDGKEIAVKRLSKMSSQ 555
Query: 255 GLKEFKNEVNLIAKLQHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDW 314
G EF NEV LIAKLQH NLVR IYEY+ N SLD HLFD TRS L+W
Sbjct: 556 GTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSNLNW 615
Query: 315 KRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQ 374
++R IINGIARG+LYLH+DSR +IIHRDLKASNVLLD +M PKISDFG ARIFG + +
Sbjct: 616 QKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGREETE 675
Query: 375 ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTY 434
ANT + GTYGYM+PEYAM GIFS+KSDVFSFGVLLLEIISG++N GFY S LL +
Sbjct: 676 ANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNLLGF 735
Query: 435 TWKLWCEGHAVELIDPV----LKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLA 490
W+ W EG+ +E++DP+ L E+L+ I IGLLCVQ+ DRP MSSV+VML
Sbjct: 736 VWRHWKEGNELEIVDPINIDSLSSKFPTHEILRCIQIGLLCVQERAEDRPVMSSVMVMLG 795
Query: 491 SDSMTIPQPTEPAFSVGR--VVANSGHLLSSAKVGSVNNVTVSDVSPR 536
S++ IPQP P F +GR + A+S +VN +T+S + R
Sbjct: 796 SETTAIPQPKRPGFCIGRSPLEADSSSSTQRDDECTVNQITLSVIDAR 843
|
|
| TAIR|locus:2141201 CRK29 "cysteine-rich RLK (RECEPTOR-like protein kinase) 29" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 855 (306.0 bits), Expect = 5.9e-101, Sum P(2) = 5.9e-101
Identities = 179/330 (54%), Positives = 229/330 (69%)
Query: 214 ATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKN 273
AT++FS EN+LG+GGFG VYKG G+ IAVKRLS SGQG EFKNE+ L+AKLQH+N
Sbjct: 353 ATDNFSSENELGRGGFGSVYKGVFPQGQEIAVKRLSGNSGQGDNEFKNEILLLAKLQHRN 412
Query: 274 LVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHE 333
LVR +YE++ N SLD +FD + LDW R +I GIARG+LYLHE
Sbjct: 413 LVRLIGFCIQGEERLLVYEFIKNASLDQFIFDTEKRQLLDWVVRYKMIGGIARGLLYLHE 472
Query: 334 DSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQAN--TNIIAGTYGYMAPEY 391
DSR +IIHRDLKASN+LLD +MNPKI+DFG A++F Q + T+ IAGTYGYMAPEY
Sbjct: 473 DSRFRIIHRDLKASNILLDQEMNPKIADFGLAKLFDSGQTMTHRFTSRIAGTYGYMAPEY 532
Query: 392 AMGGIFSIKSDVFSFGVLLLEIISGRKNN--GFYFSEHGQTLLTYTWKLWCEGHAVELID 449
AM G FS+K+DVFSFGVL++EII+G++NN G E + LL++ W+ W E + +ID
Sbjct: 533 AMHGQFSVKTDVFSFGVLVIEIITGKRNNNGGSNGDEDAEDLLSWVWRSWREDTILSVID 592
Query: 450 PVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSMTIPQPTEPAFSVGRV 509
P L + +E+L+ IHIGLLCVQ+ A RPTM++V +ML S S T+P P PAF + V
Sbjct: 593 PSLTAG-SRNEILRCIHIGLLCVQESAATRPTMATVSLMLNSYSFTLPTPLRPAFVLESV 651
Query: 510 VANSGHLLSSAKVG---SVNNVTVSDVSPR 536
V S +SS+ G S N+VTVS+ SPR
Sbjct: 652 VIPSN--VSSSTEGLQMSSNDVTVSEFSPR 679
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.10.2 | LOW CONFIDENCE prediction! |
| 4th Layer | 2.7.11.1 | 0.824 |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 536 | |||
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 9e-58 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-55 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-55 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 4e-54 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-52 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-52 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 8e-51 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-47 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-40 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-37 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-36 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 5e-36 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 7e-36 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-35 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 5e-34 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 8e-34 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 6e-33 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-32 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-32 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 6e-32 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-31 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-31 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 4e-31 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 9e-31 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-30 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-30 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 5e-30 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-29 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 4e-29 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-28 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-28 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-28 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 4e-28 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-27 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-27 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-27 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 5e-27 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 6e-27 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-26 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-26 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-26 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-26 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-26 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 4e-26 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 4e-26 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 4e-26 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 9e-26 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-25 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-25 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-25 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-25 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 4e-25 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-25 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 4e-25 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 9e-25 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-24 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-24 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-24 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-24 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-24 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-24 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-24 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-24 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 4e-24 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 6e-24 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 8e-24 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 9e-24 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-23 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-23 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-23 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-23 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-23 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-23 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-23 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 3e-23 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-22 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 4e-22 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 5e-22 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 6e-22 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 7e-22 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 7e-22 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 7e-22 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 8e-22 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 8e-22 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 9e-22 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 9e-22 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-21 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-21 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-21 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-21 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-21 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-21 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-21 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 4e-21 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 4e-21 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 6e-21 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 7e-21 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 8e-21 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 9e-21 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-20 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-20 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-20 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-20 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-20 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-20 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-20 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-20 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-20 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-20 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-20 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 4e-20 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 7e-20 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 7e-20 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 8e-20 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-19 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-19 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-19 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-19 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-19 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-19 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-19 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-19 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-19 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-19 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 5e-19 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 6e-19 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 8e-19 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 8e-19 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-18 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-18 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-18 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-18 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-18 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-18 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-18 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-18 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-18 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-18 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-18 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 4e-18 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 5e-18 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 5e-18 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 6e-18 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 6e-18 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 7e-18 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 8e-18 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 8e-18 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-17 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-17 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-17 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-17 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-17 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 4e-17 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 5e-17 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 7e-17 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-16 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-16 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-16 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-16 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-16 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-16 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-16 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-16 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-16 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-16 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-16 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-16 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-15 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-15 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-15 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-15 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 5e-15 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 7e-15 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 7e-15 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 7e-15 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 7e-15 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 7e-15 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 9e-15 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-14 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-14 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-14 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-14 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-14 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-14 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-14 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-14 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 4e-14 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 4e-14 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 5e-14 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 5e-14 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 5e-14 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 5e-14 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 5e-14 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 6e-14 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 7e-14 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-13 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-13 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-13 | |
| pfam01657 | 106 | pfam01657, Stress-antifung, Salt stress response/a | 1e-13 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-13 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-13 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-13 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 3e-13 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 3e-13 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-13 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 4e-13 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 4e-13 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 4e-13 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 4e-13 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 4e-13 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 5e-13 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 6e-13 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 7e-13 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 7e-13 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-12 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-12 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-12 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-12 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-12 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-12 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-12 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-12 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-12 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 3e-12 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 4e-12 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 5e-12 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 6e-12 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 6e-12 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 6e-12 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 9e-12 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 9e-12 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 9e-12 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-11 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-11 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-11 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-11 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-11 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-11 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-11 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-11 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-11 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-11 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 4e-11 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 5e-11 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 6e-11 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 6e-11 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 7e-11 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 7e-11 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 7e-11 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 8e-11 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-10 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 1e-10 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-10 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-10 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-10 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-10 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-10 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-10 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-10 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 7e-10 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 8e-10 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 8e-10 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-09 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-09 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-09 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 5e-09 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 6e-09 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 6e-09 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 7e-09 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 9e-09 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-08 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-08 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-08 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-08 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-08 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-08 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-08 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-08 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-08 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-08 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 4e-08 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 4e-08 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-07 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 2e-07 | |
| pfam01657 | 106 | pfam01657, Stress-antifung, Salt stress response/a | 5e-07 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 5e-07 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 5e-07 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 1e-06 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-06 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-06 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-06 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 3e-06 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 4e-06 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 4e-06 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 2e-05 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 3e-05 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 3e-05 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 6e-05 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 6e-05 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 7e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-04 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 2e-04 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 4e-04 | |
| pfam11883 | 48 | pfam11883, DUF3403, Domain of unknown function (DU | 5e-04 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 5e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 5e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 7e-04 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 0.001 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 192 bits (491), Expect = 9e-58
Identities = 106/292 (36%), Positives = 140/292 (47%), Gaps = 53/292 (18%)
Query: 222 NKLGQGGFGPVYKGTLADGK----AIAVKRL-SRTSGQGLKEFKNEVNLIAKLQHKNLVR 276
KLG+G FG VYKG L +AVK L S + K+F E ++ KL H N+VR
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 277 LLGCCLEGQELLLIYEYMPNKSLDVHL------FDATRSVQLDWKRRLSIINGIARGILY 330
LLG C E + L L+ EYM L +L F + L K LS IA+G+ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 331 LHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTAR-IFGGNQNQANTN---IIAGTYGY 386
L K +HRDL A N L+ +D+ KISDFG +R ++ + + T I +
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR----W 173
Query: 387 MAPEYAMGGIFSIKSDVFSFGVLLLEIIS-------GRKNNGFYFSEHGQTLLTYTWKLW 439
MAPE GIF+ KSDV+SFGVLL EI + G N + +L Y
Sbjct: 174 MAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN---------EEVLEYL---- 220
Query: 440 CEGHAVELIDPVLKQ-SCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLA 490
+G+ L + PDEL + + L C Q DP DRPT S +V L
Sbjct: 221 RKGY-------RLPKPEYCPDELYELM---LSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 187 bits (477), Expect = 1e-55
Identities = 102/285 (35%), Positives = 137/285 (48%), Gaps = 46/285 (16%)
Query: 221 ENKLGQGGFGPVYKGTLADGKA-----IAVKRL-SRTSGQGLKEFKNEVNLIAKLQHKNL 274
KLG+G FG VYKGTL +AVK L S Q ++EF E ++ KL H N+
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63
Query: 275 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHED 334
V+LLG C E + L+++ EYMP L +L R +L LS IARG+ YL
Sbjct: 64 VKLLGVCTEEEPLMIVMEYMPGGDLLDYLRK-NRPKELSLSDLLSFALQIARGMEYLE-- 120
Query: 335 SRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQ--NQANTNIIAGTYGYMAPEYA 392
IHRDL A N L+ +++ KISDFG +R + + +MAPE
Sbjct: 121 -SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKL---PIRWMAPESL 176
Query: 393 MGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVL 452
G F+ KSDV+SFGVLL EI + G+ Y G + + L
Sbjct: 177 KEGKFTSKSDVWSFGVLLWEIFTL-----------GEEP--Y------PGMSNAEVLEYL 217
Query: 453 KQ--------SCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 489
K+ +C P EL K + L C +DP DRPT S +V +L
Sbjct: 218 KKGYRLPKPPNC-PPELYKLM---LQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 187 bits (477), Expect = 1e-55
Identities = 99/285 (34%), Positives = 133/285 (46%), Gaps = 47/285 (16%)
Query: 221 ENKLGQGGFGPVYKGTLADGK-----AIAVKRL-SRTSGQGLKEFKNEVNLIAKLQHKNL 274
KLG+G FG VYKG L +AVK L S Q ++EF E ++ KL H N+
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63
Query: 275 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHED 334
V+LLG C E + L ++ EYM L +L +L LS IARG+ YL
Sbjct: 64 VKLLGVCTEEEPLYIVMEYMEGGDLLSYL--RKNRPKLSLSDLLSFALQIARGMEYLE-- 119
Query: 335 SRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQ--NQANTNIIAGTYGYMAPEYA 392
IHRDL A N L+ +++ KISDFG +R + + + +MAPE
Sbjct: 120 -SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKL---PIRWMAPESL 175
Query: 393 MGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVL 452
G F+ KSDV+SFGVLL EI + G+ Y G + E + L
Sbjct: 176 KEGKFTSKSDVWSFGVLLWEIFTL-----------GEQP--Y------PGMSNEEVLEYL 216
Query: 453 KQ--------SCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 489
K +C P EL + L C +DP DRPT S +V +L
Sbjct: 217 KNGYRLPQPPNC-PPELYDLM---LQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 183 bits (466), Expect = 4e-54
Identities = 101/285 (35%), Positives = 135/285 (47%), Gaps = 50/285 (17%)
Query: 223 KLGQGGFGPVYKGTLADGKA-----IAVKRLSR-TSGQGLKEFKNEVNLIAKLQHKNLVR 276
KLG+G FG VYKGTL +AVK L S + +EF E +++ KL H N+VR
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65
Query: 277 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSR 336
LLG C +G+ L ++ EYMP L L + L L + IA+G+ YL
Sbjct: 66 LLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDL--LQMALQIAKGMEYLES--- 120
Query: 337 LKIIHRDLKASNVLLDDDMNPKISDFGTAR-IFGGNQNQANTNIIAGTYG---YMAPEYA 392
+HRDL A N L+ +++ KISDFG +R I+ + + G +MAPE
Sbjct: 121 KNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRG----GGKLPIKWMAPESL 176
Query: 393 MGGIFSIKSDVFSFGVLLLEIIS-------GRKNNGFYFS-EHGQTLLTYTWKLWCEGHA 444
G F+ KSDV+SFGVLL EI + G N E G L
Sbjct: 177 KDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGYRLPR----------- 225
Query: 445 VELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 489
P ++C PDEL + + L C DP DRPT S +V L
Sbjct: 226 -----P---ENC-PDELYELM---LQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 178 bits (455), Expect = 1e-52
Identities = 87/270 (32%), Positives = 123/270 (45%), Gaps = 26/270 (9%)
Query: 223 KLGQGGFGPVYKGT-LADGKAIAVKRL--SRTSGQGLKEFKNEVNLIAKLQHKNLVRLLG 279
KLG G FG VYK GK +AVK L + + + E+ ++ +L H N+VRL+
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 280 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKI 339
+ L L+ EY L +L +R L I I RG+ YLH I
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYL---SRGGPLSEDEAKKIALQILRGLEYLHS---NGI 119
Query: 340 IHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGI-FS 398
IHRDLK N+LLD++ KI+DFG A+ + ++ GT YMAPE +GG +
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLK--SSSSLTTFVGTPWYMAPEVLLGGNGYG 177
Query: 399 IKSDVFSFGVLLLEIISGRKNNGFYFSEHGQT--LLTYTWKLWCEGHAVELIDPVLKQSC 456
K DV+S GV+L E+++G+ FS L L L K S
Sbjct: 178 PKVDVWSLGVILYELLTGK----PPFSGENILDQLQLIRRILGP-----PLEFDEPKWSS 228
Query: 457 APDELLKFIHIGLLCVQQDPADRPTMSSVV 486
+E I L +DP+ RPT ++
Sbjct: 229 GSEEAKDLIK-KCLN--KDPSKRPTAEEIL 255
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 177 bits (451), Expect = 2e-52
Identities = 74/194 (38%), Positives = 107/194 (55%), Gaps = 11/194 (5%)
Query: 224 LGQGGFGPVYKGT-LADGKAIAVKRLSR-TSGQGLKEFKNEVNLIAKLQHKNLVRLLGCC 281
LG+GGFG VY GK +A+K + + S L+E E+ ++ KL H N+V+L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 282 LEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIH 341
+ L L+ EY SL L + +L L I+ I G+ YLH IIH
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKE--NEGKLSEDEILRILLQILEGLEYLHS---NGIIH 115
Query: 342 RDLKASNVLLD-DDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMG-GIFSI 399
RDLK N+LLD D+ K++DFG +++ +++ T I GT YMAPE +G G +S
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT--IVGTPAYMAPEVLLGKGYYSE 173
Query: 400 KSDVFSFGVLLLEI 413
KSD++S GV+L E+
Sbjct: 174 KSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 174 bits (443), Expect = 8e-51
Identities = 77/266 (28%), Positives = 115/266 (43%), Gaps = 24/266 (9%)
Query: 218 FSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLKE-FKNEVNLIAKLQHKNLV 275
+ KLG+G FG VY GK +A+K + + + +E E+ ++ KL+H N+V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 276 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDS 335
RL + +L L+ EY L L + D R + I + YLH
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLL-KKRGRLSEDEAR--FYLRQILSALEYLHS-- 115
Query: 336 RLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGG 395
I+HRDLK N+LLD+D + K++DFG AR + GT YMAPE +G
Sbjct: 116 -KGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGE---KLTTFVGTPEYMAPEVLLGK 171
Query: 396 IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQS 455
+ D++S GV+L E+++G+ F Q L + K + +
Sbjct: 172 GYGKAVDIWSLGVILYELLTGK----PPFPGDDQLLELF--KKIGKPK----PPFPPPEW 221
Query: 456 CAPDELLKFIHIGLLCVQQDPADRPT 481
E I LL DP R T
Sbjct: 222 DISPEAKDLIR-KLLVK--DPEKRLT 244
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 164 bits (418), Expect = 4e-47
Identities = 80/265 (30%), Positives = 127/265 (47%), Gaps = 25/265 (9%)
Query: 222 NKLGQGGFGPVYKGTLAD-GKAIAVK--RLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLL 278
LG+G FG VY D G+ +AVK LS S + L+ + E+ +++ LQH N+VR
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 279 GCCL--EGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSR 336
G E L + EY+ SL L + R+ + I G+ YLH
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLS-SLLKKFGKLPEPVIRKYT--RQILEGLAYLH---S 119
Query: 337 LKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGI 396
I+HRD+K +N+L+D D K++DFG A+ G + T + GT +MAPE G
Sbjct: 120 NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEE 179
Query: 397 FSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQSC 456
+ +D++S G ++E+ +G+ +SE G + L+ G + E P +
Sbjct: 180 YGRAADIWSLGCTVIEMATGKPP----WSELGNPM----AALYKIGSSGEP--PEIP-EH 228
Query: 457 APDELLKFIHIGLLCVQQDPADRPT 481
+E F+ C+++DP RPT
Sbjct: 229 LSEEAKDFL---RKCLRRDPKKRPT 250
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 2e-40
Identities = 79/272 (29%), Positives = 125/272 (45%), Gaps = 35/272 (12%)
Query: 217 HFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLV 275
F K+G+GGFG VYK GK +A+K + S + ++ NE+ ++ K +H N+V
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIV 60
Query: 276 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRL--SIINGIARGIL---- 329
+ G L+ EL ++ E+ SL D +S + L S I + + +L
Sbjct: 61 KYYGSYLKKDELWIVMEFCSGGSLK----DLLKS----TNQTLTESQIAYVCKELLKGLE 112
Query: 330 YLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAP 389
YLH IIHRD+KA+N+LL D K+ DFG + + +A ++ GT +MAP
Sbjct: 113 YLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQL--SDTKARNTMV-GTPYWMAP 166
Query: 390 EYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELID 449
E G + K+D++S G+ +E+ G+ Y L L +
Sbjct: 167 EVINGKPYDYKADIWSLGITAIELAEGKPP---YSELPPMKALFKIAT----NGPPGLRN 219
Query: 450 PVLKQSCAPDELLKFIHIGLLCVQQDPADRPT 481
P DE F+ C+Q++P RPT
Sbjct: 220 PEK----WSDEFKDFL---KKCLQKNPEKRPT 244
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 2e-37
Identities = 89/272 (32%), Positives = 133/272 (48%), Gaps = 34/272 (12%)
Query: 224 LGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLE 283
+G+G FG V G G+ +AVK L S + F E +++ L+H NLV+LLG L+
Sbjct: 14 IGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 284 GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRD 343
G L ++ EYM SL +L R+V + ++L + G+ YL E +HRD
Sbjct: 72 GNPLYIVTEYMAKGSLVDYLRSRGRAV-ITLAQQLGFALDVCEGMEYLEEK---NFVHRD 127
Query: 344 LKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTY--GYMAPEYAMGGIFSIKS 401
L A NVL+ +D+ K+SDFG A+ +A+ +G + APE FS KS
Sbjct: 128 LAARNVLVSEDLVAKVSDFGLAK-------EASQGQDSGKLPVKWTAPEALREKKFSTKS 180
Query: 402 DVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQSCAPDE 460
DV+SFG+LL EI S GR Y + ++ + K G+ +E AP+
Sbjct: 181 DVWSFGILLWEIYSFGRVP---YPRIPLKDVVPHVEK----GYRME----------APEG 223
Query: 461 LLKFIH-IGLLCVQQDPADRPTMSSVVVMLAS 491
++ + C + DPA RPT + LA
Sbjct: 224 CPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 2e-36
Identities = 84/266 (31%), Positives = 129/266 (48%), Gaps = 25/266 (9%)
Query: 218 FSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRL 277
F+ E KLG G FG V++G + +A+K L ++F+ EV + +L+HK+L+ L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 278 LGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRL 337
C G+ + +I E M SL L V L + + +A G+ YL E
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQV-LPVASLIDMACQVAEGMAYLEEQ--- 123
Query: 338 KIIHRDLKASNVLLDDDMNPKISDFGTARIFGGN-QNQANTNIIAGTYGYMAPEYAMGGI 396
IHRDL A N+L+ +D+ K++DFG AR+ + ++ I Y + APE A G
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI---PYKWTAPEAASHGT 180
Query: 397 FSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQSC 456
FS KSDV+SFG+LL E+ + +GQ + Y + I + C
Sbjct: 181 FSTKSDVWSFGILLYEMFT-----------YGQ--VPYPGMN--NHEVYDQITAGYRMPC 225
Query: 457 APDELLKFIH-IGLLCVQQDPADRPT 481
P + + I+ I L C +P DRP+
Sbjct: 226 -PAKCPQEIYKIMLECWAAEPEDRPS 250
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 5e-36
Identities = 84/277 (30%), Positives = 132/277 (47%), Gaps = 45/277 (16%)
Query: 217 HFSDENKLGQGGFGPVYKG-TLADGKAIAVKRLSRT--SGQGLKEFKNEVNLIAKLQHKN 273
++ + +G+G FG VYKG L G +A+K++S + LK E++L+ L+H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 274 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKR------RLSI--INGIA 325
+V+ +G L +I EY N SL R + K+ L + +
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSL--------RQII---KKFGPFPESLVAVYVYQVL 109
Query: 326 RGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYG 385
+G+ YLHE +IHRD+KA+N+L D K++DFG A + + GT
Sbjct: 110 QGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS--VVGTPY 164
Query: 386 YMAPE-YAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHA 444
+MAPE M G S SD++S G ++E+++G N Y+ L L+
Sbjct: 165 WMAPEVIEMSGA-STASDIWSLGCTVIELLTG---NPPYYD------LNPMAALFR---I 211
Query: 445 VELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPT 481
V+ P L + +P EL F+ + C Q+DP RPT
Sbjct: 212 VQDDHPPLPEGISP-ELKDFL---MQCFQKDPNLRPT 244
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 7e-36
Identities = 81/284 (28%), Positives = 134/284 (47%), Gaps = 35/284 (12%)
Query: 222 NKLGQGGFGPVYKGTL-----ADGKAIAVKRLSRTSG-QGLKEFKNEVNLIAKLQHKNLV 275
+LG+G FG V G+ +AVK L+ + Q +F+ E+ ++ L H+N+V
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 276 RLLGCCLE--GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHE 333
+ G C + G+ L LI EY+P+ SL +L Q++ KR L + I +G+ YL
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYL--QRHRDQINLKRLLLFSSQICKGMDYLGS 127
Query: 334 DSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQN--QANTNIIAGTYGYMAPEY 391
+ IHRDL A N+L++ + KISDFG A++ +++ + + Y APE
Sbjct: 128 ---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APEC 183
Query: 392 AMGGIFSIKSDVFSFGVLLLEIIS-GRKNNG-------FYFSEHGQTLLTYTWKLWCEGH 443
FS SDV+SFGV L E+ + G + GQ ++T
Sbjct: 184 LRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVT---------R 234
Query: 444 AVELIDPVLKQSCAPDELLKFI-HIGLLCVQQDPADRPTMSSVV 486
+EL+ + P + + LC + +P DRP+ + ++
Sbjct: 235 LLELLKEGERLPR-PPSCPDEVYDLMKLCWEAEPQDRPSFADLI 277
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 3e-35
Identities = 88/272 (32%), Positives = 130/272 (47%), Gaps = 43/272 (15%)
Query: 221 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGC 280
E KLG G FG V+ GT +AVK L + + F E ++ KL+H LV+L
Sbjct: 11 ERKLGAGQFGEVWMGTWNGTTKVAVKTL-KPGTMSPEAFLQEAQIMKKLRHDKLVQLYAV 69
Query: 281 CLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKII 340
C E + + ++ EYM SL L +L + + + IA G+ YL I
Sbjct: 70 CSEEEPIYIVTEYMSKGSLLDFLKSGEGK-KLRLPQLVDMAAQIAEGMAYLE---SRNYI 125
Query: 341 HRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNI---IAGTYGYMAPEYAMGGIF 397
HRDL A N+L+ +++ KI+DFG AR+ ++ A I T APE A G F
Sbjct: 126 HRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWT----APEAANYGRF 181
Query: 398 SIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEG-HAVELIDPVLK--- 453
+IKSDV+SFG+LL EI++ +G+ Y G E+++ V +
Sbjct: 182 TIKSDVWSFGILLTEIVT-----------YGRV--PY------PGMTNREVLEQVERGYR 222
Query: 454 ----QSCAPDELLKFIHIGLLCVQQDPADRPT 481
+C P+EL + L C +DP +RPT
Sbjct: 223 MPRPPNC-PEELYD---LMLQCWDKDPEERPT 250
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 5e-34
Identities = 74/280 (26%), Positives = 126/280 (45%), Gaps = 49/280 (17%)
Query: 222 NKLGQGGFGPVYKGT-LADGKAIAVKR--LSRTSGQGLKEFKNEVNLIAKLQHKNLVRLL 278
++G+G FG VY +DGK +K LS S + ++ NEV ++ KL H N+++
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65
Query: 279 GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQ-------LDWKRRLSIINGIARGILYL 331
E +L ++ EY L + + + LDW +L + + YL
Sbjct: 66 ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCL------ALKYL 119
Query: 332 HEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEY 391
H KI+HRD+K N+ L + K+ DFG +++ + A T + GT Y++PE
Sbjct: 120 HSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV--GTPYYLSPEL 174
Query: 392 AMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPV 451
++ KSD++S G +L E+ + + F G+ LL EL +
Sbjct: 175 CQNKPYNYKSDIWSLGCVLYELCTLKH--PFE----GENLL-------------ELALKI 215
Query: 452 LKQSCAP------DELLKFIHIGLLCVQQDPADRPTMSSV 485
LK P EL + +Q+DP +RP+++ +
Sbjct: 216 LKGQYPPIPSQYSSELRNLVSS---LLQKDPEERPSIAQI 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 8e-34
Identities = 80/267 (29%), Positives = 122/267 (45%), Gaps = 33/267 (12%)
Query: 223 KLGQGGFGPVYKGTL-ADGKAIAVKRL---SRTSGQGLKEFKNEVNLIAKLQHKNLVRLL 278
LGQG G VYK GK A+K++ + K+ E+ + + +V+
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFR--KQLLRELKTLRSCESPYVVKCY 65
Query: 279 GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGIL----YLHED 334
G + E+ ++ EYM SL D + V ++ IAR IL YLH
Sbjct: 66 GAFYKEGEISIVLEYMDGGSLA----DLLKKVGK-IPEP--VLAYIARQILKGLDYLH-- 116
Query: 335 SRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMG 394
++ IIHRD+K SN+L++ KI+DFG +++ +Q NT + GT YM+PE G
Sbjct: 117 TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV--GTVTYMSPERIQG 174
Query: 395 GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQ 454
+S +D++S G+ LLE G+ F F GQ ++L + P L
Sbjct: 175 ESYSYAADIWSLGLTLLECALGK----FPFLPPGQPSF---FELMQ--AICDGPPPSLPA 225
Query: 455 SCAPDELLKFIHIGLLCVQQDPADRPT 481
E FI C+Q+DP RP+
Sbjct: 226 EEFSPEFRDFIS---ACLQKDPKKRPS 249
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 6e-33
Identities = 85/264 (32%), Positives = 130/264 (49%), Gaps = 31/264 (11%)
Query: 223 KLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCL 282
KLG G FG V++G + +AVK L + K+F E ++ KL+H L++L C
Sbjct: 13 KLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQLYAVCT 71
Query: 283 EGQELLLIYEYMPNKSLDVHL-FDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIH 341
+ + ++ E M SL +L A R+++L + + + +A G+ YL + IH
Sbjct: 72 LEEPIYIVTELMKYGSLLEYLQGGAGRALKL--PQLIDMAAQVASGMAYLEAQN---YIH 126
Query: 342 RDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNI---IAGTYGYMAPEYAMGGIFS 398
RDL A NVL+ ++ K++DFG AR+ + +A I T APE A+ FS
Sbjct: 127 RDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWT----APEAALYNRFS 182
Query: 399 IKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQSCA 457
IKSDV+SFG+LL EI++ GR G T ++ +D + C
Sbjct: 183 IKSDVWSFGILLTEIVTYGR------MPYPGMT----------NAEVLQQVDQGYRMPCP 226
Query: 458 PDELLKFIHIGLLCVQQDPADRPT 481
P + I L C ++DP DRPT
Sbjct: 227 PGCPKELYDIMLDCWKEDPDDRPT 250
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 2e-32
Identities = 75/223 (33%), Positives = 114/223 (51%), Gaps = 35/223 (15%)
Query: 218 FSDENKLGQGGFGPVYKG---TLADGK---AIAVKRLSRT-SGQGLKEFKNEVNLIAKLQ 270
F +E LG+G FG VYKG + ++A+K L + +EF+ E L++ LQ
Sbjct: 9 FLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQ 66
Query: 271 HKNLVRLLGCCLEGQELLLIYEYMPNKSL-----------DVHLFDATRSVQ--LDWKRR 317
H N+V LLG C + Q +++EY+ + L DV +V+ LD
Sbjct: 67 HPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDF 126
Query: 318 LSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTAR-IFGGN----Q 372
L I IA G+ YL S +HRDL A N L+ + + KISDFG +R I+ + Q
Sbjct: 127 LHIAIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQ 183
Query: 373 NQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 415
+++ + +M PE + G F+ +SD++SFGV+L EI S
Sbjct: 184 SKSLLPV-----RWMPPEAILYGKFTTESDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 2e-32
Identities = 83/282 (29%), Positives = 127/282 (45%), Gaps = 46/282 (16%)
Query: 224 LGQGGFGPVYKGTLADGKA------IAVKRLSRTSGQGLKE-FKNEVNLIAKLQHKNLVR 276
LG+G FG V+ G + +AVK L T+ ++ F+ E L+ QH+N+V+
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 277 LLGCCLEGQELLLIYEYMP----NKSLDVHLFDATRSV-------QLDWKRRLSIINGIA 325
G C EG ++++EYM NK L H DA +L + L I IA
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 326 RGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTAR-IFGGNQNQANTNIIAGT- 383
G++YL + +HRDL N L+ D+ KI DFG +R ++ + + + G
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYR-----VGGHT 184
Query: 384 ---YGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWC 440
+M PE M F+ +SDV+SFGV+L EI + K + S + C
Sbjct: 185 MLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEV--------IEC 236
Query: 441 EGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTM 482
L P ++C P E+ I L C ++DP R +
Sbjct: 237 ITQGRLLQRP---RTC-PSEVY---DIMLGCWKRDPQQRINI 271
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 6e-32
Identities = 94/282 (33%), Positives = 129/282 (45%), Gaps = 38/282 (13%)
Query: 222 NKLGQGGFGPVYKGT--LADGK--AIAVKRLSR-TSGQGLKEFKNEVNLIAKLQHKNLVR 276
+LG G FG V KG + GK +AVK L + G KEF E +++A+L H +VR
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 277 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSR 336
L+G C G+ L+L+ E P L +L D K +A G+ YL
Sbjct: 61 LIGVCK-GEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAH---QVAMGMAYLESK-- 114
Query: 337 LKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQN--QANTNIIAGTY--GYMAPEYA 392
+HRDL A NVLL + KISDFG +R G + +A T AG + + APE
Sbjct: 115 -HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATT---AGRWPLKWYAPECI 170
Query: 393 MGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPV 451
G FS KSDV+S+GV L E S G K Y G + +++
Sbjct: 171 NYGKFSSKSDVWSYGVTLWEAFSYGAKP---YGEMKGA-------------EVIAMLESG 214
Query: 452 LKQSCAPDELLKFIH-IGLLCVQQDPADRPTMSSVVVMLASD 492
+ P+E + I+ I L C + P DRPT S + D
Sbjct: 215 ERLPR-PEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 125 bits (313), Expect = 2e-31
Identities = 84/326 (25%), Positives = 133/326 (40%), Gaps = 23/326 (7%)
Query: 223 KLGQGGFGPVYKGTLADGKAIAVKRLSRT---SGQGLKEFKNEVNLIAKLQH-KNLVRLL 278
KLG+G FG VY D K +A+K L++ + ++ F E+ ++A L H N+V+L
Sbjct: 7 KLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64
Query: 279 GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLK 338
+ L L+ EY+ SL+ L R L L I+ I + YLH
Sbjct: 65 DFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS---KG 121
Query: 339 IIHRDLKASNVLLD-DDMNPKISDFGTARIFGGNQ----NQANTNIIAGTYGYMAPEYAM 393
IIHRD+K N+LLD D K+ DFG A++ A + GT GYMAPE +
Sbjct: 122 IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLL 181
Query: 394 GGIF---SIKSDVFSFGVLLLEIISGRK-NNGFYFSEHGQTLLTYTWKLWCEGHAVELID 449
G S SD++S G+ L E+++G G S L +L +
Sbjct: 182 GLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILEL-----PTPSLA 236
Query: 450 PVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSMTIPQPTEPAFSVGRV 509
L S + + +DP +R + SS + + + +
Sbjct: 237 SPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLKPDD 296
Query: 510 VANSGHLLSSAKVGSVNNVTVSDVSP 535
A L + ++++ +S
Sbjct: 297 SAPLRLSLPPSLEALISSLNSLAISG 322
|
Length = 384 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 3e-31
Identities = 81/269 (30%), Positives = 139/269 (51%), Gaps = 28/269 (10%)
Query: 221 ENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLG 279
++KLG G +G VY+G +AVK L + ++EF E ++ +++H NLV+LLG
Sbjct: 11 KHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 69
Query: 280 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKI 339
C +I E+M +L +L + R +++ L + I+ + YL + +
Sbjct: 70 VCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEKKN---F 125
Query: 340 IHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGT---YGYMAPEYAMGGI 396
IHRDL A N L+ ++ K++DFG +R+ G+ A+ AG + APE
Sbjct: 126 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH----AGAKFPIKWTAPESLAYNK 181
Query: 397 FSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQSC 456
FSIKSDV++FGVLL EI + + S + L+ ++L +G+ +E P + C
Sbjct: 182 FSIKSDVWAFGVLLWEIAT------YGMSPYPGIDLSQVYELLEKGYRME--RP---EGC 230
Query: 457 APDELLKFIHIGLLCVQQDPADRPTMSSV 485
P ++ + + C Q +P+DRP+ + +
Sbjct: 231 -PPKVYELMR---ACWQWNPSDRPSFAEI 255
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 4e-31
Identities = 80/267 (29%), Positives = 125/267 (46%), Gaps = 27/267 (10%)
Query: 223 KLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKE-FKNEVNLIAKLQHKNLVRLLGCC 281
K+G+G FG VYKG L +AVK T LK F E ++ + H N+V+L+G C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 282 LEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIH 341
++ Q + ++ E +P SL L + +L K+ L + A G+ YL +S+ IH
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFL--RKKKNRLTVKKLLQMSLDAAAGMEYL--ESK-NCIH 116
Query: 342 RDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKS 401
RDL A N L+ ++ KISDFG +R G + + + APE G ++ +S
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSES 176
Query: 402 DVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQSC---AP 458
DV+S+G+LL E S G T + E I+ + P
Sbjct: 177 DVWSYGILLWETFSL-----------GDT----PYPGMSNQQTRERIESGYRMPAPQLCP 221
Query: 459 DELLKFIHIGLLCVQQDPADRPTMSSV 485
+E+ + + L C DP +RP+ S +
Sbjct: 222 EEIYR---LMLQCWAYDPENRPSFSEI 245
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 9e-31
Identities = 75/277 (27%), Positives = 124/277 (44%), Gaps = 41/277 (14%)
Query: 215 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKN 273
+ + K+G+G G VYK T A GK +A+K++ R Q + NE+ ++ +H N
Sbjct: 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKM-RLRKQNKELIINEILIMKDCKHPN 76
Query: 274 LVRLLGCCLEGQELLLIYEYMPNKSL-DVHLFDATRSVQLDWKR-RLS------IINGIA 325
+V L G EL ++ EYM SL D+ + R++ + +
Sbjct: 77 IVDYYDSYLVGDELWVVMEYMDGGSLTDI----------ITQNFVRMNEPQIAYVCREVL 126
Query: 326 RGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYG 385
+G+ YLH +IHRD+K+ N+LL D + K++DFG A +++ N+ + GT
Sbjct: 127 QGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS--VVGTPY 181
Query: 386 YMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAV 445
+MAPE + K D++S G++ +E+ G Y E L
Sbjct: 182 WMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPP---YLREPPLRALFLITTKGI----- 233
Query: 446 ELIDPVLKQSCA-PDELLKFIHIGLLCVQQDPADRPT 481
P LK E F++ C+ +DP RP+
Sbjct: 234 ----PPLKNPEKWSPEFKDFLN---KCLVKDPEKRPS 263
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 1e-30
Identities = 70/206 (33%), Positives = 113/206 (54%), Gaps = 21/206 (10%)
Query: 224 LGQGGFGPVYKGT-LADGK----AIAVKRLSRTSG-QGLKEFKNEVNLIAKLQHKNLVRL 277
LG G FG VYKG + +G+ +A+K L + + KE +E ++A + H ++VRL
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 278 LGCCLEGQELLLIYEYMPNKSLDVHLF---DATRSVQ-LDWKRRLSIINGIARGILYLHE 333
LG CL ++ LI + MP L ++ D S L+W + IA+G+ YL E
Sbjct: 75 LGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ------IAKGMSYL-E 126
Query: 334 DSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAM 393
+ RL +HRDL A NVL+ + KI+DFG A++ ++ + + +MA E +
Sbjct: 127 EKRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESIL 184
Query: 394 GGIFSIKSDVFSFGVLLLEIIS-GRK 418
I++ KSDV+S+GV + E+++ G K
Sbjct: 185 HRIYTHKSDVWSYGVTVWELMTFGAK 210
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 2e-30
Identities = 74/201 (36%), Positives = 107/201 (53%), Gaps = 14/201 (6%)
Query: 221 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGC 280
KLG G FG V+ G +A+K L + S + F E NL+ +LQH LVRL
Sbjct: 11 VKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAV 69
Query: 281 CLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKII 340
+ + + +I EYM N SL V ++L + + + IA G+ ++ R I
Sbjct: 70 VTQ-EPIYIITEYMENGSL-VDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYI 124
Query: 341 HRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNI---IAGTYGYMAPEYAMGGIF 397
HRDL+A+N+L+ + + KI+DFG AR+ N+ A I T APE G F
Sbjct: 125 HRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWT----APEAINYGTF 180
Query: 398 SIKSDVFSFGVLLLEIIS-GR 417
+IKSDV+SFG+LL EI++ GR
Sbjct: 181 TIKSDVWSFGILLTEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 5e-30
Identities = 87/296 (29%), Positives = 131/296 (44%), Gaps = 60/296 (20%)
Query: 224 LGQGGFGPVYKGTLAD------GKAIAVKRLSRTSGQGLK-EFKNEVNLIAKLQHKNLVR 276
LGQG FG VY+G +A+K ++ + + EF NE +++ + ++VR
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 277 LLGCCLEGQELLLIYEYMPNKSLDVHLF----DATRSVQLDWKRRLSIIN---GIARGIL 329
LLG GQ L++ E M L +L +A + L I IA G+
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 330 YLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTAR-IFGGNQNQANTNII-AGTYG-- 385
YL K +HRDL A N ++ +D+ KI DFG R I+ T+ G G
Sbjct: 134 YLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIY-------ETDYYRKGGKGLL 183
Query: 386 ---YMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-------GRKNNGFYFSEHGQTLLTYT 435
+MAPE G+F+ KSDV+SFGV+L E+ + G N + L
Sbjct: 184 PVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE--------EVL---- 231
Query: 436 WKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 491
K +G ++L + PD+LL+ + +C Q +P RPT +V L
Sbjct: 232 -KFVIDGGHLDLPE------NCPDKLLELM---RMCWQYNPKMRPTFLEIVSSLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 2e-29
Identities = 58/202 (28%), Positives = 101/202 (50%), Gaps = 12/202 (5%)
Query: 218 FSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVR 276
F KLG+G +G VYK G+ +A+K + L+E E++++ + +V+
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVK 62
Query: 277 LLGCCLEGQELLLIYEYMPNKS-LDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDS 335
G + +L ++ EY S D + T L + +I+ +G+ YLH
Sbjct: 63 YYGSYFKNTDLWIVMEYCGAGSVSD--IMKITNK-TLTEEEIAAILYQTLKGLEYLH--- 116
Query: 336 RLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGG 395
K IHRD+KA N+LL+++ K++DFG + + NT I GT +MAPE
Sbjct: 117 SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVI--GTPFWMAPEVIQEI 174
Query: 396 IFSIKSDVFSFGVLLLEIISGR 417
++ K+D++S G+ +E+ G+
Sbjct: 175 GYNNKADIWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 4e-29
Identities = 68/206 (33%), Positives = 109/206 (52%), Gaps = 15/206 (7%)
Query: 218 FSDENKLGQGGFGPVYKGTL-ADGKAIAVKR--LSRTSGQGLKEFKNEVNLIAKLQHKNL 274
F NK+G+G FG V+K AD + A+K+ LS+ + + +E +E ++AKL +
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 275 VRLLGCCLEGQELLLIYEYMPNKSLD--VHLFDATR-SVQLDWKRRLSIINGIARGILYL 331
+R L+ +L ++ EY N L + + W+ + I+ G+A +L
Sbjct: 62 IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLA----HL 117
Query: 332 HEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEY 391
H KI+HRD+K+ N+ LD N KI D G A++ N N ANT I GT Y++PE
Sbjct: 118 HSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT--IVGTPYYLSPEL 172
Query: 392 AMGGIFSIKSDVFSFGVLLLEIISGR 417
++ KSDV++ GV+L E +G+
Sbjct: 173 CEDKPYNEKSDVWALGVVLYECCTGK 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 1e-28
Identities = 73/194 (37%), Positives = 102/194 (52%), Gaps = 8/194 (4%)
Query: 223 KLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCL 282
KLG G FG V+ G + +AVK L + ++ F E NL+ LQH LVRL
Sbjct: 13 KLGAGQFGEVWMGYYNNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 71
Query: 283 EGQELLLIYEYMPNKSL-DVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIH 341
+ + + +I EYM SL D D V L + + IA G+ Y+ R IH
Sbjct: 72 KEEPIYIITEYMAKGSLLDFLKSDEGGKVLL--PKLIDFSAQIAEGMAYIE---RKNYIH 126
Query: 342 RDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKS 401
RDL+A+NVL+ + + KI+DFG AR+ N+ A + APE G F+IKS
Sbjct: 127 RDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREG-AKFPIKWTAPEAINFGSFTIKS 185
Query: 402 DVFSFGVLLLEIIS 415
DV+SFG+LL EI++
Sbjct: 186 DVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 2e-28
Identities = 82/279 (29%), Positives = 134/279 (48%), Gaps = 35/279 (12%)
Query: 221 ENKLGQGGFGPVYKGTLA----DGKAIAVKRLSRTSGQGLK-EFKNEVNLIAKLQHKNLV 275
E +G G FG V +G L +A+K L S + +F E +++ + H N++
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68
Query: 276 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDS 335
RL G + + +++I EYM N SLD L + + + ++ GIA G+ YL S
Sbjct: 69 RLEGVVTKSRPVMIITEYMENGSLDKFL--RENDGKFTVGQLVGMLRGIASGMKYL---S 123
Query: 336 RLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGG 395
+ +HRDL A N+L++ ++ K+SDFG +R ++ T + APE
Sbjct: 124 EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYR 183
Query: 396 IFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVE----LIDP 450
F+ SDV+SFG+++ E++S G + Y+ Q ++ AVE L P
Sbjct: 184 KFTSASDVWSFGIVMWEVMSYGERP---YWDMSNQDVI----------KAVEDGYRLPPP 230
Query: 451 VLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 489
+ C P L + + L C Q+D +RPT S +V L
Sbjct: 231 M---DC-PSALYQLM---LDCWQKDRNERPTFSQIVSTL 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 2e-28
Identities = 77/268 (28%), Positives = 120/268 (44%), Gaps = 32/268 (11%)
Query: 222 NKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGL-KEFKNEVNLIAKLQHKNLVRLLG 279
+LG G G V K GK +AVK + + + K+ E++++ K +V G
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYG 66
Query: 280 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKI 339
++ + EYM SLD L + + + I + +G+ YLHE KI
Sbjct: 67 AFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGK--IAVAVLKGLTYLHEK--HKI 122
Query: 340 IHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSI 399
IHRD+K SN+L++ K+ DFG + + A T GT YMAPE G +S+
Sbjct: 123 IHRDVKPSNILVNSRGQIKLCDFGVSGQL--VNSLAKTF--VGTSSYMAPERIQGNDYSV 178
Query: 400 KSDVFSFGVLLLEIISGRKNNGFYFSEHGQT------LLTYTWKLWCEGHAVELIDPVLK 453
KSD++S G+ L+E+ +GR F + LL Y V P L
Sbjct: 179 KSDIWSLGLSLIELATGR----FPYPPENDPPDGIFELLQYI---------VNEPPPRLP 225
Query: 454 QSCAPDELLKFIHIGLLCVQQDPADRPT 481
+ F++ LC+ +DP +RP+
Sbjct: 226 SGKFSPDFQDFVN---LCLIKDPRERPS 250
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 4e-28
Identities = 92/276 (33%), Positives = 134/276 (48%), Gaps = 37/276 (13%)
Query: 224 LGQGGFGPVYKGT----LADGKA---IAVKRLSRTS-GQGLKEFKNEVNLIAKLQHKNLV 275
LG G FG VY+GT L G +AVK L + + Q KEF E +L++ H N+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 276 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDA----TRSVQLDWKRRLSIINGIARGILYL 331
+LLG CL + +I E M L +L DA L K L I +A+G +YL
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 332 HEDSRLKIIHRDLKASNVLL-----DDDMNPKISDFGTAR-IFGGNQNQANTNIIAGTYG 385
++ IHRDL A N L+ D D KI DFG AR I+ + + +
Sbjct: 123 E---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVR- 178
Query: 386 YMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAV 445
+MAPE + G F+ +SDV+SFGVL+ EI++ Y + + Q +L + G +
Sbjct: 179 WMAPESLLDGKFTTQSDVWSFGVLMWEILT--LGQQPYPALNNQEVLQHV----TAGGRL 232
Query: 446 ELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPT 481
+ K PD++ + + C QDP++RPT
Sbjct: 233 Q------KPENCPDKIYQLM---TNCWAQDPSERPT 259
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 2e-27
Identities = 82/282 (29%), Positives = 132/282 (46%), Gaps = 38/282 (13%)
Query: 223 KLGQGGFGPVYKGTLA------DGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVR 276
+LG+G FG V+ D +AVK L S ++F+ E L+ LQH+++VR
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 277 LLGCCLEGQELLLIYEYMPNKSL---------DVHLFDATRSV---QLDWKRRLSIINGI 324
G C EG+ LL+++EYM + L D + V QL + L+I + I
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 325 ARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTAR-IFGGNQNQANTNIIAGT 383
A G++YL + L +HRDL N L+ + KI DFG +R I+ + + +
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 188
Query: 384 YGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGH 443
+M PE + F+ +SD++SFGV+L EI F + + L+ T + C
Sbjct: 189 R-WMPPESILYRKFTTESDIWSFGVVLWEI--------FTYGKQPWYQLSNTEAIECITQ 239
Query: 444 AVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSV 485
EL P ++C P E+ + C Q++P R + +
Sbjct: 240 GRELERP---RTC-PPEVYAIMQ---GCWQREPQQRMVIKDI 274
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 2e-27
Identities = 67/266 (25%), Positives = 122/266 (45%), Gaps = 26/266 (9%)
Query: 218 FSDENKLGQGGFGPVYKGT-LADGKAIAVKRLS-RTSGQGLKEFKNEVNLIAKLQHKNLV 275
F+ +G+G FG VYK + +A+K + + +++ + E+ +++ + +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 276 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDS 335
+ G L+G +L +I EY S D + +LD I+ + G+ YLHE+
Sbjct: 63 KYYGSFLKGSKLWIIMEYCGGGSC----LDLLKPGKLDETYIAFILREVLLGLEYLHEE- 117
Query: 336 RLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGG 395
IHRD+KA+N+LL ++ + K++DFG + ++ NT GT +MAPE
Sbjct: 118 --GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT--FVGTPFWMAPEVIKQS 173
Query: 396 IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQS 455
+ K+D++S G+ +E+ G H +L K P L+ +
Sbjct: 174 GYDEKADIWSLGITAIELAKGEPPLSDL---HPMRVLFLIPKNNP---------PSLEGN 221
Query: 456 CAPDELLKFIHIGLLCVQQDPADRPT 481
F+ LC+ +DP +RP+
Sbjct: 222 KFSKPFKDFVS---LCLNKDPKERPS 244
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 2e-27
Identities = 82/262 (31%), Positives = 131/262 (50%), Gaps = 24/262 (9%)
Query: 221 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGC 280
KLG G FG V+ GT +AVK L + + F E ++ KL+H LV+L
Sbjct: 11 IKKLGNGQFGEVWMGTWNGNTKVAVKTL-KPGTMSPESFLEEAQIMKKLRHDKLVQLYAV 69
Query: 281 CLEGQELLLIYEYMPNKSLDVHLFDAT-RSVQLDWKRRLSIINGIARGILYLHEDSRLKI 339
E + + ++ EYM SL L D R+++L + + +A G+ Y+ R+
Sbjct: 70 VSE-EPIYIVTEYMSKGSLLDFLKDGEGRALKL--PNLVDMAAQVAAGMAYIE---RMNY 123
Query: 340 IHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSI 399
IHRDL+++N+L+ D + KI+DFG AR+ N+ A + APE A+ G F+I
Sbjct: 124 IHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQG-AKFPIKWTAPEAALYGRFTI 182
Query: 400 KSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQSCAPD 459
KSDV+SFG+LL E+++ K Y + + +L E ++ + C D
Sbjct: 183 KSDVWSFGILLTELVT--KGRVPYPGMNNREVL-------------EQVERGYRMPCPQD 227
Query: 460 ELLKFIHIGLLCVQQDPADRPT 481
+ + L C ++DP +RPT
Sbjct: 228 CPISLHELMLQCWKKDPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 5e-27
Identities = 82/297 (27%), Positives = 138/297 (46%), Gaps = 48/297 (16%)
Query: 221 ENKLGQGGFGPVYKGTLA------DGKAIAVKRLSR-TSGQGLKEFKNEVNLIAKLQHKN 273
+GQG FG V++ +AVK L S +F+ E L+A+ H N
Sbjct: 10 VRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPN 69
Query: 274 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDAT-------------------RSVQLDW 314
+V+LLG C G+ + L++EYM L+ L + + L
Sbjct: 70 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSC 129
Query: 315 KRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTAR-IFGGNQN 373
+L I +A G+ YL E K +HRDL N L+ ++M KI+DFG +R I+ +
Sbjct: 130 TEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY 186
Query: 374 QANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLL 432
+A+ N A +M PE ++ +SDV+++GV+L EI S G + Y+ + ++
Sbjct: 187 KASEN-DAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQP---YYGMAHEEVI 242
Query: 433 TYTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 489
Y +G+ + SC + L+ ++ LC + P+DRP+ +S+ +L
Sbjct: 243 YYVR----DGNVL---------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRIL 286
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 6e-27
Identities = 77/271 (28%), Positives = 124/271 (45%), Gaps = 29/271 (10%)
Query: 222 NKLGQGGFGPVYKG-TLADGKAIAVK--RLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLL 278
NK+G G FG VY L G+ +AVK R+ + +KE +E+ ++ L+H NLV+
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 279 GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLK 338
G + +++ + EY +L+ L + R + R + + G+ YLH
Sbjct: 66 GVEVHREKVYIFMEYCSGGTLE-ELLEHGRILDEHVIRVYT--LQLLEGLAYLHSH---G 119
Query: 339 IIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANT--NIIAGTYGYMAPEYAMGGI 396
I+HRD+K +N+ LD + K+ DFG A N +AGT YMAPE GG
Sbjct: 120 IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGK 179
Query: 397 FSIK---SDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLK 453
+D++S G ++LE+ +G++ +E + + GH P +
Sbjct: 180 GKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF-----QIMFHV-GAGHK-----PPIP 228
Query: 454 QS-CAPDELLKFIHIGLLCVQQDPADRPTMS 483
S E F+ C++ DP RPT S
Sbjct: 229 DSLQLSPEGKDFLD---RCLESDPKKRPTAS 256
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 83/275 (30%), Positives = 123/275 (44%), Gaps = 37/275 (13%)
Query: 222 NKLGQGGFGPVYKGTLADGKAI-AVKRLSRTSGQGL-KEFKNEVNLIAKLQHKNLVRLLG 279
++LG+G G V K L + I A+K ++ L K+ E+ + + +V+ G
Sbjct: 7 SRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYG 66
Query: 280 CCLEGQE--LLLIYEYMPNKSLD-VHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSR 336
L+ + + EY SLD ++ R ++ K I + +G+ YLH
Sbjct: 67 AFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR-- 124
Query: 337 LKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGI 396
KIIHRD+K SN+LL K+ DFG + + A T GT YMAPE G
Sbjct: 125 -KIIHRDIKPSNILLTRKGQVKLCDFGVSGELV--NSLAGT--FTGTSFYMAPERIQGKP 179
Query: 397 FSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQT------LLTYTWKLWCEGHAVELIDP 450
+SI SDV+S G+ LLE+ R F F G+ LL+Y V + +P
Sbjct: 180 YSITSDVWSLGLTLLEVAQNR----FPFPPEGEPPLGPIELLSYI---------VNMPNP 226
Query: 451 VLKQSCAPDELLK----FIHIGLLCVQQDPADRPT 481
LK P +K F C+++DP RPT
Sbjct: 227 ELKDE--PGNGIKWSEEFKDFIKQCLEKDPTRRPT 259
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 1e-26
Identities = 70/207 (33%), Positives = 101/207 (48%), Gaps = 30/207 (14%)
Query: 224 LGQGGFGPVY----KGTLADGKAIAVKRLSRTSGQGLKEF---KNEVNLIAKLQHKNLVR 276
LG+G FG V K T GK A+K L + KE E N+++++ H +V+
Sbjct: 1 LGKGSFGKVLLVRKKDT---GKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVK 57
Query: 277 LLGCCLEGQE-LLLIYEYMPNKSLDVHL-----FDATRSVQLDWKRRLSIINGIARGILY 330
L + +E L L+ EY P L HL F R+ R I + Y
Sbjct: 58 LH-YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERA------RF--YAAEIVLALEY 108
Query: 331 LHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPE 390
LH L II+RDLK N+LLD D + K++DFG A+ ++ NT GT Y+APE
Sbjct: 109 LH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT--FCGTPEYLAPE 163
Query: 391 YAMGGIFSIKSDVFSFGVLLLEIISGR 417
+G + D +S GVLL E+++G+
Sbjct: 164 VLLGKGYGKAVDWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 1e-26
Identities = 79/267 (29%), Positives = 130/267 (48%), Gaps = 35/267 (13%)
Query: 224 LGQGGFGPVYKG-TLADGKAIAVKRLS-----RTSGQGLKEFKNEVNLIAKLQHKNLVRL 277
LG G FG VY+G L DG AVK +S +T + +K+ + E+ L++KLQH N+V+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 278 LGCCLEGQELLLIYEYMPNKSLDVHL--FDATRSVQLDWKRRLSIINGIARGILYLHEDS 335
LG E L + E +P SL L + + + R I+ G+ YLH+
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTR-QILLGLE----YLHDR- 121
Query: 336 RLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMG- 394
+HRD+K +N+L+D + K++DFG A+ + G+ +MAPE
Sbjct: 122 --NTVHRDIKGANILVDTNGVVKLADFGMAKQV---VEFSFAKSFKGSPYWMAPEVIAQQ 176
Query: 395 GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQ 454
G + + +D++S G +LE+ +G+ +S+ + +K+ + D +
Sbjct: 177 GGYGLAADIWSLGCTVLEMATGKPP----WSQ--LEGVAAVFKIGRSKELPPIPDHL--- 227
Query: 455 SCAPDELLKFIHIGLLCVQQDPADRPT 481
DE FI L C+Q+DP+ RPT
Sbjct: 228 ---SDEAKDFI---LKCLQRDPSLRPT 248
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 1e-26
Identities = 78/274 (28%), Positives = 131/274 (47%), Gaps = 34/274 (12%)
Query: 223 KLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCL 282
++G G FG V+ G + + +A+K + R ++F E ++ KL H LV+L G C
Sbjct: 11 EIGSGQFGLVWLGYWLEKRKVAIKTI-REGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCT 69
Query: 283 EGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHR 342
E + L++E+M + L +L + + + L + + G+ YL + +IHR
Sbjct: 70 ERSPICLVFEFMEHGCLSDYL--RAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHR 124
Query: 343 DLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGT---YGYMAPEYAMGGIFSI 399
DL A N L+ ++ K+SDFG R +Q ++T GT + +PE +S
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST----GTKFPVKWSSPEVFSFSKYSS 180
Query: 400 KSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDP---VLKQSC 456
KSDV+SFGVL+ E+ FSE G+T ++ VE I+ + K
Sbjct: 181 KSDVWSFGVLMWEV----------FSE-GKT----PYENRSNSEVVETINAGFRLYKPRL 225
Query: 457 APDELLKFIHIGLLCVQQDPADRPTMSSVVVMLA 490
A + + + C ++ P DRP+ S ++ LA
Sbjct: 226 ASQSVYELMQ---HCWKERPEDRPSFSLLLHQLA 256
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 2e-26
Identities = 68/198 (34%), Positives = 108/198 (54%), Gaps = 8/198 (4%)
Query: 221 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGC 280
E KLGQG FG V+ GT +A+K L + + F E ++ KL+H+ LV+L
Sbjct: 11 EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 69
Query: 281 CLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKII 340
E + + ++ EYM SL + L + + + IA G+ Y+ R+ +
Sbjct: 70 VSE-EPIYIVTEYMSKGSL-LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 124
Query: 341 HRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIK 400
HRDL+A+N+L+ +++ K++DFG AR+ N+ A + APE A+ G F+IK
Sbjct: 125 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG-AKFPIKWTAPEAALYGRFTIK 183
Query: 401 SDVFSFGVLLLEIIS-GR 417
SDV+SFG+LL E+ + GR
Sbjct: 184 SDVWSFGILLTELTTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 4e-26
Identities = 88/287 (30%), Positives = 132/287 (45%), Gaps = 45/287 (15%)
Query: 224 LGQGGFGPVYKGTLAD------GKAIAVKRL-SRTSGQGLKEFKNEVNLIAKL-QHKNLV 275
LG+G FG V K +AVK L + + L + +E+ ++ + +HKN++
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79
Query: 276 RLLGCCLEGQELLLIYEYMPNKSLDVHL-----------FDATRSV--QLDWKRRLSIIN 322
LLG C + L ++ EY + +L L D R L K +S
Sbjct: 80 NLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAY 139
Query: 323 GIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTAR-IFGGNQNQANTNIIA 381
+ARG+ +L S+ K IHRDL A NVL+ +D KI+DFG AR I + + TN
Sbjct: 140 QVARGMEFL--ASK-KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTN--- 193
Query: 382 G--TYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLW 439
G +MAPE +++ +SDV+SFGVLL EI + S + + +KL
Sbjct: 194 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT------LGGSPYPGIPVEELFKLL 247
Query: 440 CEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVV 486
EG+ +E K EL H+ C + P+ RPT +V
Sbjct: 248 KEGYRME------KPQNCTQELY---HLMRDCWHEVPSQRPTFKQLV 285
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 4e-26
Identities = 61/227 (26%), Positives = 98/227 (43%), Gaps = 33/227 (14%)
Query: 216 NHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLKEFK-----NEVNLIAKL 269
+ F +G+G F V K A+K L + Q +KE K E ++ +L
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKR--QLIKEKKVKYVKIEKEVLTRL 58
Query: 270 -QHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGI 328
H +++L + + L + EY PN L ++ + LD K I +
Sbjct: 59 NGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYI---RKYGSLDEKCTRFYAAEILLAL 115
Query: 329 LYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQ---------------- 372
YLH IIHRDLK N+LLD DM+ KI+DFGTA++ N
Sbjct: 116 EYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQI 172
Query: 373 --NQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGR 417
N+ GT Y++PE SD+++ G ++ ++++G+
Sbjct: 173 EKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 4e-26
Identities = 84/287 (29%), Positives = 121/287 (42%), Gaps = 49/287 (17%)
Query: 223 KLGQGGFGPVYKGTL--ADGKAI--AVKRLSRTSGQG-LKEFKNEVNLIAKLQHKNLVRL 277
KLG G FG V +G + GK I AVK L + +F E ++ L H+NL+RL
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 278 LGCCLEGQELLLIYEYMPNKSL-----DVHLFDATRSVQLDWKRRLSIINGIARGILYLH 332
G L L+++ E P SL L S D+ + IA G+ YL
Sbjct: 62 YGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQ------IANGMRYLE 114
Query: 333 EDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQN----QANTNIIAGTYGYMA 388
+ IHRDL A N+LL D KI DFG R N++ + + + + + A
Sbjct: 115 SK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV---PFAWCA 168
Query: 389 PEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLW--CEGHAV- 445
PE FS SDV+ FGV L E + TY + W G +
Sbjct: 169 PESLRTRTFSHASDVWMFGVTLWE------------------MFTYGEEPWAGLSGSQIL 210
Query: 446 ELIDPVLKQSCAPDEL-LKFIHIGLLCVQQDPADRPTMSSVVVMLAS 491
+ ID ++ P+ ++ L C +PADRPT +++ L
Sbjct: 211 KKIDKEGERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLPE 257
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 9e-26
Identities = 85/282 (30%), Positives = 133/282 (47%), Gaps = 42/282 (14%)
Query: 223 KLGQGGFGPVYK-GTLADGKAIAVKR--LSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLG 279
KLG+G +G VYK L+D + A+K L S + ++ NE+ ++A + H N++
Sbjct: 7 KLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKE 66
Query: 280 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRL-------SIINGIARGILYLH 332
L+G +L ++ EY P L + + KR+L I + RG+ LH
Sbjct: 67 AFLDGNKLCIVMEYAPFGDL------SKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 333 EDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYA 392
E KI+HRDLK++N+LL + KI D G +++ +N A T I GT YMAPE
Sbjct: 121 E---QKILHRDLKSANILLVANDLVKIGDLGISKVL--KKNMAKTQI--GTPHYMAPEVW 173
Query: 393 MGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVL 452
G +S KSD++S G LL E+ + +++ +K+ G I P+
Sbjct: 174 KGRPYSYKSDIWSLGCLLYEMATFA------PPFEARSMQDLRYKV-QRGKYPP-IPPIY 225
Query: 453 KQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSM 494
Q +L FI +Q P RP + LAS ++
Sbjct: 226 SQ-----DLQNFIR---SMLQVKPKLRPNCDKI---LASPAV 256
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 1e-25
Identities = 64/202 (31%), Positives = 105/202 (51%), Gaps = 19/202 (9%)
Query: 224 LGQGGFGPVYKGTLAD-GKAIAVKR-----LSRTSGQGLKEFKNEVNLIAKLQHKNLVRL 277
LGQG FG VY D G+ +AVK+ S + + + + E+ L+ LQH+ +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 278 LGCCLEGQELLLIYEYMPNKSLDVHL--FDA-TRSVQLDWKRRLSIINGIARGILYLHED 334
GC + + L + EYMP S+ L + A T +V + R+ I G+ YLH +
Sbjct: 70 YGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQ------ILEGVEYLHSN 123
Query: 335 SRLKIIHRDLKASNVLLDDDMNPKISDFGTA-RIFGGNQNQANTNIIAGTYGYMAPEYAM 393
I+HRD+K +N+L D N K+ DFG + R+ + + GT +M+PE
Sbjct: 124 ---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVIS 180
Query: 394 GGIFSIKSDVFSFGVLLLEIIS 415
G + K+DV+S G ++E+++
Sbjct: 181 GEGYGRKADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 65/211 (30%), Positives = 109/211 (51%), Gaps = 26/211 (12%)
Query: 218 FSDENKLGQGGFGPVYKGT-LADGKAIAVKR---------LSRTSGQGLKEFKNEVNLIA 267
+ KLG+G +G VYK G+ +A+K+ + T+ L+E ++L+
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTA---LRE----ISLLK 53
Query: 268 KLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARG 327
+L+H N+V+LL ++L L++EY +D+ + R L SI+ + RG
Sbjct: 54 ELKHPNIVKLLDVIHTERKLYLVFEYC---DMDLKKYLDKRPGPLSPNLIKSIMYQLLRG 110
Query: 328 ILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYM 387
+ Y H S +I+HRDLK N+L++ D K++DFG AR FG ++ T Y
Sbjct: 111 LAYCH--SH-RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV--TLWYR 165
Query: 388 APEYAMGG-IFSIKSDVFSFGVLLLEIISGR 417
APE +G +S D++S G + E+I+G+
Sbjct: 166 APEILLGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 3e-25
Identities = 66/198 (33%), Positives = 98/198 (49%), Gaps = 13/198 (6%)
Query: 224 LGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLE 283
LG G FG V+ G +A+K + R +F E ++ KL H NLV+L G C +
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMI-REGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 284 GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRD 343
+ + ++ EYM N L +L + + +W L + + + + YL + IHRD
Sbjct: 71 QRPIFIVTEYMANGCLLNYLRERKGKLGTEW--LLDMCSDVCEAMEYLESNG---FIHRD 125
Query: 344 LKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGT---YGYMAPEYAMGGIFSIK 400
L A N L+ +D K+SDFG AR +Q ++ GT + PE FS K
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ----GTKFPVKWAPPEVFDYSRFSSK 181
Query: 401 SDVFSFGVLLLEIISGRK 418
SDV+SFGVL+ E+ S K
Sbjct: 182 SDVWSFGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 3e-25
Identities = 81/290 (27%), Positives = 130/290 (44%), Gaps = 51/290 (17%)
Query: 224 LGQGGFGPVYKGTLA--DGKA--IAVK--RLSRTSGQGLKEFKNEVNLIAKLQHKNLVRL 277
LG+G FG V +G L+ DG +AVK +L + ++EF +E + H N+++L
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 278 LGCCLEGQEL------LLIYEYMPNKSLDVHLFD---ATRSVQLDWKRRLSIINGIARGI 328
+G C E L ++I +M + L L +L + L + IA G+
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 329 LYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTAR-IFGGNQNQANTNIIAGTYGYM 387
YL S IHRDL A N +L +DM ++DFG ++ I+ G+ + I ++
Sbjct: 127 EYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYR-QGRIAKMPVKWI 182
Query: 388 APEYAMGGIFSIKSDVFSFGVLLLEIIS-------GRKNNGFY-FSEHGQTLLTYTWKLW 439
A E +++ KSDV++FGV + EI + G +N+ Y + HG
Sbjct: 183 AIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNR--------- 233
Query: 440 CEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 489
LKQ D L + + C + DP DRPT + + +L
Sbjct: 234 ------------LKQ--PEDCLDELYDLMYSCWRADPKDRPTFTKLREVL 269
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 4e-25
Identities = 81/266 (30%), Positives = 131/266 (49%), Gaps = 24/266 (9%)
Query: 221 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGC 280
+ KLGQG FG V+ GT +A+K L + + F E ++ KL+H LV L
Sbjct: 11 DVKLGQGCFGEVWMGTWNGTTKVAIKTL-KPGTMMPEAFLQEAQIMKKLRHDKLVPLYAV 69
Query: 281 CLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKII 340
E + + ++ E+M SL + L + + + IA G+ Y+ R+ I
Sbjct: 70 VSE-EPIYIVTEFMGKGSL-LDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYI 124
Query: 341 HRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIK 400
HRDL+A+N+L+ D++ KI+DFG AR+ N+ A + APE A+ G F+IK
Sbjct: 125 HRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQG-AKFPIKWTAPEAALYGRFTIK 183
Query: 401 SDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQSCAPD 459
SDV+SFG+LL E+++ GR + + +++ C Q C P+
Sbjct: 184 SDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPC------------PQGC-PE 230
Query: 460 ELLKFIHIGLLCVQQDPADRPTMSSV 485
L + + LC ++DP +RPT +
Sbjct: 231 SLHELMK---LCWKKDPDERPTFEYI 253
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 4e-25
Identities = 82/290 (28%), Positives = 128/290 (44%), Gaps = 57/290 (19%)
Query: 224 LGQGGFGPVYK---GTLAD--GKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLL 278
LG+G FG V L D G+ +AVK+L ++ + L++F+ E+ ++ LQH N+V+
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 279 GCCLEG--QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSR 336
G C + L L+ EY+P SL +L +LD ++ L + I +G+ YL
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYL--QKHRERLDHRKLLLYASQICKGMEYL---GS 126
Query: 337 LKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGN------QNQANTNIIAGTYGYMAPE 390
+ +HRDL N+L++ + KI DFG ++ + + + I + APE
Sbjct: 127 KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIF-----WYAPE 181
Query: 391 YAMGGIFSIKSDVFSFGVLLLEIIS----------------GRKNNGFYFSEHGQTLLTY 434
FS+ SDV+SFGV+L E+ + G G H LL
Sbjct: 182 SLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKN 241
Query: 435 TWKLWCEGHAVELIDPVLKQSCAPDELLKFIH-IGLLCVQQDPADRPTMS 483
+L P C P E I+ I C DP+ RP+ S
Sbjct: 242 NGRL-----------PA-PPGC-PAE----IYAIMKECWNNDPSQRPSFS 274
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 4e-25
Identities = 58/206 (28%), Positives = 104/206 (50%), Gaps = 21/206 (10%)
Query: 222 NKLGQGGFGPVYKG-TLADGKAIAVKRLSRTSGQGLKE-----FKNEVNLIAKLQHKNLV 275
++G+G +G VYK G+ +A+K++ + KE E+ L+ KL+H N+V
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIR---MENEKEGFPITAIREIKLLQKLRHPNIV 61
Query: 276 RLLGCCLE--GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHE 333
RL + +++EYM + D+ + V+ + + + G+ YLH
Sbjct: 62 RLKEIVTSKGKGSIYMVFEYMDH---DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHS 118
Query: 334 DSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTN-IIAGTYGYMAPEYA 392
+ I+HRD+K SN+L+++D K++DFG AR + + TN +I T Y PE
Sbjct: 119 N---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI--TLWYRPPELL 173
Query: 393 MGGI-FSIKSDVFSFGVLLLEIISGR 417
+G + + D++S G +L E+ G+
Sbjct: 174 LGATRYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 9e-25
Identities = 81/264 (30%), Positives = 127/264 (48%), Gaps = 28/264 (10%)
Query: 221 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGC 280
E KLG G FG V+ T +AVK + + ++ F E N++ LQH LV+L
Sbjct: 11 EKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKL-HA 68
Query: 281 CLEGQELLLIYEYMPNKSL-DVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKI 339
+ + + +I E+M SL D D L + + IA G+ ++ + +
Sbjct: 69 VVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQRN---Y 123
Query: 340 IHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSI 399
IHRDL+A+N+L+ + KI+DFG AR+ N+ A + APE G F+I
Sbjct: 124 IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGA-KFPIKWTAPEAINFGSFTI 182
Query: 400 KSDVFSFGVLLLEIIS-GR-KNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQSCA 457
KSDV+SFG+LL+EI++ GR G E + L G+ + + +C
Sbjct: 183 KSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE--------RGYRMPRPE-----NC- 228
Query: 458 PDELLKFIHIGLLCVQQDPADRPT 481
P+EL + + C + P +RPT
Sbjct: 229 PEELYNIM---MRCWKNRPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 1e-24
Identities = 85/290 (29%), Positives = 131/290 (45%), Gaps = 46/290 (15%)
Query: 224 LGQGGFGPVYKGT------LADGKAIAVKRLSRTSGQG-LKEFKNEVNLIAKLQHKNLVR 276
LG+G FG V K T A +AVK L + L++ +E NL+ ++ H ++++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 277 LLGCCLEGQELLLIYEYMPNKSLDVHL---------------------FDATRSVQLDWK 315
L G C + LLLI EY SL L D L
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 316 RRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQA 375
+S I+RG+ YL E +K++HRDL A NVL+ + KISDFG +R +
Sbjct: 128 DLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184
Query: 376 NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYT 435
+ +MA E I++ +SDV+SFGVLL EI++ N Y + L
Sbjct: 185 KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP--YPGIAPERL---- 238
Query: 436 WKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSV 485
+ L G+ +E + +C+ +E+ + L C +Q+P RPT + +
Sbjct: 239 FNLLKTGYRMERPE-----NCS-EEMYNLM---LTCWKQEPDKRPTFADI 279
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 85/299 (28%), Positives = 128/299 (42%), Gaps = 50/299 (16%)
Query: 217 HFSDEN-----KLGQGGFGPVY----KGTLADGK--AIAVKRLSRTSGQG-LKEFKNEVN 264
F N LG+G FG V+ KG +G + VK L +T + EF+ E++
Sbjct: 1 AFPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELD 60
Query: 265 LIAKLQHKNLVRLLGCCLEGQELLLIYEY----------MPNKSLDVHLFDATRSVQLDW 314
+ KL HKN+VRLLG C E + +I EY KS D + + L
Sbjct: 61 MFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKD----EKLKPPPLST 116
Query: 315 KRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQ 374
K+++++ IA G+ +L S + +HRDL A N L+ K+S ++ ++
Sbjct: 117 KQKVALCTQIALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYY 173
Query: 375 ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTY 434
N + ++APE FS KSDV+SFGVL+ E+ + Q L +
Sbjct: 174 KLRNALI-PLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT-------------QGELPF 219
Query: 435 TWKLWCEGHAVELIDPVLKQSCA---PDELLKFIHIGLLCVQQDPADRPTMSSVVVMLA 490
L E L L+ P L K + C +P DRP+ S +V L
Sbjct: 220 Y-GLSDEEVLNRLQAGKLELPVPEGCPSRLYK---LMTRCWAVNPKDRPSFSELVSALG 274
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 2e-24
Identities = 82/278 (29%), Positives = 127/278 (45%), Gaps = 40/278 (14%)
Query: 224 LGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLK-EFKNEVNLIAKLQHKNLVRLLGCCL 282
LG+G FG V+KGTL D +AVK Q LK +F +E ++ + H N+V+L+G C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 283 EGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHR 342
+ Q + ++ E +P D F + +L K+ + A G+ YL + IHR
Sbjct: 63 QRQPIYIVMELVPGG--DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHR 117
Query: 343 DLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGT------YGYMAPEYAMGGI 396
DL A N L+ ++ KISDFG +R Q + I + + + APE G
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSR-------QEDDGIYSSSGLKQIPIKWTAPEALNYGR 170
Query: 397 FSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQSC 456
+S +SDV+S+G+LL E S L + A E ++ + SC
Sbjct: 171 YSSESDVWSYGILLWETFS---------------LGVCPYPGMTNQQAREQVEKGYRMSC 215
Query: 457 ---APDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 491
PD++ K + C P +RP S + LA+
Sbjct: 216 PQKCPDDVYK---VMQRCWDYKPENRPKFSELQKELAA 250
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 2e-24
Identities = 69/215 (32%), Positives = 116/215 (53%), Gaps = 29/215 (13%)
Query: 216 NHFSDENKLGQGGFGPVYKGTL-ADGK---AIAVKRLS--RTSGQGLKEFKNEVNLIAKL 269
+H + + +G G FG V++G L G+ A+A+K L T Q ++F +E +++ +
Sbjct: 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQ-RQDFLSEASIMGQF 63
Query: 270 QHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDAT---RSVQLDWKRRLSIINGIAR 326
H N++RL G + + ++I EYM N +LD +L D S QL + ++ GIA
Sbjct: 64 SHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQL-----VGMLRGIAA 118
Query: 327 GILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYG- 385
G+ YL S + +HRDL A N+L++ ++ K+SDFG +R+ + T T G
Sbjct: 119 GMKYL---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYT-----TSGG 170
Query: 386 -----YMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 415
+ APE F+ SDV+SFG+++ E++S
Sbjct: 171 KIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 78/223 (34%), Positives = 120/223 (53%), Gaps = 27/223 (12%)
Query: 214 ATNHFSDENKLGQGGFGPVYKGTL---ADG---KAIAVKRLSRTSGQGLKE-FKNEVNLI 266
+T F +E LG+ FG VYKG L A G +A+A+K L + L+E FK+E +
Sbjct: 5 STVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMR 62
Query: 267 AKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSL-----------DVHLFDATRSVQ--LD 313
++LQH N+V LLG + Q L +I+ Y + L DV D ++V+ L+
Sbjct: 63 SRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLE 122
Query: 314 WKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTAR-IFGGNQ 372
+ I+ IA G+ +L S ++H+DL NVL+ D +N KISD G R ++ +
Sbjct: 123 PADFVHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADY 179
Query: 373 NQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 415
+ N + +M+PE M G FSI SD++S+GV+L E+ S
Sbjct: 180 YKLMGNSLLPIR-WMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 74/209 (35%), Positives = 100/209 (47%), Gaps = 19/209 (9%)
Query: 222 NKLGQGGFGPVYKGTLA--DGKA----IAVKRL-SRTSGQGLKEFKNEVNLIAKLQHKNL 274
LG G FG VY+G DG A +AVK L S Q +F E +++K H+N+
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 275 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFD----ATRSVQLDWKRRLSIINGIARGILY 330
VRL+G E ++ E M L L + R L K L +A+G Y
Sbjct: 72 VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131
Query: 331 LHEDSRLKIIHRDLKASNVLLDD---DMNPKISDFGTAR-IFGGNQNQANTNIIAGTYGY 386
L E+ IHRD+ A N LL KI+DFG AR I+ + + + +
Sbjct: 132 LEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAML-PIKW 187
Query: 387 MAPEYAMGGIFSIKSDVFSFGVLLLEIIS 415
M PE + GIF+ K+DV+SFGVLL EI S
Sbjct: 188 MPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 3e-24
Identities = 87/281 (30%), Positives = 131/281 (46%), Gaps = 25/281 (8%)
Query: 224 LGQGGFGPV----YKGTLAD-GKAIAVKRLSRTSGQGLKE-FKNEVNLIAKLQHKNLVRL 277
LG+G FG V Y G+ +AVK L R GQ +K E+N++ L H+N+V+
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 278 LGCCLE--GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDS 335
GCC E G+ L LI EY+P SL +L + L + L I G+ YLH
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYL--PKHKLNL--AQLLLFAQQICEGMAYLHSQ- 126
Query: 336 RLKIIHRDLKASNVLLDDDMNPKISDFGTARIF--GGNQNQANTNIIAGTYGYMAPEYAM 393
IHRDL A NVLLD+D KI DFG A+ G + + + + Y A E
Sbjct: 127 --HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-AVECLK 183
Query: 394 GGIFSIKSDVFSFGVLLLEIIS---GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDP 450
FS SDV+SFGV L E+++ +++ F E ++ +EL++
Sbjct: 184 ENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEE----MIGPKQGQMTVVRLIELLER 239
Query: 451 VLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 491
++ C + + + C + + RPT S++ +L
Sbjct: 240 GMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKE 280
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 102 bits (254), Expect = 4e-24
Identities = 84/301 (27%), Positives = 139/301 (46%), Gaps = 50/301 (16%)
Query: 221 ENKLGQGGFGPVYKGTL------ADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNL 274
+ +LG+G FG V+ D +AVK L S K+F E L+ LQH+++
Sbjct: 10 KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHI 69
Query: 275 VRLLGCCLEGQELLLIYEYMP----NKSLDVHLFDA------TRSVQLDWKRRLSIINGI 324
V+ G C+EG L++++EYM NK L H DA R +L + L I I
Sbjct: 70 VKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQI 129
Query: 325 ARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTAR-IFGGNQNQANTNIIAGT 383
A G++YL + +HRDL N L+ +++ KI DFG +R ++ + + + +
Sbjct: 130 AAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 186
Query: 384 YGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGH 443
+M PE M F+ +SDV+S GV+L EI TY + W +
Sbjct: 187 R-WMPPESIMYRKFTTESDVWSLGVVLWEI------------------FTYGKQPWYQLS 227
Query: 444 AVELIDPVLK-------QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSMTI 496
E+I+ + + ++C P E+ + L C Q++P R + + +L + +
Sbjct: 228 NNEVIECITQGRVLQRPRTC-PKEVYDLM---LGCWQREPHMRLNIKEIHSLLQNLAKAS 283
Query: 497 P 497
P
Sbjct: 284 P 284
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 4e-24
Identities = 64/198 (32%), Positives = 93/198 (46%), Gaps = 11/198 (5%)
Query: 224 LGQGGFGPVYKGTLAD-GKAIAVKRLSRT---SGQGLKEFKNEVNLIAKLQHKNLVRLLG 279
LG+GGFG V + GK A K+L + +G + NE ++ K+ + +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 280 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKI 339
+L L+ M L H+++ R + I G+ +LH + +I
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPG-FPEARAIFYAAQIICGLEHLH---QRRI 116
Query: 340 IHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSI 399
++RDLK NVLLDD N +ISD G A G AGT GYMAPE G ++
Sbjct: 117 VYRDLKPENVLLDDHGNVRISDLGLAVELKG---GKKIKGRAGTPGYMAPEVLQGEVYDF 173
Query: 400 KSDVFSFGVLLLEIISGR 417
D F+ G L E+I+GR
Sbjct: 174 SVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 6e-24
Identities = 70/270 (25%), Positives = 122/270 (45%), Gaps = 27/270 (10%)
Query: 224 LGQGGFGP--VYKGTLADGKAIAVKR--LSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLG 279
LG+G FG +Y+ T D + K L+R S + ++ NE+ +++ LQH N++
Sbjct: 8 LGKGAFGEATLYRRT-EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYN 66
Query: 280 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKI 339
++ LL+ EY +L + + + L + I + Y+H+ I
Sbjct: 67 HFMDDNTLLIEMEYANGGTL-YDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG---I 122
Query: 340 IHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSI 399
+HRD+K N+ L K+ DFG ++I G + A T + GT YM+PE G ++
Sbjct: 123 LHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET--VVGTPYYMSPELCQGVKYNF 180
Query: 400 KSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQSCAPD 459
KSD+++ G +L E+++ ++ F L K+ + + S
Sbjct: 181 KSDIWALGCVLYELLTLKRT----FD--ATNPLNLVVKIVQGNYTPVV-------SVYSS 227
Query: 460 ELLKFIHIGLLCVQQDPADRPTMSSVVVML 489
EL+ +H +QQDP RPT V+
Sbjct: 228 ELISLVH---SLLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 8e-24
Identities = 68/208 (32%), Positives = 111/208 (53%), Gaps = 20/208 (9%)
Query: 224 LGQGGFGPVYKGTLA-DGKAIAVKR--LSRTSGQG-------LKEFKNEVNLIAKLQHKN 273
+G G FG VY G A G+ +AVK+ L S L E+ L+ +LQH+N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 274 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHE 333
+V+ LG L+ L + EY+P S+ L + + + R + + I +G+ YLH
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAA-LLNNYGAFEETLVR--NFVRQILKGLNYLH- 123
Query: 334 DSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNI----IAGTYGYMAP 389
+R IIHRD+K +N+L+D+ KISDFG ++ N TN + G+ +MAP
Sbjct: 124 -NR-GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAP 181
Query: 390 EYAMGGIFSIKSDVFSFGVLLLEIISGR 417
E ++ K+D++S G L++E+++G+
Sbjct: 182 EVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 9e-24
Identities = 66/210 (31%), Positives = 100/210 (47%), Gaps = 21/210 (10%)
Query: 220 DENK----LGQGGFGPVYKG-TLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNL 274
DEN LG+G +G VY L+ IA+K + + ++ E+ L + L+H+N+
Sbjct: 8 DENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNI 67
Query: 275 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGIL----Y 330
V+ LG E + E +P SL L RS K I + IL Y
Sbjct: 68 VQYLGSDSENGFFKIFMEQVPGGSLSALL----RSKWGPLKDNEQTIIFYTKQILEGLKY 123
Query: 331 LHEDSRLKIIHRDLKASNVLLDDDMNP-KISDFGTARIFGGNQNQANTNIIAGTYGYMAP 389
LH+ +I+HRD+K NVL++ KISDFGT++ G T GT YMAP
Sbjct: 124 LHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTET--FTGTLQYMAP 178
Query: 390 EYAMGGI--FSIKSDVFSFGVLLLEIISGR 417
E G + +D++S G ++E+ +G+
Sbjct: 179 EVIDKGPRGYGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 84/297 (28%), Positives = 136/297 (45%), Gaps = 39/297 (13%)
Query: 221 ENKLGQGGFGPVYKGT------LADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNL 274
+ +LG+G FG V+ D +AVK L + K+F+ E L+ LQH+++
Sbjct: 10 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 69
Query: 275 VRLLGCCLEGQELLLIYEYMP----NKSLDVHLFDATRSV---------QLDWKRRLSII 321
V+ G C +G L++++EYM NK L H DA V +L + L I
Sbjct: 70 VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 129
Query: 322 NGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTAR-IFGGNQNQANTNII 380
+ IA G++YL + +HRDL N L+ ++ KI DFG +R ++ + + + +
Sbjct: 130 SQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 186
Query: 381 AGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWC 440
+M PE M F+ +SDV+SFGV+L EI + K F S T +
Sbjct: 187 LPIR-WMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN------TEVIECIT 239
Query: 441 EGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSMTIP 497
+G +E + P E+ I L C Q++P R + + +L + P
Sbjct: 240 QGRVLE------RPRVCPKEVYD---IMLGCWQREPQQRLNIKEIYKILHALGKATP 287
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 1e-23
Identities = 71/198 (35%), Positives = 103/198 (52%), Gaps = 18/198 (9%)
Query: 223 KLGQGGFGPVYKGTLADGKAIAVKRLS-RTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCC 281
+G+G FG V +G G+ +AVK + + Q F E ++ KL HKNLVRLLG
Sbjct: 13 IIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQA---FLEETAVMTKLHHKNLVRLLGVI 68
Query: 282 LEGQELLLIYEYMPNKSLDVHLFDATRS-VQLDWKRRLSIINGIARGILYLHEDSRLKII 340
L L ++ E M +L L R+ V + + S+ +A G+ YL K++
Sbjct: 69 LH-NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSL--DVAEGMEYLESK---KLV 122
Query: 341 HRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIK 400
HRDL A N+L+ +D K+SDFG AR+ + + + + APE FS K
Sbjct: 123 HRDLAARNILVSEDGVAKVSDFGLARV---GSMGVDNSKLP--VKWTAPEALKHKKFSSK 177
Query: 401 SDVFSFGVLLLEIIS-GR 417
SDV+S+GVLL E+ S GR
Sbjct: 178 SDVWSYGVLLWEVFSYGR 195
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 87/295 (29%), Positives = 133/295 (45%), Gaps = 50/295 (16%)
Query: 223 KLGQGGFGPVYKGTL-----ADGKAIAVKRLSR-TSGQGLKEFKNEVNLIAKLQHKNLVR 276
+LG+ FG +YKG L + +A+K L + Q EF+ E +L+A+L H N+V
Sbjct: 12 ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71
Query: 277 LLGCCLEGQELLLIYEYMPNKSLDVHLF----------------DATRSVQLDWKRRLSI 320
LLG + Q + +++EY+ D+H F D T LD L I
Sbjct: 72 LLGVVTQEQPVCMLFEYLNQG--DLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHI 129
Query: 321 INGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTAR-IFGGNQNQANTNI 379
IA G+ YL S +H+DL A N+L+ + ++ KISD G +R I+ + +
Sbjct: 130 AIQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKS 186
Query: 380 IAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLW 439
+ +M PE M G FS SD++SFGV+L EI S + FS
Sbjct: 187 LLPIR-WMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ------------ 233
Query: 440 CEGHAVELIDPVLKQS---CAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 491
E+I+ V K+ C+ D + + C Q+ P+ RP + L S
Sbjct: 234 ------EVIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 75/284 (26%), Positives = 125/284 (44%), Gaps = 56/284 (19%)
Query: 224 LGQGGFGPVYKGTLAD-GKAIAVKR--LSRTSGQGLKE--------FKNEVNLIAKLQHK 272
+G+G +G VY G+ +AVK+ L T ++E+ + L H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 273 NLVRLLGCCLEGQELLLIY-EYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYL 331
N+V+ LG +E L I+ EY+P S+ L + + + + G+ YL
Sbjct: 69 NIVQYLGF-ETTEEYLSIFLEYVPGGSIGSCL---RTYGRFEEQLVRFFTEQVLEGLAYL 124
Query: 332 HEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTAR----IFGGNQNQANTNIIAGTYGYM 387
H I+HRDLKA N+L+D D KISDFG ++ I+ N N + + G+ +M
Sbjct: 125 HSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYD---NDQNMS-MQGSVFWM 177
Query: 388 APE--YAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAV 445
APE ++ +S K D++S G ++LE+ +GR+ W + A+
Sbjct: 178 APEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP-------------------WSDEEAI 218
Query: 446 ELIDPVLKQSCAP----DELLKFIHIGL----LCVQQDPADRPT 481
+ + + AP D + + L C +P +RPT
Sbjct: 219 AAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPT 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.8 bits (249), Expect = 2e-23
Identities = 58/199 (29%), Positives = 107/199 (53%), Gaps = 15/199 (7%)
Query: 224 LGQGGFGPVYKGT-LADGKAIAVKRLS-RTSGQGLKEFKNEVNLIAKLQH---KNLVRLL 278
+G+G +G VY+G + G+ +A+K ++ T + + + EV L+++L+ N+ +
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 279 GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLK 338
G L+G L +I EY S+ + ++ + K II + + Y+H+
Sbjct: 69 GSYLKGPRLWIIMEYAEGGSVRTLM----KAGPIAEKYISVIIREVLVALKYIHKVG--- 121
Query: 339 IIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGI-F 397
+IHRD+KA+N+L+ + N K+ DFG A + NQN + + GT +MAPE G +
Sbjct: 122 VIHRDIKAANILVTNTGNVKLCDFGVAALL--NQNSSKRSTFVGTPYWMAPEVITEGKYY 179
Query: 398 SIKSDVFSFGVLLLEIISG 416
K+D++S G+ + E+ +G
Sbjct: 180 DTKADIWSLGITIYEMATG 198
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 3e-23
Identities = 69/196 (35%), Positives = 100/196 (51%), Gaps = 14/196 (7%)
Query: 224 LGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLE 283
+G+G FG V G G +AVK + + + F E +++ +L+H NLV+LLG +E
Sbjct: 14 IGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 284 GQ-ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHR 342
+ L ++ EYM SL +L RSV L L + + YL ++ +HR
Sbjct: 71 EKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEANN---FVHR 126
Query: 343 DLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSD 402
DL A NVL+ +D K+SDFG + Q+ + + APE FS KSD
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV-----KWTAPEALREKKFSTKSD 181
Query: 403 VFSFGVLLLEIIS-GR 417
V+SFG+LL EI S GR
Sbjct: 182 VWSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 99.8 bits (248), Expect = 3e-23
Identities = 69/202 (34%), Positives = 113/202 (55%), Gaps = 20/202 (9%)
Query: 224 LGQGGFGPVYKGT-LADGKAI----AVKRLSRTSG-QGLKEFKNEVNLIAKLQHKNLVRL 277
LG G FG VYKG + +G+ + A+K L+ T+G + EF +E ++A + H +LVRL
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 278 LGCCLEGQELLLIYEYMPNKSL----DVHLFDATRSVQLDWKRRLSIINGIARGILYLHE 333
LG CL + L+ + MP+ L H + + L+W + IA+G++YL E
Sbjct: 75 LGVCLS-PTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQ------IAKGMMYLEE 127
Query: 334 DSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAM 393
+++HRDL A NVL+ + KI+DFG AR+ G++ + N + +MA E
Sbjct: 128 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 184
Query: 394 GGIFSIKSDVFSFGVLLLEIIS 415
F+ +SDV+S+GV + E+++
Sbjct: 185 YRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 99.9 bits (249), Expect = 3e-23
Identities = 79/274 (28%), Positives = 135/274 (49%), Gaps = 40/274 (14%)
Query: 218 FSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLKEFKN---EVNLIAKLQHKN 273
F+D ++G G FG VY + + +A+K++S + Q +++++ EV + +L+H N
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 274 LVRLLGCCLEGQELLLIYEYMPNKS---LDVHLFDATRSVQLDWKRRLSIINGIARGILY 330
+ GC L L+ EY + L+VH + V++ +I +G +G+ Y
Sbjct: 77 TIEYKGCYLREHTAWLVMEYCLGSASDILEVHK-KPLQEVEI-----AAICHGALQGLAY 130
Query: 331 LHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPE 390
LH + IHRD+KA N+LL + K++DFG+A + + AN+ + GT +MAPE
Sbjct: 131 LHS---HERIHRDIKAGNILLTEPGTVKLADFGSASL----VSPANSFV--GTPYWMAPE 181
Query: 391 --YAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVEL 447
AM G + K DV+S G+ +E ++ RK F+ + + L H +
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIE-LAERKPP--LFNMNAMSALY---------HIAQN 229
Query: 448 IDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPT 481
P L + D F+ C+Q+ P DRP+
Sbjct: 230 DSPTLSSNDWSDYFRNFVD---SCLQKIPQDRPS 260
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.4 bits (243), Expect = 1e-22
Identities = 57/199 (28%), Positives = 99/199 (49%), Gaps = 12/199 (6%)
Query: 223 KLGQGGFGPVYKG-TLADGKAIAVKRLSRTSGQGLKEFKN--EVNLIAKLQHKNLVRLLG 279
K+G+G +G VYK G+ +A+K++ E+ L+ +L H N+++LL
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65
Query: 280 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKI 339
+L L++E+M D++ R L S + + +G+ + H I
Sbjct: 66 VFRHKGDLYLVFEFM---DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHGI 119
Query: 340 IHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMG-GIFS 398
+HRDLK N+L++ + K++DFG AR FG + T+ + T Y APE +G +S
Sbjct: 120 LHRDLKPENLLINTEGVLKLADFGLARSFGS-PVRPYTHYVV-TRWYRAPELLLGDKGYS 177
Query: 399 IKSDVFSFGVLLLEIISGR 417
D++S G + E++S R
Sbjct: 178 TPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 4e-22
Identities = 81/284 (28%), Positives = 136/284 (47%), Gaps = 44/284 (15%)
Query: 223 KLGQGGFGPVYKGTLADG-------KAIAVKRLSRTSGQGLK-EFKNEVNLIAKLQHKNL 274
+LGQG FG VY+G +A G +A+K ++ + + EF NE +++ + ++
Sbjct: 13 ELGQGSFGMVYEG-IAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 71
Query: 275 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLD-----------WKRRLSIING 323
VRLLG +GQ L+I E M L +L RS++ + K+ + +
Sbjct: 72 VRLLGVVSQGQPTLVIMELMTRGDLKSYL----RSLRPEMENNPVQAPPSLKKMIQMAGE 127
Query: 324 IARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTAR-IFGGNQNQANTNIIAG 382
IA G+ YL+ + K +HRDL A N ++ +D KI DFG R I+ + + +
Sbjct: 128 IADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 184
Query: 383 TYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEG 442
+M+PE G+F+ SDV+SFGV+L EI + + Y + +L + EG
Sbjct: 185 VR-WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP--YQGMSNEQVLRFV----MEG 237
Query: 443 HAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVV 486
++ K PD L + + +C Q +P RP+ ++
Sbjct: 238 GLLD------KPDNCPDMLFELMR---MCWQYNPKMRPSFLEII 272
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 5e-22
Identities = 91/294 (30%), Positives = 132/294 (44%), Gaps = 51/294 (17%)
Query: 224 LGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNE------VNLIAKLQ------- 270
LG+G FG V + A+ I R +T +K K+ +LI++++
Sbjct: 20 LGEGCFGQVVR---AEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGK 76
Query: 271 HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHL-----------FDATRSV--QLDWKRR 317
HKN++ LLG C + L +I EY +L L FD T+ QL +K
Sbjct: 77 HKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDL 136
Query: 318 LSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANT 377
+S +ARG+ YL +SR + IHRDL A NVL+ +D KI+DFG AR T
Sbjct: 137 VSCAYQVARGMEYL--ESR-RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKT 193
Query: 378 NIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEI--ISGRKNNGFYFSEHGQTLLTYT 435
+ +MAPE +++ +SDV+SFG+L+ EI + G G E
Sbjct: 194 SNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE--------L 245
Query: 436 WKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 489
+KL EGH ++ K S EL + C P RPT +V L
Sbjct: 246 FKLLREGHRMD------KPSNCTHELYMLMR---ECWHAVPTQRPTFKQLVEAL 290
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 6e-22
Identities = 64/201 (31%), Positives = 108/201 (53%), Gaps = 15/201 (7%)
Query: 223 KLGQGGFGPVYKG-TLADGKAIAVKRLSRTSGQGLKEFK-NEVNLIAKLQHKNLVRLLGC 280
KLG+G + VYKG G+ +A+K + + +G E++L+ +L+H+N+VRL
Sbjct: 7 KLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDV 66
Query: 281 CLEGQELLLIYEYMPN---KSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRL 337
+L+L++EYM K +D H LD S + +GI + HE+
Sbjct: 67 IHTENKLMLVFEYMDKDLKKYMDTH----GVRGALDPNTVKSFTYQLLKGIAFCHEN--- 119
Query: 338 KIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGG-I 396
+++HRDLK N+L++ K++DFG AR FG N + ++ T Y AP+ +G
Sbjct: 120 RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV--TLWYRAPDVLLGSRT 177
Query: 397 FSIKSDVFSFGVLLLEIISGR 417
+S D++S G ++ E+I+GR
Sbjct: 178 YSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 7e-22
Identities = 88/287 (30%), Positives = 130/287 (45%), Gaps = 48/287 (16%)
Query: 224 LGQGGFGPVYKGT---LADGKA---IAVKRLSRTSGQGLKE-FKNEVNLIAKL-QHKNLV 275
LG G FG V + T L+ A +AVK L T+ +E +E+ +++ L H+N+V
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102
Query: 276 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDS 335
LLG C G +L+I EY L ++ R L + LS +A+G+ +L +
Sbjct: 103 NLLGACTIGGPILVITEYCCYGDL-LNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN 161
Query: 336 RLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQN---QANTNIIAGTYGYMAPEYA 392
IHRDL A NVLL KI DFG AR + N + N + +MAPE
Sbjct: 162 ---CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARL---PVKWMAPESI 215
Query: 393 MGGIFSIKSDVFSFGVLLLEIIS-GRK-------NNGFYFSEHGQTLLTYTWKLWCEGHA 444
+++ +SDV+S+G+LL EI S G ++ FY KL EG+
Sbjct: 216 FNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFY-------------KLIKEGYR 262
Query: 445 VELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 491
+ + AP E+ I C DP RPT +V ++
Sbjct: 263 ------MAQPEHAPAEIYD---IMKTCWDADPLKRPTFKQIVQLIGK 300
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.5 bits (238), Expect = 7e-22
Identities = 63/200 (31%), Positives = 107/200 (53%), Gaps = 13/200 (6%)
Query: 223 KLGQGGFGPVYKG-TLADGKAIAVKRLS-RTSGQGLKEFK-NEVNLIAKLQHKNLVRLLG 279
K+G+G +G VYK G+ +A+K++ T +G+ E++L+ +L H N+VRLL
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLD 65
Query: 280 CCLEGQELLLIYEYMPNKSLDV-HLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLK 338
+L L++E++ LD+ D++ LD S + + +GI Y H S +
Sbjct: 66 VVHSENKLYLVFEFL---DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH--SH-R 119
Query: 339 IIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGG-IF 397
++HRDLK N+L+D + K++DFG AR FG ++ T Y APE +G +
Sbjct: 120 VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILLGSRQY 177
Query: 398 SIKSDVFSFGVLLLEIISGR 417
S D++S G + E+++ R
Sbjct: 178 STPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 7e-22
Identities = 63/206 (30%), Positives = 112/206 (54%), Gaps = 14/206 (6%)
Query: 218 FSDENKLGQGGFGPVYKG-TLADGKAIAVKRLSRTS-GQGLKEFK-NEVNLIAKLQHKNL 274
++ K+G+G +G VYKG G+ +A+K++ S +G+ E++L+ +LQH N+
Sbjct: 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNI 61
Query: 275 VRLLGCCLEGQELLLIYEYMPNKSLDVHLF-DATRSVQ-LDWKRRLSIINGIARGILYLH 332
V L ++ L LI+E++ S+D+ + D+ Q +D + S + I +GIL+ H
Sbjct: 62 VCLQDVLMQESRLYLIFEFL---SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH 118
Query: 333 EDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYA 392
+++HRDLK N+L+D+ K++DFG AR FG ++ T Y APE
Sbjct: 119 ---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV--TLWYRAPEVL 173
Query: 393 MGGI-FSIKSDVFSFGVLLLEIISGR 417
+G +S D++S G + E+ + +
Sbjct: 174 LGSPRYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 8e-22
Identities = 78/271 (28%), Positives = 130/271 (47%), Gaps = 34/271 (12%)
Query: 218 FSDENKLGQGGFGPVYKG-TLADGKAIAVKRLSRTSGQGLKEFKN---EVNLIAKLQHKN 273
FSD ++G G FG VY + + + +A+K++S + Q +++++ EV + KL+H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 274 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHE 333
++ GC L L+ EY + D L + + L ++ +G +G+ YLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASD--LLEVHKK-PLQEVEIAAVTHGALQGLAYLHS 133
Query: 334 DSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAM 393
+ +IHRD+KA N+LL + K+ DFG+A I A N GT +MAPE +
Sbjct: 134 HN---MIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANXFVGTPYWMAPEVIL 184
Query: 394 G---GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDP 450
G + K DV+S G+ +E ++ RK F+ + + L H + P
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIE-LAERKPP--LFNMNAMSALY---------HIAQNESP 232
Query: 451 VLKQSCAPDELLKFIHIGLLCVQQDPADRPT 481
L+ + F+ C+Q+ P DRPT
Sbjct: 233 ALQSGHWSEYFRNFVDS---CLQKIPQDRPT 260
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 8e-22
Identities = 81/275 (29%), Positives = 123/275 (44%), Gaps = 42/275 (15%)
Query: 223 KLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLK-EFKNEVNLIAKLQHKNLVRLLGC 280
++G+G FG V+ G L AD +AVK T LK +F E ++ + H N+VRL+G
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 281 CLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKII 340
C + Q + ++ E + + D F T +L K + ++ A G+ YL I
Sbjct: 62 CTQKQPIYIVMELV--QGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CI 116
Query: 341 HRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYG-------YMAPEYAM 393
HRDL A N L+ + KISDFG +R + + A T G + APE
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSR-------EEEDGVYASTGGMKQIPVKWTAPEALN 169
Query: 394 GGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLK 453
G +S +SDV+SFG+LL E S L + E I+ ++
Sbjct: 170 YGRYSSESDVWSFGILLWEAFS---------------LGAVPYANLSNQQTREAIEQGVR 214
Query: 454 QSC---APDELLKFIHIGLLCVQQDPADRPTMSSV 485
C PD + + + C + DP RP+ S+V
Sbjct: 215 LPCPELCPDAVYRLM---ERCWEYDPGQRPSFSTV 246
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 9e-22
Identities = 61/205 (29%), Positives = 106/205 (51%), Gaps = 11/205 (5%)
Query: 218 FSDENKLGQGGFGPVYKGTLADGK-AIAVKRLSRTSGQG-LKEFKNEVNLIAKLQHKNLV 275
F+ ++G+G FG VYKG K +A+K + + +++ + E+ ++++ +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 276 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDS 335
R G L+G +L +I EY+ S D + L+ +I+ I +G+ YLH +
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSA----LDLLKPGPLEETYIATILREILKGLDYLHSER 121
Query: 336 RLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGG 395
+ IHRD+KA+NVLL + + K++DFG A Q + NT GT +MAPE
Sbjct: 122 K---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQS 176
Query: 396 IFSIKSDVFSFGVLLLEIISGRKNN 420
+ K+D++S G+ +E+ G N
Sbjct: 177 AYDFKADIWSLGITAIELAKGEPPN 201
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 94.6 bits (236), Expect = 9e-22
Identities = 58/204 (28%), Positives = 99/204 (48%), Gaps = 10/204 (4%)
Query: 222 NKLGQGGFGPVYKGT-LADGKAIAVKRLS-RTSGQGLKE-FKNEVNLIAKLQHKNLVRLL 278
+G+G FG V K +DGK + K + + K+ +EVN++ +L+H N+VR
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65
Query: 279 GCCL--EGQELLLIYEYMPNKSLDVHLFDATRSVQ-LDWKRRLSIINGIARGILYLH--E 333
+ Q L ++ EY L + + + ++ + I+ + + H
Sbjct: 66 DRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRS 125
Query: 334 DSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAM 393
D ++HRDLK +N+ LD + N K+ DFG A+I G + + A T GT YM+PE
Sbjct: 126 DPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKT--YVGTPYYMSPEQLN 183
Query: 394 GGIFSIKSDVFSFGVLLLEIISGR 417
+ KSD++S G L+ E+ +
Sbjct: 184 HMSYDEKSDIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 1e-21
Identities = 59/211 (27%), Positives = 93/211 (44%), Gaps = 23/211 (10%)
Query: 217 HFSDENKLGQGGFGPVYKGTLADGKAI-AVKRLSRT---SGQGLKEFKNEVNLIAKLQHK 272
HF +G+G FG V D K + A+K +++ ++ NE ++ +L H
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 273 NLVRLLGCCLEGQELLLIYEYMPNKSLDVHL-----FDATRSVQLDWKRRLSIINGIARG 327
LV L + + + L+ + + L HL F + V+ I I
Sbjct: 61 FLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQ-VKF-------WICEIVLA 112
Query: 328 ILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYM 387
+ YLH IIHRD+K N+LLD+ + I+DF A + T +GT GYM
Sbjct: 113 LEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---LTTSTSGTPGYM 166
Query: 388 APEYAMGGIFSIKSDVFSFGVLLLEIISGRK 418
APE +S+ D +S GV E + G++
Sbjct: 167 APEVLCRQGYSVAVDWWSLGVTAYECLRGKR 197
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 1e-21
Identities = 65/198 (32%), Positives = 105/198 (53%), Gaps = 12/198 (6%)
Query: 224 LGQGGFGPVYKGT-LADGKAI----AVKRL-SRTSGQGLKEFKNEVNLIAKLQHKNLVRL 277
LG G FG V+KG + +G +I A+K + R+ Q +E + + + L H +VRL
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 278 LGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRL 337
LG C G L L+ + P SL H+ LD +R L+ IA+G+ YL E
Sbjct: 75 LGIC-PGASLQLVTQLSPLGSLLDHV--RQHRDSLDPQRLLNWCVQIAKGMYYLEEH--- 128
Query: 338 KIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIF 397
+++HR+L A N+LL D +I+DFG A + + + + +MA E + G +
Sbjct: 129 RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRY 188
Query: 398 SIKSDVFSFGVLLLEIIS 415
+ +SDV+S+GV + E++S
Sbjct: 189 THQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 2e-21
Identities = 59/204 (28%), Positives = 102/204 (50%), Gaps = 21/204 (10%)
Query: 223 KLGQGGFGPVYKGT-LADGKAIAVKR--LSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLG 279
++G+G G V+K G+ +A+K+ L R G + E+ + QH +V+LL
Sbjct: 7 RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66
Query: 280 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKI 339
G +L+ EYMP+ +V L D R + + + + +G+ Y+H I
Sbjct: 67 VFPHGSGFVLVMEYMPSDLSEV-LRDEERPLPEAQVKSYMRM--LLKGVAYMHA---NGI 120
Query: 340 IHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMG----- 394
+HRDLK +N+L+ D KI+DFG AR+F + + ++ +A T Y APE G
Sbjct: 121 MHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVA-TRWYRAPELLYGARKYD 179
Query: 395 -GIFSIKSDVFSFGVLLLEIISGR 417
G+ D+++ G + E+++G
Sbjct: 180 PGV-----DLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 2e-21
Identities = 87/285 (30%), Positives = 142/285 (49%), Gaps = 46/285 (16%)
Query: 221 ENKLGQGGFGPVYKGTLA-DGK---AIAVKRLS--RTSGQGLKEFKNEVNLIAKLQHKNL 274
E +G G FG V G L GK +A+K L T Q ++F +E +++ + H N+
Sbjct: 9 EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQ-RRDFLSEASIMGQFDHPNI 67
Query: 275 VRLLGCCLEGQELLLIYEYMPNKSLDVHL--FDATRSV-QLDWKRRLSIINGIARGILYL 331
+ L G + + ++++ EYM N SLD L D +V QL + ++ GIA G+ YL
Sbjct: 68 IHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQL-----VGMLRGIASGMKYL 122
Query: 332 HEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYG------ 385
S + +HRDL A N+L++ ++ K+SDFG +R+ + A T T G
Sbjct: 123 ---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYT-----TRGGKIPIR 174
Query: 386 YMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGHA 444
+ APE F+ SDV+S+G+++ E++S G + Y+ Q ++ K EG+
Sbjct: 175 WTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP---YWEMSNQDVI----KAIEEGY- 226
Query: 445 VELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 489
L P+ C P L + + L C Q+D +RP +V +L
Sbjct: 227 -RLPAPM---DC-PAALHQLM---LDCWQKDRNERPKFEQIVSIL 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 3e-21
Identities = 59/202 (29%), Positives = 100/202 (49%), Gaps = 10/202 (4%)
Query: 222 NKLGQGGFGPVYKG-TLADGKAIAVKRLS-RTSGQGLKEFKNEVNLIAKLQHKNLVRLLG 279
+G G VY L + + +A+KR+ + E + EV +++ H N+V+
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYT 66
Query: 280 CCLEGQELLLIYEYMPNKS-LDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLK 338
+ G EL L+ Y+ S LD+ R LD +++ + +G+ YLH + +
Sbjct: 67 SFVVGDELWLVMPYLSGGSLLDIMKSSYPRGG-LDEAIIATVLKEVLKGLEYLHSNGQ-- 123
Query: 339 IIHRDLKASNVLLDDDMNPKISDFG-TARIFGGNQNQANT-NIIAGTYGYMAPEYAMGGI 396
IHRD+KA N+LL +D + KI+DFG +A + G GT +MAPE
Sbjct: 124 -IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVH 182
Query: 397 -FSIKSDVFSFGVLLLEIISGR 417
+ K+D++SFG+ +E+ +G
Sbjct: 183 GYDFKADIWSFGITAIELATGA 204
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 94.0 bits (233), Expect = 3e-21
Identities = 75/274 (27%), Positives = 130/274 (47%), Gaps = 40/274 (14%)
Query: 218 FSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLKEFKN---EVNLIAKLQHKN 273
F+D ++G G FG VY + +A+K++S + Q +++++ EV + +++H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 274 LVRLLGCCLEGQELLLIYEYMPNKS---LDVHLFDATRSVQLDWKRRLSIINGIARGILY 330
+ GC L L+ EY + L+VH + V++ +I +G +G+ Y
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLGSASDLLEVHK-KPLQEVEI-----AAITHGALQGLAY 140
Query: 331 LHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPE 390
LH + +IHRD+KA N+LL + K++DFG+A I + N GT +MAPE
Sbjct: 141 LHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASI------ASPANSFVGTPYWMAPE 191
Query: 391 YAMG---GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVEL 447
+ G + K DV+S G+ +E+ + F+ + + L H +
Sbjct: 192 VILAMDEGQYDGKVDVWSLGITCIELAERKPP---LFNMNAMSALY---------HIAQN 239
Query: 448 IDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPT 481
P L+ + D F+ C+Q+ P DRPT
Sbjct: 240 ESPTLQSNEWSDYFRNFVDS---CLQKIPQDRPT 270
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 93.8 bits (234), Expect = 4e-21
Identities = 61/212 (28%), Positives = 100/212 (47%), Gaps = 31/212 (14%)
Query: 221 ENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLKEFKN-----EVNLIAKLQHKNL 274
KLG+G + VYK G+ +A+K++ + K+ N E+ L+ +L+H N+
Sbjct: 5 GKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNI 64
Query: 275 VRLLGCCLEGQELLLIYEYMP--------NKSLDVHLFDATRSVQLDWKRRLSIINGIAR 326
+ LL + L++E+M +KS+ L A D K S + R
Sbjct: 65 IGLLDVFGHKSNINLVFEFMETDLEKVIKDKSIV--LTPA------DIK---SYMLMTLR 113
Query: 327 GILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGY 386
G+ YLH I+HRDLK +N+L+ D K++DFG AR FG + ++ T Y
Sbjct: 114 GLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV--TRWY 168
Query: 387 MAPEYAMGG-IFSIKSDVFSFGVLLLEIISGR 417
APE G + + D++S G + E++
Sbjct: 169 RAPELLFGARHYGVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 4e-21
Identities = 72/230 (31%), Positives = 102/230 (44%), Gaps = 51/230 (22%)
Query: 223 KLGQGGFGPVY------------KGTLADGKA-----IAVKRLSRT-SGQGLKEFKNEVN 264
KLG+G FG V+ K + A +AVK L S ++F EV
Sbjct: 12 KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVK 71
Query: 265 LIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHL--------FDATRSVQLDWKR 316
++++L N+ RLLG C L +I EYM N L+ L A S L +
Sbjct: 72 ILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFST 131
Query: 317 RLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQAN 376
L + IA G+ YL L +HRDL N L+ + KI+DFG +R
Sbjct: 132 LLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSR---------- 178
Query: 377 TNIIAGTY----G-------YMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 415
N+ + Y G +MA E + G F+ KSDV++FGV L EI++
Sbjct: 179 -NLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 4e-21
Identities = 66/200 (33%), Positives = 100/200 (50%), Gaps = 12/200 (6%)
Query: 224 LGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLKEFKN---EVNLIAKLQHKNLVRLLG 279
LG+GGFG V + A GK A K+L++ + K ++ E ++AK+ H + L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV-HSRFIVSLA 59
Query: 280 CCLEGQ-ELLLIYEYMPNKSLDVHLFDATR-SVQLDWKRRLSIINGIARGILYLHEDSRL 337
+ + +L L+ M L H+++ + R I G+ +LH+
Sbjct: 60 YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR--- 116
Query: 338 KIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIF 397
+II+RDLK NVLLD+D N +ISD G A Q++ T AGT G+MAPE G +
Sbjct: 117 RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TKGYAGTPGFMAPELLQGEEY 174
Query: 398 SIKSDVFSFGVLLLEIISGR 417
D F+ GV L E+I+ R
Sbjct: 175 DFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 6e-21
Identities = 61/206 (29%), Positives = 105/206 (50%), Gaps = 16/206 (7%)
Query: 222 NKLGQGGFGPVYKGTLADGKAIAVKRLS-RTSGQGLKE-----FKNEVNLIAKLQHKNLV 275
LG+G +G VY G G+ IAVK++ TS E + EV+L+ L+H N+V
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 276 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDS 335
+ LG CL+ + + E++P S+ L + + + I G+ YLH +
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCK---YTKQILDGVAYLHNNC 122
Query: 336 RLKIIHRDLKASNVLLDDDMNPKISDFGTA-RIFGGNQNQANTNIIAGTYG---YMAPEY 391
++HRD+K +NV+L + K+ DFG A R+ + ++N++ +G +MAPE
Sbjct: 123 ---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEV 179
Query: 392 AMGGIFSIKSDVFSFGVLLLEIISGR 417
+ KSD++S G + E+ +G+
Sbjct: 180 INESGYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 7e-21
Identities = 81/296 (27%), Positives = 134/296 (45%), Gaps = 51/296 (17%)
Query: 223 KLGQGGFGPVYKGTLADGKA----------------IAVKRL-SRTSGQGLKEFKNEVNL 265
KLG+G FG V+ A+G A +AVK L + + +F E+ +
Sbjct: 12 KLGEGQFGEVHLCE-AEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKI 70
Query: 266 IAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQ-----------LDW 314
+++L++ N++RLLG C+ L +I EYM N D++ F + R ++ +
Sbjct: 71 MSRLKNPNIIRLLGVCVSDDPLCMITEYMENG--DLNQFLSQREIESTFTHANNIPSVSI 128
Query: 315 KRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTAR-IFGGN-- 371
L + IA G+ YL + L +HRDL N L+ + KI+DFG +R ++ G+
Sbjct: 129 ANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYY 185
Query: 372 --QNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQ 429
Q +A I +MA E + G F+ SDV++FGV L E+ + K + Q
Sbjct: 186 RIQGRAVLPI-----RWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240
Query: 430 TLLTYTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSV 485
+ +G + L L P + K + + C +D DRPT + +
Sbjct: 241 VIENTGEFFRNQGRQIYLSQTPL----CPSPVFKLM---MRCWSRDIKDRPTFNKI 289
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 8e-21
Identities = 60/207 (28%), Positives = 108/207 (52%), Gaps = 15/207 (7%)
Query: 218 FSDENKLGQGGFGPVYKGTLADGKA---IAVKRLSRTSGQG-LKEFKNEVNLIAKLQHKN 273
F+ ++G+G FG V+KG D + +A+K + + +++ + E+ ++++
Sbjct: 6 FTKLERIGKGSFGEVFKGI--DNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 274 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHE 333
+ + G L+G +L +I EY+ S D R+ D + +++ I +G+ YLH
Sbjct: 64 VTKYYGSYLKGTKLWIIMEYLGGGSA----LDLLRAGPFDEFQIATMLKEILKGLDYLHS 119
Query: 334 DSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAM 393
+ K IHRD+KA+NVLL + + K++DFG A Q + NT GT +MAPE
Sbjct: 120 E---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIQ 174
Query: 394 GGIFSIKSDVFSFGVLLLEIISGRKNN 420
+ K+D++S G+ +E+ G N
Sbjct: 175 QSAYDSKADIWSLGITAIELAKGEPPN 201
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 9e-21
Identities = 85/288 (29%), Positives = 130/288 (45%), Gaps = 45/288 (15%)
Query: 224 LGQGGFGPVY--------KGTLADGKAIAVKRLS-RTSGQGLKEFKNEVNLIAKL-QHKN 273
LG+G FG V K + +AVK L + + L + +E+ ++ + +HKN
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 274 LVRLLGCCLEGQELLLIYEYMPNKSLDVHL-----------FDATR--SVQLDWKRRLSI 320
++ LLG C + L +I EY +L +L +D R Q+ +K +S
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 321 INGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNII 380
+ARG+ YL + K IHRDL A NVL+ ++ KI+DFG AR T
Sbjct: 143 TYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199
Query: 381 AGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS--GRKNNGFYFSEHGQTLLTYTWKL 438
+MAPE +++ +SDV+SFGVL+ EI + G G E +KL
Sbjct: 200 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--------LFKL 251
Query: 439 WCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVV 486
EGH ++ K + +EL + C P+ RPT +V
Sbjct: 252 LKEGHRMD------KPANCTNELYMMMRD---CWHAIPSHRPTFKQLV 290
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 1e-20
Identities = 63/195 (32%), Positives = 98/195 (50%), Gaps = 11/195 (5%)
Query: 223 KLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCL 282
+LG G FG V G +A+K + S EF E ++ KL H+ LV+L G C
Sbjct: 11 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCT 69
Query: 283 EGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHR 342
+ + + ++ EYM N L +L + + Q + L + + G+ YL + IHR
Sbjct: 70 KQRPIYIVTEYMSNGCLLNYLREHGKRFQP--SQLLEMCKDVCEGMAYLESK---QFIHR 124
Query: 343 DLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTY--GYMAPEYAMGGIFSIK 400
DL A N L+DD K+SDFG +R ++ T+ + + + PE + FS K
Sbjct: 125 DLAARNCLVDDQGCVKVSDFGLSRYVLDDE---YTSSVGSKFPVRWSPPEVLLYSKFSSK 181
Query: 401 SDVFSFGVLLLEIIS 415
SDV++FGVL+ E+ S
Sbjct: 182 SDVWAFGVLMWEVYS 196
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 91.9 bits (228), Expect = 1e-20
Identities = 59/196 (30%), Positives = 105/196 (53%), Gaps = 12/196 (6%)
Query: 223 KLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLKEFK-NEVNLIAKLQHKNLVRLLGC 280
K+GQG G VY +A G+ +A+K+++ Q KE NE+ ++ + +H N+V L
Sbjct: 26 KIGQGASGTVYTAIDVATGQEVAIKQMN-LQQQPKKELIINEILVMRENKHPNIVNYLDS 84
Query: 281 CLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKII 340
L G EL ++ EY+ SL D +D + ++ + + +LH + ++I
Sbjct: 85 YLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHSN---QVI 137
Query: 341 HRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIK 400
HRD+K+ N+LL D + K++DFG Q++ +T + GT +MAPE + K
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYGPK 195
Query: 401 SDVFSFGVLLLEIISG 416
D++S G++ +E++ G
Sbjct: 196 VDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 1e-20
Identities = 85/291 (29%), Positives = 131/291 (45%), Gaps = 51/291 (17%)
Query: 224 LGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEV------NLIAKLQ------- 270
LG+G FG V +A+ I + ++ +K K++ +L+++++
Sbjct: 20 LGEGCFGQV---VMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGK 76
Query: 271 HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHL-----------FDATR--SVQLDWKRR 317
HKN++ LLG C + L ++ EY +L +L FD + QL +K
Sbjct: 77 HKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDL 136
Query: 318 LSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANT 377
+S +ARG+ YL + K IHRDL A NVL+ +D KI+DFG AR T
Sbjct: 137 VSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKT 193
Query: 378 NIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS--GRKNNGFYFSEHGQTLLTYT 435
+MAPE +++ +SDV+SFGVLL EI + G G E
Sbjct: 194 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE--------L 245
Query: 436 WKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVV 486
+KL EGH ++ P +C + + I C P+ RPT +V
Sbjct: 246 FKLLKEGHRMD--KPA---NCTHELYM----IMRECWHAVPSQRPTFKQLV 287
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 2e-20
Identities = 76/274 (27%), Positives = 132/274 (48%), Gaps = 40/274 (14%)
Query: 218 FSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLKEFKN---EVNLIAKLQHKN 273
F +++G G FG VY T + + +AVK++S + Q +++++ EV + +L+H N
Sbjct: 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82
Query: 274 LVRLLGCCLEGQELLLIYEYMPNKS---LDVHLFDATRSVQLDWKRRLSIINGIARGILY 330
+ GC L+ L+ EY + L+VH + V++ +I +G +G+ Y
Sbjct: 83 TIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHK-KPLQEVEI-----AAITHGALQGLAY 136
Query: 331 LHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPE 390
LH + +IHRD+KA N+LL + K++DFG+A + N GT +MAPE
Sbjct: 137 LHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASK------SSPANSFVGTPYWMAPE 187
Query: 391 YAMG---GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVEL 447
+ G + K DV+S G+ +E ++ RK F+ + + L H +
Sbjct: 188 VILAMDEGQYDGKVDVWSLGITCIE-LAERKPP--LFNMNAMSALY---------HIAQN 235
Query: 448 IDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPT 481
P L+ + D F+ C+Q+ P +RP
Sbjct: 236 DSPTLQSNEWTDSFRGFVD---YCLQKIPQERPA 266
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 2e-20
Identities = 63/206 (30%), Positives = 113/206 (54%), Gaps = 19/206 (9%)
Query: 221 ENKLGQGGFGPVYKGTL-ADGKA---IAVKRL-SRTSGQGLKEFKNEVNLIAKLQHKNLV 275
E +G G FG V +G L GK +A+K L S + + ++F +E +++ + H N++
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 276 RLLGCCLEGQELLLIYEYMPNKSLD--VHLFDATRSV-QLDWKRRLSIINGIARGILYLH 332
L G + + +++I E+M N +LD + D +V QL + ++ GIA G+ YL
Sbjct: 69 HLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQL-----VGMLRGIAAGMKYLS 123
Query: 333 EDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGN-QNQANTNIIAGTYG--YMAP 389
E + +HRDL A N+L++ ++ K+SDFG +R + + T+ + G + AP
Sbjct: 124 E---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAP 180
Query: 390 EYAMGGIFSIKSDVFSFGVLLLEIIS 415
E F+ SDV+S+G+++ E++S
Sbjct: 181 EAIAYRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 2e-20
Identities = 80/279 (28%), Positives = 125/279 (44%), Gaps = 36/279 (12%)
Query: 223 KLGQGGFGPVYKG---TLADGKAIAVKRLSRTSG-QGLK-EFKNEVNLIAKLQHKNLVRL 277
+LG G FG V KG K +AVK L + LK E E N++ +L + +VR+
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 278 LGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRL 337
+G C E + +L+ E L+ L ++ + K +++ ++ G+ YL E +
Sbjct: 62 IGIC-EAESWMLVMELAELGPLNKFL---QKNKHVTEKNITELVHQVSMGMKYLEETN-- 115
Query: 338 KIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYG-----YMAPEYA 392
+HRDL A NVLL KISDFG ++ G ++N A T+G + APE
Sbjct: 116 -FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK----AKTHGKWPVKWYAPECM 170
Query: 393 MGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVL 452
FS KSDV+SFGVL+ E S +GQ +K ++I+
Sbjct: 171 NYYKFSSKSDVWSFGVLMWEAFS-----------YGQK----PYKGMKGNEVTQMIESGE 215
Query: 453 KQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 491
+ C + + LC +RP + V + L +
Sbjct: 216 RMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 2e-20
Identities = 83/290 (28%), Positives = 135/290 (46%), Gaps = 44/290 (15%)
Query: 223 KLGQGGFGPVYKGTLAD---GKA---IAVKRLSRTSGQGLK-EFKNEVNLIAKLQHKNLV 275
+LGQG FG VY+G D G+A +AVK ++ ++ + EF NE +++ ++V
Sbjct: 13 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 72
Query: 276 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLD-----------WKRRLSIINGI 324
RLLG +GQ L++ E M + L +L RS++ + + + + I
Sbjct: 73 RLLGVVSKGQPTLVVMELMAHGDLKSYL----RSLRPEAENNPGRPPPTLQEMIQMAAEI 128
Query: 325 ARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTAR-IFGGNQNQANTNIIAGT 383
A G+ YL+ K +HRDL A N ++ D KI DFG R I+ + + +
Sbjct: 129 ADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 185
Query: 384 YGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGH 443
MAPE G+F+ SD++SFGV+L E I+ + + Q L K +G
Sbjct: 186 RW-MAPESLKDGVFTTSSDMWSFGVVLWE-ITSLAEQPYQGLSNEQVL-----KFVMDGG 238
Query: 444 AVELIDPVLKQSCAPDELLKFIH-IGLLCVQQDPADRPTMSSVVVMLASD 492
++ PD + + + +C Q +P RPT +V +L D
Sbjct: 239 YLD----------QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.4 bits (225), Expect = 3e-20
Identities = 59/201 (29%), Positives = 100/201 (49%), Gaps = 23/201 (11%)
Query: 222 NKLGQGGFGPVYKG-TLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGC 280
++G G +G VYK +A G+ +A+K + G + + E++++ + +H N+V G
Sbjct: 9 QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGS 68
Query: 281 CLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLS--IINGIAR----GILYLHED 334
L +L ++ EY SL ++ TR LS I + R G+ YLHE
Sbjct: 69 YLRRDKLWIVMEYCGGGSLQ-DIYQVTR-------GPLSELQIAYVCRETLKGLAYLHE- 119
Query: 335 SRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYA-- 392
IHRD+K +N+LL +D + K++DFG + + + I GT +MAPE A
Sbjct: 120 --TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFI--GTPYWMAPEVAAV 175
Query: 393 -MGGIFSIKSDVFSFGVLLLE 412
G + K D+++ G+ +E
Sbjct: 176 ERKGGYDGKCDIWALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 3e-20
Identities = 62/200 (31%), Positives = 94/200 (47%), Gaps = 15/200 (7%)
Query: 224 LGQGGFGPV------YKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRL 277
LG+GGFG V G + K + KRL + SG+ + + E+ + K+ +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEI--LEKVNSPFIVNL 58
Query: 278 LGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRL 337
L L+ M L H+++ L+ +R + I GIL+LH +
Sbjct: 59 AYAFESKTHLCLVMSLMNGGDLKYHIYNVG-ERGLEMERVIHYSAQITCGILHLHS---M 114
Query: 338 KIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIF 397
I++RD+K NVLLDD N ++SD G A + AGT GYMAPE +
Sbjct: 115 DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQRAGTNGYMAPEILKEEPY 171
Query: 398 SIKSDVFSFGVLLLEIISGR 417
S D F+ G + E+++GR
Sbjct: 172 SYPVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 3e-20
Identities = 80/278 (28%), Positives = 123/278 (44%), Gaps = 54/278 (19%)
Query: 222 NKLGQGGFGPVYK----GTLADGKAIAVKRLSRTSGQGLK-EFKNEVNLIAKLQHKNLVR 276
N++G G G VYK T G+ A+K + ++ + E+ ++ + H N+V+
Sbjct: 80 NRIGSGAGGTVYKVIHRPT---GRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVK 136
Query: 277 LLGCCLEGQELLLIYEYMPNKSLDVH-------LFDATRSVQLDWKRRLSIINGIARGIL 329
E+ ++ E+M SL+ L D R I++GIA
Sbjct: 137 CHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVARQ----------ILSGIA---- 182
Query: 330 YLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAP 389
YLH R I+HRD+K SN+L++ N KI+DFG +RI + N+++ GT YM+P
Sbjct: 183 YLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV--GTIAYMSP 237
Query: 390 E-----YAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTW-KLWCEGH 443
E G D++S GV +LE GR F F Q W L C
Sbjct: 238 ERINTDLNHGAYDGYAGDIWSLGVSILEFYLGR----FPFGVGRQG----DWASLMC--- 286
Query: 444 AVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPT 481
A+ + P + A E FI C+Q++PA R +
Sbjct: 287 AICMSQPPEAPATASREFRHFIS---CCLQREPAKRWS 321
|
Length = 353 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 4e-20
Identities = 73/281 (25%), Positives = 130/281 (46%), Gaps = 25/281 (8%)
Query: 220 DENKLGQGGFGPVYKG-TLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLL 278
+EN + +G G YKG ++ +G VK ++ + E + + KLQH N+V+L+
Sbjct: 694 EENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIAD----MGKLQHPNIVKLI 749
Query: 279 GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLK 338
G C + LI+EY+ K+L L + L W+RR I GIA+ + +LH
Sbjct: 750 GLCRSEKGAYLIHEYIEGKNLSEVLRN------LSWERRRKIAIGIAKALRFLHCRCSPA 803
Query: 339 IIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFS 398
++ +L +++D P + + Y+APE +
Sbjct: 804 VVVGNLSPEKIIIDGKDEPHL-------RLSLPGLLCTDTKCFISSAYVAPETRETKDIT 856
Query: 399 IKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWC--EGHAVELIDPVLKQ-- 454
KSD++ FG++L+E+++G+ F HG + W +C + H IDP ++
Sbjct: 857 EKSDIYGFGLILIELLTGKSPADAEFGVHGSIV---EWARYCYSDCHLDMWIDPSIRGDV 913
Query: 455 SCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSMT 495
S +E+++ +++ L C DP RP + V+ L S S +
Sbjct: 914 SVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS 954
|
Length = 968 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 89.6 bits (223), Expect = 4e-20
Identities = 54/200 (27%), Positives = 88/200 (44%), Gaps = 17/200 (8%)
Query: 224 LGQGGFGPVYKGTLA-DGKAIAVKRLSR---TSGQGLKEFKNEVNLIAKLQHKNLVRLLG 279
LG GGFG V + + A+K + + + +E ++ + H +V+L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 280 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQL--DWKRRLSIINGIARGILYLHEDSRL 337
+ + + ++ EY L + R L ++ R I + YLH
Sbjct: 61 TFKDKKYIYMLMEYCLGGEL----WTILRDRGLFDEYTARF-YIACVVLAFEYLH---NR 112
Query: 338 KIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIF 397
II+RDLK N+LLD + K+ DFG A+ Q T GT Y+APE + +
Sbjct: 113 GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTPEYVAPEIILNKGY 169
Query: 398 SIKSDVFSFGVLLLEIISGR 417
D +S G+LL E+++GR
Sbjct: 170 DFSVDYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 7e-20
Identities = 69/212 (32%), Positives = 111/212 (52%), Gaps = 28/212 (13%)
Query: 218 FSDENKLGQGGFGPVYKGT-LADGKAI----AVKRLSR-TSGQGLKEFKNEVNLIAKLQH 271
F LG G FG VYKG + +G+ + A+K L TS + KE +E ++A + +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 272 KNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQ--------LDWKRRLSIING 323
++ RLLG CL + LI + MP L D R + L+W +
Sbjct: 69 PHVCRLLGICLT-STVQLITQLMPFGCL----LDYVREHKDNIGSQYLLNWCVQ------ 117
Query: 324 IARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGT 383
IA+G+ YL E+ RL +HRDL A NVL+ + KI+DFG A++ G ++ + +
Sbjct: 118 IAKGMNYL-EERRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVP 174
Query: 384 YGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 415
+MA E + I++ +SDV+S+GV + E+++
Sbjct: 175 IKWMALESILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 7e-20
Identities = 71/204 (34%), Positives = 108/204 (52%), Gaps = 21/204 (10%)
Query: 224 LGQGGFGPVYKGTL--ADGKAI--AVKRLSR-TSGQGLKEFKNEVNLIAKLQHKNLVRLL 278
+G+G FG VY GTL +DG+ I AVK L+R T + +++F E ++ H N++ LL
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 279 GCCL--EGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSR 336
G CL EG L+++ YM + L + T + + K + +A+G+ YL
Sbjct: 63 GICLPSEGSPLVVL-PYMKHGDLRNFIRSETHNPTV--KDLIGFGLQVAKGMEYLASK-- 117
Query: 337 LKIIHRDLKASNVLLDDDMNPKISDFGTAR-IFGGN----QNQANTNIIAGTYGYMAPEY 391
K +HRDL A N +LD+ K++DFG AR I+ N + +MA E
Sbjct: 118 -KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKL---PVKWMALES 173
Query: 392 AMGGIFSIKSDVFSFGVLLLEIIS 415
F+ KSDV+SFGVLL E+++
Sbjct: 174 LQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 8e-20
Identities = 61/211 (28%), Positives = 102/211 (48%), Gaps = 35/211 (16%)
Query: 224 LGQGGFGPVYK------GTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRL 277
LG G FG VYK G A K I ++ S + L++F E++++++ +H N+V L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIE-----SEEELEDFMVEIDILSECKHPNIVGL 67
Query: 278 LGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLS------IINGIARGILYL 331
+L ++ E+ +LD S+ L+ +R L+ + + + +L
Sbjct: 68 YEAYFYENKLWILIEFCDGGALD--------SIMLELERGLTEPQIRYVCRQMLEALNFL 119
Query: 332 HEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEY 391
H K+IHRDLKA N+LL D + K++DFG + + +T I GT +MAPE
Sbjct: 120 HSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI--GTPYWMAPEV 174
Query: 392 AMGGIFS-----IKSDVFSFGVLLLEIISGR 417
F K+D++S G+ L+E+
Sbjct: 175 VACETFKDNPYDYKADIWSLGITLIELAQME 205
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 1e-19
Identities = 64/202 (31%), Positives = 102/202 (50%), Gaps = 23/202 (11%)
Query: 223 KLGQGGFGPVYK------GTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVR 276
+LG G FG VYK G LA K I K S + L+++ E+ ++A H +V+
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETK-----SEEELEDYMVEIEILATCNHPYIVK 73
Query: 277 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSR 336
LLG +L ++ E+ P ++D + + R + + I + + YLH
Sbjct: 74 LLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQ--VICRQMLEALQYLHS--- 128
Query: 337 LKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAM--- 393
+KIIHRDLKA NVLL D + K++DFG + + ++ I GT +MAPE M
Sbjct: 129 MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI--GTPYWMAPEVVMCET 186
Query: 394 --GGIFSIKSDVFSFGVLLLEI 413
+ K+D++S G+ L+E+
Sbjct: 187 MKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 89.0 bits (220), Expect = 1e-19
Identities = 58/201 (28%), Positives = 101/201 (50%), Gaps = 11/201 (5%)
Query: 218 FSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQG-LKEFKNEVNLIAKLQHKNLV 275
F+ K+G+G FG V+KG K +A+K + + +++ + E+ ++++ +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 276 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDS 335
+ G L+ +L +I EY+ S D LD + +I+ I +G+ YLH +
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGSA----LDLLEPGPLDETQIATILREILKGLDYLHSEK 121
Query: 336 RLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGG 395
+ IHRD+KA+NVLL + K++DFG A Q N GT +MAPE
Sbjct: 122 K---IHRDIKAANVLLSEHGEVKLADFGVAGQL--TDTQIKRNTFVGTPFWMAPEVIKQS 176
Query: 396 IFSIKSDVFSFGVLLLEIISG 416
+ K+D++S G+ +E+ G
Sbjct: 177 AYDSKADIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 89.0 bits (220), Expect = 1e-19
Identities = 56/200 (28%), Positives = 106/200 (53%), Gaps = 10/200 (5%)
Query: 218 FSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVR 276
++ K+GQG G V+ +A G+ +A+K+++ + NE+ ++ +L++ N+V
Sbjct: 21 YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVN 80
Query: 277 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSR 336
L L G EL ++ EY+ SL D +D + ++ + + +LH +
Sbjct: 81 FLDSFLVGDELFVVMEYLAGGSLT----DVVTETCMDEAQIAAVCRECLQALEFLHAN-- 134
Query: 337 LKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGI 396
++IHRD+K+ NVLL D + K++DFG Q++ +T + GT +MAPE
Sbjct: 135 -QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKA 191
Query: 397 FSIKSDVFSFGVLLLEIISG 416
+ K D++S G++ +E++ G
Sbjct: 192 YGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 1e-19
Identities = 87/291 (29%), Positives = 130/291 (44%), Gaps = 51/291 (17%)
Query: 224 LGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEV------NLIAKLQ------- 270
LG+G FG V +A+ + ++ +R + +K K++ +LI++++
Sbjct: 26 LGEGCFGQV---VMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 82
Query: 271 HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLF-------------DATRSVQLDWKRR 317
HKN++ LLG C + L +I EY +L +L QL +K
Sbjct: 83 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDL 142
Query: 318 LSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANT 377
+S +ARG+ YL + K IHRDL A NVL+ +D KI+DFG AR T
Sbjct: 143 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 199
Query: 378 NIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS--GRKNNGFYFSEHGQTLLTYT 435
+MAPE I++ +SDV+SFGVLL EI + G G E
Sbjct: 200 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE--------L 251
Query: 436 WKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVV 486
+KL EGH ++ K S +EL + C P+ RPT +V
Sbjct: 252 FKLLKEGHRMD------KPSNCTNELYMMMRD---CWHAVPSQRPTFKQLV 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 2e-19
Identities = 73/274 (26%), Positives = 128/274 (46%), Gaps = 42/274 (15%)
Query: 224 LGQGGFGPVYKGT-LADGKAIAVKRLS---RTSGQG---LKEFKNEVNLIAKLQHKNLVR 276
LG G F Y+ + G +AVK+++ TS + ++ + E+ L+A+L H +++R
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 277 LLGCCLEGQELLLIYEYMPNKSLDVHLFDA---TRSVQLDWKRRLSIINGIARGILYLHE 333
+LG E L E+M S+ L +V +++ + + RG+ YLHE
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQ------LLRGLSYLHE 121
Query: 334 DSRLKIIHRDLKASNVLLDDD-MNPKISDFGTA-----RIFGGNQNQANTNIIAGTYGYM 387
+ +IIHRD+K +N+L+D +I+DFG A + G + Q + GT +M
Sbjct: 122 N---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQ---LLGTIAFM 175
Query: 388 APEYAMGGIFSIKSDVFSFGVLLLEIISGRKN-NGFYFSEHGQTLLTYTWKLWCEGHAVE 446
APE G + DV+S G +++E+ + + N S H + +K+ A
Sbjct: 176 APEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALI----FKIASATTA-- 229
Query: 447 LIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRP 480
P + + +P + L C++ P DRP
Sbjct: 230 ---PSIPEHLSPG----LRDVTLRCLELQPEDRP 256
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 2e-19
Identities = 60/193 (31%), Positives = 94/193 (48%), Gaps = 7/193 (3%)
Query: 223 KLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCL 282
+LG G FG V+ G +A+K + ++F E ++ KL H LV+L G C
Sbjct: 11 ELGSGQFGVVHLGKWRAQIKVAIKAI-NEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69
Query: 283 EGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHR 342
+ + L ++ E+M N L +L R +L LS+ + G+ YL +S IHR
Sbjct: 70 QQKPLYIVTEFMENGCLLNYL--RQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHR 124
Query: 343 DLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSD 402
DL A N L+ K+SDFG R ++ +++ + PE +S KSD
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSG-AKFPVKWSPPEVFNFSKYSSKSD 183
Query: 403 VFSFGVLLLEIIS 415
V+SFGVL+ E+ +
Sbjct: 184 VWSFGVLMWEVFT 196
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 3e-19
Identities = 80/282 (28%), Positives = 136/282 (48%), Gaps = 35/282 (12%)
Query: 224 LGQGGFGPVY------KGTLADGKAIAVKRLS-RTSGQGLKEFKNEVNLIAKLQHKNLVR 276
LG+G FG V +G G+ +AVK L + G + + K E+ ++ L H+N+V+
Sbjct: 12 LGEGHFGKVELCRYDPEGD-NTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 70
Query: 277 LLGCCLE--GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHED 334
G C E G + LI E++P+ SL +L + L K++L I +G+ YL
Sbjct: 71 YKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINL--KQQLKYAVQICKGMDYL--G 126
Query: 335 SRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQN--QANTNIIAGTYGYMAPEYA 392
SR + +HRDL A NVL++ + KI DFG + ++ ++ + + Y APE
Sbjct: 127 SR-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWY-APECL 184
Query: 393 MGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSE--------HGQTLLTYTWKLWCEGHA 444
+ F I SDV+SFGV L E+++ + + HGQ +T ++ EG
Sbjct: 185 IQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKR 244
Query: 445 VELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVV 486
+ +C P+E+ + + C + P+ R T +++
Sbjct: 245 LPRPP-----NC-PEEVYQLMR---KCWEFQPSKRTTFQNLI 277
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 3e-19
Identities = 81/289 (28%), Positives = 136/289 (47%), Gaps = 43/289 (14%)
Query: 221 ENKLGQGGFGPVYKGTL-ADGKAI--AVKRLSRTSGQG-LKEFKNEVNLIAKL-QHKNLV 275
++ +G+G FG V K + DG + A+KR+ + + ++F E+ ++ KL H N++
Sbjct: 12 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 71
Query: 276 RLLGCCLEGQELLLIYEYMPNKSL------------DVHLFDATRSVQ-LDWKRRLSIIN 322
LLG C L L EY P+ +L D A + L ++ L
Sbjct: 72 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 131
Query: 323 GIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAG 382
+ARG+ YL S+ + IHRDL A N+L+ ++ KI+DFG +R G + +
Sbjct: 132 DVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRL 185
Query: 383 TYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS--GRKNNGFYFSEHGQTLLTYTWKLWC 440
+MA E +++ SDV+S+GVLL EI+S G G +E + L
Sbjct: 186 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL--------P 237
Query: 441 EGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 489
+G+ +E K DE+ + C ++ P +RP+ + ++V L
Sbjct: 238 QGYRLE------KPLNCDDEVYDLMR---QCWREKPYERPSFAQILVSL 277
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 3e-19
Identities = 57/196 (29%), Positives = 100/196 (51%), Gaps = 11/196 (5%)
Query: 224 LGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKE---FKNEVNLIAKLQHKNLVRLLGC 280
+G+G FG V+ + + + + E +NE ++ L H N++
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67
Query: 281 CLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKII 340
LE + L+++ EY P +L ++ S+ LD +I++ + +L LH I+
Sbjct: 68 FLEDKALMIVMEYAPGGTLAEYIQKRCNSL-LDED---TILHFFVQILLALHHVHTKLIL 123
Query: 341 HRDLKASNVLLDD-DMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSI 399
HRDLK N+LLD M KI DFG ++I ++++A T + GT Y++PE G ++
Sbjct: 124 HRDLKTQNILLDKHKMVVKIGDFGISKIL-SSKSKAYT--VVGTPCYISPELCEGKPYNQ 180
Query: 400 KSDVFSFGVLLLEIIS 415
KSD+++ G +L E+ S
Sbjct: 181 KSDIWALGCVLYELAS 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 3e-19
Identities = 67/214 (31%), Positives = 107/214 (50%), Gaps = 26/214 (12%)
Query: 221 ENKLGQGGFGPVYKGTLA-DGKAI--AVKRLSR-TSGQGLKEFKNEVNLIAKL-QHKNLV 275
E+ +G+G FG V + + DG + A+K L S ++F E+ ++ KL H N++
Sbjct: 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66
Query: 276 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLD--------------WKRRLSII 321
LLG C L + EY P +L + +R ++ D ++ L
Sbjct: 67 NLLGACENRGYLYIAIEYAPYGNL-LDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFA 125
Query: 322 NGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIA 381
+ +A G+ YL E + IHRDL A NVL+ +++ KI+DFG +R G + +
Sbjct: 126 SDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSR---GEEVYVKKTMGR 179
Query: 382 GTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 415
+MA E +++ KSDV+SFGVLL EI+S
Sbjct: 180 LPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 5e-19
Identities = 63/208 (30%), Positives = 103/208 (49%), Gaps = 35/208 (16%)
Query: 223 KLGQGGFGPVYKGTLADGKAIAVKRLSRT-SGQGLKEFKNEVNLIAKLQHKNLVRLLGCC 281
+LG G FG VYK + +A ++ T S + L+++ E++++A H N+V+LL
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 282 LEGQELLLIYEYMPNKSLDVHLFDATRS-----VQLDWKRRLSIINGIARGILYLHEDSR 336
L ++ E+ ++D + + R +++ K+ L +N YLHE+
Sbjct: 72 YYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALN-------YLHEN-- 122
Query: 337 LKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIA------GTYGYMAPE 390
KIIHRDLKA N+L D + K++DFG + NT I GT +MAPE
Sbjct: 123 -KIIHRDLKAGNILFTLDGDIKLADFGVS--------AKNTRTIQRRDSFIGTPYWMAPE 173
Query: 391 YAMGGI-----FSIKSDVFSFGVLLLEI 413
M + K+DV+S G+ L+E+
Sbjct: 174 VVMCETSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 86.9 bits (215), Expect = 6e-19
Identities = 71/268 (26%), Positives = 116/268 (43%), Gaps = 40/268 (14%)
Query: 224 LGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGL-KEFKNEVNLIAKLQHKNLVRLLGCC 281
LG G G VYK L + +AVK + L K+ +E+ ++ K ++ G
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 282 LEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIH 341
+ + E+M SLDV+ R + R+++ + +G+ YL LKI+H
Sbjct: 69 FVENRISICTEFMDGGSLDVY-----RKIPEHVLGRIAV--AVVKGLTYLWS---LKILH 118
Query: 342 RDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTY----GYMAPEYAMGGIF 397
RD+K SN+L++ K+ DFG + N IA TY YMAPE G +
Sbjct: 119 RDVKPSNMLVNTRGQVKLCDFGVSTQL--------VNSIAKTYVGTNAYMAPERISGEQY 170
Query: 398 SIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQSCA 457
I SDV+S G+ +E+ GR G + ++L+ ++ +
Sbjct: 171 GIHSDVWSLGISFMELALGRFPYPQIQKNQGSLM------------PLQLLQCIVDEDPP 218
Query: 458 --PDELL--KFIHIGLLCVQQDPADRPT 481
P KF+H C+++ P +RP
Sbjct: 219 VLPVGQFSEKFVHFITQCMRKQPKERPA 246
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 8e-19
Identities = 59/216 (27%), Positives = 100/216 (46%), Gaps = 34/216 (15%)
Query: 215 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRL-------SRTSGQGLKEFKNEVNLI 266
+F E K+G+G F VYK L DG+ +A+K++ ++ LKE ++L+
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKE----IDLL 56
Query: 267 AKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSL---------DVHLFDATRSVQLDWKRR 317
+L H N+++ L +E EL ++ E L L R++ WK
Sbjct: 57 KQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPE-RTI---WK-- 110
Query: 318 LSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANT 377
+ + ++H +I+HRD+K +NV + K+ D G R F A++
Sbjct: 111 --YFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS 165
Query: 378 NIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEI 413
+ GT YM+PE ++ KSD++S G LL E+
Sbjct: 166 LV--GTPYYMSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 8e-19
Identities = 63/210 (30%), Positives = 108/210 (51%), Gaps = 29/210 (13%)
Query: 224 LGQGGFGPVYKGTLAD-GKAIAVKRL-----SRTSGQGLKEFKNEVNLIAKLQHKNLVRL 277
LGQG FG VY AD G+ +AVK++ S + + + + E+ L+ L H+ +V+
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 278 LGCCLEGQE--LLLIYEYMPNKSLDVHL--FDA-TRSVQLDWKRRLSIINGIARGILYLH 332
GC + E L + E+MP S+ L + A T +V + R+ I G+ YLH
Sbjct: 70 YGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQ------ILEGVSYLH 123
Query: 333 EDSRLKIIHRDLKASNVLLDDDMNPKISDFGTAR-----IFGGNQNQANTNIIAGTYGYM 387
+ I+HRD+K +N+L D N K+ DFG ++ G ++ + GT +M
Sbjct: 124 SN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS----VTGTPYWM 176
Query: 388 APEYAMGGIFSIKSDVFSFGVLLLEIISGR 417
+PE G + K+D++S G ++E+++ +
Sbjct: 177 SPEVISGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 1e-18
Identities = 58/201 (28%), Positives = 96/201 (47%), Gaps = 15/201 (7%)
Query: 223 KLGQGGFGPVYKG-TLADGKAIAVKRLSRTSGQGLKEFKN----EVNLIAKLQHKNLVRL 277
+G+G +G V K A G+ +A+K+ + ++ K EV ++ +L+H+N+V L
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDD--EDVKKTALREVKVLRQLRHENIVNL 65
Query: 278 LGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRL 337
L L++EY+ L+ L +A+ L S I + + I Y H
Sbjct: 66 KEAFRRKGRLYLVFEYVERTLLE--LLEASPG-GLPPDAVRSYIWQLLQAIAYCH---SH 119
Query: 338 KIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIF 397
IIHRD+K N+L+ + K+ DFG AR T+ +A T Y APE +G
Sbjct: 120 NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVA-TRWYRAPELLVGDTN 178
Query: 398 SIKS-DVFSFGVLLLEIISGR 417
K DV++ G ++ E++ G
Sbjct: 179 YGKPVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 1e-18
Identities = 81/308 (26%), Positives = 134/308 (43%), Gaps = 74/308 (24%)
Query: 223 KLGQGGFGPVY------------KGTLADGKA-----IAVKRLSRTSGQGLK-EFKNEVN 264
KLG+G FG V+ K D +AVK L + + + +F E+
Sbjct: 12 KLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK 71
Query: 265 LIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHL--------FDATRSVQLDWKR 316
++++L+ N++RLL C+ L +I EYM N L+ L + V + +
Sbjct: 72 IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYST 131
Query: 317 RLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTAR-IFGGN---- 371
+ + IA G+ YL S L +HRDL N L+ + KI+DFG +R ++ G+
Sbjct: 132 LIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRI 188
Query: 372 QNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRK------------- 418
Q +A I +M+ E + G F+ SDV++FGV L EI++ K
Sbjct: 189 QGRAVLPI-----RWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVI 243
Query: 419 -NNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPA 477
N G +F + G+ Y + K + PD L K + L C +++
Sbjct: 244 ENTGEFFRDQGRQ--VY----------------LPKPALCPDSLYKLM---LSCWRRNAK 282
Query: 478 DRPTMSSV 485
+RP+ +
Sbjct: 283 ERPSFQEI 290
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.8 bits (213), Expect = 1e-18
Identities = 61/214 (28%), Positives = 94/214 (43%), Gaps = 34/214 (15%)
Query: 224 LGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLKEFKNEVNLIAKL-QHKNLVRLLGCC 281
+G+G +G VYK G+ +A+K + +E K E N++ K H N+ G
Sbjct: 14 IGEGTYGKVYKARHKKTGQLVAIKIMDII-EDEEEEIKEEYNILRKYSNHPNIATFYGAF 72
Query: 282 L------EGQELLLIYEYMPNKSLDVHLFDATRSVQ--LDWKRRLS------IINGIARG 327
+ +L L+ E S T V+ +RL I+ RG
Sbjct: 73 IKKNPPGNDDQLWLVMELCGGGS-------VTDLVKGLRKKGKRLKEEWIAYILRETLRG 125
Query: 328 ILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYM 387
+ YLHE+ K+IHRD+K N+LL + K+ DFG + + NT I GT +M
Sbjct: 126 LAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI--GTPYWM 180
Query: 388 APE-----YAMGGIFSIKSDVFSFGVLLLEIISG 416
APE + +SDV+S G+ +E+ G
Sbjct: 181 APEVIACDEQPDASYDARSDVWSLGITAIELADG 214
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 1e-18
Identities = 65/206 (31%), Positives = 108/206 (52%), Gaps = 21/206 (10%)
Query: 224 LGQGGFGPVYKGTLAD-GKAIAVKRL-----SRTSGQGLKEFKNEVNLIAKLQHKNLVRL 277
LGQG FG VY D G+ +A K++ S + + + + E+ L+ LQH+ +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 278 LGCCLE-GQELLLIY-EYMPNKSLDVHL--FDA-TRSVQLDWKRRLSIINGIARGILYLH 332
GC + ++ L I+ EYMP S+ L + A T SV + R+ I G+ YLH
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQ------ILEGMSYLH 123
Query: 333 EDSRLKIIHRDLKASNVLLDDDMNPKISDFGTA-RIFGGNQNQANTNIIAGTYGYMAPEY 391
+ I+HRD+K +N+L D N K+ DFG + R+ + + GT +M+PE
Sbjct: 124 SN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEV 180
Query: 392 AMGGIFSIKSDVFSFGVLLLEIISGR 417
G + K+DV+S G ++E+++ +
Sbjct: 181 ISGEGYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 1e-18
Identities = 60/198 (30%), Positives = 98/198 (49%), Gaps = 16/198 (8%)
Query: 223 KLGQGGFGPVYKGTLADGKA------IAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVR 276
K+G+G FG +Y LA K+ I L++ + + K EV L+AK++H N+V
Sbjct: 7 KIGEGSFGKIY---LAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVT 63
Query: 277 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSR 336
E L ++ EY L + + R V + LS I+ G+ ++H+
Sbjct: 64 FFASFQENGRLFIVMEYCDGGDL-MKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR-- 120
Query: 337 LKIIHRDLKASNVLLDDD-MNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGG 395
KI+HRD+K+ N+ L + M K+ DFG AR + A T GT Y++PE
Sbjct: 121 -KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYT--CVGTPYYLSPEICQNR 177
Query: 396 IFSIKSDVFSFGVLLLEI 413
++ K+D++S G +L E+
Sbjct: 178 PYNNKTDIWSLGCVLYEL 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 2e-18
Identities = 60/228 (26%), Positives = 102/228 (44%), Gaps = 33/228 (14%)
Query: 214 ATNHFSDENKLGQGGFGPVYKG-TLADGKAIAVKRLSRTSGQGLKEFKN--------EVN 264
+ KLG+G FG VYK + G+ +A+K++ + K+ E+
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKIL------MHNEKDGFPITALREIK 59
Query: 265 LIAKLQHKNLVRLLGCCLE-----GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLS 319
++ KL+H N+V L+ +E ++ +Y P D+ SV+L +
Sbjct: 60 ILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKC 119
Query: 320 IINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNI 379
+ + GI YLHE+ I+HRD+KA+N+L+D+ KI+DFG AR + G
Sbjct: 120 YMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGG 176
Query: 380 IAG---------TYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGR 417
G T Y PE +G ++ D++ G + E+ + R
Sbjct: 177 GGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 2e-18
Identities = 70/274 (25%), Positives = 122/274 (44%), Gaps = 43/274 (15%)
Query: 224 LGQGGFGPVYK------GTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRL 277
LG G G V K GT+ K + + S Q L+E + ++ + + +V
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRE----LQIMHECRSPYIVSF 68
Query: 278 LGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRL 337
G L + + E+M SLD ++ + ++ + I + G+ YL+ R
Sbjct: 69 YGAFLNENNICMCMEFMDCGSLD-RIYKKGGPIPVEILGK--IAVAVVEGLTYLYNVHR- 124
Query: 338 KIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIF 397
I+HRD+K SN+L++ K+ DFG + G + + GT YM+PE GG +
Sbjct: 125 -IMHRDIKPSNILVNSRGQIKLCDFGVS----GELINSIADTFVGTSTYMSPERIQGGKY 179
Query: 398 SIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELID-------- 449
++KSDV+S G+ ++E+ G+ F F+ + + ++D
Sbjct: 180 TVKSDVWSLGISIIELALGK----FPFAFSNIDDDG-------QDDPMGILDLLQQIVQE 228
Query: 450 --PVLKQSCAPDELLKFIHIGLLCVQQDPADRPT 481
P L S P++L F+ C+ +DP +RPT
Sbjct: 229 PPPRLPSSDFPEDLRDFVDA---CLLKDPTERPT 259
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 2e-18
Identities = 55/195 (28%), Positives = 103/195 (52%), Gaps = 10/195 (5%)
Query: 223 KLGQGGFGPVYKG-TLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCC 281
K+GQG G VY +A G+ +A+K+++ + NE+ ++ + ++ N+V L
Sbjct: 26 KIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 85
Query: 282 LEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIH 341
L G EL ++ EY+ SL D +D + ++ + + +LH + ++IH
Sbjct: 86 LVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALDFLHSN---QVIH 138
Query: 342 RDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKS 401
RD+K+ N+LL D + K++DFG Q++ +T + GT +MAPE + K
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYGPKV 196
Query: 402 DVFSFGVLLLEIISG 416
D++S G++ +E++ G
Sbjct: 197 DIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 2e-18
Identities = 73/282 (25%), Positives = 132/282 (46%), Gaps = 33/282 (11%)
Query: 217 HFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLS---RTSGQGLKEFKNEVNLIAKLQHK 272
+F E K+G+G F VY+ T L DG +A+K++ + + E++L+ +L H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 273 NLVRLLGCCLEGQELLLIYEYMPNKSLD--VHLFDATRSV---QLDWKRRLSIINGIARG 327
N+++ +E EL ++ E L + F + + + WK + + + +
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALE-- 120
Query: 328 ILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYM 387
H SR +++HRD+K +NV + K+ D G R F A++ + GT YM
Sbjct: 121 ----HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYM 173
Query: 388 APEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVEL 447
+PE ++ KSD++S G LL E+ + + FY G + Y+ C+ +E
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEMAA--LQSPFY----GDKMNLYS---LCK--KIEQ 222
Query: 448 ID-PVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488
D P L +EL + ++ +C+ DP RP ++ V +
Sbjct: 223 CDYPPLPSDHYSEELRQLVN---MCINPDPEKRPDITYVYDV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 2e-18
Identities = 64/204 (31%), Positives = 108/204 (52%), Gaps = 21/204 (10%)
Query: 224 LGQGGFGPVYKGTLAD-GKAIAVKRL-----SRTSGQGLKEFKNEVNLIAKLQHKNLVRL 277
LG+G FG VY AD G+ +AVK++ S+ + + + + E+ L+ L+H +V+
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69
Query: 278 LGCCLEGQE--LLLIYEYMPNKSLDVHL--FDA-TRSVQLDWKRRLSIINGIARGILYLH 332
GC + +E L + EYMP S+ L + A T +V + R+ I +G+ YLH
Sbjct: 70 YGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQ------ILQGVSYLH 123
Query: 333 EDSRLKIIHRDLKASNVLLDDDMNPKISDFGTA-RIFGGNQNQANTNIIAGTYGYMAPEY 391
+ I+HRD+K +N+L D N K+ DFG + RI + + GT +M+PE
Sbjct: 124 SN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEV 180
Query: 392 AMGGIFSIKSDVFSFGVLLLEIIS 415
G + K+DV+S ++E+++
Sbjct: 181 ISGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 3e-18
Identities = 65/215 (30%), Positives = 101/215 (46%), Gaps = 24/215 (11%)
Query: 216 NHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTS-GQGLKEFKNEVNLIAKLQH-K 272
D ++G+G FG V K G +AVKR+ T + K +++++ +
Sbjct: 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCP 63
Query: 273 NLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRL--SIINGIA----R 326
+V+ G + + E M D+ L + V K + I+ IA +
Sbjct: 64 YIVKFYGALFREGDCWICMELM-----DISLDKFYKYVYEVLKSVIPEEILGKIAVATVK 118
Query: 327 GILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGY 386
+ YL E+ LKIIHRD+K SN+LLD + N K+ DFG I G + AG Y
Sbjct: 119 ALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFG---ISGQLVDSIAKTRDAGCRPY 173
Query: 387 MAPE----YAMGGIFSIKSDVFSFGVLLLEIISGR 417
MAPE A G + ++SDV+S G+ L E+ +G+
Sbjct: 174 MAPERIDPSARDG-YDVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 4e-18
Identities = 64/208 (30%), Positives = 102/208 (49%), Gaps = 29/208 (13%)
Query: 221 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFK--------NEVNLIAKLQHK 272
+ +LG+G FG VY + D KA+A +RL + E E L++KL H
Sbjct: 5 QQRLGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHP 62
Query: 273 NLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQ-------LDWKRRLSIINGIA 325
+V+ LE +I EY + LD L + + + +W +L +
Sbjct: 63 AIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLL----- 117
Query: 326 RGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYG 385
G+ Y+H+ +I+HRDLKA N+ L +++ KI DFG +R+ G+ + A T GT
Sbjct: 118 -GVHYMHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATT--FTGTPY 170
Query: 386 YMAPEYAMGGIFSIKSDVFSFGVLLLEI 413
YM+PE + KSD++S G +L E+
Sbjct: 171 YMSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 5e-18
Identities = 57/204 (27%), Positives = 107/204 (52%), Gaps = 11/204 (5%)
Query: 218 FSDENKLGQGGFGPVYKG-TLADGKAIAVKRLS-RTSGQGLKEFK-NEVNLIAKLQHKNL 274
F K+G+G +G VYK G+ +A+K++ T +G+ E++L+ +L H N+
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 61
Query: 275 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHED 334
V+LL +L L++E++ ++ L + DA+ + S + + +G+ + H
Sbjct: 62 VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASPLSGIPLPLIKSYLFQLLQGLAFCHSH 119
Query: 335 SRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMG 394
+++HRDLK N+L++ + K++DFG AR FG ++ T Y APE +G
Sbjct: 120 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILLG 174
Query: 395 G-IFSIKSDVFSFGVLLLEIISGR 417
+S D++S G + E+++ R
Sbjct: 175 CKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 84.4 bits (208), Expect = 5e-18
Identities = 56/196 (28%), Positives = 104/196 (53%), Gaps = 12/196 (6%)
Query: 223 KLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCC 281
K+GQG G VY +A G+ +A+++++ + NE+ ++ + ++ N+V L
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 282 LEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIH 341
L G EL ++ EY+ SL D +D + ++ + + +LH + ++IH
Sbjct: 87 LVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHSN---QVIH 139
Query: 342 RDLKASNVLLDDDMNPKISDFG-TARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIK 400
RD+K+ N+LL D + K++DFG A+I Q+ + + GT +MAPE + K
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQI---TPEQSKRSTMVGTPYWMAPEVVTRKAYGPK 196
Query: 401 SDVFSFGVLLLEIISG 416
D++S G++ +E+I G
Sbjct: 197 VDIWSLGIMAIEMIEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 6e-18
Identities = 61/205 (29%), Positives = 105/205 (51%), Gaps = 19/205 (9%)
Query: 224 LGQGGFGPVYKGTLADGKAI---AVK--RLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLL 278
LG+G FG V +G L +I AVK +++ + +++F +E + + H N++RL+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 279 GCCLEGQEL------LLIYEYMPNKSLDVHLFDA---TRSVQLDWKRRLSIINGIARGIL 329
G CL+ E ++I +M + L L + L + + + IA G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 330 YLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFG-TARIFGGNQNQANTNIIAGTYGYMA 388
YL S IHRDL A N +L+++MN ++DFG + +I+ G+ + I ++A
Sbjct: 127 YL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQG-RIAKMPVKWIA 182
Query: 389 PEYAMGGIFSIKSDVFSFGVLLLEI 413
E +++ KSDV+SFGV + EI
Sbjct: 183 IESLADRVYTTKSDVWSFGVTMWEI 207
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 6e-18
Identities = 65/200 (32%), Positives = 106/200 (53%), Gaps = 16/200 (8%)
Query: 224 LGQGGFGPVYKGTLA-DGKAI----AVKRL-SRTSGQGLKEFKNEVNLIAKLQHKNLVRL 277
LG G FG VYKG DG+ + A+K L TS + KE +E ++A + + RL
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 278 LGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQ--LDWKRRLSIINGIARGILYLHEDS 335
LG CL + L+ + MP L D R + + + L+ IA+G+ YL E
Sbjct: 75 LGICLT-STVQLVTQLMPYGCL----LDYVRENKDRIGSQDLLNWCVQIAKGMSYLEE-- 127
Query: 336 RLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGG 395
++++HRDL A NVL+ + KI+DFG AR+ ++ + + + +MA E +
Sbjct: 128 -VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHR 186
Query: 396 IFSIKSDVFSFGVLLLEIIS 415
F+ +SDV+S+GV + E+++
Sbjct: 187 RFTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 7e-18
Identities = 52/201 (25%), Positives = 103/201 (51%), Gaps = 12/201 (5%)
Query: 218 FSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVR 276
+ K+G+G G V T + G+ +AVK++ Q + NEV ++ QH N+V
Sbjct: 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVE 80
Query: 277 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSR 336
+ L G EL ++ E++ +L D +++ ++ ++ + + + +LH
Sbjct: 81 MYSSYLVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLAVLKALSFLHAQ-- 134
Query: 337 LKIIHRDLKASNVLLDDDMNPKISDFG-TARIFGGNQNQANTNIIAGTYGYMAPEYAMGG 395
+IHRD+K+ ++LL D K+SDFG A++ ++ + GT +MAPE
Sbjct: 135 -GVIHRDIKSDSILLTSDGRVKLSDFGFCAQV---SKEVPRRKSLVGTPYWMAPEVISRL 190
Query: 396 IFSIKSDVFSFGVLLLEIISG 416
+ + D++S G++++E++ G
Sbjct: 191 PYGTEVDIWSLGIMVIEMVDG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 8e-18
Identities = 79/281 (28%), Positives = 129/281 (45%), Gaps = 48/281 (17%)
Query: 221 ENKLGQGGFGPVYKGTLA-DGK---AIAVKRL-SRTSGQGLKEFKNEVNLIAKLQHKNLV 275
E LG G FG + +G L K +A+ L + S + + F E + + H N+V
Sbjct: 10 ERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIV 69
Query: 276 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDS 335
RL G G ++++ EYM N +LD L QL + + ++ G+A G+ YL E
Sbjct: 70 RLEGVITRGNTMMIVTEYMSNGALDSFL--RKHEGQLVAGQLMGMLPGLASGMKYLSE-- 125
Query: 336 RLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYG------YMAP 389
+ +H+ L A VL++ D+ KIS F ++++ I T + AP
Sbjct: 126 -MGYVHKGLAAHKVLVNSDLVCKISGFRR-----LQEDKSEA--IYTTMSGKSPVLWAAP 177
Query: 390 EYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVE-- 446
E FS SDV+SFG+++ E++S G + Y+ GQ ++ AVE
Sbjct: 178 EAIQYHHFSSASDVWSFGIVMWEVMSYGERP---YWDMSGQDVIK----------AVEDG 224
Query: 447 --LIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSV 485
L P +C P+ L + + L C Q++ +RP S +
Sbjct: 225 FRLPAPR---NC-PNLLHQLM---LDCWQKERGERPRFSQI 258
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 8e-18
Identities = 70/238 (29%), Positives = 109/238 (45%), Gaps = 59/238 (24%)
Query: 223 KLGQGGFGPV---------------YKGTLADGKA--IAVKRLSRTSGQGLK-EFKNEVN 264
KLG+G FG V + + G+ +AVK L + + + +F EV
Sbjct: 12 KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK 71
Query: 265 LIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDV-----HLFDATRS---------- 309
++++L+ N++RLLG C++ L +I EYM N L+ HL D +
Sbjct: 72 ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHC 131
Query: 310 -VQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIF 368
+ + L + IA G+ YL S L +HRDL N L+ +++ KI+DFG +R
Sbjct: 132 LPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSR-- 186
Query: 369 GGNQNQANTNIIAGTY-----------GYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 415
N+ AG Y +MA E + G F+ SDV++FGV L EI+
Sbjct: 187 ---------NLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 1e-17
Identities = 64/211 (30%), Positives = 106/211 (50%), Gaps = 26/211 (12%)
Query: 224 LGQGGFGPVYKGTLA-DGKAI--AVKRLSRTSGQG-LKEFKNEVNLIAKL-QHKNLVRLL 278
+G+G FG V K + DG + A+KR+ + + ++F E+ ++ KL H N++ LL
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 279 GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLD--------------WKRRLSIINGI 324
G C L L EY P+ +L + +R ++ D ++ L +
Sbjct: 63 GACEHRGYLYLAIEYAPHGNL-LDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121
Query: 325 ARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTY 384
ARG+ YL + + IHRDL A N+L+ ++ KI+DFG +R G + +
Sbjct: 122 ARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLPV 175
Query: 385 GYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 415
+MA E +++ SDV+S+GVLL EI+S
Sbjct: 176 RWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 1e-17
Identities = 58/209 (27%), Positives = 108/209 (51%), Gaps = 21/209 (10%)
Query: 223 KLGQGGFGPVYKGTLA----DGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLL 278
K+G+G G V +A G+ +AVK + Q + NEV ++ QH+N+V +
Sbjct: 28 KIGEGSTGIV---CIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMY 84
Query: 279 GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLK 338
L G+EL ++ E++ +L D +L+ ++ ++ + + + YLH
Sbjct: 85 KSYLVGEELWVLMEFLQGGALT----DIVSQTRLNEEQIATVCESVLQALCYLHSQG--- 137
Query: 339 IIHRDLKASNVLLDDDMNPKISDFG-TARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIF 397
+IHRD+K+ ++LL D K+SDFG A+I +++ + GT +MAPE +
Sbjct: 138 VIHRDIKSDSILLTLDGRVKLSDFGFCAQI---SKDVPKRKSLVGTPYWMAPEVISRTPY 194
Query: 398 SIKSDVFSFGVLLLEIISGRKNNGFYFSE 426
+ D++S G++++E++ G YFS+
Sbjct: 195 GTEVDIWSLGIMVIEMVDGEPP---YFSD 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.7 bits (205), Expect = 2e-17
Identities = 60/203 (29%), Positives = 107/203 (52%), Gaps = 19/203 (9%)
Query: 222 NKLGQGGFGPVYKGT-LADGKAIAVKRLS-RTSGQGLKEFK-NEVNLIAKLQ---HKNLV 275
++G+G +G VYK L G+ +A+K++ S +G+ E+ L+ +L+ H N+V
Sbjct: 5 AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIV 64
Query: 276 RLLGCCL-----EGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILY 330
RLL C +L L++E++ ++ L +L + L + ++ + RG+ +
Sbjct: 65 RLLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPG-LPPETIKDLMRQLLRGVDF 122
Query: 331 LHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPE 390
LH +I+HRDLK N+L+ D KI+DFG ARI+ A T+++ T Y APE
Sbjct: 123 LHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYS--FEMALTSVVV-TLWYRAPE 176
Query: 391 YAMGGIFSIKSDVFSFGVLLLEI 413
+ ++ D++S G + E+
Sbjct: 177 VLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 2e-17
Identities = 61/205 (29%), Positives = 107/205 (52%), Gaps = 18/205 (8%)
Query: 223 KLGQGGFGPVYKGTLADGKA---IAVKRLSRTSGQGLK-EFKNEVNLIAKLQHKNLVRLL 278
+LG G FG V KG K +A+K L + + ++ E E ++ +L + +VR++
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 279 GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLK 338
G C E + L+L+ E L + F + + ++ + +++ ++ G+ YL +
Sbjct: 62 GVC-EAEALMLVMEMASGGPL--NKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN--- 115
Query: 339 IIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQN--QANTNIIAGTY--GYMAPEYAMG 394
+HRDL A NVLL + KISDFG ++ G + + +A + AG + + APE
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARS---AGKWPLKWYAPECINF 172
Query: 395 GIFSIKSDVFSFGVLLLEIIS-GRK 418
FS +SDV+S+G+ + E S G+K
Sbjct: 173 RKFSSRSDVWSYGITMWEAFSYGQK 197
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 2e-17
Identities = 71/278 (25%), Positives = 127/278 (45%), Gaps = 33/278 (11%)
Query: 218 FSDENKLGQGGFGPVYKGT-LADGKAIAVKRLS---RTSGQGLKEFKNEVNLIAKLQHKN 273
F E K+G+G F VY+ T L D K +A+K++ + ++ E++L+ +L H N
Sbjct: 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63
Query: 274 LVRLLGCCLEGQELLLIYEYMPNKSLD--VHLFDATRSV---QLDWKRRLSIINGIARGI 328
+++ L +E EL ++ E L + F + + + WK + + + +
Sbjct: 64 VIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE--- 120
Query: 329 LYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMA 388
H SR +++HRD+K +NV + K+ D G R F A++ + GT YM+
Sbjct: 121 ---HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMS 174
Query: 389 PEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELI 448
PE ++ KSD++S G LL E+ + + FY + L+ +E
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEMAA--LQSPFYGDK---------MNLFSLCQKIEQC 223
Query: 449 D-PVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSV 485
D P L ++L + + +C+ DP RP + V
Sbjct: 224 DYPPLPTEHYSEKLRELVS---MCIYPDPDQRPDIGYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 81.1 bits (201), Expect = 4e-17
Identities = 61/208 (29%), Positives = 99/208 (47%), Gaps = 26/208 (12%)
Query: 224 LGQGGFGPVY----KGTLADGKAIAVKRLSRTSGQG---LKEFKNEVNLIAKLQHKNLVR 276
+ +G +G V+ K T G A+K + + + + E +++++ Q +V+
Sbjct: 1 ISKGAYGRVFLAKKKST---GDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVK 57
Query: 277 LLGCCLEGQE-LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDS 335
L +G++ L L+ EY+P L L + S+ D R I I + YLH
Sbjct: 58 LY-YSFQGKKNLYLVMEYLPGGDL-ASLLENVGSLDEDVAR--IYIAEIVLALEYLH--- 110
Query: 336 RLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNI-------IAGTYGYMA 388
IIHRDLK N+L+D + + K++DFG ++ G + Q N N I GT Y+A
Sbjct: 111 SNGIIHRDLKPDNILIDSNGHLKLTDFGLSK-VGLVRRQINLNDDEKEDKRIVGTPDYIA 169
Query: 389 PEYAMGGIFSIKSDVFSFGVLLLEIISG 416
PE +G S D +S G +L E + G
Sbjct: 170 PEVILGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 5e-17
Identities = 56/206 (27%), Positives = 107/206 (51%), Gaps = 15/206 (7%)
Query: 223 KLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCC 281
K+G+G G V T+ + GK +AVK++ Q + NEV ++ QH+N+V +
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 282 LEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIH 341
L G EL ++ E++ +L D +++ ++ ++ + + + LH +IH
Sbjct: 87 LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLAVLKALSVLHAQG---VIH 139
Query: 342 RDLKASNVLLDDDMNPKISDFG-TARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIK 400
RD+K+ ++LL D K+SDFG A++ ++ + GT +MAPE + +
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFCAQV---SKEVPRRKSLVGTPYWMAPELISRLPYGPE 196
Query: 401 SDVFSFGVLLLEIISGRKNNGFYFSE 426
D++S G++++E++ G YF+E
Sbjct: 197 VDIWSLGIMVIEMVDGEPP---YFNE 219
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 7e-17
Identities = 63/210 (30%), Positives = 105/210 (50%), Gaps = 18/210 (8%)
Query: 216 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVK--RLSRTSGQGLKEFKNEVNLIAKLQHK 272
+ + K+G+G +G VYK + IA+K RL + E++L+ ++QH
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
Query: 273 NLVRLLGCCLEGQELLLIYEYMPNKSLDVHL---FDATRSVQLDWKRRLSIINGIARGIL 329
N+VRL + L L++EY LD+ L D++ + + + + I RGI
Sbjct: 62 NIVRLQDVVHSEKRLYLVFEY-----LDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIA 116
Query: 330 YLHEDSRLKIIHRDLKASNVLLDDDMNP-KISDFGTARIFGGNQNQANTNIIAGTYGYMA 388
Y H S +++HRDLK N+L+D N K++DFG AR FG ++ T Y A
Sbjct: 117 YCH--SH-RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV--TLWYRA 171
Query: 389 PEYAMGG-IFSIKSDVFSFGVLLLEIISGR 417
PE +G +S D++S G + E+++ +
Sbjct: 172 PEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 1e-16
Identities = 59/205 (28%), Positives = 94/205 (45%), Gaps = 15/205 (7%)
Query: 216 NHFSDENKLGQGGFGPVYKGTLADGKAI-AVKRLSRTSGQGLKEFK---NEVNLIAKLQH 271
F ++GQGG+G V+ D I A+KR+ ++ L E + E +++ +
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS 60
Query: 272 KNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYL 331
+ LV+LL + + L L EY+P L + + D R + + L
Sbjct: 61 EWLVKLLYAFQDDEYLYLAMEYVPGGDFRT-LLNNLGVLSED-HARFYMAEMFE-AVDAL 117
Query: 332 HEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEY 391
H L IHRDLK N L+D + K++DFG ++ G AN+ + G+ YMAPE
Sbjct: 118 H---ELGYIHRDLKPENFLIDASGHIKLTDFGLSK---GIVTYANS--VVGSPDYMAPEV 169
Query: 392 AMGGIFSIKSDVFSFGVLLLEIISG 416
G + D +S G +L E + G
Sbjct: 170 LRGKGYDFTVDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 1e-16
Identities = 59/222 (26%), Positives = 107/222 (48%), Gaps = 32/222 (14%)
Query: 208 LGLALEATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLKEFKN----- 261
G E TN + D +G G FG V G+ +A+K++ +K F
Sbjct: 2 FGTVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKI-------MKPFSTPVLAK 54
Query: 262 ----EVNLIAKLQHKNLVRLLGCCLEGQE-LLLIYEYMPNKSLDVHLFDATRSVQLDWKR 316
E+ L+ L+H+N++ L + E + + E + D+H +R ++ + +
Sbjct: 55 RTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL---GTDLHRLLTSRPLEKQFIQ 111
Query: 317 RLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQAN 376
+ I RG+ Y+H ++HRDLK SN+L++++ + KI DFG ARI Q+
Sbjct: 112 YF--LYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI----QDPQM 162
Query: 377 TNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGR 417
T ++ Y Y APE + + ++ D++S G + E++ G+
Sbjct: 163 TGYVSTRY-YRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 80.3 bits (199), Expect = 1e-16
Identities = 69/213 (32%), Positives = 97/213 (45%), Gaps = 47/213 (22%)
Query: 224 LGQGGFGPV----YKGTLADGKAIAVKRLSRTSGQGLKE---FKNEVNLIAKLQHKNLVR 276
LG G FG V +KG+ GK A+K LS+ LK+ NE ++ ++H LV
Sbjct: 9 LGTGSFGRVMLVRHKGS---GKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVN 65
Query: 277 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIAR--------GI 328
L G + L L+ EY+P L F R R +AR +
Sbjct: 66 LYGSFQDDSNLYLVMEYVPGGEL----FSHLRKS-----GRFP--EPVARFYAAQVVLAL 114
Query: 329 LYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMA 388
YLH L I++RDLK N+LLD D KI+DFG A+ G T + GT Y+A
Sbjct: 115 EYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG-----RTYTLCGTPEYLA 166
Query: 389 PEYAMGGIFSIK-----SDVFSFGVLLLEIISG 416
PE I K D ++ G+L+ E+++G
Sbjct: 167 PE-----IILSKGYGKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 1e-16
Identities = 55/201 (27%), Positives = 101/201 (50%), Gaps = 18/201 (8%)
Query: 223 KLGQGGFGPVYKG-TLADGKAIAVKRLSRTS-GQGLKEFK-NEVNLIAKLQHKNLVRLLG 279
K+G+G +G V+K + +A+KR+ +G+ E+ L+ +L+HKN+VRL
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66
Query: 280 CCLEGQELLLIYEYMPNKSLDVHL---FDATRSVQLDWKRRLSIINGIARGILYLHEDSR 336
++L L++EY D L FD+ +D + S + + +G+ + H
Sbjct: 67 VLHSDKKLTLVFEY-----CDQDLKKYFDSCNG-DIDPEIVKSFMFQLLKGLAFCHSH-- 118
Query: 337 LKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGG- 395
++HRDLK N+L++ + K++DFG AR FG + ++ T Y P+ G
Sbjct: 119 -NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV--TLWYRPPDVLFGAK 175
Query: 396 IFSIKSDVFSFGVLLLEIISG 416
++S D++S G + E+ +
Sbjct: 176 LYSTSIDMWSAGCIFAELANA 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 1e-16
Identities = 58/206 (28%), Positives = 105/206 (50%), Gaps = 15/206 (7%)
Query: 223 KLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCC 281
K+G+G G V T GK +AVK++ Q + NEV ++ H+N+V +
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 282 LEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIH 341
L G EL ++ E++ +L D +++ ++ ++ + R + YLH +IH
Sbjct: 89 LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLSVLRALSYLHNQG---VIH 141
Query: 342 RDLKASNVLLDDDMNPKISDFG-TARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIK 400
RD+K+ ++LL D K+SDFG A++ ++ + GT +MAPE + +
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFGFCAQV---SKEVPKRKSLVGTPYWMAPEVISRLPYGTE 198
Query: 401 SDVFSFGVLLLEIISGRKNNGFYFSE 426
D++S G++++E+I G YF+E
Sbjct: 199 VDIWSLGIMVIEMIDGEPP---YFNE 221
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 1e-16
Identities = 58/206 (28%), Positives = 97/206 (47%), Gaps = 23/206 (11%)
Query: 224 LGQGGFGPVYK--GTLADGKAIAVKRLSRTS---GQGLKE-------FKNEVNLIAK-LQ 270
LG G FG VYK +A+K ++ + G+ +E +EV +I + L+
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 271 HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQ-LDWKRRLSIINGIARGIL 329
H N+VR LE L ++ + + L H Q +R +I + +
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127
Query: 330 YLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNI--IAGTYGYM 387
YLH++ R I+HRDL +N++L +D I+DFG A+ Q Q + + + GT Y
Sbjct: 128 YLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAK-----QKQPESKLTSVVGTILYS 180
Query: 388 APEYAMGGIFSIKSDVFSFGVLLLEI 413
PE + K+DV++FG +L ++
Sbjct: 181 CPEIVKNEPYGEKADVWAFGCILYQM 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 79.4 bits (195), Expect = 2e-16
Identities = 60/205 (29%), Positives = 97/205 (47%), Gaps = 18/205 (8%)
Query: 224 LGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKL-QHKNLVRLLGCCL 282
+G G +G VYKG +A ++ +G +E K E+N++ K H+N+ G +
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 73
Query: 283 EGQ------ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSR 336
+ +L L+ E+ S+ L T+ L + I I RG+ +LH+
Sbjct: 74 KKNPPGMDDQLWLVMEFCGAGSV-TDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH-- 130
Query: 337 LKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAM--- 393
K+IHRD+K NVLL ++ K+ DFG + + NT I GT +MAPE
Sbjct: 131 -KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI--GTPYWMAPEVIACDE 187
Query: 394 --GGIFSIKSDVFSFGVLLLEIISG 416
+ KSD++S G+ +E+ G
Sbjct: 188 NPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 2e-16
Identities = 81/298 (27%), Positives = 129/298 (43%), Gaps = 74/298 (24%)
Query: 226 QGGFGPVYKGTLADGK-----AIAVKRLSRTSGQ-GLKEFKNEVNLIAKLQHKNLVRLLG 279
+G FG ++ G L D K + VK + + + + E L+ L H+N++ +L
Sbjct: 16 EGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILH 75
Query: 280 CCLEGQEL-LLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIIN------GIARGILYLH 332
C+E E ++Y YM +L + L R + + + LS IA G+ YLH
Sbjct: 76 VCIEDGEPPFVLYPYMNWGNLKLFLQQC-RLGEANNPQALSTQQLVHMAIQIACGMSYLH 134
Query: 333 EDSRLKIIHRDLKASNVLLDDDMNPKISDFGTAR-IF-------GGNQNQANTNIIAGTY 384
+ +IH+D+ A N ++D+++ KI+D +R +F G N+N+
Sbjct: 135 ---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRP--------V 183
Query: 385 GYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHA 444
+MA E + +S SDV+SFGVLL E+++ GQT
Sbjct: 184 KWMALESLVNKEYSSASDVWSFGVLLWELMT-----------LGQT-------------P 219
Query: 445 VELIDPV-----------LKQ--SCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 489
IDP L Q +C PDEL + C DP +RP+ S +V L
Sbjct: 220 YVEIDPFEMAAYLKDGYRLAQPINC-PDELFA---VMACCWALDPEERPSFSQLVQCL 273
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 2e-16
Identities = 62/201 (30%), Positives = 104/201 (51%), Gaps = 15/201 (7%)
Query: 222 NKLGQGGFGPVYKG--TLADGKAIAVK--RLSRTSGQGLKEFKNEVNLIAKLQHKNLVRL 277
+KLG+G + VYKG L D +A+K RL G + EV+L+ L+H N+V L
Sbjct: 12 DKLGEGTYATVYKGRSKLTD-NLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTL 69
Query: 278 LGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRL 337
+ L L++EY+ +K L +L D S+ + +L + + RG+ Y H R
Sbjct: 70 HDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMH-NVKLFLFQ-LLRGLNYCH---RR 123
Query: 338 KIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGI- 396
K++HRDLK N+L+++ K++DFG AR + ++ T Y P+ +G
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV--TLWYRPPDILLGSTD 181
Query: 397 FSIKSDVFSFGVLLLEIISGR 417
+S + D++ G + E+ +GR
Sbjct: 182 YSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 3e-16
Identities = 61/226 (26%), Positives = 98/226 (43%), Gaps = 36/226 (15%)
Query: 286 ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLK 345
E+ + E+M SLD L A R + + ++SI + RG+ YL E + KI+HRD+K
Sbjct: 73 EISICMEHMDGGSLDQVLKKAGR-IPENILGKISI--AVLRGLTYLRE--KHKIMHRDVK 127
Query: 346 ASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFS 405
SN+L++ K+ DFG + G + N GT YM+PE G ++++SD++S
Sbjct: 128 PSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQGTHYTVQSDIWS 183
Query: 406 FGVLLLEIISGR--------KNNGFYFSEHGQTLLTYTWKLWCEGHA---------VELI 448
G+ L+E+ GR K F GH EL+
Sbjct: 184 LGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELL 243
Query: 449 D-------PVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 487
D P L DE F+ C++++P +R + +
Sbjct: 244 DYIVNEPPPKLPSGAFSDEFQDFVDK---CLKKNPKERADLKELTK 286
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.2 bits (196), Expect = 3e-16
Identities = 56/213 (26%), Positives = 104/213 (48%), Gaps = 18/213 (8%)
Query: 218 FSDENKLGQGGFGPVYKG---TLADGKAIAVKRL--SRTSGQGLKEFK-NEVNLIAKLQH 271
+ E +G+G +G VYK DGK A+K+ + G+ + E+ L+ +L+H
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61
Query: 272 KNLVRLLGCCLEGQE--LLLIYEYMPNKSLDV-HLFDATRSVQLDWKRRLSIINGIARGI 328
+N+V L+ LE + + L+++Y + + + V + S++ I G+
Sbjct: 62 ENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGV 121
Query: 329 LYLHEDSRLKIIHRDLKASNVLLDDDMNP----KISDFGTARIFGGNQNQ-ANTNIIAGT 383
YLH + ++HRDLK +N+L+ + KI D G AR+F A+ + + T
Sbjct: 122 HYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVT 178
Query: 384 YGYMAPEYAMGGIFSIKS-DVFSFGVLLLEIIS 415
Y APE +G K+ D+++ G + E+++
Sbjct: 179 IWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 3e-16
Identities = 60/204 (29%), Positives = 102/204 (50%), Gaps = 18/204 (8%)
Query: 224 LGQGGFGPVYKGT-LADGKAIAVKRLSRT-SGQGLKEFKNEVNLIAKLQH-KNLVRLLGC 280
LG+G +G V K + G +AVKR+ T + Q K ++++ + V G
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGA 68
Query: 281 CLEGQELLLIYEYMPNKSLD---VHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRL 337
++ + E M + SLD ++D ++ D ++++ I + + YLH +L
Sbjct: 69 LFREGDVWICMEVM-DTSLDKFYKKVYDKGLTIPEDILGKIAV--SIVKALEYLHS--KL 123
Query: 338 KIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGI- 396
+IHRD+K SNVL++ + K+ DFG I G + I AG YMAPE +
Sbjct: 124 SVIHRDVKPSNVLINRNGQVKLCDFG---ISGYLVDSVAKTIDAGCKPYMAPERINPELN 180
Query: 397 ---FSIKSDVFSFGVLLLEIISGR 417
+ +KSDV+S G+ ++E+ +GR
Sbjct: 181 QKGYDVKSDVWSLGITMIELATGR 204
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 1e-15
Identities = 58/199 (29%), Positives = 98/199 (49%), Gaps = 15/199 (7%)
Query: 223 KLGQGGFGPVYKGTLA----DGKAIAVKRL--SRTSGQGLKEFKNEVNLIAKLQHKNLVR 276
K+G+G FG K L DGK +K + S+ S + +E + EV +++ ++H N+V+
Sbjct: 7 KIGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQ 63
Query: 277 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSR 336
E L ++ +Y L +A R V + L I + ++H+
Sbjct: 64 YQESFEENGNLYIVMDYCEGGDL-YKKINAQRGVLFPEDQILDWFVQICLALKHVHDR-- 120
Query: 337 LKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGI 396
KI+HRD+K+ N+ L D K+ DFG AR+ A T I GT Y++PE
Sbjct: 121 -KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCI--GTPYYLSPEICENRP 177
Query: 397 FSIKSDVFSFGVLLLEIIS 415
++ KSD+++ G +L E+ +
Sbjct: 178 YNNKSDIWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 1e-15
Identities = 58/199 (29%), Positives = 102/199 (51%), Gaps = 14/199 (7%)
Query: 223 KLGQGGFGPVYKGTLAD-GKAIAVKR-LSRTSGQGLKEFK-NEVNLIAKLQHKNLVRLLG 279
+G+G +G V K + G+ +A+K+ L + +K+ E+ ++ +L+H+NLV L+
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 280 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQ-LDWKRRLSIINGIARGILYLHEDSRLK 338
+ L L++E++ + LD D + LD R + I RGI + H +
Sbjct: 68 VFRRKKRLYLVFEFVDHTVLD----DLEKYPNGLDESRVRKYLFQILRGIEFCHSHN--- 120
Query: 339 IIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGI-F 397
IIHRD+K N+L+ K+ DFG AR + T+ +A T Y APE +G +
Sbjct: 121 IIHRDIKPENILVSQSGVVKLCDFGFARTLAA-PGEVYTDYVA-TRWYRAPELLVGDTKY 178
Query: 398 SIKSDVFSFGVLLLEIISG 416
D+++ G L+ E+++G
Sbjct: 179 GRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 2e-15
Identities = 52/198 (26%), Positives = 90/198 (45%), Gaps = 12/198 (6%)
Query: 223 KLGQGGFGPVYKGTLADGK----AIAVKRLSRTSGQGLKE-FKNEVNLIAKLQHKNLVRL 277
+G+G FG VY+G + A+AVK + ++E F E ++ + H ++V+L
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 278 LGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRL 337
+G E + ++ E P L +L LD + ++ + YL
Sbjct: 73 IGVITE-NPVWIVMELAPLGELRSYL--QVNKYSLDLASLILYSYQLSTALAYLES---K 126
Query: 338 KIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIF 397
+ +HRD+ A NVL+ K+ DFG +R +++ + +MAPE F
Sbjct: 127 RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE-DESYYKASKGKLPIKWMAPESINFRRF 185
Query: 398 SIKSDVFSFGVLLLEIIS 415
+ SDV+ FGV + EI+
Sbjct: 186 TSASDVWMFGVCMWEILM 203
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 3e-15
Identities = 58/200 (29%), Positives = 92/200 (46%), Gaps = 15/200 (7%)
Query: 224 LGQGGFGPV------YKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRL 277
LG+GGFG V G + K + KR+ + G+ + NE ++ K+ + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMA--LNEKQILEKVNSRFVVSL 65
Query: 278 LGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRL 337
L L+ M L H++ + + R + I G+ LH++
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYHMGEA-GFEEGRAVFYAAEICCGLEDLHQE--- 121
Query: 338 KIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIF 397
+I++RDLK N+LLDD + +ISD G A Q GT GYMAPE +
Sbjct: 122 RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR---VGTVGYMAPEVVKNERY 178
Query: 398 SIKSDVFSFGVLLLEIISGR 417
+ D ++ G LL E+I+G+
Sbjct: 179 TFSPDWWALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 5e-15
Identities = 69/203 (33%), Positives = 100/203 (49%), Gaps = 21/203 (10%)
Query: 224 LGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLKEFKNEVNLIAK----LQHKN-LVRL 277
LG+G FG V L G+ AVK L + L + E ++ K L +N +
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVV--LIDDDVECTMVEKRVLALAWENPFLTH 60
Query: 278 LGCCLEGQE-LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSR 336
L C + +E L + E++ L H+ D R D R I G+ +LH
Sbjct: 61 LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGR---FDLYRATFYAAEIVCGLQFLHSKG- 116
Query: 337 LKIIHRDLKASNVLLDDDMNPKISDFGTAR--IFGGNQNQANTNIIAGTYGYMAPEYAMG 394
II+RDLK NV+LD D + KI+DFG + +FG N+A+T GT Y+APE G
Sbjct: 117 --IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG--DNRAST--FCGTPDYIAPEILQG 170
Query: 395 GIFSIKSDVFSFGVLLLEIISGR 417
++ D +SFGVLL E++ G+
Sbjct: 171 LKYTFSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 7e-15
Identities = 61/199 (30%), Positives = 93/199 (46%), Gaps = 13/199 (6%)
Query: 224 LGQGGFGPVYKGTL-ADGKAIAVKRLSRT---SGQGLKEFKNEVNLIAKLQHKNLVRLLG 279
LG+GGFG V + A GK A KRL + +G NE ++ K+ + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAY 67
Query: 280 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKI 339
L L+ M L H+++ + +R L I G+ LH ++
Sbjct: 68 AYETKDALCLVLTIMNGGDLKFHIYNMGNP-GFEEERALFYAAEILCGLEDLHREN---T 123
Query: 340 IHRDLKASNVLLDDDMNPKISDFGTA-RIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFS 398
++RDLK N+LLDD + +ISD G A +I G + GT GYMAPE ++
Sbjct: 124 VYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRV----GTVGYMAPEVLNNQRYT 179
Query: 399 IKSDVFSFGVLLLEIISGR 417
+ D + G L+ E+I G+
Sbjct: 180 LSPDYWGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 7e-15
Identities = 66/209 (31%), Positives = 97/209 (46%), Gaps = 33/209 (15%)
Query: 224 LGQGGFGPV----YKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNL------IAKLQ--H 271
LG+G FG V KGT + AVK L + + ++V + L H
Sbjct: 3 LGKGSFGKVLLAELKGT---DELYAVKVLKK----DVILQDDDVECTMTEKRVLALAGKH 55
Query: 272 KNLVRLLGCCLEGQE-LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILY 330
L +L C + ++ L + EY+ L H+ RS + D R I G+ +
Sbjct: 56 PFLTQLH-SCFQTKDRLFFVMEYVNGGDLMFHI---QRSGRFDEPRARFYAAEIVLGLQF 111
Query: 331 LHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTAR--IFGGNQNQANTNIIAGTYGYMA 388
LHE II+RDLK NVLLD + + KI+DFG + I GG T+ GT Y+A
Sbjct: 112 LHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT----TSTFCGTPDYIA 164
Query: 389 PEYAMGGIFSIKSDVFSFGVLLLEIISGR 417
PE + D ++ GVLL E+++G+
Sbjct: 165 PEILSYQPYGPAVDWWALGVLLYEMLAGQ 193
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 7e-15
Identities = 63/204 (30%), Positives = 95/204 (46%), Gaps = 23/204 (11%)
Query: 224 LGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLKEFKNEVNLIAK------LQHKNLVR 276
LG+G FG V+ L + A+K L + L + E ++ K +H L
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVV--LMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 277 LLGCCLEGQE-LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDS 335
L C + +E L + EY+ L H+ + D R I G+ +LH
Sbjct: 61 LY-CTFQTKENLFFVMEYLNGGDLMFHIQSCHK---FDLPRATFYAAEIICGLQFLHSKG 116
Query: 336 RLKIIHRDLKASNVLLDDDMNPKISDFGTAR--IFGGNQNQANTNIIAGTYGYMAPEYAM 393
I++RDLK N+LLD D + KI+DFG + + G A T GT Y+APE +
Sbjct: 117 ---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLG----DAKTCTFCGTPDYIAPEILL 169
Query: 394 GGIFSIKSDVFSFGVLLLEIISGR 417
G ++ D +SFGVLL E++ G+
Sbjct: 170 GQKYNTSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 7e-15
Identities = 42/154 (27%), Positives = 75/154 (48%), Gaps = 9/154 (5%)
Query: 262 EVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSII 321
E L+ + H +++R+ + G ++ +P+ S D++ + RS L + L I
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKRSRPLPIDQALIIE 163
Query: 322 NGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIA 381
I G+ YLH +IIHRD+K N+ ++D I D G A+ +A
Sbjct: 164 KQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQF---PVVAPAFLGLA 217
Query: 382 GTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 415
GT APE ++ K+D++S G++L E+++
Sbjct: 218 GTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA 251
|
Length = 357 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 7e-15
Identities = 56/197 (28%), Positives = 100/197 (50%), Gaps = 16/197 (8%)
Query: 223 KLGQGGFGPVYKG-TLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCC 281
++G G +G VYK L G+ AVK + G + E+ ++ + +H N+V G
Sbjct: 16 RVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSY 75
Query: 282 LEGQELLLIYEYMPNKSL-DV-HLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKI 339
L ++L + EY SL D+ H+ +Q+ + R ++ +G+ YLH ++
Sbjct: 76 LSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL-----QGLAYLHSKGKM-- 128
Query: 340 IHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAM---GGI 396
HRD+K +N+LL D+ + K++DFG A + + I GT +MAPE A G
Sbjct: 129 -HRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI--GTPYWMAPEVAAVEKNGG 185
Query: 397 FSIKSDVFSFGVLLLEI 413
++ D+++ G+ +E+
Sbjct: 186 YNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 9e-15
Identities = 64/202 (31%), Positives = 105/202 (51%), Gaps = 20/202 (9%)
Query: 224 LGQGGFGPVY---KGTLAD-GKAIAVKRLSRTSGQGLK-----EFKNEVNLIAKLQHKNL 274
LGQG FG V+ K T D G+ A+K L + + LK K E +++A++ H +
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKAT---LKVRDRVRTKMERDILAEVNHPFI 60
Query: 275 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHED 334
V+L +L LI +++ L L + D K L+ +A + +LH
Sbjct: 61 VKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA---ELALALDHLH-- 115
Query: 335 SRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMG 394
L II+RDLK N+LLD++ + K++DFG ++ ++ +A + GT YMAPE
Sbjct: 116 -SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYMAPEVVNR 172
Query: 395 GIFSIKSDVFSFGVLLLEIISG 416
+ +D +SFGVL+ E+++G
Sbjct: 173 RGHTQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 74.9 bits (185), Expect = 1e-14
Identities = 55/222 (24%), Positives = 99/222 (44%), Gaps = 39/222 (17%)
Query: 217 HFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLKEFKN---------EVNLI 266
+ +G G +G V G+ +A+K++S F + E+ L+
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNV-------FDDLIDAKRILREIKLL 53
Query: 267 AKLQHKNLVRLL-----GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQ-LDWKRRLSI 320
L+H+N++ LL + ++ ++ E M + L +S Q L
Sbjct: 54 RHLRHENIIGLLDILRPPSPEDFNDVYIVTELM-----ETDLHKVIKSPQPLTDDHIQYF 108
Query: 321 INGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQAN--TN 378
+ I RG+ YLH +IHRDLK SN+L++ + + KI DFG AR ++++ T
Sbjct: 109 LYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTE 165
Query: 379 IIAGTYGYMAPEYAMGGI---FSIKSDVFSFGVLLLEIISGR 417
+ T Y APE + +I D++S G + E+++ +
Sbjct: 166 YVV-TRWYRAPELLLSSSRYTKAI--DIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 1e-14
Identities = 65/229 (28%), Positives = 100/229 (43%), Gaps = 60/229 (26%)
Query: 218 FSDENKLGQGGFGPVYKG-TLADGKAIAVK--RLSRTSG----QGLKEFKNEVNLIAKLQ 270
F N++G+G +G VY+ G+ +A+K R+ L+E + L+ L+
Sbjct: 9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLRE----ITLLLNLR 64
Query: 271 HKNLVRLLGCCLEGQEL---LLIYEY-----------MPN-------KSLDVHLFDATRS 309
H N+V L + G+ L L+ EY MP K L + L
Sbjct: 65 HPNIVELKEV-VVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLL----- 118
Query: 310 VQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFG 369
RG+ YLHE+ IIHRDLK SN+LL D KI+DFG AR +G
Sbjct: 119 ----------------RGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159
Query: 370 GNQNQANTNIIAGTYGYMAPEYAMGGIFSIKS-DVFSFGVLLLEIISGR 417
++ T Y APE +G + D+++ G +L E+++ +
Sbjct: 160 LPAKPMTPKVV--TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 1e-14
Identities = 59/201 (29%), Positives = 101/201 (50%), Gaps = 15/201 (7%)
Query: 222 NKLGQGGFGPVYKG--TLADGKAIAVK--RLSRTSGQGLKEFKNEVNLIAKLQHKNLVRL 277
KLG+G + V+KG L + +A+K RL G + EV+L+ L+H N+V L
Sbjct: 12 EKLGEGTYATVFKGRSKLTE-NLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTL 69
Query: 278 LGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRL 337
+ L L++EY+ +K L ++ D + + + + I RG+ Y H R
Sbjct: 70 HDIVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIF--LYQILRGLAYCH---RR 123
Query: 338 KIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGI- 396
K++HRDLK N+L+++ K++DFG AR + ++ T Y P+ +G
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLGSSE 181
Query: 397 FSIKSDVFSFGVLLLEIISGR 417
+S + D++ G + E+ SGR
Sbjct: 182 YSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 2e-14
Identities = 63/208 (30%), Positives = 103/208 (49%), Gaps = 24/208 (11%)
Query: 224 LGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKL-QHKNLVRLLGCC 281
+G G +G VYKG + G+ A+K + T + +E K E+N++ K H+N+ G
Sbjct: 24 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE-EEIKLEINMLKKYSHHRNIATYYGAF 82
Query: 282 LE----GQ--ELLLIYEYMPNKSLDVHLFDATR--SVQLDWKRRLSIINGIARGILYLHE 333
++ G +L L+ E+ S+ L T+ +++ DW I I RG+ +LH
Sbjct: 83 IKKSPPGHDDQLWLVMEFCGAGSV-TDLVKNTKGNALKEDWIA--YICREILRGLAHLHA 139
Query: 334 DSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAM 393
K+IHRD+K NVLL ++ K+ DFG + + NT I GT +MAPE
Sbjct: 140 H---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI--GTPYWMAPEVIA 194
Query: 394 -----GGIFSIKSDVFSFGVLLLEIISG 416
+ +SD++S G+ +E+ G
Sbjct: 195 CDENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 2e-14
Identities = 64/202 (31%), Positives = 96/202 (47%), Gaps = 19/202 (9%)
Query: 224 LGQGGFGPVYKGTLADGKAI-AVKRLSRTSGQGLKEFKNEVNLIAK------LQHKNLVR 276
LG+G FG V L A+K L + L++ E ++ + +H L
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVV--LEDDDVECTMVERRVLALAWEHPFLTH 60
Query: 277 LLGCCLEGQE-LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDS 335
L C + +E L + EY+ L H+ + R D R I G+ +LH+
Sbjct: 61 LF-CTFQTKEHLFFVMEYLNGGDLMFHIQSSGR---FDEARARFYAAEIICGLQFLHKKG 116
Query: 336 RLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGG 395
II+RDLK NVLLD D + KI+DFG + + +A+T GT Y+APE G
Sbjct: 117 ---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST--FCGTPDYIAPEILKGQ 171
Query: 396 IFSIKSDVFSFGVLLLEIISGR 417
++ D +SFGVLL E++ G+
Sbjct: 172 KYNESVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 3e-14
Identities = 57/169 (33%), Positives = 79/169 (46%), Gaps = 23/169 (13%)
Query: 324 IARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGT 383
+ARG+ +L SR K IHRDL A N+LL ++ KI DFG AR + +
Sbjct: 182 VARGMEFL--ASR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238
Query: 384 YGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS--GRKNNGFYFSEHGQTLLTYTWKLWCE 441
+MAPE +++ +SDV+SFGVLL EI S G E +C
Sbjct: 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE-----------FCR 287
Query: 442 GHAVELIDPVLKQSCAPDELLKFIH-IGLLCVQQDPADRPTMSSVVVML 489
L + + AP+ I+ I L C +P DRPT S +V +L
Sbjct: 288 ----RLKEGT--RMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEIL 330
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 3e-14
Identities = 80/274 (29%), Positives = 125/274 (45%), Gaps = 39/274 (14%)
Query: 222 NKLGQGGFGPVYKGT-LADGKAIAVK--RLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLL 278
++LG+G +G VYK G +A+K RL + + E++++ K +V
Sbjct: 7 DELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESK-FNQIIMELDILHKAVSPYIVDFY 65
Query: 279 GCCLEGQELLLIYEYMPNKSLDVHLFD---ATRSVQLDWKRRLSIINGIARGILYLHEDS 335
G + + EYM SLD L+ AT + D RR I + +G+ +L E+
Sbjct: 66 GAFFIEGAVYMCMEYMDAGSLD-KLYAGGVATEGIPEDVLRR--ITYAVVKGLKFLKEE- 121
Query: 336 RLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGN--QNQANTNIIAGTYGYMAPEYAM 393
IIHRD+K +NVL++ + K+ DFG + GN + A TNI G YMAPE
Sbjct: 122 -HNIIHRDVKPTNVLVNGNGQVKLCDFGVS----GNLVASLAKTNI--GCQSYMAPERIK 174
Query: 394 GG------IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVEL 447
G ++++SDV+S G+ +LE+ GR Y E + + +G
Sbjct: 175 SGGPNQNPTYTVQSDVWSLGLSILEMALGRYP---YPPETYANIFAQLSAI-VDG----- 225
Query: 448 IDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPT 481
DP S D+ F+ C+ + P RPT
Sbjct: 226 -DPPTLPSGYSDDAQDFVA---KCLNKIPNRRPT 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 3e-14
Identities = 63/202 (31%), Positives = 95/202 (47%), Gaps = 19/202 (9%)
Query: 224 LGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLKEFK------NEVNLIAKLQHKNLVR 276
LG+GGFG V + A GK A K+L + + +K+ K NE ++ K+ + +V
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEK---KRIKKRKGEAMALNEKQILEKVNSRFVVS 64
Query: 277 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSR 336
L L L+ M L H+++ D +R + I G+ LH R
Sbjct: 65 LAYAYETKDALCLVLTLMNGGDLKFHIYNMGNP-GFDEERAVFYAAEITCGLEDLH---R 120
Query: 337 LKIIHRDLKASNVLLDDDMNPKISDFGTA-RIFGGNQNQANTNIIAGTYGYMAPEYAMGG 395
+I++RDLK N+LLDD + +ISD G A I G + GT GYMAPE
Sbjct: 121 ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRV----GTVGYMAPEVVKNE 176
Query: 396 IFSIKSDVFSFGVLLLEIISGR 417
++ D + G L+ E+I G+
Sbjct: 177 RYTFSPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 4e-14
Identities = 61/203 (30%), Positives = 93/203 (45%), Gaps = 54/203 (26%)
Query: 240 GKAIAVKRLSRTSGQGLKEFKN---------EVNLIAKLQHKNLVRLLGCCLEGQELLLI 290
G+ +A+K+LSR F+N E+ L+ + HKN++ LL
Sbjct: 41 GQNVAIKKLSRP-------FQNVTHAKRAYRELVLMKLVNHKNIIGLLNV---------- 83
Query: 291 YEYMPNKSLD--------VHLFDAT--RSVQ--LDWKRRLSIINGIARGILYLHEDSRLK 338
+ P KSL+ + L DA + +Q LD +R ++ + GI +LH
Sbjct: 84 --FTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAG--- 138
Query: 339 IIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTY----GYMAPEYAMG 394
IIHRDLK SN+++ D KI DFG AR A T+ + Y Y APE +G
Sbjct: 139 IIHRDLKPSNIVVKSDCTLKILDFGLART-------AGTSFMMTPYVVTRYYRAPEVILG 191
Query: 395 GIFSIKSDVFSFGVLLLEIISGR 417
+ D++S G ++ E+I G
Sbjct: 192 MGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 73.4 bits (181), Expect = 4e-14
Identities = 67/221 (30%), Positives = 108/221 (48%), Gaps = 48/221 (21%)
Query: 222 NKLGQGGFGPVYKGTLAD---GKAIAVKRL-----SRTSGQGLKEFKNEVNLIAKL-QHK 272
KLG+G +G V+K D + +A+K++ + T Q + F+ E+ + +L H
Sbjct: 13 QKLGKGAYGIVWKAI--DRRTKEVVALKKIFDAFRNATDAQ--RTFR-EIMFLQELGDHP 67
Query: 273 NLVRLLGC--CLEGQELLLIYEYM---------PNKSLDVHLFDATRSVQLDWKRRLSII 321
N+V+LL +++ L++EYM N DVH KR I+
Sbjct: 68 NIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANILEDVH------------KR--YIM 113
Query: 322 NGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIF----GGNQNQANT 377
+ + + Y+H S +IHRDLK SN+LL+ D K++DFG AR +N T
Sbjct: 114 YQLLKALKYIH--SG-NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLT 170
Query: 378 NIIAGTYGYMAPEYAMGGIFSIKS-DVFSFGVLLLEIISGR 417
+ +A T Y APE +G K D++S G +L E++ G+
Sbjct: 171 DYVA-TRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 72.3 bits (178), Expect = 5e-14
Identities = 59/203 (29%), Positives = 104/203 (51%), Gaps = 22/203 (10%)
Query: 222 NKLGQGGFGPVYKG-TLADGKAIAVKRLSRTSGQGLKEFKN--EVNLIAKLQ-HKNLVRL 277
K+G+G F V K + GK A+K + + + L++ N E+ + +L H N++RL
Sbjct: 5 GKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHF-KSLEQVNNLREIQALRRLSPHPNILRL 63
Query: 278 LGCCLEGQE--LLLIYEYMPNKSLDVHLFDATRSVQ--LDWKRRLSIINGIARGILYLHE 333
+ + + L L++E M D++L++ + + L KR S + + + + ++H
Sbjct: 64 IEVLFDRKTGRLALVFELM-----DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH- 117
Query: 334 DSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAM 393
R I HRD+K N+L+ DD K++DFG+ R G T I+ T Y APE +
Sbjct: 118 --RNGIFHRDIKPENILIKDD-ILKLADFGSCR--GIYSKPPYTEYIS-TRWYRAPECLL 171
Query: 394 -GGIFSIKSDVFSFGVLLLEIIS 415
G + K D+++ G + EI+S
Sbjct: 172 TDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 5e-14
Identities = 53/198 (26%), Positives = 97/198 (48%), Gaps = 18/198 (9%)
Query: 223 KLGQGGFGPVYKG-TLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCC 281
++G G +G VYK + G+ A+K + G+ + E+ ++ +H N+V G
Sbjct: 16 RIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSY 75
Query: 282 LEGQELLLIYEYMPNKSLD--VHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKI 339
L +L + E+ SL H+ Q+ + R ++ +G+ YLH +
Sbjct: 76 LRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL-----QGLYYLHSKGK--- 127
Query: 340 IHRDLKASNVLLDDDMNPKISDFG-TARIFGGNQNQANTNIIAGTYGYMAPEYAM---GG 395
+HRD+K +N+LL D+ + K++DFG +A+I A GT +MAPE A G
Sbjct: 128 MHRDIKGANILLTDNGHVKLADFGVSAQI---TATIAKRKSFIGTPYWMAPEVAAVERKG 184
Query: 396 IFSIKSDVFSFGVLLLEI 413
++ D+++ G+ +E+
Sbjct: 185 GYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 5e-14
Identities = 60/189 (31%), Positives = 91/189 (48%), Gaps = 28/189 (14%)
Query: 240 GKAIAVKRLSR--TSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCL------EGQELLLIY 291
G +AVK+LSR + K E+ L+ + HKN++ LL E Q++ L+
Sbjct: 46 GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVM 105
Query: 292 EYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLL 351
E M D +L ++LD +R ++ + GI +LH IIHRDLK SN+++
Sbjct: 106 ELM-----DANLCQVIH-MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVV 156
Query: 352 DDDMNPKISDFGTARIFGGNQNQANTNIIAGTY----GYMAPEYAMGGIFSIKSDVFSFG 407
D KI DFG AR A TN + Y Y APE +G + D++S G
Sbjct: 157 KSDCTLKILDFGLAR-------TACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVG 209
Query: 408 VLLLEIISG 416
++ E++ G
Sbjct: 210 CIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 5e-14
Identities = 51/196 (26%), Positives = 86/196 (43%), Gaps = 17/196 (8%)
Query: 226 QGGFGPVYKG-TLADGKAIAVKRLSRTSGQGLKEFKN----EVNLIAKLQHKNLVRLLGC 280
+G FG VY + G A+K L ++ + N ++ + + + +L
Sbjct: 6 KGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYS 65
Query: 281 CLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKII 340
L L+ EY+ L + DW ++ I + G+ LH+ II
Sbjct: 66 FQSKDYLYLVMEYLNGGDCAS-LIKTLGGLPEDWAKQY--IAEVVLGVEDLHQRG---II 119
Query: 341 HRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIK 400
HRD+K N+L+D + K++DFG +R G +N+ GT Y+APE +G
Sbjct: 120 HRDIKPENLLIDQTGHLKLTDFGLSRN--GLENKK----FVGTPDYLAPETILGVGDDKM 173
Query: 401 SDVFSFGVLLLEIISG 416
SD +S G ++ E + G
Sbjct: 174 SDWWSLGCVIFEFLFG 189
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 5e-14
Identities = 49/156 (31%), Positives = 83/156 (53%), Gaps = 9/156 (5%)
Query: 262 EVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSII 321
E+ ++ + +V G E+ + E+M SLD L +A R + + ++SI
Sbjct: 53 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKR-IPEEILGKVSI- 110
Query: 322 NGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIA 381
+ RG+ YL E + +I+HRD+K SN+L++ K+ DFG + G + N
Sbjct: 111 -AVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFV 163
Query: 382 GTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGR 417
GT YM+PE G +S++SD++S G+ L+E+ GR
Sbjct: 164 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 6e-14
Identities = 45/150 (30%), Positives = 70/150 (46%), Gaps = 9/150 (6%)
Query: 222 NKLGQGGFGPVYKGTLADGKAIA---VKRLSRTSG-QGLKEFKNEVNLIAKLQHKNLVRL 277
+++G G FG V G G + A VK L ++ F EV +L H N+++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 278 LGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRL--SIINGIARGILYLHEDS 335
LG C+E LL+ E+ P L +L V ++ + + +A G+L+LH
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH--- 117
Query: 336 RLKIIHRDLKASNVLLDDDMNPKISDFGTA 365
+ IH DL N L D++ KI D+G A
Sbjct: 118 QADFIHSDLALRNCQLTADLSVKIGDYGLA 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.8 bits (177), Expect = 7e-14
Identities = 79/297 (26%), Positives = 121/297 (40%), Gaps = 67/297 (22%)
Query: 223 KLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLKEFKN--------EVNLIAKLQ-HK 272
+LG G FG VY G+ +A+K++ + F + EV + KL H
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKMKKK-------FYSWEECMNLREVKSLRKLNEHP 58
Query: 273 NLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLH 332
N+V+L E EL ++EYM +L L + SII I +G+ ++H
Sbjct: 59 NIVKLKEVFRENDELYFVFEYM-EGNL-YQLMKDRKGKPFSESVIRSIIYQILQGLAHIH 116
Query: 333 EDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQAN-TNIIAGTYGYMAPE- 390
+ HRDLK N+L+ KI+DFG AR +++ T+ + T Y APE
Sbjct: 117 ---KHGFFHRDLKPENLLVSGPEVVKIADFGLAR---EIRSRPPYTDYV-STRWYRAPEI 169
Query: 391 ------YAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYF---SEHGQ------TLLTYT 435
Y S D+++ G ++ E+ + R F SE Q L T T
Sbjct: 170 LLRSTSY------SSPVDIWALGCIMAELYTLRP----LFPGSSEIDQLYKICSVLGTPT 219
Query: 436 WKLWCEGHAV---------ELIDPVLKQ--SCAPDELLKFIHIGLLCVQQDPADRPT 481
+ W EG+ + + L Q A E + I ++ DP RPT
Sbjct: 220 KQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKD---MLRWDPKKRPT 273
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 71.9 bits (177), Expect = 1e-13
Identities = 55/216 (25%), Positives = 97/216 (44%), Gaps = 25/216 (11%)
Query: 213 EATNHFSDENKLGQGGFGPVYKGTLADGKA-IAVKRLSR--TSGQGLKEFKNEVNLIAKL 269
E + + + + +G G +G V +A+K+LSR S K E+ L+ +
Sbjct: 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHM 71
Query: 270 QHKNLVRLLGCCLEGQELLLIYE-YMPNKSLDVHLFDATRSVQLDWKRRLS------IIN 322
H+N++ LL L + Y+ + L + + ++LS ++
Sbjct: 72 DHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKC------QKLSDDHIQFLVY 125
Query: 323 GIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAG 382
I RG+ Y+H IIHRDLK SN+ +++D KI DFG AR
Sbjct: 126 QILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLAR-----HTDDEMTGYVA 177
Query: 383 TYGYMAPEYAMGGIFSIKS-DVFSFGVLLLEIISGR 417
T Y APE + + ++ D++S G ++ E+++G+
Sbjct: 178 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 57/198 (28%), Positives = 100/198 (50%), Gaps = 13/198 (6%)
Query: 223 KLGQGGFGPVYKG-TLADGKAIAVK--RLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLG 279
KLG+G + VYKG + +GK +A+K RL G + E +L+ L+H N+V L
Sbjct: 12 KLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-EASLLKGLKHANIVLLHD 70
Query: 280 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKI 339
+ L L++EY+ + L ++ + + +L + + RG+ Y+H+ I
Sbjct: 71 IIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPE-NVKLFLFQ-LLRGLSYIHQRY---I 124
Query: 340 IHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGI-FS 398
+HRDLK N+L+ D K++DFG AR + + ++ T Y P+ +G +S
Sbjct: 125 LHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV--TLWYRPPDVLLGSTEYS 182
Query: 399 IKSDVFSFGVLLLEIISG 416
D++ G + +E+I G
Sbjct: 183 TCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 1e-13
Identities = 59/213 (27%), Positives = 102/213 (47%), Gaps = 30/213 (14%)
Query: 224 LGQGGFGPVYKGTL----ADGKAIAVKRLSRT--SGQGLKEFKNEVNLIAKLQHKNLVRL 277
LG+G FG V + L + +AVK L S ++EF E + + H N+++L
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66
Query: 278 LGCCLEGQEL------LLIYEYMPNKSLDVHLF-----DATRSVQLDWKRRLSIINGIAR 326
+G L + ++I +M K D+H F L + + + IA
Sbjct: 67 IGVSLRSRAKGRLPIPMVILPFM--KHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIAS 124
Query: 327 GILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTAR-IFGGN---QNQANTNIIAG 382
G+ YL S IHRDL A N +L+++M ++DFG ++ I+ G+ Q A+ +
Sbjct: 125 GMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVK- 180
Query: 383 TYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 415
++A E +++ SDV++FGV + EI++
Sbjct: 181 ---WLALESLADNVYTTHSDVWAFGVTMWEIMT 210
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|216632 pfam01657, Stress-antifung, Salt stress response/antifungal | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 1e-13
Identities = 17/49 (34%), Positives = 27/49 (55%)
Query: 1 FGLYLCKFDITFQSCQRCIATAVKAVMKKCNGTRKAIIWYRECMVRYSD 49
+GL C+ D++ C+ C+ATAV + + C + IWY C +RY
Sbjct: 55 YGLAQCRGDLSASDCRSCLATAVSELRRCCPNKKGGRIWYDSCFLRYES 103
|
This domain is often found in association with the kinase domains pfam00069 or pfam07714. In many proteins it is duplicated. It contains six conserved cysteines which are involved in disulphide bridges. It has a role in salt stress response and has antifungal activity. Length = 106 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 1e-13
Identities = 60/199 (30%), Positives = 92/199 (46%), Gaps = 13/199 (6%)
Query: 224 LGQGGFGPVYKGTL-ADGKAIAVKRLSRT---SGQGLKEFKNEVNLIAKLQHKNLVRLLG 279
LG+GGFG V + A GK A K+L + +G NE ++ K+ + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAY 67
Query: 280 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKI 339
L L+ M L H+++ D +R + + G+ L R +I
Sbjct: 68 AYETKDALCLVLTIMNGGDLKFHIYNMGNP-GFDEQRAIFYAAELCCGLEDLQ---RERI 123
Query: 340 IHRDLKASNVLLDDDMNPKISDFGTA-RIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFS 398
++RDLK N+LLDD + +ISD G A +I G + GT GYMAPE ++
Sbjct: 124 VYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRV----GTVGYMAPEVINNEKYT 179
Query: 399 IKSDVFSFGVLLLEIISGR 417
D + G L+ E+I G+
Sbjct: 180 FSPDWWGLGCLIYEMIQGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 2e-13
Identities = 60/200 (30%), Positives = 91/200 (45%), Gaps = 17/200 (8%)
Query: 224 LGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLKEFKNEVNLIAK------LQHKNLVR 276
LG+G FG V L G+ AVK L + L++ E + K H L +
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVI--LQDDDVECTMTEKRILSLARNHPFLTQ 60
Query: 277 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSR 336
L C L + E++ L +F +S + D R I +++LH+
Sbjct: 61 LYCCFQTPDRLFFVMEFVNGGDL---MFHIQKSRRFDEARARFYAAEITSALMFLHDKG- 116
Query: 337 LKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGI 396
II+RDLK NVLLD + + K++DFG + G N T+ GT Y+APE +
Sbjct: 117 --IIYRDLKLDNVLLDHEGHCKLADFGMCK--EGIFNGKTTSTFCGTPDYIAPEILQEML 172
Query: 397 FSIKSDVFSFGVLLLEIISG 416
+ D ++ GVLL E++ G
Sbjct: 173 YGPSVDWWAMGVLLYEMLCG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 2e-13
Identities = 55/212 (25%), Positives = 102/212 (48%), Gaps = 31/212 (14%)
Query: 199 ESQEFPLFPLGLALEATNHFSDENKLGQGGFGPVYKG-TLADGKAIAVKRL---SRTSGQ 254
+ EFP + + + K+GQG FG V+K + +A+K++ + G
Sbjct: 1 DQYEFPF------CDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGF 54
Query: 255 GLKEFKNEVNLIAKLQHKNLVRLLGCC---------LEGQELLLIYEYMPNKSLDVHLFD 305
+ + E+ ++ L+H+N+V L+ C +G L++E+ + D+
Sbjct: 55 PITALR-EIKILQLLKHENVVNLIEICRTKATPYNRYKGS-FYLVFEFCEH---DLAGLL 109
Query: 306 ATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTA 365
+ ++V+ ++ + G+ Y+H R KI+HRD+KA+N+L+ D K++DFG A
Sbjct: 110 SNKNVKFTLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLA 166
Query: 366 RIFGGNQNQAN---TNIIAGTYGYMAPEYAMG 394
R F ++N TN + T Y PE +G
Sbjct: 167 RAFSLSKNSKPNRYTNRVV-TLWYRPPELLLG 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 3e-13
Identities = 58/207 (28%), Positives = 103/207 (49%), Gaps = 17/207 (8%)
Query: 223 KLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFK-NEVNLIAKLQHKNLVRLLGCC 281
K+G+G +G VYK DGK L + G G+ E+ L+ +L+H N++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 67
Query: 282 LE--GQELLLIYEYMPNKSLDVHLFDAT-----RSVQLDWKRRLSIINGIARGILYLHED 334
L +++ L+++Y + + F + VQL S++ I GI YLH +
Sbjct: 68 LSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN 127
Query: 335 SRLKIIHRDLKASNVLL----DDDMNPKISDFGTARIFGGN-QNQANTNIIAGTYGYMAP 389
++HRDLK +N+L+ + KI+D G AR+F + A+ + + T+ Y AP
Sbjct: 128 W---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184
Query: 390 EYAMGGIFSIKS-DVFSFGVLLLEIIS 415
E +G K+ D+++ G + E+++
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 3e-13
Identities = 59/212 (27%), Positives = 92/212 (43%), Gaps = 31/212 (14%)
Query: 224 LGQGGFGPVYKGTL-------ADGKAIAVKRLSRTSGQGLK---EFKNEVNLIAKLQHKN 273
LGQG F +YKG L G V + + G + F +L+++L HK+
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 274 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHE 333
LV+L G C+ E +++ EY+ LDV L +V L WK L + +A + YL +
Sbjct: 63 LVKLYGVCVR-DENIMVEEYVKFGPLDVFLHREKNNVSLHWK--LDVAKQLASALHYLED 119
Query: 334 DSRLKIIHRDLKASNVLL---DDDMNP----KISDFGTARIFGGNQNQANTNIIAGTYGY 386
K++H ++ N+L+ + K+SD G + +
Sbjct: 120 K---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVL------SREERVERIPW 170
Query: 387 MAPEYAMGGIFSIKS--DVFSFGVLLLEIISG 416
+APE G S+ D +SFG LLEI S
Sbjct: 171 IAPECIRNGQASLTIAADKWSFGTTLLEICSN 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 3e-13
Identities = 54/207 (26%), Positives = 103/207 (49%), Gaps = 20/207 (9%)
Query: 223 KLGQGGFGPVYKGT--LADGKAIAVKRLS-RTSGQGLK-EFKNEVNLIAKLQ---HKNLV 275
++G+G +G V+K G+ +A+KR+ +T +G+ EV ++ L+ H N+V
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 276 RLLGCCLEGQ-----ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILY 330
RL C + +L L++E++ ++ L +L D + + ++ + RG+ +
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMMFQLLRGLDF 125
Query: 331 LHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPE 390
LH +++HRDLK N+L+ K++DFG ARI+ Q + T Y APE
Sbjct: 126 LHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVTLWYRAPE 179
Query: 391 YAMGGIFSIKSDVFSFGVLLLEIISGR 417
+ ++ D++S G + E+ +
Sbjct: 180 VLLQSSYATPVDLWSVGCIFAEMFRRK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 4e-13
Identities = 59/203 (29%), Positives = 99/203 (48%), Gaps = 13/203 (6%)
Query: 218 FSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGL--KEFKNEVNLIAKLQHKNLV 275
F ++LG G G V+K + I ++L + + E+ ++ + +V
Sbjct: 7 FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 66
Query: 276 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATR-SVQLDWKRRLSIINGIARGILYLHED 334
G E+ + E+M SLD L A R Q+ K +++I +G+ YL E
Sbjct: 67 GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVI----KGLTYLRE- 121
Query: 335 SRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMG 394
+ KI+HRD+K SN+L++ K+ DFG + G + N GT YM+PE G
Sbjct: 122 -KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQG 176
Query: 395 GIFSIKSDVFSFGVLLLEIISGR 417
+S++SD++S G+ L+E+ GR
Sbjct: 177 THYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 4e-13
Identities = 65/209 (31%), Positives = 100/209 (47%), Gaps = 32/209 (15%)
Query: 224 LGQGGFGPVY---KGTLAD-GKAIAVKRLSR----TSGQGLKEFKNEVNLIAKLQHKNLV 275
LG+GG+G V+ K T AD GK A+K L + + + K E N++ ++H +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 276 RLLGCCLEGQELLLIYEYMPNKSLDVHL------FDATRSVQLDWKRRLSIINGIARGIL 329
L+ G +L LI EY+ L +HL + T L + I+ +
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYL---------SEISLALE 114
Query: 330 YLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTAR--IFGGNQNQANTNIIAGTYGYM 387
+LH + II+RDLK N+LLD + K++DFG + I G T+ GT YM
Sbjct: 115 HLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG----TVTHTFCGTIEYM 167
Query: 388 APEYAMGGIFSIKSDVFSFGVLLLEIISG 416
APE M D +S G L+ ++++G
Sbjct: 168 APEILMRSGHGKAVDWWSLGALMYDMLTG 196
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 4e-13
Identities = 76/287 (26%), Positives = 119/287 (41%), Gaps = 74/287 (25%)
Query: 224 LGQGGFGPVYKGT-LADGKAIAVKRLSRTSG-QGLKEFKNEVNLIAKLQH--KNLVRLLG 279
+G G G VYK G +AVK++ RT + K +++++ K H +V+ G
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLK-SHDCPYIVKCYG 81
Query: 280 C----------------CLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIING 323
CL+ + L I +P L K ++I+
Sbjct: 82 YFITDSDVFICMELMSTCLD-KLLKRIQGPIPEDILG--------------KMTVAIVKA 126
Query: 324 IARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTA-RIFGGNQNQANTNIIAG 382
+ YL E +IHRD+K SN+LLD N K+ DFG + R+ ++A T AG
Sbjct: 127 L----HYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLV---DSKAKTR-SAG 176
Query: 383 TYGYMAPEY----AMGGIFSIKSDVFSFGVLLLEIISGR---KNNGFYFSEHGQTLLTYT 435
YMAPE + I++DV+S G+ L+E+ +G+ KN F +LT
Sbjct: 177 CAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF-----EVLT-- 229
Query: 436 WKLWCEGHAVELIDPVL--KQSCAPDELLKFIHIGLLCVQQDPADRP 480
++ P L + +PD F LC+ +D RP
Sbjct: 230 -------KILQEEPPSLPPNEGFSPD----FCSFVDLCLTKDHRKRP 265
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 4e-13
Identities = 60/210 (28%), Positives = 102/210 (48%), Gaps = 13/210 (6%)
Query: 213 EATNHFSDENKLGQGGFGPVYKG-TLADGKAIAVKRLSR--TSGQGLKEFKNEVNLIAKL 269
E + + + +G G +G V G +AVK+LSR S K E+ L+ +
Sbjct: 14 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 73
Query: 270 QHKNLVRLLGCCLEGQELLLIYE-YMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGI 328
+H+N++ LL + L + Y+ + L + + +L +I I RG+
Sbjct: 74 KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 133
Query: 329 LYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMA 388
Y+H IIHRDLK SN+ +++D KI DFG AR + + T +A T Y A
Sbjct: 134 KYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVA-TRWYRA 185
Query: 389 PEYAMGGI-FSIKSDVFSFGVLLLEIISGR 417
PE + + ++ D++S G ++ E+++GR
Sbjct: 186 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 4e-13
Identities = 63/221 (28%), Positives = 108/221 (48%), Gaps = 31/221 (14%)
Query: 216 NHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLKE-FK----NEVNLIAKL 269
+ F ++G+G +G VYK D G+ +A+K++ R + KE F E+ ++ +L
Sbjct: 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKV-RLDNE--KEGFPITAIREIKILRQL 63
Query: 270 QHKNLVRLLGCCLEGQELL----------LIYEYMPNKSLDVHLFDATRS--VQLDWKRR 317
H+N+V L + Q+ L L++EYM D L S V
Sbjct: 64 NHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYM-----DHDLMGLLESGLVHFSEDHI 118
Query: 318 LSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANT 377
S + + G+ Y H+ + L HRD+K SN+LL++ K++DFG AR++ +++ T
Sbjct: 119 KSFMKQLLEGLNYCHKKNFL---HRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYT 175
Query: 378 NIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGR 417
N + T Y PE +G + DV+S G +L E+ + +
Sbjct: 176 NKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 5e-13
Identities = 56/201 (27%), Positives = 100/201 (49%), Gaps = 15/201 (7%)
Query: 222 NKLGQGGFGPVYKG-TLADGKAIAVK--RLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLL 278
+KLG+G + V+KG + +A+K RL G + EV+L+ L+H N+V L
Sbjct: 11 DKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKNLKHANIVTLH 69
Query: 279 GCCLEGQELLLIYEYMPNKSLDV-HLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRL 337
+ L L++EY+ + D+ D ++ ++ + + RG+ Y H +
Sbjct: 70 DIIHTERCLTLVFEYLDS---DLKQYLDNCGNLMSMHNVKIFMFQ-LLRGLSYCH---KR 122
Query: 338 KIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGI- 396
KI+HRDLK N+L+++ K++DFG AR + ++ T Y P+ +G
Sbjct: 123 KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLGSTE 180
Query: 397 FSIKSDVFSFGVLLLEIISGR 417
+S D++ G +L E+ +GR
Sbjct: 181 YSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 6e-13
Identities = 57/207 (27%), Positives = 103/207 (49%), Gaps = 17/207 (8%)
Query: 223 KLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFK-NEVNLIAKLQHKNLVRLLGCC 281
K+G+G +G VYK DGK L + G G+ E+ L+ +L+H N++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVF 67
Query: 282 L--EGQELLLIYEYMPNKSLDVHLFDAT-----RSVQLDWKRRLSIINGIARGILYLHED 334
L +++ L+++Y + + F + +QL S++ I GI YLH +
Sbjct: 68 LSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN 127
Query: 335 SRLKIIHRDLKASNVLL----DDDMNPKISDFGTARIFGGN-QNQANTNIIAGTYGYMAP 389
++HRDLK +N+L+ + KI+D G AR+F + A+ + + T+ Y AP
Sbjct: 128 W---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184
Query: 390 EYAMGGIFSIKS-DVFSFGVLLLEIIS 415
E +G K+ D+++ G + E+++
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 7e-13
Identities = 59/203 (29%), Positives = 90/203 (44%), Gaps = 22/203 (10%)
Query: 224 LGQGGFGPV----YKGTLADGKAIAVKRL------SRTSGQGLKEFKNEVNLIAKLQHKN 273
LG+G FG V YK T G+ A+K L +R + L K +H
Sbjct: 7 LGRGHFGKVLLAEYKKT---GELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPF 63
Query: 274 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHE 333
LV L C + + EY L +H+ R + + G+ YLHE
Sbjct: 64 LVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTD----VFSEPRAVFYAACVVLGLQYLHE 119
Query: 334 DSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAM 393
+ KI++RDLK N+LLD + KI+DFG + G ++ +T GT ++APE
Sbjct: 120 N---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTST--FCGTPEFLAPEVLT 174
Query: 394 GGIFSIKSDVFSFGVLLLEIISG 416
++ D + GVL+ E++ G
Sbjct: 175 ETSYTRAVDWWGLGVLIYEMLVG 197
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 68.8 bits (169), Expect = 7e-13
Identities = 58/214 (27%), Positives = 106/214 (49%), Gaps = 38/214 (17%)
Query: 222 NKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLKEFKN----------EVNLIAKLQ 270
N++ +G +G VY+ G+ +A+K+L K K E+N++ KLQ
Sbjct: 11 NRIEEGTYGVVYRARDKKTGEIVALKKL--------KMEKEKEGFPITSLREINILLKLQ 62
Query: 271 HKNLVRL----LGCCLEGQELLLIYEYMPN--KSLDVHLFDATRSVQLDWKRRLSIINGI 324
H N+V + +G L+ ++ ++ EY+ + KSL + ++ ++ +
Sbjct: 63 HPNIVTVKEVVVGSNLD--KIYMVMEYVEHDLKSLMETMKQPFLQSEVK-----CLMLQL 115
Query: 325 ARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTY 384
G+ +LH++ I+HRDLK SN+LL++ KI DFG AR +G ++ T
Sbjct: 116 LSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV--TL 170
Query: 385 GYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGR 417
Y APE +G +S D++S G + E+++ +
Sbjct: 171 WYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 71/265 (26%), Positives = 105/265 (39%), Gaps = 76/265 (28%)
Query: 224 LGQGGFGPVYKGT------LADGKAIAVKRLSRTSGQG-LKEFKNEVNLIAKL-QHKNLV 275
LG+G FG V + A + +AVK L + + +E+ ++ + H N+V
Sbjct: 15 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 74
Query: 276 RLLGCCLE-GQELLLIYEY-----------------MPNKSLDVHLF---DATRSVQLDW 314
LLG C + G L++I E+ +P K+ D + D
Sbjct: 75 NLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDL 134
Query: 315 KRRLSIING--------------------------------------------IARGILY 330
KRRL I +A+G+ +
Sbjct: 135 KRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEF 194
Query: 331 LHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPE 390
L SR K IHRDL A N+LL ++ KI DFG AR + + +MAPE
Sbjct: 195 LA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE 251
Query: 391 YAMGGIFSIKSDVFSFGVLLLEIIS 415
+++I+SDV+SFGVLL EI S
Sbjct: 252 TIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 1e-12
Identities = 39/96 (40%), Positives = 55/96 (57%), Gaps = 9/96 (9%)
Query: 324 IARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTAR--IFGGNQNQANTNIIA 381
IA G+ +LH II+RDLK NV+LD + + KI+DFG + IFGG T
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG----KTTRTFC 162
Query: 382 GTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGR 417
GT Y+APE + D ++FGVLL E+++G+
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 58/219 (26%), Positives = 104/219 (47%), Gaps = 35/219 (15%)
Query: 217 HFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLS---------RTSGQGLKEFKNEVNLI 266
+ + + +G+G +G V T G +A+K++S RT L+E K ++
Sbjct: 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRT----LREIK----IL 57
Query: 267 AKLQHKNLVRLL-----GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSII 321
+ +H+N++ +L ++ ++ E M D++ ++ L +
Sbjct: 58 RRFKHENIIGILDIIRPPSFESFNDVYIVQELMET---DLY--KLIKTQHLSNDHIQYFL 112
Query: 322 NGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQAN--TNI 379
I RG+ Y+H + ++HRDLK SN+LL+ + + KI DFG ARI + T
Sbjct: 113 YQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEY 169
Query: 380 IAGTYGYMAPEYAMGGIFSIKS-DVFSFGVLLLEIISGR 417
+A T Y APE + K+ D++S G +L E++S R
Sbjct: 170 VA-TRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 60/234 (25%), Positives = 95/234 (40%), Gaps = 57/234 (24%)
Query: 224 LGQGGFGPVYKGTLA----DGKAIAVKRLSRT----SGQGLKEFKNEVNLIAKLQHKNLV 275
+G+G FG V+ L G+ A+K L ++ Q + E +++A +V
Sbjct: 9 IGRGAFGEVW---LVRDKDTGQVYAMKVLRKSDMIKRNQIA-HVRAERDILADADSPWIV 64
Query: 276 RLLGCCLEGQE-LLLIYEYMPNKSL-----DVHLFDATRSVQLDWKRRLSIINGIARGIL 329
+L + +E L L+ EYMP L +F + R IA +L
Sbjct: 65 KLY-YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPE------ETARFY-----IAELVL 112
Query: 330 YLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTA------------------------ 365
L +L IHRD+K N+L+D D + K++DFG
Sbjct: 113 ALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDN 172
Query: 366 ---RIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISG 416
R Q + N GT Y+APE G + ++ D +S GV+L E++ G
Sbjct: 173 VLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 2e-12
Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 27/211 (12%)
Query: 223 KLGQGGFGPVYKG-TLADGKAIAVKR-LSRTSGQGLKEFK-NEVNLIAKLQHKN-LVRLL 278
K+G+G +G VYK GK +A+K+ +G+ E++L+ L +VRLL
Sbjct: 8 KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLL 67
Query: 279 GCCLEGQE-------LLLIYEYMPNKSLDVHLF-DATR---SVQLDWKRRLSIINGIARG 327
+E E L L++EY+ D+ F D+ L K S + + +G
Sbjct: 68 --DVEHVEEKNGKPSLYLVFEYL---DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKG 122
Query: 328 ILYLHEDSRLKIIHRDLKASNVLLDDDMNP-KISDFGTARIFGGNQNQANTNIIAGTYGY 386
+ + H + ++HRDLK N+L+D KI+D G R F I+ T Y
Sbjct: 123 VAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV--TLWY 177
Query: 387 MAPEYAMGGI-FSIKSDVFSFGVLLLEIISG 416
APE +G +S D++S G + E+
Sbjct: 178 RAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 57/202 (28%), Positives = 102/202 (50%), Gaps = 19/202 (9%)
Query: 223 KLGQGGFGPVYKG-TLADGKAIAVKRLSRTSGQ-GLK-EFKNEVNLIAKLQ---HKNLVR 276
++G G +G VYK G +A+K + + + GL EV L+ +L+ H N+VR
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 277 LLGCCLEGQ-----ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYL 331
L+ C + ++ L++E++ ++ L +L D L + ++ RG+ +L
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHV-DQDLRTYL-DKVPPPGLPAETIKDLMRQFLRGLDFL 124
Query: 332 HEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEY 391
H + I+HRDLK N+L+ K++DFG ARI+ + A T ++ T Y APE
Sbjct: 125 HAN---CIVHRDLKPENILVTSGGQVKLADFGLARIY--SCQMALTPVVV-TLWYRAPEV 178
Query: 392 AMGGIFSIKSDVFSFGVLLLEI 413
+ ++ D++S G + E+
Sbjct: 179 LLQSTYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 2e-12
Identities = 55/181 (30%), Positives = 84/181 (46%), Gaps = 17/181 (9%)
Query: 309 SVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIF 368
+ LD + LS +A+G+ +L + IHRDL A N+LL KI DFG AR
Sbjct: 208 ELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDI 264
Query: 369 GGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHG 428
+ N +MAPE +++ +SDV+S+G+LL EI S + Y G
Sbjct: 265 RNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS--LGSSPY---PG 319
Query: 429 QTLLTYTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488
+ + +K+ EG+ +L CAP E+ + C DP RPT +V +
Sbjct: 320 MPVDSKFYKMIKEGYR------MLSPECAPSEMYDIMKS---CWDADPLKRPTFKQIVQL 370
Query: 489 L 489
+
Sbjct: 371 I 371
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 3e-12
Identities = 63/210 (30%), Positives = 96/210 (45%), Gaps = 42/210 (20%)
Query: 224 LGQGGFGPVYKGTL----ADGKAIAVKRLS--RTSGQGLKEFKNEVNLIAKLQHKNLVR- 276
+G+G +G V +L DGK +K+L+ S + K + E L+++L+H N+V
Sbjct: 8 VGKGSYGEV---SLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAY 64
Query: 277 -------------LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIING 323
++G C EG +L Y K L + V +W +
Sbjct: 65 RESWEGEDGLLYIVMGFC-EGGDL-----YHKLKEQKGKLLPENQVV--EWFVQ------ 110
Query: 324 IARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGT 383
IA + YLHE I+HRDLK NV L K+ D G AR+ + A+T I GT
Sbjct: 111 IAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLI--GT 165
Query: 384 YGYMAPEYAMGGIFSIKSDVFSFGVLLLEI 413
YM+PE ++ KSDV++ G + E+
Sbjct: 166 PYYMSPELFSNKPYNYKSDVWALGCCVYEM 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 3e-12
Identities = 62/198 (31%), Positives = 90/198 (45%), Gaps = 13/198 (6%)
Query: 224 LGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLKEFKN---EVN-LIAKLQHKNLVRLL 278
+G+G FG V ADGK AVK L + + KE K+ E N L+ ++H LV L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 279 GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLK 338
+L + +Y+ L HL R R IA + YLH L
Sbjct: 63 YSFQTADKLYFVLDYVNGGELFFHL---QRERSFPEPRARFYAAEIASALGYLHS---LN 116
Query: 339 IIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFS 398
II+RDLK N+LLD + ++DFG + G ++ T+ GT Y+APE +
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCK--EGIEHSKTTSTFCGTPEYLAPEVLRKQPYD 174
Query: 399 IKSDVFSFGVLLLEIISG 416
D + G +L E++ G
Sbjct: 175 RTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 3e-12
Identities = 67/215 (31%), Positives = 99/215 (46%), Gaps = 32/215 (14%)
Query: 284 GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIIN------GIARGILYLHEDSRL 337
GQ +L + P+ S + + WK L++ + +ARG+ +L SR
Sbjct: 140 GQASVLFSRFQPSTSGST---NPPQETDDLWKSPLTMEDLICYSFQVARGMEFLA--SR- 193
Query: 338 KIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIF 397
K IHRDL A N+LL ++ KI DFG AR + + +MAPE ++
Sbjct: 194 KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVY 253
Query: 398 SIKSDVFSFGVLLLEIIS--GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQS 455
+ +SDV+SFGVLL EI S G +E +C+ L D +
Sbjct: 254 TTQSDVWSFGVLLWEIFSLGASPYPGVQINEE-----------FCQ----RLKDGTRMR- 297
Query: 456 CAPDELLKFIH-IGLLCVQQDPADRPTMSSVVVML 489
AP+ I+ I L C Q DP +RPT S++V +L
Sbjct: 298 -APENATPEIYRIMLACWQGDPKERPTFSALVEIL 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 4e-12
Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 31/205 (15%)
Query: 224 LGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLKE---FKNEVNLIAKLQHKNLVRLLG 279
+G G FG V+ A+K ++ LK+ NE ++ ++ H ++RL
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFW 68
Query: 280 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIAR--------GILYL 331
+ + L ++ EY+P LF R+ R S N + YL
Sbjct: 69 TEHDQRFLYMLMEYVPGG----ELFSYLRN-----SGRFS--NSTGLFYASEIVCALEYL 117
Query: 332 HEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEY 391
H +I++RDLK N+LLD + + K++DFG A+ + + T + GT Y+APE
Sbjct: 118 HS---KEIVYRDLKPENILLDKEGHIKLTDFGFAK-----KLRDRTWTLCGTPEYLAPEV 169
Query: 392 AMGGIFSIKSDVFSFGVLLLEIISG 416
+ D ++ G+L+ E++ G
Sbjct: 170 IQSKGHNKAVDWWALGILIYEMLVG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 5e-12
Identities = 55/199 (27%), Positives = 99/199 (49%), Gaps = 14/199 (7%)
Query: 223 KLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGL--KEFKNEVNLIAKLQHKNLVRLLG 279
K+G+G +G V+K + G+ +A+K+ + + K E+ ++ +L+H NLV L+
Sbjct: 8 KIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIE 67
Query: 280 CCLEGQELLLIYEYMPNKSLDVHLFDA-TRSVQLDWKRRLSIINGIARGILYLHEDSRLK 338
++L L++EY + L + + R V ++ II + + + H +
Sbjct: 68 VFRRKRKLHLVFEYCDHTVL--NELEKNPRGVPEHLIKK--IIWQTLQAVNFCH---KHN 120
Query: 339 IIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGI-F 397
IHRD+K N+L+ K+ DFG ARI G T+ +A T Y APE +G +
Sbjct: 121 CIHRDVKPENILITKQGQIKLCDFGFARILTG-PGDDYTDYVA-TRWYRAPELLVGDTQY 178
Query: 398 SIKSDVFSFGVLLLEIISG 416
DV++ G + E+++G
Sbjct: 179 GPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 6e-12
Identities = 58/189 (30%), Positives = 92/189 (48%), Gaps = 28/189 (14%)
Query: 241 KAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLD 300
+ +A+K+LSR F+N+ + AK ++ LV L+ C + L+ + P KSL+
Sbjct: 50 RNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKCVNHKNIIGLLNVFTPQKSLE 99
Query: 301 --------VHLFDATR----SVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASN 348
+ L DA ++LD +R ++ + GI +LH IIHRDLK SN
Sbjct: 100 EFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSN 156
Query: 349 VLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGV 408
+++ D KI DFG AR G ++ T Y APE +G + D++S G
Sbjct: 157 IVVKSDCTLKILDFGLART-AGTSFMMTPYVV--TRYYRAPEVILGMGYKENVDIWSVGC 213
Query: 409 LLLEIISGR 417
++ E+I G
Sbjct: 214 IMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 6e-12
Identities = 57/205 (27%), Positives = 92/205 (44%), Gaps = 20/205 (9%)
Query: 224 LGQGGFGPVY----KGTLADGKAIAVKRLSRTS----GQGLKEFKNEVNLIAKLQHKN-L 274
LG G +G V+ G GK A+K L + + + + + E ++ ++ L
Sbjct: 8 LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFL 67
Query: 275 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHED 334
V L +L LI +Y+ L HL+ I I + +LH+
Sbjct: 68 VTLHYAFQTDTKLHLILDYVNGGELFTHLYQREH---FTESEVRVYIAEIVLALDHLHQ- 123
Query: 335 SRLKIIHRDLKASNVLLDDDMNPKISDFGTARIF-GGNQNQANTNIIAGTYGYMAPEYAM 393
L II+RD+K N+LLD + + ++DFG ++ F + +A + GT YMAPE
Sbjct: 124 --LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYS--FCGTIEYMAPEVIR 179
Query: 394 GGI--FSIKSDVFSFGVLLLEIISG 416
GG D +S GVL E+++G
Sbjct: 180 GGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 6e-12
Identities = 54/199 (27%), Positives = 97/199 (48%), Gaps = 13/199 (6%)
Query: 223 KLGQGGFGPVYKG-TLADGKAIAVKRLSRTSGQGLKEFK--NEVNLIAKLQHKNLVRLLG 279
KLG+G + VYKG + +G+ +A+K +S + +G+ F E +L+ L+H N+V L
Sbjct: 12 KLGEGSYATVYKGISRINGQLVALKVISMKTEEGVP-FTAIREASLLKGLKHANIVLLHD 70
Query: 280 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKI 339
+ L ++EYM D+ + L + + RG+ Y+H I
Sbjct: 71 IIHTKETLTFVFEYM---HTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIH---GQHI 124
Query: 340 IHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGI-FS 398
+HRDLK N+L+ K++DFG AR ++ ++ T Y P+ +G +S
Sbjct: 125 LHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPDVLLGATDYS 182
Query: 399 IKSDVFSFGVLLLEIISGR 417
D++ G + +E++ G+
Sbjct: 183 SALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 9e-12
Identities = 47/166 (28%), Positives = 79/166 (47%), Gaps = 24/166 (14%)
Query: 218 FSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVR 276
+ D LG G G V+ +D K +AVK++ T Q +K E+ +I +L H N+V+
Sbjct: 7 YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 66
Query: 277 L--------------LGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIIN 322
+ +G E + ++ EYM + L + L + +
Sbjct: 67 VYEVLGPSGSDLTEDVGSLTELNSVYIVQEYM-----ETDLANVLEQGPLSEEHARLFMY 121
Query: 323 GIARGILYLHEDSRLKIIHRDLKASNVLLD-DDMNPKISDFGTARI 367
+ RG+ Y+H + ++HRDLK +NV ++ +D+ KI DFG ARI
Sbjct: 122 QLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARI 164
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 9e-12
Identities = 69/231 (29%), Positives = 106/231 (45%), Gaps = 23/231 (9%)
Query: 203 FPLFPLGLALEATNHFSDE----NKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLK 257
FP L LE+ +D +G+G +G VYK T DG AVK L S +
Sbjct: 5 FPYNSSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD-E 63
Query: 258 EFKNEVNLIAKL-QHKNLVRLLGCC-----LEGQELLLIYEYMPNKSLDVHLFDATRSVQ 311
E + E N++ L H N+V+ G L G +L L+ E S+ + Q
Sbjct: 64 EIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQ 123
Query: 312 -LDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGG 370
LD I+ G G+ +LH + +IIHRD+K +N+LL + K+ DFG +
Sbjct: 124 RLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS 180
Query: 371 NQNQANTNIIAGTYGYMAPEY-----AMGGIFSIKSDVFSFGVLLLEIISG 416
+ + NT++ GT +MAPE + + DV+S G+ +E+ G
Sbjct: 181 TRLRRNTSV--GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 9e-12
Identities = 47/147 (31%), Positives = 71/147 (48%), Gaps = 8/147 (5%)
Query: 271 HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILY 330
H LV L C L + EY+ L +F R +L + I+ + Y
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLALNY 111
Query: 331 LHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPE 390
LHE II+RDLK NVLLD + + K++D+G + G + T+ GT Y+APE
Sbjct: 112 LHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPE 166
Query: 391 YAMGGIFSIKSDVFSFGVLLLEIISGR 417
G + D ++ GVL+ E+++GR
Sbjct: 167 ILRGEDYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 1e-11
Identities = 59/225 (26%), Positives = 95/225 (42%), Gaps = 39/225 (17%)
Query: 223 KLGQGGFGPVYKG-TLADGKAIAVKRLSRT-SGQGL--KEFKNEVNLIAKLQHKNLVRLL 278
+G+GG G VY + +A+K++ S L K F E + A L H +V +
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68
Query: 279 GCCLEGQELLLIYEYMP---NKSLDVHLFDATR---------SVQLDWKRRLSIINGIAR 326
C +G +Y MP +L L + + + LSI + I
Sbjct: 69 SICSDGD---PVYYTMPYIEGYTLK-SLLKSVWQKESLSKELAEKTSVGAFLSIFHKICA 124
Query: 327 GILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQ------------ 374
I Y+H S+ ++HRDLK N+LL I D+G A +
Sbjct: 125 TIEYVH--SK-GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNIC 181
Query: 375 -ANTNI---IAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 415
++ I I GT YMAPE +G S +D+++ GV+L ++++
Sbjct: 182 YSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 1e-11
Identities = 59/210 (28%), Positives = 94/210 (44%), Gaps = 37/210 (17%)
Query: 222 NKLGQGGFGPV----YKGTLADGKAIAVKRLSRTSGQGLKEFKN---EVNLIAKLQHKNL 274
LG G FG V +KGT G+ A+K L + +K+ ++ E +++ +L H +
Sbjct: 24 ETLGTGSFGRVRIAKHKGT---GEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFI 80
Query: 275 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIAR-------- 326
V ++ + + + E++ L HL A R N +A+
Sbjct: 81 VNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGR-----------FPNDVAKFYHAELVL 129
Query: 327 GILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGY 386
YLH II+RDLK N+LLD+ + K++DFG A+ + T + GT Y
Sbjct: 130 AFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAK-----KVPDRTFTLCGTPEY 181
Query: 387 MAPEYAMGGIFSIKSDVFSFGVLLLEIISG 416
+APE D ++ GVLL E I+G
Sbjct: 182 LAPEVIQSKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 1e-11
Identities = 59/224 (26%), Positives = 101/224 (45%), Gaps = 37/224 (16%)
Query: 211 ALEATNHFSDENKLGQGGFGPV-YKGTLADGKAIAVKRLSRTSGQGL--KEFKNEVNLIA 267
E + + D ++G G +G V G +A+K+L R L K E+ L+
Sbjct: 10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLK 69
Query: 268 KLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLD-------VHLFDATRSVQLDWKRRLS- 319
++H+N++ LL + P+ SLD V F T +L +LS
Sbjct: 70 HMKHENVIGLLDV------------FTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSE 117
Query: 320 -----IINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQ 374
++ + +G+ Y+H IIHRDLK N+ +++D KI DFG AR Q
Sbjct: 118 DRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-----QTD 169
Query: 375 ANTNIIAGTYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGR 417
+ T Y APE + + ++ D++S G ++ E+++G+
Sbjct: 170 SEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 2e-11
Identities = 57/206 (27%), Positives = 100/206 (48%), Gaps = 27/206 (13%)
Query: 223 KLGQGGFGPVYKG-TLADGKAIAVK--RLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLG 279
KLG+G + VYKG + G+ +A+K RL G + E +L+ L+H N+V L
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIR-EASLLKDLKHANIVTLHD 70
Query: 280 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKI 339
+ L L++EY+ + L ++ D + + RL + + RG+ Y H + ++
Sbjct: 71 IIHTKKTLTLVFEYL-DTDLKQYMDDCGGGLSMH-NVRLFLFQ-LLRGLAYCH---QRRV 124
Query: 340 IHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYG-------YMAPEYA 392
+HRDLK N+L+ + K++DFG AR ++ + TY Y P+
Sbjct: 125 LHRDLKPQNLLISERGELKLADFGLARA---------KSVPSKTYSNEVVTLWYRPPDVL 175
Query: 393 MGGI-FSIKSDVFSFGVLLLEIISGR 417
+G +S D++ G + E+ +GR
Sbjct: 176 LGSTEYSTSLDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 2e-11
Identities = 47/144 (32%), Positives = 69/144 (47%), Gaps = 8/144 (5%)
Query: 274 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHE 333
LV L C L L+ EY+ L +F R +L + I + +LHE
Sbjct: 58 LVGLHSCFQTTSRLFLVIEYVNGGDL---MFHMQRQRKLPEEHARFYAAEICIALNFLHE 114
Query: 334 DSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAM 393
II+RDLK NVLLD D + K++D+G + G T+ GT Y+APE
Sbjct: 115 RG---IIYRDLKLDNVLLDADGHIKLTDYGMCK--EGLGPGDTTSTFCGTPNYIAPEILR 169
Query: 394 GGIFSIKSDVFSFGVLLLEIISGR 417
G + D ++ GVL+ E+++GR
Sbjct: 170 GEEYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 2e-11
Identities = 62/208 (29%), Positives = 100/208 (48%), Gaps = 25/208 (12%)
Query: 218 FSDENKLGQGGFGPV---YKGTLADGKAIAVKRLSR--TSGQGLKEFKNEVNLIAKLQHK 272
+ + +G G G V Y L + +A+K+LSR + K E+ L+ + HK
Sbjct: 19 YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 273 NLVRLLGCCL------EGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIAR 326
N++ LL E Q++ L+ E M D +L + ++LD +R ++ +
Sbjct: 77 NIISLLNVFTPQKSLEEFQDVYLVMELM-----DANLCQVIQ-MELDHERMSYLLYQMLC 130
Query: 327 GILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGY 386
GI +LH IIHRDLK SN+++ D KI DFG AR G + T + Y Y
Sbjct: 131 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRY-Y 184
Query: 387 MAPEYAMGGIFSIKSDVFSFGVLLLEII 414
APE +G + D++S G ++ E++
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 2e-11
Identities = 51/192 (26%), Positives = 90/192 (46%), Gaps = 22/192 (11%)
Query: 240 GKAIAVKRLSRTSGQGLKE---FKNEVNLIAKLQHKNLVRLL--GCCLEGQELLLIYEYM 294
G +A+K L + + + F+ E L A+L H N+V LL G G L ++EY+
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGL-LFAVFEYV 61
Query: 295 PNKSL-DVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLL-- 351
P ++L +V D + L +++ +A H I+HRDLK N+++
Sbjct: 62 PGRTLREVLAADGALPAGETGRLMLQVLDALACA----H---NQGIVHRDLKPQNIMVSQ 114
Query: 352 -DDDMNPKISDFGTARIFGGNQNQANTNIIA-----GTYGYMAPEYAMGGIFSIKSDVFS 405
+ K+ DFG + G ++ + GT Y APE G + SD+++
Sbjct: 115 TGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYA 174
Query: 406 FGVLLLEIISGR 417
+G++ LE ++G+
Sbjct: 175 WGLIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 2e-11
Identities = 62/201 (30%), Positives = 98/201 (48%), Gaps = 18/201 (8%)
Query: 224 LGQGGFGPVYKGTLAD-GKAIAVKRLSRTS---GQGLKEFKNE---VNLIAKLQHKNLVR 276
+G+GGFG VY AD GK A+K L + QG NE ++L++ +V
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 277 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSR 336
+ +L I + M L HL + V + + R I G+ ++H +R
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHL--SQHGVFSEKEMRFYATE-IILGLEHMH--NR 116
Query: 337 LKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGI 396
+++RDLK +N+LLD+ + +ISD G A F + A+ GT+GYMAPE G
Sbjct: 117 F-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGYMAPEVLQKGT 171
Query: 397 -FSIKSDVFSFGVLLLEIISG 416
+ +D FS G +L +++ G
Sbjct: 172 AYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 3e-11
Identities = 61/202 (30%), Positives = 97/202 (48%), Gaps = 20/202 (9%)
Query: 224 LGQGGFGPVYKGTLAD-GKAIAVKRLSRTS---GQGLKEFKNE---VNLIAKLQHKNLVR 276
+G+GGFG VY AD GK A+K L + QG NE ++L++ +V
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 277 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLS-IINGIARGILYLHEDS 335
+ +L I + M L HL + + + + II G+ H +
Sbjct: 62 MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLE------HMHN 115
Query: 336 RLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGG 395
R +++RDLK +N+LLD+ + +ISD G A F + A+ GT+GYMAPE G
Sbjct: 116 RF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGYMAPEVLQKG 170
Query: 396 I-FSIKSDVFSFGVLLLEIISG 416
+ + +D FS G +L +++ G
Sbjct: 171 VAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 3e-11
Identities = 56/190 (29%), Positives = 86/190 (45%), Gaps = 41/190 (21%)
Query: 312 LDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGN 371
LD L + +A+G+ +L + IHRD+ A NVLL D KI DFG AR +
Sbjct: 209 LDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMND 265
Query: 372 QN---QANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRK-------NN 420
N + N + +MAPE +++++SDV+S+G+LL EI S G+ N+
Sbjct: 266 SNYVVKGNARL---PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS 322
Query: 421 GFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQSCAPDELLKFIH-IGLLCVQQDPADR 479
FY K+ G+ Q PD I+ I +C +P +R
Sbjct: 323 KFY-------------KMVKRGY----------QMSRPDFAPPEIYSIMKMCWNLEPTER 359
Query: 480 PTMSSVVVML 489
PT S + ++
Sbjct: 360 PTFSQISQLI 369
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 4e-11
Identities = 55/234 (23%), Positives = 98/234 (41%), Gaps = 55/234 (23%)
Query: 222 NKLGQGGFGPVYKG-TLADGKAIAVKRLSRTSGQG------------------LKEFKNE 262
LG+G +G V K GK +A+K++ L+E K
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELK-- 72
Query: 263 VNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLS--- 319
++ +++H+N++ L+ +EG + L+ + M + +D K RL+
Sbjct: 73 --IMNEIKHENIMGLVDVYVEGDFINLVMDIM----------ASDLKKVVDRKIRLTESQ 120
Query: 320 ---IINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGN----- 371
I+ I G+ LH+ +HRDL +N+ ++ KI+DFG AR +G
Sbjct: 121 VKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDT 177
Query: 372 -----QNQANTNIIAG--TYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGR 417
Q + + T Y APE MG + D++S G + E+++G+
Sbjct: 178 LSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 5e-11
Identities = 61/300 (20%), Positives = 109/300 (36%), Gaps = 57/300 (19%)
Query: 224 LGQGGFGPVYKGTLADGKAIAVKR--LSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCC 281
+ K +AVK+ L S + LK + E+ +LQH N++ +
Sbjct: 10 FEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSF 68
Query: 282 LEGQELLLIYEYMPNKS----LDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRL 337
+ EL ++ M S L H + + + + I+ + + Y+H
Sbjct: 69 IVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAF-----ILKDVLNALDYIH---SK 120
Query: 338 KIIHRDLKASNVLLDDDMNPKISDFGTAR-IFGGNQNQAN----TNIIAGTYGYMAPEY- 391
IHR +KAS++LL D +S + + + Q +++PE
Sbjct: 121 GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVL 180
Query: 392 --AMGGIFSIKSDVFSFGVLLLEIISGRKNNGFY-FSEHGQTLLTYTWKLWCEGHAVELI 448
+ G ++ KSD++S G+ E+ NG F + T + K+ G L+
Sbjct: 181 QQNLQG-YNEKSDIYSVGITACEL-----ANGHVPFKDMPATQM-LLEKV--RGTVPCLL 231
Query: 449 D----PVLKQSCAPDELL--------------------KFIHIGLLCVQQDPADRPTMSS 484
D P+ + S + F LC+Q+DP RP+ S
Sbjct: 232 DKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQ 291
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 6e-11
Identities = 57/205 (27%), Positives = 100/205 (48%), Gaps = 10/205 (4%)
Query: 216 NHFSDENKLGQGGFGPVYKGTLADGKAI-AVKRLSRTSG-QGLKEFK-NEVNLIAKLQHK 272
N F +G+G +G V K + K I A+K+ + + +KE E+ ++ L+ +
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60
Query: 273 NLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLH 332
N+V L +L L++EY+ L++ L + V + R S I + + I + H
Sbjct: 61 NIVELKEAFRRRGKLYLVFEYVEKNMLEL-LEEMPNGVPPEKVR--SYIYQLIKAIHWCH 117
Query: 333 EDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYA 392
++ I+HRD+K N+L+ + K+ DFG AR N T +A T Y +PE
Sbjct: 118 KN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVA-TRWYRSPELL 173
Query: 393 MGGIFSIKSDVFSFGVLLLEIISGR 417
+G + D++S G +L E+ G+
Sbjct: 174 LGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 6e-11
Identities = 45/147 (30%), Positives = 71/147 (48%), Gaps = 8/147 (5%)
Query: 271 HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILY 330
H LV L C L + E++ L H+ R +L + I+ + +
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHM---QRQRKLPEEHARFYSAEISLALNF 111
Query: 331 LHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPE 390
LHE II+RDLK NVLLD + + K++D+G + G + T+ GT Y+APE
Sbjct: 112 LHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCK--EGIRPGDTTSTFCGTPNYIAPE 166
Query: 391 YAMGGIFSIKSDVFSFGVLLLEIISGR 417
G + D ++ GVL+ E+++GR
Sbjct: 167 ILRGEDYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 7e-11
Identities = 50/179 (27%), Positives = 87/179 (48%), Gaps = 23/179 (12%)
Query: 245 VKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI--YEYMPNKSLDVH 302
VK SR + Q +NE+ + +L H+N++++ +E+L YM + D
Sbjct: 200 VKAGSRAAIQ----LENEILALGRLNHENILKI-------EEILRSEANTYMITQKYDFD 248
Query: 303 LFDATRSVQLDWKRR------LSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMN 356
L+ DWK R +I+ + + Y+H+ K+IHRD+K N+ L+ D
Sbjct: 249 LYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGK 305
Query: 357 PKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 415
+ DFGTA F + +A GT +PE G + +D++S G++LL+++S
Sbjct: 306 IVLGDFGTAMPF-EKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 7e-11
Identities = 61/213 (28%), Positives = 99/213 (46%), Gaps = 30/213 (14%)
Query: 223 KLGQGGFGPV----YKGTLADGKAIAVKRLSRTSGQGL--KEFKNEVNLIAKLQ-HKNLV 275
+LGQG +G V T ++ + +A+K+++ + + K E+ L+ + HKN+
Sbjct: 7 ELGQGAYGIVCSARNAET-SEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNIT 65
Query: 276 RLLGCCLEGQELLL------IYEYMPNKSLDVHLFDATRS-VQLDWKRRLSIINGIARGI 328
CL +++ +Y Y D+H RS L S I I G+
Sbjct: 66 -----CLYDMDIVFPGNFNELYLYEELMEADLH--QIIRSGQPLTDAHFQSFIYQILCGL 118
Query: 329 LYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQAN---TNIIAGTYG 385
Y+H + ++HRDLK N+L++ D KI DFG AR F N + T +A T
Sbjct: 119 KYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVA-TRW 174
Query: 386 YMAPEYAMGGIFSIKS-DVFSFGVLLLEIISGR 417
Y APE + K+ DV+S G +L E++ +
Sbjct: 175 YRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 7e-11
Identities = 56/201 (27%), Positives = 92/201 (45%), Gaps = 18/201 (8%)
Query: 224 LGQGGFGPVYKGT-LADGKAIAVKRLSR--TSGQGLKEFKNEVNLIAKLQHKNLVRLLG- 279
+G G +G V G+ +A+K+LSR S K E+ L+ +QH+N++ LL
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV 82
Query: 280 --CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRL 337
+ G E Y MP D+ L + ++ + G+ Y+H
Sbjct: 83 FTSAVSGDEFQDFYLVMPYMQTDLQ---KIMGHPLSEDKVQYLVYQMLCGLKYIHSAG-- 137
Query: 338 KIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIF 397
IIHRDLK N+ +++D KI DFG AR A T Y APE + +
Sbjct: 138 -IIHRDLKPGNLAVNEDCELKILDFGLAR-----HADAEMTGYVVTRWYRAPEVILNWMH 191
Query: 398 SIKS-DVFSFGVLLLEIISGR 417
++ D++S G ++ E+++G+
Sbjct: 192 YNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 8e-11
Identities = 58/204 (28%), Positives = 92/204 (45%), Gaps = 23/204 (11%)
Query: 224 LGQGGFGPVY----KGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAK------LQHKN 273
LG+G FG V KGT + A+K L + L++ + + K +H
Sbjct: 3 LGKGSFGKVMLAELKGT---DEVYAIKVLKKDVI--LQDDDVDCTMTEKRILALAAKHPF 57
Query: 274 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHE 333
L L C L + EY+ L +F RS + D R + +++LH
Sbjct: 58 LTALHCCFQTKDRLFFVMEYVNGGDL---MFQIQRSRKFDEPRSRFYAAEVTLALMFLH- 113
Query: 334 DSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAM 393
R +I+RDLK N+LLD + + K++DFG + G N T GT Y+APE
Sbjct: 114 --RHGVIYRDLKLDNILLDAEGHCKLADFGMCK--EGILNGVTTTTFCGTPDYIAPEILQ 169
Query: 394 GGIFSIKSDVFSFGVLLLEIISGR 417
+ D ++ GVL+ E+++G+
Sbjct: 170 ELEYGPSVDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 60/198 (30%), Positives = 90/198 (45%), Gaps = 13/198 (6%)
Query: 224 LGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLKEFKN---EVNLIAK-LQHKNLVRLL 278
+G+G FG V +DG AVK L + + KE + E N++ K L+H LV L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 279 GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLK 338
++L + +Y+ L HL R R +A I YLH L
Sbjct: 63 YSFQTAEKLYFVLDYVNGGELFFHL---QRERCFLEPRARFYAAEVASAIGYLHS---LN 116
Query: 339 IIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFS 398
II+RDLK N+LLD + ++DFG + G + + T+ GT Y+APE +
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFCGTPEYLAPEVLRKEPYD 174
Query: 399 IKSDVFSFGVLLLEIISG 416
D + G +L E++ G
Sbjct: 175 RTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 1e-10
Identities = 56/210 (26%), Positives = 94/210 (44%), Gaps = 28/210 (13%)
Query: 224 LGQGGFGPVYKGT---LADGKA-----IAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLV 275
LGQG F ++KG + D + +K L ++ + F +++++L HK+LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 276 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDS 335
G C+ G E +++ EY+ SLD +L + + WK L + +A + +L +
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWK--LEVAKQLAWALHFLEDK- 119
Query: 336 RLKIIHRDLKASNVLL-----DDDMNP---KISDFGTARIFGGNQNQANTNIIAGTYGYM 387
+ H ++ A NVLL NP K+SD G + I+ ++
Sbjct: 120 --GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITV------LPKEILLERIPWV 171
Query: 388 APE-YAMGGIFSIKSDVFSFGVLLLEIISG 416
PE S+ +D +SFG L EI SG
Sbjct: 172 PPECIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 2e-10
Identities = 59/213 (27%), Positives = 102/213 (47%), Gaps = 19/213 (8%)
Query: 213 EATNHFSDENKLGQGGFGPV---YKGTLADGKAIAVKRLSRTSGQGL---KEFKNEVNLI 266
E + + +G G +G V Y L + +AVK+LSR Q L + E+ L+
Sbjct: 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLR--QKVAVKKLSRPF-QSLIHARRTYRELRLL 68
Query: 267 AKLQHKNLVRLLGCCLEGQELLLIYE-YMPNKSLDVHLFDATRSVQLDWKRRLSIINGIA 325
++H+N++ LL + E Y+ + L + + +L + +I +
Sbjct: 69 KHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLL 128
Query: 326 RGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYG 385
RG+ Y+H IIHRDLK SNV +++D +I DFG AR + T +A T
Sbjct: 129 RGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLAR----QADDEMTGYVA-TRW 180
Query: 386 YMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGR 417
Y APE + + ++ D++S G ++ E++ G+
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 59/205 (28%), Positives = 100/205 (48%), Gaps = 20/205 (9%)
Query: 224 LGQGGFGPVY---KGTLAD-GKAIAVKRLSRTS----GQGLKEFKNEVNLIAKL-QHKNL 274
LG G +G V+ K + D GK A+K L + + + + + E ++ + Q L
Sbjct: 8 LGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 67
Query: 275 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIING-IARGILYLHE 333
V L +L LI +Y+ L HL R + + + I +G I + +LH
Sbjct: 68 VTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKE----QEVQIYSGEIVLALEHLH- 122
Query: 334 DSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAM 393
+L II+RD+K N+LLD + + ++DFG ++ F ++ + + GT YMAP+
Sbjct: 123 --KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYS-FCGTIEYMAPDIVR 179
Query: 394 GGI--FSIKSDVFSFGVLLLEIISG 416
GG D +S GVL+ E+++G
Sbjct: 180 GGDGGHDKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 2e-10
Identities = 52/198 (26%), Positives = 95/198 (47%), Gaps = 20/198 (10%)
Query: 224 LGQGGFGP--VYKGTLADGK-AIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGC 280
+G+G FG + + +D K A+ RL ++S +++ + E L+AK++H N+V
Sbjct: 8 VGEGSFGRALLVQHVNSDQKYAMKEIRLPKSS-SAVEDSRKEAVLLAKMKHPNIVAFKES 66
Query: 281 CLEGQELLLIYEYMPNKSLDVHLFDA-----TRSVQLDWKRRLSIINGIARGILYLHEDS 335
L ++ EY L + L W ++ + G+ ++HE
Sbjct: 67 FEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCL------GVQHIHEK- 119
Query: 336 RLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGG 395
+++HRD+K+ N+ L + K+ DFG+AR+ A T + GT Y+ PE
Sbjct: 120 --RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV--GTPYYVPPEIWENM 175
Query: 396 IFSIKSDVFSFGVLLLEI 413
++ KSD++S G +L E+
Sbjct: 176 PYNNKSDIWSLGCILYEL 193
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 61/208 (29%), Positives = 88/208 (42%), Gaps = 14/208 (6%)
Query: 224 LGQGGFGPV-YKGTLADGKAIAVKRLSRTSGQGLKEFKN---EVNLIAKLQHKNLVRLLG 279
LG+G FG V A GK A+K L + E + E ++ +H L L
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62
Query: 280 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKI 339
L + EY+ L HL +R R I + YLH KI
Sbjct: 63 SFQTKDRLCFVMEYVNGGELFFHL---SRERVFSEDRTRFYGAEIVSALDYLHSG---KI 116
Query: 340 IHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSI 399
++RDLK N++LD D + KI+DFG + G + A GT Y+APE +
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCK--EGITDAATMKTFCGTPEYLAPEVLEDNDYGR 174
Query: 400 KSDVFSFGVLLLEIISGRKNNGFYFSEH 427
D + GV++ E++ GR FY +H
Sbjct: 175 AVDWWGLGVVMYEMMCGRLP--FYNQDH 200
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 2e-10
Identities = 49/150 (32%), Positives = 72/150 (48%), Gaps = 11/150 (7%)
Query: 223 KLGQGGFGPVYKGTLADG---KAIAVKRLSRTSG-QGLKEFKNEVNLIAKLQHKNLVRLL 278
++G G FG V G + G + VK L ++ Q +F E LQH NL++ L
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 279 GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQL---DWKRRLSIINGIARGILYLHEDS 335
G C E LL+ E+ P L +L + R +L D + IA G+L+LH+++
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYL-RSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN 120
Query: 336 RLKIIHRDLKASNVLLDDDMNPKISDFGTA 365
IH DL N LL D+ KI D+G +
Sbjct: 121 ---FIHSDLALRNCLLTADLTVKIGDYGLS 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 3e-10
Identities = 57/201 (28%), Positives = 91/201 (45%), Gaps = 16/201 (7%)
Query: 224 LGQGGFGPVYKGTLADGKAI-AVKRLSRTSGQGLKEFKN---EVNLIAKLQHKNLVRLLG 279
+G+G FG VY+ D + I A+K LS+ KE + E N++ + ++G
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 280 CCLEGQ---ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSR 336
Q +L L+ +YM L HL R R I + + +LH+
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGR---FSEDRAKFYIAELVLALEHLHKYD- 116
Query: 337 LKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGI 396
I++RDLK N+LLD + + DFG ++ + TN GT Y+APE +
Sbjct: 117 --IVYRDLKPENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGTTEYLAPEVLLDEK 172
Query: 397 -FSIKSDVFSFGVLLLEIISG 416
++ D +S GVL+ E+ G
Sbjct: 173 GYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 3e-10
Identities = 58/211 (27%), Positives = 98/211 (46%), Gaps = 33/211 (15%)
Query: 224 LGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLKEFKN---EVNLIAKLQHKNLVRLLG 279
+G G FG V+ T DGK +A+K++ Q L K E+ ++ +H N++ L
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVF-QNLVSCKRVFRELKMLCFFKHDNVLSAL- 65
Query: 280 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKR------RLS------IINGIARG 327
++L P+ ++ T +Q D + LS + I RG
Sbjct: 66 ------DIL----QPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRG 115
Query: 328 ILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYM 387
+ YLH I+HRD+K N+L++ + KI DFG AR+ ++++ T + Y Y
Sbjct: 116 LKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY-YR 171
Query: 388 APEYAMGGI-FSIKSDVFSFGVLLLEIISGR 417
APE MG ++ D++S G + E++ R
Sbjct: 172 APEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 7e-10
Identities = 56/203 (27%), Positives = 99/203 (48%), Gaps = 17/203 (8%)
Query: 224 LGQGGFGPVY---KGTLAD-GKAIAVKRLSRTS----GQGLKEFKNEVNLIAKLQHKNLV 275
LG G +G V+ K T D GK A+K L + + + ++ + E N++ ++ +
Sbjct: 8 LGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFL 67
Query: 276 RLLGCCLEGQ-ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHED 334
L + + +L LI +Y+ + HL+ Q D + IL L
Sbjct: 68 VTLHYAFQTEAKLHLILDYVSGGEMFTHLY------QRDNFSEDEVRFYSGEIILALEHL 121
Query: 335 SRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMG 394
+L I++RD+K N+LLD + + ++DFG ++ F ++ + T GT YMAPE G
Sbjct: 122 HKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEF-LSEEKERTYSFCGTIEYMAPEIIRG 180
Query: 395 GIFSIKS-DVFSFGVLLLEIISG 416
K+ D +S G+L+ E+++G
Sbjct: 181 KGGHGKAVDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 8e-10
Identities = 56/206 (27%), Positives = 98/206 (47%), Gaps = 19/206 (9%)
Query: 224 LGQGGFGPVYK-GTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQ-HKNLVRLLGCC 281
+G+G +G V+K +G AVK L +E + E N++ L H N+V+ G
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID-EEIEAEYNILKALSDHPNVVKFYGMY 84
Query: 282 LE-----GQELLLIYEYMPNKSL-DVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDS 335
+ G +L L+ E S+ D+ R +++ I++ G+ +LH +
Sbjct: 85 YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN- 143
Query: 336 RLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEY---- 391
K IHRD+K +N+LL + K+ DFG + + + NT++ GT +MAPE
Sbjct: 144 --KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV--GTPFWMAPEVIACE 199
Query: 392 -AMGGIFSIKSDVFSFGVLLLEIISG 416
+ + + DV+S G+ +E+ G
Sbjct: 200 QQLDSTYDARCDVWSLGITAIELGDG 225
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 8e-10
Identities = 37/98 (37%), Positives = 51/98 (52%), Gaps = 3/98 (3%)
Query: 318 LSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANT 377
LS +ARG+ +L + +HRDL A NVLL KI DFG AR + N +
Sbjct: 240 LSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSK 296
Query: 378 NIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 415
+MAPE +++ SDV+S+G+LL EI S
Sbjct: 297 GSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 1e-09
Identities = 36/96 (37%), Positives = 54/96 (56%), Gaps = 9/96 (9%)
Query: 324 IARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTAR--IFGGNQNQANTNIIA 381
IA G+ +LH II+RDLK NV+LD + + KI+DFG + ++ G T
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG----VTTKTFC 162
Query: 382 GTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGR 417
GT Y+APE + D ++FGVLL E+++G+
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 58/198 (29%), Positives = 87/198 (43%), Gaps = 13/198 (6%)
Query: 224 LGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLKEFKN---EVNLIAK-LQHKNLVRLL 278
+G+G FG V DGK AVK L + KE K+ E N++ K ++H LV L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 279 GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLK 338
++L + +++ L HL R R IA + YLH +
Sbjct: 63 YSFQTTEKLYFVLDFVNGGELFFHL---QRERSFPEPRARFYAAEIASALGYLHS---IN 116
Query: 339 IIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFS 398
I++RDLK N+LLD + ++DFG + G T GT Y+APE +
Sbjct: 117 IVYRDLKPENILLDSQGHVVLTDFGLCK--EGIAQSDTTTTFCGTPEYLAPEVIRKQPYD 174
Query: 399 IKSDVFSFGVLLLEIISG 416
D + G +L E++ G
Sbjct: 175 NTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 3e-09
Identities = 34/96 (35%), Positives = 53/96 (55%), Gaps = 9/96 (9%)
Query: 324 IARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTAR--IFGGNQNQANTNIIA 381
I+ G+ +LH II+RDLK NV+LD + + KI+DFG + + G T
Sbjct: 110 ISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG----VTTRTFC 162
Query: 382 GTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGR 417
GT Y+APE + D +++GVLL E+++G+
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 5e-09
Identities = 61/209 (29%), Positives = 87/209 (41%), Gaps = 27/209 (12%)
Query: 234 KGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAK------------LQHKNLVRLLGCC 281
KGT GK I VK + +K K EV ++AK LQ+ L
Sbjct: 5 KGTF--GKVILVKEKATGRYYAMKILKKEV-IVAKDEVAHTLTENRVLQNSRHPFLTALK 61
Query: 282 LEGQ---ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLK 338
Q L + EY L HL +R R I + YLH S
Sbjct: 62 YSFQTHDRLCFVMEYANGGELFFHL---SRERVFSEDRARFYGAEIVSALDYLH--SEKN 116
Query: 339 IIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFS 398
+++RDLK N++LD D + KI+DFG + G ++ A GT Y+APE +
Sbjct: 117 VVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLAPEVLEDNDYG 174
Query: 399 IKSDVFSFGVLLLEIISGRKNNGFYFSEH 427
D + GV++ E++ GR FY +H
Sbjct: 175 RAVDWWGLGVVMYEMMCGRLP--FYNQDH 201
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 57.3 bits (139), Expect = 6e-09
Identities = 33/100 (33%), Positives = 55/100 (55%), Gaps = 11/100 (11%)
Query: 324 IARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQAN---TNII 380
+ RG+ Y+H +IHRDLK SN+L+++D +I DFG AR + + T +
Sbjct: 116 LLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYV 172
Query: 381 AGTYGYMAPE--YAMGGIFSIKSDVFSFGVLLLEIISGRK 418
A T Y APE ++ ++ D++S G + E++ GR+
Sbjct: 173 A-TRWYRAPELLLSLPE-YTTAIDMWSVGCIFAEML-GRR 209
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 6e-09
Identities = 56/228 (24%), Positives = 100/228 (43%), Gaps = 48/228 (21%)
Query: 216 NHFSDENKLGQGGFGPVY----KGTLADGKAIAVKRLSRT---SGQGLKEFKNEVNLIAK 268
F ++ +G+G FG V K T G A+K + ++ + + + F+ E ++++
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKAT---GDIYAMKVMKKSVLLAQETVSFFEEERDILSI 57
Query: 269 LQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIING----- 323
+ +L + L L+ EY P L LS++N
Sbjct: 58 SNSPWIPQLQYAFQDKDNLYLVMEYQPGGDL------------------LSLLNRYEDQF 99
Query: 324 --------IARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQA 375
+A +L +H ++ +HRD+K NVL+D + K++DFG+A N+
Sbjct: 100 DEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK-MV 158
Query: 376 NTNIIAGTYGYMAPEY------AMGGIFSIKSDVFSFGVLLLEIISGR 417
N+ + GT Y+APE G + ++ D +S GV+ E+I GR
Sbjct: 159 NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 7e-09
Identities = 43/152 (28%), Positives = 67/152 (44%), Gaps = 20/152 (13%)
Query: 223 KLGQGGFGPVYKGTLADGKAIA---VKRLSRTSG-QGLKEFKNEVNLIAKLQHKNLVRLL 278
++G G FG V + +A VK L + + EF + + LQH N+++ L
Sbjct: 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61
Query: 279 GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLS-------IINGIARGILYL 331
G C+E LL++EY L +L Q W RR S + IA G+ ++
Sbjct: 62 GQCVEAIPYLLVFEYCELGDLKSYL------SQEQWHRRNSQLLLLQRMACEIAAGVTHM 115
Query: 332 HEDSRLKIIHRDLKASNVLLDDDMNPKISDFG 363
H + +H DL N L D+ K+ D+G
Sbjct: 116 H---KHNFLHSDLALRNCFLTSDLTVKVGDYG 144
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 9e-09
Identities = 30/86 (34%), Positives = 50/86 (58%), Gaps = 5/86 (5%)
Query: 331 LHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPE 390
LH+ +I+RDLK N+LLD + + DFG ++ + ++ NT GT Y+APE
Sbjct: 109 LHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT--FCGTPEYLAPE 163
Query: 391 YAMGGIFSIKSDVFSFGVLLLEIISG 416
+G ++ D ++ GVLL E+++G
Sbjct: 164 LLLGHGYTKAVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 1e-08
Identities = 52/203 (25%), Positives = 86/203 (42%), Gaps = 26/203 (12%)
Query: 224 LGQGGFGPVYKGTLADGK--AIAVKRLSRTSGQGLKEFK---NEVNLIAKLQHKNLVRLL 278
LG G FG V T + +A+KR ++ K+ +E ++ + H V L
Sbjct: 38 LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLY 97
Query: 279 GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGI-----ARGILYLHE 333
G + L L+ E++ L +R N + A+ +L
Sbjct: 98 GSFKDESYLYLVLEFVIGGEFFTFL-----------RRNKRFPNDVGCFYAAQIVLIFEY 146
Query: 334 DSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAM 393
L I++RDLK N+LLD D K++DFG A++ T + GT Y+APE +
Sbjct: 147 LQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV-----DTRTYTLCGTPEYIAPEILL 201
Query: 394 GGIFSIKSDVFSFGVLLLEIISG 416
+D ++ G+ + EI+ G
Sbjct: 202 NVGHGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 42/156 (26%), Positives = 74/156 (47%), Gaps = 8/156 (5%)
Query: 262 EVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSII 321
E +++ + H ++++L G + LI +P D++ + A + + L+I
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKR-NIAICDILAIE 188
Query: 322 NGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIA 381
+ R I YLHE+ IIHRD+KA N+ ++ + + DFG A F + N A
Sbjct: 189 RSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAA-CFPVDINANKYYGWA 244
Query: 382 GTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGR 417
GT APE + D++S G++L E+ +
Sbjct: 245 GTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 56/217 (25%), Positives = 98/217 (45%), Gaps = 45/217 (20%)
Query: 224 LGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLKEFKN---------EVNLIAKLQHKN 273
+G+G +G V ++ + +A+K+++ F N E+ L+ L H+N
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIA-------NAFDNRIDAKRTLREIKLLRHLDHEN 65
Query: 274 LVRLLGCCLEGQ-----ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLS------IIN 322
++ + ++ ++YE M D L RS Q LS +
Sbjct: 66 VIAIKDIMPPPHREAFNDVYIVYELM-----DTDLHQIIRSSQT-----LSDDHCQYFLY 115
Query: 323 GIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAG 382
+ RG+ Y+H + ++HRDLK SN+LL+ + + KI DFG AR + ++
Sbjct: 116 QLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV-- 170
Query: 383 TYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRK 418
T Y APE + ++ DV+S G + E++ GRK
Sbjct: 171 TRWYRAPELLLNCSEYTTAIDVWSVGCIFAELL-GRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 57/208 (27%), Positives = 87/208 (41%), Gaps = 14/208 (6%)
Query: 224 LGQGGFGPV-YKGTLADGKAIAVKRLSRTSGQGLKEFKN---EVNLIAKLQHKNLVRLLG 279
LG+G FG V A G+ A+K L + E + E ++ +H L L
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 62
Query: 280 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKI 339
L + EY L HL +R +R I + YLH +
Sbjct: 63 AFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGAEIVSALEYLHSRD---V 116
Query: 340 IHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSI 399
++RD+K N++LD D + KI+DFG + G + A GT Y+APE +
Sbjct: 117 VYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDNDYGR 174
Query: 400 KSDVFSFGVLLLEIISGRKNNGFYFSEH 427
D + GV++ E++ GR FY +H
Sbjct: 175 AVDWWGLGVVMYEMMCGRLP--FYNQDH 200
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 1e-08
Identities = 55/186 (29%), Positives = 87/186 (46%), Gaps = 24/186 (12%)
Query: 328 ILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYM 387
+L +H +IHRD+K++N+LL + K+ DFG ++++ + GT Y+
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYV 212
Query: 388 APEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVE 446
APE +S K+D+FS GVLL E+++ R +G E L +
Sbjct: 213 APEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRY---------- 262
Query: 447 LIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM-----LASDSMTIPQPTE 501
DP L S +P+ ++ I LL DP RP+ S ++ M S + I Q T+
Sbjct: 263 --DP-LPPSISPE--MQEIVTALLS--SDPKRRPSSSKLLNMPICKLFISGLLEIVQ-TQ 314
Query: 502 PAFSVG 507
P FS
Sbjct: 315 PGFSGP 320
|
Length = 496 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 58/204 (28%), Positives = 92/204 (45%), Gaps = 22/204 (10%)
Query: 224 LGQGGFGPV----YKGTLADGKAIAVKRLSRTSGQGLKE---FKNEVNLIAKLQHKNLVR 276
+G+G FG V +K T K A+K LS+ + F E +++A +V+
Sbjct: 51 IGRGAFGEVQLVRHKST---RKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQ 107
Query: 277 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSR 336
L + + L ++ EYMP L V+L + V W R + A +L L
Sbjct: 108 LFYAFQDDRYLYMVMEYMPGGDL-VNLM-SNYDVPEKWARFYT-----AEVVLALDAIHS 160
Query: 337 LKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMG-- 394
+ IHRD+K N+LLD + K++DFGT + + GT Y++PE
Sbjct: 161 MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM-NKEGMVRCDTAVGTPDYISPEVLKSQG 219
Query: 395 --GIFSIKSDVFSFGVLLLEIISG 416
G + + D +S GV L E++ G
Sbjct: 220 GDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 58/198 (29%), Positives = 91/198 (45%), Gaps = 13/198 (6%)
Query: 224 LGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLKEFK---NEVNLIAK-LQHKNLVRLL 278
+G+G FG V A+ K AVK L + + KE K +E N++ K ++H LV L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 279 GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLK 338
+L + +Y+ L HL L+ + R IA + YLH L
Sbjct: 63 FSFQTADKLYFVLDYINGGELFYHL--QRERCFLEPRARFYAAE-IASALGYLHS---LN 116
Query: 339 IIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFS 398
I++RDLK N+LLD + ++DFG + ++ T+ GT Y+APE +
Sbjct: 117 IVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNGTTSTFCGTPEYLAPEVLHKQPYD 174
Query: 399 IKSDVFSFGVLLLEIISG 416
D + G +L E++ G
Sbjct: 175 RTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 3e-08
Identities = 34/104 (32%), Positives = 52/104 (50%), Gaps = 7/104 (6%)
Query: 324 IARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGT 383
I + YLH +++RDLK N++LD D + KI+DFG + G + A GT
Sbjct: 104 IVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGT 158
Query: 384 YGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEH 427
Y+APE + D + GV++ E++ GR FY +H
Sbjct: 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP--FYNQDH 200
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 3e-08
Identities = 57/206 (27%), Positives = 94/206 (45%), Gaps = 26/206 (12%)
Query: 224 LGQGGFGPV----YKGTLADGKAIAVKRLSRTSGQGLKE-----FKNEVNLIAKLQHKNL 274
+G+G FG V +K + + A+K LS+ + +K F E +++A + +
Sbjct: 51 IGRGAFGEVQLVRHKSS---KQVYAMKLLSKF--EMIKRSDSAFFWEERDIMAHANSEWI 105
Query: 275 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHED 334
V+L + + L ++ EYMP L V+L + + W R A +L L
Sbjct: 106 VQLHYAFQDDKYLYMVMEYMPGGDL-VNLM-SNYDIPEKWARFY-----TAEVVLALDAI 158
Query: 335 SRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMG 394
+ IHRD+K N+LLD + K++DFGT N + GT Y++PE
Sbjct: 159 HSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN-GMVRCDTAVGTPDYISPEVLKS 217
Query: 395 ----GIFSIKSDVFSFGVLLLEIISG 416
G + + D +S GV L E++ G
Sbjct: 218 QGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 56/204 (27%), Positives = 92/204 (45%), Gaps = 22/204 (10%)
Query: 224 LGQGGFGPV----YKGTLADGKAIAVKRLSRTSGQGLKE---FKNEVNLIAKLQHKNLVR 276
+G+G FG V +K + K A+K LS+ + F E +++A +V+
Sbjct: 51 IGRGAFGEVQLVRHK---SSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQ 107
Query: 277 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSR 336
L + + L ++ EYMP L V+L + V W + + A +L L
Sbjct: 108 LFCAFQDDKYLYMVMEYMPGGDL-VNLM-SNYDVPEKWAKFYT-----AEVVLALDAIHS 160
Query: 337 LKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMG-- 394
+ +IHRD+K N+LLD + K++DFGT + GT Y++PE
Sbjct: 161 MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKM-DETGMVRCDTAVGTPDYISPEVLKSQG 219
Query: 395 --GIFSIKSDVFSFGVLLLEIISG 416
G + + D +S GV L E++ G
Sbjct: 220 GDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 4e-08
Identities = 59/257 (22%), Positives = 95/257 (36%), Gaps = 69/257 (26%)
Query: 216 NHFSDENKLGQGGFGPV-YKGTLADGKAIAVKRLSRTS---GQGLKEFKNEVNLIAKLQH 271
F +G+G FG V GK A+K L ++ L K E +++A+
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60
Query: 272 KNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLF-------DATRSVQLDWKRRLSIINGI 324
+V L + Q L LI E++P L L D TR +
Sbjct: 61 PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFY-------------M 107
Query: 325 ARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTA-------------RIFGGN 371
A +L + +L IHRD+K N+L+D + K+SDFG + ++ G
Sbjct: 108 AECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGK 167
Query: 372 QNQ----------------------------ANTNIIA----GTYGYMAPEYAMGGIFSI 399
N+ N ++A GT Y+APE + +
Sbjct: 168 SNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQ 227
Query: 400 KSDVFSFGVLLLEIISG 416
+ D +S G ++ E + G
Sbjct: 228 ECDWWSLGAIMFECLIG 244
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 33/92 (35%), Positives = 49/92 (53%), Gaps = 3/92 (3%)
Query: 324 IARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGT 383
+A G+ +L + +HRDL A NVL+ + KI DFG AR + N +
Sbjct: 248 VANGMEFLASKN---CVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLP 304
Query: 384 YGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 415
+MAPE +++ SDV+SFG+LL EI +
Sbjct: 305 LKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 60/221 (27%), Positives = 104/221 (47%), Gaps = 51/221 (23%)
Query: 222 NKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLKEFKN-EVNLIAKLQHKNLVRLLG 279
N +G G FG VY+ D + +A+K++ + ++KN E+ ++ L H N++ L
Sbjct: 72 NIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLNHINIIFLKD 126
Query: 280 C----CLEGQE----LLLIYEYMP-------------NKSLDVHLFDATRSVQLDWKRRL 318
C + E L ++ E++P N +L + L S QL
Sbjct: 127 YYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVK-LYSYQL------ 179
Query: 319 SIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNP-KISDFGTAR-IFGGNQNQAN 376
R + Y+H S+ I HRDLK N+L+D + + K+ DFG+A+ + G Q +
Sbjct: 180 ------CRALAYIH--SKF-ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAG---QRS 227
Query: 377 TNIIAGTYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISG 416
+ I + Y APE +G ++ D++S G ++ E+I G
Sbjct: 228 VSYICSRF-YRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 1e-07
Identities = 42/176 (23%), Positives = 79/176 (44%), Gaps = 12/176 (6%)
Query: 238 ADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNK 297
K + VK + G K E++++ + H+ ++ L+ + ++ MP
Sbjct: 117 EQRKKVIVK-----AVTGGKTPGREIDILKTISHRAIINLIHAYRWKSTVCMV---MPKY 168
Query: 298 SLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNP 357
D+ + RS L ++ ++I + + YLH IIHRD+K N+ LD+ N
Sbjct: 169 KCDLFTY-VDRSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENA 224
Query: 358 KISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEI 413
+ DFG A + + +GT +PE + K+D++S G++L E+
Sbjct: 225 VLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEM 280
|
Length = 392 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 2e-07
Identities = 48/163 (29%), Positives = 81/163 (49%), Gaps = 19/163 (11%)
Query: 259 FKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRL 318
F +L++++ H +L + G C+ G E +++ E++ + LDV L V + WK +
Sbjct: 63 FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWK--I 120
Query: 319 SIINGIARGILYLHEDSRLKIIHRDLKASNVL-----LDDDMNP--KISDFGTARIFGGN 371
++ +A + YL ED L +H ++ A N+L L + +P K+SD G + F
Sbjct: 121 TVAQQLASALSYL-EDKNL--VHGNVCAKNILLARLGLAEGTSPFIKLSDPGVS--FTAL 175
Query: 372 QNQANTNIIAGTYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEI 413
+ I ++APE GG S +D +SFG LLEI
Sbjct: 176 SREERVERIP----WIAPECVPGGNSLSTAADKWSFGTTLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|216632 pfam01657, Stress-antifung, Salt stress response/antifungal | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 5e-07
Identities = 30/109 (27%), Positives = 41/109 (37%), Gaps = 10/109 (9%)
Query: 61 LCMYIVRNFSVPRNVT-----RILAQSFNDVIAMPSLSSFRNATKGTNISNINRLETFGQ 115
LC N T L S + A S F T G + L Q
Sbjct: 3 LCSSNTSGNYTTANSTFESNLNALLSSLSSNAASSSGKGFAAGTSGAAPDTVYGL---AQ 59
Query: 116 CIPVLSVDDCRDCLNNTIRWIQKCFDPPGTGFGRILFPSCIMGFELHPY 164
C LS DCR CL + +++C P GRI + SC + +E +P+
Sbjct: 60 CRGDLSASDCRSCLATAVSELRRCC--PNKKGGRIWYDSCFLRYESYPF 106
|
This domain is often found in association with the kinase domains pfam00069 or pfam07714. In many proteins it is duplicated. It contains six conserved cysteines which are involved in disulphide bridges. It has a role in salt stress response and has antifungal activity. Length = 106 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 5e-07
Identities = 58/233 (24%), Positives = 100/233 (42%), Gaps = 30/233 (12%)
Query: 260 KNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLS 319
++E++ +A H +V+ +LLLI EY L+ + ++ K L
Sbjct: 113 RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLN-------KQIKQRLKEHLP 165
Query: 320 IINGIARGILY-----LHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQ 374
+ Y L E K++HRDLK++N+ L K+ DFG ++ + + +
Sbjct: 166 FQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL 225
Query: 375 ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLT 433
+ GT Y+APE +S K+D++S GV+L E+++ R G E Q +L
Sbjct: 226 DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLY 285
Query: 434 YTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVV 486
+ DP C +K + LL ++PA RPT ++
Sbjct: 286 GKY------------DPF---PCPVSSGMKALLDPLL--SKNPALRPTTQQLL 321
|
Length = 478 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 5e-07
Identities = 34/99 (34%), Positives = 49/99 (49%), Gaps = 14/99 (14%)
Query: 326 RGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNII----A 381
R + Y+H + + HRDLK N+L + D KI DFG AR+ N T I
Sbjct: 114 RALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARV---AFNDTPTAIFWTDYV 167
Query: 382 GTYGYMAPEYAMGGIFSIKS---DVFSFGVLLLEIISGR 417
T Y APE G FS + D++S G + E+++G+
Sbjct: 168 ATRWYRAPELC-GSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 1e-06
Identities = 44/156 (28%), Positives = 75/156 (48%), Gaps = 14/156 (8%)
Query: 261 NEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSI 320
+E L+ +L H ++ LL + G L+ +P D++ + R L L+
Sbjct: 209 HEARLLRRLSHPAVLALLDVRVVGGLTCLV---LPKYRSDLYTYLGARLRPLG----LAQ 261
Query: 321 INGIARGIL----YLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQAN 376
+ +AR +L Y+H + IIHRD+K NVL++ + + DFG A G+ +
Sbjct: 262 VTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPF 318
Query: 377 TNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLE 412
IAGT APE G ++ D++S G+++ E
Sbjct: 319 HYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 1e-06
Identities = 60/243 (24%), Positives = 89/243 (36%), Gaps = 57/243 (23%)
Query: 217 HFSDENKLGQGGFGPVY----KGTLADGKAIAVKRLSRTSGQGLKEFKN---EVNLIAKL 269
HF LG+G G V+ KGT GK A+K L + + K E ++A L
Sbjct: 2 HFKKIKLLGKGDVGRVFLVRLKGT---GKLFALKVLDKKEMIKRNKVKRVLTEQEILATL 58
Query: 270 QHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIAR--- 326
H L L L L+ +Y P ++ + + LS +AR
Sbjct: 59 DHPFLPTLYASFQTETYLCLVMDYCPGG--ELFRLLQRQP-----GKCLSE--EVARFYA 109
Query: 327 -----GILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDF---------GTARIF---- 368
+ YLH L I++RDLK N+LL + + +SDF
Sbjct: 110 AEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRK 166
Query: 369 ---GGNQNQ-----------ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEII 414
+ N +N GT Y+APE G D ++ G+LL E++
Sbjct: 167 GSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEML 226
Query: 415 SGR 417
G
Sbjct: 227 YGT 229
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.3 bits (122), Expect = 1e-06
Identities = 69/255 (27%), Positives = 114/255 (44%), Gaps = 66/255 (25%)
Query: 216 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSR------TSGQGLKEFKN-----EVN 264
N + K+G G FG V+ + KR S +GLKE + EVN
Sbjct: 13 NEYEVIKKIGNGRFGEVF--------LVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVN 64
Query: 265 LIAKLQHKNLVRLLGCCLE--GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSI-- 320
++ +L+HKN+VR + L Q+L ++ E+ D +R++Q +K I
Sbjct: 65 VMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAG-------DLSRNIQKCYKMFGKIEE 117
Query: 321 --INGIARGIL----YLHE----DSRLKIIHRDLKASNVLLD-------------DDMN- 356
I I R +L Y H + +++HRDLK N+ L +++N
Sbjct: 118 HAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNG 177
Query: 357 ---PKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSI--KSDVFSFGVLLL 411
KI DFG ++ G ++ A++ + GT Y +PE + S KSD+++ G ++
Sbjct: 178 RPIAKIGDFGLSKNI-GIESMAHSCV--GTPYYWSPELLLHETKSYDDKSDMWALGCIIY 234
Query: 412 EIISGR----KNNGF 422
E+ SG+ K N F
Sbjct: 235 ELCSGKTPFHKANNF 249
|
Length = 1021 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 62/244 (25%), Positives = 96/244 (39%), Gaps = 68/244 (27%)
Query: 224 LGQGGFGPV----YKGTLADGKAIAVKRLSRTSGQGLKE----FKNEVNLIAKLQHKNLV 275
+G+G FG V K T G A+K+L R S KE + E +++A+ + +V
Sbjct: 9 IGRGAFGEVRLVQKKDT---GHIYAMKKL-RKSEMLEKEQVAHVRAERDILAEADNPWVV 64
Query: 276 RLLGCCLEGQELLLIYEYMPNKSL-------DVHLFDATRSVQLDWKRRLSIINGIARGI 328
+L + L LI EY+P + D + TR IA I
Sbjct: 65 KLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFY-------------IAETI 111
Query: 329 LYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGT------------ARIFGGNQNQAN 376
L + +L IHRD+K N+LLD + K+SDFG RI
Sbjct: 112 LAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNF 171
Query: 377 TNIIA------------------------GTYGYMAPEYAMGGIFSIKSDVFSFGVLLLE 412
+ I+ GT Y+APE + ++ + D +S GV++ E
Sbjct: 172 LDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYE 231
Query: 413 IISG 416
++ G
Sbjct: 232 MLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 3e-06
Identities = 32/99 (32%), Positives = 55/99 (55%), Gaps = 8/99 (8%)
Query: 324 IARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTA-RIFGGNQNQANTNIIAG 382
+A +L + +L +HRD+K NVLLD + + +++DFG+ R+ Q +N+ G
Sbjct: 108 LAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQ--SNVAVG 165
Query: 383 TYGYMAPEY--AMG---GIFSIKSDVFSFGVLLLEIISG 416
T Y++PE AM G + + D +S GV + E++ G
Sbjct: 166 TPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 4e-06
Identities = 42/196 (21%), Positives = 87/196 (44%), Gaps = 22/196 (11%)
Query: 232 VYKGTLADGKAIAVKRL---SRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELL 288
+YKG + K + ++ + + +NE+ + ++ N++++ G ++ + L
Sbjct: 36 IYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94
Query: 289 ----LIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDL 344
LI EY L L + L +K +L + +G+ L+ +++L
Sbjct: 95 PRLSLILEYCTRGYLREVL---DKEKDLSFKTKLDMAIDCCKGLYNLY--KYTNKPYKNL 149
Query: 345 KASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFS---IKS 401
+ + L+ ++ KI G +I + N N + Y + + + IFS IK
Sbjct: 150 TSVSFLVTENYKLKIICHGLEKILS-SPPFKNVNFMV----YFSYKM-LNDIFSEYTIKD 203
Query: 402 DVFSFGVLLLEIISGR 417
D++S GV+L EI +G+
Sbjct: 204 DIYSLGVVLWEIFTGK 219
|
Length = 283 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 4e-06
Identities = 29/98 (29%), Positives = 52/98 (53%), Gaps = 6/98 (6%)
Query: 324 IARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGT 383
IA +L +H +L +HRD+K NVLLD + + +++DFG+ + +++ GT
Sbjct: 108 IAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSC-LKMNQDGTVQSSVAVGT 166
Query: 384 YGYMAPEYAMG-----GIFSIKSDVFSFGVLLLEIISG 416
Y++PE G + + D +S GV + E++ G
Sbjct: 167 PDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 2e-05
Identities = 33/151 (21%), Positives = 56/151 (37%), Gaps = 15/151 (9%)
Query: 219 SDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLV--R 276
S L G VY D + +K +E EV ++ L K L +
Sbjct: 1 SSIKLLKGGLTNRVYLLGTKDEDYV-LKINPSREKGADRE--REVAILQLLARKGLPVPK 57
Query: 277 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSR 336
+L L+ E++ ++LD ++ + + I +A + LH+
Sbjct: 58 VLASGESDGWSYLLMEWIEGETLD----------EVSEEEKEDIAEQLAELLAKLHQLPL 107
Query: 337 LKIIHRDLKASNVLLDDDMNPKISDFGTARI 367
L + H DL N+L+DD I D+ A
Sbjct: 108 LVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 3e-05
Identities = 63/289 (21%), Positives = 115/289 (39%), Gaps = 44/289 (15%)
Query: 235 GTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 294
GTL + + L + + LK +NEV L +H N++ G L +I +M
Sbjct: 25 GTLV---TVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFM 81
Query: 295 PNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDD 354
S + L + +I+ G RG+ YLH++ IHR++KAS++L+ D
Sbjct: 82 AYGSAN-SLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGD 137
Query: 355 MNPKISDFGTARIFGGNQNQANT-----NIIAGTYGYMAPEYAMGGI--FSIKSDVFSFG 407
+S N +A +++PE + +++KSD++S G
Sbjct: 138 GLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVG 197
Query: 408 VLLLEIISGR--------------KNNGFYFS-------EHGQTLLTYTWKLWCEGHAVE 446
+ E+ +GR K G +S ++ + + G
Sbjct: 198 ITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGES 257
Query: 447 LIDPVLKQSCAPDELLK---------FIHIGLLCVQQDPADRPTMSSVV 486
++ + Q+ + L F ++ LC+QQDP RP+ SS++
Sbjct: 258 VVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLL 306
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 3e-05
Identities = 54/237 (22%), Positives = 94/237 (39%), Gaps = 45/237 (18%)
Query: 218 FSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKE----FKNEVNLIAKLQHKN 273
F +G+G FG V D I ++ R + KE + E +++ +
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAW 62
Query: 274 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHE 333
+V++ + + L LI E++P + T ++ D + IA +L +
Sbjct: 63 VVKMFYSFQDKRNLYLIMEFLPGGDM------MTLLMKKDTLSEEATQFYIAETVLAIDA 116
Query: 334 DSRLKIIHRDLKASNVLLDDDMNPKISDFG------------------------------ 363
+L IHRD+K N+LLD + K+SDFG
Sbjct: 117 IHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNM 176
Query: 364 ----TARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISG 416
A + N+ Q + + GT Y+APE M ++ D +S GV++ E++ G
Sbjct: 177 NSKRKAETWKKNRRQLAYSTV-GTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 6e-05
Identities = 53/237 (22%), Positives = 92/237 (38%), Gaps = 45/237 (18%)
Query: 218 FSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKE----FKNEVNLIAKLQHKN 273
F +G+G FG V D + ++ R + KE + E +++ +
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLW 62
Query: 274 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHE 333
+V++ + L LI E++P + T ++ D IA +L +
Sbjct: 63 VVKMFYSFQDKLNLYLIMEFLPGGDM------MTLLMKKDTLTEEETQFYIAETVLAIDS 116
Query: 334 DSRLKIIHRDLKASNVLLDDDMNPKISDFG------------------------------ 363
+L IHRD+K N+LLD + K+SDFG
Sbjct: 117 IHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNM 176
Query: 364 ----TARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISG 416
A + N+ Q + + GT Y+APE M ++ D +S GV++ E++ G
Sbjct: 177 NSKRKAETWKRNRRQLAFSTV-GTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 6e-05
Identities = 45/202 (22%), Positives = 88/202 (43%), Gaps = 15/202 (7%)
Query: 224 LGQGGFGPVYKGTLADG-KAIAVKRLSRTSGQGLKE---FKNEVNLIAKLQHKNLVRLLG 279
+G+G FG V L + K A+K L++ E F+ E +++ ++ + L
Sbjct: 9 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHY 68
Query: 280 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKI 339
+ L L+ +Y L L + D R +A ++ + +L
Sbjct: 69 AFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFY-----LAEMVIAIDSVHQLHY 123
Query: 340 IHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMG----- 394
+HRD+K N+L+D + + +++DFG+ +++ GT Y++PE
Sbjct: 124 VHRDIKPDNILMDMNGHIRLADFGSCLKL-MEDGTVQSSVAVGTPDYISPEILQAMEDGK 182
Query: 395 GIFSIKSDVFSFGVLLLEIISG 416
G + + D +S GV + E++ G
Sbjct: 183 GKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 7e-05
Identities = 45/175 (25%), Positives = 73/175 (41%), Gaps = 32/175 (18%)
Query: 218 FSDENKLGQGGFGPVYKGTLADGKAIAVKR--LSRTSGQGLKE-FKNE------VNLIAK 268
F KLG+G FG VYK +L + ++ + L + + G E + NE N A
Sbjct: 134 FVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNERVRRACPNSCAD 193
Query: 269 LQHKNLVRLLGCCLEGQELLLIYEY---------MPNK----SLDVHLFDATRSVQLDWK 315
+ L + + E L++ Y M +K +++ +L + + +
Sbjct: 194 FVYGFLEPVSS--KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLE 251
Query: 316 RRLSIINGIARGILY----LHEDSRLKIIHRDLKASNVLLDDDMNP-KISDFGTA 365
R II I R IL+ LH I+HRD+K N++ + KI D G A
Sbjct: 252 RENKIIQTIMRQILFALDGLHSTG---IVHRDVKPQNIIFSEGSGSFKIIDLGAA 303
|
Length = 566 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 2e-04
Identities = 30/78 (38%), Positives = 43/78 (55%), Gaps = 8/78 (10%)
Query: 224 LGQGGFGPVYKGT-LADGK-----AIAVKRLSRTSGQGLKE-FKNEVNLIAKL-QHKNLV 275
LG G FG V + T GK +AVK L ++ +E +E+ +++ L QHKN+V
Sbjct: 46 LGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIV 105
Query: 276 RLLGCCLEGQELLLIYEY 293
LLG C G +L+I EY
Sbjct: 106 NLLGACTHGGPVLVITEY 123
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 2e-04
Identities = 49/211 (23%), Positives = 86/211 (40%), Gaps = 32/211 (15%)
Query: 224 LGQGGFGPVYKGTLAD---------GKAIAVKRLSRTSGQGLKE----FKNEVNLIAKLQ 270
LG+G +Y G L +K + + ++ F +++ ++
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 271 HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILY 330
HK++V L G C+ E +++ E++ LD+ + + + WK + +A + Y
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWK--FKVAKQLASALSY 120
Query: 331 LHEDSRLKIIHRDLKASNVLL-----DDDMNP--KISDFGTARIFGGNQNQANTNIIAGT 383
L ED L +H ++ N+LL D + P K+SD G Q
Sbjct: 121 L-EDKDL--VHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVE------R 171
Query: 384 YGYMAPEYAM-GGIFSIKSDVFSFGVLLLEI 413
++APE SI +D +SFG L EI
Sbjct: 172 IPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 2e-04
Identities = 52/249 (20%), Positives = 100/249 (40%), Gaps = 57/249 (22%)
Query: 217 HFSDENKLGQGGFGPVYKGTLADGKAI-AVKRLSRTS---GQGLKEFKNEVNLIAKLQHK 272
F +G G FG V D A+ A+K L + K E +++A+ ++
Sbjct: 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNE 61
Query: 273 NLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLD-WKRRLS--IINGIARGIL 329
+V+L + L + +Y+P + L ++L ++ L+ I + I
Sbjct: 62 WVVKLYYSFQDKDNLYFVMDYIPGGDMMSLL------IRLGIFEEDLARFYIAELTCAIE 115
Query: 330 YLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFG---------TARIFGGNQN------- 373
+H ++ IHRD+K N+L+D D + K++DFG ++ + +
Sbjct: 116 SVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSME 172
Query: 374 ---------------------QANTNIIA----GTYGYMAPEYAMGGIFSIKSDVFSFGV 408
+ + +A GT Y+APE + ++ D +S GV
Sbjct: 173 PSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 232
Query: 409 LLLEIISGR 417
+L E++ G+
Sbjct: 233 ILYEMLVGQ 241
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 4e-04
Identities = 54/243 (22%), Positives = 92/243 (37%), Gaps = 55/243 (22%)
Query: 224 LGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLK----EFKNEVNLIAKLQHKNLVRLLG 279
LG G FG V D KA+ + R L+ K E +++A+ ++ +VRL
Sbjct: 9 LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYY 68
Query: 280 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKI 339
+ L + +Y+P + + L D R IA + ++
Sbjct: 69 SFQDKDNLYFVMDYIPGGDM-MSLLIRMGIFPEDLARFY-----IAELTCAVESVHKMGF 122
Query: 340 IHRDLKASNVLLDDDMNPKISDFGTARIF-----------GGNQNQANTNI--------- 379
IHRD+K N+L+D D + K++DFG F G + Q + +
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182
Query: 380 -------------------------IAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEII 414
+ GT Y+APE + ++ D +S GV+L E++
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242
Query: 415 SGR 417
G+
Sbjct: 243 VGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|221289 pfam11883, DUF3403, Domain of unknown function (DUF3403) | Back alignment and domain information |
|---|
Score = 37.7 bits (88), Expect = 5e-04
Identities = 19/50 (38%), Positives = 26/50 (52%), Gaps = 6/50 (12%)
Query: 491 SDSMTIPQPTEPAFSVGRVVANSGHLLSSAKVG----SVNNVTVSDVSPR 536
S++ IPQP +P F VGR + SS+ +VN VTVS + R
Sbjct: 1 SETTEIPQPKQPGFCVGRSPYETD--SSSSTQRDESWTVNQVTVSVIDAR 48
|
This domain is functionally uncharacterized. This domain is found in eukaryotes. This presumed domain is about 50 amino acids in length. This domain is found associated with pfam00069, pfam08276, pfam00954, pfam01453. Length = 48 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 5e-04
Identities = 22/52 (42%), Positives = 33/52 (63%), Gaps = 1/52 (1%)
Query: 315 KRRLSIINGIARGILY-LHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTA 365
KR +++I G+ R +L L + R+ I+HRD+K N+L+ D KI DFG A
Sbjct: 305 KRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAA 356
|
Length = 507 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 5e-04
Identities = 36/108 (33%), Positives = 54/108 (50%), Gaps = 24/108 (22%)
Query: 263 VNLIAKLQHKNLVRLLGCCLEG---QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLS 319
V+L LQ N V L+ L G + LL IY Y FD +V+
Sbjct: 67 VHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGY----------FDEEMAVKY------- 109
Query: 320 IINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARI 367
I+ +A + YLH R IIHRDLK N+L+ ++ + K++DFG +++
Sbjct: 110 -ISEVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 7e-04
Identities = 54/244 (22%), Positives = 99/244 (40%), Gaps = 57/244 (23%)
Query: 224 LGQGGFGPVYKGTLADGKAI-AVKRLSRT---SGQGLKEFKNEVNLIAKLQHKNLVRLLG 279
LG G FG V D A+ A+K L + + + K E +++A+ ++ +V+L
Sbjct: 9 LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYY 68
Query: 280 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLD-WKRRLSIINGIARGILYLHEDSRLK 338
+ L + +Y+P + L ++++ + L+ IA L + ++
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLL------IRMEVFPEVLARFY-IAELTLAIESVHKMG 121
Query: 339 IIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQN----QANTNI--------------- 379
IHRD+K N+L+D D + K++DFG F N Q ++I
Sbjct: 122 FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVS 181
Query: 380 --------------------------IAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEI 413
+ GT Y+APE + ++ D +S GV+L E+
Sbjct: 182 NCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEM 241
Query: 414 ISGR 417
+ G+
Sbjct: 242 LVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.001
Identities = 30/103 (29%), Positives = 49/103 (47%), Gaps = 22/103 (21%)
Query: 330 YLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNI---------- 379
YLH I+HRDLK N+L+ + K++DFG ++I G + TN+
Sbjct: 116 YLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKI--GLMSLT-TNLYEGHIEKDTR 169
Query: 380 ------IAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISG 416
+ GT Y+APE + + D ++ G++L E + G
Sbjct: 170 EFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 536 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.98 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.98 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.97 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.95 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.93 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.93 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.92 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.92 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.9 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.89 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.87 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.87 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.87 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.85 | |
| PF01657 | 106 | Stress-antifung: Salt stress response/antifungal; | 99.85 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.84 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.84 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.83 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.82 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.81 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.8 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.79 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.78 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.76 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.76 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.75 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.75 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.73 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.73 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.72 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.67 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.67 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.67 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.62 | |
| PF01657 | 106 | Stress-antifung: Salt stress response/antifungal; | 99.53 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.5 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.46 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.41 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.4 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.4 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.33 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.31 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.24 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.24 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.14 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.08 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.06 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.04 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.0 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.99 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.95 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.84 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.73 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.72 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.71 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.58 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.58 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.57 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.56 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.45 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.39 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.39 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.32 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.26 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.16 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.13 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.09 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.09 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 98.03 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.02 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.99 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.85 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.85 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.79 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.73 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.62 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.61 | |
| PF11883 | 48 | DUF3403: Domain of unknown function (DUF3403); Int | 97.54 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.52 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.51 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.43 | |
| PLN02236 | 344 | choline kinase | 97.39 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.26 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.22 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.06 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.81 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.7 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.68 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.66 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.62 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 96.49 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.35 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.27 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.22 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.22 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 96.16 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.94 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 95.71 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.69 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-52 Score=420.86 Aligned_cols=288 Identities=48% Similarity=0.793 Sum_probs=254.2
Q ss_pred CCCCcChhhHHHHhcCCccccccCCCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEE
Q 039168 202 EFPLFPLGLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCC 281 (536)
Q Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~ 281 (536)
....|++..+..+|++|...++||+|+||.||+|...++..||||++.........+|.+|+.++.+++|||+|+++|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 45568999999999999999999999999999999999999999988765543135599999999999999999999999
Q ss_pred eeCc-eEEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEe
Q 039168 282 LEGQ-ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKIS 360 (536)
Q Consensus 282 ~~~~-~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~ 360 (536)
.+.+ +.+||+|||++|+|.++|+..... .++|.++.+|+.++|+||+|||+....+||||||||+|||+|+++++||+
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 9998 599999999999999999875544 78999999999999999999999887789999999999999999999999
Q ss_pred cccCccccCCCCCccccccc-cccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHh
Q 039168 361 DFGTARIFGGNQNQANTNII-AGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLW 439 (536)
Q Consensus 361 Dfg~a~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 439 (536)
|||+++..... ....... .||.+|+|||++..+..+.|+|||||||+|+||+||+.+.+...+.....+..|.+..+
T Consensus 220 DFGLa~~~~~~--~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~ 297 (361)
T KOG1187|consen 220 DFGLAKLGPEG--DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL 297 (361)
T ss_pred CccCcccCCcc--ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH
Confidence 99999655431 1111112 79999999999999999999999999999999999999877655555556899999999
Q ss_pred hcCCcccccccccc-CCCCH-HHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 440 CEGHAVELIDPVLK-QSCAP-DELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 440 ~~~~~~~l~~~~l~-~~~~~-~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
.++...+++|+.+. ..... .++.++..++.+|++.+|++||+|.+|+++|+..
T Consensus 298 ~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~ 352 (361)
T KOG1187|consen 298 EEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGI 352 (361)
T ss_pred HCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhh
Confidence 99999999999987 55554 6899999999999999999999999999999554
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-48 Score=371.50 Aligned_cols=252 Identities=30% Similarity=0.419 Sum_probs=206.4
Q ss_pred cCCccccccCCCCceeEEEEEeC-CCcEEEEEEcccc-ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCc-eEEEEEe
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT-SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQ-ELLLIYE 292 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-~~~lv~e 292 (536)
.+.+.++.||+|..|+|||+.++ +++.+|+|.+... .....+++.+|+++++..+||+||++|+.|..+. ...++||
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE 158 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME 158 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence 46677889999999999999986 5889999999543 4456688999999999999999999999999998 5999999
Q ss_pred ecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCC
Q 039168 293 YMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQ 372 (536)
Q Consensus 293 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 372 (536)
||++|+|+.++... +.+++.....++.+|++||.|||+.. +||||||||+||||+..|.|||+|||.++.+-+.
T Consensus 159 YMDgGSLd~~~k~~---g~i~E~~L~~ia~~VL~GL~YLh~~~--~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS- 232 (364)
T KOG0581|consen 159 YMDGGSLDDILKRV---GRIPEPVLGKIARAVLRGLSYLHEER--KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS- 232 (364)
T ss_pred hcCCCCHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhcc--CeeeccCCHHHeeeccCCCEEeccccccHHhhhh-
Confidence 99999999999544 45999999999999999999999632 5999999999999999999999999999987544
Q ss_pred CccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCC--chhHHHHHHHhhcCCccccccc
Q 039168 373 NQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHG--QTLLTYTWKLWCEGHAVELIDP 450 (536)
Q Consensus 373 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~ 450 (536)
...+++||..|||||.+.+..|+.++||||||++++|+++|+.|+........ -.++.+ +..+..+
T Consensus 233 ---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~----Iv~~ppP----- 300 (364)
T KOG0581|consen 233 ---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCA----IVDEPPP----- 300 (364)
T ss_pred ---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHH----HhcCCCC-----
Confidence 33457899999999999999999999999999999999999999876522111 122221 1122222
Q ss_pred cccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 451 VLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 451 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
.+.....++++..++ ..||++||.+|||+.++++.
T Consensus 301 ~lP~~~fS~ef~~FV---~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 301 RLPEGEFSPEFRSFV---SCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred CCCcccCCHHHHHHH---HHHhcCCcccCCCHHHHhcC
Confidence 222222344455555 49999999999999999853
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-48 Score=390.46 Aligned_cols=247 Identities=26% Similarity=0.395 Sum_probs=206.9
Q ss_pred cCCccccccCCCCceeEEEEEe-CCCcEEEEEEcccc---ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEE
Q 039168 216 NHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRT---SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 291 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 291 (536)
.+|...+.||+|||+.||++++ ..|+.||+|++.+. .....+.+.+|++|.++|+|||||+++++|++.+++|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5799999999999999999998 67999999999864 3445678899999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCC
Q 039168 292 EYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGN 371 (536)
Q Consensus 292 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 371 (536)
|+|.+++|..++. +.+.++|.+++.++.||+.||.|||+++ |+|||||..|+|++++.+|||+|||+|..+..+
T Consensus 98 ELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence 9999999999984 5567999999999999999999999996 999999999999999999999999999988644
Q ss_pred CCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcccccccc
Q 039168 372 QNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPV 451 (536)
Q Consensus 372 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 451 (536)
. ....+++|||-|+|||++.....+..+||||+||+||.||.|++||+...-. + ....+...+ -.
T Consensus 172 ~--Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vk------e-ty~~Ik~~~------Y~ 236 (592)
T KOG0575|consen 172 G--ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVK------E-TYNKIKLNE------YS 236 (592)
T ss_pred c--cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHH------H-HHHHHHhcC------cc
Confidence 3 3344589999999999999999999999999999999999999998632111 1 111111111 01
Q ss_pred ccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 452 LKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 452 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
+ ......+ ..+||.++|+.||.+|||+++||.
T Consensus 237 ~-P~~ls~~---A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 237 M-PSHLSAE---AKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred c-ccccCHH---HHHHHHHHhcCCcccCCCHHHHhc
Confidence 1 1112333 445555999999999999999994
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-49 Score=378.62 Aligned_cols=255 Identities=24% Similarity=0.369 Sum_probs=203.1
Q ss_pred HHhcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccChh-------hHHHHHHHHHHHHHcCCCCceeEeeEEeeC
Q 039168 213 EATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQ-------GLKEFKNEVNLIAKLQHKNLVRLLGCCLEG 284 (536)
Q Consensus 213 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~hpniv~l~~~~~~~ 284 (536)
...+.|.+.+.||+|+||.|-+|..+ +|+.||||++++.... ......+|+++|++|+|||||+++++|...
T Consensus 169 s~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ 248 (475)
T KOG0615|consen 169 SFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVP 248 (475)
T ss_pred hhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecC
Confidence 45678999999999999999999864 6999999999754221 122356999999999999999999999999
Q ss_pred ceEEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCC---CCeEEec
Q 039168 285 QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDD---MNPKISD 361 (536)
Q Consensus 285 ~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~---~~~kl~D 361 (536)
+..||||||++||.|.+.+..+. .+.+..-..++.|++.||.|||++| |+||||||+|||++.+ ..+||+|
T Consensus 249 ds~YmVlE~v~GGeLfd~vv~nk---~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItD 322 (475)
T KOG0615|consen 249 DSSYMVLEYVEGGELFDKVVANK---YLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITD 322 (475)
T ss_pred CceEEEEEEecCccHHHHHHhcc---ccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecc
Confidence 99999999999999999986543 4788888899999999999999998 9999999999999866 6799999
Q ss_pred ccCccccCCCCCccccccccccccccCcchhcCCC---CCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHH
Q 039168 362 FGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGI---FSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKL 438 (536)
Q Consensus 362 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 438 (536)
||+|+..+ ......+++|||.|.|||++.+.. +..++|+|||||+||-+++|.+||....... .+.+.
T Consensus 323 FGlAK~~g---~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~--sl~eQ---- 393 (475)
T KOG0615|consen 323 FGLAKVSG---EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP--SLKEQ---- 393 (475)
T ss_pred cchhhccc---cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc--cHHHH----
Confidence 99999875 334456789999999999997765 3458999999999999999999986433322 11111
Q ss_pred hhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 439 WCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 439 ~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
...++... .+ ........+.+++|.+||..||++|||+.|+|+.
T Consensus 394 I~~G~y~f--~p----~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 394 ILKGRYAF--GP----LQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred HhcCcccc--cC----hhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 11111111 00 1122334456677779999999999999999853
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=363.70 Aligned_cols=200 Identities=29% Similarity=0.512 Sum_probs=180.9
Q ss_pred hcCCccccccCCCCceeEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEE
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 291 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 291 (536)
..+|...+.||+|+||+||+|+++ ++..||||.+.+. ..+..+.+..|+++|+.++|||||++++++..++.+||||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 468899999999999999999975 5899999999876 5666777899999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCC------CCeEEecccCc
Q 039168 292 EYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDD------MNPKISDFGTA 365 (536)
Q Consensus 292 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~------~~~kl~Dfg~a 365 (536)
|||.||+|..+|+... .+++..+..++.||+.||++||+++ ||||||||+||||+.. -.+||+|||+|
T Consensus 89 EyC~gGDLs~yi~~~~---~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRG---RLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred EeCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 9999999999996544 5999999999999999999999996 9999999999999865 45899999999
Q ss_pred cccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 039168 366 RIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFY 423 (536)
Q Consensus 366 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~ 423 (536)
+.+.... ...+.+|+|.|||||+++..+|+.|+|+||+|+++|+|++|+.||...
T Consensus 163 R~L~~~~---~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~ 217 (429)
T KOG0595|consen 163 RFLQPGS---MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAE 217 (429)
T ss_pred hhCCchh---HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcccc
Confidence 9986433 334579999999999999999999999999999999999999998643
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-48 Score=356.30 Aligned_cols=260 Identities=25% Similarity=0.385 Sum_probs=209.5
Q ss_pred cCCccccccCCCCceeEEEEEe-CCCcEEEEEEcccc--ChhhHHHHHHHHHHHHHcCCCCceeEee-EEeeCce-EEEE
Q 039168 216 NHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRT--SGQGLKEFKNEVNLIAKLQHKNLVRLLG-CCLEGQE-LLLI 290 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~-~~~~~~~-~~lv 290 (536)
.+|+++++||+|.||+|||+.. .+|+.+|.|.+.-. +.+..+....|+.+|++|+|||||++++ .|.++.. ++||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 4789999999999999999985 57999999998733 4455667889999999999999999998 4555555 9999
Q ss_pred EeecCCCChhhhhhcc-cCCCCCCHHHHHHHHHHHHHHHHHHhcCC-CCCeeeCCCCCCcEEEcCCCCeEEecccCcccc
Q 039168 291 YEYMPNKSLDVHLFDA-TRSVQLDWKRRLSIINGIARGILYLHEDS-RLKIIHRDLKASNVLLDDDMNPKISDFGTARIF 368 (536)
Q Consensus 291 ~e~~~~~sL~~~l~~~-~~~~~l~~~~~~~i~~qi~~al~~LH~~~-~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 368 (536)
||||.+|+|...+... .....+++..+|+++.|++.||.++|++. +.-|+||||||.||+|+.+|.|||+|||+++.+
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 9999999999999763 34567999999999999999999999843 224999999999999999999999999999998
Q ss_pred CCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccc
Q 039168 369 GGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELI 448 (536)
Q Consensus 369 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 448 (536)
.+.... ....+|||.||+||.+.+.+|+.+|||||+||++|||+..+.||... .+... ...+.+++...+.
T Consensus 179 ~s~~tf--A~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~------n~~~L-~~KI~qgd~~~~p 249 (375)
T KOG0591|consen 179 SSKTTF--AHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD------NLLSL-CKKIEQGDYPPLP 249 (375)
T ss_pred cchhHH--HHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc------cHHHH-HHHHHcCCCCCCc
Confidence 654433 34578999999999999999999999999999999999999997532 33332 2233344332221
Q ss_pred cccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 449 DPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 449 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
+ ..-..++..||..|+..||+.||+.-.+++.+.+.
T Consensus 250 ~--------~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~~ 285 (375)
T KOG0591|consen 250 D--------EHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQSE 285 (375)
T ss_pred H--------HHhhhHHHHHHHHHccCCcccCCCcchHHHHHHHH
Confidence 1 12234556666699999999999977777666553
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-46 Score=372.92 Aligned_cols=258 Identities=34% Similarity=0.512 Sum_probs=209.6
Q ss_pred CCccccccCCCCceeEEEEEeCCCcEEEEEEccccCh--hhHHHHHHHHHHHHHcCCCCceeEeeEEeeCc-eEEEEEee
Q 039168 217 HFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSG--QGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQ-ELLLIYEY 293 (536)
Q Consensus 217 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-~~~lv~e~ 293 (536)
.....+.||+|+||+||+|.+.....||||++..... ...+.|.+|+.+|.+++|||||+++|++.+.. .+.+||||
T Consensus 42 ~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy 121 (362)
T KOG0192|consen 42 ELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEY 121 (362)
T ss_pred HhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEe
Confidence 4455567999999999999997555599999976432 22568999999999999999999999999887 79999999
Q ss_pred cCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCC-CeEEecccCccccCCCC
Q 039168 294 MPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDM-NPKISDFGTARIFGGNQ 372 (536)
Q Consensus 294 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~-~~kl~Dfg~a~~~~~~~ 372 (536)
+++|+|.++++.. ....+++..+..++.||++|+.|||+++ +||||||||+||||+.++ ++||+|||+++......
T Consensus 122 ~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~--~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~ 198 (362)
T KOG0192|consen 122 MPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEG--PIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK 198 (362)
T ss_pred CCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCC--CeeecccChhhEEEcCCCCEEEECCCccceeecccc
Confidence 9999999999764 4567999999999999999999999985 299999999999999998 99999999998764322
Q ss_pred CccccccccccccccCcchhc--CCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccc
Q 039168 373 NQANTNIIAGTYGYMAPEYAM--GGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDP 450 (536)
Q Consensus 373 ~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 450 (536)
.......||+.|||||++. ...|+.|+|||||||++|||+||+.||..... .+........+..+.+...
T Consensus 199 --~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~------~~~~~~v~~~~~Rp~~p~~ 270 (362)
T KOG0192|consen 199 --TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP------VQVASAVVVGGLRPPIPKE 270 (362)
T ss_pred --ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhcCCCCCCCcc
Confidence 2222367999999999999 56899999999999999999999999865433 2223333333333332221
Q ss_pred cccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccCCC
Q 039168 451 VLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSM 494 (536)
Q Consensus 451 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 494 (536)
....+..|+.+||+.||+.||++.+++..|+....
T Consensus 271 ---------~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~ 305 (362)
T KOG0192|consen 271 ---------CPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMS 305 (362)
T ss_pred ---------CCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence 23345666669999999999999999999996533
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=360.86 Aligned_cols=242 Identities=27% Similarity=0.390 Sum_probs=199.2
Q ss_pred hcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEE
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 290 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 290 (536)
.++|+++++||+|+||.|+.++.+ .++.||+|++.+.. ....+...+|..+|.+++||+||+++..|++.+.+|+|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 478999999999999999999876 48999999997653 34567788999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCC
Q 039168 291 YEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGG 370 (536)
Q Consensus 291 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 370 (536)
+||+.||.|..+|.+ ...+++..+.-++..|+.||.|||++| ||||||||+|||+|++|+++|+|||+++..-.
T Consensus 104 ld~~~GGeLf~hL~~---eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQR---EGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred EeccCCccHHHHHHh---cCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence 999999999999954 445999999999999999999999997 99999999999999999999999999985433
Q ss_pred CCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccc
Q 039168 371 NQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDP 450 (536)
Q Consensus 371 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 450 (536)
.. ..+.+++||+.|||||++.+..|+..+|+||||+++|||++|.+||....... .. .....++..
T Consensus 178 ~~--~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~------~~-~~I~~~k~~----- 243 (357)
T KOG0598|consen 178 DG--DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKK------MY-DKILKGKLP----- 243 (357)
T ss_pred CC--CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHH------HH-HHHhcCcCC-----
Confidence 22 23445899999999999999999999999999999999999999986543221 11 111112111
Q ss_pred cccCCCCHHHHHHHHHHHHhhcCCCCCCCC
Q 039168 451 VLKQSCAPDELLKFIHIGLLCVQQDPADRP 480 (536)
Q Consensus 451 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RP 480 (536)
........+ ..+++..+|+.||++|.
T Consensus 244 -~~p~~ls~~---ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 244 -LPPGYLSEE---ARDLLKKLLKRDPRQRL 269 (357)
T ss_pred -CCCccCCHH---HHHHHHHHhccCHHHhc
Confidence 111112333 44555599999999996
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-46 Score=345.07 Aligned_cols=260 Identities=23% Similarity=0.344 Sum_probs=203.9
Q ss_pred cCCccccccCCCCceeEEEEEeCC-CcEEEEEEccccC--hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEe
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTS--GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 292 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 292 (536)
++|+.+.++|+|+||+|||++.++ |+.||||++.... +...+-..+|+++|++|+|||+|.++.+|.....+++|+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 478889999999999999999875 9999999997543 3345567899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCC
Q 039168 293 YMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQ 372 (536)
Q Consensus 293 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 372 (536)
||+..-|+++-. ....++...+..++.|+++|+.|+|++. +|||||||+||||+.+|.+||+|||+|+.+....
T Consensus 82 ~~dhTvL~eLe~---~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg 155 (396)
T KOG0593|consen 82 YCDHTVLHELER---YPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAPG 155 (396)
T ss_pred ecchHHHHHHHh---ccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCCc
Confidence 999987776543 2334889999999999999999999995 9999999999999999999999999999887432
Q ss_pred CccccccccccccccCcchhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHH-----------Hhh
Q 039168 373 NQANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWK-----------LWC 440 (536)
Q Consensus 373 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~-----------~~~ 440 (536)
. .-+..+.|.+|.|||++.+ ..|+..+||||+||++.||++|.+.|+.....+. +..+.. .+.
T Consensus 156 d--~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQ---Ly~I~ktLG~L~prhq~iF~ 230 (396)
T KOG0593|consen 156 D--NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQ---LYLIRKTLGNLIPRHQSIFS 230 (396)
T ss_pred c--hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHH---HHHHHHHHcccCHHHHHHhc
Confidence 2 2223467999999999998 5799999999999999999999998765433222 221111 111
Q ss_pred cCCc------cccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHH
Q 039168 441 EGHA------VELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVV 486 (536)
Q Consensus 441 ~~~~------~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl 486 (536)
.+.. ++.-++.--....+....-+++++..||+.||.+|++-++++
T Consensus 231 ~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll 282 (396)
T KOG0593|consen 231 SNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLL 282 (396)
T ss_pred cCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHh
Confidence 1111 111111101111223334677888899999999999999988
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-44 Score=356.84 Aligned_cols=254 Identities=26% Similarity=0.366 Sum_probs=206.5
Q ss_pred HHhcCCccccccCCCCceeEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHHHc-CCCCceeEeeEEeeCceE
Q 039168 213 EATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLKEFKNEVNLIAKL-QHKNLVRLLGCCLEGQEL 287 (536)
Q Consensus 213 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~ 287 (536)
...++|.+++.||+|+|++|++|+.+ .+++||||++.+. .....+-+..|-.+|.+| .||.|++|+..|+++..+
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL 149 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL 149 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence 34578999999999999999999976 5999999998653 222334466789999999 899999999999999999
Q ss_pred EEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccc
Q 039168 288 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARI 367 (536)
Q Consensus 288 ~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 367 (536)
|+|+||+++|+|..+|.+. +.+++...+.++.+|+.||+|||++| ||||||||+|||||.+|++||+|||.|+.
T Consensus 150 YFvLe~A~nGdll~~i~K~---Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~ 223 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIKKY---GSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKI 223 (604)
T ss_pred EEEEEecCCCcHHHHHHHh---CcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeecccccc
Confidence 9999999999999999554 55999999999999999999999997 99999999999999999999999999998
Q ss_pred cCCCCCc---------ccc--ccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHH
Q 039168 368 FGGNQNQ---------ANT--NIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTW 436 (536)
Q Consensus 368 ~~~~~~~---------~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~ 436 (536)
+...... ... ..++||..|.+||++.....++.+|||+||||||+|+.|++||..... .+.+..
T Consensus 224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne-----yliFqk 298 (604)
T KOG0592|consen 224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE-----YLIFQK 298 (604)
T ss_pred CChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH-----HHHHHH
Confidence 8543222 112 458999999999999999999999999999999999999999864321 111111
Q ss_pred HHhhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHh
Q 039168 437 KLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 489 (536)
Q Consensus 437 ~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 489 (536)
-. . ++-.+...++ ....+|+.+.|..||.+|+|..+|-+..
T Consensus 299 I~-------~-l~y~fp~~fp----~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp 339 (604)
T KOG0592|consen 299 IQ-------A-LDYEFPEGFP----EDARDLIKKLLVRDPSDRLTSQQIKAHP 339 (604)
T ss_pred HH-------H-hcccCCCCCC----HHHHHHHHHHHccCccccccHHHHhhCc
Confidence 11 1 1111222222 3455666699999999999999998654
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=329.10 Aligned_cols=274 Identities=25% Similarity=0.377 Sum_probs=213.6
Q ss_pred cCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccChh--hHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEe
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQ--GLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 292 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 292 (536)
.+|...++||+|.||.||+|++. +|+.||||++...... ......+|++.|+.++||||+.++++|...+.+.+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 46888999999999999999975 6999999999755322 23567899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCC
Q 039168 293 YMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQ 372 (536)
Q Consensus 293 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 372 (536)
||+ .+|+..+.+. ...+...++..++.++++||+|||.++ |+||||||.|+||+++|.+||+|||+++.+....
T Consensus 82 fm~-tdLe~vIkd~--~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 82 FMP-TDLEVVIKDK--NIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred ecc-ccHHHHhccc--ccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence 994 5788888653 346889999999999999999999997 9999999999999999999999999999987655
Q ss_pred CccccccccccccccCcchhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccc-
Q 039168 373 NQANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDP- 450 (536)
Q Consensus 373 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~- 450 (536)
...... +-|.+|.|||++.|. .|+..+||||.|||+.||+-|.+-|... .+.+.+..+...+.-+...++.+-
T Consensus 156 ~~~~~~--V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~---sDidQL~~If~~LGTP~~~~WP~~~ 230 (318)
T KOG0659|consen 156 RIQTHQ--VVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGD---SDIDQLSKIFRALGTPTPDQWPEMT 230 (318)
T ss_pred cccccc--eeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCC---chHHHHHHHHHHcCCCCcccCcccc
Confidence 444332 569999999999886 5999999999999999999988765432 222333333333322222221110
Q ss_pred -------------cccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccCCCCCCCCCCC
Q 039168 451 -------------VLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSMTIPQPTEP 502 (536)
Q Consensus 451 -------------~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~p~~p 502 (536)
......-+....+.++++..|+..||.+|+|++++|++=--.+ +|.|+.|
T Consensus 231 ~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~--~P~pt~~ 293 (318)
T KOG0659|consen 231 SLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKS--LPLPTPP 293 (318)
T ss_pred ccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhc--CCCCCCh
Confidence 0111123444566788899999999999999999997643332 4444444
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=362.35 Aligned_cols=255 Identities=33% Similarity=0.485 Sum_probs=207.7
Q ss_pred cCCccccccCCCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEeecC
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMP 295 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 295 (536)
+.+..++.||+|-||+||.|.++....||+|.+... ....+.|.+|+++|++|+|+|||++++++..++.++||||||.
T Consensus 206 ~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~ 284 (468)
T KOG0197|consen 206 EELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMP 284 (468)
T ss_pred HHHHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecc
Confidence 455678899999999999999988889999998754 2344788899999999999999999999999999999999999
Q ss_pred CCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCCcc
Q 039168 296 NKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQA 375 (536)
Q Consensus 296 ~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 375 (536)
.|+|.++|.. .....+...+.+.++.||++|++||+++. +|||||.+.||||+++..+||+|||+|+...++....
T Consensus 285 ~GsLl~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~ 360 (468)
T KOG0197|consen 285 KGSLLDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTA 360 (468)
T ss_pred cCcHHHHhhh-cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCceee
Confidence 9999999976 33456899999999999999999999985 9999999999999999999999999999655444332
Q ss_pred ccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHHHHHhhcCCccccccccccC
Q 039168 376 NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQ 454 (536)
Q Consensus 376 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~ 454 (536)
... ..-...|.|||.+..+.++.|||||||||+||||+| |+.|++.....+ +...+..+.. -
T Consensus 361 ~~~-~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~e-------v~~~le~GyR---------l 423 (468)
T KOG0197|consen 361 SEG-GKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEE-------VLELLERGYR---------L 423 (468)
T ss_pred cCC-CCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHH-------HHHHHhccCc---------C
Confidence 221 122567999999999999999999999999999999 666654332221 1122222222 2
Q ss_pred CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 455 SCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 455 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
..+......+.+||..||+.+|++|||++.+...|...
T Consensus 424 p~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~ 461 (468)
T KOG0197|consen 424 PRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDF 461 (468)
T ss_pred CCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHh
Confidence 22333444566777899999999999999999988765
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-44 Score=346.19 Aligned_cols=262 Identities=25% Similarity=0.384 Sum_probs=210.1
Q ss_pred hcCCccccccCCCCceeEEEEEe-CCCcEEEEEEccccChh-hHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEe
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQ-GLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 292 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 292 (536)
.+.|++..+||.|..++||+|+. ..++.||||++...... ..+.+++|+..|+.++||||++++..|..+..+|+||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 36899999999999999999985 46899999999865433 36889999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCC
Q 039168 293 YMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQ 372 (536)
Q Consensus 293 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 372 (536)
||.+|++.+++...... .++|..+..|++++++||.|||.+| .||||||+.||||+++|.|||+|||....+-...
T Consensus 105 fMa~GS~ldIik~~~~~-Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYPD-GLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG 180 (516)
T ss_pred hhcCCcHHHHHHHHccc-cccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence 99999999999765443 4999999999999999999999998 9999999999999999999999999987664433
Q ss_pred Cc--cccccccccccccCcchhcC--CCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccc
Q 039168 373 NQ--ANTNIIAGTYGYMAPEYAMG--GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELI 448 (536)
Q Consensus 373 ~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 448 (536)
.. .....++||+.|||||+++. .+|+.|+||||||++..||++|+.||..+.+-. .++. -.++..+.+.
T Consensus 181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmk--vLl~-----tLqn~pp~~~ 253 (516)
T KOG0582|consen 181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMK--VLLL-----TLQNDPPTLL 253 (516)
T ss_pred ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHH--HHHH-----HhcCCCCCcc
Confidence 21 12256799999999999654 469999999999999999999999987654321 1111 1122222222
Q ss_pred cccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 449 DPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 449 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
...+..+........+.+++..||++||.+|||++++++
T Consensus 254 t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 254 TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 111211111222346777778999999999999999993
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-44 Score=352.08 Aligned_cols=264 Identities=25% Similarity=0.363 Sum_probs=202.7
Q ss_pred HhcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC--hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeC--ceEE
Q 039168 214 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEG--QELL 288 (536)
Q Consensus 214 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~~ 288 (536)
..+.|+.+++||+|.||.||+|++. +|+.||+|++.... ........+|+.||++|+||||++|.+...+. ..+|
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY 194 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY 194 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence 3467899999999999999999964 69999999997654 45566778999999999999999999998876 7899
Q ss_pred EEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCcccc
Q 039168 289 LIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIF 368 (536)
Q Consensus 289 lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 368 (536)
||+|||++. |..++. .....+++.++..++.||+.||+|+|++| |+|||||.+|||||++|.+||+|||+|+++
T Consensus 195 lVFeYMdhD-L~GLl~--~p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y 268 (560)
T KOG0600|consen 195 LVFEYMDHD-LSGLLS--SPGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFY 268 (560)
T ss_pred EEEecccch-hhhhhc--CCCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeec
Confidence 999999874 555553 23345999999999999999999999997 999999999999999999999999999988
Q ss_pred CCCCCccccccccccccccCcchhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhh---cCCc
Q 039168 369 GGNQNQANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWC---EGHA 444 (536)
Q Consensus 369 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~ 444 (536)
........+ ..+-|.+|.|||++.|. .|+.++|+||.||||.||+.|++.+........ +..+.+... +..|
T Consensus 269 ~~~~~~~~T-~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQ---l~kIfklcGSP~e~~W 344 (560)
T KOG0600|consen 269 TPSGSAPYT-SRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQ---LHKIFKLCGSPTEDYW 344 (560)
T ss_pred cCCCCcccc-cceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHH---HHHHHHHhCCCChhcc
Confidence 655544333 34569999999999986 599999999999999999999998765433221 111211111 1111
Q ss_pred c-------cccccccc-CCCCHH----HHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 445 V-------ELIDPVLK-QSCAPD----ELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 445 ~-------~l~~~~l~-~~~~~~----~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
. ..+.+... .....+ .....++|+..+|..||.+|.|+.++|+
T Consensus 345 ~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 345 PVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred ccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 1 11111100 000001 1124566777999999999999999985
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=346.00 Aligned_cols=258 Identities=27% Similarity=0.432 Sum_probs=204.0
Q ss_pred cCCccccccCCCCceeEEEEEeCC-CcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCc--eEEEEEe
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQ--ELLLIYE 292 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~--~~~lv~e 292 (536)
.+|...+.||+|+||.||++...+ |...|||.+...+....+.+.+|+.+|++++|||||+++|...... .++++||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 467888999999999999999765 8999999987664444677899999999999999999999844443 6999999
Q ss_pred ecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcC-CCCeEEecccCccccCC-
Q 039168 293 YMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDD-DMNPKISDFGTARIFGG- 370 (536)
Q Consensus 293 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~-~~~~kl~Dfg~a~~~~~- 370 (536)
|+.+|+|.+++.+... .+++..+..++.||++||.|||++| |+||||||+||||+. ++.+||+|||+++....
T Consensus 97 y~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~ 171 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESK 171 (313)
T ss_pred ccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence 9999999999966443 5999999999999999999999997 999999999999999 79999999999987764
Q ss_pred CCCccccccccccccccCcchhcCCC-CCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcccccc
Q 039168 371 NQNQANTNIIAGTYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELID 449 (536)
Q Consensus 371 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 449 (536)
...........||+.|||||++.++. ..+++|||||||++.||+||+.||... .....+..........+++
T Consensus 172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----~~~~~~~~~ig~~~~~P~i-- 244 (313)
T KOG0198|consen 172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-----FEEAEALLLIGREDSLPEI-- 244 (313)
T ss_pred cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-----cchHHHHHHHhccCCCCCC--
Confidence 11222233478999999999999643 346999999999999999999998654 1112222222222222221
Q ss_pred ccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 450 PVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 450 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
... .+++..+++ .+|++.||++|||++++|+..-..
T Consensus 245 ---p~~-ls~~a~~Fl---~~C~~~~p~~Rpta~eLL~hpf~~ 280 (313)
T KOG0198|consen 245 ---PDS-LSDEAKDFL---RKCFKRDPEKRPTAEELLEHPFLK 280 (313)
T ss_pred ---Ccc-cCHHHHHHH---HHHhhcCcccCcCHHHHhhChhhh
Confidence 111 334445555 499999999999999999876543
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=347.53 Aligned_cols=264 Identities=23% Similarity=0.311 Sum_probs=206.8
Q ss_pred HHhcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccChhhHHHH--HHHHHHHHHcC-CCCceeEeeEEeeCc-eE
Q 039168 213 EATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLKEF--KNEVNLIAKLQ-HKNLVRLLGCCLEGQ-EL 287 (536)
Q Consensus 213 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~--~~E~~~l~~l~-hpniv~l~~~~~~~~-~~ 287 (536)
...++|...++||.|.||.||+|+.+ .+..||||++++.-.. +++. .+|+..|++|+ |||||++++++.+.+ .+
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L 85 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRIL 85 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceE
Confidence 34578999999999999999999865 5899999999765332 3333 47999999998 999999999999988 99
Q ss_pred EEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccc
Q 039168 288 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARI 367 (536)
Q Consensus 288 ~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 367 (536)
++|||||+ .+|.+++.+. ...+++..+..|+.||++||+|+|.+| +.|||+||+|||+.....+||+|||+|+.
T Consensus 86 ~fVfE~Md-~NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARe 159 (538)
T KOG0661|consen 86 YFVFEFMD-CNLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLARE 159 (538)
T ss_pred eeeHHhhh-hhHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccc
Confidence 99999994 5788888654 667999999999999999999999998 99999999999999999999999999998
Q ss_pred cCCCCCccccccccccccccCcchhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccc
Q 039168 368 FGGNQNQANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVE 446 (536)
Q Consensus 368 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 446 (536)
+.+... -+..+.|.+|+|||++.. +.|+.++|||++|||++|+.+.++.|......+ ....+...+..+....
T Consensus 160 v~SkpP---YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~D---qi~KIc~VLGtP~~~~ 233 (538)
T KOG0661|consen 160 VRSKPP---YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEID---QIYKICEVLGTPDKDS 233 (538)
T ss_pred cccCCC---cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHH---HHHHHHHHhCCCcccc
Confidence 754333 223467999999998865 568999999999999999999999886543322 2222222222222222
Q ss_pred ccc-----cccc-----------CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHh
Q 039168 447 LID-----PVLK-----------QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 489 (536)
Q Consensus 447 l~~-----~~l~-----------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 489 (536)
+.. ..+. ....+....++++++.+|+..||.+|||+.+.|+.-
T Consensus 234 ~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p 292 (538)
T KOG0661|consen 234 WPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHP 292 (538)
T ss_pred chhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence 211 0000 011122455788888899999999999999999753
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=351.98 Aligned_cols=251 Identities=27% Similarity=0.433 Sum_probs=209.2
Q ss_pred hcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEee
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 293 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 293 (536)
...|....+||+|+.|.||.|... .++.||||++........+-+.+|+.+|+..+|+|||++++.|...+++|+||||
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy 351 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY 351 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence 457888899999999999999864 5889999999877666667889999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCC
Q 039168 294 MPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQN 373 (536)
Q Consensus 294 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 373 (536)
|+||+|.+.+.. ..+++.++..|+++++.||+|||.+| |+|||||.+|||++.+|.+||+|||++..+.....
T Consensus 352 m~ggsLTDvVt~----~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~ 424 (550)
T KOG0578|consen 352 MEGGSLTDVVTK----TRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS 424 (550)
T ss_pred cCCCchhhhhhc----ccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC
Confidence 999999988843 23899999999999999999999997 99999999999999999999999999998865554
Q ss_pred ccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcccccccccc
Q 039168 374 QANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLK 453 (536)
Q Consensus 374 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~ 453 (536)
.....+|||.|||||+.....|++++||||||++++||+-|.+||-...+ +...+....++.. ++- .
T Consensus 425 --KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~P------lrAlyLIa~ng~P-~lk----~ 491 (550)
T KOG0578|consen 425 --KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENP------LRALYLIATNGTP-KLK----N 491 (550)
T ss_pred --ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCCh------HHHHHHHhhcCCC-CcC----C
Confidence 33457899999999999999999999999999999999999999754222 2222222222221 111 1
Q ss_pred CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 454 QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 454 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
.+....++++|++ +||+.|+++|+|+.|+|+.
T Consensus 492 ~~klS~~~kdFL~---~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 492 PEKLSPELKDFLD---RCLVVDVEQRASAKELLEH 523 (550)
T ss_pred ccccCHHHHHHHH---HHhhcchhcCCCHHHHhcC
Confidence 1223445555555 9999999999999999964
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-43 Score=347.77 Aligned_cols=253 Identities=21% Similarity=0.275 Sum_probs=199.8
Q ss_pred HhcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEE
Q 039168 214 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 289 (536)
Q Consensus 214 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 289 (536)
..++|+.+++||+|+||.||+|+.+ +|..+|+|++.+.. ...++.++.|-.+|...++|+||+++..|++.+++||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 4579999999999999999999876 59999999998764 3445678899999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccC
Q 039168 290 IYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFG 369 (536)
Q Consensus 290 v~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 369 (536)
||||++||++..+|. +...|++..+..++.+++.|+..||+.| +|||||||+|+|||..|++||+||||+..+.
T Consensus 219 iMEylPGGD~mTLL~---~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~ 292 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLM---RKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD 292 (550)
T ss_pred EEEecCCccHHHHHH---hcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhh
Confidence 999999999999994 4566999999999999999999999997 9999999999999999999999999986432
Q ss_pred CCC----------------------Cc-----cc------------------cccccccccccCcchhcCCCCCccchHH
Q 039168 370 GNQ----------------------NQ-----AN------------------TNIIAGTYGYMAPEYAMGGIFSIKSDVF 404 (536)
Q Consensus 370 ~~~----------------------~~-----~~------------------~~~~~gt~~y~aPE~~~~~~~~~~~Dvw 404 (536)
... .. .. ....+|||-|||||++.+..|+..+|+|
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW 372 (550)
T KOG0605|consen 293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW 372 (550)
T ss_pred hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence 100 00 00 0124699999999999999999999999
Q ss_pred HHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCC---
Q 039168 405 SFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPT--- 481 (536)
Q Consensus 405 slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt--- 481 (536)
||||||||||.|-+||....+...-.........|..+. ..... .+..+||.+||. ||++|.-
T Consensus 373 SLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~----------~~~~s---~eA~DLI~rll~-d~~~RLG~~G 438 (550)
T KOG0605|consen 373 SLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPE----------EVDLS---DEAKDLITRLLC-DPENRLGSKG 438 (550)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCC----------cCccc---HHHHHHHHHHhc-CHHHhcCccc
Confidence 999999999999999865444322111111111111100 00112 345556668888 9999976
Q ss_pred HHHHH
Q 039168 482 MSSVV 486 (536)
Q Consensus 482 ~~evl 486 (536)
+.||-
T Consensus 439 ~~EIK 443 (550)
T KOG0605|consen 439 AEEIK 443 (550)
T ss_pred HHHHh
Confidence 44444
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=322.62 Aligned_cols=237 Identities=27% Similarity=0.324 Sum_probs=198.1
Q ss_pred hcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccCh---hhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEE
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG---QGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 290 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 290 (536)
.++|+..+.||.|+||.|.+++.+ +|..+|+|++.+... ...++..+|..+|+.+.||+++++++.+.+.+.+|||
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence 368999999999999999999976 488999999987543 3345677899999999999999999999999999999
Q ss_pred EeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCC
Q 039168 291 YEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGG 370 (536)
Q Consensus 291 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 370 (536)
|||++||.|..++.+ .+.+++..++-++.||+.||+|||+.+ |++|||||+|||+|.+|.+||+|||+|+....
T Consensus 123 meyv~GGElFS~Lrk---~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~ 196 (355)
T KOG0616|consen 123 MEYVPGGELFSYLRK---SGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSG 196 (355)
T ss_pred EeccCCccHHHHHHh---cCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecC
Confidence 999999999999954 345999999999999999999999997 99999999999999999999999999997643
Q ss_pred CCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccc
Q 039168 371 NQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDP 450 (536)
Q Consensus 371 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 450 (536)
.+.+++|||.|+|||+++...|..++|+|||||++|||+.|.+||...... .....+.++++.
T Consensus 197 -----rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~-------~iY~KI~~~~v~----- 259 (355)
T KOG0616|consen 197 -----RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPI-------QIYEKILEGKVK----- 259 (355)
T ss_pred -----cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChH-------HHHHHHHhCccc-----
Confidence 255689999999999999999999999999999999999999998654331 111222222211
Q ss_pred cccCCCCHHHHHHHHHHHHhhcCCCCCCC
Q 039168 451 VLKQSCAPDELLKFIHIGLLCVQQDPADR 479 (536)
Q Consensus 451 ~l~~~~~~~~~~~l~~li~~cl~~dP~~R 479 (536)
+++--...+.+|+...|+.|-.+|
T Consensus 260 -----fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 260 -----FPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred -----CCcccCHHHHHHHHHHHhhhhHhh
Confidence 122222335556668899999888
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=351.18 Aligned_cols=263 Identities=26% Similarity=0.398 Sum_probs=212.4
Q ss_pred cCCccccccCCCCceeEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEe
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 292 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 292 (536)
++|.+.+.||+|+||.||||+.+ +.+.||+|.+.+. ..+..+.+++|++|++.++|||||.++++|+...++|+|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 57888899999999999999976 5889999999764 44567789999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCC
Q 039168 293 YMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQ 372 (536)
Q Consensus 293 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 372 (536)
|+.| +|..+|... ..++++.+..++.+++.||.|||+.+ |+|||+||.|||++..|.+|++|||+|+..+.+.
T Consensus 82 ~a~g-~L~~il~~d---~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t 154 (808)
T KOG0597|consen 82 YAVG-DLFTILEQD---GKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT 154 (808)
T ss_pred hhhh-hHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccCc
Confidence 9988 999999543 44999999999999999999999986 9999999999999999999999999999876433
Q ss_pred CccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccccc
Q 039168 373 NQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVL 452 (536)
Q Consensus 373 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l 452 (536)
.....+.|||.|||||+..+..|+..+|+|||||++|||.+|++||-. ....+.+.....++ ..
T Consensus 155 --~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a------~si~~Lv~~I~~d~--------v~ 218 (808)
T KOG0597|consen 155 --SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA------RSITQLVKSILKDP--------VK 218 (808)
T ss_pred --eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH------HHHHHHHHHHhcCC--------CC
Confidence 233457899999999999999999999999999999999999999632 22222222222211 11
Q ss_pred cCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH--hccCCCCCCCCCCCCc
Q 039168 453 KQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM--LASDSMTIPQPTEPAF 504 (536)
Q Consensus 453 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~~~~~~~~p~~p~~ 504 (536)
.++.....++.++...|++||..|.|+.+++.. .++.-.-...|+.|++
T Consensus 219 ---~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~~~~~~~~~~~a~ 269 (808)
T KOG0597|consen 219 ---PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGKINIAELPAQVAF 269 (808)
T ss_pred ---CcccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhhhhhhcccccccc
Confidence 122334556677779999999999999999843 2333223334444444
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-42 Score=345.79 Aligned_cols=249 Identities=25% Similarity=0.374 Sum_probs=202.6
Q ss_pred HhcCCccccccCCCCceeEEEEEeC-CCcEEEEEEcccc----Ch-hhHHHHHHHHHHHHHcC-CCCceeEeeEEeeCce
Q 039168 214 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT----SG-QGLKEFKNEVNLIAKLQ-HKNLVRLLGCCLEGQE 286 (536)
Q Consensus 214 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~ 286 (536)
..++|.+.+.||+|+||.|++|... ++..||+|++.+. .. ...+.+.+|+.++++++ ||||++++.++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 4578999999999999999999764 6899999977654 22 33456778999999999 9999999999999999
Q ss_pred EEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCC-CCeEEecccCc
Q 039168 287 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDD-MNPKISDFGTA 365 (536)
Q Consensus 287 ~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~-~~~kl~Dfg~a 365 (536)
+++||||+.||+|.+++.+ ...+.+.++..+++||+.|++|+|++| |+||||||+|||++.+ +++||+|||++
T Consensus 95 ~~ivmEy~~gGdL~~~i~~---~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s 168 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVN---KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLS 168 (370)
T ss_pred EEEEEEecCCccHHHHHHH---cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccccc
Confidence 9999999999999999965 345889999999999999999999997 9999999999999999 99999999999
Q ss_pred cccCCCCCccccccccccccccCcchhcCCC-C-CccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCC
Q 039168 366 RIFGGNQNQANTNIIAGTYGYMAPEYAMGGI-F-SIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGH 443 (536)
Q Consensus 366 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~-~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 443 (536)
.... .........+||+.|+|||++.+.. | +.++||||+||+||.|++|+.||..... ..+.. . ...+.
T Consensus 169 ~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~---~~l~~---k-i~~~~ 239 (370)
T KOG0583|consen 169 AISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV---PNLYR---K-IRKGE 239 (370)
T ss_pred cccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH---HHHHH---H-HhcCC
Confidence 9774 2223344578999999999999977 7 4889999999999999999999875111 11111 1 11111
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHH
Q 039168 444 AVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVV 486 (536)
Q Consensus 444 ~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl 486 (536)
. . +..... ..++..++.+||+.||.+|+|+.+|+
T Consensus 240 ~-~-----~p~~~~---S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 240 F-K-----IPSYLL---SPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred c-c-----CCCCcC---CHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 0 0 011110 34566677799999999999999999
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=345.53 Aligned_cols=244 Identities=26% Similarity=0.440 Sum_probs=204.8
Q ss_pred cCCccccccCCCCceeEEEEEeC-CCcEEEEEEcccc-ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEee
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT-SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 293 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 293 (536)
..|+....||+|+||.||+|.+. .++.||+|++... .....+.+.+|+.+|.+++++||.++|+.+..+..++++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 45777889999999999999975 5899999999865 344578899999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCC
Q 039168 294 MPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQN 373 (536)
Q Consensus 294 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 373 (536)
|.||++.+.|. ....+++..+.-++++++.||.|||.++ .+|||||+.|||+..+|.+||+|||++..+.....
T Consensus 93 ~~gGsv~~lL~---~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 93 CGGGSVLDLLK---SGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK 166 (467)
T ss_pred hcCcchhhhhc---cCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhh
Confidence 99999999983 3334588888899999999999999996 99999999999999999999999999988765443
Q ss_pred ccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccc----c
Q 039168 374 QANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELI----D 449 (536)
Q Consensus 374 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~----~ 449 (536)
.. .+++|||.|||||++++..|+.|+||||||++.+||++|.+|+....+. ++..++ .
T Consensus 167 rr--~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPm----------------rvlflIpk~~P 228 (467)
T KOG0201|consen 167 RR--KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPM----------------RVLFLIPKSAP 228 (467)
T ss_pred cc--ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcc----------------eEEEeccCCCC
Confidence 33 5689999999999999989999999999999999999999997554442 222222 2
Q ss_pred ccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 450 PVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 450 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
|.+.+. .... +.+++..||++||+.|||+.++|+
T Consensus 229 P~L~~~-~S~~---~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 229 PRLDGD-FSPP---FKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred Cccccc-cCHH---HHHHHHHHhhcCcccCcCHHHHhh
Confidence 233332 2233 444555999999999999999983
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=350.13 Aligned_cols=260 Identities=29% Similarity=0.426 Sum_probs=202.1
Q ss_pred hcCCccccccCCCCceeEEEEEe------CCCcEEEEEEccccC-hhhHHHHHHHHHHHHHc-CCCCceeEeeEEeeC-c
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTL------ADGKAIAVKRLSRTS-GQGLKEFKNEVNLIAKL-QHKNLVRLLGCCLEG-Q 285 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~-~ 285 (536)
.++|++.++||+|+||.||+|.+ .+++.||||++.... ....+.+.+|+.+++.+ +||||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 46899999999999999999974 235689999987543 33456788999999999 899999999988764 4
Q ss_pred eEEEEEeecCCCChhhhhhcccC---------------------------------------------------------
Q 039168 286 ELLLIYEYMPNKSLDVHLFDATR--------------------------------------------------------- 308 (536)
Q Consensus 286 ~~~lv~e~~~~~sL~~~l~~~~~--------------------------------------------------------- 308 (536)
.+++||||+++|+|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 68999999999999998864221
Q ss_pred --CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCCccccccccccccc
Q 039168 309 --SVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGY 386 (536)
Q Consensus 309 --~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y 386 (536)
...+++.++..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++...............+++.|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 134778889999999999999999986 999999999999999999999999999865433222222233456789
Q ss_pred cCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHHHHHhhcCCccccccccccCCCCHHHHHHHH
Q 039168 387 MAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQSCAPDELLKFI 465 (536)
Q Consensus 387 ~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~ 465 (536)
+|||++.+..++.++||||||+++|||++ |..||....... ........+..... . ......+.
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~------~~~~~~~~~~~~~~-----~----~~~~~~l~ 307 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE------EFCQRLKDGTRMRA-----P----ENATPEIY 307 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH------HHHHHHhcCCCCCC-----C----CCCCHHHH
Confidence 99999999999999999999999999997 999976432211 11111222211111 1 11123466
Q ss_pred HHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 466 HIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 466 ~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
+|+.+||+.||++|||+.+|++.|+..
T Consensus 308 ~li~~cl~~dp~~RPs~~el~~~l~~~ 334 (338)
T cd05102 308 RIMLACWQGDPKERPTFSALVEILGDL 334 (338)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 777899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=352.45 Aligned_cols=243 Identities=26% Similarity=0.356 Sum_probs=202.1
Q ss_pred HHHhcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHHHcC-CCCceeEeeEEeeCce
Q 039168 212 LEATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLKEFKNEVNLIAKLQ-HKNLVRLLGCCLEGQE 286 (536)
Q Consensus 212 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~ 286 (536)
....++|.++++||+|+||+|+++..+ +++.+|||.+++.. .++++....|..|+.... ||.++.++.+|+..++
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 344579999999999999999999986 47899999998763 456788888999998885 9999999999999999
Q ss_pred EEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCcc
Q 039168 287 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTAR 366 (536)
Q Consensus 287 ~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 366 (536)
+|+||||+.||++..+. +...+++.++.-++..|+.||+|||+++ |||||||.+|||+|.+|++||+|||+++
T Consensus 444 l~fvmey~~Ggdm~~~~----~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcK 516 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHHI----HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCK 516 (694)
T ss_pred EEEEEEecCCCcEEEEE----ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEeccccccc
Confidence 99999999999954443 3456999999999999999999999997 9999999999999999999999999998
Q ss_pred ccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccc
Q 039168 367 IFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVE 446 (536)
Q Consensus 367 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 446 (536)
.--. ....+.+++|||.|||||++.+..|+..+|+|||||+|||||.|+.||...+.++
T Consensus 517 e~m~--~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee------------------- 575 (694)
T KOG0694|consen 517 EGMG--QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEE------------------- 575 (694)
T ss_pred ccCC--CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHH-------------------
Confidence 6432 2235667999999999999999999999999999999999999999986543321
Q ss_pred cccccccCC--CCHHHHHHHHHHHHhhcCCCCCCCCCH
Q 039168 447 LIDPVLKQS--CAPDELLKFIHIGLLCVQQDPADRPTM 482 (536)
Q Consensus 447 l~~~~l~~~--~~~~~~~~l~~li~~cl~~dP~~RPt~ 482 (536)
++|.++..+ ++.-...+.+.|+.++|.+||++|.-+
T Consensus 576 ~FdsI~~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 576 VFDSIVNDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred HHHHHhcCCCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 112211111 122234456677779999999999865
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=336.38 Aligned_cols=264 Identities=27% Similarity=0.417 Sum_probs=201.2
Q ss_pred cCCccccccCCCCceeEEEEEeCC-----------------CcEEEEEEccccC-hhhHHHHHHHHHHHHHcCCCCceeE
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLAD-----------------GKAIAVKRLSRTS-GQGLKEFKNEVNLIAKLQHKNLVRL 277 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l 277 (536)
++|++.++||+|+||.||++.+.+ +..||+|.+.... ......+.+|+.++++++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 578899999999999999997532 3469999987543 3345678999999999999999999
Q ss_pred eeEEeeCceEEEEEeecCCCChhhhhhccc----------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeee
Q 039168 278 LGCCLEGQELLLIYEYMPNKSLDVHLFDAT----------------RSVQLDWKRRLSIINGIARGILYLHEDSRLKIIH 341 (536)
Q Consensus 278 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH 341 (536)
++++.+.+..++||||+.+++|.+++.... ....+++..++.++.||+.||.|||+.+ |+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence 999999999999999999999999885421 1124678899999999999999999996 999
Q ss_pred CCCCCCcEEEcCCCCeEEecccCccccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhC--CCC
Q 039168 342 RDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISG--RKN 419 (536)
Q Consensus 342 ~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg--~~p 419 (536)
|||||+|||++.++.+||+|||+++.+.............++..|+|||++.+..++.++||||||+++|||+++ ..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 999999999999999999999999866433322222234457889999999988999999999999999999975 445
Q ss_pred CCCCCccCCchhHHHHHHHhhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcc
Q 039168 420 NGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 491 (536)
Q Consensus 420 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 491 (536)
|..... ................ .. . ...++.....+.+++.+||+.||++|||+.+|++.|+.
T Consensus 242 ~~~~~~---~~~~~~~~~~~~~~~~-~~-~----~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 242 YGELTD---EQVIENAGEFFRDQGR-QV-Y----LFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCcCCH---HHHHHHHHHHhhhccc-cc-c----ccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 443211 1122212111111100 00 0 00111223456777889999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=332.78 Aligned_cols=256 Identities=26% Similarity=0.383 Sum_probs=200.0
Q ss_pred HhcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccCh--------------hhHHHHHHHHHHHHHcCCCCceeEe
Q 039168 214 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG--------------QGLKEFKNEVNLIAKLQHKNLVRLL 278 (536)
Q Consensus 214 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~hpniv~l~ 278 (536)
..++|++.+.||+|.||.|-+|+.. +++.||||++.+... ...+..++|+.+|++++|||||+|+
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li 174 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI 174 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence 3578999999999999999999975 689999999975421 1245788999999999999999999
Q ss_pred eEEee--CceEEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCC
Q 039168 279 GCCLE--GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMN 356 (536)
Q Consensus 279 ~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~ 356 (536)
.+..+ .+.+|||+|||..|.+...= .....+.+.++++++++++.||+|||.+| ||||||||+|+||+++|+
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g~ 248 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDGT 248 (576)
T ss_pred EeecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCCc
Confidence 99876 47899999999988875332 22223899999999999999999999997 999999999999999999
Q ss_pred eEEecccCccccCCCC---CccccccccccccccCcchhcCCC----CCccchHHHHHHHHHHHHhCCCCCCCCCccCCc
Q 039168 357 PKISDFGTARIFGGNQ---NQANTNIIAGTYGYMAPEYAMGGI----FSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQ 429 (536)
Q Consensus 357 ~kl~Dfg~a~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslG~il~elltg~~p~~~~~~~~~~ 429 (536)
|||+|||.+..+.... ........+|||.|+|||...++. .+.+.||||+||+||.|+.|+.||-...
T Consensus 249 VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~----- 323 (576)
T KOG0585|consen 249 VKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDF----- 323 (576)
T ss_pred EEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccch-----
Confidence 9999999998763221 112223368999999999997743 4788999999999999999999974221
Q ss_pred hhHHHHHHHhhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 039168 430 TLLTYTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLA 490 (536)
Q Consensus 430 ~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 490 (536)
.+....+ ++...+.-...+++...+.+||++||++||+.|.++.+|....-
T Consensus 324 -~~~l~~K---------Ivn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpw 374 (576)
T KOG0585|consen 324 -ELELFDK---------IVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPW 374 (576)
T ss_pred -HHHHHHH---------HhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecce
Confidence 1111111 11222222223344556777888999999999999999986553
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=315.72 Aligned_cols=278 Identities=23% Similarity=0.284 Sum_probs=204.8
Q ss_pred hcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccChh--hHHHHHHHHHHHHHcCCCCceeEeeEEe--eCceEEE
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQ--GLKEFKNEVNLIAKLQHKNLVRLLGCCL--EGQELLL 289 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~--~~~~~~l 289 (536)
-+.|+.+++|++|.||.||+|+++ +++.||+|+++..... ..-...+|+.+|.+++|||||.+-.+.. +-+.+||
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 467899999999999999999986 5889999999765422 2234578999999999999999998876 3467999
Q ss_pred EEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccC
Q 039168 290 IYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFG 369 (536)
Q Consensus 290 v~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 369 (536)
|||||+. +|..++.... .++...++..++.|+++||+|||.++ |+||||||+|+|+++.|.+||+|||+|+.++
T Consensus 155 VMe~~Eh-DLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 155 VMEYVEH-DLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYG 228 (419)
T ss_pred eHHHHHh-hHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhc
Confidence 9999976 5666665433 56899999999999999999999998 9999999999999999999999999999987
Q ss_pred CCCCccccccccccccccCcchhcCCC-CCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcC---Ccc
Q 039168 370 GNQNQANTNIIAGTYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEG---HAV 445 (536)
Q Consensus 370 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~ 445 (536)
+... ..+..+-|.+|.|||++.+.. |++++|+||+|||+.||+++++.|......+. +..+.....-+ .+.
T Consensus 229 sp~k--~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQ---l~~If~llGtPte~iwp 303 (419)
T KOG0663|consen 229 SPLK--PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQ---LDKIFKLLGTPSEAIWP 303 (419)
T ss_pred CCcc--cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHH---HHHHHHHhCCCccccCC
Confidence 6532 233456799999999999864 99999999999999999999998765333221 12222211110 010
Q ss_pred cc--------------ccccccCCCCHH-HHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccCCCCCCCCCCCCcc
Q 039168 446 EL--------------IDPVLKQSCAPD-ELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSMTIPQPTEPAFS 505 (536)
Q Consensus 446 ~l--------------~~~~l~~~~~~~-~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~p~~p~~~ 505 (536)
.. ....++..+... ....-.+|+..+|..||.+|.|+++.|+.= --...|.|..|.+.
T Consensus 304 g~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~--~F~e~P~p~~P~~~ 376 (419)
T KOG0663|consen 304 GYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHE--YFRETPLPIDPSMF 376 (419)
T ss_pred CccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhccc--ccccCCCCCChhhc
Confidence 00 001111111111 112345566689999999999999998642 11234445444443
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=343.94 Aligned_cols=248 Identities=28% Similarity=0.367 Sum_probs=202.7
Q ss_pred cCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEE
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 291 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 291 (536)
.-|+.++.||+|+-|.|.+|++. +|+.+|||++.+.. ......+.+|+.||+.+.|||++++|++|.+..++|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 45888999999999999999974 69999999997652 222456889999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCC
Q 039168 292 EYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGN 371 (536)
Q Consensus 292 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 371 (536)
||+++|.|.+++.. .+.+.+.++.+++.||+.|+.|+|..+ |+||||||+|+|||.++++||+|||+|-.-..+
T Consensus 92 Eyv~gGELFdylv~---kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g 165 (786)
T KOG0588|consen 92 EYVPGGELFDYLVR---KGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPG 165 (786)
T ss_pred EecCCchhHHHHHh---hCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence 99999999999964 445999999999999999999999885 999999999999999999999999999754322
Q ss_pred CCccccccccccccccCcchhcCCCC-CccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccc
Q 039168 372 QNQANTNIIAGTYGYMAPEYAMGGIF-SIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDP 450 (536)
Q Consensus 372 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 450 (536)
....+-+|.|.|.+||++.|..| +.++||||.|||||.||+|+.||+ ++.-..++..+. .+. .++.
T Consensus 166 ---klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFd---DdNir~LLlKV~----~G~-f~MP-- 232 (786)
T KOG0588|consen 166 ---KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFD---DDNIRVLLLKVQ----RGV-FEMP-- 232 (786)
T ss_pred ---ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCC---CccHHHHHHHHH----cCc-ccCC--
Confidence 22334689999999999999998 789999999999999999999986 222222222221 111 1221
Q ss_pred cccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHh
Q 039168 451 VLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 489 (536)
Q Consensus 451 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 489 (536)
...+.+ +.+|+.+||..||++|.|+.||++..
T Consensus 233 ----s~Is~e---aQdLLr~ml~VDp~~RiT~~eI~kHP 264 (786)
T KOG0588|consen 233 ----SNISSE---AQDLLRRMLDVDPSTRITTEEILKHP 264 (786)
T ss_pred ----CcCCHH---HHHHHHHHhccCccccccHHHHhhCc
Confidence 122333 44555699999999999999999753
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=359.94 Aligned_cols=260 Identities=30% Similarity=0.485 Sum_probs=213.3
Q ss_pred cCCccccccCCCCceeEEEEEeC------CCcEEEEEEccccChh-hHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEE
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRTSGQ-GLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELL 288 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 288 (536)
.+-...+.||+|.||+||+|+.. +..-||||.++..... ...+|++|+++|..|+|||||+++|+|.+++.++
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~ 565 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC 565 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence 45566789999999999999843 3567999999876554 7789999999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhhccc-------C----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCe
Q 039168 289 LIYEYMPNKSLDVHLFDAT-------R----SVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNP 357 (536)
Q Consensus 289 lv~e~~~~~sL~~~l~~~~-------~----~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~ 357 (536)
||+|||..|+|.++|.... . ..+++..+.+.|+.|||.|++||-++. +|||||-..|+||.++..|
T Consensus 566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~V 642 (774)
T KOG1026|consen 566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLVV 642 (774)
T ss_pred EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceEE
Confidence 9999999999999996421 1 334889999999999999999999986 9999999999999999999
Q ss_pred EEecccCccccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHHH
Q 039168 358 KISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTW 436 (536)
Q Consensus 358 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~ 436 (536)
||+|||+++...+.+.........-..+|||||.++.+.++++|||||+||+|||+++ |+.|+.....++ +.
T Consensus 643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E-------VI 715 (774)
T KOG1026|consen 643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE-------VI 715 (774)
T ss_pred EecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH-------HH
Confidence 9999999997765554443322234679999999999999999999999999999998 777765433322 22
Q ss_pred HHhhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccCCC
Q 039168 437 KLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSM 494 (536)
Q Consensus 437 ~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 494 (536)
....++.+.+ ++.....++..||..||+.+|++||+++||-..|+.-..
T Consensus 716 e~i~~g~lL~---------~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~ 764 (774)
T KOG1026|consen 716 ECIRAGQLLS---------CPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ 764 (774)
T ss_pred HHHHcCCccc---------CCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence 2333444322 233445567888889999999999999999999987543
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-42 Score=327.83 Aligned_cols=247 Identities=22% Similarity=0.393 Sum_probs=206.9
Q ss_pred hcCCccccccCCCCceeEEEEEe-CCCcEEEEEEccccC---hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEE
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTS---GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 290 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 290 (536)
..+|++.+.||+|.||.|-+|.. ..|+.||||.+.+.. .++.-.+++|++||+.|+||||+.++.+|+..+.+.||
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 36899999999999999999986 679999999997653 45566789999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCC
Q 039168 291 YEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGG 370 (536)
Q Consensus 291 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 370 (536)
|||..+|.|.+++.+ ...+++.+++.+++||..|+.|+|.++ ++|||||.+|||+|.++++||+|||++..+..
T Consensus 132 MEYaS~GeLYDYiSe---r~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~ 205 (668)
T KOG0611|consen 132 MEYASGGELYDYISE---RGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYAD 205 (668)
T ss_pred EEecCCccHHHHHHH---hccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhcc
Confidence 999999999999955 345999999999999999999999986 99999999999999999999999999987753
Q ss_pred CCCccccccccccccccCcchhcCCCC-CccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcccccc
Q 039168 371 NQNQANTNIIAGTYGYMAPEYAMGGIF-SIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELID 449 (536)
Q Consensus 371 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 449 (536)
. ....+++|+|.|.+||++.|..| ++.+|-|||||+||.|+.|..||+..+... + + ..+..+...+
T Consensus 206 ~---kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~---l---v-rQIs~GaYrE--- 272 (668)
T KOG0611|consen 206 K---KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKR---L---V-RQISRGAYRE--- 272 (668)
T ss_pred c---cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHH---H---H-HHhhcccccC---
Confidence 3 33456899999999999999987 789999999999999999999986543321 1 1 1122222222
Q ss_pred ccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 450 PVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 450 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
++......-||.|||..||++|.|+.+|...
T Consensus 273 --------P~~PSdA~gLIRwmLmVNP~RRATieDiAsH 303 (668)
T KOG0611|consen 273 --------PETPSDASGLIRWMLMVNPERRATIEDIASH 303 (668)
T ss_pred --------CCCCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence 1112234456669999999999999998754
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-41 Score=343.79 Aligned_cols=259 Identities=32% Similarity=0.462 Sum_probs=201.9
Q ss_pred hcCCccccccCCCCceeEEEEEe------CCCcEEEEEEccccC-hhhHHHHHHHHHHHHHc-CCCCceeEeeEEeeCce
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTL------ADGKAIAVKRLSRTS-GQGLKEFKNEVNLIAKL-QHKNLVRLLGCCLEGQE 286 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~ 286 (536)
.++|++.++||+|+||.||+|++ ..+..||||++.... ....+.+.+|+.+++.+ +||||+++++++...+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 35789999999999999999973 236689999986443 33456788999999999 89999999999999999
Q ss_pred EEEEEeecCCCChhhhhhcccC----------------------------------------------------------
Q 039168 287 LLLIYEYMPNKSLDVHLFDATR---------------------------------------------------------- 308 (536)
Q Consensus 287 ~~lv~e~~~~~sL~~~l~~~~~---------------------------------------------------------- 308 (536)
.++||||+++|+|.+++.....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 9999999999999988864221
Q ss_pred --------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCCc
Q 039168 309 --------------SVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQ 374 (536)
Q Consensus 309 --------------~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 374 (536)
...+++..++.++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 124788899999999999999999986 999999999999999999999999999876543322
Q ss_pred cccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHHHHHhhcCCcccccccccc
Q 039168 375 ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLK 453 (536)
Q Consensus 375 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~ 453 (536)
.......++..|+|||.+.+..++.++||||||+++|||++ |..||...... .. .......+.... .
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~--~~----~~~~~~~~~~~~------~ 338 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD--SK----FYKMIKEGYRML------S 338 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch--HH----HHHHHHhCccCC------C
Confidence 22222334667999999999999999999999999999998 78886532211 11 111122211111 0
Q ss_pred CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcc
Q 039168 454 QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 491 (536)
Q Consensus 454 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 491 (536)
....+ .++.+|+.+||+.||++|||+.+|++.|+.
T Consensus 339 ~~~~~---~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 339 PECAP---SEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred CCCCC---HHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 11122 346677779999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=339.35 Aligned_cols=251 Identities=23% Similarity=0.334 Sum_probs=208.4
Q ss_pred cCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC--hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCce-EEEEE
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQE-LLLIY 291 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~-~~lv~ 291 (536)
++|..+++||+|+||.++..+.+ +++.|++|++.... ........+|..++++++|||||.+.+.|.+++. ++|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 57899999999999999999876 57899999987543 3344567899999999999999999999999888 99999
Q ss_pred eecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCC
Q 039168 292 EYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGN 371 (536)
Q Consensus 292 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 371 (536)
+|++||++.+.|.+.+ ...+++++++.|+.|++.|+.|||++. |+|||||+.|||++.++.|||+|||+|+.+...
T Consensus 84 ~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred eecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 9999999999997655 567999999999999999999999774 999999999999999999999999999998765
Q ss_pred CCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcccccccc
Q 039168 372 QNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPV 451 (536)
Q Consensus 372 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 451 (536)
.. .....+||+.||.||++.+..|..|+|||||||++|||++-+++|...+. ..+...+... . .
T Consensus 160 ~~--~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m---~~Li~ki~~~----~----~--- 223 (426)
T KOG0589|consen 160 DS--LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNM---SELILKINRG----L----Y--- 223 (426)
T ss_pred hh--hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccch---HHHHHHHhhc----c----C---
Confidence 52 33457899999999999999999999999999999999999999754322 1122111111 0 1
Q ss_pred ccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 452 LKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 452 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
...+.....++..++..||+++|+.||++.++|..
T Consensus 224 --~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 224 --SPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred --CCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 11223344556666679999999999999999965
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=332.22 Aligned_cols=199 Identities=28% Similarity=0.390 Sum_probs=175.6
Q ss_pred hcCCccccccCCCCceeEEEEEeC-CCcEEEEEEcccc-ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEe
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT-SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 292 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 292 (536)
.++|++.+.||+|+||.||++++. ++..||+|.+... .....+.+.+|+++|++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 368999999999999999999976 5888999988754 33445679999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCC
Q 039168 293 YMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQ 372 (536)
Q Consensus 293 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 372 (536)
|+++++|.+++... ..+++..+..++.|++.||.|||+.+ +|+||||||+|||++.++.+||+|||++..+....
T Consensus 84 ~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 158 (331)
T cd06649 84 HMDGGSLDQVLKEA---KRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 158 (331)
T ss_pred cCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccccc
Confidence 99999999998543 34889999999999999999999864 59999999999999999999999999998654321
Q ss_pred CccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCC
Q 039168 373 NQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF 422 (536)
Q Consensus 373 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~ 422 (536)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 159 ----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 204 (331)
T cd06649 159 ----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP 204 (331)
T ss_pred ----cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 2234689999999999999999999999999999999999999854
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=326.97 Aligned_cols=245 Identities=19% Similarity=0.318 Sum_probs=195.1
Q ss_pred cccCCCCceeEEEEEeCCCcEEEEEEccccChhh---HHHHHHHHHHHHHcCCCCceeEeeEEee----CceEEEEEeec
Q 039168 222 NKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQG---LKEFKNEVNLIAKLQHKNLVRLLGCCLE----GQELLLIYEYM 294 (536)
Q Consensus 222 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~----~~~~~lv~e~~ 294 (536)
..||+|+++.||+|.+ +|+.||||++....... .+.+.+|+.+|++++||||+++++++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 5799999999999998 68899999987653322 5678899999999999999999999877 45789999999
Q ss_pred CCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCCc
Q 039168 295 PNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQ 374 (536)
Q Consensus 295 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 374 (536)
++|+|.+++... ..+++...+.++.|++.||.|||+.. +++||||||+|||+++++.+||+|||+++.+....
T Consensus 105 ~~g~L~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~-- 177 (283)
T PHA02988 105 TRGYLREVLDKE---KDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP-- 177 (283)
T ss_pred CCCcHHHHHhhC---CCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcccc--
Confidence 999999999543 35889999999999999999999852 38899999999999999999999999998654322
Q ss_pred cccccccccccccCcchhcC--CCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccccc
Q 039168 375 ANTNIIAGTYGYMAPEYAMG--GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVL 452 (536)
Q Consensus 375 ~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l 452 (536)
....|+..|+|||++.+ ..++.++|||||||++|||++|+.||...... .... .....+.... +
T Consensus 178 ---~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~---~~~~---~i~~~~~~~~-----~ 243 (283)
T PHA02988 178 ---FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK---EIYD---LIINKNNSLK-----L 243 (283)
T ss_pred ---ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH---HHHH---HHHhcCCCCC-----C
Confidence 12357889999999976 67999999999999999999999998643211 1111 1111111111 1
Q ss_pred cCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 453 KQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 453 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
.. .....+.+++.+||+.||++|||++++++.|+..
T Consensus 244 ~~----~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~ 279 (283)
T PHA02988 244 PL----DCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY 279 (283)
T ss_pred CC----cCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 11 1223456667799999999999999999999865
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=325.73 Aligned_cols=251 Identities=25% Similarity=0.335 Sum_probs=197.7
Q ss_pred CCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEe
Q 039168 217 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 292 (536)
Q Consensus 217 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 292 (536)
.|+..+.||+|+||.||++... +++.||+|++.... ......+.+|+.++++++|+||+++++++.+++..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 3778899999999999999874 68999999986532 2223457889999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCC
Q 039168 293 YMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQ 372 (536)
Q Consensus 293 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 372 (536)
|+++++|..++.... ...+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||++.......
T Consensus 81 ~~~~g~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 81 IMNGGDLKFHIYNMG-NPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE 156 (285)
T ss_pred ecCCCcHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence 999999988875432 235899999999999999999999997 9999999999999999999999999998754322
Q ss_pred CccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccccc
Q 039168 373 NQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVL 452 (536)
Q Consensus 373 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l 452 (536)
. .....||+.|+|||++.+..++.++|||||||++|+|++|+.||......... ........... ..
T Consensus 157 ~---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~---~~~~~~~~~~~-~~------ 223 (285)
T cd05631 157 T---VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKR---EEVDRRVKEDQ-EE------ 223 (285)
T ss_pred e---ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhH---HHHHHHhhccc-cc------
Confidence 1 12346899999999999999999999999999999999999998653322111 11111111100 00
Q ss_pred cCCCCHHHHHHHHHHHHhhcCCCCCCCCC-----HHHHHH
Q 039168 453 KQSCAPDELLKFIHIGLLCVQQDPADRPT-----MSSVVV 487 (536)
Q Consensus 453 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~ 487 (536)
........+.+|+.+||+.||++||+ ++++++
T Consensus 224 ---~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 224 ---YSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred ---CCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 11111234566777999999999997 788885
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=342.60 Aligned_cols=259 Identities=31% Similarity=0.470 Sum_probs=201.7
Q ss_pred hcCCccccccCCCCceeEEEEEeC------CCcEEEEEEccccC-hhhHHHHHHHHHHHHHc-CCCCceeEeeEEeeCce
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRTS-GQGLKEFKNEVNLIAKL-QHKNLVRLLGCCLEGQE 286 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~ 286 (536)
.++|++.+.||+|+||.||++.+. ++..||||++.... ....+.+.+|+.+++.+ +||||+++++++.....
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 457999999999999999998742 34689999997543 33456788999999999 89999999999999999
Q ss_pred EEEEEeecCCCChhhhhhcccC----------------------------------------------------------
Q 039168 287 LLLIYEYMPNKSLDVHLFDATR---------------------------------------------------------- 308 (536)
Q Consensus 287 ~~lv~e~~~~~sL~~~l~~~~~---------------------------------------------------------- 308 (536)
.++||||+.+|+|.+++.....
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 9999999999999998854211
Q ss_pred ---------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCCcccccc
Q 039168 309 ---------SVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNI 379 (536)
Q Consensus 309 ---------~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 379 (536)
...+++.+++.++.||++||.|||+++ |+||||||+|||+++++.+||+|||+++.+...........
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 124788899999999999999999997 99999999999999999999999999986543322222222
Q ss_pred ccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHHHHHhhcCCccccccccccCCCCH
Q 039168 380 IAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQSCAP 458 (536)
Q Consensus 380 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~ 458 (536)
..++..|+|||++.+..++.++|||||||++|+|++ |+.||....... . .......+.... .. ...+
T Consensus 274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~--~----~~~~~~~~~~~~-----~~-~~~~ 341 (374)
T cd05106 274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS--K----FYKMVKRGYQMS-----RP-DFAP 341 (374)
T ss_pred CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH--H----HHHHHHcccCcc-----CC-CCCC
Confidence 334668999999999899999999999999999997 999976432211 1 111111111000 00 1112
Q ss_pred HHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcc
Q 039168 459 DELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 491 (536)
Q Consensus 459 ~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 491 (536)
.++.+++.+||+.||++|||+.+|+++|+.
T Consensus 342 ---~~l~~li~~cl~~dp~~RPs~~~l~~~l~~ 371 (374)
T cd05106 342 ---PEIYSIMKMCWNLEPTERPTFSQISQLIQR 371 (374)
T ss_pred ---HHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 346667779999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=320.35 Aligned_cols=271 Identities=23% Similarity=0.270 Sum_probs=215.8
Q ss_pred cCCccccccCCCCceeEEEEEeCC-CcEEEEEEccccC---hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEE
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTS---GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 291 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 291 (536)
+.|+.++.||.|.-|+||++++++ +..+|+|++.+.. .+...+.+.|-+||+.++||.++.||..|+.++..+++|
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 578899999999999999999875 6899999998754 344566788999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCC-
Q 039168 292 EYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGG- 370 (536)
Q Consensus 292 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~- 370 (536)
|||.||+|....+++. ...+++..++-++..|+.||+|||..| ||+|||||+||||.++|++.|+||.++.....
T Consensus 157 eyCpGGdL~~LrqkQp-~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQP-GKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred ecCCCccHHHHHhhCC-CCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence 9999999998886643 456999999999999999999999998 99999999999999999999999988653311
Q ss_pred --------------------------------C-C--------------------CccccccccccccccCcchhcCCCC
Q 039168 371 --------------------------------N-Q--------------------NQANTNIIAGTYGYMAPEYAMGGIF 397 (536)
Q Consensus 371 --------------------------------~-~--------------------~~~~~~~~~gt~~y~aPE~~~~~~~ 397 (536)
. . .......++||-.|+|||++.|...
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 0 0 0011223679999999999999999
Q ss_pred CccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCC
Q 039168 398 SIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPA 477 (536)
Q Consensus 398 ~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~ 477 (536)
+.++|+|+|||++|||+.|.-||........ +... +.+.+.-...+.....+.+||.+.|.+||+
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~T--l~NI-------------v~~~l~Fp~~~~vs~~akDLIr~LLvKdP~ 377 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKET--LRNI-------------VGQPLKFPEEPEVSSAAKDLIRKLLVKDPS 377 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCchhh--HHHH-------------hcCCCcCCCCCcchhHHHHHHHHHhccChh
Confidence 9999999999999999999999875544321 1111 111111112233445677777899999999
Q ss_pred CCCC----HHHHHH--HhccCCCCCCCCCCCCcc
Q 039168 478 DRPT----MSSVVV--MLASDSMTIPQPTEPAFS 505 (536)
Q Consensus 478 ~RPt----~~evl~--~L~~~~~~~~~p~~p~~~ 505 (536)
+|.- +.||-+ +.++.++.+-.-..|++.
T Consensus 378 kRlg~~rGA~eIK~HpFF~gVnWaLir~~~PP~i 411 (459)
T KOG0610|consen 378 KRLGSKRGAAEIKRHPFFEGVNWALIRCARPPEI 411 (459)
T ss_pred hhhccccchHHhhcCccccCCChhheeccCCCcC
Confidence 9998 888874 456777766555555553
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=335.10 Aligned_cols=263 Identities=29% Similarity=0.485 Sum_probs=205.1
Q ss_pred HhcCCccccccCCCCceeEEEEEeCCCcEEEEEEcccc--ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEE
Q 039168 214 ATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRT--SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 291 (536)
Q Consensus 214 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 291 (536)
..+...+...||+|.||+||+|++- ..||||++... +.+..+.|++|+.++++-+|.||+=++|++..... .||+
T Consensus 390 p~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiT 466 (678)
T KOG0193|consen 390 PPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIIT 466 (678)
T ss_pred CHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeee
Confidence 3456677889999999999999984 36999998754 45568899999999999999999999999998877 9999
Q ss_pred eecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCC
Q 039168 292 EYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGN 371 (536)
Q Consensus 292 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 371 (536)
.+|+|.+|..+|+..+ ..++..+.+.|++||++|+.|||.+. |||||||..|||+.++++|||+|||++..-..-
T Consensus 467 qwCeGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w 541 (678)
T KOG0193|consen 467 QWCEGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRW 541 (678)
T ss_pred hhccCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccceeeeeee
Confidence 9999999999997543 45899999999999999999999995 999999999999999999999999998654322
Q ss_pred CCccccccccccccccCcchhcC---CCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccc
Q 039168 372 QNQANTNIIAGTYGYMAPEYAMG---GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELI 448 (536)
Q Consensus 372 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 448 (536)
..........|...|||||++.. ..|++++||||||+++|||++|..||.....+ +.+ |.-++-.-..
T Consensus 542 ~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~d--qIi-------fmVGrG~l~p 612 (678)
T KOG0193|consen 542 SGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRD--QII-------FMVGRGYLMP 612 (678)
T ss_pred ccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChh--heE-------EEecccccCc
Confidence 22222223457789999999964 45899999999999999999999998622211 111 1112221222
Q ss_pred cccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccCCCCC
Q 039168 449 DPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSMTI 496 (536)
Q Consensus 449 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 496 (536)
|........+.+++ +|+..||+.++++||++.+||..|.....++
T Consensus 613 d~s~~~s~~pk~mk---~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~ 657 (678)
T KOG0193|consen 613 DLSKIRSNCPKAMK---RLLSDCWKFDREERPLFPQLLSKLEELLPSL 657 (678)
T ss_pred cchhhhccCHHHHH---HHHHHHHhcCcccCccHHHHHHHHHHhhhcc
Confidence 22222222344444 5555999999999999999999888764433
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=337.51 Aligned_cols=253 Identities=22% Similarity=0.316 Sum_probs=200.9
Q ss_pred cCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEE
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 291 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 291 (536)
++|++.+.||+|+||.||+|++. +++.||||++.... ......+.+|+.++..++||||+++++++...+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36899999999999999999976 48999999987542 234567889999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCC
Q 039168 292 EYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGN 371 (536)
Q Consensus 292 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 371 (536)
||+++++|..++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~- 153 (333)
T cd05600 81 EYVPGGDFRTLLNN---LGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT- 153 (333)
T ss_pred eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence 99999999999854 235889999999999999999999997 99999999999999999999999999986543
Q ss_pred CCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcccccccc
Q 039168 372 QNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPV 451 (536)
Q Consensus 372 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 451 (536)
......||+.|+|||++.+..++.++|||||||++|||++|+.||....... .... ...+. ..... +
T Consensus 154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~---~~~~-i~~~~--~~~~~--~- 220 (333)
T cd05600 154 ----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE---TWEN-LKYWK--ETLQR--P- 220 (333)
T ss_pred ----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHH---HHHH-HHhcc--ccccC--C-
Confidence 2234568999999999999999999999999999999999999985432211 1110 01110 00000 0
Q ss_pred ccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 452 LKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 452 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
...........++.+++.+||+.+|.+|||+.++++.
T Consensus 221 ~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 221 VYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 0000001122345667779999999999999999965
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=322.74 Aligned_cols=268 Identities=24% Similarity=0.316 Sum_probs=201.7
Q ss_pred HhcCCccccccCCCCceeEEEEEeC-CCcEEEEEEcc--ccChhhHHHHHHHHHHHHHcCCCCceeEeeEEee-----Cc
Q 039168 214 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLS--RTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLE-----GQ 285 (536)
Q Consensus 214 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-----~~ 285 (536)
....|...+.||+|+||.|..+.++ +|+.||||++. -......++..+|+++|+.++|+||+.+++++.. -+
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 3456777899999999999999875 58999999997 3455667889999999999999999999999865 46
Q ss_pred eEEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCc
Q 039168 286 ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTA 365 (536)
Q Consensus 286 ~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 365 (536)
.+|+|+|+| +.+|...+. ....+++..+..++.||++||+|+|+.+ |+||||||+|+|++.+..+||+|||+|
T Consensus 100 DvYiV~elM-etDL~~iik---~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLA 172 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIK---SQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLA 172 (359)
T ss_pred eeEEehhHH-hhHHHHHHH---cCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccce
Confidence 799999999 678888884 3344899999999999999999999985 999999999999999999999999999
Q ss_pred cccCCCCCccccccccccccccCcchhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHH--------H
Q 039168 366 RIFGGNQNQANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYT--------W 436 (536)
Q Consensus 366 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~--------~ 436 (536)
+...........+..+-|.+|.|||++.. ..|+.++||||+|||+.||++|++.|...+....-.+.... .
T Consensus 173 R~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l 252 (359)
T KOG0660|consen 173 RYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDL 252 (359)
T ss_pred eeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHH
Confidence 98765422233344567999999998865 56999999999999999999999998764432221111100 0
Q ss_pred HHhhcCCcccccccc-ccCCCC-----HHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 437 KLWCEGHAVELIDPV-LKQSCA-----PDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 437 ~~~~~~~~~~l~~~~-l~~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
..+........+... .....+ +......++|+.+||..||.+|+|++|+|+.
T Consensus 253 ~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 253 QKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 000000000000000 000000 1112346677779999999999999999964
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-40 Score=324.36 Aligned_cols=263 Identities=22% Similarity=0.302 Sum_probs=199.7
Q ss_pred cCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC--hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEe
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 292 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 292 (536)
++|++.+.||+|+||.||+++++ +++.||+|++.... ....+.+.+|+++++.++||||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 46899999999999999999986 58899999986542 2335678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCC
Q 039168 293 YMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQ 372 (536)
Q Consensus 293 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 372 (536)
|++++++..+.. ....+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 154 (287)
T cd07848 81 YVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS 154 (287)
T ss_pred cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence 999987765542 2345899999999999999999999986 9999999999999999999999999998764322
Q ss_pred CccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHH----------HHHhh-c
Q 039168 373 NQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYT----------WKLWC-E 441 (536)
Q Consensus 373 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~----------~~~~~-~ 441 (536)
.. ......|++.|+|||++.+..++.++|||||||++|||++|+.||....... .+.... +..+. .
T Consensus 155 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 231 (287)
T cd07848 155 NA-NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEID--QLFTIQKVLGPLPAEQMKLFYSN 231 (287)
T ss_pred cc-cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhhCCCCHHHHHhhhcc
Confidence 21 2223568999999999999899999999999999999999999986432211 111000 00000 0
Q ss_pred CCccccccccccCC------CCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 442 GHAVELIDPVLKQS------CAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 442 ~~~~~l~~~~l~~~------~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
........+..... ........+.+++.+||+.||++|||++++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 232 PRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred chhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000000000000 00111235778888999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=325.28 Aligned_cols=257 Identities=31% Similarity=0.495 Sum_probs=204.6
Q ss_pred cCCccccccCCCCceeEEEEEeCC------CcEEEEEEccccC-hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEE
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLAD------GKAIAVKRLSRTS-GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELL 288 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 288 (536)
++|++.+.||+|+||.||+|.... ...||+|.+.... ......+.+|+.++++++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 478899999999999999998643 2579999986543 334567899999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhhcccC-------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCC
Q 039168 289 LIYEYMPNKSLDVHLFDATR-------------SVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDM 355 (536)
Q Consensus 289 lv~e~~~~~sL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~ 355 (536)
++|||+++++|.+++..... ...+++..++.++.||+.||.|||+++ ++|+||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 99999999999999865321 145888999999999999999999996 99999999999999999
Q ss_pred CeEEecccCccccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHH
Q 039168 356 NPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTY 434 (536)
Q Consensus 356 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~ 434 (536)
.++|+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..||...... ...
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~---~~~-- 236 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ---EVI-- 236 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH---HHH--
Confidence 999999999986543332222333456789999999998899999999999999999998 99887543221 111
Q ss_pred HHHHhhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcc
Q 039168 435 TWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 491 (536)
Q Consensus 435 ~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 491 (536)
..+..+.... .+......+.+|+.+||+.||.+|||+.+|++.|++
T Consensus 237 --~~i~~~~~~~---------~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 237 --EMIRSRQLLP---------CPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred --HHHHcCCcCC---------CcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 1111221111 111223456677779999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=330.80 Aligned_cols=245 Identities=22% Similarity=0.252 Sum_probs=198.1
Q ss_pred cCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEE
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 291 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 291 (536)
++|++.+.||+|+||.||++..+ +++.||+|++.... ....+.+.+|+.++++++||||+++++++.++...++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36889999999999999999976 58999999986432 233466889999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCC
Q 039168 292 EYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGN 371 (536)
Q Consensus 292 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 371 (536)
||+.+++|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~ 154 (291)
T cd05612 81 EYVPGGELFSYLRNS---GRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR 154 (291)
T ss_pred eCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence 999999999998543 35889999999999999999999997 999999999999999999999999999865432
Q ss_pred CCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcccccccc
Q 039168 372 QNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPV 451 (536)
Q Consensus 372 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 451 (536)
.....|++.|+|||++.+..++.++|||||||++|+|++|+.||...... ... ........ .
T Consensus 155 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~------~~~-~~i~~~~~-~----- 216 (291)
T cd05612 155 -----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF------GIY-EKILAGKL-E----- 216 (291)
T ss_pred -----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHH-HHHHhCCc-C-----
Confidence 22356899999999999989999999999999999999999997542211 111 11111110 0
Q ss_pred ccCCCCHHHHHHHHHHHHhhcCCCCCCCCC-----HHHHHHH
Q 039168 452 LKQSCAPDELLKFIHIGLLCVQQDPADRPT-----MSSVVVM 488 (536)
Q Consensus 452 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~ 488 (536)
+.... ...+.+++.+||+.||.+||+ ++++++.
T Consensus 217 ~~~~~----~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 217 FPRHL----DLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred CCccC----CHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 11111 234566777999999999995 8888754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=317.13 Aligned_cols=265 Identities=25% Similarity=0.331 Sum_probs=203.8
Q ss_pred hcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccCh--hhHHHHHHHHHHHHHcCCCC-ceeEeeEEeeCc-----
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG--QGLKEFKNEVNLIAKLQHKN-LVRLLGCCLEGQ----- 285 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpn-iv~l~~~~~~~~----- 285 (536)
...|+.+++||+|+||+||+|+.+ +|+.||+|++..... .......+|+.+|++|+|+| |+++++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 346778889999999999999975 689999999976543 23456789999999999999 999999999877
Q ss_pred -eEEEEEeecCCCChhhhhhcccCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEeccc
Q 039168 286 -ELLLIYEYMPNKSLDVHLFDATRS-VQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFG 363 (536)
Q Consensus 286 -~~~lv~e~~~~~sL~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg 363 (536)
.+++|+||+ ..+|..++...... ..++...+..++.||+.||+|||+++ |+||||||+||||++.|.+||+|||
T Consensus 90 ~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 90 GKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred ceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccc
Confidence 899999999 55788888664432 34777889999999999999999997 9999999999999999999999999
Q ss_pred CccccCCCCCccccccccccccccCcchhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcC
Q 039168 364 TARIFGGNQNQANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEG 442 (536)
Q Consensus 364 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 442 (536)
+|+.+.-.... ....++|.+|.|||++.+. .|+..+||||+|||+.||++++..|..... .+....+......+
T Consensus 166 lAra~~ip~~~--yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se---~~ql~~If~~lGtP 240 (323)
T KOG0594|consen 166 LARAFSIPMRT--YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE---IDQLFRIFRLLGTP 240 (323)
T ss_pred hHHHhcCCccc--ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH---HHHHHHHHHHcCCC
Confidence 99976533322 3335689999999999987 699999999999999999999988765433 22222222222211
Q ss_pred ---Ccccc-----ccccccCCC-----CH---HHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 443 ---HAVEL-----IDPVLKQSC-----AP---DELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 443 ---~~~~l-----~~~~l~~~~-----~~---~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
.+... .+....... .. ....+.++++.+||+.+|.+|.|+..+|+.
T Consensus 241 ~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 241 NEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 11111 111111100 00 111367788889999999999999999986
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=327.09 Aligned_cols=261 Identities=23% Similarity=0.311 Sum_probs=196.2
Q ss_pred cCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC-hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEee
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 293 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 293 (536)
++|++.++||+|+||.||+|..+ +++.||+|++.... ......+.+|+.++++++||||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 57999999999999999999875 58999999986443 22345678899999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCC
Q 039168 294 MPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQN 373 (536)
Q Consensus 294 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 373 (536)
+++ +|..++... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 85 ~~~-~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~ 158 (288)
T cd07871 85 LDS-DLKQYLDNC--GNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK 158 (288)
T ss_pred CCc-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence 975 787777432 234788999999999999999999996 99999999999999999999999999976543221
Q ss_pred ccccccccccccccCcchhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcC--------C-
Q 039168 374 QANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEG--------H- 443 (536)
Q Consensus 374 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--------~- 443 (536)
......+++.|+|||++.+ ..++.++|||||||++|+|++|+.||....... ............ .
T Consensus 159 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07871 159 --TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKE---ELHLIFRLLGTPTEETWPGITS 233 (288)
T ss_pred --cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCChHHhhcccc
Confidence 1223467899999999876 468999999999999999999999986432211 111111110000 0
Q ss_pred ---ccccccccccCCC----CHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 444 ---AVELIDPVLKQSC----APDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 444 ---~~~l~~~~l~~~~----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
......+...... .+....++++++.+||+.||.+|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 234 NEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred chhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0000000000000 0011234667788999999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=336.16 Aligned_cols=193 Identities=23% Similarity=0.284 Sum_probs=166.8
Q ss_pred hcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEee
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 293 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 293 (536)
..+|++.+.||+|+||.||++.+. .++.||+|+... ..+.+|++++++++||||+++++++..+...++|+|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 367999999999999999999975 588999997542 3567899999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCC
Q 039168 294 MPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQN 373 (536)
Q Consensus 294 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 373 (536)
+. ++|..++... ..+++.+++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 165 ~~-~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~ 237 (391)
T PHA03212 165 YK-TDLYCYLAAK---RNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA 237 (391)
T ss_pred CC-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccccccc
Confidence 95 5777776432 34889999999999999999999996 99999999999999999999999999975432211
Q ss_pred ccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCC
Q 039168 374 QANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNG 421 (536)
Q Consensus 374 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~ 421 (536)
.......||+.|+|||++.+..++.++|||||||++|||++|+.|+-
T Consensus 238 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~ 284 (391)
T PHA03212 238 -NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLF 284 (391)
T ss_pred -cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcC
Confidence 12223579999999999999999999999999999999999998753
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=324.58 Aligned_cols=257 Identities=29% Similarity=0.458 Sum_probs=204.4
Q ss_pred cCCccccccCCCCceeEEEEEeCC------CcEEEEEEccccChh-hHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEE
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLAD------GKAIAVKRLSRTSGQ-GLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELL 288 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 288 (536)
++|.+.+.||+|+||.||+|...+ ++.||+|++...... ..+.+.+|+++++.++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 568889999999999999998633 478999998765444 4578999999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhhccc-----------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCe
Q 039168 289 LIYEYMPNKSLDVHLFDAT-----------RSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNP 357 (536)
Q Consensus 289 lv~e~~~~~sL~~~l~~~~-----------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~ 357 (536)
+||||+++++|..++.... ....+++..+..++.||+.||.|||+++ ++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeE
Confidence 9999999999999986432 2345788999999999999999999997 9999999999999999999
Q ss_pred EEecccCccccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHHH
Q 039168 358 KISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTW 436 (536)
Q Consensus 358 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~ 436 (536)
||+|||++................+++.|+|||++.+..++.++||||||+++|||++ |..||...... ....
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~---~~~~--- 235 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE---EVIE--- 235 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH---HHHH---
Confidence 9999999976543322222223345788999999999999999999999999999998 99987533221 1111
Q ss_pred HHhhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcc
Q 039168 437 KLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 491 (536)
Q Consensus 437 ~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 491 (536)
....+..... +......+.+++.+||+.||++|||+.||++.|++
T Consensus 236 -~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 236 -CITQGRLLQR---------PRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred -HHHcCCcCCC---------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 1111111111 01122346677779999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=333.95 Aligned_cols=241 Identities=24% Similarity=0.263 Sum_probs=192.8
Q ss_pred cccCCCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEeecCCC
Q 039168 222 NKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNK 297 (536)
Q Consensus 222 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~~ 297 (536)
+.||+|+||.||++..+ +++.||||++.... ......+.+|+.++++++||||+++++++...+..++||||+.++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999875 68999999987532 234456788999999999999999999999999999999999999
Q ss_pred ChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCCcccc
Q 039168 298 SLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANT 377 (536)
Q Consensus 298 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 377 (536)
+|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~--~~~ 152 (323)
T cd05571 81 ELFFHLSR---ERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG--ATM 152 (323)
T ss_pred cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC--Ccc
Confidence 99888854 345899999999999999999999997 9999999999999999999999999987532211 122
Q ss_pred ccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccccccCCCC
Q 039168 378 NIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQSCA 457 (536)
Q Consensus 378 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~ 457 (536)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .... . ...... .+...
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~---~~~~---~-~~~~~~------~~p~~-- 217 (323)
T cd05571 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KLFE---L-ILMEEI------RFPRT-- 217 (323)
T ss_pred cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH---HHHH---H-HHcCCC------CCCCC--
Confidence 3457999999999999999999999999999999999999997532211 1111 1 111110 11111
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHH
Q 039168 458 PDELLKFIHIGLLCVQQDPADRP-----TMSSVVV 487 (536)
Q Consensus 458 ~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 487 (536)
....+.+++.+||+.||++|| ++.++++
T Consensus 218 --~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 218 --LSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred --CCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 123455667799999999999 7999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=321.92 Aligned_cols=255 Identities=31% Similarity=0.488 Sum_probs=208.1
Q ss_pred hcCCccccccCCCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEeec
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 294 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 294 (536)
..+|++.++||.|+||.||+|.+.+++.+++|.+........+.+.+|+.+++.++||||+++++++......++||||+
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM 84 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence 46789999999999999999999889999999998776656778999999999999999999999999999999999999
Q ss_pred CCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCCc
Q 039168 295 PNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQ 374 (536)
Q Consensus 295 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 374 (536)
++++|.+++.+.. ...+++..++.++.||+.||.|||+++ ++|+||||+||++++++.+||+|||++.........
T Consensus 85 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~ 160 (261)
T cd05148 85 EKGSLLAFLRSPE-GQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL 160 (261)
T ss_pred ccCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCcccc
Confidence 9999999996533 345899999999999999999999997 999999999999999999999999999876432211
Q ss_pred cccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHHHHHhhcCCcccccccccc
Q 039168 375 ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLK 453 (536)
Q Consensus 375 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~ 453 (536)
. ....++..|+|||.+.+..++.++||||||+++|+|++ |+.||..... ...... ...+....
T Consensus 161 ~--~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~---~~~~~~----~~~~~~~~------- 224 (261)
T cd05148 161 S--SDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN---HEVYDQ----ITAGYRMP------- 224 (261)
T ss_pred c--cCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH---HHHHHH----HHhCCcCC-------
Confidence 1 12335678999999998889999999999999999998 8888754321 111111 11111100
Q ss_pred CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcc
Q 039168 454 QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 491 (536)
Q Consensus 454 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 491 (536)
.+......+.+++.+||+.||++|||+.++++.|+.
T Consensus 225 --~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 225 --CPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred --CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 111222446677789999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=324.85 Aligned_cols=263 Identities=22% Similarity=0.298 Sum_probs=194.9
Q ss_pred hcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccCh-hhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEe
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG-QGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 292 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 292 (536)
.++|++.++||+|+||.||+|+.+ +++.||||++..... .....+.+|+.+++.++||||+++++++.+....++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 368999999999999999999986 689999999875432 223467789999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCC
Q 039168 293 YMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQ 372 (536)
Q Consensus 293 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 372 (536)
|+. ++|..++... ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 84 ~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 84 YVH-TDLCQYMDKH--PGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS 157 (303)
T ss_pred CCC-cCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence 996 5666666432 345888999999999999999999997 9999999999999999999999999997543222
Q ss_pred CccccccccccccccCcchhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCC---ccc--
Q 039168 373 NQANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGH---AVE-- 446 (536)
Q Consensus 373 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~-- 446 (536)
. ......|++.|+|||++.+. .++.++|||||||++|+|++|+.||....... .............. +..
T Consensus 158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 233 (303)
T cd07869 158 H--TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQ--DQLERIFLVLGTPNEDTWPGVH 233 (303)
T ss_pred c--cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHH--HHHHHHHHHhCCCChhhccchh
Confidence 1 12234678999999998764 58899999999999999999999986432211 11111111110000 000
Q ss_pred ---cccc-ccc---CCCCHH------HHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 447 ---LIDP-VLK---QSCAPD------ELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 447 ---l~~~-~l~---~~~~~~------~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
...+ ... ...... ....+.+++.+||+.||++|||+.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 234 SLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred hccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 0000 000 000000 1134567777999999999999999985
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=332.30 Aligned_cols=245 Identities=23% Similarity=0.295 Sum_probs=198.2
Q ss_pred cCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEE
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 291 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 291 (536)
++|++.+.||+|+||.||+|+++ +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 57899999999999999999976 58999999986532 233467889999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCC
Q 039168 292 EYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGN 371 (536)
Q Consensus 292 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 371 (536)
||+.+++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 98 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 98 EFVVGGELFTHLRKA---GRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred cCCCCChHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 999999999988543 35889999999999999999999996 999999999999999999999999999866432
Q ss_pred CCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcccccccc
Q 039168 372 QNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPV 451 (536)
Q Consensus 372 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 451 (536)
. ....||+.|+|||++.+..++.++|||||||++|+|++|+.||..... .. .......+.. .
T Consensus 172 ~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~------~~-~~~~i~~~~~-~----- 233 (329)
T PTZ00263 172 T-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP------FR-IYEKILAGRL-K----- 233 (329)
T ss_pred c-----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH------HH-HHHHHhcCCc-C-----
Confidence 1 235689999999999999999999999999999999999999753211 11 1111111111 1
Q ss_pred ccCCCCHHHHHHHHHHHHhhcCCCCCCCCC-----HHHHHHH
Q 039168 452 LKQSCAPDELLKFIHIGLLCVQQDPADRPT-----MSSVVVM 488 (536)
Q Consensus 452 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~ 488 (536)
+.. ..+ ..+.+++.+||+.||.+||+ +.++++.
T Consensus 234 ~p~-~~~---~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 234 FPN-WFD---GRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred CCC-CCC---HHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 011 112 23556677999999999997 6777743
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=300.55 Aligned_cols=249 Identities=26% Similarity=0.369 Sum_probs=205.6
Q ss_pred hcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEE
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 290 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 290 (536)
.++|++++.||+|.||.||.|+.+ ++-.||+|++.+.. .....++++|+++-+.|+||||++++++|.+....||+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 368999999999999999999865 57889999987653 23356789999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCC
Q 039168 291 YEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGG 370 (536)
Q Consensus 291 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 370 (536)
+||..+|++...|.+. ....+++...+.++.|++.||.|+|... +|||||||+|+|++..+.+||+|||.+..-.
T Consensus 101 lEya~~gel~k~L~~~-~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p- 175 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEG-RMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP- 175 (281)
T ss_pred EEecCCchHHHHHHhc-ccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC-
Confidence 9999999999999643 3455899999999999999999999985 9999999999999999999999999987532
Q ss_pred CCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccc
Q 039168 371 NQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDP 450 (536)
Q Consensus 371 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 450 (536)
.....+.+||..|++||+..+..++..+|+|++|++.||++.|.+||..... ......+.+. .+..
T Consensus 176 ---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~---~etYkrI~k~-------~~~~- 241 (281)
T KOG0580|consen 176 ---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSH---SETYKRIRKV-------DLKF- 241 (281)
T ss_pred ---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhh---HHHHHHHHHc-------cccC-
Confidence 3334568999999999999999999999999999999999999999875431 1111111111 1111
Q ss_pred cccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 451 VLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 451 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
++.......++|..|+.++|.+|.+..+++..
T Consensus 242 ------p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 242 ------PSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred ------CcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 12223345667779999999999999999863
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=347.19 Aligned_cols=252 Identities=19% Similarity=0.222 Sum_probs=202.8
Q ss_pred CCccccccCCCCceeEEEEEeC-C-CcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEeec
Q 039168 217 HFSDENKLGQGGFGPVYKGTLA-D-GKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 294 (536)
Q Consensus 217 ~~~~~~~lg~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 294 (536)
.|.+.+.||+|++|.||+|... + ++.||+|++..........+++|+.+|+.++||||+++++++..++..++||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 4888999999999999999864 3 6788999876666555667889999999999999999999999999999999999
Q ss_pred CCCChhhhhhcc-cCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCC
Q 039168 295 PNKSLDVHLFDA-TRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQN 373 (536)
Q Consensus 295 ~~~sL~~~l~~~-~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 373 (536)
++++|.+++... .....+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 999999888643 23446889999999999999999999986 99999999999999999999999999987654333
Q ss_pred ccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcccccccccc
Q 039168 374 QANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLK 453 (536)
Q Consensus 374 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~ 453 (536)
........||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ........ .+.... ..
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~------~~~~~~~~-~~~~~~-----~~ 292 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ------REIMQQVL-YGKYDP-----FP 292 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHH-hCCCCC-----CC
Confidence 2333446799999999999999999999999999999999999999753211 11111111 111111 01
Q ss_pred CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 454 QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 454 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
......+.+++.+||+.||++|||+.+++.
T Consensus 293 ----~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 293 ----CPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred ----ccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 111234666777999999999999999874
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-41 Score=302.46 Aligned_cols=265 Identities=24% Similarity=0.292 Sum_probs=208.5
Q ss_pred HhcCCccccccCCCCceeEEEEE-eCCCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeC-----ceE
Q 039168 214 ATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEG-----QEL 287 (536)
Q Consensus 214 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-----~~~ 287 (536)
..++|++.+.||+|||+-||.++ ..+++.||+|++...+.++.+...+|++..++++|||+++++++...+ ...
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 45789999999999999999998 456899999999988888889999999999999999999999886543 359
Q ss_pred EEEEeecCCCChhhhhhcccCCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCcc
Q 039168 288 LLIYEYMPNKSLDVHLFDATRSV-QLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTAR 366 (536)
Q Consensus 288 ~lv~e~~~~~sL~~~l~~~~~~~-~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 366 (536)
|++++|...|+|.+.+......+ .+++.+++.|+.+|++||++||+.. .++.||||||.|||+.+.+.++|.|||.+.
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCcc
Confidence 99999999999999987654444 7999999999999999999999984 479999999999999999999999999987
Q ss_pred ccCCCCCccc-------cccccccccccCcchhc---CCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHH
Q 039168 367 IFGGNQNQAN-------TNIIAGTYGYMAPEYAM---GGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTW 436 (536)
Q Consensus 367 ~~~~~~~~~~-------~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~ 436 (536)
...-.-.... .....-|..|.|||++. +...+.++|||||||+||+|+.|..||+......+...+.
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLA--- 254 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALA--- 254 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEe---
Confidence 5421111000 00123478999999985 4557999999999999999999999987644422221111
Q ss_pred HHhhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 437 KLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 437 ~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
.....+.....+.....+.+++.+||+.||.+||++.+++..+...
T Consensus 255 ----------v~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 255 ----------VQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred ----------eeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 1111111111112344566677799999999999999999988753
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=345.04 Aligned_cols=257 Identities=26% Similarity=0.314 Sum_probs=205.8
Q ss_pred hcCCccccccCCCCceeEEEEEeCCC-cEEEEEEccccChhhHHHHHHHHHHHHHcC-CCCceeEeeEE-ee------Cc
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLADG-KAIAVKRLSRTSGQGLKEFKNEVNLIAKLQ-HKNLVRLLGCC-LE------GQ 285 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~-~~------~~ 285 (536)
..+.++.+.|.+|||+.||.|++..+ ..||+|++...+....+.+.+|+++|++|+ |+|||.+++.. .. .-
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence 35678899999999999999998765 999999998888889999999999999997 99999999932 21 24
Q ss_pred eEEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCc
Q 039168 286 ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTA 365 (536)
Q Consensus 286 ~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 365 (536)
+++|.||||+||.|-++|....... |.+.++++|+.|+++|+.+||.. ..+|||||||-+||||+.+|+.||||||.+
T Consensus 116 EvllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSa 193 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSA 193 (738)
T ss_pred EEEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCccccc
Confidence 6899999999999999996544433 99999999999999999999998 478999999999999999999999999998
Q ss_pred cccCCCC-Ccccc------ccccccccccCcchh---cCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHH
Q 039168 366 RIFGGNQ-NQANT------NIIAGTYGYMAPEYA---MGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYT 435 (536)
Q Consensus 366 ~~~~~~~-~~~~~------~~~~gt~~y~aPE~~---~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~ 435 (536)
.-.-... ..... -....|+.|+|||++ .+..+++|+|||+|||+||-|+....||+....-
T Consensus 194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l--------- 264 (738)
T KOG1989|consen 194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL--------- 264 (738)
T ss_pred ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce---------
Confidence 6332111 11100 012358999999988 5778999999999999999999999998643111
Q ss_pred HHHhhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 436 WKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 436 ~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
.+++-...-.-.+.....+.+||..||+.||++||++-+|+..+...
T Consensus 265 ----------aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l 311 (738)
T KOG1989|consen 265 ----------AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFEL 311 (738)
T ss_pred ----------eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHH
Confidence 11111111111244566777888899999999999999999877653
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=324.47 Aligned_cols=260 Identities=28% Similarity=0.431 Sum_probs=208.7
Q ss_pred cCCccccccCCCCceeEEEEEeC------CCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEE
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 289 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 289 (536)
.+|.+.+.||+|+||.||++... ++..+++|.+........+.+.+|++++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 46888899999999999999742 356789999877666666789999999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhccc-------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCC
Q 039168 290 IYEYMPNKSLDVHLFDAT-------------RSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMN 356 (536)
Q Consensus 290 v~e~~~~~sL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~ 356 (536)
||||+++++|.+++.... ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 999999999999986532 1234889999999999999999999997 999999999999999999
Q ss_pred eEEecccCccccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHH
Q 039168 357 PKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYT 435 (536)
Q Consensus 357 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~ 435 (536)
++|+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |+.||...... . .
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~---~----~ 234 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT---E----V 234 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---H----H
Confidence 99999999986544332222233456788999999999999999999999999999999 99887543221 1 1
Q ss_pred HHHhhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccCCC
Q 039168 436 WKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSM 494 (536)
Q Consensus 436 ~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 494 (536)
......+...+.. ......+.+++.+||+.||++|||+.+|+++|+....
T Consensus 235 ~~~~~~~~~~~~~---------~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 235 IECITQGRVLERP---------RVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred HHHHhCCCCCCCC---------ccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 1122222222211 1112346677779999999999999999999998744
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=317.10 Aligned_cols=252 Identities=27% Similarity=0.414 Sum_probs=200.7
Q ss_pred cCCccccccCCCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEeecC
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMP 295 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 295 (536)
++|++.+.||+|+||.||++.++++..+|+|.+.... ...+.+.+|+.++++++||||+++++++......++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 4688899999999999999999888899999886432 234678899999999999999999999999999999999999
Q ss_pred CCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCCcc
Q 039168 296 NKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQA 375 (536)
Q Consensus 296 ~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 375 (536)
+++|.+++.... ..+++..+..++.|++.||.|||+++ ++|+||||+||++++++.+||+|||.++.........
T Consensus 83 ~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05114 83 NGCLLNYLRQRQ--GKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS 157 (256)
T ss_pred CCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence 999999886432 35889999999999999999999996 9999999999999999999999999998654322211
Q ss_pred ccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHHHHHhhcCCccccccccccC
Q 039168 376 NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQ 454 (536)
Q Consensus 376 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~ 454 (536)
.....++..|+|||.+.+..++.++||||||+++|+|++ |+.||..... ...... ..++.... .+
T Consensus 158 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~---~~~~~~----i~~~~~~~--~~---- 223 (256)
T cd05114 158 -SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN---YEVVEM----ISRGFRLY--RP---- 223 (256)
T ss_pred -cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH---HHHHHH----HHCCCCCC--CC----
Confidence 112234568999999998889999999999999999999 8888743221 111111 11111110 11
Q ss_pred CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 039168 455 SCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLA 490 (536)
Q Consensus 455 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 490 (536)
... ...+.+++.+||+.+|++|||+.++++.|+
T Consensus 224 ~~~---~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 224 KLA---SMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred CCC---CHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 111 235677778999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=319.57 Aligned_cols=255 Identities=26% Similarity=0.383 Sum_probs=200.3
Q ss_pred hcCCccccccCCCCceeEEEEEeC----CCcEEEEEEccccC-hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEE
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA----DGKAIAVKRLSRTS-GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 289 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 289 (536)
.++|++.+.||+|+||.||+|.++ .+..||+|.+.... ......+.+|+.++++++||||+++++++..++..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 357889999999999999999753 36789999987543 3334578899999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccC
Q 039168 290 IYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFG 369 (536)
Q Consensus 290 v~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 369 (536)
||||+++++|..++... ...+++..++.++.||+.||+|||+++ ++||||||+|||++.++.++++|||.+....
T Consensus 84 v~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 84 VTEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDK 158 (266)
T ss_pred EEEeCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCccccccc
Confidence 99999999999998643 235899999999999999999999996 9999999999999999999999999876543
Q ss_pred CCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHHHHHhhcCCccccc
Q 039168 370 GNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELI 448 (536)
Q Consensus 370 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 448 (536)
.... .......++..|+|||.+.+..++.++||||||+++|||++ |+.||...... .... ...++....
T Consensus 159 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~---~~~~----~~~~~~~~~-- 228 (266)
T cd05064 159 SEAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ---DVIK----AVEDGFRLP-- 228 (266)
T ss_pred ccch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH---HHHH----HHHCCCCCC--
Confidence 2211 11112234678999999999999999999999999999775 99997543211 1111 111111111
Q ss_pred cccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcc
Q 039168 449 DPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 491 (536)
Q Consensus 449 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 491 (536)
. +......+.+++..||+.+|++|||+.+|++.|+.
T Consensus 229 ---~----~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~ 264 (266)
T cd05064 229 ---A----PRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSK 264 (266)
T ss_pred ---C----CCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHh
Confidence 1 11122346667779999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=327.04 Aligned_cols=199 Identities=28% Similarity=0.399 Sum_probs=174.4
Q ss_pred hcCCccccccCCCCceeEEEEEeC-CCcEEEEEEcccc-ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEe
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT-SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 292 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 292 (536)
.++|++.++||+|+||.||++.++ ++..+|+|++... .....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 368999999999999999999976 5888999988654 33345678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCC
Q 039168 293 YMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQ 372 (536)
Q Consensus 293 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 372 (536)
|+.+++|.+++... ..+++..+..++.|++.||.|||+.+ +++|+||||+|||+++++.+||+|||++..+....
T Consensus 84 ~~~~~~L~~~l~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~ 158 (333)
T cd06650 84 HMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 158 (333)
T ss_pred cCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc
Confidence 99999999998543 34889999999999999999999753 49999999999999999999999999997653221
Q ss_pred CccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCC
Q 039168 373 NQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF 422 (536)
Q Consensus 373 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~ 422 (536)
.....|+..|+|||++.+..++.++|||||||++|+|++|+.||..
T Consensus 159 ----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~ 204 (333)
T cd06650 159 ----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP 204 (333)
T ss_pred ----cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 1234689999999999998899999999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=322.33 Aligned_cols=260 Identities=28% Similarity=0.482 Sum_probs=206.8
Q ss_pred hcCCccccccCCCCceeEEEEEeC------CCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEE
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELL 288 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 288 (536)
.++|.+.+.||+|+||.||++... ++..+|+|.+........+.+.+|++++++++||||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 357889999999999999999742 34668999988766666778999999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhhccc----------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeE
Q 039168 289 LIYEYMPNKSLDVHLFDAT----------RSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPK 358 (536)
Q Consensus 289 lv~e~~~~~sL~~~l~~~~----------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~k 358 (536)
+||||+++++|.+++.... ....+++..++.++.||+.||+|||+++ ++||||||+|||+++++.+|
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEE
Confidence 9999999999999986432 2234899999999999999999999987 99999999999999999999
Q ss_pred EecccCccccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHHHH
Q 039168 359 ISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWK 437 (536)
Q Consensus 359 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~ 437 (536)
|+|||+++...............++..|+|||++.+..++.++||||||+++|+|++ |..||...... .. ..
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~---~~----~~ 233 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN---EV----IE 233 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HH----HH
Confidence 999999986643332222223345778999999998899999999999999999998 88886432211 11 11
Q ss_pred HhhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccCC
Q 039168 438 LWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDS 493 (536)
Q Consensus 438 ~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 493 (536)
....+..... .... ...+.+++.+||+.||.+|||+.+++..|+...
T Consensus 234 ~i~~~~~~~~-----~~~~----~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~ 280 (288)
T cd05093 234 CITQGRVLQR-----PRTC----PKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA 280 (288)
T ss_pred HHHcCCcCCC-----CCCC----CHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 1122221111 1111 234677778999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=335.85 Aligned_cols=260 Identities=29% Similarity=0.390 Sum_probs=203.5
Q ss_pred hcCCccccccCCCCceeEEEEEeC------CCcEEEEEEccccC-hhhHHHHHHHHHHHHHcC-CCCceeEeeEEeeCce
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRTS-GQGLKEFKNEVNLIAKLQ-HKNLVRLLGCCLEGQE 286 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~ 286 (536)
.++|.+.++||+|+||.||+|++. .+..||||++.... ....+.+.+|+++|+++. ||||+++++++.+...
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 468899999999999999999853 23579999997543 333567899999999996 9999999999999999
Q ss_pred EEEEEeecCCCChhhhhhcccC----------------------------------------------------------
Q 039168 287 LLLIYEYMPNKSLDVHLFDATR---------------------------------------------------------- 308 (536)
Q Consensus 287 ~~lv~e~~~~~sL~~~l~~~~~---------------------------------------------------------- 308 (536)
.++||||+++|+|.+++.....
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 9999999999999988864211
Q ss_pred -----------------------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcC
Q 039168 309 -----------------------------------SVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDD 353 (536)
Q Consensus 309 -----------------------------------~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~ 353 (536)
...+++..++.++.||++||.|||+.+ |+|+||||+|||++.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEeC
Confidence 124778888999999999999999986 999999999999999
Q ss_pred CCCeEEecccCccccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhH
Q 039168 354 DMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLL 432 (536)
Q Consensus 354 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~ 432 (536)
++.+||+|||+++.+.............+++.|+|||.+.+..++.++||||||+++|||++ |..||....... .
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~--~-- 348 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS--T-- 348 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH--H--
Confidence 99999999999987643332222233456788999999999899999999999999999997 888875432111 1
Q ss_pred HHHHHHhhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 433 TYTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 433 ~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
.......+.... . .......+.+++.+||+.||++|||+.+|.++|+..
T Consensus 349 --~~~~~~~~~~~~-----~----~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l 397 (400)
T cd05105 349 --FYNKIKSGYRMA-----K----PDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL 397 (400)
T ss_pred --HHHHHhcCCCCC-----C----CccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHH
Confidence 111111111111 0 111234566777899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=316.72 Aligned_cols=255 Identities=32% Similarity=0.477 Sum_probs=203.6
Q ss_pred hcCCccccccCCCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEeec
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 294 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 294 (536)
.++|++.+.||+|++|.||+|.+.+++.||+|.+.... ...+.+.+|+.++++++||||+++++++...+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 35789999999999999999998778899999987543 23567889999999999999999999999999999999999
Q ss_pred CCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCCc
Q 039168 295 PNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQ 374 (536)
Q Consensus 295 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 374 (536)
.+++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||+++........
T Consensus 84 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05068 84 KYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE 159 (261)
T ss_pred cCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence 9999999986533 345899999999999999999999997 999999999999999999999999999877532211
Q ss_pred cccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHHHHHhhcCCcccccccccc
Q 039168 375 ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLK 453 (536)
Q Consensus 375 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~ 453 (536)
. ......+..|+|||.+.+..++.++||||||+++|+|++ |+.||..... .... .........
T Consensus 160 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~----~~~~~~~~~-------- 223 (261)
T cd05068 160 A-REGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN---AEVL----QQVDQGYRM-------- 223 (261)
T ss_pred c-cCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH---HHHH----HHHHcCCCC--------
Confidence 1 111223457999999998899999999999999999999 8888753211 1111 111111100
Q ss_pred CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcc
Q 039168 454 QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 491 (536)
Q Consensus 454 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 491 (536)
.........+.+++.+||+.+|++||++.+|++.|+.
T Consensus 224 -~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 224 -PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred -CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 0011123456777789999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=331.19 Aligned_cols=248 Identities=27% Similarity=0.394 Sum_probs=192.7
Q ss_pred cCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC-hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEee
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 293 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 293 (536)
++|+..++||+|+||.||++++. +++.||||++.... ....+.+.+|+++++.++|+||+++++++..++.+++||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 56788899999999999999975 58999999986543 33456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCC
Q 039168 294 MPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQN 373 (536)
Q Consensus 294 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 373 (536)
+++++|.... ...+..+..++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+++.+.....
T Consensus 154 ~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~ 223 (353)
T PLN00034 154 MDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD 223 (353)
T ss_pred CCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecccccc
Confidence 9999986432 2567788899999999999999996 99999999999999999999999999987643221
Q ss_pred ccccccccccccccCcchhcC-----CCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccc
Q 039168 374 QANTNIIAGTYGYMAPEYAMG-----GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELI 448 (536)
Q Consensus 374 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 448 (536)
......||..|+|||++.. ...+.++|||||||++|||++|+.||....... ......... ......
T Consensus 224 --~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~---~~~~~~~~~-~~~~~~-- 295 (353)
T PLN00034 224 --PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD---WASLMCAIC-MSQPPE-- 295 (353)
T ss_pred --cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc---HHHHHHHHh-ccCCCC--
Confidence 1223568999999998743 234578999999999999999999986322111 111111110 000000
Q ss_pred cccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 449 DPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 449 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
.......++.+++.+||+.||++|||+.|+++.
T Consensus 296 -------~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 296 -------APATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred -------CCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111222346677779999999999999999964
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=320.45 Aligned_cols=259 Identities=27% Similarity=0.433 Sum_probs=201.4
Q ss_pred HhcCCccccccCCCCceeEEEEEeC------CCcEEEEEEccccC-hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCce
Q 039168 214 ATNHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRTS-GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQE 286 (536)
Q Consensus 214 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 286 (536)
..++|++.+.||+|+||.||+|.+. .+..||+|++.... ......+.+|+.+++.++||||+++++++.+...
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 3578999999999999999998753 25679999986432 2344568899999999999999999999999999
Q ss_pred EEEEEeecCCCChhhhhhcccC-------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEE
Q 039168 287 LLLIYEYMPNKSLDVHLFDATR-------SVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKI 359 (536)
Q Consensus 287 ~~lv~e~~~~~sL~~~l~~~~~-------~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl 359 (536)
.++||||+.+++|.+++..... ...+++..+..++.|+++||.|||+.+ ++|+||||+||++++++.++|
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 9999999999999999865321 224678889999999999999999986 999999999999999999999
Q ss_pred ecccCccccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHHHHH
Q 039168 360 SDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKL 438 (536)
Q Consensus 360 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 438 (536)
+|||+++...............+++.|+|||++.+..++.++||||||+++|||++ |..||...... . ....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~---~----~~~~ 233 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE---Q----VLRF 233 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---H----HHHH
Confidence 99999986543332222222345778999999999889999999999999999999 67776432211 1 1111
Q ss_pred hhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcc
Q 039168 439 WCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 491 (536)
Q Consensus 439 ~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 491 (536)
..+...... ... . ...+.+++.+||+.||++|||+.|+++.|+.
T Consensus 234 ~~~~~~~~~-----~~~-~---~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 234 VMEGGLLDK-----PDN-C---PDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred HHcCCcCCC-----CCC-C---CHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 111111111 111 1 2346677779999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=325.70 Aligned_cols=252 Identities=24% Similarity=0.326 Sum_probs=196.1
Q ss_pred CCccccccCCCCceeEEEEEeC----CCcEEEEEEcccc----ChhhHHHHHHHHHHHHHc-CCCCceeEeeEEeeCceE
Q 039168 217 HFSDENKLGQGGFGPVYKGTLA----DGKAIAVKRLSRT----SGQGLKEFKNEVNLIAKL-QHKNLVRLLGCCLEGQEL 287 (536)
Q Consensus 217 ~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~ 287 (536)
+|++.++||+|+||.||+++.. +++.||+|++.+. .....+.+.+|+.+++.+ +||||+++++++..++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4788999999999999998753 5889999998643 223345678899999999 589999999999999999
Q ss_pred EEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccc
Q 039168 288 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARI 367 (536)
Q Consensus 288 ~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 367 (536)
++||||+++++|..++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQR---DNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 9999999999999988543 34899999999999999999999997 99999999999999999999999999986
Q ss_pred cCCCCCccccccccccccccCcchhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccc
Q 039168 368 FGGNQNQANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVE 446 (536)
Q Consensus 368 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 446 (536)
+...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.......... ... ......
T Consensus 155 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~--~~~-~~~~~~---- 226 (332)
T cd05614 155 FLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQS--EVS-RRILKC---- 226 (332)
T ss_pred ccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHH--HHH-HHHhcC----
Confidence 5432222 22235789999999999875 47899999999999999999999986433222111 111 111110
Q ss_pred cccccccCCCCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHHH
Q 039168 447 LIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRP-----TMSSVVVM 488 (536)
Q Consensus 447 l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 488 (536)
++.+... .+ ..+.+++.+||+.||++|| ++.++++.
T Consensus 227 --~~~~~~~-~~---~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 227 --DPPFPSF-IG---PEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred --CCCCCCC-CC---HHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 1111111 12 2355666799999999999 67777753
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=304.57 Aligned_cols=251 Identities=23% Similarity=0.292 Sum_probs=200.2
Q ss_pred HhcCCccccccCCCCceeEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEE
Q 039168 214 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 290 (536)
Q Consensus 214 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 290 (536)
+.+.|++.++||+|.|+.||++... +|+.+|+|++.-. +..+.+.+.+|+.|-+.|+||||+++.+.+.+....|||
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 4578899999999999999998764 6899999987532 344678899999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCC---CCeEEecccCccc
Q 039168 291 YEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDD---MNPKISDFGTARI 367 (536)
Q Consensus 291 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~---~~~kl~Dfg~a~~ 367 (536)
+|+|.|++|..-|... ..+++..+...++||++||.|+|.++ |||||+||+|+|+-.. .-+||+|||+|..
T Consensus 89 Fe~m~G~dl~~eIV~R---~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVAR---EFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred EecccchHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEE
Confidence 9999999997776433 45888999999999999999999997 9999999999999643 3589999999998
Q ss_pred cCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcccc
Q 039168 368 FGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVEL 447 (536)
Q Consensus 368 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 447 (536)
+++. .....++|||+|||||++....|+..+|||+.||+||-|+.|.+||-.. ....+.+.+.+ +...-
T Consensus 163 l~~g---~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~---~~~rlye~I~~----g~yd~- 231 (355)
T KOG0033|consen 163 VNDG---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE---DQHRLYEQIKA----GAYDY- 231 (355)
T ss_pred eCCc---cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCc---cHHHHHHHHhc----cccCC-
Confidence 8722 2233468999999999999999999999999999999999999996431 22222222221 11110
Q ss_pred ccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHH
Q 039168 448 IDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVV 486 (536)
Q Consensus 448 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl 486 (536)
.....+....+..+|+.+||..||.+|.|+.|.|
T Consensus 232 -----~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL 265 (355)
T KOG0033|consen 232 -----PSPEWDTVTPEAKSLIRRMLTVNPKKRITADEAL 265 (355)
T ss_pred -----CCcccCcCCHHHHHHHHHHhccChhhhccHHHHh
Confidence 1111111222344555699999999999999988
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=316.77 Aligned_cols=255 Identities=30% Similarity=0.444 Sum_probs=204.2
Q ss_pred hcCCccccccCCCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEeec
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 294 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 294 (536)
.++|++.++||+|+||.||+|...++..||+|.+.... ...+.+.+|+.+++.++||||+++++.+......+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 36789999999999999999998888899999886543 23578899999999999999999999999999999999999
Q ss_pred CCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCCc
Q 039168 295 PNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQ 374 (536)
Q Consensus 295 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 374 (536)
.+++|.+++.... ...+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||++.........
T Consensus 84 ~~~~L~~~l~~~~-~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05072 84 AKGSLLDFLKSDE-GGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT 159 (261)
T ss_pred CCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence 9999999986532 345888999999999999999999986 999999999999999999999999999876533221
Q ss_pred cccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHHHHHhhcCCcccccccccc
Q 039168 375 ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLK 453 (536)
Q Consensus 375 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~ 453 (536)
. .....++..|+|||.+.+..++.++||||||+++|+|++ |+.||...... ... .......... ..
T Consensus 160 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~---~~~----~~~~~~~~~~-----~~ 226 (261)
T cd05072 160 A-REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS---DVM----SALQRGYRMP-----RM 226 (261)
T ss_pred c-cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH---HHH----HHHHcCCCCC-----CC
Confidence 1 122345678999999998889999999999999999998 89887532211 111 1111111111 00
Q ss_pred CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcc
Q 039168 454 QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 491 (536)
Q Consensus 454 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 491 (536)
.. ....+.+++.+||+.+|++|||++++++.|+.
T Consensus 227 ~~----~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 227 EN----CPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred CC----CCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 11 12346677779999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=328.11 Aligned_cols=241 Identities=22% Similarity=0.281 Sum_probs=190.2
Q ss_pred cCCCCceeEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEeecCCCCh
Q 039168 224 LGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSL 299 (536)
Q Consensus 224 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~~sL 299 (536)
||+|+||.||++++. +++.||+|++... .......+.+|+.++++++||||+++++++...+..++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999976 4889999998643 233456778899999999999999999999999999999999999999
Q ss_pred hhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCCcccccc
Q 039168 300 DVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNI 379 (536)
Q Consensus 300 ~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 379 (536)
..++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~ 152 (312)
T cd05585 81 FHHLQRE---GRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNT 152 (312)
T ss_pred HHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Ccccc
Confidence 9988543 35899999999999999999999996 9999999999999999999999999997543222 12234
Q ss_pred ccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccccccCCCCHH
Q 039168 380 IAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQSCAPD 459 (536)
Q Consensus 380 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~ 459 (536)
..||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ........ .... . +... .+
T Consensus 153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~------~~~~~~~~-~~~~-~-----~~~~-~~- 217 (312)
T cd05585 153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV------NEMYRKIL-QEPL-R-----FPDG-FD- 217 (312)
T ss_pred ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH------HHHHHHHH-cCCC-C-----CCCc-CC-
Confidence 5789999999999999999999999999999999999999753211 11111111 1110 0 1111 12
Q ss_pred HHHHHHHHHHhhcCCCCCCCCCHHHHHHHh
Q 039168 460 ELLKFIHIGLLCVQQDPADRPTMSSVVVML 489 (536)
Q Consensus 460 ~~~~l~~li~~cl~~dP~~RPt~~evl~~L 489 (536)
..+.+++.+||+.||++||++..+.+.|
T Consensus 218 --~~~~~li~~~L~~dp~~R~~~~~~~e~l 245 (312)
T cd05585 218 --RDAKDLLIGLLSRDPTRRLGYNGAQEIK 245 (312)
T ss_pred --HHHHHHHHHHcCCCHHHcCCCCCHHHHH
Confidence 3455666799999999998654444433
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=320.20 Aligned_cols=257 Identities=30% Similarity=0.474 Sum_probs=201.7
Q ss_pred cCCccccccCCCCceeEEEEEe-----CCCcEEEEEEcccc-ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEE
Q 039168 216 NHFSDENKLGQGGFGPVYKGTL-----ADGKAIAVKRLSRT-SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 289 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 289 (536)
++|++.+.||+|+||.||+|.. ..+..|++|.+... .......+.+|+.+++.++||||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4688889999999999999984 24678999998753 33445678899999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhcccC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCC
Q 039168 290 IYEYMPNKSLDVHLFDATR--------------SVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDM 355 (536)
Q Consensus 290 v~e~~~~~sL~~~l~~~~~--------------~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~ 355 (536)
||||+.+++|.+++..... ...+++.++..++.|++.||.|||+++ ++|+||||+|||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 9999999999998853221 234788999999999999999999997 99999999999999999
Q ss_pred CeEEecccCccccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHH
Q 039168 356 NPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTY 434 (536)
Q Consensus 356 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~ 434 (536)
.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||..... .....
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~---~~~~~- 237 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN---QEVIE- 237 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH---HHHHH-
Confidence 999999999987643332222333445678999999998889999999999999999998 8888643211 11111
Q ss_pred HHHHhhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcc
Q 039168 435 TWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 491 (536)
Q Consensus 435 ~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 491 (536)
......... ..... + ..+.+++.+||+.||++||++.+|++.|.+
T Consensus 238 ---~~~~~~~~~-----~~~~~-~---~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 238 ---MVRKRQLLP-----CSEDC-P---PRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred ---HHHcCCcCC-----CCCCC-C---HHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 111111111 11111 2 345566679999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=313.85 Aligned_cols=248 Identities=29% Similarity=0.436 Sum_probs=194.6
Q ss_pred cccCCCCceeEEEEEeC-CCcEEEEEEcccc-ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEeecCCCCh
Q 039168 222 NKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT-SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSL 299 (536)
Q Consensus 222 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~~sL 299 (536)
+.||+|+||.||+|++. +++.||+|.+... ..+....+.+|++++++++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46999999999999975 6899999987654 334456789999999999999999999999999999999999999999
Q ss_pred hhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCCcccccc
Q 039168 300 DVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNI 379 (536)
Q Consensus 300 ~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 379 (536)
.+++... ...+++..++.++.|++.||.|||+++ ++|+||||+|||++.++.+||+|||++..............
T Consensus 81 ~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 155 (252)
T cd05084 81 LTFLRTE--GPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM 155 (252)
T ss_pred HHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence 9998542 235889999999999999999999997 99999999999999999999999999876543221111111
Q ss_pred ccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHHHHHhhcCCccccccccccCCCCH
Q 039168 380 IAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQSCAP 458 (536)
Q Consensus 380 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~ 458 (536)
...+..|+|||.+.+..++.++||||||+++|+|++ |..||...... . ............ .+.
T Consensus 156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~---~----~~~~~~~~~~~~---------~~~ 219 (252)
T cd05084 156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ---Q----TREAIEQGVRLP---------CPE 219 (252)
T ss_pred CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH---H----HHHHHHcCCCCC---------Ccc
Confidence 223457999999999899999999999999999998 88776432211 1 111111111001 111
Q ss_pred HHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 039168 459 DELLKFIHIGLLCVQQDPADRPTMSSVVVMLA 490 (536)
Q Consensus 459 ~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 490 (536)
.....+.+++.+||+.+|++|||+.+|+++|+
T Consensus 220 ~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 220 LCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 12235667777999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=329.76 Aligned_cols=242 Identities=24% Similarity=0.256 Sum_probs=193.1
Q ss_pred cccCCCCceeEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEeecCCC
Q 039168 222 NKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNK 297 (536)
Q Consensus 222 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~~ 297 (536)
+.||+|+||.||++... +++.||+|++.+. .......+.+|+.+++.++||||+++++++...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999875 5899999998753 2334567788999999999999999999999999999999999999
Q ss_pred ChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCCcccc
Q 039168 298 SLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANT 377 (536)
Q Consensus 298 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 377 (536)
+|..++... ..+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~ 152 (328)
T cd05593 81 ELFFHLSRE---RVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--ATM 152 (328)
T ss_pred CHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCcc--ccc
Confidence 998888543 35899999999999999999999996 9999999999999999999999999987532211 122
Q ss_pred ccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccccccCCCC
Q 039168 378 NIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQSCA 457 (536)
Q Consensus 378 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~ 457 (536)
....||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ....... ... ..+....
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~------~~~~~~~-~~~------~~~p~~~- 218 (328)
T cd05593 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------KLFELIL-MED------IKFPRTL- 218 (328)
T ss_pred ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH------HHHHHhc-cCC------ccCCCCC-
Confidence 3357899999999999999999999999999999999999998532211 1111111 000 0111111
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHHH
Q 039168 458 PDELLKFIHIGLLCVQQDPADRP-----TMSSVVVM 488 (536)
Q Consensus 458 ~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 488 (536)
..++.+++.+||+.||++|| ++.++++.
T Consensus 219 ---~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 219 ---SADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred ---CHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 23455666799999999997 89998854
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=331.29 Aligned_cols=263 Identities=22% Similarity=0.270 Sum_probs=206.1
Q ss_pred hcCCccccccCCCCceeEEEEEeCC--CcEEEEEEcccc---ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEE
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLAD--GKAIAVKRLSRT---SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 289 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 289 (536)
.++|++.+.||+|+||.||+|.+++ +..||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 3679999999999999999998643 468999998643 22345678899999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccC
Q 039168 290 IYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFG 369 (536)
Q Consensus 290 v~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 369 (536)
||||+.+++|..++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 109 v~Ey~~~g~L~~~i~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRRN---KRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred EEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence 99999999999998543 35899999999999999999999997 9999999999999999999999999998653
Q ss_pred CCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcccccc
Q 039168 370 GNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELID 449 (536)
Q Consensus 370 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 449 (536)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||...... . .......+.. .
T Consensus 183 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~------~-~~~~i~~~~~-~--- 246 (340)
T PTZ00426 183 TR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL------L-IYQKILEGII-Y--- 246 (340)
T ss_pred CC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH------H-HHHHHhcCCC-C---
Confidence 21 22357899999999999988999999999999999999999998532211 1 1111111111 0
Q ss_pred ccccCCCCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHHHh--ccC------CCCCCCCCCCCcc
Q 039168 450 PVLKQSCAPDELLKFIHIGLLCVQQDPADRP-----TMSSVVVML--ASD------SMTIPQPTEPAFS 505 (536)
Q Consensus 450 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~L--~~~------~~~~~~p~~p~~~ 505 (536)
.... .+ ..+.+++.+||+.||++|+ |++++++.- .+. ...++.|..|.+.
T Consensus 247 --~p~~-~~---~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~~~~~~~~~~~~~p~~~ 309 (340)
T PTZ00426 247 --FPKF-LD---NNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWVSLLHKNVEVPYKPKYK 309 (340)
T ss_pred --CCCC-CC---HHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCC
Confidence 1111 12 2345666799999999995 899988652 221 1244566666654
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=328.99 Aligned_cols=241 Identities=23% Similarity=0.271 Sum_probs=191.7
Q ss_pred cccCCCCceeEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEeecCCC
Q 039168 222 NKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNK 297 (536)
Q Consensus 222 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~~ 297 (536)
+.||+|+||.||+++.. +|+.||+|++... .......+.+|+++++.++||||+++++++...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999875 5899999998753 2234456778999999999999999999999999999999999999
Q ss_pred ChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCCcccc
Q 039168 298 SLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANT 377 (536)
Q Consensus 298 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 377 (536)
+|..++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~ 152 (323)
T cd05595 81 ELFFHLSRE---RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATM 152 (323)
T ss_pred cHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCC--Ccc
Confidence 998888543 35899999999999999999999996 9999999999999999999999999987532221 112
Q ss_pred ccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccccccCCCC
Q 039168 378 NIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQSCA 457 (536)
Q Consensus 378 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~ 457 (536)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .. ..... .... .+....
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~---~~---~~~~~-~~~~------~~p~~~- 218 (323)
T cd05595 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---RL---FELIL-MEEI------RFPRTL- 218 (323)
T ss_pred ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH---HH---HHHHh-cCCC------CCCCCC-
Confidence 2356899999999999999999999999999999999999997532211 11 11111 1110 011111
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHH
Q 039168 458 PDELLKFIHIGLLCVQQDPADRP-----TMSSVVV 487 (536)
Q Consensus 458 ~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 487 (536)
+ ..+.+++.+||+.||++|| ++.++++
T Consensus 219 ~---~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 219 S---PEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred C---HHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 2 2355666699999999998 8888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=315.77 Aligned_cols=256 Identities=29% Similarity=0.434 Sum_probs=203.2
Q ss_pred cCCccccccCCCCceeEEEEEeCC----CcEEEEEEccccC-hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEE
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLAD----GKAIAVKRLSRTS-GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 290 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 290 (536)
++|++.+.||+|+||.||+|.++. ...||+|.+.... ......+.+|+.++++++||||+++++.+...+..+++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 578999999999999999998742 4579999887543 33456788999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCC
Q 039168 291 YEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGG 370 (536)
Q Consensus 291 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 370 (536)
|||+++++|.+++.... ..+++..++.++.|++.||.|||+++ |+|+||||+|||+++++.++|+|||+++.+..
T Consensus 84 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 84 TEYMENGSLDKFLREND--GKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLED 158 (266)
T ss_pred EEcCCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence 99999999999986533 35899999999999999999999986 99999999999999999999999999998753
Q ss_pred CCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHHHHHhhcCCcccccc
Q 039168 371 NQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELID 449 (536)
Q Consensus 371 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 449 (536)
...........++..|+|||.+.+..++.++||||||+++|+|++ |..||...... . .............
T Consensus 159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~---~----~~~~~~~~~~~~~-- 229 (266)
T cd05033 159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ---D----VIKAVEDGYRLPP-- 229 (266)
T ss_pred cccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH---H----HHHHHHcCCCCCC--
Confidence 222222222334678999999999899999999999999999998 98887432211 1 1111111111110
Q ss_pred ccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 450 PVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 450 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
.......+.+++.+||+.+|++||++.+|++.|+..
T Consensus 230 -------~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 230 -------PMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred -------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 111223466777899999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=327.33 Aligned_cols=262 Identities=21% Similarity=0.323 Sum_probs=193.2
Q ss_pred CCccccccCCCCceeEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeC-----ceEE
Q 039168 217 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEG-----QELL 288 (536)
Q Consensus 217 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-----~~~~ 288 (536)
+|++.++||+|+||.||+|.++ +++.||||++... .......+.+|+.+++.++||||+++++++... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 5888999999999999999975 5899999998643 223345688999999999999999999988643 3589
Q ss_pred EEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCcccc
Q 039168 289 LIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIF 368 (536)
Q Consensus 289 lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 368 (536)
+||||+. ++|..++.. ...+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 81 VVFELME-SDLHQVIKA---NDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEEecCC-CCHHHHHHh---cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 9999995 578877743 335899999999999999999999997 999999999999999999999999999865
Q ss_pred CCCCC-ccccccccccccccCcchhcC--CCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHH--------
Q 039168 369 GGNQN-QANTNIIAGTYGYMAPEYAMG--GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWK-------- 437 (536)
Q Consensus 369 ~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~-------- 437 (536)
..... ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....... .......
T Consensus 154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~---~~~~~~~~~~~~~~~ 230 (338)
T cd07859 154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVH---QLDLITDLLGTPSPE 230 (338)
T ss_pred ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHH---HHHHHHHHhCCCCHH
Confidence 33221 112233568999999999876 578999999999999999999999985432111 0000000
Q ss_pred ---HhhcCCccccccccccCC-C-----CHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 438 ---LWCEGHAVELIDPVLKQS-C-----APDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 438 ---~~~~~~~~~l~~~~l~~~-~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
.+........+....... . .+.....+.+++.+||+.||++|||++++++.
T Consensus 231 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 231 TISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 000000000000000000 0 00112345677789999999999999999954
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=328.35 Aligned_cols=260 Identities=30% Similarity=0.436 Sum_probs=202.4
Q ss_pred hcCCccccccCCCCceeEEEEEeC------CCcEEEEEEccccC-hhhHHHHHHHHHHHHHc-CCCCceeEeeEEee-Cc
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRTS-GQGLKEFKNEVNLIAKL-QHKNLVRLLGCCLE-GQ 285 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~-~~ 285 (536)
.++|++.++||+|+||.||+|... .++.||+|++.... ....+.+.+|+.+++++ +||||+++++++.. +.
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 357999999999999999999642 25789999987543 23345678899999999 89999999998764 46
Q ss_pred eEEEEEeecCCCChhhhhhcccC---------------------------------------------------------
Q 039168 286 ELLLIYEYMPNKSLDVHLFDATR--------------------------------------------------------- 308 (536)
Q Consensus 286 ~~~lv~e~~~~~sL~~~l~~~~~--------------------------------------------------------- 308 (536)
.++++|||+++++|..++.....
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 78999999999999988854221
Q ss_pred -CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCCcccccccccccccc
Q 039168 309 -SVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYM 387 (536)
Q Consensus 309 -~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~ 387 (536)
...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.++|+|||+++.+.............++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 125789999999999999999999986 9999999999999999999999999998764433222233345677899
Q ss_pred CcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHHHHHhhcCCccccccccccCCCCHHHHHHHHH
Q 039168 388 APEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQSCAPDELLKFIH 466 (536)
Q Consensus 388 aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~ 466 (536)
|||++.+..++.++|||||||++|||++ |..||....... . .......+.... . +.....++.+
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~--~----~~~~~~~~~~~~-----~----~~~~~~~~~~ 307 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE--E----FCRRLKEGTRMR-----A----PEYATPEIYS 307 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH--H----HHHHHhccCCCC-----C----CccCCHHHHH
Confidence 9999999999999999999999999998 998875422111 1 111111111111 0 1112345778
Q ss_pred HHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 467 IGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 467 li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
++.+||+.+|++||++.+|++.|+..
T Consensus 308 l~~~cl~~~p~~RPs~~ell~~l~~~ 333 (337)
T cd05054 308 IMLDCWHNNPEDRPTFSELVEILGDL 333 (337)
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHH
Confidence 88899999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=334.31 Aligned_cols=253 Identities=22% Similarity=0.299 Sum_probs=194.1
Q ss_pred CCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEe
Q 039168 217 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 292 (536)
Q Consensus 217 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 292 (536)
.|+.++.||+|+||.||+|++. +++.||||++.... ......+.+|+.++++++||||+++++++.+.+.+++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5888999999999999999875 58899999987542 3345678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCC
Q 039168 293 YMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQ 372 (536)
Q Consensus 293 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 372 (536)
|+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+||||+.++++||+|||++..+....
T Consensus 82 ~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 82 YIPGGDMMSLLIRM---EVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred cCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence 99999999998543 34889999999999999999999986 9999999999999999999999999986432110
Q ss_pred Cc---------------------------------------------cccccccccccccCcchhcCCCCCccchHHHHH
Q 039168 373 NQ---------------------------------------------ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFG 407 (536)
Q Consensus 373 ~~---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG 407 (536)
.. .......||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence 00 001235699999999999998999999999999
Q ss_pred HHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccccccCCCCHHHHHHHHHHHHh--hcCCCCCCCCCHHHH
Q 039168 408 VLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLL--CVQQDPADRPTMSSV 485 (536)
Q Consensus 408 ~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~--cl~~dP~~RPt~~ev 485 (536)
|++|||++|+.||....... .. ............ . .....+.+ +.+++.+ |+..+|..||++.++
T Consensus 236 ~il~elltG~~Pf~~~~~~~----~~--~~i~~~~~~~~~-~---~~~~~s~~---~~dli~~ll~~~~~~~~R~~~~~~ 302 (381)
T cd05626 236 VILFEMLVGQPPFLAPTPTE----TQ--LKVINWENTLHI-P---PQVKLSPE---AVDLITKLCCSAEERLGRNGADDI 302 (381)
T ss_pred hHHHHHHhCCCCCcCCCHHH----HH--HHHHccccccCC-C---CCCCCCHH---HHHHHHHHccCcccccCCCCHHHH
Confidence 99999999999986432211 01 111100000110 0 00011233 3444445 556677779999999
Q ss_pred HHH
Q 039168 486 VVM 488 (536)
Q Consensus 486 l~~ 488 (536)
++.
T Consensus 303 l~h 305 (381)
T cd05626 303 KAH 305 (381)
T ss_pred hcC
Confidence 964
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=320.88 Aligned_cols=261 Identities=23% Similarity=0.325 Sum_probs=192.2
Q ss_pred cCCccccccCCCCceeEEEEEeC--CCcEEEEEEccccC--hhhHHHHHHHHHHHHHc---CCCCceeEeeEEe-----e
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA--DGKAIAVKRLSRTS--GQGLKEFKNEVNLIAKL---QHKNLVRLLGCCL-----E 283 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~hpniv~l~~~~~-----~ 283 (536)
++|++.+.||+|+||.||+|++. +++.||+|++.... ......+.+|+.+++.+ +||||+++++++. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 37899999999999999999863 46889999886432 22234566777777766 6999999999985 3
Q ss_pred CceEEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEeccc
Q 039168 284 GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFG 363 (536)
Q Consensus 284 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg 363 (536)
...+++||||+. ++|..++.... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEcccc
Confidence 456899999996 57888875432 234899999999999999999999997 9999999999999999999999999
Q ss_pred CccccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhc--
Q 039168 364 TARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCE-- 441 (536)
Q Consensus 364 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-- 441 (536)
+++..... .......|++.|+|||++.+..++.++|||||||++|||++|++||....... ...........
T Consensus 156 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~---~~~~i~~~~~~~~ 229 (290)
T cd07862 156 LARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD---QLGKILDVIGLPG 229 (290)
T ss_pred ceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH---HHHHHHHHhCCCC
Confidence 99866433 22234568999999999998899999999999999999999999986432211 11111110000
Q ss_pred -CCccc---ccccccc--CC-----CCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 442 -GHAVE---LIDPVLK--QS-----CAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 442 -~~~~~---l~~~~l~--~~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
..+.. +....+. .. ..+.....+.+++.+||+.||++|||+.++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 230 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 00000 0000000 00 00111234567888999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=325.09 Aligned_cols=248 Identities=23% Similarity=0.352 Sum_probs=193.6
Q ss_pred cccCCCCceeEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHHHc-CCCCceeEeeEEeeCceEEEEEeecCC
Q 039168 222 NKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLKEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYEYMPN 296 (536)
Q Consensus 222 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~ 296 (536)
++||+|+||.||+++++ +++.||+|++.+. .....+.+.+|..+++.+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999975 5889999999753 233456688899999998 799999999999999999999999999
Q ss_pred CChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCCccc
Q 039168 297 KSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQAN 376 (536)
Q Consensus 297 ~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 376 (536)
++|..++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~~~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--~~ 152 (329)
T cd05588 81 GDLMFHMQRQ---RKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG--DT 152 (329)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccCC--Cc
Confidence 9998887543 45899999999999999999999997 9999999999999999999999999987532111 12
Q ss_pred cccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccC--CchhHHHHHHHhhcCCccccccccccC
Q 039168 377 TNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEH--GQTLLTYTWKLWCEGHAVELIDPVLKQ 454 (536)
Q Consensus 377 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~l~~~~l~~ 454 (536)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ......+.......... . +..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~-----~p~ 226 (329)
T cd05588 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI-R-----IPR 226 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC-C-----CCC
Confidence 234578999999999999999999999999999999999999986432211 11111222222222111 1 111
Q ss_pred CCCHHHHHHHHHHHHhhcCCCCCCCCC------HHHHHH
Q 039168 455 SCAPDELLKFIHIGLLCVQQDPADRPT------MSSVVV 487 (536)
Q Consensus 455 ~~~~~~~~~l~~li~~cl~~dP~~RPt------~~evl~ 487 (536)
.. ...+.+++.+||+.||.+||| +.++++
T Consensus 227 ~~----~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 227 SL----SVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred CC----CHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 11 234566777999999999997 667764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=314.39 Aligned_cols=252 Identities=27% Similarity=0.407 Sum_probs=200.9
Q ss_pred cCCccccccCCCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEeecC
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMP 295 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 295 (536)
++|++.+.||+|+||.||++...++..+|+|.+.... ...+.+.+|+.++++++||||+++++++.+....++||||+.
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 4688899999999999999998777789999887543 234678999999999999999999999999999999999999
Q ss_pred CCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCCcc
Q 039168 296 NKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQA 375 (536)
Q Consensus 296 ~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 375 (536)
+++|.+++.... ..+++..++.++.||+.||.|||+.+ ++|+||||+||++++++.+||+|||.++.........
T Consensus 83 ~~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05113 83 NGCLLNYLREHG--KRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS 157 (256)
T ss_pred CCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence 999999885432 25899999999999999999999997 9999999999999999999999999988654332211
Q ss_pred ccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHHHHHhhcCCccccccccccC
Q 039168 376 NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQ 454 (536)
Q Consensus 376 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~ 454 (536)
.....++..|+|||.+.+..++.++||||||+++|+|++ |..||...... ... .....+.....
T Consensus 158 -~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~---~~~----~~~~~~~~~~~------- 222 (256)
T cd05113 158 -SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS---ETV----EKVSQGLRLYR------- 222 (256)
T ss_pred -cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH---HHH----HHHhcCCCCCC-------
Confidence 112235678999999998889999999999999999998 88887532221 111 11111111110
Q ss_pred CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 039168 455 SCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLA 490 (536)
Q Consensus 455 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 490 (536)
.......+.+++.+||+.||.+|||+.+|++.|+
T Consensus 223 --~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 223 --PHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred --CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 0111245677777999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=328.91 Aligned_cols=201 Identities=24% Similarity=0.348 Sum_probs=174.2
Q ss_pred cCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEE
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 291 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 291 (536)
++|++.+.||+|+||+||++... +++.||||++.+.. ......+.+|+.++.+++||||+++++.+.+...+++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47899999999999999999875 58999999987532 233456888999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCC
Q 039168 292 EYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGN 371 (536)
Q Consensus 292 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 371 (536)
||+++++|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~ 154 (363)
T cd05628 81 EFLPGGDMMTLLMK---KDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA 154 (363)
T ss_pred cCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence 99999999999854 345899999999999999999999996 999999999999999999999999998765321
Q ss_pred CCc---------------------------------cccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCC
Q 039168 372 QNQ---------------------------------ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRK 418 (536)
Q Consensus 372 ~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~ 418 (536)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 234 (363)
T cd05628 155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (363)
T ss_pred ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence 100 00123579999999999999999999999999999999999999
Q ss_pred CCCC
Q 039168 419 NNGF 422 (536)
Q Consensus 419 p~~~ 422 (536)
||..
T Consensus 235 Pf~~ 238 (363)
T cd05628 235 PFCS 238 (363)
T ss_pred CCCC
Confidence 9854
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=343.47 Aligned_cols=256 Identities=22% Similarity=0.273 Sum_probs=202.9
Q ss_pred HhcCCccccccCCCCceeEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCc-----
Q 039168 214 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQ----- 285 (536)
Q Consensus 214 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~----- 285 (536)
..++|.+.+.||+|+||.||++++. +++.||||++... .......+.+|+..+..++|+|+++++..+...+
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~ 109 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE 109 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence 3579999999999999999999864 6899999998654 3445567889999999999999999988775432
Q ss_pred ---eEEEEEeecCCCChhhhhhccc-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEec
Q 039168 286 ---ELLLIYEYMPNKSLDVHLFDAT-RSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISD 361 (536)
Q Consensus 286 ---~~~lv~e~~~~~sL~~~l~~~~-~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~D 361 (536)
.+++||||+.+|+|.+++.... ....+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|
T Consensus 110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL~D 186 (496)
T PTZ00283 110 NVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKLGD 186 (496)
T ss_pred cceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEEEe
Confidence 3789999999999999886532 2346899999999999999999999996 99999999999999999999999
Q ss_pred ccCccccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhc
Q 039168 362 FGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCE 441 (536)
Q Consensus 362 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 441 (536)
||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||..... ...... ...
T Consensus 187 FGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~------~~~~~~-~~~ 259 (496)
T PTZ00283 187 FGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM------EEVMHK-TLA 259 (496)
T ss_pred cccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH------HHHHHH-Hhc
Confidence 9999876543333333456799999999999999999999999999999999999999853211 111111 111
Q ss_pred CCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 442 GHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 442 ~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
+.... +... ....+.+++.+||+.||.+|||+.++++.
T Consensus 260 ~~~~~-----~~~~----~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 260 GRYDP-----LPPS----ISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CCCCC-----CCCC----CCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 11111 1111 12346667779999999999999999864
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=324.64 Aligned_cols=255 Identities=28% Similarity=0.449 Sum_probs=200.0
Q ss_pred cCCccccccCCCCceeEEEEEeC-CCc----EEEEEEccccC-hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEE
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA-DGK----AIAVKRLSRTS-GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 289 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 289 (536)
.+|+..+.||+|+||.||+|++. ++. .||+|++.... ....+.+.+|+.+++.++||||+++++++... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 57999999999999999999864 233 48999986543 34557788999999999999999999998765 5789
Q ss_pred EEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccC
Q 039168 290 IYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFG 369 (536)
Q Consensus 290 v~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 369 (536)
++||+.+|+|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 86 v~e~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 86 ITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred eeecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccccc
Confidence 999999999999986432 34888999999999999999999996 9999999999999999999999999998775
Q ss_pred CCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHHHHHhhcCCccccc
Q 039168 370 GNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELI 448 (536)
Q Consensus 370 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 448 (536)
............++..|+|||.+.+..++.++||||||+++|||++ |+.||...... . .......+.....
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~------~-~~~~~~~~~~~~~- 232 (316)
T cd05108 161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS------E-ISSILEKGERLPQ- 232 (316)
T ss_pred CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH------H-HHHHHhCCCCCCC-
Confidence 4333222222334678999999999999999999999999999998 99887532111 1 1111111111110
Q ss_pred cccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 449 DPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 449 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
++.....+.+++.+||+.||.+|||+.+++..|...
T Consensus 233 --------~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~ 268 (316)
T cd05108 233 --------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 268 (316)
T ss_pred --------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 111123466777899999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=325.53 Aligned_cols=241 Identities=29% Similarity=0.452 Sum_probs=196.1
Q ss_pred ccccCCCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEeecCCCChh
Q 039168 221 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLD 300 (536)
Q Consensus 221 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~~sL~ 300 (536)
++-||.|+.|.||+|++ .++.||||++..-. ..+++-|++|+||||+.+.|+|...-.++||||||..|-|.
T Consensus 129 LeWlGSGaQGAVF~Grl-~netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~ 200 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRL-HNETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLY 200 (904)
T ss_pred hhhhccCcccceeeeec-cCceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHH
Confidence 56799999999999998 57899999885322 24788899999999999999999999999999999999999
Q ss_pred hhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCCccccccc
Q 039168 301 VHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNII 380 (536)
Q Consensus 301 ~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 380 (536)
.+|.. ...+.......|..+|+.|+.|||.+. |||||||.-||||+.+..|||+|||-++.+.+. ...-.+
T Consensus 201 ~VLka---~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---STkMSF 271 (904)
T KOG4721|consen 201 EVLKA---GRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDK---STKMSF 271 (904)
T ss_pred HHHhc---cCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhh---hhhhhh
Confidence 99943 345788889999999999999999995 999999999999999999999999999977543 222247
Q ss_pred cccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccccccCCCCHHH
Q 039168 381 AGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQSCAPDE 460 (536)
Q Consensus 381 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~ 460 (536)
+||..|||||++.+...+.|+|||||||+|||||||..||..-+. +..+|..- ...+.+ ..+...
T Consensus 272 aGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVds------sAIIwGVG--sNsL~L-------pvPstc 336 (904)
T KOG4721|consen 272 AGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDS------SAIIWGVG--SNSLHL-------PVPSTC 336 (904)
T ss_pred hhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccch------heeEEecc--CCcccc-------cCcccC
Confidence 899999999999999999999999999999999999999643211 11222211 111111 122333
Q ss_pred HHHHHHHHHhhcCCCCCCCCCHHHHHHHhccCC
Q 039168 461 LLKFIHIGLLCVQQDPADRPTMSSVVVMLASDS 493 (536)
Q Consensus 461 ~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 493 (536)
...|.-|+.+||+..|.+||++++|+..|.=-.
T Consensus 337 P~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~ 369 (904)
T KOG4721|consen 337 PDGFKLLLKQCWNSKPRNRPSFRQILLHLDIAS 369 (904)
T ss_pred chHHHHHHHHHHhcCCCCCccHHHHHHHHhhcC
Confidence 344555666999999999999999999887543
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=319.69 Aligned_cols=257 Identities=30% Similarity=0.416 Sum_probs=200.4
Q ss_pred cCCccccccCCCCceeEEEEEeC------CCcEEEEEEccccCh-hhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEE
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRTSG-QGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELL 288 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 288 (536)
.+|++.+.||+|+||.||+|.+. .++.||+|++..... ...+.+.+|+.+++.++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 35778899999999999999863 257899999975433 23466889999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhhcc-------------cCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCC
Q 039168 289 LIYEYMPNKSLDVHLFDA-------------TRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDM 355 (536)
Q Consensus 289 lv~e~~~~~sL~~~l~~~-------------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~ 355 (536)
+++||+.+++|..++... .....+++..++.++.|++.||.|||+++ |+||||||+|||+++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCC
Confidence 999999999999988532 11234788899999999999999999997 99999999999999999
Q ss_pred CeEEecccCccccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHH
Q 039168 356 NPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTY 434 (536)
Q Consensus 356 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~ 434 (536)
.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |..||...... .
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~------~- 234 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ------D- 234 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH------H-
Confidence 999999999886643332222223345778999999998889999999999999999998 77776432111 1
Q ss_pred HHHHhhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcc
Q 039168 435 TWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 491 (536)
Q Consensus 435 ~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 491 (536)
.......+.... .... . ...+.+++..||+.+|.+||++++|++.|+.
T Consensus 235 ~~~~i~~~~~~~-----~~~~-~---~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 235 VIEMIRNRQVLP-----CPDD-C---PAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHHHHcCCcCC-----CCCC-C---CHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 111111211111 1111 2 2335667779999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=318.47 Aligned_cols=250 Identities=34% Similarity=0.546 Sum_probs=191.8
Q ss_pred cccccCCCCceeEEEEEeC-----CCcEEEEEEcccc-ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEee
Q 039168 220 DENKLGQGGFGPVYKGTLA-----DGKAIAVKRLSRT-SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 293 (536)
Q Consensus 220 ~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 293 (536)
..+.||.|.||.||+|.+. .+..|+||.+... .....+.+.+|++.+++++||||+++++++...+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4578999999999999876 3678999999654 334578899999999999999999999999988889999999
Q ss_pred cCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCC
Q 039168 294 MPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQN 373 (536)
Q Consensus 294 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 373 (536)
+++++|.++|... ....+++..++.|+.||++||.|||+++ ++|++|+++|||+++++.+||+|||++........
T Consensus 83 ~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 83 CPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp -TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred ccccccccccccc-cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence 9999999999764 2345899999999999999999999986 99999999999999999999999999987633322
Q ss_pred ccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHHHHHhhcCCccccccccc
Q 039168 374 QANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVL 452 (536)
Q Consensus 374 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l 452 (536)
............|+|||.+.+..++.++||||||+++|||++ |+.|+..... .... ....++.....
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~------~~~~-~~~~~~~~~~~----- 226 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN------EEII-EKLKQGQRLPI----- 226 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH------HHHH-HHHHTTEETTS-----
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccc------cccc-cccccccccee-----
Confidence 222333456778999999999999999999999999999999 6777543311 1111 11122222111
Q ss_pred cCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHh
Q 039168 453 KQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 489 (536)
Q Consensus 453 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 489 (536)
... . ...+.+++..||..||++|||+.+|++.|
T Consensus 227 ~~~-~---~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 227 PDN-C---PKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp BTT-S---BHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ccc-h---hHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 111 1 23355677799999999999999999986
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=320.50 Aligned_cols=240 Identities=26% Similarity=0.351 Sum_probs=187.2
Q ss_pred cccCCCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHHHc-CCCCceeEeeEEeeCceEEEEEeecCC
Q 039168 222 NKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLKEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYEYMPN 296 (536)
Q Consensus 222 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~ 296 (536)
++||+|+||.||+|+.. +++.||||++.... ....+.+..|..++..+ +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999975 48899999987532 23344556677777654 899999999999999999999999999
Q ss_pred CChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCCccc
Q 039168 297 KSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQAN 376 (536)
Q Consensus 297 ~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 376 (536)
++|..++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~ 152 (316)
T cd05592 81 GDLMFHIQSS---GRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GK 152 (316)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Cc
Confidence 9999888543 35899999999999999999999986 9999999999999999999999999997643222 22
Q ss_pred cccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccccccCCC
Q 039168 377 TNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQSC 456 (536)
Q Consensus 377 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~ 456 (536)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ........ ... +.+...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~------~~~~~~i~-~~~------~~~~~~- 218 (316)
T cd05592 153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE------DELFDSIL-NDR------PHFPRW- 218 (316)
T ss_pred cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH------HHHHHHHH-cCC------CCCCCC-
Confidence 3345789999999999999999999999999999999999999864321 11111111 110 111111
Q ss_pred CHHHHHHHHHHHHhhcCCCCCCCCCHH-HHH
Q 039168 457 APDELLKFIHIGLLCVQQDPADRPTMS-SVV 486 (536)
Q Consensus 457 ~~~~~~~l~~li~~cl~~dP~~RPt~~-evl 486 (536)
.+ ..+.+++.+||+.||++||++. +++
T Consensus 219 ~~---~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 219 IS---KEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred CC---HHHHHHHHHHccCCHHHcCCChHHHH
Confidence 12 2345666799999999999876 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=314.07 Aligned_cols=254 Identities=29% Similarity=0.431 Sum_probs=202.0
Q ss_pred cCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEeec
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 294 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 294 (536)
.+|.+.++||+|+||.||+|.++ .++.||+|++... ....+.+.+|++++++++||||+++++++..+...+++|||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 45788899999999999999875 4889999988654 334567889999999999999999999999999999999999
Q ss_pred CCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCCc
Q 039168 295 PNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQ 374 (536)
Q Consensus 295 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 374 (536)
++++|.+++.... ...+++..++.++.|+++||.|||+++ ++|+||||+||++++++.+||+|||++.........
T Consensus 85 ~~~~L~~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 85 TYGNLLDYLRECN-RQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred CCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence 9999999985432 345899999999999999999999986 999999999999999999999999999876543221
Q ss_pred cccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHHHHHhhcCCcccccccccc
Q 039168 375 ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLK 453 (536)
Q Consensus 375 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~ 453 (536)
. .....++..|+|||.+.+..++.++||||||+++|||++ |..|+...... . .+........ ....
T Consensus 161 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~---~----~~~~~~~~~~-----~~~~ 227 (263)
T cd05052 161 A-HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---Q----VYELLEKGYR-----MERP 227 (263)
T ss_pred c-cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---H----HHHHHHCCCC-----CCCC
Confidence 1 111234568999999999999999999999999999998 88886532111 1 1111111111 1111
Q ss_pred CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcc
Q 039168 454 QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 491 (536)
Q Consensus 454 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 491 (536)
.. ....+.+++.+||+.||++|||+.++++.|+.
T Consensus 228 ~~----~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~ 261 (263)
T cd05052 228 EG----CPPKVYELMRACWQWNPSDRPSFAEIHQAFET 261 (263)
T ss_pred CC----CCHHHHHHHHHHccCCcccCCCHHHHHHHHHh
Confidence 11 12346667779999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=330.00 Aligned_cols=253 Identities=21% Similarity=0.271 Sum_probs=196.5
Q ss_pred cCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEE
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 291 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 291 (536)
++|++.+.||+|+||.||+++.. +++.||||++.... ......+.+|+.+++.++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47899999999999999999976 58999999987532 234456788999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCC
Q 039168 292 EYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGN 371 (536)
Q Consensus 292 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 371 (536)
||+.+++|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 E~~~~g~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 154 (364)
T cd05599 81 EYLPGGDMMTLLMKK---DTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS 154 (364)
T ss_pred CCCCCcHHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence 999999999998543 35899999999999999999999997 999999999999999999999999998765322
Q ss_pred CCcc------------------------------------ccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh
Q 039168 372 QNQA------------------------------------NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 415 (536)
Q Consensus 372 ~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt 415 (536)
.... .....+||+.|+|||++.+..++.++|||||||++|||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~ 234 (364)
T cd05599 155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234 (364)
T ss_pred ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence 1100 0112468999999999999999999999999999999999
Q ss_pred CCCCCCCCCccCCchhHHHHHHHhhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCC---HHHHHHH
Q 039168 416 GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPT---MSSVVVM 488 (536)
Q Consensus 416 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt---~~evl~~ 488 (536)
|+.||...... ................. ....++ .+.+++.+|+. +|.+|++ +.++++.
T Consensus 235 G~~Pf~~~~~~------~~~~~i~~~~~~~~~~~----~~~~s~---~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 235 GYPPFCSDNPQ------ETYRKIINWKETLQFPD----EVPLSP---EAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCCCCCCHH------HHHHHHHcCCCccCCCC----CCCCCH---HHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 99998543211 11111111000001000 001223 34455568886 9999998 8888763
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=329.70 Aligned_cols=253 Identities=23% Similarity=0.337 Sum_probs=200.7
Q ss_pred cCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEE
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 291 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 291 (536)
++|++.+.||+|+||.||+|+.. +++.||||++.... ......+.+|++++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46889999999999999999976 68999999987532 234567889999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCC
Q 039168 292 EYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGN 371 (536)
Q Consensus 292 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 371 (536)
||+++++|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 81 EYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 999999999998654 45899999999999999999999986 999999999999999999999999999876543
Q ss_pred C---------------------------CccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 039168 372 Q---------------------------NQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYF 424 (536)
Q Consensus 372 ~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~ 424 (536)
. .........||+.|+|||++.+..++.++|||||||++|+|++|+.||....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 234 (350)
T cd05573 155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234 (350)
T ss_pred CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence 2 0011223568999999999999999999999999999999999999986433
Q ss_pred ccCCchhHHHHHHHhhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCC-HHHHHHH
Q 039168 425 SEHGQTLLTYTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPT-MSSVVVM 488 (536)
Q Consensus 425 ~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt-~~evl~~ 488 (536)
.. ..............+ +. ... .+ ..+.+++..||+ ||.+||+ +.++++.
T Consensus 235 ~~------~~~~~i~~~~~~~~~--p~-~~~-~~---~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 235 LQ------ETYNKIINWKESLRF--PP-DPP-VS---PEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HH------HHHHHHhccCCcccC--CC-CCC-CC---HHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 11 111111110000000 00 000 12 345566668997 9999999 9999975
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=313.00 Aligned_cols=252 Identities=28% Similarity=0.410 Sum_probs=199.2
Q ss_pred cCCccccccCCCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEeecC
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMP 295 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 295 (536)
.+|++.+.||+|+||.||++.++++..+|+|++..... ....+.+|+++++.++||||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 46888999999999999999988788899999864332 33568889999999999999999999999999999999999
Q ss_pred CCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCCcc
Q 039168 296 NKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQA 375 (536)
Q Consensus 296 ~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 375 (536)
+++|.+++.... ..+++..++.++.||+.||.|||+.+ ++||||||+||++++++.+||+|||+++...+.....
T Consensus 83 ~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~ 157 (256)
T cd05059 83 NGCLLNYLRERK--GKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS 157 (256)
T ss_pred CCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence 999999986432 35899999999999999999999997 9999999999999999999999999998654322111
Q ss_pred ccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHHHHHhhcCCccccccccccC
Q 039168 376 NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQ 454 (536)
Q Consensus 376 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~ 454 (536)
.....++..|+|||.+.+..++.++||||||+++|+|++ |+.||...... . .. ......... ..
T Consensus 158 -~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~---~~-~~~~~~~~~-----~~-- 222 (256)
T cd05059 158 -SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS---E---VV-ESVSAGYRL-----YR-- 222 (256)
T ss_pred -cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH---H---HH-HHHHcCCcC-----CC--
Confidence 111123457999999999999999999999999999999 78887543221 1 11 111111110 01
Q ss_pred CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 039168 455 SCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLA 490 (536)
Q Consensus 455 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 490 (536)
+......+.+++.+||+.+|++|||+.++++.|.
T Consensus 223 --~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~ 256 (256)
T cd05059 223 --PKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256 (256)
T ss_pred --CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence 1112234667777999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-40 Score=299.42 Aligned_cols=257 Identities=27% Similarity=0.375 Sum_probs=203.4
Q ss_pred hhHHHHhcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC-----h---hhHHHHHHHHHHHHHc-CCCCceeEe
Q 039168 209 GLALEATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-----G---QGLKEFKNEVNLIAKL-QHKNLVRLL 278 (536)
Q Consensus 209 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~---~~~~~~~~E~~~l~~l-~hpniv~l~ 278 (536)
.....+..+|...+.||.|..++|.++..+ +|+++|+|++.... + .-.+.-.+|+.||+++ .||+|+++.
T Consensus 10 ~aa~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~ 89 (411)
T KOG0599|consen 10 DAAKGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQ 89 (411)
T ss_pred hhHhhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEee
Confidence 344566788999999999999999998765 68999999985321 1 1234556799999999 699999999
Q ss_pred eEEeeCceEEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeE
Q 039168 279 GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPK 358 (536)
Q Consensus 279 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~k 358 (536)
++++.+..+++|+|.|+.|.|.++| .....+++++...|++|+++|+.|||.+. ||||||||+|||++++.++|
T Consensus 90 D~yes~sF~FlVFdl~prGELFDyL---ts~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~ 163 (411)
T KOG0599|consen 90 DVYESDAFVFLVFDLMPRGELFDYL---TSKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIK 163 (411)
T ss_pred eeccCcchhhhhhhhcccchHHHHh---hhheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceE
Confidence 9999999999999999999999999 44566999999999999999999999984 99999999999999999999
Q ss_pred EecccCccccCCCCCccccccccccccccCcchhc------CCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhH
Q 039168 359 ISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAM------GGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLL 432 (536)
Q Consensus 359 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~ 432 (536)
|+|||+++.+.... .....+|||+|+|||.+. ..+|+..+|+|++|||||.|+.|.+||-. ..+.++
T Consensus 164 isDFGFa~~l~~Ge---kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwH----RkQmlM 236 (411)
T KOG0599|consen 164 ISDFGFACQLEPGE---KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWH----RKQMLM 236 (411)
T ss_pred EeccceeeccCCch---hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhH----HHHHHH
Confidence 99999999875433 334579999999999984 34589999999999999999999999521 111111
Q ss_pred HHHHHHhhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 433 TYTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 433 ~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
. ..+.++... .......+......+||.+||+.||.+|.|++|+|.
T Consensus 237 L---R~ImeGkyq------F~speWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 237 L---RMIMEGKYQ------FRSPEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred H---HHHHhcccc------cCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 1 111111110 111112233345667777999999999999999984
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=316.25 Aligned_cols=265 Identities=28% Similarity=0.416 Sum_probs=204.0
Q ss_pred hcCCccccccCCCCceeEEEEEeCC-----------------CcEEEEEEccccC-hhhHHHHHHHHHHHHHcCCCCcee
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLAD-----------------GKAIAVKRLSRTS-GQGLKEFKNEVNLIAKLQHKNLVR 276 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~ 276 (536)
.++|++.+.||+|+||.||++...+ +..||+|++.... ....+.+.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3689999999999999999987542 2468999987553 345678899999999999999999
Q ss_pred EeeEEeeCceEEEEEeecCCCChhhhhhccc--------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCc
Q 039168 277 LLGCCLEGQELLLIYEYMPNKSLDVHLFDAT--------RSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASN 348 (536)
Q Consensus 277 l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~N 348 (536)
+++++..++..+++||++.+++|..++.... ....+++..++.++.|++.||.|||+++ ++|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 9999999999999999999999999986533 1125899999999999999999999986 9999999999
Q ss_pred EEEcCCCCeEEecccCccccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh--CCCCCCCCCcc
Q 039168 349 VLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS--GRKNNGFYFSE 426 (536)
Q Consensus 349 Ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt--g~~p~~~~~~~ 426 (536)
|+++.++.++|+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ +..|+....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~-- 238 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT-- 238 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC--
Confidence 9999999999999999986544332222333456788999999998889999999999999999998 555653221
Q ss_pred CCchhHHHHHHHhhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcc
Q 039168 427 HGQTLLTYTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 491 (536)
Q Consensus 427 ~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 491 (536)
...........+.......... .......++.+++.+||+.||++|||+.+|++.|+.
T Consensus 239 -~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 239 -DQQVIENAGHFFRDDGRQIYLP------RPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred -hHHHHHHHHhccccccccccCC------CccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 1111121111111111111000 111122457778889999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=313.41 Aligned_cols=258 Identities=29% Similarity=0.454 Sum_probs=204.1
Q ss_pred hcCCccccccCCCCceeEEEEEeCC------CcEEEEEEccccC-hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceE
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLAD------GKAIAVKRLSRTS-GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQEL 287 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 287 (536)
.++|++.+.||+|+||.||+|..+. +..||+|.+.... ......+.+|+.+++.++||||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 3688999999999999999998642 4789999986543 34456788999999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhhcccC-------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEe
Q 039168 288 LLIYEYMPNKSLDVHLFDATR-------SVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKIS 360 (536)
Q Consensus 288 ~lv~e~~~~~sL~~~l~~~~~-------~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~ 360 (536)
++||||+++++|..++..... ...+++..++.++.||+.||.|||+.+ ++|+||||+|||++.++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence 999999999999999865322 224788899999999999999999986 9999999999999999999999
Q ss_pred cccCccccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHHHHHh
Q 039168 361 DFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLW 439 (536)
Q Consensus 361 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 439 (536)
|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.||...... .... ..
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~---~~~~----~~ 234 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE---EVLK----FV 234 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHH---HHHH----HH
Confidence 9999986654332222233456789999999998889999999999999999998 88887532211 1111 11
Q ss_pred hcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcc
Q 039168 440 CEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 491 (536)
Q Consensus 440 ~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 491 (536)
..+..... .... ...+.+++.+||+.+|++|||+.++++.|+.
T Consensus 235 ~~~~~~~~-----~~~~----~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 235 IDGGHLDL-----PENC----PDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred hcCCCCCC-----CCCC----CHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 12211111 1111 3356677779999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-39 Score=323.29 Aligned_cols=248 Identities=24% Similarity=0.362 Sum_probs=192.6
Q ss_pred cccCCCCceeEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHHHc-CCCCceeEeeEEeeCceEEEEEeecCC
Q 039168 222 NKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLKEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYEYMPN 296 (536)
Q Consensus 222 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~ 296 (536)
+.||+|+||.||+++.+ +++.||+|++.+. .......+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999975 5789999998753 233455678899988877 899999999999999999999999999
Q ss_pred CChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCCccc
Q 039168 297 KSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQAN 376 (536)
Q Consensus 297 ~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 376 (536)
++|..++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~~---~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~--~~ 152 (329)
T cd05618 81 GDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DT 152 (329)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCC--Cc
Confidence 9998887443 35899999999999999999999996 9999999999999999999999999987532221 12
Q ss_pred cccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCC--chhHHHHHHHhhcCCccccccccccC
Q 039168 377 TNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHG--QTLLTYTWKLWCEGHAVELIDPVLKQ 454 (536)
Q Consensus 377 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~~l~~ 454 (536)
.....||+.|+|||++.+..++.++||||||+++|+|++|+.||........ .....+.......... . +
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~-~-----~-- 224 (329)
T cd05618 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-R-----I-- 224 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC-C-----C--
Confidence 2345789999999999999999999999999999999999999864222111 1111222222222111 1 1
Q ss_pred CCCHHHHHHHHHHHHhhcCCCCCCCCC------HHHHHH
Q 039168 455 SCAPDELLKFIHIGLLCVQQDPADRPT------MSSVVV 487 (536)
Q Consensus 455 ~~~~~~~~~l~~li~~cl~~dP~~RPt------~~evl~ 487 (536)
+......+.+++.+||+.||++||| +.++++
T Consensus 225 --p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05618 225 --PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 261 (329)
T ss_pred --CCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhc
Confidence 1112234566777999999999998 456653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=317.81 Aligned_cols=257 Identities=31% Similarity=0.445 Sum_probs=201.1
Q ss_pred CCccccccCCCCceeEEEEEeC------CCcEEEEEEccccC-hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEE
Q 039168 217 HFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRTS-GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 289 (536)
Q Consensus 217 ~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 289 (536)
+|++.+.||+|+||.||+|... ....+++|.+.... ......+.+|+.+++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4778899999999999999853 23578888886543 3345678899999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhccc---------------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCc
Q 039168 290 IYEYMPNKSLDVHLFDAT---------------------RSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASN 348 (536)
Q Consensus 290 v~e~~~~~sL~~~l~~~~---------------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~N 348 (536)
++||+.+++|.+++.... ....+++..++.++.|++.||.|||+.+ ++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 999999999999875421 1234789999999999999999999986 9999999999
Q ss_pred EEEcCCCCeEEecccCccccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccC
Q 039168 349 VLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEH 427 (536)
Q Consensus 349 Ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~ 427 (536)
||+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|+|++ |..||......
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~- 236 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE- 236 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH-
Confidence 9999999999999999986543332222222345678999999988889999999999999999998 88887532211
Q ss_pred CchhHHHHHHHhhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 428 GQTLLTYTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 428 ~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
..+.......... ... .....+.+++.+||+.+|++||++.++++.|++.
T Consensus 237 ------~~~~~~~~~~~~~-----~~~----~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~ 286 (290)
T cd05045 237 ------RLFNLLKTGYRME-----RPE----NCSEEMYNLMLTCWKQEPDKRPTFADISKELEKM 286 (290)
T ss_pred ------HHHHHHhCCCCCC-----CCC----CCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHH
Confidence 1122221111111 111 1123566777899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=315.76 Aligned_cols=263 Identities=26% Similarity=0.387 Sum_probs=199.2
Q ss_pred cCCccccccCCCCceeEEEEEeCC---------------CcEEEEEEcccc-ChhhHHHHHHHHHHHHHcCCCCceeEee
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLAD---------------GKAIAVKRLSRT-SGQGLKEFKNEVNLIAKLQHKNLVRLLG 279 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~~---------------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~ 279 (536)
.+|++.++||+|+||.||++...+ ...||+|++... .....+.+.+|++++++++|||++++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 589999999999999999987532 235899998754 3334567899999999999999999999
Q ss_pred EEeeCceEEEEEeecCCCChhhhhhcccC---------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEE
Q 039168 280 CCLEGQELLLIYEYMPNKSLDVHLFDATR---------SVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVL 350 (536)
Q Consensus 280 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~~---------~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIl 350 (536)
++...+..++||||+.+++|.+++..... ...+++..++.++.|++.||.|||+++ ++|+||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEE
Confidence 99999999999999999999999854321 123688899999999999999999997 999999999999
Q ss_pred EcCCCCeEEecccCccccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh--CCCCCCCCCccCC
Q 039168 351 LDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS--GRKNNGFYFSEHG 428 (536)
Q Consensus 351 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt--g~~p~~~~~~~~~ 428 (536)
+++++.+||+|||++..+.............++..|+|||.+.+..++.++||||||+++|+|++ +..||.....
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~--- 238 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD--- 238 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh---
Confidence 99999999999999986543322222222345678999999998889999999999999999998 4455433221
Q ss_pred chhHHHHHHHhhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 039168 429 QTLLTYTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLA 490 (536)
Q Consensus 429 ~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 490 (536)
..........+.......... ..+.....+.+++.+||+.||++|||+.+|++.|.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 239 EQVIENTGEFFRNQGRQIYLS------QTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HHHHHHHHHhhhhccccccCC------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 111111111111110000000 01111235777888999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=324.88 Aligned_cols=241 Identities=26% Similarity=0.340 Sum_probs=191.4
Q ss_pred cccCCCCceeEEEEEe----CCCcEEEEEEccccC----hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEee
Q 039168 222 NKLGQGGFGPVYKGTL----ADGKAIAVKRLSRTS----GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 293 (536)
Q Consensus 222 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 293 (536)
++||+|+||.||+++. ..++.||+|++.... ......+.+|+.+|+.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6899999999999985 357899999986532 23345678899999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCC
Q 039168 294 MPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQN 373 (536)
Q Consensus 294 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 373 (536)
+.+++|..++.. ...+.+..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (323)
T cd05584 82 LSGGELFMHLER---EGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT 155 (323)
T ss_pred CCCchHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence 999999988854 334788899999999999999999996 99999999999999999999999999875432221
Q ss_pred ccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcccccccccc
Q 039168 374 QANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLK 453 (536)
Q Consensus 374 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~ 453 (536)
......||+.|+|||++.+..++.++||||||+++|||++|+.||...... ..... ...+.. . +.
T Consensus 156 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~------~~~~~-~~~~~~-~-----~~ 220 (323)
T cd05584 156 --VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK------KTIDK-ILKGKL-N-----LP 220 (323)
T ss_pred --cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH------HHHHH-HHcCCC-C-----CC
Confidence 223356899999999999988999999999999999999999998542211 11111 111111 1 11
Q ss_pred CCCCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHH
Q 039168 454 QSCAPDELLKFIHIGLLCVQQDPADRP-----TMSSVVV 487 (536)
Q Consensus 454 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 487 (536)
.. ....+.+++.+||+.||++|| ++.++++
T Consensus 221 ~~----~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 221 PY----LTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred CC----CCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 11 123456677799999999999 7888876
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=309.30 Aligned_cols=259 Identities=23% Similarity=0.356 Sum_probs=205.2
Q ss_pred cCCccccccCCCCceeEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEE
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 291 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 291 (536)
++|++.++||+|+||.||+|+.. +++.||||++... .......+.+|+++++.++||||+++++++...+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57899999999999999999975 6899999987542 2334456889999999999999999999999999999999
Q ss_pred eecCCCChhhhhhccc-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCC
Q 039168 292 EYMPNKSLDVHLFDAT-RSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGG 370 (536)
Q Consensus 292 e~~~~~sL~~~l~~~~-~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 370 (536)
||+++++|..++.... ....+++..+..++.||+.||.|||+++ ++|+||||+||+++.++.++|+|||++..+..
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 9999999998885432 2345789999999999999999999986 99999999999999999999999999987643
Q ss_pred CCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccc
Q 039168 371 NQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDP 450 (536)
Q Consensus 371 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 450 (536)
... ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||..... ........ ........
T Consensus 159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~----~~~~~~~~-~~~~~~~~---- 227 (267)
T cd08228 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLFSLCQK-IEQCDYPP---- 227 (267)
T ss_pred hhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc----cHHHHHHH-HhcCCCCC----
Confidence 322 11234578899999999988899999999999999999999999743211 11111111 11111111
Q ss_pred cccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 451 VLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 451 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
. ........+.+++.+||+.+|++|||++++++.|+..
T Consensus 228 -~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 228 -L---PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred -C---ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 1 0112234566777799999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=329.98 Aligned_cols=253 Identities=22% Similarity=0.260 Sum_probs=194.3
Q ss_pred cCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEE
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 291 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 291 (536)
++|++.++||+|+||.||++... +++.||||++.+.. ....+.+.+|++++++++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47889999999999999999875 68999999986532 334567889999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCC
Q 039168 292 EYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGN 371 (536)
Q Consensus 292 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 371 (536)
||+++++|..++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~~---~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~ 154 (377)
T cd05629 81 EFLPGGDLMTMLIKY---DTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ 154 (377)
T ss_pred eCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence 999999999988543 45889999999999999999999997 999999999999999999999999999643211
Q ss_pred CCc------------c---------------------------------ccccccccccccCcchhcCCCCCccchHHHH
Q 039168 372 QNQ------------A---------------------------------NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSF 406 (536)
Q Consensus 372 ~~~------------~---------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dvwsl 406 (536)
... . ......||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 234 (377)
T cd05629 155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234 (377)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence 000 0 0012468999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCC---CCHH
Q 039168 407 GVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADR---PTMS 483 (536)
Q Consensus 407 G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~R---Pt~~ 483 (536)
||++|||++|+.||...... ... ...........+.+. ...+. .+.+++.+||+ +|.+| +|+.
T Consensus 235 Gvil~elltG~~Pf~~~~~~---~~~---~~i~~~~~~~~~p~~----~~~s~---~~~dli~~lL~-~~~~r~~r~~~~ 300 (377)
T cd05629 235 GAIMFECLIGWPPFCSENSH---ETY---RKIINWRETLYFPDD----IHLSV---EAEDLIRRLIT-NAENRLGRGGAH 300 (377)
T ss_pred chhhhhhhcCCCCCCCCCHH---HHH---HHHHccCCccCCCCC----CCCCH---HHHHHHHHHhc-CHhhcCCCCCHH
Confidence 99999999999998543221 111 111110011111000 01122 34556668887 67765 5999
Q ss_pred HHHHH
Q 039168 484 SVVVM 488 (536)
Q Consensus 484 evl~~ 488 (536)
++++.
T Consensus 301 ~~l~h 305 (377)
T cd05629 301 EIKSH 305 (377)
T ss_pred HHhcC
Confidence 98875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=333.00 Aligned_cols=200 Identities=25% Similarity=0.370 Sum_probs=172.1
Q ss_pred CCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEe
Q 039168 217 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 292 (536)
Q Consensus 217 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 292 (536)
.|+.+++||+|+||.||+|+.. +++.||+|++.+.. ......+.+|+.++++++||||+++++.+.+++..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5889999999999999999875 58899999987542 2335678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCC
Q 039168 293 YMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQ 372 (536)
Q Consensus 293 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 372 (536)
|+++|+|..++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++..+....
T Consensus 82 ~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 82 YIPGGDMMSLLIRM---GIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred CCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 99999999988543 35889999999999999999999996 9999999999999999999999999975432100
Q ss_pred C---------------------------------------------ccccccccccccccCcchhcCCCCCccchHHHHH
Q 039168 373 N---------------------------------------------QANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFG 407 (536)
Q Consensus 373 ~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG 407 (536)
. ........||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence 0 0001234689999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCC
Q 039168 408 VLLLEIISGRKNNGF 422 (536)
Q Consensus 408 ~il~elltg~~p~~~ 422 (536)
|++|||++|+.||..
T Consensus 236 vil~elltG~~Pf~~ 250 (382)
T cd05625 236 VILYEMLVGQPPFLA 250 (382)
T ss_pred HHHHHHHhCCCCCCC
Confidence 999999999999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=336.13 Aligned_cols=261 Identities=21% Similarity=0.277 Sum_probs=190.3
Q ss_pred HhcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeC--------
Q 039168 214 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEG-------- 284 (536)
Q Consensus 214 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-------- 284 (536)
...+|++.++||+|+||.||+|... +++.||||++.... ....+|+.+|+.++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 3468999999999999999999975 58899999886533 2345799999999999999999886432
Q ss_pred ceEEEEEeecCCCChhhhhhcc-cCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCC-CeEEecc
Q 039168 285 QELLLIYEYMPNKSLDVHLFDA-TRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDM-NPKISDF 362 (536)
Q Consensus 285 ~~~~lv~e~~~~~sL~~~l~~~-~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~-~~kl~Df 362 (536)
..+++||||+++ +|..++... .....+++..++.++.||+.||.|||+++ |+||||||+||||+.++ .+||+||
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecc
Confidence 247799999976 565555432 23456899999999999999999999997 99999999999999665 6999999
Q ss_pred cCccccCCCCCccccccccccccccCcchhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhc
Q 039168 363 GTARIFGGNQNQANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCE 441 (536)
Q Consensus 363 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 441 (536)
|+++.+..... .....||+.|+|||++.+. .++.++|||||||++|||++|.+||...... ............
T Consensus 216 Gla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~---~~~~~i~~~~~~ 289 (440)
T PTZ00036 216 GSAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSV---DQLVRIIQVLGT 289 (440)
T ss_pred ccchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCC
Confidence 99987643222 1234679999999998764 6899999999999999999999998543221 111111111100
Q ss_pred CC---------------ccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 442 GH---------------AVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 442 ~~---------------~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
.. ........+....+.....++++++.+||+.||.+|||+.++++.
T Consensus 290 p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 290 PTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred CCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 00 000000001000111112356777789999999999999999843
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=315.85 Aligned_cols=257 Identities=30% Similarity=0.478 Sum_probs=202.5
Q ss_pred cCCccccccCCCCceeEEEEEeC------CCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEE
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 289 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 289 (536)
.+|...++||+|+||.||++... ++..+++|.+........+.+.+|+++++.++||||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 56788899999999999999642 366899999887776677889999999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhcccC------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCe
Q 039168 290 IYEYMPNKSLDVHLFDATR------------SVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNP 357 (536)
Q Consensus 290 v~e~~~~~sL~~~l~~~~~------------~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~ 357 (536)
+|||+.+++|.+++..... ...+++..++.++.||+.||+|||+.+ ++|+||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence 9999999999999865321 134789999999999999999999986 9999999999999999999
Q ss_pred EEecccCccccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHHH
Q 039168 358 KISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTW 436 (536)
Q Consensus 358 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~ 436 (536)
||+|||++................+++.|+|||.+.+..++.++|||||||++|||++ |..||...... .....
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~~-- 236 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT---EAIEC-- 236 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH---HHHHH--
Confidence 9999999976543222111222345678999999999999999999999999999998 88886432211 11111
Q ss_pred HHhhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcc
Q 039168 437 KLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 491 (536)
Q Consensus 437 ~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 491 (536)
...+.... ..... + ..+.+++.+||+.||++||++.+|++.|+.
T Consensus 237 --~~~~~~~~-----~~~~~-~---~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 237 --ITQGRELE-----RPRTC-P---PEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred --HHcCccCC-----CCCCC-C---HHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 11111111 01111 2 235566779999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=316.77 Aligned_cols=263 Identities=28% Similarity=0.462 Sum_probs=200.0
Q ss_pred cCCccccccCCCCceeEEEEEe-----CCCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEee--CceEE
Q 039168 216 NHFSDENKLGQGGFGPVYKGTL-----ADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLE--GQELL 288 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~--~~~~~ 288 (536)
++|++.+.||+|+||.||++.. .+++.||+|++........+.+.+|++++++++||||+++++++.. ....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 5788999999999999999974 2578999999987766667889999999999999999999998753 35689
Q ss_pred EEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCcccc
Q 039168 289 LIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIF 368 (536)
Q Consensus 289 lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 368 (536)
+||||+++++|.+++... ...+++..++.++.|++.||.|||+++ ++|+||||+||++++++.+||+|||++..+
T Consensus 84 lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKH--RERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred EEEEecCCCCHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 999999999999998543 234899999999999999999999996 999999999999999999999999999876
Q ss_pred CCCCCccc-cccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCC---------chhHHHHHHH
Q 039168 369 GGNQNQAN-TNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHG---------QTLLTYTWKL 438 (536)
Q Consensus 369 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~---------~~~~~~~~~~ 438 (536)
........ .....++..|+|||++.+..++.++||||||+++|||++|..++........ ..........
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05081 159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIEL 238 (284)
T ss_pred cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHH
Confidence 43322111 1112234569999999988899999999999999999998776432211000 0000000000
Q ss_pred hhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 439 WCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 439 ~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
....... .........+.+++.+||+.+|++|||+.+|++.|+..
T Consensus 239 ~~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 239 LKNNGRL---------PAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HhcCCcC---------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 0000000 00111123466777799999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=314.84 Aligned_cols=257 Identities=30% Similarity=0.430 Sum_probs=199.7
Q ss_pred hcCCccccccCCCCceeEEEEEeCC------CcEEEEEEccccC-hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceE
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLAD------GKAIAVKRLSRTS-GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQEL 287 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 287 (536)
.++|.+.+.||+|++|.||+|.+.. +..|++|.+.... ......+.+|+.+++.++||||+++++++.+....
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 4678999999999999999998753 5678999886443 33345688999999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhhcccC----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCC---CeEEe
Q 039168 288 LLIYEYMPNKSLDVHLFDATR----SVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDM---NPKIS 360 (536)
Q Consensus 288 ~lv~e~~~~~sL~~~l~~~~~----~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~---~~kl~ 360 (536)
++||||+++++|..++..... ...+++..+..++.||+.||.|||+++ ++|+||||+||+++.++ .+||+
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEec
Confidence 999999999999999865431 235899999999999999999999996 99999999999998765 58999
Q ss_pred cccCccccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHHHHHh
Q 039168 361 DFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLW 439 (536)
Q Consensus 361 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 439 (536)
|||+++.+..............+..|+|||++.+..++.++|||||||++|||++ |+.||...... .... ..
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~---~~~~----~~ 234 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ---EVME----FV 234 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHH----HH
Confidence 9999987643222111112233568999999999999999999999999999997 88887542221 1111 11
Q ss_pred hcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 039168 440 CEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLA 490 (536)
Q Consensus 440 ~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 490 (536)
....... .+......+.+++.+||+.+|++|||+.+|++.|+
T Consensus 235 ~~~~~~~---------~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 235 TGGGRLD---------PPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HcCCcCC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 1111111 01111235667777999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=348.76 Aligned_cols=259 Identities=34% Similarity=0.512 Sum_probs=207.2
Q ss_pred hcCCccccccCCCCceeEEEEEeCC--Cc----EEEEEEcccc-ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceE
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLAD--GK----AIAVKRLSRT-SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQEL 287 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~~--~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 287 (536)
.+.-+..+.||+|+||.||+|...+ +. .||||.+.+. +.+...+|.+|..+|+.++|||||+++|++.+....
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 3455677899999999999998643 33 4899999765 566778999999999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhhccc----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEeccc
Q 039168 288 LLIYEYMPNKSLDVHLFDAT----RSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFG 363 (536)
Q Consensus 288 ~lv~e~~~~~sL~~~l~~~~----~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg 363 (536)
++++|||++|+|..+|.+.+ ....+...+.+.++.|||+|+.||++++ +|||||...|+||++...|||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccc
Confidence 99999999999999997641 2446889999999999999999999996 9999999999999999999999999
Q ss_pred CccccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHHHHHhhcC
Q 039168 364 TARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEG 442 (536)
Q Consensus 364 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 442 (536)
+|+.+.+.+.........-...|||||.++.+.++.|+|||||||++||++| |..||+.....+ .+. .....+
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~---v~~---~~~~gg 921 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFE---VLL---DVLEGG 921 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHH---HHH---HHHhCC
Confidence 9996544433322222122458999999999999999999999999999999 677765433221 111 111122
Q ss_pred CccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 443 HAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 443 ~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
+ +. .+......+.+||.+||+.+|++||++..|++.+...
T Consensus 922 R-L~---------~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i 961 (1025)
T KOG1095|consen 922 R-LD---------PPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAI 961 (1025)
T ss_pred c-cC---------CCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhh
Confidence 1 11 1223344567888899999999999999999988765
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=312.00 Aligned_cols=247 Identities=28% Similarity=0.343 Sum_probs=193.1
Q ss_pred cCCCCceeEEEEEeC-CCcEEEEEEccccCh---hhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEeecCCCCh
Q 039168 224 LGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG---QGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSL 299 (536)
Q Consensus 224 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~~sL 299 (536)
||+|+||+||++.+. +++.||+|++..... ...+.+..|+++++.++||||+++.+++......++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999875 588999999865422 2345677899999999999999999999999999999999999999
Q ss_pred hhhhhccc-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCCccccc
Q 039168 300 DVHLFDAT-RSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTN 378 (536)
Q Consensus 300 ~~~l~~~~-~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 378 (536)
...+.... ....+++..++.++.||+.||.|||+++ |+||||||+||++++++.++|+|||++..+...... ..
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~--~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc--cc
Confidence 88875422 3456899999999999999999999996 999999999999999999999999999866433221 22
Q ss_pred cccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccccccCCCCH
Q 039168 379 IIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQSCAP 458 (536)
Q Consensus 379 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~ 458 (536)
...||+.|+|||++.+..++.++||||||+++|+|++|+.||........ ... ......... . ..+.
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~--~~~-~~~~~~~~~-------~---~~~~ 222 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--NKE-LKQRILNDS-------V---TYPD 222 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh--HHH-HHHhhcccC-------C---CCcc
Confidence 35689999999999999999999999999999999999999864322111 001 011000000 0 0111
Q ss_pred HHHHHHHHHHHhhcCCCCCCCC-----CHHHHHHH
Q 039168 459 DELLKFIHIGLLCVQQDPADRP-----TMSSVVVM 488 (536)
Q Consensus 459 ~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 488 (536)
.....+.+++.+||+.||++|| |++++++.
T Consensus 223 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 223 KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 1223456667799999999999 67777753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=333.52 Aligned_cols=253 Identities=21% Similarity=0.293 Sum_probs=193.7
Q ss_pred cCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEE
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 291 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 291 (536)
.+|++.+.||+|+||.||+++.. +++.||||++.... ......+.+|+++|++++||||+++++.+.+++.+++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 36899999999999999999975 58999999986532 223456889999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCC
Q 039168 292 EYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGN 371 (536)
Q Consensus 292 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 371 (536)
||+++++|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 E~~~~g~L~~~i~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~ 154 (376)
T cd05598 81 DYIPGGDMMSLLIRL---GIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (376)
T ss_pred eCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence 999999999998543 35889999999999999999999997 999999999999999999999999997533210
Q ss_pred CC-----------------------------------------ccccccccccccccCcchhcCCCCCccchHHHHHHHH
Q 039168 372 QN-----------------------------------------QANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLL 410 (536)
Q Consensus 372 ~~-----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il 410 (536)
.. ........||+.|+|||++.+..++.++|||||||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 234 (376)
T cd05598 155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 234 (376)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence 00 0001134799999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCC---CHHHHHH
Q 039168 411 LEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRP---TMSSVVV 487 (536)
Q Consensus 411 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP---t~~evl~ 487 (536)
|||++|+.||....... .............. + .... .+.+ +.+++.+|+ .+|.+|+ |+.++++
T Consensus 235 yell~G~~Pf~~~~~~~------~~~~i~~~~~~~~~--~-~~~~-~s~~---~~~li~~l~-~~p~~R~~~~t~~ell~ 300 (376)
T cd05598 235 YEMLVGQPPFLADTPAE------TQLKVINWETTLHI--P-SQAK-LSRE---ASDLILRLC-CGAEDRLGKNGADEIKA 300 (376)
T ss_pred eehhhCCCCCCCCCHHH------HHHHHhccCccccC--C-CCCC-CCHH---HHHHHHHHh-cCHhhcCCCCCHHHHhC
Confidence 99999999986432211 00111000000000 0 0011 1223 344445655 5999999 8888885
Q ss_pred H
Q 039168 488 M 488 (536)
Q Consensus 488 ~ 488 (536)
.
T Consensus 301 h 301 (376)
T cd05598 301 H 301 (376)
T ss_pred C
Confidence 5
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=315.69 Aligned_cols=267 Identities=30% Similarity=0.426 Sum_probs=197.9
Q ss_pred CccccccCCCCceeEEEEEe-----CCCcEEEEEEccccC-hhhHHHHHHHHHHHHHcCCCCceeEeeEEee--CceEEE
Q 039168 218 FSDENKLGQGGFGPVYKGTL-----ADGKAIAVKRLSRTS-GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLE--GQELLL 289 (536)
Q Consensus 218 ~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~--~~~~~l 289 (536)
|+..+.||+|+||+||++.. .+++.||+|.+.... ......+.+|+++++.++||||+++++++.. ....++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 38889999999999988652 357889999987543 2345678899999999999999999998765 346899
Q ss_pred EEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccC
Q 039168 290 IYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFG 369 (536)
Q Consensus 290 v~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 369 (536)
+|||+.+++|.+++... .+++.+++.++.|++.||.|||+++ ++|+||||+|||+++++.++|+|||++....
T Consensus 86 v~e~~~~~~l~~~~~~~----~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 86 IMEYVPLGSLRDYLPKH----KLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158 (283)
T ss_pred EecCCCCCCHHHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccC
Confidence 99999999999998542 3899999999999999999999996 9999999999999999999999999998765
Q ss_pred CCCCccc-cccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccc
Q 039168 370 GNQNQAN-TNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELI 448 (536)
Q Consensus 370 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 448 (536)
....... .....++..|+|||.+.+..++.++||||||+++|+|++|..|+........ ................++.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd05080 159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE-EMIGPKQGQMTVVRLIELL 237 (283)
T ss_pred CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhh-hhhcccccccchhhhhhhh
Confidence 3322111 1122346679999999988899999999999999999999999754321110 0000000000000011111
Q ss_pred cccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 449 DPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 449 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
+.......+......+.+++.+||+.+|++|||+++|+++|+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 238 ERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred hcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 11111111112234566777799999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=309.96 Aligned_cols=251 Identities=25% Similarity=0.381 Sum_probs=197.7
Q ss_pred cCCccccccCCCCceeEEEEEeC-CCcEEEEEEcccc-ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEee
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT-SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 293 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 293 (536)
++|++.++||+|+||.||+|.+. +++.||+|++... .....+.+.+|++++++++||||+++++.+...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 36788899999999999999864 6889999998654 333456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCC
Q 039168 294 MPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQN 373 (536)
Q Consensus 294 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 373 (536)
+++++|..+. .+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.++|+|||++..+....
T Consensus 81 ~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~- 149 (279)
T cd06619 81 MDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI- 149 (279)
T ss_pred CCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceeccccc-
Confidence 9999996542 3678889999999999999999997 9999999999999999999999999998654221
Q ss_pred ccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcccccccccc
Q 039168 374 QANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLK 453 (536)
Q Consensus 374 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~ 453 (536)
.....|+..|+|||++.+..++.++||||||+++|+|++|+.||......................... .+.
T Consensus 150 ---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~ 221 (279)
T cd06619 150 ---AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPP-----VLP 221 (279)
T ss_pred ---ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCC-----CCC
Confidence 223568999999999999899999999999999999999999986533322211111111111111111 111
Q ss_pred CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 454 QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 454 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
.... ..++.+++.+||+.||++||++.++++.
T Consensus 222 ~~~~---~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 222 VGQF---SEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred CCcC---CHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 1111 2345667779999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=321.01 Aligned_cols=243 Identities=25% Similarity=0.370 Sum_probs=191.2
Q ss_pred cccCCCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHHHc-CCCCceeEeeEEeeCceEEEEEeecCC
Q 039168 222 NKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLKEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYEYMPN 296 (536)
Q Consensus 222 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~ 296 (536)
+.||+|+||.||++... +++.||+|++.+.. ....+.+.+|..++.++ +||||+++++++...+.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999975 57899999997542 23456688899999888 699999999999999999999999999
Q ss_pred CChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCCccc
Q 039168 297 KSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQAN 376 (536)
Q Consensus 297 ~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 376 (536)
++|..++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (327)
T cd05617 81 GDLMFHMQRQ---RKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG--DT 152 (327)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCC--Cc
Confidence 9998887533 35899999999999999999999997 9999999999999999999999999987532211 12
Q ss_pred cccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccccccCCC
Q 039168 377 TNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQSC 456 (536)
Q Consensus 377 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~ 456 (536)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||........................ . +...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~-----~p~~- 225 (327)
T cd05617 153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI-R-----IPRF- 225 (327)
T ss_pred eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCC-C-----CCCC-
Confidence 23457899999999999999999999999999999999999998653332222222222232222111 0 1111
Q ss_pred CHHHHHHHHHHHHhhcCCCCCCCCCH
Q 039168 457 APDELLKFIHIGLLCVQQDPADRPTM 482 (536)
Q Consensus 457 ~~~~~~~l~~li~~cl~~dP~~RPt~ 482 (536)
.+ ..+.+++.+||+.||++|+++
T Consensus 226 ~~---~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 226 LS---VKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred CC---HHHHHHHHHHhccCHHHcCCC
Confidence 12 335566779999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=322.87 Aligned_cols=246 Identities=25% Similarity=0.311 Sum_probs=193.7
Q ss_pred CCccccccCCCCceeEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHHHcCCC-CceeEeeEEeeCceEEEEE
Q 039168 217 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLKEFKNEVNLIAKLQHK-NLVRLLGCCLEGQELLLIY 291 (536)
Q Consensus 217 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hp-niv~l~~~~~~~~~~~lv~ 291 (536)
+|++.+.||+|+||.||+|+.+ +++.||||++.+. .....+.+..|.+++..++|+ +|+++++++...+..|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4788999999999999999876 4789999998753 233456778899999999765 6888999999999999999
Q ss_pred eecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCC
Q 039168 292 EYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGN 371 (536)
Q Consensus 292 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 371 (536)
||+++++|..++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05587 81 EYVNGGDLMYHIQQV---GKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG 154 (324)
T ss_pred cCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence 999999999888543 34889999999999999999999996 999999999999999999999999998753221
Q ss_pred CCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcccccccc
Q 039168 372 QNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPV 451 (536)
Q Consensus 372 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 451 (536)
. .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...... .... . ...... .
T Consensus 155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~---~~~~---~-i~~~~~------~ 219 (324)
T cd05587 155 G--KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED---ELFQ---S-IMEHNV------S 219 (324)
T ss_pred C--CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---HHHH---H-HHcCCC------C
Confidence 1 1223457899999999999999999999999999999999999998533211 1111 1 111110 0
Q ss_pred ccCCCCHHHHHHHHHHHHhhcCCCCCCCCCH-----HHHHH
Q 039168 452 LKQSCAPDELLKFIHIGLLCVQQDPADRPTM-----SSVVV 487 (536)
Q Consensus 452 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~-----~evl~ 487 (536)
.... ....+.+++.+||+.||++|++. .++++
T Consensus 220 ~~~~----~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 256 (324)
T cd05587 220 YPKS----LSKEAVSICKGLLTKHPAKRLGCGPTGERDIRE 256 (324)
T ss_pred CCCC----CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 1111 12345677779999999999986 56654
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=323.39 Aligned_cols=245 Identities=24% Similarity=0.321 Sum_probs=191.3
Q ss_pred CccccccCCCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHH---HHcCCCCceeEeeEEeeCceEEEE
Q 039168 218 FSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLKEFKNEVNLI---AKLQHKNLVRLLGCCLEGQELLLI 290 (536)
Q Consensus 218 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~hpniv~l~~~~~~~~~~~lv 290 (536)
|++.+.||+|+||.||++.+. +++.||||++.+.. ....+.+.+|.+++ +.++||||+++++++...+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 677899999999999999875 58999999987532 23345566676655 566899999999999999999999
Q ss_pred EeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCC
Q 039168 291 YEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGG 370 (536)
Q Consensus 291 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 370 (536)
|||+++++|..++.. ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~E~~~~~~L~~~~~~----~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 81 MEYAAGGDLMMHIHT----DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG 153 (324)
T ss_pred EcCCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence 999999999887743 35899999999999999999999996 99999999999999999999999999875322
Q ss_pred CCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccc
Q 039168 371 NQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDP 450 (536)
Q Consensus 371 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 450 (536)
.. .......|++.|+|||++.+..++.++|||||||++|+|++|+.||...... ..... ......
T Consensus 154 ~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~------~~~~~-i~~~~~------ 218 (324)
T cd05589 154 FG--DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE------EVFDS-IVNDEV------ 218 (324)
T ss_pred CC--CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH------HHHHH-HHhCCC------
Confidence 21 1223457899999999999999999999999999999999999997543211 11111 111111
Q ss_pred cccCCCCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHHH
Q 039168 451 VLKQSCAPDELLKFIHIGLLCVQQDPADRP-----TMSSVVVM 488 (536)
Q Consensus 451 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 488 (536)
...... ...+.+++.+||+.||.+|| ++.++++.
T Consensus 219 ~~p~~~----~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 219 RYPRFL----SREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred CCCCCC----CHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 011111 23456677799999999999 56676653
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=311.97 Aligned_cols=255 Identities=27% Similarity=0.447 Sum_probs=196.4
Q ss_pred CccccccCCCCceeEEEEEeCCC---cEEEEEEcccc--ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeC------ce
Q 039168 218 FSDENKLGQGGFGPVYKGTLADG---KAIAVKRLSRT--SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEG------QE 286 (536)
Q Consensus 218 ~~~~~~lg~G~~g~Vy~~~~~~~---~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~------~~ 286 (536)
|.+.++||+|+||.||+|.+... ..+|+|.+... .....+.+.+|+++++.++||||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 35678999999999999997643 26899988653 344567788999999999999999999987432 25
Q ss_pred EEEEEeecCCCChhhhhhccc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEeccc
Q 039168 287 LLLIYEYMPNKSLDVHLFDAT---RSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFG 363 (536)
Q Consensus 287 ~~lv~e~~~~~sL~~~l~~~~---~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg 363 (536)
.+++|||+.+++|..++.... ....+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence 789999999999998874321 2345889999999999999999999986 9999999999999999999999999
Q ss_pred CccccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHHHHHhhcC
Q 039168 364 TARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEG 442 (536)
Q Consensus 364 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 442 (536)
+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||..... .. .......+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~----~~~~~~~~ 230 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN---SE----IYDYLRQG 230 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH---HH----HHHHHHcC
Confidence 9987654332222223345778999999999999999999999999999999 7888753211 11 11122222
Q ss_pred CccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcc
Q 039168 443 HAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 491 (536)
Q Consensus 443 ~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 491 (536)
..... . +.....+.+++.+||+.||++|||+.+|++.|+.
T Consensus 231 ~~~~~-----~----~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~ 270 (272)
T cd05075 231 NRLKQ-----P----PDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEK 270 (272)
T ss_pred CCCCC-----C----CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 21111 1 1112346677779999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=318.21 Aligned_cols=260 Identities=31% Similarity=0.441 Sum_probs=204.1
Q ss_pred HhcCCccccccCCCCceeEEEEEeC------CCcEEEEEEcccc-ChhhHHHHHHHHHHHHHc-CCCCceeEeeEEeeCc
Q 039168 214 ATNHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRT-SGQGLKEFKNEVNLIAKL-QHKNLVRLLGCCLEGQ 285 (536)
Q Consensus 214 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~ 285 (536)
..++|+..+.||+|+||.||++... ....+|+|.+... .......+.+|+.+++++ +||||+++++++..++
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 3467899999999999999999864 2467999988754 334456788999999999 8999999999999999
Q ss_pred eEEEEEeecCCCChhhhhhcc-------------cCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEc
Q 039168 286 ELLLIYEYMPNKSLDVHLFDA-------------TRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLD 352 (536)
Q Consensus 286 ~~~lv~e~~~~~sL~~~l~~~-------------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~ 352 (536)
..+++|||+.+++|..++... .....+++..++.++.||+.||.|||+.+ |+|+||||+|||++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~ 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVT 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEc
Confidence 999999999999999998642 22346889999999999999999999986 99999999999999
Q ss_pred CCCCeEEecccCccccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchh
Q 039168 353 DDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTL 431 (536)
Q Consensus 353 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~ 431 (536)
+++.+||+|||+++.+.............++..|+|||.+.+..++.++|||||||++|||++ |..||...... .
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~- 242 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE---E- 242 (293)
T ss_pred CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHH---H-
Confidence 999999999999987654332222222234578999999998899999999999999999998 88886432111 1
Q ss_pred HHHHHHHhhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 432 LTYTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 432 ~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
.......+.... .+......+.+++.+||+.||++|||+.++++.|+..
T Consensus 243 ---~~~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 243 ---LFKLLKEGYRME---------KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred ---HHHHHHcCCcCC---------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence 111111111111 1112234577788899999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=311.66 Aligned_cols=256 Identities=27% Similarity=0.452 Sum_probs=199.1
Q ss_pred CccccccCCCCceeEEEEEeCC----CcEEEEEEcccc--ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCce-----
Q 039168 218 FSDENKLGQGGFGPVYKGTLAD----GKAIAVKRLSRT--SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQE----- 286 (536)
Q Consensus 218 ~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~----- 286 (536)
|.+.+.||+|+||.||+|.+.. +..||+|++... .....+.+.+|+..++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5678899999999999998642 478999998743 23345678999999999999999999998876554
Q ss_pred -EEEEEeecCCCChhhhhhccc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecc
Q 039168 287 -LLLIYEYMPNKSLDVHLFDAT---RSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDF 362 (536)
Q Consensus 287 -~~lv~e~~~~~sL~~~l~~~~---~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Df 362 (536)
.++++||+++++|..++.... ....+++..+..++.|++.||.|||+++ ++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 799999999999998885432 2245899999999999999999999986 999999999999999999999999
Q ss_pred cCccccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHHHHHhhc
Q 039168 363 GTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCE 441 (536)
Q Consensus 363 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 441 (536)
|+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||..... ...... ...
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~---~~~~~~----~~~ 230 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN---HEIYDY----LRH 230 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH---HHHHHH----HHc
Confidence 99987654332222222334678999999988889999999999999999999 8888643211 111111 111
Q ss_pred CCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 442 GHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 442 ~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
+..... +.....++.+++.+||+.||++|||+.++++.|+..
T Consensus 231 ~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 231 GNRLKQ---------PEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CCCCCC---------CcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 111111 112234577777899999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=310.25 Aligned_cols=253 Identities=31% Similarity=0.487 Sum_probs=200.4
Q ss_pred cCCccccccCCCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEeecC
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMP 295 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 295 (536)
++|++.++||+|+||.||+|.+.+...||+|++..... ..+.+.+|+++++.++||||+++++.+.+ ...++||||+.
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~ 83 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 83 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCC
Confidence 57999999999999999999987777899999875332 34678899999999999999999998754 56899999999
Q ss_pred CCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCCcc
Q 039168 296 NKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQA 375 (536)
Q Consensus 296 ~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 375 (536)
+++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||.+..+.......
T Consensus 84 ~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~ 159 (262)
T cd05071 84 KGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 159 (262)
T ss_pred CCcHHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeecccccccc
Confidence 999999996432 235789999999999999999999986 9999999999999999999999999998664332211
Q ss_pred ccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHHHHHhhcCCccccccccccC
Q 039168 376 NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQ 454 (536)
Q Consensus 376 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~ 454 (536)
.....++..|+|||++.+..++.++||||||+++|+|++ |+.||...... ... .........
T Consensus 160 -~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~---~~~----~~~~~~~~~--------- 222 (262)
T cd05071 160 -RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---EVL----DQVERGYRM--------- 222 (262)
T ss_pred -ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH---HHH----HHHhcCCCC---------
Confidence 112345678999999988889999999999999999999 77786532211 111 111111000
Q ss_pred CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcc
Q 039168 455 SCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 491 (536)
Q Consensus 455 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 491 (536)
.........+.+++.+|++.||++|||+.+++++|+.
T Consensus 223 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~ 259 (262)
T cd05071 223 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 259 (262)
T ss_pred CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence 1112233457788889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=311.06 Aligned_cols=252 Identities=29% Similarity=0.491 Sum_probs=198.3
Q ss_pred CccccccCCCCceeEEEEEeCC-CcEEEEEEccccChhhHH--HHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEeec
Q 039168 218 FSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLK--EFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 294 (536)
Q Consensus 218 ~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~--~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 294 (536)
|++.+.||+|+||+||+++... ++.||+|++......... ...+|+.++++++||||+++++++.+....++|||++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 5778999999999999999865 678999999876554333 3456999999999999999999999999999999999
Q ss_pred CCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCCc
Q 039168 295 PNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQ 374 (536)
Q Consensus 295 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 374 (536)
.+++|.+++. ....+++..++.++.||++||.+||+.+ ++|+||||+||++++++.++|+|||.+.... ...
T Consensus 81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~--~~~ 152 (260)
T PF00069_consen 81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLS--ENN 152 (260)
T ss_dssp TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEEST--STT
T ss_pred cccccccccc---cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc--ccc
Confidence 9999999996 3345899999999999999999999996 9999999999999999999999999998652 122
Q ss_pred cccccccccccccCcchhc-CCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcccccccccc
Q 039168 375 ANTNIIAGTYGYMAPEYAM-GGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLK 453 (536)
Q Consensus 375 ~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~ 453 (536)
.......++..|+|||++. +..++.++||||||+++|+|++|..||............. .... . ........
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~---~~~~-~---~~~~~~~~ 225 (260)
T PF00069_consen 153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIE---KILK-R---PLPSSSQQ 225 (260)
T ss_dssp SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHH---HHHH-T---HHHHHTTS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhh---hccc-c---cccccccc
Confidence 2333456899999999998 7889999999999999999999999976541111111111 1100 0 00000000
Q ss_pred CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 454 QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 454 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
.......+.+++.+||+.||++|||+.++++
T Consensus 226 ---~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 226 ---SREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp ---HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred ---cchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0001156777778999999999999999985
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=321.47 Aligned_cols=236 Identities=25% Similarity=0.358 Sum_probs=187.5
Q ss_pred cccCCCCceeEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHHHc-CCCCceeEeeEEeeCceEEEEEeecCC
Q 039168 222 NKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLKEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYEYMPN 296 (536)
Q Consensus 222 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~ 296 (536)
+.||+|+||.||+++++ +++.||||++.+. .....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999976 5889999998653 223455677888888877 699999999999999999999999999
Q ss_pred CChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCCccc
Q 039168 297 KSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQAN 376 (536)
Q Consensus 297 ~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 376 (536)
++|..++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~i~~~---~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~~ 152 (320)
T cd05590 81 GDLMFHIQKS---RRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KT 152 (320)
T ss_pred chHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--Cc
Confidence 9999888543 35899999999999999999999997 9999999999999999999999999987542221 12
Q ss_pred cccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccccccCCC
Q 039168 377 TNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQSC 456 (536)
Q Consensus 377 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~ 456 (536)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ... ........ . .. ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~------~~~-~~i~~~~~-~-----~~-~~ 218 (320)
T cd05590 153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED------DLF-EAILNDEV-V-----YP-TW 218 (320)
T ss_pred ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH------HHH-HHHhcCCC-C-----CC-CC
Confidence 23457899999999999999999999999999999999999998643211 111 11111111 0 01 11
Q ss_pred CHHHHHHHHHHHHhhcCCCCCCCCCH
Q 039168 457 APDELLKFIHIGLLCVQQDPADRPTM 482 (536)
Q Consensus 457 ~~~~~~~l~~li~~cl~~dP~~RPt~ 482 (536)
.+ ..+.+++.+||+.||++||++
T Consensus 219 ~~---~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 219 LS---QDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CC---HHHHHHHHHHcccCHHHCCCC
Confidence 12 345667779999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=312.97 Aligned_cols=257 Identities=25% Similarity=0.340 Sum_probs=191.7
Q ss_pred CCccccccCCCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCc-----eEEEE
Q 039168 217 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQ-----ELLLI 290 (536)
Q Consensus 217 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-----~~~lv 290 (536)
.|...+++|.|+||.||+|... +++.||||+...... --.+|+++|+.+.|||||++..+|.... ...+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 5777889999999999999975 479999999876543 1236999999999999999999987532 45689
Q ss_pred EeecCCCChhhhhhcc-cCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCC-CCeEEecccCcccc
Q 039168 291 YEYMPNKSLDVHLFDA-TRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDD-MNPKISDFGTARIF 368 (536)
Q Consensus 291 ~e~~~~~sL~~~l~~~-~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~-~~~kl~Dfg~a~~~ 368 (536)
||||+. +|.+.+... .....++...+.-+..||++||.|||+.+ |+||||||.|+|||.+ |.+||+|||.|+.+
T Consensus 101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 999966 566666531 22445788888899999999999999986 9999999999999966 89999999999988
Q ss_pred CCCCCccccccccccccccCcchhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccc-
Q 039168 369 GGNQNQANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVE- 446 (536)
Q Consensus 369 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~- 446 (536)
....... + ..-|..|+|||.+.|. .|+.+.||||.||++.||+-|++-|..... .+.+..+.+.+.-+...+
T Consensus 177 ~~~epni--S-YicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~---~dQL~eIik~lG~Pt~e~I 250 (364)
T KOG0658|consen 177 VKGEPNI--S-YICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSS---VDQLVEIIKVLGTPTREDI 250 (364)
T ss_pred ccCCCce--e-EEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCH---HHHHHHHHHHhCCCCHHHH
Confidence 6544432 1 2347899999999886 599999999999999999999998865322 222222222222111111
Q ss_pred ---------cccccccCC-----CCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 447 ---------LIDPVLKQS-----CAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 447 ---------l~~~~l~~~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
.-.+.+... .......+.++++.++|+.+|.+|.++.+++.
T Consensus 251 ~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 251 KSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred hhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 111111111 11222345777777999999999999999984
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=322.66 Aligned_cols=253 Identities=25% Similarity=0.322 Sum_probs=207.4
Q ss_pred HHhcCCccccccCCCCceeEEEEEeCC-CcEEEEEEccccChh---hHHHHHHHHHHHHHcC-CCCceeEeeEEeeCceE
Q 039168 213 EATNHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQ---GLKEFKNEVNLIAKLQ-HKNLVRLLGCCLEGQEL 287 (536)
Q Consensus 213 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~ 287 (536)
.....|++.+.||.|.||.||+++.+. |+.+|+|.+.+.... ..+.+.+|+.+|+++. |||||.++++|+..+.+
T Consensus 32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~ 111 (382)
T KOG0032|consen 32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSV 111 (382)
T ss_pred cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeE
Confidence 345689999999999999999999875 999999999765432 4568999999999998 99999999999999999
Q ss_pred EEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCC----CCeEEeccc
Q 039168 288 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDD----MNPKISDFG 363 (536)
Q Consensus 288 ~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~----~~~kl~Dfg 363 (536)
++|||++.||.|.+.+... .+++..+..++.||+.++.|||+.| |+||||||+|+|+... +.+|++|||
T Consensus 112 ~lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFG 184 (382)
T KOG0032|consen 112 YLVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFG 184 (382)
T ss_pred EEEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence 9999999999999999765 3999999999999999999999987 9999999999999643 479999999
Q ss_pred CccccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCC
Q 039168 364 TARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGH 443 (536)
Q Consensus 364 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 443 (536)
++..... .......+||+.|+|||++....|+..+||||+|+++|.|++|..||........ .. ....++
T Consensus 185 la~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~--~~-----~i~~~~ 254 (382)
T KOG0032|consen 185 LAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEI--FL-----AILRGD 254 (382)
T ss_pred CceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHH--HH-----HHHcCC
Confidence 9998764 3445568999999999999999999999999999999999999999754332211 11 112222
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 444 AVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 444 ~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
. .......+.....+.+++..||..||..|+|+.++|+.
T Consensus 255 ~------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 255 F------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred C------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 2 11111122223344555569999999999999999984
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=327.92 Aligned_cols=252 Identities=23% Similarity=0.308 Sum_probs=198.0
Q ss_pred cCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEE
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 291 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 291 (536)
++|++.+.||+|+||.||++... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46889999999999999999875 58999999987542 234566889999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCC
Q 039168 292 EYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGN 371 (536)
Q Consensus 292 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 371 (536)
||+++++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 81 EYQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred CCCCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 999999999998653 235899999999999999999999996 999999999999999999999999999876543
Q ss_pred CCccccccccccccccCcchhc------CCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcc
Q 039168 372 QNQANTNIIAGTYGYMAPEYAM------GGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAV 445 (536)
Q Consensus 372 ~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 445 (536)
... ......||+.|+|||++. +..++.++|||||||++|+|++|+.||...... .............
T Consensus 156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~------~~~~~i~~~~~~~ 228 (330)
T cd05601 156 KMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA------KTYNNIMNFQRFL 228 (330)
T ss_pred Cce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH------HHHHHHHcCCCcc
Confidence 322 222346899999999986 456789999999999999999999997532211 1111111111111
Q ss_pred ccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 446 ELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 446 ~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
...+ .+.....+.+++..||+ +|.+|||+.++++
T Consensus 229 ~~~~-------~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 229 KFPE-------DPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred CCCC-------CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 1100 01112335556668997 9999999999985
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=323.92 Aligned_cols=242 Identities=23% Similarity=0.275 Sum_probs=191.7
Q ss_pred cccCCCCceeEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEeecCCC
Q 039168 222 NKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNK 297 (536)
Q Consensus 222 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~~ 297 (536)
+.||+|+||.||++... +++.||+|++... .......+.+|+++++.++||||+++++++...+..++||||++++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999875 6899999998753 2233456778999999999999999999999999999999999999
Q ss_pred ChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCCccc
Q 039168 298 SLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHE-DSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQAN 376 (536)
Q Consensus 298 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 376 (536)
+|..++... ..+++..+..++.||+.||.|||+ .+ |+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~ 152 (325)
T cd05594 81 ELFFHLSRE---RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--T 152 (325)
T ss_pred cHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc--c
Confidence 998888543 358999999999999999999997 55 99999999999999999999999999875432211 1
Q ss_pred cccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccccccCCC
Q 039168 377 TNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQSC 456 (536)
Q Consensus 377 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~ 456 (536)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||.....+ ..... .. .... .+....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~---~~~~~---i~-~~~~------~~p~~~ 219 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KLFEL---IL-MEEI------RFPRTL 219 (325)
T ss_pred cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH---HHHHH---Hh-cCCC------CCCCCC
Confidence 22356899999999999999999999999999999999999998542211 11111 11 1100 011111
Q ss_pred CHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHHH
Q 039168 457 APDELLKFIHIGLLCVQQDPADRP-----TMSSVVVM 488 (536)
Q Consensus 457 ~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 488 (536)
+ .++.+++.+||+.||++|+ ++.++++.
T Consensus 220 -~---~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 220 -S---PEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred -C---HHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 2 2355666799999999997 89999854
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=310.42 Aligned_cols=255 Identities=24% Similarity=0.365 Sum_probs=199.9
Q ss_pred hcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEee
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 293 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 293 (536)
.++|++.+.||+|+||.||+|+.. +++.||+|++..........+.+|+.++++++||||+++++.+..+...++||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 468999999999999999999974 6889999998765555566788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCC
Q 039168 294 MPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQN 373 (536)
Q Consensus 294 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 373 (536)
+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++..+.....
T Consensus 88 ~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06646 88 CGGGSLQDIYHVT---GPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIA 161 (267)
T ss_pred CCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeeccccc
Confidence 9999999988542 35899999999999999999999986 99999999999999999999999999986643221
Q ss_pred ccccccccccccccCcchhc---CCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccc
Q 039168 374 QANTNIIAGTYGYMAPEYAM---GGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDP 450 (536)
Q Consensus 374 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 450 (536)
......|++.|+|||.+. ...++.++||||||+++|||++|+.|+.......... . ..... +..+
T Consensus 162 --~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~--~-----~~~~~---~~~~ 229 (267)
T cd06646 162 --KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF--L-----MSKSN---FQPP 229 (267)
T ss_pred --ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe--e-----eecCC---CCCC
Confidence 122346788999999884 3457889999999999999999999974322111000 0 00000 0000
Q ss_pred cccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHh
Q 039168 451 VLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 489 (536)
Q Consensus 451 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 489 (536)
.... .......+.+++.+||+.+|++|||+++|++.|
T Consensus 230 ~~~~--~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 230 KLKD--KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CCcc--ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 0100 011123566777799999999999999999754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=309.71 Aligned_cols=254 Identities=31% Similarity=0.481 Sum_probs=200.3
Q ss_pred hcCCccccccCCCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEeec
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 294 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 294 (536)
.++|++.++||+|+||.||+|...++..+|+|++..... ..+.+.+|+.++++++|||++++++++. ....+++|||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYM 82 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEec
Confidence 357899999999999999999988888999999875433 3467899999999999999999999885 45689999999
Q ss_pred CCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCCc
Q 039168 295 PNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQ 374 (536)
Q Consensus 295 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 374 (536)
.+++|.+++.... ...+++..++.++.|++.||.|||+++ ++|+||||+||++++++.++|+|||++..+......
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05070 83 SKGSLLDFLKDGE-GRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcccc
Confidence 9999999986532 334899999999999999999999996 999999999999999999999999999876433221
Q ss_pred cccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHHHHHhhcCCcccccccccc
Q 039168 375 ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLK 453 (536)
Q Consensus 375 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~ 453 (536)
. .....++..|+|||.+.+..++.++||||||+++|+|++ |..||..... ..... . +....... .
T Consensus 159 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~---~~~~~---~-~~~~~~~~-----~- 224 (260)
T cd05070 159 A-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN---REVLE---Q-VERGYRMP-----C- 224 (260)
T ss_pred c-ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH---HHHHH---H-HHcCCCCC-----C-
Confidence 1 111234567999999988889999999999999999999 8888753211 11111 1 11111000 1
Q ss_pred CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcc
Q 039168 454 QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 491 (536)
Q Consensus 454 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 491 (536)
+......+.+++.+||+++|++|||++++++.|+.
T Consensus 225 ---~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 225 ---PQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred ---CCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 11122346677779999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=304.40 Aligned_cols=250 Identities=38% Similarity=0.520 Sum_probs=201.5
Q ss_pred cccCCCCceeEEEEEeCC----CcEEEEEEccccChhh-HHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEeecCC
Q 039168 222 NKLGQGGFGPVYKGTLAD----GKAIAVKRLSRTSGQG-LKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPN 296 (536)
Q Consensus 222 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 296 (536)
++||+|+||.||++.... +..|++|.+....... .+.+.+|+++++.++|+|++++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 479999999999998753 8899999987654433 67889999999999999999999999999999999999999
Q ss_pred CChhhhhhcccC------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCC
Q 039168 297 KSLDVHLFDATR------SVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGG 370 (536)
Q Consensus 297 ~sL~~~l~~~~~------~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 370 (536)
++|.+++..... ...+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 999999865421 256899999999999999999999986 99999999999999999999999999987765
Q ss_pred CCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHHHHHhhcCCcccccc
Q 039168 371 NQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELID 449 (536)
Q Consensus 371 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 449 (536)
...........+++.|+|||.+.+..++.++||||||+++|+|++ |..||...... . .......+....
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~----~~~~~~~~~~~~--- 227 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE---E----VLEYLRKGYRLP--- 227 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH---H----HHHHHHcCCCCC---
Confidence 432222334557889999999998899999999999999999999 58887544111 1 111111111111
Q ss_pred ccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 039168 450 PVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLA 490 (536)
Q Consensus 450 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 490 (536)
. +.....++.+++.+||+.||++|||+.++++.|+
T Consensus 228 --~----~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 228 --K----PEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred --C----CccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 1 1111345667777999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=326.90 Aligned_cols=260 Identities=20% Similarity=0.253 Sum_probs=198.9
Q ss_pred HhcCCccccccCCCCceeEEEEEeC---CCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEE
Q 039168 214 ATNHFSDENKLGQGGFGPVYKGTLA---DGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 290 (536)
Q Consensus 214 ~~~~~~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 290 (536)
...+|++.+.||+|+||.||++... .++.||+|.+... ....+|+++|++++||||+++++++......++|
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv 164 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMV 164 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEE
Confidence 3468999999999999999999753 3678999988643 2356899999999999999999999999999999
Q ss_pred EeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCC
Q 039168 291 YEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGG 370 (536)
Q Consensus 291 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 370 (536)
||++. ++|..++. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++..+..
T Consensus 165 ~e~~~-~~l~~~l~---~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~ 237 (392)
T PHA03207 165 MPKYK-CDLFTYVD---RSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDA 237 (392)
T ss_pred ehhcC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCc
Confidence 99996 56777772 3345899999999999999999999997 99999999999999999999999999987654
Q ss_pred CCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCc------
Q 039168 371 NQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHA------ 444 (536)
Q Consensus 371 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~------ 444 (536)
...........||+.|+|||++.+..++.++|||||||++|||++|+.||...........+............
T Consensus 238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~ 317 (392)
T PHA03207 238 HPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNG 317 (392)
T ss_pred ccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCcc
Confidence 43333333467999999999999999999999999999999999999998554332211111111111100000
Q ss_pred ----------------c-ccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 445 ----------------V-ELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 445 ----------------~-~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
. ..+.+.+..... ..++.+++.+||+.||++|||+.+++..
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 318 STNLCKHFKQYAIVLRPPYTIPPVIRKYGM---HMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred chhHHHHHHhhcccccCCccccchhhccCc---chhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0 000000110111 1345667779999999999999999976
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=311.71 Aligned_cols=252 Identities=26% Similarity=0.318 Sum_probs=198.1
Q ss_pred CCccccccCCCCceeEEEEEeC-CCcEEEEEEccccCh---hhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEe
Q 039168 217 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG---QGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 292 (536)
Q Consensus 217 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 292 (536)
.|+..++||+|+||.||++... +++.||+|++..... .....+.+|+.+++.++||||+++++.+..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4788899999999999999975 589999999865322 223456789999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCC
Q 039168 293 YMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQ 372 (536)
Q Consensus 293 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 372 (536)
|+++++|..++... ....+++..+..++.|++.||.|||+.+ ++||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 81 LMNGGDLKFHIYNM-GNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred ccCCCcHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence 99999999887543 2345899999999999999999999997 9999999999999999999999999998754322
Q ss_pred CccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccccc
Q 039168 373 NQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVL 452 (536)
Q Consensus 373 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l 452 (536)
. .....|++.|+|||++.+..++.++||||+|+++|+|++|+.||....... ............ .
T Consensus 157 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~---~~~~~~~~~~~~-~-------- 221 (285)
T cd05605 157 T---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV---KREEVERRVKED-Q-------- 221 (285)
T ss_pred c---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh---HHHHHHHHhhhc-c--------
Confidence 1 123468999999999998889999999999999999999999986432211 111111111000 0
Q ss_pred cCCCCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHHH
Q 039168 453 KQSCAPDELLKFIHIGLLCVQQDPADRP-----TMSSVVVM 488 (536)
Q Consensus 453 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 488 (536)
...+......+.+++..||+.||++|| ++.++++.
T Consensus 222 -~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 222 -EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred -cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 011111223456677799999999999 88888654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=311.70 Aligned_cols=264 Identities=25% Similarity=0.398 Sum_probs=200.0
Q ss_pred cCCccccccCCCCceeEEEEEeC-----------------CCcEEEEEEcccc-ChhhHHHHHHHHHHHHHcCCCCceeE
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA-----------------DGKAIAVKRLSRT-SGQGLKEFKNEVNLIAKLQHKNLVRL 277 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l 277 (536)
++|++.++||+|+||.||++... +...||+|++... .....+.+.+|+.+++.++||||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 57999999999999999998532 2446899998754 33445688999999999999999999
Q ss_pred eeEEeeCceEEEEEeecCCCChhhhhhcccC--------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcE
Q 039168 278 LGCCLEGQELLLIYEYMPNKSLDVHLFDATR--------SVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNV 349 (536)
Q Consensus 278 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~--------~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NI 349 (536)
++++...+..++||||+.+++|..++..... ...+++..++.++.||+.||+|||+.+ ++|+||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheE
Confidence 9999999999999999999999999865321 124778899999999999999999996 99999999999
Q ss_pred EEcCCCCeEEecccCccccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh--CCCCCCCCCccC
Q 039168 350 LLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS--GRKNNGFYFSEH 427 (536)
Q Consensus 350 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt--g~~p~~~~~~~~ 427 (536)
|++.++.++|+|||++..+.............+++.|++||...++.++.++||||||+++|||++ |..||......
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~- 240 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE- 240 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH-
Confidence 999999999999999986643322222222334678999999988889999999999999999998 66665432211
Q ss_pred CchhHHHHHHHhhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcc
Q 039168 428 GQTLLTYTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 491 (536)
Q Consensus 428 ~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 491 (536)
.........+..... ....+ . +......+.+++.+||+.||++|||+.+|++.|+.
T Consensus 241 --~~~~~~~~~~~~~~~-~~~~~-~----~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 241 --QVIENTGEFFRDQGR-QVYLP-K----PALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred --HHHHHHHHHHhhccc-cccCC-C----CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 111111111111100 00000 0 11112456677779999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=326.39 Aligned_cols=259 Identities=23% Similarity=0.342 Sum_probs=194.9
Q ss_pred CCccccccCCCCceeEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCc-----eEE
Q 039168 217 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQ-----ELL 288 (536)
Q Consensus 217 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-----~~~ 288 (536)
+|+..++||+|+||.||++.+. +++.||||++... .....+.+.+|+.+++.++||||+++++++.... ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4788999999999999999974 6899999998653 2334567889999999999999999999998776 899
Q ss_pred EEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCcccc
Q 039168 289 LIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIF 368 (536)
Q Consensus 289 lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 368 (536)
+|+||+. ++|..++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~l~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 81 VVTELMQ-SDLHKIIVS---PQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred EEeeccc-cCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence 9999996 467666633 345899999999999999999999997 999999999999999999999999999865
Q ss_pred CCCCCccccccccccccccCcchhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHH---------
Q 039168 369 GGNQNQANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKL--------- 438 (536)
Q Consensus 369 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~--------- 438 (536)
...... ......+++.|+|||++.+. .++.++|||||||++|||++|+.||....... ........
T Consensus 154 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~i~~~~g~~~~~~~ 229 (372)
T cd07853 154 EPDESK-HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQ---QLDLITDLLGTPSLEAM 229 (372)
T ss_pred ccCccc-cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHH---HHHHHHHHcCCCCHHHH
Confidence 432221 12234578999999999874 47999999999999999999999986433211 11111000
Q ss_pred ----------hh-cCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 439 ----------WC-EGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 439 ----------~~-~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
+. ............ .........+.+++.+||+.||++|||+.++++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 230 RSACEGARAHILRGPHKPPSLPVLY--TLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHhhHHHHHHHHhCCCCCCchHHhc--ccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 00 000000000000 0011113456678889999999999999999964
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=317.20 Aligned_cols=258 Identities=31% Similarity=0.444 Sum_probs=202.3
Q ss_pred hcCCccccccCCCCceeEEEEEeC------CCcEEEEEEccccC-hhhHHHHHHHHHHHHHc-CCCCceeEeeEEeeCce
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRTS-GQGLKEFKNEVNLIAKL-QHKNLVRLLGCCLEGQE 286 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~ 286 (536)
.++|.+.+.||+|+||.||++... .+..||+|++.... ....+.+.+|+.+++++ +||||+++++++...+.
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 357899999999999999999742 35689999887543 33456789999999999 79999999999999999
Q ss_pred EEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCcc
Q 039168 287 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTAR 366 (536)
Q Consensus 287 ~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 366 (536)
.++||||+.+++|..++.... ...+++.++..++.||+.||.|||+++ |+|+||||+|||++.++.++|+|||+++
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcccc
Confidence 999999999999999986432 233899999999999999999999986 9999999999999999999999999998
Q ss_pred ccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHHHHHhhcCCcc
Q 039168 367 IFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGHAV 445 (536)
Q Consensus 367 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 445 (536)
.+.............++..|+|||.+.+..++.++||||||+++|+|++ |..||...... ... ......+...
T Consensus 190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~--~~~----~~~~~~~~~~ 263 (302)
T cd05055 190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD--SKF----YKLIKEGYRM 263 (302)
T ss_pred cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch--HHH----HHHHHcCCcC
Confidence 6654322212222345778999999999999999999999999999998 88886532211 011 1111111110
Q ss_pred ccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcc
Q 039168 446 ELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 491 (536)
Q Consensus 446 ~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 491 (536)
. .. ......+.+++.+||+.+|++|||+.++++.|+.
T Consensus 264 ~-----~~----~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~ 300 (302)
T cd05055 264 A-----QP----EHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGK 300 (302)
T ss_pred C-----CC----CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence 0 00 1112346667779999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=326.36 Aligned_cols=260 Identities=34% Similarity=0.468 Sum_probs=203.6
Q ss_pred CCccccccCCCCceeEEEEEeCC--C---cEEEEEEccc---cChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEE
Q 039168 217 HFSDENKLGQGGFGPVYKGTLAD--G---KAIAVKRLSR---TSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELL 288 (536)
Q Consensus 217 ~~~~~~~lg~G~~g~Vy~~~~~~--~---~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 288 (536)
+-...++||+|+||.||+|+++. + ..||||.... ...+...++.+|.++|++++|||||+++|+......++
T Consensus 158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ 237 (474)
T KOG0194|consen 158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLM 237 (474)
T ss_pred CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccE
Confidence 34556899999999999998643 2 2389998874 34566788999999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCcccc
Q 039168 289 LIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIF 368 (536)
Q Consensus 289 lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 368 (536)
+|||+|.||+|.++|..... .++..+...++.+.+.||+|||++. +|||||-..|+|++.++.+||+|||+++.-
T Consensus 238 ivmEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~~~ 312 (474)
T KOG0194|consen 238 LVMELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSRAG 312 (474)
T ss_pred EEEEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccccccCC
Confidence 99999999999999965443 5899999999999999999999996 999999999999999999999999998754
Q ss_pred CCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHHHHHhhcCCcccc
Q 039168 369 GGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVEL 447 (536)
Q Consensus 369 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 447 (536)
......... ..-...|+|||.+....|+.++|||||||++||+++ |..|+...... +.......++.....
T Consensus 313 ~~~~~~~~~--~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~------~v~~kI~~~~~r~~~ 384 (474)
T KOG0194|consen 313 SQYVMKKFL--KKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY------EVKAKIVKNGYRMPI 384 (474)
T ss_pred cceeecccc--ccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH------HHHHHHHhcCccCCC
Confidence 311111111 123568999999999999999999999999999999 77776433221 111222122222221
Q ss_pred ccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccCCCCCCC
Q 039168 448 IDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSMTIPQ 498 (536)
Q Consensus 448 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~ 498 (536)
....+.++..++ .+|+..+|++||||.++.+.|+........
T Consensus 385 ------~~~~p~~~~~~~---~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 385 ------PSKTPKELAKVM---KQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred ------CCCCHHHHHHHH---HHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 113455555444 499999999999999999999887554443
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=310.13 Aligned_cols=249 Identities=27% Similarity=0.336 Sum_probs=192.4
Q ss_pred cCCCCceeEEEEEeC-CCcEEEEEEccccCh---hhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEeecCCCCh
Q 039168 224 LGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG---QGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSL 299 (536)
Q Consensus 224 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~~sL 299 (536)
||+|+||.||+++.+ +|+.||+|++..... .....+..|++++++++||||+++++++..+...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999875 589999999864321 1234456799999999999999999999999999999999999999
Q ss_pred hhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCCcccccc
Q 039168 300 DVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNI 379 (536)
Q Consensus 300 ~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 379 (536)
..++.... ...+++..+..++.||+.||+|||+.+ ++||||||+||+++.++.++|+|||++........ ...
T Consensus 81 ~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~---~~~ 153 (277)
T cd05607 81 KYHIYNVG-ERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---ITQ 153 (277)
T ss_pred HHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCce---eec
Confidence 88875433 234889999999999999999999986 99999999999999999999999999987643221 123
Q ss_pred ccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccccccCCCCHH
Q 039168 380 IAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQSCAPD 459 (536)
Q Consensus 380 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~ 459 (536)
..|++.|+|||++.+..++.++|||||||++|+|++|+.||........ ......... ..... ......+
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~--~~~~~~~~~-~~~~~------~~~~~~~- 223 (277)
T cd05607 154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA--KEELKRRTL-EDEVK------FEHQNFT- 223 (277)
T ss_pred cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh--HHHHHHHhh-ccccc------cccccCC-
Confidence 4689999999999998899999999999999999999999764322111 111111111 11110 0001112
Q ss_pred HHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcc
Q 039168 460 ELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 491 (536)
Q Consensus 460 ~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 491 (536)
.++.+++.+||+.||++||++.|+++.+..
T Consensus 224 --~~~~~li~~~L~~~P~~R~~~~~~~~~~~~ 253 (277)
T cd05607 224 --EESKDICRLFLAKKPEDRLGSREKNDDPRK 253 (277)
T ss_pred --HHHHHHHHHHhccCHhhCCCCccchhhhhc
Confidence 235667779999999999999887754443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=306.26 Aligned_cols=259 Identities=24% Similarity=0.368 Sum_probs=206.1
Q ss_pred cCCccccccCCCCceeEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEE
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 291 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 291 (536)
++|++.+.||+|+||.||+|... +++.||+|.+... .....+.+.+|++++++++|+|++++++.+...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57899999999999999999986 7899999988642 2233567889999999999999999999999999999999
Q ss_pred eecCCCChhhhhhccc-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCC
Q 039168 292 EYMPNKSLDVHLFDAT-RSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGG 370 (536)
Q Consensus 292 e~~~~~sL~~~l~~~~-~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 370 (536)
||+++++|..++.... ....+++.+++.++.+|+.||.|||+.+ ++|+||||+||+++.++.++|+|||++..+..
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 9999999999886532 2345899999999999999999999997 99999999999999999999999999886543
Q ss_pred CCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccc
Q 039168 371 NQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDP 450 (536)
Q Consensus 371 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 450 (536)
.... .....+++.|+|||.+.+..++.++||||||+++|+|++|+.||..... ..... ...+..+....
T Consensus 159 ~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~-~~~~~~~~~~~---- 227 (267)
T cd08224 159 KTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSL-CKKIEKCDYPP---- 227 (267)
T ss_pred CCcc--cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc----cHHHH-HhhhhcCCCCC----
Confidence 3221 2234578899999999988899999999999999999999999743221 11111 11111111111
Q ss_pred cccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 451 VLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 451 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
.. .......+.+++.+||+.+|++|||+.+|+++|+..
T Consensus 228 -~~---~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 228 -LP---ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred -CC---hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 10 112233566777799999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=313.43 Aligned_cols=255 Identities=29% Similarity=0.436 Sum_probs=198.5
Q ss_pred cCCccccccCCCCceeEEEEEeC-CCc----EEEEEEccccC-hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEE
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA-DGK----AIAVKRLSRTS-GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 289 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 289 (536)
++|++.+.||+|+||+||+|.+. +++ .+++|.+.... .....++..|+.++++++||||+++++++. ....++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 57888999999999999999874 343 47888875433 233467788899999999999999999875 456789
Q ss_pred EEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccC
Q 039168 290 IYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFG 369 (536)
Q Consensus 290 v~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 369 (536)
++||+.+++|.+++... ...+++..+..++.||+.||.|||+++ ++|+||||+|||+++++.+||+|||+++...
T Consensus 86 i~e~~~~gsL~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 86 VTQLSPLGSLLDHVRQH--RDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred EEEeCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 99999999999998643 235899999999999999999999986 9999999999999999999999999998764
Q ss_pred CCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHHHHHhhcCCccccc
Q 039168 370 GNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELI 448 (536)
Q Consensus 370 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 448 (536)
............++..|+|||.+.+..++.++||||||+++|||++ |+.||...... . ....+..+.....
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~---~----~~~~~~~~~~~~~- 232 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH---E----VPDLLEKGERLAQ- 232 (279)
T ss_pred CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH---H----HHHHHHCCCcCCC-
Confidence 3332222333456778999999998899999999999999999998 99887533211 1 1111222221111
Q ss_pred cccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 449 DPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 449 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
+ ... ...+..++.+||..||++|||+.|+++.|...
T Consensus 233 -~---~~~----~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~ 268 (279)
T cd05111 233 -P---QIC----TIDVYMVMVKCWMIDENVRPTFKELANEFTRM 268 (279)
T ss_pred -C---CCC----CHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 1 111 12456677799999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=320.14 Aligned_cols=242 Identities=23% Similarity=0.322 Sum_probs=191.6
Q ss_pred cccCCCCceeEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHHHc-CCCCceeEeeEEeeCceEEEEEeecCC
Q 039168 222 NKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLKEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYEYMPN 296 (536)
Q Consensus 222 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~ 296 (536)
++||+|+||.||+|+.+ +++.||||++... .....+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999976 4789999998753 233445677899998876 799999999999999999999999999
Q ss_pred CChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCCccc
Q 039168 297 KSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQAN 376 (536)
Q Consensus 297 ~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 376 (536)
++|...+... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++........ .
T Consensus 81 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~--~ 152 (321)
T cd05591 81 GDLMFQIQRS---RKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV--T 152 (321)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCCc--c
Confidence 9999888543 34889999999999999999999997 99999999999999999999999999875432221 2
Q ss_pred cccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccccccCCC
Q 039168 377 TNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQSC 456 (536)
Q Consensus 377 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~ 456 (536)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ... .. ....... .. ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~---~~~---~~-i~~~~~~------~p-~~ 218 (321)
T cd05591 153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED---DLF---ES-ILHDDVL------YP-VW 218 (321)
T ss_pred ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH---HHH---HH-HHcCCCC------CC-CC
Confidence 23356899999999999999999999999999999999999998643211 111 11 1111110 00 11
Q ss_pred CHHHHHHHHHHHHhhcCCCCCCCC-------CHHHHHHH
Q 039168 457 APDELLKFIHIGLLCVQQDPADRP-------TMSSVVVM 488 (536)
Q Consensus 457 ~~~~~~~l~~li~~cl~~dP~~RP-------t~~evl~~ 488 (536)
.+ ..+.+++..||+.||++|| ++.++++.
T Consensus 219 ~~---~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 219 LS---KEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CC---HHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 12 3456677799999999999 78888744
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=308.36 Aligned_cols=246 Identities=30% Similarity=0.422 Sum_probs=192.7
Q ss_pred ccCCCCceeEEEEEe---CCCcEEEEEEccccC--hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEeecCCC
Q 039168 223 KLGQGGFGPVYKGTL---ADGKAIAVKRLSRTS--GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNK 297 (536)
Q Consensus 223 ~lg~G~~g~Vy~~~~---~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~~ 297 (536)
.||+|+||.||+|.+ +++..+|+|++.... ....+.+.+|+.+++.++||||+++++++. .+..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 699999999999965 357889999986443 334567899999999999999999999875 45679999999999
Q ss_pred ChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCCccc-
Q 039168 298 SLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQAN- 376 (536)
Q Consensus 298 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~- 376 (536)
+|..++... ..+++..+..++.|++.||+|||+++ ++||||||.||++++++.+||+|||++...........
T Consensus 81 ~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 154 (257)
T cd05116 81 PLNKFLQKN---KHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA 154 (257)
T ss_pred cHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence 999998542 35899999999999999999999996 99999999999999999999999999987654332111
Q ss_pred cccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHHHHHhhcCCccccccccccCC
Q 039168 377 TNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQS 455 (536)
Q Consensus 377 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~ 455 (536)
.....++..|+|||.+....++.++||||||+++|||++ |+.||...... .... ....+.... ....
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~----~i~~~~~~~-----~~~~ 222 (257)
T cd05116 155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN---EVTQ----MIESGERME-----CPQR 222 (257)
T ss_pred cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHH----HHHCCCCCC-----CCCC
Confidence 112234578999999988889999999999999999998 99997543221 1111 111111111 1111
Q ss_pred CCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcc
Q 039168 456 CAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 491 (536)
Q Consensus 456 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 491 (536)
...++.+++.+||+.||++||++.+|.+.|+.
T Consensus 223 ----~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 223 ----CPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred ----CCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 22345667779999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=327.91 Aligned_cols=194 Identities=25% Similarity=0.308 Sum_probs=167.1
Q ss_pred hcCCccccccCCCCceeEEEEEeCC-CcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEee
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 293 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 293 (536)
...|.+.+.||+|+||.||++.+.. ++.||||.... ..+.+|+++|++++||||+++++++..++..++|||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 4579999999999999999999764 78899996432 3456899999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCC
Q 039168 294 MPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQN 373 (536)
Q Consensus 294 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 373 (536)
+. ++|..++... ...+++.+++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.+.....
T Consensus 242 ~~-~~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 242 YR-SDLYTYLGAR--LRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS 315 (461)
T ss_pred cC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence 95 5777776432 235899999999999999999999997 99999999999999999999999999987644332
Q ss_pred ccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCC
Q 039168 374 QANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNN 420 (536)
Q Consensus 374 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~ 420 (536)
........||+.|+|||++.+..++.++|||||||++|||++|..++
T Consensus 316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l 362 (461)
T PHA03211 316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL 362 (461)
T ss_pred cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence 22223457999999999999999999999999999999999988654
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=325.70 Aligned_cols=253 Identities=21% Similarity=0.248 Sum_probs=197.5
Q ss_pred hcCCccccccCCCCceeEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEE
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 290 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 290 (536)
.++|++.++||+|+||.||+++.+ +++.||+|++.+. .......+.+|+.+++.++||||+++++++.+++..++|
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv 121 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV 121 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence 468999999999999999999975 5889999998643 223345577899999999999999999999999999999
Q ss_pred EeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCC
Q 039168 291 YEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGG 370 (536)
Q Consensus 291 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 370 (536)
|||+++++|..++.. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 122 ~Ey~~gg~L~~~l~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~ 194 (370)
T cd05596 122 MEYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA 194 (370)
T ss_pred EcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence 999999999998853 23788889999999999999999997 99999999999999999999999999986643
Q ss_pred CCCccccccccccccccCcchhcCC----CCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccc
Q 039168 371 NQNQANTNIIAGTYGYMAPEYAMGG----IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVE 446 (536)
Q Consensus 371 ~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 446 (536)
... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||...... ..............
T Consensus 195 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~~~~~i~~~~~~~~ 267 (370)
T cd05596 195 NGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------GTYSKIMDHKNSLT 267 (370)
T ss_pred CCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH------HHHHHHHcCCCcCC
Confidence 221 122345789999999998653 3789999999999999999999998542211 11111111111111
Q ss_pred cccccccCCCCHHHHHHHHHHHHhhcCCCCCC--CCCHHHHHHH
Q 039168 447 LIDPVLKQSCAPDELLKFIHIGLLCVQQDPAD--RPTMSSVVVM 488 (536)
Q Consensus 447 l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~~ 488 (536)
..+ .......+.+++.+||+.+|.+ |||+.++++.
T Consensus 268 ~~~-------~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 268 FPD-------DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred CCC-------cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 100 0011234556667999999988 9999999864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=314.15 Aligned_cols=260 Identities=28% Similarity=0.426 Sum_probs=201.6
Q ss_pred HhcCCccccccCCCCceeEEEEEeC------CCcEEEEEEccccC-hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCce
Q 039168 214 ATNHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRTS-GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQE 286 (536)
Q Consensus 214 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 286 (536)
..++|++.++||+|+||.||+|..+ .+..||+|.+.... ......+.+|+.+++.++||||+++++++.+...
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 3578999999999999999999753 25589999886443 2334567889999999999999999999999999
Q ss_pred EEEEEeecCCCChhhhhhcccC-------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEE
Q 039168 287 LLLIYEYMPNKSLDVHLFDATR-------SVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKI 359 (536)
Q Consensus 287 ~~lv~e~~~~~sL~~~l~~~~~-------~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl 359 (536)
.++||||+.+++|.+++..... ...+.+..+..++.||+.||.|||+++ |+||||||+|||+++++.++|
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence 9999999999999999964321 234567788999999999999999986 999999999999999999999
Q ss_pred ecccCccccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHHHHH
Q 039168 360 SDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKL 438 (536)
Q Consensus 360 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 438 (536)
+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||.....+ .... .
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~---~~~~----~ 233 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE---QVLK----F 233 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHH----H
Confidence 99999986543322222222345678999999999899999999999999999998 67776432211 1111 1
Q ss_pred hhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 439 WCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 439 ~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
...+..... .. .....+.+++.+||+.||++|||+.++++.|...
T Consensus 234 ~~~~~~~~~-----~~----~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 234 VMDGGYLDQ-----PD----NCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred HHcCCCCCC-----CC----CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 111111110 11 1123566777799999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=317.81 Aligned_cols=259 Identities=31% Similarity=0.420 Sum_probs=201.6
Q ss_pred hcCCccccccCCCCceeEEEEEeC--------CCcEEEEEEccccC-hhhHHHHHHHHHHHHHc-CCCCceeEeeEEeeC
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA--------DGKAIAVKRLSRTS-GQGLKEFKNEVNLIAKL-QHKNLVRLLGCCLEG 284 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~ 284 (536)
.++|.+.+.||+|+||.||++... +...+|+|.+.... ......+.+|+.+++.+ +||||+++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 357999999999999999999752 23579999987542 34456788899999999 799999999999999
Q ss_pred ceEEEEEeecCCCChhhhhhcccC-------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEE
Q 039168 285 QELLLIYEYMPNKSLDVHLFDATR-------------SVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLL 351 (536)
Q Consensus 285 ~~~~lv~e~~~~~sL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll 351 (536)
+..++||||+.+++|..++..... ...+++.+++.++.|++.||+|||+++ ++||||||+|||+
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence 999999999999999999965321 234888999999999999999999986 9999999999999
Q ss_pred cCCCCeEEecccCccccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCch
Q 039168 352 DDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQT 430 (536)
Q Consensus 352 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~ 430 (536)
+.++.+||+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||.....
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~----- 248 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV----- 248 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH-----
Confidence 9999999999999976543222111212224568999999999889999999999999999998 7788643211
Q ss_pred hHHHHHHHhhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 431 LLTYTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 431 ~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
.. ...........+ .+......+.+++.+||+.+|++|||+.+|++.|...
T Consensus 249 -~~-~~~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~ 299 (307)
T cd05098 249 -EE-LFKLLKEGHRMD---------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 299 (307)
T ss_pred -HH-HHHHHHcCCCCC---------CCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 11 111111111111 1111224566677799999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=308.45 Aligned_cols=252 Identities=25% Similarity=0.396 Sum_probs=199.4
Q ss_pred cCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccCh-----hhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEE
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG-----QGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 289 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 289 (536)
++|+..+.||+|++|.||++... +++.||+|.+..... .....+.+|++++++++||||+++++++.++...++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 57899999999999999999865 589999998864321 224568889999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccC
Q 039168 290 IYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFG 369 (536)
Q Consensus 290 v~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 369 (536)
|+||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++++++++|+|||+++...
T Consensus 82 v~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLKAY---GALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 99999999999988543 34889999999999999999999997 9999999999999999999999999997654
Q ss_pred CCCCccc-cccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccc
Q 039168 370 GNQNQAN-TNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELI 448 (536)
Q Consensus 370 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 448 (536)
....... .....|+..|+|||++.+..++.++||||||+++|+|++|+.||..... ..............
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------~~~~~~~~~~~~~~--- 226 (263)
T cd06625 156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA------MAAIFKIATQPTNP--- 226 (263)
T ss_pred ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccch------HHHHHHHhccCCCC---
Confidence 3221111 1234578899999999998899999999999999999999999753211 11111111111111
Q ss_pred cccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 449 DPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 449 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
.+ +......+.+++.+||+.+|++|||+.++++.
T Consensus 227 --~~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 227 --QL----PSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred --CC----CccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 11 11122345667779999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=317.18 Aligned_cols=259 Identities=30% Similarity=0.431 Sum_probs=202.9
Q ss_pred hcCCccccccCCCCceeEEEEEeC--------CCcEEEEEEccccC-hhhHHHHHHHHHHHHHc-CCCCceeEeeEEeeC
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA--------DGKAIAVKRLSRTS-GQGLKEFKNEVNLIAKL-QHKNLVRLLGCCLEG 284 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~ 284 (536)
.++|.+.+.||+|+||.||+++.. ++..||+|.+.... ......+.+|+.+++.+ +||||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 467889999999999999999741 24579999886542 34457789999999999 899999999999999
Q ss_pred ceEEEEEeecCCCChhhhhhcccC-------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEE
Q 039168 285 QELLLIYEYMPNKSLDVHLFDATR-------------SVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLL 351 (536)
Q Consensus 285 ~~~~lv~e~~~~~sL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll 351 (536)
...++||||+.+++|..++..... ...+++..+..++.||+.||.|||+++ ++||||||+|||+
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEE
Confidence 999999999999999999865321 234788899999999999999999997 9999999999999
Q ss_pred cCCCCeEEecccCccccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCch
Q 039168 352 DDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQT 430 (536)
Q Consensus 352 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~ 430 (536)
+.++.+||+|||+++.+.............+++.|+|||++.+..++.++||||||+++|+|++ |..|+....
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~------ 244 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP------ 244 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC------
Confidence 9999999999999987654333222223345678999999999889999999999999999998 777754321
Q ss_pred hHHHHHHHhhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 431 LLTYTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 431 ~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
... .......+..... +......+.+++.+||+.+|++|||+.++++.|...
T Consensus 245 ~~~-~~~~~~~~~~~~~---------~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~ 296 (304)
T cd05101 245 VEE-LFKLLKEGHRMDK---------PANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRI 296 (304)
T ss_pred HHH-HHHHHHcCCcCCC---------CCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHH
Confidence 111 1111111111110 111223466677799999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=320.64 Aligned_cols=241 Identities=24% Similarity=0.313 Sum_probs=190.8
Q ss_pred CCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHHHc-CCCCceeEeeEEeeCceEEEEE
Q 039168 217 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLKEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIY 291 (536)
Q Consensus 217 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv~ 291 (536)
+|++.+.||+|+||.||+|... +++.||||++.+.. ....+.+..|..++..+ +||+|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4788999999999999999876 47899999987542 22344567788888877 5899999999999999999999
Q ss_pred eecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCC
Q 039168 292 EYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGN 371 (536)
Q Consensus 292 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 371 (536)
||+++++|..++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~ 154 (323)
T cd05616 81 EYVNGGDLMYQIQQV---GRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD 154 (323)
T ss_pred cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence 999999999888543 34889999999999999999999997 999999999999999999999999999754322
Q ss_pred CCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcccccccc
Q 039168 372 QNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPV 451 (536)
Q Consensus 372 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 451 (536)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .... . ...... .
T Consensus 155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~---~~~~---~-i~~~~~-~----- 219 (323)
T cd05616 155 G--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED---ELFQ---S-IMEHNV-A----- 219 (323)
T ss_pred C--CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH---HHHH---H-HHhCCC-C-----
Confidence 1 1223457899999999999999999999999999999999999998543211 1111 1 111111 0
Q ss_pred ccCCCCHHHHHHHHHHHHhhcCCCCCCCCCH
Q 039168 452 LKQSCAPDELLKFIHIGLLCVQQDPADRPTM 482 (536)
Q Consensus 452 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 482 (536)
. +.....++.+++.+||+.||.+|++.
T Consensus 220 ~----p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 220 Y----PKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred C----CCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 1 11122345677779999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=308.65 Aligned_cols=254 Identities=31% Similarity=0.485 Sum_probs=201.7
Q ss_pred hcCCccccccCCCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEeec
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 294 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 294 (536)
.++|++.++||+|+||.||+|..++++.||+|.+..... ....+.+|+.++++++||||+++++++. .+..+++|||+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM 82 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence 467899999999999999999988899999999875443 3467889999999999999999999874 46789999999
Q ss_pred CCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCCc
Q 039168 295 PNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQ 374 (536)
Q Consensus 295 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 374 (536)
.+++|.+++.... ...+++.++..++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||++.........
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05067 83 ENGSLVDFLKTPE-GIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCcc
Confidence 9999999885433 345899999999999999999999986 999999999999999999999999999876532211
Q ss_pred cccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHHHHHhhcCCcccccccccc
Q 039168 375 ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLK 453 (536)
Q Consensus 375 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~ 453 (536)
. .....++..|+|||.+.+..++.++||||||+++|+|++ |+.||...... ... .......... ..
T Consensus 159 ~-~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~----~~~~~~~~~~-----~~ 225 (260)
T cd05067 159 A-REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP---EVI----QNLERGYRMP-----RP 225 (260)
T ss_pred c-ccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH---HHH----HHHHcCCCCC-----CC
Confidence 1 112345678999999998889999999999999999999 99997532211 111 1111111111 11
Q ss_pred CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcc
Q 039168 454 QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 491 (536)
Q Consensus 454 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 491 (536)
...+ ..+.+++.+||+.+|++|||++++++.|+.
T Consensus 226 -~~~~---~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 226 -DNCP---EELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred -CCCC---HHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 1122 346667779999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=305.34 Aligned_cols=249 Identities=30% Similarity=0.440 Sum_probs=196.8
Q ss_pred cccCCCCceeEEEEEeCCCcEEEEEEccccChh-hHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEeecCCCChh
Q 039168 222 NKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQ-GLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLD 300 (536)
Q Consensus 222 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~~sL~ 300 (536)
++||+|+||.||++.+.+++.|++|++...... ....+.+|++++++++||||+++++++.+....++||||+.+++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 479999999999999877999999998765433 5678899999999999999999999999999999999999999999
Q ss_pred hhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCCccccccc
Q 039168 301 VHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNII 380 (536)
Q Consensus 301 ~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 380 (536)
+++.... ..+++..+..++.+++.||.|||+++ ++||||||+|||++.++.+||+|||++...............
T Consensus 81 ~~l~~~~--~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 81 TFLRKKK--NRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred HHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence 9985432 35789999999999999999999986 999999999999999999999999999865432222111222
Q ss_pred cccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHHHHHhhcCCccccccccccCCCCHH
Q 039168 381 AGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQSCAPD 459 (536)
Q Consensus 381 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~ 459 (536)
.++..|+|||.+.+..++.++||||||+++|+|++ |..||...... .... ...... .. ..+..
T Consensus 156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~---~~~~----~~~~~~--~~-------~~~~~ 219 (251)
T cd05041 156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ---QTRE----RIESGY--RM-------PAPQL 219 (251)
T ss_pred cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH---HHHH----HHhcCC--CC-------CCCcc
Confidence 33567999999998899999999999999999999 77776433221 1111 111110 00 00111
Q ss_pred HHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcc
Q 039168 460 ELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 491 (536)
Q Consensus 460 ~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 491 (536)
....+.+++.+||+.+|++|||+.+|++.|..
T Consensus 220 ~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 220 CPEEIYRLMLQCWAYDPENRPSFSEIYNELQI 251 (251)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence 22356677779999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=313.59 Aligned_cols=259 Identities=25% Similarity=0.399 Sum_probs=203.8
Q ss_pred hcCCccccccCCCCceeEEEEEeCC-----CcEEEEEEcccc-ChhhHHHHHHHHHHHHHcCCCCceeEeeEEee-CceE
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLAD-----GKAIAVKRLSRT-SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLE-GQEL 287 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~ 287 (536)
.++|++.+.||+|+||.||+|.+.+ +..|++|++... .....+.+.+|+.+++.++||||+++++++.. +...
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4688999999999999999999765 788999988654 33446778899999999999999999998765 5778
Q ss_pred EEEEeecCCCChhhhhhcccCC-----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecc
Q 039168 288 LLIYEYMPNKSLDVHLFDATRS-----VQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDF 362 (536)
Q Consensus 288 ~lv~e~~~~~sL~~~l~~~~~~-----~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Df 362 (536)
++++||+.+++|..++...... ..+++..++.++.||+.||+|||+++ ++|+||||+||++++++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECCC
Confidence 9999999999999998654322 45899999999999999999999986 999999999999999999999999
Q ss_pred cCccccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHHHHHhhc
Q 039168 363 GTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCE 441 (536)
Q Consensus 363 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 441 (536)
|+++.+.............++..|+|||.+.+..++.++||||||+++|||++ |+.||..... .... .....
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~------~~~~-~~~~~ 234 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP------FEMA-AYLKD 234 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH------HHHH-HHHHc
Confidence 99986643322222222345678999999998889999999999999999999 9998753221 1111 11111
Q ss_pred CCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 442 GHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 442 ~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
+.... .... .+ ..+.+++.+||+.||++|||+.++++.|+..
T Consensus 235 ~~~~~-----~~~~-~~---~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~ 276 (280)
T cd05043 235 GYRLA-----QPIN-CP---DELFAVMACCWALDPEERPSFSQLVQCLTDF 276 (280)
T ss_pred CCCCC-----CCCc-CC---HHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 11100 0111 12 3456777799999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=315.17 Aligned_cols=240 Identities=27% Similarity=0.354 Sum_probs=188.2
Q ss_pred cccCCCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHHHc-CCCCceeEeeEEeeCceEEEEEeecCC
Q 039168 222 NKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLKEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYEYMPN 296 (536)
Q Consensus 222 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~ 296 (536)
++||+|+||.||+++++ +++.||+|++.... ....+.+..|..++..+ +||||+++++++.+.+..++||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 47999999999999976 58899999987532 23345567788888765 899999999999999999999999999
Q ss_pred CChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCCccc
Q 039168 297 KSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQAN 376 (536)
Q Consensus 297 ~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 376 (536)
++|..++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~i~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (316)
T cd05620 81 GDLMFHIQDK---GRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--NR 152 (316)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCC--Cc
Confidence 9999888543 35889999999999999999999996 9999999999999999999999999987432111 12
Q ss_pred cccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccccccCCC
Q 039168 377 TNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQSC 456 (536)
Q Consensus 377 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~ 456 (536)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||..... .... ....... +.+...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~---~~~~----~~~~~~~------~~~~~~- 218 (316)
T cd05620 153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE---DELF----ESIRVDT------PHYPRW- 218 (316)
T ss_pred eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH---HHHH----HHHHhCC------CCCCCC-
Confidence 2345789999999999999999999999999999999999999853221 1111 1111110 111111
Q ss_pred CHHHHHHHHHHHHhhcCCCCCCCCCHH-HHH
Q 039168 457 APDELLKFIHIGLLCVQQDPADRPTMS-SVV 486 (536)
Q Consensus 457 ~~~~~~~l~~li~~cl~~dP~~RPt~~-evl 486 (536)
.+ .++.+++.+||+.||++||++. +++
T Consensus 219 ~~---~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 219 IT---KESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CC---HHHHHHHHHHccCCHHHcCCChHHHH
Confidence 12 3455666799999999999985 555
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=305.99 Aligned_cols=254 Identities=28% Similarity=0.414 Sum_probs=191.2
Q ss_pred cccCCCCceeEEEEEeCC---CcEEEEEEccccC-hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEeecCCC
Q 039168 222 NKLGQGGFGPVYKGTLAD---GKAIAVKRLSRTS-GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNK 297 (536)
Q Consensus 222 ~~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~~ 297 (536)
+.||+|+||.||+|...+ +..+|+|++.... ......+.+|+.++++++||||+++++++.+....++||||++++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 469999999999998643 4679999887543 233457888999999999999999999999999999999999999
Q ss_pred Chhhhhhccc--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCCcc
Q 039168 298 SLDVHLFDAT--RSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQA 375 (536)
Q Consensus 298 sL~~~l~~~~--~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 375 (536)
+|.+++.... .....++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 9999986532 2234677788899999999999999986 9999999999999999999999999997544332222
Q ss_pred ccccccccccccCcchhcCC-------CCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHHHHHhhcCCcccc
Q 039168 376 NTNIIAGTYGYMAPEYAMGG-------IFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVEL 447 (536)
Q Consensus 376 ~~~~~~gt~~y~aPE~~~~~-------~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 447 (536)
......++..|+|||++.+. .++.++||||||+++|||++ |+.||....... ..... . .......
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~---~~~~~---~-~~~~~~~ 230 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ---VLTYT---V-REQQLKL 230 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH---HHHHH---h-hcccCCC
Confidence 22334567889999998643 35789999999999999996 999985432211 11111 1 1111122
Q ss_pred ccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 039168 448 IDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLA 490 (536)
Q Consensus 448 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 490 (536)
.++.+... .++ .+.+++..|+ .+|++|||+++|+..|+
T Consensus 231 ~~~~~~~~-~~~---~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 231 PKPRLKLP-LSD---RWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCccCCC-CCh---HHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 22222211 223 3445566888 58999999999999885
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=313.43 Aligned_cols=258 Identities=29% Similarity=0.476 Sum_probs=202.0
Q ss_pred hcCCccccccCCCCceeEEEEEeC------CCcEEEEEEccccC-hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceE
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRTS-GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQEL 287 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 287 (536)
.++|++.+.||+|+||.||++... ++..||+|++.... ......+.+|+.++++++||||+++++++.++...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 467999999999999999999863 46789999987543 34456788999999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhhccc-------------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCc
Q 039168 288 LLIYEYMPNKSLDVHLFDAT-------------------RSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASN 348 (536)
Q Consensus 288 ~lv~e~~~~~sL~~~l~~~~-------------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~N 348 (536)
++||||+.+++|.+++.... ....+++..++.++.||+.||.|||+++ ++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 99999999999999986421 1234788899999999999999999986 9999999999
Q ss_pred EEEcCCCCeEEecccCccccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccC
Q 039168 349 VLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEH 427 (536)
Q Consensus 349 Ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~ 427 (536)
||++.++.++|+|||++..+..............+..|+|||.+.+..++.++|||||||++|+|++ |..||......
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~- 239 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE- 239 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-
Confidence 9999999999999999876543322211222234667999999998899999999999999999998 77776422111
Q ss_pred CchhHHHHHHHhhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcc
Q 039168 428 GQTLLTYTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 491 (536)
Q Consensus 428 ~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 491 (536)
. .......+..... +.....++.+++.+||+.+|++|||+.|+++.|+.
T Consensus 240 --~----~~~~~~~~~~~~~---------~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 240 --E----VIYYVRDGNVLSC---------PDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred --H----HHHHHhcCCCCCC---------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 1 1111112221110 11122456677789999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=306.96 Aligned_cols=258 Identities=23% Similarity=0.364 Sum_probs=203.8
Q ss_pred cCCccccccCCCCceeEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEE
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 291 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 291 (536)
++|++.+.||+|++|.||++... +++.++||.+... .......+.+|+.+++.++||||+++++++.+++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 46888999999999999999964 7899999987643 2334467889999999999999999999999999999999
Q ss_pred eecCCCChhhhhhccc-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCC
Q 039168 292 EYMPNKSLDVHLFDAT-RSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGG 370 (536)
Q Consensus 292 e~~~~~sL~~~l~~~~-~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 370 (536)
||+++++|..++.... ....+++..++.++.||++||.|||+++ ++|+||||+||+++.++.++|+|||++..+..
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 9999999999886422 2345899999999999999999999997 99999999999999999999999999887643
Q ss_pred CCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccc
Q 039168 371 NQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDP 450 (536)
Q Consensus 371 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 450 (536)
.... .....|+..|+|||.+.+..++.++||||||+++|+|++|..||...... ..... ...... ..+
T Consensus 159 ~~~~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~-~~~~~~-----~~~ 226 (267)
T cd08229 159 KTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLC-KKIEQC-----DYP 226 (267)
T ss_pred CCcc--cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch----HHHHh-hhhhcC-----CCC
Confidence 3221 12345788999999999888999999999999999999999997432111 11111 111111 111
Q ss_pred cccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcc
Q 039168 451 VLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 491 (536)
Q Consensus 451 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 491 (536)
.+.... ....+.+++.+||+.||++|||+.+|++.++.
T Consensus 227 ~~~~~~---~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~ 264 (267)
T cd08229 227 PLPSDH---YSEELRQLVNMCINPDPEKRPDITYVYDVAKR 264 (267)
T ss_pred CCCccc---ccHHHHHHHHHhcCCCcccCCCHHHHHHHHhh
Confidence 111111 22345666679999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=302.76 Aligned_cols=250 Identities=27% Similarity=0.379 Sum_probs=202.2
Q ss_pred CCccccccCCCCceeEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEee
Q 039168 217 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 293 (536)
Q Consensus 217 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 293 (536)
+|++.+.||+|++|.||++..+ +++.|++|.+... .......+.+|+++++.++|||++++++++.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4778899999999999999975 5899999998643 344567788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCC
Q 039168 294 MPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQN 373 (536)
Q Consensus 294 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 373 (536)
+++++|.+++.... ...+++..++.++.||+.||.|||+.+ ++|+||||+||++++++.++|+|||+++.+.....
T Consensus 81 ~~~~~L~~~l~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 81 AENGDLHKLLKMQR-GRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred CCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence 99999999986532 346899999999999999999999986 99999999999999999999999999987654322
Q ss_pred ccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcccccccccc
Q 039168 374 QANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLK 453 (536)
Q Consensus 374 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~ 453 (536)
. .....|++.|+|||++.+..++.++||||||+++|+|++|+.||...... ..... ...+.... +
T Consensus 157 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~-~~~~~~~~-----~- 221 (256)
T cd08529 157 F--ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG------ALILK-IIRGVFPP-----V- 221 (256)
T ss_pred h--hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH------HHHHH-HHcCCCCC-----C-
Confidence 2 22346789999999999988999999999999999999999997643311 11111 11111111 1
Q ss_pred CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 454 QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 454 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
.......+.+++.+||+.+|++||++.++++.
T Consensus 222 ---~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 222 ---SQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred ---ccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 11122456777779999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=320.62 Aligned_cols=237 Identities=26% Similarity=0.299 Sum_probs=185.3
Q ss_pred cccCCCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHH-HHHHcCCCCceeEeeEEeeCceEEEEEeecCC
Q 039168 222 NKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLKEFKNEVN-LIAKLQHKNLVRLLGCCLEGQELLLIYEYMPN 296 (536)
Q Consensus 222 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 296 (536)
+.||+|+||+||+|.+. +++.||+|++.... ......+.+|.. +++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999975 58999999986532 122334445544 56889999999999999999999999999999
Q ss_pred CChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCCccc
Q 039168 297 KSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQAN 376 (536)
Q Consensus 297 ~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 376 (536)
++|..++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (323)
T cd05575 81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS--KT 152 (323)
T ss_pred CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCC--Cc
Confidence 999988854 335899999999999999999999997 9999999999999999999999999987532211 22
Q ss_pred cccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccccccCCC
Q 039168 377 TNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQSC 456 (536)
Q Consensus 377 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~ 456 (536)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ........ .... . +...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~------~~~~~~i~-~~~~-~-----~~~~- 218 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT------AEMYDNIL-NKPL-R-----LKPN- 218 (323)
T ss_pred cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH------HHHHHHHH-cCCC-C-----CCCC-
Confidence 2345689999999999999999999999999999999999999754221 11111111 1110 0 1111
Q ss_pred CHHHHHHHHHHHHhhcCCCCCCCCCHH
Q 039168 457 APDELLKFIHIGLLCVQQDPADRPTMS 483 (536)
Q Consensus 457 ~~~~~~~l~~li~~cl~~dP~~RPt~~ 483 (536)
....+.+++.+||+.||.+||++.
T Consensus 219 ---~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 219 ---ISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred ---CCHHHHHHHHHHhhcCHHhCCCCC
Confidence 123456677799999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=318.51 Aligned_cols=241 Identities=27% Similarity=0.378 Sum_probs=188.6
Q ss_pred cccCCCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHHHc-CCCCceeEeeEEeeCceEEEEEeecCC
Q 039168 222 NKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLKEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYEYMPN 296 (536)
Q Consensus 222 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~ 296 (536)
+.||+|+||.||+|++. +++.||||++.... ......+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999976 47899999987542 23345566788888764 999999999999999999999999999
Q ss_pred CChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCCccc
Q 039168 297 KSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQAN 376 (536)
Q Consensus 297 ~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 376 (536)
++|..++... ..+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (316)
T cd05619 81 GDLMFHIQSC---HKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--AK 152 (316)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--Cc
Confidence 9999888542 34889999999999999999999997 9999999999999999999999999987532211 12
Q ss_pred cccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccccccCCC
Q 039168 377 TNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQSC 456 (536)
Q Consensus 377 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~ 456 (536)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ..... ..... +.... .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~---~~~~~----i~~~~------~~~~~-~ 218 (316)
T cd05619 153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE---ELFQS----IRMDN------PCYPR-W 218 (316)
T ss_pred eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH---HHHHH----HHhCC------CCCCc-c
Confidence 23356899999999999999999999999999999999999998543211 11111 11110 11111 1
Q ss_pred CHHHHHHHHHHHHhhcCCCCCCCCCHH-HHHH
Q 039168 457 APDELLKFIHIGLLCVQQDPADRPTMS-SVVV 487 (536)
Q Consensus 457 ~~~~~~~l~~li~~cl~~dP~~RPt~~-evl~ 487 (536)
.+ ..+.+++.+||+.||++||++. ++++
T Consensus 219 ~~---~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 219 LT---REAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred CC---HHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 12 3455667799999999999997 6653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=324.18 Aligned_cols=238 Identities=25% Similarity=0.298 Sum_probs=188.9
Q ss_pred cccCCCCceeEEEEEe----CCCcEEEEEEccccCh--hhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEeecC
Q 039168 222 NKLGQGGFGPVYKGTL----ADGKAIAVKRLSRTSG--QGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMP 295 (536)
Q Consensus 222 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 295 (536)
+.||+|+||.||+++. .+++.||+|++..... .....+.+|++++++++||||+++++++..++..|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999875 3588999999875432 234457789999999999999999999999999999999999
Q ss_pred CCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCCcc
Q 039168 296 NKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQA 375 (536)
Q Consensus 296 ~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 375 (536)
+++|..++.. ...+++..++.++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-- 153 (318)
T cd05582 82 GGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-- 153 (318)
T ss_pred CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC--
Confidence 9999988844 345899999999999999999999996 99999999999999999999999999986543211
Q ss_pred ccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccccccCC
Q 039168 376 NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQS 455 (536)
Q Consensus 376 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~ 455 (536)
......|++.|+|||++.+..++.++||||||+++|+|++|+.||..... ........ .... . +...
T Consensus 154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~------~~~~~~i~-~~~~-~-----~p~~ 220 (318)
T cd05582 154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR------KETMTMIL-KAKL-G-----MPQF 220 (318)
T ss_pred ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH------HHHHHHHH-cCCC-C-----CCCC
Confidence 22235789999999999998899999999999999999999999754321 11111111 1110 0 1111
Q ss_pred CCHHHHHHHHHHHHhhcCCCCCCCCCHHH
Q 039168 456 CAPDELLKFIHIGLLCVQQDPADRPTMSS 484 (536)
Q Consensus 456 ~~~~~~~~l~~li~~cl~~dP~~RPt~~e 484 (536)
. ...+.+++.+||+.||++|||+.+
T Consensus 221 -~---~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 221 -L---SPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred -C---CHHHHHHHHHHhhcCHhHcCCCCC
Confidence 1 234556667999999999999555
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=307.40 Aligned_cols=248 Identities=26% Similarity=0.422 Sum_probs=205.4
Q ss_pred cCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEeec
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 294 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 294 (536)
+-|.++.+||+|+||.||++.++ .|..+|||++... .+++++.+|+.+|++.+.|++|++|+.+.....+|+|||||
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC 110 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC 110 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence 45788899999999999999876 5999999998654 35688999999999999999999999999999999999999
Q ss_pred CCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCCc
Q 039168 295 PNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQ 374 (536)
Q Consensus 295 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 374 (536)
..|+..+++.- +.+++.+.++..+++..++||+|||... -||||||..|||++.+|..||+|||.|..+.+. .
T Consensus 111 GAGSiSDI~R~--R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT--M 183 (502)
T KOG0574|consen 111 GAGSISDIMRA--RRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT--M 183 (502)
T ss_pred CCCcHHHHHHH--hcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhh--H
Confidence 99999999853 4567999999999999999999999874 899999999999999999999999999887543 3
Q ss_pred cccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccccccC
Q 039168 375 ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQ 454 (536)
Q Consensus 375 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~ 454 (536)
....+..|||.|||||++..-.|..++||||||++..||.-|++|+....+-.. ..++...-..
T Consensus 184 AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA----------------IFMIPT~PPP 247 (502)
T KOG0574|consen 184 AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRA----------------IFMIPTKPPP 247 (502)
T ss_pred HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccce----------------eEeccCCCCC
Confidence 334457899999999999999999999999999999999999999754333211 1111111111
Q ss_pred C-CCHHH-HHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 455 S-CAPDE-LLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 455 ~-~~~~~-~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
. ..+++ ..++-+.+..||-++|++|-|+..+++.
T Consensus 248 TF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 248 TFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred CCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 1 11222 3355666679999999999999998854
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=317.89 Aligned_cols=264 Identities=24% Similarity=0.346 Sum_probs=195.0
Q ss_pred cCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccCh-hhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEee
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG-QGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 293 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 293 (536)
++|.+.++||+|+||.||+|+++ +++.||+|++..... .....+.+|+.++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 57899999999999999999876 578899999875432 2334677899999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCC
Q 039168 294 MPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQN 373 (536)
Q Consensus 294 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 373 (536)
+++ +|..++... ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 86 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 159 (309)
T cd07872 86 LDK-DLKQYMDDC--GNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTK 159 (309)
T ss_pred CCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence 976 677666432 234788999999999999999999997 99999999999999999999999999976533221
Q ss_pred ccccccccccccccCcchhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHH--------HHHHhhcCCc
Q 039168 374 QANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTY--------TWKLWCEGHA 444 (536)
Q Consensus 374 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~--------~~~~~~~~~~ 444 (536)
......+++.|+|||++.+ ..++.++||||||+++|+|++|+.||.............. .|..+.....
T Consensus 160 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07872 160 --TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDE 237 (309)
T ss_pred --ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhh
Confidence 1223457899999999865 4589999999999999999999999864332111000000 0110000000
Q ss_pred ccccc-ccccC----CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 445 VELID-PVLKQ----SCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 445 ~~l~~-~~l~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
....+ +.... ...+....++.+++.+||+.||.+|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 238 FKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 00000 00000 000111234567778999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=314.91 Aligned_cols=197 Identities=28% Similarity=0.460 Sum_probs=160.7
Q ss_pred ccccCCCCceeEEEEEeC---CCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEee--CceEEEEEeecC
Q 039168 221 ENKLGQGGFGPVYKGTLA---DGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLE--GQELLLIYEYMP 295 (536)
Q Consensus 221 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~--~~~~~lv~e~~~ 295 (536)
.++||+|+||+||+|+.+ +++.||+|.+..... ...+.+|+.++++++||||+++++++.. +...+++|||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999864 468899999865432 2457789999999999999999999864 467899999986
Q ss_pred CCChhhhhhcc------cCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEE----cCCCCeEEecccCc
Q 039168 296 NKSLDVHLFDA------TRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLL----DDDMNPKISDFGTA 365 (536)
Q Consensus 296 ~~sL~~~l~~~------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll----~~~~~~kl~Dfg~a 365 (536)
+ +|..++... .....+++..+..++.||+.||.|||+++ |+||||||+|||+ +..+.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 5 666665422 12235889999999999999999999997 9999999999999 45678999999999
Q ss_pred cccCCCCCc-cccccccccccccCcchhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCC
Q 039168 366 RIFGGNQNQ-ANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFY 423 (536)
Q Consensus 366 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~ 423 (536)
+.+...... .......||+.|+|||++.+. .++.++||||+||++|+|++|++||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 876543221 222345789999999999874 5899999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=326.59 Aligned_cols=260 Identities=27% Similarity=0.379 Sum_probs=201.4
Q ss_pred hcCCccccccCCCCceeEEEEEeC------CCcEEEEEEccccC-hhhHHHHHHHHHHHHHcC-CCCceeEeeEEeeCce
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRTS-GQGLKEFKNEVNLIAKLQ-HKNLVRLLGCCLEGQE 286 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~ 286 (536)
.++|.+.++||+|+||.||+|++. .++.||||++.... ....+.+.+|+.+|.++. ||||+++++++...+.
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~ 115 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP 115 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence 356888899999999999999853 35689999997643 233457889999999997 9999999999999999
Q ss_pred EEEEEeecCCCChhhhhhcccC----------------------------------------------------------
Q 039168 287 LLLIYEYMPNKSLDVHLFDATR---------------------------------------------------------- 308 (536)
Q Consensus 287 ~~lv~e~~~~~sL~~~l~~~~~---------------------------------------------------------- 308 (536)
.++||||+.+|+|.+++.....
T Consensus 116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (401)
T cd05107 116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM 195 (401)
T ss_pred cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence 9999999999999999864321
Q ss_pred -------------------------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEE
Q 039168 309 -------------------------------------SVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLL 351 (536)
Q Consensus 309 -------------------------------------~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll 351 (536)
...+++..++.++.||+.||.|||+.+ ++||||||+|||+
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiLl 272 (401)
T cd05107 196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVLI 272 (401)
T ss_pred hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEEE
Confidence 123677888999999999999999986 9999999999999
Q ss_pred cCCCCeEEecccCccccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCch
Q 039168 352 DDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQT 430 (536)
Q Consensus 352 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~ 430 (536)
++++.+||+|||+++.+.............+++.|+|||.+.+..++.++||||||+++|||++ |+.||......
T Consensus 273 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~---- 348 (401)
T cd05107 273 CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN---- 348 (401)
T ss_pred eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch----
Confidence 9999999999999986543322222223356788999999998889999999999999999998 88886532111
Q ss_pred hHHHHHHHhhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 431 LLTYTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 431 ~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
.........+.... . +......+.+|+.+||+.+|.+||++++|++.|+..
T Consensus 349 --~~~~~~~~~~~~~~-----~----p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~ 399 (401)
T cd05107 349 --EQFYNAIKRGYRMA-----K----PAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399 (401)
T ss_pred --HHHHHHHHcCCCCC-----C----CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 11111111111111 0 111123466677799999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=317.12 Aligned_cols=265 Identities=26% Similarity=0.411 Sum_probs=215.0
Q ss_pred hcCCccccccCCCCceeEEEEEeCCCcEEEEEEccccChhh-HHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEee
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQG-LKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 293 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 293 (536)
.+...+.++||+|-||+|.++....+..||||+++...... .++|.+|+++|.+|+||||+.++++|..++.+++|+||
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY 616 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY 616 (807)
T ss_pred hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence 45667889999999999999999888999999998765554 48899999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCC
Q 039168 294 MPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQN 373 (536)
Q Consensus 294 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 373 (536)
|++|+|.+++..+.... +.......|+.||+.|++||.+- ++|||||.+.|+|++.++++||+|||+++.+...+.
T Consensus 617 mEnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~y 692 (807)
T KOG1094|consen 617 MENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDY 692 (807)
T ss_pred HhcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccccCCc
Confidence 99999999997764433 45566778999999999999976 699999999999999999999999999998776666
Q ss_pred ccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh--CCCCCCCCCccCCchhHHHHHHHhhcCCcccccccc
Q 039168 374 QANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS--GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPV 451 (536)
Q Consensus 374 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 451 (536)
.......+-..+|||||.+.-++++.++|||+||+++||+++ ...||.....+. ..+.....+..+....
T Consensus 693 y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~---vven~~~~~~~~~~~~----- 764 (807)
T KOG1094|consen 693 YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ---VVENAGEFFRDQGRQV----- 764 (807)
T ss_pred eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH---HHHhhhhhcCCCCcce-----
Confidence 555555666789999999999999999999999999999865 566754332221 1222222221111111
Q ss_pred ccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 452 LKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 452 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
....++....++.++++.||..|-++|||++++...|+..
T Consensus 765 -~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 765 -VLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred -eccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 1122344456677899999999999999999999998764
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=316.13 Aligned_cols=242 Identities=26% Similarity=0.307 Sum_probs=191.8
Q ss_pred cccCCCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHHHc-CCCCceeEeeEEeeCceEEEEEeecCC
Q 039168 222 NKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLKEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYEYMPN 296 (536)
Q Consensus 222 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~ 296 (536)
+.||+|+||.||++.+. +++.||||++.+.. ......+..|..+++.+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999876 47899999987542 33456677899999888 799999999999999999999999999
Q ss_pred CChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCCccc
Q 039168 297 KSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQAN 376 (536)
Q Consensus 297 ~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 376 (536)
++|..++... ..+++..+..++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (318)
T cd05570 81 GDLMFHIQRS---GRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--VT 152 (318)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCC--Cc
Confidence 9999888543 35899999999999999999999996 9999999999999999999999999987532211 12
Q ss_pred cccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccccccCCC
Q 039168 377 TNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQSC 456 (536)
Q Consensus 377 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~ 456 (536)
.....|++.|+|||++.+..++.++|||||||++|+|++|+.||..... .... ........ .....
T Consensus 153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~------~~~~-~~i~~~~~------~~~~~- 218 (318)
T cd05570 153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE------DELF-QSILEDEV------RYPRW- 218 (318)
T ss_pred ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH------HHHH-HHHHcCCC------CCCCc-
Confidence 2235689999999999999999999999999999999999999853221 1111 11111111 01111
Q ss_pred CHHHHHHHHHHHHhhcCCCCCCCCCH-----HHHHHH
Q 039168 457 APDELLKFIHIGLLCVQQDPADRPTM-----SSVVVM 488 (536)
Q Consensus 457 ~~~~~~~l~~li~~cl~~dP~~RPt~-----~evl~~ 488 (536)
. ...+.+++.+||+.||++|||+ .++++.
T Consensus 219 ~---~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 219 L---SKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred C---CHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 1 2345667779999999999999 888753
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=324.22 Aligned_cols=254 Identities=20% Similarity=0.247 Sum_probs=195.8
Q ss_pred HhcCCccccccCCCCceeEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEE
Q 039168 214 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 289 (536)
Q Consensus 214 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 289 (536)
..++|++.++||+|+||.||+++.. +++.||+|++.+. .......+.+|+.+++.++||||+++++++.+++..++
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l 120 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM 120 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 3478999999999999999999976 4889999998642 22334567889999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccC
Q 039168 290 IYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFG 369 (536)
Q Consensus 290 v~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 369 (536)
||||+++++|..++.. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++..+.
T Consensus 121 v~Ey~~gg~L~~~l~~----~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~ 193 (370)
T cd05621 121 VMEYMPGGDLVNLMSN----YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMD 193 (370)
T ss_pred EEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceecc
Confidence 9999999999998843 24788999999999999999999996 9999999999999999999999999998764
Q ss_pred CCCCccccccccccccccCcchhcCC----CCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcc
Q 039168 370 GNQNQANTNIIAGTYGYMAPEYAMGG----IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAV 445 (536)
Q Consensus 370 ~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 445 (536)
.... .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||..... ..............
T Consensus 194 ~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~------~~~~~~i~~~~~~~ 266 (370)
T cd05621 194 ETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL------VGTYSKIMDHKNSL 266 (370)
T ss_pred cCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCccc
Confidence 3221 122345799999999999754 378999999999999999999999854321 11111111111111
Q ss_pred ccccccccCCCCHHHHHHHHHHHHhhcCCCCCC--CCCHHHHHHH
Q 039168 446 ELIDPVLKQSCAPDELLKFIHIGLLCVQQDPAD--RPTMSSVVVM 488 (536)
Q Consensus 446 ~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~~ 488 (536)
.+.. .......+.+++..||+.+|.+ |+|+.++++.
T Consensus 267 ~~p~-------~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 267 NFPE-------DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred CCCC-------cccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 1100 0111233445566888755543 8999999876
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=318.17 Aligned_cols=259 Identities=31% Similarity=0.429 Sum_probs=201.8
Q ss_pred cCCccccccCCCCceeEEEEEeC--------CCcEEEEEEcccc-ChhhHHHHHHHHHHHHHc-CCCCceeEeeEEeeCc
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA--------DGKAIAVKRLSRT-SGQGLKEFKNEVNLIAKL-QHKNLVRLLGCCLEGQ 285 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~ 285 (536)
.+|++.+.||+|+||.||++... +...||+|.+... .....+.+.+|+++++++ +||||+++++++...+
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 46899999999999999999742 1236899988753 334567889999999999 8999999999999999
Q ss_pred eEEEEEeecCCCChhhhhhccc-------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEc
Q 039168 286 ELLLIYEYMPNKSLDVHLFDAT-------------RSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLD 352 (536)
Q Consensus 286 ~~~lv~e~~~~~sL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~ 352 (536)
..++++||+.+++|.+++.... ....+++..+..++.||+.||.|||+++ ++||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEc
Confidence 9999999999999999986432 1234788999999999999999999987 99999999999999
Q ss_pred CCCCeEEecccCccccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchh
Q 039168 353 DDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTL 431 (536)
Q Consensus 353 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~ 431 (536)
.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||.....
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~------ 242 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV------ 242 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH------
Confidence 999999999999986643322222222234567999999999999999999999999999998 7777643211
Q ss_pred HHHHHHHhhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccCC
Q 039168 432 LTYTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDS 493 (536)
Q Consensus 432 ~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 493 (536)
.. .......+..... +......+.+++.+||+.+|++|||+.++++.|....
T Consensus 243 ~~-~~~~~~~~~~~~~---------~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~ 294 (334)
T cd05100 243 EE-LFKLLKEGHRMDK---------PANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL 294 (334)
T ss_pred HH-HHHHHHcCCCCCC---------CCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence 11 1111111111111 1112235667778999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=312.59 Aligned_cols=198 Identities=28% Similarity=0.386 Sum_probs=172.3
Q ss_pred cCCccccccCCCCceeEEEEEeC-CCcEEEEEEcccc-ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEee
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT-SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 293 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 293 (536)
++|++.++||+|+||.||++.+. ++..+|+|.+... .......+.+|++++++++||||+++++++.+++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 36889999999999999999875 5788899988654 333456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCC
Q 039168 294 MPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQN 373 (536)
Q Consensus 294 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 373 (536)
+++++|..++... ..+++..+..++.||++||.|||+.. +++|+||||+|||++.++.+||+|||++.......
T Consensus 81 ~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 154 (308)
T cd06615 81 MDGGSLDQVLKKA---GRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 154 (308)
T ss_pred cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCcccccccc-
Confidence 9999999998543 45889999999999999999999742 49999999999999999999999999987553221
Q ss_pred ccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCC
Q 039168 374 QANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF 422 (536)
Q Consensus 374 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~ 422 (536)
.....|++.|+|||.+.+..++.++||||||+++|+|++|+.||..
T Consensus 155 ---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~ 200 (308)
T cd06615 155 ---ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPP 200 (308)
T ss_pred ---cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCC
Confidence 2235688999999999888899999999999999999999999753
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=314.92 Aligned_cols=256 Identities=29% Similarity=0.432 Sum_probs=197.7
Q ss_pred cCCccccccCCCCceeEEEEEeCC-C--cEEEEEEcccc-ChhhHHHHHHHHHHHHHc-CCCCceeEeeEEeeCceEEEE
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLAD-G--KAIAVKRLSRT-SGQGLKEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLI 290 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~~-~--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv 290 (536)
++|++.++||+|+||.||+|.+++ + ..+++|.+... .....+.+.+|+.++.++ +||||+++++++......++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 578899999999999999998753 3 34788887642 334456788999999999 799999999999999999999
Q ss_pred EeecCCCChhhhhhccc-------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCe
Q 039168 291 YEYMPNKSLDVHLFDAT-------------RSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNP 357 (536)
Q Consensus 291 ~e~~~~~sL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~ 357 (536)
+||+++++|.+++.... ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 99999999999986432 1234889999999999999999999986 9999999999999999999
Q ss_pred EEecccCccccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHHH
Q 039168 358 KISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTW 436 (536)
Q Consensus 358 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~ 436 (536)
||+|||++....... .......+..|+|||.+.+..++.++|||||||++|||++ |..||...... ...
T Consensus 159 kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~---~~~---- 228 (297)
T cd05089 159 KIADFGLSRGEEVYV---KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA---ELY---- 228 (297)
T ss_pred EECCcCCCcccccee---ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH---HHH----
Confidence 999999986432111 1111122457999999998889999999999999999997 99987533211 111
Q ss_pred HHhhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccCC
Q 039168 437 KLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDS 493 (536)
Q Consensus 437 ~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 493 (536)
.....+.... .... ....+.+++.+||+.+|.+|||+.++++.|....
T Consensus 229 ~~~~~~~~~~-----~~~~----~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~ 276 (297)
T cd05089 229 EKLPQGYRME-----KPRN----CDDEVYELMRQCWRDRPYERPPFAQISVQLSRML 276 (297)
T ss_pred HHHhcCCCCC-----CCCC----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1111111111 1111 1234667777999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=306.62 Aligned_cols=255 Identities=33% Similarity=0.497 Sum_probs=203.0
Q ss_pred hcCCccccccCCCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEeec
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 294 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 294 (536)
.++|++.++||+|+||.||++..++++.||||.+.... ...+.+.+|+.++++++||||+++++++......++||||+
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM 83 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence 46899999999999999999998888899999987543 33467899999999999999999999999989999999999
Q ss_pred CCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCCc
Q 039168 295 PNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQ 374 (536)
Q Consensus 295 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 374 (536)
++++|.+++.... ...+++..+..++.|++.||.|||+++ ++|+||||+||++++++.+||+|||++..+......
T Consensus 84 ~~~~L~~~i~~~~-~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 159 (261)
T cd05034 84 SKGSLLDFLKSGE-GKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEYT 159 (261)
T ss_pred CCCCHHHHHhccc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhhh
Confidence 9999999986532 235899999999999999999999986 999999999999999999999999999876532211
Q ss_pred cccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHHHHHhhcCCcccccccccc
Q 039168 375 ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLK 453 (536)
Q Consensus 375 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~ 453 (536)
. .....++..|+|||.+.+..++.++||||||+++|+|++ |+.||..... ...... ...... ....
T Consensus 160 ~-~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~---~~~~~~----~~~~~~-----~~~~ 226 (261)
T cd05034 160 A-REGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN---REVLEQ----VERGYR-----MPRP 226 (261)
T ss_pred h-hhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHH----HHcCCC-----CCCC
Confidence 1 111234568999999998889999999999999999998 8988743211 111111 111100 0001
Q ss_pred CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcc
Q 039168 454 QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 491 (536)
Q Consensus 454 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 491 (536)
... ...+.+++.+||+.+|++||+++++++.|+.
T Consensus 227 ~~~----~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 227 PNC----PEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCC----CHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 111 2346667779999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=305.46 Aligned_cols=250 Identities=33% Similarity=0.464 Sum_probs=202.2
Q ss_pred hcCCccccccCCCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEeec
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 294 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 294 (536)
.++|++.+.||.|+||.||++... ++.||+|.+..... ..+++.+|+.+++.++|+||+++++++......++||||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 357889999999999999999874 78999999976544 4678899999999999999999999999999999999999
Q ss_pred CCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCCc
Q 039168 295 PNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQ 374 (536)
Q Consensus 295 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 374 (536)
++++|.+++..... ..+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||.++.......
T Consensus 83 ~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~- 157 (256)
T cd05039 83 AKGSLVDYLRSRGR-AVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD- 157 (256)
T ss_pred CCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc-
Confidence 99999999864332 35899999999999999999999997 99999999999999999999999999987632221
Q ss_pred cccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHHHHHhhcCCcccccccccc
Q 039168 375 ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLK 453 (536)
Q Consensus 375 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~ 453 (536)
...++..|+|||.+.+..++.++||||||+++|+|++ |+.||...... .+. .....+...+.
T Consensus 158 ----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~----~~~~~~~~~~~------ 220 (256)
T cd05039 158 ----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVV----PHVEKGYRMEA------ 220 (256)
T ss_pred ----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH---HHH----HHHhcCCCCCC------
Confidence 1234567999999998889999999999999999997 88887533111 111 11111111111
Q ss_pred CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcc
Q 039168 454 QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 491 (536)
Q Consensus 454 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 491 (536)
+......+.+++.+||+.+|++|||+.+++++|+.
T Consensus 221 ---~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 221 ---PEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred ---ccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 11112446677779999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=311.08 Aligned_cols=251 Identities=24% Similarity=0.373 Sum_probs=202.5
Q ss_pred hcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEee
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 293 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 293 (536)
..+|+..+.||+|++|.||+|... +++.|++|.+........+.+.+|+.+++.++|||++++++.+..+...++||||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 368999999999999999999864 5899999999876655667889999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCC
Q 039168 294 MPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQN 373 (536)
Q Consensus 294 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 373 (536)
+++++|..++.. ..+++.++..++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||++........
T Consensus 99 ~~~~~L~~~~~~----~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 171 (296)
T cd06654 99 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (296)
T ss_pred cCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhcccccc
Confidence 999999998843 24788999999999999999999997 99999999999999999999999999876543221
Q ss_pred ccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcccccccccc
Q 039168 374 QANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLK 453 (536)
Q Consensus 374 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~ 453 (536)
. .....|++.|+|||.+.+..++.++|||||||++|+|++|+.||....... ......... ...+
T Consensus 172 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~------~~~~~~~~~-~~~~------ 236 (296)
T cd06654 172 K--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR------ALYLIATNG-TPEL------ 236 (296)
T ss_pred c--cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH------hHHHHhcCC-CCCC------
Confidence 1 223468899999999998889999999999999999999999985432211 111111111 1110
Q ss_pred CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 454 QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 454 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
..+......+.+++.+||+.+|++|||+.++++.
T Consensus 237 -~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 237 -QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred -CCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 0111222446677789999999999999999973
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=303.15 Aligned_cols=247 Identities=29% Similarity=0.422 Sum_probs=195.8
Q ss_pred cccCCCCceeEEEEEeCCCcEEEEEEccccCh-hhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEeecCCCChh
Q 039168 222 NKLGQGGFGPVYKGTLADGKAIAVKRLSRTSG-QGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLD 300 (536)
Q Consensus 222 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~~sL~ 300 (536)
++||+|+||.||+|...++..+|+|.+..... .....+.+|+++++.++||||+++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 37999999999999988899999999876543 33456889999999999999999999999999999999999999999
Q ss_pred hhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCCccccccc
Q 039168 301 VHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNII 380 (536)
Q Consensus 301 ~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 380 (536)
.++... ...+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++......... .....
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~~ 154 (250)
T cd05085 81 SFLRKK--KDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-SSGLK 154 (250)
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccc-cCCCC
Confidence 988543 235789999999999999999999986 999999999999999999999999998754322211 11122
Q ss_pred cccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHHHHHhhcCCccccccccccCCCCHH
Q 039168 381 AGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQSCAPD 459 (536)
Q Consensus 381 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~ 459 (536)
.++..|+|||++.+..++.++||||||+++|+|++ |..||...... . .......+.... .+..
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~---~----~~~~~~~~~~~~---------~~~~ 218 (250)
T cd05085 155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ---Q----AREQVEKGYRMS---------CPQK 218 (250)
T ss_pred CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH---H----HHHHHHcCCCCC---------CCCC
Confidence 34567999999998889999999999999999998 88887532111 1 111111111111 0111
Q ss_pred HHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 039168 460 ELLKFIHIGLLCVQQDPADRPTMSSVVVMLA 490 (536)
Q Consensus 460 ~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 490 (536)
....+.+++.+|++.+|++|||+.++++.|.
T Consensus 219 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 219 CPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 2345677778999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=305.63 Aligned_cols=249 Identities=31% Similarity=0.450 Sum_probs=197.6
Q ss_pred cccCCCCceeEEEEEeCC--C--cEEEEEEccccCh-hhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEeecCC
Q 039168 222 NKLGQGGFGPVYKGTLAD--G--KAIAVKRLSRTSG-QGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPN 296 (536)
Q Consensus 222 ~~lg~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 296 (536)
++||+|++|.||+|.+.+ + ..||||.+..... ...+.+.+|+.++++++||||+++++.+.. ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998743 3 3689999987665 567789999999999999999999999988 899999999999
Q ss_pred CChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCCc-c
Q 039168 297 KSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQ-A 375 (536)
Q Consensus 297 ~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~-~ 375 (536)
++|..++..... ..+++..++.++.|+++||.|||+++ ++|+||||+||+++.++.+||+|||+++.+...... .
T Consensus 80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccccccee
Confidence 999999865432 46899999999999999999999996 999999999999999999999999999877543221 1
Q ss_pred ccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHHHHHhhcCCccccccccccC
Q 039168 376 NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQ 454 (536)
Q Consensus 376 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~ 454 (536)
......++..|+|||.+.+..++.++||||||+++|+|++ |+.||...... ...... ........ .
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~~---~~~~~~~~-----~-- 222 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS---QILKKI---DKEGERLE-----R-- 222 (257)
T ss_pred cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHH---HhcCCcCC-----C--
Confidence 1122456788999999998899999999999999999999 99997432111 111111 11111100 0
Q ss_pred CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 039168 455 SCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLA 490 (536)
Q Consensus 455 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 490 (536)
+......+.+++.+||+.+|++|||+.++++.|.
T Consensus 223 --~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 223 --PEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred --CccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 1111234667777999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=315.58 Aligned_cols=259 Identities=31% Similarity=0.443 Sum_probs=201.5
Q ss_pred hcCCccccccCCCCceeEEEEEeC--------CCcEEEEEEcccc-ChhhHHHHHHHHHHHHHc-CCCCceeEeeEEeeC
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA--------DGKAIAVKRLSRT-SGQGLKEFKNEVNLIAKL-QHKNLVRLLGCCLEG 284 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~ 284 (536)
.++|.+.++||+|+||.||+++.. ....+|+|.+... .......+.+|+.+++++ +||||+++++++...
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 357889999999999999999742 2457899988754 334466788999999999 699999999999999
Q ss_pred ceEEEEEeecCCCChhhhhhccc-------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEE
Q 039168 285 QELLLIYEYMPNKSLDVHLFDAT-------------RSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLL 351 (536)
Q Consensus 285 ~~~~lv~e~~~~~sL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll 351 (536)
...+++|||+.+++|..++.... ....+++.++..++.||+.||.|||+++ ++|+||||+|||+
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEE
Confidence 99999999999999999986532 1245889999999999999999999987 9999999999999
Q ss_pred cCCCCeEEecccCccccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCch
Q 039168 352 DDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQT 430 (536)
Q Consensus 352 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~ 430 (536)
++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|+|++ |..||..... ..
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~---~~ 244 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV---EE 244 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH---HH
Confidence 9999999999999986643222111112234467999999998889999999999999999999 7888643211 11
Q ss_pred hHHHHHHHhhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 431 LLTYTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 431 ~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
... ....+...+. +.....++.+++.+||+.||++|||+.++++.|...
T Consensus 245 ~~~----~~~~~~~~~~---------~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~ 293 (314)
T cd05099 245 LFK----LLREGHRMDK---------PSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKV 293 (314)
T ss_pred HHH----HHHcCCCCCC---------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 111 1111111111 111123466777899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=320.04 Aligned_cols=198 Identities=30% Similarity=0.385 Sum_probs=167.7
Q ss_pred HhcCCccccccCCCCceeEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCc-----
Q 039168 214 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQ----- 285 (536)
Q Consensus 214 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~----- 285 (536)
..++|++.+.||+|+||.||++.+. .++.||+|++... .......+.+|+.+++.++||||+++++++...+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 4578999999999999999999875 5899999998643 2334567889999999999999999999986543
Q ss_pred -eEEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccC
Q 039168 286 -ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGT 364 (536)
Q Consensus 286 -~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~ 364 (536)
..++||||++++ |...+. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 99 ~~~~lv~e~~~~~-l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 99 QDVYLVMELMDAN-LCQVIH-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred ceeEEEEeCCCcC-HHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCC
Confidence 579999999765 444442 23788999999999999999999997 99999999999999999999999999
Q ss_pred ccccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 039168 365 ARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFY 423 (536)
Q Consensus 365 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~ 423 (536)
++...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus 170 a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 225 (359)
T cd07876 170 ARTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGT 225 (359)
T ss_pred ccccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 97543221 122346899999999999999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=321.91 Aligned_cols=240 Identities=25% Similarity=0.286 Sum_probs=186.7
Q ss_pred cccCCCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHH-HHHHcCCCCceeEeeEEeeCceEEEEEeecCC
Q 039168 222 NKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLKEFKNEVN-LIAKLQHKNLVRLLGCCLEGQELLLIYEYMPN 296 (536)
Q Consensus 222 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 296 (536)
+.||+|+||.||++... +|+.||+|++.+.. ......+..|.. +++.++||||+++++++...+..++||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999875 58999999986532 223344555554 57789999999999999999999999999999
Q ss_pred CChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCCccc
Q 039168 297 KSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQAN 376 (536)
Q Consensus 297 ~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 376 (536)
++|..++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~--~~ 152 (325)
T cd05604 81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS--DT 152 (325)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCC--CC
Confidence 999888743 345899999999999999999999997 9999999999999999999999999987532211 12
Q ss_pred cccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccccccCCC
Q 039168 377 TNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQSC 456 (536)
Q Consensus 377 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~ 456 (536)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ........ .... .+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~------~~~~~~~~-~~~~------~~~~-- 217 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDV------AEMYDNIL-HKPL------VLRP-- 217 (325)
T ss_pred cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCH------HHHHHHHH-cCCc------cCCC--
Confidence 2345789999999999999999999999999999999999999753221 11111111 1110 0111
Q ss_pred CHHHHHHHHHHHHhhcCCCCCCCCCHHHHH
Q 039168 457 APDELLKFIHIGLLCVQQDPADRPTMSSVV 486 (536)
Q Consensus 457 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl 486 (536)
.....+.+++.+||+.||.+||++.+.+
T Consensus 218 --~~~~~~~~ll~~ll~~~p~~R~~~~~~~ 245 (325)
T cd05604 218 --GASLTAWSILEELLEKDRQRRLGAKEDF 245 (325)
T ss_pred --CCCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence 1223455677799999999999886433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=303.96 Aligned_cols=254 Identities=25% Similarity=0.353 Sum_probs=187.5
Q ss_pred cccCCCCceeEEEEEeCC---CcEEEEEEccccC-hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEeecCCC
Q 039168 222 NKLGQGGFGPVYKGTLAD---GKAIAVKRLSRTS-GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNK 297 (536)
Q Consensus 222 ~~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~~ 297 (536)
+.||+|+||.||+|...+ ...+++|.+.... ......+.+|+.+++.++||||+++++.+......++||||++++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 369999999999997543 4578888876443 333456889999999999999999999999999999999999999
Q ss_pred ChhhhhhcccC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCCcc
Q 039168 298 SLDVHLFDATR--SVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQA 375 (536)
Q Consensus 298 sL~~~l~~~~~--~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 375 (536)
+|.+++..... ....++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 99999865432 233567888899999999999999996 9999999999999999999999999987543222211
Q ss_pred ccccccccccccCcchhcC-------CCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHHHHHhhcCCcccc
Q 039168 376 NTNIIAGTYGYMAPEYAMG-------GIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVEL 447 (536)
Q Consensus 376 ~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 447 (536)
......+++.|+|||++.. ..++.++||||||+++|||++ |..||...... .. ...... .....+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~---~~---~~~~~~-~~~~~~ 230 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE---QV---LKQVVR-EQDIKL 230 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH---HH---HHHHhh-ccCccC
Confidence 1223345678999998743 356889999999999999999 77776432211 11 111111 111122
Q ss_pred ccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 039168 448 IDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLA 490 (536)
Q Consensus 448 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 490 (536)
..+.+... .+ ..+.+++..|+ .||++|||+++|+++|+
T Consensus 231 ~~~~~~~~-~~---~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 231 PKPQLDLK-YS---DRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCCccccc-CC---HHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 22222222 22 23344555777 59999999999999985
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=308.45 Aligned_cols=255 Identities=26% Similarity=0.436 Sum_probs=199.3
Q ss_pred cCCccccccCCCCceeEEEEEeCC-C---cEEEEEEcccc-ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEE
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLAD-G---KAIAVKRLSRT-SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 290 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 290 (536)
..|++.+.||+|+||.||+|.++. + ..||||.+... .......+..|+.++++++||||+++++++.++...++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 357889999999999999998753 3 36999998754 344567899999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCC
Q 039168 291 YEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGG 370 (536)
Q Consensus 291 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 370 (536)
|||+++++|..++... ...+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++.....
T Consensus 84 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 84 TEFMENGALDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred EecCCCCcHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCcccccccc
Confidence 9999999999988543 245899999999999999999999997 99999999999999999999999999886643
Q ss_pred CCCccccc-ccc--ccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHHHHHhhcCCccc
Q 039168 371 NQNQANTN-IIA--GTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVE 446 (536)
Q Consensus 371 ~~~~~~~~-~~~--gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 446 (536)
........ ... .+..|+|||.+.+..++.++||||||+++|||++ |..||...... ...... ....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~---~~~~~i----~~~~--- 228 (269)
T cd05065 159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ---DVINAI----EQDY--- 228 (269)
T ss_pred CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH---HHHHHH----HcCC---
Confidence 32211111 111 1357999999999999999999999999999886 99887432211 111111 1110
Q ss_pred cccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcc
Q 039168 447 LIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 491 (536)
Q Consensus 447 l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 491 (536)
.... ..+....+.+++..||+.+|++||++.+|+..|+.
T Consensus 229 --~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 267 (269)
T cd05065 229 --RLPP----PMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDK 267 (269)
T ss_pred --cCCC----cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 0000 11112345677779999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=307.16 Aligned_cols=256 Identities=29% Similarity=0.475 Sum_probs=201.3
Q ss_pred cCCccccccCCCCceeEEEEEeCC-C---cEEEEEEcccc-ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEE
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLAD-G---KAIAVKRLSRT-SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 290 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 290 (536)
++|+..+.||+|+||.||+|.++. + ..+++|++... .....+.+.+|++++++++|||++++++++...+..++|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 578889999999999999998753 3 37999998754 334456788999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCC
Q 039168 291 YEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGG 370 (536)
Q Consensus 291 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 370 (536)
|||+++++|..++... ...+++.++..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++.....
T Consensus 85 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 85 TEYMENGALDKYLRDH--DGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLED 159 (268)
T ss_pred EEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceeccc
Confidence 9999999999998543 245899999999999999999999986 99999999999999999999999999986643
Q ss_pred CCCcccc-ccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHHHHHhhcCCccccc
Q 039168 371 NQNQANT-NIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELI 448 (536)
Q Consensus 371 ~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 448 (536)
....... .....+..|+|||++.+..++.++||||||+++|||++ |+.||...... . ............
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~---~----~~~~i~~~~~~~-- 230 (268)
T cd05063 160 DPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH---E----VMKAINDGFRLP-- 230 (268)
T ss_pred ccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH---H----HHHHHhcCCCCC--
Confidence 3221111 11123457999999998889999999999999999997 99997432211 1 111111111100
Q ss_pred cccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 449 DPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 449 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
........+.+++.+||+.+|++||++.+|++.|...
T Consensus 231 -------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 231 -------APMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred -------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0111224567788899999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=309.32 Aligned_cols=256 Identities=29% Similarity=0.415 Sum_probs=199.4
Q ss_pred hcCCccccccCCCCceeEEEEEeC-CCc----EEEEEEcccc-ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEE
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA-DGK----AIAVKRLSRT-SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELL 288 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 288 (536)
.++|++.++||+|+||.||+|++. ++. .||+|.+... .......+.+|+.+++.++||||+++++++.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 367899999999999999999853 343 4899988654 33445678899999999999999999999875 4578
Q ss_pred EEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCcccc
Q 039168 289 LIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIF 368 (536)
Q Consensus 289 lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 368 (536)
+++||+++|+|.+++... ...+++..++.++.||+.||.|||+++ ++||||||+|||+++++.+||+|||+++.+
T Consensus 85 l~~~~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 85 LVTQLMPYGCLLDYVREN--KDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred EEEEcCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeec
Confidence 999999999999988543 235899999999999999999999996 999999999999999999999999999876
Q ss_pred CCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHHHHHhhcCCcccc
Q 039168 369 GGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVEL 447 (536)
Q Consensus 369 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 447 (536)
.............+++.|+|||.+.+..++.++||||||+++|||++ |..||..... .... ..+..+.....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~----~~~~~~~~~~~ 232 (279)
T cd05109 160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA---REIP----DLLEKGERLPQ 232 (279)
T ss_pred ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH---HHHH----HHHHCCCcCCC
Confidence 53332222222234678999999999899999999999999999998 8888653221 1111 11111111110
Q ss_pred ccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 448 IDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 448 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
.......+.+++.+||+.||++|||+.++++.|...
T Consensus 233 ---------~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~ 268 (279)
T cd05109 233 ---------PPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRM 268 (279)
T ss_pred ---------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 111223466777899999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=304.70 Aligned_cols=253 Identities=31% Similarity=0.481 Sum_probs=198.9
Q ss_pred cCCccccccCCCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEeecC
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMP 295 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 295 (536)
++|++.++||+|++|.||++.+..+..+|+|++.... ...+.+.+|+++++.++|||++++++++. .+..+++|||+.
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 5688899999999999999998777789999886543 23467889999999999999999999875 456899999999
Q ss_pred CCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCCcc
Q 039168 296 NKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQA 375 (536)
Q Consensus 296 ~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 375 (536)
+++|.+++.... ...+++..+..++.||+.||.|||+.+ ++|+||||+||++++++.++|+|||++..........
T Consensus 84 ~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05069 84 KGSLLDFLKEGD-GKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CCCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCcccc
Confidence 999999986532 334789999999999999999999986 9999999999999999999999999998664332211
Q ss_pred ccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHHHHHhhcCCccccccccccC
Q 039168 376 NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQ 454 (536)
Q Consensus 376 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~ 454 (536)
.....++..|+|||.+.+..++.++||||||+++|+|++ |+.||...... ... ..........
T Consensus 160 -~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~----~~~~~~~~~~-------- 223 (260)
T cd05069 160 -RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR---EVL----EQVERGYRMP-------- 223 (260)
T ss_pred -cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHH----HHHHcCCCCC--------
Confidence 112235678999999998889999999999999999999 88887532211 111 1111111000
Q ss_pred CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcc
Q 039168 455 SCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 491 (536)
Q Consensus 455 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 491 (536)
.+......+.+++.+||++||++||++++|+++|+.
T Consensus 224 -~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 224 -CPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred -CCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 111123446667779999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=319.77 Aligned_cols=241 Identities=24% Similarity=0.261 Sum_probs=185.6
Q ss_pred cccCCCCceeEEEEEeC-CCcEEEEEEccccCh---hhHHHHHHH-HHHHHHcCCCCceeEeeEEeeCceEEEEEeecCC
Q 039168 222 NKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG---QGLKEFKNE-VNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPN 296 (536)
Q Consensus 222 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E-~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 296 (536)
+.||+|+||.||++++. +++.||+|++..... .....+..| ..+++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999976 478899999865321 222334444 4457889999999999999999999999999999
Q ss_pred CChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCCccc
Q 039168 297 KSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQAN 376 (536)
Q Consensus 297 ~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 376 (536)
++|..++.. ...+.+..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~--~~ 152 (325)
T cd05602 81 GELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--GT 152 (325)
T ss_pred CcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCC--CC
Confidence 999988854 234788899999999999999999997 9999999999999999999999999997543221 12
Q ss_pred cccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccccccCCC
Q 039168 377 TNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQSC 456 (536)
Q Consensus 377 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~ 456 (536)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ....... .... . +..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~~~i~-~~~~-~-----~~~-- 217 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA------EMYDNIL-NKPL-Q-----LKP-- 217 (325)
T ss_pred cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH------HHHHHHH-hCCc-C-----CCC--
Confidence 33457899999999999999999999999999999999999997532211 1111111 1110 0 111
Q ss_pred CHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 457 APDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 457 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
.....+.+++.+||+.||.+||++.+.+.
T Consensus 218 --~~~~~~~~li~~~l~~~p~~R~~~~~~~~ 246 (325)
T cd05602 218 --NITNSARHLLEGLLQKDRTKRLGAKDDFM 246 (325)
T ss_pred --CCCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence 11234556667999999999999875443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=311.97 Aligned_cols=263 Identities=28% Similarity=0.451 Sum_probs=201.4
Q ss_pred cCCccccccCCCCceeEEEEEe-----CCCcEEEEEEccccC-hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeC--ceE
Q 039168 216 NHFSDENKLGQGGFGPVYKGTL-----ADGKAIAVKRLSRTS-GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEG--QEL 287 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~ 287 (536)
..|++.+.||+|+||.||++.. .++..||+|.+.... ......+.+|+.+++.++|||++++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 4578899999999999999974 357899999987543 34456789999999999999999999998875 568
Q ss_pred EEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccc
Q 039168 288 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARI 367 (536)
Q Consensus 288 ~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 367 (536)
++||||+++++|..++.... ..+++..++.++.||+.||+|||+++ ++||||||+||+++.++.++|+|||++..
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNK--NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred EEEEEccCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence 99999999999999985432 35899999999999999999999997 99999999999999999999999999987
Q ss_pred cCCCCCc-cccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCcc--------CCchhHHHHHHH
Q 039168 368 FGGNQNQ-ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSE--------HGQTLLTYTWKL 438 (536)
Q Consensus 368 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~--------~~~~~~~~~~~~ 438 (536)
+...... .......++..|+|||.+.+..++.++||||||+++|+|++++.|....... ............
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05079 159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV 238 (284)
T ss_pred cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 6533221 1122345677899999999888999999999999999999987764221110 011111111111
Q ss_pred hhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 439 WCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 439 ~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
...+..... .......+.+++.+||+.||++|||+.++++.|+..
T Consensus 239 ~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 239 LEEGKRLPR---------PPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHcCccCCC---------CCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 111111110 111234577778899999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=322.31 Aligned_cols=245 Identities=29% Similarity=0.477 Sum_probs=198.0
Q ss_pred cCCccccccCCCCceeEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEE
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 291 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 291 (536)
+.|..++.||.|+||.||.|++. +.+.||||++.-. +.+.+..+.+|+..|++++|||++.+.++|..+...||||
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM 105 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM 105 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence 45788899999999999999975 5788999999743 4566788999999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCC
Q 039168 292 EYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGN 371 (536)
Q Consensus 292 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 371 (536)
|||- |+-.+++.- ..+++.+.++..|..+.+.||.|||+.+ .||||||..|||+++.|.|||+|||.|-...
T Consensus 106 EYCl-GSAsDlleV--hkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~-- 177 (948)
T KOG0577|consen 106 EYCL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMA-- 177 (948)
T ss_pred HHHh-ccHHHHHHH--HhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcC--
Confidence 9995 466666633 3346899999999999999999999996 9999999999999999999999999997542
Q ss_pred CCccccccccccccccCcchhc---CCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccc
Q 039168 372 QNQANTNIIAGTYGYMAPEYAM---GGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELI 448 (536)
Q Consensus 372 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 448 (536)
....++|||.|||||++. .+.|+-++||||||++..||.-.++|.-.... +. +.-++..++
T Consensus 178 ----PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA------MS-ALYHIAQNe----- 241 (948)
T KOG0577|consen 178 ----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MS-ALYHIAQNE----- 241 (948)
T ss_pred ----chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH------HH-HHHHHHhcC-----
Confidence 234579999999999985 46799999999999999999999988422111 11 111122222
Q ss_pred cccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 449 DPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 449 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
.|.+.....++.+..+++ .||++-|.+|||..+++.
T Consensus 242 sPtLqs~eWS~~F~~Fvd---~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 242 SPTLQSNEWSDYFRNFVD---SCLQKIPQERPTSEELLK 277 (948)
T ss_pred CCCCCCchhHHHHHHHHH---HHHhhCcccCCcHHHHhh
Confidence 233444444555555555 999999999999999883
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=341.08 Aligned_cols=259 Identities=23% Similarity=0.308 Sum_probs=198.7
Q ss_pred cCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEE
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 291 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 291 (536)
++|++.++||+|+||.||+|.+. +++.||+|++.... ....+++.+|++++++++||||+++++++.+++..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57999999999999999999975 58999999987532 233567889999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcccC--------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEeccc
Q 039168 292 EYMPNKSLDVHLFDATR--------SVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFG 363 (536)
Q Consensus 292 e~~~~~sL~~~l~~~~~--------~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg 363 (536)
||++|++|..++..... ...+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 99999999998864211 223566788899999999999999996 9999999999999999999999999
Q ss_pred CccccCCCCC----------------ccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccC
Q 039168 364 TARIFGGNQN----------------QANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEH 427 (536)
Q Consensus 364 ~a~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~ 427 (536)
+++....... ........||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~- 237 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR- 237 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh-
Confidence 9987621110 00112356999999999999999999999999999999999999998542211
Q ss_pred CchhHHHHHHHhhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCC-CHHHHHHHhcc
Q 039168 428 GQTLLTYTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRP-TMSSVVVMLAS 491 (536)
Q Consensus 428 ~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~evl~~L~~ 491 (536)
.... . . ........ .. .......+.+++.+||+.||++|| +++++++.|+.
T Consensus 238 --ki~~-~-~-----~i~~P~~~-~p---~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~ 289 (932)
T PRK13184 238 --KISY-R-D-----VILSPIEV-AP---YREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEP 289 (932)
T ss_pred --hhhh-h-h-----hccChhhc-cc---cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1100 0 0 00000000 00 011123455677799999999996 56667666654
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=311.38 Aligned_cols=260 Identities=23% Similarity=0.334 Sum_probs=190.9
Q ss_pred CCccccccCCCCceeEEEEEeC-CCcEEEEEEccccCh--hhHHHHHHHHHHHHHc---CCCCceeEeeEEee-----Cc
Q 039168 217 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG--QGLKEFKNEVNLIAKL---QHKNLVRLLGCCLE-----GQ 285 (536)
Q Consensus 217 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~hpniv~l~~~~~~-----~~ 285 (536)
+|++.+.||+|+||.||+|.++ +++.||+|.+..... .....+.+|+.+++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4888999999999999999876 588999998865321 2223456677777665 79999999998864 34
Q ss_pred eEEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCc
Q 039168 286 ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTA 365 (536)
Q Consensus 286 ~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 365 (536)
..++||||+.+ +|..++.... ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVP-PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence 68999999975 7777775432 244899999999999999999999997 999999999999999999999999999
Q ss_pred cccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcC---
Q 039168 366 RIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEG--- 442 (536)
Q Consensus 366 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--- 442 (536)
+....... .....|++.|+|||++.+..++.++|||||||++|+|++|++||...... .............
T Consensus 156 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~---~~~~~~~~~~~~~~~~ 229 (288)
T cd07863 156 RIYSCQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA---DQLGKIFDLIGLPPED 229 (288)
T ss_pred ccccCccc---CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHH---HHHHHHHHHhCCCChh
Confidence 87643221 22346789999999999989999999999999999999999997542211 1111111111000
Q ss_pred Ccccc-------cccccc---CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 443 HAVEL-------IDPVLK---QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 443 ~~~~l-------~~~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
.+... +.+... ....+.....+.+++.+||+.||++|||+.+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 230 DWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred hCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00000 000000 0011112345677888999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=304.22 Aligned_cols=250 Identities=22% Similarity=0.339 Sum_probs=200.5
Q ss_pred CCccccccCCCCceeEEEEEeC-CCcEEEEEEcccc-ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEeec
Q 039168 217 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT-SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 294 (536)
Q Consensus 217 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 294 (536)
+|++.++||+|+||.||++... +++.+|+|.+... .....+.+.+|+.+++.++||||+++++.+..++..+++|||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4788899999999999999976 5899999988643 3345677889999999999999999999999999999999999
Q ss_pred CCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCCc
Q 039168 295 PNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQ 374 (536)
Q Consensus 295 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 374 (536)
++++|..++... ....+++..++.++.||+.||.|||+++ ++|+||||+||++++++.++|+|||++........
T Consensus 81 ~~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~- 155 (255)
T cd08219 81 DGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA- 155 (255)
T ss_pred CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccccc-
Confidence 999998887542 2345789999999999999999999986 99999999999999999999999999986643222
Q ss_pred cccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccccccC
Q 039168 375 ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQ 454 (536)
Q Consensus 375 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~ 454 (536)
......|++.|+|||++.+..++.++|+||||+++|+|++|+.||..... ....... ..+....+ .
T Consensus 156 -~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~------~~~~~~~-~~~~~~~~-----~- 221 (255)
T cd08219 156 -YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW------KNLILKV-CQGSYKPL-----P- 221 (255)
T ss_pred -ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH------HHHHHHH-hcCCCCCC-----C-
Confidence 12235688999999999988899999999999999999999999753211 1111111 11111111 1
Q ss_pred CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 455 SCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 455 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
......+.+++.+||+.||++|||+.+++..
T Consensus 222 ---~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 222 ---SHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred ---cccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 1112345677779999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=319.48 Aligned_cols=260 Identities=28% Similarity=0.421 Sum_probs=199.3
Q ss_pred hcCCccccccCCCCceeEEEEEe------CCCcEEEEEEccccC-hhhHHHHHHHHHHHHHc-CCCCceeEeeEEee-Cc
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTL------ADGKAIAVKRLSRTS-GQGLKEFKNEVNLIAKL-QHKNLVRLLGCCLE-GQ 285 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~-~~ 285 (536)
.++|++.+.||+|+||.||+|.+ .+++.||||++.... ......+.+|+.++.++ +||||+++++++.. +.
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 35899999999999999999974 347889999997543 33456788999999999 68999999998765 45
Q ss_pred eEEEEEeecCCCChhhhhhcccC---------------------------------------------------------
Q 039168 286 ELLLIYEYMPNKSLDVHLFDATR--------------------------------------------------------- 308 (536)
Q Consensus 286 ~~~lv~e~~~~~sL~~~l~~~~~--------------------------------------------------------- 308 (536)
..++||||+++++|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 68999999999999998854210
Q ss_pred -------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCCcccccccc
Q 039168 309 -------SVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIA 381 (536)
Q Consensus 309 -------~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~ 381 (536)
...+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||++................
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 123678888999999999999999997 9999999999999999999999999998654332222222234
Q ss_pred ccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHHHHHhhcCCccccccccccCCCCHHH
Q 039168 382 GTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQSCAPDE 460 (536)
Q Consensus 382 gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~ 460 (536)
+++.|+|||.+.+..++.++||||||+++|+|++ |..||...... .. .......+..... .. ..
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~----~~~~~~~~~~~~~-----~~-~~--- 307 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--EE----FCRRLKEGTRMRA-----PD-YT--- 307 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc--HH----HHHHHhccCCCCC-----CC-CC---
Confidence 5678999999999899999999999999999997 88887542211 01 1111111111111 01 11
Q ss_pred HHHHHHHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 461 LLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 461 ~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
...+.+++..||+.||++|||+.+|++.|+..
T Consensus 308 ~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~ 339 (343)
T cd05103 308 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 339 (343)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 12467777899999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=318.18 Aligned_cols=192 Identities=25% Similarity=0.328 Sum_probs=163.7
Q ss_pred HhcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEe
Q 039168 214 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 292 (536)
Q Consensus 214 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 292 (536)
...+|++.+.||+|+||.||+|+.. +++.||+|+.... ....|+.++++++||||+++++++......++|||
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 3467999999999999999999976 4788999975432 23569999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCC
Q 039168 293 YMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQ 372 (536)
Q Consensus 293 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 372 (536)
++. ++|..++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 138 ~~~-~~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~- 210 (357)
T PHA03209 138 HYS-SDLYTYLTK--RSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA- 210 (357)
T ss_pred ccC-CcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC-
Confidence 995 567767643 2345899999999999999999999996 999999999999999999999999999753221
Q ss_pred CccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCC
Q 039168 373 NQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNN 420 (536)
Q Consensus 373 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~ 420 (536)
.......||+.|+|||++.+..++.++|||||||++|||+++..++
T Consensus 211 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 211 --PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred --cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 1122356899999999999999999999999999999999976553
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=313.44 Aligned_cols=255 Identities=29% Similarity=0.446 Sum_probs=197.2
Q ss_pred cCCccccccCCCCceeEEEEEeC-CCc--EEEEEEcccc-ChhhHHHHHHHHHHHHHc-CCCCceeEeeEEeeCceEEEE
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA-DGK--AIAVKRLSRT-SGQGLKEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLI 290 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv 290 (536)
++|++.+.||+|+||.||+|.++ ++. .+++|.+... .......+.+|+.++.++ +||||+++++++..++..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 57889999999999999999875 343 4578777543 334456788999999999 899999999999999999999
Q ss_pred EeecCCCChhhhhhccc-------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCe
Q 039168 291 YEYMPNKSLDVHLFDAT-------------RSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNP 357 (536)
Q Consensus 291 ~e~~~~~sL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~ 357 (536)
|||+++++|..++.... ....+++.+++.++.||+.||+|||+++ ++||||||+|||++.++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence 99999999999986432 1235789999999999999999999986 9999999999999999999
Q ss_pred EEecccCccccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHHH
Q 039168 358 KISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTW 436 (536)
Q Consensus 358 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~ 436 (536)
||+|||++...... .......++..|+|||++.+..++.++||||||+++|||++ |..||...... ....
T Consensus 164 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~~--- 234 (303)
T cd05088 164 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---ELYE--- 234 (303)
T ss_pred EeCccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH---HHHH---
Confidence 99999998643211 11111234567999999988889999999999999999998 99887432211 1111
Q ss_pred HHhhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 437 KLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 437 ~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
........+ .... ....+.+++.+||+.+|++|||+.++++.|...
T Consensus 235 -~~~~~~~~~-----~~~~----~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~ 280 (303)
T cd05088 235 -KLPQGYRLE-----KPLN----CDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 280 (303)
T ss_pred -HHhcCCcCC-----CCCC----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 111110000 0111 123466777899999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=304.00 Aligned_cols=252 Identities=28% Similarity=0.438 Sum_probs=200.0
Q ss_pred cCCccccccCCCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEeecC
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMP 295 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 295 (536)
.+|++.+.||+|+||.||++.+.++..+|+|++..... ....+.+|++++++++|||++++++++......++||||+.
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 46888899999999999999987788999998865432 34578899999999999999999999999999999999999
Q ss_pred CCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCCcc
Q 039168 296 NKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQA 375 (536)
Q Consensus 296 ~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 375 (536)
+++|.+++.... ..+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++..........
T Consensus 83 ~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 157 (256)
T cd05112 83 HGCLSDYLRAQR--GKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS 157 (256)
T ss_pred CCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence 999998885432 34789999999999999999999986 9999999999999999999999999998654322111
Q ss_pred ccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHHHHHhhcCCccccccccccC
Q 039168 376 NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQ 454 (536)
Q Consensus 376 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~ 454 (536)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||...... .... ...++. ....+
T Consensus 158 -~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~------~~~~-~~~~~~--~~~~~---- 223 (256)
T cd05112 158 -STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS------EVVE-TINAGF--RLYKP---- 223 (256)
T ss_pred -cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH------HHHH-HHhCCC--CCCCC----
Confidence 112234678999999998889999999999999999998 88887532211 1111 111110 11111
Q ss_pred CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 039168 455 SCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLA 490 (536)
Q Consensus 455 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 490 (536)
... ...+.+++.+||+.+|++|||+.++++.|.
T Consensus 224 ~~~---~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 224 RLA---SQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred CCC---CHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 111 245667778999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=310.82 Aligned_cols=263 Identities=30% Similarity=0.458 Sum_probs=203.3
Q ss_pred cCCccccccCCCCceeEEEEEeC-----CCcEEEEEEccccChh-hHHHHHHHHHHHHHcCCCCceeEeeEEee--CceE
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA-----DGKAIAVKRLSRTSGQ-GLKEFKNEVNLIAKLQHKNLVRLLGCCLE--GQEL 287 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~--~~~~ 287 (536)
+.|++.+.||+|+||.||++... .++.||||++...... ..+.+.+|+++++.++||||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 46788899999999999999853 3789999998765443 46789999999999999999999999887 5689
Q ss_pred EEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccc
Q 039168 288 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARI 367 (536)
Q Consensus 288 ~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 367 (536)
+++|||+++++|.+++.... ..+++..+..++.||+.||+|||+++ ++|+||||+||+++.++.++|+|||++..
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHR--DQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred EEEEecCCCCCHHHHHHhCc--cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 99999999999999986533 24899999999999999999999987 99999999999999999999999999987
Q ss_pred cCCCCCc-cccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCc--------hhHHHHHHH
Q 039168 368 FGGNQNQ-ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQ--------TLLTYTWKL 438 (536)
Q Consensus 368 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~--------~~~~~~~~~ 438 (536)
....... .......++..|+|||.+.+..++.++||||||+++|||++|+.|+......... .........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05038 159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLEL 238 (284)
T ss_pred cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHH
Confidence 6532221 1111223456799999998889999999999999999999999886542221110 001111111
Q ss_pred hhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 439 WCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 439 ~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
...... ...+......+.+++.+||+.+|++|||+.+|+++|...
T Consensus 239 ~~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 239 LKEGER---------LPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHcCCc---------CCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 111110 001111224577788899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=324.67 Aligned_cols=201 Identities=24% Similarity=0.355 Sum_probs=173.8
Q ss_pred cCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEE
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 291 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 291 (536)
++|+..+.||+|+||.||++..+ +++.||||++.... ......+.+|+.++.+++||||+++++.+.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36889999999999999999876 58999999986432 234567888999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCC
Q 039168 292 EYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGN 371 (536)
Q Consensus 292 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 371 (536)
||+++++|..++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~ 154 (360)
T cd05627 81 EFLPGGDMMTLLMKK---DTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA 154 (360)
T ss_pred eCCCCccHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence 999999999998543 35899999999999999999999997 999999999999999999999999998755321
Q ss_pred CCc---------------------------------cccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCC
Q 039168 372 QNQ---------------------------------ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRK 418 (536)
Q Consensus 372 ~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~ 418 (536)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~ 234 (360)
T cd05627 155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (360)
T ss_pred cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence 100 00113469999999999999999999999999999999999999
Q ss_pred CCCC
Q 039168 419 NNGF 422 (536)
Q Consensus 419 p~~~ 422 (536)
||..
T Consensus 235 Pf~~ 238 (360)
T cd05627 235 PFCS 238 (360)
T ss_pred CCCC
Confidence 9854
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=306.20 Aligned_cols=255 Identities=27% Similarity=0.449 Sum_probs=200.6
Q ss_pred cCCccccccCCCCceeEEEEEeC----CCcEEEEEEccccC-hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEE
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA----DGKAIAVKRLSRTS-GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 290 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 290 (536)
.+|++.+.||+|+||.||+|.+. .+..+|+|.+.... ....+.+.+|+.++++++||||+++++++..++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 57888999999999999999864 23479999886543 33456789999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCC
Q 039168 291 YEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGG 370 (536)
Q Consensus 291 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 370 (536)
|||+++++|..++.... ..+++.+++.++.|++.||.|||+++ ++|+||||+|||++.++.++|+|||++..+..
T Consensus 84 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 84 TEYMENGSLDAFLRKHD--GQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 99999999999986432 35899999999999999999999986 99999999999999999999999999987654
Q ss_pred CCCccc-cccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHHHHHhhcCCccccc
Q 039168 371 NQNQAN-TNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELI 448 (536)
Q Consensus 371 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 448 (536)
...... .....++..|+|||.+.+..++.++||||||+++|++++ |..||...... .... ...++....
T Consensus 159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~---~~~~----~~~~~~~~~-- 229 (267)
T cd05066 159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ---DVIK----AIEEGYRLP-- 229 (267)
T ss_pred ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH---HHHH----HHhCCCcCC--
Confidence 322111 111223568999999998899999999999999999886 99987543221 1111 111111000
Q ss_pred cccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcc
Q 039168 449 DPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 491 (536)
Q Consensus 449 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 491 (536)
. .......+.+++.+||+.+|.+|||+.++++.|..
T Consensus 230 ---~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 265 (267)
T cd05066 230 ---A----PMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDK 265 (267)
T ss_pred ---C----CCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHh
Confidence 0 11112345677779999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=316.67 Aligned_cols=241 Identities=24% Similarity=0.325 Sum_probs=190.5
Q ss_pred CCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHHHcC-CCCceeEeeEEeeCceEEEEE
Q 039168 217 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLKEFKNEVNLIAKLQ-HKNLVRLLGCCLEGQELLLIY 291 (536)
Q Consensus 217 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lv~ 291 (536)
+|+..+.||+|+||.||++..+ +++.||+|++.+.. ....+.+..|..++..+. |++|+++++++...+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4778899999999999999875 58999999987532 233456778999998886 577888999999999999999
Q ss_pred eecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCC
Q 039168 292 EYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGN 371 (536)
Q Consensus 292 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 371 (536)
||+++++|..++... ..+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 Ey~~~g~L~~~i~~~---~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~ 154 (323)
T cd05615 81 EYVNGGDLMYHIQQV---GKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD 154 (323)
T ss_pred cCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence 999999999888543 35899999999999999999999997 999999999999999999999999998754322
Q ss_pred CCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcccccccc
Q 039168 372 QNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPV 451 (536)
Q Consensus 372 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 451 (536)
. .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ... .... .... .
T Consensus 155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~---~~~---~~i~-~~~~-~----- 219 (323)
T cd05615 155 G--VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED---ELF---QSIM-EHNV-S----- 219 (323)
T ss_pred C--ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH---HHH---HHHH-hCCC-C-----
Confidence 2 1223356899999999999989999999999999999999999998643211 111 1111 1111 0
Q ss_pred ccCCCCHHHHHHHHHHHHhhcCCCCCCCCCH
Q 039168 452 LKQSCAPDELLKFIHIGLLCVQQDPADRPTM 482 (536)
Q Consensus 452 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 482 (536)
. +......+.+++.+||+++|.+|++.
T Consensus 220 ~----p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 220 Y----PKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred C----CccCCHHHHHHHHHHcccCHhhCCCC
Confidence 0 11112345667779999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=303.27 Aligned_cols=248 Identities=25% Similarity=0.406 Sum_probs=192.5
Q ss_pred ccCCCCceeEEEEEeC---CCcEEEEEEccccC-hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEeecCCCC
Q 039168 223 KLGQGGFGPVYKGTLA---DGKAIAVKRLSRTS-GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKS 298 (536)
Q Consensus 223 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~~s 298 (536)
.||+|+||.||+|.+. .+..||+|++.... ....+.+.+|+.++++++||||+++++++. ....++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4899999999999763 35679999987553 334567899999999999999999999885 457899999999999
Q ss_pred hhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCCccc-c
Q 039168 299 LDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQAN-T 377 (536)
Q Consensus 299 L~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~-~ 377 (536)
|.+++... ...+++..++.++.||+.||.|||+++ ++|+||||+|||++.++.+||+|||++..+........ .
T Consensus 81 L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05115 81 LNKFLSGK--KDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR 155 (257)
T ss_pred HHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence 99988542 345899999999999999999999997 99999999999999999999999999986543322111 1
Q ss_pred ccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHHHHHhhcCCccccccccccCCC
Q 039168 378 NIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQSC 456 (536)
Q Consensus 378 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~ 456 (536)
....+++.|+|||.+.+..++.++||||||+++|+|++ |+.||...... . .......+.... .
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~----~~~~~~~~~~~~---------~ 219 (257)
T cd05115 156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP---E----VMSFIEQGKRLD---------C 219 (257)
T ss_pred CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH---H----HHHHHHCCCCCC---------C
Confidence 11223578999999988889999999999999999996 99987543211 1 111111221111 1
Q ss_pred CHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 457 APDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 457 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
++....++.+++.+||+.||++||++.+|.+.|+..
T Consensus 220 ~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 220 PAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 111233455677799999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=302.69 Aligned_cols=248 Identities=34% Similarity=0.491 Sum_probs=194.2
Q ss_pred cccCCCCceeEEEEEeCC----CcEEEEEEccccCh-hhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEeecCC
Q 039168 222 NKLGQGGFGPVYKGTLAD----GKAIAVKRLSRTSG-QGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPN 296 (536)
Q Consensus 222 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 296 (536)
++||+|+||.||+|.+.. +..+|+|.+..... ...+.+.+|+.++++++||||+++++++. ....++||||+.+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 479999999999997532 37899999876543 34567889999999999999999999876 4568999999999
Q ss_pred CChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCCccc
Q 039168 297 KSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQAN 376 (536)
Q Consensus 297 ~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 376 (536)
++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||||+|||++.++.+||+|||+++.+........
T Consensus 80 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 80 GPLLKYLKKRR---EIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred CcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence 99999996433 5899999999999999999999986 99999999999999999999999999987643332211
Q ss_pred -cccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHHHHHhhcCCccccccccccC
Q 039168 377 -TNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQ 454 (536)
Q Consensus 377 -~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~ 454 (536)
.....++..|+|||.+.+..++.++||||||+++|+|++ |..||..... ...... ........ .
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~---~~~~~~----~~~~~~~~-----~-- 219 (257)
T cd05060 154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG---AEVIAM----LESGERLP-----R-- 219 (257)
T ss_pred cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH---HHHHHH----HHcCCcCC-----C--
Confidence 111223467999999998899999999999999999998 9999754322 111111 11111111 0
Q ss_pred CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 455 SCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 455 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
+......+.+++.+||+.+|++|||+.+|++.|+..
T Consensus 220 --~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 220 --PEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred --CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 111123566777899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=305.57 Aligned_cols=252 Identities=26% Similarity=0.393 Sum_probs=200.3
Q ss_pred cCCccccccCCCCceeEEEEEeCC-CcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEeec
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 294 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 294 (536)
+.|++.++||.|+||.||+|+... ++.|++|.+........+.+.+|+.+++.++||||+++++.+..+...++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 679999999999999999999764 8999999998777777788999999999999999999999999999999999999
Q ss_pred CCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCCc
Q 039168 295 PNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQ 374 (536)
Q Consensus 295 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 374 (536)
++++|..++.... ..+++..+..++.|++.||.|||+++ ++|+||||+||+++.++++||+|||++.......
T Consensus 92 ~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-- 164 (292)
T cd06644 92 PGGAVDAIMLELD--RGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-- 164 (292)
T ss_pred CCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceeccccc--
Confidence 9999988775432 35899999999999999999999986 9999999999999999999999999987543221
Q ss_pred cccccccccccccCcchhc-----CCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcccccc
Q 039168 375 ANTNIIAGTYGYMAPEYAM-----GGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELID 449 (536)
Q Consensus 375 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 449 (536)
.......+++.|+|||++. ...++.++||||||+++|+|++|+.||..... ...... ..........
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~------~~~~~~-~~~~~~~~~~- 236 (292)
T cd06644 165 QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP------MRVLLK-IAKSEPPTLS- 236 (292)
T ss_pred cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH------HHHHHH-HhcCCCccCC-
Confidence 1122345788999999985 34478899999999999999999999754221 111111 1111111100
Q ss_pred ccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 450 PVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 450 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
.......++.+++.+||+.||++||++.++++.
T Consensus 237 ------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 237 ------QPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred ------CCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 011122346677789999999999999999863
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=307.27 Aligned_cols=265 Identities=25% Similarity=0.336 Sum_probs=195.3
Q ss_pred CCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC--hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEee
Q 039168 217 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 293 (536)
Q Consensus 217 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 293 (536)
+|++.+.||+|++|.||+|+.. ++..||+|++.... ....+.+.+|+.++++++||||+++++++.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4788899999999999999975 58999999986432 22346788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCC
Q 039168 294 MPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQN 373 (536)
Q Consensus 294 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 373 (536)
+. ++|..++........+++..++.++.||++||.|||+++ ++|+||||+||++++++.+||+|||++........
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR 156 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence 97 578777765444456899999999999999999999986 99999999999999999999999999976543221
Q ss_pred ccccccccccccccCcchhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhH--------HHHHHHhh----
Q 039168 374 QANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLL--------TYTWKLWC---- 440 (536)
Q Consensus 374 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~--------~~~~~~~~---- 440 (536)
......+++.|+|||.+.+. .++.++||||||+++|+|++|+.||............ ...|..+.
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
T cd07861 157 --VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD 234 (285)
T ss_pred --cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHH
Confidence 11223568899999988764 4789999999999999999999997542211000000 00000000
Q ss_pred -cCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 441 -EGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 441 -~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
...........+.. .......++.+++.+||+.||++|||+.+|++.
T Consensus 235 ~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 235 YKNTFPKWKKGSLRS-AVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred HHhhccccCcchhHH-hcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 00000000000000 000112345577779999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=320.34 Aligned_cols=256 Identities=21% Similarity=0.247 Sum_probs=196.3
Q ss_pred HHhcCCccccccCCCCceeEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEE
Q 039168 213 EATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELL 288 (536)
Q Consensus 213 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 288 (536)
...++|++.+.||+|+||.||+++.+ +++.||+|++.+. .......+.+|+.+++.++||||+++++.+.+++..+
T Consensus 40 ~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (371)
T cd05622 40 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLY 119 (371)
T ss_pred cchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence 34579999999999999999999976 5889999998642 2233455788999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCcccc
Q 039168 289 LIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIF 368 (536)
Q Consensus 289 lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 368 (536)
+||||+++++|..++.. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.+
T Consensus 120 lv~Ey~~gg~L~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a~~~ 192 (371)
T cd05622 120 MVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (371)
T ss_pred EEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCceeEc
Confidence 99999999999988843 23788899999999999999999997 999999999999999999999999999876
Q ss_pred CCCCCccccccccccccccCcchhcCC----CCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCc
Q 039168 369 GGNQNQANTNIIAGTYGYMAPEYAMGG----IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHA 444 (536)
Q Consensus 369 ~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 444 (536)
..... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||..... .............
T Consensus 193 ~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------~~~~~~i~~~~~~ 265 (371)
T cd05622 193 NKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------VGTYSKIMNHKNS 265 (371)
T ss_pred CcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH------HHHHHHHHcCCCc
Confidence 43222 122345799999999999754 378999999999999999999999853221 1111111111111
Q ss_pred cccccccccCCCCHHHHHHHHHHHHhhcCCCCCC--CCCHHHHHHHh
Q 039168 445 VELIDPVLKQSCAPDELLKFIHIGLLCVQQDPAD--RPTMSSVVVML 489 (536)
Q Consensus 445 ~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~~L 489 (536)
....+ .......+.+++.+||+.++.+ |+++.++++..
T Consensus 266 ~~~~~-------~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 266 LTFPD-------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred ccCCC-------cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 11111 0111233455666899844433 78999998754
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=303.45 Aligned_cols=254 Identities=30% Similarity=0.455 Sum_probs=201.8
Q ss_pred hcCCccccccCCCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEeec
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 294 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 294 (536)
.++|++.++||+|+||.||++.+.++..+++|.+.... ...+.+.+|+++++.++|+||+++++.+.. ...+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 82 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence 46889999999999999999998778889999886542 345678899999999999999999999887 7789999999
Q ss_pred CCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCCc
Q 039168 295 PNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQ 374 (536)
Q Consensus 295 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 374 (536)
++++|.+++.... ...+++..+..++.||+.||.|||+.+ ++|+||||+||+++.++.+||+|||.+..+......
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 158 (260)
T cd05073 83 AKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT 158 (260)
T ss_pred CCCcHHHHHHhCC-ccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCcc
Confidence 9999999986532 345788999999999999999999986 999999999999999999999999999876433221
Q ss_pred cccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHHHHHhhcCCcccccccccc
Q 039168 375 ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLK 453 (536)
Q Consensus 375 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~ 453 (536)
. .....++..|+|||++.+..++.++||||||+++|+|++ |+.||...... ... .....+...+.
T Consensus 159 ~-~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~---~~~----~~~~~~~~~~~------ 224 (260)
T cd05073 159 A-REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP---EVI----RALERGYRMPR------ 224 (260)
T ss_pred c-ccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH---HHH----HHHhCCCCCCC------
Confidence 1 112335677999999998889999999999999999999 88887532111 111 11111111111
Q ss_pred CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcc
Q 039168 454 QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 491 (536)
Q Consensus 454 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 491 (536)
.......+.+++.+||+.+|++||++.++++.|+.
T Consensus 225 ---~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 225 ---PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred ---cccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 11122346677779999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=318.08 Aligned_cols=198 Identities=29% Similarity=0.386 Sum_probs=167.8
Q ss_pred HHhcCCccccccCCCCceeEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeC-----
Q 039168 213 EATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEG----- 284 (536)
Q Consensus 213 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~----- 284 (536)
...++|++.+.||+|+||.||++.+. .++.||||++... .......+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 34579999999999999999999875 5889999998754 233456778899999999999999999998643
Q ss_pred -ceEEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEeccc
Q 039168 285 -QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFG 363 (536)
Q Consensus 285 -~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg 363 (536)
...++||||+++ +|...+. ..+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg 164 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCc
Confidence 357999999976 4555542 23788999999999999999999997 9999999999999999999999999
Q ss_pred CccccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCC
Q 039168 364 TARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF 422 (536)
Q Consensus 364 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~ 422 (536)
+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||..
T Consensus 165 ~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 220 (355)
T cd07874 165 LARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG 220 (355)
T ss_pred ccccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 998653321 12234689999999999999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=305.93 Aligned_cols=251 Identities=26% Similarity=0.353 Sum_probs=196.6
Q ss_pred CCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEe
Q 039168 217 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 292 (536)
Q Consensus 217 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 292 (536)
.|+..+.||+|+||.||++.+. +++.||+|++.... ......+.+|+.++++++|++++++++.+.+.+..++|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 3677889999999999999875 58999999986542 2223457789999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCC
Q 039168 293 YMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQ 372 (536)
Q Consensus 293 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 372 (536)
|+.+++|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~g~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05630 81 LMNGGDLKFHIYHMG-EAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 156 (285)
T ss_pred ecCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence 999999998885432 235899999999999999999999986 9999999999999999999999999987654322
Q ss_pred CccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccccc
Q 039168 373 NQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVL 452 (536)
Q Consensus 373 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l 452 (536)
. .....|++.|+|||++.+..++.++||||||+++|+|++|+.||........... ....... . ....
T Consensus 157 ~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~---~~~~~~~--~----~~~~ 224 (285)
T cd05630 157 T---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREE---VERLVKE--V----QEEY 224 (285)
T ss_pred c---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHH---HHhhhhh--h----hhhc
Confidence 1 1234689999999999999999999999999999999999999864322111111 1111000 0 0011
Q ss_pred cCCCCHHHHHHHHHHHHhhcCCCCCCCCC-----HHHHHH
Q 039168 453 KQSCAPDELLKFIHIGLLCVQQDPADRPT-----MSSVVV 487 (536)
Q Consensus 453 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~ 487 (536)
.... ...+.+++.+||+.||++||| +.++++
T Consensus 225 ~~~~----~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 225 SEKF----SPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred CccC----CHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 1111 223556667999999999999 788885
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=302.53 Aligned_cols=248 Identities=29% Similarity=0.381 Sum_probs=195.8
Q ss_pred cCCccccccCCCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEe-eCceEEEEEeec
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCL-EGQELLLIYEYM 294 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~~lv~e~~ 294 (536)
++|.+.+.||+|+||.||++... +..||+|.+.... ..+.+.+|+.++++++|||++++++++. .+...+++|||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 57889999999999999999874 7889999886443 3467889999999999999999999764 556789999999
Q ss_pred CCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCCc
Q 039168 295 PNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQ 374 (536)
Q Consensus 295 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 374 (536)
++++|.+++.... ...+++..++.++.||+.||+|||+++ ++||||||+||++++++.+||+|||+++......
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-- 156 (256)
T cd05082 83 AKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 156 (256)
T ss_pred CCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence 9999999986432 234889999999999999999999986 9999999999999999999999999987653222
Q ss_pred cccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHHHHHhhcCCcccccccccc
Q 039168 375 ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLK 453 (536)
Q Consensus 375 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~ 453 (536)
....++..|+|||++.+..++.++||||||+++|+|++ |+.||..... .... .....+.... ..
T Consensus 157 ---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~------~~~~-~~~~~~~~~~-----~~ 221 (256)
T cd05082 157 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL------KDVV-PRVEKGYKMD-----AP 221 (256)
T ss_pred ---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH------HHHH-HHHhcCCCCC-----CC
Confidence 12234568999999998889999999999999999998 8888653211 1111 1111111111 11
Q ss_pred CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcc
Q 039168 454 QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 491 (536)
Q Consensus 454 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 491 (536)
......+.+++.+||+.+|++|||+.++++.|+.
T Consensus 222 ----~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 222 ----DGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred ----CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 1112345667779999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=300.71 Aligned_cols=249 Identities=25% Similarity=0.422 Sum_probs=201.5
Q ss_pred cCCccccccCCCCceeEEEEEeCC-CcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEeec
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 294 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 294 (536)
++|+..++||+|+||.||++...+ ++.|++|.+..... .+.+.+|++++++++||||+++++.+......++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 578999999999999999999865 88999999875433 678999999999999999999999999999999999999
Q ss_pred CCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCCc
Q 039168 295 PNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQ 374 (536)
Q Consensus 295 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 374 (536)
.+++|.+++... ...+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (256)
T cd06612 81 GAGSVSDIMKIT--NKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA- 154 (256)
T ss_pred CCCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc-
Confidence 999999998542 345899999999999999999999986 99999999999999999999999999987653321
Q ss_pred cccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccccccC
Q 039168 375 ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQ 454 (536)
Q Consensus 375 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~ 454 (536)
......++..|+|||++.+..++.++||||||+++|+|++|+.||......... ..... ... +.+
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~-------~~~~~-~~~----~~~-- 219 (256)
T cd06612 155 -KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI-------FMIPN-KPP----PTL-- 219 (256)
T ss_pred -ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh-------hhhcc-CCC----CCC--
Confidence 122345788999999999989999999999999999999999997643221100 00000 000 000
Q ss_pred CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 455 SCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 455 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
..+......+.+++.+||+.||++|||+.++++
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 220 SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 011112235667777999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=311.28 Aligned_cols=261 Identities=24% Similarity=0.355 Sum_probs=195.1
Q ss_pred cCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC-hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEee
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 293 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 293 (536)
++|++.++||+|+||.||+|.++ +++.||+|.+.... ......+.+|+.+++.++||||+++++++...+..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 57999999999999999999875 58899999986443 22345677899999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCC
Q 039168 294 MPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQN 373 (536)
Q Consensus 294 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 373 (536)
+. ++|..++... ...+++..+..++.||++||.|||+.+ |+|+||||+|||+++++.+||+|||++........
T Consensus 86 ~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 159 (301)
T cd07873 86 LD-KDLKQYLDDC--GNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 159 (301)
T ss_pred cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence 97 4787777543 235789999999999999999999986 99999999999999999999999999976533221
Q ss_pred ccccccccccccccCcchhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHH-----------HHHhhc
Q 039168 374 QANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYT-----------WKLWCE 441 (536)
Q Consensus 374 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~-----------~~~~~~ 441 (536)
. .....+++.|+|||++.+. .++.++||||||+++|+|++|+.||....... ..... |..+..
T Consensus 160 ~--~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 234 (301)
T cd07873 160 T--YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEE---QLHFIFRILGTPTEETWPGILS 234 (301)
T ss_pred c--ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcCCCChhhchhhhc
Confidence 1 1223568899999998764 47899999999999999999999986432211 11111 110000
Q ss_pred CCcccccc-ccccCCC----CHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 442 GHAVELID-PVLKQSC----APDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 442 ~~~~~l~~-~~l~~~~----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
.......+ +...... .......+.+++.+||+.||.+|||+.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 235 NEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred cccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00000000 0000000 0011224567778999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=303.40 Aligned_cols=254 Identities=22% Similarity=0.352 Sum_probs=199.3
Q ss_pred hcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEee
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 293 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 293 (536)
.++|++.+.||+|+||.||+|++. +++.||+|.+..........+.+|+.+++.++||||+++++.+...+..++||||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 357889999999999999999875 5889999998766555566788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCC
Q 039168 294 MPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQN 373 (536)
Q Consensus 294 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 373 (536)
+++++|.+++... ..+++.+++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 88 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~- 160 (267)
T cd06645 88 CGGGSLQDIYHVT---GPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATI- 160 (267)
T ss_pred cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCcc-
Confidence 9999999988533 35899999999999999999999996 9999999999999999999999999987654322
Q ss_pred ccccccccccccccCcchhc---CCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccc
Q 039168 374 QANTNIIAGTYGYMAPEYAM---GGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDP 450 (536)
Q Consensus 374 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 450 (536)
.......|++.|+|||++. ...++.++|||||||++|+|++|..|+....... . ................
T Consensus 161 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~--~----~~~~~~~~~~~~~~~~ 233 (267)
T cd06645 161 -AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR--A----LFLMTKSNFQPPKLKD 233 (267)
T ss_pred -cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh--h----HHhhhccCCCCCcccc
Confidence 1223356899999999984 4558899999999999999999999974322111 0 0110001000000000
Q ss_pred cccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 451 VLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 451 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
. .. .+ ..+.+++.+||+.+|++|||+++|++.
T Consensus 234 ~--~~-~~---~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 234 K--MK-WS---NSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred c--CC-CC---HHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 0 01 11 245667779999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=317.28 Aligned_cols=237 Identities=24% Similarity=0.264 Sum_probs=184.8
Q ss_pred cccCCCCceeEEEEEeC-CCcEEEEEEccccCh---hhHHHHHHHH-HHHHHcCCCCceeEeeEEeeCceEEEEEeecCC
Q 039168 222 NKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG---QGLKEFKNEV-NLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPN 296 (536)
Q Consensus 222 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~-~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 296 (536)
++||+|+||.||+|++. +++.||+|++.+... .....+.+|. .+++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999975 588999999865321 2233445554 468889999999999999999999999999999
Q ss_pred CChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCCccc
Q 039168 297 KSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQAN 376 (536)
Q Consensus 297 ~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 376 (536)
++|..++.. ...+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (321)
T cd05603 81 GELFFHLQR---ERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--ET 152 (321)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--Cc
Confidence 999888743 345889999999999999999999986 9999999999999999999999999987532221 22
Q ss_pred cccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccccccCCC
Q 039168 377 TNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQSC 456 (536)
Q Consensus 377 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~ 456 (536)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ........ ... .. .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~i~-~~~-~~---------~ 215 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV------SQMYDNIL-HKP-LQ---------L 215 (321)
T ss_pred cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH------HHHHHHHh-cCC-CC---------C
Confidence 2345789999999999998999999999999999999999999754221 11111111 111 01 1
Q ss_pred CHHHHHHHHHHHHhhcCCCCCCCCCHH
Q 039168 457 APDELLKFIHIGLLCVQQDPADRPTMS 483 (536)
Q Consensus 457 ~~~~~~~l~~li~~cl~~dP~~RPt~~ 483 (536)
++.....+.+++.+||+.||.+||+..
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 216 PGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 112233466777799999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=301.43 Aligned_cols=253 Identities=24% Similarity=0.382 Sum_probs=202.7
Q ss_pred cCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEeec
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 294 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 294 (536)
++|++.+.||+|+||.||++... +++.+++|.+........+.+.+|++++++++||||+++++.+......+++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 67899999999999999999875 57889999998766666788999999999999999999999999999999999999
Q ss_pred CCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCCc
Q 039168 295 PNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQ 374 (536)
Q Consensus 295 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 374 (536)
.+++|..++... ...+++..+..++.|++.||.|||+++ ++|+||||+||++++++.+||+|||++........
T Consensus 83 ~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~- 156 (262)
T cd06613 83 GGGSLQDIYQVT--RGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA- 156 (262)
T ss_pred CCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhhh-
Confidence 999999988543 235889999999999999999999986 99999999999999999999999999986543221
Q ss_pred cccccccccccccCcchhcCC---CCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcccccccc
Q 039168 375 ANTNIIAGTYGYMAPEYAMGG---IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPV 451 (536)
Q Consensus 375 ~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 451 (536)
......++..|+|||.+.+. .++.++||||||+++|+|++|+.||....... . ..... ... +..+.
T Consensus 157 -~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~--~----~~~~~-~~~---~~~~~ 225 (262)
T cd06613 157 -KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMR--A----LFLIS-KSN---FPPPK 225 (262)
T ss_pred -ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--H----HHHHH-hcc---CCCcc
Confidence 12234678899999999777 78999999999999999999999975322111 0 00010 000 00000
Q ss_pred ccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 452 LKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 452 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
+ .........+.+++.+||+.+|.+|||+.+|+.
T Consensus 226 ~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 226 L--KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred c--cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0 011222345777888999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=309.67 Aligned_cols=201 Identities=23% Similarity=0.342 Sum_probs=172.4
Q ss_pred cCCccccccCCCCceeEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEE
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 291 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 291 (536)
++|++.+.||+|+||.||+++.. +++.||+|++.+. .....+.+.+|+.++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47899999999999999999975 5899999998642 2233456888999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCC
Q 039168 292 EYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGN 371 (536)
Q Consensus 292 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 371 (536)
||+.+++|..++... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred ecCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 999999999998542 235889999999999999999999997 999999999999999999999999998765432
Q ss_pred CCccccccccccccccCcchhcC-----CCCCccchHHHHHHHHHHHHhCCCCCCC
Q 039168 372 QNQANTNIIAGTYGYMAPEYAMG-----GIFSIKSDVFSFGVLLLEIISGRKNNGF 422 (536)
Q Consensus 372 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~elltg~~p~~~ 422 (536)
... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..
T Consensus 156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 210 (331)
T cd05597 156 GTV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA 210 (331)
T ss_pred CCc-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCC
Confidence 221 1223468999999999963 4578899999999999999999999753
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=303.41 Aligned_cols=249 Identities=29% Similarity=0.463 Sum_probs=197.2
Q ss_pred CCccccccCCCCceeEEEEEeC-CCcEEEEEEccccChh---------hHHHHHHHHHHHHHcCCCCceeEeeEEeeCce
Q 039168 217 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQ---------GLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQE 286 (536)
Q Consensus 217 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 286 (536)
+|.+.+.||+|++|.||+|... +++.||+|.+...... ..+.+.+|+.++++++||||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4778889999999999999875 5889999988654321 23568889999999999999999999999999
Q ss_pred EEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCcc
Q 039168 287 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTAR 366 (536)
Q Consensus 287 ~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 366 (536)
.++||||+++++|..++... ..+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||+++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNY---GAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred cEEEEEecCCCCHHHHHHhc---cCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCc
Confidence 99999999999999998543 45889999999999999999999986 9999999999999999999999999998
Q ss_pred ccCCCCCc----cccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcC
Q 039168 367 IFGGNQNQ----ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEG 442 (536)
Q Consensus 367 ~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 442 (536)
.+...... .......|+..|+|||.+.+..++.++||||||+++|+|++|+.||...... ...... ...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~-~~~ 227 (267)
T cd06628 155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL------QAIFKI-GEN 227 (267)
T ss_pred ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH------HHHHHH-hcc
Confidence 76532211 1112345788999999999888999999999999999999999997642211 111110 011
Q ss_pred CccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 443 HAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 443 ~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
..+.+ +......+.+++.+||+.||.+||++.+|++
T Consensus 228 -----~~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 228 -----ASPEI----PSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred -----CCCcC----CcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 11111 1112234566667999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=302.90 Aligned_cols=240 Identities=22% Similarity=0.343 Sum_probs=186.8
Q ss_pred cccCCCCceeEEEEEeCC-------------CcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEE
Q 039168 222 NKLGQGGFGPVYKGTLAD-------------GKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELL 288 (536)
Q Consensus 222 ~~lg~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 288 (536)
+.||+|+||.||+|+... ...|++|.+..........+.+|+.+++.++||||+++++++..+...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 368999999999998532 2358999887665555667889999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCC-------eEEec
Q 039168 289 LIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMN-------PKISD 361 (536)
Q Consensus 289 lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~-------~kl~D 361 (536)
+||||+++++|..++... ...+++..++.++.||++||.|||+++ |+||||||+|||++.++. ++++|
T Consensus 81 lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRK--SDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred EEEecccCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 999999999998887532 235899999999999999999999996 999999999999987664 89999
Q ss_pred ccCccccCCCCCccccccccccccccCcchhc-CCCCCccchHHHHHHHHHHHH-hCCCCCCCCCccCCchhHHHHHHHh
Q 039168 362 FGTARIFGGNQNQANTNIIAGTYGYMAPEYAM-GGIFSIKSDVFSFGVLLLEII-SGRKNNGFYFSEHGQTLLTYTWKLW 439 (536)
Q Consensus 362 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~ell-tg~~p~~~~~~~~~~~~~~~~~~~~ 439 (536)
||++...... ....++..|+|||.+. +..++.++||||||+++|||+ .|..|+...... .. ....
T Consensus 156 ~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~------~~-~~~~ 222 (262)
T cd05077 156 PGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLA------EK-ERFY 222 (262)
T ss_pred CCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchh------HH-HHHH
Confidence 9998754321 1235678899999887 466899999999999999998 577775432111 00 0111
Q ss_pred hcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 039168 440 CEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLA 490 (536)
Q Consensus 440 ~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 490 (536)
. ... ... ......+.+|+.+||+.||++||++.+|++.|+
T Consensus 223 ~-~~~-~~~---------~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 223 E-GQC-MLV---------TPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred h-cCc-cCC---------CCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 1 110 000 111234667777999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=310.77 Aligned_cols=196 Identities=28% Similarity=0.464 Sum_probs=159.7
Q ss_pred ccccCCCCceeEEEEEeC---CCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEee--CceEEEEEeecC
Q 039168 221 ENKLGQGGFGPVYKGTLA---DGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLE--GQELLLIYEYMP 295 (536)
Q Consensus 221 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~--~~~~~lv~e~~~ 295 (536)
..+||+|+||.||+|+.+ ++..||+|.+..... ...+.+|+.++++++||||+++++++.. +...++||||+.
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC--cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 358999999999999865 357899998865432 2467789999999999999999999853 567899999987
Q ss_pred CCChhhhhhcc------cCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEE----cCCCCeEEecccCc
Q 039168 296 NKSLDVHLFDA------TRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLL----DDDMNPKISDFGTA 365 (536)
Q Consensus 296 ~~sL~~~l~~~------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll----~~~~~~kl~Dfg~a 365 (536)
+ +|..++... .....+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 6 555555321 12335889999999999999999999997 9999999999999 46678999999999
Q ss_pred cccCCCCCc-cccccccccccccCcchhcCC-CCCccchHHHHHHHHHHHHhCCCCCCC
Q 039168 366 RIFGGNQNQ-ANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGF 422 (536)
Q Consensus 366 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~ 422 (536)
+.+...... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||..
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 876543221 222345689999999999774 589999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=306.67 Aligned_cols=256 Identities=25% Similarity=0.376 Sum_probs=202.1
Q ss_pred cCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC-hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEee
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 293 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 293 (536)
++|++.+.||+|+||+||++... +++.||+|++.... ....+.+.+|+++++.++||||+++++.+......++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 57889999999999999999875 58899999876543 34457789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCC
Q 039168 294 MPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQN 373 (536)
Q Consensus 294 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 373 (536)
+++++|..++.. ...+++..+..++.+++.||.|||+.. +++|+||||+||++++++.++|+|||++.......
T Consensus 85 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~- 158 (284)
T cd06620 85 MDCGSLDRIYKK---GGPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI- 158 (284)
T ss_pred CCCCCHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhhc-
Confidence 999999988854 235899999999999999999999742 49999999999999999999999999987543221
Q ss_pred ccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCc-----hhHHHHHHHhhcCCccccc
Q 039168 374 QANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQ-----TLLTYTWKLWCEGHAVELI 448 (536)
Q Consensus 374 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~-----~~~~~~~~~~~~~~~~~l~ 448 (536)
.....|+..|+|||++.+..++.++|||||||++|+|++|+.||......... ............ ..
T Consensus 159 ---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~---- 230 (284)
T cd06620 159 ---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQE-PP---- 230 (284)
T ss_pred ---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhc-cC----
Confidence 22356899999999998889999999999999999999999998754332111 111111111111 00
Q ss_pred cccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHh
Q 039168 449 DPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 489 (536)
Q Consensus 449 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 489 (536)
+.+.. ......+.+++.+||+.||++|||+.|+++.+
T Consensus 231 -~~~~~---~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 231 -PRLPS---SDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred -CCCCc---hhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 00100 11223466777799999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=304.53 Aligned_cols=249 Identities=25% Similarity=0.420 Sum_probs=201.2
Q ss_pred cCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC-hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEee
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 293 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 293 (536)
++|++.+.||.|++|.||+|.+. +++.||+|++.... ......+.+|+++++.++|||++++++++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 36888999999999999999975 58899999987543 34456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCC
Q 039168 294 MPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQN 373 (536)
Q Consensus 294 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 373 (536)
+++++|.+++... .+++..++.++.|++.||.|||+++ ++|+||+|+||++++++.++|+|||++..+.....
T Consensus 81 ~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 153 (274)
T cd06609 81 CGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS 153 (274)
T ss_pred eCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeeccccc
Confidence 9999999998542 6899999999999999999999986 99999999999999999999999999987754321
Q ss_pred ccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcccccccccc
Q 039168 374 QANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLK 453 (536)
Q Consensus 374 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~ 453 (536)
......+++.|+|||.+.+..++.++||||||+++|+|++|+.||...... .... ......... +.
T Consensus 154 --~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~------~~~~-~~~~~~~~~-----~~ 219 (274)
T cd06609 154 --KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM------RVLF-LIPKNNPPS-----LE 219 (274)
T ss_pred --ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH------HHHH-HhhhcCCCC-----Cc
Confidence 222346788999999999888999999999999999999999997543211 1111 111111111 11
Q ss_pred CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 454 QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 454 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
... ....+.+++.+||..+|++|||++++++.
T Consensus 220 ~~~---~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 220 GNK---FSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred ccc---cCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 110 12345667779999999999999999863
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=306.30 Aligned_cols=251 Identities=26% Similarity=0.334 Sum_probs=196.0
Q ss_pred CccccccCCCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEee
Q 039168 218 FSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 293 (536)
Q Consensus 218 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 293 (536)
|+..+.||+|+||+||++.+. +++.||+|++.... ......+.+|+++++.++|+|++++++.+..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 677889999999999999875 58899999986542 22334577899999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCC
Q 039168 294 MPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQN 373 (536)
Q Consensus 294 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 373 (536)
+.+++|..++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++........
T Consensus 82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05632 82 MNGGDLKFHIYNMG-NPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES 157 (285)
T ss_pred ccCccHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCCc
Confidence 99999998886432 235899999999999999999999997 99999999999999999999999999976542221
Q ss_pred ccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcccccccccc
Q 039168 374 QANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLK 453 (536)
Q Consensus 374 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~ 453 (536)
.....|+..|+|||.+.+..++.++||||||+++|+|++|..||........ ............ ....
T Consensus 158 ---~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~---~~~~~~~~~~~~------~~~~ 225 (285)
T cd05632 158 ---IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK---REEVDRRVLETE------EVYS 225 (285)
T ss_pred ---ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhhhccc------cccC
Confidence 1234689999999999998999999999999999999999999864322111 111111111110 0011
Q ss_pred CCCCHHHHHHHHHHHHhhcCCCCCCCCC-----HHHHHHH
Q 039168 454 QSCAPDELLKFIHIGLLCVQQDPADRPT-----MSSVVVM 488 (536)
Q Consensus 454 ~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~ 488 (536)
... ...+.+++..||+.||++||| +.++++.
T Consensus 226 ~~~----~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 226 AKF----SEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred ccC----CHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 111 223556667999999999999 6677753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=306.38 Aligned_cols=254 Identities=23% Similarity=0.365 Sum_probs=199.1
Q ss_pred cCCccccccCCCCceeEEEEEeC-CCcEEEEEEcccc-ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEee
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT-SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 293 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 293 (536)
++|++.+.||+|+||.||++... +++.||+|.+... .......+.+|+.++++++||||+++++.+...+..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 36888999999999999999976 6899999988654 334456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCC
Q 039168 294 MPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQN 373 (536)
Q Consensus 294 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 373 (536)
+++++|..++........+++..+..++.||+.||.|||+.. +++|+||||+||+++.++.+||+|||++..+....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 157 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL- 157 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc-
Confidence 999999988865433446899999999999999999999742 49999999999999999999999999997653222
Q ss_pred ccccccccccccccCcchhcCCC------CCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcccc
Q 039168 374 QANTNIIAGTYGYMAPEYAMGGI------FSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVEL 447 (536)
Q Consensus 374 ~~~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 447 (536)
.....+++.|+|||.+.+.. ++.++|||||||++|+|++|+.||..... ....... ..........
T Consensus 158 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~---~~~~~~~-~~~~~~~~~~- 229 (286)
T cd06622 158 ---AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETY---ANIFAQL-SAIVDGDPPT- 229 (286)
T ss_pred ---cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcch---hhHHHHH-HHHhhcCCCC-
Confidence 22345788999999985543 58899999999999999999999753211 1111111 1111111111
Q ss_pred ccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 448 IDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 448 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
.++.....+.+++.+||+.+|++||++.++++.
T Consensus 230 --------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 230 --------LPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred --------CCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 122233446667779999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=301.49 Aligned_cols=256 Identities=25% Similarity=0.383 Sum_probs=198.3
Q ss_pred HhcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEe
Q 039168 214 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 292 (536)
Q Consensus 214 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 292 (536)
.++.+.....||+|+||.||+|.+. ++..|++|.+........+.+.+|+.++++++||||+++++++..++..++|+|
T Consensus 6 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 85 (268)
T cd06624 6 EYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFME 85 (268)
T ss_pred ccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEe
Confidence 4456666679999999999999965 578899999887766667789999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcC-CCCeEEecccCccccCCC
Q 039168 293 YMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDD-DMNPKISDFGTARIFGGN 371 (536)
Q Consensus 293 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~-~~~~kl~Dfg~a~~~~~~ 371 (536)
|+++++|..++.........++..+..++.||+.||.|||+.+ |+||||||+||+++. .+.++|+|||++......
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~ 162 (268)
T cd06624 86 QVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI 162 (268)
T ss_pred cCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheecccC
Confidence 9999999999865432222378888999999999999999986 999999999999976 679999999999765432
Q ss_pred CCccccccccccccccCcchhcCCC--CCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcccccc
Q 039168 372 QNQANTNIIAGTYGYMAPEYAMGGI--FSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELID 449 (536)
Q Consensus 372 ~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 449 (536)
.. ......|++.|+|||++.+.. ++.++||||||+++|+|++|+.||........ . .+....... .
T Consensus 163 ~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~---~--~~~~~~~~~-----~ 230 (268)
T cd06624 163 NP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA---A--MFKVGMFKI-----H 230 (268)
T ss_pred CC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh---h--Hhhhhhhcc-----C
Confidence 22 122245789999999986643 78999999999999999999999753221110 0 000000000 0
Q ss_pred ccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 450 PVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 450 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
+.+ +......+.+++.+||+.+|++|||+.++++.
T Consensus 231 ~~~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 231 PEI----PESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred CCC----CcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 111 11122345667779999999999999999863
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=303.14 Aligned_cols=251 Identities=25% Similarity=0.382 Sum_probs=197.9
Q ss_pred CCccccccCCCCceeEEEEEeCC-CcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEeecC
Q 039168 217 HFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMP 295 (536)
Q Consensus 217 ~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 295 (536)
.|++.++||+|+||.||++.+.. +..+++|.+........+.+.+|+++++.++|||++++++.+..+...++|+||++
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~ 85 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA 85 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence 46788999999999999999764 78889999877666667788999999999999999999999999999999999999
Q ss_pred CCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCCcc
Q 039168 296 NKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQA 375 (536)
Q Consensus 296 ~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 375 (536)
+++|..++... ...+++..+..++.||++||.|||+.+ ++|+||||+|||++.++++||+|||++........
T Consensus 86 ~~~l~~~~~~~--~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~-- 158 (282)
T cd06643 86 GGAVDAVMLEL--ERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-- 158 (282)
T ss_pred CCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccccccc--
Confidence 99998887542 245899999999999999999999997 99999999999999999999999999876533221
Q ss_pred ccccccccccccCcchhc-----CCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccc
Q 039168 376 NTNIIAGTYGYMAPEYAM-----GGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDP 450 (536)
Q Consensus 376 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 450 (536)
......+++.|+|||++. +..++.++|||||||++|+|++|+.||...... ...... .......+..
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~------~~~~~~-~~~~~~~~~~- 230 (282)
T cd06643 159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM------RVLLKI-AKSEPPTLAQ- 230 (282)
T ss_pred ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH------HHHHHH-hhcCCCCCCC-
Confidence 122346889999999984 345788999999999999999999997532211 111111 1111111101
Q ss_pred cccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 451 VLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 451 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
... . ...+.+++.+||+.||.+|||+.++++.
T Consensus 231 --~~~-~---~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 231 --PSR-W---SSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred --ccc-c---CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111 1 2345667779999999999999998754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=304.57 Aligned_cols=250 Identities=35% Similarity=0.499 Sum_probs=194.9
Q ss_pred cccCCCCceeEEEEEeCC-------CcEEEEEEccccC-hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEee
Q 039168 222 NKLGQGGFGPVYKGTLAD-------GKAIAVKRLSRTS-GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 293 (536)
Q Consensus 222 ~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 293 (536)
+.||+|+||.||+|+.++ ++.+|+|.+.... ......+.+|+.+++.++||||+++++++......++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 369999999999998643 3579999886543 23456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhccc----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCC-----CeEEecccC
Q 039168 294 MPNKSLDVHLFDAT----RSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDM-----NPKISDFGT 364 (536)
Q Consensus 294 ~~~~sL~~~l~~~~----~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~-----~~kl~Dfg~ 364 (536)
+++++|.+++.... ....+++.++..++.||+.||.|||+.+ ++|+||||+||+++.++ .++|+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999986532 2234788999999999999999999986 99999999999999877 899999999
Q ss_pred ccccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHHHHHhhcCC
Q 039168 365 ARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGH 443 (536)
Q Consensus 365 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 443 (536)
++...............++..|+|||.+.+..++.++||||||+++|+|++ |+.||...... ..... ...+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~---~~~~~----~~~~~ 230 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ---EVLQH----VTAGG 230 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH---HHHHH----HhcCC
Confidence 986643322222222345678999999999999999999999999999998 99887532211 11111 11111
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 039168 444 AVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLA 490 (536)
Q Consensus 444 ~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 490 (536)
... . .......+.+++.+||+.+|++||++.+|++.|+
T Consensus 231 ~~~-----~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 231 RLQ-----K----PENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred ccC-----C----cccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 111 0 1112234567777999999999999999999986
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=302.13 Aligned_cols=251 Identities=27% Similarity=0.413 Sum_probs=197.5
Q ss_pred CCccccccCCCCceeEEEEEeCCCcEEEEEEccccC------hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEE
Q 039168 217 HFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTS------GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 290 (536)
Q Consensus 217 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 290 (536)
+|+..+.||+|+||.||+|...+++.+|+|.+.... ......+.+|++++++++|+||+++++++.+.+..+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 478889999999999999998889999999886432 12245688999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCC
Q 039168 291 YEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGG 370 (536)
Q Consensus 291 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 370 (536)
+||+++++|.+++.+. ..+++..+..++.|++.||+|||+.+ |+|+||||+||++++++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 81 MEFVPGGSISSILNRF---GPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred EecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 9999999999998543 34789999999999999999999986 99999999999999999999999999986532
Q ss_pred CCC----ccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccc
Q 039168 371 NQN----QANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVE 446 (536)
Q Consensus 371 ~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 446 (536)
... ........|+..|+|||.+.+..++.++||||||+++|+|++|+.||....... ............
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-----~~~~~~~~~~~~-- 227 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA-----AMFYIGAHRGLM-- 227 (265)
T ss_pred ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH-----HHHHhhhccCCC--
Confidence 111 111223457899999999999889999999999999999999999985322110 000000000111
Q ss_pred cccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 447 LIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 447 l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
+.+.. .....+.+++.+||+.+|++|||+.++++
T Consensus 228 ---~~~~~----~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 228 ---PRLPD----SFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred ---CCCCC----CCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 11111 12234566667999999999999999985
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=307.35 Aligned_cols=251 Identities=24% Similarity=0.364 Sum_probs=201.6
Q ss_pred hcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEee
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 293 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 293 (536)
.++|++.+.||+|+||.||++... +++.||+|.+........+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 368999999999999999999964 6999999999766555567788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCC
Q 039168 294 MPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQN 373 (536)
Q Consensus 294 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 373 (536)
+++++|..++.+ ..+++.++..++.|++.||.|||+.+ ++|+||||+|||++.++.++|+|||++........
T Consensus 98 ~~~~~L~~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~ 170 (297)
T cd06656 98 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (297)
T ss_pred cCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence 999999998843 34788999999999999999999986 99999999999999999999999999976543322
Q ss_pred ccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcccccccccc
Q 039168 374 QANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLK 453 (536)
Q Consensus 374 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~ 453 (536)
. .....+++.|+|||.+.+..++.++||||||+++|+|++|+.||......... . .....+ .....
T Consensus 171 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~--~----~~~~~~-~~~~~----- 236 (297)
T cd06656 171 K--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL--Y----LIATNG-TPELQ----- 236 (297)
T ss_pred C--cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhe--e----eeccCC-CCCCC-----
Confidence 1 22346788999999999988999999999999999999999998543221110 0 000000 00000
Q ss_pred CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 454 QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 454 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
.+......+.+++.+||+.+|++|||+.++++.
T Consensus 237 --~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 237 --NPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred --CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 011112335567779999999999999999973
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=317.18 Aligned_cols=198 Identities=30% Similarity=0.388 Sum_probs=167.7
Q ss_pred HhcCCccccccCCCCceeEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeC------
Q 039168 214 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEG------ 284 (536)
Q Consensus 214 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~------ 284 (536)
..++|++.+.||+|+||.||++.+. .++.||||++... .......+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 3578999999999999999999875 5889999998753 233456788899999999999999999987543
Q ss_pred ceEEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccC
Q 039168 285 QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGT 364 (536)
Q Consensus 285 ~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~ 364 (536)
...++||||+++ +|...+. ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~ 172 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 172 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHH-----hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCC
Confidence 357999999976 5555552 23788999999999999999999996 99999999999999999999999999
Q ss_pred ccccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 039168 365 ARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFY 423 (536)
Q Consensus 365 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~ 423 (536)
++...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus 173 a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 228 (364)
T cd07875 173 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT 228 (364)
T ss_pred ccccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCC
Confidence 98653321 122346899999999999999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=310.57 Aligned_cols=256 Identities=30% Similarity=0.477 Sum_probs=198.3
Q ss_pred hcCCccccccCCCCceeEEEEEeC-CCc----EEEEEEccccCh-hhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEE
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA-DGK----AIAVKRLSRTSG-QGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELL 288 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 288 (536)
.++|+..+.||+|+||.||+|.+. ++. .||+|.+..... .....+.+|+.+++.++||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 357888999999999999999864 343 578998865433 3344688999999999999999999998754 467
Q ss_pred EEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCcccc
Q 039168 289 LIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIF 368 (536)
Q Consensus 289 lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 368 (536)
+++||+++|+|.+++... ...+++..++.++.|++.||.|||+++ |+|+||||+||++++++.+||+|||+++.+
T Consensus 85 ~v~e~~~~g~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEH--KDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred eeehhcCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccc
Confidence 999999999999988543 234789999999999999999999996 999999999999999999999999999876
Q ss_pred CCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHHHHHhhcCCcccc
Q 039168 369 GGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVEL 447 (536)
Q Consensus 369 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 447 (536)
.............++..|+|||.+.+..++.++||||||+++|||++ |+.||..... ... ......+.....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~---~~~----~~~~~~~~~~~~ 232 (303)
T cd05110 160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT---REI----PDLLEKGERLPQ 232 (303)
T ss_pred cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH---HHH----HHHHHCCCCCCC
Confidence 53332222222345678999999999899999999999999999997 8888743211 111 111111111110
Q ss_pred ccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 448 IDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 448 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
.+.....+.+++..||..+|++||++.++++.|+..
T Consensus 233 ---------~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~ 268 (303)
T cd05110 233 ---------PPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRM 268 (303)
T ss_pred ---------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 111223567778899999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=318.78 Aligned_cols=244 Identities=30% Similarity=0.459 Sum_probs=200.7
Q ss_pred ccCCCCceeEEEEEeCC-CcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEeecCCCChhh
Q 039168 223 KLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDV 301 (536)
Q Consensus 223 ~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~~sL~~ 301 (536)
+||+|.||+||-|++.+ ...+|||.+........+-+.+|+.+.++|+|.|||+++|.+.+++.+-+.||-++||+|..
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 69999999999999865 67899999987776667778899999999999999999999999999999999999999999
Q ss_pred hhhcccCCCCC--CHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEc-CCCCeEEecccCccccCCCCCccccc
Q 039168 302 HLFDATRSVQL--DWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLD-DDMNPKISDFGTARIFGGNQNQANTN 378 (536)
Q Consensus 302 ~l~~~~~~~~l--~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~-~~~~~kl~Dfg~a~~~~~~~~~~~~~ 378 (536)
+|.. +-+++ ++..+-.+.+||++||.|||++. |||||||-+|+||+ -.|.+||+|||-++.+..-. ..+.
T Consensus 662 LLrs--kWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin--P~TE 734 (1226)
T KOG4279|consen 662 LLRS--KWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN--PCTE 734 (1226)
T ss_pred HHHh--ccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccCC--cccc
Confidence 9954 33445 78888899999999999999996 99999999999996 57899999999999886433 3345
Q ss_pred cccccccccCcchhcCC--CCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccccccCCC
Q 039168 379 IIAGTYGYMAPEYAMGG--IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQSC 456 (536)
Q Consensus 379 ~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~ 456 (536)
++.||..|||||++..+ +|+.++|||||||++.||.||++||-........ +-.+ .+ .+ .. ...
T Consensus 735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAA--MFkV-Gm------yK-vH----P~i 800 (1226)
T KOG4279|consen 735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAA--MFKV-GM------YK-VH----PPI 800 (1226)
T ss_pred ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHh--hhhh-cc------ee-cC----CCC
Confidence 57899999999999765 4999999999999999999999997543333211 1100 00 00 11 122
Q ss_pred CHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 457 APDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 457 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
+.+...+....|++|+.+||.+||++.++|+
T Consensus 801 Peelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 801 PEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred cHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 3444556777788999999999999999995
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=305.79 Aligned_cols=239 Identities=23% Similarity=0.367 Sum_probs=185.6
Q ss_pred ccCCCCceeEEEEEeC-------------------------CCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeE
Q 039168 223 KLGQGGFGPVYKGTLA-------------------------DGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRL 277 (536)
Q Consensus 223 ~lg~G~~g~Vy~~~~~-------------------------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l 277 (536)
.||+|+||.||+|... ....|++|++..........+.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 6999999999998741 124589998876555555678889999999999999999
Q ss_pred eeEEeeCceEEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCC--
Q 039168 278 LGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDM-- 355 (536)
Q Consensus 278 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~-- 355 (536)
++++.+....++||||+++++|..++... ...+++..+..++.||++||+|||+++ |+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE--KGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence 99999999999999999999999888542 335889999999999999999999986 99999999999998644
Q ss_pred -----CeEEecccCccccCCCCCccccccccccccccCcchhcC-CCCCccchHHHHHHHHHHHH-hCCCCCCCCCccCC
Q 039168 356 -----NPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEII-SGRKNNGFYFSEHG 428 (536)
Q Consensus 356 -----~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell-tg~~p~~~~~~~~~ 428 (536)
.+|++|||++...... ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.||.......
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~- 229 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE- 229 (274)
T ss_pred cCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH-
Confidence 3899999998644221 12346788999998876 56899999999999999995 6888875432211
Q ss_pred chhHHHHHHHhhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 039168 429 QTLLTYTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLA 490 (536)
Q Consensus 429 ~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 490 (536)
.... ..... . ..... ...+.+++.+||+.+|++|||+.+|++.|+
T Consensus 230 --~~~~----~~~~~--~-----~~~~~----~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 230 --KERF----YEKKH--R-----LPEPS----CKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred --HHHH----HHhcc--C-----CCCCC----ChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 1111 10000 0 00111 134677778999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=310.01 Aligned_cols=201 Identities=22% Similarity=0.324 Sum_probs=171.6
Q ss_pred cCCccccccCCCCceeEEEEEeCC-CcEEEEEEcccc---ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEE
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRT---SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 291 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 291 (536)
++|++.++||+|+||.||+++.+. ++.||+|++.+. .......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 478899999999999999999764 788999998642 2223345788999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCC
Q 039168 292 EYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGN 371 (536)
Q Consensus 292 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 371 (536)
||+.+|+|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 ey~~~g~L~~~l~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred eccCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 999999999999642 235889999999999999999999986 999999999999999999999999999765432
Q ss_pred CCccccccccccccccCcchhc-----CCCCCccchHHHHHHHHHHHHhCCCCCCC
Q 039168 372 QNQANTNIIAGTYGYMAPEYAM-----GGIFSIKSDVFSFGVLLLEIISGRKNNGF 422 (536)
Q Consensus 372 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~p~~~ 422 (536)
.. .......||+.|+|||++. ...++.++|||||||++|||++|+.||..
T Consensus 156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~ 210 (332)
T cd05623 156 GT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYA 210 (332)
T ss_pred Cc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCC
Confidence 22 1222357899999999986 34588999999999999999999999753
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=305.22 Aligned_cols=253 Identities=25% Similarity=0.372 Sum_probs=201.3
Q ss_pred hcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEee
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 293 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 293 (536)
.++|++.+.||.|+||.||++.+. ++..+|+|.+........+.+.+|++++++++||||+++++.+..+...++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 357999999999999999999975 5899999999877666677899999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCC
Q 039168 294 MPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQN 373 (536)
Q Consensus 294 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 373 (536)
+++++|..++.... ..+++..+..++.|++.||.|||+++ |+|+||||+||+++.++.++|+|||++........
T Consensus 84 ~~~~~L~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (280)
T cd06611 84 CDGGALDSIMLELE--RGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ 158 (280)
T ss_pred cCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhccccc
Confidence 99999999885432 35899999999999999999999997 99999999999999999999999999876543221
Q ss_pred ccccccccccccccCcchhc-----CCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccc
Q 039168 374 QANTNIIAGTYGYMAPEYAM-----GGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELI 448 (536)
Q Consensus 374 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 448 (536)
......+++.|+|||.+. ...++.++||||||+++|+|++|+.||...... ... ..+.......+.
T Consensus 159 --~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~------~~~-~~~~~~~~~~~~ 229 (280)
T cd06611 159 --KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM------RVL-LKILKSEPPTLD 229 (280)
T ss_pred --ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH------HHH-HHHhcCCCCCcC
Confidence 222356889999999985 344788999999999999999999997543211 111 111111111110
Q ss_pred cccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 449 DPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 449 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
. +......+.+++..||+.+|.+|||+.++++.
T Consensus 230 ~-------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 230 Q-------PSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred C-------cccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 0 11112345567779999999999999999864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=310.81 Aligned_cols=201 Identities=23% Similarity=0.323 Sum_probs=172.8
Q ss_pred cCCccccccCCCCceeEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEE
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 291 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 291 (536)
++|++.+.||+|+||.||+++.+ +++.||+|++.+. .......+.+|..++..++|+||+++++++.+.+..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47899999999999999999976 5788999998653 2223455788999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCC
Q 039168 292 EYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGN 371 (536)
Q Consensus 292 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 371 (536)
||+.+|+|..++... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 Ey~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred eCCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 999999999999643 235889999999999999999999986 999999999999999999999999999876433
Q ss_pred CCccccccccccccccCcchhcC-----CCCCccchHHHHHHHHHHHHhCCCCCCC
Q 039168 372 QNQANTNIIAGTYGYMAPEYAMG-----GIFSIKSDVFSFGVLLLEIISGRKNNGF 422 (536)
Q Consensus 372 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~elltg~~p~~~ 422 (536)
... ......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||..
T Consensus 156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~ 210 (331)
T cd05624 156 GTV-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA 210 (331)
T ss_pred Cce-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccC
Confidence 221 1223568999999999876 4678999999999999999999999753
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=302.87 Aligned_cols=252 Identities=27% Similarity=0.421 Sum_probs=196.1
Q ss_pred HhcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHHc-CCCCceeEeeEEeeC------c
Q 039168 214 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLKEFKNEVNLIAKL-QHKNLVRLLGCCLEG------Q 285 (536)
Q Consensus 214 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~------~ 285 (536)
+.+.|+..+.||+|+||.||+|... +++.||+|++.... .....+.+|+.+++++ +||||+++++++... .
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 4577899999999999999999875 58899999986543 3346788999999998 799999999998753 4
Q ss_pred eEEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCc
Q 039168 286 ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTA 365 (536)
Q Consensus 286 ~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 365 (536)
..+++|||+.+++|..++... ....+++..+..++.|++.||.|||+++ |+|+||||+||++++++.++|+|||++
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~~ 158 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVS 158 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCCc
Confidence 689999999999999988643 2345889999999999999999999996 999999999999999999999999999
Q ss_pred cccCCCCCccccccccccccccCcchhc-----CCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhh
Q 039168 366 RIFGGNQNQANTNIIAGTYGYMAPEYAM-----GGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWC 440 (536)
Q Consensus 366 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 440 (536)
....... .......|++.|+|||++. +..++.++|||||||++|+|++|+.||...... ........
T Consensus 159 ~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~------~~~~~~~~ 230 (272)
T cd06637 159 AQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM------RALFLIPR 230 (272)
T ss_pred eeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH------HHHHHHhc
Confidence 8653322 1223456899999999986 345888999999999999999999997532211 11111111
Q ss_pred cCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 441 EGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 441 ~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
. .. +.......+ ..+.+++.+||+.||.+|||+.++++
T Consensus 231 ~-~~-----~~~~~~~~~---~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 231 N-PA-----PRLKSKKWS---KKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred C-CC-----CCCCCCCcC---HHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 1 00 111111112 34667777999999999999999985
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=326.71 Aligned_cols=197 Identities=20% Similarity=0.309 Sum_probs=162.4
Q ss_pred HhcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHHcCCC------CceeEeeEEeeC-c
Q 039168 214 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHK------NLVRLLGCCLEG-Q 285 (536)
Q Consensus 214 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp------niv~l~~~~~~~-~ 285 (536)
..++|++.++||+|+||+||+|.+. .++.||||++.... .....+..|+.+++.++|. +++++++++... .
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~ 205 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETG 205 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCc
Confidence 4578999999999999999999875 57889999986432 2334566788888887654 588899888764 5
Q ss_pred eEEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCeeeCCCCCCcEEEcCCC---------
Q 039168 286 ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHED-SRLKIIHRDLKASNVLLDDDM--------- 355 (536)
Q Consensus 286 ~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~~~~ivH~Dikp~NIll~~~~--------- 355 (536)
+.++|||++ +++|.+++... ..+++..+..++.||+.||.|||++ + ||||||||+|||++.++
T Consensus 206 ~~~iv~~~~-g~~l~~~l~~~---~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~~~~ 278 (467)
T PTZ00284 206 HMCIVMPKY-GPCLLDWIMKH---GPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPVTNR 278 (467)
T ss_pred eEEEEEecc-CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCccccccccc
Confidence 789999988 66777777543 3589999999999999999999974 5 99999999999998765
Q ss_pred -------CeEEecccCccccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 039168 356 -------NPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFY 423 (536)
Q Consensus 356 -------~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~ 423 (536)
.+||+|||.+.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 279 ~~~~~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~ 348 (467)
T PTZ00284 279 ALPPDPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTH 348 (467)
T ss_pred ccCCCCceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 49999999876422 1223467899999999999999999999999999999999999998653
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=301.46 Aligned_cols=248 Identities=26% Similarity=0.426 Sum_probs=201.1
Q ss_pred cCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC-hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEee
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 293 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 293 (536)
..|+..++||+|+||.||+|.+. ++..||+|.+.... ......+.+|+.+++.++||||+++++++.++...++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 46788899999999999999975 58899999887543 34567788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCC
Q 039168 294 MPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQN 373 (536)
Q Consensus 294 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 373 (536)
+++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 84 ~~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 84 LGGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence 999999988843 34788999999999999999999986 99999999999999999999999999987643322
Q ss_pred ccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcccccccccc
Q 039168 374 QANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLK 453 (536)
Q Consensus 374 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~ 453 (536)
......++..|+|||++.+..++.++|+||||+++|||++|+.||........ .. ..... ..
T Consensus 157 --~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~------~~-~~~~~---------~~ 218 (277)
T cd06640 157 --KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV------LF-LIPKN---------NP 218 (277)
T ss_pred --ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhH------hh-hhhcC---------CC
Confidence 12234578899999999988899999999999999999999999753322110 00 00000 01
Q ss_pred CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 454 QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 454 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
..........+.+++.+||+.+|++||++.++++.
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 219 PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 11222344567778889999999999999999865
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=307.79 Aligned_cols=249 Identities=24% Similarity=0.382 Sum_probs=200.7
Q ss_pred cCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEeec
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 294 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 294 (536)
.+|+..+.||.|++|.||++.+. +++.|++|.+........+.+.+|+.+++.++|||++++++.+......++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 46999999999999999999864 68999999987665555678899999999999999999999999999999999999
Q ss_pred CCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCCc
Q 039168 295 PNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQ 374 (536)
Q Consensus 295 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 374 (536)
++++|..++.. ..+++.++..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.........
T Consensus 99 ~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 171 (296)
T cd06655 99 AGGSLTDVVTE----TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK 171 (296)
T ss_pred CCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhccccccc
Confidence 99999998843 24899999999999999999999997 999999999999999999999999998866433221
Q ss_pred cccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccccccC
Q 039168 375 ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQ 454 (536)
Q Consensus 375 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~ 454 (536)
.....+++.|+|||.+.+..++.++|||||||++|+|++|+.||....... ....... .....+..
T Consensus 172 --~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~------~~~~~~~-~~~~~~~~----- 237 (296)
T cd06655 172 --RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR------ALYLIAT-NGTPELQN----- 237 (296)
T ss_pred --CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHh-cCCcccCC-----
Confidence 223467889999999998889999999999999999999999975432211 1111111 11111100
Q ss_pred CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 455 SCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 455 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
+......+.+++.+||+.||++|||+.+++.
T Consensus 238 --~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 238 --PEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred --cccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 1111224556777999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=304.11 Aligned_cols=257 Identities=28% Similarity=0.408 Sum_probs=201.0
Q ss_pred cCCccccccCCCCceeEEEEEeC------CCcEEEEEEccccChh-hHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEE
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRTSGQ-GLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELL 288 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 288 (536)
++|+..+.||+|+||.||+|+.+ +.+.|++|.+...... ..+.+.+|++++++++||||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 57889999999999999999864 3467999988765443 4577999999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhhcccCC------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecc
Q 039168 289 LIYEYMPNKSLDVHLFDATRS------VQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDF 362 (536)
Q Consensus 289 lv~e~~~~~sL~~~l~~~~~~------~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Df 362 (536)
+||||+++++|.+++...... ..+++..+..++.||+.||+|||+.+ |+|+||||+||+++.++.++|+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 999999999999998654422 25899999999999999999999986 999999999999999999999999
Q ss_pred cCccccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHHHHHhhc
Q 039168 363 GTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCE 441 (536)
Q Consensus 363 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 441 (536)
|++........ .......++..|+|||.+.+..++.++||||||+++|+|++ |..||..... ... ......
T Consensus 162 ~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~---~~~----~~~~~~ 233 (275)
T cd05046 162 SLSKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD---EEV----LNRLQA 233 (275)
T ss_pred ccccccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch---HHH----HHHHHc
Confidence 99875432221 11222356778999999988889999999999999999999 7777643211 111 111111
Q ss_pred CCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcc
Q 039168 442 GHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 491 (536)
Q Consensus 442 ~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 491 (536)
+.... . .... .+ ..+.+++.+||+.+|++|||+.+++..|+.
T Consensus 234 ~~~~~-~---~~~~-~~---~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~ 275 (275)
T cd05046 234 GKLEL-P---VPEG-CP---SRLYKLMTRCWAVNPKDRPSFSELVSALGE 275 (275)
T ss_pred CCcCC-C---CCCC-CC---HHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence 11111 0 0111 12 346667779999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=299.60 Aligned_cols=258 Identities=25% Similarity=0.405 Sum_probs=204.0
Q ss_pred cCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC-hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEee
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 293 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 293 (536)
++|++.+.||.|+||.||+|... ++..+++|++.... ......+.+|+++++.++|||++++++.+......++|+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 47899999999999999999965 58899999986543 33567889999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCC
Q 039168 294 MPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQN 373 (536)
Q Consensus 294 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 373 (536)
+++++|..++........+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||++..+.....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999999999865433356899999999999999999999986 99999999999999999999999999987654332
Q ss_pred cc--ccccccccccccCcchhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccc
Q 039168 374 QA--NTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDP 450 (536)
Q Consensus 374 ~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 450 (536)
.. ......|+..|+|||++... .++.++|+||||+++|+|++|+.||....... ........ .... +..
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~------~~~~~~~~-~~~~-~~~ 229 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK------VLMLTLQN-DPPS-LET 229 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh------hHHHHhcC-CCCC-cCC
Confidence 21 22345688999999999877 78999999999999999999999975432211 11111111 1000 110
Q ss_pred cccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 451 VLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 451 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
... .......+.+++.+||+.||++|||+.+|++
T Consensus 230 ~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 230 GAD---YKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred ccc---cccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 000 0122345667777999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=317.16 Aligned_cols=197 Identities=27% Similarity=0.373 Sum_probs=170.0
Q ss_pred cCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHHcC-C-----CCceeEeeEEeeCceEE
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQ-H-----KNLVRLLGCCLEGQELL 288 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----pniv~l~~~~~~~~~~~ 288 (536)
.+|++.++||+|+||.|.+|.+. +++.||||+++.. .....+...|+.+|..|+ | -|+|+++++|...++++
T Consensus 186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlc 264 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLC 264 (586)
T ss_pred EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccccee
Confidence 48999999999999999999875 5999999998654 344567788999999997 4 38999999999999999
Q ss_pred EEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCC--CeEEecccCcc
Q 039168 289 LIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDM--NPKISDFGTAR 366 (536)
Q Consensus 289 lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~--~~kl~Dfg~a~ 366 (536)
||+|.+ ..+|.++|..... ..++...++.++.||+.||.+||+.+ |||+||||+||||.+.+ .|||+|||++.
T Consensus 265 iVfELL-~~NLYellK~n~f-~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc 339 (586)
T KOG0667|consen 265 IVFELL-STNLYELLKNNKF-RGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSC 339 (586)
T ss_pred eeehhh-hhhHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEeccccc
Confidence 999998 6689889876444 45999999999999999999999886 99999999999997544 69999999998
Q ss_pred ccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 039168 367 IFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFY 423 (536)
Q Consensus 367 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~ 423 (536)
....... ...-+..|+|||++.|..|+.+.||||||||+.||++|.+.|...
T Consensus 340 ~~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ 391 (586)
T KOG0667|consen 340 FESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGD 391 (586)
T ss_pred ccCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCC
Confidence 7543222 234577899999999999999999999999999999998777553
|
|
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=302.71 Aligned_cols=249 Identities=29% Similarity=0.451 Sum_probs=192.0
Q ss_pred cccCCCCceeEEEEEeCC-Cc--EEEEEEcccc-ChhhHHHHHHHHHHHHHc-CCCCceeEeeEEeeCceEEEEEeecCC
Q 039168 222 NKLGQGGFGPVYKGTLAD-GK--AIAVKRLSRT-SGQGLKEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYEYMPN 296 (536)
Q Consensus 222 ~~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~ 296 (536)
+.||+|+||.||+|.+++ +. .+++|.+... .....+.+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 369999999999999754 43 5688888643 344556788999999999 899999999999999999999999999
Q ss_pred CChhhhhhccc-------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEeccc
Q 039168 297 KSLDVHLFDAT-------------RSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFG 363 (536)
Q Consensus 297 ~sL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg 363 (536)
++|.+++.... ....+++..+..++.|++.||+|||+.+ ++|+||||+|||+++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 99999986432 1234789999999999999999999986 9999999999999999999999999
Q ss_pred CccccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHHHHHhhcC
Q 039168 364 TARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEG 442 (536)
Q Consensus 364 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 442 (536)
++...... ........+..|+|||++.+..++.++||||||+++|||++ |..||..... .... .....+
T Consensus 158 l~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~---~~~~----~~~~~~ 227 (270)
T cd05047 158 LSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---AELY----EKLPQG 227 (270)
T ss_pred Cccccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH---HHHH----HHHhCC
Confidence 98632211 11111223567999999988889999999999999999997 9988743211 1111 111111
Q ss_pred CccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 443 HAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 443 ~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
...+ . .......+.+++.+||+.||.+|||+.++++.|...
T Consensus 228 ~~~~-----~----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~ 268 (270)
T cd05047 228 YRLE-----K----PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 268 (270)
T ss_pred CCCC-----C----CCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence 1111 1 111123466777899999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=305.10 Aligned_cols=240 Identities=25% Similarity=0.393 Sum_probs=188.4
Q ss_pred cccCCCCceeEEEEEeCC--------CcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEee
Q 039168 222 NKLGQGGFGPVYKGTLAD--------GKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 293 (536)
Q Consensus 222 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 293 (536)
+.||+|+||.||+|.... ...|++|.+........+.+.+|..+++.++|||++++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 369999999999998642 335888888765555567888999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCC--------eEEecccCc
Q 039168 294 MPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMN--------PKISDFGTA 365 (536)
Q Consensus 294 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~--------~kl~Dfg~a 365 (536)
+.+++|..++.... ..+++..+..++.||+.||.|||+++ |+||||||+||+++.++. ++++|||++
T Consensus 81 ~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 81 VKFGSLDTYLKKNK--NLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred CCCCcHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence 99999999986433 25889999999999999999999996 999999999999987765 699999998
Q ss_pred cccCCCCCccccccccccccccCcchhcCC-CCCccchHHHHHHHHHHHHhCC-CCCCCCCccCCchhHHHHHHHhhcCC
Q 039168 366 RIFGGNQNQANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGR-KNNGFYFSEHGQTLLTYTWKLWCEGH 443 (536)
Q Consensus 366 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~ 443 (536)
..... .....+++.|+|||.+.+. .++.++||||||+++|+|++|. .|+...... ... . ....
T Consensus 156 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~------~~~-~-~~~~- 220 (258)
T cd05078 156 ITVLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ------KKL-Q-FYED- 220 (258)
T ss_pred cccCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHH------HHH-H-HHHc-
Confidence 65432 1234578899999999874 5799999999999999999995 443321111 000 0 1010
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 039168 444 AVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLA 490 (536)
Q Consensus 444 ~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 490 (536)
... .+.....++.+++.+||+.||++|||++++++.|+
T Consensus 221 ~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 221 RHQ---------LPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred ccc---------CCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 001 11112245677788999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=299.15 Aligned_cols=251 Identities=25% Similarity=0.398 Sum_probs=202.0
Q ss_pred CCccccccCCCCceeEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEee
Q 039168 217 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 293 (536)
Q Consensus 217 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 293 (536)
+|+..+.||+|+||.||.++.. +++.+++|++... +......+.+|++++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 5888999999999999999864 5889999987654 344456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCC
Q 039168 294 MPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQN 373 (536)
Q Consensus 294 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 373 (536)
+++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 99999999986532 345899999999999999999999986 99999999999999999999999999987644332
Q ss_pred ccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcccccccccc
Q 039168 374 QANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLK 453 (536)
Q Consensus 374 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~ 453 (536)
......|++.|+|||.+.+..++.++||||||+++|+|++|+.||..... ....... ..+.....
T Consensus 157 --~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~------~~~~~~~-~~~~~~~~------ 221 (256)
T cd08221 157 --MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP------LNLVVKI-VQGNYTPV------ 221 (256)
T ss_pred --cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH------HHHHHHH-HcCCCCCC------
Confidence 22335689999999999888899999999999999999999999753221 1111111 11111111
Q ss_pred CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHh
Q 039168 454 QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 489 (536)
Q Consensus 454 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 489 (536)
.......+.+++.+||+.+|++|||+.++++.+
T Consensus 222 ---~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 222 ---VSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred ---ccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 111223466677799999999999999999763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=305.24 Aligned_cols=261 Identities=23% Similarity=0.323 Sum_probs=197.0
Q ss_pred CCccccccCCCCceeEEEEEeC-CCcEEEEEEccccChh-----hHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEE
Q 039168 217 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQ-----GLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 290 (536)
Q Consensus 217 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 290 (536)
+|+..+.||+|++|.||+|.+. +++.||||++...... ....+.+|++++++++||||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4778889999999999999975 5899999998754322 234567899999999999999999999999999999
Q ss_pred EeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCC
Q 039168 291 YEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGG 370 (536)
Q Consensus 291 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 370 (536)
|||+ +++|..++.... ..+++..++.++.||++||.|||+++ ++|+||||+|||++.++.++|+|||++.....
T Consensus 81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9999 899999985433 35899999999999999999999997 99999999999999999999999999987654
Q ss_pred CCCccccccccccccccCcchhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcC-------
Q 039168 371 NQNQANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEG------- 442 (536)
Q Consensus 371 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~------- 442 (536)
.... .....+++.|+|||.+.+ ..++.++||||||+++|+|++|.++|...... .............
T Consensus 155 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 229 (298)
T cd07841 155 PNRK--MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDI---DQLGKIFEALGTPTEENWPG 229 (298)
T ss_pred CCcc--ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccH---HHHHHHHHHcCCCchhhhhh
Confidence 3221 122346788999999865 45789999999999999999997776532211 1111111100000
Q ss_pred --CccccccccccCCCC-----HHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 443 --HAVELIDPVLKQSCA-----PDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 443 --~~~~l~~~~l~~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
............... ......+.+++.+||+.||++|||+.++++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 230 VTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 000000000000000 1123467778889999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=313.23 Aligned_cols=258 Identities=24% Similarity=0.308 Sum_probs=193.6
Q ss_pred HHhcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccCh--hhHHHHHHHHHHHHHcCCCCceeEeeEEeeC-----
Q 039168 213 EATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG--QGLKEFKNEVNLIAKLQHKNLVRLLGCCLEG----- 284 (536)
Q Consensus 213 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~----- 284 (536)
+..++|++.+.||+|+||.||+|.+. +++.||||++..... .....+.+|+.+++.++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 45678999999999999999999875 588999999875422 2345677899999999999999999987543
Q ss_pred -ceEEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEeccc
Q 039168 285 -QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFG 363 (536)
Q Consensus 285 -~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg 363 (536)
...++++|++ +++|..++.. ..+++..+..++.||+.||.|||+++ |+||||||+|||+++++.+||+|||
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg 163 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKC----QKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFG 163 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCc
Confidence 4579999988 7788877632 34899999999999999999999997 9999999999999999999999999
Q ss_pred CccccCCCCCccccccccccccccCcchhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcC
Q 039168 364 TARIFGGNQNQANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEG 442 (536)
Q Consensus 364 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 442 (536)
+++..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...... .......... ..
T Consensus 164 ~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~~~~~~-~~ 234 (343)
T cd07878 164 LARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYI---DQLKRIMEVV-GT 234 (343)
T ss_pred cceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHH---HHHHHHHHHh-CC
Confidence 99865432 223468999999999977 56899999999999999999999998542211 0010000000 00
Q ss_pred Cccccccc-----------cccCCCCH--------HHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 443 HAVELIDP-----------VLKQSCAP--------DELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 443 ~~~~l~~~-----------~l~~~~~~--------~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
...+.... .+. ..+. .....+++++.+||+.||++|||+.++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 235 PSPEVLKKISSEHARKYIQSLP-HMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred CCHHHHHhcchhhHHHHhhccc-cccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000 000 0000 011235678889999999999999999954
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=305.00 Aligned_cols=248 Identities=28% Similarity=0.462 Sum_probs=199.0
Q ss_pred cCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC-hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEee
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 293 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 293 (536)
+.|+..+.||+|+||.||+|.+. +++.||+|.+.... ....+.+.+|++++++++||||+++++++..+...++||||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 35777889999999999999875 57889999887443 34456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCC
Q 039168 294 MPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQN 373 (536)
Q Consensus 294 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 373 (536)
+++++|..++.. ..+++..+..++.||++||.|||+++ ++|+||+|+||++++++.++|+|||++..+.....
T Consensus 84 ~~~~~L~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06642 84 LGGGSALDLLKP----GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred cCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence 999999988742 35889999999999999999999986 99999999999999999999999999987643221
Q ss_pred ccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcccccccccc
Q 039168 374 QANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLK 453 (536)
Q Consensus 374 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~ 453 (536)
......|+..|+|||.+.+..++.++||||||+++|||++|+.|+....... ... ...... .+.+
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~---~~~----~~~~~~-----~~~~- 221 (277)
T cd06642 157 --KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR---VLF----LIPKNS-----PPTL- 221 (277)
T ss_pred --hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh---HHh----hhhcCC-----CCCC-
Confidence 1223457889999999999889999999999999999999999975322111 000 011111 1111
Q ss_pred CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 454 QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 454 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
.......+.+++.+||+.+|++|||+.++++.
T Consensus 222 ---~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 222 ---EGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred ---CcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 11223456677789999999999999999974
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=298.10 Aligned_cols=238 Identities=26% Similarity=0.427 Sum_probs=187.1
Q ss_pred cccCCCCceeEEEEEeCCCc-----------EEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEE
Q 039168 222 NKLGQGGFGPVYKGTLADGK-----------AIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 290 (536)
Q Consensus 222 ~~lg~G~~g~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 290 (536)
+.||+|+||.||+|.+.+.. .+++|.+...... ...+.+|+.+++.++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46999999999999976432 5788877654433 5788899999999999999999999988 778999
Q ss_pred EeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCC-------CeEEeccc
Q 039168 291 YEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDM-------NPKISDFG 363 (536)
Q Consensus 291 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~-------~~kl~Dfg 363 (536)
|||+++++|..++..... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||
T Consensus 79 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 79 EEYVKFGPLDVFLHREKN--NVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EEcCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence 999999999999865332 5889999999999999999999986 99999999999999887 79999999
Q ss_pred CccccCCCCCccccccccccccccCcchhcCC--CCCccchHHHHHHHHHHHHhC-CCCCCCCCccCCchhHHHHHHHhh
Q 039168 364 TARIFGGNQNQANTNIIAGTYGYMAPEYAMGG--IFSIKSDVFSFGVLLLEIISG-RKNNGFYFSEHGQTLLTYTWKLWC 440 (536)
Q Consensus 364 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~elltg-~~p~~~~~~~~~~~~~~~~~~~~~ 440 (536)
++..... .....++..|+|||++.+. .++.++||||||+++|+|++| ..|+....... .. ..+.
T Consensus 154 ~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~---~~----~~~~ 220 (259)
T cd05037 154 IPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE---KE----RFYQ 220 (259)
T ss_pred ccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh---HH----HHHh
Confidence 9986543 1223467789999999876 789999999999999999995 66654332110 00 0111
Q ss_pred cCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 039168 441 EGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLA 490 (536)
Q Consensus 441 ~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 490 (536)
...... ......+.+++.+||+.+|.+|||+.+|++.|+
T Consensus 221 ~~~~~~-----------~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 221 DQHRLP-----------MPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred cCCCCC-----------CCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 111000 001155677778999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=308.71 Aligned_cols=199 Identities=18% Similarity=0.255 Sum_probs=165.8
Q ss_pred cccccCCC--CceeEEEEEeC-CCcEEEEEEccccC--hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEeec
Q 039168 220 DENKLGQG--GFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 294 (536)
Q Consensus 220 ~~~~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 294 (536)
++++||+| +|++||++..+ +|+.||+|++.... ....+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 46789999 78999999875 68999999987542 334566788999999999999999999999999999999999
Q ss_pred CCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCCc
Q 039168 295 PNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQ 374 (536)
Q Consensus 295 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 374 (536)
++++|.+++..... ..+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+++.||+...........
T Consensus 82 ~~~~l~~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 82 AYGSAKDLICTHFM-DGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred CCCcHHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 99999999854322 34889999999999999999999986 999999999999999999999999876543221111
Q ss_pred c-----ccccccccccccCcchhcC--CCCCccchHHHHHHHHHHHHhCCCCCCC
Q 039168 375 A-----NTNIIAGTYGYMAPEYAMG--GIFSIKSDVFSFGVLLLEIISGRKNNGF 422 (536)
Q Consensus 375 ~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~p~~~ 422 (536)
. ......++..|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 212 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 212 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 0 1112346778999999976 4589999999999999999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=303.95 Aligned_cols=255 Identities=29% Similarity=0.434 Sum_probs=200.5
Q ss_pred cCCccccccCCCCceeEEEEEeCC-C----cEEEEEEccccC-hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEE
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLAD-G----KAIAVKRLSRTS-GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 289 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~~-~----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 289 (536)
.+|++.+.||+|+||.||+|.+++ + ..+|+|.+.... ......+.+|+.++++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 578889999999999999998643 3 368999887654 3345678899999999999999999999887 78999
Q ss_pred EEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccC
Q 039168 290 IYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFG 369 (536)
Q Consensus 290 v~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 369 (536)
||||+.+++|.+++.... ..+++..++.++.||+.||+|||+.+ ++|+||||+||++++++.+||+|||+++.+.
T Consensus 86 v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHK--DNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred EEecCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccccccc
Confidence 999999999999986432 34899999999999999999999986 9999999999999999999999999998765
Q ss_pred CCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHHHHHhhcCCccccc
Q 039168 370 GNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELI 448 (536)
Q Consensus 370 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 448 (536)
............++..|+|||.+....++.++||||||+++|||++ |+.||...... ... .....+....
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~----~~~~~~~~~~-- 231 (279)
T cd05057 161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV---EIP----DLLEKGERLP-- 231 (279)
T ss_pred CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH---HHH----HHHhCCCCCC--
Confidence 3322222112223568999999988889999999999999999998 99997543221 111 1111111110
Q ss_pred cccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 449 DPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 449 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
. +......+.+++.+||..||++|||+.++++.|...
T Consensus 232 ---~----~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~ 268 (279)
T cd05057 232 ---Q----PPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKM 268 (279)
T ss_pred ---C----CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 0 111123466777799999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=298.76 Aligned_cols=254 Identities=22% Similarity=0.335 Sum_probs=187.4
Q ss_pred cccCCCCceeEEEEEeCC---CcEEEEEEccccC-hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEeecCCC
Q 039168 222 NKLGQGGFGPVYKGTLAD---GKAIAVKRLSRTS-GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNK 297 (536)
Q Consensus 222 ~~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~~ 297 (536)
+.||+|+||.||++...+ ...+++|.+.... ....+.+.+|+.+++.++||||+++++.+......++||||++++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 369999999999997543 3456677765433 344578899999999999999999999999999999999999999
Q ss_pred ChhhhhhcccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCCccc
Q 039168 298 SLDVHLFDATR-SVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQAN 376 (536)
Q Consensus 298 sL~~~l~~~~~-~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 376 (536)
+|..++..... ....++..+..++.||+.||+|||+.+ ++||||||+|||++.++.++|+|||++...........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 99999865322 234677788899999999999999986 99999999999999999999999999864322222222
Q ss_pred cccccccccccCcchhcC-------CCCCccchHHHHHHHHHHHHhC-CCCCCCCCccCCchhHHHHHHHhhcCCccccc
Q 039168 377 TNIIAGTYGYMAPEYAMG-------GIFSIKSDVFSFGVLLLEIISG-RKNNGFYFSEHGQTLLTYTWKLWCEGHAVELI 448 (536)
Q Consensus 377 ~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~il~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 448 (536)
.....++..|+|||++.. ..++.++||||||+++|||+++ ..||..... .......+ .+....+.
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~------~~~~~~~~-~~~~~~~~ 230 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD------REVLNHVI-KDQQVKLF 230 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHH-hhcccccC
Confidence 233567889999998853 2357899999999999999975 556532211 11111111 12222333
Q ss_pred cccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 039168 449 DPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLA 490 (536)
Q Consensus 449 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 490 (536)
++.+.... .+ .+.+++..|| .+|++|||+.+|++.|.
T Consensus 231 ~~~~~~~~-~~---~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 231 KPQLELPY-SE---RWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCccCCCC-cH---HHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 33332222 22 3445556888 67999999999999885
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=304.68 Aligned_cols=263 Identities=23% Similarity=0.341 Sum_probs=198.0
Q ss_pred cCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC--hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEe
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 292 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 292 (536)
++|+..+.||+|++|.||+|.++ +++.||+|++.... ....+.+.+|+.++++++|||++++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46888999999999999999976 58999999886432 2233567899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCC
Q 039168 293 YMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQ 372 (536)
Q Consensus 293 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 372 (536)
|+++++|..++.. ...+++..++.++.||+.||.|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07847 81 YCDHTVLNELEKN---PRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPG 154 (286)
T ss_pred ccCccHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence 9999988877643 234899999999999999999999986 9999999999999999999999999998765432
Q ss_pred CccccccccccccccCcchhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHH----------HHhhc
Q 039168 373 NQANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTW----------KLWCE 441 (536)
Q Consensus 373 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~----------~~~~~ 441 (536)
. ......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||........ ...... ..+..
T Consensus 155 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd07847 155 D--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQ--LYLIRKTLGDLIPRHQQIFST 230 (286)
T ss_pred c--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHHHhCCCChHHhhhccc
Confidence 2 1222457889999999876 4578999999999999999999999864332111 110000 00000
Q ss_pred CCcc-ccccccccCCCC-----HHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 442 GHAV-ELIDPVLKQSCA-----PDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 442 ~~~~-~l~~~~l~~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
.... .+..+....... +.....+.+++.+||+.+|++|||+.+++..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 231 NQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred ccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 0000 000000000000 0112456778889999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=337.99 Aligned_cols=255 Identities=22% Similarity=0.305 Sum_probs=195.8
Q ss_pred HhcCCccccccCCCCceeEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHHHcCCCCceeEeeEEee--CceEE
Q 039168 214 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLE--GQELL 288 (536)
Q Consensus 214 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~--~~~~~ 288 (536)
..++|+++++||+|+||.||++.+. .+..||+|++... .......+..|+.+|++|+|||||+++++|.. ...+|
T Consensus 11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly 90 (1021)
T PTZ00266 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY 90 (1021)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence 4578999999999999999999976 4778899988643 33345678899999999999999999999864 45799
Q ss_pred EEEeecCCCChhhhhhccc-CCCCCCHHHHHHHHHHHHHHHHHHhcCCC----CCeeeCCCCCCcEEEcC----------
Q 039168 289 LIYEYMPNKSLDVHLFDAT-RSVQLDWKRRLSIINGIARGILYLHEDSR----LKIIHRDLKASNVLLDD---------- 353 (536)
Q Consensus 289 lv~e~~~~~sL~~~l~~~~-~~~~l~~~~~~~i~~qi~~al~~LH~~~~----~~ivH~Dikp~NIll~~---------- 353 (536)
|||||+++++|..+|.... ....+++..++.|+.||+.||.|||+.+. .+||||||||+||||+.
T Consensus 91 IVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~ 170 (1021)
T PTZ00266 91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA 170 (1021)
T ss_pred EEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccc
Confidence 9999999999999986532 23469999999999999999999998531 24999999999999964
Q ss_pred -------CCCeEEecccCccccCCCCCccccccccccccccCcchhcC--CCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 039168 354 -------DMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMG--GIFSIKSDVFSFGVLLLEIISGRKNNGFYF 424 (536)
Q Consensus 354 -------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~p~~~~~ 424 (536)
.+.+||+|||++..+..... .....||+.|+|||++.+ ..++.++||||||||||+|++|+.||....
T Consensus 171 ~~~n~ng~~iVKLsDFGlAr~l~~~s~---~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~ 247 (1021)
T PTZ00266 171 QANNLNGRPIAKIGDFGLSKNIGIESM---AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN 247 (1021)
T ss_pred cccccCCCCceEEccCCcccccccccc---ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence 23489999999986643221 223568999999999865 458899999999999999999999985322
Q ss_pred ccCCchhHHHHHHHhhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 425 SEHGQTLLTYTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 425 ~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
. ..... ..+.... .+..... ...+.+||..||+.+|.+|||+.++|.
T Consensus 248 ~-----~~qli-~~lk~~p-------~lpi~~~---S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 248 N-----FSQLI-SELKRGP-------DLPIKGK---SKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred c-----HHHHH-HHHhcCC-------CCCcCCC---CHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 1 11111 1111111 0111111 234666777999999999999999983
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=305.82 Aligned_cols=248 Identities=24% Similarity=0.324 Sum_probs=205.4
Q ss_pred cCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccChh--hHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEe
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQ--GLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 292 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 292 (536)
.-|...+.||+|.|.+|-+|++- .|..||||++.++.-+ ...++.+|++-|+.++|||||++|.+......+|||+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 46788899999999999999864 7999999999887544 34578899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEc-CCCCeEEecccCccccCCC
Q 039168 293 YMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLD-DDMNPKISDFGTARIFGGN 371 (536)
Q Consensus 293 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~-~~~~~kl~Dfg~a~~~~~~ 371 (536)
+-++|+|.++|..+.. .+.+..+.+++.||+.|+.|+|+.+ +|||||||+|+.+- .-|-|||.|||++..+...
T Consensus 98 LGD~GDl~DyImKHe~--Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG 172 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHEE--GLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG 172 (864)
T ss_pred ecCCchHHHHHHhhhc--cccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence 9999999999976554 4899999999999999999999886 99999999999875 5688999999999876533
Q ss_pred CCccccccccccccccCcchhcCCCCC-ccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccc
Q 039168 372 QNQANTNIIAGTYGYMAPEYAMGGIFS-IKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDP 450 (536)
Q Consensus 372 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 450 (536)
. ...+.+|+..|.|||++.|..|+ +++||||||||||-|++|++||.....-.... . +.|-
T Consensus 173 ~---kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLT---m------------ImDC 234 (864)
T KOG4717|consen 173 K---KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLT---M------------IMDC 234 (864)
T ss_pred c---hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhh---h------------hhcc
Confidence 3 33457899999999999999884 78999999999999999999986433221111 0 0110
Q ss_pred cccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 451 VLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 451 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
.-..+.-...++.+||..||+.||++|.|.+||+..
T Consensus 235 --KYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 235 --KYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred --cccCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 112234445677788889999999999999999853
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=298.40 Aligned_cols=251 Identities=36% Similarity=0.536 Sum_probs=198.3
Q ss_pred CccccccCCCCceeEEEEEeCC-----CcEEEEEEccccChh-hHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEE
Q 039168 218 FSDENKLGQGGFGPVYKGTLAD-----GKAIAVKRLSRTSGQ-GLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 291 (536)
Q Consensus 218 ~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 291 (536)
+++.+.||.|+||.||++.+.+ +..||+|++...... ..+.+.+|+.+++.++||||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3567899999999999998754 488999999765433 5678999999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCC
Q 039168 292 EYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGN 371 (536)
Q Consensus 292 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 371 (536)
||+++++|.+++..... ..+++..+..++.|++.||.+||+.+ ++|+||||+||++++++.++|+|||++......
T Consensus 81 e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 81 EYMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred eccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccc
Confidence 99999999999864322 12899999999999999999999996 999999999999999999999999999876544
Q ss_pred CCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHHHHHhhcCCccccccc
Q 039168 372 QNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDP 450 (536)
Q Consensus 372 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 450 (536)
...... ...+++.|+|||.+.+..++.++||||||+++|+|++ |+.||..... ..... ..........
T Consensus 157 ~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~---~~~~~----~~~~~~~~~~--- 225 (258)
T smart00219 157 DYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN---EEVLE----YLKKGYRLPK--- 225 (258)
T ss_pred cccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHH----HHhcCCCCCC---
Confidence 222211 2236789999999988889999999999999999998 7777643111 11111 1111111111
Q ss_pred cccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHh
Q 039168 451 VLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 489 (536)
Q Consensus 451 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 489 (536)
. ......+.+++.+||+.||++|||+.++++.|
T Consensus 226 --~----~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 226 --P----ENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred --C----CcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 1 11233466677799999999999999999875
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=298.08 Aligned_cols=250 Identities=24% Similarity=0.347 Sum_probs=198.6
Q ss_pred CCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC--hhhHHHHHHHHHHHHHcCCCCceeEeeEEee-CceEEEEEe
Q 039168 217 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLE-GQELLLIYE 292 (536)
Q Consensus 217 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~~lv~e 292 (536)
+|++.+.||+|++|.||++..+ +++.||+|++.... ....+.+.+|++++++++|||++++++.+.. +...+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4888999999999999999975 47899999986432 3445678899999999999999999998764 456899999
Q ss_pred ecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCC
Q 039168 293 YMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQ 372 (536)
Q Consensus 293 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 372 (536)
|+++++|.+++... ....+++.+++.++.|++.||.+||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 81 FCEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred ccCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 99999999988653 2345899999999999999999999997 9999999999999999999999999998764332
Q ss_pred CccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccccc
Q 039168 373 NQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVL 452 (536)
Q Consensus 373 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l 452 (536)
. ......+++.|+|||++.+..++.++||||||+++|+|++|+.||..... ....... ..+.... +
T Consensus 157 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~------~~~~~~~-~~~~~~~-----~ 222 (257)
T cd08223 157 D--MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM------NSLVYRI-IEGKLPP-----M 222 (257)
T ss_pred C--ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH------HHHHHHH-HhcCCCC-----C
Confidence 2 22235678999999999999999999999999999999999999753221 1111111 1111111 1
Q ss_pred cCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 453 KQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 453 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
.......+.+++.+||+.||++|||+.++++.
T Consensus 223 ----~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 223 ----PKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred ----ccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 11223456677779999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=298.85 Aligned_cols=253 Identities=26% Similarity=0.442 Sum_probs=199.7
Q ss_pred CCccccccCCCCceeEEEEEe-CCCcEEEEEEccccC------hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEE
Q 039168 217 HFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTS------GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 289 (536)
Q Consensus 217 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 289 (536)
+|+..+.||+|++|.||++.. .+++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477889999999999999986 468999999986433 1235678899999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCC-CeEEecccCcccc
Q 039168 290 IYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDM-NPKISDFGTARIF 368 (536)
Q Consensus 290 v~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~-~~kl~Dfg~a~~~ 368 (536)
|+||+++++|.+++... ..+++..++.++.||+.||.|||+++ ++|+||||+||+++.++ .+||+|||++..+
T Consensus 81 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 81 FVEWMAGGSVSHLLSKY---GAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEeccCCCcHHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 99999999999998543 35889999999999999999999996 99999999999998776 5999999999876
Q ss_pred CCCCCcc--ccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccc
Q 039168 369 GGNQNQA--NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVE 446 (536)
Q Consensus 369 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 446 (536)
....... ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||....... .............
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~--- 228 (268)
T cd06630 155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSN---HLALIFKIASATT--- 228 (268)
T ss_pred ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcc---hHHHHHHHhccCC---
Confidence 5432111 1223467889999999988889999999999999999999999975432211 1111111110000
Q ss_pred cccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 447 LIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 447 l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
....+......+.+++.+||+.+|++|||+.++++
T Consensus 229 ------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 229 ------APSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred ------CCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 11112223355777888999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=299.17 Aligned_cols=250 Identities=26% Similarity=0.419 Sum_probs=192.7
Q ss_pred cCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC-----hhhHHHHHHHHHHHHHcCCCCceeEeeEEee--CceE
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-----GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLE--GQEL 287 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~--~~~~ 287 (536)
.+|+..+.||+|+||.||++... .++.|++|++.... ......+.+|+.+++.++||||+++++++.+ ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 47889999999999999999875 58999999886432 2234568889999999999999999999875 3678
Q ss_pred EEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccc
Q 039168 288 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARI 367 (536)
Q Consensus 288 ~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 367 (536)
++++||+++++|.+++... ..+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++.
T Consensus 82 ~l~~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAY---GALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 9999999999999998543 34789999999999999999999986 99999999999999999999999999986
Q ss_pred cCCCCC-ccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccc
Q 039168 368 FGGNQN-QANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVE 446 (536)
Q Consensus 368 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 446 (536)
...... ........++..|+|||.+.+..++.++||||||+++|+|++|+.||..... ............
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~------~~~~~~~~~~~~--- 226 (266)
T cd06651 156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA------MAAIFKIATQPT--- 226 (266)
T ss_pred cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch------HHHHHHHhcCCC---
Confidence 543211 1112234578899999999998899999999999999999999999753211 111111111111
Q ss_pred cccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 447 LIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 447 l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
.+.+ +......+..++ .||..+|++|||+++|++
T Consensus 227 --~~~~----~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 227 --NPQL----PSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred --CCCC----chhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 1111 111122233344 688899999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=296.12 Aligned_cols=247 Identities=28% Similarity=0.418 Sum_probs=198.5
Q ss_pred CCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC-----hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEE
Q 039168 217 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-----GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 290 (536)
Q Consensus 217 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 290 (536)
+|+..+.||+|++|.||+|... +++.|++|.+.... .+..+.+.+|+.+++.++||||+++++++..+...+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4777889999999999999976 68999999886543 23456788999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCC
Q 039168 291 YEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGG 370 (536)
Q Consensus 291 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 370 (536)
+||+++++|..++... ..+++..++.++.||+.||.|||+.+ ++|+||+|+||+++.++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 81 LELVPGGSLAKLLKKY---GSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEecCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 9999999999998543 34889999999999999999999987 99999999999999999999999999886643
Q ss_pred CCCccccccccccccccCcchhcCCC-CCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcccccc
Q 039168 371 NQNQANTNIIAGTYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELID 449 (536)
Q Consensus 371 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 449 (536)
.. ......|++.|++||.+.... ++.++|+||||+++|+|++|+.||..... ....+..........
T Consensus 155 ~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~------~~~~~~~~~~~~~~~--- 222 (258)
T cd06632 155 FS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG------VAAVFKIGRSKELPP--- 222 (258)
T ss_pred cc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH------HHHHHHHHhcccCCC---
Confidence 32 123356789999999997776 89999999999999999999999754321 111111111011111
Q ss_pred ccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 450 PVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 450 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
. +......+.+++.+||+.+|++|||+.++++
T Consensus 223 --~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 223 --I----PDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred --c----CCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 1 1112244566777999999999999999985
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=299.71 Aligned_cols=254 Identities=24% Similarity=0.397 Sum_probs=198.5
Q ss_pred CCccccccCCCCceeEEEEEeCC--CcEEEEEEcccc----------ChhhHHHHHHHHHHHHH-cCCCCceeEeeEEee
Q 039168 217 HFSDENKLGQGGFGPVYKGTLAD--GKAIAVKRLSRT----------SGQGLKEFKNEVNLIAK-LQHKNLVRLLGCCLE 283 (536)
Q Consensus 217 ~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~----------~~~~~~~~~~E~~~l~~-l~hpniv~l~~~~~~ 283 (536)
.|++.+.||+|+||.||++.++. ++.+|+|.+... .......+.+|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47888999999999999999765 788999987532 22334567788888875 799999999999999
Q ss_pred CceEEEEEeecCCCChhhhhhcc-cCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecc
Q 039168 284 GQELLLIYEYMPNKSLDVHLFDA-TRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDF 362 (536)
Q Consensus 284 ~~~~~lv~e~~~~~sL~~~l~~~-~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Df 362 (536)
++..+++|||+++++|.+++... .....+++..++.++.|++.||.|||+.. +++|+||||+||+++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEecc
Confidence 99999999999999999887542 23345899999999999999999999632 4999999999999999999999999
Q ss_pred cCccccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcC
Q 039168 363 GTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEG 442 (536)
Q Consensus 363 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 442 (536)
|++....... ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||..... ...... ..+.
T Consensus 159 g~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~------~~~~~~-~~~~ 228 (269)
T cd08528 159 GLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM------LSLATK-IVEA 228 (269)
T ss_pred cceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH------HHHHHH-Hhhc
Confidence 9998764432 22345688999999999988899999999999999999999999743211 111111 1111
Q ss_pred CccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 039168 443 HAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLA 490 (536)
Q Consensus 443 ~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 490 (536)
.... . ..... ...+.+++.+||+.||++||++.|+.++|+
T Consensus 229 ~~~~----~-~~~~~---~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 229 VYEP----L-PEGMY---SEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred cCCc----C-CcccC---CHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 1111 0 11111 234566777999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=298.79 Aligned_cols=247 Identities=30% Similarity=0.418 Sum_probs=195.4
Q ss_pred cCCccccccCCCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEeecC
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMP 295 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 295 (536)
++|++.+.||+|+||.||++.. +++.||+|++.... ..+.+.+|+.+++.++|||++++++++..+ ..+++|||+.
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 5689999999999999999975 67889999986543 236788999999999999999999998765 4799999999
Q ss_pred CCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCCcc
Q 039168 296 NKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQA 375 (536)
Q Consensus 296 ~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 375 (536)
+++|..++.... ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~--- 154 (254)
T cd05083 82 KGNLVNFLRTRG-RALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV--- 154 (254)
T ss_pred CCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccccC---
Confidence 999999986533 235789999999999999999999986 9999999999999999999999999987543211
Q ss_pred ccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHHHHHhhcCCccccccccccC
Q 039168 376 NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQ 454 (536)
Q Consensus 376 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~ 454 (536)
.....+..|+|||.+.+..++.++||||||+++|+|++ |+.||...... .. ......+..... .
T Consensus 155 --~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~------~~-~~~~~~~~~~~~-----~- 219 (254)
T cd05083 155 --DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK------EV-KECVEKGYRMEP-----P- 219 (254)
T ss_pred --CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH------HH-HHHHhCCCCCCC-----C-
Confidence 11223567999999998899999999999999999998 88887533211 11 111111111110 1
Q ss_pred CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcc
Q 039168 455 SCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 491 (536)
Q Consensus 455 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 491 (536)
......+.+++.+||+.+|++||++.+|++.|+.
T Consensus 220 ---~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 220 ---EGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred ---CcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 1112345677779999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=306.92 Aligned_cols=205 Identities=27% Similarity=0.414 Sum_probs=169.8
Q ss_pred CCccccccCCCCceeEEEEEeC---CCcEEEEEEccccC---hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeC--ceEE
Q 039168 217 HFSDENKLGQGGFGPVYKGTLA---DGKAIAVKRLSRTS---GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEG--QELL 288 (536)
Q Consensus 217 ~~~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~~ 288 (536)
+|++.++||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.+++.++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4788899999999999999975 47899999987633 33446778899999999999999999999988 8899
Q ss_pred EEEeecCCCChhhhhhcccC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcC----CCCeEEecc
Q 039168 289 LIYEYMPNKSLDVHLFDATR--SVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDD----DMNPKISDF 362 (536)
Q Consensus 289 lv~e~~~~~sL~~~l~~~~~--~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~----~~~~kl~Df 362 (536)
+||||+++ +|..++..... ...+++..++.++.||+.||.|||+.+ |+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999976 55555543222 236899999999999999999999997 999999999999999 899999999
Q ss_pred cCccccCCCCC-ccccccccccccccCcchhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCc
Q 039168 363 GTARIFGGNQN-QANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFYFS 425 (536)
Q Consensus 363 g~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~ 425 (536)
|++..+..... ........+++.|+|||.+.+. .++.++||||||+++|+|++|+.||.....
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~ 221 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREA 221 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcc
Confidence 99987643322 1222335678899999988764 579999999999999999999999865433
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=311.77 Aligned_cols=240 Identities=23% Similarity=0.311 Sum_probs=183.5
Q ss_pred cCCCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHHHc---CCCCceeEeeEEeeCceEEEEEeecCC
Q 039168 224 LGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLKEFKNEVNLIAKL---QHKNLVRLLGCCLEGQELLLIYEYMPN 296 (536)
Q Consensus 224 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l---~hpniv~l~~~~~~~~~~~lv~e~~~~ 296 (536)
||+|+||+||+|+.+ +++.||||++.... ......+..|..++..+ +||||+++++.+.+.+..++||||+.+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999975 58999999986432 12233455567777665 699999999999999999999999999
Q ss_pred CChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCCccc
Q 039168 297 KSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQAN 376 (536)
Q Consensus 297 ~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 376 (536)
++|..++.. ...+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~--~ 152 (330)
T cd05586 81 GELFWHLQK---EGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNK--T 152 (330)
T ss_pred ChHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC--C
Confidence 999988854 345899999999999999999999997 99999999999999999999999999875432221 2
Q ss_pred cccccccccccCcchhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccccccCC
Q 039168 377 TNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQS 455 (536)
Q Consensus 377 ~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~ 455 (536)
.....||+.|+|||++.+. .++.++|||||||++|+|++|+.||..... ... ......+.. . +...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~------~~~-~~~i~~~~~-~-----~~~~ 219 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT------QQM-YRNIAFGKV-R-----FPKN 219 (330)
T ss_pred ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH------HHH-HHHHHcCCC-C-----CCCc
Confidence 2345789999999999765 489999999999999999999999753221 111 111111111 1 1111
Q ss_pred CCHHHHHHHHHHHHhhcCCCCCCCC----CHHHHHH
Q 039168 456 CAPDELLKFIHIGLLCVQQDPADRP----TMSSVVV 487 (536)
Q Consensus 456 ~~~~~~~~l~~li~~cl~~dP~~RP----t~~evl~ 487 (536)
..++ .+.+++.+||+.||++|| ++.++++
T Consensus 220 ~~~~---~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 220 VLSD---EGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred cCCH---HHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 1223 345566699999999998 5666665
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=299.96 Aligned_cols=262 Identities=24% Similarity=0.352 Sum_probs=199.0
Q ss_pred CCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC--hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEee
Q 039168 217 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 293 (536)
Q Consensus 217 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 293 (536)
+|++.+.||+|++|.||+|.+. +++.||+|++.... ....+.+.+|+.++++++||||+++++++..+...++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4788899999999999999975 68999999987543 33456789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCC
Q 039168 294 MPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQN 373 (536)
Q Consensus 294 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 373 (536)
+ +++|..++.... ..+++.+++.++.||++||.|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 81 ~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 81 M-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred c-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 9 999999886433 45899999999999999999999986 99999999999999999999999999987654322
Q ss_pred ccccccccccccccCcchhcCCC-CCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCC---------
Q 039168 374 QANTNIIAGTYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGH--------- 443 (536)
Q Consensus 374 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--------- 443 (536)
.......|+..|+|||.+.+.. ++.++||||||+++|+|++|+++|..... ...............
T Consensus 155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd07832 155 -RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEND---IEQLAIVFRTLGTPNEETWPGLTS 230 (286)
T ss_pred -CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCH---HHHHHHHHHHcCCCChHHHhhccC
Confidence 1122346889999999987644 68999999999999999999777643221 111111111100000
Q ss_pred ---cccccccccc----CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 444 ---AVELIDPVLK----QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 444 ---~~~l~~~~l~----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
...+..+... ....+.....+.+++.+||+.||++|||++++++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 231 LPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred cchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000000000 00001123567778889999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=297.75 Aligned_cols=254 Identities=27% Similarity=0.392 Sum_probs=201.7
Q ss_pred cCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC-hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEee
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 293 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 293 (536)
++|+..+.||+|++|.||++.++ +++.|++|++.... ......+.+|++++++++||||+++++.+..+...++++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 36788899999999999999986 58999999987653 34456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCC
Q 039168 294 MPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHE-DSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQ 372 (536)
Q Consensus 294 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 372 (536)
+.+++|.+++.... ..+++..+..++.|+++||.|||+ .+ ++|+||||+||++++++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 81 MDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred cCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence 99999999986532 468899999999999999999999 75 9999999999999999999999999987653222
Q ss_pred CccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccccc
Q 039168 373 NQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVL 452 (536)
Q Consensus 373 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l 452 (536)
.. ...++..|+|||.+.+..++.++||||||+++|+|++|+.||........ ......... ....... +
T Consensus 156 ~~----~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~-~~~~~~~-----~ 224 (265)
T cd06605 156 AK----TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPD-GIFELLQYI-VNEPPPR-----L 224 (265)
T ss_pred hh----cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccc-cHHHHHHHH-hcCCCCC-----C
Confidence 11 15678899999999999999999999999999999999999764432111 111111111 1111111 1
Q ss_pred cCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 453 KQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 453 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
... .....+.+++.+||..||++|||+.+++..
T Consensus 225 ~~~---~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 225 PSG---KFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred Chh---hcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 111 023346677779999999999999999853
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=305.17 Aligned_cols=261 Identities=25% Similarity=0.364 Sum_probs=196.8
Q ss_pred cCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccCh--hhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEe
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG--QGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 292 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 292 (536)
++|++.++||+|+||.||+|.++ +++.||+|++..... ...+.+.+|+++++.++||||+++++++..+...++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46888999999999999999986 489999998865322 234568899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCC
Q 039168 293 YMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQ 372 (536)
Q Consensus 293 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 372 (536)
|+++++|..+... ...+++.++..++.||+.||.|||+.+ ++|+||+|+||++++++.++|+|||++..+....
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07846 81 FVDHTVLDDLEKY---PNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 154 (286)
T ss_pred cCCccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence 9999999877643 234899999999999999999999986 9999999999999999999999999998764332
Q ss_pred CccccccccccccccCcchhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHh-----------h
Q 039168 373 NQANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLW-----------C 440 (536)
Q Consensus 373 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~-----------~ 440 (536)
. ......++..|+|||++.+. .++.++||||||+++|+|++|++||...... .......... .
T Consensus 155 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 229 (286)
T cd07846 155 E--VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDI---DQLYHIIKCLGNLIPRHQEIFQ 229 (286)
T ss_pred c--ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchH---HHHHHHHHHhCCCchhhHHHhc
Confidence 2 12234578899999998764 4788999999999999999999887532211 1100000000 0
Q ss_pred cCCc-cccccccccC-----CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 441 EGHA-VELIDPVLKQ-----SCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 441 ~~~~-~~l~~~~l~~-----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
.... .....+.... ...+.....+.+++.+||+.+|++|||+.++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 230 KNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred cchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 0000 0000000000 001112345777888999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=306.09 Aligned_cols=253 Identities=23% Similarity=0.282 Sum_probs=199.3
Q ss_pred cCCccccccCCCCceeEEEEEeCC-CcEEEEEEccccCh---hhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEE
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSG---QGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 291 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 291 (536)
++|+..+.||+|++|.||++...+ ++.||+|.+..... ...+.+.+|+++++.++||||+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 368889999999999999999764 89999999876532 24567889999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCC
Q 039168 292 EYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGN 371 (536)
Q Consensus 292 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 371 (536)
||+.+++|.+++... ....+++..+..++.||++||.|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~L~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 81 DYCPGGELFRLLQRQ-PGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EecCCCCHHHHHHhC-CCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence 999999999988543 2345899999999999999999999986 999999999999999999999999998765322
Q ss_pred CCc---------------------------cccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 039168 372 QNQ---------------------------ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYF 424 (536)
Q Consensus 372 ~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~ 424 (536)
... .......|+..|+|||++.+..++.++||||||+++|+|++|+.||....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 110 01123467889999999999889999999999999999999999975432
Q ss_pred ccCCchhHHHHHHHhhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCC----HHHHHH
Q 039168 425 SEHGQTLLTYTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPT----MSSVVV 487 (536)
Q Consensus 425 ~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt----~~evl~ 487 (536)
... .. .... .... .. . ........+.+++.+||+.||++||| +.++++
T Consensus 237 ~~~---~~---~~~~-~~~~-~~-----~--~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 237 RDE---TF---SNIL-KKEV-TF-----P--GSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred hHH---HH---HHHh-cCCc-cC-----C--CccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 211 01 1111 1110 00 0 01112345666667999999999999 777776
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=295.64 Aligned_cols=250 Identities=29% Similarity=0.402 Sum_probs=189.3
Q ss_pred cccCCCCceeEEEEEeC----CCcEEEEEEcccc-ChhhHHHHHHHHHHHHHcCCCCceeEeeEEe-eCceEEEEEeecC
Q 039168 222 NKLGQGGFGPVYKGTLA----DGKAIAVKRLSRT-SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCL-EGQELLLIYEYMP 295 (536)
Q Consensus 222 ~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~~lv~e~~~ 295 (536)
+.||+|+||.||+|.+. ++..+|+|++... .....+.+.+|+.+++.++||||+++++++. .+...+++|||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999853 2457999998643 3345678889999999999999999999765 4566899999999
Q ss_pred CCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCCc-
Q 039168 296 NKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQ- 374 (536)
Q Consensus 296 ~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~- 374 (536)
+++|..++.... ..+++..+..++.||++||.|||+.+ ++||||||+|||+++++.+||+|||+++........
T Consensus 81 ~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 81 HGDLRNFIRSET--HNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 999999985432 33677888899999999999999986 999999999999999999999999999765432211
Q ss_pred -cccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCC-CCCCCCCccCCchhHHHHHHHhhcCCccccccccc
Q 039168 375 -ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGR-KNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVL 452 (536)
Q Consensus 375 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l 452 (536)
.......++..|+|||.+.+..++.++||||||+++|||++|. +|+.... ...... ... .+.... .
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~---~~~~~~---~~~-~~~~~~-----~ 223 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD---SFDITV---YLL-QGRRLL-----Q 223 (262)
T ss_pred ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC---HHHHHH---HHh-cCCCCC-----C
Confidence 1111234567899999998889999999999999999999964 4443211 111111 111 111100 0
Q ss_pred cCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 453 KQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 453 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
. ... ...+.+++.+||+.+|++||++.+|++.|+..
T Consensus 224 ~-~~~---~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~ 259 (262)
T cd05058 224 P-EYC---PDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI 259 (262)
T ss_pred C-CcC---CHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 1 111 23466777899999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=304.55 Aligned_cols=250 Identities=24% Similarity=0.366 Sum_probs=197.9
Q ss_pred cCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEeec
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 294 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 294 (536)
+.|.....||+|+||.||++... ++..||||++........+.+.+|+.+++.++||||+++++.+...+..++||||+
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 101 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFL 101 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCC
Confidence 44555678999999999999875 58899999987665566677899999999999999999999999999999999999
Q ss_pred CCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCCc
Q 039168 295 PNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQ 374 (536)
Q Consensus 295 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 374 (536)
++++|..++.. ..+++.+++.++.||+.||.|||+++ |+||||||+||++++++.++|+|||++........
T Consensus 102 ~~~~L~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~- 173 (292)
T cd06658 102 EGGALTDIVTH----TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP- 173 (292)
T ss_pred CCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-
Confidence 99999988743 24789999999999999999999996 99999999999999999999999999876543222
Q ss_pred cccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccccccC
Q 039168 375 ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQ 454 (536)
Q Consensus 375 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~ 454 (536)
......|+..|+|||.+.+..++.++||||||+++|||++|+.||...... .... . .... +.+....
T Consensus 174 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~---~~~~---~-~~~~-----~~~~~~~ 240 (292)
T cd06658 174 -KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL---QAMR---R-IRDN-----LPPRVKD 240 (292)
T ss_pred -cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHH---H-HHhc-----CCCcccc
Confidence 122346889999999998888999999999999999999999997532211 1111 1 1100 0111111
Q ss_pred CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 455 SCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 455 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
. ......+.+++.+||+.||++|||+.++++.
T Consensus 241 ~--~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 241 S--HKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred c--cccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 0 0112234556669999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=300.13 Aligned_cols=255 Identities=24% Similarity=0.365 Sum_probs=199.0
Q ss_pred hcCCccccccCCCCceeEEEEEeCC----CcEEEEEEccccC-hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEE
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLAD----GKAIAVKRLSRTS-GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 289 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 289 (536)
.++|.+.++||+|+||.||+|.+.+ ...|++|...... ....+.+.+|+.++++++||||+++++++.+ ...++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 3568889999999999999998643 3578999887654 4456788999999999999999999998875 45789
Q ss_pred EEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccC
Q 039168 290 IYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFG 369 (536)
Q Consensus 290 v~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 369 (536)
||||+++++|.+++.... ..+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++...
T Consensus 84 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 158 (270)
T cd05056 84 VMELAPLGELRSYLQVNK--YSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158 (270)
T ss_pred EEEcCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeecc
Confidence 999999999999985432 34899999999999999999999986 9999999999999999999999999998765
Q ss_pred CCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHHHHHhhcCCccccc
Q 039168 370 GNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELI 448 (536)
Q Consensus 370 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 448 (536)
...... .....++..|+|||.+....++.++||||||+++|+|++ |+.||...... .... . ...+....
T Consensus 159 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~---~~~~---~-~~~~~~~~-- 228 (270)
T cd05056 159 DESYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN---DVIG---R-IENGERLP-- 228 (270)
T ss_pred ccccee-cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH---HHHH---H-HHcCCcCC--
Confidence 432211 112234568999999988889999999999999999996 99997533221 1111 1 11111111
Q ss_pred cccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 449 DPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 449 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
.... .+ ..+.+++.+|+..+|++|||+.++++.|...
T Consensus 229 ---~~~~-~~---~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~ 265 (270)
T cd05056 229 ---MPPN-CP---PTLYSLMTKCWAYDPSKRPRFTELKAQLSDI 265 (270)
T ss_pred ---CCCC-CC---HHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1111 12 3466666799999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=306.61 Aligned_cols=254 Identities=24% Similarity=0.368 Sum_probs=200.6
Q ss_pred HhcCCccccccCCCCceeEEEEEeCCCcEEEEEEcc--ccChhhHHHHHHHHHHHHHcC-CCCceeEeeEEeeCceEEEE
Q 039168 214 ATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLS--RTSGQGLKEFKNEVNLIAKLQ-HKNLVRLLGCCLEGQELLLI 290 (536)
Q Consensus 214 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lv 290 (536)
....|+++++||+||.+.||++...+.+.||+|++. ..+...+..|.+|+.+|.+|+ |.+||++++|-..++.+|||
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv 438 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV 438 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence 346799999999999999999999888889998875 345667888999999999994 89999999999999999999
Q ss_pred EeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCC
Q 039168 291 YEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGG 370 (536)
Q Consensus 291 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 370 (536)
|||- ..+|..+|...... ...| .+..+..|++.|+.++|++| |||.||||.|+|+- .|.+||+|||+|..+..
T Consensus 439 mE~G-d~DL~kiL~k~~~~-~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~ 511 (677)
T KOG0596|consen 439 MECG-DIDLNKILKKKKSI-DPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLV-KGRLKLIDFGIANAIQP 511 (677)
T ss_pred eecc-cccHHHHHHhccCC-CchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEE-eeeEEeeeechhcccCc
Confidence 9974 66888888654332 2223 77888999999999999997 99999999999986 46999999999999887
Q ss_pred CCCccccccccccccccCcchhcCC-----------CCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHh
Q 039168 371 NQNQANTNIIAGTYGYMAPEYAMGG-----------IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLW 439 (536)
Q Consensus 371 ~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 439 (536)
+.........+||+.||+||.+... ..++++||||||||||+|+.|+.||+.+... |..
T Consensus 512 DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~---------~aK- 581 (677)
T KOG0596|consen 512 DTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQ---------IAK- 581 (677)
T ss_pred cccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHH---------HHH-
Confidence 7666666678999999999998432 2678999999999999999999997643211 111
Q ss_pred hcCCccccccccccCCCCH-HHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 440 CEGHAVELIDPVLKQSCAP-DELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 440 ~~~~~~~l~~~~l~~~~~~-~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
+..+.++.-.-.++. ..-..+++++..||+.||++|||+.++|+.
T Consensus 582 ----l~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 582 ----LHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred ----HHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 112222211111110 011128888889999999999999999964
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=297.31 Aligned_cols=251 Identities=24% Similarity=0.363 Sum_probs=195.1
Q ss_pred cCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC-----hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeC--ceE
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-----GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEG--QEL 287 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~ 287 (536)
++|++.+.||+|+||.||++.+. +++.||||.+.... ....+.+.+|+.++++++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 57889999999999999999875 58999999875321 23356788899999999999999999998763 568
Q ss_pred EEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccc
Q 039168 288 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARI 367 (536)
Q Consensus 288 ~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 367 (536)
+++|||+++++|.+++... ..+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++..
T Consensus 82 ~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY---GALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence 8999999999999988543 34788899999999999999999996 99999999999999999999999999986
Q ss_pred cCCCCC-ccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccc
Q 039168 368 FGGNQN-QANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVE 446 (536)
Q Consensus 368 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 446 (536)
...... ........|+..|+|||.+.+..++.++||||||+++|+|++|+.||...... .. .........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-----~~-~~~~~~~~~--- 226 (265)
T cd06652 156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM-----AA-IFKIATQPT--- 226 (265)
T ss_pred cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH-----HH-HHHHhcCCC---
Confidence 543211 11222345888999999999888999999999999999999999997532111 11 111110100
Q ss_pred cccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 447 LIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 447 l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
. ...+......+.+++.+|+. +|++|||+++|++.
T Consensus 227 --~----~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 227 --N----PVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred --C----CCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 1 11122333456666778885 99999999999853
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=304.21 Aligned_cols=247 Identities=28% Similarity=0.377 Sum_probs=200.3
Q ss_pred hcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEE
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 290 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 290 (536)
.+.|+.-++||+|+||.|+-++.+ +|+.||.|++.+.. .....-..+|-.||.+++.|.||.+-..|+..+.+++|
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 467888999999999999999865 59999999986543 23345578899999999999999999999999999999
Q ss_pred EeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCC
Q 039168 291 YEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGG 370 (536)
Q Consensus 291 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 370 (536)
+..|.||+|.-+|.+... ..+++.++..++.+|+.||++||... ||+||+||+|||+|+.|+++|+|+|+|..+..
T Consensus 264 LtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~ 339 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPE 339 (591)
T ss_pred EEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCC
Confidence 999999999999987654 56999999999999999999999986 99999999999999999999999999998875
Q ss_pred CCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccc
Q 039168 371 NQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDP 450 (536)
Q Consensus 371 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 450 (536)
..... ..+||.+|||||++.++.|+...|+|||||++|||+.|+.||..+-.......+. .++.+ ++
T Consensus 340 g~~~~---~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvd--------rr~~~--~~ 406 (591)
T KOG0986|consen 340 GKPIR---GRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVD--------RRTLE--DP 406 (591)
T ss_pred CCccc---cccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHH--------HHHhc--ch
Confidence 55433 2489999999999999999999999999999999999999987654432211111 01111 11
Q ss_pred cccCCCCHHHHHHHHHHHHhhcCCCCCCCCC
Q 039168 451 VLKQSCAPDELLKFIHIGLLCVQQDPADRPT 481 (536)
Q Consensus 451 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt 481 (536)
.-..+.-+++.+.+.+ ..|++||++|.-
T Consensus 407 ~ey~~kFS~eakslc~---~LL~Kdp~~RLG 434 (591)
T KOG0986|consen 407 EEYSDKFSEEAKSLCE---GLLTKDPEKRLG 434 (591)
T ss_pred hhcccccCHHHHHHHH---HHHccCHHHhcc
Confidence 1111223344555554 788999999964
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=317.23 Aligned_cols=253 Identities=25% Similarity=0.417 Sum_probs=204.0
Q ss_pred hcCCccccccCCCCceeEEEEEeCCCc-EEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEee
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLADGK-AIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 293 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~-~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 293 (536)
.+.|+++..||.|+||.||+|..++.. -.|.|.|...+.+.++.+.-|++||....||+||++++.|..++.+||..||
T Consensus 31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEF 110 (1187)
T KOG0579|consen 31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEF 110 (1187)
T ss_pred HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEee
Confidence 356888999999999999999987644 4467888878888899999999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCC
Q 039168 294 MPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQN 373 (536)
Q Consensus 294 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 373 (536)
|.||-.+.++....+ .+.+.++.-+++|++.||.|||++ +|||||||..|||++-+|.++|+|||.+..... .
T Consensus 111 C~GGAVDaimlEL~r--~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~--t 183 (1187)
T KOG0579|consen 111 CGGGAVDAIMLELGR--VLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS--T 183 (1187)
T ss_pred cCCchHhHHHHHhcc--ccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchh--H
Confidence 999999999876443 589999999999999999999998 599999999999999999999999999865422 2
Q ss_pred ccccccccccccccCcchhc-----CCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccc
Q 039168 374 QANTNIIAGTYGYMAPEYAM-----GGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELI 448 (536)
Q Consensus 374 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 448 (536)
......+.|||.|||||+.+ ..+|+.++||||||++|.||..+.+|-. + ...+....+ +.....+.++
T Consensus 184 ~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHh----e--lnpMRVllK-iaKSePPTLl 256 (1187)
T KOG0579|consen 184 RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHH----E--LNPMRVLLK-IAKSEPPTLL 256 (1187)
T ss_pred HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCcc----c--cchHHHHHH-HhhcCCCccc
Confidence 23344588999999999874 4579999999999999999999998822 1 122222221 1222222222
Q ss_pred cccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 449 DPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 449 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
. ++.....+-+++..||.+||..||+++++++.
T Consensus 257 q-------PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 257 Q-------PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred C-------cchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 2 22233445566669999999999999999854
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=301.31 Aligned_cols=262 Identities=23% Similarity=0.339 Sum_probs=195.0
Q ss_pred cCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccChh-hHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEee
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQ-GLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 293 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 293 (536)
++|+..+.||+|++|.||+|..+ +++.||+|.+...... ....+.+|++++++++||||+++++++.+++..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 67899999999999999999976 5899999998654322 234567899999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCC
Q 039168 294 MPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQN 373 (536)
Q Consensus 294 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 373 (536)
+.+ +|..++.... ..+++..+..++.||++||.|||+.+ |+|+||||+|||+++++.+||+|||+++.......
T Consensus 85 ~~~-~L~~~~~~~~--~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 158 (291)
T cd07844 85 LDT-DLKQYMDDCG--GGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSK 158 (291)
T ss_pred CCC-CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence 985 8888875433 35889999999999999999999986 99999999999999999999999999875432211
Q ss_pred ccccccccccccccCcchhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccc------
Q 039168 374 QANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVE------ 446 (536)
Q Consensus 374 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 446 (536)
. .....++..|+|||++.+ ..++.++||||+|+++|+|++|+.||...... .......+..........
T Consensus 159 ~--~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 234 (291)
T cd07844 159 T--YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDV--EDQLHKIFRVLGTPTEETWPGVSS 234 (291)
T ss_pred c--ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccH--HHHHHHHHHhcCCCChhhhhhhhh
Confidence 1 112346788999999876 45889999999999999999999998543211 111111111111000000
Q ss_pred ---c-------c-cccccCCC-CHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 447 ---L-------I-DPVLKQSC-APDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 447 ---l-------~-~~~l~~~~-~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
. . ...+.... .......+.+++.+||+.+|++|||+.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 235 NPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred ccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0 0 00000000 0001145677888999999999999999885
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=289.00 Aligned_cols=281 Identities=22% Similarity=0.303 Sum_probs=206.2
Q ss_pred HHhcCCccccccCCCCceeEEEEEeCC-----CcEEEEEEccccCh--hhHHHHHHHHHHHHHcCCCCceeEeeEEee-C
Q 039168 213 EATNHFSDENKLGQGGFGPVYKGTLAD-----GKAIAVKRLSRTSG--QGLKEFKNEVNLIAKLQHKNLVRLLGCCLE-G 284 (536)
Q Consensus 213 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~ 284 (536)
+....|+..+.||+|.||.||+|..++ .+.+|||++..... ..-...-+|+.+++.++|||++.+..+|.. +
T Consensus 21 e~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d 100 (438)
T KOG0666|consen 21 EDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHD 100 (438)
T ss_pred HHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccC
Confidence 345689999999999999999996432 34799999975422 122456789999999999999999999987 7
Q ss_pred ceEEEEEeecCCCChhhhhhc--ccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCC----CCeE
Q 039168 285 QELLLIYEYMPNKSLDVHLFD--ATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDD----MNPK 358 (536)
Q Consensus 285 ~~~~lv~e~~~~~sL~~~l~~--~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~----~~~k 358 (536)
..+++++||.+.. |..+|+- ..+...++...+..|+.||+.|+.|||+++ |+||||||.||||..+ |.||
T Consensus 101 ~~v~l~fdYAEhD-L~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VK 176 (438)
T KOG0666|consen 101 KKVWLLFDYAEHD-LWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVK 176 (438)
T ss_pred ceEEEEehhhhhh-HHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeE
Confidence 8999999999875 4445532 233457899999999999999999999998 9999999999999877 8999
Q ss_pred EecccCccccCCCCCcc-ccccccccccccCcchhcCCC-CCccchHHHHHHHHHHHHhCCCCCCCCCccCC------ch
Q 039168 359 ISDFGTARIFGGNQNQA-NTNIIAGTYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGRKNNGFYFSEHG------QT 430 (536)
Q Consensus 359 l~Dfg~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~elltg~~p~~~~~~~~~------~~ 430 (536)
|+|||+++.+.+.-... ....++-|.+|.|||++.|.. |+.+.|||++|||+.||++..+.|........ .+
T Consensus 177 IaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~d 256 (438)
T KOG0666|consen 177 IADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHD 256 (438)
T ss_pred eecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHH
Confidence 99999999887654332 445567799999999999864 89999999999999999999988755322111 12
Q ss_pred hHHHHHHHhhcC---Ccccccc---------ccccCCCCHH---H--------HHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 431 LLTYTWKLWCEG---HAVELID---------PVLKQSCAPD---E--------LLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 431 ~~~~~~~~~~~~---~~~~l~~---------~~l~~~~~~~---~--------~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
.+..+......+ .+..+.. ..-.....+- . .....+|+.++|+.||-+|.|+++.++
T Consensus 257 Ql~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAle 336 (438)
T KOG0666|consen 257 QLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALE 336 (438)
T ss_pred HHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhc
Confidence 222222222111 1111100 0000000000 0 012567777999999999999999998
Q ss_pred HhccCCCCCC
Q 039168 488 MLASDSMTIP 497 (536)
Q Consensus 488 ~L~~~~~~~~ 497 (536)
..=-...++|
T Consensus 337 h~yF~~d~lp 346 (438)
T KOG0666|consen 337 HPYFTEDPLP 346 (438)
T ss_pred ccccccCCCC
Confidence 7655555555
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=298.73 Aligned_cols=255 Identities=26% Similarity=0.406 Sum_probs=197.1
Q ss_pred CCccccccCCCCceeEEEEEeC-CCcEEEEEEccccCh----------hhHHHHHHHHHHHHHcCCCCceeEeeEEeeCc
Q 039168 217 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG----------QGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQ 285 (536)
Q Consensus 217 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 285 (536)
+|...+.||+|+||.||+|... +++.||+|.+..... ...+.+.+|+.+++.++|||++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 5778899999999999999865 589999998753211 12346788999999999999999999999999
Q ss_pred eEEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCc
Q 039168 286 ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTA 365 (536)
Q Consensus 286 ~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 365 (536)
..++||||+.+++|..++... ..+++..+..++.||+.||.|||+++ ++|+||||+||+++.++.++|+|||++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence 999999999999999998543 45889999999999999999999986 999999999999999999999999999
Q ss_pred cccCCCCCccccccccccccccCcchhcCCC--CCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCC
Q 039168 366 RIFGGNQNQANTNIIAGTYGYMAPEYAMGGI--FSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGH 443 (536)
Q Consensus 366 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 443 (536)
+...............|+..|+|||.+.... ++.++|+||||+++|+|++|..||..... ............
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~------~~~~~~~~~~~~ 229 (272)
T cd06629 156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA------IAAMFKLGNKRS 229 (272)
T ss_pred ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch------HHHHHHhhcccc
Confidence 8654322222223346788999999987654 88999999999999999999999742111 111111111111
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 444 AVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 444 ~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
...+ .. .........+.+++.+||+.+|++|||+.+|++.
T Consensus 230 ~~~~-~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 230 APPI-PP----DVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred CCcC-Cc----cccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 1111 11 1111223456667779999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=331.90 Aligned_cols=255 Identities=28% Similarity=0.401 Sum_probs=192.7
Q ss_pred HHhcCCccccccCCCCceeEEEEEeC-CCcEEEEEEcccc-ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeC------
Q 039168 213 EATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT-SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEG------ 284 (536)
Q Consensus 213 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~------ 284 (536)
....+|+.++.||+||||.|||++.+ ||+.||||+|... +......+.+|+..|++|+|||||+++..|.+.
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 34578999999999999999999976 8999999999765 344456788999999999999999998644210
Q ss_pred --------------------------------------------------------------------------------
Q 039168 285 -------------------------------------------------------------------------------- 284 (536)
Q Consensus 285 -------------------------------------------------------------------------------- 284 (536)
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence
Q ss_pred ---------------------------------ceEEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHH
Q 039168 285 ---------------------------------QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYL 331 (536)
Q Consensus 285 ---------------------------------~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~L 331 (536)
..+||-||||+..++.+++.+.... -.....|+++++|++||.|+
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~--~~~d~~wrLFreIlEGLaYI 713 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN--SQRDEAWRLFREILEGLAYI 713 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc--hhhHHHHHHHHHHHHHHHHH
Confidence 1368889999998888888553321 14678899999999999999
Q ss_pred hcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccC----C------------CCCccccccccccccccCcchhcCC
Q 039168 332 HEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFG----G------------NQNQANTNIIAGTYGYMAPEYAMGG 395 (536)
Q Consensus 332 H~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~----~------------~~~~~~~~~~~gt~~y~aPE~~~~~ 395 (536)
|++| ||||||||.|||+++...|||+|||+|.... . .......+..+||..|+|||++.+.
T Consensus 714 H~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~ 790 (1351)
T KOG1035|consen 714 HDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT 790 (1351)
T ss_pred HhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence 9998 9999999999999999999999999998721 0 0111123446899999999999765
Q ss_pred C---CCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccccccCCCCHHHHHHHHHHHHhhc
Q 039168 396 I---FSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCV 472 (536)
Q Consensus 396 ~---~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl 472 (536)
. |+.|+|+||||||++||+. ||... .-...+...+..+.+++. ..+..++...-.++|.+||
T Consensus 791 ~~~~Yn~KiDmYSLGIVlFEM~y---PF~Ts------MERa~iL~~LR~g~iP~~------~~f~~~~~~~e~slI~~Ll 855 (1351)
T KOG1035|consen 791 SSNKYNSKIDMYSLGIVLFEMLY---PFGTS------MERASILTNLRKGSIPEP------ADFFDPEHPEEASLIRWLL 855 (1351)
T ss_pred ccccccchhhhHHHHHHHHHHhc---cCCch------HHHHHHHHhcccCCCCCC------cccccccchHHHHHHHHHh
Confidence 4 9999999999999999985 33211 111112222333333332 1122333344456777999
Q ss_pred CCCCCCCCCHHHHHH
Q 039168 473 QQDPADRPTMSSVVV 487 (536)
Q Consensus 473 ~~dP~~RPt~~evl~ 487 (536)
+.||.+|||+.|+|.
T Consensus 856 ~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 856 SHDPSKRPTATELLN 870 (1351)
T ss_pred cCCCccCCCHHHHhh
Confidence 999999999999985
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=299.40 Aligned_cols=256 Identities=25% Similarity=0.422 Sum_probs=197.0
Q ss_pred CccccccCCCCceeEEEEEeC----CCcEEEEEEcccc--ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCc------
Q 039168 218 FSDENKLGQGGFGPVYKGTLA----DGKAIAVKRLSRT--SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQ------ 285 (536)
Q Consensus 218 ~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~------ 285 (536)
|.+.+.||+|+||.||+|.+. +++.||||++... .....+++.+|++++++++||||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 567889999999999999853 3688999988654 3344667889999999999999999999886532
Q ss_pred eEEEEEeecCCCChhhhhhccc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecc
Q 039168 286 ELLLIYEYMPNKSLDVHLFDAT---RSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDF 362 (536)
Q Consensus 286 ~~~lv~e~~~~~sL~~~l~~~~---~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Df 362 (536)
..++++||+.+++|..++.... ....+++..++.++.||+.||+|||+.+ |+||||||+||++++++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 3478999999999988875322 2234788999999999999999999986 999999999999999999999999
Q ss_pred cCccccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHHHHHhhc
Q 039168 363 GTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCE 441 (536)
Q Consensus 363 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 441 (536)
|+++...............+++.|++||.+.+..++.++||||||+++|+|++ |+.||..... .....+ ...
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~---~~~~~~----~~~ 230 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN---SEIYNY----LIK 230 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH---HHHHHH----HHc
Confidence 99987643332222222345678999999998889999999999999999999 7887643211 111111 111
Q ss_pred CCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 442 GHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 442 ~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
..... ..+.....+.+++.+||+.+|++|||+.++++.|++.
T Consensus 231 ~~~~~---------~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 231 GNRLK---------QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CCcCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11111 0112234677788899999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=302.06 Aligned_cols=261 Identities=21% Similarity=0.296 Sum_probs=192.7
Q ss_pred CCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC--hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEee
Q 039168 217 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 293 (536)
Q Consensus 217 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 293 (536)
+|+..+.||+|+||.||+|.+. +|+.||+|++.... ......+.+|++++++++||||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4788899999999999999975 58999999986432 22235677899999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCC
Q 039168 294 MPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQN 373 (536)
Q Consensus 294 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 373 (536)
+++ +|..++... ...+++..++.++.||++||.|||+++ ++|+||||+||+++.++.+||+|||+++.+.....
T Consensus 81 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 154 (284)
T cd07839 81 CDQ-DLKKYFDSC--NGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR 154 (284)
T ss_pred CCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence 975 676666432 245899999999999999999999996 99999999999999999999999999986543221
Q ss_pred ccccccccccccccCcchhcCCC-CCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHH-----------HHHhhc
Q 039168 374 QANTNIIAGTYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYT-----------WKLWCE 441 (536)
Q Consensus 374 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~-----------~~~~~~ 441 (536)
. .....+++.|+|||.+.+.. ++.++||||||+++|+|++|+.|+...... ....... |.....
T Consensus 155 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07839 155 C--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV--DDQLKRIFRLLGTPTEESWPGVSK 230 (284)
T ss_pred C--cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCH--HHHHHHHHHHhCCCChHHhHHhhh
Confidence 1 12245688999999987754 789999999999999999999885322111 1111111 111000
Q ss_pred CCcccccccccc----CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 442 GHAVELIDPVLK----QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 442 ~~~~~l~~~~l~----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
......+..... ....+.....+.+++.+||+.||.+|||++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 231 LPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred cccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 000000000000 0001112235567777999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=304.14 Aligned_cols=258 Identities=18% Similarity=0.220 Sum_probs=200.1
Q ss_pred cCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEE
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 291 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 291 (536)
++|++.+.||+|+||.||++... .++.|++|.+.... ....+.+.+|+++++.++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36888999999999999999976 47899999887543 233457889999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCC
Q 039168 292 EYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGN 371 (536)
Q Consensus 292 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 371 (536)
||+++++|..++... ..+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||+++.....
T Consensus 81 e~~~g~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~ 154 (305)
T cd05609 81 EYVEGGDCATLLKNI---GALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS 154 (305)
T ss_pred ecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence 999999999998543 35899999999999999999999986 999999999999999999999999998642110
Q ss_pred CC-------------ccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHH
Q 039168 372 QN-------------QANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKL 438 (536)
Q Consensus 372 ~~-------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 438 (536)
.. ........++..|+|||.+.+..++.++||||||+++|||++|..||..... ......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~------~~~~~~- 227 (305)
T cd05609 155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP------EELFGQ- 227 (305)
T ss_pred ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHH-
Confidence 00 0011123578899999999988899999999999999999999999753211 111111
Q ss_pred hhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccCC
Q 039168 439 WCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDS 493 (536)
Q Consensus 439 ~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 493 (536)
....... .+.... ..+ ..+.+++.+||+.||++||++.++.+.|+...
T Consensus 228 ~~~~~~~---~~~~~~-~~~---~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~ 275 (305)
T cd05609 228 VISDDIE---WPEGDE-ALP---ADAQDLISRLLRQNPLERLGTGGAFEVKQHRF 275 (305)
T ss_pred HHhcccC---CCCccc-cCC---HHHHHHHHHHhccChhhccCccCHHHHHhCcc
Confidence 1111110 011111 122 23556667999999999999888888887753
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=299.72 Aligned_cols=257 Identities=25% Similarity=0.348 Sum_probs=197.3
Q ss_pred HHHhcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHHc-CCCCceeEeeEEe-----eC
Q 039168 212 LEATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLKEFKNEVNLIAKL-QHKNLVRLLGCCL-----EG 284 (536)
Q Consensus 212 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~-----~~ 284 (536)
....++|++.+.||+|+||.||++.+. +++.+|+|++.... .....+.+|+.+++.+ +||||+++++++. .+
T Consensus 14 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 92 (286)
T cd06638 14 PDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNG 92 (286)
T ss_pred CCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCC
Confidence 345689999999999999999999875 58899999876432 2235678899999999 6999999999874 34
Q ss_pred ceEEEEEeecCCCChhhhhhcc-cCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEeccc
Q 039168 285 QELLLIYEYMPNKSLDVHLFDA-TRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFG 363 (536)
Q Consensus 285 ~~~~lv~e~~~~~sL~~~l~~~-~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg 363 (536)
...++||||+++++|.+++... .....+++..++.++.|+++||.|||+.+ ++||||||+||++++++.+||+|||
T Consensus 93 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl~dfg 169 (286)
T cd06638 93 DQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKLVDFG 169 (286)
T ss_pred CeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEEccCC
Confidence 6789999999999999887542 23345889999999999999999999986 9999999999999999999999999
Q ss_pred CccccCCCCCccccccccccccccCcchhcC-----CCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHH
Q 039168 364 TARIFGGNQNQANTNIIAGTYGYMAPEYAMG-----GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKL 438 (536)
Q Consensus 364 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 438 (536)
++........ ......|++.|+|||++.. ..++.++|||||||++|+|++|+.|+....... ....
T Consensus 170 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~------~~~~- 240 (286)
T cd06638 170 VSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR------ALFK- 240 (286)
T ss_pred ceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH------HHhh-
Confidence 9986643221 1223468999999999853 447899999999999999999999975432111 0000
Q ss_pred hhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 439 WCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 439 ~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
........+..+ .. ....+.+++.+||+.||++|||+.+|++.
T Consensus 241 ~~~~~~~~~~~~----~~---~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 241 IPRNPPPTLHQP----EL---WSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred ccccCCCcccCC----CC---cCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 101111111111 11 12346677779999999999999999975
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=300.75 Aligned_cols=260 Identities=27% Similarity=0.357 Sum_probs=199.6
Q ss_pred hhHHHHhcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHHc-CCCCceeEeeEEeeC--
Q 039168 209 GLALEATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLKEFKNEVNLIAKL-QHKNLVRLLGCCLEG-- 284 (536)
Q Consensus 209 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~-- 284 (536)
..+....++|++.+.||+|+||.||++... +++.+|+|.+.... .....+.+|+.+++++ +|||++++++++...
T Consensus 15 ~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~ 93 (291)
T cd06639 15 ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADK 93 (291)
T ss_pred ccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccc
Confidence 334445688999999999999999999975 58899999886542 2235677899999999 899999999998754
Q ss_pred ---ceEEEEEeecCCCChhhhhhcc-cCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEe
Q 039168 285 ---QELLLIYEYMPNKSLDVHLFDA-TRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKIS 360 (536)
Q Consensus 285 ---~~~~lv~e~~~~~sL~~~l~~~-~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~ 360 (536)
...++||||+++++|.+++... .....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+
T Consensus 94 ~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~kl~ 170 (291)
T cd06639 94 LVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKLV 170 (291)
T ss_pred cCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEe
Confidence 3689999999999999887542 22345899999999999999999999986 9999999999999999999999
Q ss_pred cccCccccCCCCCccccccccccccccCcchhcCC-----CCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHH
Q 039168 361 DFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGG-----IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYT 435 (536)
Q Consensus 361 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~ 435 (536)
|||++......... .....|+..|+|||.+... .++.++||||||+++|+|++|+.||....... ..
T Consensus 171 dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~--~~---- 242 (291)
T cd06639 171 DFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK--TL---- 242 (291)
T ss_pred ecccchhccccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHH--HH----
Confidence 99999865432221 1234678899999998643 36899999999999999999999975322111 11
Q ss_pred HHHhhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 436 WKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 436 ~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
.. +.......+.+ .......+.+++.+||+.+|++||++.++++.
T Consensus 243 ~~-~~~~~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 243 FK-IPRNPPPTLLH-------PEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred HH-HhcCCCCCCCc-------ccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 11 11111111111 11122357778889999999999999999863
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=294.08 Aligned_cols=253 Identities=27% Similarity=0.393 Sum_probs=203.9
Q ss_pred cCCccccccCCCCceeEEEEEeCC-CcEEEEEEccccCh-hhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEee
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSG-QGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 293 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 293 (536)
++|++.+.||+|++|.||+++... ++.|++|++..... .....+.+|+..+.+++|||++++++++......++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 368889999999999999999864 99999999876544 4567899999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCC
Q 039168 294 MPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHE-DSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQ 372 (536)
Q Consensus 294 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 372 (536)
+++++|.+++... ..+++..++.++.||++||.|||+ .+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 81 MDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 9999999998543 458999999999999999999999 86 9999999999999999999999999998764333
Q ss_pred CccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccccc
Q 039168 373 NQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVL 452 (536)
Q Consensus 373 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l 452 (536)
... ....++..|+|||.+.+..++.++||||||+++|+|++|+.|+....... ......... ..... .+
T Consensus 155 ~~~--~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~---~~~~~~~~~-~~~~~-----~~ 223 (264)
T cd06623 155 DQC--NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPS---FFELMQAIC-DGPPP-----SL 223 (264)
T ss_pred Ccc--cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccC---HHHHHHHHh-cCCCC-----CC
Confidence 221 23457889999999999899999999999999999999999975543211 111111111 11111 11
Q ss_pred cCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 453 KQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 453 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
.... ....+.+++.+||+.+|++|||+.++++.
T Consensus 224 ~~~~---~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 224 PAEE---FSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred Cccc---CCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 1110 22456667779999999999999999974
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=347.70 Aligned_cols=261 Identities=26% Similarity=0.491 Sum_probs=209.3
Q ss_pred HhcCCccccccCCCCceeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEe
Q 039168 214 ATNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 292 (536)
Q Consensus 214 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 292 (536)
....|...++||+|+||.||+|+. .+++.||||++...... ..+|++++++++|||||++++++.+.+..++|||
T Consensus 688 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E 763 (968)
T PLN00113 688 ILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHE 763 (968)
T ss_pred HHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEe
Confidence 345678888999999999999997 46899999998654321 2356889999999999999999999999999999
Q ss_pred ecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCC
Q 039168 293 YMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQ 372 (536)
Q Consensus 293 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 372 (536)
|+++++|.+++. .++|.++..++.||++||+|||.....+|+||||||+||+++.++..++. ||........
T Consensus 764 y~~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~- 835 (968)
T PLN00113 764 YIEGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD- 835 (968)
T ss_pred CCCCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC-
Confidence 999999999984 27899999999999999999996544569999999999999999888775 6655432211
Q ss_pred CccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccccc
Q 039168 373 NQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVL 452 (536)
Q Consensus 373 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l 452 (536)
....|++.|+|||++.+..++.++|||||||++|||++|+.|+...... ......+............++++.+
T Consensus 836 -----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 909 (968)
T PLN00113 836 -----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGV-HGSIVEWARYCYSDCHLDMWIDPSI 909 (968)
T ss_pred -----CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCC-CCcHHHHHHHhcCccchhheeCccc
Confidence 1235789999999999999999999999999999999999998543332 2334444444333344444555555
Q ss_pred cC--CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 453 KQ--SCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 453 ~~--~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
.. .....+..++.+++.+||+.||++||||+++++.|+..
T Consensus 910 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~ 951 (968)
T PLN00113 910 RGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESA 951 (968)
T ss_pred cCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHh
Confidence 33 23456777889999999999999999999999999876
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=295.87 Aligned_cols=250 Identities=22% Similarity=0.370 Sum_probs=199.9
Q ss_pred CCccccccCCCCceeEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEee
Q 039168 217 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 293 (536)
Q Consensus 217 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 293 (536)
+|++.+.||+|+||.||++... +++.||+|++... .....+.+.+|+.++++++||||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 5888999999999999999875 5899999998643 233456789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCC
Q 039168 294 MPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQN 373 (536)
Q Consensus 294 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 373 (536)
+.+++|..++.... ...+++..++.++.|++.||.|||+++ ++|+||+|+|||++.++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 81 CEGGDLYKKINAQR-GVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred CCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence 99999998885422 234789999999999999999999986 99999999999999999999999999986643322
Q ss_pred ccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcccccccccc
Q 039168 374 QANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLK 453 (536)
Q Consensus 374 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~ 453 (536)
. .....|++.|+|||.+.+..++.++|+||||+++++|++|+.|+..... ....... ..+.... .
T Consensus 157 ~--~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~------~~~~~~~-~~~~~~~-----~- 221 (256)
T cd08218 157 L--ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM------KNLVLKI-IRGSYPP-----V- 221 (256)
T ss_pred h--hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH------HHHHHHH-hcCCCCC-----C-
Confidence 1 2234578899999999988899999999999999999999999753211 1111111 1111111 1
Q ss_pred CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 454 QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 454 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
+......+.+++.+||+.+|++||++.+|++.
T Consensus 222 ---~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 222 ---SSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred ---cccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 11123346677779999999999999999973
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=302.73 Aligned_cols=263 Identities=24% Similarity=0.323 Sum_probs=199.4
Q ss_pred cCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC--hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEe
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 292 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 292 (536)
++|++.++||+|++|.||+|.++ +++.|++|++.... ....+.+.+|+++++.++||||+++++++..++..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36889999999999999999976 58899999886432 2335678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCC
Q 039168 293 YMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQ 372 (536)
Q Consensus 293 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 372 (536)
|++++.+..++.. ...+++..++.++.||+.||.|||+++ ++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 154 (288)
T cd07833 81 YVERTLLELLEAS---PGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARP 154 (288)
T ss_pred cCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence 9998777665532 234899999999999999999999996 9999999999999999999999999998765433
Q ss_pred CccccccccccccccCcchhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHh-----------h
Q 039168 373 NQANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLW-----------C 440 (536)
Q Consensus 373 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~-----------~ 440 (536)
.. ......++..|+|||++.+. .++.++||||||+++|+|++|+.||...... .........+ .
T Consensus 155 ~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T cd07833 155 AS-PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDI---DQLYLIQKCLGPLPPSHQELFS 230 (288)
T ss_pred cc-cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCCCHHHhhhcc
Confidence 21 12234678899999999888 7899999999999999999999987543211 1111000000 0
Q ss_pred c-C-----Ccccccccc-ccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 441 E-G-----HAVELIDPV-LKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 441 ~-~-----~~~~l~~~~-l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
. . ...+..++. .....+.....++.+++.+||+.+|++|||++++++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 231 SNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred cCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 0 0 000000000 0000111114567778889999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=303.65 Aligned_cols=249 Identities=22% Similarity=0.343 Sum_probs=197.6
Q ss_pred CCccccccCCCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEeecC
Q 039168 217 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMP 295 (536)
Q Consensus 217 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 295 (536)
.|+....||+|+||.||++... +++.||+|.+........+.+.+|+.+++.++|||++++++++..++..++|+||++
T Consensus 22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~ 101 (297)
T cd06659 22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQ 101 (297)
T ss_pred hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCC
Confidence 4455668999999999999875 589999999876555556778899999999999999999999999999999999999
Q ss_pred CCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCCcc
Q 039168 296 NKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQA 375 (536)
Q Consensus 296 ~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 375 (536)
+++|..++.. ..+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++..+......
T Consensus 102 ~~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~- 173 (297)
T cd06659 102 GGALTDIVSQ----TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK- 173 (297)
T ss_pred CCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccccccc-
Confidence 9999887633 34889999999999999999999986 999999999999999999999999998765433221
Q ss_pred ccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccccccCC
Q 039168 376 NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQS 455 (536)
Q Consensus 376 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~ 455 (536)
.....|+..|+|||++.+..++.++||||||+++|||++|+.||...... ... .. ..... ..... .
T Consensus 174 -~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~---~~~---~~-~~~~~-~~~~~---~-- 239 (297)
T cd06659 174 -RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV---QAM---KR-LRDSP-PPKLK---N-- 239 (297)
T ss_pred -ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHH---HH-HhccC-CCCcc---c--
Confidence 22356889999999999888999999999999999999999997532211 111 11 11110 00000 0
Q ss_pred CCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 456 CAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 456 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
.......+.+++.+||+.+|++|||++++++.
T Consensus 240 -~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 240 -AHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred -cCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 01112335566779999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=295.30 Aligned_cols=254 Identities=24% Similarity=0.358 Sum_probs=199.4
Q ss_pred CCccccccCCCCceeEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHHHcCCCCceeEeeEEee--CceEEEEE
Q 039168 217 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLE--GQELLLIY 291 (536)
Q Consensus 217 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~--~~~~~lv~ 291 (536)
+|++.+.||.|+||.||++... +++.||+|.+... .....+.+.+|+++++.++||||+++++++.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4788899999999999999865 5889999988643 33445678899999999999999999998764 45689999
Q ss_pred eecCCCChhhhhhccc-CCCCCCHHHHHHHHHHHHHHHHHHhcCC--CCCeeeCCCCCCcEEEcCCCCeEEecccCcccc
Q 039168 292 EYMPNKSLDVHLFDAT-RSVQLDWKRRLSIINGIARGILYLHEDS--RLKIIHRDLKASNVLLDDDMNPKISDFGTARIF 368 (536)
Q Consensus 292 e~~~~~sL~~~l~~~~-~~~~l~~~~~~~i~~qi~~al~~LH~~~--~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 368 (536)
||+++++|..++.... ....+++..++.++.||+.||.|||..+ ..+++|+||||+||++++++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 9999999999986532 2356899999999999999999999222 224999999999999999999999999999876
Q ss_pred CCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccc
Q 039168 369 GGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELI 448 (536)
Q Consensus 369 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 448 (536)
...... .....+++.|+|||.+.+..++.++||||||+++|+|++|+.||..... .... .....+....
T Consensus 161 ~~~~~~--~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~----~~~~~~~~~~-- 229 (265)
T cd08217 161 GHDSSF--AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ---LQLA----SKIKEGKFRR-- 229 (265)
T ss_pred cCCccc--ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH---HHHH----HHHhcCCCCC--
Confidence 543321 2234688999999999998899999999999999999999999764321 1111 1111111111
Q ss_pred cccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 449 DPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 449 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
.+......+.+++.+||+.+|++|||+.+|++.
T Consensus 230 -------~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 230 -------IPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred -------CccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 111223456677789999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=295.36 Aligned_cols=261 Identities=27% Similarity=0.328 Sum_probs=200.0
Q ss_pred cCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccCh-hhHHHHHHHHHHHHHcCCCCceeEeeEEeeC--ceEEEEE
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG-QGLKEFKNEVNLIAKLQHKNLVRLLGCCLEG--QELLLIY 291 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~~lv~ 291 (536)
++|+..++||.|++|.||++.+. +++.+|+|.+..... .....+.+|++++++++||||+++++++.+. ..+++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 36888999999999999999985 588999999875433 3456789999999999999999999998653 4789999
Q ss_pred eecCCCChhhhhhcc-cCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCC
Q 039168 292 EYMPNKSLDVHLFDA-TRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGG 370 (536)
Q Consensus 292 e~~~~~sL~~~l~~~-~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 370 (536)
||+++++|.+++... .....+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 999999998887542 23445889999999999999999999986 99999999999999999999999999875532
Q ss_pred CCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccc
Q 039168 371 NQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDP 450 (536)
Q Consensus 371 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 450 (536)
... ....++..|+|||.+.+..++.++||||||+++|+|++|+.||......... ....... ........+.+.
T Consensus 158 ~~~----~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~~~-~~~~~~~~~~~~ 231 (287)
T cd06621 158 SLA----GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLG-PIELLSY-IVNMPNPELKDE 231 (287)
T ss_pred ccc----ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCC-hHHHHHH-HhcCCchhhccC
Confidence 221 1345688999999999989999999999999999999999998654321111 1111111 111111111111
Q ss_pred cccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 451 VLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 451 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
..... .....+.+++.+||+.+|++|||+.|+++.
T Consensus 232 ~~~~~---~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 232 PGNGI---KWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred CCCCC---chHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 11001 123456677789999999999999999973
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=299.05 Aligned_cols=244 Identities=27% Similarity=0.332 Sum_probs=197.4
Q ss_pred cCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEE
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 291 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 291 (536)
++|++.+.||+|++|.||++.+. +++.||+|.+.... ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 36888999999999999999976 58999999986532 234567889999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCC
Q 039168 292 EYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGN 371 (536)
Q Consensus 292 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 371 (536)
||+++++|.+++... ..+++..+..++.||++||.|||+.+ ++|+||+|.|||++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~---~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 81 EYVPGGELFSHLRKS---GRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred ecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 999999999998543 45899999999999999999999986 999999999999999999999999999876433
Q ss_pred CCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcccccccc
Q 039168 372 QNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPV 451 (536)
Q Consensus 372 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 451 (536)
.....|++.|+|||.+.+..++.++||||||+++|+|++|+.||...... . .......+.. .
T Consensus 155 -----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~----~~~~~~~~~~------~ 216 (290)
T cd05580 155 -----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI---Q----IYEKILEGKV------R 216 (290)
T ss_pred -----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH---H----HHHHHhcCCc------c
Confidence 22346889999999998888899999999999999999999997543211 1 1111111111 1
Q ss_pred ccCCCCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHH
Q 039168 452 LKQSCAPDELLKFIHIGLLCVQQDPADRP-----TMSSVVV 487 (536)
Q Consensus 452 l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 487 (536)
+... ....+.+++.+||+.||.+|+ +++++++
T Consensus 217 ~~~~----~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 217 FPSF----FSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred CCcc----CCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 1111 123456677799999999999 7777764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=293.58 Aligned_cols=249 Identities=25% Similarity=0.406 Sum_probs=198.3
Q ss_pred CCccccccCCCCceeEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEee
Q 039168 217 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 293 (536)
Q Consensus 217 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 293 (536)
+|+..+.||+|+||.||++... +++.+|+|.+... .....+.+.+|++++++++|||++++++.+..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 5788999999999999999875 5889999998654 234467788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCC-CeEEecccCccccCCCC
Q 039168 294 MPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDM-NPKISDFGTARIFGGNQ 372 (536)
Q Consensus 294 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~-~~kl~Dfg~a~~~~~~~ 372 (536)
+++++|.+++.... ...+++..+..++.|++.||.|||+++ ++|+||||+||++++++ .+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 81 APGGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred CCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 99999999986532 345899999999999999999999986 99999999999998654 58999999998765332
Q ss_pred CccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccccc
Q 039168 373 NQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVL 452 (536)
Q Consensus 373 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l 452 (536)
. .....|+..|+|||.+.+..++.++||||||+++|+|++|+.||...... ... ... .......+
T Consensus 157 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~---~~~---~~~-~~~~~~~~----- 221 (256)
T cd08220 157 K---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP---ALV---LKI-MSGTFAPI----- 221 (256)
T ss_pred c---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH---HHH---HHH-HhcCCCCC-----
Confidence 2 22346788999999999888999999999999999999999997543221 111 111 11111111
Q ss_pred cCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 453 KQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 453 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
. ......+.+++.+||+.+|++|||+.++++.
T Consensus 222 ~----~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 222 S----DRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred C----CCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 1 1122346677779999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=297.42 Aligned_cols=262 Identities=27% Similarity=0.390 Sum_probs=197.7
Q ss_pred CCccccccCCCCceeEEEEEeC-CCcEEEEEEccccCh-hhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEeec
Q 039168 217 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG-QGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 294 (536)
Q Consensus 217 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 294 (536)
+|+..++||.|++|.||+|++. +++.||||++..... ...+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 4788999999999999999986 588999999875432 23466778999999999999999999999999999999999
Q ss_pred CCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCCc
Q 039168 295 PNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQ 374 (536)
Q Consensus 295 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 374 (536)
++ +|..++........+++..+..++.||+.||.|||+.+ ++|+||||+||++++++.++|+|||++........
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence 85 78777765544456899999999999999999999986 99999999999999999999999999976543221
Q ss_pred cccccccccccccCcchhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCC--------cc
Q 039168 375 ANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGH--------AV 445 (536)
Q Consensus 375 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--------~~ 445 (536)
......++..|++||.+.+. .++.++||||||+++|+|++|+.||....... ............. ..
T Consensus 156 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07836 156 -TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNED---QLLKIFRIMGTPTESTWPGISQL 231 (284)
T ss_pred -ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHH---HHHHHHHHhCCCChhhHHHHhcC
Confidence 11223568899999998664 57899999999999999999999976433211 1111100000000 00
Q ss_pred cccccccc-------CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 446 ELIDPVLK-------QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 446 ~l~~~~l~-------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
..+..... ....+.....+.+++.+||+.||.+|||+.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 232 PEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred chhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00000000 0001112345677888999999999999999985
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=289.19 Aligned_cols=251 Identities=27% Similarity=0.447 Sum_probs=203.2
Q ss_pred CCccccccCCCCceeEEEEEeC-CCcEEEEEEccccCh--hhHHHHHHHHHHHHHcCCCCceeEeeEEeeC--ceEEEEE
Q 039168 217 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG--QGLKEFKNEVNLIAKLQHKNLVRLLGCCLEG--QELLLIY 291 (536)
Q Consensus 217 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~~lv~ 291 (536)
+|...+.||+|++|.||+|... +++.|++|++..... ...+.+.+|+.++++++||||+++++.+... ...++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4777889999999999999986 689999999876542 4567889999999999999999999999988 8999999
Q ss_pred eecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCC
Q 039168 292 EYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGN 371 (536)
Q Consensus 292 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 371 (536)
||+++++|.+++.... .+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 81 EYVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred EecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 9999999999986433 6899999999999999999999986 999999999999999999999999999877554
Q ss_pred CCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcccccccc
Q 039168 372 QNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPV 451 (536)
Q Consensus 372 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 451 (536)
..........++..|+|||.+.+...+.++||||||+++|+|++|+.||.... ......+..........
T Consensus 155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~~~~----- 224 (260)
T cd06606 155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG-----NPMAALYKIGSSGEPPE----- 224 (260)
T ss_pred cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----chHHHHHhccccCCCcC-----
Confidence 33212233567889999999988889999999999999999999999976543 11111221111111111
Q ss_pred ccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 452 LKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 452 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
.+......+.+++.+|++.||++||++.++++
T Consensus 225 ----~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 225 ----IPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred ----CCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 11112345666777999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=326.45 Aligned_cols=255 Identities=28% Similarity=0.454 Sum_probs=207.7
Q ss_pred CCccccccCCCCceeEEEEEeCC----CcEEEEEEcccc-ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEE
Q 039168 217 HFSDENKLGQGGFGPVYKGTLAD----GKAIAVKRLSRT-SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 291 (536)
Q Consensus 217 ~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 291 (536)
.-.+.++||.|.||+|++|+++. ...||||.++.. .++...+|+.|..||-+++||||++|.|+.......+||+
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT 709 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT 709 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence 34667899999999999999763 467999999754 4455678999999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCC
Q 039168 292 EYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGN 371 (536)
Q Consensus 292 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 371 (536)
|||++|+|+.+|..+. +.+...++..+++.|+.|++||-+.+ +|||||...||||+.+...|++|||+++.+.++
T Consensus 710 EyMENGsLDsFLR~~D--GqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvledd 784 (996)
T KOG0196|consen 710 EYMENGSLDSFLRQND--GQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 784 (996)
T ss_pred hhhhCCcHHHHHhhcC--CceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecccC
Confidence 9999999999996543 45899999999999999999999986 999999999999999999999999999988655
Q ss_pred CCcccccc-ccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHHHHHhhcCCcccccc
Q 039168 372 QNQANTNI-IAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELID 449 (536)
Q Consensus 372 ~~~~~~~~-~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 449 (536)
.....+.. -.-..+|.|||.+...+++.+|||||+||+|||.++ |.+|+-.+.. ++. ..-++
T Consensus 785 ~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN---QdV-------------IkaIe 848 (996)
T KOG0196|consen 785 PEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN---QDV-------------IKAIE 848 (996)
T ss_pred CCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch---HHH-------------HHHHH
Confidence 42222111 112468999999999999999999999999999887 7788422111 111 11122
Q ss_pred ccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 450 PVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 450 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
...+-..+.+....|.+||+.|||+|-.+||++.+|+..|.+.
T Consensus 849 ~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDkl 891 (996)
T KOG0196|consen 849 QGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKL 891 (996)
T ss_pred hccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHH
Confidence 2222223445666789999999999999999999999999864
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=299.31 Aligned_cols=264 Identities=22% Similarity=0.315 Sum_probs=196.2
Q ss_pred cCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccCh--hhHHHHHHHHHHHHHcCCCCceeEeeEEeeC--ceEEEE
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG--QGLKEFKNEVNLIAKLQHKNLVRLLGCCLEG--QELLLI 290 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~~lv 290 (536)
++|+..+.||.|+||.||+|.+. +++.+++|.+..... .....+.+|+.++++++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 57899999999999999999986 588999999864432 2234567899999999999999999999877 899999
Q ss_pred EeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCC
Q 039168 291 YEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGG 370 (536)
Q Consensus 291 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 370 (536)
|||+.+ +|..++.... ..+++..++.++.||+.||.|||+++ ++|+||||+|||++.++.+||+|||++..+..
T Consensus 85 ~e~~~~-~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 85 MEYVEH-DLKSLMETMK--QPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred ehhcCc-CHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 999975 8887775432 35899999999999999999999997 99999999999999999999999999987654
Q ss_pred CCCccccccccccccccCcchhcCCC-CCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhH--------HHHHHHhhc
Q 039168 371 NQNQANTNIIAGTYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLL--------TYTWKLWCE 441 (536)
Q Consensus 371 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~--------~~~~~~~~~ 441 (536)
.... .....+++.|+|||.+.+.. ++.++||||||+++|+|++|+.||............ ...|..+..
T Consensus 159 ~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (293)
T cd07843 159 PLKP--YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE 236 (293)
T ss_pred Cccc--cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhc
Confidence 3221 12245688999999987654 689999999999999999999998643221110000 000111100
Q ss_pred ------CCccccccccccCCCCHH-HHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 442 ------GHAVELIDPVLKQSCAPD-ELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 442 ------~~~~~l~~~~l~~~~~~~-~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
..........+....... ....+.+++.+||+.||++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 237 LPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred cchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 000000001111111111 2344667777999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=295.67 Aligned_cols=248 Identities=27% Similarity=0.441 Sum_probs=198.2
Q ss_pred cCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC-hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEee
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 293 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 293 (536)
+-|+..++||+|+||.||+|... +++.||||.+.... ......+.+|+.++++++||||+++++.+..+...++||||
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 34778889999999999999864 68899999886443 33456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCC
Q 039168 294 MPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQN 373 (536)
Q Consensus 294 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 373 (536)
+++++|..++.. ..+++..+..++.|++.|+.+||+.+ ++|+||||+||+++.++.++|+|||++..+.....
T Consensus 84 ~~~~~l~~~i~~----~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06641 84 LGGGSALDLLEP----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchh
Confidence 999999988843 34889999999999999999999986 99999999999999999999999999876643221
Q ss_pred ccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcccccccccc
Q 039168 374 QANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLK 453 (536)
Q Consensus 374 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~ 453 (536)
......++..|+|||.+.+..++.++||||||+++|+|++|..|+...... .... ....... +.+
T Consensus 157 --~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~------~~~~-~~~~~~~-----~~~- 221 (277)
T cd06641 157 --KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM------KVLF-LIPKNNP-----PTL- 221 (277)
T ss_pred --hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH------HHHH-HHhcCCC-----CCC-
Confidence 122345788999999998888999999999999999999999997532211 1111 1111111 111
Q ss_pred CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 454 QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 454 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
.......+.+++.+||+.+|.+||++.++++.
T Consensus 222 ---~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 222 ---EGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred ---CcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 11122345667779999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=290.77 Aligned_cols=241 Identities=25% Similarity=0.280 Sum_probs=195.9
Q ss_pred hcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEE
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 290 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 290 (536)
-++|..+++||+|.||.|.+++.+ .++.||+|++++.. .+...+-..|-++|+..+||.+..+...|+..+++++|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 478999999999999999999876 59999999998653 33445567899999999999999999999999999999
Q ss_pred EeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCC
Q 039168 291 YEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGG 370 (536)
Q Consensus 291 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 370 (536)
|||..||.|.-+|.+ ...+++...+.+-..|+.||.|||+++ ||+||||.+|+|+|.+|++||+|||+++.--
T Consensus 247 MeyanGGeLf~HLsr---er~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I- 319 (516)
T KOG0690|consen 247 MEYANGGELFFHLSR---ERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEI- 319 (516)
T ss_pred EEEccCceEeeehhh---hhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcc-
Confidence 999999999988844 455899999999999999999999985 9999999999999999999999999998432
Q ss_pred CCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccc
Q 039168 371 NQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDP 450 (536)
Q Consensus 371 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 450 (536)
.....+++++|||.|+|||++....|+.++|+|.+||+||||++|+.||...+.+.- .+.+.. . +-
T Consensus 320 -~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kL---FeLIl~----e------d~ 385 (516)
T KOG0690|consen 320 -KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKL---FELILM----E------DL 385 (516)
T ss_pred -cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHH---HHHHHh----h------hc
Confidence 233445678999999999999999999999999999999999999999865443321 111100 0 11
Q ss_pred cccCCCCHHHHHHHHHHHHhhcCCCCCCCC
Q 039168 451 VLKQSCAPDELLKFIHIGLLCVQQDPADRP 480 (536)
Q Consensus 451 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RP 480 (536)
..+.. ..++. ..|+...|.+||.+|.
T Consensus 386 kFPr~-ls~eA---ktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 386 KFPRT-LSPEA---KTLLSGLLKKDPKKRL 411 (516)
T ss_pred cCCcc-CCHHH---HHHHHHHhhcChHhhc
Confidence 11111 22333 3444588999999996
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=291.66 Aligned_cols=252 Identities=29% Similarity=0.459 Sum_probs=199.3
Q ss_pred CCccccccCCCCceeEEEEEeC-CCcEEEEEEccccCh--hhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEee
Q 039168 217 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG--QGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 293 (536)
Q Consensus 217 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 293 (536)
+|...+.||+|+||.||++... +++.|++|.+..... ...+.+.+|+.+++.++|+||+++++.+...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 5788899999999999999865 689999999876544 3667899999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCC
Q 039168 294 MPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQN 373 (536)
Q Consensus 294 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 373 (536)
+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 81 CSGGTLEELLEHG---RILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred CCCCcHHHHHhhc---CCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence 9999999998542 34788999999999999999999997 99999999999999999999999999987654332
Q ss_pred ccc--cccccccccccCcchhcCCC---CCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccc
Q 039168 374 QAN--TNIIAGTYGYMAPEYAMGGI---FSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELI 448 (536)
Q Consensus 374 ~~~--~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 448 (536)
... .....+++.|+|||++.+.. ++.++||||||+++|+|++|+.||...... . ....... ......
T Consensus 155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~---~--~~~~~~~-~~~~~~-- 226 (264)
T cd06626 155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE---F--QIMFHVG-AGHKPP-- 226 (264)
T ss_pred cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch---H--HHHHHHh-cCCCCC--
Confidence 211 12345788999999998766 889999999999999999999998543211 1 1111100 011111
Q ss_pred cccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 449 DPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 449 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
+... ......+.+++.+||+.+|++|||+.+++.
T Consensus 227 ---~~~~--~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 227 ---IPDS--LQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred ---CCcc--cccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 1110 011234556777999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=296.81 Aligned_cols=254 Identities=26% Similarity=0.401 Sum_probs=195.9
Q ss_pred HHHhcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHHc-CCCCceeEeeEEee------
Q 039168 212 LEATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLKEFKNEVNLIAKL-QHKNLVRLLGCCLE------ 283 (536)
Q Consensus 212 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~------ 283 (536)
....+.|++.++||+|+||.||+|.+. +++.+|+|++.... .....+..|+.+++++ +||||+++++++..
T Consensus 12 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 90 (282)
T cd06636 12 RDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGH 90 (282)
T ss_pred cChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCC
Confidence 345578999999999999999999975 58899999886543 3345688899999998 79999999999853
Q ss_pred CceEEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEeccc
Q 039168 284 GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFG 363 (536)
Q Consensus 284 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg 363 (536)
....+++|||+.+++|..++.... ...+++..++.++.||+.||.|||+.+ |+|+||||+||++++++.++|+|||
T Consensus 91 ~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l~dfg 166 (282)
T cd06636 91 DDQLWLVMEFCGAGSVTDLVKNTK-GNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKLVDFG 166 (282)
T ss_pred CCEEEEEEEeCCCCcHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCc
Confidence 467899999999999998886433 345788889999999999999999986 9999999999999999999999999
Q ss_pred CccccCCCCCccccccccccccccCcchhc-----CCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHH
Q 039168 364 TARIFGGNQNQANTNIIAGTYGYMAPEYAM-----GGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKL 438 (536)
Q Consensus 364 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 438 (536)
++........ ......|++.|+|||.+. +..++.++||||||+++|+|++|+.||....... . ...
T Consensus 167 ~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~--~----~~~- 237 (282)
T cd06636 167 VSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMR--A----LFL- 237 (282)
T ss_pred chhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHh--h----hhh-
Confidence 9876532211 122356889999999986 3458889999999999999999999975322110 0 000
Q ss_pred hhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 439 WCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 439 ~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
..... .+...... ....+.+++.+||+.||.+|||+.+|++
T Consensus 238 ~~~~~-----~~~~~~~~---~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 238 IPRNP-----PPKLKSKK---WSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred HhhCC-----CCCCcccc---cCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 00000 11111111 1234666777999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=295.70 Aligned_cols=254 Identities=26% Similarity=0.415 Sum_probs=197.9
Q ss_pred HhcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHHc-CCCCceeEeeEEeeCc------
Q 039168 214 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLKEFKNEVNLIAKL-QHKNLVRLLGCCLEGQ------ 285 (536)
Q Consensus 214 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~------ 285 (536)
.+++|++.+.||+|++|.||+|..+ +++.+++|++..... ..+.+.+|+.+++++ +||||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 3578999999999999999999985 578999998876543 346789999999999 7999999999997644
Q ss_pred eEEEEEeecCCCChhhhhhccc-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccC
Q 039168 286 ELLLIYEYMPNKSLDVHLFDAT-RSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGT 364 (536)
Q Consensus 286 ~~~lv~e~~~~~sL~~~l~~~~-~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~ 364 (536)
..++||||+++++|.+++.... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCcc
Confidence 5899999999999998886532 2356899999999999999999999986 99999999999999999999999999
Q ss_pred ccccCCCCCccccccccccccccCcchhcC-----CCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHh
Q 039168 365 ARIFGGNQNQANTNIIAGTYGYMAPEYAMG-----GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLW 439 (536)
Q Consensus 365 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 439 (536)
+........ ......|+..|+|||++.. ..++.++||||||+++|+|++|+.||...... ... .. .
T Consensus 160 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~----~~-~ 230 (275)
T cd06608 160 SAQLDSTLG--RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM--RAL----FK-I 230 (275)
T ss_pred ceecccchh--hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH--HHH----HH-h
Confidence 876543221 1223458899999998854 34678999999999999999999997532111 111 11 1
Q ss_pred hcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 440 CEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 440 ~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
.......+ . ........+.+++.+||..||++|||+.++++
T Consensus 231 ~~~~~~~~-----~--~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 231 PRNPPPTL-----K--SPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred hccCCCCC-----C--chhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 11111111 0 11112345667778999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=301.56 Aligned_cols=263 Identities=25% Similarity=0.339 Sum_probs=193.4
Q ss_pred hcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccCh--hhHHHHHHHHHHHHHcCCCCceeEeeEEeeC--ceEEE
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG--QGLKEFKNEVNLIAKLQHKNLVRLLGCCLEG--QELLL 289 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~~l 289 (536)
.++|++.+.||+|+||.||+|.+. +|+.||+|++..... .....+.+|+.++++++||||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 468999999999999999999975 589999999864322 2223566899999999999999999998755 56899
Q ss_pred EEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccC
Q 039168 290 IYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFG 369 (536)
Q Consensus 290 v~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 369 (536)
||||+.+ +|..++.... ..+++.+++.++.||+.||.|||+.+ ++|+||||+||++++++.+||+|||++....
T Consensus 86 v~e~~~~-~l~~~l~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 86 VMEYCEQ-DLASLLDNMP--TPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159 (309)
T ss_pred EEecCCC-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecC
Confidence 9999975 6777775422 45899999999999999999999997 9999999999999999999999999998765
Q ss_pred CCCCccccccccccccccCcchhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhh--------
Q 039168 370 GNQNQANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWC-------- 440 (536)
Q Consensus 370 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~-------- 440 (536)
..... .....+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||...... ...........
T Consensus 160 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~---~~~~~~~~~~~~~~~~~~~ 234 (309)
T cd07845 160 LPAKP--MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEI---EQLDLIIQLLGTPNESIWP 234 (309)
T ss_pred CccCC--CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHhcCCCChhhch
Confidence 43211 112245788999999876 45799999999999999999999998643221 11111111000
Q ss_pred ---cCCcccccc---ccccC--CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 441 ---EGHAVELID---PVLKQ--SCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 441 ---~~~~~~l~~---~~l~~--~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
.......+. ..... .........+.+++.+||+.||++|||+.++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 235 GFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred hhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000000000 00000 0000013345677789999999999999999964
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=289.45 Aligned_cols=250 Identities=30% Similarity=0.473 Sum_probs=202.0
Q ss_pred CCccccccCCCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEeecC
Q 039168 217 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMP 295 (536)
Q Consensus 217 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 295 (536)
+|+..+.||+|++|.||++... +++.+++|++........+.+.+|++++++++|||++++++++..+...++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4778899999999999999986 688999999987655566789999999999999999999999999999999999999
Q ss_pred CCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCCcc
Q 039168 296 NKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQA 375 (536)
Q Consensus 296 ~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 375 (536)
+++|.+++.... ..+++..++.++.|++.||.+||+.+ ++|+||+|+||++++++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 153 (253)
T cd05122 81 GGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-- 153 (253)
T ss_pred CCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence 999999885532 45899999999999999999999986 99999999999999999999999999987654322
Q ss_pred ccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccccccCC
Q 039168 376 NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQS 455 (536)
Q Consensus 376 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~ 455 (536)
.....++..|+|||.+.+..++.++||||||+++|+|++|+.|+...... .... ... ......+... .
T Consensus 154 -~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~---~~~-~~~~~~~~~~----~ 221 (253)
T cd05122 154 -RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM---KALF---KIA-TNGPPGLRNP----E 221 (253)
T ss_pred -ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH---HHHH---HHH-hcCCCCcCcc----c
Confidence 23456789999999999888999999999999999999999997533211 1111 110 0111111110 0
Q ss_pred CCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 456 CAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 456 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
.. ...+.+++.+||+.||++|||+.++++.
T Consensus 222 ~~---~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 222 KW---SDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred cc---CHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 01 2346667779999999999999999863
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=293.84 Aligned_cols=248 Identities=25% Similarity=0.440 Sum_probs=197.4
Q ss_pred CCccccccCCCCceeEEEEEeC-CCcEEEEEEcccc-ChhhHHHHHHHHHHHHHcC---CCCceeEeeEEeeCceEEEEE
Q 039168 217 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT-SGQGLKEFKNEVNLIAKLQ---HKNLVRLLGCCLEGQELLLIY 291 (536)
Q Consensus 217 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~---hpniv~l~~~~~~~~~~~lv~ 291 (536)
.|+..+.||+|+||.||+|.+. +++.||+|.+... .....+.+.+|+.++++++ |||++++++++..+...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 5778899999999999999974 6899999998654 3344567889999999997 999999999999999999999
Q ss_pred eecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCC
Q 039168 292 EYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGN 371 (536)
Q Consensus 292 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 371 (536)
||+++++|.+++.. ..+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++..+...
T Consensus 82 e~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 82 EYAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred ecCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 99999999988743 25889999999999999999999997 999999999999999999999999999876543
Q ss_pred CCccccccccccccccCcchhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccc
Q 039168 372 QNQANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDP 450 (536)
Q Consensus 372 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 450 (536)
... .....|+..|+|||.+.++ .++.++||||||+++|+|++|+.||....... ... ..... ..+
T Consensus 155 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~------~~~-~~~~~-----~~~ 220 (277)
T cd06917 155 SSK--RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR------AMM-LIPKS-----KPP 220 (277)
T ss_pred ccc--cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh------hhh-ccccC-----CCC
Confidence 321 2234688999999998754 46899999999999999999999975422111 000 00000 011
Q ss_pred cccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 451 VLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 451 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
.+.... ....+.+++.+||+.||++|||+.++++.
T Consensus 221 ~~~~~~---~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 221 RLEDNG---YSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred CCCccc---CCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 111111 22346667779999999999999999863
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=295.49 Aligned_cols=247 Identities=25% Similarity=0.310 Sum_probs=199.0
Q ss_pred CCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEe
Q 039168 217 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 292 (536)
Q Consensus 217 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 292 (536)
+|++.++||.|+||.||++.+. +++.||+|.+.+.. ....+.+.+|++++++++||||+++++.+.++...++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4788999999999999999986 58999999987543 2346788999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCC
Q 039168 293 YMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQ 372 (536)
Q Consensus 293 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 372 (536)
|+.+++|..++... ..+++..+..++.||++||.|||+++ ++|+||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 154 (258)
T cd05578 81 LLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154 (258)
T ss_pred CCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence 99999999998543 46899999999999999999999986 9999999999999999999999999998764332
Q ss_pred CccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccccc
Q 039168 373 NQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVL 452 (536)
Q Consensus 373 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l 452 (536)
......|+..|+|||.+.+..++.++|+||||+++|+|++|+.||......... . ....... .. ...
T Consensus 155 ---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~---~-~~~~~~~--~~----~~~ 221 (258)
T cd05578 155 ---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRD---Q-IRAKQET--AD----VLY 221 (258)
T ss_pred ---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHH---H-HHHHhcc--cc----ccC
Confidence 122345788999999999888999999999999999999999997654332111 1 1111110 00 011
Q ss_pred cCCCCHHHHHHHHHHHHhhcCCCCCCCCCH--HHHH
Q 039168 453 KQSCAPDELLKFIHIGLLCVQQDPADRPTM--SSVV 486 (536)
Q Consensus 453 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~--~evl 486 (536)
+......+.+++.+||+.||.+||++ .+++
T Consensus 222 ----~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 222 ----PATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred ----cccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 11112456677779999999999999 6554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=298.02 Aligned_cols=251 Identities=24% Similarity=0.378 Sum_probs=201.2
Q ss_pred hcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEee
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 293 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 293 (536)
.++|++.+.||+|+||.||++... +++.|++|.+........+.+.+|+.+++.++|||++++++.+...+..++|+||
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 368999999999999999999864 5889999998765555567789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCC
Q 039168 294 MPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQN 373 (536)
Q Consensus 294 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 373 (536)
+++++|.+++.. ..+++.++..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++..+.....
T Consensus 98 ~~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~ 170 (293)
T cd06647 98 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (293)
T ss_pred CCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence 999999998843 24788999999999999999999997 99999999999999999999999999876543322
Q ss_pred ccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcccccccccc
Q 039168 374 QANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLK 453 (536)
Q Consensus 374 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~ 453 (536)
......|++.|+|||.+.+..++.++||||||+++|+|++|+.||.......... .....+. +..
T Consensus 171 --~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~------~~~~~~~------~~~- 235 (293)
T cd06647 171 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY------LIATNGT------PEL- 235 (293)
T ss_pred --ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee------ehhcCCC------CCC-
Confidence 1223467889999999988889999999999999999999999986432211100 0000000 000
Q ss_pred CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 454 QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 454 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
.........+.+++.+||+.+|++||++.+++..
T Consensus 236 -~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 236 -QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred -CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0011122346667779999999999999999965
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=296.02 Aligned_cols=248 Identities=23% Similarity=0.359 Sum_probs=198.3
Q ss_pred CCccccccCCCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEeecC
Q 039168 217 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMP 295 (536)
Q Consensus 217 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 295 (536)
.|...++||+|++|.||++... +++.+++|++........+.+.+|+.+++.++||||+++++++...+..++++||+.
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 4666789999999999999864 688999999876555556678899999999999999999999999999999999999
Q ss_pred CCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCCcc
Q 039168 296 NKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQA 375 (536)
Q Consensus 296 ~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 375 (536)
+++|.+++.. ..+++.++..++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++.........
T Consensus 100 ~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~- 171 (285)
T cd06648 100 GGALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR- 171 (285)
T ss_pred CCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCcc-
Confidence 9999998854 34889999999999999999999997 999999999999999999999999998765432221
Q ss_pred ccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccccccCC
Q 039168 376 NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQS 455 (536)
Q Consensus 376 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~ 455 (536)
.....|++.|+|||.+.+..++.++||||||+++|+|++|+.||..... ....... ....... ...
T Consensus 172 -~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~------~~~~~~~-~~~~~~~-----~~~- 237 (285)
T cd06648 172 -RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP------LQAMKRI-RDNLPPK-----LKN- 237 (285)
T ss_pred -cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH------HHHHHHH-HhcCCCC-----Ccc-
Confidence 1234588999999999988899999999999999999999999753211 1111111 1111101 100
Q ss_pred CCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 456 CAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 456 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
.......+.+++.+||+.+|++|||+.++++
T Consensus 238 -~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 238 -LHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred -cccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 0111234667777999999999999999996
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=297.18 Aligned_cols=263 Identities=23% Similarity=0.307 Sum_probs=193.2
Q ss_pred hcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccCh-hhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEe
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG-QGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 292 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 292 (536)
+++|.+.+.||+|+||.||+|... +++.||+|++..... .....+.+|+.+++.++|+||+++++++..+...++|||
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 468999999999999999999875 588999999865432 223467789999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCC
Q 039168 293 YMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQ 372 (536)
Q Consensus 293 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 372 (536)
|+. ++|..++... ...+.+..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||+++......
T Consensus 84 ~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 157 (291)
T cd07870 84 YMH-TDLAQYMIQH--PGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPS 157 (291)
T ss_pred ccc-CCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCCC
Confidence 996 5666565432 234778888999999999999999986 9999999999999999999999999997643322
Q ss_pred CccccccccccccccCcchhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcC---------
Q 039168 373 NQANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEG--------- 442 (536)
Q Consensus 373 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--------- 442 (536)
.. .....+++.|+|||.+.+. .++.++||||||+++|+|++|+.||...... .......+..+...
T Consensus 158 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 233 (291)
T cd07870 158 QT--YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDV--FEQLEKIWTVLGVPTEDTWPGVS 233 (291)
T ss_pred CC--CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhH--HHHHHHHHHHcCCCChhhhhhhh
Confidence 11 1223568899999998764 5789999999999999999999998643221 11111111111000
Q ss_pred ----CccccccccccCCC-----CHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 443 ----HAVELIDPVLKQSC-----APDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 443 ----~~~~l~~~~l~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
...+.......... .......+.+++.+|++.||.+|||+.+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 234 KLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 00000000000000 0001234566777999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=304.23 Aligned_cols=198 Identities=30% Similarity=0.393 Sum_probs=168.4
Q ss_pred HhcCCccccccCCCCceeEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeC------
Q 039168 214 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEG------ 284 (536)
Q Consensus 214 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~------ 284 (536)
..++|+..+.||+|+||.||++... +++.||||++.+. .......+.+|+.++++++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4578999999999999999999975 6899999998643 333456778899999999999999999998643
Q ss_pred ceEEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccC
Q 039168 285 QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGT 364 (536)
Q Consensus 285 ~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~ 364 (536)
...++||||+.+ +|...+.. .+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||+
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~ 164 (353)
T cd07850 94 QDVYLVMELMDA-NLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 164 (353)
T ss_pred CcEEEEEeccCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCcc
Confidence 357999999965 67666632 2788999999999999999999996 99999999999999999999999999
Q ss_pred ccccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 039168 365 ARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFY 423 (536)
Q Consensus 365 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~ 423 (536)
++....... .....+++.|+|||.+.+..++.++||||||+++|+|++|+.||...
T Consensus 165 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~ 220 (353)
T cd07850 165 ARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGT 220 (353)
T ss_pred ceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCC
Confidence 986543221 22345788999999999999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=320.23 Aligned_cols=201 Identities=24% Similarity=0.375 Sum_probs=159.0
Q ss_pred HHhcCCccccccCCCCceeEEEEEeCC--CcEEEEE------------------EccccChhhHHHHHHHHHHHHHcCCC
Q 039168 213 EATNHFSDENKLGQGGFGPVYKGTLAD--GKAIAVK------------------RLSRTSGQGLKEFKNEVNLIAKLQHK 272 (536)
Q Consensus 213 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK------------------~~~~~~~~~~~~~~~E~~~l~~l~hp 272 (536)
...++|+++++||+|+||+||++..+. +...++| ++. ........+.+|+.+|++++||
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hp 223 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHE 223 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCC
Confidence 445789999999999999999987532 2222222 111 1222345688999999999999
Q ss_pred CceeEeeEEeeCceEEEEEeecCCCChhhhhhcccC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEE
Q 039168 273 NLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATR--SVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVL 350 (536)
Q Consensus 273 niv~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~--~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIl 350 (536)
||+++++++...+..|+|+|++.+ +|..++..... ........+..++.||+.||.|||+++ |+||||||+|||
T Consensus 224 nIv~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NIL 299 (501)
T PHA03210 224 NILKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIF 299 (501)
T ss_pred CcCcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEE
Confidence 999999999999999999999855 55555533211 122345677889999999999999996 999999999999
Q ss_pred EcCCCCeEEecccCccccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCC
Q 039168 351 LDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKN 419 (536)
Q Consensus 351 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p 419 (536)
++.++.+||+|||+++.+...... ......||+.|+|||++.+..++.++|||||||++|||++|..+
T Consensus 300 l~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~ 367 (501)
T PHA03210 300 LNCDGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFC 367 (501)
T ss_pred ECCCCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCC
Confidence 999999999999999876543222 12235789999999999999999999999999999999998754
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=296.25 Aligned_cols=261 Identities=22% Similarity=0.334 Sum_probs=194.0
Q ss_pred CCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC--hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEee
Q 039168 217 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 293 (536)
Q Consensus 217 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 293 (536)
+|+..+.||+|++|.||+|+.. +++.||||++.... ......+.+|++++++++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4788999999999999999875 58999999886432 22345788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCC
Q 039168 294 MPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQN 373 (536)
Q Consensus 294 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 373 (536)
+. ++|..++.... ...+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||++..+.....
T Consensus 81 ~~-~~l~~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 81 LH-QDLKKFMDASP-LSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 155 (284)
T ss_pred cc-cCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence 96 57877775432 345899999999999999999999986 99999999999999999999999999876543221
Q ss_pred ccccccccccccccCcchhcCCC-CCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcC----------
Q 039168 374 QANTNIIAGTYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEG---------- 442 (536)
Q Consensus 374 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---------- 442 (536)
. .....+++.|+|||.+.+.. ++.++||||||+++|+|++|+.||...... ....... ......
T Consensus 156 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~--~~~~~~~-~~~~~~~~~~~~~~~~ 230 (284)
T cd07860 156 T--YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI--DQLFRIF-RTLGTPDEVVWPGVTS 230 (284)
T ss_pred c--cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH--HHHHHHH-HHhCCCChhhhhhhhH
Confidence 1 12234688999999887654 688999999999999999999997542211 1111100 000000
Q ss_pred ------CccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 443 ------HAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 443 ------~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
.........+.. ..+.....+.+++.+||+.||++|||+.++++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 231 LPDYKPSFPKWARQDFSK-VVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred HHHHHhhcccccccCHHH-HcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 000000000000 000112345677789999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=294.20 Aligned_cols=252 Identities=25% Similarity=0.374 Sum_probs=191.0
Q ss_pred cCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC-hhhHHHHHHHHHH-HHHcCCCCceeEeeEEeeCceEEEEEe
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLKEFKNEVNL-IAKLQHKNLVRLLGCCLEGQELLLIYE 292 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~-l~~l~hpniv~l~~~~~~~~~~~lv~e 292 (536)
++|++.+.||+|+||.||++.++ +|+.||+|++.... ......+..|+.+ ++.++||||+++++++..++..+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 36888999999999999999976 59999999987543 2233445556664 677799999999999999999999999
Q ss_pred ecCCCChhhhhhcc-cCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCC
Q 039168 293 YMPNKSLDVHLFDA-TRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGN 371 (536)
Q Consensus 293 ~~~~~sL~~~l~~~-~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 371 (536)
|++ ++|..++... .....+++..++.++.||+.||.|||++. +++||||||+|||++.++.+||+|||++..+...
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 996 5777776542 23356899999999999999999999862 3999999999999999999999999999865432
Q ss_pred CCccccccccccccccCcchhcC----CCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcccc
Q 039168 372 QNQANTNIIAGTYGYMAPEYAMG----GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVEL 447 (536)
Q Consensus 372 ~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 447 (536)
. ......|+..|+|||.+.+ ..++.++|+||||+++|+|++|+.||...... ........ ......
T Consensus 158 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~-~~~~~~- 227 (283)
T cd06617 158 V---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP-----FQQLKQVV-EEPSPQ- 227 (283)
T ss_pred c---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC-----HHHHHHHH-hcCCCC-
Confidence 1 1122467889999998865 44689999999999999999999997532211 11111111 111111
Q ss_pred ccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 448 IDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 448 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
+.....+ ..+.+++.+||+.+|++|||+.++++
T Consensus 228 ----~~~~~~~---~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 228 ----LPAEKFS---PEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred ----CCccccC---HHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1111112 34566777999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=297.67 Aligned_cols=263 Identities=25% Similarity=0.325 Sum_probs=192.5
Q ss_pred cCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccCh--hhHHHHHHHHHHHHHcC-CCCceeEeeEEeeCce-----
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG--QGLKEFKNEVNLIAKLQ-HKNLVRLLGCCLEGQE----- 286 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~----- 286 (536)
++|++.+.||+|+||.||+|.+. +++.||||++..... .....+.+|+.+++.++ ||||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46889999999999999999975 589999998765422 23456888999999995 6999999999887665
Q ss_pred EEEEEeecCCCChhhhhhcccC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcC-CCCeEEeccc
Q 039168 287 LLLIYEYMPNKSLDVHLFDATR--SVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDD-DMNPKISDFG 363 (536)
Q Consensus 287 ~~lv~e~~~~~sL~~~l~~~~~--~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~-~~~~kl~Dfg 363 (536)
.|+||||+++ +|..++..... ...+++..++.++.||++||.|||+++ |+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999986 78777754322 245899999999999999999999996 999999999999998 8899999999
Q ss_pred CccccCCCCCccccccccccccccCcchhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcC
Q 039168 364 TARIFGGNQNQANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEG 442 (536)
Q Consensus 364 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 442 (536)
++..+...... .....+++.|+|||++.+ ..++.++||||||+++|+|++|..||....... .... ....+...
T Consensus 157 ~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~--~~~~-~~~~~~~~ 231 (295)
T cd07837 157 LGRAFSIPVKS--YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ--QLLH-IFKLLGTP 231 (295)
T ss_pred cceecCCCccc--cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH--HHHH-HHHHhCCC
Confidence 99865432211 112346889999998865 457999999999999999999999975422111 0000 00000000
Q ss_pred Cc------cccc--------cccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 443 HA------VELI--------DPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 443 ~~------~~l~--------~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
.. .... .+.......+.....+.+++.+||+.||.+|||+.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 232 TEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred ChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 00 0000 000000000112345677788999999999999999985
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=294.84 Aligned_cols=253 Identities=26% Similarity=0.399 Sum_probs=202.6
Q ss_pred HhcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEe
Q 039168 214 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 292 (536)
Q Consensus 214 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 292 (536)
..+.|+..+.||+|++|.||++.+. +++.|++|++..... ..+.+.+|+++++.++|+|++++++.+......++++|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 4567899999999999999999986 689999999876544 45678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCC
Q 039168 293 YMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQ 372 (536)
Q Consensus 293 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 372 (536)
|+++++|.+++.... ..+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 96 ~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 170 (286)
T cd06614 96 YMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK 170 (286)
T ss_pred ccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence 999999999996543 36899999999999999999999986 9999999999999999999999999987654322
Q ss_pred CccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccccc
Q 039168 373 NQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVL 452 (536)
Q Consensus 373 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l 452 (536)
. ......++..|++||.+.+..++.++||||||+++|+|++|+.|+....... .... ...........
T Consensus 171 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~------~~~~-~~~~~~~~~~~--- 238 (286)
T cd06614 171 S--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR------ALFL-ITTKGIPPLKN--- 238 (286)
T ss_pred h--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH------HHHH-HHhcCCCCCcc---
Confidence 1 1223457889999999988889999999999999999999999975322211 0111 11111111100
Q ss_pred cCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 453 KQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 453 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
. ......+.+++.+||+.+|.+|||+.++++.
T Consensus 239 -~---~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 239 -P---EKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred -h---hhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 0 1112345667779999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=309.55 Aligned_cols=245 Identities=24% Similarity=0.378 Sum_probs=191.6
Q ss_pred ccccccCCCCceeEEEEEeC-CCcEEEEEEcc----ccChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCce--EEEEE
Q 039168 219 SDENKLGQGGFGPVYKGTLA-DGKAIAVKRLS----RTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQE--LLLIY 291 (536)
Q Consensus 219 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~----~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~--~~lv~ 291 (536)
+...+||+|+|-+||||.+. +|.+||--.+. ..++...++|..|+.+|+.|+||||+++++.|.+... ..+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 45668999999999999985 48888743322 1245567899999999999999999999999987654 88999
Q ss_pred eecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEc-CCCCeEEecccCccccCC
Q 039168 292 EYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLD-DDMNPKISDFGTARIFGG 370 (536)
Q Consensus 292 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~-~~~~~kl~Dfg~a~~~~~ 370 (536)
|++..|+|..++.+.++ ++.+.+..|++||++||.|||++ .++|||||||-+||||+ ..|.|||+|+|+|.....
T Consensus 123 EL~TSGtLr~Y~kk~~~---vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~ 198 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKHRR---VNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK 198 (632)
T ss_pred ecccCCcHHHHHHHhcc---CCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence 99999999999966554 88899999999999999999998 57999999999999998 468999999999987643
Q ss_pred CCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccc
Q 039168 371 NQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDP 450 (536)
Q Consensus 371 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 450 (536)
.. .....|||.|||||+.. ..|...+||||||+.|+||+|+..||.-.... .+.- +....+.-+.-+
T Consensus 199 s~----aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~-----AQIY-KKV~SGiKP~sl-- 265 (632)
T KOG0584|consen 199 SH----AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNP-----AQIY-KKVTSGIKPAAL-- 265 (632)
T ss_pred cc----cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCH-----HHHH-HHHHcCCCHHHh--
Confidence 22 23368999999999987 78999999999999999999999996432211 1111 111111111111
Q ss_pred cccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 451 VLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 451 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
......+.+ ++|.+||.. .++|||+.|+|.
T Consensus 266 ---~kV~dPevr---~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 266 ---SKVKDPEVR---EFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred ---hccCCHHHH---HHHHHHhcC-chhccCHHHHhh
Confidence 111233444 455599999 999999999995
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=295.28 Aligned_cols=261 Identities=23% Similarity=0.333 Sum_probs=196.0
Q ss_pred CccccccCCCCceeEEEEEeC-CCcEEEEEEccccC--hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeC--ceEEEEEe
Q 039168 218 FSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEG--QELLLIYE 292 (536)
Q Consensus 218 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~~lv~e 292 (536)
|++.+.||.|++|.||+|... +++.+|+|++.... ......+.+|++++++++|||++++++++... +..++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 567889999999999999976 48899999998653 33446788999999999999999999999988 89999999
Q ss_pred ecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCC
Q 039168 293 YMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQ 372 (536)
Q Consensus 293 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 372 (536)
|+++ +|..++.... ..+++..++.++.||++||.|||+.+ ++|+||||+||++++++.+||+|||++.......
T Consensus 81 ~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 81 YMDH-DLTGLLDSPE--VKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred cccc-cHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 9975 7877775432 45899999999999999999999986 9999999999999999999999999998765433
Q ss_pred CccccccccccccccCcchhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcC---Ccccc-
Q 039168 373 NQANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEG---HAVEL- 447 (536)
Q Consensus 373 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~l- 447 (536)
.. ......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||....... ............ .+...
T Consensus 155 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 230 (287)
T cd07840 155 SA-DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELE---QLEKIFELCGSPTDENWPGVS 230 (287)
T ss_pred cc-cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCCchhhccccc
Confidence 21 1222356788999998765 457899999999999999999999975433211 111111100000 00000
Q ss_pred -------------ccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 448 -------------IDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 448 -------------~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
....+...........+++++.+||+.+|++|||++++++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 231 KLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred cchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 00000000000013467788889999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=312.17 Aligned_cols=251 Identities=30% Similarity=0.395 Sum_probs=204.4
Q ss_pred CCccccccCCCCceeEEEEEeCC--C--cEEEEEEccccChh-hHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEE
Q 039168 217 HFSDENKLGQGGFGPVYKGTLAD--G--KAIAVKRLSRTSGQ-GLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 291 (536)
Q Consensus 217 ~~~~~~~lg~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 291 (536)
+....++||+|.||+|++|.|+. | ..||||.+...... ....|++|+.+|-+|+|||+++|||+..+ ..+.|||
T Consensus 111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ 189 (1039)
T KOG0199|consen 111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVF 189 (1039)
T ss_pred HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHh
Confidence 44567789999999999999863 4 46799999766544 67899999999999999999999999987 7899999
Q ss_pred eecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCC
Q 039168 292 EYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGN 371 (536)
Q Consensus 292 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 371 (536)
|+++.|+|.+.|.+ .....+-......++.||+.|+.||..++ +|||||...|+||-..-.|||+|||+.+.++.+
T Consensus 190 ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~n 265 (1039)
T KOG0199|consen 190 ELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGEN 265 (1039)
T ss_pred hhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCC
Confidence 99999999999987 45566888889999999999999999996 999999999999999999999999999998765
Q ss_pred CCcccc-ccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHHHHHhhcCCcccccc
Q 039168 372 QNQANT-NIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELID 449 (536)
Q Consensus 372 ~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 449 (536)
+..... ....-...|.|||.+....++.++|||+|||++|||+| |..||..... .. +++.+|
T Consensus 266 ed~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g---~q-------------IL~~iD 329 (1039)
T KOG0199|consen 266 EDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG---IQ-------------ILKNID 329 (1039)
T ss_pred CcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH---HH-------------HHHhcc
Confidence 543322 22233568999999999999999999999999999999 5566543211 11 122233
Q ss_pred ccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 450 PVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 450 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
..-+-..+....+++.+|+..||..+|++|||+..|.+.
T Consensus 330 ~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~ 368 (1039)
T KOG0199|consen 330 AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED 368 (1039)
T ss_pred ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence 222233455566788889999999999999999999743
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=290.51 Aligned_cols=242 Identities=25% Similarity=0.291 Sum_probs=184.0
Q ss_pred ccCCCCceeEEEEEeC-CCcEEEEEEccccCh---hhHHHHHHHHHHHHH---cCCCCceeEeeEEeeCceEEEEEeecC
Q 039168 223 KLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG---QGLKEFKNEVNLIAK---LQHKNLVRLLGCCLEGQELLLIYEYMP 295 (536)
Q Consensus 223 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~---l~hpniv~l~~~~~~~~~~~lv~e~~~ 295 (536)
.||+|+||.||++... +++.+|+|.+.+... .....+.+|..+++. .+|||++.+++.+...+..++||||+.
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999975 589999998865321 112234445444443 479999999999999999999999999
Q ss_pred CCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCCcc
Q 039168 296 NKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQA 375 (536)
Q Consensus 296 ~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 375 (536)
+++|..++... ..+++..+..++.|++.||.|||+.+ |+|+||||+|||+++++.++|+|||++.......
T Consensus 81 ~~~L~~~i~~~---~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--- 151 (279)
T cd05633 81 GGDLHYHLSQH---GVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (279)
T ss_pred CCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC---
Confidence 99999888543 35899999999999999999999997 9999999999999999999999999987654321
Q ss_pred ccccccccccccCcchhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccccccC
Q 039168 376 NTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQ 454 (536)
Q Consensus 376 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~ 454 (536)
.....|++.|+|||.+.+ ..++.++||||||+++|+|++|+.||......... . ....... ....+.
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~---~-~~~~~~~------~~~~~~- 219 (279)
T cd05633 152 -PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH---E-IDRMTLT------VNVELP- 219 (279)
T ss_pred -ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH---H-HHHHhhc------CCcCCc-
Confidence 122468999999999864 55899999999999999999999998643322111 1 1111000 011111
Q ss_pred CCCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHHH
Q 039168 455 SCAPDELLKFIHIGLLCVQQDPADRP-----TMSSVVVM 488 (536)
Q Consensus 455 ~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 488 (536)
.....++.+++.+||+.||++|| |++++++.
T Consensus 220 ---~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 220 ---DSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred ---cccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 11223456666799999999999 69999874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=294.70 Aligned_cols=256 Identities=26% Similarity=0.389 Sum_probs=193.1
Q ss_pred cCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC-hhhHHHHHHHHHHHHHcC-CCCceeEeeEEeeCceEEEEEe
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLKEFKNEVNLIAKLQ-HKNLVRLLGCCLEGQELLLIYE 292 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lv~e 292 (536)
++|+..++||+|+||.||++.+. +++.||+|++.... ......+.+|+.++.++. ||||+++++++..+...+++||
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 45677889999999999999875 58999999987543 234567889999999996 9999999999999999999999
Q ss_pred ecCCCChhhhhhc--ccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCC
Q 039168 293 YMPNKSLDVHLFD--ATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGG 370 (536)
Q Consensus 293 ~~~~~sL~~~l~~--~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 370 (536)
|+.. ++..+... ......+++..+..++.|++.||+|||+.. +++||||||+||+++.++.+||+|||++..+..
T Consensus 84 ~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 84 LMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred cccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 9864 44433211 122346899999999999999999999752 499999999999999999999999999986643
Q ss_pred CCCccccccccccccccCcchhcCC---CCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcccc
Q 039168 371 NQNQANTNIIAGTYGYMAPEYAMGG---IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVEL 447 (536)
Q Consensus 371 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 447 (536)
.... ....|++.|+|||++.+. .++.++||||||+++|+|++|+.||.... .......... .+..
T Consensus 161 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~~~~~~~-~~~~--- 228 (288)
T cd06616 161 SIAK---TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-----SVFDQLTQVV-KGDP--- 228 (288)
T ss_pred CCcc---ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-----hHHHHHhhhc-CCCC---
Confidence 2221 223578899999999876 68999999999999999999999976432 1111111111 1111
Q ss_pred ccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 448 IDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 448 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
+.+...........+.+++.+||+.||++|||+.+|++.
T Consensus 229 --~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 229 --PILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred --CcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111111111123356677779999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=291.86 Aligned_cols=244 Identities=29% Similarity=0.396 Sum_probs=190.3
Q ss_pred cCCCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEeecCCCCh
Q 039168 224 LGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSL 299 (536)
Q Consensus 224 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~~sL 299 (536)
||+|+||+||++... +++.||+|.+.... ......+.+|++++++++||||+++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999865 58999999986532 22344567899999999999999999999999999999999999999
Q ss_pred hhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCCcccccc
Q 039168 300 DVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNI 379 (536)
Q Consensus 300 ~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 379 (536)
..++..... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++....... ....
T Consensus 81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~ 153 (277)
T cd05577 81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKG 153 (277)
T ss_pred HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCC---cccc
Confidence 998865432 35899999999999999999999997 9999999999999999999999999987654321 1223
Q ss_pred ccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccccccCCCCHH
Q 039168 380 IAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQSCAPD 459 (536)
Q Consensus 380 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~ 459 (536)
..++..|+|||.+.+..++.++||||||+++|+|++|+.||............. . ... .. .... +..
T Consensus 154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~---~----~~~-~~-~~~~----~~~ 220 (277)
T cd05577 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELK---R----RTL-EM-AVEY----PDK 220 (277)
T ss_pred ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHH---h----ccc-cc-cccC----Ccc
Confidence 457889999999988889999999999999999999999986433321111110 0 000 00 0001 111
Q ss_pred HHHHHHHHHHhhcCCCCCCCC-----CHHHHHH
Q 039168 460 ELLKFIHIGLLCVQQDPADRP-----TMSSVVV 487 (536)
Q Consensus 460 ~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 487 (536)
....+.+++.+||+.||++|| ++.++++
T Consensus 221 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 221 FSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred CCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 123456667799999999999 6666764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=304.69 Aligned_cols=245 Identities=26% Similarity=0.366 Sum_probs=203.5
Q ss_pred hcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccCh--hhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEE
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG--QGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 291 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 291 (536)
...|.+.+.||+|.|+.|.++++. ++..||||.++++.. .....+.+|+++|+.|+|||||+++.+......+|+||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 357899999999999999999865 599999999987643 33456889999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCC
Q 039168 292 EYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGN 371 (536)
Q Consensus 292 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 371 (536)
||+.+|.+.+++..+.+ ..+..+..++.|+..|++|||++. |+|||||++||||+.+.++||+|||++..+...
T Consensus 135 eya~~ge~~~yl~~~gr---~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~ 208 (596)
T KOG0586|consen 135 EYASGGELFDYLVKHGR---MKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDYG 208 (596)
T ss_pred EeccCchhHHHHHhccc---chhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeeccc
Confidence 99999999999976554 667888999999999999999996 999999999999999999999999999987632
Q ss_pred CCccccccccccccccCcchhcCCCC-CccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccc
Q 039168 372 QNQANTNIIAGTYGYMAPEYAMGGIF-SIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDP 450 (536)
Q Consensus 372 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 450 (536)
......+|++.|.|||++.+..| ++++|+||+|+++|.|+.|..||+...-. ++-++
T Consensus 209 ---~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk-------------------~Lr~r 266 (596)
T KOG0586|consen 209 ---LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLK-------------------ELRPR 266 (596)
T ss_pred ---ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccc-------------------cccch
Confidence 33345789999999999999876 78999999999999999999998642211 11111
Q ss_pred cccCCC--CHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 451 VLKQSC--APDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 451 ~l~~~~--~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
.+...+ +..-..++-+|++++|-.+|.+|++++++.+
T Consensus 267 vl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 267 VLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred heeeeecccceeechhHHHHHHhhccCccccCCHHHhhh
Confidence 111111 1112235667777999999999999999874
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=296.38 Aligned_cols=247 Identities=28% Similarity=0.435 Sum_probs=193.1
Q ss_pred hcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEE
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 290 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 290 (536)
.+.|...+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+++++.++||||+++++++..++..++|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 356899999999999999999875 58999999886432 23446788999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCC
Q 039168 291 YEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGG 370 (536)
Q Consensus 291 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 370 (536)
+||+.+ ++.+++... ...+++..+..++.||+.||.|||+.+ ++|+||+|+||++++++.++|+|||++.....
T Consensus 94 ~e~~~g-~l~~~~~~~--~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 94 MEYCLG-SASDILEVH--KKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSP 167 (307)
T ss_pred HHhhCC-CHHHHHHHc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence 999975 555555332 235899999999999999999999986 99999999999999999999999999875432
Q ss_pred CCCccccccccccccccCcchhc---CCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcccc
Q 039168 371 NQNQANTNIIAGTYGYMAPEYAM---GGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVEL 447 (536)
Q Consensus 371 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 447 (536)
. ....+++.|+|||++. ...++.++||||||+++|+|++|+.||...... ...... .......
T Consensus 168 ~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~------~~~~~~-~~~~~~~- 233 (307)
T cd06607 168 A------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHI-AQNDSPT- 233 (307)
T ss_pred C------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHH------HHHHHH-hcCCCCC-
Confidence 2 2245788999999874 356889999999999999999999997432111 101110 0111111
Q ss_pred ccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 448 IDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 448 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
+. .......+.+++.+||+.||++|||+.+|+..
T Consensus 234 ----~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 234 ----LS---SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred ----CC---chhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 11 11123456777789999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=298.06 Aligned_cols=265 Identities=23% Similarity=0.346 Sum_probs=192.2
Q ss_pred hcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC--hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCc------
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQ------ 285 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~------ 285 (536)
-++|++.++||+|+||.||+|... +++.||||++.... ......+.+|++++++++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 357999999999999999999975 58999999886432 222345678999999999999999999987543
Q ss_pred --eEEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEeccc
Q 039168 286 --ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFG 363 (536)
Q Consensus 286 --~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg 363 (536)
..++||||+.+ +|..++.. ....+++.+++.++.||+.||.|||+++ ++|+||||+||+++.++.+||+|||
T Consensus 91 ~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg 164 (310)
T cd07865 91 KGSFYLVFEFCEH-DLAGLLSN--KNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFG 164 (310)
T ss_pred CceEEEEEcCCCc-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCC
Confidence 45999999965 67666643 2235899999999999999999999996 9999999999999999999999999
Q ss_pred CccccCCCCCc--cccccccccccccCcchhcCCC-CCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhh
Q 039168 364 TARIFGGNQNQ--ANTNIIAGTYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWC 440 (536)
Q Consensus 364 ~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 440 (536)
++..+...... .......++..|+|||.+.+.. ++.++||||||+++|+|++|+.||........ .........
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~---~~~~~~~~~ 241 (310)
T cd07865 165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQ---LTLISQLCG 241 (310)
T ss_pred CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhC
Confidence 99866433221 1112345688899999887654 78999999999999999999998754332111 111111100
Q ss_pred c--------CCccccccc-cccCCC---------CHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 441 E--------GHAVELIDP-VLKQSC---------APDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 441 ~--------~~~~~l~~~-~l~~~~---------~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
. .......+. ...... .......+.+++.+||+.||++|||++++++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 242 SITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred CCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 0 000000000 000000 00012345678889999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=293.27 Aligned_cols=260 Identities=25% Similarity=0.362 Sum_probs=193.9
Q ss_pred CccccccCCCCceeEEEEEeC-CCcEEEEEEccccC--hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEeec
Q 039168 218 FSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 294 (536)
Q Consensus 218 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 294 (536)
|++.+.||.|++|.||+|.+. +|+.||+|++.... ....+.+.+|+++++.++|||++++++++.+++..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 577889999999999999875 69999999986543 223456888999999999999999999999999999999999
Q ss_pred CCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCCc
Q 039168 295 PNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQ 374 (536)
Q Consensus 295 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 374 (536)
+ ++|..++..... ..+++..++.++.|+++||.|||+++ ++|+||+|+||+++.++.++|+|||++.........
T Consensus 81 ~-~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~ 155 (283)
T cd07835 81 D-LDLKKYMDSSPL-TGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT 155 (283)
T ss_pred C-cCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc
Confidence 5 688888754332 35899999999999999999999986 999999999999999999999999999765432211
Q ss_pred cccccccccccccCcchhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcC---------Cc
Q 039168 375 ANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEG---------HA 444 (536)
Q Consensus 375 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---------~~ 444 (536)
.....+++.|+|||++.+. .++.++||||||+++|+|++|+.||....... ..... ....... ..
T Consensus 156 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--~~~~~-~~~~~~~~~~~~~~~~~~ 230 (283)
T cd07835 156 --YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEID--QLFRI-FRTLGTPDEDVWPGVTSL 230 (283)
T ss_pred --cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHH-HHHhCCCChHHhhhhhhc
Confidence 1223468899999988764 47899999999999999999999975432211 11110 0000000 00
Q ss_pred cc-------cccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 445 VE-------LIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 445 ~~-------l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
.+ ...... ....+.....+.+++.+||+.||++|||++++++.
T Consensus 231 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 231 PDYKPTFPKWARQDL-SKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhhhhhcccccccch-hhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00 000000 00011112456778889999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=292.03 Aligned_cols=258 Identities=22% Similarity=0.285 Sum_probs=190.0
Q ss_pred CccccccCCCCceeEEEEEeC-CCcEEEEEEccccC-hhhHHHHHHHHHHHHHcC-CCCceeEeeEEeeC--ceEEEEEe
Q 039168 218 FSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLKEFKNEVNLIAKLQ-HKNLVRLLGCCLEG--QELLLIYE 292 (536)
Q Consensus 218 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~--~~~~lv~e 292 (536)
|++.++||+|+||.||++... +++.||+|++.... ........+|+.+++++. |||++++++++.+. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 567889999999999999875 58999999987542 222233457888999885 99999999999987 89999999
Q ss_pred ecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCC
Q 039168 293 YMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQ 372 (536)
Q Consensus 293 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 372 (536)
|+.+ +|.+.+... ...+++.+++.++.||+.||.|||+.+ ++|+||||+||+++. +.+||+|||++.......
T Consensus 81 ~~~~-~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 81 LMDM-NLYELIKGR--KRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred cCCc-cHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 9975 666666432 245899999999999999999999996 999999999999999 999999999998764332
Q ss_pred CccccccccccccccCcchhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHH-----------Hhh
Q 039168 373 NQANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWK-----------LWC 440 (536)
Q Consensus 373 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~-----------~~~ 440 (536)
.. ....++..|+|||.+.. ..++.++|||||||++|||++|..||....... ....... ...
T Consensus 154 ~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 227 (282)
T cd07831 154 PY---TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD---QIAKIHDVLGTPDAEVLKKFR 227 (282)
T ss_pred Cc---CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH---HHHHHHHHcCCCCHHHHHhhc
Confidence 21 22457889999997654 557899999999999999999999985432211 1111100 000
Q ss_pred cCCccccccccccC----CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 441 EGHAVELIDPVLKQ----SCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 441 ~~~~~~l~~~~l~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
.........+.... ...+.....+.+++.+||+++|++|||++++++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 228 KSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred ccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 00000000000000 0011224567888889999999999999999863
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=287.04 Aligned_cols=250 Identities=25% Similarity=0.414 Sum_probs=198.4
Q ss_pred CCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC--hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEee
Q 039168 217 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 293 (536)
Q Consensus 217 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 293 (536)
+|++.+.||+|+||.||++..+ ++..+|+|.+.... ....+.+.+|+++++.++||||+++++.+......++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4788899999999999999976 48899999986542 23346788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCC-eEEecccCccccCCCC
Q 039168 294 MPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMN-PKISDFGTARIFGGNQ 372 (536)
Q Consensus 294 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~-~kl~Dfg~a~~~~~~~ 372 (536)
+.+++|.+++.... ...+++..+..++.|+++||.|||+.+ ++|+||||+||++++++. +||+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 81 CDGGDLMKRINRQR-GVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred CCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 99999999886533 235789999999999999999999986 999999999999998864 6999999998765332
Q ss_pred CccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccccc
Q 039168 373 NQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVL 452 (536)
Q Consensus 373 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l 452 (536)
.. .....|++.|+|||.+.+..++.++|+||||+++|+|++|+.||.... ........ ........
T Consensus 157 ~~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~------~~~~~~~~-~~~~~~~~----- 222 (257)
T cd08225 157 EL--AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN------LHQLVLKI-CQGYFAPI----- 222 (257)
T ss_pred cc--ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc------HHHHHHHH-hcccCCCC-----
Confidence 21 222457889999999988889999999999999999999999975321 11111111 11111111
Q ss_pred cCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 453 KQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 453 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
.+.....+.+++.+||+.+|++|||+.++++.
T Consensus 223 ----~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 223 ----SPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred ----CCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 11112346677779999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=298.22 Aligned_cols=264 Identities=23% Similarity=0.347 Sum_probs=195.7
Q ss_pred HhcCCccccccCCCCceeEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHHHc-CCCCceeEeeEEeeC--ceE
Q 039168 214 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLKEFKNEVNLIAKL-QHKNLVRLLGCCLEG--QEL 287 (536)
Q Consensus 214 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~--~~~ 287 (536)
..++|++.+.||+|+||.||+|.+. +++.+|+|++... .......+.+|+.+++++ +||||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 4578999999999999999999976 5889999988542 223345677899999999 999999999998653 468
Q ss_pred EEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccc
Q 039168 288 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARI 367 (536)
Q Consensus 288 ~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 367 (536)
++||||+. ++|..++... .+++..++.++.||+.||.|||+.+ |+|+||||+||+++.++.+||+|||++..
T Consensus 85 ~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN----ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred EEEecccc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 99999997 4887777432 5788999999999999999999986 99999999999999999999999999987
Q ss_pred cCCCCCc---cccccccccccccCcchhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHH------
Q 039168 368 FGGNQNQ---ANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWK------ 437 (536)
Q Consensus 368 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~------ 437 (536)
+...... .......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||........ ......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~---~~~~~~~~~~~~ 233 (337)
T cd07852 157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQ---LEKIIEVIGPPS 233 (337)
T ss_pred cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCC
Confidence 6543321 12233568999999998865 4578999999999999999999999854322110 000000
Q ss_pred -----HhhcCCccccccccccC------CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 438 -----LWCEGHAVELIDPVLKQ------SCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 438 -----~~~~~~~~~l~~~~l~~------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
.+.......+++..... ...+.....+.+++.+||+.||++|||+.++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 234 AEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 00000000011000000 0001123456778889999999999999999965
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=288.07 Aligned_cols=249 Identities=27% Similarity=0.376 Sum_probs=201.7
Q ss_pred CCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC--hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEee
Q 039168 217 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 293 (536)
Q Consensus 217 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 293 (536)
+|++.++||+|++|.||++... +++.+++|.+.... ......+.+|+++++.++||||+++++++.+....++|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4788899999999999999865 58899999987542 33456778899999999999999999999999999999999
Q ss_pred cCCCChhhhhhccc-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCC
Q 039168 294 MPNKSLDVHLFDAT-RSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQ 372 (536)
Q Consensus 294 ~~~~sL~~~l~~~~-~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 372 (536)
+++++|..++.+.. ....+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 99999999886522 2345899999999999999999999987 999999999999999999999999999876543
Q ss_pred CccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccccc
Q 039168 373 NQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVL 452 (536)
Q Consensus 373 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l 452 (536)
......+++.|++||.+.+..++.++|+||||+++|+|++|+.||...... ... ..........
T Consensus 157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~------~~~-~~~~~~~~~~------ 220 (256)
T cd08530 157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ------DLR-YKVQRGKYPP------ 220 (256)
T ss_pred ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHH-HHHhcCCCCC------
Confidence 122245788999999999988999999999999999999999997543221 111 1111111111
Q ss_pred cCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 453 KQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 453 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
.......++.+++.+||+.+|++|||+.++++.
T Consensus 221 ---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 221 ---IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred ---CchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 112233557778889999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=303.56 Aligned_cols=261 Identities=22% Similarity=0.315 Sum_probs=195.0
Q ss_pred hcCCccccccCCCCceeEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeC-----ce
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEG-----QE 286 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-----~~ 286 (536)
..+|.+.+.||+|+||.||++.+. +++.||||++... .......+.+|+.+++.++||||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 467999999999999999999875 5899999998653 233345677899999999999999999987654 35
Q ss_pred EEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCcc
Q 039168 287 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTAR 366 (536)
Q Consensus 287 ~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 366 (536)
.++|+||+. ++|..++.. ...+++..+..++.||+.||.|||+++ ++|+||||+||+++.++.+||+|||++.
T Consensus 84 ~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRS---SQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred EEEEEeCCC-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 899999996 678777743 345899999999999999999999996 9999999999999999999999999998
Q ss_pred ccCCCCCccccccccccccccCcchhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhh-----
Q 039168 367 IFGGNQNQANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWC----- 440 (536)
Q Consensus 367 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~----- 440 (536)
...... .......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...... ...........
T Consensus 157 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~ 231 (337)
T cd07858 157 TTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYV---HQLKLITELLGSPSEE 231 (337)
T ss_pred ccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChH---HHHHHHHHHhCCCChH
Confidence 664322 11223457889999998865 46899999999999999999999998543211 11111111000
Q ss_pred ------cCCccccc-------cccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 441 ------EGHAVELI-------DPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 441 ------~~~~~~l~-------~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
........ +.... ...+.....+.+++.+||+.+|++|||++++++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 232 DLGFIRNEKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred HhhhcCchhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 00000000 00000 0011223456788889999999999999999976
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=287.60 Aligned_cols=242 Identities=24% Similarity=0.307 Sum_probs=192.8
Q ss_pred cCCCCceeEEEEEeCC-CcEEEEEEccccC---hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEeecCCCCh
Q 039168 224 LGQGGFGPVYKGTLAD-GKAIAVKRLSRTS---GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSL 299 (536)
Q Consensus 224 lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~~sL 299 (536)
||.|++|.||++++.. ++.||+|++.... ....+.+.+|+.+++.++||||+++++.+.++...++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 7999999999999864 8999999987543 23446788999999999999999999999999999999999999999
Q ss_pred hhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCCcccccc
Q 039168 300 DVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNI 379 (536)
Q Consensus 300 ~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 379 (536)
.+++... ..+++..+..++.||+.||.|||+.+ ++|+||||+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~ 151 (262)
T cd05572 81 WTILRDR---GLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWT 151 (262)
T ss_pred HHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cccc
Confidence 9998543 34889999999999999999999986 9999999999999999999999999998765432 1223
Q ss_pred ccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccccccCCCCHH
Q 039168 380 IAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQSCAPD 459 (536)
Q Consensus 380 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~ 459 (536)
..+++.|++||.+.+..++.++|+||||+++|+|++|..||....... .............. ..+..
T Consensus 152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~~~~~~~~~~~---------~~~~~ 218 (262)
T cd05572 152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP----MEIYNDILKGNGKL---------EFPNY 218 (262)
T ss_pred ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH----HHHHHHHhccCCCC---------CCCcc
Confidence 467899999999988889999999999999999999999986543211 11111111000000 11111
Q ss_pred HHHHHHHHHHhhcCCCCCCCCC-----HHHHHH
Q 039168 460 ELLKFIHIGLLCVQQDPADRPT-----MSSVVV 487 (536)
Q Consensus 460 ~~~~l~~li~~cl~~dP~~RPt-----~~evl~ 487 (536)
....+.+++.+||+.||++||| +.|+++
T Consensus 219 ~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 219 IDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred cCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 1345667777999999999999 677765
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=303.58 Aligned_cols=262 Identities=23% Similarity=0.328 Sum_probs=193.5
Q ss_pred hcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC-hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeC-----ceE
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEG-----QEL 287 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-----~~~ 287 (536)
.++|++.++||+|+||.||+|.+. +++.||||++.... ......+.+|+.++++++||||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 468999999999999999999865 58999999986432 23456678899999999999999999987654 358
Q ss_pred EEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccc
Q 039168 288 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARI 367 (536)
Q Consensus 288 ~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 367 (536)
++|+||+.+ +|...+. ...+++..++.++.||++||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 84 ~lv~e~~~~-~l~~~~~----~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 84 YIVQELMET-DLYKLIK----TQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred EEEehhccc-CHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceee
Confidence 999999975 6665553 235899999999999999999999997 99999999999999999999999999986
Q ss_pred cCCCCCcc-ccccccccccccCcchhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcc
Q 039168 368 FGGNQNQA-NTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAV 445 (536)
Q Consensus 368 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 445 (536)
........ ......|++.|+|||.+.+ ..++.++||||||+++|+|++|+.||....... ..............
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~---~~~~~~~~~~~~~~- 231 (336)
T cd07849 156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH---QLNLILGVLGTPSQ- 231 (336)
T ss_pred ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcCCCCH-
Confidence 54322211 1223467899999998765 468999999999999999999999985422110 00000000000000
Q ss_pred ccccc-----------ccc--CCC-----CHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 446 ELIDP-----------VLK--QSC-----APDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 446 ~l~~~-----------~l~--~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
+.++. ... ... .+.....+.+++.+||+.||++|||+.++++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 232 EDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000 000 000 01123456788889999999999999999986
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=296.82 Aligned_cols=261 Identities=24% Similarity=0.331 Sum_probs=191.6
Q ss_pred cccCCC--CceeEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEeecCC
Q 039168 222 NKLGQG--GFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPN 296 (536)
Q Consensus 222 ~~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 296 (536)
..||+| +||+||++++. .++.||+|++... .....+.+.+|+.+++.++||||+++++++..++..++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 457777 89999999975 6999999998643 233457788999999999999999999999999999999999999
Q ss_pred CChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCCcc-
Q 039168 297 KSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQA- 375 (536)
Q Consensus 297 ~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~- 375 (536)
++|..++.... ...+++..+..++.||+.||.|||+.+ ++||||||+|||++.++.++++||+.+..........
T Consensus 84 ~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 84 GSANSLLKTYF-PEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CCHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 99999886532 234889999999999999999999986 9999999999999999999999998654332211110
Q ss_pred ----ccccccccccccCcchhcCC--CCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHH-------------
Q 039168 376 ----NTNIIAGTYGYMAPEYAMGG--IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTW------------- 436 (536)
Q Consensus 376 ----~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~------------- 436 (536)
......++..|+|||++.+. .++.++||||||+++|+|++|+.||....... .......
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 237 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ--MLLQKLKGPPYSPLDITTFP 237 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHH--HHHHHhcCCCCCCccccccc
Confidence 01112345679999999764 47899999999999999999999986432211 0000000
Q ss_pred ---HHhh----------------cCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 437 ---KLWC----------------EGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 437 ---~~~~----------------~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
..+. ......+....+...........+.+++.+||+.||++|||+.++++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 238 CEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred hhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 0000 000000001111111122344567888899999999999999999843
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=287.28 Aligned_cols=250 Identities=25% Similarity=0.390 Sum_probs=194.0
Q ss_pred cCCccccccCCCCceeEEEEEeC-CCcEEEEEEcccc-----ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeC--ceE
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT-----SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEG--QEL 287 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~ 287 (536)
.+|++.+.||+|+||.||++.+. +++.||+|.+... .......+.+|++++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 47899999999999999999975 5899999987532 233456788999999999999999999998764 568
Q ss_pred EEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccc
Q 039168 288 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARI 367 (536)
Q Consensus 288 ~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 367 (536)
++++||+++++|.+++... ..+++..+..++.||+.||.|||+++ ++|+||||+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAY---GALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence 9999999999999888542 34789999999999999999999997 99999999999999999999999999986
Q ss_pred cCCCCC-ccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccc
Q 039168 368 FGGNQN-QANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVE 446 (536)
Q Consensus 368 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 446 (536)
...... ........++..|+|||.+.+..++.++||||||+++|+|++|+.||..... ..........+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~~~-- 227 (264)
T cd06653 156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA------MAAIFKIATQPTK-- 227 (264)
T ss_pred cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH------HHHHHHHHcCCCC--
Confidence 543211 1112234588999999999988899999999999999999999999753211 1111111111111
Q ss_pred cccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 447 LIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 447 l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
+.+ +......+.+++.+||+ +|..|||+.++++
T Consensus 228 ---~~~----p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 228 ---PML----PDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred ---CCC----CcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 111 11222345556669999 5799999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=282.67 Aligned_cols=251 Identities=23% Similarity=0.385 Sum_probs=203.0
Q ss_pred CCccccccCCCCceeEEEEEeC-CCcEEEEEEccccCh--hhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEee
Q 039168 217 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG--QGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 293 (536)
Q Consensus 217 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 293 (536)
+|++.+.||.|+||.||++.+. +++.|++|++..... .....+.+|+++++.++|||++++++.+......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4788899999999999999975 589999999876533 4567788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhccc-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCC
Q 039168 294 MPNKSLDVHLFDAT-RSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQ 372 (536)
Q Consensus 294 ~~~~sL~~~l~~~~-~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 372 (536)
+++++|..++.... ....+++..+..++.+++.||.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999886532 1356899999999999999999999996 9999999999999999999999999998765433
Q ss_pred CccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccccc
Q 039168 373 NQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVL 452 (536)
Q Consensus 373 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l 452 (536)
.......|++.|+|||.+.+..++.++||||+|+++++|++|+.||..... ...... ........+
T Consensus 158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~------~~~~~~-~~~~~~~~~----- 223 (258)
T cd08215 158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL------LELALK-ILKGQYPPI----- 223 (258)
T ss_pred --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH------HHHHHH-HhcCCCCCC-----
Confidence 122334688999999999988899999999999999999999999754321 111111 111111111
Q ss_pred cCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 453 KQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 453 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
.. .....+.+++.+||+.+|++|||+.++++.
T Consensus 224 ~~----~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 224 PS----QYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred CC----CCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 11 112346667779999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=291.44 Aligned_cols=260 Identities=17% Similarity=0.195 Sum_probs=181.6
Q ss_pred hcCCccccccCCCCceeEEEEEeCC----CcEEEEEEccccChhhH-----------HHHHHHHHHHHHcCCCCceeEee
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLAD----GKAIAVKRLSRTSGQGL-----------KEFKNEVNLIAKLQHKNLVRLLG 279 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~hpniv~l~~ 279 (536)
.++|++.++||+|+||.||+|...+ +..+|+|+......... .....+...+..++|++++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 4689999999999999999999754 45566665433221110 01123344556678999999999
Q ss_pred EEeeCc----eEEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCC
Q 039168 280 CCLEGQ----ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDM 355 (536)
Q Consensus 280 ~~~~~~----~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~ 355 (536)
++.... ..++++|++.. ++...+.. ....++..+..++.|+++||.|||+.+ |+||||||+|||++.++
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~ 163 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKR---IKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNN 163 (294)
T ss_pred eeeEecCCceEEEEEEehhcc-CHHHHHHh---hccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCC
Confidence 866543 44777887643 45444432 123578888999999999999999986 99999999999999999
Q ss_pred CeEEecccCccccCCCCCc-----cccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCch
Q 039168 356 NPKISDFGTARIFGGNQNQ-----ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQT 430 (536)
Q Consensus 356 ~~kl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~ 430 (536)
.++|+|||+++.+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||....... .
T Consensus 164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~--~ 241 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNG--N 241 (294)
T ss_pred cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccch--H
Confidence 9999999999876432211 11223469999999999999999999999999999999999999986542211 1
Q ss_pred hHHHHHHHhhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 039168 431 LLTYTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLA 490 (536)
Q Consensus 431 ~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 490 (536)
........+.. .+..........+ ..+.+++..|++.+|++||++.+|++.|.
T Consensus 242 ~~~~~~~~~~~----~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 242 LIHAAKCDFIK----RLHEGKIKIKNAN---KFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHHHhHHHHHH----HhhhhhhccCCCC---HHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 11111100000 0000101111123 34556666999999999999999999863
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=277.87 Aligned_cols=252 Identities=26% Similarity=0.399 Sum_probs=194.4
Q ss_pred cCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC-hhhHHHHHHHHHHHHHcC-CCCceeEeeEEeeCceEEEEEe
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLKEFKNEVNLIAKLQ-HKNLVRLLGCCLEGQELLLIYE 292 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lv~e 292 (536)
++.+.+..||.|..|.||+++.. .|..+|||.+.++. .+..+++...+.++..-+ +|.||+.+|+|..+...++.||
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe 171 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME 171 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence 34566778999999999999976 48999999998764 345677888888777665 8999999999999999999999
Q ss_pred ecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCC
Q 039168 293 YMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQ 372 (536)
Q Consensus 293 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 372 (536)
.| ..-++.++.+. ..+++|..+-++...+++||.||.+++ .|+|||+||+|||+|+.|++||+|||++..+-+..
T Consensus 172 lM-s~C~ekLlkri--k~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk 246 (391)
T KOG0983|consen 172 LM-STCAEKLLKRI--KGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK 246 (391)
T ss_pred HH-HHHHHHHHHHh--cCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccc
Confidence 88 44455555432 345888888899999999999999887 79999999999999999999999999998775443
Q ss_pred CccccccccccccccCcchhcC---CCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcccccc
Q 039168 373 NQANTNIIAGTYGYMAPEYAMG---GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELID 449 (536)
Q Consensus 373 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 449 (536)
... ...|-+.|||||.+.. ..|+.++||||||++++||.||+.||.....+- +.+. .... .+.
T Consensus 247 Aht---rsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdF--e~lt---kvln-~eP----- 312 (391)
T KOG0983|consen 247 AHT---RSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDF--EVLT---KVLN-EEP----- 312 (391)
T ss_pred ccc---cccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccH--HHHH---HHHh-cCC-----
Confidence 332 3478999999999964 358999999999999999999999986543321 1111 1111 111
Q ss_pred ccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 450 PVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 450 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
+.+.... .....+++++..||++|+.+||...++|+.
T Consensus 313 P~L~~~~--gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 313 PLLPGHM--GFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred CCCCccc--CcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 2222211 012345556669999999999999999864
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=293.29 Aligned_cols=261 Identities=25% Similarity=0.373 Sum_probs=192.3
Q ss_pred cCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccCh--hhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEe
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG--QGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 292 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 292 (536)
++|+..+.||+|++|.||+|.++ +++.||+|++..... ...+.+.+|++++++++||||+++++++..+...++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 57889999999999999999976 588999999865422 234568889999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcC-CCCeEEecccCccccCCC
Q 039168 293 YMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDD-DMNPKISDFGTARIFGGN 371 (536)
Q Consensus 293 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~-~~~~kl~Dfg~a~~~~~~ 371 (536)
|+++ +|..++... ....+++..++.++.||+.||+|||+++ ++|+||||+||+++. ++.+||+|||++......
T Consensus 82 ~~~~-~l~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 82 YLDL-DLKKHMDSS-PDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred cccc-cHHHHHHhC-CCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 9964 676666432 2234678889999999999999999986 999999999999985 557999999999765432
Q ss_pred CCccccccccccccccCcchhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcccccc-
Q 039168 372 QNQANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELID- 449 (536)
Q Consensus 372 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~- 449 (536)
.. ......+++.|+|||.+.+. .++.++||||||+++|+|++|+.||...... ..... ........ ......
T Consensus 157 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~--~~~~~-~~~~~~~~-~~~~~~~ 230 (294)
T PLN00009 157 VR--TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEI--DELFK-IFRILGTP-NEETWPG 230 (294)
T ss_pred cc--ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHH-HHHHhCCC-Chhhccc
Confidence 11 11223568899999998764 5789999999999999999999998643221 11111 10100000 000000
Q ss_pred -----------ccccC----CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 450 -----------PVLKQ----SCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 450 -----------~~l~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
+.... ...+.....+.+++.+||+.+|++||++.++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 231 VTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred cccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00000 001112234667778999999999999999996
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=294.59 Aligned_cols=249 Identities=28% Similarity=0.422 Sum_probs=193.5
Q ss_pred cCCccccccCCCCceeEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEE
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 291 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 291 (536)
+.|...+.||+|+||.||++... ++..||+|++... ..+....+.+|+++++.++|||++++++++.++...++||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 34788899999999999999975 5889999998643 2334567889999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCC
Q 039168 292 EYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGN 371 (536)
Q Consensus 292 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 371 (536)
||+.+ +|.+.+... ...+++.++..++.||+.||.|||+++ ++|+||+|+||+++.++.++|+|||++......
T Consensus 105 e~~~g-~l~~~~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (317)
T cd06635 105 EYCLG-SASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPA 178 (317)
T ss_pred eCCCC-CHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCCc
Confidence 99975 666665432 345899999999999999999999997 999999999999999999999999998754321
Q ss_pred CCccccccccccccccCcchhc---CCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccc
Q 039168 372 QNQANTNIIAGTYGYMAPEYAM---GGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELI 448 (536)
Q Consensus 372 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 448 (536)
....|++.|+|||++. ...++.++||||||+++|+|++|+.||...... ... ..+.......
T Consensus 179 ------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~------~~~-~~~~~~~~~~-- 243 (317)
T cd06635 179 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SAL-YHIAQNESPT-- 243 (317)
T ss_pred ------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH------HHH-HHHHhccCCC--
Confidence 2345788999999974 456899999999999999999999996432111 000 1111111100
Q ss_pred cccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcc
Q 039168 449 DPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 491 (536)
Q Consensus 449 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 491 (536)
... ......+.+++.+||+.+|.+|||+.++++.+-.
T Consensus 244 ---~~~---~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~ 280 (317)
T cd06635 244 ---LQS---NEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFV 280 (317)
T ss_pred ---CCC---ccccHHHHHHHHHHccCCcccCcCHHHHHhChhh
Confidence 111 1122345667779999999999999999986543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=281.50 Aligned_cols=247 Identities=28% Similarity=0.431 Sum_probs=200.2
Q ss_pred CCccccccCCCCceeEEEEEeC-CCcEEEEEEccccCh--hhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEee
Q 039168 217 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG--QGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 293 (536)
Q Consensus 217 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 293 (536)
+|++.+.||+|++|.||++... +++.|++|.+..... ...+.+.+|++++++++|||++++++++.++...+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4788899999999999999875 578999999876543 4567899999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCC
Q 039168 294 MPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQN 373 (536)
Q Consensus 294 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 373 (536)
+++++|.+++... ..+++..++.++.|++.||.+||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 81 ~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 81 AENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK 154 (254)
T ss_pred CCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence 9999999998543 45899999999999999999999986 99999999999999999999999999987654332
Q ss_pred ccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcccccccccc
Q 039168 374 QANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLK 453 (536)
Q Consensus 374 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~ 453 (536)
. .....++..|+|||.+.+..++.++||||||+++|+|++|+.|+..... ....+... ...... +.
T Consensus 155 ~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~------~~~~~~~~-~~~~~~-----~~ 220 (254)
T cd06627 155 D--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP------MAALFRIV-QDDHPP-----LP 220 (254)
T ss_pred c--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH------HHHHHHHh-ccCCCC-----CC
Confidence 2 2234678899999999888889999999999999999999999753221 11111111 111111 11
Q ss_pred CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 454 QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 454 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
. .....+.+++.+||+.+|++|||+.+++.
T Consensus 221 ~----~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 221 E----GISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred C----CCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 1 11234556777999999999999999984
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=290.95 Aligned_cols=247 Identities=24% Similarity=0.355 Sum_probs=195.2
Q ss_pred CccccccCCCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEeecCC
Q 039168 218 FSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPN 296 (536)
Q Consensus 218 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 296 (536)
|....+||+|+||.||++..+ +++.||+|++..........+.+|+.+++.++|||++++++.+...+..++||||+++
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 101 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 101 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCC
Confidence 344568999999999999875 6899999998765555567788999999999999999999999999999999999999
Q ss_pred CChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCCccc
Q 039168 297 KSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQAN 376 (536)
Q Consensus 297 ~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 376 (536)
++|.+++.. ..+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++........ .
T Consensus 102 ~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~ 172 (292)
T cd06657 102 GALTDIVTH----TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--R 172 (292)
T ss_pred CcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccc--c
Confidence 999987742 24789999999999999999999997 99999999999999999999999999876543221 1
Q ss_pred cccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccccccCCC
Q 039168 377 TNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQSC 456 (536)
Q Consensus 377 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~ 456 (536)
.....|++.|+|||.+.+..++.++|+||+|+++|+|++|..||...... ..... ...... +.+..
T Consensus 173 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~---~~~~~----~~~~~~-----~~~~~-- 238 (292)
T cd06657 173 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL---KAMKM----IRDNLP-----PKLKN-- 238 (292)
T ss_pred ccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHH----HHhhCC-----cccCC--
Confidence 22346789999999998888999999999999999999999997532211 11111 111000 00000
Q ss_pred CHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 457 APDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 457 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
.......+.+++.+||+.||.+||++.++++
T Consensus 239 ~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 239 LHKVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred cccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 0011223556667999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=300.33 Aligned_cols=265 Identities=21% Similarity=0.328 Sum_probs=196.1
Q ss_pred hcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC--hhhHHHHHHHHHHHHHcCCCCceeEeeEEee----CceE
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLE----GQEL 287 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~----~~~~ 287 (536)
..+|++.+.||+|++|.||++..+ +++.||+|++.... ......+.+|+.+|++++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 368999999999999999999975 58999999987542 2345677889999999999999999998763 3578
Q ss_pred EEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccc
Q 039168 288 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARI 367 (536)
Q Consensus 288 ~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 367 (536)
++||||+. ++|..++.. ...+++..++.++.||+.||.|||+++ |+||||||+||++++++.+||+|||++..
T Consensus 84 ~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 84 YVVMDLME-SDLHHIIHS---DQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred EEEEehhh-hhHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEeccccccee
Confidence 99999996 578888743 334899999999999999999999986 99999999999999999999999999976
Q ss_pred cCCCCCc--cccccccccccccCcchhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHh-----
Q 039168 368 FGGNQNQ--ANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLW----- 439 (536)
Q Consensus 368 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~----- 439 (536)
....... .......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||....... .........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~---~~~~~~~~~g~~~~ 233 (334)
T cd07855 157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVH---QLKLILSVLGSPSE 233 (334)
T ss_pred ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHH---HHHHHHHHhCCChh
Confidence 5432221 11123468899999999866 458999999999999999999999985422110 000000000
Q ss_pred ------hcCCccccccccc-cCCC-----CHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHh
Q 039168 440 ------CEGHAVELIDPVL-KQSC-----APDELLKFIHIGLLCVQQDPADRPTMSSVVVML 489 (536)
Q Consensus 440 ------~~~~~~~l~~~~l-~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 489 (536)
......+..+... .... .+.....+.+++.+||+.+|++|||+.+++...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~ 295 (334)
T cd07855 234 EVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHP 295 (334)
T ss_pred HhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhCh
Confidence 0000000000000 0000 011234577777899999999999999998743
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=294.20 Aligned_cols=265 Identities=23% Similarity=0.350 Sum_probs=194.4
Q ss_pred HHhcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC--hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCc----
Q 039168 213 EATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQ---- 285 (536)
Q Consensus 213 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~---- 285 (536)
...++|++.+.||+|+||.||+|.++ +++.||+|++.... ......+.+|++++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 34578999999999999999999986 58899999986543 223356778999999999999999999987654
Q ss_pred ------eEEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEE
Q 039168 286 ------ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKI 359 (536)
Q Consensus 286 ------~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl 359 (536)
..++|+||+++ ++...+... ...+++..++.++.||+.||.|||+.+ |+|+||||+||++++++.+||
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl 157 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKL 157 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEe
Confidence 79999999987 555555332 335899999999999999999999996 999999999999999999999
Q ss_pred ecccCccccCCCCCccccccccccccccCcchhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHH
Q 039168 360 SDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKL 438 (536)
Q Consensus 360 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 438 (536)
+|||++..+...... ......++..|+|||.+.+. .++.++||||||+++|+|++|+.||..... ..........
T Consensus 158 ~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~---~~~~~~~~~~ 233 (302)
T cd07864 158 ADFGLARLYNSEESR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE---LAQLELISRL 233 (302)
T ss_pred CcccccccccCCccc-ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHH
Confidence 999999876433321 11123457789999988654 578999999999999999999999753221 1111111111
Q ss_pred hhcCCc---cccc--------cc------cccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 439 WCEGHA---VELI--------DP------VLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 439 ~~~~~~---~~l~--------~~------~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
...... ..+. +. ...... ......+.+++.+||+.||.+|||+.++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 234 CGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEF-SFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred hCCCChhhcccccccccccccccccccccchhhhc-CCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 110000 0000 00 000000 0012356677779999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=289.69 Aligned_cols=269 Identities=30% Similarity=0.414 Sum_probs=204.9
Q ss_pred hcCCccccccCCCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHHc--CCCCceeEeeEEeeCc----eEE
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKL--QHKNLVRLLGCCLEGQ----ELL 288 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~hpniv~l~~~~~~~~----~~~ 288 (536)
.......+.||+|.||.||||.+. ++.||||++.. +..+.|.+|-+|.+.. +|+||+++++.-.... +++
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw 284 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW 284 (534)
T ss_pred CCchhhHHHhhcCccceeehhhcc-CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence 345667889999999999999994 59999999864 3446778888877764 8999999999877655 899
Q ss_pred EEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcC------CCCCeeeCCCCCCcEEEcCCCCeEEecc
Q 039168 289 LIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHED------SRLKIIHRDLKASNVLLDDDMNPKISDF 362 (536)
Q Consensus 289 lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~------~~~~ivH~Dikp~NIll~~~~~~kl~Df 362 (536)
||+||.+.|+|.++|..+ .++|....+++..+++||+|||+. ..+.|+|||||..||||.++++..|+||
T Consensus 285 LVt~fh~kGsL~dyL~~n----tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF 360 (534)
T KOG3653|consen 285 LVTEFHPKGSLCDYLKAN----TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF 360 (534)
T ss_pred EEeeeccCCcHHHHHHhc----cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence 999999999999999543 489999999999999999999963 3468999999999999999999999999
Q ss_pred cCccccCCCCCccccccccccccccCcchhcCCCC-C-----ccchHHHHHHHHHHHHhCCCCCC--------CCCc-cC
Q 039168 363 GTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIF-S-----IKSDVFSFGVLLLEIISGRKNNG--------FYFS-EH 427 (536)
Q Consensus 363 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~-----~~~DvwslG~il~elltg~~p~~--------~~~~-~~ 427 (536)
|+|..+............+||.+|||||++.+... . .+.||||+|.+||||++.-.... ..+. +-
T Consensus 361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ev 440 (534)
T KOG3653|consen 361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEV 440 (534)
T ss_pred ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHh
Confidence 99999876655555555789999999999977542 2 47899999999999998643321 1111 11
Q ss_pred C--chhHHHHHHHhhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccCCCC
Q 039168 428 G--QTLLTYTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSMT 495 (536)
Q Consensus 428 ~--~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 495 (536)
+ ..+.+.......+...+.+.+.... ...+.-+.+.+..||..||+-|.|+.=+-+.+......
T Consensus 441 G~hPt~e~mq~~VV~kK~RP~~p~~W~~----h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~ 506 (534)
T KOG3653|consen 441 GNHPTLEEMQELVVRKKQRPKIPDAWRK----HAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMML 506 (534)
T ss_pred cCCCCHHHHHHHHHhhccCCCChhhhhc----CccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhcc
Confidence 1 1111111122233333333333222 13345566777799999999999999999988876443
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=291.50 Aligned_cols=260 Identities=24% Similarity=0.338 Sum_probs=196.5
Q ss_pred CccccccCCCCceeEEEEEeC-CCcEEEEEEccccCh--hhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEeec
Q 039168 218 FSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG--QGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 294 (536)
Q Consensus 218 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 294 (536)
|+..+.||.|++|.||++... +++.+++|++..... .....+.+|++++++++||||+++++++..+...++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 567789999999999999875 689999999875432 24567888999999999999999999999999999999999
Q ss_pred CCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCCc
Q 039168 295 PNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQ 374 (536)
Q Consensus 295 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 374 (536)
++ +|..++.... ..+++..+..++.||++||.|||+++ ++|+||||+||+++.++.++|+|||.+........
T Consensus 81 ~~-~l~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~- 153 (283)
T cd05118 81 DT-DLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR- 153 (283)
T ss_pred CC-CHHHHHHhhc--ccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc-
Confidence 76 7777775422 45899999999999999999999996 99999999999999999999999999987654331
Q ss_pred cccccccccccccCcchhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcC---Ccccccc-
Q 039168 375 ANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEG---HAVELID- 449 (536)
Q Consensus 375 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~l~~- 449 (536)
......++..|+|||.+.+. .++.++||||||+++|+|++|+.||....... ............ ....+.+
T Consensus 154 -~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd05118 154 -PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEID---QLFKIFRTLGTPDPEVWPKFTSL 229 (283)
T ss_pred -cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcCCCchHhcccchhh
Confidence 11223578899999999876 78999999999999999999999875432211 111110100000 0000000
Q ss_pred ----------c--cccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 450 ----------P--VLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 450 ----------~--~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
. .......+....++.+++.+||+.||.+||++.+++..
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 230 ARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 0 00000111224567788889999999999999999863
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=305.48 Aligned_cols=257 Identities=25% Similarity=0.387 Sum_probs=199.7
Q ss_pred cCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC-hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeC------ceE
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEG------QEL 287 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~------~~~ 287 (536)
..|...+.||+|+||.||+|+.+ .|+.||||.+.... ....+..-+|+++|++|+|||||+++++=++. ...
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~ 92 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP 92 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence 34566789999999999999954 69999999987643 33456778899999999999999999986543 357
Q ss_pred EEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEc--CCCC--eEEeccc
Q 039168 288 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLD--DDMN--PKISDFG 363 (536)
Q Consensus 288 ~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~--~~~~--~kl~Dfg 363 (536)
.+|||||.+|+|...|.+......+++.+.+.++.++..||.|||+++ |+||||||.||++- ++|+ -||+|||
T Consensus 93 vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG 169 (732)
T KOG4250|consen 93 VLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFG 169 (732)
T ss_pred eEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccc
Confidence 899999999999999998888888999999999999999999999996 99999999999984 3344 6999999
Q ss_pred CccccCCCCCccccccccccccccCcchhc-CCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcC
Q 039168 364 TARIFGGNQNQANTNIIAGTYGYMAPEYAM-GGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEG 442 (536)
Q Consensus 364 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 442 (536)
.|+.+.++. ....++||..|++||+.. ...|+..+|.|||||++|+.+||..||......... ....|....++
T Consensus 170 ~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~--~~~~~~~~tkk 244 (732)
T KOG4250|consen 170 AARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNN--KEIMWHIITKK 244 (732)
T ss_pred ccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCcccc--chhhhhhhccC
Confidence 999886544 445679999999999998 478999999999999999999999999765544321 12222222221
Q ss_pred Cccccc--cc----------cc--cCCCCHHHHHHHHHHHHhhcCCCCCCCC
Q 039168 443 HAVELI--DP----------VL--KQSCAPDELLKFIHIGLLCVQQDPADRP 480 (536)
Q Consensus 443 ~~~~l~--~~----------~l--~~~~~~~~~~~l~~li~~cl~~dP~~RP 480 (536)
.-...+ .+ .+ .....+.....+-.....+|..+|++|.
T Consensus 245 p~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 245 PSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred CCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 111100 00 01 1122334445556666678899999998
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=292.12 Aligned_cols=263 Identities=20% Similarity=0.209 Sum_probs=191.2
Q ss_pred ccccccCCCCceeEEEEEeCCCcEEEEEEcccc--ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEeecCC
Q 039168 219 SDENKLGQGGFGPVYKGTLADGKAIAVKRLSRT--SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPN 296 (536)
Q Consensus 219 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 296 (536)
.+.+.+|.|+++.|+++.. +++.||||++... .....+.+.+|+++++.++||||+++++++.+.+..+++|||+.+
T Consensus 5 ~i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~ 83 (314)
T cd08216 5 LIGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY 83 (314)
T ss_pred hhhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCC
Confidence 3444555555555555554 6899999998754 345567899999999999999999999999999999999999999
Q ss_pred CChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCC---
Q 039168 297 KSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQN--- 373 (536)
Q Consensus 297 ~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~--- 373 (536)
++|..++.... ...+++..+..++.||++||.|||+++ |+|+||||+||+++.++.+||+|||.+..+.....
T Consensus 84 ~~l~~~l~~~~-~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~ 159 (314)
T cd08216 84 GSCEDLLKTHF-PEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR 159 (314)
T ss_pred CCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeecccccccc
Confidence 99999986532 234889999999999999999999996 99999999999999999999999999876532221
Q ss_pred --ccccccccccccccCcchhcCC--CCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHH----hhcC---
Q 039168 374 --QANTNIIAGTYGYMAPEYAMGG--IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKL----WCEG--- 442 (536)
Q Consensus 374 --~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~----~~~~--- 442 (536)
........++..|+|||++.+. .++.++||||||+++|+|++|+.||....... ......... +...
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 237 (314)
T cd08216 160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKVRGTVPCLLDKSTYP 237 (314)
T ss_pred ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhccCccccccCchh
Confidence 1111234567889999998763 58899999999999999999999986432111 111110000 0000
Q ss_pred ----Cccc----cccccc----cCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 443 ----HAVE----LIDPVL----KQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 443 ----~~~~----l~~~~l----~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
.... ..++.. ..........++.+++.+||+.||++|||+.++++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 238 LYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred hhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 0000 000000 001111223467788889999999999999999964
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=287.20 Aligned_cols=248 Identities=25% Similarity=0.339 Sum_probs=195.2
Q ss_pred cCCCCceeEEEEEeCC-CcEEEEEEccccCh---hhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEeecCCCCh
Q 039168 224 LGQGGFGPVYKGTLAD-GKAIAVKRLSRTSG---QGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSL 299 (536)
Q Consensus 224 lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~~sL 299 (536)
||+|+||.||++.+.. ++.+++|.+..... ...+.+.+|++++++++||||+++++.+..+...++++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999864 89999999875433 4456788999999999999999999999999999999999999999
Q ss_pred hhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCC------
Q 039168 300 DVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQN------ 373 (536)
Q Consensus 300 ~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~------ 373 (536)
..++.... .+++..++.++.||++||.|||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~l~~~~---~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 81 ASLLENVG---SLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred HHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 99985433 5899999999999999999999997 99999999999999999999999999876543221
Q ss_pred ccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcccccccccc
Q 039168 374 QANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLK 453 (536)
Q Consensus 374 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~ 453 (536)
........++..|+|||.+.+...+.++||||||+++|+|++|+.||...... ..... ...+.. ....
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~------~~~~~-~~~~~~-~~~~---- 222 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE------EIFQN-ILNGKI-EWPE---- 222 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH------HHHHH-HhcCCc-CCCc----
Confidence 11223356788999999998888999999999999999999999997543211 11111 111111 0000
Q ss_pred CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 454 QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 454 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
.. .....+.+++.+||+.+|++|||+.++.+.|+-.
T Consensus 223 --~~-~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~ 258 (265)
T cd05579 223 --DV-EVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHP 258 (265)
T ss_pred --cc-cCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCc
Confidence 00 0123456677799999999999997777666644
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=293.56 Aligned_cols=278 Identities=22% Similarity=0.316 Sum_probs=200.1
Q ss_pred HHHHhcCCccccccCCCCceeEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCc--
Q 039168 211 ALEATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQ-- 285 (536)
Q Consensus 211 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-- 285 (536)
+....++|++.+.||+|+||.||++... ++..||||++... .....+.+.+|+.++++++||||+++++++....
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89 (343)
T ss_pred hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence 3445788999999999999999999865 6899999998643 2233456889999999999999999999987653
Q ss_pred ----eEEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEec
Q 039168 286 ----ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISD 361 (536)
Q Consensus 286 ----~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~D 361 (536)
..++||||+ +++|..++.. ..+++..++.++.||++||.|||+.+ |+||||||+||+++.++.++|+|
T Consensus 90 ~~~~~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~d 161 (343)
T cd07880 90 DRFHDFYLVMPFM-GTDLGKLMKH----EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILD 161 (343)
T ss_pred cccceEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEee
Confidence 468999998 7788877742 35899999999999999999999987 99999999999999999999999
Q ss_pred ccCccccCCCCCccccccccccccccCcchhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHH-----
Q 039168 362 FGTARIFGGNQNQANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYT----- 435 (536)
Q Consensus 362 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~----- 435 (536)
||++...... .....+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||....... ......
T Consensus 162 fg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~--~~~~~~~~~~~ 234 (343)
T cd07880 162 FGLARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLD--QLMEIMKVTGT 234 (343)
T ss_pred cccccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhcCC
Confidence 9999865322 122456889999999876 458899999999999999999999986432110 000000
Q ss_pred -----HHHhhcCCccccccc--cccC----CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHH--HHhccCCCCCCCCCCC
Q 039168 436 -----WKLWCEGHAVELIDP--VLKQ----SCAPDELLKFIHIGLLCVQQDPADRPTMSSVV--VMLASDSMTIPQPTEP 502 (536)
Q Consensus 436 -----~~~~~~~~~~~l~~~--~l~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl--~~L~~~~~~~~~p~~p 502 (536)
...+........... .... ...+.....+.+++.+||+.||++|||+.+++ ..++....+...+..|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~~~~~~~~ 314 (343)
T cd07880 235 PSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPEDETEAP 314 (343)
T ss_pred CCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCcccccCCC
Confidence 000000000000000 0000 00011123467788899999999999999999 3344433333333333
Q ss_pred C
Q 039168 503 A 503 (536)
Q Consensus 503 ~ 503 (536)
+
T Consensus 315 ~ 315 (343)
T cd07880 315 P 315 (343)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=285.88 Aligned_cols=242 Identities=26% Similarity=0.300 Sum_probs=184.6
Q ss_pred ccCCCCceeEEEEEeC-CCcEEEEEEccccChh---hHHHHHHHH---HHHHHcCCCCceeEeeEEeeCceEEEEEeecC
Q 039168 223 KLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQ---GLKEFKNEV---NLIAKLQHKNLVRLLGCCLEGQELLLIYEYMP 295 (536)
Q Consensus 223 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~---~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 295 (536)
.||+|+||.||++... +++.||+|.+.+.... ....+..|. .+++...||+|+++++++...+..++||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999875 5889999998754221 112233443 34455689999999999999999999999999
Q ss_pred CCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCCcc
Q 039168 296 NKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQA 375 (536)
Q Consensus 296 ~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 375 (536)
+++|..++.. ...+++..+..++.|+++||.|||+.+ ++|+||||+||+++.++.+||+|||++..+....
T Consensus 81 g~~L~~~l~~---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--- 151 (278)
T cd05606 81 GGDLHYHLSQ---HGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (278)
T ss_pred CCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC---
Confidence 9999988843 345899999999999999999999986 9999999999999999999999999987654322
Q ss_pred ccccccccccccCcchhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccccccC
Q 039168 376 NTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQ 454 (536)
Q Consensus 376 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~ 454 (536)
.....|+..|+|||.+.++ .++.++||||+|+++|+|++|+.||.......... . ...... ....+..
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~---~-~~~~~~------~~~~~~~ 220 (278)
T cd05606 152 -PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE---I-DRMTLT------MAVELPD 220 (278)
T ss_pred -CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHH---H-HHHhhc------cCCCCCC
Confidence 1234689999999999754 58999999999999999999999986532221111 1 111000 0111111
Q ss_pred CCCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHHH
Q 039168 455 SCAPDELLKFIHIGLLCVQQDPADRP-----TMSSVVVM 488 (536)
Q Consensus 455 ~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 488 (536)
. ....+.+++.+||+.+|.+|| ++.++++.
T Consensus 221 ~----~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 221 S----FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred c----CCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 1 123466666799999999999 99999853
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=329.50 Aligned_cols=255 Identities=29% Similarity=0.425 Sum_probs=202.4
Q ss_pred hcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC--hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEE
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 291 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 291 (536)
+-+|.-..+||.|.||.||.|... +|.-.|+|.+.... ....+.+.+|..+|..++|||+|+++|+=.+.+..+|.|
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence 456777889999999999999864 58888999876432 344566789999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCC
Q 039168 292 EYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGN 371 (536)
Q Consensus 292 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 371 (536)
|||++|+|.+.+... ...++.....+..|++.|+.|||++| ||||||||.|||++.+|.+|++|||.|..+...
T Consensus 1314 EyC~~GsLa~ll~~g---ri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~ 1387 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHG---RIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNN 1387 (1509)
T ss_pred HHhccCcHHHHHHhc---chhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecCc
Confidence 999999999998543 23566666778899999999999998 999999999999999999999999999988655
Q ss_pred CCc--cccccccccccccCcchhcCC---CCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccc
Q 039168 372 QNQ--ANTNIIAGTYGYMAPEYAMGG---IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVE 446 (536)
Q Consensus 372 ~~~--~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 446 (536)
... .......||+.|||||++.+. +...+.|||||||++.||+||+.||...+.+-. ..|. ...+..++
T Consensus 1388 ~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~a---IMy~---V~~gh~Pq 1461 (1509)
T KOG4645|consen 1388 AQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWA---IMYH---VAAGHKPQ 1461 (1509)
T ss_pred hhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhH---HHhH---HhccCCCC
Confidence 311 122346799999999999764 467899999999999999999999876554321 1111 11222222
Q ss_pred cccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 039168 447 LIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLA 490 (536)
Q Consensus 447 l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 490 (536)
+ +.. ...+-.++++ .||+.||+.|.++.++++.=-
T Consensus 1462 ~-----P~~-ls~~g~dFle---~Cl~~dP~~Rw~~~qlle~~f 1496 (1509)
T KOG4645|consen 1462 I-----PER-LSSEGRDFLE---HCLEQDPKMRWTASQLLEHAF 1496 (1509)
T ss_pred C-----chh-hhHhHHHHHH---HHHhcCchhhhHHHHHHHhhc
Confidence 2 111 3444555665 999999999999999987643
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=287.05 Aligned_cols=249 Identities=26% Similarity=0.352 Sum_probs=199.2
Q ss_pred cCCccccccCCCCceeEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHHHcC-CCCceeEeeEEeeCceEEEE
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLKEFKNEVNLIAKLQ-HKNLVRLLGCCLEGQELLLI 290 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lv 290 (536)
++|.+.+.||+|+||.||++... +++.||+|++... .......+.+|++++++++ ||||+++++++..++..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46889999999999999999975 6899999998653 2233467888999999998 99999999999999999999
Q ss_pred EeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCC
Q 039168 291 YEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGG 370 (536)
Q Consensus 291 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 370 (536)
||++++++|.+++... ..+++..++.++.|++.||.+||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~~---~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 81 LEYAPNGELLQYIRKY---GSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EcCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 9999999999998543 35999999999999999999999986 99999999999999999999999999987654
Q ss_pred CCCc------------------cccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhH
Q 039168 371 NQNQ------------------ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLL 432 (536)
Q Consensus 371 ~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~ 432 (536)
.... .......++..|+|||.+.+..++.++||||||+++++|++|+.||..... .
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~ 228 (280)
T cd05581 155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE------Y 228 (280)
T ss_pred ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH------H
Confidence 3321 222334678899999999888899999999999999999999999764321 0
Q ss_pred HHHHHHhhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCH----HHHHH
Q 039168 433 TYTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTM----SSVVV 487 (536)
Q Consensus 433 ~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~----~evl~ 487 (536)
....... .... ..+......+.+++.+||+.+|++|||+ .++++
T Consensus 229 ~~~~~~~-~~~~----------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 229 LTFQKIL-KLEY----------SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred HHHHHHH-hcCC----------CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 1111111 0000 0111113346677779999999999999 77664
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=295.91 Aligned_cols=263 Identities=22% Similarity=0.284 Sum_probs=191.7
Q ss_pred hcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeC---------
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEG--------- 284 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--------- 284 (536)
..+|++.+.||.|+||.||+|... +++.||+|++........+.+.+|+++++.++||||+++++.+...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 368999999999999999999975 5899999998776656667888999999999999999999776543
Q ss_pred -----ceEEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcC-CCCeE
Q 039168 285 -----QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDD-DMNPK 358 (536)
Q Consensus 285 -----~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~-~~~~k 358 (536)
...++||||+. ++|..++.. ..+++..++.++.||++||.|||+.+ ++||||||+||+++. ++.+|
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~k 155 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQ----GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLK 155 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEE
Confidence 35899999997 477777632 34889999999999999999999987 999999999999984 55789
Q ss_pred EecccCccccCCCCCcc-ccccccccccccCcchhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHH
Q 039168 359 ISDFGTARIFGGNQNQA-NTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTW 436 (536)
Q Consensus 359 l~Dfg~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~ 436 (536)
|+|||++..+....... ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||........ ......
T Consensus 156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~--~~~~~~ 233 (342)
T cd07854 156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQ--MQLILE 233 (342)
T ss_pred ECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHH
Confidence 99999998654322111 1122357889999998755 5688999999999999999999999854321100 000000
Q ss_pred H----------HhhcCCccccccccccCCCC-----HHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 437 K----------LWCEGHAVELIDPVLKQSCA-----PDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 437 ~----------~~~~~~~~~l~~~~l~~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
. ...................+ +....++.+++.+||+.||++|||+.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 234 SVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred hcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 0 00000000000000000000 111245667888999999999999999984
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=275.23 Aligned_cols=251 Identities=22% Similarity=0.310 Sum_probs=194.8
Q ss_pred ccccCCCCceeEEEEE-eCCCcEEEEEEccccChhhHHHHHHHHHHHHHcC-CCCceeEeeEEeeCceEEEEEeecCCCC
Q 039168 221 ENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQ-HKNLVRLLGCCLEGQELLLIYEYMPNKS 298 (536)
Q Consensus 221 ~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lv~e~~~~~s 298 (536)
.+.||+|+|+.|-.+. ..+|.+||||++.+.......++.+|++++.+.+ |+||++++++|+++..+|||||-|.||+
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGp 162 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGP 162 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCch
Confidence 3579999999999886 5689999999999888788889999999999995 9999999999999999999999999999
Q ss_pred hhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCC---eEEecccCccccCCCC--C
Q 039168 299 LDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMN---PKISDFGTARIFGGNQ--N 373 (536)
Q Consensus 299 L~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~---~kl~Dfg~a~~~~~~~--~ 373 (536)
|..+|+.. ..+++.++.+++++|+.||.+||.+| |.|||+||+|||-.+..+ |||+||.+.--..... .
T Consensus 163 lLshI~~~---~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~s 236 (463)
T KOG0607|consen 163 LLSHIQKR---KHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCS 236 (463)
T ss_pred HHHHHHHh---hhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCCC
Confidence 99988654 44999999999999999999999998 999999999999976654 7999998875432211 1
Q ss_pred c---cccccccccccccCcchhc-----CCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCch--------hHHHHHH
Q 039168 374 Q---ANTNIIAGTYGYMAPEYAM-----GGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQT--------LLTYTWK 437 (536)
Q Consensus 374 ~---~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~--------~~~~~~~ 437 (536)
. ....+.+|+..|||||+.. ...|+.++|.||||||+|-||+|.+||-..-..+-.. =.+....
T Consensus 237 pastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFe 316 (463)
T KOG0607|consen 237 PASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFE 316 (463)
T ss_pred CCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHH
Confidence 1 1122357899999999763 2358999999999999999999999996543322110 0000111
Q ss_pred HhhcCCccccccccccCCCCHHH----HHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 438 LWCEGHAVELIDPVLKQSCAPDE----LLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 438 ~~~~~~~~~l~~~~l~~~~~~~~----~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
.+.++.. +++..+ .....+++...|..|+.+|.++..+++
T Consensus 317 sIQEGkY----------eFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 317 SIQEGKY----------EFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred HHhccCC----------cCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 1112211 122222 223445666888999999999999886
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=284.37 Aligned_cols=245 Identities=21% Similarity=0.241 Sum_probs=187.5
Q ss_pred cccCCCCceeEEEEEeC-CCcEEEEEEccccChh---hHHHHHHHHHH-HHHcCCCCceeEeeEEeeCceEEEEEeecCC
Q 039168 222 NKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQ---GLKEFKNEVNL-IAKLQHKNLVRLLGCCLEGQELLLIYEYMPN 296 (536)
Q Consensus 222 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~-l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 296 (536)
+.||+|+||.||+|... +++.||+|.+...... ....+..|..+ ....+|||++++++++..++..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 57999999999999875 5899999998754321 22334445444 4455899999999999999999999999999
Q ss_pred CChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCCccc
Q 039168 297 KSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQAN 376 (536)
Q Consensus 297 ~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 376 (536)
++|..++... ..+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 ~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------ 149 (260)
T cd05611 82 GDCASLIKTL---GGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------ 149 (260)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc------
Confidence 9999998543 35889999999999999999999986 99999999999999999999999999875432
Q ss_pred cccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccccccCCC
Q 039168 377 TNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQSC 456 (536)
Q Consensus 377 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~ 456 (536)
.....++..|+|||.+.+..++.++||||||+++|+|++|..||...... . .+......... .....
T Consensus 150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~-~~~~~~~~~~~--~~~~~---- 216 (260)
T cd05611 150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD------A-VFDNILSRRIN--WPEEV---- 216 (260)
T ss_pred cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH------H-HHHHHHhcccC--CCCcc----
Confidence 22345788999999998888999999999999999999999997532211 1 11111111110 00001
Q ss_pred CHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcc
Q 039168 457 APDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 491 (536)
Q Consensus 457 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 491 (536)
.......+.+++.+||+.||++|||+.++.+.|+-
T Consensus 217 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~ 251 (260)
T cd05611 217 KEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSH 251 (260)
T ss_pred cccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcC
Confidence 11122346667779999999999988777666654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=291.71 Aligned_cols=263 Identities=26% Similarity=0.352 Sum_probs=191.9
Q ss_pred hcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccChh--hHHHHHHHHHHHHHcCCCCceeEeeEEeeC-------
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQ--GLKEFKNEVNLIAKLQHKNLVRLLGCCLEG------- 284 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~------- 284 (536)
.++|++.++||+|+||.||+|.++ +++.+|||++...... ....+.+|+++++.++||||+++++++.+.
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 478999999999999999999975 5899999988644322 234567899999999999999999987543
Q ss_pred -ceEEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEeccc
Q 039168 285 -QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFG 363 (536)
Q Consensus 285 -~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg 363 (536)
..+++|+||+.+ +|...+.. ....+++..+..++.||++||.|||+++ ++|+||||+||++++++.++|+|||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLEN--PSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence 357999999976 45555533 2345899999999999999999999997 9999999999999999999999999
Q ss_pred CccccCCCCCcc---------ccccccccccccCcchhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHH
Q 039168 364 TARIFGGNQNQA---------NTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLT 433 (536)
Q Consensus 364 ~a~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~ 433 (536)
++.......... ......+++.|+|||.+.+. .++.++||||||+++|+|++|++||....... ...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~---~~~ 237 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDID---QLH 237 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHH---HHH
Confidence 998654322111 11224568889999988664 57899999999999999999999975432211 111
Q ss_pred HHHHHhhcCC---------cccc--------ccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 434 YTWKLWCEGH---------AVEL--------IDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 434 ~~~~~~~~~~---------~~~l--------~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
..+..+.... .... ..+.+... .......+.+++.+||+.||++|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 238 LIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEER-FGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHH-cccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 1111111000 0000 00000000 0111245777888999999999999999885
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=281.03 Aligned_cols=246 Identities=20% Similarity=0.229 Sum_probs=187.6
Q ss_pred HHHhcCCcccccc--CCCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHHc-CCCCceeEeeEEeeCceE
Q 039168 212 LEATNHFSDENKL--GQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLKEFKNEVNLIAKL-QHKNLVRLLGCCLEGQEL 287 (536)
Q Consensus 212 ~~~~~~~~~~~~l--g~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~ 287 (536)
....++|++.+.+ |+|+||.||++..+ +++.+|+|.+....... .|+.....+ +|||++++++.+...+..
T Consensus 10 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~~~~~ 84 (267)
T PHA03390 10 VQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTTLKGH 84 (267)
T ss_pred HHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEecCCee
Confidence 3445677777776 99999999999875 58889999886532211 122223222 799999999999999999
Q ss_pred EEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCC-CeEEecccCcc
Q 039168 288 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDM-NPKISDFGTAR 366 (536)
Q Consensus 288 ~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~-~~kl~Dfg~a~ 366 (536)
++||||+++++|.+++... ..+++.+++.++.||++||.|||+.+ ++||||||+||+++.++ .++|+|||++.
T Consensus 85 ~iv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~ 158 (267)
T PHA03390 85 VLIMDYIKDGDLFDLLKKE---GKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCK 158 (267)
T ss_pred EEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccce
Confidence 9999999999999998543 26899999999999999999999997 99999999999999998 99999999987
Q ss_pred ccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccc
Q 039168 367 IFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVE 446 (536)
Q Consensus 367 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 446 (536)
...... ...++..|+|||++.+..++.++||||||+++|+|++|+.||....... .....+... . .....
T Consensus 159 ~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~-~--~~~~~ 228 (267)
T PHA03390 159 IIGTPS------CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLESLLKR-Q--QKKLP 228 (267)
T ss_pred ecCCCc------cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHHHHHh-h--cccCC
Confidence 654221 2357899999999999899999999999999999999999986332221 011111110 0 00001
Q ss_pred cccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCC-HHHHHH
Q 039168 447 LIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPT-MSSVVV 487 (536)
Q Consensus 447 l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt-~~evl~ 487 (536)
. .......+.+++.+||+.+|.+||+ ++++++
T Consensus 229 ~---------~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 229 F---------IKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred c---------ccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 1 1122334666777999999999996 688874
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=298.22 Aligned_cols=262 Identities=23% Similarity=0.319 Sum_probs=198.0
Q ss_pred CCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC--hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCc-----eEE
Q 039168 217 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQ-----ELL 288 (536)
Q Consensus 217 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-----~~~ 288 (536)
+|++.+.||.|++|.||+|+.. +++.||||++.... ....+.+.+|+.+++.++||||+++++++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5788999999999999999976 48999999987643 344567889999999999999999999988775 789
Q ss_pred EEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCcccc
Q 039168 289 LIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIF 368 (536)
Q Consensus 289 lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 368 (536)
++|||+.+ +|..++... ..+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.++|+|||++...
T Consensus 81 lv~e~~~~-~l~~~l~~~---~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 81 IVTELMET-DLHKVIKSP---QPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred EEecchhh-hHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 99999974 787777432 36899999999999999999999997 999999999999999999999999999876
Q ss_pred CCCCC-ccccccccccccccCcchhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhc-----
Q 039168 369 GGNQN-QANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCE----- 441 (536)
Q Consensus 369 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----- 441 (536)
..... ........+++.|+|||.+.+. .++.++||||||+++|+|++|+.||....... ...........
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~ 230 (330)
T cd07834 154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYID---QLNLIVEVLGTPSEED 230 (330)
T ss_pred cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHH---HHHHHHHhcCCCChhH
Confidence 54321 0112234578899999999887 78999999999999999999999986443211 00000000000
Q ss_pred ------CCccccccccc-c-----CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 442 ------GHAVELIDPVL-K-----QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 442 ------~~~~~l~~~~l-~-----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
......+.... . ....+.....+.+++.+||+.+|++|||+.++++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 231 LKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred hhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 00000000000 0 00001123456677789999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=287.63 Aligned_cols=256 Identities=23% Similarity=0.318 Sum_probs=198.2
Q ss_pred CCccccccCCCCceeEEEEEe----CCCcEEEEEEccccC----hhhHHHHHHHHHHHHHc-CCCCceeEeeEEeeCceE
Q 039168 217 HFSDENKLGQGGFGPVYKGTL----ADGKAIAVKRLSRTS----GQGLKEFKNEVNLIAKL-QHKNLVRLLGCCLEGQEL 287 (536)
Q Consensus 217 ~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~ 287 (536)
+|++.+.||+|++|.||+++. .+++.||||.+.... ....+.+.+|++++.++ +||||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 477889999999999999974 257889999886432 22345678899999999 599999999999999999
Q ss_pred EEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccc
Q 039168 288 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARI 367 (536)
Q Consensus 288 ~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 367 (536)
++||||+.+++|..++... ..+++..+..++.|+++||.|||+.+ ++|+||||+||+++.++.++|+|||++..
T Consensus 81 ~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR---EHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEEecCCCCcHHHHHhhc---CCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccc
Confidence 9999999999999888542 35889999999999999999999986 99999999999999999999999999886
Q ss_pred cCCCCCccccccccccccccCcchhcCCC--CCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcc
Q 039168 368 FGGNQNQANTNIIAGTYGYMAPEYAMGGI--FSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAV 445 (536)
Q Consensus 368 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 445 (536)
+...... ......|+..|+|||.+.+.. .+.++||||||+++|+|++|..||....... ............
T Consensus 155 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~~~~~~~~~~~---- 227 (288)
T cd05583 155 FLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN--SQSEISRRILKS---- 227 (288)
T ss_pred ccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc--hHHHHHHHHHcc----
Confidence 6433221 122345789999999987765 7889999999999999999999975322111 111111111110
Q ss_pred ccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 446 ELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 446 ~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
....... ....+.+++.+||+.||++|||+.++.+.|+-.
T Consensus 228 ---~~~~~~~----~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 228 ---KPPFPKT----MSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred ---CCCCCcc----cCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 0111111 123455677799999999999999888887764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=319.38 Aligned_cols=255 Identities=23% Similarity=0.300 Sum_probs=205.0
Q ss_pred HHhcCCccccccCCCCceeEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEE
Q 039168 213 EATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELL 288 (536)
Q Consensus 213 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 288 (536)
-..++|+++++||+|+||.|..++.+ .++.||+|++.+. .......|..|-.+|..-+.+-|+.++..|+++.++|
T Consensus 72 l~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LY 151 (1317)
T KOG0612|consen 72 LKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLY 151 (1317)
T ss_pred CCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceE
Confidence 34579999999999999999999986 4889999999863 3344567899999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCcccc
Q 039168 289 LIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIF 368 (536)
Q Consensus 289 lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 368 (536)
+||||++||+|-.+|.+.. .+++..++.++..|+.||.-||+.| +|||||||+|||||..|++||+|||.+-.+
T Consensus 152 lVMdY~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGsClkm 225 (1317)
T KOG0612|consen 152 LVMDYMPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGSCLKM 225 (1317)
T ss_pred EEEecccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchhHHhc
Confidence 9999999999999995543 5999999999999999999999997 999999999999999999999999999887
Q ss_pred CCCCCccccccccccccccCcchhc----C-CCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCC
Q 039168 369 GGNQNQANTNIIAGTYGYMAPEYAM----G-GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGH 443 (536)
Q Consensus 369 ~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 443 (536)
..+... .....+|||-|++||++. + +.|++.+|+||+||++|||+.|.-||.. ..++.--.+......
T Consensus 226 ~~dG~V-~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa------dslveTY~KIm~hk~ 298 (1317)
T KOG0612|consen 226 DADGTV-RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA------DSLVETYGKIMNHKE 298 (1317)
T ss_pred CCCCcE-EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH------HHHHHHHHHHhchhh
Confidence 654433 344578999999999995 2 5699999999999999999999999742 233333333333333
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCC---HHHHHHH
Q 039168 444 AVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPT---MSSVVVM 488 (536)
Q Consensus 444 ~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt---~~evl~~ 488 (536)
...+.+... .+++...||. -|--+|+.|.. +.++-..
T Consensus 299 ~l~FP~~~~----VSeeakdLI~----~ll~~~e~RLgrngiedik~H 338 (1317)
T KOG0612|consen 299 SLSFPDETD----VSEEAKDLIE----ALLCDREVRLGRNGIEDIKNH 338 (1317)
T ss_pred hcCCCcccc----cCHHHHHHHH----HHhcChhhhcccccHHHHHhC
Confidence 333332111 3455566664 33468888888 8877653
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=295.16 Aligned_cols=265 Identities=22% Similarity=0.315 Sum_probs=194.4
Q ss_pred hcCCcc-ccccCCCCceeEEEEEeC-CCcEEEEEEccccChhh--------------HHHHHHHHHHHHHcCCCCceeEe
Q 039168 215 TNHFSD-ENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQG--------------LKEFKNEVNLIAKLQHKNLVRLL 278 (536)
Q Consensus 215 ~~~~~~-~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~hpniv~l~ 278 (536)
.++|.. .+.||.|+||+||+|.+. +++.||||++....... ...+.+|+++++.++||||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 356654 567999999999999975 58999999986542211 12467899999999999999999
Q ss_pred eEEeeCceEEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeE
Q 039168 279 GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPK 358 (536)
Q Consensus 279 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~k 358 (536)
+++..++..++||||+. ++|..++.. ...+++.....++.||+.||.|||+.+ ++|+||||+||+++.++.++
T Consensus 87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~k 159 (335)
T PTZ00024 87 DVYVEGDFINLVMDIMA-SDLKKVVDR---KIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICK 159 (335)
T ss_pred EEEecCCcEEEEEeccc-cCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEE
Confidence 99999999999999997 578877743 345899999999999999999999997 99999999999999999999
Q ss_pred EecccCccccCCCC------------CccccccccccccccCcchhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCc
Q 039168 359 ISDFGTARIFGGNQ------------NQANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFYFS 425 (536)
Q Consensus 359 l~Dfg~a~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~ 425 (536)
|+|||++....... .........+++.|+|||.+.+. .++.++||||||+++|+|++|+.||.....
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~ 239 (335)
T PTZ00024 160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE 239 (335)
T ss_pred ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 99999998664111 01111123467889999998764 468999999999999999999999864432
Q ss_pred cCCchhHHHHHHHhhcCCcc---cc--------ccccccC---CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHh
Q 039168 426 EHGQTLLTYTWKLWCEGHAV---EL--------IDPVLKQ---SCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 489 (536)
Q Consensus 426 ~~~~~~~~~~~~~~~~~~~~---~l--------~~~~l~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 489 (536)
. ................ .. ....... .........+.+++.+||+.+|++|||+.+++..-
T Consensus 240 ~---~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~ 314 (335)
T PTZ00024 240 I---DQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHE 314 (335)
T ss_pred H---HHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCc
Confidence 1 1111111111111000 00 0000000 00011134567788899999999999999999643
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=286.38 Aligned_cols=252 Identities=23% Similarity=0.315 Sum_probs=193.9
Q ss_pred CCccccccCCCCceeEEEEEe----CCCcEEEEEEccccC----hhhHHHHHHHHHHHHHc-CCCCceeEeeEEeeCceE
Q 039168 217 HFSDENKLGQGGFGPVYKGTL----ADGKAIAVKRLSRTS----GQGLKEFKNEVNLIAKL-QHKNLVRLLGCCLEGQEL 287 (536)
Q Consensus 217 ~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~ 287 (536)
+|++.+.||+|+||.||++.. .+|+.||+|++.... ....+.+.+|+.+++++ +||||+++++.+..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 478889999999999999986 368999999986532 22346678899999999 589999999999999999
Q ss_pred EEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccc
Q 039168 288 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARI 367 (536)
Q Consensus 288 ~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 367 (536)
++||||+++++|.+++... ..+++..+..++.||++||.|||+.+ ++||||||+|||++.++.+||+|||++..
T Consensus 81 ~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 81 HLILDYINGGELFTHLSQR---ERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 9999999999999998543 34889999999999999999999986 99999999999999999999999999987
Q ss_pred cCCCCCccccccccccccccCcchhcCC--CCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcc
Q 039168 368 FGGNQNQANTNIIAGTYGYMAPEYAMGG--IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAV 445 (536)
Q Consensus 368 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 445 (536)
....... ......|+..|+|||.+.+. .++.++||||||+++|+|++|+.||....... .............
T Consensus 155 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~--~~~~~~~~~~~~~--- 228 (290)
T cd05613 155 FHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN--SQAEISRRILKSE--- 228 (290)
T ss_pred ccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccc--cHHHHHHHhhccC---
Confidence 6433221 12234688999999998753 46889999999999999999999976422211 1111111111110
Q ss_pred ccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHHH
Q 039168 446 ELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRP-----TMSSVVVM 488 (536)
Q Consensus 446 ~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 488 (536)
+.. +......+.+++.+||+.||++|| ++.+++..
T Consensus 229 ----~~~----~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 229 ----PPY----PQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred ----CCC----CccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 001 111123455667799999999997 67777653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=285.04 Aligned_cols=259 Identities=24% Similarity=0.351 Sum_probs=191.9
Q ss_pred CccccccCCCCceeEEEEEeCC-CcEEEEEEccccCh--hhHHHHHHHHHHHHHc---CCCCceeEeeEEeeCce-----
Q 039168 218 FSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSG--QGLKEFKNEVNLIAKL---QHKNLVRLLGCCLEGQE----- 286 (536)
Q Consensus 218 ~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~hpniv~l~~~~~~~~~----- 286 (536)
|++.+.||+|+||.||+|+++. ++.||+|++..... .....+.+|+.+++++ +|||++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 5678899999999999999864 89999999874322 2234566788877766 59999999999988776
Q ss_pred EEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCcc
Q 039168 287 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTAR 366 (536)
Q Consensus 287 ~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 366 (536)
.+++|||+.+ +|..++.... ...+++..++.++.||+.||.|||+.+ ++|+||+|+||+++.++.+||+|||++.
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~-~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCP-KPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eEEEehhccc-CHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence 9999999975 7877775432 235899999999999999999999986 9999999999999999999999999998
Q ss_pred ccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccc
Q 039168 367 IFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVE 446 (536)
Q Consensus 367 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 446 (536)
.+...... ....++..|+|||.+.+..++.++||||||+++|+|++|++||...... .................
T Consensus 156 ~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~ 229 (287)
T cd07838 156 IYSFEMAL---TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEA---DQLDKIFDVIGLPSEEE 229 (287)
T ss_pred eccCCccc---ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChH---HHHHHHHHHcCCCChHh
Confidence 76433221 1234688999999999989999999999999999999999887542221 11111111000000000
Q ss_pred ----------ccccccc---CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 447 ----------LIDPVLK---QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 447 ----------l~~~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
.+..... ....+.....+.+++.+||+.||++||++.++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 230 WPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred cCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 0000000 0011122345677888999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=289.09 Aligned_cols=245 Identities=27% Similarity=0.433 Sum_probs=189.5
Q ss_pred CCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEe
Q 039168 217 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 292 (536)
Q Consensus 217 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 292 (536)
.|...++||+|+||.||+|+.. +++.|++|++.... ......+.+|+++++.++|||++++++++.+....++|||
T Consensus 22 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 101 (313)
T cd06633 22 IFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVME 101 (313)
T ss_pred HhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEe
Confidence 3677788999999999999875 58899999986432 2344568889999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCC
Q 039168 293 YMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQ 372 (536)
Q Consensus 293 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 372 (536)
|+.+ ++..++... ...+++..+..++.||+.||.|||+.+ ++|+||||+||+++.++.+||+|||++.....
T Consensus 102 ~~~~-~l~~~l~~~--~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-- 173 (313)
T cd06633 102 YCLG-SASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP-- 173 (313)
T ss_pred cCCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC--
Confidence 9965 666665432 235899999999999999999999997 99999999999999999999999999864321
Q ss_pred CccccccccccccccCcchhc---CCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcccccc
Q 039168 373 NQANTNIIAGTYGYMAPEYAM---GGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELID 449 (536)
Q Consensus 373 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 449 (536)
.....|+..|+|||++. ...++.++||||||+++|+|++|..|+..... ........ .......
T Consensus 174 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~------~~~~~~~~-~~~~~~~-- 240 (313)
T cd06633 174 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIA-QNDSPTL-- 240 (313)
T ss_pred ----CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHH-hcCCCCC--
Confidence 12346788999999984 45688999999999999999999999643221 11111111 1111111
Q ss_pred ccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 450 PVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 450 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
.....+ ..+.+++.+||+.+|.+||++.++++.
T Consensus 241 ---~~~~~~---~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 241 ---QSNEWT---DSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred ---CccccC---HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111111 235667779999999999999999954
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=298.81 Aligned_cols=253 Identities=30% Similarity=0.455 Sum_probs=203.7
Q ss_pred cCCccccccCCCCceeEEEEEeCC-CcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEeec
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 294 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 294 (536)
.+....++||-|-||.||.|.|+. .-.||||.++.+ ...+++|++|..+|+.++|||+|+++++|..+..+|||+|||
T Consensus 267 tdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM 345 (1157)
T KOG4278|consen 267 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFM 345 (1157)
T ss_pred hheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecc
Confidence 344556799999999999999975 678999998654 455789999999999999999999999999999999999999
Q ss_pred CCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCCc
Q 039168 295 PNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQ 374 (536)
Q Consensus 295 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 374 (536)
..|+|.++|.+..+ ..++....+.++.||..|+.||..+ ++|||||...|+||.++-.||++|||+++.+..+...
T Consensus 346 ~yGNLLdYLRecnr-~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYT 421 (1157)
T KOG4278|consen 346 CYGNLLDYLRECNR-SEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYT 421 (1157)
T ss_pred cCccHHHHHHHhch-hhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhhhcCCcee
Confidence 99999999987655 3467777889999999999999988 4999999999999999999999999999988655433
Q ss_pred cccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHHHHHhhcCCcccccccccc
Q 039168 375 ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLK 453 (536)
Q Consensus 375 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~ 453 (536)
.... ..-..-|.|||-+....++.|+|||+|||+|||+.| |..|+.. .++.+ +...+.++. +
T Consensus 422 AHAG-AKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPG------idlSq-VY~LLEkgy---------R 484 (1157)
T KOG4278|consen 422 AHAG-AKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPG------IDLSQ-VYGLLEKGY---------R 484 (1157)
T ss_pred cccC-ccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCC------ccHHH-HHHHHhccc---------c
Confidence 3221 122567999999999999999999999999999999 5555432 22222 222222222 2
Q ss_pred CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 039168 454 QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLA 490 (536)
Q Consensus 454 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 490 (536)
...+..+..++.+||+.||+.+|.+||++.|+.+-++
T Consensus 485 M~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafE 521 (1157)
T KOG4278|consen 485 MDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFE 521 (1157)
T ss_pred ccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHH
Confidence 2233334456788888999999999999999886543
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=278.70 Aligned_cols=257 Identities=26% Similarity=0.351 Sum_probs=195.7
Q ss_pred cCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccCh-hhHHHHHHHHHHHHH-cCCCCceeEeeEEeeCceEEEEEe
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG-QGLKEFKNEVNLIAK-LQHKNLVRLLGCCLEGQELLLIYE 292 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~-l~hpniv~l~~~~~~~~~~~lv~e 292 (536)
++.+.+..||.|+||+|+|-.++ .|+.+|||++..... .+.++++.|.+...+ -++||||+++|....++..|+.||
T Consensus 64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCME 143 (361)
T KOG1006|consen 64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICME 143 (361)
T ss_pred chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHH
Confidence 45566788999999999998875 599999999986654 556778888886544 478999999999999999999999
Q ss_pred ecCCCChhhhhhc--ccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCC
Q 039168 293 YMPNKSLDVHLFD--ATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGG 370 (536)
Q Consensus 293 ~~~~~sL~~~l~~--~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 370 (536)
+| ..||+.+-.. ..+...+++..+-+|..-.+.||.||.+.. +||||||||+|||++..|.+||+|||++..+.+
T Consensus 144 LM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~ 220 (361)
T KOG1006|consen 144 LM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD 220 (361)
T ss_pred HH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHH
Confidence 99 5566654322 233456889988899999999999998765 799999999999999999999999999987643
Q ss_pred CCCccccccccccccccCcchhcC--CCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccc
Q 039168 371 NQNQANTNIIAGTYGYMAPEYAMG--GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELI 448 (536)
Q Consensus 371 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 448 (536)
.- ..+.-+|-..|||||.+.. ..|+.+|||||||++|||+.||+.|+..+.+. ++.... ...+....+.
T Consensus 221 Si---AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~sv-----feql~~-Vv~gdpp~l~ 291 (361)
T KOG1006|consen 221 SI---AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSV-----FEQLCQ-VVIGDPPILL 291 (361)
T ss_pred HH---HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHH-----HHHHHH-HHcCCCCeec
Confidence 22 2223468889999999954 45999999999999999999999998766542 222221 1223332222
Q ss_pred cccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 449 DPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 449 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
.+.- .......++..+..||.+|-..||...+++++
T Consensus 292 ~~~~----~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 292 FDKE----CVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred Cccc----ccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 2111 11122345555669999999999999998854
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=289.45 Aligned_cols=248 Identities=29% Similarity=0.427 Sum_probs=192.5
Q ss_pred cCCccccccCCCCceeEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEE
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 291 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 291 (536)
+.|...+.||+|+||.||+|+.. ++..+|+|.+... .......+.+|+++++.++|||++++++++......++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 45778889999999999999975 5788999988642 3334567888999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCC
Q 039168 292 EYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGN 371 (536)
Q Consensus 292 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 371 (536)
||+. +++..++... ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 95 e~~~-~~l~~~~~~~--~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 168 (308)
T cd06634 95 EYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (308)
T ss_pred EccC-CCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence 9997 5676666432 234889999999999999999999986 999999999999999999999999998765321
Q ss_pred CCccccccccccccccCcchhc---CCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccc
Q 039168 372 QNQANTNIIAGTYGYMAPEYAM---GGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELI 448 (536)
Q Consensus 372 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 448 (536)
....+++.|+|||.+. ...++.++||||||+++|+|++|+.|+...... . ... .+.......
T Consensus 169 ------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---~---~~~-~~~~~~~~~-- 233 (308)
T cd06634 169 ------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM---S---ALY-HIAQNESPA-- 233 (308)
T ss_pred ------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH---H---HHH-HHhhcCCCC--
Confidence 2345788999999985 356788999999999999999999996432111 0 000 111111111
Q ss_pred cccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 039168 449 DPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLA 490 (536)
Q Consensus 449 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 490 (536)
... ......+.+++.+||+.+|++||++.++++..-
T Consensus 234 ---~~~---~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 234 ---LQS---GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred ---cCc---ccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence 111 112234566777999999999999999997643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=285.72 Aligned_cols=263 Identities=24% Similarity=0.282 Sum_probs=193.1
Q ss_pred CccccccCCCCceeEEEEEeC-CCcEEEEEEccccCh-hhHHHHHHHHHHHHHcC-CCCceeEeeEEeeCceEEEEEeec
Q 039168 218 FSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG-QGLKEFKNEVNLIAKLQ-HKNLVRLLGCCLEGQELLLIYEYM 294 (536)
Q Consensus 218 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lv~e~~ 294 (536)
|.+.+.||+|++|+||+|... +++.|+||++..... .......+|+..+++++ |||++++++++..++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 567889999999999999986 478999999865432 12234457999999999 999999999999999999999999
Q ss_pred CCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCCc
Q 039168 295 PNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQ 374 (536)
Q Consensus 295 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 374 (536)
+++|.+++.... ...+++..+..++.|++.+|.|||+++ ++|+||+|+||++++++.++|+|||++........
T Consensus 81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~- 154 (283)
T cd07830 81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP- 154 (283)
T ss_pred -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCC-
Confidence 778888775433 245899999999999999999999986 99999999999999999999999999986543222
Q ss_pred cccccccccccccCcchhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchh--------H--HHHHHHhhcCC
Q 039168 375 ANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTL--------L--TYTWKLWCEGH 443 (536)
Q Consensus 375 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~--------~--~~~~~~~~~~~ 443 (536)
.....++..|+|||++.+ ..++.++|+||||+++++|++|+.||........... . .+.........
T Consensus 155 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07830 155 --YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK 232 (283)
T ss_pred --cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence 122457889999998854 4578999999999999999999998754322110000 0 00000000000
Q ss_pred cccccccccc---CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 444 AVELIDPVLK---QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 444 ~~~l~~~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
+...+..... ....+.....+.+++.+||+.||++|||+.|++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 0000000000 00001113457788889999999999999999864
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=285.74 Aligned_cols=252 Identities=26% Similarity=0.388 Sum_probs=190.5
Q ss_pred cCCccccccCCCCceeEEEEEeCC-CcEEEEEEccccC-hhhHHHHHHHHHHHHHcC-CCCceeEeeEEeeCceEEEEEe
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTS-GQGLKEFKNEVNLIAKLQ-HKNLVRLLGCCLEGQELLLIYE 292 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lv~e 292 (536)
++|++.+.||+|++|.||+|.+.+ ++.||||++.... ......+..|+.++.++. ||||+++++++.++...+++||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 678999999999999999999865 8999999987543 233455667777776665 9999999999999999999999
Q ss_pred ecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCC
Q 039168 293 YMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQ 372 (536)
Q Consensus 293 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 372 (536)
|+.+ ++..++... ...+++..+..++.||+.||.|||+.. +|+||||+|+||++++++.+||+|||++..+....
T Consensus 95 ~~~~-~l~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~ 169 (296)
T cd06618 95 LMST-CLDKLLKRI--QGPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK 169 (296)
T ss_pred ccCc-CHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhccCCC
Confidence 9854 666655432 236899999999999999999999742 49999999999999999999999999998664322
Q ss_pred CccccccccccccccCcchhcCCC----CCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccc
Q 039168 373 NQANTNIIAGTYGYMAPEYAMGGI----FSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELI 448 (536)
Q Consensus 373 ~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 448 (536)
.. ....++..|+|||.+.+.. ++.++||||||+++|+|++|+.||...... .......... ....+
T Consensus 170 ~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~~~~~~~-~~~~~- 239 (296)
T cd06618 170 AK---TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-----FEVLTKILQE-EPPSL- 239 (296)
T ss_pred cc---cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-----HHHHHHHhcC-CCCCC-
Confidence 21 1234678999999987553 789999999999999999999997532111 1111111111 11111
Q ss_pred cccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 449 DPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 449 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
.... .....+.+++.+||+.||++|||+.++++.
T Consensus 240 ----~~~~--~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 240 ----PPNE--GFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred ----CCCC--CCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0000 112346677779999999999999999865
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=284.19 Aligned_cols=261 Identities=27% Similarity=0.348 Sum_probs=196.4
Q ss_pred CccccccCCCCceeEEEEEeC-CCcEEEEEEccccC--hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEeec
Q 039168 218 FSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 294 (536)
Q Consensus 218 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 294 (536)
|+..+.||+|++|.||+|+.. +++.||+|++.... ....+.+.+|+.++++++|||++++++++.+....++|+||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 566789999999999999976 48999999987653 333467788999999999999999999999999999999999
Q ss_pred CCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCCc
Q 039168 295 PNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQ 374 (536)
Q Consensus 295 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 374 (536)
+ ++|.+++.... ..+++..++.++.|++.||.|||+++ |+|+||+|+||++++++.++|+|||++.........
T Consensus 81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 154 (282)
T cd07829 81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT 154 (282)
T ss_pred C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCccc
Confidence 8 58988886532 35899999999999999999999997 999999999999999999999999999876433221
Q ss_pred cccccccccccccCcchhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchh--------HHHHHHHhhcC---
Q 039168 375 ANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTL--------LTYTWKLWCEG--- 442 (536)
Q Consensus 375 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~--------~~~~~~~~~~~--- 442 (536)
.....++..|+|||.+.+. .++.++||||||+++|||++|+.||........... ....|..+..-
T Consensus 155 --~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
T cd07829 155 --YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDY 232 (282)
T ss_pred --cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccc
Confidence 1223457789999999776 789999999999999999999988754321110000 00011111000
Q ss_pred --CccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 443 --HAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 443 --~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
........... ...+.....+.+++.+||+.||++||++.+++.
T Consensus 233 ~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 233 KPTFPKFPPKDLE-KVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred cccccccCccchH-HhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 00000000000 001111346778888999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=289.67 Aligned_cols=264 Identities=22% Similarity=0.363 Sum_probs=194.2
Q ss_pred HHHhcCCccccccCCCCceeEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHHHcCCCCceeEeeEEee-CceE
Q 039168 212 LEATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLE-GQEL 287 (536)
Q Consensus 212 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~ 287 (536)
...+++|++.+.||+|+||.||++... +++.||+|++... .....+.+.+|+++++.++||||+++++++.. ....
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 345788999999999999999999865 6899999988643 22334678899999999999999999999875 5678
Q ss_pred EEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccc
Q 039168 288 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARI 367 (536)
Q Consensus 288 ~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 367 (536)
++++||+ +++|..++.. ..+++..+..++.||++||.|||+.+ ++|+||||+||++++++.++|+|||++..
T Consensus 86 ~lv~e~~-~~~L~~~~~~----~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~ 157 (328)
T cd07856 86 YFVTELL-GTDLHRLLTS----RPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI 157 (328)
T ss_pred EEEeehh-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccc
Confidence 9999998 5678777632 34788888999999999999999996 99999999999999999999999999875
Q ss_pred cCCCCCccccccccccccccCcchhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhH--------HHHHHH
Q 039168 368 FGGNQNQANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLL--------TYTWKL 438 (536)
Q Consensus 368 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~--------~~~~~~ 438 (536)
.... .....+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||............ ......
T Consensus 158 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (328)
T cd07856 158 QDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINT 232 (328)
T ss_pred cCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 4321 122356889999998766 56899999999999999999999998543321100000 000000
Q ss_pred hhcCCcccccccc-ccCCCCH-----HHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 439 WCEGHAVELIDPV-LKQSCAP-----DELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 439 ~~~~~~~~l~~~~-l~~~~~~-----~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
+......+.+... .....+. .....+.+++.+||+.+|++|||+.+++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 233 ICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred ccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000110000 0000111 112456677789999999999999999765
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=292.58 Aligned_cols=252 Identities=25% Similarity=0.431 Sum_probs=199.7
Q ss_pred CCccccccCCCCceeEEEEEeC---CCc--EEEEEEccc-cChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEE
Q 039168 217 HFSDENKLGQGGFGPVYKGTLA---DGK--AIAVKRLSR-TSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 290 (536)
Q Consensus 217 ~~~~~~~lg~G~~g~Vy~~~~~---~~~--~vavK~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 290 (536)
.-...+.||+|-||.||+|... .|+ .||||.-+. ...+..+.|..|..+|++++||||++++|++.+ ...|+|
T Consensus 390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wiv 468 (974)
T KOG4257|consen 390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIV 468 (974)
T ss_pred hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEE
Confidence 3345678999999999999853 333 578887765 345567889999999999999999999999986 478999
Q ss_pred EeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCC
Q 039168 291 YEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGG 370 (536)
Q Consensus 291 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 370 (536)
||+++-|.|..+|...+ ..++......++.||..||.|||+. +.|||||...||||....-|||+|||+++.+.+
T Consensus 469 mEL~~~GELr~yLq~nk--~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed 543 (974)
T KOG4257|consen 469 MELAPLGELREYLQQNK--DSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSRYLED 543 (974)
T ss_pred EecccchhHHHHHHhcc--ccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhhhccc
Confidence 99999999999996533 4588889999999999999999998 599999999999999999999999999998876
Q ss_pred CCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHHHHHhhcCCcccccc
Q 039168 371 NQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELID 449 (536)
Q Consensus 371 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 449 (536)
+..-... ...-..-|||||.+.-..++.++|||-|||.+||++. |..||..-... ++.-.+.
T Consensus 544 ~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNs----------------DVI~~iE 606 (974)
T KOG4257|consen 544 DAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNS----------------DVIGHIE 606 (974)
T ss_pred cchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccccc----------------ceEEEec
Confidence 6544333 2223567999999999999999999999999999987 78886432111 1111112
Q ss_pred ccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcc
Q 039168 450 PVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 491 (536)
Q Consensus 450 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 491 (536)
..-+...++.....|..|+.+||..||.+||++.+|...|+.
T Consensus 607 nGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsd 648 (974)
T KOG4257|consen 607 NGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSD 648 (974)
T ss_pred CCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHH
Confidence 212222333444457788889999999999999999877754
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=287.15 Aligned_cols=262 Identities=25% Similarity=0.313 Sum_probs=194.0
Q ss_pred hHHHHhcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC--hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeC--
Q 039168 210 LALEATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEG-- 284 (536)
Q Consensus 210 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-- 284 (536)
.+....++|.+.+.||+|+||.||++.+. +++.||+|++.... ....+.+.+|+.++++++||||+++++++...
T Consensus 11 ~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~ 90 (345)
T cd07877 11 TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS 90 (345)
T ss_pred HHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccc
Confidence 34567789999999999999999999864 68999999987542 22346678899999999999999999988643
Q ss_pred ----ceEEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEe
Q 039168 285 ----QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKIS 360 (536)
Q Consensus 285 ----~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~ 360 (536)
...+++++++ +++|..++.. ..+++..++.++.||++||+|||+.+ |+||||||+||++++++.+||+
T Consensus 91 ~~~~~~~~lv~~~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~ 162 (345)
T cd07877 91 LEEFNDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKIL 162 (345)
T ss_pred ccccccEEEEehhc-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEEEe
Confidence 3478888887 7788877642 24899999999999999999999997 9999999999999999999999
Q ss_pred cccCccccCCCCCccccccccccccccCcchhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHh
Q 039168 361 DFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLW 439 (536)
Q Consensus 361 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 439 (536)
|||++...... .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||....... .........
T Consensus 163 dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~---~~~~~~~~~ 234 (345)
T cd07877 163 DFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID---QLKLILRLV 234 (345)
T ss_pred ccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHh
Confidence 99998764321 123457889999999876 468899999999999999999999975322211 111000000
Q ss_pred hcCCccccc---------------cccccCCC---CHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 440 CEGHAVELI---------------DPVLKQSC---APDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 440 ~~~~~~~l~---------------~~~l~~~~---~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
......+. ........ .......+.+++.+||+.||.+|||+.++++.
T Consensus 235 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 235 -GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred -CCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 00000000 00000000 00012346677789999999999999999865
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=286.32 Aligned_cols=260 Identities=25% Similarity=0.294 Sum_probs=188.9
Q ss_pred CCccccccCCCCceeEEEEEeC-C--CcEEEEEEcccc--ChhhHHHHHHHHHHHHHc-CCCCceeEeeEEeeC----ce
Q 039168 217 HFSDENKLGQGGFGPVYKGTLA-D--GKAIAVKRLSRT--SGQGLKEFKNEVNLIAKL-QHKNLVRLLGCCLEG----QE 286 (536)
Q Consensus 217 ~~~~~~~lg~G~~g~Vy~~~~~-~--~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~----~~ 286 (536)
+|++.+.||+|+||.||++... . +..||+|++... .....+.+.+|+.+++++ +||||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4788899999999999999975 3 788999998643 222345678899999999 599999999875432 45
Q ss_pred EEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCcc
Q 039168 287 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTAR 366 (536)
Q Consensus 287 ~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 366 (536)
.++++||+. ++|..++.. ...+++..+..++.||+.||.|||+++ ++||||||+|||++.++.+||+|||+++
T Consensus 81 ~~~~~e~~~-~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 81 LYLYEELME-ADLHQIIRS---GQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEEEEeccc-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 789999986 578877743 345899999999999999999999997 9999999999999999999999999998
Q ss_pred ccCCCCCc--cccccccccccccCcchhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHH-------
Q 039168 367 IFGGNQNQ--ANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTW------- 436 (536)
Q Consensus 367 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~------- 436 (536)
.+...... .......|++.|+|||.+.+ ..++.++||||||+++|+|++|+.||....... ......
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~ 230 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVD---QLNQILQVLGTPD 230 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHH---HHHHHHHHhCCCC
Confidence 76532221 11223468999999998766 468999999999999999999999976432110 000000
Q ss_pred ----HHhhcCCcc-------ccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 437 ----KLWCEGHAV-------ELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 437 ----~~~~~~~~~-------~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
..+...... ......+. ...+.....+.+++.+||+.||++|||+.+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 231 EETLSRIGSPKAQNYIRSLPNIPKKPFE-SIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HHHHHhhhhhhHHHHHHhccccCCcchH-hhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000000000 00000000 000111245667778999999999999999874
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=280.07 Aligned_cols=250 Identities=26% Similarity=0.369 Sum_probs=191.8
Q ss_pred CCccccccCCCCceeEEEEEeCC-CcEEEEEEcccc-----ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEE
Q 039168 217 HFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRT-----SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 290 (536)
Q Consensus 217 ~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 290 (536)
+|.+.++||+|+||.||++.+.. +..+++|.+... .......+..|+.+++.++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 57888999999999999998754 444555554321 122334577899999999999999999999999999999
Q ss_pred EeecCCCChhhhhhcc-cCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccC
Q 039168 291 YEYMPNKSLDVHLFDA-TRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFG 369 (536)
Q Consensus 291 ~e~~~~~sL~~~l~~~-~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 369 (536)
+||+++++|..++... .....+++..++.++.|++.||.|||+.+ ++|+||||+||++++ +.++|+|||++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999999888642 23346899999999999999999999986 999999999999975 569999999997764
Q ss_pred CCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcccccc
Q 039168 370 GNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELID 449 (536)
Q Consensus 370 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 449 (536)
.... ......|++.|+|||.+.+..++.++|+||||+++|+|++|+.||.... ....... ...+....
T Consensus 157 ~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~------~~~~~~~-~~~~~~~~--- 224 (260)
T cd08222 157 GSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN------FLSVVLR-IVEGPTPS--- 224 (260)
T ss_pred CCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc------HHHHHHH-HHcCCCCC---
Confidence 3222 1223457889999999988888999999999999999999999974211 1111111 11111111
Q ss_pred ccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 450 PVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 450 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
.+......+.+++.+||+.||++||++.++++.
T Consensus 225 ------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 225 ------LPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred ------CcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 112223456677779999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=288.64 Aligned_cols=263 Identities=25% Similarity=0.354 Sum_probs=192.3
Q ss_pred HHhcCCccccccCCCCceeEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeC-----
Q 039168 213 EATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEG----- 284 (536)
Q Consensus 213 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~----- 284 (536)
+..++|...+.||+|+||.||+|.+. +++.||||++... .......+.+|+.+++.++||||+++++++...
T Consensus 12 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 91 (342)
T cd07879 12 ELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDE 91 (342)
T ss_pred ccccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCC
Confidence 34578999999999999999999975 6899999998653 222345678999999999999999999998754
Q ss_pred -ceEEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEeccc
Q 039168 285 -QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFG 363 (536)
Q Consensus 285 -~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg 363 (536)
...++|+||+.. +|..++ ...+++..+..++.|++.||.|||+++ ++||||||+|||++.++.+||+|||
T Consensus 92 ~~~~~lv~e~~~~-~l~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg 162 (342)
T cd07879 92 FQDFYLVMPYMQT-DLQKIM-----GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFG 162 (342)
T ss_pred CceEEEEeccccc-CHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCC
Confidence 356999999864 565544 124889999999999999999999986 9999999999999999999999999
Q ss_pred CccccCCCCCccccccccccccccCcchhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHH----
Q 039168 364 TARIFGGNQNQANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKL---- 438 (536)
Q Consensus 364 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~---- 438 (536)
+++..... .....+++.|+|||.+.+ ..++.++||||||+++|||++|+.||...... .........
T Consensus 163 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~---~~~~~~~~~~~~~ 234 (342)
T cd07879 163 LARHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL---DQLTQILKVTGVP 234 (342)
T ss_pred CCcCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHhcCCC
Confidence 98764321 122457889999999876 45899999999999999999999998643211 001100000
Q ss_pred -------hhcCCcccccc--ccc-cCC---CCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH--hccC
Q 039168 439 -------WCEGHAVELID--PVL-KQS---CAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM--LASD 492 (536)
Q Consensus 439 -------~~~~~~~~l~~--~~l-~~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~~ 492 (536)
+.......... +.. ... ..+.....+.+++.+||+.||++|||+.+++.. ++..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~ 303 (342)
T cd07879 235 GPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303 (342)
T ss_pred CHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence 00000000000 000 000 001122356778889999999999999999943 5443
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=291.88 Aligned_cols=259 Identities=25% Similarity=0.344 Sum_probs=194.5
Q ss_pred HHhcCCccccccCCCCceeEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCce---
Q 039168 213 EATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQE--- 286 (536)
Q Consensus 213 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~--- 286 (536)
+..++|++.+.||+|++|.||+|... +++.||+|++... .....+.+.+|+.+++.++|||++++++++...+.
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 34678999999999999999999976 5889999998653 22334667789999999999999999998876554
Q ss_pred ---EEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEeccc
Q 039168 287 ---LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFG 363 (536)
Q Consensus 287 ---~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg 363 (536)
.++|+||+ +++|.+++.. ..+++..++.++.||++||.|||+.+ |+|+||||+||++++++.++|+|||
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg 163 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFG 163 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEcccc
Confidence 89999998 6688887743 35899999999999999999999986 9999999999999999999999999
Q ss_pred CccccCCCCCccccccccccccccCcchhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcC
Q 039168 364 TARIFGGNQNQANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEG 442 (536)
Q Consensus 364 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 442 (536)
++...... .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...... .......... ..
T Consensus 164 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~---~~~~~i~~~~-~~ 234 (343)
T cd07851 164 LARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHI---DQLKRIMNLV-GT 234 (343)
T ss_pred cccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHhc-CC
Confidence 99865432 222357889999999865 36789999999999999999999998543211 0001000000 00
Q ss_pred Cccccc------------cccc---cCCC---CHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 443 HAVELI------------DPVL---KQSC---APDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 443 ~~~~l~------------~~~l---~~~~---~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
...++. .... .... .......+.+++.+||+.||++|||+.+|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 235 PDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred CCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 000000 0000 0000 00113467788889999999999999999863
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=281.72 Aligned_cols=241 Identities=25% Similarity=0.320 Sum_probs=193.9
Q ss_pred hcCCccccccCCCCceeEEEEEeCC-CcEEEEEEccccC---hhhHHHHHHHHHHHHHc-CCCCceeEeeEEeeCceEEE
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTS---GQGLKEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLL 289 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~l 289 (536)
..+|.++.+||+|+||.|.+|..+. .+.||||++++.. .++.+--..|-++|... +-|.+++++.+|+.-+.+|+
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 4578999999999999999998764 6789999987652 23344445677788777 56899999999999999999
Q ss_pred EEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccC
Q 039168 290 IYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFG 369 (536)
Q Consensus 290 v~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 369 (536)
||||+.||+|-..+... +.+.+..+.-++..|+-||-+||++| ||+||||.+|||++.+|++||+|||+++.--
T Consensus 428 VMEyvnGGDLMyhiQQ~---GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni 501 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQQV---GKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI 501 (683)
T ss_pred EEEEecCchhhhHHHHh---cccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccccccc
Confidence 99999999998888543 34888899999999999999999998 9999999999999999999999999997422
Q ss_pred CCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcccccc
Q 039168 370 GNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELID 449 (536)
Q Consensus 370 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 449 (536)
-....+.+++|||.|+|||++....|+..+|+||+||+||||+.|++||+..+.+ .+.+.+... .
T Consensus 502 --~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~---elF~aI~eh----n------ 566 (683)
T KOG0696|consen 502 --FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED---ELFQAIMEH----N------ 566 (683)
T ss_pred --cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHHHHc----c------
Confidence 2334556789999999999999999999999999999999999999998654332 222222111 0
Q ss_pred ccccCCCCHHHHHHHHHHHHhhcCCCCCCCC
Q 039168 450 PVLKQSCAPDELLKFIHIGLLCVQQDPADRP 480 (536)
Q Consensus 450 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP 480 (536)
-.++.....+.+.|....|.++|.+|.
T Consensus 567 ----vsyPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 567 ----VSYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred ----CcCcccccHHHHHHHHHHhhcCCcccc
Confidence 112233344566666688999999995
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=295.82 Aligned_cols=241 Identities=24% Similarity=0.307 Sum_probs=190.1
Q ss_pred HhcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHHc-CCCCceeEeeEEeeCceEEEEE
Q 039168 214 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLKEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIY 291 (536)
Q Consensus 214 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv~ 291 (536)
+++.|+....+|.|+|+.|-++.+. +++..++|++.+.. ..-.+|+.++... +||||+++++.+.++.+.|+||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 4678889999999999999999865 58899999998662 2234567555555 8999999999999999999999
Q ss_pred eecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEE-cCCCCeEEecccCccccCC
Q 039168 292 EYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLL-DDDMNPKISDFGTARIFGG 370 (536)
Q Consensus 292 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll-~~~~~~kl~Dfg~a~~~~~ 370 (536)
|.+.|+.+.+.+.... ....++..|+.+|+.|+.|||++| +|||||||+|||+ ++.++++|+|||.++....
T Consensus 396 e~l~g~ell~ri~~~~----~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~ 468 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSKP----EFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELER 468 (612)
T ss_pred hhccccHHHHHHHhcc----hhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence 9999998877774322 233778889999999999999997 9999999999999 5899999999999987654
Q ss_pred CCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccc
Q 039168 371 NQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDP 450 (536)
Q Consensus 371 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 450 (536)
. -...+-|..|.|||++....|++++||||||++||+||+|+.||...... ..++. ....+...
T Consensus 469 ~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~ei~~----~i~~~~~s----- 532 (612)
T KOG0603|consen 469 S-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IEIHT----RIQMPKFS----- 532 (612)
T ss_pred h-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HHHHH----hhcCCccc-----
Confidence 4 11234588999999999999999999999999999999999998654333 11111 11111111
Q ss_pred cccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 451 VLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 451 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
...+++.++|+ .+||+.||.+||++.+++..
T Consensus 533 ----~~vS~~AKdLl---~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 533 ----ECVSDEAKDLL---QQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred ----cccCHHHHHHH---HHhccCChhhCcChhhhccC
Confidence 22344455554 59999999999999999853
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=271.71 Aligned_cols=236 Identities=28% Similarity=0.352 Sum_probs=189.0
Q ss_pred cCCCCceeEEEEEeC-CCcEEEEEEccccCh---hhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEeecCCCCh
Q 039168 224 LGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG---QGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSL 299 (536)
Q Consensus 224 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~~sL 299 (536)
||+|+||.||++... +++.+++|.+..... .....+.+|+.++++++||||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 799999999999976 489999999875432 2456788999999999999999999999999999999999999999
Q ss_pred hhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCCcccccc
Q 039168 300 DVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNI 379 (536)
Q Consensus 300 ~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 379 (536)
.+++... ..+++..+..++.|+++||.|||+.+ ++|+||||+||+++.++.++|+|||++....... .....
T Consensus 81 ~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~ 152 (250)
T cd05123 81 FSHLSKE---GRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNT 152 (250)
T ss_pred HHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccC
Confidence 9998543 35899999999999999999999986 9999999999999999999999999998764332 12233
Q ss_pred ccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccccccCCCCHH
Q 039168 380 IAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQSCAPD 459 (536)
Q Consensus 380 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~ 459 (536)
..++..|+|||.+.+...+.++|+||||+++|+|++|+.||..... ........ ... ..+. ..
T Consensus 153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~------~~~~~~~~-~~~------~~~~----~~ 215 (250)
T cd05123 153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR------KEIYEKIL-KDP------LRFP----EF 215 (250)
T ss_pred CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHh-cCC------CCCC----CC
Confidence 5678899999999888899999999999999999999999754322 11111111 100 0011 11
Q ss_pred HHHHHHHHHHhhcCCCCCCCCCHHH
Q 039168 460 ELLKFIHIGLLCVQQDPADRPTMSS 484 (536)
Q Consensus 460 ~~~~l~~li~~cl~~dP~~RPt~~e 484 (536)
....+.+++.+||+.||++|||+.+
T Consensus 216 ~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 216 LSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCHHHHHHHHHHhcCCHhhCCCccc
Confidence 1234566777999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=268.15 Aligned_cols=269 Identities=21% Similarity=0.213 Sum_probs=199.2
Q ss_pred hcCCccc-cccCCCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHHc-CCCCceeEeeEEee----CceE
Q 039168 215 TNHFSDE-NKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLKEFKNEVNLIAKL-QHKNLVRLLGCCLE----GQEL 287 (536)
Q Consensus 215 ~~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~----~~~~ 287 (536)
+++|.+. ++||-|-.|.|..+..+ +++.+|+|++... ...++|+++.-.. .|||||.+++++.. ...+
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL 134 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCL 134 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence 4566553 68999999999999865 6899999988532 4567899987666 69999999999864 3578
Q ss_pred EEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcC---CCCeEEecccC
Q 039168 288 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDD---DMNPKISDFGT 364 (536)
Q Consensus 288 ~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~---~~~~kl~Dfg~ 364 (536)
.+|||.|+||.|...+.+.. ...+.+.++..|++||..|+.|||+. +|.||||||+|+|.+. +..+||+|||+
T Consensus 135 LiVmE~meGGeLfsriq~~g-~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfGF 210 (400)
T KOG0604|consen 135 LIVMECMEGGELFSRIQDRG-DQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFGF 210 (400)
T ss_pred EeeeecccchHHHHHHHHcc-cccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEeccccc
Confidence 99999999999999887644 45699999999999999999999988 5999999999999974 44699999999
Q ss_pred ccccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCc
Q 039168 365 ARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHA 444 (536)
Q Consensus 365 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 444 (536)
|+.-... ....+.+-||.|.|||++-...|+..+|+||+||++|-|++|.+||-......-.--+. ..+..+..
T Consensus 211 AK~t~~~---~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk---~rI~~gqy 284 (400)
T KOG0604|consen 211 AKETQEP---GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK---RRIRTGQY 284 (400)
T ss_pred ccccCCC---ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHH---hHhhccCc
Confidence 9865432 22334567999999999999999999999999999999999999985433311111010 00111110
Q ss_pred cccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccCCCCCCCCCCCCcc
Q 039168 445 VELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSMTIPQPTEPAFS 505 (536)
Q Consensus 445 ~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~p~~p~~~ 505 (536)
++ .............++|+.+|+.+|.+|.|+.+++..-= ++..-..|..|.+-
T Consensus 285 -~F-----P~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpw-i~~~~~vp~tpl~t 338 (400)
T KOG0604|consen 285 -EF-----PEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPW-INQYEAVPQTPLST 338 (400)
T ss_pred -cC-----CChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCch-hcccccCCCCCchh
Confidence 10 11112222345566777999999999999999985421 12233445555543
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=280.13 Aligned_cols=256 Identities=29% Similarity=0.388 Sum_probs=196.2
Q ss_pred hcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC-------hhhHHHHHHHHHHHHHcCCCCceeEeeEEee-Cc
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-------GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLE-GQ 285 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-------~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~ 285 (536)
.++|-.++.||+|||+.||+|.+- ..+.||+|+-..+. ....+..-+|..|.+.|.||.||++|++|.- .+
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 457888899999999999999864 57888999764321 1223456789999999999999999999974 56
Q ss_pred eEEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcC---CCCeEEecc
Q 039168 286 ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDD---DMNPKISDF 362 (536)
Q Consensus 286 ~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~---~~~~kl~Df 362 (536)
.++-|+|||+|.+|+-+|.. ...+++++++.|+.||+.||.||.+. ..+|||.||||.|||+.+ .|.+||.||
T Consensus 542 sFCTVLEYceGNDLDFYLKQ---hklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDF 617 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLKQ---HKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDF 617 (775)
T ss_pred cceeeeeecCCCchhHHHHh---hhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeec
Confidence 78999999999999999944 44599999999999999999999988 579999999999999954 578999999
Q ss_pred cCccccCCCCCc-----cccccccccccccCcchhcCC----CCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHH
Q 039168 363 GTARIFGGNQNQ-----ANTNIIAGTYGYMAPEYAMGG----IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLT 433 (536)
Q Consensus 363 g~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~ 433 (536)
|+++.+.++... ..+....||.+|++||.+.-+ .++.++||||+|||+|..+.|+.||+...... +.++
T Consensus 618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ--dILq 695 (775)
T KOG1151|consen 618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ--DILQ 695 (775)
T ss_pred chhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHH--HHHh
Confidence 999988654433 234457899999999988543 47899999999999999999999987543322 2222
Q ss_pred HHHHHhhcCCccccccccc-cCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHH
Q 039168 434 YTWKLWCEGHAVELIDPVL-KQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVV 486 (536)
Q Consensus 434 ~~~~~~~~~~~~~l~~~~l-~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl 486 (536)
++.+.....-.+ .......+...+| .+||+.--++|...-++.
T Consensus 696 -------eNTIlkAtEVqFP~KPvVsseAkaFI---RRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 696 -------ENTILKATEVQFPPKPVVSSEAKAFI---RRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred -------hhchhcceeccCCCCCccCHHHHHHH---HHHHHhhhhhhhhHHHHc
Confidence 112211111111 1112234455555 499999999998766553
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=297.50 Aligned_cols=259 Identities=25% Similarity=0.405 Sum_probs=207.1
Q ss_pred hhHHHHhcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHHc-CCCCceeEeeEEee---
Q 039168 209 GLALEATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLKEFKNEVNLIAKL-QHKNLVRLLGCCLE--- 283 (536)
Q Consensus 209 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~--- 283 (536)
......++.|++..+||.|.+|.||+++.. +++..|+|++...... -+++..|+++|+.+ .|||++.+++++..
T Consensus 12 ~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~-deEiE~eynil~~~~~hpnv~~fyg~~~k~~~ 90 (953)
T KOG0587|consen 12 SSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE-EEEIELEYNMLKKYSHHPNVATFYGAFIKKDP 90 (953)
T ss_pred hhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc-cHHHHHHHHHHHhccCCCCcceEEEEEEEecC
Confidence 333345678999999999999999999864 5888899988765433 36788899999998 68999999999863
Q ss_pred --CceEEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEec
Q 039168 284 --GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISD 361 (536)
Q Consensus 284 --~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~D 361 (536)
++.+|||||||.+||..+++.... ...+.|..+..|++.++.||.+||.+. ++|||||-.|||++.++.|||+|
T Consensus 91 ~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLvD 166 (953)
T KOG0587|consen 91 GNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLVD 166 (953)
T ss_pred CCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEee
Confidence 578999999999999999987655 677999999999999999999999885 99999999999999999999999
Q ss_pred ccCccccCCCCCccccccccccccccCcchhcCC-----CCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHH
Q 039168 362 FGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGG-----IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTW 436 (536)
Q Consensus 362 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~ 436 (536)
||++..+.... ....+..|||.|||||++... .|+..+|+||||++..||.-|.+|+-...+-..
T Consensus 167 FGvSaQldsT~--grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmra-------- 236 (953)
T KOG0587|consen 167 FGVSAQLDSTV--GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRA-------- 236 (953)
T ss_pred eeeeeeeeccc--ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhh--------
Confidence 99998875433 334457899999999999643 378899999999999999999999543322211
Q ss_pred HHhhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 437 KLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 437 ~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
.+.-. . +|......+..-.+++.+.|..||.+|-++||++.++|+.
T Consensus 237 -LF~Ip---R--NPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 237 -LFLIP---R--NPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred -hccCC---C--CCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 01000 0 1111112234456678888889999999999999999854
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=307.50 Aligned_cols=145 Identities=26% Similarity=0.410 Sum_probs=130.9
Q ss_pred cCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEE
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 291 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 291 (536)
++|.+.++||+|+||.||+|.+. +++.||||++.... ......+.+|+.+++.++||||+++++++......++||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 67999999999999999999986 58999999986532 334567889999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCcc
Q 039168 292 EYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTAR 366 (536)
Q Consensus 292 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 366 (536)
||+.+++|..++... ..+++..++.++.||+.||.|||.++ |+||||||+||||+.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~~---~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIY---GYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999998543 34889999999999999999999986 9999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=272.93 Aligned_cols=276 Identities=25% Similarity=0.330 Sum_probs=208.1
Q ss_pred CCcChhhHHHHhcCCccccccCCCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHH--cCCCCceeEeeEE
Q 039168 204 PLFPLGLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAK--LQHKNLVRLLGCC 281 (536)
Q Consensus 204 ~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~hpniv~l~~~~ 281 (536)
+-+|+........+-.+.+.||+|.||+||+|.+ .|+.||||++....+ ..+.+|.+|.+. |+|+||+.+++.-
T Consensus 199 SGlplLVQRTiarqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgFIaaD 274 (513)
T KOG2052|consen 199 SGLPLLVQRTIARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGFIAAD 274 (513)
T ss_pred CCchhHhHHhhhheeEEEEEecCccccceeeccc-cCCceEEEEecccch---hhhhhHHHHHHHHHhccchhhhhhhcc
Confidence 3455555566677889999999999999999999 588999999976554 455677777766 4999999999875
Q ss_pred eeC----ceEEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHh-----cCCCCCeeeCCCCCCcEEEc
Q 039168 282 LEG----QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLH-----EDSRLKIIHRDLKASNVLLD 352 (536)
Q Consensus 282 ~~~----~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH-----~~~~~~ivH~Dikp~NIll~ 352 (536)
..+ .++|||++|.++|||.++|.+ ..++.+..++++..++.||+||| .+|.+.|.|||||..||||.
T Consensus 275 ~~~~gs~TQLwLvTdYHe~GSL~DyL~r----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVK 350 (513)
T KOG2052|consen 275 NKDNGSWTQLWLVTDYHEHGSLYDYLNR----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK 350 (513)
T ss_pred ccCCCceEEEEEeeecccCCcHHHHHhh----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEc
Confidence 433 479999999999999999954 35889999999999999999999 46788999999999999999
Q ss_pred CCCCeEEecccCccccCCCC--CccccccccccccccCcchhcCCC------CCccchHHHHHHHHHHHHhC--------
Q 039168 353 DDMNPKISDFGTARIFGGNQ--NQANTNIIAGTYGYMAPEYAMGGI------FSIKSDVFSFGVLLLEIISG-------- 416 (536)
Q Consensus 353 ~~~~~kl~Dfg~a~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwslG~il~elltg-------- 416 (536)
.++...|+|+|+|....... ........+||.+|||||++.... --..+||||||.++||++-.
T Consensus 351 kn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~e 430 (513)
T KOG2052|consen 351 KNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVE 430 (513)
T ss_pred cCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEeh
Confidence 99999999999998775442 233445578999999999996532 12468999999999999752
Q ss_pred --CCCCCCCCccCCchhHHHHHHHhhcCCccccccccccC-CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccCC
Q 039168 417 --RKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQ-SCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDS 493 (536)
Q Consensus 417 --~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~-~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 493 (536)
+.||....+-+.. .+.-.+.....+ +.|.+++ ....+.+..+.+||..||..||.-|.|+--|-+.|.+..
T Consensus 431 ey~~Pyyd~Vp~DPs--~eeMrkVVCv~~----~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~ 504 (513)
T KOG2052|consen 431 EYQLPYYDVVPSDPS--FEEMRKVVCVQK----LRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLS 504 (513)
T ss_pred hhcCCcccCCCCCCC--HHHHhcceeecc----cCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence 3444322211111 110111111111 1222222 234567888999999999999999999999888887653
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=267.04 Aligned_cols=248 Identities=23% Similarity=0.337 Sum_probs=196.2
Q ss_pred hcCCccccccCCCCceeEEEEEeCC-CcEEEEEEcccc---ChhhHHHHHHHHHHHHHc-CCCCceeEeeEEeeCceEEE
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRT---SGQGLKEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLL 289 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~l 289 (536)
..+|..+++||+|+|..|..++++. .+.||+|++++. ..++.+..+.|-.+..+. +||.+|.++.+|+.+..+++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 4689999999999999999999764 778899998754 445567778888888887 79999999999999999999
Q ss_pred EEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccC
Q 039168 290 IYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFG 369 (536)
Q Consensus 290 v~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 369 (536)
|.||++||+|--++... ..++++.++.+...|..||.|||++| ||+||||.+|+|+|.+|++||.|+|+++.--
T Consensus 329 vieyv~ggdlmfhmqrq---rklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l 402 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL 402 (593)
T ss_pred EEEEecCcceeeehhhh---hcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCC
Confidence 99999999997777443 44999999999999999999999998 9999999999999999999999999998532
Q ss_pred CCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCC-chhHHHHHHHhhcCCccccc
Q 039168 370 GNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHG-QTLLTYTWKLWCEGHAVELI 448 (536)
Q Consensus 370 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~ 448 (536)
.....+++++|||.|+|||++.+..|+..+|+|+|||+|+||+.|+.||+.-..... .....+..+.+.+..+.-
T Consensus 403 --~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiri-- 478 (593)
T KOG0695|consen 403 --GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRI-- 478 (593)
T ss_pred --CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccc--
Confidence 233345678999999999999999999999999999999999999999976222111 111223333322221110
Q ss_pred cccccCCCCHHHHHHHHHHHHhhcCCCCCCCC
Q 039168 449 DPVLKQSCAPDELLKFIHIGLLCVQQDPADRP 480 (536)
Q Consensus 449 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP 480 (536)
+.....+.-.++..-|++||.+|.
T Consensus 479 --------prslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 479 --------PRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred --------cceeehhhHHHHHHhhcCCcHHhc
Confidence 111112333455578899999985
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=245.60 Aligned_cols=262 Identities=23% Similarity=0.283 Sum_probs=192.9
Q ss_pred CCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC--hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEee
Q 039168 217 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 293 (536)
Q Consensus 217 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 293 (536)
+|...++||+|.||+||+|+.. .++.||+|++.... ........+|+-+|+.++|.|||+++++...++.+-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 4666789999999999999965 58899999987543 33456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCC
Q 039168 294 MPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQN 373 (536)
Q Consensus 294 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 373 (536)
|. .+|..+... -.+.++.+.+..++.|+++||.+.|++. +.|||+||.|+||+.+|.+||+|||+++.++-...
T Consensus 83 cd-qdlkkyfds--lng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipvr 156 (292)
T KOG0662|consen 83 CD-QDLKKYFDS--LNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR 156 (292)
T ss_pred hh-HHHHHHHHh--cCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence 94 456555543 2345889999999999999999999985 99999999999999999999999999998764332
Q ss_pred ccccccccccccccCcchhcCCC-CCccchHHHHHHHHHHHHhCCCC-CCCCCccCCchhHHHHHHHh--hcCCcccc--
Q 039168 374 QANTNIIAGTYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGRKN-NGFYFSEHGQTLLTYTWKLW--CEGHAVEL-- 447 (536)
Q Consensus 374 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~elltg~~p-~~~~~~~~~~~~~~~~~~~~--~~~~~~~l-- 447 (536)
. .+..+-|.+|.+|.++.+.. |+...|+||.||++.|+.....| |...+ ..+.+....|..- .+..+..+
T Consensus 157 c--ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~d--vddqlkrif~~lg~p~ed~wps~t~ 232 (292)
T KOG0662|consen 157 C--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND--VDDQLKRIFRLLGTPTEDQWPSMTK 232 (292)
T ss_pred e--eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCc--HHHHHHHHHHHhCCCccccCCcccc
Confidence 2 22234589999999998875 89999999999999999985554 43322 2222222222221 12222221
Q ss_pred -ccccccCCCCH---------HHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 448 -IDPVLKQSCAP---------DELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 448 -~~~~l~~~~~~---------~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
.|-.....++. .....=.++..+.|.-+|..|.++++.++.
T Consensus 233 lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 233 LPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred CCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 11111111111 111112345557888999999999998864
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=268.35 Aligned_cols=267 Identities=23% Similarity=0.375 Sum_probs=193.3
Q ss_pred cCCccccccCCCCceeEEEEEeCC-CcEEEEEEcccc--ChhhHHHHHHHHHHHHHcCCCCceeEeeEEee--------C
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRT--SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLE--------G 284 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~--------~ 284 (536)
..|+-..+||+|.||+||+|+.++ |+.||+|++-.. .........+|+++|..|+|+|++.++..|.. .
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 567788899999999999999764 788999887543 22334567889999999999999999888753 3
Q ss_pred ceEEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccC
Q 039168 285 QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGT 364 (536)
Q Consensus 285 ~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~ 364 (536)
..+|+||.+|+. +|..+|.+ ....++..++.+++.++..||.|+|... |+|||+||.|+||+.+|.+||+|||+
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn--~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSN--RKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcC--ccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeecccc
Confidence 458999999976 56666643 3345889999999999999999999885 99999999999999999999999999
Q ss_pred ccccCCCCCcc--ccccccccccccCcchhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhc
Q 039168 365 ARIFGGNQNQA--NTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCE 441 (536)
Q Consensus 365 a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 441 (536)
++.+...+... ..+..+-|.+|++||.+.|. .|+++.|||+.||++.||+++.+.+..........+..........
T Consensus 171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tk 250 (376)
T KOG0669|consen 171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITK 250 (376)
T ss_pred ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCc
Confidence 98775433222 22234569999999999886 5999999999999999999998875433222211111111111111
Q ss_pred CCccc-----ccccc----ccCC---CCHHHHH------HHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 442 GHAVE-----LIDPV----LKQS---CAPDELL------KFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 442 ~~~~~-----l~~~~----l~~~---~~~~~~~------~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
..++. +.... +... ...+.++ ...+|+..+|..||.+|+++++++..
T Consensus 251 evWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 251 EVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred ccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 11111 11111 1110 0111122 45667779999999999999999854
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=288.55 Aligned_cols=242 Identities=23% Similarity=0.284 Sum_probs=197.8
Q ss_pred cCCccccccCCCCceeEEEEEeCCCc-EEEEEEcccc---ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEE
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLADGK-AIAVKRLSRT---SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 291 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~~~~-~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 291 (536)
.+++.+..||-|+||.|-++..++.+ .+|+|++++. .....+++..|-.+|...+.|.||++|..|.+++++||.|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 45666778999999999999876543 4888888654 3344567888999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCC
Q 039168 292 EYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGN 371 (536)
Q Consensus 292 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 371 (536)
|-|-||.|...|.+ .+.+++.....++..+++|++|||.++ ||+|||||+|++++.+|-+||.|||+|+.+...
T Consensus 500 EaClGGElWTiLrd---Rg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g 573 (732)
T KOG0614|consen 500 EACLGGELWTILRD---RGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG 573 (732)
T ss_pred HhhcCchhhhhhhh---cCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence 99999999999954 445899999999999999999999997 999999999999999999999999999988644
Q ss_pred CCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcccccccc
Q 039168 372 QNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPV 451 (536)
Q Consensus 372 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 451 (536)
..+.+++|||.|.|||++.+...+.++|.||||+++|||++|.+||...++-....+..... +..+
T Consensus 574 ---~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGi------d~i~----- 639 (732)
T KOG0614|consen 574 ---RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGI------DKIE----- 639 (732)
T ss_pred ---CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhh------hhhh-----
Confidence 34556899999999999999999999999999999999999999987654432222111111 1111
Q ss_pred ccCCCCHHHHHHHHHHHHhhcCCCCCCCCC
Q 039168 452 LKQSCAPDELLKFIHIGLLCVQQDPADRPT 481 (536)
Q Consensus 452 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt 481 (536)
++....+...+|+++..+.+|.+|.-
T Consensus 640 ----~Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 640 ----FPRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred ----cccccchhHHHHHHHHHhcCcHhhhc
Confidence 12223345667777888999999975
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=284.59 Aligned_cols=243 Identities=24% Similarity=0.331 Sum_probs=194.1
Q ss_pred ccccCCCCceeEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEeecCCC
Q 039168 221 ENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNK 297 (536)
Q Consensus 221 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~~ 297 (536)
.++||.|-||+||-|+++ +|+.||||++.+- ..+...++++|+.||++++||.||.+..-|+..+..++|||-+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 468999999999999864 6999999999754 2334478999999999999999999999999999999999999877
Q ss_pred ChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCC---CCeEEecccCccccCCCCCc
Q 039168 298 SLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDD---MNPKISDFGTARIFGGNQNQ 374 (536)
Q Consensus 298 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~---~~~kl~Dfg~a~~~~~~~~~ 374 (536)
-|+-+|.. ....+++.....++.||+.||.|||.++ |+|+||||+|||+.+. .++||+|||+|+.++...
T Consensus 649 MLEMILSs--EkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks-- 721 (888)
T KOG4236|consen 649 MLEMILSS--EKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS-- 721 (888)
T ss_pred HHHHHHHh--hcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhh--
Confidence 77766643 3456899888999999999999999985 9999999999999654 479999999999986433
Q ss_pred cccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccccccC
Q 039168 375 ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQ 454 (536)
Q Consensus 375 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~ 454 (536)
.....+|||.|+|||++....|...-|+||.|||+|--++|..||...... .+..+.+ ..++. .
T Consensus 722 -FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdI--ndQIQNA---------aFMyP----p 785 (888)
T KOG4236|consen 722 -FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDI--NDQIQNA---------AFMYP----P 785 (888)
T ss_pred -hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccch--hHHhhcc---------ccccC----C
Confidence 234578999999999999999999999999999999999999996422111 1111111 01111 1
Q ss_pred CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHH
Q 039168 455 SCAPDELLKFIHIGLLCVQQDPADRPTMSSVV 486 (536)
Q Consensus 455 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl 486 (536)
+-..+.....+++|...||..-.+|-|...-+
T Consensus 786 ~PW~eis~~AidlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 786 NPWSEISPEAIDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred CchhhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence 11233344567777799999999999988765
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=267.89 Aligned_cols=219 Identities=19% Similarity=0.143 Sum_probs=173.1
Q ss_pred CCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEeecCCCChhhhhhc
Q 039168 227 GGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFD 305 (536)
Q Consensus 227 G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~ 305 (536)
|.+|.||++.+. +++.||+|++.... .+.+|...+....||||+++++++.+.+..++||||+++++|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 889999999975 58999999987643 234455566667899999999999999999999999999999998854
Q ss_pred ccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCCcccccccccccc
Q 039168 306 ATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYG 385 (536)
Q Consensus 306 ~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~ 385 (536)
. ..+++..+..++.|+++||.|||+.+ ++||||||+||+++.++.++|+|||.+....... ....++..
T Consensus 79 ~---~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~ 147 (237)
T cd05576 79 F---LNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAVENM 147 (237)
T ss_pred h---cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCCcCcc
Confidence 3 34899999999999999999999987 9999999999999999999999999887654321 12345678
Q ss_pred ccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccccccCCCCHHHHHHHH
Q 039168 386 YMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQSCAPDELLKFI 465 (536)
Q Consensus 386 y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~ 465 (536)
|+|||.+.+..++.++||||+|+++|||++|+.|+....... .... ...+. ......+.
T Consensus 148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------------~~~~-----~~~~~----~~~~~~~~ 206 (237)
T cd05576 148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI------------NTHT-----TLNIP----EWVSEEAR 206 (237)
T ss_pred ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------------cccc-----ccCCc----ccCCHHHH
Confidence 999999988889999999999999999999998754211100 0000 00011 11123456
Q ss_pred HHHHhhcCCCCCCCCCH
Q 039168 466 HIGLLCVQQDPADRPTM 482 (536)
Q Consensus 466 ~li~~cl~~dP~~RPt~ 482 (536)
+++.+||+.||++|||+
T Consensus 207 ~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 207 SLLQQLLQFNPTERLGA 223 (237)
T ss_pred HHHHHHccCCHHHhcCC
Confidence 67779999999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=272.26 Aligned_cols=266 Identities=20% Similarity=0.233 Sum_probs=201.6
Q ss_pred HHHHhcCCccccccCCCCceeEEEEEeCC-CcEEEEEEccccChhhHHHHHHHHHHHHHcCC--C----CceeEeeEEee
Q 039168 211 ALEATNHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQH--K----NLVRLLGCCLE 283 (536)
Q Consensus 211 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--p----niv~l~~~~~~ 283 (536)
....+++|.+...+|+|.||.|-.+.+.. +..||||+++.- ....+..+-|+++|+++.+ | -+|++.++|.-
T Consensus 84 gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdy 162 (415)
T KOG0671|consen 84 GDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDY 162 (415)
T ss_pred ccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhc
Confidence 34457899999999999999999998754 789999988542 3334556679999999943 3 37888899999
Q ss_pred CceEEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcC----------
Q 039168 284 GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDD---------- 353 (536)
Q Consensus 284 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~---------- 353 (536)
.++.++|+|.+ |-|+.++|.. ....+++...+..+..|+++++++||+.+ ++|-||||+|||+.+
T Consensus 163 rghiCivfell-G~S~~dFlk~-N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k 237 (415)
T KOG0671|consen 163 RGHICIVFELL-GLSTFDFLKE-NNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPK 237 (415)
T ss_pred cCceEEEEecc-ChhHHHHhcc-CCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccC
Confidence 99999999988 6788888865 34456899999999999999999999996 999999999999831
Q ss_pred ----------CCCeEEecccCccccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 039168 354 ----------DMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFY 423 (536)
Q Consensus 354 ----------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~ 423 (536)
+..++|+|||.|..-... ...++.|..|.|||++.+-+++.++||||+||||+||.+|...|...
T Consensus 238 ~~~~~~r~~ks~~I~vIDFGsAtf~~e~-----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtH 312 (415)
T KOG0671|consen 238 KKVCFIRPLKSTAIKVIDFGSATFDHEH-----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTH 312 (415)
T ss_pred CccceeccCCCcceEEEecCCcceeccC-----cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccC
Confidence 234899999999864322 24567899999999999999999999999999999999999887654
Q ss_pred CccCCchhHHHH--------------HHHhhcCCccccccccc----------------cCCCCHHHHHHHHHHHHhhcC
Q 039168 424 FSEHGQTLLTYT--------------WKLWCEGHAVELIDPVL----------------KQSCAPDELLKFIHIGLLCVQ 473 (536)
Q Consensus 424 ~~~~~~~~~~~~--------------~~~~~~~~~~~l~~~~l----------------~~~~~~~~~~~l~~li~~cl~ 473 (536)
...+.-.+++.+ .+.+..+ ...+.+... .......+..+|++|+..||.
T Consensus 313 en~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~-rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~ 391 (415)
T KOG0671|consen 313 ENLEHLAMMERILGPIPSRMIKKTRKEKYFRRG-RLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLE 391 (415)
T ss_pred CcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcc-cccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHc
Confidence 422211122211 1111111 111110000 011234566789999999999
Q ss_pred CCCCCCCCHHHHHHH
Q 039168 474 QDPADRPTMSSVVVM 488 (536)
Q Consensus 474 ~dP~~RPt~~evl~~ 488 (536)
.||.+|+|+.|+|..
T Consensus 392 fDP~~RiTl~EAL~H 406 (415)
T KOG0671|consen 392 FDPARRITLREALSH 406 (415)
T ss_pred cCccccccHHHHhcC
Confidence 999999999999853
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=293.75 Aligned_cols=254 Identities=29% Similarity=0.397 Sum_probs=207.9
Q ss_pred CCccccccCCCCceeEEEEEeC-C----CcEEEEEEcccc-ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEE
Q 039168 217 HFSDENKLGQGGFGPVYKGTLA-D----GKAIAVKRLSRT-SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 290 (536)
Q Consensus 217 ~~~~~~~lg~G~~g~Vy~~~~~-~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 290 (536)
..+..++||+|+||+||+|.+- + +-+||+|++... ..+.-.++.+|..+|.+|+|||++++++++.... +.||
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlv 775 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLV 775 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHH
Confidence 3456789999999999999862 2 457899988654 4455678999999999999999999999998776 8999
Q ss_pred EeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCC
Q 039168 291 YEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGG 370 (536)
Q Consensus 291 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 370 (536)
++||+.|.|.+++..++ ..+..+..+.|..||++|+.|||++. ++||||-..|+||..-..+||.|||+++.+..
T Consensus 776 tq~mP~G~LlDyvr~hr--~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~ 850 (1177)
T KOG1025|consen 776 TQLMPLGCLLDYVREHR--DNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAP 850 (1177)
T ss_pred HHhcccchHHHHHHHhh--ccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCc
Confidence 99999999999997644 45888999999999999999999995 99999999999999999999999999998876
Q ss_pred CCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHHHHHhhcCCcccccc
Q 039168 371 NQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELID 449 (536)
Q Consensus 371 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 449 (536)
+..........-.+-|||=|.+....|+.++|||||||++||++| |..|+.....+ .+... +.
T Consensus 851 d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~-------eI~dl---------le 914 (1177)
T KOG1025|consen 851 DEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAE-------EIPDL---------LE 914 (1177)
T ss_pred ccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHH-------HhhHH---------Hh
Confidence 655554444444678999999999999999999999999999998 77775432221 12222 22
Q ss_pred ccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 450 PVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 450 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
...+-..++....++..++.+||..|++.||+++++...++.-
T Consensus 915 ~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ 957 (1177)
T KOG1025|consen 915 KGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRM 957 (1177)
T ss_pred ccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHH
Confidence 2223344666777888888999999999999999999877654
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=292.68 Aligned_cols=260 Identities=19% Similarity=0.239 Sum_probs=167.4
Q ss_pred HhcCCccccccCCCCceeEEEEEeC-C----CcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeE------Ee
Q 039168 214 ATNHFSDENKLGQGGFGPVYKGTLA-D----GKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGC------CL 282 (536)
Q Consensus 214 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~------~~ 282 (536)
..++|++.++||+|+||.||+|++. + +..||||++...... +....| .++...+.+++.++.. ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 3578999999999999999999975 4 689999987643221 111111 1222222222222221 24
Q ss_pred eCceEEEEEeecCCCChhhhhhcccCC-----------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCC
Q 039168 283 EGQELLLIYEYMPNKSLDVHLFDATRS-----------------VQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLK 345 (536)
Q Consensus 283 ~~~~~~lv~e~~~~~sL~~~l~~~~~~-----------------~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dik 345 (536)
.+...++|+||+.+++|.+++...... ....+..+..++.||+.||.|||+++ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 567899999999999999888643211 01123446689999999999999986 9999999
Q ss_pred CCcEEEcC-CCCeEEecccCccccCCCCCccccccccccccccCcchhcCC----------------------CCCccch
Q 039168 346 ASNVLLDD-DMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGG----------------------IFSIKSD 402 (536)
Q Consensus 346 p~NIll~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~D 402 (536)
|+|||++. ++.+||+|||+++.+...... ......+++.|+|||.+... .++.++|
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~-~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCcccccccccc-CCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 99999985 579999999999865432221 22345789999999976432 2345679
Q ss_pred HHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcc----cccccc----ccCCC--CHHHHHHHHHHHHhhc
Q 039168 403 VFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAV----ELIDPV----LKQSC--APDELLKFIHIGLLCV 472 (536)
Q Consensus 403 vwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~----~l~~~~----l~~~~--~~~~~~~l~~li~~cl 472 (536)
||||||++|||+++..++.. ....+.......+... ..+.+. +...+ .........+|+.+||
T Consensus 362 VwSlGviL~el~~~~~~~~~-------~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL 434 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDS-------NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMM 434 (566)
T ss_pred cHHHHHHHHHHHhCcCCCch-------HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHc
Confidence 99999999999997665321 1111111110000000 000000 00000 0001123446778999
Q ss_pred CCCCCCCCCHHHHHHH
Q 039168 473 QQDPADRPTMSSVVVM 488 (536)
Q Consensus 473 ~~dP~~RPt~~evl~~ 488 (536)
+.||++|||+.++|+.
T Consensus 435 ~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 435 RFKGRQRISAKAALAH 450 (566)
T ss_pred cCCcccCCCHHHHhCC
Confidence 9999999999999964
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-31 Score=256.18 Aligned_cols=238 Identities=28% Similarity=0.349 Sum_probs=190.7
Q ss_pred CceeEEEEEeCC-CcEEEEEEccccChhh-HHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEeecCCCChhhhhhc
Q 039168 228 GFGPVYKGTLAD-GKAIAVKRLSRTSGQG-LKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFD 305 (536)
Q Consensus 228 ~~g~Vy~~~~~~-~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~ 305 (536)
+||.||++...+ ++.+++|++....... .+.+.+|++.+++++|+|++++++.+......++++||+++++|..++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 589999999864 8999999997665444 68899999999999999999999999999999999999999999998854
Q ss_pred ccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCCcccccccccccc
Q 039168 306 ATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYG 385 (536)
Q Consensus 306 ~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~ 385 (536)
... +++..++.++.+++.++.+||+.+ ++|+||+|+||++++++.++|+|||.+....... ......++..
T Consensus 81 ~~~---~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~ 151 (244)
T smart00220 81 RGR---LSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPE 151 (244)
T ss_pred ccC---CCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcC
Confidence 332 889999999999999999999986 9999999999999999999999999998765432 2223457889
Q ss_pred ccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccccccCCCCHHHHHHHH
Q 039168 386 YMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQSCAPDELLKFI 465 (536)
Q Consensus 386 y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~ 465 (536)
|++||.+.+..++.++||||||+++++|++|..||..... ... ............. . ........+.
T Consensus 152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~--~~~----~~~~~~~~~~~~~-~------~~~~~~~~~~ 218 (244)
T smart00220 152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQ--LLE----LFKKIGKPKPPFP-P------PEWKISPEAK 218 (244)
T ss_pred CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--HHH----HHHHHhccCCCCc-c------ccccCCHHHH
Confidence 9999999988899999999999999999999999754211 111 1111111111100 0 0000224567
Q ss_pred HHHHhhcCCCCCCCCCHHHHHH
Q 039168 466 HIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 466 ~li~~cl~~dP~~RPt~~evl~ 487 (536)
+++.+||..+|++||++.++++
T Consensus 219 ~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 219 DLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHccCCchhccCHHHHhh
Confidence 7778999999999999999996
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=290.34 Aligned_cols=260 Identities=32% Similarity=0.441 Sum_probs=203.4
Q ss_pred HhcCCccccccCCCCceeEEEEEeC----C----CcEEEEEEccccC-hhhHHHHHHHHHHHHHc-CCCCceeEeeEEee
Q 039168 214 ATNHFSDENKLGQGGFGPVYKGTLA----D----GKAIAVKRLSRTS-GQGLKEFKNEVNLIAKL-QHKNLVRLLGCCLE 283 (536)
Q Consensus 214 ~~~~~~~~~~lg~G~~g~Vy~~~~~----~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~ 283 (536)
..++..+.+.||+|.||.|++|... . ...||||.+.... ....+.+..|+++|+.+ +||||+.+++++..
T Consensus 294 ~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~ 373 (609)
T KOG0200|consen 294 PRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ 373 (609)
T ss_pred chhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc
Confidence 3445566779999999999999743 1 4578999987543 34567889999999999 69999999999999
Q ss_pred CceEEEEEeecCCCChhhhhhccc-----C------C--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEE
Q 039168 284 GQELLLIYEYMPNKSLDVHLFDAT-----R------S--VQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVL 350 (536)
Q Consensus 284 ~~~~~lv~e~~~~~sL~~~l~~~~-----~------~--~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIl 350 (536)
.+..++|+||+..|+|..+|.... . . ..+...+.+.++.||+.|++||++.. +|||||-..|||
T Consensus 374 ~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRNVL 450 (609)
T KOG0200|consen 374 DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARNVL 450 (609)
T ss_pred CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhhEE
Confidence 999999999999999999997654 0 0 23888999999999999999999985 999999999999
Q ss_pred EcCCCCeEEecccCccccCCCCCccccccccc--cccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccC
Q 039168 351 LDDDMNPKISDFGTARIFGGNQNQANTNIIAG--TYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEH 427 (536)
Q Consensus 351 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~ 427 (536)
+.++..+||+|||+++............ -.| ...|||||.+....|+.++|||||||+||||+| |..|+.....
T Consensus 451 i~~~~~~kIaDFGlar~~~~~~~y~~~~-~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~-- 527 (609)
T KOG0200|consen 451 ITKNKVIKIADFGLARDHYNKDYYRTKS-SAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP-- 527 (609)
T ss_pred ecCCCEEEEccccceeccCCCCceEecC-CCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc--
Confidence 9999999999999999655433322111 111 345999999999999999999999999999999 5566543110
Q ss_pred CchhHHHHHHHhhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 428 GQTLLTYTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 428 ~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
....+....++...+. +.....++.++|+.||+.+|++||++.++++.+...
T Consensus 528 ----~~~l~~~l~~G~r~~~---------P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 528 ----TEELLEFLKEGNRMEQ---------PEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred ----HHHHHHHHhcCCCCCC---------CCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 1111233444444332 222234566788899999999999999999999883
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.4e-32 Score=273.40 Aligned_cols=206 Identities=24% Similarity=0.349 Sum_probs=174.1
Q ss_pred cCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccCh---hhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEE
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG---QGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 291 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 291 (536)
.-|..++.||-|+||+|-++... +...||+|.+.+.+. ..+...+.|-.||...+.+-||+||..|.+++.+|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 35777889999999999999754 467789999876543 33456788999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccC--
Q 039168 292 EYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFG-- 369 (536)
Q Consensus 292 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~-- 369 (536)
+|++||++-.+|.+ .+.++|..++.++..+..|+++.|..| +|||||||+|||||.+|++||.||||+.-+.
T Consensus 709 dYIPGGDmMSLLIr---mgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWT 782 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLIR---MGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 782 (1034)
T ss_pred eccCCccHHHHHHH---hccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceec
Confidence 99999999888843 445889999999999999999999998 9999999999999999999999999985431
Q ss_pred -------CCCCccc-------------------------------cccccccccccCcchhcCCCCCccchHHHHHHHHH
Q 039168 370 -------GNQNQAN-------------------------------TNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLL 411 (536)
Q Consensus 370 -------~~~~~~~-------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ 411 (536)
+.+.... ...++||+.|+|||++....|+..+|+||.|||||
T Consensus 783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~ 862 (1034)
T KOG0608|consen 783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILY 862 (1034)
T ss_pred cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHH
Confidence 1110000 11256999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCccC
Q 039168 412 EIISGRKNNGFYFSEH 427 (536)
Q Consensus 412 elltg~~p~~~~~~~~ 427 (536)
||+.|+.||....+..
T Consensus 863 em~~g~~pf~~~tp~~ 878 (1034)
T KOG0608|consen 863 EMLVGQPPFLADTPGE 878 (1034)
T ss_pred HHhhCCCCccCCCCCc
Confidence 9999999986654443
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=278.58 Aligned_cols=262 Identities=19% Similarity=0.232 Sum_probs=177.4
Q ss_pred hcCCccccccCCCCceeEEEEEe-----------------CCCcEEEEEEccccChhhHHHH--------------HHHH
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTL-----------------ADGKAIAVKRLSRTSGQGLKEF--------------KNEV 263 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~~~--------------~~E~ 263 (536)
.++|++.++||+|+||.||+|.+ .+++.||||++........++| ..|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 46899999999999999999964 2356899999875443322333 3467
Q ss_pred HHHHHcCCCCc-----eeEeeEEee--------CceEEEEEeecCCCChhhhhhcccC---------------------C
Q 039168 264 NLIAKLQHKNL-----VRLLGCCLE--------GQELLLIYEYMPNKSLDVHLFDATR---------------------S 309 (536)
Q Consensus 264 ~~l~~l~hpni-----v~l~~~~~~--------~~~~~lv~e~~~~~sL~~~l~~~~~---------------------~ 309 (536)
.++.+++|.++ +++++++.. .+..++||||+++++|.++++.... .
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 77788876554 667777653 3568999999999999998864211 1
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCCccccccccccccccCc
Q 039168 310 VQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAP 389 (536)
Q Consensus 310 ~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP 389 (536)
..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++......... ......+++.|+||
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~aP 379 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYSPP 379 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCcceeCh
Confidence 23467788899999999999999986 999999999999999999999999999765432211 11122347899999
Q ss_pred chhcCCC--------------------C--CccchHHHHHHHHHHHHhCCC-CCCCCCccC----CchhHHHHHHHhhcC
Q 039168 390 EYAMGGI--------------------F--SIKSDVFSFGVLLLEIISGRK-NNGFYFSEH----GQTLLTYTWKLWCEG 442 (536)
Q Consensus 390 E~~~~~~--------------------~--~~~~DvwslG~il~elltg~~-p~~~~~~~~----~~~~~~~~~~~~~~~ 442 (536)
|.+.... + ..+.||||+||++|+|++|.. |+....... ........|..+...
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~ 459 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQ 459 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhccc
Confidence 9885432 1 234799999999999999875 543211000 000111112222111
Q ss_pred CccccccccccCCCCHHHHHHHHHHHHhhcCCCC---CCCCCHHHHHHH
Q 039168 443 HAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDP---ADRPTMSSVVVM 488 (536)
Q Consensus 443 ~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP---~~RPt~~evl~~ 488 (536)
.. +-.. .........+++.++|.++| .+|+|++|+|+.
T Consensus 460 ~~----~~~~----~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 460 KY----DFSL----LDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred CC----Cccc----ccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 11 1000 11112334556668888765 689999999853
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-32 Score=241.75 Aligned_cols=205 Identities=27% Similarity=0.381 Sum_probs=168.1
Q ss_pred cCCccccccCCCCceeEEEEEeC-CCcEEEEEEcccc-ChhhHHHHHHHHHHHHHc-CCCCceeEeeEEeeCceEEEEEe
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT-SGQGLKEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYE 292 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e 292 (536)
+....+..||+|++|.|-+-++. +|...|+|++... +.+..++..+|+.+..+- .+|.+|.+||........|+.||
T Consensus 46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME 125 (282)
T KOG0984|consen 46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICME 125 (282)
T ss_pred hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHH
Confidence 34455678999999999888864 7999999999754 334456677888875554 79999999999999999999999
Q ss_pred ecCCCChhhhhhc-ccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCC
Q 039168 293 YMPNKSLDVHLFD-ATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGN 371 (536)
Q Consensus 293 ~~~~~sL~~~l~~-~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 371 (536)
.| ..||+.+-.. ..+...+++.-+-+|+..++.||.|||++- .+||||+||+||||+.+|+||++|||++..+.+.
T Consensus 126 ~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dS 202 (282)
T KOG0984|consen 126 LM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLVDS 202 (282)
T ss_pred Hh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeehhh
Confidence 99 5577765433 234566899999999999999999999975 8999999999999999999999999999877543
Q ss_pred CCccccccccccccccCcchhcC----CCCCccchHHHHHHHHHHHHhCCCCCCCCCcc
Q 039168 372 QNQANTNIIAGTYGYMAPEYAMG----GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSE 426 (536)
Q Consensus 372 ~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslG~il~elltg~~p~~~~~~~ 426 (536)
-. .+...|-..|||||.+.. ..|+.++||||||+++.||.+++.|++.+..+
T Consensus 203 iA---kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tp 258 (282)
T KOG0984|consen 203 IA---KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTP 258 (282)
T ss_pred hH---HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCH
Confidence 22 222457789999999854 36999999999999999999999998766544
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-32 Score=281.15 Aligned_cols=245 Identities=28% Similarity=0.417 Sum_probs=187.0
Q ss_pred CccccccCCCCcee-EEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHHc-CCCCceeEeeEEeeCceEEEEEeecC
Q 039168 218 FSDENKLGQGGFGP-VYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYEYMP 295 (536)
Q Consensus 218 ~~~~~~lg~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~ 295 (536)
|...+++|.|+.|+ ||+|.. +|+.||||++-... ...+.+|+..|+.- +|||||++++.-.+.+..||..|.|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC- 585 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC- 585 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-
Confidence 45567899999874 689988 68899999986433 35678999999998 6999999999999999999999999
Q ss_pred CCChhhhhhcc-cCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcC---C--CCeEEecccCccccC
Q 039168 296 NKSLDVHLFDA-TRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDD---D--MNPKISDFGTARIFG 369 (536)
Q Consensus 296 ~~sL~~~l~~~-~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~---~--~~~kl~Dfg~a~~~~ 369 (536)
..+|.+++... ...........+.++.|+++||++||+-+ ||||||||.||||+. + .+++|+|||+++.+.
T Consensus 586 ~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 586 ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 56898888653 11111122456788999999999999975 999999999999975 3 468999999999987
Q ss_pred CCCCc-cccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhC-CCCCCCCCccCCchhHHHHHHHhhcCCcccc
Q 039168 370 GNQNQ-ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISG-RKNNGFYFSEHGQTLLTYTWKLWCEGHAVEL 447 (536)
Q Consensus 370 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 447 (536)
.+... .......||.+|+|||++....-+.++|||||||++|+.++| ..||+.....+...+ -.+.....+
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl-------~~~~~L~~L 735 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANIL-------TGNYTLVHL 735 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhh-------cCccceeee
Confidence 65533 334557899999999999999888999999999999999997 888865333221110 001111111
Q ss_pred ccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHH
Q 039168 448 IDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVV 486 (536)
Q Consensus 448 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl 486 (536)
.+ ..+. ...+||.+|+.++|..||++.+||
T Consensus 736 -~~------~~d~--eA~dLI~~ml~~dP~~RPsa~~VL 765 (903)
T KOG1027|consen 736 -EP------LPDC--EAKDLISRMLNPDPQLRPSATDVL 765 (903)
T ss_pred -cc------CchH--HHHHHHHHhcCCCcccCCCHHHHh
Confidence 11 1111 455666799999999999999998
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-32 Score=252.58 Aligned_cols=267 Identities=24% Similarity=0.350 Sum_probs=193.4
Q ss_pred CCccccccCCCCceeEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeC-----ceEE
Q 039168 217 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEG-----QELL 288 (536)
Q Consensus 217 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-----~~~~ 288 (536)
+.+..+.||-|+||.||.+++. +|+.||+|++... +-..-+.+.+|+++|.-++|.|++..+++.... +++|
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 4456789999999999999974 7999999998643 223456788999999999999999999887653 3578
Q ss_pred EEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCcccc
Q 039168 289 LIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIF 368 (536)
Q Consensus 289 lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 368 (536)
+++|+|. .+|..++. ....++...+.-++.||++||+|||+.+ |+||||||.|+|++.+..+||+|||+++..
T Consensus 134 V~TELmQ-SDLHKIIV---SPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARve 206 (449)
T KOG0664|consen 134 VLTELMQ-SDLHKIIV---SPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTW 206 (449)
T ss_pred HHHHHHH-hhhhheec---cCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEeccccccccc
Confidence 8889884 46666663 3455888888889999999999999986 999999999999999999999999999876
Q ss_pred CCCCCccccccccccccccCcchhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHH--------HHHHHh
Q 039168 369 GGNQNQANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLT--------YTWKLW 439 (536)
Q Consensus 369 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~--------~~~~~~ 439 (536)
..++....+ ..+-|..|.|||+++|. .|+.++||||.|||+.||+..+..|....+....++.. ......
T Consensus 207 e~d~~~hMT-qEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~A 285 (449)
T KOG0664|consen 207 DQRDRLNMT-HEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYA 285 (449)
T ss_pred chhhhhhhH-HHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHH
Confidence 543333322 34568899999999986 59999999999999999998887765433322211110 011111
Q ss_pred hcCCcccccccccc---------CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcc
Q 039168 440 CEGHAVELIDPVLK---------QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 491 (536)
Q Consensus 440 ~~~~~~~l~~~~l~---------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 491 (536)
.++....++....+ -......-.+.+.+..+++..||.+|.+.++.+..+-.
T Consensus 286 CEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~ 346 (449)
T KOG0664|consen 286 CEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYL 346 (449)
T ss_pred hhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccc
Confidence 11111111110000 00111223345566678999999999999999876543
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-29 Score=234.31 Aligned_cols=211 Identities=36% Similarity=0.608 Sum_probs=182.8
Q ss_pred cCCCCceeEEEEEeCC-CcEEEEEEccccChh-hHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEeecCCCChhh
Q 039168 224 LGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQ-GLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDV 301 (536)
Q Consensus 224 lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~~sL~~ 301 (536)
||+|.+|.||++...+ ++.+++|++...... ..+.+.+|++.++.++|++++++++++......++++|++.+++|..
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999864 899999998765443 35678999999999999999999999999999999999999999999
Q ss_pred hhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcC-CCCeEEecccCccccCCCCCccccccc
Q 039168 302 HLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDD-DMNPKISDFGTARIFGGNQNQANTNII 380 (536)
Q Consensus 302 ~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 380 (536)
++.... ..+++..++.++.+++++|.+||+.+ ++|+||+|.||+++. +++++|+|||.+........ .....
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~ 153 (215)
T cd00180 81 LLKENE--GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTI 153 (215)
T ss_pred HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcc
Confidence 985432 35889999999999999999999996 999999999999999 89999999999987643321 12224
Q ss_pred cccccccCcchhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccccccCCCCHH
Q 039168 381 AGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQSCAPD 459 (536)
Q Consensus 381 ~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~ 459 (536)
.+...|++||.+... .++.+.|+|++|+++++|
T Consensus 154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------------- 187 (215)
T cd00180 154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------------- 187 (215)
T ss_pred cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------
Confidence 567899999999887 789999999999999999
Q ss_pred HHHHHHHHHHhhcCCCCCCCCCHHHHHHHh
Q 039168 460 ELLKFIHIGLLCVQQDPADRPTMSSVVVML 489 (536)
Q Consensus 460 ~~~~l~~li~~cl~~dP~~RPt~~evl~~L 489 (536)
..+.+++..|++.||++||++.++++.|
T Consensus 188 --~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 --PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred --HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 3466777799999999999999998753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=233.72 Aligned_cols=192 Identities=22% Similarity=0.409 Sum_probs=163.4
Q ss_pred hcCCccccccCCCCceeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHHHcC-CCCceeEeeEEeeC--ceEEEE
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQ-HKNLVRLLGCCLEG--QELLLI 290 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~--~~~~lv 290 (536)
.++|++.+++|+|.|++||.|.. .+++.++||+++.-. .+.+.+|+.+|+.|. ||||++++++..+. ....||
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 57899999999999999999984 568899999986533 367899999999997 99999999998764 567899
Q ss_pred EeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCC-CeEEecccCccccC
Q 039168 291 YEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDM-NPKISDFGTARIFG 369 (536)
Q Consensus 291 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~-~~kl~Dfg~a~~~~ 369 (536)
+||+++.+...+. ..+....+..++.++++||.|+|++| |.|||+||.|++||... .++|+|||+|.++.
T Consensus 114 FE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH 184 (338)
T KOG0668|consen 114 FEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
T ss_pred hhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcC
Confidence 9999998877655 34777889999999999999999998 99999999999999655 69999999999875
Q ss_pred CCCCccccccccccccccCcchhcCC-CCCccchHHHHHHHHHHHHhCCCCCC
Q 039168 370 GNQNQANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNG 421 (536)
Q Consensus 370 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~ 421 (536)
.... -...+.+..|--||++..- .|+..-|+|||||++..|+..+.||-
T Consensus 185 p~~e---YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFF 234 (338)
T KOG0668|consen 185 PGKE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF 234 (338)
T ss_pred CCce---eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCccc
Confidence 3332 2233556778899999764 58899999999999999999999974
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=262.43 Aligned_cols=210 Identities=22% Similarity=0.289 Sum_probs=178.8
Q ss_pred CcChhhHHHHhcCCccccccCCCCceeEEEEEeCC-CcEEEEEEccccChhhHHHHHHHHHHHHHcCC------CCceeE
Q 039168 205 LFPLGLALEATNHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQH------KNLVRL 277 (536)
Q Consensus 205 ~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------pniv~l 277 (536)
.|.+...+....+|.+....|+|-|++|-+|.+.. |..||||+|..+.. -.+.=+.|+++|++|+. -+++++
T Consensus 421 YYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~-M~KtGl~EleiLkKL~~AD~Edk~Hclrl 499 (752)
T KOG0670|consen 421 YYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV-MHKTGLKELEILKKLNDADPEDKFHCLRL 499 (752)
T ss_pred eEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH-HhhhhhHHHHHHHHhhccCchhhhHHHHH
Confidence 45566667778899999999999999999999764 88999999975432 23445679999999963 489999
Q ss_pred eeEEeeCceEEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCC-C
Q 039168 278 LGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDM-N 356 (536)
Q Consensus 278 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~-~ 356 (536)
+..|...++++||||-+ ..+|.++|....+...|....+..++.|++.||..|...+ |+|.||||+||||++.- .
T Consensus 500 ~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~i 575 (752)
T KOG0670|consen 500 FRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNI 575 (752)
T ss_pred HHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcce
Confidence 99999999999999987 6789999988888888999999999999999999999886 99999999999998654 6
Q ss_pred eEEecccCccccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 039168 357 PKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFY 423 (536)
Q Consensus 357 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~ 423 (536)
+||||||.|-..+.+.. +.. .-+..|.|||++.|..|+...|+||.||+||||.||+..|+..
T Consensus 576 LKLCDfGSA~~~~enei---tPY-LVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~ 638 (752)
T KOG0670|consen 576 LKLCDFGSASFASENEI---TPY-LVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGR 638 (752)
T ss_pred eeeccCccccccccccc---cHH-HHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCC
Confidence 89999999987654432 222 2256799999999999999999999999999999999887653
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=270.31 Aligned_cols=251 Identities=24% Similarity=0.362 Sum_probs=201.7
Q ss_pred hcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEee
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 293 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 293 (536)
.++|+.+.++|.|.||.|||++++ .++..|+|+++....+...-+++|+-+++..+|||||.+++.+...+.+|+.|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 468999999999999999999976 5899999999988888888899999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCC
Q 039168 294 MPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQN 373 (536)
Q Consensus 294 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 373 (536)
|.+|+|.+.-+ ....+++.++..+.+..++||+|||++| -+|||||-.|||+++.|.+|++|||.+..+...
T Consensus 94 cgggslQdiy~---~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitat-- 165 (829)
T KOG0576|consen 94 CGGGSLQDIYH---VTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITAT-- 165 (829)
T ss_pred cCCCcccceee---ecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhh--
Confidence 99999988764 3456999999999999999999999997 899999999999999999999999999876532
Q ss_pred ccccccccccccccCcchh---cCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccc
Q 039168 374 QANTNIIAGTYGYMAPEYA---MGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDP 450 (536)
Q Consensus 374 ~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 450 (536)
-.....+.||+.|||||+. ..+.|..++|||++|++..|+--.++|--...+- ......-.. .+++
T Consensus 166 i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpm--------r~l~LmTkS---~~qp 234 (829)
T KOG0576|consen 166 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPM--------RALFLMTKS---GFQP 234 (829)
T ss_pred hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchH--------HHHHHhhcc---CCCC
Confidence 2233457899999999987 4567999999999999999998888772211111 111111111 1111
Q ss_pred -ccc-CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 451 -VLK-QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 451 -~l~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
.++ .....+. +.++++.+|.++|++|||++.+|+
T Consensus 235 p~lkDk~kws~~---fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 235 PTLKDKTKWSEF---FHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred CcccCCccchHH---HHHHHHHHhcCCCccCCChhhhee
Confidence 111 1122333 445555899999999999988763
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=261.68 Aligned_cols=195 Identities=25% Similarity=0.393 Sum_probs=167.4
Q ss_pred cCCccccccCCCCceeEEEEEeCC-CcEEEEEEccccChh--------hHHHHHHHHHHHHHcC---CCCceeEeeEEee
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQ--------GLKEFKNEVNLIAKLQ---HKNLVRLLGCCLE 283 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~---hpniv~l~~~~~~ 283 (536)
.+|..++.||+|+||.|++|.++. ...|+||.+.+...- .+-.+-.|++||..|+ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 458999999999999999999874 678889988764321 1223456999999997 9999999999999
Q ss_pred CceEEEEEeecC-CCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecc
Q 039168 284 GQELLLIYEYMP-NKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDF 362 (536)
Q Consensus 284 ~~~~~lv~e~~~-~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Df 362 (536)
++.+||+||.-. +.+|.++|. ....+++.++..|+.||+.|+++||++| |||||||-+|+.++.+|-+||+||
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE---~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIE---FKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhh---ccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeec
Confidence 999999999754 457777874 3455999999999999999999999998 999999999999999999999999
Q ss_pred cCccccCCCCCccccccccccccccCcchhcCCCC-CccchHHHHHHHHHHHHhCCCCC
Q 039168 363 GTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIF-SIKSDVFSFGVLLLEIISGRKNN 420 (536)
Q Consensus 363 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~p~ 420 (536)
|.+....+ .....++||..|.|||++.|..| +..-|||+||++||.++....||
T Consensus 715 gsaa~~ks----gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpy 769 (772)
T KOG1152|consen 715 GSAAYTKS----GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPY 769 (772)
T ss_pred cchhhhcC----CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCC
Confidence 99976543 33556899999999999999887 67899999999999999888885
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.1e-30 Score=245.43 Aligned_cols=262 Identities=22% Similarity=0.293 Sum_probs=204.6
Q ss_pred HHHHhcCCccccccCCCCceeEEEEEeC------CCcEEEEEEcccc-ChhhHHHHHHHHHHHHHcCCCCceeEeeEEee
Q 039168 211 ALEATNHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRT-SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLE 283 (536)
Q Consensus 211 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 283 (536)
+.....+++....+-+|.||.||+|.+. +.+.|-+|.++.. +......+..|.-++..+.|||+.++.++..+
T Consensus 279 l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie 358 (563)
T KOG1024|consen 279 LTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIE 358 (563)
T ss_pred hhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEee
Confidence 3344567888889999999999999654 3456777777643 44456778899999999999999999999765
Q ss_pred -CceEEEEEeecCCCChhhhhh-----cccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCe
Q 039168 284 -GQELLLIYEYMPNKSLDVHLF-----DATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNP 357 (536)
Q Consensus 284 -~~~~~lv~e~~~~~sL~~~l~-----~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~ 357 (536)
....++++.++.-|+|..+|. +......+...+...++.|++.|++|||+++ +||.||...|.+|++..++
T Consensus 359 ~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~LqV 435 (563)
T KOG1024|consen 359 DYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQLQV 435 (563)
T ss_pred ccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhheeE
Confidence 467889999999999999997 4455566788889999999999999999997 9999999999999999999
Q ss_pred EEecccCccccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHHH
Q 039168 358 KISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTW 436 (536)
Q Consensus 358 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~ 436 (536)
||+|=.+++.+-..+...-.........||+||.+.+..|+.++|||||||+||||+| |+.|+..-++.+..
T Consensus 436 kltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~------- 508 (563)
T KOG1024|consen 436 KLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEME------- 508 (563)
T ss_pred EeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHH-------
Confidence 9999999987654443333323334568999999999999999999999999999998 77775433332211
Q ss_pred HHhhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcc
Q 039168 437 KLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 491 (536)
Q Consensus 437 ~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 491 (536)
..+.++.... .+.....++..++.-||..+|++||++++++.-|+.
T Consensus 509 ~ylkdGyRla---------QP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse 554 (563)
T KOG1024|consen 509 HYLKDGYRLA---------QPFNCPDELFTVMACCWALLPEERPSFSQLVICLSE 554 (563)
T ss_pred HHHhccceec---------CCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 1122222221 122333457777889999999999999999998875
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=242.23 Aligned_cols=141 Identities=25% Similarity=0.367 Sum_probs=114.8
Q ss_pred cChhhHHHHh-cCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHHcC-----C---CCce
Q 039168 206 FPLGLALEAT-NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQ-----H---KNLV 275 (536)
Q Consensus 206 ~~~~~~~~~~-~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h---pniv 275 (536)
-|+.....+. .+|-+.++||.|.|++||++.+. +.+.||+|+.+.. ....+....|+++|++++ | ..||
T Consensus 67 HpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV 145 (590)
T KOG1290|consen 67 HPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVV 145 (590)
T ss_pred ceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceee
Confidence 3444455555 79999999999999999999975 5778899987543 333466788999999983 3 3699
Q ss_pred eEeeEEee----CceEEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEE
Q 039168 276 RLLGCCLE----GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLL 351 (536)
Q Consensus 276 ~l~~~~~~----~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll 351 (536)
+|++.|.. +.+++||+|++ |.+|..+|... ....++...+.+|++||+.||.|||... +|||-||||+|||+
T Consensus 146 ~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s-~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 146 QLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYS-NYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred eeeccceecCCCCcEEEEEehhh-hhHHHHHHHHh-CCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 99999975 57899999999 55666666543 3345899999999999999999999987 89999999999998
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-29 Score=238.73 Aligned_cols=257 Identities=25% Similarity=0.297 Sum_probs=190.9
Q ss_pred hcCCccccccCCCCceeEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeC------c
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEG------Q 285 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~------~ 285 (536)
..+|..++.+|.|.- .|-.+.+. .+++||+|++... .....++..+|..++..++|+||++++.+|... .
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 357888889999998 55555543 5899999998654 334567788999999999999999999998643 4
Q ss_pred eEEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCc
Q 039168 286 ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTA 365 (536)
Q Consensus 286 ~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 365 (536)
..|+|||+| ..+|...+. ..++.+.+..++.|++.|++|||+.+ |+||||||+||++..+..+||.|||++
T Consensus 95 e~y~v~e~m-~~nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~a 165 (369)
T KOG0665|consen 95 EVYLVMELM-DANLCQVIL-----MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLA 165 (369)
T ss_pred hHHHHHHhh-hhHHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhh
Confidence 689999999 456766664 23788899999999999999999997 999999999999999999999999999
Q ss_pred cccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHH-------
Q 039168 366 RIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKL------- 438 (536)
Q Consensus 366 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~------- 438 (536)
+.-.. .-..+..+.|..|.|||++.+..+...+||||+||++.||++|+.-|...+.. .+|....
T Consensus 166 r~e~~---~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~i-----dQ~~ki~~~lgtpd 237 (369)
T KOG0665|consen 166 RTEDT---DFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHI-----DQWNKIIEQLGTPD 237 (369)
T ss_pred cccCc---ccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHH-----HHHHHHHHHhcCCC
Confidence 85322 22333456789999999999999999999999999999999999887642221 1111110
Q ss_pred -------------hhcCCc-------ccccccc-cc--CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHh
Q 039168 439 -------------WCEGHA-------VELIDPV-LK--QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 489 (536)
Q Consensus 439 -------------~~~~~~-------~~l~~~~-l~--~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 489 (536)
+.+... .+++... .. ....+.....+.+++.+||..||++|.++.++|+.-
T Consensus 238 ~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HP 311 (369)
T KOG0665|consen 238 PSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHP 311 (369)
T ss_pred HHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCC
Confidence 000000 0000000 00 011112233455677799999999999999999753
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.9e-28 Score=229.73 Aligned_cols=198 Identities=32% Similarity=0.478 Sum_probs=172.3
Q ss_pred CccccccCCCCceeEEEEEeCC-CcEEEEEEccccChh-hHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEeecC
Q 039168 218 FSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQ-GLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMP 295 (536)
Q Consensus 218 ~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 295 (536)
|.+.+.||.|++|.||++...+ ++.+++|.+...... ..+.+.+|++.+++++|+|++++++++......++++|++.
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 5667899999999999999865 899999999876554 67789999999999999999999999999999999999999
Q ss_pred CCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCCcc
Q 039168 296 NKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQA 375 (536)
Q Consensus 296 ~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 375 (536)
+++|..++..... .+++..++.++.+++.++.+||+.+ ++|+||+|.||+++.++.++|+|||++.........
T Consensus 81 ~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~- 154 (225)
T smart00221 81 GGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA- 154 (225)
T ss_pred CCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc-
Confidence 9999999864322 1789999999999999999999996 999999999999999999999999999877543211
Q ss_pred ccccccccccccCcchh-cCCCCCccchHHHHHHHHHHHHhCCCCCC
Q 039168 376 NTNIIAGTYGYMAPEYA-MGGIFSIKSDVFSFGVLLLEIISGRKNNG 421 (536)
Q Consensus 376 ~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~il~elltg~~p~~ 421 (536)
......++..|++||.+ ....++.++|||+||+++++|++|+.||.
T Consensus 155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~ 201 (225)
T smart00221 155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFS 201 (225)
T ss_pred cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCcc
Confidence 22334678899999998 66678889999999999999999999974
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=233.31 Aligned_cols=201 Identities=27% Similarity=0.428 Sum_probs=167.7
Q ss_pred HHhcCCccccccCCCCceeEEEEEeC----CCcEEEEEEccccChhhHHHHHHHHHHHHHc-CCCCceeEeeEEeeCceE
Q 039168 213 EATNHFSDENKLGQGGFGPVYKGTLA----DGKAIAVKRLSRTSGQGLKEFKNEVNLIAKL-QHKNLVRLLGCCLEGQEL 287 (536)
Q Consensus 213 ~~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~ 287 (536)
...+.|..+++||+|.|++||++.+. ..+.||+|.+...+.. ..+.+|+++|..+ -+.||+++.+++..++..
T Consensus 33 ~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p--~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v 110 (418)
T KOG1167|consen 33 FISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP--SRILNELEMLYRLGGSDNIIKLNGCFRNNDQV 110 (418)
T ss_pred hhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc--hHHHHHHHHHHHhccchhhhcchhhhccCCee
Confidence 44578999999999999999999864 4688999999765433 6789999999999 589999999999999999
Q ss_pred EEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcC-CCCeEEecccCcc
Q 039168 288 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDD-DMNPKISDFGTAR 366 (536)
Q Consensus 288 ~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~-~~~~kl~Dfg~a~ 366 (536)
.+|+||+++....++... ++..++..+++.++.||.++|.+| ||||||||+|+|.+. .++-.|.|||+|.
T Consensus 111 ~ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgLA~ 181 (418)
T KOG1167|consen 111 AIVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGLAQ 181 (418)
T ss_pred EEEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechhHH
Confidence 999999999999888743 778899999999999999999997 999999999999985 4578999999997
Q ss_pred ccCCCC-------------Cc-----------------------------cccccccccccccCcchhcCC-CCCccchH
Q 039168 367 IFGGNQ-------------NQ-----------------------------ANTNIIAGTYGYMAPEYAMGG-IFSIKSDV 403 (536)
Q Consensus 367 ~~~~~~-------------~~-----------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv 403 (536)
...... .. .......||++|.|||++..- ..++++||
T Consensus 182 ~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDi 261 (418)
T KOG1167|consen 182 RYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDI 261 (418)
T ss_pred HHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccce
Confidence 321100 00 000114599999999999764 47899999
Q ss_pred HHHHHHHHHHHhCCCCCCCCC
Q 039168 404 FSFGVLLLEIISGRKNNGFYF 424 (536)
Q Consensus 404 wslG~il~elltg~~p~~~~~ 424 (536)
||.|||++-+++++.||-...
T Consensus 262 ws~GVI~Lslls~~~PFf~a~ 282 (418)
T KOG1167|consen 262 WSAGVILLSLLSRRYPFFKAK 282 (418)
T ss_pred eeccceeehhhccccccccCc
Confidence 999999999999999985533
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.5e-27 Score=264.45 Aligned_cols=197 Identities=20% Similarity=0.230 Sum_probs=137.6
Q ss_pred HHcCC-CCceeEeeEE-------eeCceEEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 039168 267 AKLQH-KNLVRLLGCC-------LEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLK 338 (536)
Q Consensus 267 ~~l~h-pniv~l~~~~-------~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ 338 (536)
+.++| +||++++++| .+...+++++|++ +++|.++|... ...+++.+++.++.||++||.|||+++
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~g--- 100 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP--DRSVDAFECFHVFRQIVEIVNAAHSQG--- 100 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc--cccccHHHHHHHHHHHHHHHHHHHhCC---
Confidence 34556 5788888877 2334678889987 66999999542 345899999999999999999999997
Q ss_pred eeeCCCCCCcEEEcCCC-------------------CeEEecccCccccCCCCC--------------cccccccccccc
Q 039168 339 IIHRDLKASNVLLDDDM-------------------NPKISDFGTARIFGGNQN--------------QANTNIIAGTYG 385 (536)
Q Consensus 339 ivH~Dikp~NIll~~~~-------------------~~kl~Dfg~a~~~~~~~~--------------~~~~~~~~gt~~ 385 (536)
|+||||||+||||+..+ .+||+|||+++....... ........||+.
T Consensus 101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 180 (793)
T PLN00181 101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW 180 (793)
T ss_pred eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence 99999999999996544 455666666653211000 000112357899
Q ss_pred ccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccccccCCCCHHHHHHHH
Q 039168 386 YMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQSCAPDELLKFI 465 (536)
Q Consensus 386 y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~ 465 (536)
|||||++.+..++.++|||||||+||||++|..|+.... ..... +.... +.+. .........
T Consensus 181 Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~----~~~~~-----~~~~~----~~~~-----~~~~~~~~~ 242 (793)
T PLN00181 181 YTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS----RTMSS-----LRHRV----LPPQ-----ILLNWPKEA 242 (793)
T ss_pred eEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH----HHHHH-----HHHhh----cChh-----hhhcCHHHH
Confidence 999999999999999999999999999999887743110 00000 00000 0110 011123345
Q ss_pred HHHHhhcCCCCCCCCCHHHHHH
Q 039168 466 HIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 466 ~li~~cl~~dP~~RPt~~evl~ 487 (536)
.++.+||++||.+|||+.++++
T Consensus 243 ~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 243 SFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHHHhCCCChhhCcChHHHhh
Confidence 6777999999999999999985
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3e-26 Score=210.57 Aligned_cols=251 Identities=18% Similarity=0.304 Sum_probs=186.9
Q ss_pred HhcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHHc-CCCCceeEeeE-EeeCceEEEE
Q 039168 214 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLKEFKNEVNLIAKL-QHKNLVRLLGC-CLEGQELLLI 290 (536)
Q Consensus 214 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~-~~~~~~~~lv 290 (536)
..+.|.+.+.||+|.||.+.+++++ .+..+++|-+.+.- -...+|.+|+..--.| .|.||+.-|++ |+..+.++++
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~ 100 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV 100 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence 3468999999999999999999986 57889999887543 3357788888765555 58999998876 6677888999
Q ss_pred EeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEc--CCCCeEEecccCcccc
Q 039168 291 YEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLD--DDMNPKISDFGTARIF 368 (536)
Q Consensus 291 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~--~~~~~kl~Dfg~a~~~ 368 (536)
+||++.|+|..-+-. ..+.+.....++.|++.|+.|+|++ ++||||||.+||||- +.-++||+|||+.+..
T Consensus 101 qE~aP~gdL~snv~~----~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~ 173 (378)
T KOG1345|consen 101 QEFAPRGDLRSNVEA----AGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKV 173 (378)
T ss_pred eccCccchhhhhcCc----ccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeeccccccc
Confidence 999999999877633 3478888899999999999999998 599999999999994 3348999999999765
Q ss_pred CCCCCccccccccccccccCcchhcC---CC--CCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCC
Q 039168 369 GGNQNQANTNIIAGTYGYMAPEYAMG---GI--FSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGH 443 (536)
Q Consensus 369 ~~~~~~~~~~~~~gt~~y~aPE~~~~---~~--~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 443 (536)
+..- ....-+..|.+||.... +. ..+.+|||.||+++|.++||..||.... ..+...+.|..|..+.
T Consensus 174 g~tV-----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~---~~d~~Y~~~~~w~~rk 245 (378)
T KOG1345|consen 174 GTTV-----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKAS---IMDKPYWEWEQWLKRK 245 (378)
T ss_pred Ccee-----hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhh---ccCchHHHHHHHhccc
Confidence 3221 12233567999997743 22 4688999999999999999999987322 2233455666676665
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHH
Q 039168 444 AVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVV 486 (536)
Q Consensus 444 ~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl 486 (536)
...+.+..- .+ . .+++++..+-|..+|++|--..++-
T Consensus 246 ~~~~P~~F~--~f-s---~~a~r~Fkk~lt~~~~drcki~~~k 282 (378)
T KOG1345|consen 246 NPALPKKFN--PF-S---EKALRLFKKSLTPRFKDRCKIWTAK 282 (378)
T ss_pred CccCchhhc--cc-C---HHHHHHHHHhcCCcccccchhHHHH
Confidence 554433211 11 1 2344444588999999994444433
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.2e-25 Score=222.23 Aligned_cols=168 Identities=20% Similarity=0.196 Sum_probs=130.8
Q ss_pred HHHhcCCccccccCCCCceeEEEEEeC--CCcEEEEEEcccc-----ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeC
Q 039168 212 LEATNHFSDENKLGQGGFGPVYKGTLA--DGKAIAVKRLSRT-----SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEG 284 (536)
Q Consensus 212 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~ 284 (536)
....++|.+.+.||+|+||+||+|.++ +++.||||++... .....+.+.+|+++|++++|+|+++.+.. .
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~ 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---T 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---c
Confidence 344578999999999999999999865 4777899987533 12235668999999999999999853322 2
Q ss_pred ceEEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCC-CCCcEEEcCCCCeEEeccc
Q 039168 285 QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDL-KASNVLLDDDMNPKISDFG 363 (536)
Q Consensus 285 ~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Di-kp~NIll~~~~~~kl~Dfg 363 (536)
+..++||||++|++|.... . .. ...++.|+++||.|||++| |+|||| ||+|||++.++++||+|||
T Consensus 91 ~~~~LVmE~~~G~~L~~~~----~---~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFG 157 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHLAR----P---HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQ 157 (365)
T ss_pred CCcEEEEEccCCCCHHHhC----c---cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECc
Confidence 4579999999999996221 1 11 1467889999999999997 999999 9999999999999999999
Q ss_pred CccccCCCCCccc------cccccccccccCcchhcCC
Q 039168 364 TARIFGGNQNQAN------TNIIAGTYGYMAPEYAMGG 395 (536)
Q Consensus 364 ~a~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~ 395 (536)
+++.+........ -....+++.|+|||.+...
T Consensus 158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred cceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 9997754332211 1245678899999998654
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.5e-25 Score=202.44 Aligned_cols=165 Identities=20% Similarity=0.191 Sum_probs=122.1
Q ss_pred CChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCCccc
Q 039168 297 KSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQAN 376 (536)
Q Consensus 297 ~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 376 (536)
|+|.+++... ...+++.+++.++.||+.||.|||+++ ||+|||++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~---- 63 (176)
T smart00750 1 VSLADILEVR--GRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ---- 63 (176)
T ss_pred CcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc----
Confidence 5788888542 345999999999999999999999874 999999999999999 99998654321
Q ss_pred cccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccccccCCC
Q 039168 377 TNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQSC 456 (536)
Q Consensus 377 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~ 456 (536)
..||+.|+|||++.+..++.++|||||||++|||++|+.||....... ............ . .+. ...
T Consensus 64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~--~~~~~~~~~~~~----~--~~~--~~~ 130 (176)
T smart00750 64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS--AILEILLNGMPA----D--DPR--DRS 130 (176)
T ss_pred ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc--HHHHHHHHHhcc----C--Ccc--ccc
Confidence 257899999999999999999999999999999999999975332211 111111111000 0 000 000
Q ss_pred CHHHH---HHHHHHHHhhcCCCCCCCCCHHHHHHHhcc
Q 039168 457 APDEL---LKFIHIGLLCVQQDPADRPTMSSVVVMLAS 491 (536)
Q Consensus 457 ~~~~~---~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 491 (536)
..... ..+.+++.+||+.||++|||+.++++.+..
T Consensus 131 ~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~ 168 (176)
T smart00750 131 NLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRA 168 (176)
T ss_pred cHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHH
Confidence 11111 257888889999999999999999998754
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.6e-24 Score=214.33 Aligned_cols=259 Identities=22% Similarity=0.264 Sum_probs=195.8
Q ss_pred CCccccccCCCCceeEEEEEeCCC--cEEEEEEccccChhhHHHHHHHHHHHHHcCC----CCceeEeeEE-eeCceEEE
Q 039168 217 HFSDENKLGQGGFGPVYKGTLADG--KAIAVKRLSRTSGQGLKEFKNEVNLIAKLQH----KNLVRLLGCC-LEGQELLL 289 (536)
Q Consensus 217 ~~~~~~~lg~G~~g~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----pniv~l~~~~-~~~~~~~l 289 (536)
+|.+.++||+|+||.||++...+. ..+|+|............+..|..++..+.. +++..+++.. ..+...++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 899999999999999999997653 5889988766533322367889999999973 6899999999 57888999
Q ss_pred EEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCC-----CCeEEecccC
Q 039168 290 IYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDD-----MNPKISDFGT 364 (536)
Q Consensus 290 v~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~-----~~~kl~Dfg~ 364 (536)
||+.+ |.+|.++..... ...++...+..++.|++.+|++||+.| ++||||||+|+++... -.+.|.|||+
T Consensus 99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 99987 889988775444 567999999999999999999999998 9999999999999855 3599999999
Q ss_pred cc--ccCCCCCc----c-c-cccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHH
Q 039168 365 AR--IFGGNQNQ----A-N-TNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTW 436 (536)
Q Consensus 365 a~--~~~~~~~~----~-~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~ 436 (536)
++ .+...... . . ...+.||..|.+++...+...+++.|+||++.++.+|+.|..||.............
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~--- 250 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFE--- 250 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHH---
Confidence 99 43222211 1 1 224569999999999999999999999999999999999999985433222111111
Q ss_pred HHhhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 437 KLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 437 ~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
... ....... .....+.+..++...+. ..+..++|....+...|+..
T Consensus 251 ~~~----~~~~~~~--~~~~~~~~~~~~~~~~~---~~~~~~~Pdy~~~~~~l~~~ 297 (322)
T KOG1164|consen 251 KDP----RKLLTDR--FGDLKPEEFAKILEYID---SLDYEDKPDYEKLAELLKDV 297 (322)
T ss_pred HHh----hhhcccc--ccCCChHHHHHHHHHhh---ccCCcCCCCHHHHHHHHHHH
Confidence 110 0011111 12334566666665433 58999999999999987654
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.7e-24 Score=201.46 Aligned_cols=254 Identities=20% Similarity=0.301 Sum_probs=197.7
Q ss_pred cCCccccccCCCCceeEEEEE-eCCCcEEEEEEccccChhhHHHHHHHHHHHHHcC-CCCceeEeeEEeeCceEEEEEee
Q 039168 216 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQ-HKNLVRLLGCCLEGQELLLIYEY 293 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lv~e~ 293 (536)
-.|++.++||+|+||+.+.|+ +-+++.||||.-...+. +.++..|++..+.|. .++|...+.+..++.+-.||+|+
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~--APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL 105 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE--APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL 105 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccCC--cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence 479999999999999999998 45899999998765443 367888999999995 58999999999999999999998
Q ss_pred cCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCC-----CeEEecccCcccc
Q 039168 294 MPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDM-----NPKISDFGTARIF 368 (536)
Q Consensus 294 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~-----~~kl~Dfg~a~~~ 368 (536)
+ |-||+++..-..+ .++.+.+..++.|++.-++|+|++. +|+|||||+|.||...+ .+.|+|||+|+.+
T Consensus 106 L-GPSLEDLFD~CgR--~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y 179 (449)
T KOG1165|consen 106 L-GPSLEDLFDLCGR--RFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY 179 (449)
T ss_pred h-CcCHHHHHHHhcC--cccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence 8 8899988754443 4899999999999999999999996 99999999999996433 4899999999998
Q ss_pred CCCCCccc-----cccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCC
Q 039168 369 GGNQNQAN-----TNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGH 443 (536)
Q Consensus 369 ~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 443 (536)
.+..+... .....||.+||+-....|.+.+++.|+-|||-++++.|-|..||...-........+.+. +.+
T Consensus 180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIG----e~K 255 (449)
T KOG1165|consen 180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIG----ETK 255 (449)
T ss_pred cCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhc----ccc
Confidence 77665443 334679999999999999999999999999999999999999987655544333333222 222
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHH
Q 039168 444 AVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVV 486 (536)
Q Consensus 444 ~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl 486 (536)
....++.... ..|+|+...++.+. ..+-.+-|..+-+.
T Consensus 256 r~T~i~~Lc~--g~P~efa~Yl~yvR---~L~F~E~PDYdylr 293 (449)
T KOG1165|consen 256 RSTPIEVLCE--GFPEEFATYLRYVR---RLDFFETPDYDYLR 293 (449)
T ss_pred ccCCHHHHHh--cCHHHHHHHHHHHH---hcCcccCCCHHHHH
Confidence 2222222111 24666666666555 45555666655443
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3e-22 Score=200.36 Aligned_cols=262 Identities=30% Similarity=0.390 Sum_probs=196.4
Q ss_pred CccccccCCCCceeEEEEEeCCCcEEEEEEccccChh---hHHHHHHHHHHHHHcCCC-CceeEeeEEeeCceEEEEEee
Q 039168 218 FSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQ---GLKEFKNEVNLIAKLQHK-NLVRLLGCCLEGQELLLIYEY 293 (536)
Q Consensus 218 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hp-niv~l~~~~~~~~~~~lv~e~ 293 (536)
|...+.||.|+||.||++.+. ..+++|.+...... ....+.+|+.+++.+.|+ +++++.+.+......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 677889999999999999986 88899988755332 367889999999999988 799999999887888999999
Q ss_pred cCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCC-CeEEecccCccccCCCC
Q 039168 294 MPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDM-NPKISDFGTARIFGGNQ 372 (536)
Q Consensus 294 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~-~~kl~Dfg~a~~~~~~~ 372 (536)
+.++++..++........+.......++.|++.++.|+|+.+ ++||||||+||+++..+ .+++.|||+++.+....
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999966643221125889999999999999999999997 99999999999999988 79999999998665443
Q ss_pred Ccc----ccccccccccccCcchhcC---CCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcc
Q 039168 373 NQA----NTNIIAGTYGYMAPEYAMG---GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAV 445 (536)
Q Consensus 373 ~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 445 (536)
... ......|+..|++||.+.+ ..+....|+|++|++++++++|..|+...... ................
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~---~~~~~~~~~~~~~~~~ 233 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS---SATSQTLKIILELPTP 233 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc---ccHHHHHHHHHhcCCc
Confidence 322 2345689999999999988 57899999999999999999999995443321 0011111111111100
Q ss_pred ccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 446 ELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 446 ~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
.................+.+++..++..+|..|.+..+....
T Consensus 234 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 234 -SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred -ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 000000000001222456667778999999999999887754
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.7e-24 Score=226.79 Aligned_cols=255 Identities=24% Similarity=0.284 Sum_probs=186.1
Q ss_pred ccccccCCCCceeEEEEEeC-CCcEEEEEEcc----cc-Chhh-HHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEE
Q 039168 219 SDENKLGQGGFGPVYKGTLA-DGKAIAVKRLS----RT-SGQG-LKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 291 (536)
Q Consensus 219 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~----~~-~~~~-~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 291 (536)
...+++|.|++|.|+..... ..+.++.|... .. .... ...+..|+.+-..++|||++..+..+.+.....-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 45678999999988777643 34444444332 11 1111 122566888888899999998888877776666679
Q ss_pred eecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCC
Q 039168 292 EYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGN 371 (536)
Q Consensus 292 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 371 (536)
|||++ +|...+... ..+...++..++.|++.||+|||+.| |.||||||+|++++.+|.+||+|||.+..+...
T Consensus 401 E~~~~-Dlf~~~~~~---~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSN---GKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred hcccH-HHHHHHhcc---cccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 99999 888888543 34788899999999999999999998 999999999999999999999999999877654
Q ss_pred CCc--cccccccccccccCcchhcCCCCCc-cchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccc
Q 039168 372 QNQ--ANTNIIAGTYGYMAPEYAMGGIFSI-KSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELI 448 (536)
Q Consensus 372 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~-~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 448 (536)
... .....++|+..|+|||.+.+..|.+ ..||||.|+++..|++|+.||......+... .... ........
T Consensus 474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-~~~~-----~~~~~~~~ 547 (601)
T KOG0590|consen 474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-KTNN-----YSDQRNIF 547 (601)
T ss_pred cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-hhhc-----cccccccc
Confidence 443 4455678999999999999999864 6899999999999999999987655443321 0000 00000000
Q ss_pred cccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 449 DPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 449 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
. -..............++.+||+.||.+|.|+++|++.
T Consensus 548 ~--~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 548 E--GPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred c--ChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 0 0000112223445667789999999999999999864
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.9e-22 Score=182.71 Aligned_cols=204 Identities=22% Similarity=0.298 Sum_probs=171.9
Q ss_pred HhcCCccccccCCCCceeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHHHcCC-CCceeEeeEEeeCceEEEEE
Q 039168 214 ATNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQH-KNLVRLLGCCLEGQELLLIY 291 (536)
Q Consensus 214 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~l~~~~~~~~~~~lv~ 291 (536)
...+|.++++||.|+||.+|.|.. .+|..||||.-+..... .++..|..+.+.|++ ..|..+..+..+..+-.+||
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h--pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH--PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC--cchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 347899999999999999999984 67999999987544322 467789999999986 67888888888999999999
Q ss_pred eecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEc---CCCCeEEecccCcccc
Q 039168 292 EYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLD---DDMNPKISDFGTARIF 368 (536)
Q Consensus 292 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~---~~~~~kl~Dfg~a~~~ 368 (536)
+++ |-+|++++.-..+ .++.++++-++-|++.-++|+|.++ +|||||||+|.|.. ...++.|+|||+++.+
T Consensus 91 dLL-GPsLEdLfnfC~R--~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 91 DLL-GPSLEDLFNFCSR--RFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred ecc-CccHHHHHHHHhh--hhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhh
Confidence 988 8899988854443 4888999999999999999999996 99999999999985 4457999999999988
Q ss_pred CCCCCcc-----ccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCc
Q 039168 369 GGNQNQA-----NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFS 425 (536)
Q Consensus 369 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~ 425 (536)
.+..... ......||..|.+-....+...+.+.|+-|+|.+|.++.-|..||.....
T Consensus 165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka 226 (341)
T KOG1163|consen 165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKA 226 (341)
T ss_pred ccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccch
Confidence 6544332 22346799999999988888899999999999999999999999865443
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.1e-22 Score=187.66 Aligned_cols=173 Identities=15% Similarity=0.165 Sum_probs=134.9
Q ss_pred HHHhcCCccccccCCCCceeEEEEEeCCCcEEEEEEccccChhh---HHH------HHHHHHHHHHcCCCCceeEeeEEe
Q 039168 212 LEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQG---LKE------FKNEVNLIAKLQHKNLVRLLGCCL 282 (536)
Q Consensus 212 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~------~~~E~~~l~~l~hpniv~l~~~~~ 282 (536)
....++|+..++||.|+||.||++.. ++..+|||.+....... ... +.+|++.+.+++||+|..+..++.
T Consensus 27 ~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~ 105 (232)
T PRK10359 27 DFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL 105 (232)
T ss_pred HHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence 34578999999999999999999766 57789999996443222 222 578999999999999999988866
Q ss_pred eC--------ceEEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCC
Q 039168 283 EG--------QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDD 354 (536)
Q Consensus 283 ~~--------~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~ 354 (536)
.. ...+++|||++|.+|.++.. +++ ....+++.+|..+|+.| ++|+||||+||+++++
T Consensus 106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~ 171 (232)
T PRK10359 106 LAERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKN 171 (232)
T ss_pred ecccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCC
Confidence 43 35899999999999987631 222 24569999999999997 9999999999999998
Q ss_pred CCeEEecccCccccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHH
Q 039168 355 MNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEII 414 (536)
Q Consensus 355 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell 414 (536)
| ++|+|||........... ..+.....+..++|+|+||+++..+.
T Consensus 172 g-i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 172 G-LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred C-EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence 8 999999998755221111 01334445678999999999987764
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.1e-23 Score=188.81 Aligned_cols=246 Identities=25% Similarity=0.374 Sum_probs=185.3
Q ss_pred CccccccCCCCceeEEEEEeCCCcEEEEEEcccc--ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEeecC
Q 039168 218 FSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRT--SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMP 295 (536)
Q Consensus 218 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 295 (536)
..+..+|.+...|+.|+|++. |..+++|++.-. +...-..|..|.-.|+.+.||||+++++.|.....+.++..||+
T Consensus 192 lnl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp 270 (448)
T KOG0195|consen 192 LNLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMP 270 (448)
T ss_pred hhhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeecc
Confidence 345668999999999999996 445666766432 23334578899999999999999999999999999999999999
Q ss_pred CCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCee-eCCCCCCcEEEcCCCCeEEe--cccCccccCCCC
Q 039168 296 NKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKII-HRDLKASNVLLDDDMNPKIS--DFGTARIFGGNQ 372 (536)
Q Consensus 296 ~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iv-H~Dikp~NIll~~~~~~kl~--Dfg~a~~~~~~~ 372 (536)
.|+|...|++... ...+..++.+++.+|++|+.|||+.. +++ ---|....++||++.+.+|. |--++. .
T Consensus 271 ~gslynvlhe~t~-vvvd~sqav~faldiargmaflhsle--p~ipr~~lns~hvmidedltarismad~kfsf--q--- 342 (448)
T KOG0195|consen 271 FGSLYNVLHEQTS-VVVDHSQAVRFALDIARGMAFLHSLE--PMIPRFYLNSKHVMIDEDLTARISMADTKFSF--Q--- 342 (448)
T ss_pred chHHHHHHhcCcc-EEEecchHHHHHHHHHhhHHHHhhcc--hhhhhhhcccceEEecchhhhheecccceeee--e---
Confidence 9999999987543 45788899999999999999999986 444 44688999999999887764 321111 0
Q ss_pred CccccccccccccccCcchhcCCC---CCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcccccc
Q 039168 373 NQANTNIIAGTYGYMAPEYAMGGI---FSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELID 449 (536)
Q Consensus 373 ~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 449 (536)
.....-.|.||+||.++..+ .-+++|+|||++++|||.|...||....+-+- ..+...++
T Consensus 343 ----e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmec------gmkialeg------- 405 (448)
T KOG0195|consen 343 ----EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMEC------GMKIALEG------- 405 (448)
T ss_pred ----ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhh------hhhhhhcc-------
Confidence 11123478999999997654 45789999999999999999999865433221 11111122
Q ss_pred ccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcc
Q 039168 450 PVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 491 (536)
Q Consensus 450 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 491 (536)
++...++.....+.+|+.-|++.||.+||.+..|+-+|++
T Consensus 406 --lrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilek 445 (448)
T KOG0195|consen 406 --LRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEK 445 (448)
T ss_pred --ccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHH
Confidence 2223344444556667778999999999999999998875
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.4e-22 Score=182.13 Aligned_cols=139 Identities=17% Similarity=0.180 Sum_probs=108.4
Q ss_pred ccccCCCCceeEEEEEeCCCcEEEEEEccccChh--h------------------------HHHHHHHHHHHHHcCCCCc
Q 039168 221 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQ--G------------------------LKEFKNEVNLIAKLQHKNL 274 (536)
Q Consensus 221 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~------------------------~~~~~~E~~~l~~l~hpni 274 (536)
...||+|++|.||+|...+|+.||||++...... . ......|++++.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4689999999999999888999999998653211 0 1123459999999988776
Q ss_pred eeEeeEEeeCceEEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHH-hcCCCCCeeeCCCCCCcEEEcC
Q 039168 275 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYL-HEDSRLKIIHRDLKASNVLLDD 353 (536)
Q Consensus 275 v~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~L-H~~~~~~ivH~Dikp~NIll~~ 353 (536)
.....+... ..+|||||++++++...+.. ...+++.++..++.|++.+|.++ |+.+ |+||||||+|||++
T Consensus 82 ~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~---~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~- 152 (190)
T cd05147 82 PCPEPILLK--SHVLVMEFIGDDGWAAPRLK---DAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH- 152 (190)
T ss_pred CCCcEEEec--CCEEEEEEeCCCCCcchhhh---cCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-
Confidence 443332222 23899999999877654322 23588999999999999999999 6876 99999999999998
Q ss_pred CCCeEEecccCcccc
Q 039168 354 DMNPKISDFGTARIF 368 (536)
Q Consensus 354 ~~~~kl~Dfg~a~~~ 368 (536)
++.++|+|||++...
T Consensus 153 ~~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 DGKLYIIDVSQSVEH 167 (190)
T ss_pred CCcEEEEEccccccC
Confidence 478999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=8.8e-21 Score=176.15 Aligned_cols=140 Identities=19% Similarity=0.245 Sum_probs=111.3
Q ss_pred ccccCCCCceeEEEEEeCCCcEEEEEEccccChh--------------------------hHHHHHHHHHHHHHcCCCCc
Q 039168 221 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQ--------------------------GLKEFKNEVNLIAKLQHKNL 274 (536)
Q Consensus 221 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~E~~~l~~l~hpni 274 (536)
.+.||+|++|.||+|.+.+|+.||||++...... ....+..|...+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4689999999999999878999999998754211 01234679999999999987
Q ss_pred eeEeeEEeeCceEEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeeeCCCCCCcEEEcC
Q 039168 275 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHE-DSRLKIIHRDLKASNVLLDD 353 (536)
Q Consensus 275 v~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~ivH~Dikp~NIll~~ 353 (536)
.....+... ..++||||++++++...... ...++......++.|++.+|.++|+ .| |+||||||+|||++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~---~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~- 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLK---DVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH- 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhh---hccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-
Confidence 554444333 24899999998865443222 2347788999999999999999999 86 99999999999999
Q ss_pred CCCeEEecccCccccC
Q 039168 354 DMNPKISDFGTARIFG 369 (536)
Q Consensus 354 ~~~~kl~Dfg~a~~~~ 369 (536)
+++++|+|||++....
T Consensus 153 ~~~~~liDFG~a~~~~ 168 (190)
T cd05145 153 DGKPYIIDVSQAVELD 168 (190)
T ss_pred CCCEEEEEcccceecC
Confidence 7899999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PF01657 Stress-antifung: Salt stress response/antifungal; InterPro: IPR002902 This domain is found in plants and has no known function | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.3e-21 Score=163.10 Aligned_cols=100 Identities=24% Similarity=0.396 Sum_probs=76.7
Q ss_pred EEee---ccCc-cChhhHHHHHHHHHHHHhhccccC-ccccccccccccCCcceeEEEeecCCCChhhhhHHHHHHHhhc
Q 039168 62 CMYI---VRNF-SVPRNVTRILAQSFNDVIAMPSLS-SFRNATKGTNISNINRLETFGQCIPVLSVDDCRDCLNNTIRWI 136 (536)
Q Consensus 62 ~~~~---~~~~-~~~~~f~~~~~~ll~~l~~~a~~~-~~~fa~~~~~~~~~~~vyglaQC~~Dls~~~C~~Cl~~~~~~~ 136 (536)
+.|+ .+++ +.++.|++++++||.+|+..|+.+ +.+|+++.. ..+.++||||+||++||+++||..||..++..+
T Consensus 2 ~~Cs~~~~~~~~~~~~~f~~~l~~ll~~l~~~a~~~~~~~f~~~~~-~~~~~~vYgl~qC~~Dls~~dC~~Cl~~a~~~~ 80 (106)
T PF01657_consen 2 HFCSSNTNNNYTTDNSTFEQNLNSLLSSLVSNAASSSSKGFATGSA-GSGPDTVYGLAQCRGDLSPSDCRACLADAVANI 80 (106)
T ss_dssp --E---SSB----TT-THHHHHHHHHHHHHHHGGGTT-TEEEEEE---ST---EEEEEEE-TTS-HHHHHHHHHHHHCCH
T ss_pred CcCCCCCCCCcCCCCchHHHHHHHHHHHHHHHHhhccccCcEEeec-CCCCCeEEEEEEcCCCCChhhhHHHHHHHHHHH
Confidence 4455 3344 456679999999999999998765 479999986 457789999999999999999999999999999
Q ss_pred ccccCCCCCcceEEeccccccccccCCC
Q 039168 137 QKCFDPPGTGFGRILFPSCIMGFELHPY 164 (536)
Q Consensus 137 ~~~c~~~~~~~~~~~~~~C~lry~~~~F 164 (536)
+.+|+. +.||+|++++|+|||++++|
T Consensus 81 ~~~C~~--~~g~~v~~~~C~lRY~~~~F 106 (106)
T PF01657_consen 81 SSCCPG--SRGGRVWYDSCFLRYENYPF 106 (106)
T ss_dssp HHHTTS--BSSEEEEESSEEEEEESS--
T ss_pred HHhCCC--CceEEEECCCEEEEEECCCC
Confidence 999987 99999999999999999988
|
The structure of this domain is known and it is thought to be involved in antifungal responses in plants []. Two copies of this domain are also found together in cysteine-rich protein kinases and cysteine-rich repeat secretory proteins. The domain contains four conserved cysteines.; PDB: 3A2E_D. |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.9e-22 Score=212.74 Aligned_cols=252 Identities=20% Similarity=0.255 Sum_probs=181.4
Q ss_pred CCccccccCCCCceeEEEEEeCCCcEEEEEEccccC-hhhHHHHHH---HHHHHHHcCCCCceeEeeEEeeCceEEEEEe
Q 039168 217 HFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTS-GQGLKEFKN---EVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 292 (536)
Q Consensus 217 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~---E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 292 (536)
++...+.||.+.|=.|.+|++.+|. |+||++.+.. ...+..|.+ |++ ...++|||++++..+...+...|||-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 5677889999999999999998887 8899886554 333444443 444 566699999999999888888999999
Q ss_pred ecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccC-CC
Q 039168 293 YMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFG-GN 371 (536)
Q Consensus 293 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~-~~ 371 (536)
|..+ +|.+.| .-+..+...+...|+-||+.||..+|..| |+|+|||.+||||+.-..+.|+||...+... ..
T Consensus 102 yvkh-nLyDRl---STRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPe 174 (1431)
T KOG1240|consen 102 YVKH-NLYDRL---STRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPE 174 (1431)
T ss_pred HHhh-hhhhhh---ccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCC
Confidence 9866 455555 23345777888889999999999999997 9999999999999999999999999887532 12
Q ss_pred CCccccccccc----cccccCcchhcCC----------C-CCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHH
Q 039168 372 QNQANTNIIAG----TYGYMAPEYAMGG----------I-FSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYT 435 (536)
Q Consensus 372 ~~~~~~~~~~g----t~~y~aPE~~~~~----------~-~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~ 435 (536)
+.......+.. -..|+|||.+... . .+++.||||+||++.||++ |+++|... .+..|.
T Consensus 175 DNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS------QL~aYr 248 (1431)
T KOG1240|consen 175 DNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS------QLLAYR 248 (1431)
T ss_pred CCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH------HHHhHh
Confidence 22222222222 3479999988441 1 6789999999999999998 56666421 111111
Q ss_pred HHHhhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccCC
Q 039168 436 WKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDS 493 (536)
Q Consensus 436 ~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 493 (536)
.. . .......+.. -+...+.++++.|++.||++|.++++.|+.-.+..
T Consensus 249 ~~-----~-~~~~e~~Le~----Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~~ 296 (1431)
T KOG1240|consen 249 SG-----N-ADDPEQLLEK----IEDVSLRNLILSMIQRDPSKRLSAEDYLQKYRGLV 296 (1431)
T ss_pred cc-----C-ccCHHHHHHh----CcCccHHHHHHHHHccCchhccCHHHHHHhhhccc
Confidence 10 0 0000011110 01124667888999999999999999998866653
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.8e-20 Score=169.83 Aligned_cols=184 Identities=18% Similarity=0.127 Sum_probs=139.8
Q ss_pred ccccccCCCCceeEEEEEeCCCcEEEEEEccccChh----hHHHHHHHHHHHHHcC-CCCceeEeeEEeeCceEEEEEee
Q 039168 219 SDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQ----GLKEFKNEVNLIAKLQ-HKNLVRLLGCCLEGQELLLIYEY 293 (536)
Q Consensus 219 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lv~e~ 293 (536)
.+...|++|+||+||.+.. .+.+++.+.+.....- ....+.+|+++|++|+ |+++++++++ ...+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 4567899999999998776 6788887777654331 1225789999999995 4889999886 346999999
Q ss_pred cCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCC-CCCcEEEcCCCCeEEecccCccccCCCC
Q 039168 294 MPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDL-KASNVLLDDDMNPKISDFGTARIFGGNQ 372 (536)
Q Consensus 294 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Di-kp~NIll~~~~~~kl~Dfg~a~~~~~~~ 372 (536)
+.|.+|...+.. ....++.|++++|.++|++| |+|||| ||+|||++.++.++|+|||++.......
T Consensus 80 I~G~~L~~~~~~----------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~ 146 (218)
T PRK12274 80 LAGAAMYQRPPR----------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA 146 (218)
T ss_pred ecCccHHhhhhh----------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence 999998654311 12357889999999999997 999999 7999999999999999999998654322
Q ss_pred Cc----cc-------cccccccccccCcchhcC--CCCCccchHHHHHHHHHHHHhCCCCC
Q 039168 373 NQ----AN-------TNIIAGTYGYMAPEYAMG--GIFSIKSDVFSFGVLLLEIISGRKNN 420 (536)
Q Consensus 373 ~~----~~-------~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~p~ 420 (536)
.. .. ......++.|++|+...- ..--...++++.|.-+|.++|++.+.
T Consensus 147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~ 207 (218)
T PRK12274 147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLH 207 (218)
T ss_pred hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCc
Confidence 10 00 111236888888886532 22336789999999999999999873
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.8e-21 Score=199.16 Aligned_cols=233 Identities=25% Similarity=0.275 Sum_probs=179.2
Q ss_pred ccCCCCceeEEEEE----eCCCcEEEEEEccccChh--hHHHHHHHHHHHHHcC-CCCceeEeeEEeeCceEEEEEeecC
Q 039168 223 KLGQGGFGPVYKGT----LADGKAIAVKRLSRTSGQ--GLKEFKNEVNLIAKLQ-HKNLVRLLGCCLEGQELLLIYEYMP 295 (536)
Q Consensus 223 ~lg~G~~g~Vy~~~----~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lv~e~~~ 295 (536)
++|+|.||.|+++. .+.+.-+|+|.+.+.... .......|..++...+ ||.+|++...++.+...++++++..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 47999999999865 235788899988754322 1124566888999997 9999999999999999999999999
Q ss_pred CCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCCcc
Q 039168 296 NKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQA 375 (536)
Q Consensus 296 ~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 375 (536)
++.|...+. ....+.+.....+...++.+++++|+.+ |+|||+|++||+++.+|++++.|||+.+..-....
T Consensus 81 gg~lft~l~---~~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~-- 152 (612)
T KOG0603|consen 81 GGDLFTRLS---KEVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI-- 152 (612)
T ss_pred cchhhhccc---cCCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhh--
Confidence 999987773 3445778888888999999999999997 99999999999999999999999999986533222
Q ss_pred ccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccccccCC
Q 039168 376 NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQS 455 (536)
Q Consensus 376 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~ 455 (536)
.+||..|||||++. .....+|+||||++++||++|..||.. +.+..+-.. + ..
T Consensus 153 ----~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-------~~~~~Il~~-------~-------~~ 205 (612)
T KOG0603|consen 153 ----ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-------DTMKRILKA-------E-------LE 205 (612)
T ss_pred ----cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-------HHHHHHhhh-------c-------cC
Confidence 28899999999998 567899999999999999999999764 111111000 0 01
Q ss_pred CCHHHHHHHHHHHHhhcCCCCCCCCCH--HHHHHHhc
Q 039168 456 CAPDELLKFIHIGLLCVQQDPADRPTM--SSVVVMLA 490 (536)
Q Consensus 456 ~~~~~~~~l~~li~~cl~~dP~~RPt~--~evl~~L~ 490 (536)
.+........+++..++..+|.+|.-. ..+.++++
T Consensus 206 ~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~ 242 (612)
T KOG0603|consen 206 MPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQ 242 (612)
T ss_pred CchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhc
Confidence 122233344455568889999999755 45555544
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.82 E-value=6e-20 Score=177.33 Aligned_cols=233 Identities=21% Similarity=0.297 Sum_probs=145.7
Q ss_pred CCccccccCCCCceeEEEEEeCC-CcEEEEEEccccC---hhhHHHHHHHHHHHHHcCC----------CCceeEeeEEe
Q 039168 217 HFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTS---GQGLKEFKNEVNLIAKLQH----------KNLVRLLGCCL 282 (536)
Q Consensus 217 ~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h----------pniv~l~~~~~ 282 (536)
.....+.||.|+++.||.+++.. ++++|||++.... ...++.+++|.-....+.+ -.++..++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 34567789999999999999864 8999999875432 3346677777655544322 12222222221
Q ss_pred ---------eC---c-----eEEEEEeecCCCChhhhhhc---ccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeee
Q 039168 283 ---------EG---Q-----ELLLIYEYMPNKSLDVHLFD---ATR-SVQLDWKRRLSIINGIARGILYLHEDSRLKIIH 341 (536)
Q Consensus 283 ---------~~---~-----~~~lv~e~~~~~sL~~~l~~---~~~-~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH 341 (536)
.. . ..+++|+-+ -++|..++.- ... ...+....+..+..|+++.+++||..| ++|
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVH 168 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVH 168 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEe
Confidence 11 1 235677766 5566666432 111 122344555677799999999999998 999
Q ss_pred CCCCCCcEEEcCCCCeEEecccCccccCCCCCccccccccccccccCcchhcC--------CCCCccchHHHHHHHHHHH
Q 039168 342 RDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMG--------GIFSIKSDVFSFGVLLLEI 413 (536)
Q Consensus 342 ~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwslG~il~el 413 (536)
+||||+|+|++.+|.++|+||+.....+..... ...+..|.+||.... ..++.+.|.|+||+++|.|
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~l 243 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC-----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSL 243 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG-----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHH
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCceeec-----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHH
Confidence 999999999999999999999888765422111 233578999997743 2478899999999999999
Q ss_pred HhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCC
Q 039168 414 ISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADR 479 (536)
Q Consensus 414 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~R 479 (536)
++++.||+....+..... .+ ..+. +-...+..||..+|+.||.+|
T Consensus 244 WC~~lPf~~~~~~~~~~~-------------------~f-~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 244 WCGRLPFGLSSPEADPEW-------------------DF-SRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHSS-STCCCGGGSTSGG-------------------GG-TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHccCCCCCCCccccccc-------------------cc-hhcC-CcCHHHHHHHHHHccCCcccC
Confidence 999999886544433221 01 1222 333344556669999999988
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=4.9e-19 Score=165.55 Aligned_cols=136 Identities=19% Similarity=0.315 Sum_probs=106.1
Q ss_pred ccccccCCCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHHc-----CCCCceeEeeEEeeCc---e-EEE
Q 039168 219 SDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKL-----QHKNLVRLLGCCLEGQ---E-LLL 289 (536)
Q Consensus 219 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~hpniv~l~~~~~~~~---~-~~l 289 (536)
...+.||+|+||.||. +.+....+||++........+.+.+|+.+++.+ .||||+++++++.++. . ..+
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 4467899999999996 433333379988765444567899999999999 5799999999999873 4 337
Q ss_pred EEee--cCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHH-HHHhcCCCCCeeeCCCCCCcEEEcC----CCCeEEecc
Q 039168 290 IYEY--MPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGI-LYLHEDSRLKIIHRDLKASNVLLDD----DMNPKISDF 362 (536)
Q Consensus 290 v~e~--~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al-~~LH~~~~~~ivH~Dikp~NIll~~----~~~~kl~Df 362 (536)
|+|| +.+++|.+++.+. .+++. ..++.|++.++ +|||+++ |+||||||+|||++. +++++|+||
T Consensus 83 I~e~~G~~~~tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQC----RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred EecCCCCcchhHHHHHHcc----cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 8999 5579999999542 25554 35678888887 8999997 999999999999973 347999995
Q ss_pred cCc
Q 039168 363 GTA 365 (536)
Q Consensus 363 g~a 365 (536)
+.+
T Consensus 154 ~G~ 156 (210)
T PRK10345 154 IGE 156 (210)
T ss_pred CCC
Confidence 444
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.3e-19 Score=196.08 Aligned_cols=248 Identities=19% Similarity=0.246 Sum_probs=182.1
Q ss_pred HHhcCCccccccCCCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHHcC---CCCceeEeeEEeeCceEEE
Q 039168 213 EATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQ---HKNLVRLLGCCLEGQELLL 289 (536)
Q Consensus 213 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~l~~~~~~~~~~~l 289 (536)
...+.|.+.+.||+|+||.||+|...+|+.||||+-.....- +|.=-.+++.+|+ -+.|..+...+.-.+..++
T Consensus 695 ~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~l 771 (974)
T KOG1166|consen 695 VGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQNASVL 771 (974)
T ss_pred ecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccCCccee
Confidence 345788999999999999999999888999999987665432 1111244555665 2345555555666778899
Q ss_pred EEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcC-------CCCeEEecc
Q 039168 290 IYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDD-------DMNPKISDF 362 (536)
Q Consensus 290 v~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~-------~~~~kl~Df 362 (536)
|+||.+-|+|.+++. ..+.++|..+..++.|++..|++||..+ |||+||||+|.||.. .--++|+||
T Consensus 772 v~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lIDf 845 (974)
T KOG1166|consen 772 VSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLIDF 845 (974)
T ss_pred eeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEec
Confidence 999999999999995 4556999999999999999999999997 999999999999942 234899999
Q ss_pred cCccccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcC
Q 039168 363 GTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEG 442 (536)
Q Consensus 363 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 442 (536)
|.+-.+.--.........++|-.+--+|+..|..|+.+.|.|.|+-+++-||.|+.-- .+ ++
T Consensus 846 G~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q-----------------~~-~g 907 (974)
T KOG1166|consen 846 GRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME-----------------VK-NG 907 (974)
T ss_pred ccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH-----------------hc-CC
Confidence 9997654333344555678899999999999999999999999999999999997431 11 11
Q ss_pred CccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcc
Q 039168 443 HAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 491 (536)
Q Consensus 443 ~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 491 (536)
.. ..++..++.....+-+.+++++ +|+.|-..=|...+|...|+.
T Consensus 908 ~~-~~~~~~~~Ry~~~~~W~~~F~~---lLN~~~~~~p~l~~lr~~~~~ 952 (974)
T KOG1166|consen 908 SS-WMVKTNFPRYWKRDMWNKFFDL---LLNPDCDTLPNLQELRTELEE 952 (974)
T ss_pred cc-eeccccchhhhhHHHHHHHHHH---HhCcCcccchhHHHHHHHHHH
Confidence 11 1112223333344556666663 445444444666666655554
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=5.4e-19 Score=181.24 Aligned_cols=216 Identities=25% Similarity=0.415 Sum_probs=161.5
Q ss_pred HHHcCCCCceeEeeEEeeCceEEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCC
Q 039168 266 IAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLK 345 (536)
Q Consensus 266 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dik 345 (536)
|+.+.|.|+.++++.+.++...++|.+||..|+|.+.+.. ....+++.....++++|++||.|||... -..|+.++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeec
Confidence 4578999999999999999999999999999999999965 3456899999999999999999999874 22999999
Q ss_pred CCcEEEcCCCCeEEecccCccccCCCCCccccccccccccccCcchhcCCC-------CCccchHHHHHHHHHHHHhCCC
Q 039168 346 ASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGI-------FSIKSDVFSFGVLLLEIISGRK 418 (536)
Q Consensus 346 p~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~DvwslG~il~elltg~~ 418 (536)
+.|.+++..+.+||+|||+.................-...|.|||.+.+.. .+.+.||||+|++++|+++.+.
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~ 156 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG 156 (484)
T ss_pred cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence 999999999999999999988764311111111122345799999997642 4677999999999999999999
Q ss_pred CCCCCCccCCc-hhHHHHHHHhhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 419 NNGFYFSEHGQ-TLLTYTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 419 p~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
||......... ....+... .....+.|.+.... +....++.++..||..+|.+||++..|-..++..
T Consensus 157 ~~~~~~~~~~~~eii~~~~~-----~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~ 224 (484)
T KOG1023|consen 157 PFDLRNLVEDPDEIILRVKK-----GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTI 224 (484)
T ss_pred ccccccccCChHHHHHHHHh-----cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhh
Confidence 98764333222 22222111 11111222221110 1122577788899999999999999999888765
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.9e-18 Score=165.51 Aligned_cols=144 Identities=17% Similarity=0.194 Sum_probs=112.4
Q ss_pred cCCccccccCCCCceeEEEEE--eCCCcEEEEEEccccChh------------------------hHHHHHHHHHHHHHc
Q 039168 216 NHFSDENKLGQGGFGPVYKGT--LADGKAIAVKRLSRTSGQ------------------------GLKEFKNEVNLIAKL 269 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l 269 (536)
..|.+.+.||+|++|.||+|. ..+|+.||||++...... ....+.+|+.+++++
T Consensus 28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L 107 (237)
T smart00090 28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL 107 (237)
T ss_pred chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 358889999999999999998 457999999998643210 112356899999999
Q ss_pred CCC--CceeEeeEEeeCceEEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCC
Q 039168 270 QHK--NLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKAS 347 (536)
Q Consensus 270 ~hp--niv~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~ 347 (536)
.+. .+.+++.. ...++||||+++.+|...+.. ...+...+...++.||+.+|.+||+++ +++|+||||+
T Consensus 108 ~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp~ 178 (237)
T smart00090 108 YEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK---DVEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSEY 178 (237)
T ss_pred HhcCCCCCeeeEe----cCceEEEEEecCCcccccccc---cCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCChh
Confidence 763 34445543 234899999999888765422 223566677899999999999999985 4999999999
Q ss_pred cEEEcCCCCeEEecccCccccC
Q 039168 348 NVLLDDDMNPKISDFGTARIFG 369 (536)
Q Consensus 348 NIll~~~~~~kl~Dfg~a~~~~ 369 (536)
||+++ +++++|+|||.+....
T Consensus 179 NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 179 NILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred hEEEE-CCCEEEEEChhhhccC
Confidence 99999 8899999999987543
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.76 E-value=4.3e-19 Score=178.61 Aligned_cols=125 Identities=30% Similarity=0.448 Sum_probs=109.2
Q ss_pred ceEEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccC
Q 039168 285 QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGT 364 (536)
Q Consensus 285 ~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~ 364 (536)
.++|+.|++|+..+|.+||.+.......++.....++.|++.|++| ++ .+|+|+||.||+...+.++||.|||+
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhh
Confidence 3689999999999999999765555667888999999999999999 65 99999999999999999999999999
Q ss_pred ccccCCCC----CccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh
Q 039168 365 ARIFGGNQ----NQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 415 (536)
Q Consensus 365 a~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt 415 (536)
........ ........+||..||+||.+.+..|+.++||||||++|+||+.
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 87765443 1223344679999999999999999999999999999999997
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=9.5e-18 Score=158.59 Aligned_cols=134 Identities=19% Similarity=0.302 Sum_probs=112.6
Q ss_pred cccCCCCceeEEEEEeCCCcEEEEEEccccChh--------hHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEee
Q 039168 222 NKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQ--------GLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 293 (536)
Q Consensus 222 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 293 (536)
+.||+|++|.||+|.. .+..+++|+....... ....+.+|+.++..+.|+++.....++......+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 6778999976532211 124577899999999999988777777777888999999
Q ss_pred cCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccc
Q 039168 294 MPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARI 367 (536)
Q Consensus 294 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 367 (536)
++|++|.+++... .. .+..++.+++.+|.+||+.+ ++|+|++|.|||++ ++.++|+|||.+..
T Consensus 81 ~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999888431 12 77889999999999999997 99999999999999 78999999999864
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.75 E-value=1e-17 Score=156.69 Aligned_cols=142 Identities=20% Similarity=0.200 Sum_probs=111.4
Q ss_pred HHhcCCccccccCCCCceeEEEEEeCCCcEEEEEEccccChh----------------------hHHHHHHHHHHHHHcC
Q 039168 213 EATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQ----------------------GLKEFKNEVNLIAKLQ 270 (536)
Q Consensus 213 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~E~~~l~~l~ 270 (536)
.....|.+.+.||+|+||.||++...+|+.||||++...... ....+..|+.++..+.
T Consensus 12 ~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 91 (198)
T cd05144 12 KRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALY 91 (198)
T ss_pred HcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHH
Confidence 333447888999999999999999888999999987543210 1123567899999998
Q ss_pred CCC--ceeEeeEEeeCceEEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCc
Q 039168 271 HKN--LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASN 348 (536)
Q Consensus 271 hpn--iv~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~N 348 (536)
|++ +++.++ ....++||||+++++|..... ......++.+++.++.++|+.+ ++|+||||+|
T Consensus 92 ~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~---------~~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~N 155 (198)
T cd05144 92 EEGFPVPKPID----WNRHAVVMEYIDGVELYRVRV---------LEDPEEVLDEILEEIVKAYKHG---IIHGDLSEFN 155 (198)
T ss_pred HcCCCCCceee----cCCceEEEEEeCCcchhhccc---------cccHHHHHHHHHHHHHHHHHCC---CCcCCCCccc
Confidence 874 444443 245589999999999876542 0235678899999999999986 9999999999
Q ss_pred EEEcCCCCeEEecccCccccCC
Q 039168 349 VLLDDDMNPKISDFGTARIFGG 370 (536)
Q Consensus 349 Ill~~~~~~kl~Dfg~a~~~~~ 370 (536)
|+++++++++|+|||++..+..
T Consensus 156 ill~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 156 ILVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred EEEcCCCcEEEEECCccccCCC
Confidence 9999999999999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.75 E-value=9.6e-19 Score=187.72 Aligned_cols=214 Identities=21% Similarity=0.279 Sum_probs=142.7
Q ss_pred cCCccccccCCCCceeEEEEEeCC-CcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEeec
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 294 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 294 (536)
.+|..++.|..|+||.||..+++. .+++|+ ++.+.+-. +++ ++.....|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~-kiNkq~li----lRn---ilt~a~npfvv------------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAM-KINKQNLI----LRN---ILTFAGNPFVV------------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhh-cccccchh----hhc---cccccCCccee-------------------
Confidence 689999999999999999999874 678888 44433211 111 33333445444
Q ss_pred CCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCC--
Q 039168 295 PNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQ-- 372 (536)
Q Consensus 295 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~-- 372 (536)
|+-...+. ..+.++. +++.+++|||+.| |+|||+||+|.+|+.-|++|+.|||+.+.-....
T Consensus 136 --gDc~tllk---~~g~lPv--------dmvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at 199 (1205)
T KOG0606|consen 136 --GDCATLLK---NIGPLPV--------DMVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT 199 (1205)
T ss_pred --chhhhhcc---cCCCCcc--------hhhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhccc
Confidence 22233332 2122332 2278999999997 9999999999999999999999999987532111
Q ss_pred -----------CccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhc
Q 039168 373 -----------NQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCE 441 (536)
Q Consensus 373 -----------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 441 (536)
.....+..+|||.|+|||++....|+..+|+|++|+|+||.+-|..||....++ .++..... ..
T Consensus 200 nl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpe---elfg~vis--d~ 274 (1205)
T KOG0606|consen 200 NLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE---ELFGQVIS--DD 274 (1205)
T ss_pred hhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHH---HHHhhhhh--hh
Confidence 011123358999999999999999999999999999999999999997644332 12211111 01
Q ss_pred CCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHH
Q 039168 442 GHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVV 486 (536)
Q Consensus 442 ~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl 486 (536)
..+.+- ....+.|.+.+++ ++|+.+|..|.-....+
T Consensus 275 i~wpE~------dea~p~Ea~dli~---~LL~qnp~~Rlgt~ga~ 310 (1205)
T KOG0606|consen 275 IEWPEE------DEALPPEAQDLIE---QLLRQNPLCRLGTGGAL 310 (1205)
T ss_pred cccccc------CcCCCHHHHHHHH---HHHHhChHhhcccchhh
Confidence 111221 1223445555554 88999999996443444
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.73 E-value=3.4e-17 Score=153.35 Aligned_cols=130 Identities=21% Similarity=0.319 Sum_probs=105.4
Q ss_pred ccCCCCceeEEEEEeCCCcEEEEEEccccCh--------hhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEeec
Q 039168 223 KLGQGGFGPVYKGTLADGKAIAVKRLSRTSG--------QGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 294 (536)
Q Consensus 223 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 294 (536)
.||+|++|.||+|.+ ++..+++|+...... ....++.+|+++++.++|+++....-++......++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999995 578899998653221 11356778999999999887655555555666779999999
Q ss_pred CCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccc
Q 039168 295 PNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARI 367 (536)
Q Consensus 295 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 367 (536)
+|++|.+++.... ..++.+++.+|.+||+.+ ++|+|++|.||+++ ++.+++.|||++..
T Consensus 80 ~g~~l~~~~~~~~----------~~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGN----------DELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcH----------HHHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999988773311 078899999999999997 99999999999999 78999999999865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.5e-17 Score=177.22 Aligned_cols=137 Identities=18% Similarity=0.296 Sum_probs=111.4
Q ss_pred hcCCccccccCCCCceeEEEEEeCCCcEEEEEE-cccc-C------hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCce
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKR-LSRT-S------GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQE 286 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~-~~~~-~------~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 286 (536)
...|...+.||+|+||+||++.+.... +++|+ +.+. . ....+.+.+|+++++.++|++++....+......
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 345567889999999999999875443 33333 2211 1 1123568899999999999999988777777778
Q ss_pred EEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCcc
Q 039168 287 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTAR 366 (536)
Q Consensus 287 ~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 366 (536)
.++||||+++++|.+++. ....++.+++++|.+||+.+ ++||||||+|||+ +++.++|+|||+++
T Consensus 411 ~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~ 475 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGK 475 (535)
T ss_pred CEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCcccc
Confidence 899999999999988873 34678999999999999996 9999999999999 67899999999997
Q ss_pred c
Q 039168 367 I 367 (536)
Q Consensus 367 ~ 367 (536)
.
T Consensus 476 ~ 476 (535)
T PRK09605 476 Y 476 (535)
T ss_pred c
Confidence 5
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=5.1e-17 Score=157.39 Aligned_cols=199 Identities=24% Similarity=0.332 Sum_probs=134.5
Q ss_pred CCCCceeEeeEEee---------------------------CceEEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHH
Q 039168 270 QHKNLVRLLGCCLE---------------------------GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIIN 322 (536)
Q Consensus 270 ~hpniv~l~~~~~~---------------------------~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~ 322 (536)
+|||||+++++|.+ ...+|+||... ..+|..++.... .+.....-++.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~~----~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTRH----RSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcCC----CchHHHHHHHH
Confidence 59999999988743 34688999876 346777775322 45566677899
Q ss_pred HHHHHHHHHhcCCCCCeeeCCCCCCcEEEc--CCC--CeEEecccCccccCCCCCc----cccccccccccccCcchhcC
Q 039168 323 GIARGILYLHEDSRLKIIHRDLKASNVLLD--DDM--NPKISDFGTARIFGGNQNQ----ANTNIIAGTYGYMAPEYAMG 394 (536)
Q Consensus 323 qi~~al~~LH~~~~~~ivH~Dikp~NIll~--~~~--~~kl~Dfg~a~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~ 394 (536)
|+++|+.|||.+| |.|||+|.+||||. +++ .+.|+|||.+..-....-. ...-..-|...-||||+...
T Consensus 349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 9999999999998 99999999999984 333 5789999998643221111 11112346778999999854
Q ss_pred CC------CCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccccccCCCCHHHHHHHHHHH
Q 039168 395 GI------FSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIG 468 (536)
Q Consensus 395 ~~------~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li 468 (536)
.. .-.++|.|+.|-+.||++....||-. .+...+... .+.+..... +....++. +.+++
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~----rGem~L~~r--~Yqe~qLPa-----lp~~vpp~----~rqlV 490 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYK----RGEMLLDTR--TYQESQLPA-----LPSRVPPV----ARQLV 490 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccc----cchheechh--hhhhhhCCC-----CcccCChH----HHHHH
Confidence 32 24689999999999999999999754 111111110 012222222 22223332 44556
Q ss_pred HhhcCCCCCCCCCHHHHHHHhcc
Q 039168 469 LLCVQQDPADRPTMSSVVVMLAS 491 (536)
Q Consensus 469 ~~cl~~dP~~RPt~~evl~~L~~ 491 (536)
...|+.||++|++..-.-..|+-
T Consensus 491 ~~lL~r~pskRvsp~iAANvl~L 513 (598)
T KOG4158|consen 491 FDLLKRDPSKRVSPNIAANVLNL 513 (598)
T ss_pred HHHhcCCccccCCccHHHhHHHH
Confidence 68999999999998766665543
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.67 E-value=4.2e-16 Score=144.39 Aligned_cols=137 Identities=20% Similarity=0.262 Sum_probs=99.6
Q ss_pred ccccCCCCceeEEEEEeCCCcEEEEEEccccChh--hHHH----------------------HHHHHHHHHHcCCCC--c
Q 039168 221 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQ--GLKE----------------------FKNEVNLIAKLQHKN--L 274 (536)
Q Consensus 221 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~----------------------~~~E~~~l~~l~hpn--i 274 (536)
.+.||+|+||.||+|.+.+++.||||++...... .... ...|...+..+.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4689999999999999888999999987653211 1111 135666676665442 4
Q ss_pred eeEeeEEeeCceEEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeeeCCCCCCcEEEcC
Q 039168 275 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHE-DSRLKIIHRDLKASNVLLDD 353 (536)
Q Consensus 275 v~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~ivH~Dikp~NIll~~ 353 (536)
.+.++. ...++||||++++.+......... .. .+...++.+++.++.++|. .+ |+|+||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~- 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD- 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-
Confidence 445543 245899999999654322111110 11 5678899999999999998 75 99999999999999
Q ss_pred CCCeEEecccCccccC
Q 039168 354 DMNPKISDFGTARIFG 369 (536)
Q Consensus 354 ~~~~kl~Dfg~a~~~~ 369 (536)
++.++|+|||.+....
T Consensus 150 ~~~~~liDfg~a~~~~ 165 (187)
T cd05119 150 DGKVYIIDVPQAVEID 165 (187)
T ss_pred CCcEEEEECccccccc
Confidence 8899999999997553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.67 E-value=7.5e-18 Score=180.81 Aligned_cols=256 Identities=22% Similarity=0.306 Sum_probs=192.1
Q ss_pred cCCccccccCCCCceeEEEEEeC--CCcEEEEEEccccC--hhhHHHHHHHHHHHHHcC-CCCceeEeeEEeeCceEEEE
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA--DGKAIAVKRLSRTS--GQGLKEFKNEVNLIAKLQ-HKNLVRLLGCCLEGQELLLI 290 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lv 290 (536)
..|.+.+.||+|+|+.|-..... ....+|+|.+.... ....+.+..|..+-+.+. |+|++.+++...+.+..+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 35677778999999999888753 35567777776543 344556667888888887 99999999999999999999
Q ss_pred EeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHh-cCCCCCeeeCCCCCCcEEEcCCC-CeEEecccCcccc
Q 039168 291 YEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLH-EDSRLKIIHRDLKASNVLLDDDM-NPKISDFGTARIF 368 (536)
Q Consensus 291 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH-~~~~~~ivH~Dikp~NIll~~~~-~~kl~Dfg~a~~~ 368 (536)
++|..++++...+.. ......+....-.++.|+..++.|+| ..+ +.|+||||+|.+++..+ .++++|||+|..+
T Consensus 100 ~~~s~g~~~f~~i~~-~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISH-PDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAY 175 (601)
T ss_pred cCccccccccccccc-CCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhccc
Confidence 999999999888731 11113555667778999999999999 776 99999999999999999 9999999999988
Q ss_pred CC-CCCccccccccc-cccccCcchhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcc
Q 039168 369 GG-NQNQANTNIIAG-TYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAV 445 (536)
Q Consensus 369 ~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 445 (536)
.. ...........| ++.|+|||...+. ...+..|+||.|+++.-+++|..|+........... . |.+....
T Consensus 176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~-~-----~~~~~~~ 249 (601)
T KOG0590|consen 176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYS-S-----WKSNKGR 249 (601)
T ss_pred cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccce-e-----ecccccc
Confidence 76 454455555678 9999999999885 457889999999999999999999877555442211 1 1111100
Q ss_pred ccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 446 ELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 446 ~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
. .. .....-....+++..+++..+|..|.+.+++-.
T Consensus 250 ~--~~----~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 250 F--TQ----LPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred c--cc----CccccCChhhhhcccccccCCchhccccccccc
Confidence 0 00 001111223445555888999999999888763
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.67 E-value=9.1e-16 Score=136.15 Aligned_cols=135 Identities=21% Similarity=0.206 Sum_probs=114.4
Q ss_pred cccccCCCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHHcCC--CCceeEeeEEeeCceEEEEEeecCCC
Q 039168 220 DENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQH--KNLVRLLGCCLEGQELLLIYEYMPNK 297 (536)
Q Consensus 220 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--pniv~l~~~~~~~~~~~lv~e~~~~~ 297 (536)
+.+.||+|.++.||++...+ ..+++|....... ...+.+|+.+++.++| +++++++.+....+..+++|||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 45789999999999999854 7899998865443 4678899999999977 58999999888888899999999988
Q ss_pred ChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccc
Q 039168 298 SLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARI 367 (536)
Q Consensus 298 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 367 (536)
.+..+ +......++.+++++|.+||.....+++|+|++|+||++++.+.+++.|||.+..
T Consensus 79 ~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 77543 4456677889999999999986444599999999999999989999999999864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.62 E-value=4.6e-15 Score=142.43 Aligned_cols=136 Identities=22% Similarity=0.275 Sum_probs=104.7
Q ss_pred ccccC-CCCceeEEEEEeCCCcEEEEEEccccC-------------hhhHHHHHHHHHHHHHcCCCCc--eeEeeEEeeC
Q 039168 221 ENKLG-QGGFGPVYKGTLADGKAIAVKRLSRTS-------------GQGLKEFKNEVNLIAKLQHKNL--VRLLGCCLEG 284 (536)
Q Consensus 221 ~~~lg-~G~~g~Vy~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~hpni--v~l~~~~~~~ 284 (536)
...|| .|+.|+||++... +..++||++.... ......+.+|++++.+|+|+++ ++.+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 34687 8999999999874 7789999875321 1223467889999999998874 6677664432
Q ss_pred -c---eEEEEEeecCC-CChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEE
Q 039168 285 -Q---ELLLIYEYMPN-KSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKI 359 (536)
Q Consensus 285 -~---~~~lv~e~~~~-~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl 359 (536)
. ..++|||+++| .+|.+++.. ..+++. .+.+|+.+|.+||+.| |+|+||||.|||++.++.++|
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~L 183 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE----APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWL 183 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc----CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEE
Confidence 2 23599999997 688887743 224443 3578999999999997 999999999999999899999
Q ss_pred ecccCcccc
Q 039168 360 SDFGTARIF 368 (536)
Q Consensus 360 ~Dfg~a~~~ 368 (536)
+|||.+...
T Consensus 184 IDfg~~~~~ 192 (239)
T PRK01723 184 IDFDRGELR 192 (239)
T ss_pred EECCCcccC
Confidence 999998753
|
|
| >PF01657 Stress-antifung: Salt stress response/antifungal; InterPro: IPR002902 This domain is found in plants and has no known function | Back alignment and domain information |
|---|
Probab=99.53 E-value=4.7e-15 Score=123.50 Aligned_cols=52 Identities=33% Similarity=0.868 Sum_probs=47.5
Q ss_pred CEeeeccCCCChhchHHHHHHHHHHHHHhCCCCcceEEEcCeeEEEeCCCCC
Q 039168 1 FGLYLCKFDITFQSCQRCIATAVKAVMKKCNGTRKAIIWYRECMVRYSDKSL 52 (536)
Q Consensus 1 ygl~~Cr~d~~~~~C~~c~~~a~~~~~~~C~~~~~~~~~~~~C~lrys~~~f 52 (536)
|||+||++|+++.+|..||+.|+..+.+.|+..++|+||++.|+|||++++|
T Consensus 55 Ygl~qC~~Dls~~dC~~Cl~~a~~~~~~~C~~~~g~~v~~~~C~lRY~~~~F 106 (106)
T PF01657_consen 55 YGLAQCRGDLSPSDCRACLADAVANISSCCPGSRGGRVWYDSCFLRYENYPF 106 (106)
T ss_dssp EEEEEE-TTS-HHHHHHHHHHHHCCHHHHTTSBSSEEEEESSEEEEEESS--
T ss_pred EEEEEcCCCCChhhhHHHHHHHHHHHHHhCCCCceEEEECCCEEEEEECCCC
Confidence 8999999999999999999999999999999999999999999999999987
|
The structure of this domain is known and it is thought to be involved in antifungal responses in plants []. Two copies of this domain are also found together in cysteine-rich protein kinases and cysteine-rich repeat secretory proteins. The domain contains four conserved cysteines.; PDB: 3A2E_D. |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.2e-13 Score=143.91 Aligned_cols=141 Identities=23% Similarity=0.279 Sum_probs=99.2
Q ss_pred ccccCCCCceeEEEEEeCCCcEEEEEEccccChhhH------------------------------H----------HHH
Q 039168 221 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGL------------------------------K----------EFK 260 (536)
Q Consensus 221 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~------------------------------~----------~~~ 260 (536)
.+.||.|++|.||+|++++|+.||||+......... + .|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 368999999999999999999999999865421110 0 134
Q ss_pred HHHHHHHHcC----CCCceeEeeEE-eeCceEEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHH-HHHHHhcC
Q 039168 261 NEVNLIAKLQ----HKNLVRLLGCC-LEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIAR-GILYLHED 334 (536)
Q Consensus 261 ~E~~~l~~l~----hpniv~l~~~~-~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~-al~~LH~~ 334 (536)
+|...+.++. |.+-+.+-.++ ...+..++||||++|++|.+....... ..+ ...++.+++. .+..+|..
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~~---~~~ia~~~~~~~l~ql~~~ 276 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--GLD---RKALAENLARSFLNQVLRD 276 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc--CCC---HHHHHHHHHHHHHHHHHhC
Confidence 4555555552 33333333333 224457999999999999887643211 122 3345566665 46788988
Q ss_pred CCCCeeeCCCCCCcEEEcCCCCeEEecccCccccC
Q 039168 335 SRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFG 369 (536)
Q Consensus 335 ~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 369 (536)
| ++|+|+||.||+++++++++|.|||++..+.
T Consensus 277 g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 277 G---FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred C---ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 6 9999999999999999999999999998764
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.46 E-value=1.8e-13 Score=140.86 Aligned_cols=251 Identities=21% Similarity=0.228 Sum_probs=180.2
Q ss_pred hcCCccccccCC--CCceeEEEEEe--C-CCcEEEEEEcc--ccChhhHHHHHHHHHHHHHc-CCCCceeEeeEEeeCce
Q 039168 215 TNHFSDENKLGQ--GGFGPVYKGTL--A-DGKAIAVKRLS--RTSGQGLKEFKNEVNLIAKL-QHKNLVRLLGCCLEGQE 286 (536)
Q Consensus 215 ~~~~~~~~~lg~--G~~g~Vy~~~~--~-~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~ 286 (536)
...|.+.+.+|. |.+|.||.+.. . ++..+|+|+-. .........=.+|+...+.+ .|+|.++.+..+...+.
T Consensus 113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~ 192 (524)
T KOG0601|consen 113 DQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGI 192 (524)
T ss_pred hhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCc
Confidence 456778889999 99999999986 3 58889999833 22223323334577777777 58999999999999999
Q ss_pred EEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHH----HHHHHhcCCCCCeeeCCCCCCcEEEcCC-CCeEEec
Q 039168 287 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIAR----GILYLHEDSRLKIIHRDLKASNVLLDDD-MNPKISD 361 (536)
Q Consensus 287 ~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~----al~~LH~~~~~~ivH~Dikp~NIll~~~-~~~kl~D 361 (536)
.++-+|++. .+|..+.+. ....++...++..+.+..+ ||.++|... ++|-|+||.||++..+ ...+++|
T Consensus 193 lfiqtE~~~-~sl~~~~~~--~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~d 266 (524)
T KOG0601|consen 193 LFIQTELCG-ESLQSYCHT--PCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTD 266 (524)
T ss_pred ceeeecccc-chhHHhhhc--ccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCC
Confidence 999999996 566555532 3334778888888888888 999999985 9999999999999999 7899999
Q ss_pred ccCccccCCCCCcccc---ccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHH
Q 039168 362 FGTARIFGGNQNQANT---NIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKL 438 (536)
Q Consensus 362 fg~a~~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 438 (536)
||+...++........ ....|...|++||.+. +.++...|||++|.++.+-.++.......-.. .
T Consensus 267 f~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~--------~--- 334 (524)
T KOG0601|consen 267 FGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNS--------S--- 334 (524)
T ss_pred cceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCC--------C---
Confidence 9999988765532222 1225788899999764 45789999999999999999987653221000 1
Q ss_pred hhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 439 WCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 439 ~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
|.+.+-..+-+... .....++-..+.+|++.+|-.|++.+.++..
T Consensus 335 W~~~r~~~ip~e~~-----~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l 379 (524)
T KOG0601|consen 335 WSQLRQGYIPLEFC-----EGGSSSLRSVTSQMLDEDPRLRLTAQILTAL 379 (524)
T ss_pred ccccccccCchhhh-----cCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence 11111111111111 1111233336678999999999998887743
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.41 E-value=3.6e-13 Score=128.12 Aligned_cols=205 Identities=20% Similarity=0.250 Sum_probs=140.5
Q ss_pred HHHHHHcCCCCceeEeeEEeeCc-----eEEEEEeecCCCChhhhhhcccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCC
Q 039168 263 VNLIAKLQHKNLVRLLGCCLEGQ-----ELLLIYEYMPNKSLDVHLFDATR-SVQLDWKRRLSIINGIARGILYLHEDSR 336 (536)
Q Consensus 263 ~~~l~~l~hpniv~l~~~~~~~~-----~~~lv~e~~~~~sL~~~l~~~~~-~~~l~~~~~~~i~~qi~~al~~LH~~~~ 336 (536)
+.-|-++.|.|||+++.+|.+.+ +..++.|||..|++..+|.+..+ ...+......+|+-||+.||.|||+. .
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~ 196 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-D 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-C
Confidence 44555667999999999987644 47899999999999999987443 44577788889999999999999998 5
Q ss_pred CCeeeCCCCCCcEEEcCCCCeEEecc--cCccccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHH
Q 039168 337 LKIIHRDLKASNVLLDDDMNPKISDF--GTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEII 414 (536)
Q Consensus 337 ~~ivH~Dikp~NIll~~~~~~kl~Df--g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell 414 (536)
+.|+|+.+..+-|++..+|-+|+.-- ......-............+.++|.+||.-.....+.++|||+||+..++|.
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 78999999999999999998887521 1111110011111122234678999999876667788999999999999999
Q ss_pred hCCCCCCCCCccCCchhHHHHHHHhhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 415 SGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 415 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
.+..-......... .+.. ....+.. +...+ -. ..+..|++..|..||+|++++.
T Consensus 277 ilEiq~tnseS~~~---~ee~----ia~~i~~-len~l--------qr---~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 277 ILEIQSTNSESKVE---VEEN----IANVIIG-LENGL--------QR---GSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred HheeccCCCcceee---hhhh----hhhheee-ccCcc--------cc---CcCcccccCCCCCCcchhhhhc
Confidence 88754222111100 0000 0000000 01111 11 2334899999999999999873
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.40 E-value=1.4e-12 Score=118.51 Aligned_cols=130 Identities=22% Similarity=0.170 Sum_probs=97.4
Q ss_pred ccccCCCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCce-eEeeEEeeCceEEEEEeecCCCCh
Q 039168 221 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLV-RLLGCCLEGQELLLIYEYMPNKSL 299 (536)
Q Consensus 221 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv-~l~~~~~~~~~~~lv~e~~~~~sL 299 (536)
.+.|+.|.++.||+++.. ++.|++|....... ....+.+|+.+++.+.+.+++ +++.+. ....++||||++|.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence 357899999999999874 77899998765432 123467899999999765544 444443 2345899999999887
Q ss_pred hhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCC--CCCeeeCCCCCCcEEEcCCCCeEEecccCcc
Q 039168 300 DVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDS--RLKIIHRDLKASNVLLDDDMNPKISDFGTAR 366 (536)
Q Consensus 300 ~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 366 (536)
.... . ....++.+++++|..||..+ ...++|+|++|.||+++ ++.++++|||.+.
T Consensus 79 ~~~~--------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 79 LTED--------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred cccc--------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 6430 1 11345678999999999886 22369999999999999 6789999999986
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.40 E-value=4.5e-13 Score=141.37 Aligned_cols=145 Identities=17% Similarity=0.175 Sum_probs=95.1
Q ss_pred hcCCccccccCCCCceeEEEEEeCC-CcEEEEEEccccChh----------------------------------hHHH-
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQ----------------------------------GLKE- 258 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~----------------------------------~~~~- 258 (536)
...|+. +.||+|++|.||+|++++ |+.||||++.+...+ ..+.
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 345766 789999999999999987 999999998754211 0111
Q ss_pred -----HHHHHHHHHHcC----CCCceeEeeEEee-CceEEEEEeecCCCChhhhhhcccCC---CCCCHHHHHHHHHHHH
Q 039168 259 -----FKNEVNLIAKLQ----HKNLVRLLGCCLE-GQELLLIYEYMPNKSLDVHLFDATRS---VQLDWKRRLSIINGIA 325 (536)
Q Consensus 259 -----~~~E~~~l~~l~----hpniv~l~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~---~~l~~~~~~~i~~qi~ 325 (536)
+.+|...+.++. +.+.+.+-.++.+ ....+|||||++|+.+.++..-.... ..+.+..+..++.|++
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif 277 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF 277 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH
Confidence 233444444442 3333443333332 45678999999999997642111111 1233333334444443
Q ss_pred HHHHHHhcCCCCCeeeCCCCCCcEEEcCCC----CeEEecccCccccCC
Q 039168 326 RGILYLHEDSRLKIIHRDLKASNVLLDDDM----NPKISDFGTARIFGG 370 (536)
Q Consensus 326 ~al~~LH~~~~~~ivH~Dikp~NIll~~~~----~~kl~Dfg~a~~~~~ 370 (536)
..| ++|+|+||.||+++.++ ++++.|||++..+..
T Consensus 278 -------~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 278 -------RDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred -------hCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 454 99999999999999888 999999999987753
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.33 E-value=9.6e-12 Score=129.40 Aligned_cols=166 Identities=20% Similarity=0.284 Sum_probs=128.9
Q ss_pred CCCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEeecCCCChhhhhhcccCCCCCCHHHH
Q 039168 238 ADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRR 317 (536)
Q Consensus 238 ~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~ 317 (536)
.++.+|.|...+..+....+...+-++.|+.++||||+++++.++.++..|+|+|-+ ..|..++.. +....+
T Consensus 35 ~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~------l~~~~v 106 (690)
T KOG1243|consen 35 ADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKE------LGKEEV 106 (690)
T ss_pred ccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHH------hHHHHH
Confidence 468889888887766655566788899999999999999999999999999999976 345555533 335666
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCCccccccccccccccCcchhcCCCC
Q 039168 318 LSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIF 397 (536)
Q Consensus 318 ~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 397 (536)
..-+.||+.||.+||+.+ +++|++|.-+.|+|+..|..||++|.++.......... ....--..|..|+.+....
T Consensus 107 ~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~--~~~~~~~s~~~P~~~~~s~- 181 (690)
T KOG1243|consen 107 CLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPA--KSLYLIESFDDPEEIDPSE- 181 (690)
T ss_pred HHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCccc--ccchhhhcccChhhcCccc-
Confidence 778899999999999877 89999999999999999999999999886543222111 1111123466777554332
Q ss_pred CccchHHHHHHHHHHHHhCC
Q 039168 398 SIKSDVFSFGVLLLEIISGR 417 (536)
Q Consensus 398 ~~~~DvwslG~il~elltg~ 417 (536)
-..|.|.||+++++++.|.
T Consensus 182 -~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 182 -WSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred -cchhhhhHHHHHHHHhCcc
Confidence 3469999999999999993
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.31 E-value=5.1e-11 Score=109.60 Aligned_cols=137 Identities=14% Similarity=0.131 Sum_probs=99.5
Q ss_pred ccccCCCCceeEEEEEeCC-------CcEEEEEEccccC----------------------hhhHHH----HHHHHHHHH
Q 039168 221 ENKLGQGGFGPVYKGTLAD-------GKAIAVKRLSRTS----------------------GQGLKE----FKNEVNLIA 267 (536)
Q Consensus 221 ~~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~----------------------~~~~~~----~~~E~~~l~ 267 (536)
...||.|--+.||.|...+ +..+|||+..... ...... .++|+..|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 4579999999999998543 5799999764210 011222 348999999
Q ss_pred HcCC--CCceeEeeEEeeCceEEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHH-hcCCCCCeeeCCC
Q 039168 268 KLQH--KNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYL-HEDSRLKIIHRDL 344 (536)
Q Consensus 268 ~l~h--pniv~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~L-H~~~~~~ivH~Di 344 (536)
++.. -++.+++.+ ..-++||||+.+..+..... +...++..+...+..+++.+|..| |..+ ++|+||
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~L---kd~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDL 151 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKL---KDAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADL 151 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhh---hccccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence 9954 466666665 45689999998764432211 112245566777889999999998 7776 999999
Q ss_pred CCCcEEEcCCCCeEEecccCcccc
Q 039168 345 KASNVLLDDDMNPKISDFGTARIF 368 (536)
Q Consensus 345 kp~NIll~~~~~~kl~Dfg~a~~~ 368 (536)
++.|||++ ++.+.|+|||.+...
T Consensus 152 s~~NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 152 SEYNMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred CHHHEEEE-CCcEEEEECCCceeC
Confidence 99999997 468999999988754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.24 E-value=5.8e-12 Score=129.86 Aligned_cols=246 Identities=21% Similarity=0.215 Sum_probs=174.9
Q ss_pred hcCCccccccCCCCceeEEEEEeC--CCcEEEEEEccccChhhHHHH--HHHHHHHHHc-CCCCceeEeeEEeeCceEEE
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA--DGKAIAVKRLSRTSGQGLKEF--KNEVNLIAKL-QHKNLVRLLGCCLEGQELLL 289 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~--~~E~~~l~~l-~hpniv~l~~~~~~~~~~~l 289 (536)
..+|..+..||.|.|+.|++.... ++..|++|.+.+.......++ ..|+.+...+ .|.++++.+..|......|+
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~i 343 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYI 343 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccC
Confidence 457888899999999999988643 588899998876544433333 3577777766 68999999999999999999
Q ss_pred EEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCC-CCeEEecccCcccc
Q 039168 290 IYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDD-MNPKISDFGTARIF 368 (536)
Q Consensus 290 v~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~-~~~kl~Dfg~a~~~ 368 (536)
-.||++++++...+ .-...+++..++.+..|++.++.++|+.. ++|+|+||+||++..+ +.-++.|||....+
T Consensus 344 p~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t~~ 417 (524)
T KOG0601|consen 344 PLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWTRL 417 (524)
T ss_pred chhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhcccccccccc
Confidence 99999999987666 22334788889999999999999999986 9999999999999986 77899999998643
Q ss_pred CCCCCcccccccccccccc--CcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccc
Q 039168 369 GGNQNQANTNIIAGTYGYM--APEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVE 446 (536)
Q Consensus 369 ~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 446 (536)
..... .....-++. +|+......+..+.|++|||..+.+.+++..-... ... |.....+..
T Consensus 418 ~~~~~-----~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~-----~~~-----~~~i~~~~~-- 480 (524)
T KOG0601|consen 418 AFSSG-----VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSES-----GVQ-----SLTIRSGDT-- 480 (524)
T ss_pred ceecc-----cccccccccccchhhccccccccccccccccccccccccCcccCcc-----ccc-----ceeeecccc--
Confidence 21111 112233344 55555566788999999999999999998754211 100 000001100
Q ss_pred cccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcc
Q 039168 447 LIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 491 (536)
Q Consensus 447 l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 491 (536)
+ ...... ..+..+...++.+++..||.+.++......
T Consensus 481 ---p--~~~~~~---~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 481 ---P--NLPGLK---LQLQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred ---c--CCCchH---HhhhhhhhhhcCCccccchhhhhhcccchh
Confidence 1 111112 334444457889999999999888765443
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.24 E-value=1e-10 Score=111.14 Aligned_cols=141 Identities=18% Similarity=0.273 Sum_probs=109.5
Q ss_pred cccCCCCceeEEEEEeCCCcEEEEEEccccCh-hhHHHHHHHHHHHHHcCC--CCceeEeeEEeeC---ceEEEEEeecC
Q 039168 222 NKLGQGGFGPVYKGTLADGKAIAVKRLSRTSG-QGLKEFKNEVNLIAKLQH--KNLVRLLGCCLEG---QELLLIYEYMP 295 (536)
Q Consensus 222 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h--pniv~l~~~~~~~---~~~~lv~e~~~ 295 (536)
+.|+.|..+.||+++..+|+.+++|....... .....+.+|+++++.+.+ .++.+++.+.... +..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 57899999999999987778999998765432 234678899999999976 3467777776654 25689999999
Q ss_pred CCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCC----------------------------------------
Q 039168 296 NKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDS---------------------------------------- 335 (536)
Q Consensus 296 ~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---------------------------------------- 335 (536)
|.++...+.. ..++..+...++.+++++|..||+..
T Consensus 84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9988766521 23667777788888888888888421
Q ss_pred -------------CCCeeeCCCCCCcEEEcC--CCCeEEecccCcc
Q 039168 336 -------------RLKIIHRDLKASNVLLDD--DMNPKISDFGTAR 366 (536)
Q Consensus 336 -------------~~~ivH~Dikp~NIll~~--~~~~kl~Dfg~a~ 366 (536)
...++|+|++|.||++++ ++.+.|+||+.+.
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 235799999999999998 5668999999875
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.14 E-value=6e-10 Score=99.11 Aligned_cols=131 Identities=22% Similarity=0.316 Sum_probs=100.0
Q ss_pred cccCCCCceeEEEEEeCCCcEEEEEEccccC--hh------hHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEee
Q 039168 222 NKLGQGGFGPVYKGTLADGKAIAVKRLSRTS--GQ------GLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 293 (536)
Q Consensus 222 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~------~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 293 (536)
..|++|+-+.+|.+.+. |..+++|.-.+.. .. ..+.-.+|..++.++.--.|.-..=+..+.....|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 46889999999999774 4446666433221 11 123467899999999766555555555667778899999
Q ss_pred cCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccc
Q 039168 294 MPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARI 367 (536)
Q Consensus 294 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 367 (536)
++|..|.+.+... ...++..|-.-+.-||..| |+|+||.++||++.... +.++|||++..
T Consensus 81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999998888443 2567788888899999997 99999999999998775 99999999974
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.08 E-value=2e-09 Score=95.33 Aligned_cols=143 Identities=22% Similarity=0.282 Sum_probs=105.8
Q ss_pred cccccCCCCceeEEEEEeCCCcEEEEEEcccc--------ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEE
Q 039168 220 DENKLGQGGFGPVYKGTLADGKAIAVKRLSRT--------SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 291 (536)
Q Consensus 220 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--------~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 291 (536)
.+..|-+|+-+.|+++.+ .|+...||.-... ..-...+.++|.++|.++.--.|.-..-++.+...-.++|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 567899999999999998 4667666643221 1122456778999999987555554444566666678999
Q ss_pred eecCC-CChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCC---CeEEecccCccc
Q 039168 292 EYMPN-KSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDM---NPKISDFGTARI 367 (536)
Q Consensus 292 e~~~~-~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~---~~kl~Dfg~a~~ 367 (536)
||++| .++.+++....... ........++.+|-+.+.-||.++ |+|+||..+||++.+++ .+.+.|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~-~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDE-SEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCc-ccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 99988 46777776544433 223333788999999999999997 99999999999997655 358999999864
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.06 E-value=5.9e-09 Score=105.64 Aligned_cols=170 Identities=24% Similarity=0.357 Sum_probs=129.8
Q ss_pred CceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEe----eCceEEEEEeecCCC-Chhh
Q 039168 228 GFGPVYKGTLA-DGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCL----EGQELLLIYEYMPNK-SLDV 301 (536)
Q Consensus 228 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~----~~~~~~lv~e~~~~~-sL~~ 301 (536)
.-.+.||+... +|..|++|+++............-+++++++.|+|+|++.++|. .+..+++|++|.++. +|.+
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 34678898754 79999999995544333334445688999999999999999887 345789999999874 5554
Q ss_pred hhhcc------------cCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccC
Q 039168 302 HLFDA------------TRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFG 369 (536)
Q Consensus 302 ~l~~~------------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 369 (536)
.-... ......+++.+|.++.|+..||.++|+.| +.-+-|.|.+||++.+.+++|+..|+...+.
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeec
Confidence 43321 12334788999999999999999999997 7779999999999999999999998887664
Q ss_pred CCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCC
Q 039168 370 GNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKN 419 (536)
Q Consensus 370 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p 419 (536)
.+.. |.+.+ -.+-|.=-||.+++.|.||...
T Consensus 445 ~d~~----------------~~le~---~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 445 EDPT----------------EPLES---QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCCC----------------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence 4331 01111 2356888999999999999755
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.04 E-value=7.2e-11 Score=127.98 Aligned_cols=251 Identities=19% Similarity=0.196 Sum_probs=169.4
Q ss_pred HHhcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccc---cChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEE
Q 039168 213 EATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSR---TSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELL 288 (536)
Q Consensus 213 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 288 (536)
...+.+.+.+.+-.|.++.++.++-. .|...++|.... -.....+..+.+-.++-...+|.++.....+......+
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~ 880 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP 880 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence 34567788888999999999887643 233333333221 11222334445555555566788887776667778899
Q ss_pred EEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCcccc
Q 039168 289 LIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIF 368 (536)
Q Consensus 289 lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 368 (536)
|+++|..+++|...|+... ..+.+-....+..+..++++||..- +.|+|++|.|+|+..+++.++.|||.....
T Consensus 881 L~~~~~~~~~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v 954 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKLHNSG---CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKV 954 (1205)
T ss_pred hhhHHhccCCchhhhhcCC---CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCcccccccc
Confidence 9999999999988885433 3566666777888999999999874 899999999999999999999999843322
Q ss_pred CCC---------------------C--------CccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCC
Q 039168 369 GGN---------------------Q--------NQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKN 419 (536)
Q Consensus 369 ~~~---------------------~--------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p 419 (536)
+-. . .........||+.|.+||.+.+......+|+|++|++++|.++|..|
T Consensus 955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen 955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCC
Confidence 100 0 00012235689999999999999999999999999999999999999
Q ss_pred CCCCCccCCchhHHHHHHHhhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHH
Q 039168 420 NGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMS 483 (536)
Q Consensus 420 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 483 (536)
|....+...- .......+.- ......-..+.+.+ +...+..+|.+|..+.
T Consensus 1035 ~na~tpq~~f-------~ni~~~~~~~----p~g~~~~s~~aq~~---~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1035 FNAETPQQIF-------ENILNRDIPW----PEGPEEGSYEAQDL---INRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCCcchhhhh-------hccccCCCCC----CCCccccChhhhhh---hhhhhccCchhccCcc
Confidence 7654333211 1111111100 00111122333444 4477789999998777
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.00 E-value=5.8e-09 Score=95.67 Aligned_cols=125 Identities=25% Similarity=0.278 Sum_probs=83.0
Q ss_pred eEEEEEeCCCcEEEEEEccccC--------------h------------hhHHHHHHHHHHHHHcCCC--CceeEeeEEe
Q 039168 231 PVYKGTLADGKAIAVKRLSRTS--------------G------------QGLKEFKNEVNLIAKLQHK--NLVRLLGCCL 282 (536)
Q Consensus 231 ~Vy~~~~~~~~~vavK~~~~~~--------------~------------~~~~~~~~E~~~l~~l~hp--niv~l~~~~~ 282 (536)
.||.|...+|..+|||+..... . ......++|++.|.++..- ++.+++.+.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 4899999899999999864321 0 0123467899999999765 566676553
Q ss_pred eCceEEEEEeecC--CCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHH-HhcCCCCCeeeCCCCCCcEEEcCCCCeEE
Q 039168 283 EGQELLLIYEYMP--NKSLDVHLFDATRSVQLDWKRRLSIINGIARGILY-LHEDSRLKIIHRDLKASNVLLDDDMNPKI 359 (536)
Q Consensus 283 ~~~~~~lv~e~~~--~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~-LH~~~~~~ivH~Dikp~NIll~~~~~~kl 359 (536)
.-.+||||++ |..+..+... . ++......++.+++..+.. +|..| |+|+||.+.|||++++ .+.|
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~-~----~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDV-D----LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHC-G----GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE
T ss_pred ---CCEEEEEecCCCccchhhHHhc-c----ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEE
Confidence 2379999999 6555543321 1 1123455677788886555 56776 9999999999999988 9999
Q ss_pred ecccCcccc
Q 039168 360 SDFGTARIF 368 (536)
Q Consensus 360 ~Dfg~a~~~ 368 (536)
+|||.+...
T Consensus 148 IDf~qav~~ 156 (188)
T PF01163_consen 148 IDFGQAVDS 156 (188)
T ss_dssp --GTTEEET
T ss_pred EecCcceec
Confidence 999998754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.99 E-value=8.6e-09 Score=100.20 Aligned_cols=139 Identities=20% Similarity=0.143 Sum_probs=99.3
Q ss_pred cCCCCceeEEEEEeCCCcEEEEEEccccChh-hHH----------HHHHHHHHHHHcCCCC--ceeEeeEEee-----Cc
Q 039168 224 LGQGGFGPVYKGTLADGKAIAVKRLSRTSGQ-GLK----------EFKNEVNLIAKLQHKN--LVRLLGCCLE-----GQ 285 (536)
Q Consensus 224 lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~----------~~~~E~~~l~~l~hpn--iv~l~~~~~~-----~~ 285 (536)
+-+.....|.+... +|+.|.||........ ..+ .+.+|+..+.+|..-+ +++++.+... ..
T Consensus 30 v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~ 108 (268)
T PRK15123 30 FRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATR 108 (268)
T ss_pred EecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccc
Confidence 33334445667665 6788999977543311 111 3778999998885333 3344445433 23
Q ss_pred eEEEEEeecCCC-ChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcC-------CCCe
Q 039168 286 ELLLIYEYMPNK-SLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDD-------DMNP 357 (536)
Q Consensus 286 ~~~lv~e~~~~~-sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~-------~~~~ 357 (536)
..++|+|++++. +|.+++.... ....+......++.+++..+.-||..| |+|+|+++.|||++. +..+
T Consensus 109 ~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~ 184 (268)
T PRK15123 109 TSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLKL 184 (268)
T ss_pred eeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCceE
Confidence 578999999986 7888875322 233566777889999999999999997 999999999999975 4679
Q ss_pred EEecccCccc
Q 039168 358 KISDFGTARI 367 (536)
Q Consensus 358 kl~Dfg~a~~ 367 (536)
.|+||+.++.
T Consensus 185 ~LIDl~r~~~ 194 (268)
T PRK15123 185 SVIDLHRAQI 194 (268)
T ss_pred EEEECCcccc
Confidence 9999998864
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.95 E-value=6.3e-09 Score=98.13 Aligned_cols=136 Identities=20% Similarity=0.207 Sum_probs=99.7
Q ss_pred CCccccccCCCCceeEEEEEeCCCcEEEEEEccccC----------------------hhhHHHHHHHHHHHHHcCCC--
Q 039168 217 HFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTS----------------------GQGLKEFKNEVNLIAKLQHK-- 272 (536)
Q Consensus 217 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~----------------------~~~~~~~~~E~~~l~~l~hp-- 272 (536)
-..+...||.|--+.||.|...+|.++|||.-.... .-.....++|+++|.+|...
T Consensus 92 ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 92 VEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 346678999999999999999999999999543210 01123467899999999755
Q ss_pred CceeEeeEEeeCceEEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEc
Q 039168 273 NLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLD 352 (536)
Q Consensus 273 niv~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~ 352 (536)
.+.+.+++ +.-.+|||+++|..|...- ++.+....++..|++-+.-+-..| |||+|+++-||+++
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~ 236 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVT 236 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEe
Confidence 67777665 3558999999997775332 122333444555555555555555 99999999999999
Q ss_pred CCCCeEEecccCccc
Q 039168 353 DDMNPKISDFGTARI 367 (536)
Q Consensus 353 ~~~~~kl~Dfg~a~~ 367 (536)
++|.+.++||--+..
T Consensus 237 ~dg~~~vIDwPQ~v~ 251 (304)
T COG0478 237 EDGDIVVIDWPQAVP 251 (304)
T ss_pred cCCCEEEEeCccccc
Confidence 999999999977654
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.84 E-value=6.9e-08 Score=95.70 Aligned_cols=192 Identities=18% Similarity=0.202 Sum_probs=126.7
Q ss_pred cccccCCCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHHc-CCCCceeEeeEE-------eeCceEEEEE
Q 039168 220 DENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKL-QHKNLVRLLGCC-------LEGQELLLIY 291 (536)
Q Consensus 220 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~-------~~~~~~~lv~ 291 (536)
..+.||+|+-+.+|-.-. -..-+.|++.........+ -+..|... .||-+-.-+.+= ..+...-+.|
T Consensus 15 ~gr~LgqGgea~ly~l~e--~~d~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 15 PGRPLGQGGEADLYTLGE--VRDQVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CCccccCCccceeeecch--hhchhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 456899999999995432 1123447776554432222 12222222 455333211110 1122366778
Q ss_pred eecCCCCh-hhhhh---cccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccc
Q 039168 292 EYMPNKSL-DVHLF---DATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARI 367 (536)
Q Consensus 292 e~~~~~sL-~~~l~---~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 367 (536)
..+.+..- ..++. +.......+|.-.+++++.|+.+.+-||+.| .+-+|++++|+||.+++.|.|.|=.....
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccceee
Confidence 87776532 22221 1223445789999999999999999999998 89999999999999999999998655443
Q ss_pred cCCCCCccccccccccccccCcchhc-----CCCCCccchHHHHHHHHHHHHhC-CCCCCC
Q 039168 368 FGGNQNQANTNIIAGTYGYMAPEYAM-----GGIFSIKSDVFSFGVLLLEIISG-RKNNGF 422 (536)
Q Consensus 368 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg-~~p~~~ 422 (536)
. .........+|.+.|.+||.-. +..-+...|.|.||+++++|+.| ++||..
T Consensus 167 ~---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysG 224 (637)
T COG4248 167 N---ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSG 224 (637)
T ss_pred c---cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCc
Confidence 2 1222233357899999999754 33457789999999999999997 889854
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.73 E-value=1.3e-07 Score=88.83 Aligned_cols=124 Identities=26% Similarity=0.252 Sum_probs=91.6
Q ss_pred CCcEEEEEEccccC-h------hhHHHHHHHHHHHHHcCCC--CceeEeeEEeeC----ceEEEEEeecCCC-Chhhhhh
Q 039168 239 DGKAIAVKRLSRTS-G------QGLKEFKNEVNLIAKLQHK--NLVRLLGCCLEG----QELLLIYEYMPNK-SLDVHLF 304 (536)
Q Consensus 239 ~~~~vavK~~~~~~-~------~~~~~~~~E~~~l~~l~hp--niv~l~~~~~~~----~~~~lv~e~~~~~-sL~~~l~ 304 (536)
.++.+.+|...... . -....+.+|...+..|..- .+++.+.+.... ...++|+|++++. +|.+++.
T Consensus 31 ~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~ 110 (206)
T PF06293_consen 31 VGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQ 110 (206)
T ss_pred cceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHH
Confidence 35667777543211 1 2234678899988888533 344555555542 3468999999985 7888885
Q ss_pred cccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCC---CeEEecccCcccc
Q 039168 305 DATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDM---NPKISDFGTARIF 368 (536)
Q Consensus 305 ~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~---~~kl~Dfg~a~~~ 368 (536)
.... .+......++.++++.+.-||+.| |+|+|+++.|||++.++ .+.|+||+.++..
T Consensus 111 ~~~~---~~~~~~~~ll~~l~~~i~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 111 QWEQ---LDPSQRRELLRALARLIAKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred hhcc---cchhhHHHHHHHHHHHHHHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 4322 566777889999999999999997 99999999999999887 8999999988753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.72 E-value=1e-07 Score=100.30 Aligned_cols=141 Identities=16% Similarity=0.206 Sum_probs=93.7
Q ss_pred cccCCCCceeEEEEEeCCCcEEEEEEccccChhh------------------------------HHH----------HHH
Q 039168 222 NKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQG------------------------------LKE----------FKN 261 (536)
Q Consensus 222 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~------------------------------~~~----------~~~ 261 (536)
+.|+.++-|.||+|++++|+.||||+....-.+. .++ +.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 6899999999999999999999999876532110 111 344
Q ss_pred HHHHHHHcC-----CCCceeEeeEEeeCceEEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHH-HHHHhcCC
Q 039168 262 EVNLIAKLQ-----HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARG-ILYLHEDS 335 (536)
Q Consensus 262 E~~~l~~l~-----hpniv~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~a-l~~LH~~~ 335 (536)
|...+.+++ .|++.--.=+++-.+...|+|||++|..+.+...-.. ..++.+.+.. .++++ +..+-..|
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~--~g~d~k~ia~---~~~~~f~~q~~~dg 285 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS--AGIDRKELAE---LLVRAFLRQLLRDG 285 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh--cCCCHHHHHH---HHHHHHHHHHHhcC
Confidence 555555552 2333222222333567799999999999988853222 2345333332 22222 22222234
Q ss_pred CCCeeeCCCCCCcEEEcCCCCeEEecccCccccCC
Q 039168 336 RLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGG 370 (536)
Q Consensus 336 ~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 370 (536)
++|.|.+|.||+++.+|++.+.|||+...+..
T Consensus 286 ---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 286 ---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred ---ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 99999999999999999999999999987643
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.71 E-value=3.5e-07 Score=84.54 Aligned_cols=140 Identities=16% Similarity=0.143 Sum_probs=103.9
Q ss_pred ccCCCCceeEEEEEeCCCcEEEEEEccccC------hhhHHHHHHHHHHHHHcCC--CCceeEeeEEee----CceEEEE
Q 039168 223 KLGQGGFGPVYKGTLADGKAIAVKRLSRTS------GQGLKEFKNEVNLIAKLQH--KNLVRLLGCCLE----GQELLLI 290 (536)
Q Consensus 223 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h--pniv~l~~~~~~----~~~~~lv 290 (536)
--|+||.+.|++.... |+.+-+|+-.... +.....|.+|+..|.+|.. -.+.+....-.. .-..+||
T Consensus 25 N~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LV 103 (216)
T PRK09902 25 NYRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLV 103 (216)
T ss_pred CcCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEE
Confidence 3577999999997764 4478999765211 3355789999999999953 224455422111 2347899
Q ss_pred EeecCC-CChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCC--eEEecccCccc
Q 039168 291 YEYMPN-KSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMN--PKISDFGTARI 367 (536)
Q Consensus 291 ~e~~~~-~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~--~kl~Dfg~a~~ 367 (536)
+|-+.| .+|.+++.+... .+.+......++.+++..+.-||+.| +.|+|+.+.|||++.++. ++++||.-++.
T Consensus 104 Te~L~g~~~L~~~l~~~~~-~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAV-SPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcCCc-CCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 997765 578888754322 24677788899999999999999997 999999999999986677 99999988764
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.58 E-value=1.4e-08 Score=106.65 Aligned_cols=153 Identities=23% Similarity=0.363 Sum_probs=99.6
Q ss_pred HHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCC-------ccccccccccccccCcchhc
Q 039168 321 INGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQN-------QANTNIIAGTYGYMAPEYAM 393 (536)
Q Consensus 321 ~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~-------~~~~~~~~gt~~y~aPE~~~ 393 (536)
+.+++.|+.|+|... .+||+.|.|++|.++..+..||+.|+++........ ............|.|||++.
T Consensus 105 l~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 345669999999875 899999999999999999999999998865433111 11111123466899999999
Q ss_pred CCCCCccchHHHHHHHHHHHHhCCCC-CCCCCccCCchhHHHHHHHhhcCCccccccccccCCCCHHHHHHHHHHHHhhc
Q 039168 394 GGIFSIKSDVFSFGVLLLEIISGRKN-NGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCV 472 (536)
Q Consensus 394 ~~~~~~~~DvwslG~il~elltg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl 472 (536)
+...+.++|+||+|+++|.+..|..+ +...... ..+..... . ...-... .....+.++.+ -+.+++
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~-----~~~~~~~~-~---~~~~~~~-~s~~~p~el~~---~l~k~l 249 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGL-----LSYSFSRN-L---LNAGAFG-YSNNLPSELRE---SLKKLL 249 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCc-----chhhhhhc-c---ccccccc-ccccCcHHHHH---HHHHHh
Confidence 98899999999999999999955544 2221111 11111000 0 0000000 01122334443 344889
Q ss_pred CCCCCCCCCHHHHHHH
Q 039168 473 QQDPADRPTMSSVVVM 488 (536)
Q Consensus 473 ~~dP~~RPt~~evl~~ 488 (536)
..++.-||++.+++..
T Consensus 250 ~~~~~~rp~~~~l~~~ 265 (700)
T KOG2137|consen 250 NGDSAVRPTLDLLLSI 265 (700)
T ss_pred cCCcccCcchhhhhcc
Confidence 9999999988777654
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.58 E-value=9.6e-09 Score=106.55 Aligned_cols=191 Identities=18% Similarity=0.158 Sum_probs=143.9
Q ss_pred HHHhcCCccccccCCCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCC-ceeEeeEEeeCceEEEE
Q 039168 212 LEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKN-LVRLLGCCLEGQELLLI 290 (536)
Q Consensus 212 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn-iv~l~~~~~~~~~~~lv 290 (536)
+..++.+...+.+++|+++.++|.+....+....+.+... ....-++++|.+++||| .+..++-+..+...+++
T Consensus 238 kDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~ 312 (829)
T KOG0576|consen 238 KDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIP 312 (829)
T ss_pred cCCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchh
Confidence 3445666777889999999999998765666666766554 34566899999999999 77777777778899999
Q ss_pred EeecCCC-ChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccC
Q 039168 291 YEYMPNK-SLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFG 369 (536)
Q Consensus 291 ~e~~~~~-sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 369 (536)
++++.++ +....+. .....+..-+...+.+.-++++++||+.. -+|+| ||+..+ +..++.||+....+.
T Consensus 313 ~~i~s~~rs~~~~~~--~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~ 382 (829)
T KOG0576|consen 313 MRICSTGRSSALEMT--VSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLT 382 (829)
T ss_pred hhhhcCCccccccCC--hhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccC
Confidence 9999887 2222211 11122444455566677778899999763 58998 777665 679999999998776
Q ss_pred CCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCC
Q 039168 370 GNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNN 420 (536)
Q Consensus 370 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~ 420 (536)
... ......+++.++|||+.....+....|+|++|+--.+|.-|-+|-
T Consensus 383 ~~~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 383 RTM---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred ccc---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 543 344567899999999999999999999999999877887777663
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.57 E-value=1.4e-06 Score=82.94 Aligned_cols=139 Identities=17% Similarity=0.206 Sum_probs=86.3
Q ss_pred cccCCCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCC--ceeEeeEEeeCceEEEEEeecCCCC-
Q 039168 222 NKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKN--LVRLLGCCLEGQELLLIYEYMPNKS- 298 (536)
Q Consensus 222 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn--iv~l~~~~~~~~~~~lv~e~~~~~s- 298 (536)
..||+|..+.||+. .+..+++|...... ......+|.++++.+..-. +.+.+.+....+...+|||+++|..
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 57899999999984 25568888876533 3356788999999996433 4677888877788899999999963
Q ss_pred hhhhhh--------------c-----cc-CCCCCCHHHHH-HHHH----------HHHHH-HHHHhcC-CCCCeeeCCCC
Q 039168 299 LDVHLF--------------D-----AT-RSVQLDWKRRL-SIIN----------GIARG-ILYLHED-SRLKIIHRDLK 345 (536)
Q Consensus 299 L~~~l~--------------~-----~~-~~~~l~~~~~~-~i~~----------qi~~a-l~~LH~~-~~~~ivH~Dik 345 (536)
+...+. . +. ........... .+.. .+.+. ..+|... ....++|+|+.
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~ 161 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ 161 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence 211110 0 00 00011111100 0000 01111 1122211 13457899999
Q ss_pred CCcEEEcCCCCeEEecccCcc
Q 039168 346 ASNVLLDDDMNPKISDFGTAR 366 (536)
Q Consensus 346 p~NIll~~~~~~kl~Dfg~a~ 366 (536)
|.||++++++ +.|+||+.+.
T Consensus 162 ~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 162 IGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCcEEEcCCC-cEEEechhcC
Confidence 9999999888 9999999875
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.56 E-value=1e-06 Score=82.64 Aligned_cols=137 Identities=19% Similarity=0.268 Sum_probs=96.1
Q ss_pred cccCCCCceeEEEEEeCCCcEEEEEEccccChhh------------------------HHHHHHHHHHHHHcC--CCCce
Q 039168 222 NKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQG------------------------LKEFKNEVNLIAKLQ--HKNLV 275 (536)
Q Consensus 222 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~------------------------~~~~~~E~~~l~~l~--hpniv 275 (536)
..|+.|--+.||+|...++..+|+|++....... .....+|+.-|+++. +=.+.
T Consensus 54 g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP 133 (268)
T COG1718 54 GCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP 133 (268)
T ss_pred eeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence 3677888999999998889999999885432111 112467888888884 33455
Q ss_pred eEeeEEeeCceEEEEEeecCCCCh-hhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCC
Q 039168 276 RLLGCCLEGQELLLIYEYMPNKSL-DVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDD 354 (536)
Q Consensus 276 ~l~~~~~~~~~~~lv~e~~~~~sL-~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~ 354 (536)
+.+.+.. -.|||||+..... .-.|. ...+...+...+..++++.+.-|-... ++||+||+.-|||+. +
T Consensus 134 ~Pi~~~~----nVLvMEfIg~~g~pAP~Lk----Dv~~e~~e~~~~~~~~v~~~~~l~~~a--~LVHgDLSEyNiL~~-~ 202 (268)
T COG1718 134 EPIAFRN----NVLVMEFIGDDGLPAPRLK----DVPLELEEAEGLYEDVVEYMRRLYKEA--GLVHGDLSEYNILVH-D 202 (268)
T ss_pred CceeecC----CeEEEEeccCCCCCCCCcc----cCCcCchhHHHHHHHHHHHHHHHHHhc--CcccccchhhheEEE-C
Confidence 5555543 3799999966521 11121 112333367777888888888877633 599999999999999 8
Q ss_pred CCeEEecccCccccC
Q 039168 355 MNPKISDFGTARIFG 369 (536)
Q Consensus 355 ~~~kl~Dfg~a~~~~ 369 (536)
+.+.|+|||-+....
T Consensus 203 ~~p~iID~~QaV~~~ 217 (268)
T COG1718 203 GEPYIIDVSQAVTID 217 (268)
T ss_pred CeEEEEECccccccC
Confidence 899999999987543
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.45 E-value=4.2e-06 Score=77.72 Aligned_cols=139 Identities=17% Similarity=0.179 Sum_probs=92.1
Q ss_pred HHhcCCccccccCCCCceeEEEEEeCCCcEEEEEEccccChhhHHH---------HHHHHHHHHHcCC---CCceeEeeE
Q 039168 213 EATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKE---------FKNEVNLIAKLQH---KNLVRLLGC 280 (536)
Q Consensus 213 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~---------~~~E~~~l~~l~h---pniv~l~~~ 280 (536)
....+|...+++-......|.+... +|+.+++|..........+. ..+++..+.+++. -.+..++-+
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~ 106 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA 106 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence 3457788888888877777777766 57899999876443222121 2233343344422 222232222
Q ss_pred E-----eeCceEEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCC
Q 039168 281 C-----LEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDM 355 (536)
Q Consensus 281 ~-----~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~ 355 (536)
. .-....+++|||++|..|.+... +++ .+...|.+++.-||+.| ++|+|.+|.|+++++++
T Consensus 107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~~ 172 (229)
T PF06176_consen 107 AEKKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNNG 172 (229)
T ss_pred eeeeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECCc
Confidence 2 22345679999999998865531 222 24456778899999997 99999999999999654
Q ss_pred CeEEecccCccc
Q 039168 356 NPKISDFGTARI 367 (536)
Q Consensus 356 ~~kl~Dfg~a~~ 367 (536)
+++.||+..+.
T Consensus 173 -i~iID~~~k~~ 183 (229)
T PF06176_consen 173 -IRIIDTQGKRM 183 (229)
T ss_pred -EEEEECccccc
Confidence 99999987764
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.39 E-value=4.3e-06 Score=79.74 Aligned_cols=143 Identities=22% Similarity=0.232 Sum_probs=85.1
Q ss_pred ccccCCCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHHcCCC--CceeEeeEEe---eCceEEEEEeecC
Q 039168 221 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHK--NLVRLLGCCL---EGQELLLIYEYMP 295 (536)
Q Consensus 221 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp--niv~l~~~~~---~~~~~~lv~e~~~ 295 (536)
++.|+.|..+.||+....+ ..+++|..... .....+.+|..+++.+... .+.+++.... .....+++|++++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 3578999999999999877 69999987654 4557788899999988533 3456665433 2345799999999
Q ss_pred CCChhh----------------hhh---ccc-CCCCCCHHH---------HHHH------------HHHHHH-HHHHHhc
Q 039168 296 NKSLDV----------------HLF---DAT-RSVQLDWKR---------RLSI------------INGIAR-GILYLHE 333 (536)
Q Consensus 296 ~~sL~~----------------~l~---~~~-~~~~l~~~~---------~~~i------------~~qi~~-al~~LH~ 333 (536)
|..+.. .+. ... ....+.... .... +..+.+ .+..++.
T Consensus 79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 998877 110 110 000111100 0000 111222 2233321
Q ss_pred ----CCCCCeeeCCCCCCcEEEc-CCCCeEEecccCcc
Q 039168 334 ----DSRLKIIHRDLKASNVLLD-DDMNPKISDFGTAR 366 (536)
Q Consensus 334 ----~~~~~ivH~Dikp~NIll~-~~~~~kl~Dfg~a~ 366 (536)
.....++|+|+.|.|||++ +++.+.|.||+.+.
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 1234699999999999999 66667899998875
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.39 E-value=4.8e-06 Score=80.39 Aligned_cols=140 Identities=15% Similarity=0.168 Sum_probs=86.5
Q ss_pred ccCCCCc-eeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHHcC-CCCceeEeeEEeeCceEEEEEeecCCCChh
Q 039168 223 KLGQGGF-GPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQ-HKNLVRLLGCCLEGQELLLIYEYMPNKSLD 300 (536)
Q Consensus 223 ~lg~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lv~e~~~~~sL~ 300 (536)
.|..|.. ..||+.... +..++||+..... ...+.+|+++++.+. +--+.+++.+....+..++|||+++|.++.
T Consensus 5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 3455555 788999764 4788889876543 345678999998884 344667788777767789999999998876
Q ss_pred hhhh-------------------cccC-CCCCCHH--HHHHHHH--------------------HHHHHHHHHhc----C
Q 039168 301 VHLF-------------------DATR-SVQLDWK--RRLSIIN--------------------GIARGILYLHE----D 334 (536)
Q Consensus 301 ~~l~-------------------~~~~-~~~l~~~--~~~~i~~--------------------qi~~al~~LH~----~ 334 (536)
.... .... ...+... ....... .+...+..|-. .
T Consensus 81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 160 (244)
T cd05150 81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE 160 (244)
T ss_pred HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence 4421 0000 0011100 0000000 01111222211 1
Q ss_pred CCCCeeeCCCCCCcEEEcCCCCeEEecccCcc
Q 039168 335 SRLKIIHRDLKASNVLLDDDMNPKISDFGTAR 366 (536)
Q Consensus 335 ~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 366 (536)
....++|+|+.|.|||+++++.+.|+||+.+.
T Consensus 161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred CceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 23458999999999999997778899998875
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.32 E-value=4.8e-06 Score=73.91 Aligned_cols=129 Identities=22% Similarity=0.281 Sum_probs=91.8
Q ss_pred ccccccCCCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCcee-EeeEEeeCceEEEEEeecCCC
Q 039168 219 SDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVR-LLGCCLEGQELLLIYEYMPNK 297 (536)
Q Consensus 219 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~-l~~~~~~~~~~~lv~e~~~~~ 297 (536)
...+.|++|.+|.||++.+. |..+|+|+-..++. ...+..|.++|..++-.++.+ ++.+-.+ ++.|||++|-
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds~--r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~G~ 97 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWR-GGEVALKVRRRDSP--RRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYIDGR 97 (201)
T ss_pred hhhhhhhcccccEEEEeecc-CceEEEEEecCCcc--hhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhcCc
Confidence 55678999999999999995 55888887665443 367889999999998776655 4444332 4559999998
Q ss_pred ChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCC-CCcEEEcCCCCeEEecccCccc
Q 039168 298 SLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLK-ASNVLLDDDMNPKISDFGTARI 367 (536)
Q Consensus 298 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dik-p~NIll~~~~~~kl~Dfg~a~~ 367 (536)
.|..+-... +.. -+..+++.---|...| |-|..|. |..++|.+++.+.|+||..|..
T Consensus 98 ~L~~~~~~~------~rk----~l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 98 PLGKLEIGG------DRK----HLLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred chhhhhhcc------cHH----HHHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 887654211 112 2334555544455555 9999996 6666666666999999999874
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.26 E-value=8.8e-06 Score=85.61 Aligned_cols=141 Identities=16% Similarity=0.208 Sum_probs=89.5
Q ss_pred ccccCCCCceeEEEEEeCCCcEEEEEEccccChhh-------------------------------HH------HHHHHH
Q 039168 221 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQG-------------------------------LK------EFKNEV 263 (536)
Q Consensus 221 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-------------------------------~~------~~~~E~ 263 (536)
.+.||.-+.|.|++|++++|+.||||+-+..-... .+ .|.+|.
T Consensus 166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 36899999999999999999999999865432110 01 133344
Q ss_pred HHHHH----cCCCC---ceeEeeEEe-eCceEEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHH-HHhcC
Q 039168 264 NLIAK----LQHKN---LVRLLGCCL-EGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGIL-YLHED 334 (536)
Q Consensus 264 ~~l~~----l~hpn---iv~l~~~~~-~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~-~LH~~ 334 (536)
+-..+ +.|-+ -|.+=.++. -.....|+||||+|..+.+...-.. ..++...+.. .+.++.. .|=..
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~--~gi~~~~i~~---~l~~~~~~qIf~~ 320 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDK--RGISPHDILN---KLVEAYLEQIFKT 320 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHH--cCCCHHHHHH---HHHHHHHHHHHhc
Confidence 33333 33444 122222222 2356799999999998877643222 2245444433 3333322 22223
Q ss_pred CCCCeeeCCCCCCcEEEcC----CCCeEEecccCccccC
Q 039168 335 SRLKIIHRDLKASNVLLDD----DMNPKISDFGTARIFG 369 (536)
Q Consensus 335 ~~~~ivH~Dikp~NIll~~----~~~~kl~Dfg~a~~~~ 369 (536)
| ++|+|=+|.||+++. ++++.+.|||+...+.
T Consensus 321 G---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 321 G---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred C---CccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 3 999999999999984 6689999999998654
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.16 E-value=1.1e-05 Score=74.42 Aligned_cols=105 Identities=23% Similarity=0.241 Sum_probs=83.0
Q ss_pred HHHHHHHHHcCC-CCceeEeeEEeeCceEEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 039168 260 KNEVNLIAKLQH-KNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLK 338 (536)
Q Consensus 260 ~~E~~~l~~l~h-pniv~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ 338 (536)
.+|.-+|+.+++ +++++++|+|-. ++|.||...+++...-.....-...+|..+.+|+.++++.+.+|+......
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 358999999987 699999999943 789999987765421100011223789999999999999999999854445
Q ss_pred eeeCCCCCCcEEEcCCCCeEEecccCcccc
Q 039168 339 IIHRDLKASNVLLDDDMNPKISDFGTARIF 368 (536)
Q Consensus 339 ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 368 (536)
+...|++|+|+-+++++++|+.|...+...
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 888999999999999999999999877543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.13 E-value=4.3e-05 Score=86.70 Aligned_cols=79 Identities=16% Similarity=0.377 Sum_probs=58.9
Q ss_pred ccccCCCCceeEEEEEeCCC---cEEEEEEccccC-hhhHHHHHHHHHHHHHcC-CCCc--eeEeeEEeeC---ceEEEE
Q 039168 221 ENKLGQGGFGPVYKGTLADG---KAIAVKRLSRTS-GQGLKEFKNEVNLIAKLQ-HKNL--VRLLGCCLEG---QELLLI 290 (536)
Q Consensus 221 ~~~lg~G~~g~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-hpni--v~l~~~~~~~---~~~~lv 290 (536)
.+.|+.|.+..+|+....++ ..+++|+..... ......+.+|+++|+.+. |+++ .+++.++.+. +..|+|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 56789999999999887553 478888765432 223457889999999995 6654 7778777654 467899
Q ss_pred EeecCCCCh
Q 039168 291 YEYMPNKSL 299 (536)
Q Consensus 291 ~e~~~~~sL 299 (536)
|||++|..+
T Consensus 123 ME~v~G~~~ 131 (822)
T PLN02876 123 MEYLEGRIF 131 (822)
T ss_pred EEecCCccc
Confidence 999998754
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.09 E-value=3.5e-05 Score=73.93 Aligned_cols=73 Identities=15% Similarity=0.254 Sum_probs=47.0
Q ss_pred cccCCCCcee-EEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHHcCCC---CceeEeeEEeeC---ceEEEEEeec
Q 039168 222 NKLGQGGFGP-VYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHK---NLVRLLGCCLEG---QELLLIYEYM 294 (536)
Q Consensus 222 ~~lg~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp---niv~l~~~~~~~---~~~~lv~e~~ 294 (536)
+.|+.|+... ||+. +..+++|..... .....+.+|.++++.+... -+.+++...... ...+++||++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 4678777764 8875 235777865432 2345788999999988532 344444433322 2358899999
Q ss_pred CCCChh
Q 039168 295 PNKSLD 300 (536)
Q Consensus 295 ~~~sL~ 300 (536)
+|.++.
T Consensus 77 ~G~~l~ 82 (235)
T cd05155 77 EGETAT 82 (235)
T ss_pred cCCCCC
Confidence 998774
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.09 E-value=5.6e-05 Score=70.00 Aligned_cols=133 Identities=19% Similarity=0.310 Sum_probs=90.9
Q ss_pred cccccCCCCceeEEEEEeCCCcEEEEEEccccC----------------hhhHHHHHHHHHHHHHcC------CCCceeE
Q 039168 220 DENKLGQGGFGPVYKGTLADGKAIAVKRLSRTS----------------GQGLKEFKNEVNLIAKLQ------HKNLVRL 277 (536)
Q Consensus 220 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~E~~~l~~l~------hpniv~l 277 (536)
....||+|+.-.||. +.+.....||+..... ....++..+|+.-...+. +.+|.++
T Consensus 5 ~~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 5 ESDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CCcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 345799999999994 4455667788776544 223456777777777766 7889999
Q ss_pred eeEEeeCceEEEEEeecCC------CChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEE
Q 039168 278 LGCCLEGQELLLIYEYMPN------KSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLL 351 (536)
Q Consensus 278 ~~~~~~~~~~~lv~e~~~~------~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll 351 (536)
+|+.+.+...-+|+|.+.+ .+|.+++ ....+++ ...+.+.++ ..||-+.+ |+.+|++|.||++
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l----~~~~~~~-~~~~~L~~f---~~~l~~~~---Iv~~dl~~~NIv~ 151 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYL----KEGGLTE-ELRQALDEF---KRYLLDHH---IVIRDLNPHNIVV 151 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHH----HcCCccH-HHHHHHHHH---HHHHHHcC---CeecCCCcccEEE
Confidence 9999999999999998654 2355555 2233554 444444433 44555554 9999999999999
Q ss_pred cCCC----CeEEec-ccCc
Q 039168 352 DDDM----NPKISD-FGTA 365 (536)
Q Consensus 352 ~~~~----~~kl~D-fg~a 365 (536)
.... .+.|+| ||-.
T Consensus 152 ~~~~~~~~~lvlIDG~G~~ 170 (199)
T PF10707_consen 152 QRRDSGEFRLVLIDGLGEK 170 (199)
T ss_pred EecCCCceEEEEEeCCCCc
Confidence 6332 577777 4443
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.03 E-value=0.00013 Score=72.64 Aligned_cols=78 Identities=10% Similarity=0.043 Sum_probs=57.7
Q ss_pred ccccccCCCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHHcCC---CCceeEeeEEee---CceEEEEEe
Q 039168 219 SDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQH---KNLVRLLGCCLE---GQELLLIYE 292 (536)
Q Consensus 219 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---pniv~l~~~~~~---~~~~~lv~e 292 (536)
...+.||.|..+.||+....++ .+++|..+.. .....+..|.+.|+.|.. -.+.++++++.. .+..++|||
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE 93 (297)
T PRK10593 17 SRVECISEQPYAALWALYDSQG-NPMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLE 93 (297)
T ss_pred heeeecCCccceeEEEEEcCCC-CEEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEe
Confidence 3456799999999999987656 4666764321 123578899999999953 367788887754 366899999
Q ss_pred ecCCCCh
Q 039168 293 YMPNKSL 299 (536)
Q Consensus 293 ~~~~~sL 299 (536)
++++.++
T Consensus 94 ~i~G~~~ 100 (297)
T PRK10593 94 RLRGVSV 100 (297)
T ss_pred ccCCEec
Confidence 9998765
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.02 E-value=5.3e-05 Score=72.61 Aligned_cols=141 Identities=18% Similarity=0.253 Sum_probs=83.2
Q ss_pred ccccCCCCceeEEEEEeCC--CcEEEEEEccccChhhHHHHHHHHHHHHHcCCCC-ceeEeeEEeeCceEEEEEeecCCC
Q 039168 221 ENKLGQGGFGPVYKGTLAD--GKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKN-LVRLLGCCLEGQELLLIYEYMPNK 297 (536)
Q Consensus 221 ~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn-iv~l~~~~~~~~~~~lv~e~~~~~ 297 (536)
++.|..|-...+|+....+ ++.|++|+....... .....+|+.+++.+.... .++++.... + .++|||++|.
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~-~---~~l~e~i~G~ 77 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ-N---GLIYEFIPGR 77 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC-C---cEEEEeeCCC
Confidence 3568888889999998764 678999977543222 123347899999985433 344444332 2 4799999998
Q ss_pred Chhhh-------h----------hcccCC--------CCCC-HHHHHHHHH----------------------HHH---H
Q 039168 298 SLDVH-------L----------FDATRS--------VQLD-WKRRLSIIN----------------------GIA---R 326 (536)
Q Consensus 298 sL~~~-------l----------~~~~~~--------~~l~-~~~~~~i~~----------------------qi~---~ 326 (536)
++... + +..... .... +..+..+.. .+. .
T Consensus 78 ~l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 157 (235)
T cd05157 78 TLEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEIS 157 (235)
T ss_pred cCCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHH
Confidence 76422 0 111111 0111 122212211 111 1
Q ss_pred HHH-HHhcC-CCCCeeeCCCCCCcEEEcC-CCCeEEecccCcc
Q 039168 327 GIL-YLHED-SRLKIIHRDLKASNVLLDD-DMNPKISDFGTAR 366 (536)
Q Consensus 327 al~-~LH~~-~~~~ivH~Dikp~NIll~~-~~~~kl~Dfg~a~ 366 (536)
.|. .+... ....++|+|+++.|||+++ ++.+.|+||..+.
T Consensus 158 ~l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 158 WLKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred HHHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 111 12211 2346899999999999998 5789999998775
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.99 E-value=4.6e-05 Score=74.14 Aligned_cols=138 Identities=17% Similarity=0.149 Sum_probs=79.7
Q ss_pred ccCCCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCc-eeEeeEEeeCceEEEEEeecCCCChhh
Q 039168 223 KLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNL-VRLLGCCLEGQELLLIYEYMPNKSLDV 301 (536)
Q Consensus 223 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpni-v~l~~~~~~~~~~~lv~e~~~~~sL~~ 301 (536)
.+..|-...+|+... +++.+++|..........-...+|..+++.+....+ .+++.... -++||||++|..+..
T Consensus 3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL 77 (256)
T ss_pred cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence 456788889998874 577888987654322211135779999999864433 33444332 368999999977653
Q ss_pred h-----------------hhcccC-CCCCCHH-HHHHHHHHH---------HHHHHHHhcC-----CCCCeeeCCCCCCc
Q 039168 302 H-----------------LFDATR-SVQLDWK-RRLSIINGI---------ARGILYLHED-----SRLKIIHRDLKASN 348 (536)
Q Consensus 302 ~-----------------l~~~~~-~~~l~~~-~~~~i~~qi---------~~al~~LH~~-----~~~~ivH~Dikp~N 348 (536)
. ++.... ...++.. .+..+..++ ...+..+-.. ....++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 2 111110 1111211 111111111 1112222111 12358999999999
Q ss_pred EEEcCCCCeEEecccCcc
Q 039168 349 VLLDDDMNPKISDFGTAR 366 (536)
Q Consensus 349 Ill~~~~~~kl~Dfg~a~ 366 (536)
|++++++ +.|+||+.+.
T Consensus 158 il~~~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYAS 174 (256)
T ss_pred EEEeCCC-CEEEeccccC
Confidence 9999876 8899998875
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.85 E-value=0.00021 Score=65.71 Aligned_cols=125 Identities=26% Similarity=0.395 Sum_probs=88.8
Q ss_pred cCCccccccCCCCc-eeEEEEEeCCCcEEEEEEccc---cCh------------------hhHHHHHHHHHHHHHcC---
Q 039168 216 NHFSDENKLGQGGF-GPVYKGTLADGKAIAVKRLSR---TSG------------------QGLKEFKNEVNLIAKLQ--- 270 (536)
Q Consensus 216 ~~~~~~~~lg~G~~-g~Vy~~~~~~~~~vavK~~~~---~~~------------------~~~~~~~~E~~~l~~l~--- 270 (536)
.+++.++.||.|.- |.||+++. +|+.||||.+.. ... ....-|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 68899999999999 99999998 577999999321 110 11224677888777774
Q ss_pred CCCc--eeEeeEEeeC------------------ceEEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHH
Q 039168 271 HKNL--VRLLGCCLEG------------------QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILY 330 (536)
Q Consensus 271 hpni--v~l~~~~~~~------------------~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~ 330 (536)
+.++ |+++|+..-. ....||.||+.... .+... -+.+|.+-+..
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~~~----~~~~~~~dl~~ 179 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQIR----DIPQMLRDLKI 179 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccchh----HHHHHHHHHHH
Confidence 4456 9999997432 12356777665533 12222 34567777888
Q ss_pred HhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCc
Q 039168 331 LHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTA 365 (536)
Q Consensus 331 LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 365 (536)
+|..| |+-+|+++.|.. .-||+|||.+
T Consensus 180 ~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 180 LHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 99887 999999999986 4689999864
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.85 E-value=0.00015 Score=81.05 Aligned_cols=198 Identities=19% Similarity=0.170 Sum_probs=134.3
Q ss_pred HHHHHHHHHHcCCCCceeEeeEEeeCceEE----EEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcC
Q 039168 259 FKNEVNLIAKLQHKNLVRLLGCCLEGQELL----LIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHED 334 (536)
Q Consensus 259 ~~~E~~~l~~l~hpniv~l~~~~~~~~~~~----lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~ 334 (536)
..-|+..+.++.|+|++.++.+..+....- +..|++...++...+.. -..++....+.+..++.+||.|+|+.
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~---v~~i~~~~~r~~~~~~~~GL~~~h~~ 305 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQS---VGSIPLETLRILHQKLLEGLAYLHSL 305 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhh---ccccCHHHHHHHHHHHhhhHHHHHHh
Confidence 445777888999999999999977654333 33467777777777643 33478888999999999999999987
Q ss_pred CCCCeeeCCCCCC---cEEEcCCCCeEEe--cccCccccCCCCCccccccccccccccCcchhcCCCCCc--cchHHHHH
Q 039168 335 SRLKIIHRDLKAS---NVLLDDDMNPKIS--DFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSI--KSDVFSFG 407 (536)
Q Consensus 335 ~~~~ivH~Dikp~---NIll~~~~~~kl~--Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--~~DvwslG 407 (536)
. ..|.-+..+ +--++.++.+.++ ||+..+.+........ ..-...+.+||......... ..|+|.+|
T Consensus 306 ~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~---~~~~~~~~~~e~~~~~~~~~~r~~dL~~lg 379 (1351)
T KOG1035|consen 306 S---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFS---DLLAEIRNADEDLKENTAKKSRLTDLWCLG 379 (1351)
T ss_pred c---cceeEEecccccccccCccceeecchhhhcccccCCCcccchh---hcCccccccccccccccchhhhhhHHHHHH
Confidence 4 555544444 4445566677777 9999887764433222 22355688888887666544 47999999
Q ss_pred HHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 408 VLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 408 ~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
..+..+..|..+.... ......+...... ........|+..++++|+++.+++.
T Consensus 380 ll~~~~~~~~~i~~~~----------------------~~~~~~l~~~~~~----~~~d~~~~~~~~~~~~Rl~~~~ll~ 433 (1351)
T KOG1035|consen 380 LLLLQLSQGEDISEKS----------------------AVPVSLLDVLSTS----ELLDALPKCLDEDSEERLSALELLT 433 (1351)
T ss_pred HHHhhhhhcCcccccc----------------------cchhhhhccccch----hhhhhhhhhcchhhhhccchhhhhh
Confidence 9999999887652211 1111111111111 2334445899999999999999997
Q ss_pred Hhcc
Q 039168 488 MLAS 491 (536)
Q Consensus 488 ~L~~ 491 (536)
..--
T Consensus 434 ~~f~ 437 (1351)
T KOG1035|consen 434 HPFL 437 (1351)
T ss_pred chhc
Confidence 6543
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.79 E-value=0.00036 Score=71.66 Aligned_cols=76 Identities=14% Similarity=0.239 Sum_probs=55.0
Q ss_pred ccccCCCCceeEEEEEeCCC-cEEEEEEcccc------C-hhhHHHHHHHHHHHHHcC---CCCceeEeeEEeeCceEEE
Q 039168 221 ENKLGQGGFGPVYKGTLADG-KAIAVKRLSRT------S-GQGLKEFKNEVNLIAKLQ---HKNLVRLLGCCLEGQELLL 289 (536)
Q Consensus 221 ~~~lg~G~~g~Vy~~~~~~~-~~vavK~~~~~------~-~~~~~~~~~E~~~l~~l~---hpniv~l~~~~~~~~~~~l 289 (536)
.+.||.|.+..||++...+| +.|+||.-... . +...++...|.+.|+.+. ..++++++.+ +.+..++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 35799999999999998876 58999975321 1 224567778888888873 2456667766 3355789
Q ss_pred EEeecCCCC
Q 039168 290 IYEYMPNKS 298 (536)
Q Consensus 290 v~e~~~~~s 298 (536)
|||++++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999998643
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.73 E-value=0.00025 Score=70.52 Aligned_cols=142 Identities=21% Similarity=0.192 Sum_probs=86.4
Q ss_pred ccccCCCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHHcCCC--CceeEeeE------EeeCceEEEEEe
Q 039168 221 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHK--NLVRLLGC------CLEGQELLLIYE 292 (536)
Q Consensus 221 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp--niv~l~~~------~~~~~~~~lv~e 292 (536)
.+.|..|....+|+.... +..+++|+... .....+..|++++..|.+. .+.+++.. ....+..+++++
T Consensus 19 i~~i~~G~~n~~y~v~~~-~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTD-SGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeC-CCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 567888888999998764 44788898764 2235677788888888533 24444432 233456789999
Q ss_pred ecCCCChhhh--------------hhcccCC--------CCCCHHHHH----------HHHHHHHHHHHHHhc----CCC
Q 039168 293 YMPNKSLDVH--------------LFDATRS--------VQLDWKRRL----------SIINGIARGILYLHE----DSR 336 (536)
Q Consensus 293 ~~~~~sL~~~--------------l~~~~~~--------~~l~~~~~~----------~i~~qi~~al~~LH~----~~~ 336 (536)
+++|..+... ++..... ....|.... .....+..++.++.. ...
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 9999876431 0110000 001111110 011122334444443 112
Q ss_pred CCeeeCCCCCCcEEEcCCCCeEEecccCcc
Q 039168 337 LKIIHRDLKASNVLLDDDMNPKISDFGTAR 366 (536)
Q Consensus 337 ~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 366 (536)
..++|+|+.|.||++++++.+.|.||+.+.
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 359999999999999998777899998875
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.62 E-value=6.1e-05 Score=73.19 Aligned_cols=136 Identities=17% Similarity=0.156 Sum_probs=95.9
Q ss_pred CCccccccCCCCceeEEEEEeCCCcEEEEEEcccc--C-------h---------hh----HHHHHHHHHHHHHcCC--C
Q 039168 217 HFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRT--S-------G---------QG----LKEFKNEVNLIAKLQH--K 272 (536)
Q Consensus 217 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~-------~---------~~----~~~~~~E~~~l~~l~h--p 272 (536)
-+.+++.||-|.-+.||.+-+.+|++.++|.-... + . .+ .-...+|+..|+.|.. -
T Consensus 93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 45778899999999999999999999999954211 0 0 00 1124578999998853 2
Q ss_pred CceeEeeEEeeCceEEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEc
Q 039168 273 NLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLD 352 (536)
Q Consensus 273 niv~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~ 352 (536)
-+.+.+++ +..++|||++.+-.|...-+ ..+... +...+..-+.-|..+| +||+|..--||+|+
T Consensus 173 pVPkpiD~----~RH~Vvmelv~g~Pl~~v~~------v~d~~~---ly~~lm~~Iv~la~~G---lIHgDFNEFNimv~ 236 (465)
T KOG2268|consen 173 PVPKPIDH----NRHCVVMELVDGYPLRQVRH------VEDPPT---LYDDLMGLIVRLANHG---LIHGDFNEFNIMVK 236 (465)
T ss_pred CCCCcccc----cceeeHHHhhcccceeeeee------cCChHH---HHHHHHHHHHHHHHcC---ceecccchheeEEe
Confidence 34455554 35589999999888764431 122233 3344444455677776 99999999999999
Q ss_pred CCCCeEEecccCcccc
Q 039168 353 DDMNPKISDFGTARIF 368 (536)
Q Consensus 353 ~~~~~kl~Dfg~a~~~ 368 (536)
+++.++++||--....
T Consensus 237 dd~~i~vIDFPQmvS~ 252 (465)
T KOG2268|consen 237 DDDKIVVIDFPQMVST 252 (465)
T ss_pred cCCCEEEeechHhhcc
Confidence 9999999999766543
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.61 E-value=0.00043 Score=69.09 Aligned_cols=140 Identities=24% Similarity=0.361 Sum_probs=84.1
Q ss_pred cccCCCCceeEEEEEeCC-------CcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCc-eeEeeEEeeCceEEEEEee
Q 039168 222 NKLGQGGFGPVYKGTLAD-------GKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNL-VRLLGCCLEGQELLLIYEY 293 (536)
Q Consensus 222 ~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpni-v~l~~~~~~~~~~~lv~e~ 293 (536)
+.|..|-...||+....+ ++.+++|+..... .......+|+++++.+....+ .++++.+.. .+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence 456677778999988654 5789999865543 223456788888888854333 345555532 368999
Q ss_pred cCCCChhhhh-----------------hcccCCC------CCC--HHHHHH--------------------------HHH
Q 039168 294 MPNKSLDVHL-----------------FDATRSV------QLD--WKRRLS--------------------------IIN 322 (536)
Q Consensus 294 ~~~~sL~~~l-----------------~~~~~~~------~l~--~~~~~~--------------------------i~~ 322 (536)
++|..+.... +...... ..+ +..... +..
T Consensus 79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (302)
T cd05156 79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE 158 (302)
T ss_pred eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence 9988765321 1111110 000 111111 111
Q ss_pred HHHHHHHHHhc------CCCCCeeeCCCCCCcEEEcCC----CCeEEecccCcc
Q 039168 323 GIARGILYLHE------DSRLKIIHRDLKASNVLLDDD----MNPKISDFGTAR 366 (536)
Q Consensus 323 qi~~al~~LH~------~~~~~ivH~Dikp~NIll~~~----~~~kl~Dfg~a~ 366 (536)
.+...+..|.. .....++|+|+.|.|||++++ +.+.|+||+.+.
T Consensus 159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 22222334432 134568999999999999985 889999998885
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PF11883 DUF3403: Domain of unknown function (DUF3403); InterPro: IPR021820 This functionally uncharacterised domain of around 50 amino acids is found in the C terminus of eukaryotic S-locus receptor kinase proteins | Back alignment and domain information |
|---|
Probab=97.54 E-value=8.3e-05 Score=51.19 Aligned_cols=45 Identities=33% Similarity=0.546 Sum_probs=37.0
Q ss_pred CCCCCCCCCCCCccccccccCCCCccCCC--CcCCcCceecccccCC
Q 039168 492 DSMTIPQPTEPAFSVGRVVANSGHLLSSA--KVGSVNNVTVSDVSPR 536 (536)
Q Consensus 492 ~~~~~~~p~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 536 (536)
....||.|.+|+|..++...+....++.. ...|+|+||+|.+++|
T Consensus 2 e~~~LP~PKqPgF~~~r~~~e~~sSss~~~~~~~SvNevTiT~l~~R 48 (48)
T PF11883_consen 2 ETATLPQPKQPGFFTGRSPSETDSSSSKQRDESCSVNEVTITMLEAR 48 (48)
T ss_pred CcccCCCCCCCCEEeEcCCCCcCCCcccccCCCCCeeeEEEEeEecC
Confidence 35689999999999998876665555544 6789999999999998
|
; GO: 0004674 protein serine/threonine kinase activity |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.52 E-value=0.0034 Score=62.84 Aligned_cols=143 Identities=18% Similarity=0.183 Sum_probs=83.3
Q ss_pred ccccCCCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCC--ceeEeeE------EeeCceEEEEEe
Q 039168 221 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKN--LVRLLGC------CLEGQELLLIYE 292 (536)
Q Consensus 221 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn--iv~l~~~------~~~~~~~~lv~e 292 (536)
.+.|+.|....+|+....++ .+++|+..... ..+.+..|.+++..|.... +.+++.. ....+..++++|
T Consensus 27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred ccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 45677888889999876544 67888765432 1245566778887774322 3444332 122456789999
Q ss_pred ecCCCChhhh--------------hhcccCCC---------CCCHHHHH------------HHHHHHHHHHHHHhc----
Q 039168 293 YMPNKSLDVH--------------LFDATRSV---------QLDWKRRL------------SIINGIARGILYLHE---- 333 (536)
Q Consensus 293 ~~~~~sL~~~--------------l~~~~~~~---------~l~~~~~~------------~i~~qi~~al~~LH~---- 333 (536)
|++|..+... ++...... ...|.... .....+.+.++++..
T Consensus 104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~ 183 (307)
T TIGR00938 104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR 183 (307)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence 9998664311 11100100 01111100 001122334544432
Q ss_pred CCCCCeeeCCCCCCcEEEcCCCCeEEecccCcc
Q 039168 334 DSRLKIIHRDLKASNVLLDDDMNPKISDFGTAR 366 (536)
Q Consensus 334 ~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 366 (536)
.-...++|+|+++.||++++++.+.|.||+.+.
T Consensus 184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred cCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 112469999999999999988777899999874
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.51 E-value=0.0028 Score=63.76 Aligned_cols=142 Identities=18% Similarity=0.197 Sum_probs=78.6
Q ss_pred ccccCCCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHHcCCC--CceeEee------EEeeCceEEEEEe
Q 039168 221 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHK--NLVRLLG------CCLEGQELLLIYE 292 (536)
Q Consensus 221 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp--niv~l~~------~~~~~~~~~lv~e 292 (536)
.+.|+.|....+|+....+| .+++|+..... .+.+..|..+++.|... .+.+.+. +....+..++++|
T Consensus 27 ~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~~---~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~ 102 (319)
T PRK05231 27 LKGIAEGIENSNFFLTTTQG-EYVLTLFERLT---AEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVT 102 (319)
T ss_pred cchhccccccceEEEEeCCC-cEEEEEeccCC---hHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEE
Confidence 35677788889999887555 68889875222 23444566666666321 1333332 1223566799999
Q ss_pred ecCCCChhhh--------------hhcccCC--------CCC-CHHHHHH------------HHHH-HHHHHHHHhcC--
Q 039168 293 YMPNKSLDVH--------------LFDATRS--------VQL-DWKRRLS------------IING-IARGILYLHED-- 334 (536)
Q Consensus 293 ~~~~~sL~~~--------------l~~~~~~--------~~l-~~~~~~~------------i~~q-i~~al~~LH~~-- 334 (536)
|++|..+... ++..... ..+ .+..... .+.+ +...+..+...
T Consensus 103 ~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 182 (319)
T PRK05231 103 FLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAW 182 (319)
T ss_pred ecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccc
Confidence 9999764211 1111100 001 1111111 1111 11122233211
Q ss_pred --CCCCeeeCCCCCCcEEEcCCCCeEEecccCcc
Q 039168 335 --SRLKIIHRDLKASNVLLDDDMNPKISDFGTAR 366 (536)
Q Consensus 335 --~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 366 (536)
-...++|+|++|.||+++++...-|.||+.+.
T Consensus 183 ~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 183 PALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred ccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 13359999999999999966556899999885
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.43 E-value=0.0021 Score=63.23 Aligned_cols=72 Identities=15% Similarity=0.027 Sum_probs=42.5
Q ss_pred ccCCCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHHcCC--CCceeEeeEEeeCceEEEEEeecCCCCh
Q 039168 223 KLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQH--KNLVRLLGCCLEGQELLLIYEYMPNKSL 299 (536)
Q Consensus 223 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--pniv~l~~~~~~~~~~~lv~e~~~~~sL 299 (536)
..++|....|+.....+|+.+++|.-.. ......+.+|.++|+.+.. |--++-+- +.. .-+++|+++.|..+
T Consensus 18 ~~~~g~~~~v~~i~~~~g~~~VlR~p~~--~~~~~~l~rE~~vL~~L~~~l~vpvP~~~-~~~--~~~~~y~~i~G~p~ 91 (276)
T cd05152 18 LNESGLDFQVVFAKDTDGVPWVLRIPRR--PDVSERAAAEKRVLALVRKHLPVQVPDWR-VHT--PELIAYPKLPGVPA 91 (276)
T ss_pred ecCCcceeEEEEEEcCCCCeEEEEecCC--HHHHHHHHHHHHHHHHHHhcCCCCCCcee-eec--CceEEEeccCCCcc
Confidence 3455555667766555688999997643 2334668899999999953 32122111 111 22456777766544
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.39 E-value=0.0012 Score=67.22 Aligned_cols=141 Identities=18% Similarity=0.270 Sum_probs=83.9
Q ss_pred ccccCCCCceeEEEEEeCC-----CcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCce-eEeeEEeeCceEEEEEeec
Q 039168 221 ENKLGQGGFGPVYKGTLAD-----GKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLV-RLLGCCLEGQELLLIYEYM 294 (536)
Q Consensus 221 ~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv-~l~~~~~~~~~~~lv~e~~ 294 (536)
...|-.|-...+|+....+ ++.|++|+.........++ .+|..+++.+..-++. ++++.+..+ .|.||+
T Consensus 41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR-~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi 115 (344)
T PLN02236 41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDR-DDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFI 115 (344)
T ss_pred EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeech-HHHHHHHHHHHHcCCCCceEEEECCc----eEEEee
Confidence 3456667888999987532 3689999886654333333 6799999998644433 456665332 589999
Q ss_pred CCCChhhh-----------------hhccc--CCC-CCCHHHHHHHHHHH-----------------HHHHHHH----hc
Q 039168 295 PNKSLDVH-----------------LFDAT--RSV-QLDWKRRLSIINGI-----------------ARGILYL----HE 333 (536)
Q Consensus 295 ~~~sL~~~-----------------l~~~~--~~~-~l~~~~~~~i~~qi-----------------~~al~~L----H~ 333 (536)
++.++... ++... ... ...+.++..++.++ ...+..| ..
T Consensus 116 ~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~ 195 (344)
T PLN02236 116 HARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSG 195 (344)
T ss_pred CCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcc
Confidence 88777522 11100 000 11123333332221 1112222 22
Q ss_pred -CCCCCeeeCCCCCCcEEEcC-CCCeEEecccCcc
Q 039168 334 -DSRLKIIHRDLKASNVLLDD-DMNPKISDFGTAR 366 (536)
Q Consensus 334 -~~~~~ivH~Dikp~NIll~~-~~~~kl~Dfg~a~ 366 (536)
.....++|+|+++.|||+++ ++.+.|+||..+.
T Consensus 196 ~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 196 DDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred cCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 22346899999999999986 4689999998875
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.26 E-value=0.0039 Score=61.87 Aligned_cols=139 Identities=17% Similarity=0.244 Sum_probs=84.8
Q ss_pred ccccccCCCCceeEEEEEeCCCcEEEEEEccc--cChhhHHHHHHHHHHHHHcCC--CCceeEeeEEeeCc--eEEEEEe
Q 039168 219 SDENKLGQGGFGPVYKGTLADGKAIAVKRLSR--TSGQGLKEFKNEVNLIAKLQH--KNLVRLLGCCLEGQ--ELLLIYE 292 (536)
Q Consensus 219 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h--pniv~l~~~~~~~~--~~~lv~e 292 (536)
.+.+.+..|..-.+|..... ++++++. ... ..........+|+.+++.+.- --+.+.++.+.++. ..+.||+
T Consensus 28 ~~v~~~~~G~sn~t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~ 105 (321)
T COG3173 28 LIVEEISGGWSNDTFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVME 105 (321)
T ss_pred ceeeeccCCcccceEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEE
Confidence 34445544544555555554 7888888 331 233445667789999998854 23444566666555 6799999
Q ss_pred ecCCCChhhhhhcccCCCCCCHHHHHHHH-HHHHHHHHHHh---------------------------------------
Q 039168 293 YMPNKSLDVHLFDATRSVQLDWKRRLSII-NGIARGILYLH--------------------------------------- 332 (536)
Q Consensus 293 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~-~qi~~al~~LH--------------------------------------- 332 (536)
|++|..+...+.... .. .+++ ..+++.|.-||
T Consensus 106 ~veGe~~~~~~~~~~----~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~ 177 (321)
T COG3173 106 WVEGEVVWSALPPES----LG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRI 177 (321)
T ss_pred EecceeccCcCCccc----ch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCC
Confidence 999854332221100 00 1111 13333333333
Q ss_pred -----------c-----CCCCCeeeCCCCCCcEEEcCCCCeEEecccCccc
Q 039168 333 -----------E-----DSRLKIIHRDLKASNVLLDDDMNPKISDFGTARI 367 (536)
Q Consensus 333 -----------~-----~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 367 (536)
. .+...++|+|+++.||++++++-+=+.||+++..
T Consensus 178 p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 178 PLADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred chHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 2 2235789999999999999988899999999863
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.22 E-value=0.0041 Score=61.87 Aligned_cols=141 Identities=17% Similarity=0.192 Sum_probs=98.3
Q ss_pred ccccccCCCCceeEEEEEeCCCcEEEEEEcccc-----C--------------------h-hhHHHHHHHHHHHHHcCCC
Q 039168 219 SDENKLGQGGFGPVYKGTLADGKAIAVKRLSRT-----S--------------------G-QGLKEFKNEVNLIAKLQHK 272 (536)
Q Consensus 219 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~-----~--------------------~-~~~~~~~~E~~~l~~l~hp 272 (536)
.+...|..|--+.||.+.-.+|..+|||+++-. . . ...-...+|++-|++|+..
T Consensus 147 ~inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred ecccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 344578899999999999999999999986421 0 0 0122356788888888754
Q ss_pred CceeEeeEEeeCceEEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEc
Q 039168 273 NLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLD 352 (536)
Q Consensus 273 niv~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~ 352 (536)
.|.-.--+.. ..-.|||+|+..... -...-+...++...+..+-.|++.-+.-|.... ++||.||.--|+|+-
T Consensus 227 GIP~PePIlL--k~hVLVM~FlGrdgw---~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyh 299 (520)
T KOG2270|consen 227 GIPCPEPILL--KNHVLVMEFLGRDGW---AAPKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYH 299 (520)
T ss_pred CCCCCCceee--ecceEeeeeccCCCC---cCcccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEE
Confidence 4322111111 133799999964322 222223445777788888899999999888776 799999999999985
Q ss_pred CCCCeEEecccCccc
Q 039168 353 DDMNPKISDFGTARI 367 (536)
Q Consensus 353 ~~~~~kl~Dfg~a~~ 367 (536)
+|.+.|+|-+-+..
T Consensus 300 -dG~lyiIDVSQSVE 313 (520)
T KOG2270|consen 300 -DGKLYIIDVSQSVE 313 (520)
T ss_pred -CCEEEEEEcccccc
Confidence 46899999877653
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.06 E-value=0.004 Score=61.32 Aligned_cols=75 Identities=17% Similarity=0.272 Sum_probs=49.0
Q ss_pred ccccccCCCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHHcC---CCCceeEeeEEeeCceEEEEEeecC
Q 039168 219 SDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQ---HKNLVRLLGCCLEGQELLLIYEYMP 295 (536)
Q Consensus 219 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~l~~~~~~~~~~~lv~e~~~ 295 (536)
+..+.|+-|....+|+.. .+++.+.||.-.. .....|..|.+-|+.|. .-.+.+++.+...++..+|+|||++
T Consensus 20 ~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~ 95 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD-TDGGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLE 95 (288)
T ss_dssp -EEEEE--SSSSEEEEEE-TTS-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE---
T ss_pred eeeEecCCCChhheEEEE-CCCccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeec
Confidence 345678989999999988 5788999997652 22356788999998883 3457788888877777799999998
Q ss_pred CC
Q 039168 296 NK 297 (536)
Q Consensus 296 ~~ 297 (536)
.+
T Consensus 96 ~~ 97 (288)
T PF03881_consen 96 MG 97 (288)
T ss_dssp --
T ss_pred CC
Confidence 77
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.81 E-value=0.00021 Score=81.66 Aligned_cols=159 Identities=12% Similarity=-0.046 Sum_probs=115.3
Q ss_pred HHHHHHHHHcCCCCceeEeeEEee--CceEEEEEeecCCCChhhhhhcccCC-CCCCHHHHHHHHHHHHHHHHHHhcCC-
Q 039168 260 KNEVNLIAKLQHKNLVRLLGCCLE--GQELLLIYEYMPNKSLDVHLFDATRS-VQLDWKRRLSIINGIARGILYLHEDS- 335 (536)
Q Consensus 260 ~~E~~~l~~l~hpniv~l~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~~- 335 (536)
..|...++...|+++.....-... ..+.+.+++|+.+|.+...|.+...+ ..++..-+.....+.+.+..-.|...
T Consensus 1277 l~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tn 1356 (2724)
T KOG1826|consen 1277 LSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTN 1356 (2724)
T ss_pred hhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhccc
Confidence 345556667789988877665543 45678999999999999888664433 33444333333333356655555432
Q ss_pred -CCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHH
Q 039168 336 -RLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEII 414 (536)
Q Consensus 336 -~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell 414 (536)
..-.+|+++|+-|.+|..+-++|++++|+.+.... .........+++.|+.|++...-.++.++|+|..|+.+|++-
T Consensus 1357 lg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp--~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1357 LGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNP--VLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRS 1434 (2724)
T ss_pred CCccchhhhhhhhccceecCCcccccccccccccCc--hHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHh
Confidence 34568999999999999999999999999984321 222233456788999999998888999999999999999998
Q ss_pred hCCCCC
Q 039168 415 SGRKNN 420 (536)
Q Consensus 415 tg~~p~ 420 (536)
.|..++
T Consensus 1435 ~~n~~f 1440 (2724)
T KOG1826|consen 1435 DGNAYF 1440 (2724)
T ss_pred cccHHH
Confidence 887664
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.70 E-value=0.019 Score=57.87 Aligned_cols=72 Identities=15% Similarity=0.230 Sum_probs=48.2
Q ss_pred ccCCCCceeEEEEEeCCC-cEEEEEEccc-------cChhhHHHHHHHHHHHHHcC--CCC-ceeEeeEEeeCceEEEEE
Q 039168 223 KLGQGGFGPVYKGTLADG-KAIAVKRLSR-------TSGQGLKEFKNEVNLIAKLQ--HKN-LVRLLGCCLEGQELLLIY 291 (536)
Q Consensus 223 ~lg~G~~g~Vy~~~~~~~-~~vavK~~~~-------~~~~~~~~~~~E~~~l~~l~--hpn-iv~l~~~~~~~~~~~lv~ 291 (536)
.||.|....||++...+| +.|+||.-.. .-+-..++..-|...|+... .|. +++++.+ +.....+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 589999999999998654 6899996421 11334566677888887763 354 4444433 334556999
Q ss_pred eecCC
Q 039168 292 EYMPN 296 (536)
Q Consensus 292 e~~~~ 296 (536)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 99854
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.68 E-value=0.011 Score=59.89 Aligned_cols=140 Identities=15% Similarity=0.246 Sum_probs=80.3
Q ss_pred cccCCCCceeEEEEEeCC----CcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCc-eeEeeEEeeCceEEEEEeecCC
Q 039168 222 NKLGQGGFGPVYKGTLAD----GKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNL-VRLLGCCLEGQELLLIYEYMPN 296 (536)
Q Consensus 222 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpni-v~l~~~~~~~~~~~lv~e~~~~ 296 (536)
+.|..|-...+|+....+ +..|++|+........ -.-.+|..+++.+..-++ .++++++. ++ +|.+|+++
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~-IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g 94 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYV-IDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINA 94 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeE-echHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcC
Confidence 456567778889887543 3478999876543322 223578999999865444 34565553 22 58999988
Q ss_pred CChhhh-------h----------hcccC--CC-CCCHHHHHHHHHHH----------------------HHHHHH---H
Q 039168 297 KSLDVH-------L----------FDATR--SV-QLDWKRRLSIINGI----------------------ARGILY---L 331 (536)
Q Consensus 297 ~sL~~~-------l----------~~~~~--~~-~l~~~~~~~i~~qi----------------------~~al~~---L 331 (536)
..+... + +.... .. ..-+..+..++.++ ..-+.. +
T Consensus 95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~ 174 (330)
T PLN02421 95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI 174 (330)
T ss_pred CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence 766321 1 11000 00 11123322222221 111211 1
Q ss_pred h-c-CCCCCeeeCCCCCCcEEEcC-CCCeEEecccCcc
Q 039168 332 H-E-DSRLKIIHRDLKASNVLLDD-DMNPKISDFGTAR 366 (536)
Q Consensus 332 H-~-~~~~~ivH~Dikp~NIll~~-~~~~kl~Dfg~a~ 366 (536)
. . .....++|.|+.+.|||+++ ++.++++||+.+.
T Consensus 175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 1 1 11234799999999999975 5789999999875
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.66 E-value=0.036 Score=55.41 Aligned_cols=65 Identities=17% Similarity=0.290 Sum_probs=40.5
Q ss_pred eEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHHcCCC--CceeEeeE------EeeCceEEEEEeecCCCChh
Q 039168 231 PVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHK--NLVRLLGC------CLEGQELLLIYEYMPNKSLD 300 (536)
Q Consensus 231 ~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp--niv~l~~~------~~~~~~~~lv~e~~~~~sL~ 300 (536)
.||+....+| .+++|++... ...+..|...+..|... .+++++.. ...++..++++||++|..+.
T Consensus 11 ~v~~v~t~~g-~~~LK~~~~~----~~~~~~~~~~~~~L~~~g~~vp~~i~t~~g~~~~~~~~~~~~l~~~i~G~~~~ 83 (313)
T TIGR02906 11 NVYKVETDSG-NKCLKKINYP----PERLLFILGAQEHLRKNGFNIPKILKTKDGELYVKYNGDLYVLTEWIEGRECD 83 (313)
T ss_pred cEEEEEeCCC-CeEEEEcCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEehhccCcCCC
Confidence 4888876545 6889987532 23455567777666332 33333322 23356789999999987653
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.62 E-value=0.034 Score=57.13 Aligned_cols=73 Identities=11% Similarity=0.089 Sum_probs=50.9
Q ss_pred ccccCCCCceeEEEEEeCCCcEEEEEEcccc----Ch---hhHHHHHHHHHHHHHcC---CCCceeEeeEEeeCceEEEE
Q 039168 221 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRT----SG---QGLKEFKNEVNLIAKLQ---HKNLVRLLGCCLEGQELLLI 290 (536)
Q Consensus 221 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~----~~---~~~~~~~~E~~~l~~l~---hpniv~l~~~~~~~~~~~lv 290 (536)
.+.||.|....||+.... +..++||.-... .. ....+...|...|+.+. ...+.+++.++. +..+++
T Consensus 37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 567899999999998874 567999976421 11 13444555677777664 247777888876 346788
Q ss_pred EeecCC
Q 039168 291 YEYMPN 296 (536)
Q Consensus 291 ~e~~~~ 296 (536)
||++++
T Consensus 114 ME~L~~ 119 (418)
T PLN02756 114 MRYLEP 119 (418)
T ss_pred EeecCC
Confidence 999977
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.49 E-value=0.12 Score=52.05 Aligned_cols=73 Identities=14% Similarity=0.076 Sum_probs=47.2
Q ss_pred CCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCC--ceeEe---e--EEeeCceEEEEEeecCCCC
Q 039168 226 QGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKN--LVRLL---G--CCLEGQELLLIYEYMPNKS 298 (536)
Q Consensus 226 ~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn--iv~l~---~--~~~~~~~~~lv~e~~~~~s 298 (536)
.+.-..||+....++..+++|+.... ......+..|.+.+..|.... ++... + ....++..+.++++++|..
T Consensus 35 ~s~eN~vy~v~~~~~~~~vlKv~r~~-~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~ 113 (325)
T PRK11768 35 NSYENRVYQFGDEDGRRVVAKFYRPE-RWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRA 113 (325)
T ss_pred ccccceEEEEecCCCCEEEEEEcCcc-cCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence 34567799998888889999987532 234466778888888774211 22211 1 1233566788999998875
Q ss_pred h
Q 039168 299 L 299 (536)
Q Consensus 299 L 299 (536)
.
T Consensus 114 ~ 114 (325)
T PRK11768 114 P 114 (325)
T ss_pred C
Confidence 4
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.35 E-value=0.007 Score=56.90 Aligned_cols=122 Identities=18% Similarity=0.240 Sum_probs=59.9
Q ss_pred CcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCc-eeEeeEEeeCceEEEEEeecCCCChhhh-hh-------------
Q 039168 240 GKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNL-VRLLGCCLEGQELLLIYEYMPNKSLDVH-LF------------- 304 (536)
Q Consensus 240 ~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpni-v~l~~~~~~~~~~~lv~e~~~~~sL~~~-l~------------- 304 (536)
++.|+|++....+ ...-.-..|..+++.+..-.+ .++++.+.. ..|.||+++..|... +.
T Consensus 2 ~~~~~~Ri~g~~t-~~~idr~~E~~~~~~l~~~g~~p~~~~~~~~----g~v~e~i~g~~l~~~~~~~~~~~~~iA~~l~ 76 (211)
T PF01633_consen 2 PEKYLVRIPGEGT-ENFIDRENENEALKLLSEAGLGPKIIYFFEN----GRVEEFIEGRTLSPEDFRNPEILKRIAKLLA 76 (211)
T ss_dssp TSEEEEEEEESCG-CSHHHHHHHHHHHHHHHHTTSSS-EEEEETT----EEEEE--SSEE--CGGGGSHHHHHHHHHHHH
T ss_pred CCEEEEEeCCCCc-ccccCHHHHHHHHHHHHHcCCCCeEEEEcCC----CcEEEEecccccChhhccChHHHHHHHHHHH
Confidence 4678888776553 333455678899998865444 455555433 256799987775431 10
Q ss_pred ---cccC----CCCCCHHHHHHH----------------------HHHHHHHHHHHh----cC-CCCCeeeCCCCCCcEE
Q 039168 305 ---DATR----SVQLDWKRRLSI----------------------INGIARGILYLH----ED-SRLKIIHRDLKASNVL 350 (536)
Q Consensus 305 ---~~~~----~~~l~~~~~~~i----------------------~~qi~~al~~LH----~~-~~~~ivH~Dikp~NIl 350 (536)
.... ....-+..+..+ +..+.+-+..+. .. ....+.|.|+.|.|||
T Consensus 77 ~lH~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~v~cHnDl~~~Nil 156 (211)
T PF01633_consen 77 KLHSIPISPNSKKPDLWDRIDKYMNKKSEFLFKRKKKKKSIDKEDLEDLQEELEELEKLLEKSNSPLVFCHNDLNPGNIL 156 (211)
T ss_dssp HHHTHHHTTSSSS-HHHHHHHHHHHHHHTCCCCHHTTTCHHHHHHHHHHHHHHHHHHHHHHTSCGGEEEE-S--SGGGEE
T ss_pred HHhhcccccccCcchHHHHhhhhccchhhhhhhhhhhccccccCCHHHHHHHHhhhhhhhhccCCCceEeeccCccccEE
Confidence 0000 000011222222 111122222221 11 1235789999999999
Q ss_pred E-cCCCCeEEecccCcc
Q 039168 351 L-DDDMNPKISDFGTAR 366 (536)
Q Consensus 351 l-~~~~~~kl~Dfg~a~ 366 (536)
+ +.++.++|+||..+.
T Consensus 157 ~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 157 INNKDGEVKLIDFEYAG 173 (211)
T ss_dssp ETSSSSCEEE--GTT-E
T ss_pred eccCCCeEEEecHHHHh
Confidence 9 888999999998875
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.27 E-value=0.023 Score=58.05 Aligned_cols=74 Identities=9% Similarity=0.129 Sum_probs=50.2
Q ss_pred ccccCCCCceeEEEEEeCC-CcEEEEEEccc------cChhhHHHHHHHHHHHHHcC--CCC-ceeEeeEEeeCceEEEE
Q 039168 221 ENKLGQGGFGPVYKGTLAD-GKAIAVKRLSR------TSGQGLKEFKNEVNLIAKLQ--HKN-LVRLLGCCLEGQELLLI 290 (536)
Q Consensus 221 ~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~------~~~~~~~~~~~E~~~l~~l~--hpn-iv~l~~~~~~~~~~~lv 290 (536)
.+.||-|.-.-||++.+.+ ++.|+||.-.. .-+-..++..-|.+.|+.+. .|. +++++.+ +.....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 5689999999999999853 67899996421 11334667777888888774 354 4445543 33455788
Q ss_pred EeecCC
Q 039168 291 YEYMPN 296 (536)
Q Consensus 291 ~e~~~~ 296 (536)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 888753
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.22 E-value=0.065 Score=53.62 Aligned_cols=31 Identities=26% Similarity=0.386 Sum_probs=27.9
Q ss_pred CCCeeeCCCCCCcEEEcCCCCeEEecccCcc
Q 039168 336 RLKIIHRDLKASNVLLDDDMNPKISDFGTAR 366 (536)
Q Consensus 336 ~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 366 (536)
+..++|+|+.++|+|+++++.+.++||..+.
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKAS 225 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence 3469999999999999999999999998875
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.22 E-value=0.072 Score=53.49 Aligned_cols=140 Identities=24% Similarity=0.315 Sum_probs=82.8
Q ss_pred ccCCCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHHcCC---CCcee---Eee----EEeeCceEEEEEe
Q 039168 223 KLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQH---KNLVR---LLG----CCLEGQELLLIYE 292 (536)
Q Consensus 223 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---pniv~---l~~----~~~~~~~~~lv~e 292 (536)
.|.+ .-..||+....+|+. ++|+.... ....++..|...|..|.- |=.++ +=| ........+-+++
T Consensus 33 ~l~s-~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~ 108 (331)
T COG2334 33 GLNS-EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFE 108 (331)
T ss_pred cccc-ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEE
Confidence 4555 567889998877776 88887664 344667778888888832 21122 211 1111237888999
Q ss_pred ecCCCChhh-hh--------------hccc------C---CCCCCHHH----H---------HHHHHHHHHHHHHHhcC-
Q 039168 293 YMPNKSLDV-HL--------------FDAT------R---SVQLDWKR----R---------LSIINGIARGILYLHED- 334 (536)
Q Consensus 293 ~~~~~sL~~-~l--------------~~~~------~---~~~l~~~~----~---------~~i~~qi~~al~~LH~~- 334 (536)
|++|..+.. .. +... + .....|.. . .....++...+..+.+.
T Consensus 109 ~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~ 188 (331)
T COG2334 109 YLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARL 188 (331)
T ss_pred ecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhc
Confidence 999998883 11 1100 0 00122220 0 01223333334433321
Q ss_pred ---CC---CCeeeCCCCCCcEEEcCCCC-eEEecccCcc
Q 039168 335 ---SR---LKIIHRDLKASNVLLDDDMN-PKISDFGTAR 366 (536)
Q Consensus 335 ---~~---~~ivH~Dikp~NIll~~~~~-~kl~Dfg~a~ 366 (536)
-. ..+||+|+.|.||+++++.. +.+.||+-+.
T Consensus 189 ~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 189 PAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred hhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 11 22999999999999999885 8999999875
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=96.16 E-value=0.028 Score=52.17 Aligned_cols=138 Identities=14% Similarity=0.135 Sum_probs=82.7
Q ss_pred EEEEEEccccChh-hHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEeecCCCChhhhhhcccCCCCCCHHHHHHH
Q 039168 242 AIAVKRLSRTSGQ-GLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSI 320 (536)
Q Consensus 242 ~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i 320 (536)
+..+|++...... ....|.+++.++.+++ .|+++..- ..-..-++.|.|..... .. ..+
T Consensus 87 ~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i------------~~----~N~ 146 (308)
T PF07387_consen 87 PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI------------NF----SNF 146 (308)
T ss_pred hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc------------ch----hHH
Confidence 4566666544333 3456788899999876 46666632 33456788888843211 11 111
Q ss_pred HHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCCccccccccccccccCcchhcCCCCCcc
Q 039168 321 INGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIK 400 (536)
Q Consensus 321 ~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 400 (536)
+.-=+++|.-.|+. ..+.+|+|-.|+||+-|..|.+||.|-+.--. .+.-|.--| ....+.+
T Consensus 147 i~agi~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~--------------~~V~~vN~~---Y~~lT~~ 208 (308)
T PF07387_consen 147 ITAGIKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVCLLE--------------NQVNMVNIE---YESLTQE 208 (308)
T ss_pred HHHhHHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhhhhh--------------heeeEEeee---ccccChH
Confidence 11114667778843 23799999999999999999999999765421 011122211 1234566
Q ss_pred chHHHHHHHHHHHHhCC
Q 039168 401 SDVFSFGVLLLEIISGR 417 (536)
Q Consensus 401 ~DvwslG~il~elltg~ 417 (536)
+.+=+|=..++++....
T Consensus 209 aE~~~fv~s~l~~v~~~ 225 (308)
T PF07387_consen 209 AEVKVFVKSCLKLVEKQ 225 (308)
T ss_pred HHHHHHHHHHHHHHHHH
Confidence 67767666666666543
|
The function of this family is unknown. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.94 E-value=0.061 Score=53.73 Aligned_cols=119 Identities=17% Similarity=0.108 Sum_probs=78.0
Q ss_pred CCceeEeeEE-eeCceEEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEE
Q 039168 272 KNLVRLLGCC-LEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVL 350 (536)
Q Consensus 272 pniv~l~~~~-~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIl 350 (536)
++..+.+-+- .+..+.|++|++- |+++... ....++++..++.+-+.-+.-+..+- ..-|||+.-.|||
T Consensus 285 ~~~e~~~vv~~de~~y~yl~~kdh-gt~is~i-------k~~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niL 354 (488)
T COG5072 285 VFLETLKVVSLDETLYLYLHFKDH-GTPISII-------KADRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNIL 354 (488)
T ss_pred hhhhcceEEecCCceEEEEEEecC-Cceeeee-------ecccHHHHHHHHHHHHHHHhhhhhcC--Cccccccccccee
Confidence 4444443333 3445677888864 5555422 23567889999999888888888765 7899999999999
Q ss_pred EcCCCCeEEecccCccccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHH
Q 039168 351 LDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVL 409 (536)
Q Consensus 351 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~i 409 (536)
|+ +|+|.|+||-+++.-....... ....--|-.+.|. -+.+-+||-+--.
T Consensus 355 Id-~GnvtLIDfklsRl~~~q~~is-------y~rldhp~lF~G~-dd~QFeIYrlMr~ 404 (488)
T COG5072 355 ID-EGNVTLIDFKLSRLSYSQGIIS-------YNRLDHPDLFNGV-DDYQFEIYRLMRR 404 (488)
T ss_pred ee-cCceEEEEeeeeecccCCceee-------ccccCchhhhcCc-cceeeeHHHHHHH
Confidence 99 9999999999998432221111 1122344445533 3677788875433
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=95.71 E-value=0.19 Score=47.12 Aligned_cols=75 Identities=17% Similarity=0.279 Sum_probs=53.2
Q ss_pred cccCCCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHHcC---CCCceeEeeEEeeCceEEEEEeecCCCC
Q 039168 222 NKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQ---HKNLVRLLGCCLEGQELLLIYEYMPNKS 298 (536)
Q Consensus 222 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~l~~~~~~~~~~~lv~e~~~~~s 298 (536)
+.+.-|.--..|...+ +..++.||.-. ......|..|+.-|+.|. .-.+.+++.+-.+.++.|+|+||++-+.
T Consensus 22 ~~v~gG~inea~~v~d-g~~~~FvK~n~---~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~ 97 (286)
T COG3001 22 EEVSGGDINEAWRLRD-GTDPFFVKCNQ---REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGP 97 (286)
T ss_pred cccCCccccceeEeec-CCcceEEEecc---hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCC
Confidence 3455555555565554 56788888633 333456778887777774 4567788888889999999999999877
Q ss_pred hh
Q 039168 299 LD 300 (536)
Q Consensus 299 L~ 300 (536)
++
T Consensus 98 ~d 99 (286)
T COG3001 98 LD 99 (286)
T ss_pred CC
Confidence 76
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.69 E-value=0.084 Score=54.34 Aligned_cols=76 Identities=21% Similarity=0.378 Sum_probs=47.1
Q ss_pred ccccCCCCceeEEEEEeCCC--cE-----EEEEEccccChhhHHHHHHHHHHHHHcCCCCc-eeEeeEEeeCceEEEEEe
Q 039168 221 ENKLGQGGFGPVYKGTLADG--KA-----IAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNL-VRLLGCCLEGQELLLIYE 292 (536)
Q Consensus 221 ~~~lg~G~~g~Vy~~~~~~~--~~-----vavK~~~~~~~~~~~~~~~E~~~l~~l~hpni-v~l~~~~~~~~~~~lv~e 292 (536)
.+.|..|-...+|++...++ .. |.++.......... .-.+|+++++.+...++ .++++.+.. +++.|
T Consensus 55 i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~I-dR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~e 129 (383)
T PTZ00384 55 IKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVI-DNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQE 129 (383)
T ss_pred EEEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEe-ccHHHHHHHHHHHhCCCCCeEEEecCC----EEEEE
Confidence 34666688899999975432 22 44443322222111 23568999999966544 455666543 69999
Q ss_pred ecCCCChhh
Q 039168 293 YMPNKSLDV 301 (536)
Q Consensus 293 ~~~~~sL~~ 301 (536)
|++|..|..
T Consensus 130 fIeGr~l~~ 138 (383)
T PTZ00384 130 WVEGNTMGI 138 (383)
T ss_pred EeccccCCh
Confidence 999988753
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 536 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 4e-48 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 5e-47 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-40 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 4e-40 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-33 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-33 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 5e-33 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-31 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-25 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-25 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-25 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-25 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 4e-25 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-24 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-24 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-24 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-24 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-24 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-24 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-24 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 9e-24 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-23 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 7e-22 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 7e-22 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-21 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-21 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-21 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-21 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-21 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-21 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-21 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-21 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-21 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-21 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-21 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 4e-21 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 4e-21 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-21 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 5e-21 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 6e-21 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 6e-21 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 7e-21 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 9e-21 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 9e-21 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-20 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-20 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-20 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-20 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-20 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-20 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-20 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-20 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 4e-20 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-19 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-19 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-19 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-19 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-19 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-19 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 4e-19 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 4e-19 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 6e-19 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 8e-19 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-18 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-18 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-18 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-18 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-18 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-18 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-18 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 5e-18 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-17 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-17 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-17 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-17 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-17 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-17 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-17 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-17 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-17 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-17 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-17 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-17 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-17 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 4e-17 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 4e-17 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 4e-17 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-17 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 4e-17 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 4e-17 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 4e-17 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 5e-17 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 5e-17 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 5e-17 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 6e-17 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 6e-17 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 7e-17 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-17 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 7e-17 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 8e-17 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 8e-17 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 8e-17 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 8e-17 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 8e-17 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 8e-17 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 9e-17 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 9e-17 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 9e-17 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 9e-17 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-16 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-16 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-16 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-16 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-16 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-16 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-16 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-16 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-16 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-16 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-16 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-16 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-16 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-16 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-16 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-16 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-16 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-16 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-16 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-16 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-16 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-16 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-16 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-16 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-16 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-16 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-16 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-16 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 4e-16 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-16 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 5e-16 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 6e-16 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 6e-16 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 7e-16 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-16 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 9e-16 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-15 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-15 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-15 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-15 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-15 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-15 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-15 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-15 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-15 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-15 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 4e-15 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 4e-15 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 4e-15 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 4e-15 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 5e-15 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 6e-15 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 6e-15 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 7e-15 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 8e-15 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-15 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-14 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-14 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-14 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-14 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-14 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-14 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-14 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-14 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-14 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-14 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-14 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-14 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-14 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-14 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-14 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-14 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-14 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-14 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-14 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-14 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-14 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-14 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-14 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-14 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-14 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-14 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-14 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-14 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-14 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-14 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-14 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 3e-14 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 3e-14 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-14 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 3e-14 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 3e-14 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-14 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-14 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-14 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-14 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 4e-14 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 4e-14 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-14 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 4e-14 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-14 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 5e-14 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 5e-14 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 5e-14 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 6e-14 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 6e-14 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 6e-14 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 6e-14 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-14 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-14 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 6e-14 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-14 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 6e-14 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 7e-14 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 7e-14 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 7e-14 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 8e-14 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 8e-14 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-14 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 8e-14 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 9e-14 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-14 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 9e-14 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 9e-14 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 9e-14 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 9e-14 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-13 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-13 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-13 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-13 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-13 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-13 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-13 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-13 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-13 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-13 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-13 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-13 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-13 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-13 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-13 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-13 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-13 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-13 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-13 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-13 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-13 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-13 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-13 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-13 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-13 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-13 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-13 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-13 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-13 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-13 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-13 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-13 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-13 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-13 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-13 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-13 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-13 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-13 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-13 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-13 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-13 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-13 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-13 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-13 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-13 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-13 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-13 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-13 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-13 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-13 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-13 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-13 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-13 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-13 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-13 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-13 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-13 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-13 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-13 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-13 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-13 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-13 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-13 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-13 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-13 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-13 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-13 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-13 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-13 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-13 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-13 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-13 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-13 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-13 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-13 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-13 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-13 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-13 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-13 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-13 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-13 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-13 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-13 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-13 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-13 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-13 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-13 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-13 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-13 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-13 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-13 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-13 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-13 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-13 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-13 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-13 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-13 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-13 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-13 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-13 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-13 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-13 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-13 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-13 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-13 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-13 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-13 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-13 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-13 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-13 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-13 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-13 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-13 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-13 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-13 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-13 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 3e-13 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-13 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-13 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-13 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-13 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-13 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 3e-13 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-13 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 4e-13 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 4e-13 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 4e-13 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 4e-13 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-13 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 4e-13 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 4e-13 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-13 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 4e-13 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-13 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 4e-13 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-13 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-13 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 4e-13 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 4e-13 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-13 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 4e-13 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 4e-13 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 4e-13 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 5e-13 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-13 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 5e-13 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 5e-13 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 5e-13 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-13 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 5e-13 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 5e-13 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 5e-13 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 5e-13 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 5e-13 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 5e-13 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 5e-13 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 5e-13 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 5e-13 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-13 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 6e-13 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 6e-13 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 6e-13 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 6e-13 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-13 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 7e-13 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 7e-13 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 7e-13 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 7e-13 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 8e-13 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 8e-13 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-13 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 8e-13 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 8e-13 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 9e-13 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 9e-13 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-12 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-12 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-12 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-12 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-12 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-12 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-12 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-12 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-12 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-12 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-12 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-12 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-12 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-12 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-12 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-12 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-12 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-12 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-12 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-12 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-12 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-12 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-12 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-12 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-12 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-12 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-12 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-12 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-12 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-12 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-12 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-12 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-12 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-12 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-12 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-12 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-12 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-12 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-12 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-12 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-12 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-12 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-12 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-12 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-12 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-12 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-12 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-12 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-12 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-12 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-12 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-12 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-12 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-12 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-12 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-12 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-12 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-12 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-12 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-12 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-12 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-12 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-12 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-12 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-12 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-12 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-12 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-12 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-12 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-12 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-12 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-12 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-12 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-12 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-12 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-12 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-12 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-12 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-12 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-12 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-12 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-12 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-12 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-12 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-12 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 3e-12 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-12 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-12 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 4e-12 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 4e-12 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 4e-12 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 4e-12 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 4e-12 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 4e-12 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 4e-12 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 4e-12 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-12 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 6e-12 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 6e-12 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 6e-12 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 6e-12 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 6e-12 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 6e-12 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 7e-12 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 7e-12 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 7e-12 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 7e-12 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 7e-12 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 7e-12 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 7e-12 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-12 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 8e-12 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 8e-12 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 9e-12 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 9e-12 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 9e-12 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-12 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-11 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-11 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-11 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-11 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-11 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-11 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-11 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-11 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-11 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-11 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-11 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-11 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-11 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-11 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-11 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-11 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-11 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-11 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-11 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 3e-11 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-11 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 3e-11 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 4e-11 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 4e-11 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 5e-11 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 5e-11 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 5e-11 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 6e-11 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-11 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 6e-11 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 6e-11 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 6e-11 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 6e-11 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 7e-11 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 7e-11 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 7e-11 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 7e-11 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 7e-11 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 7e-11 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 7e-11 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 7e-11 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 7e-11 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 7e-11 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 7e-11 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 7e-11 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 8e-11 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 8e-11 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 8e-11 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 8e-11 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 8e-11 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 8e-11 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 8e-11 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-11 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 9e-11 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 9e-11 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 9e-11 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 9e-11 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 9e-11 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 9e-11 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-11 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 9e-11 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 9e-11 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-10 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-10 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-10 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-10 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-10 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-10 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-10 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-10 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-10 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-10 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-10 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-10 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-10 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-10 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-10 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-10 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-10 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-10 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-10 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-10 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-10 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-10 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-10 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-10 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-10 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-10 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-10 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-10 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-10 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-10 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-10 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-10 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-10 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-10 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-10 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-10 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-10 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-10 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-10 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-10 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-10 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-10 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-10 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-10 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-10 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-10 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-10 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-10 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-10 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-10 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-10 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-10 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-10 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-10 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-10 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-10 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-10 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-10 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-10 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-10 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-10 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-10 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-10 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-10 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-10 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-10 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-10 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-10 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-10 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-10 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-10 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-10 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-10 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-10 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-10 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-10 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-10 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 3e-10 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 3e-10 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-10 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-10 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-10 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-10 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-10 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-10 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-10 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-10 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-10 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-10 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 3e-10 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-10 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 4e-10 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 4e-10 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-10 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-10 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 5e-10 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 5e-10 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-10 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 6e-10 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 6e-10 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-10 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 8e-10 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 8e-10 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 8e-10 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 8e-10 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 8e-10 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 8e-10 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 8e-10 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 8e-10 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 9e-10 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 9e-10 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 9e-10 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 9e-10 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 9e-10 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-09 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-09 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-09 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-09 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-09 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-09 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-09 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-09 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-09 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-09 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-09 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-09 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-09 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-09 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-09 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-09 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-09 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-09 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-09 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-09 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-09 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-09 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-09 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-09 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-09 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-09 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-09 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-09 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-09 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-09 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-09 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-09 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-09 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-09 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-09 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-09 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-09 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-09 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-09 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-09 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-09 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-09 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-09 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-09 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-09 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-09 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-09 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-09 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 3e-09 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-09 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 4e-09 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 4e-09 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-09 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 4e-09 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 4e-09 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 4e-09 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 5e-09 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 5e-09 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 5e-09 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-09 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 6e-09 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-09 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 6e-09 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 6e-09 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 7e-09 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 7e-09 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-09 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 7e-09 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 8e-09 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 8e-09 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 8e-09 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-08 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-08 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-08 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-08 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-08 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-08 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-08 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-08 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-08 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-08 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-08 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-08 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-08 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-08 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-08 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-08 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-08 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-08 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-08 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 2e-08 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-08 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-08 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-08 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-08 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-08 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-08 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-08 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-08 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-08 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-08 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-08 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 3e-08 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 3e-08 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-08 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 3e-08 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-08 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 3e-08 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-08 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-08 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-08 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 3e-08 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-08 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-08 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-08 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-08 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 3e-08 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-08 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-08 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-08 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 4e-08 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 4e-08 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 4e-08 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 4e-08 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 4e-08 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 4e-08 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 4e-08 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 4e-08 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-08 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-08 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 4e-08 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 4e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 5e-08 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 5e-08 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 6e-08 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 7e-08 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 7e-08 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 7e-08 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 8e-08 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 8e-08 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 8e-08 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 9e-08 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 9e-08 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 9e-08 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 9e-08 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-07 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-07 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-07 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-07 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-07 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-07 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-07 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-07 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-07 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-07 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-07 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-07 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-07 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-07 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-07 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-07 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-07 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-07 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-07 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-07 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-07 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-07 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-07 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-07 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-07 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-07 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-07 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-07 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-07 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-07 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-07 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-07 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-07 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-07 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 3e-07 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-07 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 4e-07 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 4e-07 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 4e-07 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-07 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 5e-07 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 5e-07 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 5e-07 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 5e-07 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 6e-07 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 6e-07 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 6e-07 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 6e-07 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 6e-07 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 7e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 7e-07 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 7e-07 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 7e-07 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 7e-07 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 7e-07 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 7e-07 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 7e-07 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 7e-07 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-07 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 8e-07 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 8e-07 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 8e-07 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 8e-07 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 9e-07 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 9e-07 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 9e-07 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-06 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-06 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-06 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-06 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-06 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-06 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-06 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-06 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-06 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-06 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-06 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-06 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-06 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-06 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 3e-06 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 3e-06 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 4e-06 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 4e-06 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 4e-06 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 4e-06 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 4e-06 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 5e-06 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 5e-06 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 6e-06 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 6e-06 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 6e-06 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 7e-06 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 8e-06 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 8e-06 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 8e-06 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 9e-06 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 9e-06 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 9e-06 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-05 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 1e-05 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-05 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 1e-05 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 1e-05 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-05 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-05 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-05 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-05 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-05 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 2e-05 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-05 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-05 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-05 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-05 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-05 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 2e-05 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 3e-05 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 3e-05 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 3e-05 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 3e-05 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 3e-05 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 4e-05 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-05 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 4e-05 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-05 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 4e-05 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 4e-05 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 5e-05 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 5e-05 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 5e-05 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 5e-05 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 5e-05 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 5e-05 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 6e-05 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 6e-05 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 6e-05 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 6e-05 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 6e-05 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 6e-05 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-05 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-05 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 6e-05 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 6e-05 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 6e-05 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 6e-05 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 6e-05 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 6e-05 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 6e-05 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 6e-05 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 7e-05 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 7e-05 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 435 bits (1120), Expect = e-151
Identities = 105/293 (35%), Positives = 153/293 (52%), Gaps = 19/293 (6%)
Query: 214 ATNHFSDE------NKLGQGGFGPVYKGTLADGKAIAVKRLS----RTSGQGLKEFKNEV 263
TN+F + NK+G+GGFG VYKG + + +AVK+L+ T+ + ++F E+
Sbjct: 23 VTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEI 81
Query: 264 NLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIING 323
++AK QH+NLV LLG +G +L L+Y YMPN SL L + L W R I G
Sbjct: 82 KVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQG 141
Query: 324 IARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGT 383
A GI +LHE+ IHRD+K++N+LLD+ KISDFG AR T+ I GT
Sbjct: 142 AANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGT 198
Query: 384 YGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGH 443
YMAPE + G + KSD++SFGV+LLEII+G Q LL ++ E
Sbjct: 199 TAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPA--VDEHREPQLLLDIKEEIEDEEK 255
Query: 444 AVE-LIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSMT 495
+E ID + + + + C+ + RP + V +L + +
Sbjct: 256 TIEDYIDKKMNDAD-STSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 307
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 434 bits (1119), Expect = e-151
Identities = 118/285 (41%), Positives = 169/285 (59%), Gaps = 5/285 (1%)
Query: 214 ATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLK-EFKNEVNLIAKLQHK 272
A+++FS++N LG+GGFG VYKG LADG +AVKRL QG + +F+ EV +I+ H+
Sbjct: 28 ASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHR 87
Query: 273 NLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRS-VQLDWKRRLSIINGIARGILYL 331
NL+RL G C+ E LL+Y YM N S+ L + S LDW +R I G ARG+ YL
Sbjct: 88 NLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYL 147
Query: 332 HEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEY 391
H+ KIIHRD+KA+N+LLD++ + DFG A++ T + GT G++APEY
Sbjct: 148 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA-VRGTIGHIAPEY 206
Query: 392 AMGGIFSIKSDVFSFGVLLLEIISGRKN--NGFYFSEHGQTLLTYTWKLWCEGHAVELID 449
G S K+DVF +GV+LLE+I+G++ ++ LL + L E L+D
Sbjct: 207 LSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVD 266
Query: 450 PVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSM 494
L+ + +E+ + I + LLC Q P +RP MS VV ML D +
Sbjct: 267 VDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGL 311
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 388 bits (1000), Expect = e-133
Identities = 108/286 (37%), Positives = 162/286 (56%), Gaps = 6/286 (2%)
Query: 206 FPLGLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNL 265
PL EATN+F + +G G FG VYKG L DG +A+KR + S QG++EF+ E+
Sbjct: 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIET 88
Query: 266 IAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQ-LDWKRRLSIINGI 324
++ +H +LV L+G C E E++LIY+YM N +L HL+ + + W++RL I G
Sbjct: 89 LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGA 148
Query: 325 ARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIF-GGNQNQANTNIIAGT 383
ARG+ YLH + IIHRD+K+ N+LLD++ PKI+DFG ++ +Q +T + GT
Sbjct: 149 ARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTV-VKGT 204
Query: 384 YGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGH 443
GY+ PEY + G + KSDV+SFGV+L E++ R L + + G
Sbjct: 205 LGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ 264
Query: 444 AVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 489
+++DP L P+ L KF + C+ DRP+M V+ L
Sbjct: 265 LEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 310 bits (797), Expect = e-102
Identities = 73/323 (22%), Positives = 124/323 (38%), Gaps = 34/323 (10%)
Query: 194 GEQQAESQEFPLFPLGLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSG 253
G + +G FG V+K L + +AVK
Sbjct: 2 GHHHHHHSSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDK 60
Query: 254 QGLKEFKNEVNLIAKLQHKNLVRLLGCCLEG----QELLLIYEYMPNKSLDVHLFDATRS 309
Q + + EV + ++H+N+++ +G G +L LI + SL L ++
Sbjct: 61 QS-WQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL----KA 115
Query: 310 VQLDWKRRLSIINGIARGILYLHED-------SRLKIIHRDLKASNVLLDDDMNPKISDF 362
+ W I +ARG+ YLHED + I HRD+K+ NVLL +++ I+DF
Sbjct: 116 NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADF 175
Query: 363 GTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGI-----FSIKSDVFSFGVLLLEIISGR 417
G A F ++ +T+ GT YMAPE G I ++ D+++ G++L E+ S
Sbjct: 176 GLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRC 235
Query: 418 KNNGFYFSEHGQTLLTYTWKLWC--------EGHAVELIDPVLKQSCAPDELLK-FIHIG 468
E+ +L + ++ E + PVL+ +
Sbjct: 236 TAADGPVDEY---MLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETI 292
Query: 469 LLCVQQDPADRPTMSSVVVMLAS 491
C D R + V +
Sbjct: 293 EECWDHDAEARLSAGCVGERITQ 315
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 268 bits (687), Expect = 5e-86
Identities = 75/324 (23%), Positives = 125/324 (38%), Gaps = 41/324 (12%)
Query: 214 ATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKN 273
++ +G+G +G VYKG+L D + +AVK S + Q K + + ++H N
Sbjct: 11 DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEK-NIYRVPLMEHDN 68
Query: 274 LVRLLGCCLEG-----QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGI 328
+ R + E LL+ EY PN SL +L T DW + + + RG+
Sbjct: 69 IARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT----SDWVSSCRLAHSVTRGL 124
Query: 329 LYLHED------SRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGN------QNQAN 376
YLH + + I HRDL + NVL+ +D ISDFG + GN +
Sbjct: 125 AYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNA 184
Query: 377 TNIIAGTYGYMAPEYAMGGI-------FSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQ 429
GT YMAPE G + + D+++ G++ EI R + F +
Sbjct: 185 AISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFM-RCTDLFPGESVPE 243
Query: 430 TLLTYTWKLWCEGHAVELID--------PVLKQSCAPDELLKFIHIGLL--CVQQDPADR 479
+ + ++ ++ P ++ + L + C QD R
Sbjct: 244 YQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEAR 303
Query: 480 PTMSSVVVMLASDSMTIPQPTEPA 503
T +A M + +
Sbjct: 304 LTAQXAEERMAELMMIWERNKSVS 327
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 231 bits (591), Expect = 4e-72
Identities = 78/294 (26%), Positives = 134/294 (45%), Gaps = 36/294 (12%)
Query: 221 ENKLGQGGFGPVYKGTLADGKAIAVKRL--SRTSGQGLKEFKNEVNLIAKLQHKNLVRLL 278
+ K+G G FG V++ G +AVK L + + EF EV ++ +L+H N+V +
Sbjct: 42 KEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFM 100
Query: 279 GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLK 338
G + L ++ EY+ SL L + QLD +RRLS+ +A+G+ YLH
Sbjct: 101 GAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPP 159
Query: 339 IIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFS 398
I+HR+LK+ N+L+D K+ DFG +R+ + + AGT +MAPE +
Sbjct: 160 IVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSA--AGTPEWMAPEVLRDEPSN 217
Query: 399 IKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQ---- 454
KSDV+SFGV+L E+ + + + W + +++ V +
Sbjct: 218 EKSDVYSFGVILWELATLQ-------------------QPWGNLNPAQVVAAVGFKCKRL 258
Query: 455 ---SCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS-DSMTIPQPTEPAF 504
++ I C +P RP+ ++++ +L +P P
Sbjct: 259 EIPRNLNPQVAAIIE---GCWTNEPWKRPSFATIMDLLRPLIKSAVPPPNRSDL 309
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 229 bits (586), Expect = 2e-71
Identities = 77/282 (27%), Positives = 119/282 (42%), Gaps = 32/282 (11%)
Query: 221 ENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLG 279
LG+G FG K T G+ + +K L R + + F EV ++ L+H N+++ +G
Sbjct: 15 GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIG 74
Query: 280 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKI 339
+ + L I EY+ +L + Q W +R+S IA G+ YLH + I
Sbjct: 75 VLYKDKRLNFITEYIKGGTLRGIIKS--MDSQYPWSQRVSFAKDIASGMAYLH---SMNI 129
Query: 340 IHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNI------------IAGTYGYM 387
IHRDL + N L+ ++ N ++DFG AR+ + Q + G +M
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189
Query: 388 APEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVEL 447
APE G + K DVFSFG++L EII ++ T + L G
Sbjct: 190 APEMINGRSYDEKVDVFSFGIVLCEIIGRVN------ADPDYLPRTMDFGLNVRGFL--- 240
Query: 448 IDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 489
D +C P + C DP RP+ + L
Sbjct: 241 -DRYCPPNC-PPSFFPIT---VRCCDLDPEKRPSFVKLEHWL 277
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 228 bits (584), Expect = 4e-71
Identities = 87/288 (30%), Positives = 127/288 (44%), Gaps = 25/288 (8%)
Query: 216 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLV 275
E +G+G FG V K K +A+K++ S K F E+ ++++ H N+V
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIE--SESERKAFIVELRQLSRVNHPNIV 64
Query: 276 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDS 335
+L G CL + L+ EY SL L A +S ++G+ YLH
Sbjct: 65 KLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122
Query: 336 RLKIIHRDLKASNVLLDDDMN-PKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMG 394
+IHRDLK N+LL KI DFGTA Q N G+ +MAPE G
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTACD---IQTHMTNNK--GSAAWMAPEVFEG 177
Query: 395 GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQ 454
+S K DVFS+G++L E+I+ RK F E G W + G P L +
Sbjct: 178 SNYSEKCDVFSWGIILWEVITRRK----PFDEIGGPAFRIMWAV-HNGTR-----PPLIK 227
Query: 455 SCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSMTIPQPTEP 502
+ P + + C +DP+ RP+M +V ++ P EP
Sbjct: 228 NL-PKPIESLMT---RCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEP 271
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 216 bits (553), Expect = 6e-67
Identities = 80/288 (27%), Positives = 125/288 (43%), Gaps = 50/288 (17%)
Query: 221 ENKLGQGGFGPVYKGTLADGKAIAVKRL----SRTSGQGLKEFKNEVNLIAKLQHKNLVR 276
E +G GGFG VY+ G +AVK Q ++ + E L A L+H N++
Sbjct: 12 EEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70
Query: 277 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSR 336
L G CL+ L L+ E+ L ++ ++ IARG+ YLH+++
Sbjct: 71 LRGVCLKEPNLCLVMEFARGGPL----NRVLSGKRIPPDILVNWAVQIARGMNYLHDEAI 126
Query: 337 LKIIHRDLKASNVLLDDDMNP--------KISDFGTARIFGGNQNQANTNIIAGTYGYMA 388
+ IIHRDLK+SN+L+ + KI+DFG AR + + AG Y +MA
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSA----AGAYAWMA 182
Query: 389 PEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELI 448
PE +FS SDV+S+GVLL E+++G + + +
Sbjct: 183 PEVIRASMFSKGSDVWSYGVLLWELLTGE-------------------VPFRGIDGLAVA 223
Query: 449 DPVLKQ-------SCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 489
V S P+ K + C DP RP+ ++++ L
Sbjct: 224 YGVAMNKLALPIPSTCPEPFAKLME---DCWNPDPHSRPSFTNILDQL 268
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 215 bits (550), Expect = 3e-66
Identities = 72/280 (25%), Positives = 129/280 (46%), Gaps = 36/280 (12%)
Query: 221 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGC 280
++G G FG VYKG A+ + ++ + Q L+ FKNEV ++ K +H N++ +G
Sbjct: 29 GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 281 CLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKII 340
Q L ++ ++ SL HL + + K+ + I ARG+ YLH II
Sbjct: 89 STAPQ-LAIVTQWCEGSSLYHHLHA--SETKFEMKKLIDIARQTARGMDYLH---AKSII 142
Query: 341 HRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPE---YAMGGIF 397
HRDLK++N+ L +D KI DFG A ++G+ +MAPE +
Sbjct: 143 HRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY 202
Query: 398 SIKSDVFSFGVLLLEIISGR---KNNGFYFSEHGQTLLTYTWKLWCEGHAVE-----LID 449
S +SDV++FG++L E+++G+ N + Q + V
Sbjct: 203 SFQSDVYAFGIVLYELMTGQLPYSN----INNRDQII-----------EMVGRGSLSPDL 247
Query: 450 PVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 489
++ +C P + + + C+++ +RP+ ++ +
Sbjct: 248 SKVRSNC-PKRMKRLM---AECLKKKRDERPSFPRILAEI 283
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 215 bits (549), Expect = 4e-66
Identities = 79/289 (27%), Positives = 135/289 (46%), Gaps = 38/289 (13%)
Query: 216 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQG-------LKEFKNEVNLIA 267
N E ++G+GGFG V+KG + D +A+K L +G +EF+ EV +++
Sbjct: 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 268 KLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARG 327
L H N+V+L G ++ E++P L L D ++ + W +L ++ IA G
Sbjct: 79 NLNHPNIVKLYGLMH--NPPRMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALG 134
Query: 328 ILYLHEDSRLKIIHRDLKASNVLLD-----DDMNPKISDFGTARIFGGNQNQANTNIIAG 382
I Y+ + I+HRDL++ N+ L + K++DFG ++ + + + G
Sbjct: 135 IEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ----SVHSVSG-LLG 188
Query: 383 TYGYMAPE--YAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWC 440
+ +MAPE A ++ K+D +SF ++L I++G F E+ + + +
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEG----PFDEYSYGKIKFINMIRE 244
Query: 441 EGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 489
EG P + + C P L I LC DP RP S +V L
Sbjct: 245 EGLR-----PTIPEDC-PPRLRNVIE---LCWSGDPKKRPHFSYIVKEL 284
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 212 bits (541), Expect = 3e-65
Identities = 66/281 (23%), Positives = 111/281 (39%), Gaps = 32/281 (11%)
Query: 216 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRL--SRTSGQGLKEFKNEVNLIAKLQHKN 273
+ KL + G ++KG G I VK L S + ++F E + H N
Sbjct: 10 KQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPN 68
Query: 274 LVRLLGCCLE--GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYL 331
++ +LG C LI +MP SL L + T V +D + + +ARG+ +L
Sbjct: 69 VLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFV-VDQSQAVKFALDMARGMAFL 127
Query: 332 HEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEY 391
H I L + +V++D+DM +IS F ++APE
Sbjct: 128 H-TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGR-------MYAPAWVAPEA 179
Query: 392 AMG---GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELI 448
+D++SF VLL E+++ + + + K+ EG +
Sbjct: 180 LQKKPEDTNRRSADMWSFAVLLWELVTREV---PF---ADLSNMEIGMKVALEG-----L 228
Query: 449 DPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 489
P + + K + I C+ +DPA RP +V +L
Sbjct: 229 RPTIPPGI-SPHVSKLMKI---CMNEDPAKRPKFDMIVPIL 265
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 2e-62
Identities = 75/283 (26%), Positives = 119/283 (42%), Gaps = 37/283 (13%)
Query: 221 ENKLGQGGFGPVYKGTLADGKAIAVKRL--SRTSGQGLKEFKNEVNLIAKLQHKNLVRLL 278
+G+G FG VY G G+ +A++ + R + LK FK EV + +H+N+V +
Sbjct: 38 GELIGKGRFGQVYHGRW-HGE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFM 95
Query: 279 GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLK 338
G C+ L +I ++L + D + LD + I I +G+ YLH
Sbjct: 96 GACMSPPHLAIITSLCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIVKGMGYLH---AKG 150
Query: 339 IIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTN---IIAGTYGYMAPE----- 390
I+H+DLK+ NV D+ I+DFG I G Q + I G ++APE
Sbjct: 151 ILHKDLKSKNVFY-DNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQL 209
Query: 391 ----YAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVE 446
FS SDVF+ G + E+ + + Q W++ G
Sbjct: 210 SPDTEEDKLPFSKHSDVFALGTIWYELHAREWP---F---KTQPAEAIIWQM-GTGM--- 259
Query: 447 LIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 489
P L Q E+ + L C + +RPT + ++ ML
Sbjct: 260 --KPNLSQIGMGKEISDIL---LFCWAFEQEERPTFTKLMDML 297
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 4e-58
Identities = 73/296 (24%), Positives = 126/296 (42%), Gaps = 34/296 (11%)
Query: 221 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNE--VNLIAKLQHKNLVRLL 278
++G+G +G V+ G G+ +AVK + E + ++H+N++ +
Sbjct: 42 VKQIGKGRYGEVWMGKW-RGEKVAVKVFFT---TEEASWFRETEIYQTVLMRHENILGFI 97
Query: 279 GCCLEGQ----ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHED 334
++G +L LI +Y N SL +L +S LD K L + G+ +LH +
Sbjct: 98 AADIKGTGSWTQLYLITDYHENGSLYDYL----KSTTLDAKSMLKLAYSSVSGLCHLHTE 153
Query: 335 -----SRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQAN--TNIIAGTYGYM 387
+ I HRDLK+ N+L+ + I+D G A F + N+ + N GT YM
Sbjct: 154 IFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYM 213
Query: 388 APEYAMGGI------FSIKSDVFSFGVLLLEIISGRKNNGFYFSE----HGQTLLTYTWK 437
PE + I +D++SFG++L E+ + G H +++
Sbjct: 214 PPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYE 273
Query: 438 LWCEGHAVELIDPVLKQSCAPDELLKFIHIGLL--CVQQDPADRPTMSSVVVMLAS 491
E ++ + P + DE L+ + L+ C +PA R T V LA
Sbjct: 274 DMREIVCIKKLRPSFPNRWSSDECLRQM-GKLMTECWAHNPASRLTALRVKKTLAK 328
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 5e-58
Identities = 71/298 (23%), Positives = 118/298 (39%), Gaps = 38/298 (12%)
Query: 221 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNE--VNLIAKLQHKNLVRLL 278
+G+G +G V++G+ G+ +AVK S + K + E + L+H+N++ +
Sbjct: 13 LECVGKGRYGEVWRGSW-QGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFI 68
Query: 279 GCCLEGQ----ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHED 334
+ + +L LI Y SL +L + LD L I+ IA G+ +LH +
Sbjct: 69 ASDMTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGLAHLHIE 124
Query: 335 -----SRLKIIHRDLKASNVLLDDDMNPKISDFGTARIF--GGNQNQANTNIIAGTYGYM 387
+ I HRDLK+ N+L+ + I+D G A + NQ N GT YM
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYM 184
Query: 388 APE------YAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF-------YFSEHG-QTLLT 433
APE + D+++FG++L E+ +NG ++
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFE 244
Query: 434 YTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 491
K+ C I L K + C Q+P+ R T + L
Sbjct: 245 DMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMK---ECWYQNPSARLTALRIKKTLTK 299
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 4e-54
Identities = 65/300 (21%), Positives = 119/300 (39%), Gaps = 42/300 (14%)
Query: 221 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNE--VNLIAKLQHKNLVRLL 278
+ +G+G FG V++G G+ +AVK S + + + E + L+H+N++ +
Sbjct: 47 QESIGKGRFGEVWRGKW-RGEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFI 102
Query: 279 GCCLEGQ----ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHED 334
+ +L L+ +Y + SL FD + + + + A G+ +LH +
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHME 158
Query: 335 -----SRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANT--NIIAGTYGYM 387
+ I HRDLK+ N+L+ + I+D G A + + N GT YM
Sbjct: 159 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 218
Query: 388 APEYAMGGI------FSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCE 441
APE I ++D+++ G++ EI G H L Y + +
Sbjct: 219 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG----IHEDYQLPYYDLVPSD 274
Query: 442 GHAVELIDPVLKQ--------SCAPDELLKFIHIGLL--CVQQDPADRPTMSSVVVMLAS 491
E+ V +Q E L+ + ++ C + A R T + L+
Sbjct: 275 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVM-AKIMRECWYANGAARLTALRIKKTLSQ 333
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 8e-52
Identities = 76/292 (26%), Positives = 119/292 (40%), Gaps = 41/292 (14%)
Query: 221 ENKLGQGGFGPVYKGTL---ADGKAI--AVKRLSRTSG-QGLKEFKNEVNLIAKLQHKNL 274
LG+G FG V DG AVK L +G Q +K E++++ L H+++
Sbjct: 36 IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95
Query: 275 VRLLGCCLE--GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLH 332
++ GCC + L L+ EY+P SL +L + + L I G+ YLH
Sbjct: 96 IKYKGCCEDAGAASLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEGMAYLH 151
Query: 333 EDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYG-----YM 387
IHRDL A NVLLD+D KI DFG A+ G +
Sbjct: 152 A---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR----VREDGDSPVFWY 204
Query: 388 APEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVE 446
APE F SDV+SFGV L E+++ + + + +
Sbjct: 205 APECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQG-----QMTVLR 259
Query: 447 LIDPVLK-------QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 491
L + + + C P E+ + C + + + RPT +++ +L +
Sbjct: 260 LTELLERGERLPRPDKC-PAEVYH---LMKNCWETEASFRPTFENLIPILKT 307
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 2e-51
Identities = 79/311 (25%), Positives = 132/311 (42%), Gaps = 41/311 (13%)
Query: 221 ENKLGQGGFGPVYKGTL-----ADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLV 275
++LG+G FG V G +AVK+L + ++F+ E+ ++ L +V
Sbjct: 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIV 87
Query: 276 RLLGCCLEGQE--LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHE 333
+ G L L+ EY+P+ L L +LD R L + I +G+ YL
Sbjct: 88 KYRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYLGS 145
Query: 334 DSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYG-----YMA 388
+ +HRDL A N+L++ + + KI+DFG A++ +++ + G + A
Sbjct: 146 ---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYY----VVREPGQSPIFWYA 198
Query: 389 PEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVEL 447
PE IFS +SDV+SFGV+L E+ + K+ +EL
Sbjct: 199 PESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSR--LLEL 256
Query: 448 ID-------PVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML---ASDSMTIP 497
++ P +C P E+ + + LC P DRP+ S++ L S S
Sbjct: 257 LEEGQRLPAP---PAC-PAEVHE---LMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCE 309
Query: 498 QPTEPAFSVGR 508
A G+
Sbjct: 310 THAFTAHPEGK 320
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 178 bits (455), Expect = 2e-51
Identities = 75/285 (26%), Positives = 115/285 (40%), Gaps = 50/285 (17%)
Query: 221 ENKLGQGGFGPVYKGTL-ADGKAIAVKRL-SRTSGQGLKEFKNEVNLIAKLQHKNLVRLL 278
++G+G FG V+ G L AD +AVK +F E ++ + H N+VRL+
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 178
Query: 279 GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLK 338
G C + Q + ++ E + L T +L K L ++ A G+ YL
Sbjct: 179 GVCTQKQPIYIVMELVQGGDFLTFL--RTEGARLRVKTLLQMVGDAAAGMEYLES---KC 233
Query: 339 IIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFS 398
IHRDL A N L+ + KISDFG +R A+ + + APE G +S
Sbjct: 234 CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYS 293
Query: 399 IKSDVFSFGVLLLEIIS-------GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPV 451
+SDV+SFG+LL E S N + + V
Sbjct: 294 SESDVWSFGILLWETFSLGASPYPNLSNQ-------------------------QTREFV 328
Query: 452 LK-------QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 489
K + C PD + + + C +P RP+ S++ L
Sbjct: 329 EKGGRLPCPELC-PDAVFR---LMEQCWAYEPGQRPSFSTIYQEL 369
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 175 bits (447), Expect = 5e-51
Identities = 73/290 (25%), Positives = 125/290 (43%), Gaps = 39/290 (13%)
Query: 221 ENKLGQGGFGPVYKGTLA-----DGKAIAVKRL-SRTSGQGLKEFKNEVNLIAKLQHKNL 274
LG+G FG V G+ +AVK L + G + + K E+ ++ L H+N+
Sbjct: 26 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 85
Query: 275 VRLLGCCLE--GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLH 332
V+ G C E G + LI E++P+ SL +L +++ K++L I +G+ YL
Sbjct: 86 VKYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKGMDYLG 143
Query: 333 EDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYG-----YM 387
+ +HRDL A NVL++ + KI DFG + ++ +
Sbjct: 144 S---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYT----VKDDRDSPVFWY 196
Query: 388 APEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVE 446
APE M F I SDV+SFGV L E+++ ++ T+ V
Sbjct: 197 APECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTR--LVN 254
Query: 447 LID-------PVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 489
+ P +C PDE+ + + C + P++R + +++
Sbjct: 255 TLKEGKRLPCP---PNC-PDEVYQ---LMRKCWEFQPSNRTSFQNLIEGF 297
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 9e-51
Identities = 77/288 (26%), Positives = 128/288 (44%), Gaps = 35/288 (12%)
Query: 221 ENKLGQGGFGPVYKGT---LADGKAI--AVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLV 275
+LG+G FG V L D AVK+L ++ + L++F+ E+ ++ LQH N+V
Sbjct: 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 74
Query: 276 RLLGCCLEGQE--LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHE 333
+ G C L LI EY+P SL +L ++D + L + I +G+ YL
Sbjct: 75 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLGT 132
Query: 334 DSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYG-----YMA 388
+ IHRDL N+L++++ KI DFG ++ ++ G + A
Sbjct: 133 ---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFF----KVKEPGESPIFWYA 185
Query: 389 PEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELI 448
PE FS+ SDV+SFGV+L E+ + + + +E + + H +EL+
Sbjct: 186 PESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 245
Query: 449 D-------PVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 489
P C PDE+ I C + RP+ + + +
Sbjct: 246 KNNGRLPRP---DGC-PDEIY---MIMTECWNNNVNQRPSFRDLALRV 286
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 2e-50
Identities = 76/288 (26%), Positives = 129/288 (44%), Gaps = 35/288 (12%)
Query: 221 ENKLGQGGFGPVYKGTL-----ADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLV 275
+LG+G FG V G+ +AVK+L ++ + L++F+ E+ ++ LQH N+V
Sbjct: 46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 105
Query: 276 RLLGCCLEGQE--LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHE 333
+ G C L LI EY+P SL +L ++D + L + I +G+ YL
Sbjct: 106 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLGT 163
Query: 334 DSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYG-----YMA 388
+ IHRDL N+L++++ KI DFG ++ ++ G + A
Sbjct: 164 ---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYY----KVKEPGESPIFWYA 216
Query: 389 PEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELI 448
PE FS+ SDV+SFGV+L E+ + + + +E + + H +EL+
Sbjct: 217 PESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 276
Query: 449 D-------PVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 489
P C PDE+ I C + RP+ + + +
Sbjct: 277 KNNGRLPRP---DGC-PDEIY---MIMTECWNNNVNQRPSFRDLALRV 317
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 7e-50
Identities = 78/301 (25%), Positives = 132/301 (43%), Gaps = 63/301 (20%)
Query: 221 ENKLGQGGFGPVYKGTLADGK------AIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNL 274
+ +LG+G FG V+ + +AVK L + K+F+ E L+ LQH+++
Sbjct: 20 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 79
Query: 275 VRLLGCCLEGQELLLIYEYMPNKSLDVHL-------------FDATRSVQLDWKRRLSII 321
V+ G C +G L++++EYM + L+ L +L + L I
Sbjct: 80 VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139
Query: 322 NGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIA 381
+ IA G++YL + +HRDL N L+ ++ KI DFG +R ++ +
Sbjct: 140 SQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR-----------DVYS 185
Query: 382 GTYGY------------MAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHG 428
Y Y M PE M F+ +SDV+SFGV+L EI + G++ +F
Sbjct: 186 TDY-YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP---WFQLSN 241
Query: 429 QTLLTYTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488
++ +G L P + C P E+ + L C Q++P R + + +
Sbjct: 242 TEVIECI----TQGR--VLERP---RVC-PKEVYD---VMLGCWQREPQQRLNIKEIYKI 288
Query: 489 L 489
L
Sbjct: 289 L 289
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 2e-49
Identities = 81/300 (27%), Positives = 134/300 (44%), Gaps = 62/300 (20%)
Query: 221 ENKLGQGGFGPVYKGTLADGK------AIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNL 274
+ +LG+G FG V+ + +AVK L S ++F+ E L+ LQH+++
Sbjct: 46 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHI 105
Query: 275 VRLLGCCLEGQELLLIYEYMPNKSLDVHL------------FDATRSVQLDWKRRLSIIN 322
VR G C EG+ LL+++EYM + L+ L + L + L++ +
Sbjct: 106 VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165
Query: 323 GIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAG 382
+A G++YL + L +HRDL N L+ + KI DFG +R +I +
Sbjct: 166 QVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR-----------DIYST 211
Query: 383 TYGY------------MAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQ 429
Y Y M PE + F+ +SDV+SFGV+L EI + G++ ++
Sbjct: 212 DY-YRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP---WYQLSNT 267
Query: 430 TLLTYTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 489
+ +G EL P ++C P E+ I C Q++P R ++ V L
Sbjct: 268 EAIDCI----TQGR--ELERP---RAC-PPEVYA---IMRGCWQREPQQRHSIKDVHARL 314
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 5e-49
Identities = 88/302 (29%), Positives = 127/302 (42%), Gaps = 64/302 (21%)
Query: 221 ENKLGQGGFGPVYKGTLADGK------AIAVKRL-SRTSGQGLKEFKNEVNLIAKLQHKN 273
+LG+ FG VYKG L A+A+K L + G +EF++E L A+LQH N
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73
Query: 274 LVRLLGCCLEGQELLLIYEYMPNKSLDVHL-------------FDATRSVQLDWKRRLSI 320
+V LLG + Q L +I+ Y + L L D T L+ + +
Sbjct: 74 VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133
Query: 321 INGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNII 380
+ IA G+ YL S ++H+DL NVL+ D +N KISD G R +
Sbjct: 134 VAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFR-----------EVY 179
Query: 381 AGTYGY------------MAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEH 427
A Y Y MAPE M G FSI SD++S+GV+L E+ S G + Y
Sbjct: 180 AADY-YKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP---YCGYS 235
Query: 428 GQTLLTYTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 487
Q ++ L P C P + + + C + P+ RP +
Sbjct: 236 NQDVVEMI----RNRQ--VLPCP---DDC-PAWVYA---LMIECWNEFPSRRPRFKDIHS 282
Query: 488 ML 489
L
Sbjct: 283 RL 284
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 2e-48
Identities = 78/308 (25%), Positives = 124/308 (40%), Gaps = 84/308 (27%)
Query: 222 NKLGQGGFGPVYKGTLADGK------AIAVKRL-SRTSGQGLKEFKNEVNLIAKLQHKNL 274
+LGQG FG VY+G +A+K + S + EF NE +++ + ++
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90
Query: 275 VRLLGCCLEGQELLLIYEYMPNKSLDVHL-------FDATRSVQLDWKRRLSIINGIARG 327
VRLLG +GQ L+I E M L +L + + + + IA G
Sbjct: 91 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150
Query: 328 ILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGY- 386
+ YL+ K +HRDL A N ++ +D KI DFG R +I Y Y
Sbjct: 151 MAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTR-----------DIYETDY-YR 195
Query: 387 -----------MAPEYAMGGIFSIKSDVFSFGVLLLEIIS-------GRKNNGFYFSEHG 428
M+PE G+F+ SDV+SFGV+L EI + G N
Sbjct: 196 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE-------- 247
Query: 429 QTLLTYTWKLWCEGHAVELIDPVLK-------QSCAPDELLKFIHIGLLCVQQDPADRPT 481
+++ V++ +C PD L + + +C Q +P RP+
Sbjct: 248 -----------------QVLRFVMEGGLLDKPDNC-PDMLFE---LMRMCWQYNPKMRPS 286
Query: 482 MSSVVVML 489
++ +
Sbjct: 287 FLEIISSI 294
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 7e-48
Identities = 75/289 (25%), Positives = 129/289 (44%), Gaps = 60/289 (20%)
Query: 221 ENKLGQGGFGPVYKGTLADGK-AIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLG 279
++KLG G +G VY+G +AVK L + ++EF E ++ +++H NLV+LLG
Sbjct: 18 KHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 76
Query: 280 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKI 339
C +I E+M +L +L + R ++ L + I+ + YL +
Sbjct: 77 VCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYL---EKKNF 132
Query: 340 IHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYG-----YMAPEYAMG 394
IHRDL A N L+ ++ K++DFG +R+ G+ A+ + APE
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG------AKFPIKWTAPESLAY 186
Query: 395 GIFSIKSDVFSFGVLLLEIIS-------GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVEL 447
FSIKSDV++FGVLL EI + G + ++
Sbjct: 187 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-------------------------QV 221
Query: 448 IDPVLK-------QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 489
+ + K + C P+++ + + C Q +P+DRP+ + +
Sbjct: 222 YELLEKDYRMERPEGC-PEKVYE---LMRACWQWNPSDRPSFAEIHQAF 266
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 1e-47
Identities = 84/305 (27%), Positives = 140/305 (45%), Gaps = 53/305 (17%)
Query: 221 ENKLGQGGFGPVYKGTLADGK----AIAVKRL-SRTSGQGLKEFKNEVNLIAKLQHKNLV 275
E +G G G V G L +A+K L + + + ++F +E +++ + H N++
Sbjct: 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 276 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDS 335
RL G G+ +++ EYM N SLD L T Q + + ++ G+ G+ YL S
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFL--RTHDGQFTIMQLVGMLRGVGAGMRYL---S 168
Query: 336 RLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYG------YMAP 389
L +HRDL A NVL+D ++ K+SDFG +R+ + + A T T G + AP
Sbjct: 169 DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYT-----TTGGKIPIRWTAP 223
Query: 390 EYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELI 448
E FS SDV+SFGV++ E+++ G + Y++ + ++I
Sbjct: 224 EAIAFRTFSSASDVWSFGVVMWEVLAYGERP---YWNMTNR----------------DVI 264
Query: 449 DPVLK-------QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSMTIPQPTE 501
V + C P L + + L C +D A RP S +V +L + P+
Sbjct: 265 SSVEEGYRLPAPMGC-PHALHQ---LMLDCWHKDRAQRPRFSQIVSVL-DALIRSPESLR 319
Query: 502 PAFSV 506
+V
Sbjct: 320 ATATV 324
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 2e-47
Identities = 74/284 (26%), Positives = 123/284 (43%), Gaps = 45/284 (15%)
Query: 221 ENKLGQGGFGPVYKGTLADGK-----AIAVKRL-SRTSGQGLKEFKNEVNLIAKLQHKNL 274
LG G FG VYKG +A+K L TS + KE +E ++A + + ++
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 275 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHED 334
RLLG CL + LI + MP L ++ + + + L+ IA+G+ YL
Sbjct: 80 CRLLGICLT-STVQLITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYL--- 133
Query: 335 SRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNI----IAGTYGYMAPE 390
+++HRDL A NVL+ + KI+DFG A++ G + + + I +MA E
Sbjct: 134 EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK----WMALE 189
Query: 391 YAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVE--- 446
+ I++ +SDV+S+GV + E+++ G K Y + +E
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMTFGSKP---YDGIPASEIS----------SILEKGE 236
Query: 447 -LIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 489
L P C ++ I C D RP +++
Sbjct: 237 RLPQP---PIC-TIDVY---MIMRKCWMIDADSRPKFRELIIEF 273
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 3e-47
Identities = 87/320 (27%), Positives = 120/320 (37%), Gaps = 77/320 (24%)
Query: 221 ENKLGQGGFGPVYKGTLADGK------AIAVKRL-SRTSGQGLKEFKNEVNLIAKLQHKN 273
LG G FG VY+G ++ +AVK L S Q +F E +I+K H+N
Sbjct: 35 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 94
Query: 274 LVRLLGCCLEGQELLLIYEYMPNKSLDVHL----FDATRSVQLDWKRRLSIINGIARGIL 329
+VR +G L+ ++ E M L L ++ L L + IA G
Sbjct: 95 IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154
Query: 330 YLHEDSRLKIIHRDLKASNVLLD---DDMNPKISDFGTARIFGGNQNQANTNIIAGTYGY 386
YL IHRD+ A N LL KI DFG AR +I +Y Y
Sbjct: 155 YL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----------DIYRASY-Y 199
Query: 387 ------------MAPEYAMGGIFSIKSDVFSFGVLLLEIIS-------GRKNNG-FYFSE 426
M PE M GIF+ K+D +SFGVLL EI S + N F
Sbjct: 200 RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT 259
Query: 427 HGQTLLTYTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVV 486
G ++ P ++C P + I C Q P DRP + ++
Sbjct: 260 SGG-------RMDP---------P---KNC-PGPVY---RIMTQCWQHQPEDRPNFAIIL 296
Query: 487 VML-----ASDSMTIPQPTE 501
+ D + P E
Sbjct: 297 ERIEYCTQDPDVINTALPIE 316
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 4e-47
Identities = 78/323 (24%), Positives = 123/323 (38%), Gaps = 98/323 (30%)
Query: 221 ENKLGQGGFGPVYKGTLADGK------AIAVKRL-SRTSGQGLKEFKNEVNLIAKLQHKN 273
LG+G FG V K T K +AVK L S L++ +E N++ ++ H +
Sbjct: 28 GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPH 87
Query: 274 LVRLLGCCLEGQELLLIYEYMPNKSL---------------------DVHLFDATRSVQL 312
+++L G C + LLLI EY SL + D L
Sbjct: 88 VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147
Query: 313 DWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQ 372
+S I++G+ YL + +K++HRDL A N+L+ + KISDFG +R
Sbjct: 148 TMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSR------ 198
Query: 373 NQANTNIIAGTYGY------------MAPEYAMGGIFSIKSDVFSFGVLLLEIIS----- 415
++ Y MA E I++ +SDV+SFGVLL EI++
Sbjct: 199 -----DVYEEDS-YVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252
Query: 416 --GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLK-------QSCAPDELLKFIH 466
G L + + +C +E+
Sbjct: 253 YPGIPPE-------------------------RLFNLLKTGHRMERPDNC-SEEMY---R 283
Query: 467 IGLLCVQQDPADRPTMSSVVVML 489
+ L C +Q+P RP + + L
Sbjct: 284 LMLQCWKQEPDKRPVFADISKDL 306
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 4e-47
Identities = 80/288 (27%), Positives = 125/288 (43%), Gaps = 50/288 (17%)
Query: 221 ENKLGQGGFGPVYKGTLADGK----AIAVKRLSR-TSGQGLKEFKNEVNLIAKLQHKNLV 275
+ +G+G FG VY G D A+K LSR T Q ++ F E L+ L H N++
Sbjct: 26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85
Query: 276 RLLGCCLEGQE-LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHED 334
L+G L + ++ YM + L + R+ + K +S +ARG+ YL
Sbjct: 86 ALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTV--KDLISFGLQVARGMEYL--- 140
Query: 335 SRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYG-----YMAP 389
+ K +HRDL A N +LD+ K++DFG AR ++ ++ + + A
Sbjct: 141 AEQKFVHRDLAARNCMLDESFTVKVADFGLARDI---LDREYYSVQQHRHARLPVKWTAL 197
Query: 390 EYAMGGIFSIKSDVFSFGVLLLEIIS-------GRKNNG-FYFSEHGQTLLTYTWKLWCE 441
E F+ KSDV+SFGVLL E+++ +F G+ L
Sbjct: 198 ESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQ-------- 249
Query: 442 GHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 489
P + C PD L + + C + DPA RPT +V +
Sbjct: 250 --------P---EYC-PDSLYQ---VMQQCWEADPAVRPTFRVLVGEV 282
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 4e-47
Identities = 76/290 (26%), Positives = 110/290 (37%), Gaps = 68/290 (23%)
Query: 221 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGC 280
+G+G FG V G G +AVK + + + F E +++ +L+H NLV+LLG
Sbjct: 198 LQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGV 254
Query: 281 CLEGQELL-LIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKI 339
+E + L ++ EYM SL +L RS L L + + YL
Sbjct: 255 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYL---EGNNF 310
Query: 340 IHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYG------YMAPEYAM 393
+HRDL A NVL+ +D K+SDFG + + + APE
Sbjct: 311 VHRDLAARNVLVSEDNVAKVSDFGLTK-----------EASSTQDTGKLPVKWTAPEALR 359
Query: 394 GGIFSIKSDVFSFGVLLLEIIS-------GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVE 446
FS KSDV+SFG+LL EI S +
Sbjct: 360 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-------------------------D 394
Query: 447 LIDPVLK-------QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 489
++ V K C P + + C D A RPT + L
Sbjct: 395 VVPRVEKGYKMDAPDGC-PPAVYD---VMKNCWHLDAATRPTFLQLREQL 440
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 6e-47
Identities = 77/303 (25%), Positives = 118/303 (38%), Gaps = 66/303 (21%)
Query: 221 ENKLGQGGFGPVYKGTLAD------GKAIAVKRL-SRTSGQGLKEFKNEVNLIAKL-QHK 272
LG G FG V + T +AVK L S + +E+ +++ L QH+
Sbjct: 51 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110
Query: 273 NLVRLLGCCLEGQELLLIYEYMPNKSL-----------DVHLFDATRSVQLDWKRRLSII 321
N+V LLG C G +L+I EY L + A + + L
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170
Query: 322 NGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTAR-IFGGNQNQANTNII 380
+ +A+G+ +L + IHRD+ A NVLL + KI DFG AR I + N
Sbjct: 171 SQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGN-- 225
Query: 381 AGTYG-----YMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-------GRKNNG--FYFSE 426
+MAPE +++++SDV+S+G+LL EI S G N + +
Sbjct: 226 ----ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVK 281
Query: 427 HGQTLLTYTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVV 486
G + + + AP + I C +P RPT +
Sbjct: 282 DGYQM--------------------AQPAFAPKNIYS---IMQACWALEPTHRPTFQQIC 318
Query: 487 VML 489
L
Sbjct: 319 SFL 321
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 6e-47
Identities = 80/308 (25%), Positives = 143/308 (46%), Gaps = 52/308 (16%)
Query: 221 ENKLGQGGFGPVYKGTLADGKA-----IAVKRL-SRTSGQGLKEFKNEVNLIAKLQHKNL 274
+ +G G FG VYKG L +A+K L + + + +F E ++ + H N+
Sbjct: 49 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108
Query: 275 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHED 334
+RL G + + +++I EYM N +LD L + + + + ++ GIA G+ YL
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFL--REKDGEFSVLQLVGMLRGIAAGMKYL--- 163
Query: 335 SRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYG------YMA 388
+ + +HRDL A N+L++ ++ K+SDFG +R+ + T T G + A
Sbjct: 164 ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYT-----TSGGKIPIRWTA 218
Query: 389 PEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVE- 446
PE F+ SDV+SFG+++ E+++ G + Y+ ++ A+
Sbjct: 219 PEAISYRKFTSASDVWSFGIVMWEVMTYGERP---YWELSNHEVM----------KAIND 265
Query: 447 ---LIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML-----ASDSMTIPQ 498
L P C P + + + + C QQ+ A RP + +V +L A DS+
Sbjct: 266 GFRLPTP---MDC-PSAIYQ---LMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTLA 318
Query: 499 PTEPAFSV 506
+P S+
Sbjct: 319 DFDPRVSI 326
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 7e-47
Identities = 74/284 (26%), Positives = 130/284 (45%), Gaps = 50/284 (17%)
Query: 221 ENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLG 279
++KLG G +G VY+G +AVK L + + ++EF E ++ +++H NLV+LLG
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 283
Query: 280 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKI 339
C +I E+M +L +L + R ++ L + I+ + YL +
Sbjct: 284 VCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYL---EKKNF 339
Query: 340 IHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSI 399
IHR+L A N L+ ++ K++DFG +R+ G+ A+ + APE FSI
Sbjct: 340 IHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAYNKFSI 398
Query: 400 KSDVFSFGVLLLEIIS-------GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVL 452
KSDV++FGVLL EI + G + ++ + +
Sbjct: 399 KSDVWAFGVLLWEIATYGMSPYPGIDLS-------------------------QVYELLE 433
Query: 453 K-------QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 489
K + C P+++ + + C Q +P+DRP+ + +
Sbjct: 434 KDYRMERPEGC-PEKVYE---LMRACWQWNPSDRPSFAEIHQAF 473
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 7e-47
Identities = 84/303 (27%), Positives = 128/303 (42%), Gaps = 72/303 (23%)
Query: 221 ENKLGQGGFGPVYKGTLADGK----AIAVKRLSR--TSGQGLKEFKNEVNLIAKLQHKNL 274
LG+G FG V +G L +AVK + +S + ++EF +E + H N+
Sbjct: 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 275 VRLLGCCLEGQ-----ELLLIYEYMPNKSLDVHL---FDATRSVQLDWKRRLSIINGIAR 326
+RLLG C+E + ++I +M L +L T + + L + IA
Sbjct: 99 IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158
Query: 327 GILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGY 386
G+ YL S +HRDL A N +L DDM ++DFG ++ I +G Y Y
Sbjct: 159 GMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSK-----------KIYSGDY-Y 203
Query: 387 ------------MAPEYAMGGIFSIKSDVFSFGVLLLEIIS-------GRKNNGFY-FSE 426
+A E +++ KSDV++FGV + EI + G +N+ Y +
Sbjct: 204 RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLL 263
Query: 427 HGQTLLTYTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVV 486
HG L P + C DEL I C + DP DRPT S +
Sbjct: 264 HGHRLKQ----------------P---EDC-LDELY---EIMYSCWRTDPLDRPTFSVLR 300
Query: 487 VML 489
+ L
Sbjct: 301 LQL 303
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 163 bits (416), Expect = 8e-47
Identities = 66/286 (23%), Positives = 114/286 (39%), Gaps = 56/286 (19%)
Query: 221 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGC 280
+LG G FG V G +A+K + + EF E ++ L H+ LV+L G
Sbjct: 29 LKELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 87
Query: 281 CLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKII 340
C + + + +I EYM N L +L + ++ L + + + YL + +
Sbjct: 88 CTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYL---ESKQFL 142
Query: 341 HRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGT---YGYMAPEYAMGGIF 397
HRDL A N L++D K+SDFG +R ++ ++ G+ + PE M F
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV----GSKFPVRWSPPEVLMYSKF 198
Query: 398 SIKSDVFSFGVLLLEIIS-------GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDP 450
S KSD+++FGVL+ EI S N+ E +
Sbjct: 199 SSKSDIWAFGVLMWEIYSLGKMPYERFTNS-------------------------ETAEH 233
Query: 451 VLK-------QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 489
+ + +++ I C + +RPT ++ +
Sbjct: 234 IAQGLRLYRPHLA-SEKVYT---IMYSCWHEKADERPTFKILLSNI 275
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 1e-46
Identities = 81/312 (25%), Positives = 126/312 (40%), Gaps = 81/312 (25%)
Query: 221 ENKLGQGGFGPVYKGTLADGK--------AIAVKRL-SRTSGQGLKEFKNEVNLIAKL-Q 270
LG+G FG V +AVK L + + L + +E+ ++ + +
Sbjct: 40 GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 271 HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHL-------------FDATRSVQLDWKRR 317
HKN++ LLG C + L +I EY +L +L + Q+ +K
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 318 LSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTAR-IFGGNQNQAN 376
+S +ARG+ YL + K IHRDL A NVL+ ++ KI+DFG AR I + +
Sbjct: 160 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 216
Query: 377 TNIIAGTYG-----YMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-------GRKNNGFYF 424
TN G +MAPE +++ +SDV+SFGVL+ EI + G
Sbjct: 217 TN------GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE---- 266
Query: 425 SEHGQTLLTYTWKLWCEGHAVELIDPVLK-------QSCAPDELLKFIHIGLLCVQQDPA 477
EL + + +C +EL + C P+
Sbjct: 267 ---------------------ELFKLLKEGHRMDKPANC-TNELY---MMMRDCWHAVPS 301
Query: 478 DRPTMSSVVVML 489
RPT +V L
Sbjct: 302 QRPTFKQLVEDL 313
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 1e-46
Identities = 79/300 (26%), Positives = 132/300 (44%), Gaps = 65/300 (21%)
Query: 221 ENKLGQGGFGPVYKGTLADGKA---IAVKRL-SRTSGQGLKEFKNEVNLIAKL-QHKNLV 275
++ +G+G FG V K + A+KR+ S ++F E+ ++ KL H N++
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 276 RLLGCCLEGQELLLIYEYMPNKSLDVHL-------------FDATRSVQLDWKRRLSIIN 322
LLG C L L EY P+ +L L + + L ++ L
Sbjct: 90 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 323 GIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNI-IA 381
+ARG+ YL S+ + IHRDL A N+L+ ++ KI+DFG +R + +
Sbjct: 150 DVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---------GQEVYVK 197
Query: 382 GTYG-----YMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTW 436
T G +MA E +++ SDV+S+GVLL EI+S G T
Sbjct: 198 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS-----------LGGT------ 240
Query: 437 KLWCEGHAVELIDPVLK-------QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 489
+C EL + + + +C DE+ + C ++ P +RP+ + ++V L
Sbjct: 241 -PYCGMTCAELYEKLPQGYRLEKPLNC-DDEVY---DLMRQCWREKPYERPSFAQILVSL 295
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 166 bits (421), Expect = 1e-46
Identities = 87/320 (27%), Positives = 119/320 (37%), Gaps = 77/320 (24%)
Query: 221 ENKLGQGGFGPVYKGTLADGK------AIAVKRL-SRTSGQGLKEFKNEVNLIAKLQHKN 273
LG G FG VY+G ++ +AVK L S Q +F E +I+K H+N
Sbjct: 76 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 135
Query: 274 LVRLLGCCLEGQELLLIYEYMPNKSLDVHL----FDATRSVQLDWKRRLSIINGIARGIL 329
+VR +G L+ ++ E M L L ++ L L + IA G
Sbjct: 136 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 195
Query: 330 YLHEDSRLKIIHRDLKASNVLLD---DDMNPKISDFGTARIFGGNQNQANTNIIAGTYGY 386
YL IHRD+ A N LL KI DFG AR +I Y Y
Sbjct: 196 YL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----------DIYRAGY-Y 240
Query: 387 ------------MAPEYAMGGIFSIKSDVFSFGVLLLEIIS-------GRKNNG-FYFSE 426
M PE M GIF+ K+D +SFGVLL EI S + N F
Sbjct: 241 RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT 300
Query: 427 HGQTLLTYTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVV 486
G ++ P ++C P + I C Q P DRP + ++
Sbjct: 301 SGG-------RMDP---------P---KNC-PGPVY---RIMTQCWQHQPEDRPNFAIIL 337
Query: 487 VML-----ASDSMTIPQPTE 501
+ D + P E
Sbjct: 338 ERIEYCTQDPDVINTALPIE 357
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 1e-46
Identities = 74/286 (25%), Positives = 122/286 (42%), Gaps = 56/286 (19%)
Query: 221 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGC 280
++G G FG V+ G + +A+K + R ++F E ++ KL H LV+L G
Sbjct: 13 VQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 71
Query: 281 CLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKII 340
CLE + L+ E+M + L +L T+ + L + + G+ YL +I
Sbjct: 72 CLEQAPICLVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYL---EEACVI 126
Query: 341 HRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGT---YGYMAPEYAMGGIF 397
HRDL A N L+ ++ K+SDFG R +Q ++T GT + +PE +
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST----GTKFPVKWASPEVFSFSRY 182
Query: 398 SIKSDVFSFGVLLLEIIS-------GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDP 450
S KSDV+SFGVL+ E+ S R N+ E+++
Sbjct: 183 SSKSDVWSFGVLMWEVFSEGKIPYENRSNS-------------------------EVVED 217
Query: 451 VLK-------QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 489
+ + + + I C ++ P DRP S ++ L
Sbjct: 218 ISTGFRLYKPRLA-STHVYQ---IMNHCWRERPEDRPAFSRLLRQL 259
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 1e-46
Identities = 71/286 (24%), Positives = 114/286 (39%), Gaps = 56/286 (19%)
Query: 221 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGC 280
+LG G FG V G +AVK + + EF E + KL H LV+ G
Sbjct: 13 LKELGSGQFGVVKLGKWKGQYDVAVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLVKFYGV 71
Query: 281 CLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKII 340
C + + ++ EY+ N L +L + L+ + L + + G+ +L + I
Sbjct: 72 CSKEYPIYIVTEYISNGCLLNYL--RSHGKGLEPSQLLEMCYDVCEGMAFL---ESHQFI 126
Query: 341 HRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGT---YGYMAPEYAMGGIF 397
HRDL A N L+D D+ K+SDFG R +Q ++ GT + APE +
Sbjct: 127 HRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSV----GTKFPVKWSAPEVFHYFKY 182
Query: 398 SIKSDVFSFGVLLLEIIS-------GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDP 450
S KSDV++FG+L+ E+ S N+ E++
Sbjct: 183 SSKSDVWAFGILMWEVFSLGKMPYDLYTNS-------------------------EVVLK 217
Query: 451 VLK-------QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 489
V + D + + I C + P RPT ++ +
Sbjct: 218 VSQGHRLYRPHLA-SDTIYQ---IMYSCWHELPEKRPTFQQLLSSI 259
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 1e-46
Identities = 81/286 (28%), Positives = 128/286 (44%), Gaps = 56/286 (19%)
Query: 221 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGC 280
E KLG G FG V+ T +AVK + + ++ F E N++ LQH LV+L
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 251
Query: 281 CLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKII 340
+ + + +I E+M SL L S + + + IA G+ ++ + I
Sbjct: 252 VTK-EPIYIITEFMAKGSLLDFLKSDEGS-KQPLPKLIDFSAQIAEGMAFI---EQRNYI 306
Query: 341 HRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGT---YGYMAPEYAMGGIF 397
HRDL+A+N+L+ + KI+DFG AR+ N+ A G + APE G F
Sbjct: 307 HRDLRAANILVSASLVCKIADFGLARVIEDNEYTARE----GAKFPIKWTAPEAINFGSF 362
Query: 398 SIKSDVFSFGVLLLEIIS-------GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDP 450
+IKSDV+SFG+LL+EI++ G N E+I
Sbjct: 363 TIKSDVWSFGILLMEIVTYGRIPYPGMSNP-------------------------EVIRA 397
Query: 451 VLK-------QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 489
+ + ++C P+EL I + C + P +RPT + +L
Sbjct: 398 LERGYRMPRPENC-PEELYN---IMMRCWKNRPEERPTFEYIQSVL 439
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 1e-46
Identities = 91/301 (30%), Positives = 137/301 (45%), Gaps = 61/301 (20%)
Query: 221 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGC 280
+LG G FG V+ G +AVK L + F E NL+ +LQH+ LVRL
Sbjct: 18 VERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAV 76
Query: 281 CLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKII 340
+ + + +I EYM N SL L ++L + L + IA G+ ++ I
Sbjct: 77 VTQ-EPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFI---EERNYI 131
Query: 341 HRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGT---YGYMAPEYAMGGIF 397
HRDL+A+N+L+ D ++ KI+DFG AR+ N+ A G + APE G F
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE----GAKFPIKWTAPEAINYGTF 187
Query: 398 SIKSDVFSFGVLLLEIIS-------GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDP 450
+IKSDV+SFG+LL EI++ G N E+I
Sbjct: 188 TIKSDVWSFGILLTEIVTHGRIPYPGMTNP-------------------------EVIQN 222
Query: 451 VLK-------QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML-----ASDSMTIPQ 498
+ + +C P+EL + + LC ++ P DRPT + +L A++ PQ
Sbjct: 223 LERGYRMVRPDNC-PEELYQ---LMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQYQPQ 278
Query: 499 P 499
P
Sbjct: 279 P 279
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 1e-46
Identities = 88/328 (26%), Positives = 146/328 (44%), Gaps = 49/328 (14%)
Query: 221 ENKLGQGGFGPVYKGTLADGK----AIAVKRL-SRTSGQGLKEFKNEVNLIAKLQHKNLV 275
+ +G G FG V G L ++A+K L + + ++F E +++ + H N++
Sbjct: 50 DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 276 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDS 335
RL G + + ++++ EYM N SLD L Q + + ++ GIA G+ YL S
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGMKYL---S 164
Query: 336 RLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYG------YMAP 389
+ +HRDL A N+L++ ++ K+SDFG R+ + A T T G + +P
Sbjct: 165 DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYT-----TRGGKIPIRWTSP 219
Query: 390 EYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVE-- 446
E F+ SDV+S+G++L E++S G + Y+ Q ++ AV+
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGERP---YWEMSNQDVI----------KAVDEG 266
Query: 447 --LIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSMTIPQPTEPAF 504
L P C P L + + L C Q+D +RP +V +L D + I P
Sbjct: 267 YRLPPP---MDC-PAALYQ---LMLDCWQKDRNNRPKFEQIVSIL--DKL-IRNPGSLKI 316
Query: 505 SVGRVVANSGHLLSSAKVGSVNNVTVSD 532
S LL + V T D
Sbjct: 317 ITSAAARPSNLLLDQSNVDITTFRTTGD 344
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 2e-46
Identities = 75/290 (25%), Positives = 111/290 (38%), Gaps = 68/290 (23%)
Query: 221 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGC 280
+G+G FG V G G +AVK + + + F E +++ +L+H NLV+LLG
Sbjct: 26 LQTIGKGEFGDVMLGD-YRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGV 82
Query: 281 CLEGQE-LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKI 339
+E + L ++ EYM SL +L RS L L + + YL
Sbjct: 83 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYL---EGNNF 138
Query: 340 IHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYG------YMAPEYAM 393
+HRDL A NVL+ +D K+SDFG + + + APE
Sbjct: 139 VHRDLAARNVLVSEDNVAKVSDFGLTK-----------EASSTQDTGKLPVKWTAPEALR 187
Query: 394 GGIFSIKSDVFSFGVLLLEIIS-------GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVE 446
FS KSDV+SFG+LL EI S +
Sbjct: 188 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-------------------------D 222
Query: 447 LIDPVLK-------QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 489
++ V K C P + + + C D A RP+ + L
Sbjct: 223 VVPRVEKGYKMDAPDGC-PPAVYE---VMKNCWHLDAAMRPSFLQLREQL 268
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 2e-46
Identities = 84/305 (27%), Positives = 130/305 (42%), Gaps = 67/305 (21%)
Query: 221 ENKLGQGGFGPVYKGTLADGK--------AIAVKRL-SRTSGQGLKEFKNEVNLIAKL-Q 270
LG+G FG V +AVK L + + L + +E+ ++ + +
Sbjct: 86 GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 145
Query: 271 HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHL-------------FDATRSVQLDWKRR 317
HKN++ LLG C + L +I EY +L +L + Q+ +K
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205
Query: 318 LSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTAR-IFGGNQNQAN 376
+S +ARG+ YL + K IHRDL A NVL+ ++ KI+DFG AR I + +
Sbjct: 206 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 262
Query: 377 TNIIAGTYG-----YMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-------GRKNNGFYF 424
TN G +MAPE +++ +SDV+SFGVL+ EI + G +
Sbjct: 263 TN------GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF- 315
Query: 425 SEHGQTLLTYTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSS 484
LL EGH ++ K + +EL + C P+ RPT
Sbjct: 316 -----KLLK-------EGHRMD------KPANCTNELYMMM---RDCWHAVPSQRPTFKQ 354
Query: 485 VVVML 489
+V L
Sbjct: 355 LVEDL 359
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 2e-46
Identities = 70/304 (23%), Positives = 117/304 (38%), Gaps = 73/304 (24%)
Query: 221 ENKLGQGGFGPVYKGTLADGK----AIAVKRL--SRTSGQGLKEFKNEVNLIAKLQHKNL 274
LG+G FG V + L +AVK L + ++EF E + + H ++
Sbjct: 28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87
Query: 275 VRLLGCCLEGQ------ELLLIYEYMPNKSLDVHLFD---ATRSVQLDWKRRLSIINGIA 325
+L+G L + ++I +M + L L L + + + IA
Sbjct: 88 AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147
Query: 326 RGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYG 385
G+ YL S IHRDL A N +L +DM ++DFG +R I +G Y
Sbjct: 148 CGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSR-----------KIYSGDY- 192
Query: 386 Y------------MAPEYAMGGIFSIKSDVFSFGVLLLEIIS-------GRKNNG-FYFS 425
Y +A E ++++ SDV++FGV + EI++ G +N + +
Sbjct: 193 YRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYL 252
Query: 426 EHGQTLLTYTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSV 485
G L P C +E+ + C DP RP+ + +
Sbjct: 253 IGGNRLKQ----------------P---PEC-MEEVY---DLMYQCWSADPKQRPSFTCL 289
Query: 486 VVML 489
+ L
Sbjct: 290 RMEL 293
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 2e-46
Identities = 82/323 (25%), Positives = 126/323 (39%), Gaps = 98/323 (30%)
Query: 221 ENKLGQGGFGPVYKGTLADGK------AIAVKRL-SRTSGQGLKEFKNEVNLIAKLQHKN 273
+G+G FG V++ +AVK L S +F+ E L+A+ + N
Sbjct: 52 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPN 111
Query: 274 LVRLLGCCLEGQELLLIYEYMPNKSLDVHL---------------------FDATRSVQL 312
+V+LLG C G+ + L++EYM L+ L + L
Sbjct: 112 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171
Query: 313 DWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQ 372
+L I +A G+ YL S K +HRDL N L+ ++M KI+DFG +R
Sbjct: 172 SCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR------ 222
Query: 373 NQANTNIIAGTYGY------------MAPEYAMGGIFSIKSDVFSFGVLLLEIIS----- 415
NI + Y Y M PE ++ +SDV+++GV+L EI S
Sbjct: 223 -----NIYSADY-YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276
Query: 416 --GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLK-------QSCAPDELLKFIH 466
G + E+I V ++C P EL
Sbjct: 277 YYGMAHE-------------------------EVIYYVRDGNILACPENC-PLELYN--- 307
Query: 467 IGLLCVQQDPADRPTMSSVVVML 489
+ LC + PADRP+ S+ +L
Sbjct: 308 LMRLCWSKLPADRPSFCSIHRIL 330
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 4e-46
Identities = 77/307 (25%), Positives = 113/307 (36%), Gaps = 70/307 (22%)
Query: 221 ENKLGQGGFGPVYKGTLADGKA------IAVKRL-SRTSGQGLKEFKNEVNLIAKL-QHK 272
LG G FG V + T +AVK L + +E+ +++ L H
Sbjct: 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87
Query: 273 NLVRLLGCCLEGQELLLIYEYMPNKSL---------------DVHLFDATRSVQLDWKRR 317
N+V LLG C G L+I EY L + LD +
Sbjct: 88 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147
Query: 318 LSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTAR-IFGGNQNQAN 376
LS +A+G+ +L + IHRDL A N+LL KI DFG AR I +
Sbjct: 148 LSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 204
Query: 377 TNIIAGTYG-----YMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-------GRKNNG--F 422
N +MAPE +++ +SDV+S+G+ L E+ S G + +
Sbjct: 205 GN------ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258
Query: 423 YFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTM 482
+ G + L AP E+ I C DP RPT
Sbjct: 259 KMIKEGFRM--------------------LSPEHAPAEMYD---IMKTCWDADPLKRPTF 295
Query: 483 SSVVVML 489
+V ++
Sbjct: 296 KQIVQLI 302
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 5e-46
Identities = 80/297 (26%), Positives = 118/297 (39%), Gaps = 68/297 (22%)
Query: 221 ENKLGQGGFGPVYKGTLADGK----AIAVKRLSR-TSGQGLKEFKNEVNLIAKLQHKNLV 275
+G+G FG VY GTL D AVK L+R T + +F E ++ H N++
Sbjct: 30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89
Query: 276 RLLGCCLEGQE-LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHED 334
LLG CL + L++ YM + L + + K + +A+G+ YL
Sbjct: 90 SLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMKYLAS- 146
Query: 335 SRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGY-------- 386
K +HRDL A N +LD+ K++DFG AR ++ Y Y
Sbjct: 147 --KKFVHRDLAARNCMLDEKFTVKVADFGLAR-----------DMYDKEY-YSVHNKTGA 192
Query: 387 ------MAPEYAMGGIFSIKSDVFSFGVLLLEIIS-------GRKNNG-FYFSEHGQTLL 432
MA E F+ KSDV+SFGVLL E+++ + G+ LL
Sbjct: 193 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLL 252
Query: 433 TYTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 489
P + C PD L + L C RP+ S +V +
Sbjct: 253 Q----------------P---EYC-PDPLY---EVMLKCWHPKAEMRPSFSELVSRI 286
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 9e-46
Identities = 91/320 (28%), Positives = 133/320 (41%), Gaps = 68/320 (21%)
Query: 221 ENKLGQGGFGPVYKGTLADGK--------AIAVKRL-SRTSGQGLKEFKNEVNLIAKL-Q 270
LG+G FG V +AVK L S + + L + +E+ ++ + +
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133
Query: 271 HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHL-------------FDATRSVQLDWKRR 317
HKN++ LLG C + L +I EY +L +L QL K
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193
Query: 318 LSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTAR-IFGGNQNQAN 376
+S +ARG+ YL + K IHRDL A NVL+ +D KI+DFG AR I + +
Sbjct: 194 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 250
Query: 377 TNIIAGTYG-----YMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-------GRKNNGFYF 424
TN G +MAPE I++ +SDV+SFGVLL EI + G +
Sbjct: 251 TN------GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF- 303
Query: 425 SEHGQTLLTYTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSS 484
KL EGH ++ K S +EL + C P+ RPT
Sbjct: 304 ------------KLLKEGHRMD------KPSNCTNELYM---MMRDCWHAVPSQRPTFKQ 342
Query: 485 VVVMLASDSMTIPQPTEPAF 504
+V L + + E +
Sbjct: 343 LVEDLD-RIVALTSNQEMGY 361
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 1e-45
Identities = 78/288 (27%), Positives = 123/288 (42%), Gaps = 50/288 (17%)
Query: 221 ENKLGQGGFGPVYKGTLADGK----AIAVKRLSR-TSGQGLKEFKNEVNLIAKLQHKNLV 275
+G+G FG VY GTL D AVK L+R T + +F E ++ H N++
Sbjct: 94 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153
Query: 276 RLLGCCLEGQE-LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHED 334
LLG CL + L++ YM + L + + + K + +A+G+ +L
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFL--- 208
Query: 335 SRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYG-----YMAP 389
+ K +HRDL A N +LD+ K++DFG AR ++ ++ T +MA
Sbjct: 209 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM---YDKEFDSVHNKTGAKLPVKWMAL 265
Query: 390 EYAMGGIFSIKSDVFSFGVLLLEIIS-------GRKNNG-FYFSEHGQTLLTYTWKLWCE 441
E F+ KSDV+SFGVLL E+++ + G+ LL
Sbjct: 266 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ-------- 317
Query: 442 GHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 489
P + C PD L + + L C RP+ S +V +
Sbjct: 318 --------P---EYC-PDPLYE---VMLKCWHPKAEMRPSFSELVSRI 350
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 2e-45
Identities = 71/283 (25%), Positives = 115/283 (40%), Gaps = 43/283 (15%)
Query: 221 ENKLGQGGFGPVYKGTLADGK-----AIAVKRLSRTSG-QGLKEFKNEVNLIAKLQHKNL 274
LG G FG V+KG + +K + SG Q + + + I L H ++
Sbjct: 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77
Query: 275 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHED 334
VRLLG C L L+ +Y+P SL H+ L + L+ IA+G+ YL
Sbjct: 78 VRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQ--HRGALGPQLLLNWGVQIAKGMYYL--- 131
Query: 335 SRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMG 394
++HR+L A NVLL +++DFG A + + Q + +MA E
Sbjct: 132 EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHF 191
Query: 395 GIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLK 453
G ++ +SDV+S+GV + E+++ G + Y E+ D + K
Sbjct: 192 GKYTHQSDVWSYGVTVWELMTFGAEP---YAGLRLA----------------EVPDLLEK 232
Query: 454 -------QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 489
Q C ++ + + C D RPT +
Sbjct: 233 GERLAQPQIC-TIDVY---MVMVKCWMIDENIRPTFKELANEF 271
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 2e-45
Identities = 76/295 (25%), Positives = 123/295 (41%), Gaps = 44/295 (14%)
Query: 221 ENKLGQGGFGPVYKGTL-ADGKAI--AVKRL-SRTSGQGLKEFKNEVNLIAKLQHKNLVR 276
+ +LG G FG V +G K I A+K L T +E E ++ +L + +VR
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74
Query: 277 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSR 336
L+G C + L+L+ E L L + ++ +++ ++ G+ YL
Sbjct: 75 LIGVCQA-EALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYL---EE 128
Query: 337 LKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYG-----YMAPEY 391
+HRDL A NVLL + KISDFG ++ G + + A + G + APE
Sbjct: 129 KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY----YTARSAGKWPLKWYAPEC 184
Query: 392 AMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVE---- 446
FS +SDV+S+GV + E +S G+K Y G ++ +E
Sbjct: 185 INFRKFSSRSDVWSYGVTMWEALSYGQKP---YKKMKGPEVM----------AFIEQGKR 231
Query: 447 LIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSMTIPQPTE 501
+ P C P EL + C DRP +V + + ++ E
Sbjct: 232 MECP---PEC-PPELYA---LMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVE 279
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 2e-45
Identities = 76/316 (24%), Positives = 116/316 (36%), Gaps = 91/316 (28%)
Query: 222 NKLGQGGFGPVYKGTLAD------GKAIAVKRL-SRTSGQGLKEFKNEVNLIAKL-QHKN 273
LG+G FG V + + +AVK L + + +E+ ++ + H N
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 274 LVRLLGCCL-EGQELLLIYEYMPNKSL-------------DVHLFDATRSVQLDWKRRLS 319
+V LLG C G L++I E+ +L + L + +
Sbjct: 93 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 320 IINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNI 379
+A+G+ +L + K IHRDL A N+LL + KI DFG AR +I
Sbjct: 153 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR-----------DI 198
Query: 380 IAGTYGY------------MAPEYAMGGIFSIKSDVFSFGVLLLEIIS-------GRKNN 420
Y MAPE +++I+SDV+SFGVLL EI S G K +
Sbjct: 199 YKDPD-YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 257
Query: 421 GFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLK-------QSCAPDELLKFIHIGLLCVQ 473
E + + E+ + L C
Sbjct: 258 ------------------------EEFCRRLKEGTRMRAPDYT-TPEMYQ---TMLDCWH 289
Query: 474 QDPADRPTMSSVVVML 489
+P+ RPT S +V L
Sbjct: 290 GEPSQRPTFSELVEHL 305
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 2e-45
Identities = 68/294 (23%), Positives = 116/294 (39%), Gaps = 48/294 (16%)
Query: 221 ENKLGQGGFGPVYKGTLADGK----AIAVKRL-SRTSGQGLKEFKNEVNLIAKLQHKNLV 275
+G+G FG V++G + A+A+K + TS ++F E + + H ++V
Sbjct: 20 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 79
Query: 276 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDS 335
+L+G E + +I E L L R LD + ++ + YL
Sbjct: 80 KLIGVITE-NPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYL---E 133
Query: 336 RLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYG-----YMAPE 390
+ +HRD+ A NVL+ + K+ DFG +R ++ + G +MAPE
Sbjct: 134 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM------EDSTYYKASKGKLPIKWMAPE 187
Query: 391 YAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVE--- 446
F+ SDV+ FGV + EI+ G K + ++ +E
Sbjct: 188 SINFRRFTSASDVWMFGVCMWEILMHGVKP---FQGVKNNDVI----------GRIENGE 234
Query: 447 -LIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSMTIPQP 499
L P +C P L + C DP+ RP + + L S + +
Sbjct: 235 RLPMP---PNC-PPTLYS---LMTKCWAYDPSRRPRFTELKAQL-STILEEEKA 280
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 3e-45
Identities = 83/282 (29%), Positives = 117/282 (41%), Gaps = 34/282 (12%)
Query: 221 ENKLGQGGFGPVYKGTL--ADGKAI--AVKRL---SRTSGQGLKEFKNEVNLIAKLQHKN 273
KLG G FG V +G GK + AVK L + + + +F EVN + L H+N
Sbjct: 23 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82
Query: 274 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHE 333
L+RL G L + ++ E P SL L L +A G+ YL E
Sbjct: 83 LIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLL--GTLSRYAVQVAEGMGYL-E 138
Query: 334 DSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGT---YGYMAPE 390
R IHRDL A N+LL KI DFG R N + + + APE
Sbjct: 139 SKRF--IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQ--EHRKVPFAWCAPE 194
Query: 391 YAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELID 449
FS SD + FGV L E+ + G++ + +G +L K+ EG L
Sbjct: 195 SLKTRTFSHASDTWMFGVTLWEMFTYGQEP---WIGLNGSQILH---KIDKEGE--RLPR 246
Query: 450 PVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 491
P + C P ++ + + C P DRPT ++ L
Sbjct: 247 P---EDC-PQDIYN---VMVQCWAHKPEDRPTFVALRDFLLE 281
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 5e-45
Identities = 79/335 (23%), Positives = 135/335 (40%), Gaps = 67/335 (20%)
Query: 221 ENKLGQGGFGPVYKGTLADGK-----AIAVKRL-SRTSGQGLKEFKNEVNLIAKLQHKNL 274
LG G FG VYKG +A+K L TS + KE +E ++A + + ++
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 275 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHED 334
RLLG CL + LI + MP L ++ + + + L+ IA+G+ YL
Sbjct: 80 CRLLGICLT-STVQLITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYL--- 133
Query: 335 SRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNI----IAGTYGYMAPE 390
+++HRDL A NVL+ + KI+DFG A++ G + + + I +MA E
Sbjct: 134 EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK----WMALE 189
Query: 391 YAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELID 449
+ I++ +SDV+S+GV + E+++ G K Y E+
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMTFGSKP---YDGIPAS----------------EISS 230
Query: 450 PVLK-------QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML------------- 489
+ K C ++ I + C D RP +++
Sbjct: 231 ILEKGERLPQPPIC-TIDVY---MIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVI 286
Query: 490 -ASDSMTIPQPTEPAFSVGRVVANSGHLLSSAKVG 523
+ M +P PT+ F R + + +
Sbjct: 287 QGDERMHLPSPTDSNFY--RALMDEEDMDDVVDAD 319
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 6e-45
Identities = 76/312 (24%), Positives = 115/312 (36%), Gaps = 75/312 (24%)
Query: 221 ENKLGQGGFGPVYKGTLADGKA------IAVKRL-SRTSGQGLKEFKNEVNLIAKL-QHK 272
LG G FG V T +AVK L + + +E+ ++ +L H+
Sbjct: 50 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 109
Query: 273 NLVRLLGCCLEGQELLLIYEYMPNKSL--------------------DVHLFDATRSVQL 312
N+V LLG C + LI+EY L L + L
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169
Query: 313 DWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTAR-IFGGN 371
++ L +A+G+ +L +HRDL A NVL+ KI DFG AR I +
Sbjct: 170 TFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDS 226
Query: 372 QNQANTNIIAGTYG-----YMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-------GRKN 419
N +MAPE GI++IKSDV+S+G+LL EI S G
Sbjct: 227 NYVVRGN------ARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 280
Query: 420 NG--FYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPA 477
+ + ++G + + A +E+ I C D
Sbjct: 281 DANFYKLIQNGFKM--------------------DQPFYATEEIY---IIMQSCWAFDSR 317
Query: 478 DRPTMSSVVVML 489
RP+ ++ L
Sbjct: 318 KRPSFPNLTSFL 329
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 9e-45
Identities = 67/284 (23%), Positives = 118/284 (41%), Gaps = 47/284 (16%)
Query: 221 ENKLGQGGFGPVYKGTLADGKA----IAVKRLSR-TSGQGLKEFKNEVNLIAKLQHKNLV 275
LG+G FG VY+G + K +AVK + + ++F +E ++ L H ++V
Sbjct: 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76
Query: 276 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDS 335
+L+G E + +I E P L +L S+++ + I + + YL
Sbjct: 77 KLIGIIEE-EPTWIIMELYPYGELGHYLERNKNSLKV--LTLVLYSLQICKAMAYL---E 130
Query: 336 RLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYG-----YMAPE 390
+ +HRD+ N+L+ K+ DFG +R + + + +M+PE
Sbjct: 131 SINCVHRDIAVRNILVASPECVKLGDFGLSRYI------EDEDYYKASVTRLPIKWMSPE 184
Query: 391 YAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVE--- 446
F+ SDV+ F V + EI+S G++ +F + ++ +E
Sbjct: 185 SINFRRFTTASDVWMFAVCMWEILSFGKQP---FFWLENKDVI----------GVLEKGD 231
Query: 447 -LIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 489
L P C P L + C DP+DRP + +V L
Sbjct: 232 RLPKP---DLC-PPVLYT---LMTRCWDYDPSDRPRFTELVCSL 268
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 1e-44
Identities = 64/300 (21%), Positives = 111/300 (37%), Gaps = 69/300 (23%)
Query: 221 ENKLGQGGFGPVYKGTL--------ADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHK 272
LGQG F ++KG + +K L + + F ++++KL HK
Sbjct: 13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 273 NLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLH 332
+LV G C+ G E +L+ E++ SLD +L + + WK L + +A + +L
Sbjct: 73 HLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWK--LEVAKQLAAAMHFL- 129
Query: 333 EDSRLKIIHRDLKASNVLLDDDMNP--------KISDFGTARIFGGNQNQANTNIIAGTY 384
+IH ++ A N+LL + + K+SD G + ++
Sbjct: 130 --EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT-----------VLPKDI 176
Query: 385 GY-----MAPE-YAMGGIFSIKSDVFSFGVLLLEIIS-------GRKNNGFYFSEHGQTL 431
+ PE ++ +D +SFG L EI S + + L
Sbjct: 177 LQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQ--------RKL 228
Query: 432 LTYTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 491
Y + H L EL I C+ +P RP+ +++ L S
Sbjct: 229 QFYE-----DRH-------QLPAPK-AAELANLI---NNCMDYEPDHRPSFRAIIRDLNS 272
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 1e-44
Identities = 81/297 (27%), Positives = 126/297 (42%), Gaps = 48/297 (16%)
Query: 221 ENKLGQGGFGPVYKGTLADGKA---IAVKRL--SRTSGQGLKEFKNEVNLIAKLQHKNLV 275
+ +LG G FG V KG K +AVK L E E N++ +L + +V
Sbjct: 22 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 81
Query: 276 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDS 335
R++G C + +L+ E L+ +L ++ + K + +++ ++ G+ YL
Sbjct: 82 RMIGICE-AESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYL---E 134
Query: 336 RLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYG-----YMAPE 390
+HRDL A NVLL KISDFG ++ ++N A T+G + APE
Sbjct: 135 ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK----AQTHGKWPVKWYAPE 190
Query: 391 YAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVE--- 446
FS KSDV+SFGVL+ E S G+K Y G + +E
Sbjct: 191 CINYYKFSSKSDVWSFGVLMWEAFSYGQKP---YRGMKGSEVT----------AMLEKGE 237
Query: 447 -LIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSMTIPQPTEP 502
+ P C P E+ + LC D +RP ++V + L + E
Sbjct: 238 RMGCP---AGC-PREMYD---LMNLCWTYDVENRPGFAAVELRL--RNYYYDVVNEG 285
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 1e-43
Identities = 89/411 (21%), Positives = 152/411 (36%), Gaps = 49/411 (11%)
Query: 96 RNATKGTNISNINRLETFGQCIPVLSVDDCRDCLNNTIRWIQKCFDPPGTGFGRILFPSC 155
++ I + +T Q + L + +G P+
Sbjct: 215 QDKAGKYCIPEGTKFDTLWQLVEYLKLKADGLIYCLK-EACPNSSASNASGAAAPTLPAH 273
Query: 156 IMGFELHPYSKVPAVGALAPSSAPGRIGNHYSYDIL---RGGEQQAESQEFPLFPLGLAL 212
HP ++ + + + P RI + + + S L L L
Sbjct: 274 PSTLT-HPQRRIDTLNSDGYTPEPARITSPDKPRPMPMDTSVFESPFSDPEELKDKKLFL 332
Query: 213 EATNHFSDENKLGQGGFGPVYKGTLADGKA---IAVKRL-SRTSGQGLKEFKNEVNLIAK 268
+ N + +LG G FG V +G K +A+K L T +E E ++ +
Sbjct: 333 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQ 392
Query: 269 LQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGI 328
L + +VRL+G C + L+L+ E L L + ++ +++ ++ G+
Sbjct: 393 LDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGM 449
Query: 329 LYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYG--- 385
YL +HR+L A NVLL + KISDFG ++ G + + A + G
Sbjct: 450 KYL---EEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSY----YTARSAGKWP 502
Query: 386 --YMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEG 442
+ APE FS +SDV+S+GV + E +S G+K Y G ++
Sbjct: 503 LKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP---YKKMKGPEVM---------- 549
Query: 443 HAVE----LIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 489
+E + P C P EL + C DRP +V +
Sbjct: 550 AFIEQGKRMECP---PEC-PPELYA---LMSDCWIYKWEDRPDFLTVEQRM 593
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 1e-43
Identities = 81/276 (29%), Positives = 133/276 (48%), Gaps = 36/276 (13%)
Query: 221 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGC 280
E KLGQG FG V+ GT +A+K L + + F E ++ KL+H+ LV+L
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 247
Query: 281 CLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKII 340
E + + ++ EYM SL L T L + + + IA G+ Y+ R+ +
Sbjct: 248 VSE-EPIYIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYV---ERMNYV 302
Query: 341 HRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIK 400
HRDL+A+N+L+ +++ K++DFG AR+ N+ A + APE A+ G F+IK
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIK 361
Query: 401 SDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELID-------PVLK 453
SDV+SFG+LL E+ + G+ Y + E ++ ++ P
Sbjct: 362 SDVWSFGILLTELTT-----------KGRV--PYPGMVNRE--VLDQVERGYRMPCP--- 403
Query: 454 QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 489
C P+ L + C +++P +RPT + L
Sbjct: 404 PEC-PESLHD---LMCQCWRKEPEERPTFEYLQAFL 435
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 3e-43
Identities = 66/294 (22%), Positives = 106/294 (36%), Gaps = 45/294 (15%)
Query: 216 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRT-SGQGLKEFKNEVNLIAKLQHKN 273
F LG+GGFG V++ D A+KR+ ++ EV +AKL+H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 274 LVRLLGCCLEGQE------------LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSII 321
+VR LE L + + ++L + + + L I
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 322 NGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIA 381
IA + +LH ++HRDLK SN+ D K+ DFG ++ +
Sbjct: 125 LQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 382 ----------GTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTL 431
GT YM+PE G +S K D+FS G++L E++ + FS Q
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL-------YPFS--TQME 232
Query: 432 LTYTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSV 485
T P+ Q + + P +RP ++
Sbjct: 233 RVRTLTDVRNLK----FPPLFTQKY--PCEYVMVQ---DMLSPSPMERPEAINI 277
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 3e-43
Identities = 81/276 (29%), Positives = 133/276 (48%), Gaps = 36/276 (13%)
Query: 221 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGC 280
E KLGQG FG V+ GT +A+K L + + F E ++ KL+H+ LV+L
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAV 330
Query: 281 CLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKII 340
E + + ++ EYM SL L T L + + + IA G+ Y+ R+ +
Sbjct: 331 VSE-EPIYIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYV---ERMNYV 385
Query: 341 HRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIK 400
HRDL+A+N+L+ +++ K++DFG AR+ N+ A + APE A+ G F+IK
Sbjct: 386 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIK 444
Query: 401 SDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELID-------PVLK 453
SDV+SFG+LL E+ + G+ Y + E ++ ++ P
Sbjct: 445 SDVWSFGILLTELTT-----------KGRV--PYPGMVNRE--VLDQVERGYRMPCP--- 486
Query: 454 QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 489
C P+ L + C +++P +RPT + L
Sbjct: 487 PEC-PESLHD---LMCQCWRKEPEERPTFEYLQAFL 518
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 2e-42
Identities = 63/272 (23%), Positives = 119/272 (43%), Gaps = 37/272 (13%)
Query: 223 KLGQGGFGPVYKGT-LADGKAIAVK--RLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLG 279
K+G+G FG DG+ +K +SR S + +E + EV ++A ++H N+V+
Sbjct: 31 KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90
Query: 280 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKI 339
E L ++ +Y L +A + V + L I + ++H+ KI
Sbjct: 91 SFEENGSLYIVMDYCEGGDLF-KRINAQKGVLFQEDQILDWFVQICLALKHVHDR---KI 146
Query: 340 IHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSI 399
+HRD+K+ N+ L D ++ DFG AR+ A GT Y++PE ++
Sbjct: 147 LHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA--CIGTPYYLSPEICENKPYNN 204
Query: 400 KSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQSCAP- 458
KSD+++ G +L E+ + + F ++ L+ ++ S P
Sbjct: 205 KSDIWALGCVLYELCTLKH----AF--EAGSMK-------------NLVLKIISGSFPPV 245
Query: 459 -----DELLKFIHIGLLCVQQDPADRPTMSSV 485
+L + +++P DRP+++S+
Sbjct: 246 SLHYSYDLRSLVS---QLFKRNPRDRPSVNSI 274
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 3e-42
Identities = 67/284 (23%), Positives = 113/284 (39%), Gaps = 47/284 (16%)
Query: 221 ENKLGQGGFGPVYKGTLADGK----AIAVKRL-SRTSGQGLKEFKNEVNLIAKLQHKNLV 275
+G+G FG V++G + A+A+K + TS ++F E + + H ++V
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 454
Query: 276 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDS 335
+L+G E + +I E L L R LD + ++ + YL
Sbjct: 455 KLIGVITE-NPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYL---E 508
Query: 336 RLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYG-----YMAPE 390
+ +HRD+ A NVL+ + K+ DFG +R ++ + G +MAPE
Sbjct: 509 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM------EDSTYYKASKGKLPIKWMAPE 562
Query: 391 YAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVE--- 446
F+ SDV+ FGV + EI+ G K + ++ +E
Sbjct: 563 SINFRRFTSASDVWMFGVCMWEILMHGVKP---FQGVKNNDVI----------GRIENGE 609
Query: 447 -LIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 489
L P +C P L + C DP+ RP + + L
Sbjct: 610 RLPMP---PNC-PPTLYS---LMTKCWAYDPSRRPRFTELKAQL 646
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 3e-42
Identities = 62/282 (21%), Positives = 118/282 (41%), Gaps = 37/282 (13%)
Query: 216 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRL---SRTSGQGLKEFKNEVNLIAKLQH 271
+F E K+G+G F VY+ L DG +A+K++ + + E++L+ +L H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 272 KNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRS-VQLDWKRRLSIINGIARGILY 330
N+++ +E EL ++ E L + + + + + + +
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 331 LHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPE 390
+H +++HRD+K +NV + K+ D G R F A++ + GT YM+PE
Sbjct: 152 MHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV--GTPYYMSPE 206
Query: 391 YAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDP 450
++ KSD++S G LL E+ + + F L L
Sbjct: 207 RIHENGYNFKSDIWSLGCLLYEMAALQSP----FYGDKMNLY-------------SLCKK 249
Query: 451 VLKQSCAP-------DELLKFIHIGLLCVQQDPADRPTMSSV 485
+ + P +EL + ++ +C+ DP RP ++ V
Sbjct: 250 IEQCDYPPLPSDHYSEELRQLVN---MCINPDPEKRPDVTYV 288
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 3e-42
Identities = 68/287 (23%), Positives = 114/287 (39%), Gaps = 49/287 (17%)
Query: 216 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNL 274
F + +G GGFG V+K DGK +KR+ + ++ + EV +AKL H N+
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNI 66
Query: 275 VRLLGC----------------CLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRL 318
V GC + + L + E+ +L+ + R +LD L
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLE-QWIEKRRGEKLDKVLAL 125
Query: 319 SIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTN 378
+ I +G+ Y+H K+I+RDLK SN+ L D KI DFG N + +
Sbjct: 126 ELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSL-KNDGKRTRS 181
Query: 379 IIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKL 438
GT YM+PE + + D+++ G++L E++ E +
Sbjct: 182 K--GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHV----CDTAFETSKFFTD----- 230
Query: 439 WCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSV 485
L D ++ + + + + P DRP S +
Sbjct: 231 --------LRDGIISDIF-DKKEKTLLQ---KLLSKKPEDRPNTSEI 265
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 4e-40
Identities = 70/277 (25%), Positives = 114/277 (41%), Gaps = 38/277 (13%)
Query: 223 KLGQGGFGPVYKGT-LADGKAIAVK--RLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLG 279
+G G +G K +DGK + K + + +EVNL+ +L+H N+VR
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 280 CCLE--GQELLLIYEYMPNKSLDVHLFDATRSVQ-LDWKRRLSIINGIARGILYLHE--D 334
++ L ++ EY L + T+ Q LD + L ++ + + H D
Sbjct: 73 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 335 SRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMG 394
++HRDLK +NV LD N K+ DFG ARI + + A T + GT YM+PE
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV--GTPYYMSPEQMNR 190
Query: 395 GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQ 454
++ KSD++S G LL E+ + F + EL + +
Sbjct: 191 MSYNEKSDIWSLGCLLYELCALMP--PFT----AFSQK-------------ELAGKIREG 231
Query: 455 SCAP------DELLKFIHIGLLCVQQDPADRPTMSSV 485
DEL + I + RP++ +
Sbjct: 232 KFRRIPYRYSDELNEIIT---RMLNLKDYHRPSVEEI 265
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 3e-39
Identities = 77/302 (25%), Positives = 117/302 (38%), Gaps = 56/302 (18%)
Query: 215 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKN 273
+ F + LGQG FG V K D + A+K++ T + L +EV L+A L H+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQY 63
Query: 274 LVRLLGCCLE-------------GQELLLIYEYMPNKSLDVHLFD--ATRSVQLDWKRRL 318
+VR LE L + EY N +L +D + ++
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTL----YDLIHSENLNQQRDEYW 119
Query: 319 SIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIF---------- 368
+ I + Y+H IIHRDLK N+ +D+ N KI DFG A+
Sbjct: 120 RLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 369 ----GGNQNQANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFY 423
G+ + + I GT Y+A E G G ++ K D++S G++ E+I
Sbjct: 177 SQNLPGSSDNLTSAI--GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPF----ST 230
Query: 424 FSEHGQTLLTYTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMS 483
E L KL +V + P K I L + DP RP
Sbjct: 231 GMERVNILK----KL----RSVSIEFPPDFDDNKMKVEKKIIR---LLIDHDPNKRPGAR 279
Query: 484 SV 485
++
Sbjct: 280 TL 281
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 4e-39
Identities = 70/320 (21%), Positives = 124/320 (38%), Gaps = 36/320 (11%)
Query: 200 SQEFPLFPLGLALEATNH-FSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLK 257
S L+ G + N + KLG+GGF V L DG A+KR+ Q +
Sbjct: 12 SGRENLYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDRE 71
Query: 258 EFKNEVNLIAKLQHKNLVRLLGCCLE----GQELLLIYEYMPNKSLDVHLFDA-TRSVQL 312
E + E ++ H N++RL+ CL E L+ + +L + + L
Sbjct: 72 EAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFL 131
Query: 313 DWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQ 372
+ L ++ GI RG+ +H HRDLK +N+LL D+ P + D G+ +
Sbjct: 132 TEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHV 188
Query: 373 NQANTNIIA-------GTYGYMAPE---YAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF 422
+ + T Y APE + ++DV+S G +L ++ G
Sbjct: 189 EGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGP--- 245
Query: 423 YFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTM 482
+ Q + + +L P + L + ++ + DP RP +
Sbjct: 246 -YDMVFQKGDSVALAV-----QNQLSIP--QSPRHSSALWQLLNS---MMTVDPHQRPHI 294
Query: 483 SSVVVMLASDSMTIPQPTEP 502
++ L +++ P P +
Sbjct: 295 PLLLSQL--EALQPPAPGQH 312
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 8e-39
Identities = 65/268 (24%), Positives = 110/268 (41%), Gaps = 33/268 (12%)
Query: 223 KLGQGGFGPVYKGT-LADGKAIAVK--RLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLG 279
++G+G F VYKG +A + + + + FK E ++ LQH N+VR
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 280 CCLEGQE----LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDS 335
+ ++L+ E M + +L +L R + K S I +G+ +LH +
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYL---KRFKVMKIKVLRSWCRQILKGLQFLHTRT 149
Query: 336 RLKIIHRDLKASNVLLD-DDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMG 394
IIHRDLK N+ + + KI D G A + + A I GT +MAPE
Sbjct: 150 P-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLK--RASFAKAVI--GTPEFMAPEMYEE 204
Query: 395 GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQ 454
+ DV++FG+ +LE+ + Y + ++ G D V
Sbjct: 205 K-YDESVDVYAFGMCMLEMATSEYP---YSECQNAAQI---YRRVTSGVKPASFDKVA-- 255
Query: 455 SCAPDELLK-FIHIGLLCVQQDPADRPT 481
+K I C++Q+ +R +
Sbjct: 256 ----IPEVKEIIE---GCIRQNKDERYS 276
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 3e-38
Identities = 75/262 (28%), Positives = 122/262 (46%), Gaps = 23/262 (8%)
Query: 224 LGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCL 282
LG+G +G VY G L++ IA+K + + + E+ L L+HKN+V+ LG
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 283 EGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHR 342
E + + E +P SL L ++ + + I G+ YLH++ +I+HR
Sbjct: 90 ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHR 146
Query: 343 DLKASNVLLDDDM-NPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGI--FSI 399
D+K NVL++ KISDFGT++ G T GT YMAPE G +
Sbjct: 147 DIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGTLQYMAPEIIDKGPRGYGK 204
Query: 400 KSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQSCAPD 459
+D++S G ++E+ +G+ FY Q + +K+ + + P + +S +
Sbjct: 205 AADIWSLGCTIIEMATGKPP--FYELGEPQAAM---FKV-----GMFKVHPEIPESMSA- 253
Query: 460 ELLKFIHIGLLCVQQDPADRPT 481
E FI L C + DP R
Sbjct: 254 EAKAFI---LKCFEPDPDKRAC 272
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 4e-38
Identities = 68/274 (24%), Positives = 100/274 (36%), Gaps = 42/274 (15%)
Query: 217 HFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLKE---FKNEVNLIAKL-QH 271
F ++LG G +G V+K DG+ AVKR S + +G K+ EV K+ QH
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKR-SMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 272 KNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYL 331
VRL EG L L E SL H L + + + +L
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELC-GPSLQQHC--EAWGASLPEAQVWGYLRDTLLALAHL 173
Query: 332 HEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEY 391
H ++H D+K +N+ L K+ DFG G G YMAPE
Sbjct: 174 HS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVEL-GTAGAGEVQE--GDPRYMAPEL 227
Query: 392 AMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHA----VEL 447
G + +DVFS G+ +LE+ +L G +
Sbjct: 228 LQGS-YGTAADVFSLGLTILEVACN-------------------MELPHGGEGWQQLRQG 267
Query: 448 IDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPT 481
P + EL + ++ ++ DP R T
Sbjct: 268 YLPPEFTAGLSSELRSVL---VMMLEPDPKLRAT 298
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 7e-37
Identities = 71/320 (22%), Positives = 124/320 (38%), Gaps = 45/320 (14%)
Query: 195 EQQAESQEFPLFPLGLALEATNH-FSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTS 252
EQQ + E L E + F ++LG G G V+K + G +A K +
Sbjct: 11 EQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI 70
Query: 253 GQG-LKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQ 311
+ E+ ++ + +V G E+ + E+M SLD + +
Sbjct: 71 KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD-QVLKKAGRIP 129
Query: 312 LDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGN 371
+ + + +G+ YL E KI+HRD+K SN+L++ K+ DFG +
Sbjct: 130 EQILGK--VSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--I 183
Query: 372 QNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGR-------------- 417
+ AN+ + GT YM+PE G +S++SD++S G+ L+E+ GR
Sbjct: 184 DSMANSFV--GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELM 241
Query: 418 -----KNNGFYFSEHGQTLLTYTWKLWCEGHAVELI-----------DPVLKQSCAPDEL 461
+ + +T K + I P L E
Sbjct: 242 FGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEF 301
Query: 462 LKFIHIGLLCVQQDPADRPT 481
F++ C+ ++PA+R
Sbjct: 302 QDFVN---KCLIKNPAERAD 318
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 3e-36
Identities = 66/270 (24%), Positives = 125/270 (46%), Gaps = 34/270 (12%)
Query: 218 FSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVR 276
++ K+GQG G VY +A G+ +A+++++ + NE+ ++ + ++ N+V
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 277 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSR 336
L L G EL ++ EY+ SL D +D + ++ + + +LH +
Sbjct: 82 YLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHSN-- 135
Query: 337 LKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGI 396
++IHRD+K+ N+LL D + K++DFG Q++ +T + GT +MAPE
Sbjct: 136 -QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKA 192
Query: 397 FSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELID----PVL 452
+ K D++S G++ +E+I G Y +E+ A+ LI P L
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGEPP---YLNENPL-------------RALYLIATNGTPEL 236
Query: 453 KQSCA-PDELLKFIHIGLLCVQQDPADRPT 481
+ F++ C++ D R +
Sbjct: 237 QNPEKLSAIFRDFLN---RCLEMDVEKRGS 263
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 5e-36
Identities = 63/278 (22%), Positives = 104/278 (37%), Gaps = 39/278 (14%)
Query: 222 NKLGQGGFGPVYKGTLADGKAIAVKR--LSRTSGQGLKEFKNEVNLIAKLQHKNL--VRL 277
++G GG V++ + A+K L Q L ++NE+ + KLQ + +RL
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 278 LGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRL 337
+ Q + ++ E N L+ L +D R S + + +H+
Sbjct: 94 YDYEITDQYIYMVMECG-NIDLNSWLKKKKS---IDPWERKSYWKNMLEAVHTIHQ---H 146
Query: 338 KIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPE------- 390
I+H DLK +N L+ D K+ DFG A + + GT YM PE
Sbjct: 147 GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 205
Query: 391 ----YAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFY-FSEHGQTLLTYTWKLWCEGHAV 445
S KSDV+S G +L + G+ F L + H +
Sbjct: 206 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTP--FQQIINQISKLH----AIIDPNHEI 259
Query: 446 ELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMS 483
E D +L + C+++DP R ++
Sbjct: 260 EFPDIP------EKDLQDVLK---CCLKRDPKQRISIP 288
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 7e-36
Identities = 67/270 (24%), Positives = 123/270 (45%), Gaps = 34/270 (12%)
Query: 218 FSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVR 276
K+G+G G V G+ +AVK + Q + NEV ++ QH N+V
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106
Query: 277 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSR 336
+ L G+EL ++ E++ +L D V+L+ ++ ++ + + + YLH
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGALT----DIVSQVRLNEEQIATVCEAVLQALAYLHAQ-- 160
Query: 337 LKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGI 396
+IHRD+K+ ++LL D K+SDFG + + + + GT +MAPE +
Sbjct: 161 -GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGTPYWMAPEVISRSL 217
Query: 397 FSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELID----PVL 452
++ + D++S G++++E++ G YFS+ A++ + P L
Sbjct: 218 YATEVDIWSLGIMVIEMVDGEPP---YFSDSPV-------------QAMKRLRDSPPPKL 261
Query: 453 KQSCA-PDELLKFIHIGLLCVQQDPADRPT 481
K S L F+ + +DP +R T
Sbjct: 262 KNSHKVSPVLRDFLE---RMLVRDPQERAT 288
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 1e-35
Identities = 69/281 (24%), Positives = 116/281 (41%), Gaps = 42/281 (14%)
Query: 216 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSG-QGLKEFKNEVN-LIAKLQHK 272
+ +LG+G +G V K + G+ +AVKR+ T Q K +++ + +
Sbjct: 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66
Query: 273 NLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLS--IINGIARGIL- 329
V G ++ + E M + SLD + + I+ IA I+
Sbjct: 67 FTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDK-----GQTIPEDILGKIAVSIVK 120
Query: 330 ---YLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGY 386
+LH S+L +IHRD+K SNVL++ K+ DFG + + + + G Y
Sbjct: 121 ALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL-VDDVAKDIDA--GCKPY 175
Query: 387 MAPE----YAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQ--TLLTYTWKLWC 440
MAPE +S+KSD++S G+ ++E+ R F + G L
Sbjct: 176 MAPERINPELNQKGYSVKSDIWSLGITMIELAILR----FPYDSWGTPFQQLKQ------ 225
Query: 441 EGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPT 481
VE P L E + F C++++ +RPT
Sbjct: 226 ---VVEEPSPQLPADKFSAEFVDFTS---QCLKKNSKERPT 260
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 1e-35
Identities = 71/281 (25%), Positives = 122/281 (43%), Gaps = 38/281 (13%)
Query: 216 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSG-QGLKEFKNEVNLIAKL-QHK 272
D ++G+G +G V K G+ +AVKR+ T + K+ +++++ +
Sbjct: 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCP 81
Query: 273 NLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLS--IINGIARGIL- 329
+V+ G + + E M + S D + V + I+ I +
Sbjct: 82 YIVQFYGALFREGDCWICMELM-STSFD----KFYKYVYSVLDDVIPEEILGKITLATVK 136
Query: 330 ---YLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGY 386
+L E+ LKIIHRD+K SN+LLD N K+ DFG + + + AG Y
Sbjct: 137 ALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRD---AGCRPY 191
Query: 387 MAPE----YAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF-YFSEHGQT-LLTYTWKLWC 440
MAPE A + ++SDV+S G+ L E+ +GR F Y + LT
Sbjct: 192 MAPERIDPSASRQGYDVRSDVWSLGITLYELATGR----FPYPKWNSVFDQLTQV----V 243
Query: 441 EGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPT 481
+G +L + ++ + F++ LC+ +D + RP
Sbjct: 244 KGDPPQLSNSEERE--FSPSFINFVN---LCLTKDESKRPK 279
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-35
Identities = 66/274 (24%), Positives = 111/274 (40%), Gaps = 30/274 (10%)
Query: 213 EATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQH 271
E + + + ++G+G FG V++ G AVK++ + E+ A L
Sbjct: 55 EEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSS 109
Query: 272 KNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYL 331
+V L G EG + + E + SL + + L R L + G+ YL
Sbjct: 110 PRIVPLYGAVREGPWVNIFMELLEGGSLGQLI---KQMGCLPEDRALYYLGQALEGLEYL 166
Query: 332 HEDSRLKIIHRDLKASNVLLDDDMNP-KISDFGTARIFGGNQNQANT---NIIAGTYGYM 387
H +I+H D+KA NVLL D + + DFG A + + + I GT +M
Sbjct: 167 HTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHM 223
Query: 388 APEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVEL 447
APE MG K D++S ++L +++G + L K+ E
Sbjct: 224 APEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP---WTQYFRGPLC---LKIASEPP---- 273
Query: 448 IDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPT 481
+ SCAP + I ++++P R +
Sbjct: 274 PIREIPPSCAP-LTAQAI---QEGLRKEPVHRAS 303
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-35
Identities = 63/278 (22%), Positives = 104/278 (37%), Gaps = 39/278 (14%)
Query: 222 NKLGQGGFGPVYKGTLADGKAIAVKR--LSRTSGQGLKEFKNEVNLIAKLQHKNL--VRL 277
++G GG V++ + A+K L Q L ++NE+ + KLQ + +RL
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 278 LGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRL 337
+ Q + ++ E N L+ L +D R S + + +H+
Sbjct: 75 YDYEITDQYIYMVMEC-GNIDLNSWLKKKKS---IDPWERKSYWKNMLEAVHTIHQ---H 127
Query: 338 KIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPE------- 390
I+H DLK +N L+ D K+ DFG A + + GT YM PE
Sbjct: 128 GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 186
Query: 391 ----YAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFY-FSEHGQTLLTYTWKLWCEGHAV 445
S KSDV+S G +L + G+ F L + H +
Sbjct: 187 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTP--FQQIINQISKLH----AIIDPNHEI 240
Query: 446 ELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMS 483
E D +L + C+++DP R ++
Sbjct: 241 EFPDIP------EKDLQDVLK---CCLKRDPKQRISIP 269
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 3e-35
Identities = 62/278 (22%), Positives = 103/278 (37%), Gaps = 39/278 (14%)
Query: 222 NKLGQGGFGPVYKGTLADGKAIAVKR--LSRTSGQGLKEFKNEVNLIAKLQHKNL--VRL 277
++G GG V++ + A+K L Q L ++NE+ + KLQ + +RL
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 278 LGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRL 337
+ Q + ++ E N L+ L +D R S + + +H+
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWLKKKKS---IDPWERKSYWKNMLEAVHTIHQ---H 174
Query: 338 KIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPE------- 390
I+H DLK +N L+ D K+ DFG A + + G YM PE
Sbjct: 175 GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSS 233
Query: 391 ----YAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFY-FSEHGQTLLTYTWKLWCEGHAV 445
S KSDV+S G +L + G+ F L + H +
Sbjct: 234 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTP--FQQIINQISKLH----AIIDPNHEI 287
Query: 446 ELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMS 483
E D +L + C+++DP R ++
Sbjct: 288 EFPDIP------EKDLQDVL---KCCLKRDPKQRISIP 316
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 8e-35
Identities = 60/283 (21%), Positives = 109/283 (38%), Gaps = 42/283 (14%)
Query: 218 FSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKL-QHKNLVR 276
F ++ LG G G + + D + +AVKR+ + EV L+ + +H N++R
Sbjct: 26 FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILP---ECFSFADREVQLLRESDEHPNVIR 82
Query: 277 LLGCCLEGQELLLIYEYMPNKSLDVHLFD--ATRSVQLDWKRRLSIINGIARGILYLHED 334
+ Q + E L + + ++++ G+ +LH
Sbjct: 83 YFCTEKDRQFQYIAIELCAAT-----LQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHS- 136
Query: 335 SRLKIIHRDLKASNVLL-----DDDMNPKISDFGTARIFGGNQN-QANTNIIAGTYGYMA 388
L I+HRDLK N+L+ + ISDFG + ++ + + + GT G++A
Sbjct: 137 --LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIA 194
Query: 389 PEYAMGGIF---SIKSDVFSFGVLLLEIISGRKNNG---FYFSEHGQTLLTYTWKLWCEG 442
PE + D+FS G + +IS G F S Q +
Sbjct: 195 PEMLSEDCKENPTYTVDIFSAGCVFYYVISE----GSHPFGKSLQRQANILL------GA 244
Query: 443 HAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSV 485
+++ + P + EL++ + DP RP+ V
Sbjct: 245 CSLDCLHPEKHEDVIARELIE------KMIAMDPQKRPSAKHV 281
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 1e-34
Identities = 72/271 (26%), Positives = 127/271 (46%), Gaps = 35/271 (12%)
Query: 217 HFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQG-LKEFKNEVNLIAKLQHKNL 274
F+ K+G+G FG V+KG K +A+K + + +++ + E+ ++++ +
Sbjct: 23 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 82
Query: 275 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHED 334
+ G L+ +L +I EY+ S D LD + +I+ I +G+ YLH +
Sbjct: 83 TKYYGSYLKDTKLWIIMEYLGGGSAL----DLLEPGPLDETQIATILREILKGLDYLHSE 138
Query: 335 SRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMG 394
K IHRD+KA+NVLL + K++DFG A Q + NT + GT +MAPE
Sbjct: 139 ---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV--GTPFWMAPEVIKQ 193
Query: 395 GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELID----P 450
+ K+D++S G+ +E+ G + H + LI P
Sbjct: 194 SAYDSKADIWSLGITAIELARGEPP---HSELHPM-------------KVLFLIPKNNPP 237
Query: 451 VLKQSCAPDELLKFIHIGLLCVQQDPADRPT 481
L+ + + L +F+ C+ ++P+ RPT
Sbjct: 238 TLEGNYSK-PLKEFVE---ACLNKEPSFRPT 264
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 2e-34
Identities = 68/271 (25%), Positives = 121/271 (44%), Gaps = 36/271 (13%)
Query: 218 FSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVR 276
F KLG+G +G VYK G+ +A+K++ L+E E++++ + ++V+
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVK 88
Query: 277 LLGCCLEGQELLLIYEYMPNKSL-DVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDS 335
G + +L ++ EY S+ D+ R+ L +I+ +G+ YLH
Sbjct: 89 YYGSYFKNTDLWIVMEYCGAGSVSDIIR---LRNKTLTEDEIATILQSTLKGLEYLHFM- 144
Query: 336 RLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGG 395
+ IHRD+KA N+LL+ + + K++DFG A + NT I GT +MAPE
Sbjct: 145 --RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI--GTPFWMAPEVIQEI 200
Query: 396 IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELID----PV 451
++ +D++S G+ +E+ G+ Y H A+ +I P
Sbjct: 201 GYNCVADIWSLGITAIEMAEGKPP---YADIHPM-------------RAIFMIPTNPPPT 244
Query: 452 LKQSCA-PDELLKFIHIGLLCVQQDPADRPT 481
++ D F+ C+ + P R T
Sbjct: 245 FRKPELWSDNFTDFVK---QCLVKSPEQRAT 272
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 4e-34
Identities = 57/214 (26%), Positives = 101/214 (47%), Gaps = 25/214 (11%)
Query: 215 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKN 273
+ +LG G FG VYK G A K + S + L+++ E+ ++A H
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 274 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLS------IINGIARG 327
+V+LLG +L ++ E+ P ++D ++ L+ R L+ + +
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCPGGAVD--------AIMLELDRGLTEPQIQVVCRQMLEA 129
Query: 328 ILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYM 387
+ +LH +IIHRDLKA NVL+ + + +++DFG + + ++ I GT +M
Sbjct: 130 LNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI--GTPYWM 184
Query: 388 APEYAMGGIFS-----IKSDVFSFGVLLLEIISG 416
APE M K+D++S G+ L+E+
Sbjct: 185 APEVVMCETMKDTPYDYKADIWSLGITLIEMAQI 218
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 9e-34
Identities = 52/211 (24%), Positives = 89/211 (42%), Gaps = 22/211 (10%)
Query: 223 KLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLKE-FKNEVNLIAKLQHKNLVRLLGC 280
LGQG V++G G A+K + S + E ++ KL HKN+V+L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 281 --CLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLK 338
+ +LI E+ P SL L + + + L L ++ + G+ +L E
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NG 132
Query: 339 IIHRDLKASNVLL----DDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPE---- 390
I+HR++K N++ D K++DFG AR ++ Q + + GT Y+ P+
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE-QFVS--LYGTEEYLHPDMYER 189
Query: 391 ----YAMGGIFSIKSDVFSFGVLLLEIISGR 417
+ D++S GV +G
Sbjct: 190 AVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 3e-33
Identities = 56/292 (19%), Positives = 96/292 (32%), Gaps = 53/292 (18%)
Query: 215 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKR--LSRTSGQGLKEFKNEVNLIAKL-Q 270
T F + K+G G FG V+K DG A+KR + EV A L Q
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 271 HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQ-LDWKRRLSIINGIARGIL 329
H ++VR E +L+ EY SL + + R + ++ + RG+
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 330 YLHEDSRLKIIHRDLKASNVLLDDDMNP-------------------KISDFGTARIFGG 370
Y+H ++H D+K SN+ + P KI D G
Sbjct: 130 YIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS- 185
Query: 371 NQNQANTNIIAGTYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQ 429
+ + G ++A E K+D+F+ + ++ +
Sbjct: 186 -----SPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEP---LPRNGDQ- 236
Query: 430 TLLTYTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPT 481
W +G + E + + + + DP RP+
Sbjct: 237 ------WHEIRQGRLPRI------PQVLSQEFTELLK---VMIHPDPERRPS 273
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 4e-33
Identities = 52/211 (24%), Positives = 89/211 (42%), Gaps = 22/211 (10%)
Query: 223 KLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLKE-FKNEVNLIAKLQHKNLVRLLGC 280
LGQG V++G G A+K + S + E ++ KL HKN+V+L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 281 --CLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLK 338
+ +LI E+ P SL L + + + L L ++ + G+ +L E
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NG 132
Query: 339 IIHRDLKASNVLL----DDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPE---- 390
I+HR++K N++ D K++DFG AR ++ Q + + GT Y+ P+
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE-QFVS--LYGTEEYLHPDMYER 189
Query: 391 ----YAMGGIFSIKSDVFSFGVLLLEIISGR 417
+ D++S GV +G
Sbjct: 190 AVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 5e-33
Identities = 73/278 (26%), Positives = 121/278 (43%), Gaps = 42/278 (15%)
Query: 215 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLS---RTSGQGLKEFKNEVNLIAKLQ 270
FSD ++G G FG VY + + + +A+K++S + S + ++ EV + KL+
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 271 HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILY 330
H N ++ GC L L+ EY + D+ L ++ +G +G+ Y
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLE---VHKKPLQEVEIAAVTHGALQGLAY 169
Query: 331 LHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPE 390
LH +IHRD+KA N+LL + K+ DFG AN+ + GT +MAPE
Sbjct: 170 LHSH---NMIHRDVKAGNILLSEPGLVKLGDFG----SASIMAPANSFV--GTPYWMAPE 220
Query: 391 YAMG---GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVEL 447
+ G + K DV+S G+ +E+ + F+ + A+
Sbjct: 221 VILAMDEGQYDGKVDVWSLGITCIELAERKPP---LFNMNAM-------------SALYH 264
Query: 448 ID----PVLKQSCAPDELLKFIHIGLLCVQQDPADRPT 481
I P L+ + F+ C+Q+ P DRPT
Sbjct: 265 IAQNESPALQSGHWSEYFRNFVD---SCLQKIPQDRPT 299
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 1e-32
Identities = 64/281 (22%), Positives = 105/281 (37%), Gaps = 30/281 (10%)
Query: 223 KLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLKE-FKNEVNLIAKLQHKNLVRLL-- 278
+LG GGFG V + G+ +A+K+ + +E + E+ ++ KL H N+V
Sbjct: 21 RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 80
Query: 279 ----GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHED 334
LL EY L +L L ++++ I+ + YLHE
Sbjct: 81 PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE- 139
Query: 335 SRLKIIHRDLKASNVLLD---DDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEY 391
+IIHRDLK N++L + KI D G A+ + GT Y+APE
Sbjct: 140 --NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE-LCTE--FVGTLQYLAPEL 194
Query: 392 AMGGIFSIKSDVFSFGVLLLEIISGR-------KNNGFYFSEHGQTLLTYTWKLWCEGHA 444
+++ D +SFG L E I+G + ++ ++ G
Sbjct: 195 LEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAV 254
Query: 445 V---ELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTM 482
L P +L +++ L R T
Sbjct: 255 KFSSVLPTPNHLSGILAGKLERWLQCML---MWHQRQRGTD 292
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-32
Identities = 63/277 (22%), Positives = 113/277 (40%), Gaps = 35/277 (12%)
Query: 216 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSG-QGLKEFKNEVNLIAKL-QHK 272
N + ++G G G V+K G IAVK++ R+ + K +++++ K
Sbjct: 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCP 84
Query: 273 NLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLH 332
+V+ G + ++ + E M + + + + I + + YL
Sbjct: 85 YIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQGPIPERILGK--MTVAIVKALYYLK 141
Query: 333 EDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPE-- 390
E +IHRD+K SN+LLD+ K+ DFG + G + + AG YMAPE
Sbjct: 142 EK--HGVIHRDVKPSNILLDERGQIKLCDFGIS---GRLVDDKAKDRSAGCAAYMAPERI 196
Query: 391 ---YAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF-YFSEHGQ-TLLTYTWKLWCEGHAV 445
+ I++DV+S G+ L+E+ +G+ F Y + +LT +
Sbjct: 197 DPPDPTKPDYDIRADVWSLGISLVELATGQ----FPYKNCKTDFEVLTKV----LQEEP- 247
Query: 446 ELIDPVLKQSCA-PDELLKFIHIGLLCVQQDPADRPT 481
P+L + F+ C+ +D RP
Sbjct: 248 ----PLLPGHMGFSGDFQSFVK---DCLTKDHRKRPK 277
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 3e-32
Identities = 57/227 (25%), Positives = 86/227 (37%), Gaps = 32/227 (14%)
Query: 216 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKL-QHKNL 274
N E LG G G V G+ +AVKR+ E+ L+ + H N+
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLI---DFCDIALMEIKLLTESDDHPNV 71
Query: 275 VRLLGCCLEGQELLLIYEYMPNKSLDV---HLFDATRSVQLDWKRRLSIINGIARGILYL 331
+R + L + E D+ +S++ IA G+ +L
Sbjct: 72 IRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHL 131
Query: 332 HEDSRLKIIHRDLKASNVLLD-------------DDMNPKISDFGTARIFGGNQN--QAN 376
H LKIIHRDLK N+L+ +++ ISDFG + Q+ + N
Sbjct: 132 HS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTN 188
Query: 377 TNIIAGTYGYMAPEYAMGGIFSI-------KSDVFSFGVLLLEIISG 416
N +GT G+ APE D+FS G + I+S
Sbjct: 189 LNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 5e-32
Identities = 50/204 (24%), Positives = 93/204 (45%), Gaps = 24/204 (11%)
Query: 224 LGQGGFGPVYKGT-LADGKAIAVKRLSRTS--GQGLKE-FKNEVNLIAKLQHKNLVRLLG 279
LG+GGF ++ + + A K + ++ +E E+++ L H+++V G
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 280 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLS------IINGIARGILYLHE 333
+ + ++ E +SL + + ++ L+ + I G YLH
Sbjct: 83 FFEDNDFVFVVLELCRRRSL----LELHKR-----RKALTEPEARYYLRQIVLGCQYLH- 132
Query: 334 DSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAM 393
R ++IHRDLK N+ L++D+ KI DFG A + + + GT Y+APE
Sbjct: 133 --RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLS 188
Query: 394 GGIFSIKSDVFSFGVLLLEIISGR 417
S + DV+S G ++ ++ G+
Sbjct: 189 KKGHSFEVDVWSIGCIMYTLLVGK 212
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 6e-32
Identities = 50/204 (24%), Positives = 93/204 (45%), Gaps = 24/204 (11%)
Query: 224 LGQGGFGPVYKGT-LADGKAIAVKRLSRTS--GQGLKE-FKNEVNLIAKLQHKNLVRLLG 279
LG+GGF ++ + + A K + ++ +E E+++ L H+++V G
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 280 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLS------IINGIARGILYLHE 333
+ + ++ E +SL + + ++ L+ + I G YLH
Sbjct: 109 FFEDNDFVFVVLELCRRRSL----LELHKR-----RKALTEPEARYYLRQIVLGCQYLH- 158
Query: 334 DSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAM 393
R ++IHRDLK N+ L++D+ KI DFG A + + + GT Y+APE
Sbjct: 159 --RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLS 214
Query: 394 GGIFSIKSDVFSFGVLLLEIISGR 417
S + DV+S G ++ ++ G+
Sbjct: 215 KKGHSFEVDVWSIGCIMYTLLVGK 238
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 9e-32
Identities = 63/314 (20%), Positives = 106/314 (33%), Gaps = 52/314 (16%)
Query: 221 ENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQ-HKNLVRLL 278
L +GGF VY+ + G+ A+KRL + + EV + KL H N+V+
Sbjct: 33 RRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFC 92
Query: 279 GCCL-------EGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYL 331
GQ L+ + L L L L I R + ++
Sbjct: 93 SAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHM 152
Query: 332 HEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIA---------- 381
H + IIHRDLK N+LL + K+ DFG+A + + +
Sbjct: 153 H-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRN 211
Query: 382 GTYGYMAPE---YAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLL---TYT 435
T Y PE K D+++ G +L + + F + + + Y+
Sbjct: 212 TTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP----FEDGAKLRIVNGKYS 267
Query: 436 WKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVV----VMLAS 491
P Q I +Q +P +R +++ VV + A+
Sbjct: 268 IP------------PHDTQY---TVFHSLIRA---MLQVNPEERLSIAEVVHQLQEIAAA 309
Query: 492 DSMTIPQPTEPAFS 505
++ P
Sbjct: 310 RNVNPKSPITELLE 323
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-31
Identities = 69/292 (23%), Positives = 114/292 (39%), Gaps = 51/292 (17%)
Query: 216 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQ-GLKEFKNEVNLIAKLQHKN 273
+ + + +G G V + +A+KR++ Q + E E+ +++ H N
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 274 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLS--IINGIARGIL-- 329
+V + EL L+ + + S+ + + L I I R +L
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVL-DIIKHIVAKGEHKSGVLDESTIATILREVLEG 133
Query: 330 --YLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFG-----TARIFGGNQNQANTNIIAG 382
YLH++ IHRD+KA N+LL +D + +I+DFG T G
Sbjct: 134 LEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKT--FVG 188
Query: 383 TYGYMAPEYAM-GGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCE 441
T +MAPE + K+D++SFG+ +E+ +G Y +L
Sbjct: 189 TPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP---YHKYPPMKVLM-------- 237
Query: 442 GHAVELI----DPVLKQSCAPDELLK--------FIHIGLLCVQQDPADRPT 481
L P L+ E+LK I LC+Q+DP RPT
Sbjct: 238 -----LTLQNDPPSLETGVQDKEMLKKYGKSFRKMIS---LCLQKDPEKRPT 281
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 124 bits (311), Expect = 2e-31
Identities = 32/326 (9%), Positives = 64/326 (19%), Gaps = 51/326 (15%)
Query: 196 QQAESQEFPLFPLGLALEATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRL---SRT 251
Q L + L G V+ + + A+K +
Sbjct: 42 ATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAEN 101
Query: 252 SGQGLKEFKNEVNLIAKLQHKNLVRLLGCC--------------------------LEGQ 285
S L+ A+L ++
Sbjct: 102 SRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVA 161
Query: 286 ELLLIYEYMPNKSLDV-HLFD--ATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHR 342
LL+ + D + + R L ++H
Sbjct: 162 NYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ---SKGLVHG 218
Query: 343 DLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGG--IFSIK 400
N+ + D + D G + Y E+ F+
Sbjct: 219 HFTPDNLFIMPDGRLMLGDVSALWKVG-----TRGPASSVPVTYAPREFLNASTATFTHA 273
Query: 401 SDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQSCAPDE 460
+ + G+ + + + ++ L PD
Sbjct: 274 LNAWQLGLSIYRVWCLFL---PFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTP--LPDF 328
Query: 461 LLKFIHIGLLCVQQDPADRPTMSSVV 486
+ I L D R +
Sbjct: 329 VKTLIG-RFLNF--DRRRRLLPLEAM 351
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 5e-31
Identities = 58/198 (29%), Positives = 101/198 (51%), Gaps = 11/198 (5%)
Query: 224 LGQGGFGPVYKGT-LADGKAIAVKRLSRTS--GQGLKE-FKNEVNLIAKLQHKNLVRLLG 279
LG+G F VY+ + G +A+K + + + G+ + +NEV + +L+H +++ L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 280 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKI 339
+ + L+ E N ++ +L + + + R ++ I G+LYLH I
Sbjct: 79 YFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARH--FMHQIITGMLYLH---SHGI 133
Query: 340 IHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSI 399
+HRDL SN+LL +MN KI+DFG A + T + GT Y++PE A +
Sbjct: 134 LHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LCGTPNYISPEIATRSAHGL 191
Query: 400 KSDVFSFGVLLLEIISGR 417
+SDV+S G + ++ GR
Sbjct: 192 ESDVWSLGCMFYTLLIGR 209
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 5e-31
Identities = 75/286 (26%), Positives = 119/286 (41%), Gaps = 43/286 (15%)
Query: 215 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKL-QHK 272
F +G G +G VYKG + G+ A+K + +G +E K E+N++ K H+
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD-VTGDEEEEIKQEINMLKKYSHHR 81
Query: 273 NLVRLLGCCLEG------QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIAR 326
N+ G ++ +L L+ E+ S+ L T+ L + I I R
Sbjct: 82 NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSV-TDLIKNTKGNTLKEEWIAYICREILR 140
Query: 327 GILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGY 386
G+ +LH+ K+IHRD+K NVLL ++ K+ DFG + + NT I GT +
Sbjct: 141 GLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI--GTPYW 195
Query: 387 MAPEYAMGGIFS-----IKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCE 441
MAPE KSD++S G+ +E+ G H +
Sbjct: 196 MAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP---LCDMH---------PMR-- 241
Query: 442 GHAVELID----PVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMS 483
A+ LI P LK + FI C+ ++ + RP
Sbjct: 242 --ALFLIPRNPAPRLKSKKWSKKFQSFIE---SCLVKNHSQRPATE 282
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 9e-31
Identities = 59/199 (29%), Positives = 97/199 (48%), Gaps = 11/199 (5%)
Query: 223 KLGQGGFGPVYKGT-LADGKAIAVKRLS---RTSGQGLKEFKNEVNLIAKLQHKNLVRLL 278
KLG GG VY +A+K + R + LK F+ EV+ ++L H+N+V ++
Sbjct: 18 KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77
Query: 279 GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLK 338
E L+ EY+ +L ++ L ++ N I GI + H ++
Sbjct: 78 DVDEEDDCYYLVMEYIEGPTLSEYIESHGP---LSVDTAINFTNQILDGIKHAH---DMR 131
Query: 339 IIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFS 398
I+HRD+K N+L+D + KI DFG A+ + TN + GT Y +PE A G
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKAL-SETSLTQTNHVLGTVQYFSPEQAKGEATD 190
Query: 399 IKSDVFSFGVLLLEIISGR 417
+D++S G++L E++ G
Sbjct: 191 ECTDIYSIGIVLYEMLVGE 209
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-30
Identities = 48/308 (15%), Positives = 102/308 (33%), Gaps = 45/308 (14%)
Query: 215 TNHFSDENKLGQG--GFGPVYKGT-LADGKAIAVKR--LSRTSGQGLKEFKNEVNLIAKL 269
+ +G+G V G+ + V+R L S + + + E+++
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83
Query: 270 QHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGIL 329
H N+V + EL ++ +M S L ++ I+ G+ + +
Sbjct: 84 NHPNIVPYRATFIADNELWVVTSFMAYGSA-KDLICTHFMDGMNELAIAYILQGVLKALD 142
Query: 330 YLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANT-----NIIAGTY 384
Y+H +HR +KAS++L+ D +S + + +
Sbjct: 143 YIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVL 199
Query: 385 GYMAPEYAMGGI--FSIKSDVFSFGVLLLEIISGR-----------------------KN 419
+++PE + + KSD++S G+ E+ +G +
Sbjct: 200 PWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLD 259
Query: 420 NGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQSCAPDELLK------FIHIGLLCVQ 473
+E + + ++ P +P F H C+Q
Sbjct: 260 TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQ 319
Query: 474 QDPADRPT 481
++P RP+
Sbjct: 320 RNPDARPS 327
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-30
Identities = 57/215 (26%), Positives = 93/215 (43%), Gaps = 28/215 (13%)
Query: 215 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRT--SGQGLKEFKNEVNLIAKLQH 271
+ + KLG G +G V A+K + +T S + EV ++ L H
Sbjct: 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95
Query: 272 KNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLS------IINGIA 325
N+++L + + L+ E LFD + + + + II +
Sbjct: 96 PNIMKLYDFFEDKRNYYLVMECYKGGE----LFD--EIIH---RMKFNEVDAAVIIKQVL 146
Query: 326 RGILYLHEDSRLKIIHRDLKASNVLL---DDDMNPKISDFGTARIFGGNQNQANTNIIAG 382
G+ YLH+ I+HRDLK N+LL + D KI DFG + +F + G
Sbjct: 147 SGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM---KERLG 200
Query: 383 TYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGR 417
T Y+APE + + K DV+S GV+L +++G
Sbjct: 201 TAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGY 234
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 4e-30
Identities = 64/216 (29%), Positives = 99/216 (45%), Gaps = 29/216 (13%)
Query: 215 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSR---TSGQGLKEFKNEVNLIAKLQ 270
++ + + LG+G FG V G+ AVK +S+ + EV L+ +L
Sbjct: 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 271 HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLS------IINGI 324
H N+++L + L+ E LFD + ++R S II +
Sbjct: 85 HPNIMKLYEFFEDKGYFYLVGEVYTGGE----LFD--EIIS---RKRFSEVDAARIIRQV 135
Query: 325 ARGILYLHEDSRLKIIHRDLKASNVLL---DDDMNPKISDFGTARIFGGNQNQANTNIIA 381
GI Y+H+ KI+HRDLK N+LL D N +I DFG + F ++
Sbjct: 136 LSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM---KDKI 189
Query: 382 GTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGR 417
GT Y+APE + G + K DV+S GV+L ++SG
Sbjct: 190 GTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGC 224
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 9e-30
Identities = 63/215 (29%), Positives = 97/215 (45%), Gaps = 28/215 (13%)
Query: 215 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRT--SGQGLKEFKNEVNLIAKLQH 271
++ LG+G FG V K + AVK +++ + EV L+ KL H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 272 KNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLS------IINGIA 325
N+++L + ++ E LFD ++ ++R S II +
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGE----LFD--EIIK---RKRFSEHDAARIIKQVF 131
Query: 326 RGILYLHEDSRLKIIHRDLKASNVLL---DDDMNPKISDFGTARIFGGNQNQANTNIIAG 382
GI Y+H+ I+HRDLK N+LL + D + KI DFG + F N G
Sbjct: 132 SGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM---KDRIG 185
Query: 383 TYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGR 417
T Y+APE + G + K DV+S GV+L ++SG
Sbjct: 186 TAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGT 219
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-29
Identities = 39/203 (19%), Positives = 81/203 (39%), Gaps = 24/203 (11%)
Query: 223 KLGQGGFGPVYKG--TLADGKAIAVKRLSRTSGQGLKE-FKNEVNLIAKLQHKNLVRLL- 278
+ GG G +Y +G+ + +K L + + E +A++ H ++V++
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 279 -GCCLEGQELLLIY---EYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHED 334
+ + Y EY+ +SL +L ++ + I + YLH
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLH-- 199
Query: 335 SRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMG 394
+ +++ DLK N++L ++ K+ D G + GT G+ APE
Sbjct: 200 -SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS------FGYLYGTPGFQAPEIVRT 251
Query: 395 GIFSIKSDVFSFGVLLLEIISGR 417
G ++ +D+++ G L +
Sbjct: 252 GP-TVATDIYTVGRTLAALTLDL 273
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 118 bits (296), Expect = 2e-29
Identities = 32/222 (14%), Positives = 68/222 (30%), Gaps = 22/222 (9%)
Query: 215 TNHFSDENKLGQGGFGPVYKGT------LADGKAIAVKRLSRTSGQGLKEFKNEVNLIAK 268
+ + LG+G F VY+ T + + +K + + +
Sbjct: 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKP 123
Query: 269 LQHKNLVRLLGCCLEGQELLLIYEYMPNKSLD--VHLFDATRSVQLDWKRRLSIINGIAR 326
++ L +L+ E +L ++L+ T + +S +
Sbjct: 124 SMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLY 183
Query: 327 GILYLHEDSRLKIIHRDLKASNVLLDDDMNP-----------KISDFGTARIFGGNQNQA 375
I +H+ +IIH D+K N +L + + D G +
Sbjct: 184 MIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGT 240
Query: 376 NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGR 417
T G+ E ++ + D F + ++ G
Sbjct: 241 IFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 3e-29
Identities = 50/204 (24%), Positives = 82/204 (40%), Gaps = 27/204 (13%)
Query: 223 KLGQGGFGPVYKGT-LADGKAIAVK-----RLSRTSGQGLKEFKNEVNLIAKLQHKNLVR 276
+G+G F V + G+ AVK + + + G ++ K E ++ L+H ++V
Sbjct: 31 VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 277 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRL-------SIINGIARGIL 329
LL L +++E+M L V+ + + I +
Sbjct: 91 LLETYSSDGMLYMVFEFMDGAD----LCF--EIVKRADAGFVYSEAVASHYMRQILEALR 144
Query: 330 YLHEDSRLKIIHRDLKASNVLL---DDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGY 386
Y H+ IIHRD+K VLL ++ K+ FG A G + A GT +
Sbjct: 145 YCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG--RVGTPHF 199
Query: 387 MAPEYAMGGIFSIKSDVFSFGVLL 410
MAPE + DV+ GV+L
Sbjct: 200 MAPEVVKREPYGKPVDVWGCGVIL 223
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 5e-29
Identities = 53/221 (23%), Positives = 90/221 (40%), Gaps = 35/221 (15%)
Query: 223 KLGQGGFGPVYKGTLA--DGKAIAVKRLSRTSGQGLKEF-----------------KNEV 263
L QG F + L D K A+K+ ++ + ++F KNE+
Sbjct: 38 TLNQGKFNKII---LCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNEL 94
Query: 264 NLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHL-----FDATRSVQLDWKRRL 318
+I ++++ + G E+ +IYEYM N S+ D + + +
Sbjct: 95 QIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIK 154
Query: 319 SIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTN 378
II + Y+H + I HRD+K SN+L+D + K+SDFG + +
Sbjct: 155 CIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKK----IK 208
Query: 379 IIAGTYGYMAPEYAMG--GIFSIKSDVFSFGVLLLEIISGR 417
GTY +M PE+ K D++S G+ L +
Sbjct: 209 GSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNV 249
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 5e-29
Identities = 51/208 (24%), Positives = 90/208 (43%), Gaps = 25/208 (12%)
Query: 215 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLKE-FKNEVNLIAKLQHK 272
+ F + KLG G FG V+ + G +K +++ Q E + E+ ++ L H
Sbjct: 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80
Query: 273 NLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKR-RLS------IINGIA 325
N++++ + + ++ E L + R V + LS ++ +
Sbjct: 81 NIIKIFEVFEDYHNMYIVMETCEGGEL----LE--RIVSAQARGKALSEGYVAELMKQMM 134
Query: 326 RGILYLHEDSRLKIIHRDLKASNVLL---DDDMNPKISDFGTARIFGGNQNQANTNIIAG 382
+ Y H ++H+DLK N+L KI DFG A +F +++ N AG
Sbjct: 135 NALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTN---AAG 188
Query: 383 TYGYMAPEYAMGGIFSIKSDVFSFGVLL 410
T YMAPE + K D++S GV++
Sbjct: 189 TALYMAPE-VFKRDVTFKCDIWSAGVVM 215
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 9e-29
Identities = 61/208 (29%), Positives = 93/208 (44%), Gaps = 28/208 (13%)
Query: 215 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRT--SGQGLKEFKNEVNLIAKLQH 271
++ LG+G FG V K + AVK +++ + EV L+ KL H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 272 KNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLS------IINGIA 325
N+++L + ++ E LFD ++ ++R S II +
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGE----LFD--EIIK---RKRFSEHDAARIIKQVF 131
Query: 326 RGILYLHEDSRLKIIHRDLKASNVLL---DDDMNPKISDFGTARIFGGNQNQANTNIIAG 382
GI Y+H+ I+HRDLK N+LL + D + KI DFG + F N G
Sbjct: 132 SGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT---KMKDRIG 185
Query: 383 TYGYMAPEYAMGGIFSIKSDVFSFGVLL 410
T Y+APE + G + K DV+S GV+L
Sbjct: 186 TAYYIAPE-VLRGTYDEKCDVWSAGVIL 212
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-28
Identities = 45/247 (18%), Positives = 82/247 (33%), Gaps = 31/247 (12%)
Query: 249 SRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATR 308
+S + ++ + KN V L L + + ++L +
Sbjct: 98 PLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS 157
Query: 309 SVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIF 368
+ L I IA + +LH ++HRDLK SN+ D K+ DFG
Sbjct: 158 LEDREHGVCLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAM 214
Query: 369 GGNQNQANTNIIA----------GTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRK 418
++ + GT YM+PE G +S K D+FS G++L E++
Sbjct: 215 DQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFS 274
Query: 419 NNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPAD 478
E + + + + Q + + + P +
Sbjct: 275 T----QMERVRIIT----DV-RNLK----FPLLFTQKY--PQEHMMVQ---DMLSPSPTE 316
Query: 479 RPTMSSV 485
RP + +
Sbjct: 317 RPEATDI 323
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-28
Identities = 51/206 (24%), Positives = 89/206 (43%), Gaps = 26/206 (12%)
Query: 215 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKN 273
+++ EN +G+G +G V A K++ + + + FK E+ ++ L H N
Sbjct: 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPN 67
Query: 274 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLS------IINGIARG 327
++RL + ++ L+ E LF+ R V KR I+ +
Sbjct: 68 IIRLYETFEDNTDIYLVMELCTGGE----LFE--RVVH---KRVFRESDAARIMKDVLSA 118
Query: 328 ILYLHEDSRLKIIHRDLKASNVLL---DDDMNPKISDFGTARIFGGNQNQANTNIIAGTY 384
+ Y H+ L + HRDLK N L D K+ DFG A F + GT
Sbjct: 119 VAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRT---KVGTP 172
Query: 385 GYMAPEYAMGGIFSIKSDVFSFGVLL 410
Y++P+ + G++ + D +S GV++
Sbjct: 173 YYVSPQ-VLEGLYGPECDEWSAGVMM 197
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-28
Identities = 59/252 (23%), Positives = 102/252 (40%), Gaps = 43/252 (17%)
Query: 193 GGEQQAESQEFPLFPLGLALEATNHFSD----ENKLGQGGFGPVYKGT-LADGKAIAVKR 247
G + Q + P + + KLG G +G V A+K
Sbjct: 9 SGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKV 68
Query: 248 LSR-------------TSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 294
+ + + +E NE++L+ L H N+++L + + L+ E+
Sbjct: 69 IKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFY 128
Query: 295 PNKSLDVHLFDATRSVQLDWKRRLS------IINGIARGILYLHEDSRLKIIHRDLKASN 348
LF+ Q+ + + I+ I GI YLH+ I+HRD+K N
Sbjct: 129 EGGE----LFE-----QIINRHKFDECDAANIMKQILSGICYLHK---HNIVHRDIKPEN 176
Query: 349 VLL---DDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFS 405
+LL + +N KI DFG + F + + GT Y+APE + ++ K DV+S
Sbjct: 177 ILLENKNSLLNIKIVDFGLSSFFSKDYKLRD---RLGTAYYIAPE-VLKKKYNEKCDVWS 232
Query: 406 FGVLLLEIISGR 417
GV++ ++ G
Sbjct: 233 CGVIMYILLCGY 244
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 59/206 (28%), Positives = 91/206 (44%), Gaps = 19/206 (9%)
Query: 223 KLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQG----LKEFKNEVNLIAKLQHKNLVRL 277
LG GG V+ L D + +AVK L R F+ E A L H +V +
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVL-RADLARDPSFYLRFRREAQNAAALNHPAIVAV 77
Query: 278 L--GCCLEGQELLLIY---EYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLH 332
G E L Y EY+ +L + + KR + +I + + + H
Sbjct: 78 YDTGE-AETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSH 133
Query: 333 EDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQ-ANTNIIAGTYGYMAPEY 391
+ IIHRD+K +N+++ K+ DFG AR + N T + GT Y++PE
Sbjct: 134 ---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 190
Query: 392 AMGGIFSIKSDVFSFGVLLLEIISGR 417
A G +SDV+S G +L E+++G
Sbjct: 191 ARGDSVDARSDVYSLGCVLYEVLTGE 216
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 5e-28
Identities = 58/200 (29%), Positives = 95/200 (47%), Gaps = 14/200 (7%)
Query: 222 NKLGQGGFGPVYKGT-LADGKAIAVKRLSRT--SGQGLKE-FKNEVNLIAKLQHKNLVRL 277
LG+G FG VY +A+K L + G++ + EV + + L+H N++RL
Sbjct: 15 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 278 LGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRL 337
G + + LI EY P ++ L ++ D +R + I +A + Y H
Sbjct: 75 YGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYCH---SK 128
Query: 338 KIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIF 397
++IHRD+K N+LL KI+DFG + ++ + GT Y+ PE G +
Sbjct: 129 RVIHRDIKPENLLLGSAGELKIADFGWSVH--APSSRRTD--LCGTLDYLPPEMIEGRMH 184
Query: 398 SIKSDVFSFGVLLLEIISGR 417
K D++S GVL E + G+
Sbjct: 185 DEKVDLWSLGVLCYEFLVGK 204
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 5e-28
Identities = 46/201 (22%), Positives = 87/201 (43%), Gaps = 15/201 (7%)
Query: 215 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKN 273
+++ +LG G FG V++ A G+ K ++ KNE++++ +L H
Sbjct: 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPK 109
Query: 274 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFD--ATRSVQLDWKRRLSIINGIARGILYL 331
L+ L + E++LI E++ LFD A ++ ++ + G+ ++
Sbjct: 110 LINLHDAFEDKYEMVLILEFLSG----GELFDRIAAEDYKMSEAEVINYMRQACEGLKHM 165
Query: 332 HEDSRLKIIHRDLKASNVLLDDDMNP--KISDFGTARIFGGNQNQANTNIIAGTYGYMAP 389
HE I+H D+K N++ + KI DFG A ++ + T + AP
Sbjct: 166 HE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE---IVKVTTATAEFAAP 219
Query: 390 EYAMGGIFSIKSDVFSFGVLL 410
E +D+++ GVL
Sbjct: 220 EIVDREPVGFYTDMWAIGVLG 240
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 115 bits (288), Expect = 5e-28
Identities = 42/309 (13%), Positives = 91/309 (29%), Gaps = 78/309 (25%)
Query: 224 LGQGGFGPVYKGT-LADGKAIAVKRLS---RTSGQGLKEFKNEVNLIAKLQ--------- 270
LGQ + T G++ V R +K+ K EV + L+
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 271 -------------HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQ------ 311
+++ L+ +++ ++ + + +L +
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 312 --LDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFG 369
L RL + + R + LH ++H L+ +++LD ++ F G
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 262
Query: 370 GNQNQANTNIIAGTYGYMAPEY----------AMGGIFSIKSDVFSFGVLLLEIISGRKN 419
+ + G+ PE + + D ++ G+ + I
Sbjct: 263 ------ASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD-- 314
Query: 420 NGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQSCA--PDELLKFIHIGLLCVQQDPA 477
L T + A+ + + +SC P + + G L +
Sbjct: 315 ------------LPNT-----DDAALGGSEWIF-RSCKNIPQPVRALLE-GFL--RYPKE 353
Query: 478 DRPTMSSVV 486
DR +
Sbjct: 354 DRLLPLQAM 362
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 6e-28
Identities = 57/212 (26%), Positives = 90/212 (42%), Gaps = 31/212 (14%)
Query: 215 TNHFSDE----NKLGQGGFGPVYKGT-LADGKAIAVKRLSRT--SGQGLKEFKNEVNLIA 267
+ FSD +LG+G F V + G A K ++ S + ++ + E +
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60
Query: 268 KLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLS------II 321
KLQH N+VRL E L+++ + LF+ V + S I
Sbjct: 61 KLQHPNIVRLHDSIQEESFHYLVFDLVTGGE----LFE--DIVA---REFYSEADASHCI 111
Query: 322 NGIARGILYLHEDSRLKIIHRDLKASNVLL---DDDMNPKISDFGTARIFGGNQNQANTN 378
I I Y H I+HR+LK N+LL K++DFG A ++ +
Sbjct: 112 QQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE---AWH 165
Query: 379 IIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLL 410
AGT GY++PE +S D+++ GV+L
Sbjct: 166 GFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 197
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 59/201 (29%), Positives = 92/201 (45%), Gaps = 21/201 (10%)
Query: 218 FSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVR 276
S LG G FG V+K A G +A K + + +E KNE++++ +L H NL++
Sbjct: 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQ 150
Query: 277 LLGCCLEGQELLLIYEYMPNKSLDVH---LFD--ATRSVQLDWKRRLSIINGIARGILYL 331
L +++L+ EY V LFD S L + + I GI ++
Sbjct: 151 LYDAFESKNDIVLVMEY-------VDGGELFDRIIDESYNLTELDTILFMKQICEGIRHM 203
Query: 332 HEDSRLKIIHRDLKASNVLL--DDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAP 389
H+ + I+H DLK N+L D KI DFG AR + + + GT ++AP
Sbjct: 204 HQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL---KVNFGTPEFLAP 257
Query: 390 EYAMGGIFSIKSDVFSFGVLL 410
E S +D++S GV+
Sbjct: 258 EVVNYDFVSFPTDMWSVGVIA 278
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 44/201 (21%), Positives = 78/201 (38%), Gaps = 11/201 (5%)
Query: 221 ENKLGQGGFGPVYKGT-LADGKAIAVKRLSR--TSGQGLKE-FKNEVNLIAKLQHKNLVR 276
+G+GG G VY+ + +A+K +S +S + + E +LQ ++V
Sbjct: 39 RRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98
Query: 277 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSR 336
+ +L + + L L L R ++I+ I + H
Sbjct: 99 IHDFGEIDGQLYVDMRLINGVDLAAMLRRQGP---LAPPRAVAIVRQIGSALDAAHAA-- 153
Query: 337 LKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGI 396
HRD+K N+L+ D + DFG A GT YMAPE
Sbjct: 154 -GATHRDVKPENILVSADDFAYLVDFGIASATTDE-KLTQLGNTVGTLYYMAPERFSESH 211
Query: 397 FSIKSDVFSFGVLLLEIISGR 417
+ ++D+++ +L E ++G
Sbjct: 212 ATYRADIYALTCVLYECLTGS 232
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 44/311 (14%), Positives = 89/311 (28%), Gaps = 81/311 (26%)
Query: 224 LGQGGFGPVYKGT-LADGKAIAVKRLSRT---SGQGLKEFKNEVNLIAKLQ--------- 270
LGQ + T G++ V T +K+ K EV + L+
Sbjct: 81 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140
Query: 271 ----------------HKNLVRLLGCC--LEGQELLLIYEYMPNKSLDV--HLFD-ATRS 309
K ++R+ + +Y M + L ++
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200
Query: 310 VQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFG 369
L RL + + R + LH ++H L+ +++LD ++ F G
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 257
Query: 370 GNQNQANTNIIAGTYGYMAPEY-----------AMGGIFSIKSDVFSFGVLLLEIISGRK 418
+ + + G+ PE + + D ++ G+++ I
Sbjct: 258 ------ARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD- 310
Query: 419 NNGFYFSEHGQTLLTYTWKL-WCEGHAVELIDPVLKQSCA--PDELLKFIHIGLLCVQQD 475
L + A+ + + + SC P + + G L
Sbjct: 311 -------------------LPITKDAALGGSEWIFR-SCKNIPQPVRALLE-GFLRY--P 347
Query: 476 PADRPTMSSVV 486
DR +
Sbjct: 348 KEDRLLPLQAM 358
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-27
Identities = 50/200 (25%), Positives = 87/200 (43%), Gaps = 26/200 (13%)
Query: 221 ENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLG 279
LG G F V+ GK A+K + ++ +NE+ ++ K++H+N+V L
Sbjct: 14 MEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLED 73
Query: 280 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLS------IINGIARGILYLHE 333
L+ + + LFD R ++ + + +I + + YLHE
Sbjct: 74 IYESTTHYYLVMQLVSGGE----LFD--RILE---RGVYTEKDASLVIQQVLSAVKYLHE 124
Query: 334 DSRLKIIHRDLKASNVLL---DDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPE 390
I+HRDLK N+L +++ I+DFG +++ + GT GY+APE
Sbjct: 125 ---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI----MSTACGTPGYVAPE 177
Query: 391 YAMGGIFSIKSDVFSFGVLL 410
+S D +S GV+
Sbjct: 178 VLAQKPYSKAVDCWSIGVIT 197
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-27
Identities = 59/225 (26%), Positives = 92/225 (40%), Gaps = 42/225 (18%)
Query: 213 EATNHFSDE----NKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLKE--------- 258
+T+ F + LG+G V + K AVK + T G
Sbjct: 10 HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69
Query: 259 FKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRR 317
EV+++ K+ H N+++L L+++ M L FD + K
Sbjct: 70 TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL----FD--YLTE---KVT 120
Query: 318 LS------IINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGN 371
LS I+ + I LH+ L I+HRDLK N+LLDDDMN K++DFG +
Sbjct: 121 LSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG 177
Query: 372 QNQANTNIIAGTYGYMAPEYAMGGIFSIKS------DVFSFGVLL 410
+ + GT Y+APE + D++S GV++
Sbjct: 178 E---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-27
Identities = 51/201 (25%), Positives = 89/201 (44%), Gaps = 15/201 (7%)
Query: 215 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKN 273
+H+ +LG G FG V++ T A G A K + + + E+ ++ L+H
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPT 215
Query: 274 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFD--ATRSVQLDWKRRLSIINGIARGILYL 331
LV L + E+++IYE+M LF+ A ++ + + + +G+ ++
Sbjct: 216 LVNLHDAFEDDNEMVMIYEFMS----GGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHM 271
Query: 332 HEDSRLKIIHRDLKASNVLLDDDMNP--KISDFGTARIFGGNQNQANTNIIAGTYGYMAP 389
HE +H DLK N++ + K+ DFG Q + + GT + AP
Sbjct: 272 HE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAP 325
Query: 390 EYAMGGIFSIKSDVFSFGVLL 410
E A G +D++S GVL
Sbjct: 326 EVAEGKPVGYYTDMWSVGVLS 346
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 4e-27
Identities = 58/276 (21%), Positives = 96/276 (34%), Gaps = 52/276 (18%)
Query: 191 LRGGEQQAESQEFPLFPLGLALEATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVK--- 246
+ + +E F G LE + + +GQG +G V A+K
Sbjct: 1 MHHHHHHSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMN 60
Query: 247 --RLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM---------- 294
++ + + + ++ K EV L+ KL H N+ RL + Q + L+ E
Sbjct: 61 KNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLN 120
Query: 295 ---------------------PNKSLDVHLFDATRSVQLDWKRRLS------IINGIARG 327
+ + + + + I+ I
Sbjct: 121 VFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180
Query: 328 ILYLHEDSRLKIIHRDLKASNVLL--DDDMNPKISDFGTARIFGGNQNQANTNI--IAGT 383
+ YLH I HRD+K N L + K+ DFG ++ F N + AGT
Sbjct: 181 LHYLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGT 237
Query: 384 YGYMAPEYAMGGIFSI--KSDVFSFGVLLLEIISGR 417
++APE S K D +S GVLL ++ G
Sbjct: 238 PYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGA 273
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 4e-27
Identities = 44/204 (21%), Positives = 90/204 (44%), Gaps = 22/204 (10%)
Query: 215 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKN 273
+ LG+G FG V++ + K K + + G K E++++ +H+N
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFV-KVKGTDQVLVKKEISILNIARHRN 62
Query: 274 LVRLLGCCLEGQELLLIYEYMPNKSLDVH---LFD--ATRSVQLDWKRRLSIINGIARGI 328
++ L +EL++I+E+ + +F+ T + +L+ + +S ++ + +
Sbjct: 63 ILHLHESFESMEELVMIFEF-------ISGLDIFERINTSAFELNEREIVSYVHQVCEAL 115
Query: 329 LYLHEDSRLKIIHRDLKASNVLLDDDMNP--KISDFGTARIFGGNQNQANTNIIAGTYGY 386
+LH I H D++ N++ + KI +FG AR N ++ Y
Sbjct: 116 QFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF---RLLFTAPEY 169
Query: 387 MAPEYAMGGIFSIKSDVFSFGVLL 410
APE + S +D++S G L+
Sbjct: 170 YAPEVHQHDVVSTATDMWSLGTLV 193
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 5e-27
Identities = 54/200 (27%), Positives = 86/200 (43%), Gaps = 27/200 (13%)
Query: 223 KLGQGGFGPVYKGT-LADGKAIAVKRLSRT--SGQGLKEFKNEVNLIAKLQHKNLVRLLG 279
+LG+G F V + G A K ++ S + ++ + E + KLQH N+VRL
Sbjct: 36 ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 95
Query: 280 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLS------IINGIARGILYLHE 333
E L+++ + LF+ V + S I I I Y H
Sbjct: 96 SIQEESFHYLVFDLVTGGE----LFE--DIVA---REFYSEADASHCIQQILESIAYCHS 146
Query: 334 DSRLKIIHRDLKASNVLL---DDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPE 390
I+HR+LK N+LL K++DFG A ++ + AGT GY++PE
Sbjct: 147 ---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE---AWHGFAGTPGYLSPE 200
Query: 391 YAMGGIFSIKSDVFSFGVLL 410
+S D+++ GV+L
Sbjct: 201 VLKKDPYSKPVDIWACGVIL 220
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 58/268 (21%), Positives = 106/268 (39%), Gaps = 46/268 (17%)
Query: 174 APSSAPGRIGNHYSYDILRGGEQQAESQEFPLFPLGLALE-----ATNHFSDE----NKL 224
+ P + N + Q ++ +G E A F + + +
Sbjct: 43 SLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVI 102
Query: 225 GQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLKE--------FKNEVNLIAKL-QHKNL 274
G+G V + A G AVK + T+ + E + E +++ ++ H ++
Sbjct: 103 GRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHI 162
Query: 275 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLS------IINGIARGI 328
+ L+ + L+++ M L FD + K LS I+ + +
Sbjct: 163 ITLIDSYESSSFMFLVFDLMRKGEL----FD--YLTE---KVALSEKETRSIMRSLLEAV 213
Query: 329 LYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMA 388
+LH I+HRDLK N+LLDD+M ++SDFG + + + GT GY+A
Sbjct: 214 SFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGE---KLRELCGTPGYLA 267
Query: 389 PE------YAMGGIFSIKSDVFSFGVLL 410
PE + + D+++ GV+L
Sbjct: 268 PEILKCSMDETHPGYGKEVDLWACGVIL 295
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 56/224 (25%), Positives = 87/224 (38%), Gaps = 38/224 (16%)
Query: 209 GLALEATNHFSD----ENKLGQGGFGPVYKGT-------LADGKAIAVKRLSRTSGQGLK 257
G+ D +LG G F V K A K I ++ + +
Sbjct: 1 GMETFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYA-AKFIKKRQSRASRRGVCR 59
Query: 258 E-FKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKR 316
E + EV+++ ++ H N++ L +++LI E + LFD Q K
Sbjct: 60 EEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSG----GELFD--FLAQ---KE 110
Query: 317 RLS------IINGIARGILYLHEDSRLKIIHRDLKASNVLL----DDDMNPKISDFGTAR 366
LS I I G+ YLH KI H DLK N++L + K+ DFG A
Sbjct: 111 SLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167
Query: 367 IFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLL 410
I GT ++APE +++D++S GV+
Sbjct: 168 EIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-26
Identities = 53/217 (24%), Positives = 89/217 (41%), Gaps = 30/217 (13%)
Query: 210 LALEATNHFSDE----NKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLKE--FKNE 262
+A F++E +LG+G F V + + G+ A ++ + E
Sbjct: 1 MATITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLERE 60
Query: 263 VNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLS--- 319
+ L+H N+VRL E LI++ + LF+ V + S
Sbjct: 61 ARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGE----LFE--DIVA---REYYSEAD 111
Query: 320 ---IINGIARGILYLHEDSRLKIIHRDLKASNVLL---DDDMNPKISDFGTARIFGGNQN 373
I I +L+ H+ + ++HR+LK N+LL K++DFG A G Q
Sbjct: 112 ASHCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ 168
Query: 374 QANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLL 410
AGT GY++PE + D+++ GV+L
Sbjct: 169 AWFG--FAGTPGYLSPEVLRKDPYGKPVDLWACGVIL 203
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 4e-26
Identities = 52/198 (26%), Positives = 89/198 (44%), Gaps = 14/198 (7%)
Query: 224 LGQGGFGPVYKG-TLADGKAIAVKRLSRT---SGQGLKEFKNEVNLIAKLQHKNLVRLLG 279
LG+G FG VY + +A+K L ++ + + E+ + + L+H N++R+
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 280 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKI 339
+ + + L+ E+ P L L R D +R + + +A + Y H K+
Sbjct: 82 YFHDRKRIYLMLEFAPRGELYKELQKHGR---FDEQRSATFMEELADALHYCH---ERKV 135
Query: 340 IHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSI 399
IHRD+K N+L+ KI+DFG + + + GT Y+ PE G
Sbjct: 136 IHRDIKPENLLMGYKGELKIADFGWSVHAPSLR----RRTMCGTLDYLPPEMIEGKTHDE 191
Query: 400 KSDVFSFGVLLLEIISGR 417
K D++ GVL E + G
Sbjct: 192 KVDLWCAGVLCYEFLVGM 209
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 4e-26
Identities = 54/214 (25%), Positives = 86/214 (40%), Gaps = 34/214 (15%)
Query: 215 TNHFSDENKLGQGGFGPVYKGT-------LADGKAIAVKRLSRTSGQGLKE-FKNEVNLI 266
+ + +LG G F V K A K I ++ + +E + EV+++
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYA-AKFIKKRQSRASRRGVSREEIEREVSIL 69
Query: 267 AKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLS------I 320
++ H N++ L +++LI E + LFD Q K LS
Sbjct: 70 RQVLHHNVITLHDVYENRTDVVLILELVSG----GELFD--FLAQ---KESLSEEEATSF 120
Query: 321 INGIARGILYLHEDSRLKIIHRDLKASNVLL----DDDMNPKISDFGTARIFGGNQNQAN 376
I I G+ YLH KI H DLK N++L + K+ DFG A
Sbjct: 121 IKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV---E 174
Query: 377 TNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLL 410
I GT ++APE +++D++S GV+
Sbjct: 175 FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 7e-26
Identities = 56/213 (26%), Positives = 90/213 (42%), Gaps = 32/213 (15%)
Query: 215 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVK-----RLSRTSGQGLKE-FKNEVNLIA 267
+H+ +LG G F V K GK A K RLS + +E + EVN++
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 268 KLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLS------II 321
+++H N++ L +++LI E + LFD + K L+ +
Sbjct: 64 EIRHPNIITLHDIFENKTDVVLILELVSGGE----LFD--FLAE---KESLTEDEATQFL 114
Query: 322 NGIARGILYLHEDSRLKIIHRDLKASNVLL----DDDMNPKISDFGTARIFGGNQNQANT 377
I G+ YLH +I H DLK N++L + K+ DFG A
Sbjct: 115 KQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN---EF 168
Query: 378 NIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLL 410
I GT ++APE +++D++S GV+
Sbjct: 169 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 201
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 8e-26
Identities = 50/201 (24%), Positives = 86/201 (42%), Gaps = 28/201 (13%)
Query: 221 ENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQ-HKNLVRLL 278
+ LG+G F K +A AVK +S+ + E+ + + H N+V+L
Sbjct: 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM---EANTQKEITALKLCEGHPNIVKLH 72
Query: 279 GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLS------IINGIARGILYLH 332
+ L+ E + L F+ R + K+ S I+ + + ++H
Sbjct: 73 EVFHDQLHTFLVMELLNGGEL----FE--RIKK---KKHFSETEASYIMRKLVSAVSHMH 123
Query: 333 EDSRLKIIHRDLKASNVLL---DDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAP 389
+ + ++HRDLK N+L +D++ KI DFG AR+ + T T Y AP
Sbjct: 124 D---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT--PCFTLHYAAP 178
Query: 390 EYAMGGIFSIKSDVFSFGVLL 410
E + D++S GV+L
Sbjct: 179 ELLNQNGYDESCDLWSLGVIL 199
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 9e-26
Identities = 55/220 (25%), Positives = 103/220 (46%), Gaps = 32/220 (14%)
Query: 213 EATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKN-EVNLIAKLQH 271
+ +++ +G G FG V++ L + +A+K++ + K FKN E+ ++ ++H
Sbjct: 37 QREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQD-----KRFKNRELQIMRIVKH 91
Query: 272 KNLVRLLGCCLEGQE------LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIING-- 323
N+V L + L L+ EY+P V+ + K+ + ++
Sbjct: 92 PNVVDLKAFFYSNGDKKDEVFLNLVLEYVP---ETVYRASRHYAKL---KQTMPMLLIKL 145
Query: 324 ----IARGILYLHEDSRLKIIHRDLKASNVLLDDDMNP-KISDFGTARIFGGNQNQANTN 378
+ R + Y+H + I HRD+K N+LLD K+ DFG+A+I + N +
Sbjct: 146 YMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL--IAGEPNVS 200
Query: 379 IIAGTYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGR 417
I Y Y APE G ++ D++S G ++ E++ G+
Sbjct: 201 YICSRY-YRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 55/209 (26%), Positives = 88/209 (42%), Gaps = 37/209 (17%)
Query: 223 KLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLKE--------FKNEVNLIAKLQHKN 273
LG G G V K +A+K +S+ + E+ ++ KL H
Sbjct: 17 TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76
Query: 274 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLS------IINGIARG 327
++++ + ++ ++ E M L FD + V +RL +
Sbjct: 77 IIKIKNFF-DAEDYYIVLELMEGGEL----FD--KVVG---NKRLKEATCKLYFYQMLLA 126
Query: 328 ILYLHEDSRLKIIHRDLKASNVLL---DDDMNPKISDFGTARIFGGNQNQANTNIIAGTY 384
+ YLHE IIHRDLK NVLL ++D KI+DFG ++I G + GT
Sbjct: 127 VQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS---LMRTLCGTP 180
Query: 385 GYMAPEYAMGGI---FSIKSDVFSFGVLL 410
Y+APE + ++ D +S GV+L
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 55/216 (25%), Positives = 88/216 (40%), Gaps = 38/216 (17%)
Query: 215 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVK-----RLSRTSGQGLKE-FKNEVNLIA 267
+++ +LG G F V K + G A K R + +E + EV+++
Sbjct: 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 268 KLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVH---LFDATRSVQLDWKRRLS----- 319
++QH N++ L +++LI E V LFD + K L+
Sbjct: 70 EIQHPNVITLHEVYENKTDVILILEL-------VAGGELFD--FLAE---KESLTEEEAT 117
Query: 320 -IINGIARGILYLHEDSRLKIIHRDLKASNVLL----DDDMNPKISDFGTARIFGGNQNQ 374
+ I G+ YLH L+I H DLK N++L KI DFG A
Sbjct: 118 EFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN-- 172
Query: 375 ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLL 410
I GT ++APE +++D++S GV+
Sbjct: 173 -EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 1e-25
Identities = 49/227 (21%), Positives = 92/227 (40%), Gaps = 35/227 (15%)
Query: 201 QEFPLFPLGLAL-EATNHFSDE----NKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQ 254
Q + + L + F+D +G G + + A AVK + ++
Sbjct: 2 QTVGVHSIVQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK-- 59
Query: 255 GLKEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLD 313
++ E+ ++ + QH N++ L +G+ + ++ E M L D + ++
Sbjct: 60 --RDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGEL----LD--KILR-- 109
Query: 314 WKRRLS------IINGIARGILYLHEDSRLKIIHRDLKASNVLL---DDDMNP-KISDFG 363
++ S ++ I + + YLH ++HRDLK SN+L + +I DFG
Sbjct: 110 -QKFFSEREASAVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFG 165
Query: 364 TARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLL 410
A+ T T ++APE + D++S GVLL
Sbjct: 166 FAKQLRAENGLLMT--PCYTANFVAPEVLERQGYDAACDIWSLGVLL 210
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-25
Identities = 54/209 (25%), Positives = 87/209 (41%), Gaps = 37/209 (17%)
Query: 223 KLGQGGFGPVYKGT-LADGKAIAVKRLSR--------TSGQGLKEFKNEVNLIAKLQHKN 273
LG G G V K +A++ +S+ + E+ ++ KL H
Sbjct: 142 TLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 201
Query: 274 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLS------IINGIARG 327
++++ + ++ ++ E M L FD + V +RL +
Sbjct: 202 IIKIKNFF-DAEDYYIVLELMEGGEL----FD--KVVG---NKRLKEATCKLYFYQMLLA 251
Query: 328 ILYLHEDSRLKIIHRDLKASNVLL---DDDMNPKISDFGTARIFGGNQNQANTNIIAGTY 384
+ YLHE IIHRDLK NVLL ++D KI+DFG ++I G + GT
Sbjct: 252 VQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS---LMRTLCGTP 305
Query: 385 GYMAPE---YAMGGIFSIKSDVFSFGVLL 410
Y+APE ++ D +S GV+L
Sbjct: 306 TYLAPEVLVSVGTAGYNRAVDCWSLGVIL 334
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 66/311 (21%), Positives = 110/311 (35%), Gaps = 64/311 (20%)
Query: 215 TNHFSD-----ENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLKEFKNEVNLIAK 268
+ F D E+ LG+G V L + AVK + + G EV ++ +
Sbjct: 7 SGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQ 66
Query: 269 LQ-HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLS------II 321
Q H+N++ L+ E L++E M S+ + +R + ++
Sbjct: 67 CQGHRNVLELIEFFEEEDRFYLVFEKMRGGSI----LS--HIHK---RRHFNELEASVVV 117
Query: 322 NGIARGILYLHEDSRLKIIHRDLKASNVLL---DDDMNPKISDFGTARIFGGNQNQANTN 378
+A + +LH I HRDLK N+L + KI DF N + + +
Sbjct: 118 QDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPIS 174
Query: 379 I-----IAGTYGYMAPEYAMGGIFSIKS-----DVFSFGVLLLEIISGRKNNGFY--FSE 426
G+ YMAPE D++S GV+L ++SG Y F
Sbjct: 175 TPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSG------YPPFVG 228
Query: 427 HGQTLLTYTWKLWCEGHAVELIDPVLKQ------------SCAPDELLKFIHIGLLCVQQ 474
+ + C L + + + SCA +L+ LL
Sbjct: 229 RCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLIS----KLLVR-- 282
Query: 475 DPADRPTMSSV 485
D R + + V
Sbjct: 283 DAKQRLSAAQV 293
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 4e-25
Identities = 59/205 (28%), Positives = 103/205 (50%), Gaps = 23/205 (11%)
Query: 222 NKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKN--------EVNLIAKLQHKN 273
K+G+G +G VYK + G+ +A+KR+ L E++L+ +L H N
Sbjct: 27 EKVGEGTYGVVYKAKDSQGRIVALKRIR------LDAEDEGIPSTAIREISLLKELHHPN 80
Query: 274 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHE 333
+V L+ + L L++E+M D+ L + + + RG+ + H+
Sbjct: 81 IVSLIDVIHSERCLTLVFEFME---KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQ 137
Query: 334 DSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAM 393
+I+HRDLK N+L++ D K++DFG AR F G ++ T+ + T Y AP+ M
Sbjct: 138 H---RILHRDLKPQNLLINSDGALKLADFGLARAF-GIPVRSYTHEVV-TLWYRAPDVLM 192
Query: 394 GG-IFSIKSDVFSFGVLLLEIISGR 417
G +S D++S G + E+I+G+
Sbjct: 193 GSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 5e-25
Identities = 53/233 (22%), Positives = 92/233 (39%), Gaps = 31/233 (13%)
Query: 196 QQAESQEFPLFPLGLALEATNHFSD-----ENKLGQGGFGPVYKGT-LADGKAIAVK--R 247
S L L ++ +F++ +LG+G F V + + G+ A K +
Sbjct: 4 HHHHSSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLK 63
Query: 248 LSRTSGQGLKEFKNEVNLIAKLQH-KNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDA 306
R E +E+ ++ + ++ L E++LI EY + F
Sbjct: 64 KRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEI----FS- 118
Query: 307 TRSVQLDWKRRLS------IINGIARGILYLHEDSRLKIIHRDLKASNVLL---DDDMNP 357
+ + +S +I I G+ YLH+ I+H DLK N+LL +
Sbjct: 119 -LCLP-ELAEMVSENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDI 173
Query: 358 KISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLL 410
KI DFG +R G I GT Y+APE + +D+++ G++
Sbjct: 174 KIVDFGMSRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIA 223
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 5e-25
Identities = 51/207 (24%), Positives = 101/207 (48%), Gaps = 24/207 (11%)
Query: 222 NKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLKEFKN--------EVNLIAKLQHK 272
K+G+G +G V+K + +A+KR+ L + E+ L+ +L+HK
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVR------LDDDDEGVPSSALREICLLKELKHK 61
Query: 273 NLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLH 332
N+VRL ++L L++E+ D+ + + + LD + S + + +G+ + H
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFC---DQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH 118
Query: 333 EDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYA 392
++HRDLK N+L++ + K+++FG AR F G + + + T Y P+
Sbjct: 119 SR---NVLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEVV-TLWYRPPDVL 173
Query: 393 MGG-IFSIKSDVFSFGVLLLEIISGRK 418
G ++S D++S G + E+ + +
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGR 200
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 57/198 (28%), Positives = 89/198 (44%), Gaps = 27/198 (13%)
Query: 223 KLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCC 281
+LG+G VY+ K A+K L +T + K + E+ ++ +L H N+++L
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK--KIVRTEIGVLLRLSHPNIIKLKEIF 117
Query: 282 LEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLS------IINGIARGILYLHEDS 335
E+ L+ E + LFD R V+ K S + I + YLHE
Sbjct: 118 ETPTEISLVLELVTGGE----LFD--RIVE---KGYYSERDAADAVKQILEAVAYLHE-- 166
Query: 336 RLKIIHRDLKASNVLL---DDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYA 392
I+HRDLK N+L D KI+DFG ++I + GT GY APE
Sbjct: 167 -NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV---LMKTVCGTPGYCAPEIL 222
Query: 393 MGGIFSIKSDVFSFGVLL 410
G + + D++S G++
Sbjct: 223 RGCAYGPEVDMWSVGIIT 240
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 54/213 (25%), Positives = 87/213 (40%), Gaps = 34/213 (15%)
Query: 224 LGQGGFGPVYKGT-LADGKAIAVKRLSRTS----GQGLKEFKNEVNLIAKLQHKNLVRLL 278
LG+G +G V + AVK L + G K E+ L+ +L+HKN+++L+
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 279 G--CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLS----------IINGIAR 326
E Q++ ++ EY + + D+ ++R +I+G+
Sbjct: 73 DVLYNEEKQKMYMVMEYCVCGMQE--MLDSVP------EKRFPVCQAHGYFCQLIDGLE- 123
Query: 327 GILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGY 386
YLH I+H+D+K N+LL KIS G A G+ +
Sbjct: 124 ---YLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAF 177
Query: 387 MAPEYAMG--GIFSIKSDVFSFGVLLLEIISGR 417
PE A G K D++S GV L I +G
Sbjct: 178 QPPEIANGLDTFSGFKVDIWSAGVTLYNITTGL 210
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-24
Identities = 63/207 (30%), Positives = 91/207 (43%), Gaps = 29/207 (14%)
Query: 224 LGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLKE-FKNEVNLIAKLQHKNLVRLLGCC 281
LG+G +G V +A+AVK + E K E+ + L H+N+V+ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 282 LEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLS----------IINGIARGILYL 331
EG L EY L FD R + ++ G+ YL
Sbjct: 75 REGNIQYLFLEYCSGGEL----FD--RIEP---DIGMPEPDAQRFFHQLMAGVV----YL 121
Query: 332 HEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEY 391
H + I HRD+K N+LLD+ N KISDFG A +F N + N + GT Y+APE
Sbjct: 122 H---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 392 AMGGIFS-IKSDVFSFGVLLLEIISGR 417
F DV+S G++L +++G
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGE 205
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-24
Identities = 57/205 (27%), Positives = 103/205 (50%), Gaps = 23/205 (11%)
Query: 222 NKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKN--------EVNLIAKLQHKN 273
K+G+G +G VYK G+ A+K++ L++ E++++ +L+H N
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIR------LEKEDEGIPSTTIREISILKELKHSN 61
Query: 274 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHE 333
+V+L + L+L++E++ D+ L+ S + + GI Y H+
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHL---DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 334 DSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAM 393
+++HRDLK N+L++ + KI+DFG AR F G + T+ I T Y AP+ M
Sbjct: 119 R---RVLHRDLKPQNLLINREGELKIADFGLARAF-GIPVRKYTHEIV-TLWYRAPDVLM 173
Query: 394 GG-IFSIKSDVFSFGVLLLEIISGR 417
G +S D++S G + E+++G
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 63/207 (30%), Positives = 91/207 (43%), Gaps = 29/207 (14%)
Query: 224 LGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLKE-FKNEVNLIAKLQHKNLVRLLGCC 281
LG+G +G V +A+AVK + E K E+ + L H+N+V+ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 282 LEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLS----------IINGIARGILYL 331
EG L EY L FD R + ++ G+ YL
Sbjct: 75 REGNIQYLFLEYCSGGEL----FD--RIEP---DIGMPEPDAQRFFHQLMAGVV----YL 121
Query: 332 HEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEY 391
H + I HRD+K N+LLD+ N KISDFG A +F N + N + GT Y+APE
Sbjct: 122 H---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 392 AMGGIFS-IKSDVFSFGVLLLEIISGR 417
F DV+S G++L +++G
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGE 205
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 3e-24
Identities = 67/219 (30%), Positives = 104/219 (47%), Gaps = 33/219 (15%)
Query: 215 TNHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLKEFKN-EVNLIAKLQHK 272
++D +G G FG VY+ L D G+ +A+K++ + K FKN E+ ++ KL H
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHC 107
Query: 273 NLVRLLGCCLEGQE------LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIING--- 323
N+VRL E L L+ +Y+P V+ S K+ L +I
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVP---ETVYRVARHYSRA---KQTLPVIYVKLY 161
Query: 324 ---IARGILYLHEDSRLKIIHRDLKASNVLLDDDMNP-KISDFGTARIFGGNQNQANTNI 379
+ R + Y+H I HRD+K N+LLD D K+ DFG+A+ + + N +
Sbjct: 162 MYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSY 216
Query: 380 IAGTYGYMAPEYAMGGIF-SIKSDVFSFGVLLLEIISGR 417
I Y Y APE G + DV+S G +L E++ G+
Sbjct: 217 ICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 63/215 (29%), Positives = 107/215 (49%), Gaps = 18/215 (8%)
Query: 212 LEATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQG-----LKEFKNEVNL 265
+ +++ F KLG G + VYKG G +A+K + S +G ++E ++L
Sbjct: 1 MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIRE----ISL 56
Query: 266 IAKLQHKNLVRLLGCCLEGQELLLIYEYMPN--KSLDVHLFDATRSVQLDWKRRLSIING 323
+ +L+H+N+VRL +L L++E+M N K L+
Sbjct: 57 MKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQ 116
Query: 324 IARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGT 383
+ +G+ + HE+ KI+HRDLK N+L++ K+ DFG AR F G ++ + T
Sbjct: 117 LLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAF-GIPVNTFSSEVV-T 171
Query: 384 YGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGR 417
Y AP+ MG +S D++S G +L E+I+G+
Sbjct: 172 LWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 7e-24
Identities = 53/209 (25%), Positives = 91/209 (43%), Gaps = 32/209 (15%)
Query: 224 LGQGGFGPVY----KGTLADGKAIAVKRLSRTSGQGLKEF---KNEVNLIAKLQHKNLVR 276
LG+G F V T + A+K L + + E +++++L H V+
Sbjct: 38 LGEGSFSTVVLARELAT---SREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 94
Query: 277 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIAR--------GI 328
L + ++L Y N L ++ ++ S R +
Sbjct: 95 LYFTFQDDEKLYFGLSYAKNGELLKYI-----------RKIGSFDETCTRFYTAEIVSAL 143
Query: 329 LYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMA 388
YLH IIHRDLK N+LL++DM+ +I+DFGTA++ QA N GT Y++
Sbjct: 144 EYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVS 200
Query: 389 PEYAMGGIFSIKSDVFSFGVLLLEIISGR 417
PE SD+++ G ++ ++++G
Sbjct: 201 PELLTEKSACKSSDLWALGCIIYQLVAGL 229
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 56/203 (27%), Positives = 103/203 (50%), Gaps = 15/203 (7%)
Query: 222 NKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLKE-FKN----EVNLIAKLQHKNLV 275
+ LG+G F VYK + +A+K++ K+ E+ L+ +L H N++
Sbjct: 16 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 75
Query: 276 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDS 335
LL + L++++M D+ + S+ L + + +G+ YLH+
Sbjct: 76 GLLDAFGHKSNISLVFDFME---TDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH- 131
Query: 336 RLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGG 395
I+HRDLK +N+LLD++ K++DFG A+ F G+ N+A T+ + T Y APE G
Sbjct: 132 --WILHRDLKPNNLLLDENGVLKLADFGLAKSF-GSPNRAYTHQVV-TRWYRAPELLFGA 187
Query: 396 -IFSIKSDVFSFGVLLLEIISGR 417
++ + D+++ G +L E++
Sbjct: 188 RMYGVGVDMWAVGCILAELLLRV 210
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 53/212 (25%), Positives = 90/212 (42%), Gaps = 36/212 (16%)
Query: 222 NKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQ--GLKEFKN-------------EVNLI 266
K+G+G +G V+K +R +GQ +K+F E+ ++
Sbjct: 9 GKIGEGSYGVVFKCR------------NRDTGQIVAIKKFLESEDDPVIKKIALREIRML 56
Query: 267 AKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIAR 326
+L+H NLV LL + L L++EY V + SI +
Sbjct: 57 KQLKHPNLVNLLEVFRRKRRLHLVFEYC---DHTVLHELDRYQRGVPEHLVKSITWQTLQ 113
Query: 327 GILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGY 386
+ + H + IHRD+K N+L+ K+ DFG AR+ G + + +A T Y
Sbjct: 114 AVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTG-PSDYYDDEVA-TRWY 168
Query: 387 MAPEYAMGG-IFSIKSDVFSFGVLLLEIISGR 417
+PE +G + DV++ G + E++SG
Sbjct: 169 RSPELLVGDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 53/209 (25%), Positives = 97/209 (46%), Gaps = 19/209 (9%)
Query: 216 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQG-----LKEFKNEVNLIAKL 269
+ +KLG+G + VYKG +A+K + +G ++E V+L+ L
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIRE----VSLLKDL 57
Query: 270 QHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGIL 329
+H N+V L + L L++EY+ D+ + ++ + + RG+
Sbjct: 58 KHANIVTLHDIIHTEKSLTLVFEYL---DKDLKQYLDDCGNIINMHNVKLFLFQLLRGLA 114
Query: 330 YLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAP 389
Y H K++HRDLK N+L+++ K++DFG AR + N + T Y P
Sbjct: 115 YCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAK-SIPTKTYDNEVV-TLWYRPP 169
Query: 390 EYAMGG-IFSIKSDVFSFGVLLLEIISGR 417
+ +G +S + D++ G + E+ +GR
Sbjct: 170 DILLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 57/225 (25%), Positives = 96/225 (42%), Gaps = 35/225 (15%)
Query: 213 EATNHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLKEFKN----EVNLIA 267
+ + F E GQG FG V G G ++A+K++ + F+N + +A
Sbjct: 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD-----PRFRNRELQIMQDLA 74
Query: 268 KLQHKNLVRLLGCCLEGQE-------LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSI 320
L H N+V+L E L ++ EY+P +H + +
Sbjct: 75 VLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP---DTLHRCCRNYYRR---QVAPPP 128
Query: 321 ING------IARGILYLHEDSRLKIIHRDLKASNVLLDDDMNP-KISDFGTARIFGGNQN 373
I + R I LH S + + HRD+K NVL+++ K+ DFG+A+ + +
Sbjct: 129 ILIKVFLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL--SPS 185
Query: 374 QANTNIIAGTYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGR 417
+ N I Y Y APE G ++ D++S G + E++ G
Sbjct: 186 EPNVAYICSRY-YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 2e-23
Identities = 53/206 (25%), Positives = 90/206 (43%), Gaps = 24/206 (11%)
Query: 222 NKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLKEFKN--------EVNLIAKLQHK 272
+G+G +G V K G+ +A+K+ + E+ L+ +L+H+
Sbjct: 31 GLVGEGSYGMVMKCRNKDTGRIVAIKKFL------ESDDDKMVKKIAMREIKLLKQLRHE 84
Query: 273 NLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLH 332
NLV LL C + + L++E++ + LD++ + I GI + H
Sbjct: 85 NLVNLLEVCKKKKRWYLVFEFV---DHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCH 141
Query: 333 EDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYA 392
IIHRD+K N+L+ K+ DFG AR + + +A T Y APE
Sbjct: 142 SH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAA-PGEVYDDEVA-TRWYRAPELL 196
Query: 393 MGG-IFSIKSDVFSFGVLLLEIISGR 417
+G + DV++ G L+ E+ G
Sbjct: 197 VGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 1e-22
Identities = 48/220 (21%), Positives = 86/220 (39%), Gaps = 50/220 (22%)
Query: 224 LGQGGFGPVYKGT-LADGKAIAVKRLSRT--------SGQGLKEFKNEVNLIAKLQHKNL 274
LG G FG V+ K + VK + + L + E+ ++++++H N+
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 275 VRLLGCCLEGQELLLIYEYMPNKS-----LDVH-----LFDATRSVQLDWKRRLS----- 319
+++ + N+ ++ H LF +D RL
Sbjct: 92 IKV-------------LDIFENQGFFQLVMEKHGSGLDLFA-----FIDRHPRLDEPLAS 133
Query: 320 -IINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTN 378
I + + YL IIHRD+K N+++ +D K+ DFG+A +
Sbjct: 134 YIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL---ERGKLFY 187
Query: 379 IIAGTYGYMAPEYAMGGIFS-IKSDVFSFGVLLLEIISGR 417
GT Y APE MG + + +++S GV L ++
Sbjct: 188 TFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEE 227
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 1e-22
Identities = 61/208 (29%), Positives = 97/208 (46%), Gaps = 33/208 (15%)
Query: 224 LGQGGFGPVYKGT-LADGKAIAVKRLSRT--SGQGLKEFKNEVNLIAKLQHKNLVRLLGC 280
+G+G F V + G+ +A+K + +T + L++ EV ++ L H N+V+L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 281 CLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLS----------IINGIARGILY 330
+ L LI EY + FD + R+ I++ + Y
Sbjct: 83 IETEKTLYLIMEYASGGEV----FDYLVA-----HGRMKEKEARSKFRQIVSAVQ----Y 129
Query: 331 LHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPE 390
H + +I+HRDLKA N+LLD DMN KI+DFG + F + + G Y APE
Sbjct: 130 CH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG-KLDAF--CGAPPYAAPE 183
Query: 391 YAMGGIFS-IKSDVFSFGVLLLEIISGR 417
G + + DV+S GV+L ++SG
Sbjct: 184 LFQGKKYDGPEVDVWSLGVILYTLVSGS 211
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 1e-22
Identities = 57/237 (24%), Positives = 94/237 (39%), Gaps = 63/237 (26%)
Query: 224 LGQGGFGPVYKGT-LADGKAIAVKRLSRT--------------------------SGQGL 256
+G+G +G V D A+K LS+ +
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 257 KEFKNEVNLIAKLQHKNLVRLLGCCLEG---QELLLIYEYMPNKSLDVHLFDATRSVQLD 313
++ E+ ++ KL H N+V+L+ L+ L +++E + + +
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLV-EVLDDPNEDHLYMVFELVNQGPV----MEVPT----- 130
Query: 314 WKRRLS----------IINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFG 363
+ LS +I GI YLH KIIHRD+K SN+L+ +D + KI+DFG
Sbjct: 131 -LKPLSEDQARFYFQDLIKGIE----YLH---YQKIIHRDIKPSNLLVGEDGHIKIADFG 182
Query: 364 TARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSI---KSDVFSFGVLLLEIISGR 417
+ F G+ + GT +MAPE DV++ GV L + G+
Sbjct: 183 VSNEFKGSDALLSNT--VGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-22
Identities = 68/210 (32%), Positives = 101/210 (48%), Gaps = 16/210 (7%)
Query: 216 NHFSDENKLGQGGFGPVY----KGTLADGKAIAVKRLSR---TSGQGLKEFKNEVNLIAK 268
+ F D LG+GGFG V+ K T GK A K+L++ +G + E ++AK
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKAT---GKLYACKKLNKKRLKKRKGYQGAMVEKKILAK 241
Query: 269 LQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDAT-RSVQLDWKRRLSIINGIARG 327
+ + +V L +L L+ M + H+++ + R + I G
Sbjct: 242 VHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG 301
Query: 328 ILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYM 387
+ +LH+ II+RDLK NVLLDDD N +ISD G A Q + AGT G+M
Sbjct: 302 LEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG--YAGTPGFM 356
Query: 388 APEYAMGGIFSIKSDVFSFGVLLLEIISGR 417
APE +G + D F+ GV L E+I+ R
Sbjct: 357 APELLLGEEYDFSVDYFALGVTLYEMIAAR 386
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 1e-22
Identities = 60/258 (23%), Positives = 99/258 (38%), Gaps = 43/258 (16%)
Query: 184 NHYSYDILRGGEQQAESQEFPLFPLGLALEATNHFSD---ENKLGQGGFGPVYKGT-LAD 239
+H+S ++ G A + L E S LG GGFG VY G ++D
Sbjct: 8 HHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSD 67
Query: 240 GKAIAVKRLSRTSGQGLKEFKN------EVNLIAKLQHK--NLVRLLGCCLEGQELLLIY 291
+A+K + + E N EV L+ K+ ++RLL +LI
Sbjct: 68 NLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLIL 127
Query: 292 EYMPNKSLDVHLFDATRSVQLDWKRRLS----------IINGIARGILYLHEDSRLKIIH 341
E P D LFD + + L ++ + + H ++H
Sbjct: 128 ER-PEPVQD--LFD-----FITERGALQEELARSFFWQVLEAVR----HCH---NCGVLH 172
Query: 342 RDLKASNVLLD-DDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFS-I 399
RD+K N+L+D + K+ DFG+ + GT Y PE+ +
Sbjct: 173 RDIKDENILIDLNRGELKLIDFGSGALLKD--TVYTD--FDGTRVYSPPEWIRYHRYHGR 228
Query: 400 KSDVFSFGVLLLEIISGR 417
+ V+S G+LL +++ G
Sbjct: 229 SAAVWSLGILLYDMVCGD 246
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 2e-22
Identities = 47/212 (22%), Positives = 79/212 (37%), Gaps = 46/212 (21%)
Query: 220 DENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQ-HKNLVRL 277
+ LG G G V + G+ A+K L + + + EV+ + ++V +
Sbjct: 33 SKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCI 87
Query: 278 LGCCLEGQELLLIYEYMPNKSLDVH----------LFDATRSVQLDWKRRLS------II 321
L +YE M + + LF +Q + + I+
Sbjct: 88 LD----------VYENMHHGKRCLLIIMECMEGGELFSR---IQERGDQAFTEREAAEIM 134
Query: 322 NGIARGILYLHEDSRLKIIHRDLKASNVLL---DDDMNPKISDFGTARIFGGNQNQANTN 378
I I +LH I HRD+K N+L + D K++DFG A+ N
Sbjct: 135 RDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA----LQ 187
Query: 379 IIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLL 410
T Y+APE + D++S GV++
Sbjct: 188 TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 219
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 99.9 bits (249), Expect = 2e-22
Identities = 60/201 (29%), Positives = 90/201 (44%), Gaps = 17/201 (8%)
Query: 224 LGQGGFGPVY----KGTLADGKAIAVKRLSR---TSGQGLKEFKNEVNLIAKLQHKNLVR 276
LG+GGFG V + T GK A K+L + +G NE ++ K+ + +V
Sbjct: 192 LGKGGFGEVCACQVRAT---GKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVS 248
Query: 277 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSR 336
L L L+ M L H++ ++ R + I G+ LH
Sbjct: 249 LAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAG-FPEARAVFYAAEICCGLEDLHR--- 304
Query: 337 LKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGI 396
+I++RDLK N+LLDD + +ISD G A Q GT GYMAPE
Sbjct: 305 ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---TIKGRVGTVGYMAPEVVKNER 361
Query: 397 FSIKSDVFSFGVLLLEIISGR 417
++ D ++ G LL E+I+G+
Sbjct: 362 YTFSPDWWALGCLLYEMIAGQ 382
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 97.2 bits (242), Expect = 5e-22
Identities = 54/211 (25%), Positives = 104/211 (49%), Gaps = 21/211 (9%)
Query: 223 KLGQGGFGPVYKG---TLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLG 279
K+G+G +G VYK D K A+K++ +G + + E+ L+ +L+H N++ L
Sbjct: 28 KVGRGTYGHVYKAKRKDGKDDKDYALKQI-EGTGISMSACR-EIALLRELKHPNVISLQK 85
Query: 280 CCLEGQE--LLLIYEYMPN---KSLDVHLFDATRSVQLDWKRRL--SIINGIARGILYLH 332
L + + L+++Y + + H + R + S++ I GI YLH
Sbjct: 86 VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 145
Query: 333 EDSRLKIIHRDLKASNVLLDDDMNP----KISDFGTARIFGG-NQNQANTNIIAGTYGYM 387
+ ++HRDLK +N+L+ + KI+D G AR+F + A+ + + T+ Y
Sbjct: 146 AN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 202
Query: 388 APEYAMGG-IFSIKSDVFSFGVLLLEIISGR 417
APE +G ++ D+++ G + E+++
Sbjct: 203 APELLLGARHYTKAIDIWAIGCIFAELLTSE 233
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 7e-22
Identities = 58/212 (27%), Positives = 94/212 (44%), Gaps = 32/212 (15%)
Query: 222 NKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLKEFKN--------EVNLIAKLQHK 272
KLG+G +G VYK + +A+KR+ L+ + EV+L+ +LQH+
Sbjct: 40 TKLGEGTYGEVYKAIDTVTNETVAIKRIR------LEHEEEGVPGTAIREVSLLKELQHR 93
Query: 273 NLVRLLGCCLEGQELLLIYEYMPNKSLDVH-LFDATRSVQLDWKRRLSIINGIARGILYL 331
N++ L L LI+EY D+ D ++ + + S + + G+ +
Sbjct: 94 NIIELKSVIHHNHRLHLIFEYA---ENDLKKYMD--KNPDVSMRVIKSFLYQLINGVNFC 148
Query: 332 HEDSRLKIIHRDLKASNVLLDDDMNP-----KISDFGTARIFGGNQNQANTNIIAGTYGY 386
H + +HRDLK N+LL KI DFG AR F G + T+ I T Y
Sbjct: 149 HSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF-GIPIRQFTHEII-TLWY 203
Query: 387 MAPEYAMGG-IFSIKSDVFSFGVLLLEIISGR 417
PE +G +S D++S + E++
Sbjct: 204 RPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 1e-21
Identities = 54/213 (25%), Positives = 87/213 (40%), Gaps = 34/213 (15%)
Query: 224 LGQGGFGPVYKGT-LADGKAIAVKRLSRT------SGQGLKEFKNEVNLIAKL----QHK 272
LG+GGFG V+ G L D +A+K + R EV L+ K+ H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 273 NLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLS------IINGIAR 326
++RLL + +L+ E P + D LFD + K L +
Sbjct: 99 GVIRLLDWFETQEGFMLVLER-PLPAQD--LFD-----YITEKGPLGEGPSRCFFGQVVA 150
Query: 327 GILYLHEDSRLKIIHRDLKASNVLLDDDMNP-KISDFGTARIFGGNQNQANTNIIAGTYG 385
I + H ++HRD+K N+L+D K+ DFG+ + GT
Sbjct: 151 AIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE----PYTDFDGTRV 203
Query: 386 YMAPEYAMGGIFS-IKSDVFSFGVLLLEIISGR 417
Y PE+ + + + V+S G+LL +++ G
Sbjct: 204 YSPPEWISRHQYHALPATVWSLGILLYDMVCGD 236
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 2e-21
Identities = 59/267 (22%), Positives = 99/267 (37%), Gaps = 39/267 (14%)
Query: 165 SKVPAVGALAPSSAPGRIGNHYSYDILRGGEQQAESQEFPLFPLGLALEA-TNHFSDE-- 221
S+ + P+ AP + Q+FP F + L+ N D+
Sbjct: 5 SQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYK 64
Query: 222 ---NKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQ-HKNLVR 276
LG G G V + + A+K L + + EV L + ++VR
Sbjct: 65 VTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVR 119
Query: 277 LLG----CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLS------IINGIAR 326
++ + LL++ E + L F +Q + + I+ I
Sbjct: 120 IVDVYENLYAGRKCLLIVMECLDGGEL----FSR---IQDRGDQAFTEREASEIMKSIGE 172
Query: 327 GILYLHEDSRLKIIHRDLKASNVLL---DDDMNPKISDFGTARIFGGNQNQANTNIIAGT 383
I YLH + I HRD+K N+L + K++DFG A+ + N T T
Sbjct: 173 AIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH-NSLTT--PCYT 226
Query: 384 YGYMAPEYAMGGIFSIKSDVFSFGVLL 410
Y+APE + D++S GV++
Sbjct: 227 PYYVAPEVLGPEKYDKSCDMWSLGVIM 253
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 97.3 bits (242), Expect = 2e-21
Identities = 58/213 (27%), Positives = 94/213 (44%), Gaps = 24/213 (11%)
Query: 216 NHFSDENKLGQGGFGPVY----KGTLADGKAIAVKRLSRTSGQGLKEF---KNEVNLIAK 268
N FS +G+GGFG VY T GK A+K L + + + NE +++
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADT---GKMYAMKCLDKKRIKMKQGETLALNERIMLSL 245
Query: 269 LQHKN---LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIA 325
+ + +V + +L I + M L HL ++ I
Sbjct: 246 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL---SQHGVFSEADMRFYAAEII 302
Query: 326 RGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYG 385
G+ ++H +++RDLK +N+LLD+ + +ISD G A F + + GT+G
Sbjct: 303 LGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHG 355
Query: 386 YMAPEYAMGGIFSIKS-DVFSFGVLLLEIISGR 417
YMAPE G+ S D FS G +L +++ G
Sbjct: 356 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 2e-21
Identities = 56/214 (26%), Positives = 101/214 (47%), Gaps = 28/214 (13%)
Query: 222 NKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLKE-FKN----EVNLIAKLQHKNLV 275
K+GQG FG V+K G+ +A+K++ + KE F E+ ++ L+H+N+V
Sbjct: 23 AKIGQGTFGEVFKARHRKTGQKVALKKV-LMENE--KEGFPITALREIKILQLLKHENVV 79
Query: 276 RLLGCCLEGQE--------LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARG 327
L+ C + L++++ D+ + V+ ++ + G
Sbjct: 80 NLIEICRTKASPYNRCKGSIYLVFDFC---EHDLAGLLSNVLVKFTLSEIKRVMQMLLNG 136
Query: 328 ILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQAN---TNIIAGTY 384
+ Y+H + KI+HRD+KA+NVL+ D K++DFG AR F +N TN + T
Sbjct: 137 LYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV-TL 192
Query: 385 GYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGR 417
Y PE +G + D++ G ++ E+ +
Sbjct: 193 WYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 2e-21
Identities = 56/211 (26%), Positives = 96/211 (45%), Gaps = 24/211 (11%)
Query: 222 NKLGQGGFGPVYKGT-LADGKAIAVKRLS-RTSGQGLKEFKN----EVNLIAKLQ---HK 272
++G G +G VYK G +A+K + G G EV L+ +L+ H
Sbjct: 15 AEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHP 74
Query: 273 NLVRLLGCCLEGQE-----LLLIYEYMPNKSLDV-HLFDATRSVQLDWKRRLSIINGIAR 326
N+VRL+ C + + L++E++ D+ D L + ++ R
Sbjct: 75 NVVRLMDVCATSRTDREIKVTLVFEHV---DQDLRTYLDKAPPPGLPAETIKDLMRQFLR 131
Query: 327 GILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGY 386
G+ +LH + I+HRDLK N+L+ K++DFG ARI+ A T ++ T Y
Sbjct: 132 GLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYS--YQMALTPVVV-TLWY 185
Query: 387 MAPEYAMGGIFSIKSDVFSFGVLLLEIISGR 417
APE + ++ D++S G + E+ +
Sbjct: 186 RAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 3e-21
Identities = 51/215 (23%), Positives = 99/215 (46%), Gaps = 34/215 (15%)
Query: 222 NKLGQGGFGPVYKG--TLADGKAIAVKRLSRTSGQGLKEFKN--------EVNLIAKLQ- 270
++G+G +G V+K G+ +A+KR+ ++ + EV ++ L+
Sbjct: 17 AEIGEGAYGKVFKARDLKNGGRFVALKRVR------VQTGEEGMPLSTIREVAVLRHLET 70
Query: 271 --HKNLVRLLGCCLEGQE-----LLLIYEYMPNKSLDV-HLFDATRSVQLDWKRRLSIIN 322
H N+VRL C + L L++E++ D+ D + + ++
Sbjct: 71 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHV---DQDLTTYLDKVPEPGVPTETIKDMMF 127
Query: 323 GIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAG 382
+ RG+ +LH +++HRDLK N+L+ K++DFG ARI+ T+++
Sbjct: 128 QLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--TSVVV- 181
Query: 383 TYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGR 417
T Y APE + ++ D++S G + E+ +
Sbjct: 182 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 94.2 bits (234), Expect = 4e-21
Identities = 72/354 (20%), Positives = 115/354 (32%), Gaps = 115/354 (32%)
Query: 221 ENKLGQGGFGPVYKGTL------ADGKAIAVKRLSRTSGQG-----------LKEFKNEV 263
LG+G FG V + A + +AVK L + L + +
Sbjct: 27 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 86
Query: 264 NLIAKL-----------------QHKNLVRLL--------------GCCLEGQELLLIYE 292
N++ L + NL L +G++ +
Sbjct: 87 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIP 146
Query: 293 YMPNKSLDVHLFDATRSV------------------------QLDWKRRLSIINGIARGI 328
+ LD + + L + + +A+G+
Sbjct: 147 VDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGM 206
Query: 329 LYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYG--- 385
+L + K IHRDL A N+LL + KI DFG AR + + +
Sbjct: 207 EFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR-----DIYKDPDYVRKGDARLP 258
Query: 386 --YMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GR-------KNNGFYFSEHGQTLLTYT 435
+MAPE +++I+SDV+SFGVLL EI S G + F
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC------------ 306
Query: 436 WKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 489
+ EG + E+ + L C +P+ RPT S +V L
Sbjct: 307 -RRLKEGTRMR------APDYTTPEMYQ---TMLDCWHGEPSQRPTFSELVEHL 350
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 8e-21
Identities = 58/209 (27%), Positives = 94/209 (44%), Gaps = 34/209 (16%)
Query: 224 LGQGGFGPVYKGT-LADGKAIAVKRLSRT---SGQGLKEFKNEVNLIAKLQHKNLVRLLG 279
LG G FG V G G +AVK L+R S + + K E+ + +H ++++L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 280 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLS----------IINGIARGIL 329
+ ++ EY+ L FD + R+ I++ +
Sbjct: 79 VISTPTDFFMVMEYVSGGEL----FD-----YICKHGRVEEMEARRLFQQILSAVD---- 125
Query: 330 YLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAP 389
Y H R ++HRDLK NVLLD MN KI+DFG + + T+ G+ Y AP
Sbjct: 126 YCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-EFLRTS--CGSPNYAAP 179
Query: 390 EYAMGGIFS-IKSDVFSFGVLLLEIISGR 417
E G +++ + D++S GV+L ++ G
Sbjct: 180 EVISGRLYAGPEVDIWSCGVILYALLCGT 208
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 2e-20
Identities = 62/209 (29%), Positives = 104/209 (49%), Gaps = 35/209 (16%)
Query: 224 LGQGGFGPVYKGT-LADGKAIAVKRLSRT--SGQGLKE-FKNEVNLIAKLQHKNLVRLLG 279
LG+G FG V T + +A+K +SR + + E++ + L+H ++++L
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 280 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLS----------IINGIARGIL 329
+++++ EY + LFD + K+R++ II I
Sbjct: 77 VITTPTDIVMVIEYAGGE-----LFD-----YIVEKKRMTEDEGRRFFQQIICAIE---- 122
Query: 330 YLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAP 389
Y H R KI+HRDLK N+LLDD++N KI+DFG + I N T+ G+ Y AP
Sbjct: 123 YCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG-NFLKTS--CGSPNYAAP 176
Query: 390 EYAMGGIFS-IKSDVFSFGVLLLEIISGR 417
E G +++ + DV+S G++L ++ GR
Sbjct: 177 EVINGKLYAGPEVDVWSCGIVLYVMLVGR 205
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 92.2 bits (229), Expect = 4e-20
Identities = 59/209 (28%), Positives = 96/209 (45%), Gaps = 34/209 (16%)
Query: 224 LGQGGFGPVYKGT-LADGKAIAVKRLSRT---SGQGLKEFKNEVNLIAKLQHKNLVRLLG 279
LG G FG V G G +AVK L+R S + + + E+ + +H ++++L
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 280 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLS----------IINGIARGIL 329
++ ++ EY+ LFD + RL I++G+
Sbjct: 84 VISTPSDIFMVMEYVSGG----ELFD-----YICKNGRLDEKESRRLFQQILSGVD---- 130
Query: 330 YLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAP 389
Y H R ++HRDLK NVLLD MN KI+DFG + + T+ G+ Y AP
Sbjct: 131 YCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-EFLRTS--CGSPNYAAP 184
Query: 390 EYAMGGIFS-IKSDVFSFGVLLLEIISGR 417
E G +++ + D++S GV+L ++ G
Sbjct: 185 EVISGRLYAGPEVDIWSSGVILYALLCGT 213
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 2e-19
Identities = 53/242 (21%), Positives = 99/242 (40%), Gaps = 28/242 (11%)
Query: 193 GGEQQAESQEFPLFPLGLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTS 252
G + + E+ L + ++ + + G +G V G ++G +A+KR+ T
Sbjct: 1 GMQAKGEAAMRDLI--AELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTV 58
Query: 253 GQGLKE--FKN---------EVNLIAKLQHKNLVRLLGCCL-----EGQELLLIYEYMPN 296
G + E+ L+ H N++ L + +L L+ E M
Sbjct: 59 SDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT 118
Query: 297 KSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMN 356
D+ + + + + + I G+ LHE ++HRDL N+LL D+ +
Sbjct: 119 ---DLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNND 172
Query: 357 PKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIIS 415
I DF AR + N+ T+ + Y APE M F+ D++S G ++ E+ +
Sbjct: 173 ITICDFNLAREDTADANK--THYVT-HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFN 229
Query: 416 GR 417
+
Sbjct: 230 RK 231
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 2e-19
Identities = 62/221 (28%), Positives = 99/221 (44%), Gaps = 35/221 (15%)
Query: 213 EATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLKEFKN---------E 262
+ + +G G G V + +A+K+LSR F+N E
Sbjct: 22 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP-------FQNQTHAKRAYRE 74
Query: 263 VNLIAKLQHKNLVRLL------GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKR 316
+ L+ + HKN++ LL E Q++ ++ E M D +L + +LD +R
Sbjct: 75 LVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-----DANLCQVIQM-ELDHER 128
Query: 317 RLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQAN 376
++ + GI +LH IIHRDLK SN+++ D KI DFG AR G +
Sbjct: 129 MSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMM 183
Query: 377 TNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGR 417
T + T Y APE +G + D++S G ++ E+I G
Sbjct: 184 TPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 2e-19
Identities = 57/209 (27%), Positives = 89/209 (42%), Gaps = 36/209 (17%)
Query: 224 LGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLKE-FKNEVNLIAKLQHKNLVRLLGCC 281
+G G FG + +AVK + R G + E + E+ L+H N+VR
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIER--GAAIDENVQREIINHRSLRHPNIVRFKEVI 85
Query: 282 LEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLS----------IINGIARGILYL 331
L L +I EY L ++ R R S +++G++ Y
Sbjct: 86 LTPTHLAIIMEYASGGEL----YE--RICN---AGRFSEDEARFFFQQLLSGVS----YC 132
Query: 332 HEDSRLKIIHRDLKASNVLLDDD--MNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAP 389
H ++I HRDLK N LLD KI DFG ++ + +Q + + GT Y+AP
Sbjct: 133 H---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTV--GTPAYIAP 186
Query: 390 EYAMGGIFS-IKSDVFSFGVLLLEIISGR 417
E + + +DV+S GV L ++ G
Sbjct: 187 EVLLRQEYDGKIADVWSCGVTLYVMLVGA 215
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 3e-19
Identities = 53/251 (21%), Positives = 101/251 (40%), Gaps = 65/251 (25%)
Query: 215 TNHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLKEFKN-EVNLIAKLQHK 272
+ +S LG G FG V + + GK A+K++ + +KN E++++ L H
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQD-----PRYKNRELDIMKVLDHV 60
Query: 273 NLVRLLGC--------------------------------------CLEGQELLLIYEYM 294
N+++L+ + + L +I EY+
Sbjct: 61 NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120
Query: 295 PNKSLDVHLFDATRSVQLDWKRRLSIING------IARGILYLHEDSRLKIIHRDLKASN 348
P +H + R + + + R + ++H L I HRD+K N
Sbjct: 121 P---DTLHKVLKSFIRS---GRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQN 171
Query: 349 VLLD-DDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGI-FSIKSDVFSF 406
+L++ D K+ DFG+A+ ++ + I + Y APE +G ++ D++S
Sbjct: 172 LLVNSKDNTLKLCDFGSAKKL--IPSEPSVAYICSRF-YRAPELMLGATEYTPSIDLWSI 228
Query: 407 GVLLLEIISGR 417
G + E+I G+
Sbjct: 229 GCVFGELILGK 239
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 4e-19
Identities = 60/218 (27%), Positives = 99/218 (45%), Gaps = 34/218 (15%)
Query: 216 NHFSDENKLGQGGFGPVY----KGTLADGKAIAVKRLSRTSGQGLKEFKN---EVNLIAK 268
+HF +G+G FG V T K A+K +++ E +N E+ ++
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDT---KKMYAMKYMNKQKCVERNEVRNVFKELQIMQG 71
Query: 269 LQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKR-RLSIINGIARG 327
L+H LV L + +++ ++ + + L HL ++V + +L I +
Sbjct: 72 LEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHL---QQNVHFKEETVKLFICE-LVMA 127
Query: 328 ILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYM 387
+ YL +IIHRD+K N+LLD+ + I+DF A + Q T +AGT YM
Sbjct: 128 LDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE-TQITT--MAGTKPYM 181
Query: 388 APEYAMGGIFSIKS--------DVFSFGVLLLEIISGR 417
APE +FS + D +S GV E++ GR
Sbjct: 182 APE-----MFSSRKGAGYSFAVDWWSLGVTAYELLRGR 214
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 87.2 bits (216), Expect = 2e-18
Identities = 59/221 (26%), Positives = 98/221 (44%), Gaps = 35/221 (15%)
Query: 213 EATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLKEFKN---------E 262
+ + +G G G V + +A+K+LSR F+N E
Sbjct: 59 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-------FQNQTHAKRAYRE 111
Query: 263 VNLIAKLQHKNLVRLL------GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKR 316
+ L+ + HKN++ LL E Q++ L+ E M ++ ++LD +R
Sbjct: 112 LVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA---NLC---QVIQMELDHER 165
Query: 317 RLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQAN 376
++ + GI +LH IIHRDLK SN+++ D KI DFG AR G +
Sbjct: 166 MSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMM 220
Query: 377 TNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGR 417
T + T Y APE +G + D++S G ++ E++ +
Sbjct: 221 TPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 3e-18
Identities = 54/222 (24%), Positives = 96/222 (43%), Gaps = 37/222 (16%)
Query: 213 EATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLKEFKN---------E 262
E + D +G G +G V G +A+K+L R F++ E
Sbjct: 22 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP-------FQSELFAKRAYRE 74
Query: 263 VNLIAKLQHKNLVRLL------GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKR 316
+ L+ ++H+N++ LL + + L+ +M L + +L R
Sbjct: 75 LRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-----GTDLGKLMKHEKLGEDR 129
Query: 317 RLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQAN 376
++ + +G+ Y+H IIHRDLK N+ +++D KI DFG AR
Sbjct: 130 IQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEM---- 182
Query: 377 TNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGR 417
T + T Y APE + ++ D++S G ++ E+I+G+
Sbjct: 183 TGYVV-TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 7e-18
Identities = 54/240 (22%), Positives = 110/240 (45%), Gaps = 37/240 (15%)
Query: 196 QQAESQEFPLFPLGLALEATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLS----- 249
A + + G + +++ + +G+G +G V + +A+K++S
Sbjct: 9 AAAAAGPEMVR--GQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQ 66
Query: 250 ----RTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCL-----EGQELLLIYEYMPNKSLD 300
RT L+E K ++ + +H+N++ + + +++ ++ + M +
Sbjct: 67 TYCQRT----LREIK----ILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-----E 113
Query: 301 VHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKIS 360
L+ ++ L + I RG+ Y+H + ++HRDLK SN+LL+ + KI
Sbjct: 114 TDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKIC 170
Query: 361 DFGTARIFGGNQNQAN--TNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGR 417
DFG AR+ + + T +A T Y APE + ++ D++S G +L E++S R
Sbjct: 171 DFGLARVADPDHDHTGFLTEYVA-TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 1e-17
Identities = 50/222 (22%), Positives = 95/222 (42%), Gaps = 38/222 (17%)
Query: 213 EATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLKEFKN---------E 262
E + +G G +G V G+ +A+K+LSR F++ E
Sbjct: 21 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRP-------FQSEIFAKRAYRE 73
Query: 263 VNLIAKLQHKNLVRLL------GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKR 316
+ L+ +QH+N++ LL + L+ +M L + ++
Sbjct: 74 LLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-----QTDLQKIMGL-KFSEEK 127
Query: 317 RLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQAN 376
++ + +G+ Y+H ++HRDLK N+ +++D KI DFG AR
Sbjct: 128 IQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEM---- 180
Query: 377 TNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGR 417
T + T Y APE + ++ D++S G ++ E+++G+
Sbjct: 181 TGYVV-TRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 2e-17
Identities = 51/232 (21%), Positives = 100/232 (43%), Gaps = 44/232 (18%)
Query: 213 EATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLS--------RTSGQGLKEFKNEV 263
+ + + D LG GG G V+ K +A+K++ L+E K
Sbjct: 8 DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHA----LREIK--- 60
Query: 264 NLIAKLQHKNLVRLL--------------GCCLEGQELLLIYEYMPNKSLDVHLFDATRS 309
+I +L H N+V++ G E + ++ EYM + L +
Sbjct: 61 -IIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-----ETDLANVLEQ 114
Query: 310 VQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLD-DDMNPKISDFGTARIF 368
L + + + RG+ Y+H + ++HRDLK +N+ ++ +D+ KI DFG ARI
Sbjct: 115 GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIM 171
Query: 369 GGNQNQAN--TNIIAGTYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGR 417
+ + + + T Y +P + ++ D+++ G + E+++G+
Sbjct: 172 DPHYSHKGHLSEGLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 2e-17
Identities = 56/209 (26%), Positives = 87/209 (41%), Gaps = 37/209 (17%)
Query: 224 LGQGGFGPVY----KGTLADGKAIAVKRLSRTSGQGLKEF---KNEVNLIAKLQHKNLVR 276
LG G FG V K + G A+K L + LK+ NE ++ + LV+
Sbjct: 49 LGTGSFGRVMLVKHKES---GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 105
Query: 277 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIAR--------GI 328
L + L ++ EY+ + HL R S AR
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRI---------GRFS--EPHARFYAAQIVLTF 154
Query: 329 LYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMA 388
YLH L +I+RDLK N+L+D +++DFG A+ G T + GT +A
Sbjct: 155 EYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWTLCGTPEALA 206
Query: 389 PEYAMGGIFSIKSDVFSFGVLLLEIISGR 417
PE + ++ D ++ GVL+ E+ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGY 235
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 3e-17
Identities = 66/243 (27%), Positives = 106/243 (43%), Gaps = 41/243 (16%)
Query: 196 QQAESQEFPLFP----LGLALEATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSR 250
SQE P F E + + + +G G +G V G +AVK+LSR
Sbjct: 5 HHHHSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR 64
Query: 251 TSGQGLKEFKN---------EVNLIAKLQHKNLVRLL------GCCLEGQELLLIYEYMP 295
F++ E+ L+ ++H+N++ LL E ++ L+ M
Sbjct: 65 P-------FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM- 116
Query: 296 NKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDM 355
L + + +L +I I RG+ Y+H S IIHRDLK SN+ +++D
Sbjct: 117 ----GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--SA-DIIHRDLKPSNLAVNEDC 169
Query: 356 NPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEII 414
KI DFG AR T +A T Y APE + ++ D++S G ++ E++
Sbjct: 170 ELKILDFGLARHTADEM----TGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 224
Query: 415 SGR 417
+GR
Sbjct: 225 TGR 227
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 82.6 bits (204), Expect = 6e-17
Identities = 40/233 (17%), Positives = 89/233 (38%), Gaps = 37/233 (15%)
Query: 176 SSAPGRIGNHYSYDILRGGEQQAESQEFPLFPLGLALEATNHFSDENKLGQGGFGPVYKG 235
+ + + + + + + + + + +G G +G V +
Sbjct: 19 TVSGSQQEGQQRKQHHSSKPTASMPRPHSDW------QIPDRYEIRHLIGTGSYGHVCEA 72
Query: 236 T-LADGKAIAVKRLSRTSGQGLKEFKN---------EVNLIAKLQHKNLVRLL-----GC 280
+ + +A+K++ R F++ E+ ++ +L H ++V++L
Sbjct: 73 YDKLEKRVVAIKKILR-------VFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKD 125
Query: 281 CLEGQELLLIYEYMPNKSLDVH-LFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKI 339
+ EL ++ E D LF + + +++ + G+ Y+H I
Sbjct: 126 VEKFDELYVVLEIAD---SDFKKLFRTPVYLTELHIK--TLLYNLLVGVKYVHSAG---I 177
Query: 340 IHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYA 392
+HRDLK +N L++ D + K+ DFG AR +N + I+ M
Sbjct: 178 LHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTF 230
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 9e-17
Identities = 45/206 (21%), Positives = 84/206 (40%), Gaps = 21/206 (10%)
Query: 224 LGQGGFGPVY----KGTLADGKAIAVKRLSRTSGQGLKE---FKNEVNLIAKLQHKNLVR 276
+G+G FG V K K A+K L++ E F+ E +++ K +
Sbjct: 82 IGRGAFGEVAVVKLKNA---DKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITT 138
Query: 277 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSR 336
L + L L+ +Y L L + + R + + I +H+
Sbjct: 139 LHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMAR--FYLAEMVIAIDSVHQ--- 193
Query: 337 LKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGI 396
L +HRD+K N+L+D + + +++DFG+ + +++ GT Y++PE
Sbjct: 194 LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED-GTVQSSVAVGTPDYISPEILQAME 252
Query: 397 FSIKS-----DVFSFGVLLLEIISGR 417
D +S GV + E++ G
Sbjct: 253 GGKGRYGPECDWWSLGVCMYEMLYGE 278
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 1e-16
Identities = 59/208 (28%), Positives = 85/208 (40%), Gaps = 31/208 (14%)
Query: 224 LGQGGFGPVY----KGTLADGKAIAVKRLSRTSGQGLKEF---KNEV-------NLIAKL 269
LG+G FG V K T G+ A+K L KE K+EV ++
Sbjct: 156 LGKGTFGKVILVKEKAT---GRYYAMKILK-------KEVIVAKDEVAHTLTENRVLQNS 205
Query: 270 QHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGIL 329
+H L L L + EY L HL +R R I +
Sbjct: 206 RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHL---SRERVFSEDRARFYGAEIVSALD 262
Query: 330 YLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAP 389
YLH S +++RDLK N++LD D + KI+DFG + + T GT Y+AP
Sbjct: 263 YLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPEYLAP 318
Query: 390 EYAMGGIFSIKSDVFSFGVLLLEIISGR 417
E + D + GV++ E++ GR
Sbjct: 319 EVLEDNDYGRAVDWWGLGVVMYEMMCGR 346
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 2e-16
Identities = 49/208 (23%), Positives = 87/208 (41%), Gaps = 23/208 (11%)
Query: 224 LGQGGFGPVY----KGTLADGKAIAVKRLSRTSGQGLKE---FKNEVNLIAKLQHKNLVR 276
+G+G F V K T G+ A+K +++ E F+ E +++ + + +
Sbjct: 69 IGRGAFSEVAVVKMKQT---GQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQ 125
Query: 277 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSR 336
L + L L+ EY L L + + R + I I +H
Sbjct: 126 LHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMAR--FYLAEIVMAIDSVHR--- 180
Query: 337 LKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPE--YAMG 394
L +HRD+K N+LLD + +++DFG+ + + + GT Y++PE A+G
Sbjct: 181 LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGT-VRSLVAVGTPDYLSPEILQAVG 239
Query: 395 GIFSIKS-----DVFSFGVLLLEIISGR 417
G S D ++ GV E+ G+
Sbjct: 240 GGPGTGSYGPECDWWALGVFAYEMFYGQ 267
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 3e-16
Identities = 53/213 (24%), Positives = 85/213 (39%), Gaps = 38/213 (17%)
Query: 224 LGQGGFGPVY----KGTLADGKAIAVKRLSRTSGQGLKE---FKNEVNLIAKLQHKNLVR 276
+G+G FG V K T K A+K LS+ + F E +++A +V+
Sbjct: 77 IGRGAFGEVQLVRHKST---RKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQ 133
Query: 277 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIAR--------GI 328
L + + L ++ EYMP L + + AR +
Sbjct: 134 LFYAFQDDRYLYMVMEYMPGG----DLVNLMS------NYDVP--EKWARFYTAEVVLAL 181
Query: 329 LYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMA 388
+H + IHRD+K N+LLD + K++DFGT + GT Y++
Sbjct: 182 DAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV-RCDTAVGTPDYIS 237
Query: 389 PE--YAMGGIFSIKSDV--FSFGVLLLEIISGR 417
PE + GG + +S GV L E++ G
Sbjct: 238 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 270
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 3e-16
Identities = 57/231 (24%), Positives = 98/231 (42%), Gaps = 44/231 (19%)
Query: 213 EATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLS---------RTSGQGLKEFKNE 262
++ F ++ LG+G +G V T G+ +A+K++ RT L+E K
Sbjct: 8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRT----LREIK-- 61
Query: 263 VNLIAKLQHKNLVRLL-----GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRR 317
++ +H+N++ + E+ +I E M L + L
Sbjct: 62 --ILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM-----QTDLHRVISTQMLSDDHI 114
Query: 318 LSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANT 377
I R + LH + +IHRDLK SN+L++ + + K+ DFG ARI +++ A+
Sbjct: 115 QYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARII--DESAADN 169
Query: 378 NIIAGTYGYM----------APEYAMG-GIFSIKSDVFSFGVLLLEIISGR 417
+ G M APE + +S DV+S G +L E+ R
Sbjct: 170 SEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 78.3 bits (194), Expect = 4e-16
Identities = 57/209 (27%), Positives = 98/209 (46%), Gaps = 37/209 (17%)
Query: 224 LGQGGFGPVY----KGTLADGKAIAVKRLSRTSGQGLKEF---KNEVNLIAKLQHKNLVR 276
LG G FG V+ + G+ A+K L + LK+ +E +++ + H ++R
Sbjct: 14 LGTGSFGRVHLIRSRHN---GRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIR 70
Query: 277 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIAR--------GI 328
+ G + Q++ +I +Y+ L L + +R N +A+ +
Sbjct: 71 MWGTFQDAQQIFMIMDYIEGGELFSLLRKS---------QRFP--NPVAKFYAAEVCLAL 119
Query: 329 LYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMA 388
YLH II+RDLK N+LLD + + KI+DFG A+ T + GT Y+A
Sbjct: 120 EYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----VTYTLCGTPDYIA 171
Query: 389 PEYAMGGIFSIKSDVFSFGVLLLEIISGR 417
PE ++ D +SFG+L+ E+++G
Sbjct: 172 PEVVSTKPYNKSIDWWSFGILIYEMLAGY 200
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 5e-16
Identities = 33/295 (11%), Positives = 80/295 (27%), Gaps = 56/295 (18%)
Query: 223 KLGQGGFGPVYKGTLAD---GKAIAVKRLSRTSG---QGLKEFKNEVNLIAKLQHKNLVR 276
G ++ D + +A+ + L+E + ++++ + R
Sbjct: 38 FHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 277 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSR 336
+L L++ E++ SL + + + +A H R
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAH---R 147
Query: 337 LKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGI 396
+ S V + D + ++ M
Sbjct: 148 AGVALSIDHPSRVRVSIDGDVVLAYPA----------------------TMPDA------ 179
Query: 397 FSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQSC 456
+ + D+ G L ++ R ++ L + A + I+P
Sbjct: 180 -NPQDDIRGIGASLYALLVNRWP---LPEAGVRSGLAPAER----DTAGQPIEPADIDRD 231
Query: 457 APDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSMTIPQPTEPAFSVGRVVA 511
P ++ VQ D R S+++ ++ + + V+
Sbjct: 232 IPFQISAVA---ARSVQGDGGIRSA-STLLNLMQQATAVADRTEVLGPIDEAPVS 282
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 6e-16
Identities = 42/216 (19%), Positives = 71/216 (32%), Gaps = 66/216 (30%)
Query: 216 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKL-QHKN 273
++ LG G G V + + A+K L + + EV L + Q +
Sbjct: 18 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPH 72
Query: 274 LVRLLGCCLEGQELLLIYEYMPNKSLDVH----------LFDATRSVQLDWKRRLS---- 319
+VR++ +YE + + LF R + +
Sbjct: 73 IVRIVD----------VYENLYAGRKCLLIVMECLDGGELFS--RIQDRG-DQAFTEREA 119
Query: 320 --IINGIARGILYLHEDSRLKIIHRDLKASNVLL---DDDMNPKISDFGTARIFGGNQNQ 374
I+ I I YLH + I HRD+K N+L + K++DFG A+
Sbjct: 120 SEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE------- 169
Query: 375 ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLL 410
Y D++S GV++
Sbjct: 170 ----TTGEKYDK-------------SCDMWSLGVIM 188
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 78.3 bits (193), Expect = 1e-15
Identities = 44/218 (20%), Positives = 90/218 (41%), Gaps = 32/218 (14%)
Query: 195 EQQAESQEFPLFPLGLAL-EATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTS 252
S L+ G+ +++ ++ +G+G +G VY K +A+K+++R
Sbjct: 4 HHHHSSGRENLYFQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM- 62
Query: 253 GQGLKEFKN---------EVNLIAKLQHKNLVRLLGCCL-----EGQELLLIYEYMPNKS 298
F++ E+ ++ +L+ ++RL + + EL ++ E +
Sbjct: 63 ------FEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADS-- 114
Query: 299 LDVHLFDATRSVQ-LDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNP 357
D+ ++ L + +I+ + G ++HE IIHRDLK +N LL+ D +
Sbjct: 115 -DLK--KLFKTPIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSV 168
Query: 358 KISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGG 395
K+ DFG AR ++ N + +
Sbjct: 169 KVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKK 206
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 1e-15
Identities = 57/208 (27%), Positives = 85/208 (40%), Gaps = 32/208 (15%)
Query: 224 LGQGGFGPV----YKGTLADGKAIAVKRLSRTSGQGLKEF---KNEV-------NLIAKL 269
LG+G FG V K T G+ A+K L KE K+EV ++
Sbjct: 13 LGKGTFGKVILVREKAT---GRYYAMKILR-------KEVIIAKDEVAHTVTESRVLQNT 62
Query: 270 QHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGIL 329
+H L L L + EY L HL +R +R I +
Sbjct: 63 RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGAEIVSALE 119
Query: 330 YLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAP 389
YLH +++RD+K N++LD D + KI+DFG + + T GT Y+AP
Sbjct: 120 YLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYLAP 174
Query: 390 EYAMGGIFSIKSDVFSFGVLLLEIISGR 417
E + D + GV++ E++ GR
Sbjct: 175 EVLEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 2e-15
Identities = 60/209 (28%), Positives = 88/209 (42%), Gaps = 33/209 (15%)
Query: 224 LGQGGFGPVY----KGTLADGKAIAVKRLSRTSGQGLKEF---KNEVN--------LIAK 268
LG+G FG V K T G AVK L K+ ++V L
Sbjct: 31 LGKGSFGKVMLARVKET---GDLYAVKVLK-------KDVILQDDDVECTMTEKRILSLA 80
Query: 269 LQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGI 328
H L +L C L + E++ L H+ +S + D R I +
Sbjct: 81 RNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHI---QKSRRFDEARARFYAAEIISAL 137
Query: 329 LYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMA 388
++LH+ II+RDLK NVLLD + + K++DFG + N T GT Y+A
Sbjct: 138 MFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTAT--FCGTPDYIA 192
Query: 389 PEYAMGGIFSIKSDVFSFGVLLLEIISGR 417
PE ++ D ++ GVLL E++ G
Sbjct: 193 PEILQEMLYGPAVDWWAMGVLLYEMLCGH 221
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 3e-15
Identities = 44/213 (20%), Positives = 89/213 (41%), Gaps = 23/213 (10%)
Query: 213 EATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQ- 270
+ + KLG+G + V++ + + + + VK L K+ K E+ ++ L+
Sbjct: 33 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRG 89
Query: 271 HKNLVRLLGCCLEGQE--LLLIYEYMPNKSLDVHLFDATRS-VQLDWKRRLSIINGIARG 327
N++ L + L++E++ N T ++ + I +
Sbjct: 90 GPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIR-------FYMYEILKA 142
Query: 328 ILYLHEDSRLKIIHRDLKASNVLLD-DDMNPKISDFGTARIFGGNQNQANTNIIAGTYGY 386
+ Y H S I+HRD+K NV++D + ++ D+G A + Q +A Y +
Sbjct: 143 LDYCH--SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAE--FYHPGQEYNVRVASRY-F 196
Query: 387 MAPEYAMGGIFSIKS-DVFSFGVLLLEIISGRK 418
PE + S D++S G +L +I ++
Sbjct: 197 KGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 229
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 76.0 bits (188), Expect = 3e-15
Identities = 57/216 (26%), Positives = 100/216 (46%), Gaps = 46/216 (21%)
Query: 224 LGQGGFGPVY---KGTLADGKAI-AVKRLSRTSGQGLKEF---KNEV------NLIAKLQ 270
LGQG FG V+ K + +D + + A+K L K ++ V +++ ++
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLK-------KATLKVRDRVRTKMERDILVEVN 84
Query: 271 HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHL-----FDATRSV----QLDWKRRLSII 321
H +V+L +L LI +++ L L F +
Sbjct: 85 HPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAE---------- 134
Query: 322 NGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIA 381
+A + +LH L II+RDLK N+LLD++ + K++DFG ++ ++ +A +
Sbjct: 135 --LALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FC 187
Query: 382 GTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGR 417
GT YMAPE + +D +SFGVL+ E+++G
Sbjct: 188 GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGT 223
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 4e-15
Identities = 60/209 (28%), Positives = 91/209 (43%), Gaps = 33/209 (15%)
Query: 224 LGQGGFGPV----YKGTLADGKAIAVKRLSRTSGQGLKEF---KNEVN--------LIAK 268
LG+G FG V +K T + A+K L K+ ++V L
Sbjct: 25 LGKGSFGKVFLAEFKKT---NQFFAIKALK-------KDVVLMDDDVECTMVEKRVLSLA 74
Query: 269 LQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGI 328
+H L + + L + EY+ L H+ + D R I G+
Sbjct: 75 WEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI---QSCHKFDLSRATFYAAEIILGL 131
Query: 329 LYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMA 388
+LH I++RDLK N+LLD D + KI+DFG + + NT GT Y+A
Sbjct: 132 QFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTPDYIA 186
Query: 389 PEYAMGGIFSIKSDVFSFGVLLLEIISGR 417
PE +G ++ D +SFGVLL E++ G+
Sbjct: 187 PEILLGQKYNHSVDWWSFGVLLYEMLIGQ 215
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 77.4 bits (190), Expect = 4e-15
Identities = 58/209 (27%), Positives = 88/209 (42%), Gaps = 33/209 (15%)
Query: 224 LGQGGFGPV----YKGTLADGKAIAVKRLSRTSGQGLKEF---KNEVN--------LIAK 268
LG+G FG V KGT + AVK L K+ ++V L
Sbjct: 349 LGKGSFGKVMLSERKGT---DELYAVKILK-------KDVVIQDDDVECTMVEKRVLALP 398
Query: 269 LQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGI 328
+ L +L C L + EY+ L H+ + + + IA G+
Sbjct: 399 GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHI---QQVGRFKEPHAVFYAAEIAIGL 455
Query: 329 LYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMA 388
+L II+RDLK NV+LD + + KI+DFG + + T GT Y+A
Sbjct: 456 FFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT--FCGTPDYIA 510
Query: 389 PEYAMGGIFSIKSDVFSFGVLLLEIISGR 417
PE + D ++FGVLL E+++G+
Sbjct: 511 PEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 8e-15
Identities = 60/211 (28%), Positives = 90/211 (42%), Gaps = 37/211 (17%)
Query: 224 LGQGGFGPV----YKGTLADGKAIAVKRLSRTSGQGLKEF---KNEVN--------LIAK 268
LG+G FG V KGT + AVK L K+ ++V L
Sbjct: 28 LGKGSFGKVMLSERKGT---DELYAVKILK-------KDVVIQDDDVECTMVEKRVLALP 77
Query: 269 LQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGI 328
+ L +L C L + EY+ L H+ + + + IA G+
Sbjct: 78 GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHI---QQVGRFKEPHAVFYAAEIAIGL 134
Query: 329 LYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTAR--IFGGNQNQANTNIIAGTYGY 386
+L II+RDLK NV+LD + + KI+DFG + I+ G T GT Y
Sbjct: 135 FFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT----TKTFCGTPDY 187
Query: 387 MAPEYAMGGIFSIKSDVFSFGVLLLEIISGR 417
+APE + D ++FGVLL E+++G+
Sbjct: 188 IAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 1e-14
Identities = 58/238 (24%), Positives = 108/238 (45%), Gaps = 48/238 (20%)
Query: 213 EATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLKEFKN---------E 262
+ KLG+G +G V+K G+ +AVK++ F+N E
Sbjct: 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA-------FQNSTDAQRTFRE 58
Query: 263 VNLIAKLQ-HKNLVRLLGCCL--EGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLS 319
+ ++ +L H+N+V LL +++ L+++YM + L R+ L+ +
Sbjct: 59 IMILTELSGHENIVNLLNVLRADNDRDVYLVFDYM-----ETDLHAVIRANILEPVHKQY 113
Query: 320 IINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNI 379
++ + + I YLH S ++HRD+K SN+LL+ + + K++DFG +R F + N
Sbjct: 114 VVYQLIKVIKYLH--SG-GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIP 170
Query: 380 IAGTYG-------------------YMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGR 417
++ Y APE +G ++ D++S G +L EI+ G+
Sbjct: 171 LSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 73.7 bits (182), Expect = 2e-14
Identities = 58/211 (27%), Positives = 99/211 (46%), Gaps = 34/211 (16%)
Query: 224 LGQGGFGPVY---KGTLADGKAI-AVKRLSRTS-GQGLKEF---KNEVNLIAKLQHKNLV 275
LG+GG+G V+ K T A+ I A+K L + + K+ K E N++ +++H +V
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 276 RLLGCCLEGQELLLIYEYMPNKSLDVHL-----FDATRSV----QLDWKRRLSIINGIAR 326
L+ G +L LI EY+ L + L F + + I+
Sbjct: 85 DLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAE------------ISM 132
Query: 327 GILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGY 386
+ +LH+ II+RDLK N++L+ + K++DFG + + +T GT Y
Sbjct: 133 ALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT--FCGTIEY 187
Query: 387 MAPEYAMGGIFSIKSDVFSFGVLLLEIISGR 417
MAPE M + D +S G L+ ++++G
Sbjct: 188 MAPEILMRSGHNRAVDWWSLGALMYDMLTGA 218
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 4e-14
Identities = 55/209 (26%), Positives = 88/209 (42%), Gaps = 33/209 (15%)
Query: 224 LGQGGFGPVY----KGTLADGKAIAVKRLSRTSGQGLKEF---KNEVN--------LIAK 268
+G+G + V K T + A+K + KE +++
Sbjct: 17 IGRGSYAKVLLVRLKKT---DRIYAMKVVK-------KELVNDDEDIDWVQTEKHVFEQA 66
Query: 269 LQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGI 328
H LV L C L + EY+ L H+ R +L + I+ +
Sbjct: 67 SNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHM---QRQRKLPEEHARFYSAEISLAL 123
Query: 329 LYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMA 388
YLHE II+RDLK NVLLD + + K++D+G + + +T GT Y+A
Sbjct: 124 NYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST--FCGTPNYIA 178
Query: 389 PEYAMGGIFSIKSDVFSFGVLLLEIISGR 417
PE G + D ++ GVL+ E+++GR
Sbjct: 179 PEILRGEDYGFSVDWWALGVLMFEMMAGR 207
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 5e-14
Identities = 54/209 (25%), Positives = 88/209 (42%), Gaps = 33/209 (15%)
Query: 224 LGQGGFGPVY----KGTLADGKAIAVKRLSRTSGQGLKEF---KNEVN--------LIAK 268
+G+G + V K T + A++ + KE +++
Sbjct: 60 IGRGSYAKVLLVRLKKT---DRIYAMRVVK-------KELVNDDEDIDWVQTEKHVFEQA 109
Query: 269 LQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGI 328
H LV L C L + EY+ L H+ R +L + I+ +
Sbjct: 110 SNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHM---QRQRKLPEEHARFYSAEISLAL 166
Query: 329 LYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMA 388
YLHE II+RDLK NVLLD + + K++D+G + + +T GT Y+A
Sbjct: 167 NYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST--FCGTPNYIA 221
Query: 389 PEYAMGGIFSIKSDVFSFGVLLLEIISGR 417
PE G + D ++ GVL+ E+++GR
Sbjct: 222 PEILRGEDYGFSVDWWALGVLMFEMMAGR 250
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 6e-14
Identities = 55/218 (25%), Positives = 84/218 (38%), Gaps = 51/218 (23%)
Query: 224 LGQGGFGPVY----KGTLADGKAIAVKRLSRTSGQGLKEF---KNEVN--------LIAK 268
+G+G FG V K AVK L K+ K E L+
Sbjct: 46 IGKGSFGKVLLARHKAE---EVFYAVKVLQ-------KKAILKKKEEKHIMSERNVLLKN 95
Query: 269 LQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHL-----FDATRSV----QLDWKRRLS 319
++H LV L +L + +Y+ L HL F R+ +
Sbjct: 96 VKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAE-------- 147
Query: 320 IINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNI 379
IA + YLH L I++RDLK N+LLD + ++DFG + + + +T
Sbjct: 148 ----IASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTST-- 198
Query: 380 IAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGR 417
GT Y+APE + D + G +L E++ G
Sbjct: 199 FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGL 236
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 1e-13
Identities = 51/223 (22%), Positives = 99/223 (44%), Gaps = 44/223 (19%)
Query: 223 KLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQ----------- 270
KLG G F V+ + + +A+K + R + ++E+ L+ ++
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 84
Query: 271 HKNLVRLLGC----CLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSI--INGI 324
++++LL G +++++E L +L + + R + + + I
Sbjct: 85 ANHILKLLDHFNHKGPNGVHVVMVFE-----VLGENLLALIKKYE---HRGIPLIYVKQI 136
Query: 325 ARGIL----YLHEDSRLKIIHRDLKASNVLLDDDMNP------KISDFGTARIFGGNQNQ 374
++ +L Y+H R IIH D+K NVL++ +P KI+D G A ++
Sbjct: 137 SKQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW----YDE 190
Query: 375 ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGR 417
TN I T Y +PE +G + +D++S L+ E+I+G
Sbjct: 191 HYTNSIQ-TREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 70.7 bits (172), Expect = 2e-13
Identities = 32/217 (14%), Positives = 60/217 (27%), Gaps = 52/217 (23%)
Query: 196 QQAESQEFPLFPLGLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTS--- 252
Q F T K+G+G FG V++ AD +A+K ++
Sbjct: 6 SQKGPVPFSHCL------PTEKLQRCEKIGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDL 58
Query: 253 -----GQGLKEFKNEVNLIAKLQ---------HKNLVRLLGCCL----EGQELLLIYEYM 294
+ +E E+ + +L + + L LL +++
Sbjct: 59 VNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHY 118
Query: 295 PNK----------------------SLDVHLFDATRSVQLDWKRRLSIINGIARGILYLH 332
+ + R+ SI++ + +
Sbjct: 119 NSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAE 178
Query: 333 EDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFG 369
L+ HRDL NVLL K+ +
Sbjct: 179 A--SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSST 213
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 2e-12
Identities = 52/222 (23%), Positives = 92/222 (41%), Gaps = 52/222 (23%)
Query: 224 LGQGGFGPVY---KGTLADGKAI-AVKRLSRTSGQGLKEF-----------KNEVNLIAK 268
LG G +G V+ K + D + A+K L K + E ++
Sbjct: 62 LGTGAYGKVFLVRKISGHDTGKLYAMKVLK-------KATIVQKAKTTEHTRTERQVLEH 114
Query: 269 LQHKN-LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIAR- 326
++ LV L +L LI +Y+ L HL ++ + +
Sbjct: 115 IRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHL---SQRERFTEHE--------VQI 163
Query: 327 -------GILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNI 379
+ +LH+ L II+RD+K N+LLD + + ++DFG ++ F ++ +
Sbjct: 164 YVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RAYD 219
Query: 380 IAGTYGYMAPE----YAMGGIFSIKSDVFSFGVLLLEIISGR 417
GT YMAP+ G ++ D +S GVL+ E+++G
Sbjct: 220 FCGTIEYMAPDIVRGGDSGHDKAV--DWWSLGVLMYELLTGA 259
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 4e-12
Identities = 52/221 (23%), Positives = 91/221 (41%), Gaps = 36/221 (16%)
Query: 215 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVK---RLSRTSGQGLKEFKNEVNLIAKLQ 270
+ + ++ +G+G FG V K + + +A+K Q E V L+ +
Sbjct: 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIE----VRLLELMN 108
Query: 271 H------KNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSI--IN 322
+V L + L L++E L +L+D R+ R +S+
Sbjct: 109 KHDTEMKYYIVHLKRHFMFRNHLCLVFE-----MLSYNLYDLLRNTN---FRGVSLNLTR 160
Query: 323 GIARGIL----YLHEDSRLKIIHRDLKASNVLLDDDMNP--KISDFGTARIFGGNQNQAN 376
A+ + +L L IIH DLK N+LL + KI DFG++ Q
Sbjct: 161 KFAQQMCTALLFLA-TPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ----LGQRI 215
Query: 377 TNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGR 417
I + Y +PE +G + + D++S G +L+E+ +G
Sbjct: 216 YQYIQSRF-YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 5e-11
Identities = 49/212 (23%), Positives = 94/212 (44%), Gaps = 38/212 (17%)
Query: 224 LGQGGFGPVYKGT-LADGKAIAVKRL---SRTSGQGLKEFKNEVNLIAKLQHK------N 273
+G+G FG V K + +A+K + R Q +E + ++ L+ + N
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEE----IRILEHLRKQDKDNTMN 160
Query: 274 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSI--INGIARGIL-- 329
++ +L + + +E L ++L++ + + + S+ + A IL
Sbjct: 161 VIHMLENFTFRNHICMTFE-----LLSMNLYELIKKNKF---QGFSLPLVRKFAHSILQC 212
Query: 330 --YLHEDSRLKIIHRDLKASNVLLDDDMNP--KISDFGTARIFGGNQNQANTNIIAGTYG 385
LH + +IIH DLK N+LL K+ DFG++ ++Q I +
Sbjct: 213 LDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY----EHQRVYTYIQSRF- 264
Query: 386 YMAPEYAMGGIFSIKSDVFSFGVLLLEIISGR 417
Y APE +G + + D++S G +L E+++G
Sbjct: 265 YRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 8e-09
Identities = 41/158 (25%), Positives = 69/158 (43%), Gaps = 13/158 (8%)
Query: 216 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNL 274
N + K+G G FG +Y GT +A G+ +A+K + E + +Q
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ--LHIESKIYKMMQGGVG 66
Query: 275 V-RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHE 333
+ + C EG +++ E + SL+ LF+ S + K L + + + I Y+H
Sbjct: 67 IPTIRWCGAEGDYNVMVMELL-GPSLE-DLFNFC-SRKFSLKTVLLLADQMISRIEYIHS 123
Query: 334 DSRLKIIHRDLKASNVLLDDDMNPK---ISDFGTARIF 368
+ IHRD+K N L+ I DFG A+ +
Sbjct: 124 KN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 55.0 bits (132), Expect = 3e-08
Identities = 40/165 (24%), Positives = 68/165 (41%), Gaps = 27/165 (16%)
Query: 216 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNL 274
N F K+G G FG +Y GT + + +A+K + + E + LQ
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ--LLYESKIYRILQGGTG 64
Query: 275 V-RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSI-------INGIAR 326
+ + +EG +L+ + + SL+ LF+ R+LS+ I R
Sbjct: 65 IPNVRWFGVEGDYNVLVMDLL-GPSLE-DLFNFC-------SRKLSLKTVLMLADQMINR 115
Query: 327 GILYLHEDSRLKIIHRDLKASNVLLDDDMNPK---ISDFGTARIF 368
+ ++H S +HRD+K N L+ I DFG A+ +
Sbjct: 116 -VEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 6e-08
Identities = 69/334 (20%), Positives = 115/334 (34%), Gaps = 101/334 (30%)
Query: 223 KLGQGGFGPVYKGT-LADGKAIAVK---RLSRTSGQGLKEFKNEVNLIAKLQH-----KN 273
K+G G FG V + + K AVK + + + E +++ K+Q+ N
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIE----ADILKKIQNDDINNNN 97
Query: 274 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSI--INGIARGIL-- 329
+V+ G + + LI+E L L++ I I IL
Sbjct: 98 IVKYHGKFMYYDHMCLIFE-----PLGPSLYEIITRNN---YNGFHIEDIKLYCIEILKA 149
Query: 330 --YLHEDSRLKIIHRDLKASNVLLDDDMNP-------------------------KISDF 362
YL + + + H DLK N+LLDD K+ DF
Sbjct: 150 LNYLRK---MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDF 206
Query: 363 GTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISG------ 416
G A F ++ + +II Y APE + + + SD++SFG +L E+ +G
Sbjct: 207 GCA-TF---KSDYHGSIINTRQ-YRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRT 261
Query: 417 --------------------------RKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDP 450
+ N Y ++ L W E +
Sbjct: 262 HEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKL------AWPENASSINSIK 315
Query: 451 VLKQSCAPDELLK---FIHIGLLCVQQDPADRPT 481
+K+ +++K F +Q DP RP+
Sbjct: 316 HVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPS 349
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 9e-08
Identities = 36/166 (21%), Positives = 71/166 (42%), Gaps = 27/166 (16%)
Query: 216 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNL 274
H+ ++G+G FG +++GT L + + +A+K R S ++E L
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQ--LRDEYRTYKLLAGCTG 67
Query: 275 V-RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSI--INGIARGIL-- 329
+ + EG +L+ + + SL+ L D R+ S+ + A+ +L
Sbjct: 68 IPNVYYFGQEGLHNVLVIDLLG-PSLE-DLLDLC-------GRKFSVKTVAMAAKQMLAR 118
Query: 330 --YLHEDSRLKIIHRDLKASNVLLDDDMNPK-----ISDFGTARIF 368
+HE S +++RD+K N L+ + + DFG + +
Sbjct: 119 VQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 53.0 bits (127), Expect = 1e-07
Identities = 49/268 (18%), Positives = 93/268 (34%), Gaps = 94/268 (35%)
Query: 223 KLGQGGFGPVYKG-TLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQ--------HKN 273
KLG G F V+ + K +A+K + +++ + +E+ L+ ++ +
Sbjct: 44 KLGWGHFSTVWLSWDIQGKKFVAMK-VVKSAEHYTETALDEIRLLKSVRNSDPNDPNREM 102
Query: 274 LVRLLGC-CLEGQELLLIYEYMPNKSLDVHL---FDATRSVQLDWKRR-------LSIIN 322
+V+LL + G N H+ F+ L W + L +
Sbjct: 103 VVQLLDDFKISG----------VN---GTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVK 149
Query: 323 GIARGIL----YLHEDSRLKIIHRDLKASNVLL--------------------------- 351
I + +L YLH ++ +IIH D+K N+LL
Sbjct: 150 KIIQQVLQGLDYLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSG 207
Query: 352 ----------------------DDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAP 389
+ + KI+D G A ++ T I T Y +
Sbjct: 208 SAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWV----HKHFTEDI-QTRQYRSL 262
Query: 390 EYAMGGIFSIKSDVFSFGVLLLEIISGR 417
E +G ++ +D++S + E+ +G
Sbjct: 263 EVLIGSGYNTPADIWSTACMAFELATGD 290
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 1e-07
Identities = 44/230 (19%), Positives = 86/230 (37%), Gaps = 56/230 (24%)
Query: 223 KLGQGGFGPVYKG--TLADGKAIAVK---RLSRTSGQGLKEFKNEVNLIAKLQHK----- 272
LG+G FG V + +A+K + + E +N++ K++ K
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLE----INVLKKIKEKDKENK 81
Query: 273 -NLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSI--INGIARGIL 329
V + + + +E L + F+ + + + + +A +
Sbjct: 82 FLCVLMSDWFNFHGHMCIAFE-----LLGKNTFEFLKENN---FQPYPLPHVRHMAYQLC 133
Query: 330 ----YLHEDSRLKIIHRDLKASNVLLDDDMNP-------------------KISDFGTAR 366
+LHE ++ H DLK N+L + +++DFG+A
Sbjct: 134 HALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA- 189
Query: 367 IFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISG 416
F ++ +T I+A + Y PE + ++ DV+S G +L E G
Sbjct: 190 TF---DHEHHTTIVATRH-YRPPEVILELGWAQPCDVWSIGCILFEYYRG 235
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 52.5 bits (126), Expect = 2e-07
Identities = 43/207 (20%), Positives = 74/207 (35%), Gaps = 42/207 (20%)
Query: 193 GGEQQAESQEFP-LFPLGLALEAT--NHFSDENKLGQGGFGPVYKGTLADGKAI------ 243
G Q + + F +G + + +GQGGFG +Y + +++
Sbjct: 9 AGRQSSAKRHLAEQFAVGEIITDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPC 68
Query: 244 AVKRLSRTSGQGLKEFK-----NEVNLIAKLQHKNLVRLLGCCL---EGQELLLIYEY-- 293
VK +G E K + I K ++ LG G Y
Sbjct: 69 VVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRF 128
Query: 294 --MP--NKSLDVHLFDATRSVQLDWKRRLSI--INGIARGIL----YLHEDSRLKIIHRD 343
M L +++A +R S + ++ IL Y+HE +H D
Sbjct: 129 MIMDRFGSDLQ-KIYEAN-------AKRFSRKTVLQLSLRILDILEYIHEHE---YVHGD 177
Query: 344 LKASNVLLDDDMNPKI--SDFGTARIF 368
+KASN+LL+ ++ D+G A +
Sbjct: 178 IKASNLLLNYKNPDQVYLVDYGLAYRY 204
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 3e-07
Identities = 37/166 (22%), Positives = 65/166 (39%), Gaps = 27/166 (16%)
Query: 216 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQH-KN 273
+F K+G G FG + G L + +A+K S + E +L
Sbjct: 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA--PQLHLEYRFYKQLGSGDG 66
Query: 274 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSI--INGIARGIL-- 329
+ ++ G+ ++ E + SL+ LFD R S+ + IA ++
Sbjct: 67 IPQVYYFGPCGKYNAMVLELL-GPSLE-DLFDLC-------DRTFSLKTVLMIAIQLISR 117
Query: 330 --YLHEDSRLKIIHRDLKASNVLLDDDMNPK-----ISDFGTARIF 368
Y+H + +I+RD+K N L+ N I DF A+ +
Sbjct: 118 MEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 7e-07
Identities = 48/230 (20%), Positives = 86/230 (37%), Gaps = 56/230 (24%)
Query: 223 KLGQGGFGPVYKG--TLADGKAIAVK---RLSRTSGQGLKEFKNEVNLIAKLQHK----- 272
LG+G FG V + A G+ +AVK + R E+ ++ L
Sbjct: 21 TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARS----EIQVLEHLNTTDPNST 76
Query: 273 -NLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSI--INGIARGIL 329
V++L + +++E L + +D + + I +A I
Sbjct: 77 FRCVQMLEWFEHHGHICIVFE-----LLGLSTYDFIKENG---FLPFRLDHIRKMAYQIC 128
Query: 330 ----YLHEDSRLKIIHRDLKASNVLLDDDMNP-------------------KISDFGTAR 366
+LH K+ H DLK N+L K+ DFG+A
Sbjct: 129 KSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA- 184
Query: 367 IFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISG 416
+ ++ ++ +++ + Y APE + +S DV+S G +L+E G
Sbjct: 185 TY---DDEHHSTLVSTRH-YRAPEVILALGWSQPCDVWSIGCILIEYYLG 230
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 1e-06
Identities = 27/176 (15%), Positives = 63/176 (35%), Gaps = 29/176 (16%)
Query: 216 NHFSDENKLGQGGFGPVYKGT---------LADGKAIAVKRLSRTSGQGLKEFK------ 260
+ ++ + G +Y+ + ++K L G+ E
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAA 100
Query: 261 --NEVNLIAKLQHKNLV---RLLGCCLEGQEL-LLIYEYMPNKSLDVHLFDATRSVQLDW 314
+VN KL L+ +G + + L+ + +SL D + L
Sbjct: 101 KPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQ-SALDVSPKHVLSE 158
Query: 315 KRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKI--SDFGTARIF 368
+ L + + + +LHE+ +H ++ A N+ +D + ++ + +G A +
Sbjct: 159 RSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRY 211
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 50.2 bits (119), Expect = 1e-06
Identities = 48/346 (13%), Positives = 96/346 (27%), Gaps = 111/346 (32%)
Query: 225 GQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEG 284
G G G K +A + V + + ++ + L C
Sbjct: 157 GVLGSG---KTWVA----LDVCLSYKV----QCKMDFKIFWLN----------LKNCNSP 195
Query: 285 QELL-----LIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKI 339
+ +L L+Y+ PN + + + L RL +
Sbjct: 196 ETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELR----------------RL-L 238
Query: 340 IHRDLKASNVLLDDDMNPKIS---DFG-----TARIFGGNQNQANTNIIAGTYGY----- 386
+ + ++L + N K + T R + T+ ++
Sbjct: 239 KSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTR------FKQVTDFLSAATTTHISLD 292
Query: 387 -----MAPEYAMGGIFS---------IKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLL 432
+ P+ + + +V + L II+ +G
Sbjct: 293 HHSMTLTPDEVK-SLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDG----------- 340
Query: 433 TYTWKLW----CEGH------AVELIDPVLKQ----SCA--PDELLKFIHIGLLCVQQDP 476
TW W C+ ++ +++P + + P I LL +
Sbjct: 341 LATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAH--IPTILLSLIWFD 398
Query: 477 ADRPTMSSVVVMLASDSMTIPQPTEPAFSVGRVVANSGHLLSSAKV 522
+ + VV L S+ QP E S+ S +L K+
Sbjct: 399 VIKSDVMVVVNKLHKYSLVEKQPKESTISI-----PSIYLELKVKL 439
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 46.4 bits (109), Expect = 2e-05
Identities = 65/437 (14%), Positives = 121/437 (27%), Gaps = 116/437 (26%)
Query: 37 IIW--YRECMVRYSDKSLPIMDTSTVLCMYIVRNFSVPRNVTRILAQSFNDVIAMPSLSS 94
I W + C S +++ M L I N++ + + + + + A L
Sbjct: 184 IFWLNLKNC---NSPETVLEMLQK--LLYQIDPNWTSRSDHSSNIKLRIHSIQA--ELRR 236
Query: 95 FRNATKGT-------NISNINRLETFG-QC-IPVLSVDDC-RDCLNNTIRWIQKCFDPPG 144
+ N+ N F C I + + D L+ D
Sbjct: 237 LLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATT-THISLDHHS 295
Query: 145 TGF----GRILFPSCI-MGFE--------LHPYSKVPAVGALAPSSAPGRIGN--HY--- 186
+ L + + +P ++ + N H
Sbjct: 296 MTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPR-RLSIIAESI-RDGLATWDNWKHVNCD 353
Query: 187 --------SYDILRGGEQQAESQEFPLFP---------LGL---ALEATNHFSDENKLGQ 226
S ++L E + +FP L L + ++ NKL
Sbjct: 354 KLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKL-- 411
Query: 227 GGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVR--LLGCCLEG 284
+K +L + + K + + E K ++ L H+++V + +
Sbjct: 412 ------HKYSLVEKQP---KESTISIPSIYLELKVKLENEYAL-HRSIVDHYNIPKTFDS 461
Query: 285 QELLL------IYEY----MPNKSLDVHLFDATRSVQLD--W---KRRLSIINGIARG-I 328
+L+ Y + + N R V LD + K R A G I
Sbjct: 462 DDLIPPYLDQYFYSHIGHHLKNIEHP-ERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSI 520
Query: 329 LYLHEDSRL--KIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTY-- 384
L + + I + L++ I DF + N+I Y
Sbjct: 521 LNTLQQLKFYKPYICDNDPKYERLVNA-----ILDF---------LPKIEENLICSKYTD 566
Query: 385 ----GYMAPEYAMGGIF 397
MA + IF
Sbjct: 567 LLRIALMAED---EAIF 580
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 46.4 bits (109), Expect = 2e-05
Identities = 82/508 (16%), Positives = 154/508 (30%), Gaps = 144/508 (28%)
Query: 8 FDITFQSCQRCIATAVKAVMKKCNGTRKAIIWYRECMVRYSDKSLPIMDTSTVLCMYI-- 65
F + + V+ V++ N Y+ M + S + MYI
Sbjct: 68 FWTLLSKQEEMVQKFVEEVLRI-N--------YKFLMSPIKTEQR---QPSMMTRMYIEQ 115
Query: 66 -------VRNFSVPRNVTRILAQSFNDVI-AMPSLSSFRNAT----KGTNISNINRLETF 113
+ F+ NV+R+ Q + + A+ L +N G
Sbjct: 116 RDRLYNDNQVFA-KYNVSRL--QPYLKLRQALLELRPAKNVLIDGVLG-----------S 161
Query: 114 GQCIPVLSVDDCRD-----CLNNTIRWIQKCFDPPGTGFGRILFPSCIMGFELHPYSKV- 167
G+ +++D C ++ I W+ P ++ ++
Sbjct: 162 GK--TWVALDVCLSYKVQCKMDFKIFWL---------NLKNCNSPETVLEMLQKLLYQID 210
Query: 168 PAVGALAPSSAPGRIGNHYSYDILRGGEQQAESQEFP--LFPLGLALEATNHFSDENKLG 225
P + + S+ ++ H LR + +S+ + L L L
Sbjct: 211 PNWTSRSDHSSNIKLRIHSIQAELR---RLLKSKPYENCL----LVL-------LN---- 252
Query: 226 QGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQ 285
V + ++ K L T + + +F + A H +L +
Sbjct: 253 ------VQNAKAWNAFNLSCKILLTTRFKQVTDFLSA----ATTTHISLDHHSMTLTPDE 302
Query: 286 --ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSII-----NGIARGILYLHED-SRL 337
LLL K LD D R V RRLSII +G+A + H + +L
Sbjct: 303 VKSLLL-------KYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKL 355
Query: 338 KIIHRDLKAS-NVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTY----GYMAPEYA 392
I +++S NVL + +F + +I +
Sbjct: 356 TTI---IESSLNVLEPAEYRKMFDRLS---VF-----PPSAHIPTILLSLIWFDVIKSDV 404
Query: 393 MGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEG----HAVELI 448
M + + + + L+E ++ S L K+ E H ++
Sbjct: 405 M----VVVNKLHKYS--LVE----KQPKESTISIPSIYLEL---KVKLENEYALHR-SIV 450
Query: 449 D--PVLKQSCAPDELLK------FIHIG 468
D + K + D + + HIG
Sbjct: 451 DHYNIPKTFDSDDLIPPYLDQYFYSHIG 478
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 2e-06
Identities = 36/206 (17%), Positives = 67/206 (32%), Gaps = 42/206 (20%)
Query: 192 RGGEQQAESQEFPLFPLGLALEAT--NHFSDENKLGQGGFGPVYKG----TLADGKAIAV 245
+ + FP G L+ N + K+G GGFG +Y V
Sbjct: 11 VDLGTENLYFQSMPFPEGKVLDDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVV 70
Query: 246 KRLSRTSGQGLKEFK-----NEVNLIAKLQHKNLVRLLG----------CCLEGQELLLI 290
K + +G E K + + I K + + LG ++
Sbjct: 71 KVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMV 130
Query: 291 YEYMPNKSLDVHLFDATRSVQLDWKRRLSI--INGIARGIL----YLHEDSRLKIIHRDL 344
E + L + + + +L Y+HE+ +H D+
Sbjct: 131 MERL-GIDLQ-KISG--------QNGTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDI 177
Query: 345 KASNVLLDDDMNPKI--SDFGTARIF 368
KA+N+LL ++ +D+G + +
Sbjct: 178 KAANLLLGYKNPDQVYLADYGLSYRY 203
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 536 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.94 | |
| 3a2e_A | 108 | Ginkbilobin-2; domain 26 unknown function (DUF26), | 99.91 | |
| 2e79_A | 108 | Ginkbilobin-2; DUF26 fold, C-X8-C-X2-C motif, lect | 99.9 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.9 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.81 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.71 | |
| 3a2e_A | 108 | Ginkbilobin-2; domain 26 unknown function (DUF26), | 99.65 | |
| 2e79_A | 108 | Ginkbilobin-2; DUF26 fold, C-X8-C-X2-C motif, lect | 99.62 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.41 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.26 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.1 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.0 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.7 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.6 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.56 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.47 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.43 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.4 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.19 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.17 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 98.0 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.97 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.78 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.72 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.63 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.55 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.55 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.51 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.41 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.36 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.28 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.23 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.08 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.95 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.1 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.99 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 88.71 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 86.9 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 82.65 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-56 Score=439.55 Aligned_cols=258 Identities=29% Similarity=0.500 Sum_probs=212.9
Q ss_pred cCCccccccCCCCceeEEEEEeC------CCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEE
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 289 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 289 (536)
++|.+.++||+|+||+||+|++. ++..||||++...+....++|.+|+++|++++|||||++++++.+++.++|
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 57888999999999999999863 478899999988777778899999999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhccc----------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEE
Q 039168 290 IYEYMPNKSLDVHLFDAT----------RSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKI 359 (536)
Q Consensus 290 v~e~~~~~sL~~~l~~~~----------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl 359 (536)
|||||++|+|.++|.... ....++|.+++.++.||++||.|||+++ ||||||||+||||++++++||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence 999999999999996532 2346999999999999999999999996 999999999999999999999
Q ss_pred ecccCccccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHHHHH
Q 039168 360 SDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKL 438 (536)
Q Consensus 360 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 438 (536)
+|||+++...............||+.|||||++.+..|+.++|||||||++|||+| |+.||..... .... ..
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~---~~~~----~~ 242 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN---NEVI----EC 242 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH---HHHH----HH
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH---HHHH----HH
Confidence 99999987754444334444679999999999999999999999999999999999 8999864321 1111 12
Q ss_pred hhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 439 WCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 439 ~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
...+..... ...+ + .++.+|+.+||+.||++|||+++|++.|+..
T Consensus 243 i~~~~~~~~-----p~~~-~---~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~ 287 (299)
T 4asz_A 243 ITQGRVLQR-----PRTC-P---QEVYELMLGCWQREPHMRKNIKGIHTLLQNL 287 (299)
T ss_dssp HHHTCCCCC-----CTTC-C---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHcCCCCCC-----Cccc-h---HHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 222322221 1122 2 3466777799999999999999999999875
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-55 Score=438.03 Aligned_cols=258 Identities=29% Similarity=0.461 Sum_probs=205.4
Q ss_pred cCCccccccCCCCceeEEEEEeC------CCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEE
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 289 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 289 (536)
++|.+.++||+|+||+||+|++. +++.||||++...+....++|.+|+++|++++|||||++++++.+.+.++|
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 56788899999999999999864 478899999988777778899999999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhcccC------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCe
Q 039168 290 IYEYMPNKSLDVHLFDATR------------SVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNP 357 (536)
Q Consensus 290 v~e~~~~~sL~~~l~~~~~------------~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~ 357 (536)
|||||++|+|.+++..... ...+++.+++.|+.||++||.|||+++ ||||||||+||||++++++
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence 9999999999999975432 346999999999999999999999986 9999999999999999999
Q ss_pred EEecccCccccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHHH
Q 039168 358 KISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTW 436 (536)
Q Consensus 358 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~ 436 (536)
||+|||+++.+.............||+.|||||++.+..++.++|||||||++|||+| |+.||..... ....
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~---~~~~---- 270 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN---TEAI---- 270 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH---HHHH----
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH---HHHH----
Confidence 9999999997765444444445679999999999999999999999999999999999 8999754321 1111
Q ss_pred HHhhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 437 KLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 437 ~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
.....+...+. ...++ .++.+|+.+||+.||++|||+.||++.|+..
T Consensus 271 ~~i~~g~~~~~-----p~~~~----~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l 317 (329)
T 4aoj_A 271 DCITQGRELER-----PRACP----PEVYAIMRGCWQREPQQRHSIKDVHARLQAL 317 (329)
T ss_dssp HHHHHTCCCCC-----CTTCC----HHHHHHHHHHCCSSTTTSCCHHHHHHHHHHH
T ss_pred HHHHcCCCCCC-----ccccc----HHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 11222222221 11222 3466777799999999999999999999875
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-55 Score=432.47 Aligned_cols=258 Identities=31% Similarity=0.438 Sum_probs=210.2
Q ss_pred cCCccccccCCCCceeEEEEEeC------CCcEEEEEEcccc-ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEE
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRT-SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELL 288 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 288 (536)
..+++.++||+|+||+||+|++. +++.||||++... .....++|.+|+.+|++++|||||++++++.+++.++
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 45677889999999999999862 4688999999754 3344678999999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhhccc-------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCC
Q 039168 289 LIYEYMPNKSLDVHLFDAT-------------RSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDM 355 (536)
Q Consensus 289 lv~e~~~~~sL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~ 355 (536)
||||||++|+|.++|.... ....+++.+++.++.||++||+|||+++ ||||||||+||||++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCC
Confidence 9999999999999996532 1345899999999999999999999996 99999999999999999
Q ss_pred CeEEecccCccccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHH
Q 039168 356 NPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTY 434 (536)
Q Consensus 356 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~ 434 (536)
++||+|||+++.+.............||+.|||||++.++.|+.++|||||||++|||+| |+.||..... ....
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~---~~~~-- 257 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN---QDVV-- 257 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH---HHHH--
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH---HHHH--
Confidence 999999999987754444444445679999999999999999999999999999999998 8999754322 1111
Q ss_pred HHHHhhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 435 TWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 435 ~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
.....+..... ...+ ...+.+|+.+||+.||++|||+++|++.|++.
T Consensus 258 --~~i~~~~~~~~-----p~~~----~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 258 --EMIRNRQVLPC-----PDDC----PAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp --HHHHTTCCCCC-----CTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred --HHHHcCCCCCC-----cccc----hHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 12223322221 1122 23466777899999999999999999999863
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-54 Score=430.73 Aligned_cols=250 Identities=22% Similarity=0.377 Sum_probs=200.5
Q ss_pred cCCccccccCCCCceeEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEe
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 292 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 292 (536)
++|+++++||+|+||+||+|+++ +|+.||||++... .....+.+.+|+.+|++|+|||||++++++.+++.+|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 68999999999999999999975 5999999999754 34456789999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCC
Q 039168 293 YMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQ 372 (536)
Q Consensus 293 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 372 (536)
||+||+|.++|... +...+++.+++.++.||+.||+|||+++ ||||||||+||||+.+|++||+|||+++.+...
T Consensus 104 y~~gg~L~~~i~~~-~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~- 178 (350)
T 4b9d_A 104 YCEGGDLFKRINAQ-KGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST- 178 (350)
T ss_dssp CCTTCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHH-
T ss_pred CCCCCcHHHHHHHc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCC-
Confidence 99999999999643 3345799999999999999999999997 999999999999999999999999999876422
Q ss_pred CccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccccc
Q 039168 373 NQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVL 452 (536)
Q Consensus 373 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l 452 (536)
.......+||+.|||||++.+..|+.++|||||||++|||++|+.||.... ......... .+.... +
T Consensus 179 -~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~------~~~~~~~i~-~~~~~~-----~ 245 (350)
T 4b9d_A 179 -VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS------MKNLVLKII-SGSFPP-----V 245 (350)
T ss_dssp -HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS------HHHHHHHHH-HTCCCC-----C
T ss_pred -cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC------HHHHHHHHH-cCCCCC-----C
Confidence 122334679999999999999999999999999999999999999985422 112122221 222211 1
Q ss_pred cCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 453 KQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 453 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
.... + .++.+|+.+||++||++|||+.|+|+
T Consensus 246 ~~~~-s---~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 246 SLHY-S---YDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp CTTS-C---HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CccC-C---HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1112 2 24566677999999999999999986
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-54 Score=424.59 Aligned_cols=264 Identities=26% Similarity=0.430 Sum_probs=202.4
Q ss_pred hcCCccccccCCCCceeEEEEEeCCCcEEEEEEcccc--ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEe
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRT--SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 292 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 292 (536)
.+++++.++||+|+||+||+|++++ .||||+++.. +.+..+.|.+|+.+|++++|||||++++++.+ +.++||||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE 111 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ 111 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence 3678889999999999999998753 6999998643 34556789999999999999999999998865 56899999
Q ss_pred ecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCC
Q 039168 293 YMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQ 372 (536)
Q Consensus 293 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 372 (536)
||++|+|.++|... ...+++.++..|+.||++||.|||+++ ||||||||+||||++++++||+|||+|+......
T Consensus 112 y~~gGsL~~~l~~~--~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~ 186 (307)
T 3omv_A 112 WCEGSSLYKHLHVQ--ETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWS 186 (307)
T ss_dssp CCSSCBHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC-----
T ss_pred cCCCCCHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCC
Confidence 99999999999643 345999999999999999999999986 9999999999999999999999999998775444
Q ss_pred CccccccccccccccCcchhcC---CCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcccccc
Q 039168 373 NQANTNIIAGTYGYMAPEYAMG---GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELID 449 (536)
Q Consensus 373 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 449 (536)
.........||+.|||||++.+ ..|+.++|||||||+||||+||+.||...... . ........+.....+.
T Consensus 187 ~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~---~---~~~~~~~~~~~~p~~~ 260 (307)
T 3omv_A 187 GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR---D---QIIFMVGRGYASPDLS 260 (307)
T ss_dssp -------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH---H---HHHHHHHTTCCCCCST
T ss_pred cceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH---H---HHHHHHhcCCCCCCcc
Confidence 4444455789999999999964 35899999999999999999999998543221 1 1111122221111110
Q ss_pred ccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccCCCCCC
Q 039168 450 PVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSMTIP 497 (536)
Q Consensus 450 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 497 (536)
.+... ....+.+|+.+||+.||++|||+.+|++.|+...-++|
T Consensus 261 -~~~~~----~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lp 303 (307)
T 3omv_A 261 -KLYKN----CPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLP 303 (307)
T ss_dssp -TSCTT----SCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCC
T ss_pred -ccccc----chHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCC
Confidence 11112 22346667779999999999999999999886544444
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-53 Score=427.33 Aligned_cols=250 Identities=23% Similarity=0.338 Sum_probs=206.1
Q ss_pred hcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEee
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 293 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 293 (536)
.+.|++.++||+|+||+||+|+++ +|+.||||++........+.+.+|+.+|++++|||||++++++.+++.+||||||
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 152 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 152 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 357999999999999999999976 5999999999766555567789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCC
Q 039168 294 MPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQN 373 (536)
Q Consensus 294 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 373 (536)
|+||+|.+++.. ..+++.++..++.||+.||+|||+++ ||||||||+||||+.+|++||+|||+++.+.....
T Consensus 153 ~~gg~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~ 225 (346)
T 4fih_A 153 LEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 225 (346)
T ss_dssp CTTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC
T ss_pred CCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCCC
Confidence 999999998853 34899999999999999999999997 99999999999999999999999999998754332
Q ss_pred ccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcccccccccc
Q 039168 374 QANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLK 453 (536)
Q Consensus 374 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~ 453 (536)
.....+||+.|||||++.+..|+.++|||||||++|||++|+.||..... ..... .........+..
T Consensus 226 --~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~---~~~~~----~i~~~~~~~~~~---- 292 (346)
T 4fih_A 226 --RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP---LKAMK----MIRDNLPPRLKN---- 292 (346)
T ss_dssp --CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHH----HHHHSSCCCCSC----
T ss_pred --cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH---HHHHH----HHHcCCCCCCCc----
Confidence 23457899999999999999999999999999999999999999853211 11111 111111111100
Q ss_pred CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 454 QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 454 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
......++.+++.+||++||++|||+.|+++
T Consensus 293 ---~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 293 ---LHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp ---GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ---cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0111234566677999999999999999986
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-54 Score=424.27 Aligned_cols=248 Identities=23% Similarity=0.319 Sum_probs=207.0
Q ss_pred cCCccccccCCCCceeEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEE
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 291 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 291 (536)
++|++.++||+|+||+||+|+++ +++.||||++.+. .....+.+.+|+++|++++|||||++++++.+++.+||||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 57999999999999999999975 6899999999753 2344678999999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCC
Q 039168 292 EYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGN 371 (536)
Q Consensus 292 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 371 (536)
||++||+|.+++... ..+++.++..++.||+.||+|||+++ |+||||||+||||+.++++||+|||+|+.+...
T Consensus 112 Ey~~gG~L~~~i~~~---~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 112 SYAKNGELLKYIRKI---GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp CCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 999999999999643 45999999999999999999999997 999999999999999999999999999988655
Q ss_pred CCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcccccccc
Q 039168 372 QNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPV 451 (536)
Q Consensus 372 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 451 (536)
.........+||+.|||||++.+..|+.++|||||||++|||++|+.||..... ..+.. .. ..... .
T Consensus 186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~---~~~~~---~i-~~~~~-~----- 252 (311)
T 4aw0_A 186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE---GLIFA---KI-IKLEY-D----- 252 (311)
T ss_dssp TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHH---HH-HHTCC-C-----
T ss_pred CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHH---HH-HcCCC-C-----
Confidence 554555567899999999999999999999999999999999999999853221 11111 11 11111 1
Q ss_pred ccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHH
Q 039168 452 LKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVV 486 (536)
Q Consensus 452 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl 486 (536)
+.... ++ ++.+++.+||++||++|||++|++
T Consensus 253 ~p~~~-s~---~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 253 FPEKF-FP---KARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp CCTTC-CH---HHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred CCccc-CH---HHHHHHHHHccCCHhHCcChHHHc
Confidence 11122 22 355667799999999999999864
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-53 Score=423.55 Aligned_cols=251 Identities=25% Similarity=0.316 Sum_probs=200.8
Q ss_pred cCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEeec
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 294 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 294 (536)
+.|+..++||+|+||+||+|+++ +|+.||||++..... ..+|+.+|++++|||||++++++.+++.+|||||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 132 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 56888899999999999999975 589999999975432 247999999999999999999999999999999999
Q ss_pred CCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCC-CeEEecccCccccCCCCC
Q 039168 295 PNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDM-NPKISDFGTARIFGGNQN 373 (536)
Q Consensus 295 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~-~~kl~Dfg~a~~~~~~~~ 373 (536)
+||+|.++|... ..+++.++..++.||+.||+|||+++ ||||||||+||||+.+| ++||+|||+++.+.....
T Consensus 133 ~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~ 206 (336)
T 4g3f_A 133 EGGSLGQLIKQM---GCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 206 (336)
T ss_dssp TTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred CCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence 999999999643 35999999999999999999999996 99999999999999987 699999999998754332
Q ss_pred cc---ccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccc
Q 039168 374 QA---NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDP 450 (536)
Q Consensus 374 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 450 (536)
.. .....+||+.|||||++.+..|+.++|||||||++|||++|+.||....... +...+ ........
T Consensus 207 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~---~~~~i---~~~~~~~~---- 276 (336)
T 4g3f_A 207 GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP---LCLKI---ASEPPPIR---- 276 (336)
T ss_dssp -------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC---CHHHH---HHSCCGGG----
T ss_pred ccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH---HHHHH---HcCCCCch----
Confidence 21 2334679999999999999999999999999999999999999986533221 11111 11111000
Q ss_pred cccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcc
Q 039168 451 VLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 491 (536)
Q Consensus 451 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 491 (536)
.+.... + ..+.+++.+||++||++|||+.||++.|..
T Consensus 277 ~~~~~~-s---~~~~~li~~~L~~dP~~R~sa~el~~~l~~ 313 (336)
T 4g3f_A 277 EIPPSC-A---PLTAQAIQEGLRKEPVHRASAMELRRKVGK 313 (336)
T ss_dssp GSCTTS-C---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred hcCccC-C---HHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence 111122 2 335566679999999999999999988764
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-52 Score=430.03 Aligned_cols=250 Identities=23% Similarity=0.341 Sum_probs=206.4
Q ss_pred hcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEee
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 293 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 293 (536)
.+.|++.++||+|+||.||+|+++ +|+.||||++........+.+.+|+.+|++++|||||+++++|.+++.+||||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 367999999999999999999975 5999999999876656667789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCC
Q 039168 294 MPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQN 373 (536)
Q Consensus 294 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 373 (536)
|+||+|.+++.. ..+++.++..++.||+.||+|||+++ ||||||||+||||+.+|++||+|||+++.+.....
T Consensus 230 ~~gG~L~~~i~~----~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~ 302 (423)
T 4fie_A 230 LEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 302 (423)
T ss_dssp CTTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC
T ss_pred CCCCcHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCCc
Confidence 999999998853 34899999999999999999999997 99999999999999999999999999997754332
Q ss_pred ccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcccccccccc
Q 039168 374 QANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLK 453 (536)
Q Consensus 374 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~ 453 (536)
.....+||+.|||||++.+..|+.++|||||||++|||++|+.||..... ...+. .........+. .
T Consensus 303 --~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~---~~~~~----~i~~~~~~~~~----~ 369 (423)
T 4fie_A 303 --RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP---LKAMK----MIRDNLPPRLK----N 369 (423)
T ss_dssp --CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHH----HHHHSCCCCCS----C
T ss_pred --cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH---HHHHH----HHHcCCCCCCc----c
Confidence 23457899999999999999999999999999999999999999853221 11111 11111111110 0
Q ss_pred CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 454 QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 454 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
....+. .+.+|+.+||+.||++|||+.|+|+
T Consensus 370 ~~~~s~---~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 370 LHKVSP---SLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp TTSSCH---HHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cccCCH---HHHHHHHHHcCCChhHCcCHHHHhc
Confidence 011223 3556667999999999999999986
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-51 Score=405.99 Aligned_cols=247 Identities=24% Similarity=0.356 Sum_probs=196.1
Q ss_pred CccccccCCCCceeEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHHHcCCCCceeEeeEEee----CceEEEE
Q 039168 218 FSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLE----GQELLLI 290 (536)
Q Consensus 218 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~----~~~~~lv 290 (536)
|++.++||+|+||+||+|.+. +++.||+|++... .....+.|.+|+.+|++|+|||||++++++.+ +..+|||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 367778999999999999975 5899999998643 34456789999999999999999999999875 3568999
Q ss_pred EeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcC-CCCeEEecccCccccC
Q 039168 291 YEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDD-DMNPKISDFGTARIFG 369 (536)
Q Consensus 291 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~-~~~~kl~Dfg~a~~~~ 369 (536)
||||++|+|.+++... ..+++..+..++.||+.||+|||+++ .+|+||||||+||||+. ++.+||+|||+|+...
T Consensus 108 mEy~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 108 TELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EeCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 9999999999999643 45999999999999999999999873 24999999999999984 7899999999998643
Q ss_pred CCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcccccc
Q 039168 370 GNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELID 449 (536)
Q Consensus 370 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 449 (536)
. ......+||+.|||||++.+ .|+.++|||||||++|||+||+.||...... .........+.....
T Consensus 184 ~----~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~------~~~~~~i~~~~~~~~-- 250 (290)
T 3fpq_A 184 A----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA------AQIYRRVTSGVKPAS-- 250 (290)
T ss_dssp T----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH------HHHHHHHTTTCCCGG--
T ss_pred C----CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH------HHHHHHHHcCCCCCC--
Confidence 2 22345689999999999865 6999999999999999999999998532211 111122222221111
Q ss_pred ccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 450 PVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 450 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
.....+ + ++.+|+.+||++||++|||+.|+++
T Consensus 251 --~~~~~~-~---~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 251 --FDKVAI-P---EVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp --GGGCCC-H---HHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --CCccCC-H---HHHHHHHHHccCChhHCcCHHHHhc
Confidence 111222 2 3556667999999999999999986
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-52 Score=403.99 Aligned_cols=245 Identities=23% Similarity=0.368 Sum_probs=187.7
Q ss_pred cCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEE
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 291 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 291 (536)
++|++.+.||+|+||+||+|++. +|+.||||++.+.. ....+.+.+|+.+|++++|||||++++++.+++.+|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 58999999999999999999975 69999999997542 334567899999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCC
Q 039168 292 EYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGN 371 (536)
Q Consensus 292 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 371 (536)
||+ +|+|.+++... ..+++.++..++.||+.||+|||+++ |+||||||+|||+++++++||+|||+|+.....
T Consensus 93 Ey~-~g~L~~~l~~~---~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 165 (275)
T 3hyh_A 93 EYA-GNELFDYIVQR---DKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG 165 (275)
T ss_dssp ECC-CEEHHHHHHHS---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred eCC-CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence 999 67888888543 45999999999999999999999997 999999999999999999999999999876432
Q ss_pred CCccccccccccccccCcchhcCCCC-CccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccc
Q 039168 372 QNQANTNIIAGTYGYMAPEYAMGGIF-SIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDP 450 (536)
Q Consensus 372 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 450 (536)
. .....+||+.|||||++.+..+ +.++|||||||++|+|++|+.||..... ..+. .....+.. .
T Consensus 166 ~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~---~~~~----~~i~~~~~-~---- 230 (275)
T 3hyh_A 166 N---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI---PVLF----KNISNGVY-T---- 230 (275)
T ss_dssp ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHH----HHHHHTCC-C----
T ss_pred C---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH---HHHH----HHHHcCCC-C----
Confidence 2 2234689999999999998876 5899999999999999999999853211 1111 11112111 1
Q ss_pred cccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 451 VLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 451 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
+... .++ ++.+++.+||+.||++|||+.|+++
T Consensus 231 -~p~~-~s~---~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 231 -LPKF-LSP---GAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp -CCTT-SCH---HHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -CCCC-CCH---HHHHHHHHHccCChhHCcCHHHHHc
Confidence 1111 122 3556677999999999999999987
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-52 Score=422.34 Aligned_cols=262 Identities=28% Similarity=0.404 Sum_probs=211.6
Q ss_pred HHhcCCccccccCCCCceeEEEEEeCC------CcEEEEEEccccC-hhhHHHHHHHHHHHHHcCC-CCceeEeeEEee-
Q 039168 213 EATNHFSDENKLGQGGFGPVYKGTLAD------GKAIAVKRLSRTS-GQGLKEFKNEVNLIAKLQH-KNLVRLLGCCLE- 283 (536)
Q Consensus 213 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h-pniv~l~~~~~~- 283 (536)
...++|++.++||+|+||+||+|++.. ++.||||++.... ....+.|.+|+.+|++++| ||||+++++|.+
T Consensus 61 i~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~ 140 (353)
T 4ase_A 61 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 140 (353)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred ecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec
Confidence 345789999999999999999998642 4689999997653 3446779999999999965 999999999876
Q ss_pred CceEEEEEeecCCCChhhhhhcccC-------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEE
Q 039168 284 GQELLLIYEYMPNKSLDVHLFDATR-------------SVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVL 350 (536)
Q Consensus 284 ~~~~~lv~e~~~~~sL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIl 350 (536)
++.+++|||||++|+|.++|..... ...+++.++..++.||++||+|||+++ ||||||||+|||
T Consensus 141 ~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDLK~~NIL 217 (353)
T 4ase_A 141 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNIL 217 (353)
T ss_dssp TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCccCcccee
Confidence 4678999999999999999975332 345899999999999999999999996 999999999999
Q ss_pred EcCCCCeEEecccCccccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCc
Q 039168 351 LDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQ 429 (536)
Q Consensus 351 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~ 429 (536)
+++++.+||+|||+|+.+.............||+.|||||++.+..|+.++|||||||++|||+| |+.||...... .
T Consensus 218 l~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~--~ 295 (353)
T 4ase_A 218 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--E 295 (353)
T ss_dssp ECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS--H
T ss_pred eCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHH--H
Confidence 99999999999999998765554444555689999999999999999999999999999999998 89998643221 1
Q ss_pred hhHHHHHHHhhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 430 TLLTYTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 430 ~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
. ......++..... .... + .++.+++.+||+.||++|||+++|++.|+..
T Consensus 296 ~----~~~~i~~g~~~~~-----p~~~-~---~~~~~li~~c~~~dP~~RPt~~eil~~L~~l 345 (353)
T 4ase_A 296 E----FCRRLKEGTRMRA-----PDYT-T---PEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 345 (353)
T ss_dssp H----HHHHHHHTCCCCC-----CTTC-C---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred H----HHHHHHcCCCCCC-----CccC-C---HHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 1 1222223322221 1122 2 3466677799999999999999999998753
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-51 Score=407.87 Aligned_cols=267 Identities=23% Similarity=0.303 Sum_probs=199.8
Q ss_pred cCCccccccCCCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCc----eEEEEE
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQ----ELLLIY 291 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~----~~~lv~ 291 (536)
++|.+.++||+|+||+||+|++ +|+.||||++...... ...+..|+..+.+++|||||++++++.+++ .++|||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 4577889999999999999998 5899999999754322 122345666677899999999999998653 689999
Q ss_pred eecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcC-----CCCCeeeCCCCCCcEEEcCCCCeEEecccCcc
Q 039168 292 EYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHED-----SRLKIIHRDLKASNVLLDDDMNPKISDFGTAR 366 (536)
Q Consensus 292 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-----~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 366 (536)
|||++|+|.++|.. ..+++..+..++.|+++||+|||++ +..+||||||||+||||+.++++||+|||+++
T Consensus 81 Ey~~~gsL~~~l~~----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 81 DYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp ECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred cCCCCCcHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence 99999999999954 2489999999999999999999986 12359999999999999999999999999998
Q ss_pred ccCCCCCc--cccccccccccccCcchhcCC------CCCccchHHHHHHHHHHHHhCCCCCCCCCccC--------Cch
Q 039168 367 IFGGNQNQ--ANTNIIAGTYGYMAPEYAMGG------IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEH--------GQT 430 (536)
Q Consensus 367 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~il~elltg~~p~~~~~~~~--------~~~ 430 (536)
........ ......+||+.|||||++.+. .++.++|||||||++|||+||+.|+....... ...
T Consensus 157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~ 236 (303)
T 3hmm_A 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence 77543322 222346799999999999764 36789999999999999999988764322111 001
Q ss_pred hHHHHHHHhhcCCccccccccccCC-CCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 431 LLTYTWKLWCEGHAVELIDPVLKQS-CAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 431 ~~~~~~~~~~~~~~~~l~~~~l~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
............. +++.+... ...+....+.+|+.+||+.||++|||+.+|++.|+..
T Consensus 237 ~~~~~~~~~~~~~----~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l 295 (303)
T 3hmm_A 237 SVEEMRKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp CHHHHHHHHTTSC----CCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred hHHHHHHHHhccc----CCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 1111112111111 11111111 1234556788889999999999999999999999764
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-51 Score=403.69 Aligned_cols=251 Identities=25% Similarity=0.345 Sum_probs=190.0
Q ss_pred cCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC-hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCc--------
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQ-------- 285 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-------- 285 (536)
++|++++.||+|+||+||+|+++ +|+.||||++.... ....+.+.+|+.+|++++|||||+++++|.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 46899999999999999999975 68999999997543 344577899999999999999999999987543
Q ss_pred ----eEEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEec
Q 039168 286 ----ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISD 361 (536)
Q Consensus 286 ----~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~D 361 (536)
.+|+|||||++|+|.+++.........++..++.++.||++||+|||+++ |+||||||+||||+.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEcc
Confidence 47999999999999999976555455677888999999999999999997 99999999999999999999999
Q ss_pred ccCccccCCCCCcc----------ccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchh
Q 039168 362 FGTARIFGGNQNQA----------NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTL 431 (536)
Q Consensus 362 fg~a~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~ 431 (536)
||+|+.+....... .....+||+.|||||++.+..|+.++|||||||++|||++ ||... ...
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~-----~~~ 233 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ-----MER 233 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH-----HHH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc-----cHH
Confidence 99999875433221 1233579999999999999999999999999999999996 54311 011
Q ss_pred HHHHHHHhhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 432 LTYTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 432 ~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
.. ............. .+.....+.+++.+||++||++|||+.++++
T Consensus 234 ~~-~~~~~~~~~~p~~---------~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 234 VR-TLTDVRNLKFPPL---------FTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HH-HHHHHHTTCCCHH---------HHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HH-HHHHHhcCCCCCC---------CcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11 1111112111111 1122234566788999999999999999987
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-52 Score=411.79 Aligned_cols=247 Identities=23% Similarity=0.297 Sum_probs=193.2
Q ss_pred cCCccccccCCCCceeEEEEEeC----CCcEEEEEEccccC--hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEE
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA----DGKAIAVKRLSRTS--GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 289 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 289 (536)
++|++++.||+|+||+||+|+.. .++.||||++.+.. ......+.+|+++|++++|||||++++++.+++.+|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999863 47899999987542 2233468889999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccC
Q 039168 290 IYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFG 369 (536)
Q Consensus 290 v~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 369 (536)
|||||+||+|.+++... ..+++.++..++.||+.||+|||+++ |+||||||+|||++.+|++||+|||+|+...
T Consensus 104 vmEy~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKE---VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EECCCTTCEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred EEEcCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 99999999999999643 35999999999999999999999997 9999999999999999999999999998654
Q ss_pred CCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcccccc
Q 039168 370 GNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELID 449 (536)
Q Consensus 370 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 449 (536)
.... .....+||+.|||||++.+..|+.++|||||||++|||++|+.||..... .... .... .... .
T Consensus 178 ~~~~--~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~---~~~~---~~i~-~~~~-~--- 244 (304)
T 3ubd_A 178 DHEK--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR---KETM---TMIL-KAKL-G--- 244 (304)
T ss_dssp ---C--CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHH---HHHH-HCCC-C---
T ss_pred CCCc--cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCH---HHHH---HHHH-cCCC-C---
Confidence 3322 23346899999999999999999999999999999999999999864221 1111 1111 1111 1
Q ss_pred ccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCH-----HHHHH
Q 039168 450 PVLKQSCAPDELLKFIHIGLLCVQQDPADRPTM-----SSVVV 487 (536)
Q Consensus 450 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~-----~evl~ 487 (536)
..... ++ ++.+++.+||++||++|||+ +|+++
T Consensus 245 --~p~~~-s~---~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 245 --MPQFL-SP---EAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp --CCTTS-CH---HHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred --CCCcC-CH---HHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 11112 22 35566679999999999984 67764
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=394.92 Aligned_cols=263 Identities=19% Similarity=0.280 Sum_probs=199.5
Q ss_pred hcCCccccccCCCCceeEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHHHcCCCCceeEeeEEee------Cc
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLE------GQ 285 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~------~~ 285 (536)
.++|+++++||+|+||+||+|+++ +|+.||||++... .....+.+.+|+++|+.++|||||++++++.. .+
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 368999999999999999999975 6999999999754 23445678899999999999999999999764 36
Q ss_pred eEEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCc
Q 039168 286 ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTA 365 (536)
Q Consensus 286 ~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 365 (536)
.+|||||||+ |+|..++.. ...+++.++..++.||+.||.|||+++ ||||||||+|||++.++.+||+|||++
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~---~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla 205 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHS---SQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMA 205 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTS---SSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEEeCCC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeeccee
Confidence 7999999996 578888843 346999999999999999999999997 999999999999999999999999999
Q ss_pred cccCCCC--CccccccccccccccCcchhcCCC-CCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcC
Q 039168 366 RIFGGNQ--NQANTNIIAGTYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEG 442 (536)
Q Consensus 366 ~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 442 (536)
+.+.... ........+||+.|||||++.+.. ++.++||||+||++|||++|+.||..... ...+..+.......
T Consensus 206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~---~~~l~~I~~~~g~p 282 (398)
T 4b99_A 206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNY---VHQLQLIMMVLGTP 282 (398)
T ss_dssp BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSH---HHHHHHHHHHHCCC
T ss_pred eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCH---HHHHHHHHHhcCCC
Confidence 8765432 222334578999999999998764 69999999999999999999999864322 11222221111111
Q ss_pred Ccccccc----------cccc--CCCCH-----HHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 443 HAVELID----------PVLK--QSCAP-----DELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 443 ~~~~l~~----------~~l~--~~~~~-----~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
....... ..+. ...+. ....++++|+.+||+.||++|||+.|+|+
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 283 SPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp CGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0000000 0000 00000 01234667778999999999999999986
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=384.29 Aligned_cols=280 Identities=37% Similarity=0.656 Sum_probs=242.4
Q ss_pred hHHHHhcCCccccccCCCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEE
Q 039168 210 LALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 289 (536)
Q Consensus 210 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 289 (536)
.+....++|+..+.||+|+||.||+|++++++.||||++........+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 33 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 112 (321)
T 2qkw_B 33 DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMIL 112 (321)
T ss_dssp CCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEE
T ss_pred HHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEE
Confidence 34456789999999999999999999988899999999987776777889999999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhcccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCcccc
Q 039168 290 IYEYMPNKSLDVHLFDATR-SVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIF 368 (536)
Q Consensus 290 v~e~~~~~sL~~~l~~~~~-~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 368 (536)
||||+++++|.+++..... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 189 (321)
T 2qkw_B 113 IYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKG 189 (321)
T ss_dssp EEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTCEEC
T ss_pred EEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeeccccccc
Confidence 9999999999999865432 235899999999999999999999996 999999999999999999999999999876
Q ss_pred CCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccc
Q 039168 369 GGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELI 448 (536)
Q Consensus 369 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 448 (536)
.............||+.|+|||++.+..++.++||||||+++|+|++|+.||.............+.......+.....+
T Consensus 190 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (321)
T 2qkw_B 190 TELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIV 269 (321)
T ss_dssp SSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSS
T ss_pred ccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhc
Confidence 54333333344568999999999999999999999999999999999999997766655555555555555566666677
Q ss_pred cccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 449 DPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 449 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
++.+.....+.....+.+++.+||+.||++|||+.++++.|+..
T Consensus 270 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 313 (321)
T 2qkw_B 270 DPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA 313 (321)
T ss_dssp SSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 77776677788888999999999999999999999999999864
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-48 Score=392.69 Aligned_cols=198 Identities=26% Similarity=0.352 Sum_probs=170.7
Q ss_pred HhcCCccccccCCCCceeEEEEEeC----CCcEEEEEEccccChhhHHHHHHHHHHHHHc-CCCCceeEeeEEeeCceEE
Q 039168 214 ATNHFSDENKLGQGGFGPVYKGTLA----DGKAIAVKRLSRTSGQGLKEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELL 288 (536)
Q Consensus 214 ~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~ 288 (536)
..++|++.++||+|+||+||+|+++ .++.||||++..... ...+.+|+++|+.+ +||||+++++++.+.+++|
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~--~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~ 96 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH--PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV 96 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC--HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC--HHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence 4578999999999999999999853 478899999865543 35688999999998 6999999999999999999
Q ss_pred EEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCC-CCeEEecccCccc
Q 039168 289 LIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDD-MNPKISDFGTARI 367 (536)
Q Consensus 289 lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~-~~~kl~Dfg~a~~ 367 (536)
+||||+++++|.+++. .+++.++..++.||+.||+|||++| |+||||||+|||++.+ +++||+|||+|+.
T Consensus 97 lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~~ 167 (361)
T 4f9c_A 97 IAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQG 167 (361)
T ss_dssp EEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence 9999999999999882 3899999999999999999999997 9999999999999876 7999999999986
Q ss_pred cCCCCCc--------------------------cccccccccccccCcchhcCC-CCCccchHHHHHHHHHHHHhCCCCC
Q 039168 368 FGGNQNQ--------------------------ANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNN 420 (536)
Q Consensus 368 ~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~ 420 (536)
....... ......+||+.|+|||++.+. .|+.++||||+||++|||++|+.||
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf 247 (361)
T 4f9c_A 168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF 247 (361)
T ss_dssp CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCC
Confidence 5432211 112235799999999999876 4899999999999999999999998
Q ss_pred CC
Q 039168 421 GF 422 (536)
Q Consensus 421 ~~ 422 (536)
..
T Consensus 248 ~~ 249 (361)
T 4f9c_A 248 YK 249 (361)
T ss_dssp SC
T ss_pred CC
Confidence 43
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=379.62 Aligned_cols=293 Identities=41% Similarity=0.679 Sum_probs=242.6
Q ss_pred CCCCcChhhHHHHhcCCccccccCCCCceeEEEEEeCCCcEEEEEEccccChh-hHHHHHHHHHHHHHcCCCCceeEeeE
Q 039168 202 EFPLFPLGLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQ-GLKEFKNEVNLIAKLQHKNLVRLLGC 280 (536)
Q Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~ 280 (536)
....++...+....++|++.+.||+|+||.||+|...+++.||||++...... ....+.+|+.+++.++||||++++++
T Consensus 16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 95 (326)
T 3uim_A 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 95 (326)
T ss_dssp CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred ccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence 34457778888889999999999999999999999888999999998754322 23368899999999999999999999
Q ss_pred EeeCceEEEEEeecCCCChhhhhhccc-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEE
Q 039168 281 CLEGQELLLIYEYMPNKSLDVHLFDAT-RSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKI 359 (536)
Q Consensus 281 ~~~~~~~~lv~e~~~~~sL~~~l~~~~-~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl 359 (536)
+...+..++||||+++++|.+++.... ....+++..++.++.||+.||.|||++...+|+||||||+|||++.++.+||
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl 175 (326)
T 3uim_A 96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV 175 (326)
T ss_dssp ECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEE
T ss_pred EecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEe
Confidence 999999999999999999999997643 2345999999999999999999999982223999999999999999999999
Q ss_pred ecccCccccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCC--ccCCchhHHHHHH
Q 039168 360 SDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYF--SEHGQTLLTYTWK 437 (536)
Q Consensus 360 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~--~~~~~~~~~~~~~ 437 (536)
+|||+++........ ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.... .........+...
T Consensus 176 ~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 254 (326)
T 3uim_A 176 GDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 254 (326)
T ss_dssp CCCSSCEECCSSSSC-EECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTT
T ss_pred ccCccccccCccccc-ccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHH
Confidence 999999876533322 2333568999999999999899999999999999999999999986321 2222334444444
Q ss_pred HhhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccCCCC
Q 039168 438 LWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSMT 495 (536)
Q Consensus 438 ~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 495 (536)
.........+.+..+...........+.+++.+||+.||++|||+.+|++.|++....
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~ 312 (326)
T 3uim_A 255 LLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLA 312 (326)
T ss_dssp TTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCS
T ss_pred HhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchh
Confidence 4555566666777777778888899999999999999999999999999999986443
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-47 Score=406.07 Aligned_cols=248 Identities=25% Similarity=0.286 Sum_probs=196.4
Q ss_pred cCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHH---HHHHHHHHcCCCCceeEeeEEeeCceEE
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLKEFK---NEVNLIAKLQHKNLVRLLGCCLEGQELL 288 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~---~E~~~l~~l~hpniv~l~~~~~~~~~~~ 288 (536)
++|+++++||+|+||.||+|+.+ +|+.||||++.+.. ......+. .++.+++.++|||||+++++|.+.+.+|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 67999999999999999999976 59999999986432 11223333 4466677779999999999999999999
Q ss_pred EEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCcccc
Q 039168 289 LIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIF 368 (536)
Q Consensus 289 lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 368 (536)
|||||++||+|..+|... ..+++..+..++.||+.||+|||+++ ||||||||+||||+.+|++||+|||+|+.+
T Consensus 269 lVmEy~~GGdL~~~l~~~---~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~~ 342 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 342 (689)
T ss_dssp EEECCCCSCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeeec
Confidence 999999999999999643 45999999999999999999999997 999999999999999999999999999877
Q ss_pred CCCCCccccccccccccccCcchhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcccc
Q 039168 369 GGNQNQANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVEL 447 (536)
Q Consensus 369 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 447 (536)
.... ....+||+.|||||++.+ ..|+.++|||||||++|||++|+.||....... .......... ...
T Consensus 343 ~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~---~~~i~~~i~~-~~~--- 411 (689)
T 3v5w_A 343 SKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD---KHEIDRMTLT-MAV--- 411 (689)
T ss_dssp SSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCC---HHHHHHHHHH-CCC---
T ss_pred CCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHhhcC-CCC---
Confidence 5432 334689999999999975 579999999999999999999999986432221 1111111111 111
Q ss_pred ccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCC-----HHHHHH
Q 039168 448 IDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPT-----MSSVVV 487 (536)
Q Consensus 448 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~ 487 (536)
...... +. ++.+|+.+||+.||.+|++ +.||++
T Consensus 412 ---~~p~~~-S~---~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 412 ---ELPDSF-SP---ELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp ---CCCTTS-CH---HHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred ---CCCccC-CH---HHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 111112 22 3556667999999999998 678774
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=405.02 Aligned_cols=252 Identities=23% Similarity=0.338 Sum_probs=207.0
Q ss_pred hcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEee
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 293 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 293 (536)
.++|++.+.||+|+||.||+|+++ +|+.||||++........+.+.+|+.+|+.|+|||||+++++|.+.+.+||||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 368999999999999999999975 5999999999877766778899999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCC--CCeEEecccCccccCCC
Q 039168 294 MPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDD--MNPKISDFGTARIFGGN 371 (536)
Q Consensus 294 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~--~~~kl~Dfg~a~~~~~~ 371 (536)
|+||+|.++|... ...+++.++..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+++.+...
T Consensus 236 ~~gg~L~~~i~~~--~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~ 310 (573)
T 3uto_A 236 MSGGELFEKVADE--HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 310 (573)
T ss_dssp CCCCBHHHHHTCT--TSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred cCCCcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence 9999999988542 345899999999999999999999997 9999999999999854 89999999999987543
Q ss_pred CCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcccccccc
Q 039168 372 QNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPV 451 (536)
Q Consensus 372 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 451 (536)
. .....+||+.|||||++.+..|+.++|||||||++|||++|+.||...... .... . ...... . +...
T Consensus 311 ~---~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~---~~~~---~-i~~~~~-~-~~~~ 378 (573)
T 3uto_A 311 Q---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD---ETLR---N-VKSCDW-N-MDDS 378 (573)
T ss_dssp S---EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHHH---H-HHTTCC-C-CCSG
T ss_pred C---ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH---HHHH---H-HHhCCC-C-CCcc
Confidence 2 233468999999999999999999999999999999999999998543221 1111 1 111111 0 0111
Q ss_pred ccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 452 LKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 452 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
..... + ..+.+|+.+||+.||.+|||+.|+|+
T Consensus 379 ~~~~~-s---~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 379 AFSGI-S---EDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp GGTTS-C---HHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cccCC-C---HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11111 2 23556677999999999999999997
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-44 Score=354.68 Aligned_cols=283 Identities=37% Similarity=0.566 Sum_probs=228.2
Q ss_pred CCCCcChhhHHHHhcCCccc------cccCCCCceeEEEEEeCCCcEEEEEEcccc----ChhhHHHHHHHHHHHHHcCC
Q 039168 202 EFPLFPLGLALEATNHFSDE------NKLGQGGFGPVYKGTLADGKAIAVKRLSRT----SGQGLKEFKNEVNLIAKLQH 271 (536)
Q Consensus 202 ~~~~~~~~~~~~~~~~~~~~------~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h 271 (536)
....+++..+...+++|... ++||+|+||.||+|.. +++.||||++... .....+.+.+|+.++++++|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 34557778888888888776 8999999999999997 6889999998643 23446789999999999999
Q ss_pred CCceeEeeEEeeCceEEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEE
Q 039168 272 KNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLL 351 (536)
Q Consensus 272 pniv~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll 351 (536)
|||+++++++.+.+..++||||+++++|.+++........+++..++.++.||+.||.|||+++ |+||||||+|||+
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili 166 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILL 166 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEE
Confidence 9999999999999999999999999999999976555567999999999999999999999997 9999999999999
Q ss_pred cCCCCeEEecccCccccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchh
Q 039168 352 DDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTL 431 (536)
Q Consensus 352 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~ 431 (536)
+.++.+||+|||++................||+.|+|||.+.+ .++.++||||||+++|+|++|+.||........ .
T Consensus 167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~ 243 (307)
T 2nru_A 167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQL--L 243 (307)
T ss_dssp CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSB--T
T ss_pred cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHH--H
Confidence 9999999999999987654443333444678999999998865 588999999999999999999999875433221 1
Q ss_pred HHHHHHHhh-cCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 432 LTYTWKLWC-EGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 432 ~~~~~~~~~-~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
..+...... ...+...+++.+ ..........+.+++.+||+.||.+|||+.+|++.|+..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l 304 (307)
T 2nru_A 244 LDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304 (307)
T ss_dssp THHHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred HHHHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 111111111 111222233322 234566677888899999999999999999999999864
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=360.95 Aligned_cols=260 Identities=30% Similarity=0.487 Sum_probs=211.5
Q ss_pred hcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEee
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 293 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 293 (536)
.++|++.++||+|+||.||+|.+. +++.||+|++........+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 368899999999999999999975 5899999999877777788899999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCC
Q 039168 294 MPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQN 373 (536)
Q Consensus 294 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 373 (536)
+++++|.+++... ...+++.+++.++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 89 ~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 89 IKGGTLRGIIKSM--DSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163 (310)
T ss_dssp CTTCBHHHHHHHC--CTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred cCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence 9999999999653 345899999999999999999999997 99999999999999999999999999987654332
Q ss_pred cc------------ccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhc
Q 039168 374 QA------------NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCE 441 (536)
Q Consensus 374 ~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 441 (536)
.. ......||+.|+|||++.+..++.++||||||+++|+|++|..|+.................
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~---- 239 (310)
T 3s95_A 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGF---- 239 (310)
T ss_dssp ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHH----
T ss_pred cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcc----
Confidence 11 11145799999999999999999999999999999999999999865443322111111000
Q ss_pred CCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccCC
Q 039168 442 GHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDS 493 (536)
Q Consensus 442 ~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 493 (536)
.+....... ...+.+++.+||+.||++|||+.++++.|+...
T Consensus 240 ------~~~~~~~~~----~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~ 281 (310)
T 3s95_A 240 ------LDRYCPPNC----PPSFFPITVRCCDLDPEKRPSFVKLEHWLETLR 281 (310)
T ss_dssp ------HHHTCCTTC----CTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ------ccccCCCCC----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 001111111 123666777999999999999999999998753
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-45 Score=364.08 Aligned_cols=262 Identities=29% Similarity=0.444 Sum_probs=202.1
Q ss_pred hcCCccccccCCCCceeEEEEEeCCCcEEEEEEccccC--hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEe
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTS--GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 292 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 292 (536)
.++|++.+.||+|+||.||+|++ +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 36 ~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 114 (309)
T 3p86_A 36 WCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTE 114 (309)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEE
T ss_pred hhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEe
Confidence 46899999999999999999987 68899999987543 4445778999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCC
Q 039168 293 YMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQ 372 (536)
Q Consensus 293 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 372 (536)
|+++++|.+++........+++..++.++.||+.||.|||+++ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 115 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~ 193 (309)
T 3p86_A 115 YLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTF 193 (309)
T ss_dssp CCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC---------
T ss_pred cCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCccccccc
Confidence 9999999999976444445899999999999999999999883 239999999999999999999999999998654322
Q ss_pred CccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccccc
Q 039168 373 NQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVL 452 (536)
Q Consensus 373 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l 452 (536)
.......||+.|+|||++.+..++.++||||||+++|+|++|+.||...... .............. +
T Consensus 194 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~------~~~~~~~~~~~~~~-----~ 260 (309)
T 3p86_A 194 --LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPA------QVVAAVGFKCKRLE-----I 260 (309)
T ss_dssp ----------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHH------HHHHHHHHSCCCCC-----C
T ss_pred --cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhcCCCCC-----C
Confidence 1223457899999999999999999999999999999999999998643221 11111111111111 1
Q ss_pred cCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccCCCC
Q 039168 453 KQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSMT 495 (536)
Q Consensus 453 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 495 (536)
.... + ..+.+++.+||+.||++|||+.++++.|+.....
T Consensus 261 ~~~~-~---~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 261 PRNL-N---PQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp CTTS-C---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred CccC-C---HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 1112 2 2466677799999999999999999999886433
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=352.85 Aligned_cols=252 Identities=23% Similarity=0.376 Sum_probs=206.3
Q ss_pred HhcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEe
Q 039168 214 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 292 (536)
Q Consensus 214 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 292 (536)
..++|++.++||+|+||.||+|.+. +++.||||++........+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 97 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence 3478999999999999999999964 689999999976665566788999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCC
Q 039168 293 YMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQ 372 (536)
Q Consensus 293 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 372 (536)
|+++++|.+++... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++++||+|||++.......
T Consensus 98 ~~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (297)
T 3fxz_A 98 YLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (297)
T ss_dssp CCTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred CCCCCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence 99999999998542 4899999999999999999999997 9999999999999999999999999998765433
Q ss_pred CccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccccc
Q 039168 373 NQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVL 452 (536)
Q Consensus 373 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l 452 (536)
. ......||+.|+|||++.+..++.++||||||+++|+|++|+.||...... ............ .+..
T Consensus 171 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~~~~~~~~~~~~-~~~~--- 238 (297)
T 3fxz_A 171 S--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL------RALYLIATNGTP-ELQN--- 238 (297)
T ss_dssp C--CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHHCSC-CCSC---
T ss_pred c--ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCCC-CCCC---
Confidence 2 233457999999999999999999999999999999999999998543221 111111111111 1100
Q ss_pred cCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 453 KQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 453 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
+......+.+++.+||+.||++|||+.++++.
T Consensus 239 ----~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 239 ----PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp ----GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ----ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 11112345667779999999999999999863
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=368.85 Aligned_cols=259 Identities=30% Similarity=0.437 Sum_probs=210.0
Q ss_pred hcCCccccccCCCCceeEEEEEeC--------CCcEEEEEEcccc-ChhhHHHHHHHHHHHHHc-CCCCceeEeeEEeeC
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA--------DGKAIAVKRLSRT-SGQGLKEFKNEVNLIAKL-QHKNLVRLLGCCLEG 284 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~ 284 (536)
.++|++.+.||+|+||.||+|++. ++..||||++... .....+.+.+|+.+++++ +||||+++++++.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 468999999999999999999852 3567999999755 334567899999999999 899999999999999
Q ss_pred ceEEEEEeecCCCChhhhhhcccC-------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEE
Q 039168 285 QELLLIYEYMPNKSLDVHLFDATR-------------SVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLL 351 (536)
Q Consensus 285 ~~~~lv~e~~~~~sL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll 351 (536)
+.+++||||+++++|.+++..... ...+++.+++.++.||+.||.|||+++ |+||||||+||||
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence 999999999999999999975431 235889999999999999999999997 9999999999999
Q ss_pred cCCCCeEEecccCccccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCch
Q 039168 352 DDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQT 430 (536)
Q Consensus 352 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~ 430 (536)
+.++.+||+|||+++.+.............+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... .
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~---~ 313 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE---E 313 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---G
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH---H
Confidence 9999999999999987765443333444567889999999999999999999999999999999 99997643221 1
Q ss_pred hHHHHHHHhhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 431 LLTYTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 431 ~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
... ....+..... ... ....+.+++.+||+.||++|||+.++++.|+..
T Consensus 314 ~~~----~~~~~~~~~~-----~~~----~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~i 362 (370)
T 2psq_A 314 LFK----LLKEGHRMDK-----PAN----CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 362 (370)
T ss_dssp HHH----HHHTTCCCCC-----CTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHH----HHhcCCCCCC-----CCC----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 111 1122211111 111 123466677799999999999999999999864
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-44 Score=359.77 Aligned_cols=248 Identities=26% Similarity=0.369 Sum_probs=203.7
Q ss_pred hcCCccccccCCCCceeEEEEEe-CCCcEEEEEEcccc--ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEE
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRT--SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 291 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 291 (536)
.++|++.+.||+|+||.||+|++ .+|+.||||++... .....+.+.+|+++|+.++||||+++++++...+..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 36899999999999999999997 47999999998654 3445677889999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCC
Q 039168 292 EYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGN 371 (536)
Q Consensus 292 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 371 (536)
||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++++||+|||++......
T Consensus 94 e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 167 (328)
T 3fe3_A 94 EYASGGEVFDYLVAH---GRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG 167 (328)
T ss_dssp CCCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred ECCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence 999999999998654 34899999999999999999999997 999999999999999999999999999876533
Q ss_pred CCccccccccccccccCcchhcCCCCC-ccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccc
Q 039168 372 QNQANTNIIAGTYGYMAPEYAMGGIFS-IKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDP 450 (536)
Q Consensus 372 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 450 (536)
. ......||+.|+|||++.+..+. .++|||||||++|+|++|+.||..... ........ .+...
T Consensus 168 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~------~~~~~~i~-~~~~~----- 232 (328)
T 3fe3_A 168 G---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL------KELRERVL-RGKYR----- 232 (328)
T ss_dssp C---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHH-HCCCC-----
T ss_pred C---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH------HHHHHHHH-hCCCC-----
Confidence 2 23346799999999999988864 899999999999999999999864321 11111111 11110
Q ss_pred cccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 451 VLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 451 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
+... .+ ..+.+++.+||+.||.+|||+.++++.
T Consensus 233 -~p~~-~s---~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 233 -IPFY-MS---TDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp -CCTT-SC---HHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred -CCCC-CC---HHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 1111 12 345667779999999999999999864
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-44 Score=358.04 Aligned_cols=266 Identities=24% Similarity=0.333 Sum_probs=207.4
Q ss_pred hcCCccccccCCCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCc----eEEEE
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQ----ELLLI 290 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~----~~~lv 290 (536)
.++|++.++||+|+||.||+|++. ++.||||++..... ....+.+|+.++++++||||+++++++.... .+++|
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 368999999999999999999885 78999999965433 3345567999999999999999999998743 47999
Q ss_pred EeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcC----------CCCCeeeCCCCCCcEEEcCCCCeEEe
Q 039168 291 YEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHED----------SRLKIIHRDLKASNVLLDDDMNPKIS 360 (536)
Q Consensus 291 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~----------~~~~ivH~Dikp~NIll~~~~~~kl~ 360 (536)
|||+++++|.+++.. ..+++..++.++.||+.||.|||+. + |+||||||+|||++.++.+||+
T Consensus 101 ~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL~ 173 (322)
T 3soc_A 101 TAFHEKGSLSDFLKA----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACIA 173 (322)
T ss_dssp EECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEEC
T ss_pred EecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEEc
Confidence 999999999999954 2389999999999999999999988 6 9999999999999999999999
Q ss_pred cccCccccCCCCCccccccccccccccCcchhcCC-----CCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhH---
Q 039168 361 DFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGG-----IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLL--- 432 (536)
Q Consensus 361 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~--- 432 (536)
|||+++.+.............||+.|+|||++.+. .++.++||||||+++|||++|+.||............
T Consensus 174 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~ 253 (322)
T 3soc_A 174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEI 253 (322)
T ss_dssp CCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHH
T ss_pred cCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhh
Confidence 99999887655444444446799999999999873 4677899999999999999999998654332211111
Q ss_pred ------HHHHHHhhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 433 ------TYTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 433 ------~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
...............+..... .......+.+++.+||+.||++|||+.+|++.|+..
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l 316 (322)
T 3soc_A 254 GQHPSLEDMQEVVVHKKKRPVLRDYWQ---KHAGMAMLCETIEECWDHDAEARLSAGCVGERITQM 316 (322)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGG---SSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ccCCchhhhhhhhhcccCCCCcccccc---ccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 011111111111111111111 123445678888899999999999999999999864
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-43 Score=350.74 Aligned_cols=273 Identities=21% Similarity=0.260 Sum_probs=214.5
Q ss_pred hcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC-hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCc--eEEEE
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQ--ELLLI 290 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~--~~~lv 290 (536)
.++|++.++||+|+||.||+|++. +++.||||++.... ....+.+.+|++++++++||||+++++++.... ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 468999999999999999999986 48999999987543 334677889999999999999999999998765 78999
Q ss_pred EeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEE----cCCCCeEEecccCcc
Q 039168 291 YEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLL----DDDMNPKISDFGTAR 366 (536)
Q Consensus 291 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll----~~~~~~kl~Dfg~a~ 366 (536)
|||+++++|.+++........+++..++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 999999999999977655556999999999999999999999997 9999999999999 778889999999998
Q ss_pred ccCCCCCccccccccccccccCcchhc--------CCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCc-hhHHHHHH
Q 039168 367 IFGGNQNQANTNIIAGTYGYMAPEYAM--------GGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQ-TLLTYTWK 437 (536)
Q Consensus 367 ~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~-~~~~~~~~ 437 (536)
....... .....||+.|+|||++. +..++.++|||||||++|||++|+.||......... ..+.....
T Consensus 165 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 241 (319)
T 4euu_A 165 ELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (319)
T ss_dssp ECCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHH
T ss_pred ecCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhc
Confidence 7654332 22356899999999986 567899999999999999999999998654332222 11111111
Q ss_pred HhhcCCccccc-----------cccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccCC
Q 039168 438 LWCEGHAVELI-----------DPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDS 493 (536)
Q Consensus 438 ~~~~~~~~~l~-----------~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 493 (536)
......+..+. ...............+.+++.+||+.||++|||++|+++..+...
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp HCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred CCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 11000000000 001111334556667788889999999999999999999988753
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=355.88 Aligned_cols=254 Identities=26% Similarity=0.352 Sum_probs=202.4
Q ss_pred hcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccCh-hhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEe
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG-QGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 292 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 292 (536)
.++|++.+.||+|+||.||+|.+. +++.||||++..... ...+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 478999999999999999999976 689999999865432 334668899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCC
Q 039168 293 YMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQ 372 (536)
Q Consensus 293 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 372 (536)
|+++++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..+....
T Consensus 86 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 159 (323)
T 3tki_A 86 YCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (323)
T ss_dssp CCTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred cCCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence 9999999999843 345899999999999999999999997 9999999999999999999999999998765443
Q ss_pred CccccccccccccccCcchhcCCCC-CccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcccccccc
Q 039168 373 NQANTNIIAGTYGYMAPEYAMGGIF-SIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPV 451 (536)
Q Consensus 373 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 451 (536)
.........||+.|+|||++.+..+ +.++||||||+++|+|++|+.||........ . ...+....... .+
T Consensus 160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~---~~~~~~~~~~~--~~- 230 (323)
T 3tki_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ---E---YSDWKEKKTYL--NP- 230 (323)
T ss_dssp EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH---H---HHHHHTTCTTS--TT-
T ss_pred cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH---H---HHHHhcccccC--Cc-
Confidence 3333445679999999999988775 7899999999999999999999864332211 1 11111111100 00
Q ss_pred ccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 452 LKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 452 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
.......+.+++.+||+.||++|||+.|+++.
T Consensus 231 -----~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 231 -----WKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp -----GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -----cccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 01112345567779999999999999999864
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-44 Score=358.91 Aligned_cols=255 Identities=28% Similarity=0.459 Sum_probs=198.8
Q ss_pred hcCCccccccCCCCceeEEEEEeC-CCc----EEEEEEcccc-ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEE
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA-DGK----AIAVKRLSRT-SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELL 288 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 288 (536)
.++|++.++||+|+||.||+|++. +++ +||+|.+... .....+.+.+|+.++++++||||+++++++.+.. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 367999999999999999999864 343 4688887543 3345678999999999999999999999998764 78
Q ss_pred EEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCcccc
Q 039168 289 LIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIF 368 (536)
Q Consensus 289 lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 368 (536)
+|+||+.+++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++++||+|||+++.+
T Consensus 93 ~v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEEECCTTCBHHHHHHHS--TTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred EEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 999999999999998653 345899999999999999999999997 999999999999999999999999999987
Q ss_pred CCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHHHHHhhcCCcccc
Q 039168 369 GGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVEL 447 (536)
Q Consensus 369 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 447 (536)
.............+|+.|+|||++.+..++.++||||||+++|||++ |+.||....... ... ....+....
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~~----~~~~~~~~~- 239 (327)
T 3poz_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISS----ILEKGERLP- 239 (327)
T ss_dssp TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHH----HHHTTCCCC-
T ss_pred cCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH---HHH----HHHcCCCCC-
Confidence 65544444444567889999999999999999999999999999999 999986433221 111 111111111
Q ss_pred ccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcc
Q 039168 448 IDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 491 (536)
Q Consensus 448 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 491 (536)
.+......+.+++.+||+.||++|||+.++++.|+.
T Consensus 240 --------~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~ 275 (327)
T 3poz_A 240 --------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 275 (327)
T ss_dssp --------CCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHH
T ss_pred --------CCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence 111223356777889999999999999999999865
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-44 Score=358.34 Aligned_cols=257 Identities=28% Similarity=0.434 Sum_probs=204.9
Q ss_pred hcCCccccccCCCCceeEEEEEeC----CCcEEEEEEcccc-ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEE
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA----DGKAIAVKRLSRT-SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 289 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 289 (536)
.++|++.+.||+|+||.||+|.+. .+..||||++... .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 467999999999999999999974 3456999999764 44456789999999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccC
Q 039168 290 IYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFG 369 (536)
Q Consensus 290 v~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 369 (536)
||||+++++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 128 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTH--DGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202 (325)
T ss_dssp EEECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EeeCCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence 99999999999998543 345899999999999999999999997 9999999999999999999999999998775
Q ss_pred CCCCcc-ccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHHHHHhhcCCcccc
Q 039168 370 GNQNQA-NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVEL 447 (536)
Q Consensus 370 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 447 (536)
...... ......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||...... .. ......+....
T Consensus 203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~---~~----~~~~~~~~~~~- 274 (325)
T 3kul_A 203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR---DV----ISSVEEGYRLP- 274 (325)
T ss_dssp ----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH---HH----HHHHHTTCCCC-
T ss_pred cCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH---HH----HHHHHcCCCCC-
Confidence 433221 2222346778999999999999999999999999999999 99997543221 11 11111111111
Q ss_pred ccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 448 IDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 448 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
.... ....+.+++.+||+.||++|||+.+|++.|+..
T Consensus 275 ----~~~~----~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l 311 (325)
T 3kul_A 275 ----APMG----CPHALHQLMLDCWHKDRAQRPRFSQIVSVLDAL 311 (325)
T ss_dssp ----CCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCCC----cCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1111 123466677799999999999999999999875
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=359.12 Aligned_cols=264 Identities=27% Similarity=0.432 Sum_probs=204.3
Q ss_pred hcCCccccccCCCCceeEEEEEe-----CCCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeC--ceE
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTL-----ADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEG--QEL 287 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~ 287 (536)
.++|++.++||+|+||.||++++ .+++.||||++........+.+.+|+.++++++||||+++++++... ...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 46899999999999999999983 35899999999887777778899999999999999999999998653 568
Q ss_pred EEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccc
Q 039168 288 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARI 367 (536)
Q Consensus 288 ~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 367 (536)
++||||+++++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++++||+|||++..
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~ 163 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV 163 (295)
T ss_dssp EEEEECCTTCBHHHHHHHCG--GGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred EEEEEeCCCCCHHHHHHhcc--cccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCccccc
Confidence 99999999999999996533 34899999999999999999999997 99999999999999999999999999987
Q ss_pred cCCCCCc-cccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCcc---------CCchhHHHHHH
Q 039168 368 FGGNQNQ-ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSE---------HGQTLLTYTWK 437 (536)
Q Consensus 368 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~---------~~~~~~~~~~~ 437 (536)
....... .......++..|+|||.+.+..++.++||||||+++|+|++|..|+...... ...........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (295)
T 3ugc_A 164 LPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 243 (295)
T ss_dssp ------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred ccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHH
Confidence 6543321 1222345678899999999999999999999999999999999987542111 00111111111
Q ss_pred HhhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 438 LWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 438 ~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
......... .+......+.+++.+||+.||++|||+.++++.|+..
T Consensus 244 ~~~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l 289 (295)
T 3ugc_A 244 LLKNNGRLP---------RPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 289 (295)
T ss_dssp HHHTTCCCC---------CCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred HHhccCcCC---------CCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 111111111 1111223466677799999999999999999999864
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=348.79 Aligned_cols=248 Identities=23% Similarity=0.364 Sum_probs=203.2
Q ss_pred CccccccCCCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEeecCC
Q 039168 218 FSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPN 296 (536)
Q Consensus 218 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 296 (536)
|+..++||+|+||.||+|++. +|+.||||++........+.+.+|+.++++++||||+++++++...+..++||||+++
T Consensus 47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 126 (321)
T 2c30_A 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQG 126 (321)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCS
T ss_pred hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCC
Confidence 677789999999999999986 6999999999876666678899999999999999999999999999999999999999
Q ss_pred CChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCCccc
Q 039168 297 KSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQAN 376 (536)
Q Consensus 297 ~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 376 (536)
++|.+++.. ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++++||+|||++.........
T Consensus 127 ~~L~~~l~~----~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~-- 197 (321)
T 2c30_A 127 GALTDIVSQ----VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK-- 197 (321)
T ss_dssp CBHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC--
T ss_pred CCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCcEEEeeeeeeeecccCccc--
Confidence 999998843 34899999999999999999999997 999999999999999999999999999876543222
Q ss_pred cccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccccccCCC
Q 039168 377 TNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQSC 456 (536)
Q Consensus 377 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~ 456 (536)
.....||+.|+|||++.+..++.++||||||+++|+|++|+.||...... ... ..........+... ..
T Consensus 198 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~------~~~-~~~~~~~~~~~~~~---~~- 266 (321)
T 2c30_A 198 RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV------QAM-KRLRDSPPPKLKNS---HK- 266 (321)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHH-HHHHHSSCCCCTTG---GG-
T ss_pred cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHH-HHHhcCCCCCcCcc---cc-
Confidence 23457999999999999999999999999999999999999997543211 111 11111111111000 01
Q ss_pred CHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 457 APDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 457 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
.+ ..+.+++.+||+.||++|||+.++++.
T Consensus 267 ~~---~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 267 VS---PVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp SC---HHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CC---HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 12 245666779999999999999999974
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=355.23 Aligned_cols=248 Identities=23% Similarity=0.260 Sum_probs=202.2
Q ss_pred cCCccccccCCCCceeEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEE
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 291 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 291 (536)
++|++.+.||+|+||.||+++.+ +++.||||++.+. .......+.+|+.+|+.++||||+++++++...+..++||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 68999999999999999999976 5899999998754 2334567889999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCC
Q 039168 292 EYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGN 371 (536)
Q Consensus 292 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 371 (536)
||+++++|..++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++++||+|||+++.....
T Consensus 85 E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 158 (337)
T 1o6l_A 85 EYANGGELFFHLSRE---RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp ECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred eCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 999999999888543 35899999999999999999999997 999999999999999999999999999864322
Q ss_pred CCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcccccccc
Q 039168 372 QNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPV 451 (536)
Q Consensus 372 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 451 (536)
. .......||+.|+|||++.+..++.++||||||+++|||++|+.||..... ........ .... .
T Consensus 159 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~------~~~~~~i~-~~~~-~----- 223 (337)
T 1o6l_A 159 G--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------ERLFELIL-MEEI-R----- 223 (337)
T ss_dssp T--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHH-HCCC-C-----
T ss_pred C--CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH------HHHHHHHH-cCCC-C-----
Confidence 2 223346799999999999999999999999999999999999999753221 11111111 1111 0
Q ss_pred ccCCCCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHHH
Q 039168 452 LKQSCAPDELLKFIHIGLLCVQQDPADRP-----TMSSVVVM 488 (536)
Q Consensus 452 l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 488 (536)
+... .+ ..+.+++.+||+.||++|| ++.+|++.
T Consensus 224 ~p~~-~s---~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 224 FPRT-LS---PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp CCTT-SC---HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred CCCC-CC---HHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 1111 12 2355666799999999999 89999853
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-43 Score=351.84 Aligned_cols=254 Identities=24% Similarity=0.337 Sum_probs=201.1
Q ss_pred HhcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC-hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCc------
Q 039168 214 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQ------ 285 (536)
Q Consensus 214 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~------ 285 (536)
..++|++.+.||+|+||.||+|++. +++.||||++.... ....+.+.+|+.+|++++||||+++++++.+..
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 3468999999999999999999986 69999999987543 345678999999999999999999999986543
Q ss_pred ---------------------------------------------------eEEEEEeecCCCChhhhhhcccCCCCCCH
Q 039168 286 ---------------------------------------------------ELLLIYEYMPNKSLDVHLFDATRSVQLDW 314 (536)
Q Consensus 286 ---------------------------------------------------~~~lv~e~~~~~sL~~~l~~~~~~~~l~~ 314 (536)
..++||||+++++|.+++.........++
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~ 163 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH 163 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence 38999999999999999987666666788
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCCc----------cccccccccc
Q 039168 315 KRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQ----------ANTNIIAGTY 384 (536)
Q Consensus 315 ~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~----------~~~~~~~gt~ 384 (536)
..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++........ .......||+
T Consensus 164 ~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred HHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 889999999999999999997 999999999999999999999999999887644321 1123356899
Q ss_pred cccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccccccCCCCHHHHHHH
Q 039168 385 GYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQSCAPDELLKF 464 (536)
Q Consensus 385 ~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l 464 (536)
.|+|||++.+..++.++||||||+++|+|++|..|+. .... ............. .......+
T Consensus 241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~--------~~~~-~~~~~~~~~~~~~---------~~~~~~~~ 302 (332)
T 3qd2_B 241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM--------ERVR-IITDVRNLKFPLL---------FTQKYPQE 302 (332)
T ss_dssp GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH--------HHHH-HHHHHHTTCCCHH---------HHHHCHHH
T ss_pred CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh--------HHHH-HHHHhhccCCCcc---------cccCChhH
Confidence 9999999999999999999999999999999876621 0011 1111111111110 12223456
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 465 IHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 465 ~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
.+++.+||+.||++|||+.++++.
T Consensus 303 ~~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 303 HMMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHccCCCCcCCCHHHHhhc
Confidence 778889999999999999999964
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=352.40 Aligned_cols=262 Identities=25% Similarity=0.360 Sum_probs=200.3
Q ss_pred hcCCccccccCCCCceeEEEEEeCCCcEEEEEEccccC--hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEe
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTS--GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 292 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 292 (536)
.++|++.++||+|+||+||+|++.+++.||+|++.... ....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 47899999999999999999999889999999987543 2335678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCC
Q 039168 293 YMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQ 372 (536)
Q Consensus 293 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 372 (536)
|+++ +|..++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 100 ~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 173 (311)
T 3niz_A 100 FMEK-DLKKVLDE--NKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPV 173 (311)
T ss_dssp CCSE-EHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSCC
T ss_pred CCCC-CHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCCc
Confidence 9985 66666643 2345899999999999999999999997 9999999999999999999999999998764332
Q ss_pred CccccccccccccccCcchhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccc---
Q 039168 373 NQANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELI--- 448 (536)
Q Consensus 373 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~--- 448 (536)
. ......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||....... ................+.
T Consensus 174 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~ 248 (311)
T 3niz_A 174 R--SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDD---QLPKIFSILGTPNPREWPQVQ 248 (311)
T ss_dssp C-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTT---HHHHHHHHHCCCCTTTSGGGT
T ss_pred c--cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHHCCCChHHhhhhh
Confidence 2 2223568999999999977 568999999999999999999999986543322 222222211111110000
Q ss_pred c------ccc--cCCCC-----HHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 449 D------PVL--KQSCA-----PDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 449 ~------~~l--~~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
+ ... ..... +....++.+++.+||+.||++|||+.++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 249 ELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp TSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred ccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 0 000 00000 011235667788999999999999999996
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=354.58 Aligned_cols=252 Identities=23% Similarity=0.264 Sum_probs=203.3
Q ss_pred HhcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccChh------hHHHHHHHHHHHHHcCCCCceeEeeEEeeCce
Q 039168 214 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQ------GLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQE 286 (536)
Q Consensus 214 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 286 (536)
..++|++.+.||+|+||.||+++.+ +|+.||+|++...... ..+.+.+|+.+|++++||||+++++++.+.+.
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 3468999999999999999999976 5899999998754321 35788999999999999999999999999999
Q ss_pred EEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCC----CeEEecc
Q 039168 287 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDM----NPKISDF 362 (536)
Q Consensus 287 ~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~----~~kl~Df 362 (536)
.++||||+++++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++ .+||+||
T Consensus 90 ~~lv~e~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DF 163 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (361)
T ss_dssp EEEEEECCCSCBHHHHHTT---CSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEec
Confidence 9999999999999999854 345999999999999999999999997 99999999999998877 7999999
Q ss_pred cCccccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcC
Q 039168 363 GTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEG 442 (536)
Q Consensus 363 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 442 (536)
|++..+.... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...... ... ..+...
T Consensus 164 G~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~---~~~----~~i~~~ 233 (361)
T 2yab_A 164 GLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ---ETL----ANITAV 233 (361)
T ss_dssp SSCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHH----HHHHTT
T ss_pred CCceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH---HHH----HHHHhc
Confidence 9998765432 223457999999999999999999999999999999999999998542211 111 111111
Q ss_pred CccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 443 HAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 443 ~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
... +++..... .+ ..+.+++.+||+.||++|||+.++++
T Consensus 234 ~~~--~~~~~~~~-~s---~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 234 SYD--FDEEFFSQ-TS---ELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp CCC--CCHHHHTT-SC---HHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCC--CCchhccC-CC---HHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 110 01111111 12 34566777999999999999999985
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-44 Score=364.24 Aligned_cols=262 Identities=28% Similarity=0.402 Sum_probs=208.6
Q ss_pred HHhcCCccccccCCCCceeEEEEEe------CCCcEEEEEEccccC-hhhHHHHHHHHHHHHHc-CCCCceeEeeEEeeC
Q 039168 213 EATNHFSDENKLGQGGFGPVYKGTL------ADGKAIAVKRLSRTS-GQGLKEFKNEVNLIAKL-QHKNLVRLLGCCLEG 284 (536)
Q Consensus 213 ~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~ 284 (536)
...++|++.+.||+|+||.||+|++ .+++.||||++.... ....+.+.+|+++++++ +||||+++++++.+.
T Consensus 19 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~ 98 (359)
T 3vhe_A 19 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 98 (359)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred ccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecC
Confidence 4467899999999999999999973 246899999997643 34456799999999999 789999999999875
Q ss_pred c-eEEEEEeecCCCChhhhhhcccC-------------------------------------------------------
Q 039168 285 Q-ELLLIYEYMPNKSLDVHLFDATR------------------------------------------------------- 308 (536)
Q Consensus 285 ~-~~~lv~e~~~~~sL~~~l~~~~~------------------------------------------------------- 308 (536)
+ ..++||||+++++|.+++.....
T Consensus 99 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (359)
T 3vhe_A 99 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 178 (359)
T ss_dssp TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------------
T ss_pred CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhh
Confidence 4 48999999999999999975432
Q ss_pred --------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCCccccccc
Q 039168 309 --------SVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNII 380 (536)
Q Consensus 309 --------~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 380 (536)
...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.+............
T Consensus 179 ~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 255 (359)
T 3vhe_A 179 EEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 255 (359)
T ss_dssp -----CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--C
T ss_pred cccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccccchhcccc
Confidence 122899999999999999999999997 999999999999999999999999999876544443444456
Q ss_pred cccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHHHHHhhcCCccccccccccCCCCHH
Q 039168 381 AGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQSCAPD 459 (536)
Q Consensus 381 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~ 459 (536)
.||+.|+|||++.+..++.++||||||+++|+|++ |+.||....... . .......+..... ... .+
T Consensus 256 ~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~----~~~~~~~~~~~~~-----~~~-~~- 322 (359)
T 3vhe_A 256 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--E----FCRRLKEGTRMRA-----PDY-TT- 322 (359)
T ss_dssp EECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH--H----HHHHHHHTCCCCC-----CTT-CC-
T ss_pred CCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH--H----HHHHHHcCCCCCC-----CCC-CC-
Confidence 78999999999999999999999999999999998 999975432211 1 1111122211111 111 12
Q ss_pred HHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 460 ELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 460 ~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
..+.+++.+||+.||++|||+.+|++.|+..
T Consensus 323 --~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 353 (359)
T 3vhe_A 323 --PEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 353 (359)
T ss_dssp --HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --HHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 3466677799999999999999999999763
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-44 Score=355.95 Aligned_cols=259 Identities=31% Similarity=0.457 Sum_probs=210.1
Q ss_pred hcCCccccccCCCCceeEEEEEe------CCCcEEEEEEcccc-ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceE
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTL------ADGKAIAVKRLSRT-SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQEL 287 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 287 (536)
.++|.+.+.||+|+||.||+|.+ .+++.||||++... .....+.+.+|+.++++++||||+++++++.+.+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 47899999999999999999986 23588999999754 345567889999999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhhcccC---------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCC
Q 039168 288 LLIYEYMPNKSLDVHLFDATR---------------------SVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKA 346 (536)
Q Consensus 288 ~lv~e~~~~~sL~~~l~~~~~---------------------~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp 346 (536)
++||||+++++|.+++..... ...+++.+++.++.||++||.|||+++ |+||||||
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dikp 178 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAA 178 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCSG
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccch
Confidence 999999999999999975432 234899999999999999999999997 99999999
Q ss_pred CcEEEcCCCCeEEecccCccccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCc
Q 039168 347 SNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFS 425 (536)
Q Consensus 347 ~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~ 425 (536)
+|||++.++.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|+|++ |+.||.....
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 258 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP 258 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999987755443333344567889999999999999999999999999999999 9999754332
Q ss_pred cCCchhHHHHHHHhhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 426 EHGQTLLTYTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 426 ~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
.. .. .....+..... ... .+ ..+.+++.+||+.||++|||+.++++.|+..
T Consensus 259 ~~---~~----~~~~~~~~~~~-----~~~-~~---~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~ 309 (314)
T 2ivs_A 259 ER---LF----NLLKTGHRMER-----PDN-CS---EEMYRLMLQCWKQEPDKRPVFADISKDLEKM 309 (314)
T ss_dssp GG---HH----HHHHTTCCCCC-----CTT-CC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HH---HH----HHhhcCCcCCC-----Ccc-CC---HHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 21 11 11112211111 111 12 3466677799999999999999999999764
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=347.96 Aligned_cols=259 Identities=25% Similarity=0.368 Sum_probs=204.1
Q ss_pred hcCCccccccCCCCceeEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEE
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 290 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 290 (536)
.++|++.+.||+|+||.||++++. +++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 468999999999999999999975 5899999998543 334567889999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCC
Q 039168 291 YEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGG 370 (536)
Q Consensus 291 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 370 (536)
|||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++++||+|||+++....
T Consensus 90 ~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESH---GPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSE 163 (294)
T ss_dssp EECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred EeCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence 9999999999998543 35899999999999999999999997 99999999999999999999999999987653
Q ss_pred CCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccc
Q 039168 371 NQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDP 450 (536)
Q Consensus 371 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 450 (536)
... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||..... .......... ..... ..
T Consensus 164 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~------~~~~~~~~~~-~~~~~-~~ 234 (294)
T 4eqm_A 164 TSL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETA------VSIAIKHIQD-SVPNV-TT 234 (294)
T ss_dssp ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCH------HHHHHHHHSS-CCCCH-HH
T ss_pred ccc-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHhhc-cCCCc-ch
Confidence 322 222345789999999999999999999999999999999999999854321 1111111111 11111 11
Q ss_pred cccCCCCHHHHHHHHHHHHhhcCCCCCCCC-CHHHHHHHhccC
Q 039168 451 VLKQSCAPDELLKFIHIGLLCVQQDPADRP-TMSSVVVMLASD 492 (536)
Q Consensus 451 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~evl~~L~~~ 492 (536)
...... ...+.+++.+||+.||++|| ++.++.+.|+..
T Consensus 235 ~~~~~~----~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~ 273 (294)
T 4eqm_A 235 DVRKDI----PQSLSNVILRATEKDKANRYKTIQEMKDDLSSV 273 (294)
T ss_dssp HSCTTS----CHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTS
T ss_pred hcccCC----CHHHHHHHHHHhcCCHhHccccHHHHHHHHHHH
Confidence 111111 23466677799999999998 999999999875
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=363.67 Aligned_cols=261 Identities=32% Similarity=0.434 Sum_probs=211.9
Q ss_pred HhcCCccccccCCCCceeEEEEEeC--------CCcEEEEEEcccc-ChhhHHHHHHHHHHHHHc-CCCCceeEeeEEee
Q 039168 214 ATNHFSDENKLGQGGFGPVYKGTLA--------DGKAIAVKRLSRT-SGQGLKEFKNEVNLIAKL-QHKNLVRLLGCCLE 283 (536)
Q Consensus 214 ~~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~ 283 (536)
..++|.+.++||+|+||.||+|++. .+..||||++... .....+.+.+|+++++++ +||||+++++++.+
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 3478999999999999999999852 2467999999754 344567889999999999 99999999999999
Q ss_pred CceEEEEEeecCCCChhhhhhcccC-------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEE
Q 039168 284 GQELLLIYEYMPNKSLDVHLFDATR-------------SVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVL 350 (536)
Q Consensus 284 ~~~~~lv~e~~~~~sL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIl 350 (536)
.+..++||||+++++|.+++..... ...+++..++.++.||+.||.|||+++ |+||||||+|||
T Consensus 147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl 223 (382)
T 3tt0_A 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVL 223 (382)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEE
T ss_pred CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEE
Confidence 9999999999999999999975432 235899999999999999999999997 999999999999
Q ss_pred EcCCCCeEEecccCccccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCc
Q 039168 351 LDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQ 429 (536)
Q Consensus 351 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~ 429 (536)
|+.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|+|++ |+.||......
T Consensus 224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~--- 300 (382)
T 3tt0_A 224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE--- 300 (382)
T ss_dssp ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---
T ss_pred EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---
Confidence 99999999999999987765443344444567899999999999999999999999999999999 99997533211
Q ss_pred hhHHHHHHHhhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccCC
Q 039168 430 TLLTYTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDS 493 (536)
Q Consensus 430 ~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 493 (536)
........+..... .... + ..+.+++.+||+.||++|||+.+|++.|+...
T Consensus 301 ----~~~~~~~~~~~~~~-----~~~~-~---~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 351 (382)
T 3tt0_A 301 ----ELFKLLKEGHRMDK-----PSNC-T---NELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 351 (382)
T ss_dssp ----HHHHHHHTTCCCCC-----CSSC-C---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----HHHHHHHcCCCCCC-----CccC-C---HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11122222221111 1111 2 34666777999999999999999999998763
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-43 Score=359.85 Aligned_cols=250 Identities=24% Similarity=0.358 Sum_probs=197.1
Q ss_pred hcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHHHc-CCCCceeEeeEEeeCceEEE
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLKEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLL 289 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~l 289 (536)
.++|++.++||+|+||.||+++.+ +++.||||++.+.. ....+.+.+|..++.++ +||||+++++++.+.+.+++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 468999999999999999999976 47899999987542 22345678899999887 89999999999999999999
Q ss_pred EEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccC
Q 039168 290 IYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFG 369 (536)
Q Consensus 290 v~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 369 (536)
||||+++++|..++... ..+++..++.++.||+.||.|||+++ |+||||||+||||+.++++||+|||+++...
T Consensus 131 V~E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~ 204 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 204 (396)
T ss_dssp EEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEcCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence 99999999999988643 34999999999999999999999997 9999999999999999999999999998533
Q ss_pred CCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCC--chhHHHHHHHhhcCCcccc
Q 039168 370 GNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHG--QTLLTYTWKLWCEGHAVEL 447 (536)
Q Consensus 370 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~l 447 (536)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||........ ................ .
T Consensus 205 ~~~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~-~- 280 (396)
T 4dc2_A 205 RPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-R- 280 (396)
T ss_dssp CTT--CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC-C-
T ss_pred cCC--CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc-C-
Confidence 222 223456899999999999999999999999999999999999999864322111 1111111121111111 0
Q ss_pred ccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCH
Q 039168 448 IDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTM 482 (536)
Q Consensus 448 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 482 (536)
+... ....+.+|+.+||+.||++||++
T Consensus 281 ----~p~~----~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 281 ----IPRS----LSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp ----CCTT----SCHHHHHHHHHHTCSCTTTSTTC
T ss_pred ----CCCc----CCHHHHHHHHHHhcCCHhHcCCC
Confidence 1111 12345667779999999999995
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=346.85 Aligned_cols=255 Identities=28% Similarity=0.409 Sum_probs=206.6
Q ss_pred hcCCccccccCCCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEeec
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 294 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 294 (536)
.++|++.+.||+|+||.||+|.+.+++.||+|++..... ..+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 87 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence 367899999999999999999998899999999975432 3467899999999999999999999999999999999999
Q ss_pred CCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCCc
Q 039168 295 PNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQ 374 (536)
Q Consensus 295 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 374 (536)
++++|.+++... ...+++..++.++.|+++||.|||+++ |+||||||+|||++.++.+||+|||++........
T Consensus 88 ~~~~L~~~l~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 161 (269)
T 4hcu_A 88 EHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY- 161 (269)
T ss_dssp TTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH-
T ss_pred CCCcHHHHHHhc--CcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEecccccccccccccc-
Confidence 999999998543 345899999999999999999999997 99999999999999999999999999986643221
Q ss_pred cccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHHHHHhhcCCcccccccccc
Q 039168 375 ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLK 453 (536)
Q Consensus 375 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~ 453 (536)
.......+++.|+|||++.+..++.++||||||+++|+|++ |+.||...... .. .......... ...
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~------~~-~~~~~~~~~~-----~~~ 229 (269)
T 4hcu_A 162 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS------EV-VEDISTGFRL-----YKP 229 (269)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HH-HHHHHTTCCC-----CCC
T ss_pred ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH------HH-HHHHhcCccC-----CCC
Confidence 12223456788999999999999999999999999999999 89997543221 11 1111111110 111
Q ss_pred CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 454 QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 454 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
. ..+ ..+.+++.+||+.||++|||+.++++.|+..
T Consensus 230 ~-~~~---~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l 264 (269)
T 4hcu_A 230 R-LAS---THVYQIMNHCWRERPEDRPAFSRLLRQLAEI 264 (269)
T ss_dssp T-TSC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred C-cCC---HHHHHHHHHHccCCcccCcCHHHHHHHHHHH
Confidence 1 112 3466677799999999999999999999763
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-44 Score=367.18 Aligned_cols=257 Identities=28% Similarity=0.422 Sum_probs=206.5
Q ss_pred hcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC-hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEe
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 292 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 292 (536)
.++|++.+.||+|+||.||+|++. +++.||||++.... ....+.+.+|+.+|++++||||+++++++...+..++|||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 468899999999999999999986 68999999987543 3344578899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCC
Q 039168 293 YMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQ 372 (536)
Q Consensus 293 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 372 (536)
|+++++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 193 ~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~ 267 (377)
T 3cbl_A 193 LVQGGDFLTFLRTE--GARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGV 267 (377)
T ss_dssp CCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTSE
T ss_pred cCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCCc
Confidence 99999999999643 234899999999999999999999997 9999999999999999999999999998654332
Q ss_pred CccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHHHHHhhcCCcccccccc
Q 039168 373 NQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPV 451 (536)
Q Consensus 373 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 451 (536)
.........+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... . .......+.....
T Consensus 268 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~---~----~~~~~~~~~~~~~---- 336 (377)
T 3cbl_A 268 YAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ---Q----TREFVEKGGRLPC---- 336 (377)
T ss_dssp EECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH---H----HHHHHHTTCCCCC----
T ss_pred eeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---H----HHHHHHcCCCCCC----
Confidence 2222222345778999999999999999999999999999998 99987543221 1 1111222211111
Q ss_pred ccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 452 LKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 452 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
... .+ ..+.+++.+||+.||++|||+.+|++.|+..
T Consensus 337 -~~~-~~---~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 372 (377)
T 3cbl_A 337 -PEL-CP---DAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372 (377)
T ss_dssp -CTT-CC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CCC-CC---HHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 111 22 2456677799999999999999999999764
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=363.52 Aligned_cols=259 Identities=31% Similarity=0.445 Sum_probs=206.9
Q ss_pred hcCCccccccCCCCceeEEEEEeC------CCcEEEEEEcccc-ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceE
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRT-SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQEL 287 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 287 (536)
.++|++.++||+|+||.||+|++. +++.||||++... .......+.+|+.++++++||||+++++++.+....
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 468999999999999999999843 4678999999654 344556788999999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhhccc----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCC---CeEEe
Q 039168 288 LLIYEYMPNKSLDVHLFDAT----RSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDM---NPKIS 360 (536)
Q Consensus 288 ~lv~e~~~~~sL~~~l~~~~----~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~---~~kl~ 360 (536)
++||||+++++|.+++.... ....+++.+++.++.||+.||.|||+++ |+||||||+|||++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence 99999999999999997543 2245899999999999999999999997 99999999999999555 59999
Q ss_pred cccCccccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHHHHHh
Q 039168 361 DFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLW 439 (536)
Q Consensus 361 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 439 (536)
|||+++.+.............||+.|+|||++.+..++.++|||||||++|||++ |..||...... ... ...
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~------~~~-~~i 299 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ------EVL-EFV 299 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH------HHH-HHH
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH------HHH-HHH
Confidence 9999986543333333334567999999999999999999999999999999998 99997543211 111 111
Q ss_pred hcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 440 CEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 440 ~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
..+..... .... + ..+.+|+.+||+.||++|||+.+|++.|+..
T Consensus 300 ~~~~~~~~-----~~~~-~---~~l~~li~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 300 TSGGRMDP-----PKNC-P---GPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp HTTCCCCC-----CTTC-C---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HcCCCCCC-----CccC-C---HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 12111111 1111 2 3466677799999999999999999999764
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=350.05 Aligned_cols=259 Identities=18% Similarity=0.188 Sum_probs=206.4
Q ss_pred hcCCccccccCCCCceeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHHHc-CCCCceeEeeEEeeCceEEEEEe
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYE 292 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e 292 (536)
.++|++.+.||+|+||.||+|++ .+++.||||++..... .+.+.+|+.+++++ +||||+++++++...+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 46899999999999999999996 4689999999865432 24688999999999 99999999999999999999999
Q ss_pred ecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCC-----eEEecccCccc
Q 039168 293 YMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMN-----PKISDFGTARI 367 (536)
Q Consensus 293 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~-----~kl~Dfg~a~~ 367 (536)
|+ +++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++. +||+|||+++.
T Consensus 86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 86 LL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred eC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 99 99999998653 346999999999999999999999997 999999999999998887 99999999997
Q ss_pred cCCCCCcc-----ccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcC
Q 039168 368 FGGNQNQA-----NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEG 442 (536)
Q Consensus 368 ~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 442 (536)
+....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||.....................
T Consensus 160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~- 238 (330)
T 2izr_A 160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRA- 238 (330)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHH-
T ss_pred eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhcc-
Confidence 65433221 123467999999999999999999999999999999999999998764333222212111111000
Q ss_pred CccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcc
Q 039168 443 HAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 491 (536)
Q Consensus 443 ~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 491 (536)
.. ...+ ....+ .+.+++..||+.||.+||++.+|++.|+.
T Consensus 239 ---~~-~~~~-~~~~p----~~~~li~~~l~~~p~~RP~~~~l~~~l~~ 278 (330)
T 2izr_A 239 ---TP-IEVL-CENFP----EMATYLRYVRRLDFFEKPDYDYLRKLFTD 278 (330)
T ss_dssp ---SC-HHHH-TTTCH----HHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred ---CC-HHHH-hccCh----HHHHHHHHHHhCCCCCCCCHHHHHHHHHH
Confidence 00 0001 11122 56677779999999999999999998864
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=343.62 Aligned_cols=256 Identities=28% Similarity=0.406 Sum_probs=208.2
Q ss_pred hcCCccccccCCCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEeec
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 294 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 294 (536)
.++|++.+.||+|+||.||++.++++..||+|++..... ..+.+.+|++++++++||||+++++++.+....++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 468999999999999999999998888999999975432 3467899999999999999999999999999999999999
Q ss_pred CCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCCc
Q 039168 295 PNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQ 374 (536)
Q Consensus 295 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 374 (536)
++++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.........
T Consensus 86 ~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 160 (268)
T 3sxs_A 86 SNGCLLNYLRSH--GKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV 160 (268)
T ss_dssp TTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE
T ss_pred CCCcHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhhh
Confidence 999999998653 235899999999999999999999997 999999999999999999999999999876543322
Q ss_pred cccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHHHHHhhcCCcccccccccc
Q 039168 375 ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLK 453 (536)
Q Consensus 375 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~ 453 (536)
. .....+|+.|+|||++.+..++.++||||||+++|+|++ |+.||....... .. .....+.... .
T Consensus 161 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~------~~-~~~~~~~~~~--~---- 226 (268)
T 3sxs_A 161 S-SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE------VV-LKVSQGHRLY--R---- 226 (268)
T ss_dssp E-CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHH------HH-HHHHTTCCCC--C----
T ss_pred c-ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHH------HH-HHHHcCCCCC--C----
Confidence 2 223446778999999999899999999999999999999 999975432211 11 1111111111 0
Q ss_pred CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccCC
Q 039168 454 QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDS 493 (536)
Q Consensus 454 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 493 (536)
....++ .+.+++.+||+.||++|||+.++++.|+...
T Consensus 227 ~~~~~~---~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (268)
T 3sxs_A 227 PHLASD---TIYQIMYSCWHELPEKRPTFQQLLSSIEPLR 263 (268)
T ss_dssp CTTSCH---HHHHHHHHTTCSSGGGSCCHHHHHHHHGGGC
T ss_pred CCcChH---HHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 111222 4566777999999999999999999998863
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=345.22 Aligned_cols=262 Identities=25% Similarity=0.321 Sum_probs=202.2
Q ss_pred hcCCccccccCCCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHH--cCCCCceeEeeEEee----CceEE
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAK--LQHKNLVRLLGCCLE----GQELL 288 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~hpniv~l~~~~~~----~~~~~ 288 (536)
.++|++.+.||+|+||.||+|++ +++.||||++.... ...+.+|.+++.. ++||||+++++++.. ....+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRD---EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecccc---chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 47899999999999999999998 68999999986542 3556677777777 799999999998654 35689
Q ss_pred EEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHh--------cCCCCCeeeCCCCCCcEEEcCCCCeEEe
Q 039168 289 LIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLH--------EDSRLKIIHRDLKASNVLLDDDMNPKIS 360 (536)
Q Consensus 289 lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH--------~~~~~~ivH~Dikp~NIll~~~~~~kl~ 360 (536)
+||||+++++|.+++.. ..+++..++.++.||+.||.||| +.+ |+||||||+|||++.++++||+
T Consensus 83 lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~ 155 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQL----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIA 155 (301)
T ss_dssp EEECCCTTCBHHHHHTT----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEEC
T ss_pred EehhhccCCCHHHHHhh----cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEe
Confidence 99999999999999943 35899999999999999999999 775 9999999999999999999999
Q ss_pred cccCccccCCCCCcc--ccccccccccccCcchhcCC------CCCccchHHHHHHHHHHHHhC----------CCCCCC
Q 039168 361 DFGTARIFGGNQNQA--NTNIIAGTYGYMAPEYAMGG------IFSIKSDVFSFGVLLLEIISG----------RKNNGF 422 (536)
Q Consensus 361 Dfg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~il~elltg----------~~p~~~ 422 (536)
|||+++......... ......||+.|+|||++.+. .++.++||||||+++|||++| +.||..
T Consensus 156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~ 235 (301)
T 3q4u_A 156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD 235 (301)
T ss_dssp CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred eCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence 999998765433221 12234789999999999877 456799999999999999999 777654
Q ss_pred CCccCCchhHHHHHHHhhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 423 YFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 423 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
........ ...............+.... ........+.+++.+||+.||++|||+.+|++.|+..
T Consensus 236 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 236 VVPNDPSF-EDMRKVVCVDQQRPNIPNRW----FSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TSCSSCCH-HHHHHHHTTSCCCCCCCGGG----GGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCCCcch-hhhhHHHhccCCCCCCChhh----ccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 33322211 11111111111111111111 1223456788888899999999999999999999763
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=356.99 Aligned_cols=262 Identities=29% Similarity=0.477 Sum_probs=210.6
Q ss_pred HhcCCccccccCCCCceeEEEEEeC------CCcEEEEEEcccc-ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCce
Q 039168 214 ATNHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRT-SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQE 286 (536)
Q Consensus 214 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 286 (536)
..++|++.+.||+|+||.||+|++. +++.||||++... .....+.+.+|+.++++++||||+++++++.+.+.
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 124 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 124 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCc
Confidence 4578999999999999999999874 3488999999764 33446779999999999999999999999999999
Q ss_pred EEEEEeecCCCChhhhhhcccC---------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCC
Q 039168 287 LLLIYEYMPNKSLDVHLFDATR---------------------SVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLK 345 (536)
Q Consensus 287 ~~lv~e~~~~~sL~~~l~~~~~---------------------~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dik 345 (536)
.++||||+++++|.+++..... ...+++.+++.++.||++||.|||+++ |+|||||
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlk 201 (343)
T 1luf_A 125 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLA 201 (343)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred eEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCC
Confidence 9999999999999999975321 256899999999999999999999997 9999999
Q ss_pred CCcEEEcCCCCeEEecccCccccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCC
Q 039168 346 ASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYF 424 (536)
Q Consensus 346 p~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~ 424 (536)
|+|||++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|+|++ |+.||....
T Consensus 202 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 281 (343)
T 1luf_A 202 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 281 (343)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred cceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCC
Confidence 9999999999999999999987654333233334567899999999999999999999999999999999 999975322
Q ss_pred ccCCchhHHHHHHHhhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccCCC
Q 039168 425 SEHGQTLLTYTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSM 494 (536)
Q Consensus 425 ~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 494 (536)
.. . .......+..... .... + ..+.+++.+||+.||++|||+.++++.|+....
T Consensus 282 ~~------~-~~~~~~~~~~~~~-----~~~~-~---~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~ 335 (343)
T 1luf_A 282 HE------E-VIYYVRDGNILAC-----PENC-P---LELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 335 (343)
T ss_dssp HH------H-HHHHHHTTCCCCC-----CTTC-C---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred hH------H-HHHHHhCCCcCCC-----CCCC-C---HHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence 11 1 1111222222111 1112 2 346667779999999999999999999998643
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=361.99 Aligned_cols=257 Identities=28% Similarity=0.461 Sum_probs=195.1
Q ss_pred hcCCccccccCCCCceeEEEEEeC----CCcEEEEEEcccc-ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEE
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA----DGKAIAVKRLSRT-SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 289 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 289 (536)
.++|++.+.||+|+||.||+|++. ++..||||++... .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 368999999999999999999865 5778999999754 34456789999999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccC
Q 039168 290 IYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFG 369 (536)
Q Consensus 290 v~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 369 (536)
||||+++++|.+++... ...+++.+++.++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 124 v~e~~~~~sL~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKH--DAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp EEECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 99999999999999643 345899999999999999999999996 9999999999999999999999999998765
Q ss_pred CCCCcc-ccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHHHHHhhcCCcccc
Q 039168 370 GNQNQA-NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVEL 447 (536)
Q Consensus 370 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 447 (536)
...... ......+++.|+|||++.+..++.++||||||+++|||++ |+.||...... ... .....+....
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~---~~~----~~i~~~~~~~- 270 (373)
T 2qol_A 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ---DVI----KAVDEGYRLP- 270 (373)
T ss_dssp ---------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH---HHH----HHHHTTEECC-
T ss_pred cCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH---HHH----HHHHcCCCCC-
Confidence 432211 1222345778999999999999999999999999999998 99997533211 111 1111111110
Q ss_pred ccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 448 IDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 448 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
.+......+.+++.+||+.||++|||+.+|++.|+..
T Consensus 271 --------~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~ 307 (373)
T 2qol_A 271 --------PPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307 (373)
T ss_dssp --------CCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --------CCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHH
Confidence 1111224566777899999999999999999999764
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=357.55 Aligned_cols=248 Identities=25% Similarity=0.347 Sum_probs=197.6
Q ss_pred hcCCccccccCCCCceeEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHHHc-CCCCceeEeeEEeeCceEEE
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLKEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLL 289 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~l 289 (536)
.++|++.++||+|+||.||+|+++ +++.||||++.+. .....+.+.+|..+++.+ +||||+++++++.+.+.+|+
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 478999999999999999999976 5899999998754 233456788999999998 79999999999999999999
Q ss_pred EEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccC
Q 039168 290 IYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFG 369 (536)
Q Consensus 290 v~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 369 (536)
||||+++++|..++... ..+++..++.++.||+.||.|||+++ |+||||||+||||+.++++||+|||+++...
T Consensus 102 v~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~ 175 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKS---RRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGI 175 (353)
T ss_dssp EEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeecc
Confidence 99999999999998653 34999999999999999999999997 9999999999999999999999999998543
Q ss_pred CCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcccccc
Q 039168 370 GNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELID 449 (536)
Q Consensus 370 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 449 (536)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...... ... ... ......
T Consensus 176 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~---~~~---~~i-~~~~~~---- 242 (353)
T 3txo_A 176 CNG--VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED---DLF---EAI-LNDEVV---- 242 (353)
T ss_dssp C-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH---HHH-HHCCCC----
T ss_pred cCC--ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH---HHH---HHH-HcCCCC----
Confidence 222 2233467999999999999989999999999999999999999998643221 111 111 111110
Q ss_pred ccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCH------HHHHH
Q 039168 450 PVLKQSCAPDELLKFIHIGLLCVQQDPADRPTM------SSVVV 487 (536)
Q Consensus 450 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~------~evl~ 487 (536)
.... .+ ..+.+++.+||+.||++||++ .++++
T Consensus 243 --~p~~-~~---~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 243 --YPTW-LH---EDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp --CCTT-SC---HHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred --CCCC-CC---HHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 1111 12 335566779999999999998 77774
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=350.50 Aligned_cols=254 Identities=24% Similarity=0.356 Sum_probs=201.3
Q ss_pred cCCccccccCCCCceeEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHHHc-CCCCceeEeeEEeeCceEEEE
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLKEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLI 290 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv 290 (536)
++|++.+.||+|+||.||+++++ +++.||||++.+. .....+.+.+|..+++++ +||||+++++++.+.+..++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 57999999999999999999976 5889999999754 334456788999999998 899999999999999999999
Q ss_pred EeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCC
Q 039168 291 YEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGG 370 (536)
Q Consensus 291 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 370 (536)
|||+++++|..++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++++||+|||+++....
T Consensus 89 ~e~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~ 162 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 162 (345)
T ss_dssp ECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred EeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence 9999999999998643 34899999999999999999999997 99999999999999999999999999986432
Q ss_pred CCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCc--hhHHHHHHHhhcCCccccc
Q 039168 371 NQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQ--TLLTYTWKLWCEGHAVELI 448 (536)
Q Consensus 371 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~l~ 448 (536)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||......... ............... .
T Consensus 163 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~-~-- 237 (345)
T 3a8x_A 163 PG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-R-- 237 (345)
T ss_dssp TT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC-C--
T ss_pred CC--CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC-C--
Confidence 22 2233467999999999999999999999999999999999999998643221110 111111122211111 1
Q ss_pred cccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCH------HHHHH
Q 039168 449 DPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTM------SSVVV 487 (536)
Q Consensus 449 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~------~evl~ 487 (536)
+.... ...+.+++.+||+.||++||++ .++++
T Consensus 238 ---~p~~~----s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~ 275 (345)
T 3a8x_A 238 ---IPRSL----SVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 275 (345)
T ss_dssp ---CCTTS----CHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHT
T ss_pred ---CCCCC----CHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhc
Confidence 11111 2345667779999999999995 56663
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=353.41 Aligned_cols=259 Identities=24% Similarity=0.426 Sum_probs=191.8
Q ss_pred hcCCccccccCCCCceeEEEEEeCCC----cEEEEEEcccc--ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceE-
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLADG----KAIAVKRLSRT--SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQEL- 287 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~~~----~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~- 287 (536)
.++|++.+.||+|+||.||+|++... ..||||++... .....+.+.+|++++++++||||+++++++......
T Consensus 22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (323)
T 3qup_A 22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG 101 (323)
T ss_dssp ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence 46899999999999999999997543 37999998754 344567899999999999999999999999877655
Q ss_pred -----EEEEeecCCCChhhhhhcccC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEE
Q 039168 288 -----LLIYEYMPNKSLDVHLFDATR---SVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKI 359 (536)
Q Consensus 288 -----~lv~e~~~~~sL~~~l~~~~~---~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl 359 (536)
++||||+++++|.+++..... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||
T Consensus 102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~kl 178 (323)
T 3qup_A 102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVCV 178 (323)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEE
T ss_pred CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCEEE
Confidence 999999999999999865332 225899999999999999999999997 999999999999999999999
Q ss_pred ecccCccccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHHHHH
Q 039168 360 SDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKL 438 (536)
Q Consensus 360 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 438 (536)
+|||+++...............+++.|+|||.+.+..++.++||||||+++|+|++ |+.||....... ... .
T Consensus 179 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~~~----~ 251 (323)
T 3qup_A 179 ADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE---IYN----Y 251 (323)
T ss_dssp CCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHH----H
T ss_pred eeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH---HHH----H
Confidence 99999987654443333334557889999999999999999999999999999999 899976433221 111 1
Q ss_pred hhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 439 WCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 439 ~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
...+..... +......+.+++.+||+.||++|||+.++++.|+..
T Consensus 252 ~~~~~~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 296 (323)
T 3qup_A 252 LIGGNRLKQ---------PPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENI 296 (323)
T ss_dssp HHTTCCCCC---------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred HhcCCCCCC---------CCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 111111111 111123466777799999999999999999999864
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=347.08 Aligned_cols=252 Identities=23% Similarity=0.283 Sum_probs=202.7
Q ss_pred hcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccCh------hhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceE
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG------QGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQEL 287 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 287 (536)
.++|++.+.||+|+||.||++.+. +++.||+|++..... ...+.+.+|+.+|++++||||+++++++.+....
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 467999999999999999999976 589999999865432 1367899999999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCC----CeEEeccc
Q 039168 288 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDM----NPKISDFG 363 (536)
Q Consensus 288 ~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~----~~kl~Dfg 363 (536)
++||||+++++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||
T Consensus 90 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 163 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG 163 (326)
T ss_dssp EEEEECCCSCBHHHHHTT---SSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence 999999999999999854 345899999999999999999999997 99999999999999887 79999999
Q ss_pred CccccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCC
Q 039168 364 TARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGH 443 (536)
Q Consensus 364 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 443 (536)
+++....... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||...... .... . .....
T Consensus 164 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~---~-~~~~~ 233 (326)
T 2y0a_A 164 LAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ---ETLA---N-VSAVN 233 (326)
T ss_dssp TCEECCTTSC---CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHHH---H-HHHTC
T ss_pred CCeECCCCCc---cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH---HHHH---H-HHhcC
Confidence 9987653322 22357899999999999999999999999999999999999997532211 1111 1 11110
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 444 AVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 444 ~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
. .. ........ ...+.+++.+||+.||++|||+.++++.
T Consensus 234 ~-~~-~~~~~~~~----~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 234 Y-EF-EDEYFSNT----SALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp C-CC-CHHHHTTS----CHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred C-Cc-CccccccC----CHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0 00 00011111 2345667779999999999999999974
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=357.76 Aligned_cols=263 Identities=29% Similarity=0.409 Sum_probs=207.5
Q ss_pred hcCCccccccCCCCceeEEEEEe------CCCcEEEEEEccccC-hhhHHHHHHHHHHHHHc-CCCCceeEeeEEeeCce
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTL------ADGKAIAVKRLSRTS-GQGLKEFKNEVNLIAKL-QHKNLVRLLGCCLEGQE 286 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~ 286 (536)
.++|++.+.||+|+||.||+|++ .++..||||++.... ....+.+.+|+.+++++ +||||+++++++...+.
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 123 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 123 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCc
Confidence 47899999999999999999986 246689999997542 33456789999999999 99999999999999999
Q ss_pred EEEEEeecCCCChhhhhhcccCC--------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCC
Q 039168 287 LLLIYEYMPNKSLDVHLFDATRS--------------------VQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKA 346 (536)
Q Consensus 287 ~~lv~e~~~~~sL~~~l~~~~~~--------------------~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp 346 (536)
.++||||+++++|.+++...... ..+++..++.++.||+.||.|||+++ |+||||||
T Consensus 124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp 200 (344)
T 1rjb_A 124 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAA 200 (344)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSG
T ss_pred cEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCh
Confidence 99999999999999999654321 34789999999999999999999997 99999999
Q ss_pred CcEEEcCCCCeEEecccCccccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCc
Q 039168 347 SNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFS 425 (536)
Q Consensus 347 ~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~ 425 (536)
+|||++.++.+||+|||++................||+.|+|||++.+..++.++||||||+++|+|++ |..||.....
T Consensus 201 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 280 (344)
T 1rjb_A 201 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 280 (344)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCc
Confidence 999999999999999999987654443333444567889999999999999999999999999999998 9999754322
Q ss_pred cCCchhHHHHHHHhhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccCCCC
Q 039168 426 EHGQTLLTYTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSMT 495 (536)
Q Consensus 426 ~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 495 (536)
.. . .......+.... .... .+ ..+.+++.+||+.||.+|||+.+|++.|+.....
T Consensus 281 ~~--~----~~~~~~~~~~~~-----~~~~-~~---~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 281 DA--N----FYKLIQNGFKMD-----QPFY-AT---EEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335 (344)
T ss_dssp SH--H----HHHHHHTTCCCC-----CCTT-CC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred HH--H----HHHHHhcCCCCC-----CCCC-CC---HHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 11 1 111111111111 1111 12 3466677799999999999999999999886443
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=362.78 Aligned_cols=255 Identities=22% Similarity=0.258 Sum_probs=202.5
Q ss_pred HHhcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC--hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEE
Q 039168 213 EATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 289 (536)
Q Consensus 213 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 289 (536)
...++|++.+.||+|+||.||++.+. +|+.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 87 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL 87 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence 35678999999999999999999875 68999999987543 3345678999999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEc---CCCCeEEecccCcc
Q 039168 290 IYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLD---DDMNPKISDFGTAR 366 (536)
Q Consensus 290 v~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~---~~~~~kl~Dfg~a~ 366 (536)
||||+.+++|.+.+... ..+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++.
T Consensus 88 v~E~~~gg~L~~~i~~~---~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~ 161 (444)
T 3soa_A 88 IFDLVTGGELFEDIVAR---EYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAI 161 (444)
T ss_dssp EECCCBCCBHHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred EEEeCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence 99999999999888643 45999999999999999999999997 99999999999998 46789999999998
Q ss_pred ccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccc
Q 039168 367 IFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVE 446 (536)
Q Consensus 367 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 446 (536)
........ .....||+.|+|||++.+..++.++|||||||++|+|++|..||..... .... .....+....
T Consensus 162 ~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~---~~~~----~~i~~~~~~~ 232 (444)
T 3soa_A 162 EVEGEQQA--WFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ---HRLY----QQIKAGAYDF 232 (444)
T ss_dssp CCCTTCCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHH----HHHHHTCCCC
T ss_pred EecCCCce--eecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH---HHHH----HHHHhCCCCC
Confidence 76543222 2335799999999999999999999999999999999999999753221 1111 1111111110
Q ss_pred cccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 447 LIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 447 l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
..+. . ...+ ..+.+++.+||+.||++|||+.++|+.
T Consensus 233 -~~~~-~-~~~s---~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 233 -PSPE-W-DTVT---PEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp -CTTT-T-TTSC---HHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred -Cccc-c-ccCC---HHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 0000 0 1112 345666779999999999999999973
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=349.48 Aligned_cols=252 Identities=19% Similarity=0.277 Sum_probs=203.5
Q ss_pred hcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEee
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 293 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 293 (536)
.++|++.+.||+|+||.||++.+. +++.||+|.+.... .....+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 478999999999999999999976 58899999987543 3456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcC--CCCeEEecccCccccCCC
Q 039168 294 MPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDD--DMNPKISDFGTARIFGGN 371 (536)
Q Consensus 294 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~--~~~~kl~Dfg~a~~~~~~ 371 (536)
+++++|.+++... ...+++.+++.++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||++..+...
T Consensus 83 ~~g~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~ 157 (321)
T 1tki_A 83 ISGLDIFERINTS--AFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTSS--SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence 9999999998532 335899999999999999999999997 999999999999997 789999999999876533
Q ss_pred CCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcccccccc
Q 039168 372 QNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPV 451 (536)
Q Consensus 372 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 451 (536)
. ......||+.|+|||++.+..++.++||||||+++|+|++|+.||...... ..... ....... +...
T Consensus 158 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~~~-i~~~~~~--~~~~ 225 (321)
T 1tki_A 158 D---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ------QIIEN-IMNAEYT--FDEE 225 (321)
T ss_dssp C---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHH-HHHTCCC--CCHH
T ss_pred C---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH------HHHHH-HHcCCCC--CChh
Confidence 2 233457899999999999988999999999999999999999998543211 11111 1111110 0000
Q ss_pred ccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 452 LKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 452 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
..... ...+.+++.+||+.||.+|||+.++++.
T Consensus 226 ~~~~~----s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 226 AFKEI----SIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HHTTS----CHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred hhccC----CHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 00111 2346677779999999999999999973
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=356.37 Aligned_cols=249 Identities=23% Similarity=0.367 Sum_probs=201.5
Q ss_pred cCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEE
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 291 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 291 (536)
++|++.+.||+|+||.||++... +++.||+|++.... ....+.+.+|+.+|+.++||||+++++++.+.+..++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 68999999999999999999976 58899999986532 234567889999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCC
Q 039168 292 EYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGN 371 (536)
Q Consensus 292 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 371 (536)
||+.+++|..++.. ...+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.+...
T Consensus 95 e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 168 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQ---NVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE 168 (384)
T ss_dssp CCCTTEEHHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence 99999999999854 345999999999999999999999997 999999999999999999999999999876533
Q ss_pred CCccccccccccccccCcchhcC---CCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccc
Q 039168 372 QNQANTNIIAGTYGYMAPEYAMG---GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELI 448 (536)
Q Consensus 372 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 448 (536)
. ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.............. ...... .
T Consensus 169 ~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~----~~~~~~-~-- 238 (384)
T 4fr4_A 169 T---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHT----FETTVV-T-- 238 (384)
T ss_dssp C---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHH----HHHCCC-C--
T ss_pred C---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHH----Hhhccc-C--
Confidence 2 2334679999999999974 4589999999999999999999999865433322111111 111110 0
Q ss_pred cccccCCCCHHHHHHHHHHHHhhcCCCCCCCCC-HHHHHH
Q 039168 449 DPVLKQSCAPDELLKFIHIGLLCVQQDPADRPT-MSSVVV 487 (536)
Q Consensus 449 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt-~~evl~ 487 (536)
. +......+.+|+.+||+.||.+||+ +.+|++
T Consensus 239 ---~----p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 239 ---Y----PSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp ---C----CTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred ---C----CCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 1 1111234666777999999999998 777764
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=342.29 Aligned_cols=263 Identities=21% Similarity=0.279 Sum_probs=198.8
Q ss_pred cCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC--hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEe
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 292 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 292 (536)
++|++.++||+|+||+||+|++. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57999999999999999999976 58999999986543 3345778899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCC
Q 039168 293 YMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQ 372 (536)
Q Consensus 293 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 372 (536)
|++++.+..+. . ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~l~~~~~-~--~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 155 (292)
T 3o0g_A 82 FCDQDLKKYFD-S--CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEEHHHHHH-H--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred cCCCCHHHHHH-h--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence 99875444433 2 2345999999999999999999999997 9999999999999999999999999998764332
Q ss_pred CccccccccccccccCcchhcCCC-CCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcccccc--
Q 039168 373 NQANTNIIAGTYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELID-- 449 (536)
Q Consensus 373 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~-- 449 (536)
. ......||+.|+|||++.+.. ++.++||||||+++|+|++|..|+..... ...................+..
T Consensus 156 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~--~~~~~~~i~~~~~~~~~~~~~~~~ 231 (292)
T 3o0g_A 156 R--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND--VDDQLKRIFRLLGTPTEEQWPSMT 231 (292)
T ss_dssp S--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS--HHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred c--cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCC--HHHHHHHHHHHhCCCChhhhhhhc
Confidence 2 223356899999999998766 79999999999999999999888532211 1122222222111111000000
Q ss_pred -------------ccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 450 -------------PVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 450 -------------~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
........+.....+.+++.+||+.||++|||++|+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 000000111122345677779999999999999999863
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=344.11 Aligned_cols=261 Identities=17% Similarity=0.225 Sum_probs=208.2
Q ss_pred hcCCccccccCCCCceeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHHHc-CCCCceeEeeEEeeCceEEEEEe
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYE 292 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e 292 (536)
.++|++.+.||+|+||.||+|.+ .+++.||||++..... .+.+.+|+.+++.+ +|+|++++++++.+....++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc--cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 46899999999999999999996 4689999999865432 24678899999999 89999999999999999999999
Q ss_pred ecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCC-----eEEecccCccc
Q 039168 293 YMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMN-----PKISDFGTARI 367 (536)
Q Consensus 293 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~-----~kl~Dfg~a~~ 367 (536)
|+ +++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++. +||+|||+++.
T Consensus 87 ~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~ 160 (298)
T 1csn_A 87 LL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160 (298)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence 99 99999999643 235899999999999999999999996 999999999999987776 99999999987
Q ss_pred cCCCCCc-----cccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcC
Q 039168 368 FGGNQNQ-----ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEG 442 (536)
Q Consensus 368 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 442 (536)
....... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||......................
T Consensus 161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (298)
T 1csn_A 161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 240 (298)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCc
Confidence 7644322 12334679999999999999999999999999999999999999987644332222222221111111
Q ss_pred CccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 443 HAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 443 ~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
...+ +.... + ..+.+++.+||+.||++|||+.+|++.|+..
T Consensus 241 ~~~~-----~~~~~-~---~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~ 281 (298)
T 1csn_A 241 PLRE-----LCAGF-P---EEFYKYMHYARNLAFDATPDYDYLQGLFSKV 281 (298)
T ss_dssp CHHH-----HTTTS-C---HHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred cHHH-----HHhhC-c---HHHHHHHHHHhcCCcccCCCHHHHHHHHHHH
Confidence 1111 11111 2 3466677799999999999999999999875
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-43 Score=345.20 Aligned_cols=255 Identities=27% Similarity=0.394 Sum_probs=204.0
Q ss_pred hcCCccccccCCCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEeec
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 294 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 294 (536)
.++|++.+.||+|+||.||++.+.++..||||++..... ..+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 101 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 101 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence 468999999999999999999998888999999975432 3467899999999999999999999999999999999999
Q ss_pred CCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCCc
Q 039168 295 PNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQ 374 (536)
Q Consensus 295 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 374 (536)
++++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++++||+|||++........
T Consensus 102 ~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~- 175 (283)
T 3gen_A 102 ANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY- 175 (283)
T ss_dssp TTCBHHHHHHCG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH-
T ss_pred CCCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEcccccccccccccc-
Confidence 999999999653 235899999999999999999999997 99999999999999999999999999987643221
Q ss_pred cccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHHHHHhhcCCcccccccccc
Q 039168 375 ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLK 453 (536)
Q Consensus 375 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~ 453 (536)
.......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||...... ... .......... ..
T Consensus 176 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~------~~~-~~~~~~~~~~-----~~ 243 (283)
T 3gen_A 176 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS------ETA-EHIAQGLRLY-----RP 243 (283)
T ss_dssp HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH------HHH-HHHHTTCCCC-----CC
T ss_pred ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh------HHH-HHHhcccCCC-----CC
Confidence 11222346788999999999999999999999999999998 99997643221 111 1111111111 11
Q ss_pred CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 454 QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 454 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
...+ ..+.+++.+||+.||++|||+.++++.|...
T Consensus 244 -~~~~---~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~ 278 (283)
T 3gen_A 244 -HLAS---EKVYTIMYSCWHEKADERPTFKILLSNILDV 278 (283)
T ss_dssp -TTCC---HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CcCC---HHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 1112 3466677799999999999999999998753
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-43 Score=350.31 Aligned_cols=260 Identities=30% Similarity=0.454 Sum_probs=209.3
Q ss_pred hcCCccccccCCCCceeEEEEEe------CCCcEEEEEEccccC-hhhHHHHHHHHHHHHHc-CCCCceeEeeEEeeCce
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTL------ADGKAIAVKRLSRTS-GQGLKEFKNEVNLIAKL-QHKNLVRLLGCCLEGQE 286 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~ 286 (536)
.++|++.+.||+|+||.||+|++ .+++.||||++.... ....+.+.+|+.+++++ +||||+++++++.+.+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 46899999999999999999984 247899999997553 34457789999999999 99999999999999999
Q ss_pred EEEEEeecCCCChhhhhhcccC---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEE
Q 039168 287 LLLIYEYMPNKSLDVHLFDATR---------------SVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLL 351 (536)
Q Consensus 287 ~~lv~e~~~~~sL~~~l~~~~~---------------~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll 351 (536)
.++||||+++++|.+++..... ...+++..++.++.||+.||.|||+++ |+||||||+|||+
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~ 178 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL 178 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEE
Confidence 9999999999999999975432 224899999999999999999999997 9999999999999
Q ss_pred cCCCCeEEecccCccccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCch
Q 039168 352 DDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQT 430 (536)
Q Consensus 352 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~ 430 (536)
+.++.+||+|||++................||+.|+|||++.+..++.++||||||+++|+|++ |+.||....... .
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~ 256 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS--K 256 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH--H
T ss_pred cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh--H
Confidence 9999999999999987765444333334567889999999999999999999999999999999 999975432211 1
Q ss_pred hHHHHHHHhhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 431 LLTYTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 431 ~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
. ......... ..... ..+ ..+.+++.+||+.||.+|||+.++++.|+..
T Consensus 257 ~----~~~~~~~~~-----~~~~~-~~~---~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 305 (313)
T 1t46_A 257 F----YKMIKEGFR-----MLSPE-HAP---AEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (313)
T ss_dssp H----HHHHHHTCC-----CCCCT-TSC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred H----HHHhccCCC-----CCCcc-cCC---HHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 1 111111111 00111 122 3456677799999999999999999999864
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-43 Score=341.41 Aligned_cols=253 Identities=32% Similarity=0.522 Sum_probs=193.9
Q ss_pred hcCCccccccCCCCceeEEEEEeCCCcEEEEEEccccCh----hhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEE
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSG----QGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 290 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 290 (536)
.++|++.+.||+|+||.||+|.+. ++.||||++..... ...+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 368999999999999999999984 88999999875432 3356789999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcC--------CCCeEEecc
Q 039168 291 YEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDD--------DMNPKISDF 362 (536)
Q Consensus 291 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~--------~~~~kl~Df 362 (536)
|||+++++|.+++. ...+++..++.++.||+.||.|||+++..+|+||||||+|||++. ++.+||+||
T Consensus 85 ~e~~~~~~L~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 85 MEFARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp EECCTTEEHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EEcCCCCCHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 99999999998884 235899999999999999999999986445899999999999986 678999999
Q ss_pred cCccccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcC
Q 039168 363 GTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEG 442 (536)
Q Consensus 363 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 442 (536)
|++........ ....||+.|+|||.+.+..++.++||||||+++|+|++|+.||...... ..........
T Consensus 161 g~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~~ 230 (271)
T 3dtc_A 161 GLAREWHRTTK----MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL------AVAYGVAMNK 230 (271)
T ss_dssp CC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHH------HHHHHHHTSC
T ss_pred Ccccccccccc----cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHhhhcCC
Confidence 99986543222 2346899999999999999999999999999999999999998543211 1111111111
Q ss_pred CccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcc
Q 039168 443 HAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 491 (536)
Q Consensus 443 ~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 491 (536)
.... ..... + ..+.+++.+||+.||++|||+.++++.|+.
T Consensus 231 ~~~~-----~~~~~-~---~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 231 LALP-----IPSTC-P---EPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp CCCC-----CCTTC-C---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred CCCC-----CCccc-C---HHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 1111 11111 2 346667779999999999999999999975
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-43 Score=353.79 Aligned_cols=252 Identities=23% Similarity=0.362 Sum_probs=194.9
Q ss_pred hcCCccccccCCCCceeEEEEEeCCCcEEEEEEcccc--ChhhHHHHHHHHHHHHHcCC--CCceeEeeEEeeCceEEEE
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRT--SGQGLKEFKNEVNLIAKLQH--KNLVRLLGCCLEGQELLLI 290 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h--pniv~l~~~~~~~~~~~lv 290 (536)
.++|++.+.||+|+||.||++.+.+++.||||++... .....+.+.+|+.+|++++| |||+++++++...+..++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 4679999999999999999999988999999998644 34456788999999999987 9999999999999999999
Q ss_pred EeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCC
Q 039168 291 YEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGG 370 (536)
Q Consensus 291 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 370 (536)
|| +.+++|.+++... ..+++.+++.++.||+.||.|||+++ |+||||||+|||++ ++.+||+|||+++.+..
T Consensus 88 ~e-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 88 ME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 159 (343)
T ss_dssp EC-CCSEEHHHHHHHS---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred Ee-CCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence 99 5688999998643 45899999999999999999999997 99999999999997 57899999999987754
Q ss_pred CCCccccccccccccccCcchhcC-----------CCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHh
Q 039168 371 NQNQANTNIIAGTYGYMAPEYAMG-----------GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLW 439 (536)
Q Consensus 371 ~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 439 (536)
...........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...... ........
T Consensus 160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-----~~~~~~~~ 234 (343)
T 3dbq_A 160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----ISKLHAII 234 (343)
T ss_dssp ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-----HHHHHHHH
T ss_pred ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH-----HHHHHHHh
Confidence 443333445679999999999865 67899999999999999999999998532211 11111111
Q ss_pred hcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 440 CEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 440 ~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
........ ....+ ..+.+++.+||+.||++|||+.++++.
T Consensus 235 ~~~~~~~~------~~~~~---~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 235 DPNHEIEF------PDIPE---KDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp CTTSCCCC------CCCSC---HHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cCCcccCC------cccCC---HHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 11111110 11112 345667779999999999999999964
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=350.18 Aligned_cols=254 Identities=23% Similarity=0.298 Sum_probs=202.3
Q ss_pred hcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC-----hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEE
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-----GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELL 288 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 288 (536)
.++|++.+.||+|+||.||+|.++ +++.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 468999999999999999999875 58999999986421 124578999999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhhccc-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCC---eEEecccC
Q 039168 289 LIYEYMPNKSLDVHLFDAT-RSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMN---PKISDFGT 364 (536)
Q Consensus 289 lv~e~~~~~sL~~~l~~~~-~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~---~kl~Dfg~ 364 (536)
+||||+++++|.+.+.... ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 9999999999988775532 3345899999999999999999999997 999999999999987654 99999999
Q ss_pred ccccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCc
Q 039168 365 ARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHA 444 (536)
Q Consensus 365 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 444 (536)
+........ ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.... ... ......+..
T Consensus 180 a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~~----~~~i~~~~~ 249 (351)
T 3c0i_A 180 AIQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK----ERL----FEGIIKGKY 249 (351)
T ss_dssp CEECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH----HHH----HHHHHHTCC
T ss_pred eeEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH----HHH----HHHHHcCCC
Confidence 987754322 2234579999999999999999999999999999999999999985421 111 111111111
Q ss_pred cccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 445 VELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 445 ~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
.. .+..... . ...+.+++.+||+.||++|||+.++++
T Consensus 250 ~~--~~~~~~~-~---s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 250 KM--NPRQWSH-I---SESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp CC--CHHHHTT-S---CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CC--Ccccccc-C---CHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 10 0000011 1 234666777999999999999999985
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=343.78 Aligned_cols=249 Identities=23% Similarity=0.311 Sum_probs=193.7
Q ss_pred hcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccCh--------------------------hhHHHHHHHHHHHH
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG--------------------------QGLKEFKNEVNLIA 267 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l~ 267 (536)
.++|++.+.||+|+||.||+|++. +++.||||++..... ...+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 368999999999999999999875 588999999865421 12356889999999
Q ss_pred HcCCCCceeEeeEEee--CceEEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCC
Q 039168 268 KLQHKNLVRLLGCCLE--GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLK 345 (536)
Q Consensus 268 ~l~hpniv~l~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dik 345 (536)
+++||||+++++++.+ .+..++||||+++++|.+++. ...+++..++.++.||++||.|||+++ |+|||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlk 164 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT----LKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIK 164 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC----SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCC
Confidence 9999999999999986 678999999999999987652 345899999999999999999999997 9999999
Q ss_pred CCcEEEcCCCCeEEecccCccccCCCCCccccccccccccccCcchhcCCC---CCccchHHHHHHHHHHHHhCCCCCCC
Q 039168 346 ASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGI---FSIKSDVFSFGVLLLEIISGRKNNGF 422 (536)
Q Consensus 346 p~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~il~elltg~~p~~~ 422 (536)
|+|||++.++++||+|||+++.+..... ......||+.|+|||++.+.. ++.++||||||+++|+|++|+.||..
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 242 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred HHHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 9999999999999999999987654322 123357899999999998765 47899999999999999999999753
Q ss_pred CCccCCchhHHHHHHHhhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 423 YFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 423 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
... ...... ...... ... .... .+ ..+.+++.+||+.||++|||+.++++
T Consensus 243 ~~~------~~~~~~-~~~~~~-~~~---~~~~-~~---~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 243 ERI------MCLHSK-IKSQAL-EFP---DQPD-IA---EDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp SSH------HHHHHH-HHHCCC-CCC---SSSC-CC---HHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ccH------HHHHHH-HhcccC-CCC---Cccc-cC---HHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 211 111111 111111 100 0111 12 34566777999999999999999975
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=341.20 Aligned_cols=261 Identities=25% Similarity=0.352 Sum_probs=197.5
Q ss_pred cCCccccccCCCCceeEEEEEeCCCcEEEEEEccccCh--hhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEee
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSG--QGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 293 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 293 (536)
++|++.+.||+|+||.||+|++.+++.||+|++..... ...+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 57899999999999999999998899999999865432 2346788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCC
Q 039168 294 MPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQN 373 (536)
Q Consensus 294 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 373 (536)
+++ +|..++... ...+++..++.++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (288)
T 1ob3_A 82 LDQ-DLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (288)
T ss_dssp CSE-EHHHHHHTS--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred cCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCcccc
Confidence 986 788777542 245899999999999999999999997 99999999999999999999999999987643222
Q ss_pred ccccccccccccccCcchhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccc------
Q 039168 374 QANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVE------ 446 (536)
Q Consensus 374 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 446 (536)
......||+.|+|||++.+. .++.++||||||+++|+|++|+.||...... .................
T Consensus 156 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T 1ob3_A 156 --KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA---DQLMRIFRILGTPNSKNWPNVTE 230 (288)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCCCTTTSTTGGG
T ss_pred --ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHHCCCChhhchhhhc
Confidence 12234689999999999764 5899999999999999999999998643221 11111111111110000
Q ss_pred --ccccccc-------CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 447 --LIDPVLK-------QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 447 --l~~~~l~-------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
..++... ..........+.+++.+||+.||++|||+.++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0000000 0000111234567777999999999999999986
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=355.02 Aligned_cols=253 Identities=21% Similarity=0.267 Sum_probs=204.9
Q ss_pred hcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEee
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 293 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 293 (536)
.++|++.+.||+|+||.||+|.++ +++.||+|++..........+.+|+.+|++++||||+++++++.+....++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 468999999999999999999976 5899999999876666667899999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcC--CCCeEEecccCccccCCC
Q 039168 294 MPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDD--DMNPKISDFGTARIFGGN 371 (536)
Q Consensus 294 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~--~~~~kl~Dfg~a~~~~~~ 371 (536)
+.+++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++. .+.+||+|||+++.....
T Consensus 130 ~~gg~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 130 LSGGELFDRIAAE--DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp CCCCBHHHHTTCT--TCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 9999999988542 335899999999999999999999997 999999999999974 568999999999876543
Q ss_pred CCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcccccccc
Q 039168 372 QNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPV 451 (536)
Q Consensus 372 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 451 (536)
.. .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...... .... . ....... ++..
T Consensus 205 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~---~~~~---~-i~~~~~~--~~~~ 272 (387)
T 1kob_A 205 EI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL---ETLQ---N-VKRCDWE--FDED 272 (387)
T ss_dssp SC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHHH---H-HHHCCCC--CCSS
T ss_pred cc---eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH---HHHH---H-HHhCCCC--CCcc
Confidence 22 23357899999999999999999999999999999999999998643211 1111 1 1111110 0111
Q ss_pred ccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 452 LKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 452 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
.... .+ ..+.+++.+||+.||++|||+.++++.
T Consensus 273 ~~~~-~s---~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 273 AFSS-VS---PEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp TTTT-SC---HHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred cccc-CC---HHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 1111 12 345667779999999999999999974
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-42 Score=348.74 Aligned_cols=254 Identities=23% Similarity=0.307 Sum_probs=203.3
Q ss_pred HHhcCCccccccCCCCceeEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEE
Q 039168 213 EATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 289 (536)
Q Consensus 213 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 289 (536)
...++|++.+.||+|+||.||++.++ +++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l 105 (362)
T 2bdw_A 26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 105 (362)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 34578999999999999999999975 5899999998654 33456778999999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCC---CeEEecccCcc
Q 039168 290 IYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDM---NPKISDFGTAR 366 (536)
Q Consensus 290 v~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~---~~kl~Dfg~a~ 366 (536)
||||+.+++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||++.
T Consensus 106 v~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~ 179 (362)
T 2bdw_A 106 VFDLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAI 179 (362)
T ss_dssp EECCCCSCBHHHHHTT---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCB
T ss_pred EEecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcce
Confidence 9999999999988854 345899999999999999999999997 99999999999998654 59999999998
Q ss_pred ccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccc
Q 039168 367 IFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVE 446 (536)
Q Consensus 367 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 446 (536)
....... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ... ......+....
T Consensus 180 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~---~~~----~~~i~~~~~~~ 249 (362)
T 2bdw_A 180 EVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ---HRL----YAQIKAGAYDY 249 (362)
T ss_dssp CCTTCCS---CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHH----HHHHHHTCCCC
T ss_pred EecCCcc---cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHH----HHHHHhCCCCC
Confidence 7653322 2335799999999999999999999999999999999999999753221 111 11111111110
Q ss_pred cccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 447 LIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 447 l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
..+. ... .+ ..+.+++.+||+.||++|||+.++++.
T Consensus 250 -~~~~-~~~-~~---~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 250 -PSPE-WDT-VT---PEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp -CTTG-GGG-SC---HHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred -Cccc-ccC-CC---HHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000 001 12 345667779999999999999999854
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=348.35 Aligned_cols=270 Identities=16% Similarity=0.180 Sum_probs=200.6
Q ss_pred hcCCccccccCCCCceeEEEEEeC----CCcEEEEEEccccChhh-----------HHHHHHHHHHHHHcCCCCceeEee
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA----DGKAIAVKRLSRTSGQG-----------LKEFKNEVNLIAKLQHKNLVRLLG 279 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~hpniv~l~~ 279 (536)
.++|++.+.||+|+||.||+|.+. .+..+|||++....... ...+.+|+.+++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 368999999999999999999975 57889999987653221 123567889999999999999999
Q ss_pred EEee----CceEEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCC
Q 039168 280 CCLE----GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDM 355 (536)
Q Consensus 280 ~~~~----~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~ 355 (536)
++.. ....++||||+ +++|.+++.... .+++.+++.++.||+.||.|||+++ |+||||||+|||++.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG---TFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKN 188 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG---BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCC
Confidence 9988 78899999999 999999985433 6999999999999999999999996 99999999999999877
Q ss_pred --CeEEecccCccccCCCCCc-----cccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCC
Q 039168 356 --NPKISDFGTARIFGGNQNQ-----ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHG 428 (536)
Q Consensus 356 --~~kl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~ 428 (536)
.+||+|||+++.+...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||.......
T Consensus 189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~- 267 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP- 267 (345)
T ss_dssp TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH-
T ss_pred CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc-
Confidence 9999999999876432211 11234578999999999999999999999999999999999999985321111
Q ss_pred chhHHHHHHHhhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccCCCCCC
Q 039168 429 QTLLTYTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSMTIP 497 (536)
Q Consensus 429 ~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 497 (536)
............ .....+.........+. .+.+++.+||+.||++|||+.+|++.|+....+++
T Consensus 268 -~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~---~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 331 (345)
T 2v62_A 268 -VAVQTAKTNLLD-ELPQSVLKWAPSGSSCC---EIAQFLVCAHSLAYDEKPNYQALKKILNPHGIPLG 331 (345)
T ss_dssp -HHHHHHHHHHHH-TTTHHHHHHSCTTSCCH---HHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCCCCC
T ss_pred -HHHHHHHHhhcc-cccHHHHhhccccccHH---HHHHHHHHHhhcCcccCCCHHHHHHHHhccCCccc
Confidence 111111111111 11111111111111222 45666679999999999999999999998765443
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=346.50 Aligned_cols=244 Identities=23% Similarity=0.308 Sum_probs=201.0
Q ss_pred cCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEE
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 291 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 291 (536)
++|++.+.||+|+||.||+++.+ +|+.||+|++.+.. ....+.+.+|..+++.++||||+++++++.+.+..++||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 67999999999999999999976 68999999987542 234567889999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCC
Q 039168 292 EYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGN 371 (536)
Q Consensus 292 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 371 (536)
||+++++|..++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++++||+|||+++.....
T Consensus 86 e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~ 159 (318)
T 1fot_A 86 DYIEGGELFSLLRKS---QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 159 (318)
T ss_dssp CCCCSCBHHHHHHHT---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred eCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCCc
Confidence 999999999999543 35899999999999999999999996 999999999999999999999999999875432
Q ss_pred CCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcccccccc
Q 039168 372 QNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPV 451 (536)
Q Consensus 372 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 451 (536)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||..... ........ .... .
T Consensus 160 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~------~~~~~~i~-~~~~-~----- 221 (318)
T 1fot_A 160 -----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT------MKTYEKIL-NAEL-R----- 221 (318)
T ss_dssp -----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHH-HCCC-C-----
T ss_pred -----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH------HHHHHHHH-hCCC-C-----
Confidence 2345799999999999999999999999999999999999999854221 11111111 1111 0
Q ss_pred ccCCCCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHH
Q 039168 452 LKQSCAPDELLKFIHIGLLCVQQDPADRP-----TMSSVVV 487 (536)
Q Consensus 452 l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 487 (536)
.... .+ ..+.+++.+||+.||++|| ++.++++
T Consensus 222 ~p~~-~~---~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 222 FPPF-FN---EDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp CCTT-SC---HHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCC-CC---HHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 1111 12 3455666799999999999 8999984
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=349.84 Aligned_cols=268 Identities=28% Similarity=0.410 Sum_probs=209.8
Q ss_pred hcCCccccccCCCCceeEEEEEe-----CCCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEe--eCceE
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTL-----ADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCL--EGQEL 287 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~--~~~~~ 287 (536)
.++|++.+.||+|+||.||++++ .+++.||||++........+.+.+|++++++++||||+++++++. +....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 36899999999999999999983 358899999998877777788999999999999999999999987 45679
Q ss_pred EEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccc
Q 039168 288 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARI 367 (536)
Q Consensus 288 ~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 367 (536)
++||||+++++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++++||+|||++..
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 176 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRHR--ARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKL 176 (327)
T ss_dssp EEEEECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred EEEEeecCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEccccccee
Confidence 99999999999999996532 34899999999999999999999997 99999999999999999999999999987
Q ss_pred cCCCCCc-cccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccC--------CchhHHHHHHH
Q 039168 368 FGGNQNQ-ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEH--------GQTLLTYTWKL 438 (536)
Q Consensus 368 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~--------~~~~~~~~~~~ 438 (536)
....... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||....... ...........
T Consensus 177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (327)
T 3lxl_A 177 LPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLEL 256 (327)
T ss_dssp CCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHH
T ss_pred cccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 7543322 12233467888999999999999999999999999999999999865322110 00001111111
Q ss_pred hhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccCCCCC
Q 039168 439 WCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSMTI 496 (536)
Q Consensus 439 ~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 496 (536)
...+... ..+......+.+++.+||+.||++|||+.++++.|+......
T Consensus 257 ~~~~~~~---------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 305 (327)
T 3lxl_A 257 LEEGQRL---------PAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305 (327)
T ss_dssp HHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred hhcccCC---------CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 1111111 111122234667777999999999999999999999874433
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=351.94 Aligned_cols=266 Identities=18% Similarity=0.228 Sum_probs=202.7
Q ss_pred hcCCccccccCCCCceeEEEEEeCC------CcEEEEEEccccChhhH-----------HHHHHHHHHHHHcCCCCceeE
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLAD------GKAIAVKRLSRTSGQGL-----------KEFKNEVNLIAKLQHKNLVRL 277 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~hpniv~l 277 (536)
.++|++.++||+|+||.||+|.+.. ++.||||++........ ..+..|+..++.++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 4689999999999999999998754 47899999876543211 123345666777889999999
Q ss_pred eeEEeeC----ceEEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEc-
Q 039168 278 LGCCLEG----QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLD- 352 (536)
Q Consensus 278 ~~~~~~~----~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~- 352 (536)
++++... ...++||||+ +++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~~ 187 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN--AKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNY 187 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEES
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEec
Confidence 9998764 5689999999 99999998653 345999999999999999999999997 99999999999999
Q ss_pred -CCCCeEEecccCccccCCCCCcc-----ccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCcc
Q 039168 353 -DDMNPKISDFGTARIFGGNQNQA-----NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSE 426 (536)
Q Consensus 353 -~~~~~kl~Dfg~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~ 426 (536)
.++.+||+|||+++.+....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~ 267 (364)
T 3op5_A 188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD 267 (364)
T ss_dssp SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC
Confidence 88999999999998765332211 113355999999999999999999999999999999999999998642221
Q ss_pred CCchhHHHHHHHhhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 427 HGQTLLTYTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 427 ~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
..........+ ...+.+++++.+.....+.+ +.+++..||+.||++|||+.+|++.|+..
T Consensus 268 --~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~---~~~li~~cl~~~p~~RP~~~~l~~~l~~~ 327 (364)
T 3op5_A 268 --PKYVRDSKIRY-RENIASLMDKCFPAANAPGE---IAKYMETVKLLDYTEKPLYENLRDILLQG 327 (364)
T ss_dssp --HHHHHHHHHHH-HHCHHHHHHHHSCTTCCCHH---HHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred --HHHHHHHHHHh-hhhHHHHHHHhcccccCHHH---HHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Confidence 11111111111 12233334443332333444 45556699999999999999999999865
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-42 Score=353.51 Aligned_cols=204 Identities=17% Similarity=0.258 Sum_probs=177.4
Q ss_pred hcCCccccccCCC--CceeEEEEEeC-CCcEEEEEEccccC--hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEE
Q 039168 215 TNHFSDENKLGQG--GFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 289 (536)
Q Consensus 215 ~~~~~~~~~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 289 (536)
.++|++.++||+| +||.||+|++. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 4689999999999 99999999986 69999999987542 4456778899999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccC
Q 039168 290 IYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFG 369 (536)
Q Consensus 290 v~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 369 (536)
||||+++++|.+++.... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 104 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~ 179 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHF-MDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMI 179 (389)
T ss_dssp EEECCTTCBHHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred EEEccCCCCHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence 999999999999986532 245899999999999999999999997 9999999999999999999999999987543
Q ss_pred CCCC-----ccccccccccccccCcchhcC--CCCCccchHHHHHHHHHHHHhCCCCCCC
Q 039168 370 GNQN-----QANTNIIAGTYGYMAPEYAMG--GIFSIKSDVFSFGVLLLEIISGRKNNGF 422 (536)
Q Consensus 370 ~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~p~~~ 422 (536)
.... ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 239 (389)
T 3gni_B 180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 239 (389)
T ss_dssp ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence 2211 111223478999999999988 5789999999999999999999999864
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=366.09 Aligned_cols=261 Identities=29% Similarity=0.440 Sum_probs=203.9
Q ss_pred hcCCccccccCCCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEeec
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 294 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 294 (536)
.++|++.++||+|+||.||+|.++++..||||++.... ...+.+.+|+.+|++++||||+++++++.+ +..++||||+
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~ 260 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 260 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhh
Confidence 46789999999999999999999888889999997543 335789999999999999999999999876 6789999999
Q ss_pred CCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCCc
Q 039168 295 PNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQ 374 (536)
Q Consensus 295 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 374 (536)
++++|.+++.... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++........
T Consensus 261 ~~gsL~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 336 (452)
T 1fmk_A 261 SKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 336 (452)
T ss_dssp TTCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred cCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCcee
Confidence 9999999996422 234899999999999999999999996 999999999999999999999999999876533221
Q ss_pred cccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHHHHHhhcCCcccccccccc
Q 039168 375 ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLK 453 (536)
Q Consensus 375 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~ 453 (536)
......+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... .. ......+.... .
T Consensus 337 -~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~------~~-~~~i~~~~~~~-----~- 402 (452)
T 1fmk_A 337 -ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR------EV-LDQVERGYRMP-----C- 402 (452)
T ss_dssp -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH------HH-HHHHHTTCCCC-----C-
T ss_pred -cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH------HH-HHHHHcCCCCC-----C-
Confidence 1222346789999999999999999999999999999999 89997543211 11 11111221111 1
Q ss_pred CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccCCCCCCC
Q 039168 454 QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSMTIPQ 498 (536)
Q Consensus 454 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~ 498 (536)
+......+.+++.+||+.||++|||+.+|++.|+.......+
T Consensus 403 ---~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~ 444 (452)
T 1fmk_A 403 ---PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 444 (452)
T ss_dssp ---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCC
T ss_pred ---CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCc
Confidence 111223466777799999999999999999999987544433
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=344.15 Aligned_cols=264 Identities=30% Similarity=0.458 Sum_probs=202.3
Q ss_pred cCCccccccCCCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEeecC
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMP 295 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 295 (536)
++|++.+.||+|+||.||++++. ++.||||++... ...+.+.+|+.++++++||||+++++++.+ ..++||||++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~ 82 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAE 82 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCT
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCC
Confidence 57899999999999999999984 788999998643 345788999999999999999999998874 4799999999
Q ss_pred CCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCC-eEEecccCccccCCCCCc
Q 039168 296 NKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMN-PKISDFGTARIFGGNQNQ 374 (536)
Q Consensus 296 ~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~-~kl~Dfg~a~~~~~~~~~ 374 (536)
+++|.+++........+++..++.++.||++||.|||+.+..+|+||||||+|||++.++. +||+|||++......
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~--- 159 (307)
T 2eva_A 83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--- 159 (307)
T ss_dssp TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc---
Confidence 9999999976554455889999999999999999999932224999999999999998887 799999999765422
Q ss_pred cccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccccccC
Q 039168 375 ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQ 454 (536)
Q Consensus 375 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~ 454 (536)
.....||+.|+|||++.+..++.++||||||+++|+|++|+.||...... .....+.. ..+..... ..
T Consensus 160 --~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~----~~~~~~~~-~~~~~~~~-----~~ 227 (307)
T 2eva_A 160 --MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGP----AFRIMWAV-HNGTRPPL-----IK 227 (307)
T ss_dssp -------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSS----HHHHHHHH-HTTCCCCC-----BT
T ss_pred --cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCcc----HHHHHHHH-hcCCCCCc-----cc
Confidence 12345899999999999999999999999999999999999998643221 11111211 11211111 11
Q ss_pred CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccCCCCCCCCCCCC
Q 039168 455 SCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSMTIPQPTEPA 503 (536)
Q Consensus 455 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~p~~p~ 503 (536)
.. + ..+.+++.+||+.||++|||+.++++.|+.....++.+..|.
T Consensus 228 ~~-~---~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~~~ 272 (307)
T 2eva_A 228 NL-P---KPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPL 272 (307)
T ss_dssp TC-C---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTTSCC
T ss_pred cc-C---HHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCCCcc
Confidence 12 2 235667779999999999999999999987655554444443
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=352.92 Aligned_cols=248 Identities=25% Similarity=0.363 Sum_probs=200.7
Q ss_pred HhcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHHHc-CCCCceeEeeEEeeCceEE
Q 039168 214 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLKEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELL 288 (536)
Q Consensus 214 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~ 288 (536)
..++|++.+.||+|+||.||+|+++ +++.||||++.+.. ....+.+..|..++..+ +||||+++++++.+.+..+
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~ 94 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF 94 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEE
Confidence 4578999999999999999999986 58999999997542 23456788899999987 9999999999999999999
Q ss_pred EEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCcccc
Q 039168 289 LIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIF 368 (536)
Q Consensus 289 lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 368 (536)
+||||+++|+|..++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++++||+|||+++..
T Consensus 95 lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 168 (345)
T 1xjd_A 95 FVMEYLNGGDLMYHIQSC---HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKEN 168 (345)
T ss_dssp EEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhhc
Confidence 999999999999998643 34899999999999999999999997 999999999999999999999999999864
Q ss_pred CCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccc
Q 039168 369 GGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELI 448 (536)
Q Consensus 369 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 448 (536)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ... .. ......
T Consensus 169 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~~---~~-i~~~~~---- 235 (345)
T 1xjd_A 169 MLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE---ELF---HS-IRMDNP---- 235 (345)
T ss_dssp CCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH---HH-HHHCCC----
T ss_pred ccCC--CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH---HHH---HH-HHhCCC----
Confidence 3222 2234567999999999999999999999999999999999999998543211 111 11 111110
Q ss_pred cccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHH-HHH
Q 039168 449 DPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMS-SVV 486 (536)
Q Consensus 449 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~-evl 486 (536)
..... .+ ..+.+++.+||+.||++||++. +|+
T Consensus 236 --~~p~~-~s---~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 236 --FYPRW-LE---KEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp --CCCTT-SC---HHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred --CCCcc-cC---HHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 11111 12 3455666799999999999997 665
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=343.74 Aligned_cols=263 Identities=28% Similarity=0.465 Sum_probs=204.5
Q ss_pred hcCCccccccCCCCceeEEEEEe-----CCCcEEEEEEccccC-hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeC--ce
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTL-----ADGKAIAVKRLSRTS-GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEG--QE 286 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~ 286 (536)
.+.|++.+.||+|+||.||+|++ .+++.||||++.... ....+.+.+|+.+++.++||||+++++++.+. ..
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 35689999999999999999983 368999999987543 34467889999999999999999999999876 67
Q ss_pred EEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCcc
Q 039168 287 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTAR 366 (536)
Q Consensus 287 ~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 366 (536)
.++||||+++++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKNK--NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEEEeCCCCcHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECcccccc
Confidence 899999999999999985433 34899999999999999999999997 9999999999999999999999999998
Q ss_pred ccCCCCCc-cccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCC--------ccCCchhHHHHHH
Q 039168 367 IFGGNQNQ-ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYF--------SEHGQTLLTYTWK 437 (536)
Q Consensus 367 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~--------~~~~~~~~~~~~~ 437 (536)
........ .......||..|+|||++.+..++.++||||||+++|+|++|..|+.... .............
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (302)
T 4e5w_A 175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVN 254 (302)
T ss_dssp ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHH
T ss_pred cccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHH
Confidence 77544322 22333567888999999999999999999999999999999998853221 1111111111111
Q ss_pred HhhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcc
Q 039168 438 LWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 491 (536)
Q Consensus 438 ~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 491 (536)
....+.... .+......+.+++.+||+.||++|||+.++++.|+.
T Consensus 255 ~~~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 299 (302)
T 4e5w_A 255 TLKEGKRLP---------CPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEA 299 (302)
T ss_dssp HHHTTCCCC---------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred HHhccCCCC---------CCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence 221211111 111122346677779999999999999999999975
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=350.14 Aligned_cols=259 Identities=31% Similarity=0.465 Sum_probs=208.0
Q ss_pred hcCCccccccCCCCceeEEEEEeC--------CCcEEEEEEcccc-ChhhHHHHHHHHHHHHHc-CCCCceeEeeEEeeC
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA--------DGKAIAVKRLSRT-SGQGLKEFKNEVNLIAKL-QHKNLVRLLGCCLEG 284 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~ 284 (536)
.++|++.+.||+|+||.||+|++. ++..||||++... .....+.+.+|+.+++++ +||||+++++++.+.
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 478999999999999999999863 4678999999754 334567789999999999 899999999999999
Q ss_pred ceEEEEEeecCCCChhhhhhcccC-------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEE
Q 039168 285 QELLLIYEYMPNKSLDVHLFDATR-------------SVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLL 351 (536)
Q Consensus 285 ~~~~lv~e~~~~~sL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll 351 (536)
+..++||||+++++|.+++..... ...+++..++.++.||++||.|||+++ |+||||||+|||+
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEEE
Confidence 999999999999999999965432 234899999999999999999999997 9999999999999
Q ss_pred cCCCCeEEecccCccccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCch
Q 039168 352 DDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQT 430 (536)
Q Consensus 352 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~ 430 (536)
+.++.+||+|||++................+++.|+|||++.+..++.++||||||+++|+|++ |+.||...... .
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~ 267 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE---E 267 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---H
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH---H
Confidence 9999999999999987765443333334567889999999999899999999999999999999 99997543211 1
Q ss_pred hHHHHHHHhhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 431 LLTYTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 431 ~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
. ......+.... ..... ...+.+++.+||+.||.+|||+.++++.|+..
T Consensus 268 ~----~~~~~~~~~~~-----~~~~~----~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l 316 (334)
T 2pvf_A 268 L----FKLLKEGHRMD-----KPANC----TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316 (334)
T ss_dssp H----HHHHHHTCCCC-----CCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred H----HHHHhcCCCCC-----CCccC----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1 11111111111 11111 23466677799999999999999999999865
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=349.56 Aligned_cols=247 Identities=24% Similarity=0.345 Sum_probs=198.6
Q ss_pred hcCCccccccCCCCceeEEEEEe-CCCcEEEEEEccccC---hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEE
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTS---GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 290 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 290 (536)
.++|++.+.||+|+||.||+|.+ .+++.||||++.... ......+.+|+.+++.++||||+++++++...+..++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 36899999999999999999997 468999999986432 22245788999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCC
Q 039168 291 YEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGG 370 (536)
Q Consensus 291 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 370 (536)
|||+ +|+|.+++... ..+++.+++.++.||+.||.|||+++ |+||||||+|||+++++.+||+|||++.....
T Consensus 88 ~E~~-~g~l~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~ 160 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEK---KRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTD 160 (336)
T ss_dssp ECCC-CEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred EECC-CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence 9999 67888887543 34899999999999999999999997 99999999999999999999999999987653
Q ss_pred CCCccccccccccccccCcchhcCCCC-CccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcccccc
Q 039168 371 NQNQANTNIIAGTYGYMAPEYAMGGIF-SIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELID 449 (536)
Q Consensus 371 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 449 (536)
... .....||+.|+|||++.+..+ +.++||||||+++|+|++|+.||.......... .+... .
T Consensus 161 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~------------~i~~~-~ 224 (336)
T 3h4j_B 161 GNF---LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFK------------KVNSC-V 224 (336)
T ss_dssp SBT---TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBC------------CCCSS-C
T ss_pred Ccc---cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHH------------HHHcC-C
Confidence 322 234579999999999988876 789999999999999999999986432211100 00000 0
Q ss_pred ccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 450 PVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 450 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
.... ...+ ..+.+++.+||+.||.+|||+.++++.
T Consensus 225 ~~~p-~~~s---~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 225 YVMP-DFLS---PGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp CCCC-TTSC---HHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred CCCc-ccCC---HHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 0011 1122 345567779999999999999999863
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-42 Score=350.58 Aligned_cols=253 Identities=23% Similarity=0.275 Sum_probs=191.8
Q ss_pred hcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEee
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 293 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 293 (536)
.++|++.+.||+|+||.||+++.. +++.||||++..... ..+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 468999999999999999999986 689999999975432 236688999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCC--eEEecccCccccCCC
Q 039168 294 MPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMN--PKISDFGTARIFGGN 371 (536)
Q Consensus 294 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~--~kl~Dfg~a~~~~~~ 371 (536)
+++++|..++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++. +||+|||+++.....
T Consensus 98 ~~~~~L~~~l~~~---~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~ 171 (361)
T 3uc3_A 98 ASGGELYERICNA---GRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 171 (361)
T ss_dssp CCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred CCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence 9999999998543 34899999999999999999999997 999999999999987765 999999999753322
Q ss_pred CCccccccccccccccCcchhcCCCCCcc-chHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccc
Q 039168 372 QNQANTNIIAGTYGYMAPEYAMGGIFSIK-SDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDP 450 (536)
Q Consensus 372 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 450 (536)
. ......||+.|+|||++.+..+..+ +||||||+++|+|++|+.||........ ......... .... ....
T Consensus 172 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~--~~~~~~~~~-~~~~-~~~~- 243 (361)
T 3uc3_A 172 S---QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD--YRKTIQRIL-SVKY-SIPD- 243 (361)
T ss_dssp ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC--HHHHHHHHH-TTCC-CCCT-
T ss_pred C---CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH--HHHHHHHHh-cCCC-CCCC-
Confidence 1 2233569999999999988887655 8999999999999999999865433221 111111111 1110 0000
Q ss_pred cccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 451 VLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 451 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
....+ ..+.+++.+||+.||++|||+.++++.
T Consensus 244 ---~~~~s---~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 244 ---DIRIS---PECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp ---TSCCC---HHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred ---cCCCC---HHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 00112 345667779999999999999999964
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=356.63 Aligned_cols=252 Identities=23% Similarity=0.357 Sum_probs=195.8
Q ss_pred hcCCccccccCCCCceeEEEEEeCCCcEEEEEEcccc--ChhhHHHHHHHHHHHHHcC--CCCceeEeeEEeeCceEEEE
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRT--SGQGLKEFKNEVNLIAKLQ--HKNLVRLLGCCLEGQELLLI 290 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--hpniv~l~~~~~~~~~~~lv 290 (536)
..+|++.+.||+|+||.||++.+.+++.||||++... .....+.+.+|+.+|++++ ||||+++++++...+..++|
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 134 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence 3569999999999999999999888999999998654 3445678999999999996 59999999999999999999
Q ss_pred EeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCC
Q 039168 291 YEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGG 370 (536)
Q Consensus 291 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 370 (536)
|| +.+++|.+++... ..+++.+++.++.||+.||.|||+++ |+||||||+|||++ ++.+||+|||+++.+..
T Consensus 135 ~E-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~ 206 (390)
T 2zmd_A 135 ME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 206 (390)
T ss_dssp EE-CCSEEHHHHHHHC---SSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred Ee-cCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence 99 6788999998653 35889999999999999999999996 99999999999995 58999999999987754
Q ss_pred CCCccccccccccccccCcchhcC-----------CCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHh
Q 039168 371 NQNQANTNIIAGTYGYMAPEYAMG-----------GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLW 439 (536)
Q Consensus 371 ~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 439 (536)
...........||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... ........
T Consensus 207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-----~~~~~~~~ 281 (390)
T 2zmd_A 207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----ISKLHAII 281 (390)
T ss_dssp -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-----HHHHHHHH
T ss_pred CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH-----HHHHHHHh
Confidence 433333345679999999999975 36899999999999999999999998532211 11111111
Q ss_pred hcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 440 CEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 440 ~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
....... .. ...+ ..+.+++.+||+.||++|||+.++++.
T Consensus 282 ~~~~~~~-----~~-~~~~---~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 282 DPNHEIE-----FP-DIPE---KDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp CTTSCCC-----CC-CCSC---HHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CccccCC-----CC-ccch---HHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 1111111 01 1112 345667779999999999999999964
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-43 Score=367.01 Aligned_cols=257 Identities=29% Similarity=0.451 Sum_probs=207.0
Q ss_pred HhcCCccccccCCCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEee
Q 039168 214 ATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 293 (536)
Q Consensus 214 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 293 (536)
..++|++.++||+|+||.||+|.++++..||||++.... ...+.+.+|+.+|++++||||+++++++. .+..++||||
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~ 263 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEF 263 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECC
T ss_pred chHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEee
Confidence 356889999999999999999999888999999997643 34678999999999999999999999986 5678999999
Q ss_pred cCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCC
Q 039168 294 MPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQN 373 (536)
Q Consensus 294 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 373 (536)
+.+++|.+++.... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 264 ~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~ 339 (454)
T 1qcf_A 264 MAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 339 (454)
T ss_dssp CTTCBHHHHHHSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHH
T ss_pred cCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCce
Confidence 99999999996432 234789999999999999999999996 99999999999999999999999999987643221
Q ss_pred ccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHHHHHhhcCCccccccccc
Q 039168 374 QANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVL 452 (536)
Q Consensus 374 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l 452 (536)
. ......+++.|+|||++....++.++||||||+++|||++ |+.||...... .... ....+.... .
T Consensus 340 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~---~~~~----~i~~~~~~~-----~ 406 (454)
T 1qcf_A 340 T-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP---EVIR----ALERGYRMP-----R 406 (454)
T ss_dssp H-TTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HHHH----HHHHTCCCC-----C
T ss_pred e-ccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH---HHHH----HHHcCCCCC-----C
Confidence 1 1122346788999999999999999999999999999999 99997543211 1111 111111111 0
Q ss_pred cCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccCC
Q 039168 453 KQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDS 493 (536)
Q Consensus 453 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 493 (536)
.... ...+.+|+.+||+.||++|||+.+|++.|+...
T Consensus 407 ~~~~----~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~ 443 (454)
T 1qcf_A 407 PENC----PEELYNIMMRCWKNRPEERPTFEYIQSVLDDFY 443 (454)
T ss_dssp CTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred CCCC----CHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 1111 234667777999999999999999999999864
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=359.53 Aligned_cols=258 Identities=17% Similarity=0.188 Sum_probs=201.7
Q ss_pred HHhcCCccccccCCCCceeEEEEEeCC-CcEEEEEEccccCh---hhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEE
Q 039168 213 EATNHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSG---QGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELL 288 (536)
Q Consensus 213 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 288 (536)
...++|++.++||+|+||+||+|+++. ++.||+|++.+... .....+.+|..++..++||||+++++++.+.+.++
T Consensus 71 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~ 150 (437)
T 4aw2_A 71 LHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLY 150 (437)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEE
T ss_pred CChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEE
Confidence 345789999999999999999999864 78999999865321 12234889999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCcccc
Q 039168 289 LIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIF 368 (536)
Q Consensus 289 lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 368 (536)
+||||+++|+|..++... ...+++..++.++.||+.||.|||+++ |+||||||+||||+.++++||+|||+++..
T Consensus 151 lV~Ey~~gg~L~~~l~~~--~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFGla~~~ 225 (437)
T 4aw2_A 151 LVMDYYVGGDLLTLLSKF--EDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKL 225 (437)
T ss_dssp EEECCCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEecCCCCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchhhhhhc
Confidence 999999999999999642 345999999999999999999999997 999999999999999999999999999876
Q ss_pred CCCCCccccccccccccccCcchhc-----CCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCC
Q 039168 369 GGNQNQANTNIIAGTYGYMAPEYAM-----GGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGH 443 (536)
Q Consensus 369 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 443 (536)
...... .....+||+.|+|||++. ...++.++|||||||++|||++|+.||...... ..............
T Consensus 226 ~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~---~~~~~i~~~~~~~~ 301 (437)
T 4aw2_A 226 MEDGTV-QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV---ETYGKIMNHKERFQ 301 (437)
T ss_dssp CTTSCE-ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHHHTHHHHCC
T ss_pred ccCCCc-ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChh---HHHHhhhhcccccc
Confidence 543322 223467999999999997 556899999999999999999999998643211 11111110000001
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHhhcCCCCCC--CCCHHHHHHH
Q 039168 444 AVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPAD--RPTMSSVVVM 488 (536)
Q Consensus 444 ~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~~ 488 (536)
.... ... .++ .+.+++.+||+.+|++ ||+++++++.
T Consensus 302 ~p~~-----~~~-~s~---~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 302 FPTQ-----VTD-VSE---NAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp CCSS-----CCC-SCH---HHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred CCcc-----ccc-CCH---HHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 1110 011 223 3555666999888888 9999999963
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-43 Score=351.70 Aligned_cols=256 Identities=27% Similarity=0.394 Sum_probs=201.1
Q ss_pred hcCCccccccCCCCceeEEEEEeC-CCcE----EEEEEccccC-hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEE
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA-DGKA----IAVKRLSRTS-GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELL 288 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 288 (536)
.++|++.++||+|+||.||+|.+. +++. ||+|.+.... ......+.+|+.++++++||||+++++++. ++..+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 90 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ 90 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence 368999999999999999999965 3443 7888775432 233456778999999999999999999986 46689
Q ss_pred EEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCcccc
Q 039168 289 LIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIF 368 (536)
Q Consensus 289 lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 368 (536)
+||||+.+++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++++||+|||+++.+
T Consensus 91 ~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQH--RGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLL 165 (325)
T ss_dssp EEEECCTTCBSHHHHHSS--GGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred EEEEeCCCCCHHHHHHHc--cccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCccccc
Confidence 999999999999998643 345889999999999999999999997 999999999999999999999999999987
Q ss_pred CCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHHHHHhhcCCcccc
Q 039168 369 GGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVEL 447 (536)
Q Consensus 369 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 447 (536)
.............|++.|+|||++.+..++.++||||||+++|+|++ |+.||...... ... ...........
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~----~~~~~~~~~~~ 238 (325)
T 3kex_A 166 PPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA---EVP----DLLEKGERLAQ 238 (325)
T ss_dssp CCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT---HHH----HHHHTTCBCCC
T ss_pred CcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHH---HHH----HHHHcCCCCCC
Confidence 65554444455678889999999999999999999999999999999 99998643221 111 11111111111
Q ss_pred ccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 448 IDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 448 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
.. .....+.+++.+||+.||++|||+.++++.|+..
T Consensus 239 ~~---------~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~ 274 (325)
T 3kex_A 239 PQ---------ICTIDVYMVMVKCWMIDENIRPTFKELANEFTRM 274 (325)
T ss_dssp CT---------TBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHH
T ss_pred CC---------cCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 00 0112355677799999999999999999999875
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=368.67 Aligned_cols=256 Identities=28% Similarity=0.421 Sum_probs=208.3
Q ss_pred hcCCccccccCCCCceeEEEEEeCC-CcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEee
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 293 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 293 (536)
.++|++.++||+|+||.||+|.++. +..||||++.... ...+.|.+|+.+|++++||||+++++++.+....++||||
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~ 297 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 297 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence 4678999999999999999999865 8899999997543 3467899999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCC
Q 039168 294 MPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQN 373 (536)
Q Consensus 294 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 373 (536)
+++++|.+++.... ...+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.......
T Consensus 298 ~~~g~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 373 (495)
T 1opk_A 298 MTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY 373 (495)
T ss_dssp CTTCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTCCE
T ss_pred cCCCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCCce
Confidence 99999999996533 345899999999999999999999997 99999999999999999999999999987653322
Q ss_pred ccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHHHHHhhcCCccccccccc
Q 039168 374 QANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVL 452 (536)
Q Consensus 374 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l 452 (536)
. ......+++.|+|||++.+..++.++||||||+++|||++ |+.||...... ... .....+.... .
T Consensus 374 ~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~---~~~----~~~~~~~~~~-----~ 440 (495)
T 1opk_A 374 T-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---QVY----ELLEKDYRME-----R 440 (495)
T ss_dssp E-CCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GHH----HHHHTTCCCC-----C
T ss_pred e-ecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH---HHH----HHHHcCCCCC-----C
Confidence 1 1223346788999999999999999999999999999999 88887643221 111 1111111111 1
Q ss_pred cCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 453 KQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 453 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
+......+.+|+.+||+.||++|||+.+|++.|+..
T Consensus 441 ----~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~ 476 (495)
T 1opk_A 441 ----PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 476 (495)
T ss_dssp ----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred ----CCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 111123466677799999999999999999999876
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=347.37 Aligned_cols=251 Identities=22% Similarity=0.237 Sum_probs=178.3
Q ss_pred ccccCCCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHHcC-CCCceeEeeEEeeCceEEEEEeecCCCC
Q 039168 221 ENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQ-HKNLVRLLGCCLEGQELLLIYEYMPNKS 298 (536)
Q Consensus 221 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lv~e~~~~~s 298 (536)
.++||+|+||.||++.++ +++.||||++... ....+.+|+.+++.+. ||||+++++++.+....++||||+++++
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 378999999999999985 5899999998653 3366788999999997 9999999999999999999999999999
Q ss_pred hhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCC---CeEEecccCccccCCCCCcc
Q 039168 299 LDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDM---NPKISDFGTARIFGGNQNQA 375 (536)
Q Consensus 299 L~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~---~~kl~Dfg~a~~~~~~~~~~ 375 (536)
|.+++... ..+++.+++.++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||+++.......
T Consensus 93 L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~-- 164 (325)
T 3kn6_A 93 LFERIKKK---KHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ-- 164 (325)
T ss_dssp HHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred HHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC--
Confidence 99999643 45999999999999999999999997 99999999999998766 799999999986643322
Q ss_pred ccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccccccCC
Q 039168 376 NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQS 455 (536)
Q Consensus 376 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~ 455 (536)
......||+.|+|||++.+..++.++||||||+++|+|++|+.||.....................+.... .....
T Consensus 165 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~--~~~~~-- 240 (325)
T 3kn6_A 165 PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSF--EGEAW-- 240 (325)
T ss_dssp -------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCC--CSHHH--
T ss_pred cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCC--Ccccc--
Confidence 22335689999999999999999999999999999999999999865433221111111112222221110 00000
Q ss_pred CCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 456 CAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 456 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
......+.+++.+||+.||++|||+.++++.
T Consensus 241 --~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 241 --KNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp --HTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred --cCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 1112346677779999999999999999843
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=345.00 Aligned_cols=268 Identities=24% Similarity=0.323 Sum_probs=206.9
Q ss_pred hcCCccccccCCCCceeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEee----CceEEE
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLE----GQELLL 289 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~----~~~~~l 289 (536)
.++|++.+.||+|+||.||+++. .+++.||||++........+.+.+|+.+++.++||||+++++++.. ....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 46899999999999999999997 4689999999977777777889999999999999999999999873 457899
Q ss_pred EEeecCCCChhhhhhccc-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCcccc
Q 039168 290 IYEYMPNKSLDVHLFDAT-RSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIF 368 (536)
Q Consensus 290 v~e~~~~~sL~~~l~~~~-~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 368 (536)
||||+++++|.+++.... ....+++.+++.++.||++||.|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 999999999999986532 2456899999999999999999999996 999999999999999999999999998765
Q ss_pred CCCCCcc-------ccccccccccccCcchhcCCC---CCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHH
Q 039168 369 GGNQNQA-------NTNIIAGTYGYMAPEYAMGGI---FSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKL 438 (536)
Q Consensus 369 ~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 438 (536)
....... ......||+.|+|||++.+.. ++.++||||||+++|+|++|+.||.......... ...
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~-~~~---- 259 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSV-ALA---- 259 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCH-HHH----
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchh-hHH----
Confidence 3211110 012245799999999987654 6899999999999999999999975321111111 110
Q ss_pred hhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccCCCCCCCC
Q 039168 439 WCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSMTIPQP 499 (536)
Q Consensus 439 ~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~p 499 (536)
..... .. .. .+.....+.+++.+||+.||.+|||+.++++.|+....+.|.+
T Consensus 260 ~~~~~--~~---~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~~ 311 (317)
T 2buj_A 260 VQNQL--SI---PQ----SPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPGQ 311 (317)
T ss_dssp HHCC----C---CC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCCC-
T ss_pred hhccC--CC---Cc----cccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCCCC
Confidence 11100 00 00 1111234667777999999999999999999999875444443
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=345.39 Aligned_cols=248 Identities=25% Similarity=0.335 Sum_probs=192.5
Q ss_pred HHhcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC--hhhHHHHHHHHHHHHHc-CCCCceeEeeEEeeCceEE
Q 039168 213 EATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLKEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELL 288 (536)
Q Consensus 213 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~ 288 (536)
...++|++.++||+|+||+||+|++. +++.||||++.... ......+..|+..+.++ +||||+++++++.+++..+
T Consensus 54 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~ 133 (311)
T 3p1a_A 54 FFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILY 133 (311)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred hhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEE
Confidence 44578999999999999999999986 69999999986532 23334455566655555 9999999999999999999
Q ss_pred EEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCcccc
Q 039168 289 LIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIF 368 (536)
Q Consensus 289 lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 368 (536)
+||||+ +++|..++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++++||+|||++...
T Consensus 134 lv~e~~-~~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~ 207 (311)
T 3p1a_A 134 LQTELC-GPSLQQHCEAW--GASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVEL 207 (311)
T ss_dssp EEEECC-CCBHHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEEC
T ss_pred EEEecc-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeec
Confidence 999999 66888887553 245999999999999999999999996 999999999999999999999999999876
Q ss_pred CCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccc
Q 039168 369 GGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELI 448 (536)
Q Consensus 369 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 448 (536)
.... ......||+.|+|||++.+ .++.++||||||+++|||++|..|+... . .+..+..+..
T Consensus 208 ~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~------~----~~~~~~~~~~---- 269 (311)
T 3p1a_A 208 GTAG---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG------E----GWQQLRQGYL---- 269 (311)
T ss_dssp C---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH------H----HHHHHTTTCC----
T ss_pred ccCC---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc------c----HHHHHhccCC----
Confidence 4332 2233568999999999876 7899999999999999999997664321 0 1112222111
Q ss_pred cccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 449 DPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 449 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
.+...... ...+.+++.+||+.||++|||+.++++.
T Consensus 270 ~~~~~~~~----~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 270 PPEFTAGL----SSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp CHHHHTTS----CHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CcccccCC----CHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 11111111 2346677779999999999999999963
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-42 Score=353.78 Aligned_cols=269 Identities=21% Similarity=0.282 Sum_probs=212.5
Q ss_pred hcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC-hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCc--eEEEE
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQ--ELLLI 290 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~--~~~lv 290 (536)
.++|++.++||+|+||.||+|++. +++.||||++.... ....+.+.+|++++++++||||+++++++...+ ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 468999999999999999999986 48999999987543 334577889999999999999999999998765 78999
Q ss_pred EeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEE----cCCCCeEEecccCcc
Q 039168 291 YEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLL----DDDMNPKISDFGTAR 366 (536)
Q Consensus 291 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll----~~~~~~kl~Dfg~a~ 366 (536)
|||+++++|.+++........+++..++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 999999999999976555555999999999999999999999997 9999999999999 777889999999998
Q ss_pred ccCCCCCccccccccccccccCcchhcC--------CCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHH
Q 039168 367 IFGGNQNQANTNIIAGTYGYMAPEYAMG--------GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKL 438 (536)
Q Consensus 367 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 438 (536)
...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||............ ....
T Consensus 165 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~--~~~~ 239 (396)
T 4eut_A 165 ELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV--MYKI 239 (396)
T ss_dssp ECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHH--HHHH
T ss_pred EccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHH--HHHH
Confidence 765332 2223568999999999865 46788999999999999999999998654333222111 1111
Q ss_pred hhcCCccccc-------------c--ccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 439 WCEGHAVELI-------------D--PVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 439 ~~~~~~~~l~-------------~--~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
... .....+ . ..............+.+++.+||+.||++|||+.++++.|...
T Consensus 240 ~~~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~i 307 (396)
T 4eut_A 240 ITG-KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (396)
T ss_dssp HHS-CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred hcC-CCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHH
Confidence 111 111100 0 0011123355666778888999999999999999999888764
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=346.35 Aligned_cols=248 Identities=24% Similarity=0.307 Sum_probs=191.4
Q ss_pred hcCCccccccCCCCceeEEEEEe----CCCcEEEEEEccccC----hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCce
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTL----ADGKAIAVKRLSRTS----GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQE 286 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 286 (536)
.++|++.+.||+|+||.||+++. .+++.||+|++.+.. ......+.+|+.+|++++||||+++++++...+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 36899999999999999999987 468999999997642 2344567889999999999999999999999999
Q ss_pred EEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCcc
Q 039168 287 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTAR 366 (536)
Q Consensus 287 ~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 366 (536)
.++||||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++++||+|||+++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLERE---GIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred EEEEEeCCCCCcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 99999999999999998543 34899999999999999999999997 9999999999999999999999999997
Q ss_pred ccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccc
Q 039168 367 IFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVE 446 (536)
Q Consensus 367 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 446 (536)
....... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||...... ....... .... .
T Consensus 170 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~~~i~-~~~~-~ 239 (327)
T 3a62_A 170 ESIHDGT--VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK------KTIDKIL-KCKL-N 239 (327)
T ss_dssp -----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHH-HTCC-C
T ss_pred ccccCCc--cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHH------HHHHHHH-hCCC-C
Confidence 6432221 223457899999999999999999999999999999999999998643211 1111111 1110 0
Q ss_pred cccccccCCCCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHH
Q 039168 447 LIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRP-----TMSSVVV 487 (536)
Q Consensus 447 l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 487 (536)
+... .+ ..+.+++.+||+.||++|| ++.++++
T Consensus 240 -----~p~~-~~---~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 240 -----LPPY-LT---QEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp -----CCTT-SC---HHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred -----CCCC-CC---HHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 1111 12 3456667799999999999 7788875
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=348.27 Aligned_cols=245 Identities=22% Similarity=0.275 Sum_probs=202.0
Q ss_pred hcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEE
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 290 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 290 (536)
.++|++.+.||+|+||.||+++++ +++.||||++.+.. ....+.+.+|+.+|+.++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 368999999999999999999976 58999999986542 23456788999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCC
Q 039168 291 YEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGG 370 (536)
Q Consensus 291 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 370 (536)
|||+++++|..++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 120 ~e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp EECCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EcCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccC
Confidence 9999999999999653 34899999999999999999999997 99999999999999999999999999987643
Q ss_pred CCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccc
Q 039168 371 NQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDP 450 (536)
Q Consensus 371 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 450 (536)
. .....||+.|+|||++.+..++.++|||||||++|+|++|+.||..... .... ..+..+.. .
T Consensus 194 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~------~~~~-~~i~~~~~-~---- 256 (350)
T 1rdq_E 194 R-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP------IQIY-EKIVSGKV-R---- 256 (350)
T ss_dssp C-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHH-HHHHHCCC-C----
T ss_pred C-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH------HHHH-HHHHcCCC-C----
Confidence 2 2345799999999999999999999999999999999999999853221 1111 11111111 1
Q ss_pred cccCCCCHHHHHHHHHHHHhhcCCCCCCCCC-----HHHHHH
Q 039168 451 VLKQSCAPDELLKFIHIGLLCVQQDPADRPT-----MSSVVV 487 (536)
Q Consensus 451 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~ 487 (536)
+.... + ..+.+++.+||+.||.+||+ +.+|++
T Consensus 257 -~p~~~-~---~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 257 -FPSHF-S---SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp -CCTTC-C---HHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred -CCCCC-C---HHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 11111 2 34566677999999999998 888885
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-42 Score=342.19 Aligned_cols=264 Identities=26% Similarity=0.363 Sum_probs=187.5
Q ss_pred hcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC-hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEe
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 292 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 292 (536)
.++|++.+.||+|+||.||+|.++ +++.||||++.... ....+.+.+|+.++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 468999999999999999999975 58999999987543 2334678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhccc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccC
Q 039168 293 YMPNKSLDVHLFDAT---RSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFG 369 (536)
Q Consensus 293 ~~~~~sL~~~l~~~~---~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 369 (536)
|++ ++|.+++.... ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 58888875432 2235899999999999999999999997 9999999999999999999999999998764
Q ss_pred CCCCccccccccccccccCcchhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCC---cc
Q 039168 370 GNQNQANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGH---AV 445 (536)
Q Consensus 370 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~ 445 (536)
.... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||...... .............. +.
T Consensus 160 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~i~~~~~~~~~~~~~ 234 (317)
T 2pmi_A 160 IPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDE---EQLKLIFDIMGTPNESLWP 234 (317)
T ss_dssp SCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCSCCTTTCG
T ss_pred CCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCCChhHhh
Confidence 3322 22235689999999999874 5899999999999999999999998643321 11111111111000 00
Q ss_pred c-----ccccc------------ccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 446 E-----LIDPV------------LKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 446 ~-----l~~~~------------l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
. ...+. +...........+.+++.+||+.||++|||+.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 235 SVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp GGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 0 00000 000000011234667777999999999999999985
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-42 Score=339.58 Aligned_cols=260 Identities=28% Similarity=0.504 Sum_probs=193.3
Q ss_pred hcCCccccccCCCCceeEEEEEeCCCcEEEEEEcccc--ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEe
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRT--SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 292 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 292 (536)
.++|++.++||+|+||.||+|++.. .||+|++... .....+.+.+|+.++++++||||++++++. .....++|||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e 99 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ 99 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence 4689999999999999999998743 5999998644 344567899999999999999999999965 5567899999
Q ss_pred ecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCC
Q 039168 293 YMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQ 372 (536)
Q Consensus 293 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 372 (536)
|+++++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++++||+|||++.......
T Consensus 100 ~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 174 (289)
T 3og7_A 100 WCEGSSLYHHLHAS--ETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS 174 (289)
T ss_dssp CCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC---------
T ss_pred ecCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecccccccc
Confidence 99999999988543 345899999999999999999999997 9999999999999999999999999998765433
Q ss_pred CccccccccccccccCcchhc---CCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcccccc
Q 039168 373 NQANTNIIAGTYGYMAPEYAM---GGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELID 449 (536)
Q Consensus 373 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 449 (536)
.........||+.|+|||++. +..++.++||||||+++|+|++|+.||....... . .......+.....+.
T Consensus 175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~----~~~~~~~~~~~~~~~ 248 (289)
T 3og7_A 175 GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--Q----IIEMVGRGSLSPDLS 248 (289)
T ss_dssp ---------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH--H----HHHHHHHTSCCCCTT
T ss_pred ccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH--H----HHHHhcccccCcchh
Confidence 333344467899999999997 5678999999999999999999999985432211 1 111111222111111
Q ss_pred ccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccCC
Q 039168 450 PVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDS 493 (536)
Q Consensus 450 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 493 (536)
. ..... ...+.+++.+||+.||++|||+.++++.|+...
T Consensus 249 ~-~~~~~----~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 249 K-VRSNC----PKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp S-SCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred h-ccccC----CHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 1 11111 234666777999999999999999999998753
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=353.71 Aligned_cols=262 Identities=28% Similarity=0.407 Sum_probs=204.0
Q ss_pred cCC-ccccccCCCCceeEEEEEeC-----CCcEEEEEEccccC-hhhHHHHHHHHHHHHHcCCCCceeEeeEEee--Cce
Q 039168 216 NHF-SDENKLGQGGFGPVYKGTLA-----DGKAIAVKRLSRTS-GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLE--GQE 286 (536)
Q Consensus 216 ~~~-~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~--~~~ 286 (536)
++| ++.++||+|+||.||++... +++.||||++.... ....+.+.+|++++++++||||+++++++.+ ...
T Consensus 30 ~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (318)
T 3lxp_A 30 KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAAS 109 (318)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTE
T ss_pred HHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCce
Confidence 344 99999999999999888642 58899999997653 3456778999999999999999999999987 468
Q ss_pred EEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCcc
Q 039168 287 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTAR 366 (536)
Q Consensus 287 ~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 366 (536)
.++||||+++++|.+++... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~ 182 (318)
T 3lxp_A 110 LQLVMEYVPLGSLRDYLPRH----SIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAK 182 (318)
T ss_dssp EEEEECCCTTCBHHHHGGGS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred EEEEEecccCCcHHHHHhhC----CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCccccc
Confidence 99999999999999998542 3899999999999999999999997 9999999999999999999999999998
Q ss_pred ccCCCCCc-cccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccC--------CchhHHHHHH
Q 039168 367 IFGGNQNQ-ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEH--------GQTLLTYTWK 437 (536)
Q Consensus 367 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~--------~~~~~~~~~~ 437 (536)
........ .......+|+.|+|||++.+..++.++||||||+++|+|++|+.||....... ..........
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (318)
T 3lxp_A 183 AVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTE 262 (318)
T ss_dssp ECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHH
T ss_pred cccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHH
Confidence 77543321 12233457888999999999999999999999999999999999975321110 0000000111
Q ss_pred HhhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccCC
Q 039168 438 LWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDS 493 (536)
Q Consensus 438 ~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 493 (536)
....... ...+......+.+++.+||+.||++|||+.++++.|+...
T Consensus 263 ~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~ 309 (318)
T 3lxp_A 263 LLERGER---------LPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVH 309 (318)
T ss_dssp HHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHhcccC---------CCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 1111111 1111122245667777999999999999999999998753
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=349.55 Aligned_cols=261 Identities=27% Similarity=0.438 Sum_probs=209.3
Q ss_pred HHhcCCccccccCCCCceeEEEEEeC------CCcEEEEEEccccC-hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCc
Q 039168 213 EATNHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRTS-GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQ 285 (536)
Q Consensus 213 ~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 285 (536)
...++|++.+.||+|+||.||+|.+. .++.||||++.... ......+.+|+.+++.++||||+++++++.+.+
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 101 (322)
T 1p4o_A 22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 101 (322)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred chhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCC
Confidence 34578999999999999999999864 37889999997543 344567889999999999999999999999999
Q ss_pred eEEEEEeecCCCChhhhhhcccC-------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeE
Q 039168 286 ELLLIYEYMPNKSLDVHLFDATR-------SVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPK 358 (536)
Q Consensus 286 ~~~lv~e~~~~~sL~~~l~~~~~-------~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~k 358 (536)
..++||||+++++|.+++..... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++++|
T Consensus 102 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~~~k 178 (322)
T 1p4o_A 102 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVK 178 (322)
T ss_dssp SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEE
T ss_pred ccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCCeEE
Confidence 99999999999999999865321 245789999999999999999999997 99999999999999999999
Q ss_pred EecccCccccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHHHH
Q 039168 359 ISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWK 437 (536)
Q Consensus 359 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~ 437 (536)
|+|||+++...............+|+.|+|||++.+..++.++||||||+++|+|++ |+.||...... . ...
T Consensus 179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~------~-~~~ 251 (322)
T 1p4o_A 179 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE------Q-VLR 251 (322)
T ss_dssp ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH------H-HHH
T ss_pred ECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH------H-HHH
Confidence 999999987654333233334467889999999999999999999999999999999 88887543211 1 111
Q ss_pred HhhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 438 LWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 438 ~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
....+..... ... .+ ..+.+++.+||+.||++|||+.++++.|+..
T Consensus 252 ~~~~~~~~~~-----~~~-~~---~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~ 297 (322)
T 1p4o_A 252 FVMEGGLLDK-----PDN-CP---DMLFELMRMCWQYNPKMRPSFLEIISSIKEE 297 (322)
T ss_dssp HHHTTCCCCC-----CTT-CC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred HHHcCCcCCC-----CCC-CC---HHHHHHHHHHcCCCcccCcCHHHHHHHHHHh
Confidence 1122221111 111 12 3456677799999999999999999999886
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=351.17 Aligned_cols=261 Identities=30% Similarity=0.459 Sum_probs=208.0
Q ss_pred HhcCCccccccCCCCceeEEEEEeCC------CcEEEEEEccccC-hhhHHHHHHHHHHHHHc-CCCCceeEeeEEeeCc
Q 039168 214 ATNHFSDENKLGQGGFGPVYKGTLAD------GKAIAVKRLSRTS-GQGLKEFKNEVNLIAKL-QHKNLVRLLGCCLEGQ 285 (536)
Q Consensus 214 ~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~ 285 (536)
..++|++.+.||+|+||.||+|.+.. .+.||+|++.... ....+.+.+|+.+++.+ +||||+++++++.+.+
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 123 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGG 123 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC
Confidence 35789999999999999999998642 3479999987553 34567789999999999 8999999999999999
Q ss_pred eEEEEEeecCCCChhhhhhcccC-----------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCC
Q 039168 286 ELLLIYEYMPNKSLDVHLFDATR-----------SVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDD 354 (536)
Q Consensus 286 ~~~lv~e~~~~~sL~~~l~~~~~-----------~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~ 354 (536)
..++||||+++++|.+++..... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 124 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~ 200 (333)
T 2i1m_A 124 PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNG 200 (333)
T ss_dssp SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEEGG
T ss_pred ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEECCC
Confidence 99999999999999999865321 345799999999999999999999997 9999999999999999
Q ss_pred CCeEEecccCccccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHH
Q 039168 355 MNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLT 433 (536)
Q Consensus 355 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~ 433 (536)
+.+||+|||++................||+.|+|||++.+..++.++||||||+++|+|++ |..||....... ..
T Consensus 201 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--~~-- 276 (333)
T 2i1m_A 201 HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS--KF-- 276 (333)
T ss_dssp GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH--HH--
T ss_pred CeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH--HH--
Confidence 9999999999987654433333334567889999999999999999999999999999999 888875432211 11
Q ss_pred HHHHHhhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 434 YTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 434 ~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
........... .. ...+ ..+.+++.+||+.||.+|||+.+|++.|+..
T Consensus 277 --~~~~~~~~~~~-----~~-~~~~---~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 324 (333)
T 2i1m_A 277 --YKLVKDGYQMA-----QP-AFAP---KNIYSIMQACWALEPTHRPTFQQICSFLQEQ 324 (333)
T ss_dssp --HHHHHHTCCCC-----CC-TTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --HHHHhcCCCCC-----CC-CCCC---HHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence 11111111111 01 1112 3466677799999999999999999999753
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=348.51 Aligned_cols=252 Identities=24% Similarity=0.355 Sum_probs=187.6
Q ss_pred HhcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEe
Q 039168 214 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 292 (536)
Q Consensus 214 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 292 (536)
..++|++.+.||+|+||.||+|++. +++.||||++.... ..+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 4578999999999999999999986 48899999987543 33678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcC---CCCeEEecccCccccC
Q 039168 293 YMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDD---DMNPKISDFGTARIFG 369 (536)
Q Consensus 293 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~---~~~~kl~Dfg~a~~~~ 369 (536)
|+++++|.+++.. ...+++.+++.++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||+++...
T Consensus 129 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~ 202 (349)
T 2w4o_A 129 LVTGGELFDRIVE---KGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202 (349)
T ss_dssp CCCSCBHHHHHTT---CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred eCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence 9999999998854 345899999999999999999999997 999999999999975 8899999999998764
Q ss_pred CCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcccccc
Q 039168 370 GNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELID 449 (536)
Q Consensus 370 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 449 (536)
... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...... . ............ ...
T Consensus 203 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~---~~~~~i~~~~~~-~~~ 272 (349)
T 2w4o_A 203 HQV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD---Q---FMFRRILNCEYY-FIS 272 (349)
T ss_dssp -------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH---H---HHHHHHHTTCCC-CCT
T ss_pred ccc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc---H---HHHHHHHhCCCc-cCC
Confidence 322 223457899999999999999999999999999999999999997532221 1 111111111111 111
Q ss_pred ccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 450 PVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 450 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
+ . .......+.+++.+||+.||++|||+.++++.
T Consensus 273 ~-~----~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 273 P-W----WDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp T-T----TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred c-h----hhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1 0 11112346667779999999999999999973
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=348.92 Aligned_cols=248 Identities=24% Similarity=0.292 Sum_probs=200.6
Q ss_pred hcCCccccccCCCCceeEEEEEeCC-CcEEEEEEccccC---hhhHHHHHHHHHHHHHc-CCCCceeEeeEEeeCceEEE
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTS---GQGLKEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLL 289 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~l 289 (536)
.++|++.+.||+|+||.||+|+.+. ++.||||++.+.. ....+.+.+|..++..+ +||||+++++++.+.+.+|+
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 4789999999999999999999864 8899999987542 23456788999999988 89999999999999999999
Q ss_pred EEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccC
Q 039168 290 IYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFG 369 (536)
Q Consensus 290 v~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 369 (536)
||||+++++|..++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++++||+|||+++...
T Consensus 99 v~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 172 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI 172 (353)
T ss_dssp EEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence 99999999999998643 34899999999999999999999997 9999999999999999999999999998643
Q ss_pred CCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcccccc
Q 039168 370 GNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELID 449 (536)
Q Consensus 370 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 449 (536)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ........ .... .
T Consensus 173 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~------~~~~~~i~-~~~~-~--- 239 (353)
T 2i0e_A 173 WDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE------DELFQSIM-EHNV-A--- 239 (353)
T ss_dssp CTT--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHH-HCCC-C---
T ss_pred cCC--cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH------HHHHHHHH-hCCC-C---
Confidence 222 223346799999999999999999999999999999999999999854221 11111111 1111 0
Q ss_pred ccccCCCCHHHHHHHHHHHHhhcCCCCCCCCC-----HHHHHH
Q 039168 450 PVLKQSCAPDELLKFIHIGLLCVQQDPADRPT-----MSSVVV 487 (536)
Q Consensus 450 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~ 487 (536)
.... .+ ..+.+++.+||+.||.+||+ +.+|++
T Consensus 240 --~p~~-~s---~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 240 --YPKS-MS---KEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp --CCTT-SC---HHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred --CCCC-CC---HHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 1111 12 34566777999999999995 577764
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-42 Score=337.21 Aligned_cols=251 Identities=24% Similarity=0.395 Sum_probs=202.4
Q ss_pred hcCCccccccCCCCceeEEEEEeCC-C-------cEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCce
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLAD-G-------KAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQE 286 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 286 (536)
.++|++.+.||+|+||.||+|.+.. + ..||+|++........+.+.+|+.++++++||||+++++++.+.+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 4689999999999999999998653 3 5799999987777777889999999999999999999999999999
Q ss_pred EEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCC--------eE
Q 039168 287 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMN--------PK 358 (536)
Q Consensus 287 ~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~--------~k 358 (536)
.++||||+++++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++. +|
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKN--KNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred CEEEEECCCCCCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceee
Confidence 99999999999999999653 234899999999999999999999997 999999999999998887 99
Q ss_pred EecccCccccCCCCCccccccccccccccCcchhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHH
Q 039168 359 ISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWK 437 (536)
Q Consensus 359 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~ 437 (536)
|+|||++..... .....||+.|+|||++.+ ..++.++||||||+++|+|++|..|+...... .. ...
T Consensus 162 l~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~-----~~-~~~ 229 (289)
T 4fvq_A 162 LSDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS-----QR-KLQ 229 (289)
T ss_dssp ECCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH-----HH-HHH
T ss_pred eccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccch-----HH-HHH
Confidence 999999875422 223467899999999987 67899999999999999999965553221111 11 111
Q ss_pred HhhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccCC
Q 039168 438 LWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDS 493 (536)
Q Consensus 438 ~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 493 (536)
...... .+ .... ...+.+++.+||+.||++|||+.++++.|+...
T Consensus 230 ~~~~~~--~~-----~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~ 274 (289)
T 4fvq_A 230 FYEDRH--QL-----PAPK----AAELANLINNCMDYEPDHRPSFRAIIRDLNSLF 274 (289)
T ss_dssp HHHTTC--CC-----CCCS----SCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC
T ss_pred HhhccC--CC-----CCCC----CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 111110 00 0011 123566777999999999999999999999863
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-42 Score=334.61 Aligned_cols=254 Identities=26% Similarity=0.365 Sum_probs=204.1
Q ss_pred HhcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC-hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEE
Q 039168 214 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 291 (536)
Q Consensus 214 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 291 (536)
..++|++.+.||+|+||.||+|.+. +++.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence 4568999999999999999999976 68999999986443 344578899999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCC
Q 039168 292 EYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGN 371 (536)
Q Consensus 292 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 371 (536)
||+++++|.+++.. ...+++..++.++.||+.||.|||+++ ++|+||||+||+++.++.+||+|||++..+...
T Consensus 85 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 158 (276)
T 2yex_A 85 EYCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (276)
T ss_dssp ECCTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred EecCCCcHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence 99999999998843 345899999999999999999999997 999999999999999999999999999876533
Q ss_pred CCccccccccccccccCcchhcCCCC-CccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccc
Q 039168 372 QNQANTNIIAGTYGYMAPEYAMGGIF-SIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDP 450 (536)
Q Consensus 372 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 450 (536)
..........|++.|+|||++.+..+ +.++||||||+++|+|++|+.||........ . ...+...... ..+
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~---~~~~~~~~~~--~~~ 230 (276)
T 2yex_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ---E---YSDWKEKKTY--LNP 230 (276)
T ss_dssp TEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH---H---HHHHHTTCTT--STT
T ss_pred cchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH---H---HHHhhhcccc--cCc
Confidence 33233344678999999999988765 7899999999999999999999865332211 1 1111111110 000
Q ss_pred cccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 451 VLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 451 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
... .+ ..+.+++.+||+.||++|||+.++++
T Consensus 231 --~~~-~~---~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 231 --WKK-ID---SAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp --GGG-SC---HHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --hhh-cC---HHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 001 12 24556777999999999999999986
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=336.97 Aligned_cols=265 Identities=22% Similarity=0.305 Sum_probs=197.4
Q ss_pred cCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC--hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEe
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 292 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 292 (536)
++|++.++||+|+||.||+|.+. +++.||||++.... ....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 68999999999999999999986 48999999986543 2335678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCC
Q 039168 293 YMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQ 372 (536)
Q Consensus 293 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 372 (536)
|+++++|..++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 83 ~~~~~~l~~~~~~---~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 156 (311)
T 4agu_A 83 YCDHTVLHELDRY---QRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPS 156 (311)
T ss_dssp CCSEEHHHHHHHT---SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred eCCCchHHHHHhh---hcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence 9999999888743 345899999999999999999999997 9999999999999999999999999998765332
Q ss_pred CccccccccccccccCcchhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHH--------HHHHhhcCC
Q 039168 373 NQANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTY--------TWKLWCEGH 443 (536)
Q Consensus 373 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~--------~~~~~~~~~ 443 (536)
. ......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.............. ....+....
T Consensus 157 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (311)
T 4agu_A 157 D--YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQ 234 (311)
T ss_dssp -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCG
T ss_pred c--ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccc
Confidence 2 1223568999999999976 5689999999999999999999999865432211110000 000111110
Q ss_pred ccccccccccCCC-C-----HHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 444 AVELIDPVLKQSC-A-----PDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 444 ~~~l~~~~l~~~~-~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
............. . +.....+.+++.+||+.||++|||++++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 235 YFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp GGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred ccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0000000000000 0 1112346677889999999999999999953
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=344.78 Aligned_cols=258 Identities=23% Similarity=0.349 Sum_probs=194.2
Q ss_pred hcCCccccccCCCCceeEEEEEe-CCCcEEEEEEcccc---ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCc----e
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRT---SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQ----E 286 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~----~ 286 (536)
.++|++.+.||+|+||.||++++ .+++.||||++... .......+.+|+.++++++||||+++++++.... .
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 47899999999999999999997 46899999999754 2344567889999999999999999999987654 3
Q ss_pred EEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCcc
Q 039168 287 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTAR 366 (536)
Q Consensus 287 ~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 366 (536)
.++||||+++++|.+++... ..+++.+++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~ 164 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 164 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred cEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence 59999999999999998643 35899999999999999999999997 9999999999999999999999999998
Q ss_pred ccCCCCCc-cccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcc
Q 039168 367 IFGGNQNQ-ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAV 445 (536)
Q Consensus 367 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 445 (536)
.+...... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||..... ..............
T Consensus 165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~------~~~~~~~~~~~~~~ 238 (311)
T 3ork_A 165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP------VSVAYQHVREDPIP 238 (311)
T ss_dssp -----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHCCCCC
T ss_pred cccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHhcCCCCC
Confidence 76543222 223345689999999999999999999999999999999999999854321 11122222211111
Q ss_pred ccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHH-HHhcc
Q 039168 446 ELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVV-VMLAS 491 (536)
Q Consensus 446 ~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl-~~L~~ 491 (536)
+.......+ ..+.+++.+||+.||++||+..+++ ..|..
T Consensus 239 ----~~~~~~~~~---~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 278 (311)
T 3ork_A 239 ----PSARHEGLS---ADLDAVVLKALAKNPENRYQTAAEMRADLVR 278 (311)
T ss_dssp ----HHHHSTTCC---HHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred ----cccccCCCC---HHHHHHHHHHHhcCHhhChhhHHHHHHHHHH
Confidence 111111112 3456677799999999999776655 34433
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=350.65 Aligned_cols=256 Identities=28% Similarity=0.449 Sum_probs=196.7
Q ss_pred hcCCccccccCCCCceeEEEEEeC-CCc----EEEEEEcccc-ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEE
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA-DGK----AIAVKRLSRT-SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELL 288 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 288 (536)
.++|++.++||+|+||.||+|.+. +++ +||+|.+... .....+.+.+|+.++++++||||+++++++.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 368999999999999999999964 344 3577777543 3445678999999999999999999999998765 78
Q ss_pred EEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCcccc
Q 039168 289 LIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIF 368 (536)
Q Consensus 289 lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 368 (536)
+|+||+.+++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 93 ~v~~~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEECCCSSCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred EEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 999999999999998653 345899999999999999999999997 999999999999999999999999999877
Q ss_pred CCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHHHHHhhcCCcccc
Q 039168 369 GGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVEL 447 (536)
Q Consensus 369 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 447 (536)
.............+|+.|+|||++.+..++.++||||||+++|+|++ |+.||....... ... ....+.....
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~~~----~~~~~~~~~~ 240 (327)
T 3lzb_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISS----ILEKGERLPQ 240 (327)
T ss_dssp ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHH----HHHTTCCCCC
T ss_pred cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH---HHH----HHHcCCCCCC
Confidence 55444333444557889999999999999999999999999999999 999986433221 111 1111111111
Q ss_pred ccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 448 IDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 448 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
+......+.+++.+||+.||.+|||+.++++.|+..
T Consensus 241 ---------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 276 (327)
T 3lzb_A 241 ---------PPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKM 276 (327)
T ss_dssp ---------CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---------CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 111223466777799999999999999999999875
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=343.88 Aligned_cols=263 Identities=23% Similarity=0.244 Sum_probs=201.8
Q ss_pred hHHHHhcCCccccccCCCCceeEEEEEeC-CCcEEEEEEcccc-----ChhhHHHHHHHHHHHHHcCCCCceeEeeEEee
Q 039168 210 LALEATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT-----SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLE 283 (536)
Q Consensus 210 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 283 (536)
.+....++|++.+.||+|+||.||+|.+. +++.||+|++... .....+.+.+|+.++++++||||+++++++.+
T Consensus 20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 99 (345)
T 3hko_A 20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED 99 (345)
T ss_dssp CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence 34567789999999999999999999975 5889999998643 33456789999999999999999999999999
Q ss_pred CceEEEEEeecCCCChhhhhhccc-------------------------------------CCCCCCHHHHHHHHHHHHH
Q 039168 284 GQELLLIYEYMPNKSLDVHLFDAT-------------------------------------RSVQLDWKRRLSIINGIAR 326 (536)
Q Consensus 284 ~~~~~lv~e~~~~~sL~~~l~~~~-------------------------------------~~~~l~~~~~~~i~~qi~~ 326 (536)
.+..++||||+++++|.+++.... ....+++..++.++.||+.
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 999999999999999999885211 1222467888999999999
Q ss_pred HHHHHhcCCCCCeeeCCCCCCcEEEcCCC--CeEEecccCccccCCCCCc--cccccccccccccCcchhcC--CCCCcc
Q 039168 327 GILYLHEDSRLKIIHRDLKASNVLLDDDM--NPKISDFGTARIFGGNQNQ--ANTNIIAGTYGYMAPEYAMG--GIFSIK 400 (536)
Q Consensus 327 al~~LH~~~~~~ivH~Dikp~NIll~~~~--~~kl~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~ 400 (536)
||.|||+++ |+||||||+|||++.++ .+||+|||++..+...... .......||+.|+|||++.+ ..++.+
T Consensus 180 ~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 256 (345)
T 3hko_A 180 ALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK 256 (345)
T ss_dssp HHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred HHHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence 999999997 99999999999998776 8999999999876432221 12334578999999999975 678999
Q ss_pred chHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCC
Q 039168 401 SDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRP 480 (536)
Q Consensus 401 ~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP 480 (536)
+||||||+++|+|++|+.||...... .............. .+.. .. . ...+.+++.+||+.||++||
T Consensus 257 ~DiwslG~il~el~~g~~pf~~~~~~------~~~~~~~~~~~~~~--~~~~-~~-~---~~~~~~li~~~l~~~p~~Rp 323 (345)
T 3hko_A 257 CDAWSAGVLLHLLLMGAVPFPGVNDA------DTISQVLNKKLCFE--NPNY-NV-L---SPLARDLLSNLLNRNVDERF 323 (345)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCCCCTT--SGGG-GG-S---CHHHHHHHHHHSCSCTTTSC
T ss_pred HHHHHHHHHHHHHHHCCCCCCCCChH------HHHHHHHhcccccC--Cccc-cc-C---CHHHHHHHHHHcCCChhHCC
Confidence 99999999999999999997543221 11122221111111 1110 01 1 23456677799999999999
Q ss_pred CHHHHHHH
Q 039168 481 TMSSVVVM 488 (536)
Q Consensus 481 t~~evl~~ 488 (536)
|+.++++.
T Consensus 324 s~~~~l~h 331 (345)
T 3hko_A 324 DAMRALQH 331 (345)
T ss_dssp CHHHHHHS
T ss_pred CHHHHhcC
Confidence 99999873
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=357.05 Aligned_cols=251 Identities=27% Similarity=0.433 Sum_probs=204.2
Q ss_pred cCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEE
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 291 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 291 (536)
++|.+.+.||+|+||.||+|++. +|+.||||++.... ....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 68999999999999999999976 69999999986542 234567899999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCC
Q 039168 292 EYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGN 371 (536)
Q Consensus 292 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 371 (536)
||+++++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++++||+|||++......
T Consensus 96 E~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~ 169 (476)
T 2y94_A 96 EYVSGGELFDYICK---NGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 169 (476)
T ss_dssp ECCSSEEHHHHTTS---SSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence 99999999999853 345999999999999999999999997 999999999999999999999999999876543
Q ss_pred CCccccccccccccccCcchhcCCCC-CccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccc
Q 039168 372 QNQANTNIIAGTYGYMAPEYAMGGIF-SIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDP 450 (536)
Q Consensus 372 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 450 (536)
.. .....||+.|+|||++.+..+ +.++|||||||++|+|++|+.||..... .... .....+.. .
T Consensus 170 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~---~~~~----~~i~~~~~-~---- 234 (476)
T 2y94_A 170 EF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV---PTLF----KKICDGIF-Y---- 234 (476)
T ss_dssp CC---BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS---HHHH----HHHHTTCC-C----
T ss_pred cc---ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH---HHHH----HHHhcCCc-C----
Confidence 22 234579999999999998775 7899999999999999999999864221 1111 11111111 0
Q ss_pred cccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH--HhccC
Q 039168 451 VLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV--MLASD 492 (536)
Q Consensus 451 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~~ 492 (536)
.... .+ ..+.+++.+||+.||++|||+.++++ .+...
T Consensus 235 -~p~~-~s---~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 235 -TPQY-LN---PSVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp -CCTT-CC---HHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred -CCcc-CC---HHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 0111 12 24566777999999999999999997 44443
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=348.35 Aligned_cols=252 Identities=15% Similarity=0.143 Sum_probs=203.0
Q ss_pred HhcCCccccccCCCCceeEEEEE------eCCCcEEEEEEccccChhhHHHHHHHHHHHHHcC---CCCceeEeeEEeeC
Q 039168 214 ATNHFSDENKLGQGGFGPVYKGT------LADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQ---HKNLVRLLGCCLEG 284 (536)
Q Consensus 214 ~~~~~~~~~~lg~G~~g~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~l~~~~~~~ 284 (536)
..++|.+.++||+|+||.||+|. ..+++.||||++.... ..++..|+++++.++ |+||+++++++...
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~ 139 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ 139 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence 45789999999999999999994 3468999999997654 356778888888887 89999999999999
Q ss_pred ceEEEEEeecCCCChhhhhhccc--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcC---------
Q 039168 285 QELLLIYEYMPNKSLDVHLFDAT--RSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDD--------- 353 (536)
Q Consensus 285 ~~~~lv~e~~~~~sL~~~l~~~~--~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~--------- 353 (536)
+..++||||+++++|.+++.... ....+++..++.++.||+.||+|||+++ |+||||||+||||+.
T Consensus 140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~~ 216 (365)
T 3e7e_A 140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDED 216 (365)
T ss_dssp SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC----
T ss_pred CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCccccc
Confidence 99999999999999999996532 2456999999999999999999999997 999999999999998
Q ss_pred --CCCeEEecccCccccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchh
Q 039168 354 --DMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTL 431 (536)
Q Consensus 354 --~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~ 431 (536)
++.+||+|||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~---- 292 (365)
T 3e7e_A 217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE---- 292 (365)
T ss_dssp --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE----
T ss_pred cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc----
Confidence 89999999999986653333334445679999999999999999999999999999999999999974322111
Q ss_pred HHHHHHHhhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCC-CCHHHHHHHhccC
Q 039168 432 LTYTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADR-PTMSSVVVMLASD 492 (536)
Q Consensus 432 ~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~R-Pt~~evl~~L~~~ 492 (536)
..+...+......+.+.+++ ..||+.+|.+| |++.++.+.|+..
T Consensus 293 --------------~~~~~~~~~~~~~~~~~~~~---~~~l~~~p~~r~~~~~~l~~~l~~~ 337 (365)
T 3e7e_A 293 --------------CKPEGLFRRLPHLDMWNEFF---HVMLNIPDCHHLPSLDLLRQKLKKV 337 (365)
T ss_dssp --------------EEECSCCTTCSSHHHHHHHH---HHHHCCCCTTCCCCHHHHHHHHHHH
T ss_pred --------------eeechhccccCcHHHHHHHH---HHHcCCCCCCcchHHHHHHHHHHHH
Confidence 00111122222345555554 48999999999 5788887777653
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=349.42 Aligned_cols=252 Identities=20% Similarity=0.286 Sum_probs=198.2
Q ss_pred HhcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHHc-CCCCceeEeeEEeeCceEEEEE
Q 039168 214 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLKEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIY 291 (536)
Q Consensus 214 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv~ 291 (536)
..++|++.+.||+|+||.||++.++ +++.||||++.+... ...+|++++.++ +||||+++++++.+.+..++||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 4578999999999999999999976 589999999976543 235688888888 7999999999999999999999
Q ss_pred eecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCC----CCeEEecccCccc
Q 039168 292 EYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDD----MNPKISDFGTARI 367 (536)
Q Consensus 292 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~----~~~kl~Dfg~a~~ 367 (536)
||+++++|.+++... ..+++.+++.++.||+.||.|||+++ |+||||||+|||+.++ +.+||+|||+++.
T Consensus 96 E~~~gg~L~~~i~~~---~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~ 169 (342)
T 2qr7_A 96 ELMKGGELLDKILRQ---KFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169 (342)
T ss_dssp CCCCSCBHHHHHHTC---TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred eCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence 999999999988543 45899999999999999999999997 9999999999998543 3599999999987
Q ss_pred cCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcccc
Q 039168 368 FGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVEL 447 (536)
Q Consensus 368 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 447 (536)
...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||............ .....+....
T Consensus 170 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~----~~i~~~~~~~- 242 (342)
T 2qr7_A 170 LRAENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEIL----ARIGSGKFSL- 242 (342)
T ss_dssp CBCTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHH----HHHHHCCCCC-
T ss_pred CcCCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHH----HHHccCCccc-
Confidence 654332 223457899999999998888999999999999999999999998643222211111 1111221110
Q ss_pred ccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 448 IDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 448 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
...........+.+++.+||+.||++|||+.++++
T Consensus 243 -----~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 243 -----SGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp -----CSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred -----CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00011111234556677999999999999999985
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=339.42 Aligned_cols=262 Identities=21% Similarity=0.271 Sum_probs=198.0
Q ss_pred hcCCccc-cccCCCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHHc-CCCCceeEeeEEeeCceEEEEE
Q 039168 215 TNHFSDE-NKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLKEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIY 291 (536)
Q Consensus 215 ~~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv~ 291 (536)
.+.|++. +.||+|+||.||+|.+. +++.||||++........+.+.+|++++.++ +||||+++++++.+.+..++||
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 4678874 78999999999999965 6899999999876666678899999999995 7999999999999999999999
Q ss_pred eecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCC---eEEecccCcccc
Q 039168 292 EYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMN---PKISDFGTARIF 368 (536)
Q Consensus 292 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~---~kl~Dfg~a~~~ 368 (536)
||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++. +||+|||++...
T Consensus 91 e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~ 164 (316)
T 2ac3_A 91 EKMRGGSILSHIHKR---RHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164 (316)
T ss_dssp ECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred EcCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence 999999999999653 35899999999999999999999997 999999999999998776 999999999865
Q ss_pred CCCCC-----ccccccccccccccCcchhcC-----CCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchh-------
Q 039168 369 GGNQN-----QANTNIIAGTYGYMAPEYAMG-----GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTL------- 431 (536)
Q Consensus 369 ~~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~------- 431 (536)
..... ........||+.|+|||++.+ ..++.++||||||+++|+|++|+.||...........
T Consensus 165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 244 (316)
T 2ac3_A 165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA 244 (316)
T ss_dssp -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence 42221 111223468999999999975 4588999999999999999999999865432211000
Q ss_pred -HHHHHHHhhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 432 -LTYTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 432 -~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
..........+.. .+... .... . ...+.+++.+||+.||++|||+.++++.
T Consensus 245 ~~~~~~~~i~~~~~-~~~~~-~~~~-~---~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 245 CQNMLFESIQEGKY-EFPDK-DWAH-I---SCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHHHHHHHHHHCCC-CCCHH-HHTT-S---CHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHHHhccCc-ccCch-hccc-C---CHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 0111111111111 00000 0001 1 2346677779999999999999999974
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=345.73 Aligned_cols=208 Identities=27% Similarity=0.338 Sum_probs=180.0
Q ss_pred CcChhhHHHHhcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHHcC-----CCCceeEe
Q 039168 205 LFPLGLALEATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQ-----HKNLVRLL 278 (536)
Q Consensus 205 ~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----hpniv~l~ 278 (536)
.+++.......++|++.++||+|+||.||+|++. +++.||||++... ......+..|+.+++.++ ||||++++
T Consensus 24 ~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~ 102 (360)
T 3llt_A 24 HFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYH 102 (360)
T ss_dssp SCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEE
T ss_pred eeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeeccc
Confidence 3444555566789999999999999999999975 6899999998643 344567788999999997 99999999
Q ss_pred eEEeeCceEEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcC-----
Q 039168 279 GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDD----- 353 (536)
Q Consensus 279 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~----- 353 (536)
+++...+..++||||+ +++|.+++.... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.
T Consensus 103 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~ 177 (360)
T 3llt_A 103 GKFMYYDHMCLIFEPL-GPSLYEIITRNN-YNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEK 177 (360)
T ss_dssp EEEEETTEEEEEECCC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCCE
T ss_pred ceeeECCeeEEEEcCC-CCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccccccc
Confidence 9999999999999999 999999986533 235899999999999999999999997 999999999999975
Q ss_pred --------------------CCCeEEecccCccccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHH
Q 039168 354 --------------------DMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEI 413 (536)
Q Consensus 354 --------------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el 413 (536)
++.+||+|||++....... ....||+.|+|||++.+..++.++|||||||++|+|
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 252 (360)
T 3llt_A 178 SLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH-----GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAEL 252 (360)
T ss_dssp EEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC-----CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHH
T ss_pred cccchhcccccccccccccCCCCEEEEeccCceecCCCC-----cCccCcccccCcHHHcCCCCCCccchHHHHHHHHHH
Confidence 7889999999998654322 235689999999999999999999999999999999
Q ss_pred HhCCCCCCCC
Q 039168 414 ISGRKNNGFY 423 (536)
Q Consensus 414 ltg~~p~~~~ 423 (536)
++|+.||...
T Consensus 253 l~g~~pf~~~ 262 (360)
T 3llt_A 253 YTGSLLFRTH 262 (360)
T ss_dssp HHSSCSCCCS
T ss_pred HHCCCCCCCC
Confidence 9999998643
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-42 Score=359.46 Aligned_cols=250 Identities=30% Similarity=0.423 Sum_probs=202.1
Q ss_pred hcCCccccccCCCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCc-eEEEEEee
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQ-ELLLIYEY 293 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-~~~lv~e~ 293 (536)
.++|++.++||+|+||.||+|.++ ++.||||++.... ..+.+.+|+.+|++++||||+++++++.+.. ..++||||
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~ 268 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 268 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence 467889999999999999999985 7899999997654 4478999999999999999999999987665 79999999
Q ss_pred cCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCC
Q 039168 294 MPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQN 373 (536)
Q Consensus 294 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 373 (536)
+++++|.+++.... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 269 ~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~- 343 (450)
T 1k9a_A 269 MAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 343 (450)
T ss_dssp CTTCBHHHHHHHHC-TTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC----
T ss_pred cCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCcccccccc-
Confidence 99999999997543 234789999999999999999999996 9999999999999999999999999998543221
Q ss_pred ccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHHHHHhhcCCccccccccc
Q 039168 374 QANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVL 452 (536)
Q Consensus 374 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l 452 (536)
....+++.|+|||++.+..++.++||||||+++|||++ |+.||....... ... ....+.... .
T Consensus 344 ----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~---~~~----~i~~~~~~~-----~ 407 (450)
T 1k9a_A 344 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVP----RVEKGYKMD-----A 407 (450)
T ss_dssp -------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT---HHH----HHHTTCCCC-----C
T ss_pred ----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH----HHHcCCCCC-----C
Confidence 12356889999999999999999999999999999998 999986433221 111 111221111 1
Q ss_pred cCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 453 KQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 453 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
...+ + ..+.+|+.+||+.||++|||+.+|++.|+..
T Consensus 408 p~~~-~---~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i 443 (450)
T 1k9a_A 408 PDGC-P---PAVYDVMKNCWHLDAATRPTFLQLREQLEHI 443 (450)
T ss_dssp CTTC-C---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCcC-C---HHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 1112 2 3466677799999999999999999999764
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=339.53 Aligned_cols=255 Identities=24% Similarity=0.349 Sum_probs=192.9
Q ss_pred hcCCccccccCCCCceeEEEEEeCC----CcEEEEEEcccc-ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEE
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLAD----GKAIAVKRLSRT-SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 289 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 289 (536)
.++|++.+.||+|+||.||+|.+.. +..||+|++... .....+.+.+|+.++++++||||+++++++. ++..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence 4689999999999999999998743 457999998754 3445677899999999999999999999985 567899
Q ss_pred EEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccC
Q 039168 290 IYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFG 369 (536)
Q Consensus 290 v~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 369 (536)
||||+++++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 93 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME 167 (281)
T ss_dssp EEECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccccC
Confidence 99999999999998643 335899999999999999999999997 9999999999999999999999999998765
Q ss_pred CCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHHHHHhhcCCccccc
Q 039168 370 GNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELI 448 (536)
Q Consensus 370 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 448 (536)
..... ......+++.|+|||++.+..++.++||||||+++|+|++ |..||...... ..... ...+....
T Consensus 168 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~---~~~~~----i~~~~~~~-- 237 (281)
T 1mp8_A 168 DSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVIGR----IENGERLP-- 237 (281)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHHH----HHTTCCCC--
T ss_pred ccccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH---HHHHH----HHcCCCCC--
Confidence 43221 1223456789999999999999999999999999999997 99997643222 11111 11111111
Q ss_pred cccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 449 DPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 449 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
+.... + ..+.+++.+||+.||++|||+.++++.|+..
T Consensus 238 ---~~~~~-~---~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 274 (281)
T 1mp8_A 238 ---MPPNC-P---PTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274 (281)
T ss_dssp ---CCTTC-C---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CCCCC-C---HHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 11112 2 3456677799999999999999999999763
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=339.99 Aligned_cols=257 Identities=29% Similarity=0.442 Sum_probs=208.7
Q ss_pred HhcCCccccccCCCCceeEEEEEeCC-CcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEe
Q 039168 214 ATNHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 292 (536)
Q Consensus 214 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 292 (536)
..++|++.+.||+|+||.||+|.+.. +..||+|++.... ...+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence 35789999999999999999999864 8899999987543 345788999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCC
Q 039168 293 YMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQ 372 (536)
Q Consensus 293 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 372 (536)
|+++++|.+++.... ...+++..++.++.||+.||.|||+++ |+|+||||+||+++.++.+||+|||++.......
T Consensus 90 ~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 165 (288)
T 3kfa_A 90 FMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165 (288)
T ss_dssp CCTTEEHHHHHHHCC-TTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred cCCCCcHHHHHHhcc-cCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence 999999999996533 345899999999999999999999997 9999999999999999999999999998765433
Q ss_pred CccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHHHHHhhcCCcccccccc
Q 039168 373 NQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPV 451 (536)
Q Consensus 373 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 451 (536)
. .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||....... ... .........
T Consensus 166 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~---~~~----~~~~~~~~~----- 232 (288)
T 3kfa_A 166 Y-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VYE----LLEKDYRME----- 232 (288)
T ss_dssp S-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHH----HHHTTCCCC-----
T ss_pred c-ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH----HHhccCCCC-----
Confidence 2 22233457889999999999999999999999999999999 988876433221 111 111111111
Q ss_pred ccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 452 LKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 452 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
.... .+ ..+.+++.+||+.||.+|||+.++++.|+..
T Consensus 233 ~~~~-~~---~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~ 269 (288)
T 3kfa_A 233 RPEG-CP---EKVYELMRACWQWNPSDRPSFAEIHQAFETM 269 (288)
T ss_dssp CCTT-CC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCC-CC---HHHHHHHHHHhCCChhhCcCHHHHHHHHHHH
Confidence 1111 12 3466677799999999999999999998763
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=335.28 Aligned_cols=254 Identities=29% Similarity=0.528 Sum_probs=199.5
Q ss_pred hcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccChhh-------HHHHHHHHHHHHHcCCCCceeEeeEEeeCce
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQG-------LKEFKNEVNLIAKLQHKNLVRLLGCCLEGQE 286 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-------~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 286 (536)
.++|++.+.||+|+||.||+|++. +++.||||++....... .+.+.+|+.++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 468999999999999999999975 68999999986543211 267889999999999999999999997665
Q ss_pred EEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCC-----eEEec
Q 039168 287 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMN-----PKISD 361 (536)
Q Consensus 287 ~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~-----~kl~D 361 (536)
++||||+++++|.+.+... ...+++..++.++.||+.||.|||+++ .+|+||||||+|||++.++. +||+|
T Consensus 97 -~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDK--AHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred -eEEEEecCCCCHHHHHhcc--cCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 6999999999998888543 345899999999999999999999883 13999999999999988776 99999
Q ss_pred ccCccccCCCCCccccccccccccccCcchhc--CCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHh
Q 039168 362 FGTARIFGGNQNQANTNIIAGTYGYMAPEYAM--GGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLW 439 (536)
Q Consensus 362 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 439 (536)
||+++.... ......||+.|+|||++. ...++.++||||||+++|+|++|+.||....... ........
T Consensus 173 fg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~----~~~~~~~~ 243 (287)
T 4f0f_A 173 FGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK----IKFINMIR 243 (287)
T ss_dssp CTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCH----HHHHHHHH
T ss_pred CCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccH----HHHHHHHh
Confidence 999975432 223357899999999984 4557899999999999999999999986433221 11111111
Q ss_pred hcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcc
Q 039168 440 CEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 491 (536)
Q Consensus 440 ~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 491 (536)
...... .+.... ...+.+++.+||+.||++|||+.++++.|+.
T Consensus 244 ~~~~~~-----~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 244 EEGLRP-----TIPEDC----PPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp HSCCCC-----CCCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred ccCCCC-----CCCccc----CHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 111111 111122 2346667779999999999999999999975
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=353.22 Aligned_cols=256 Identities=18% Similarity=0.238 Sum_probs=200.0
Q ss_pred HhcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEE
Q 039168 214 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 289 (536)
Q Consensus 214 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 289 (536)
..++|++.++||+|+||.||+++.+ +++.||||++.+.. ....+.+.+|..++..++||||+++++++.+.+.+|+
T Consensus 59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~l 138 (412)
T 2vd5_A 59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYL 138 (412)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEE
T ss_pred ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEE
Confidence 4578999999999999999999985 68999999986532 2223457899999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccC
Q 039168 290 IYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFG 369 (536)
Q Consensus 290 v~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 369 (536)
||||+++++|..++.... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++++||+|||+++...
T Consensus 139 VmE~~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFGla~~~~ 213 (412)
T 2vd5_A 139 VMEYYVGGDLLTLLSKFG--ERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLR 213 (412)
T ss_dssp EECCCCSCBHHHHHHHHS--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEcCCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeechhheecc
Confidence 999999999999996532 35899999999999999999999997 9999999999999999999999999998765
Q ss_pred CCCCccccccccccccccCcchhc-------CCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcC
Q 039168 370 GNQNQANTNIIAGTYGYMAPEYAM-------GGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEG 442 (536)
Q Consensus 370 ~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 442 (536)
.... .......||+.|+|||++. +..++.++|||||||++|||++|+.||...... .............
T Consensus 214 ~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~---~~~~~i~~~~~~~ 289 (412)
T 2vd5_A 214 ADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA---ETYGKIVHYKEHL 289 (412)
T ss_dssp TTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHHHTHHHHC
T ss_pred CCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHH---HHHHHHHhcccCc
Confidence 4322 1223457999999999997 356899999999999999999999998543221 1111111000000
Q ss_pred CccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCC---CCHHHHHHH
Q 039168 443 HAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADR---PTMSSVVVM 488 (536)
Q Consensus 443 ~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~R---Pt~~evl~~ 488 (536)
.. +..... .+. .+.+++.+||+ +|.+| |+++++++.
T Consensus 290 ~~-----p~~~~~-~s~---~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 290 SL-----PLVDEG-VPE---EARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp CC-----C----C-CCH---HHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred CC-----CccccC-CCH---HHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 00 111111 223 35566669999 99998 599999853
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=337.61 Aligned_cols=263 Identities=24% Similarity=0.342 Sum_probs=196.5
Q ss_pred HhcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC-----hhhHHHHHHHHHHHHHcC---CCCceeEeeEEeeC
Q 039168 214 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-----GQGLKEFKNEVNLIAKLQ---HKNLVRLLGCCLEG 284 (536)
Q Consensus 214 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~---hpniv~l~~~~~~~ 284 (536)
..++|++.++||+|+||.||+|++. +++.||||++.... ......+.+|+.++++++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 4679999999999999999999974 68999999986432 112345667787777765 99999999999876
Q ss_pred c-----eEEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEE
Q 039168 285 Q-----ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKI 359 (536)
Q Consensus 285 ~-----~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl 359 (536)
. ..++||||+. ++|.+++.... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++++||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl 161 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAP-PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKL 161 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCC-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEE
Confidence 5 5899999997 58988886533 234899999999999999999999997 999999999999999999999
Q ss_pred ecccCccccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHh
Q 039168 360 SDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLW 439 (536)
Q Consensus 360 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 439 (536)
+|||+++....... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ..........
T Consensus 162 ~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~i~~~~ 235 (308)
T 3g33_A 162 ADFGLARIYSYQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA---DQLGKIFDLI 235 (308)
T ss_dssp CSCSCTTTSTTCCC---SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHH---HHHHHHHHHH
T ss_pred eeCccccccCCCcc---cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHh
Confidence 99999987643222 23457899999999999999999999999999999999999998543221 1122121111
Q ss_pred hcCCccccc------cccccC--CCC-----HHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 440 CEGHAVELI------DPVLKQ--SCA-----PDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 440 ~~~~~~~l~------~~~l~~--~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
.......+. ...... ... +.....+.+++.+||+.||++|||+.++|+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 236 GLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp CCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 111100000 000000 000 011235667777999999999999999985
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=357.01 Aligned_cols=254 Identities=20% Similarity=0.239 Sum_probs=200.5
Q ss_pred HhcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEE
Q 039168 214 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 289 (536)
Q Consensus 214 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 289 (536)
..++|++.++||+|+||.||+|+++ +++.||+|++.+.. ....+.+.+|+.+++.++||||+++++++.+.+.+|+
T Consensus 67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 146 (410)
T 3v8s_A 67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYM 146 (410)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence 4578999999999999999999986 58899999986522 1223457889999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccC
Q 039168 290 IYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFG 369 (536)
Q Consensus 290 v~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 369 (536)
||||+++|+|..++.. ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++++||+|||+++...
T Consensus 147 V~E~~~gg~L~~~l~~----~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~a~~~~ 219 (410)
T 3v8s_A 147 VMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMN 219 (410)
T ss_dssp EECCCTTEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeCCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccceeEeec
Confidence 9999999999998853 24899999999999999999999997 9999999999999999999999999998765
Q ss_pred CCCCccccccccccccccCcchhcCCC----CCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcc
Q 039168 370 GNQNQANTNIIAGTYGYMAPEYAMGGI----FSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAV 445 (536)
Q Consensus 370 ~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 445 (536)
.... .......||+.|+|||++.+.. ++.++|||||||++|||++|+.||...... .............
T Consensus 220 ~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~------~~~~~i~~~~~~~ 292 (410)
T 3v8s_A 220 KEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------GTYSKIMNHKNSL 292 (410)
T ss_dssp TTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHTHHHHC
T ss_pred cCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChh------hHHHHHHhccccc
Confidence 4322 1233467999999999998765 889999999999999999999998532211 1111111100000
Q ss_pred ccccccccCCCCHHHHHHHHHHHHhhcCCCCCC--CCCHHHHHHH
Q 039168 446 ELIDPVLKQSCAPDELLKFIHIGLLCVQQDPAD--RPTMSSVVVM 488 (536)
Q Consensus 446 ~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~~ 488 (536)
.... ....+. .+.+|+.+||+.+|.+ ||++.+|++.
T Consensus 293 ~~p~----~~~~s~---~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 293 TFPD----DNDISK---EAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp CCCT----TCCCCH---HHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred cCCC----cccccH---HHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 0000 011223 3556666999999988 9999999964
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=345.02 Aligned_cols=262 Identities=28% Similarity=0.402 Sum_probs=208.5
Q ss_pred HHhcCCccccccCCCCceeEEEEEe------CCCcEEEEEEccccC-hhhHHHHHHHHHHHHHc-CCCCceeEeeEEeeC
Q 039168 213 EATNHFSDENKLGQGGFGPVYKGTL------ADGKAIAVKRLSRTS-GQGLKEFKNEVNLIAKL-QHKNLVRLLGCCLEG 284 (536)
Q Consensus 213 ~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~ 284 (536)
...++|++.+.||+|+||.||+|++ .+++.||||++.... ....+.+.+|+.+++++ +||||+++++++...
T Consensus 24 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 103 (316)
T 2xir_A 24 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 103 (316)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred cchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecC
Confidence 3457899999999999999999974 346899999997643 34456789999999999 789999999998875
Q ss_pred c-eEEEEEeecCCCChhhhhhcccC-------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEE
Q 039168 285 Q-ELLLIYEYMPNKSLDVHLFDATR-------------SVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVL 350 (536)
Q Consensus 285 ~-~~~lv~e~~~~~sL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIl 350 (536)
+ ..++||||+++++|.+++..... ...+++..++.++.||++||.|||+++ |+||||||+|||
T Consensus 104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil 180 (316)
T 2xir_A 104 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNIL 180 (316)
T ss_dssp TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEE
Confidence 4 59999999999999999965432 123789999999999999999999997 999999999999
Q ss_pred EcCCCCeEEecccCccccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCc
Q 039168 351 LDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQ 429 (536)
Q Consensus 351 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~ 429 (536)
++.++++||+|||+++...............||+.|+|||++.+..++.++||||||+++|+|++ |+.||.......
T Consensus 181 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~-- 258 (316)
T 2xir_A 181 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-- 258 (316)
T ss_dssp ECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH--
T ss_pred ECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhH--
Confidence 99999999999999987655444333444567899999999999999999999999999999998 999975432211
Q ss_pred hhHHHHHHHhhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 430 TLLTYTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 430 ~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
. .......+..... ... .+ ..+.+++.+||+.||.+|||+.++++.|+..
T Consensus 259 ~----~~~~~~~~~~~~~-----~~~-~~---~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 308 (316)
T 2xir_A 259 E----FCRRLKEGTRMRA-----PDY-TT---PEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308 (316)
T ss_dssp H----HHHHHHHTCCCCC-----CTT-CC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred H----HHHHhccCccCCC-----CCC-CC---HHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1 1111112211111 111 12 3466677799999999999999999999764
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=335.37 Aligned_cols=263 Identities=22% Similarity=0.282 Sum_probs=201.7
Q ss_pred HHhcCCccccccCCCCceeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEE-eeCceEEEE
Q 039168 213 EATNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCC-LEGQELLLI 290 (536)
Q Consensus 213 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~-~~~~~~~lv 290 (536)
...++|++.+.||+|+||.||+|++ .+++.||||++...... +.+.+|+.+++.++|++++..+..+ ...+..++|
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C--CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc--hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence 3457899999999999999999997 46899999986543322 4578899999999988776665554 677889999
Q ss_pred EeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEE---cCCCCeEEecccCccc
Q 039168 291 YEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLL---DDDMNPKISDFGTARI 367 (536)
Q Consensus 291 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll---~~~~~~kl~Dfg~a~~ 367 (536)
|||+ +++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||+++.
T Consensus 84 ~e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~ 157 (296)
T 4hgt_A 84 MELL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp EECC-CCBHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred EEcc-CCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCcccee
Confidence 9999 99999998643 235899999999999999999999997 9999999999999 7889999999999987
Q ss_pred cCCCCCcc-----ccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcC
Q 039168 368 FGGNQNQA-----NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEG 442 (536)
Q Consensus 368 ~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 442 (536)
........ ......||+.|+|||++.+..++.++||||||+++|+|++|+.||......................
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 237 (296)
T 4hgt_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST 237 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS
T ss_pred ccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccc
Confidence 75443321 2234678999999999999999999999999999999999999987644433333322222211111
Q ss_pred CccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 443 HAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 443 ~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
.. +.+.... + ..+.+++.+||+.||++|||+.+|++.|+..
T Consensus 238 ~~-----~~~~~~~-~---~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 278 (296)
T 4hgt_A 238 PI-----EVLCKGY-P---SEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 278 (296)
T ss_dssp CH-----HHHTTTS-C---HHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred hh-----hhhhccC-C---HHHHHHHHHHHhcCCCCCCCHHHHHHHHHHH
Confidence 10 0011111 2 3466677799999999999999999999874
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=346.15 Aligned_cols=261 Identities=29% Similarity=0.456 Sum_probs=196.3
Q ss_pred HhcCCccccccCCCCceeEEEEEeC----CCcEEEEEEcccc--ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCc--
Q 039168 214 ATNHFSDENKLGQGGFGPVYKGTLA----DGKAIAVKRLSRT--SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQ-- 285 (536)
Q Consensus 214 ~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-- 285 (536)
..++|.+.+.||+|+||.||+|.+. .+..||+|++... .....+.+.+|+.++++++||||+++++++.+..
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 111 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ 111 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence 4578999999999999999999864 3458999998754 3445677899999999999999999999998755
Q ss_pred ---eEEEEEeecCCCChhhhhhcc---cCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEE
Q 039168 286 ---ELLLIYEYMPNKSLDVHLFDA---TRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKI 359 (536)
Q Consensus 286 ---~~~lv~e~~~~~sL~~~l~~~---~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl 359 (536)
..++||||+++++|..++... .....+++..++.++.||++||.|||+++ |+||||||+|||++.++.+||
T Consensus 112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kl 188 (313)
T 3brb_A 112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVCV 188 (313)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCEEE
T ss_pred CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEE
Confidence 359999999999999998542 23456999999999999999999999996 999999999999999999999
Q ss_pred ecccCccccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHHHHH
Q 039168 360 SDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKL 438 (536)
Q Consensus 360 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 438 (536)
+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||...... .... .
T Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~----~ 261 (313)
T 3brb_A 189 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH---EMYD----Y 261 (313)
T ss_dssp CSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GHHH----H
T ss_pred eecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH---HHHH----H
Confidence 99999987654433333334567889999999999999999999999999999999 88887543222 1111 1
Q ss_pred hhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccCC
Q 039168 439 WCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDS 493 (536)
Q Consensus 439 ~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 493 (536)
...+..... .... ...+.+++.+||+.||.+|||+.++++.|+...
T Consensus 262 ~~~~~~~~~-----~~~~----~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~ 307 (313)
T 3brb_A 262 LLHGHRLKQ-----PEDC----LDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLL 307 (313)
T ss_dssp HHTTCCCCC-----BTTC----CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHcCCCCCC-----Cccc----cHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 111111111 1111 234667777999999999999999999998753
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=336.96 Aligned_cols=255 Identities=28% Similarity=0.399 Sum_probs=206.2
Q ss_pred hcCCccccccCCCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEeec
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 294 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 294 (536)
.++|++.+.||+|+||.||++.+.+++.||+|++..... ..+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM 85 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence 367899999999999999999998889999999976543 3467899999999999999999999999999999999999
Q ss_pred CCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCCc
Q 039168 295 PNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQ 374 (536)
Q Consensus 295 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 374 (536)
++++|.+++... ...+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++........
T Consensus 86 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~- 159 (267)
T 3t9t_A 86 EHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY- 159 (267)
T ss_dssp TTCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH-
T ss_pred CCCcHHHHHhhC--cccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEcccccccccccccc-
Confidence 999999998643 245899999999999999999999997 99999999999999999999999999987643211
Q ss_pred cccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHHHHHhhcCCcccccccccc
Q 039168 375 ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLK 453 (536)
Q Consensus 375 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~ 453 (536)
.......+++.|+|||++.+..++.++||||||+++|+|++ |+.||...... ... .....+.... ..
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~~~-~~i~~~~~~~-----~~ 227 (267)
T 3t9t_A 160 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS------EVV-EDISTGFRLY-----KP 227 (267)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHH-HHHHTTCCCC-----CC
T ss_pred cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH------HHH-HHHhcCCcCC-----CC
Confidence 11223456788999999998899999999999999999999 89887542211 111 1111111110 11
Q ss_pred CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 454 QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 454 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
...+ ..+.+++.+||+.||++|||+.++++.|+..
T Consensus 228 -~~~~---~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l 262 (267)
T 3t9t_A 228 -RLAS---THVYQIMNHCWRERPEDRPAFSRLLRQLAEI 262 (267)
T ss_dssp -TTSC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -ccCc---HHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1112 3456677799999999999999999999764
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=338.74 Aligned_cols=253 Identities=22% Similarity=0.250 Sum_probs=203.6
Q ss_pred HhcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccCh------hhHHHHHHHHHHHHHcCCCCceeEeeEEeeCce
Q 039168 214 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG------QGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQE 286 (536)
Q Consensus 214 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 286 (536)
..++|++.+.||+|+||.||+|++. +++.||+|++..... ...+.+.+|+.++++++||||+++++++.+.+.
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 89 (321)
T 2a2a_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD 89 (321)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 3467999999999999999999976 589999999865432 136789999999999999999999999999999
Q ss_pred EEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCC----CeEEecc
Q 039168 287 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDM----NPKISDF 362 (536)
Q Consensus 287 ~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~----~~kl~Df 362 (536)
.++||||+++++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++ ++||+||
T Consensus 90 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Df 163 (321)
T 2a2a_A 90 VVLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (321)
T ss_dssp EEEEECCCCSCBHHHHHHT---CSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccC
Confidence 9999999999999999954 345899999999999999999999997 99999999999999888 7999999
Q ss_pred cCccccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcC
Q 039168 363 GTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEG 442 (536)
Q Consensus 363 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 442 (536)
|++........ .....||+.|+|||++.+..++.++||||||+++|+|++|+.||...... ... ......
T Consensus 164 g~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~-~~i~~~ 233 (321)
T 2a2a_A 164 GLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ------ETL-ANITSV 233 (321)
T ss_dssp TTCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHH-HHHHTT
T ss_pred ccceecCcccc---ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH------HHH-HHHHhc
Confidence 99987654322 23356899999999999999999999999999999999999997542211 111 111111
Q ss_pred CccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 443 HAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 443 ~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
.. .+.+...... + ..+.+++.+||+.||++|||+.++++.
T Consensus 234 ~~--~~~~~~~~~~-~---~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 234 SY--DFDEEFFSHT-S---ELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp CC--CCCHHHHTTC-C---HHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred cc--ccChhhhccc-C---HHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 10 0111111111 1 345667779999999999999999973
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=347.19 Aligned_cols=248 Identities=25% Similarity=0.301 Sum_probs=195.1
Q ss_pred ccccccCCCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEeecCCC
Q 039168 219 SDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNK 297 (536)
Q Consensus 219 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~~ 297 (536)
...+.||+|+||.||+|.+. +|+.||+|++........+.+.+|+.+|++++||||+++++++.+.+..++||||++++
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~ 171 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG 171 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence 33678999999999999875 58999999998776667788999999999999999999999999999999999999999
Q ss_pred ChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEE--cCCCCeEEecccCccccCCCCCcc
Q 039168 298 SLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLL--DDDMNPKISDFGTARIFGGNQNQA 375 (536)
Q Consensus 298 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll--~~~~~~kl~Dfg~a~~~~~~~~~~ 375 (536)
+|.+++... ...+++..++.++.||++||.|||+++ |+||||||+|||+ +.++++||+|||+++.+.....
T Consensus 172 ~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~-- 244 (373)
T 2x4f_A 172 ELFDRIIDE--SYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK-- 244 (373)
T ss_dssp EEHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--
T ss_pred cHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--
Confidence 999888543 235899999999999999999999997 9999999999999 5678899999999987654322
Q ss_pred ccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccccccCC
Q 039168 376 NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQS 455 (536)
Q Consensus 376 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~ 455 (536)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ....... ..... +... ....
T Consensus 245 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~------~~~~~i~-~~~~~-~~~~-~~~~ 314 (373)
T 2x4f_A 245 -LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA------ETLNNIL-ACRWD-LEDE-EFQD 314 (373)
T ss_dssp -CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHH-HTCCC-SCSG-GGTT
T ss_pred -cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHH-hccCC-CChh-hhcc
Confidence 22346899999999999999999999999999999999999998543221 1111111 11110 0011 1111
Q ss_pred CCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 456 CAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 456 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
.+ ..+.+++.+||+.||++|||+.++++
T Consensus 315 -~~---~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 315 -IS---EEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp -SC---HHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -CC---HHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 12 34566677999999999999999996
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=333.77 Aligned_cols=262 Identities=22% Similarity=0.282 Sum_probs=205.3
Q ss_pred HhcCCccccccCCCCceeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEE-eeCceEEEEE
Q 039168 214 ATNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCC-LEGQELLLIY 291 (536)
Q Consensus 214 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~-~~~~~~~lv~ 291 (536)
..++|++.+.||+|+||.||+|++ .+++.||||++...... +.+.+|+.+++.++|++++..+..+ .+.+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC--CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch--hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence 357899999999999999999997 46899999998654332 4688999999999998766655554 6778899999
Q ss_pred eecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEE---cCCCCeEEecccCcccc
Q 039168 292 EYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLL---DDDMNPKISDFGTARIF 368 (536)
Q Consensus 292 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll---~~~~~~kl~Dfg~a~~~ 368 (536)
||+ +++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||++...
T Consensus 85 e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 158 (296)
T 3uzp_A 85 ELL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp ECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred Eec-CCCHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence 999 99999998532 235899999999999999999999997 9999999999999 48889999999999877
Q ss_pred CCCCCcc-----ccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCC
Q 039168 369 GGNQNQA-----NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGH 443 (536)
Q Consensus 369 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 443 (536)
....... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.......................
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 3uzp_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred cccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc
Confidence 6443321 12345789999999999999999999999999999999999999876443333332222222111111
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 444 AVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 444 ~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
. +.+.... + ..+.+++.+||+.||++|||+.+|++.|+..
T Consensus 239 ~-----~~~~~~~-~---~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 278 (296)
T 3uzp_A 239 I-----EVLCKGY-P---SEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 278 (296)
T ss_dssp H-----HHHTTTS-C---HHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred h-----HHHHhhC-C---HHHHHHHHHHHhcCcCcCCCHHHHHHHHHHH
Confidence 0 0111111 2 3466677799999999999999999999875
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=332.45 Aligned_cols=251 Identities=20% Similarity=0.264 Sum_probs=202.7
Q ss_pred HhcCCccccccCCCCceeEEEEEeCC-CcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEe
Q 039168 214 ATNHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 292 (536)
Q Consensus 214 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 292 (536)
..++|++.+.||+|+||.||+|.+.. +..||+|++........+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 45689999999999999999999764 78999999987666667889999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEE---cCCCCeEEecccCccccC
Q 039168 293 YMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLL---DDDMNPKISDFGTARIFG 369 (536)
Q Consensus 293 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll---~~~~~~kl~Dfg~a~~~~ 369 (536)
|+++++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||++..+.
T Consensus 87 ~~~~~~L~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 87 LCTGGELFERVVHK---RVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp CCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred ccCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 99999999888543 34899999999999999999999997 9999999999999 788899999999998765
Q ss_pred CCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcccccc
Q 039168 370 GNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELID 449 (536)
Q Consensus 370 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 449 (536)
.... .....||+.|+|||++.+. ++.++||||||+++|+|++|+.||...... ... .....+.... .
T Consensus 161 ~~~~---~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~-~~~~~~~~~~--~ 227 (277)
T 3f3z_A 161 PGKM---MRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDS------EVM-LKIREGTFTF--P 227 (277)
T ss_dssp TTSC---BCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHH------HHH-HHHHHCCCCC--C
T ss_pred Cccc---hhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHH------HHH-HHHHhCCCCC--C
Confidence 3322 2335689999999998765 899999999999999999999998543221 111 1111111110 0
Q ss_pred ccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 450 PVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 450 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
...... . ...+.+++.+||+.||++|||+.++++
T Consensus 228 ~~~~~~-~---~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 228 EKDWLN-V---SPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp HHHHTT-S---CHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred chhhhc-C---CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000001 1 234666777999999999999999985
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=347.29 Aligned_cols=259 Identities=23% Similarity=0.270 Sum_probs=189.9
Q ss_pred hcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHHcC-CCCceeEeeEEe--------eC
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQ-HKNLVRLLGCCL--------EG 284 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~--------~~ 284 (536)
..+|++.++||+|+||.||++++. +++.||||++........+.+.+|+.+++++. ||||+++++++. ..
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 358999999999999999999975 68999999997777777788999999999996 999999999994 34
Q ss_pred ceEEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccC
Q 039168 285 QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGT 364 (536)
Q Consensus 285 ~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~ 364 (536)
...++||||+. |+|.+++........+++..++.++.||+.||.|||+++ .+|+||||||+|||++.++++||+|||+
T Consensus 107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 184 (337)
T 3ll6_A 107 AEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFGS 184 (337)
T ss_dssp EEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCTT
T ss_pred ceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCcc
Confidence 56899999996 688888866455567999999999999999999999873 2399999999999999999999999999
Q ss_pred ccccCCCCCcc----------ccccccccccccCcchh---cCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchh
Q 039168 365 ARIFGGNQNQA----------NTNIIAGTYGYMAPEYA---MGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTL 431 (536)
Q Consensus 365 a~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~ 431 (536)
++......... ......||+.|+|||++ .+..++.++||||||+++|+|++|+.||.......
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~---- 260 (337)
T 3ll6_A 185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR---- 260 (337)
T ss_dssp CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------
T ss_pred ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH----
Confidence 98765432211 11134589999999998 56678999999999999999999999975322110
Q ss_pred HHHHHHHhhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccCCC
Q 039168 432 LTYTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSM 494 (536)
Q Consensus 432 ~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 494 (536)
.. ...... .. ....+ ..+.+++.+||+.||++|||+.++++.|+....
T Consensus 261 --~~-----~~~~~~----~~-~~~~~---~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~ 308 (337)
T 3ll6_A 261 --IV-----NGKYSI----PP-HDTQY---TVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA 308 (337)
T ss_dssp ------------CCC----CT-TCCSS---GGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --hh-----cCcccC----Cc-ccccc---hHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 00 000000 00 01111 225567779999999999999999999987643
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=336.34 Aligned_cols=257 Identities=26% Similarity=0.413 Sum_probs=204.9
Q ss_pred cCCcccc-ccCCCCceeEEEEEeC---CCcEEEEEEcccc-ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEE
Q 039168 216 NHFSDEN-KLGQGGFGPVYKGTLA---DGKAIAVKRLSRT-SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 290 (536)
Q Consensus 216 ~~~~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 290 (536)
++|.+.+ .||+|+||.||+|.+. ++..||||++... .....+.+.+|++++++++||||+++++++ ..+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 4566666 9999999999999853 5788999999764 344567899999999999999999999999 55679999
Q ss_pred EeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCC
Q 039168 291 YEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGG 370 (536)
Q Consensus 291 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 370 (536)
|||+++++|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 88 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 162 (287)
T 1u59_A 88 MEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA 162 (287)
T ss_dssp EECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEeCCCCCHHHHHHh--CCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence 999999999999853 2345899999999999999999999997 99999999999999999999999999987754
Q ss_pred CCCc-cccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHHHHHhhcCCccccc
Q 039168 371 NQNQ-ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELI 448 (536)
Q Consensus 371 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 448 (536)
.... .......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||...... ... .....+....
T Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~----~~i~~~~~~~-- 233 (287)
T 1u59_A 163 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVM----AFIEQGKRME-- 233 (287)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH---HHH----HHHHTTCCCC--
T ss_pred CcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH---HHH----HHHhcCCcCC--
Confidence 3322 12223456889999999998889999999999999999998 99997543221 111 1111221111
Q ss_pred cccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccCCC
Q 039168 449 DPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSM 494 (536)
Q Consensus 449 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 494 (536)
..... ...+.+++.+||+.||++|||+.++++.|+....
T Consensus 234 ---~~~~~----~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 272 (287)
T 1u59_A 234 ---CPPEC----PPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 272 (287)
T ss_dssp ---CCTTC----CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---CCCCc----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 11111 2346667779999999999999999999987643
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=331.17 Aligned_cols=252 Identities=23% Similarity=0.303 Sum_probs=202.0
Q ss_pred HhcCCccccccCCCCceeEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEE
Q 039168 214 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 290 (536)
Q Consensus 214 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 290 (536)
..++|++.+.||+|+||.||+|.+. +++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 3578999999999999999999975 5899999998643 344567788999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCC---eEEecccCccc
Q 039168 291 YEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMN---PKISDFGTARI 367 (536)
Q Consensus 291 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~---~kl~Dfg~a~~ 367 (536)
|||+++++|...+... ..+++..++.++.||+.||.|||+++ |+||||||+||+++.++. +||+|||++..
T Consensus 84 ~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~ 157 (284)
T 3kk8_A 84 FDLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE 157 (284)
T ss_dssp ECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence 9999999998888543 34899999999999999999999997 999999999999986655 99999999987
Q ss_pred cCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcccc
Q 039168 368 FGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVEL 447 (536)
Q Consensus 368 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 447 (536)
...... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||...... .... ....+....
T Consensus 158 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~---~~~~----~~~~~~~~~- 226 (284)
T 3kk8_A 158 VNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---RLYA----QIKAGAYDY- 226 (284)
T ss_dssp CCSSCB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH----HHHHTCCCC-
T ss_pred cccCcc---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh---HHHH----HHHhccccC-
Confidence 653322 22356899999999999999999999999999999999999997542211 1111 111111110
Q ss_pred ccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 448 IDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 448 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
..+ .....+ ..+.+++.+||+.||++|||+.++++
T Consensus 227 ~~~--~~~~~~---~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 227 PSP--EWDTVT---PEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp CTT--TTTTSC---HHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred Cch--hhcccC---HHHHHHHHHHcccChhhCCCHHHHhc
Confidence 000 001112 33556677999999999999999996
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=339.61 Aligned_cols=275 Identities=25% Similarity=0.341 Sum_probs=204.1
Q ss_pred CcChhhHHHHhcCCccccccCCCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHHc--CCCCceeEeeEEe
Q 039168 205 LFPLGLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKL--QHKNLVRLLGCCL 282 (536)
Q Consensus 205 ~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~hpniv~l~~~~~ 282 (536)
..+........++|++.+.||+|+||.||+|++. ++.||||++..... ..+..|.+++..+ +||||+++++++.
T Consensus 26 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~ 101 (337)
T 3mdy_A 26 GLPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEE---ASWFRETEIYQTVLMRHENILGFIAADI 101 (337)
T ss_dssp SSCHHHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEE
T ss_pred CCCcccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecccc---chhhhHHHHHHHHhhcCCCeeeEEEEEc
Confidence 3455555566789999999999999999999985 89999999864332 3445556665554 9999999999998
Q ss_pred eC----ceEEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCC-----CCCeeeCCCCCCcEEEcC
Q 039168 283 EG----QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDS-----RLKIIHRDLKASNVLLDD 353 (536)
Q Consensus 283 ~~----~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~-----~~~ivH~Dikp~NIll~~ 353 (536)
.. ...++||||+++++|.+++... .+++..++.++.|++.||.|||+++ ..+|+||||||+|||++.
T Consensus 102 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~ 177 (337)
T 3mdy_A 102 KGTGSWTQLYLITDYHENGSLYDYLKST----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKK 177 (337)
T ss_dssp ESCGGGCEEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECT
T ss_pred cCCCCCCceEEEEeccCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECC
Confidence 87 7899999999999999999542 4899999999999999999999870 113999999999999999
Q ss_pred CCCeEEecccCccccCCCCCcc--ccccccccccccCcchhcCCCCCcc------chHHHHHHHHHHHHhC---------
Q 039168 354 DMNPKISDFGTARIFGGNQNQA--NTNIIAGTYGYMAPEYAMGGIFSIK------SDVFSFGVLLLEIISG--------- 416 (536)
Q Consensus 354 ~~~~kl~Dfg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~------~DvwslG~il~elltg--------- 416 (536)
++.+||+|||+++.+....... ......||+.|+|||++.+.....+ +|||||||++|||++|
T Consensus 178 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~ 257 (337)
T 3mdy_A 178 NGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEE 257 (337)
T ss_dssp TSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCC
T ss_pred CCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccc
Confidence 9999999999998765433221 1224578999999999988776654 9999999999999999
Q ss_pred -CCCCCCCCccCCchhHHHHHHHhhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 417 -RKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 417 -~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
+.||.......... ...............+..... .......+.+++.+||+.||++|||+.+|++.|+..
T Consensus 258 ~~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 329 (337)
T 3mdy_A 258 YQLPYHDLVPSDPSY--EDMREIVCIKKLRPSFPNRWS---SDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKM 329 (337)
T ss_dssp CCCTTTTTSCSSCCH--HHHHHHHTTSCCCCCCCGGGG---GSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred ccccHhhhcCCCCch--hhhHHHHhhhccCccccccch---hhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHH
Confidence 55554332222111 111111111111111111110 124456678888899999999999999999999874
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=331.54 Aligned_cols=251 Identities=26% Similarity=0.407 Sum_probs=203.9
Q ss_pred HHhcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEee--------
Q 039168 213 EATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLE-------- 283 (536)
Q Consensus 213 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-------- 283 (536)
....+|++.+.||+|+||.||+|.+. +++.||+|++.... +.+.+|++++++++||||+++++++..
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (284)
T 2a19_B 8 RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS 83 (284)
T ss_dssp HHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred hhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence 45578999999999999999999986 69999999997654 356789999999999999999999864
Q ss_pred --------CceEEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCC
Q 039168 284 --------GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDM 355 (536)
Q Consensus 284 --------~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~ 355 (536)
....++||||+++++|.+++.... ...+++..++.++.||+.||.|||+++ |+|+||||+|||++.++
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~ 159 (284)
T 2a19_B 84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR-GEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTK 159 (284)
T ss_dssp -----CCEEEEEEEEECCCCSCBHHHHHHHGG-GSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETT
T ss_pred cccccccCcceEEEEEeccCCCCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCC
Confidence 456899999999999999996532 345899999999999999999999997 99999999999999999
Q ss_pred CeEEecccCccccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHH
Q 039168 356 NPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYT 435 (536)
Q Consensus 356 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~ 435 (536)
.+||+|||++........ .....||+.|+|||++.+..++.++||||||+++|+|++|..|+.. ....
T Consensus 160 ~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~---------~~~~ 227 (284)
T 2a19_B 160 QVKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE---------TSKF 227 (284)
T ss_dssp EEEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH---------HHHH
T ss_pred CEEECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh---------HHHH
Confidence 999999999987754332 2234689999999999999999999999999999999999987421 0111
Q ss_pred HHHhhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccCCCC
Q 039168 436 WKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSMT 495 (536)
Q Consensus 436 ~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 495 (536)
......... .... +. .+.+++.+||+.||++|||+.++++.|......
T Consensus 228 ~~~~~~~~~--------~~~~-~~---~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~ 275 (284)
T 2a19_B 228 FTDLRDGII--------SDIF-DK---KEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS 275 (284)
T ss_dssp HHHHHTTCC--------CTTS-CH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred HHHhhcccc--------cccC-CH---HHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence 111112111 1111 22 355667799999999999999999999876443
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=338.68 Aligned_cols=255 Identities=33% Similarity=0.500 Sum_probs=204.4
Q ss_pred hcCCccccccCCCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEeec
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 294 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 294 (536)
.++|++.+.||+|+||.||+|.+.+++.||||++.... ...+.+.+|++++++++||||+++++++.+ +..++||||+
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~ 89 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecC
Confidence 46899999999999999999999888899999987543 345788999999999999999999999864 5689999999
Q ss_pred CCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCCc
Q 039168 295 PNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQ 374 (536)
Q Consensus 295 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 374 (536)
++++|.+++.... ...+++..++.++.||+.||.|||+++ |+||||||+|||+++++.+||+|||++.........
T Consensus 90 ~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 165 (279)
T 1qpc_A 90 ENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT 165 (279)
T ss_dssp TTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred CCCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCcccc
Confidence 9999999985432 225899999999999999999999997 999999999999999999999999999876543221
Q ss_pred cccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHHHHHhhcCCcccccccccc
Q 039168 375 ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLK 453 (536)
Q Consensus 375 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~ 453 (536)
......+++.|+|||++.+..++.++||||||+++|+|++ |+.||...... ... .....+.... ..
T Consensus 166 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~----~~~~~~~~~~-----~~ 232 (279)
T 1qpc_A 166 -AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP---EVI----QNLERGYRMV-----RP 232 (279)
T ss_dssp -CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHH----HHHHTTCCCC-----CC
T ss_pred -cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH---HHH----HHHhcccCCC-----Cc
Confidence 1223456789999999998889999999999999999999 89887542211 111 1111111111 11
Q ss_pred CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 454 QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 454 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
.. .+ ..+.+++.+||+.||++|||+.++++.|+..
T Consensus 233 ~~-~~---~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 267 (279)
T 1qpc_A 233 DN-CP---EELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (279)
T ss_dssp TT-CC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cc-cc---HHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 11 22 3466677799999999999999999999875
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-42 Score=351.87 Aligned_cols=203 Identities=27% Similarity=0.454 Sum_probs=164.4
Q ss_pred HHhcCCccccccCCCCceeEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHHHcC-CCCceeEeeEEeeCc--e
Q 039168 213 EATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLKEFKNEVNLIAKLQ-HKNLVRLLGCCLEGQ--E 286 (536)
Q Consensus 213 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~--~ 286 (536)
...++|++.+.||+|+||.||+|.+. +++.||||++... .......+.+|+.+++.+. ||||+++++++...+ .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 45679999999999999999999975 6899999998643 3445677889999999997 999999999997544 7
Q ss_pred EEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCcc
Q 039168 287 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTAR 366 (536)
Q Consensus 287 ~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 366 (536)
+|+||||++ ++|..++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 86 ~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~ 157 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSR 157 (388)
T ss_dssp EEEEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence 999999997 578888753 35899999999999999999999997 9999999999999999999999999998
Q ss_pred ccCCCCC-------------------ccccccccccccccCcchhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 039168 367 IFGGNQN-------------------QANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFY 423 (536)
Q Consensus 367 ~~~~~~~-------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~ 423 (536)
.+..... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 234 (388)
T 3oz6_A 158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGS 234 (388)
T ss_dssp ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Confidence 7643111 111233579999999999987 57899999999999999999999998653
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=362.41 Aligned_cols=253 Identities=27% Similarity=0.354 Sum_probs=204.1
Q ss_pred hcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEE
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 290 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 290 (536)
.++|++.++||+|+||.||+|+.+ +|+.||||++.+.. ......+.+|+.+|+.++||||+++++++.+.+.+++|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 467999999999999999999975 69999999986532 23356788999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCC
Q 039168 291 YEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGG 370 (536)
Q Consensus 291 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 370 (536)
|||++||+|..++.... ...+++..++.++.||+.||.|||+++ |+||||||+||||+.++++||+|||+++....
T Consensus 263 mEy~~gg~L~~~l~~~~-~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMG-QAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp ECCCCSCBHHHHHHSSS-SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEcCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 99999999999886533 344899999999999999999999997 99999999999999999999999999987653
Q ss_pred CCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccc
Q 039168 371 NQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDP 450 (536)
Q Consensus 371 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 450 (536)
... .....||+.|+|||++.+..++.++|||||||++|||++|+.||............. ....... .
T Consensus 339 ~~~---~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~---~~i~~~~------~ 406 (576)
T 2acx_A 339 GQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE---RLVKEVP------E 406 (576)
T ss_dssp TCC---EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHH---HHHHHCC------C
T ss_pred Ccc---ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHH---HHhhccc------c
Confidence 322 233579999999999999999999999999999999999999986543322111111 1111111 0
Q ss_pred cccCCCCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHH
Q 039168 451 VLKQSCAPDELLKFIHIGLLCVQQDPADRP-----TMSSVVV 487 (536)
Q Consensus 451 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 487 (536)
..... .+ ..+.+|+.+||+.||.+|| ++.+|++
T Consensus 407 ~~p~~-~s---~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 407 EYSER-FS---PQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp CCCTT-SC---HHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred cCCcc-CC---HHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 01111 12 3456666799999999999 7888885
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=356.51 Aligned_cols=259 Identities=25% Similarity=0.279 Sum_probs=193.6
Q ss_pred hcCCccccccCCCCceeEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeC------c
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEG------Q 285 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~------~ 285 (536)
.++|++.++||+|+||.||+|.+. +++.||||++... .....+.+.+|+.+|+.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 478999999999999999999875 5899999999754 344567788999999999999999999999654 4
Q ss_pred eEEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCc
Q 039168 286 ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTA 365 (536)
Q Consensus 286 ~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 365 (536)
..|+||||++++ |...+. ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++++||+|||++
T Consensus 141 ~~~lv~E~~~~~-l~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a 211 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 211 (464)
T ss_dssp EEEEEEECCSEE-HHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred eEEEEEeCCCCC-HHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEee
Confidence 689999999876 444442 23899999999999999999999997 999999999999999999999999999
Q ss_pred cccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhh-----
Q 039168 366 RIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWC----- 440 (536)
Q Consensus 366 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~----- 440 (536)
+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..........
T Consensus 212 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~---~~~~i~~~lg~p~~~ 285 (464)
T 3ttj_A 212 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID---QWNKVIEQLGTPCPE 285 (464)
T ss_dssp -----CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCSCCHH
T ss_pred eecCCCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcCCCCHH
Confidence 8764322 2334678999999999999999999999999999999999999986433211 1111111000
Q ss_pred -------------cCC--c-----cccccccccCCCC---HHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 441 -------------EGH--A-----VELIDPVLKQSCA---PDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 441 -------------~~~--~-----~~l~~~~l~~~~~---~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
+.. . ...+...+..... ......+.+|+.+||+.||++|||+.|+|+.
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 286 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp HHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000 0 0000000000000 1113467788889999999999999999964
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-41 Score=346.19 Aligned_cols=252 Identities=22% Similarity=0.250 Sum_probs=190.0
Q ss_pred hcCCccc-cccCCCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHH-HcCCCCceeEeeEEee----CceE
Q 039168 215 TNHFSDE-NKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLKEFKNEVNLIA-KLQHKNLVRLLGCCLE----GQEL 287 (536)
Q Consensus 215 ~~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~-~l~hpniv~l~~~~~~----~~~~ 287 (536)
.++|.+. ++||+|+||.||++.++ +++.||||++... ..+.+|+.++. ..+||||+++++++.. ...+
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~ 134 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence 3567666 68999999999999976 5899999998632 45678888874 4589999999999876 5679
Q ss_pred EEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcC---CCCeEEecccC
Q 039168 288 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDD---DMNPKISDFGT 364 (536)
Q Consensus 288 ~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~---~~~~kl~Dfg~ 364 (536)
++||||+++++|.+++.... ...+++.+++.++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||+
T Consensus 135 ~lv~E~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~ 210 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 210 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEEeCCCCcHHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEeccc
Confidence 99999999999999996532 245899999999999999999999997 999999999999997 78899999999
Q ss_pred ccccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCch-hHHHHHHHhhcCC
Q 039168 365 ARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQT-LLTYTWKLWCEGH 443 (536)
Q Consensus 365 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~-~~~~~~~~~~~~~ 443 (536)
++...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.......... ..... ..+.
T Consensus 211 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i----~~~~ 283 (400)
T 1nxk_A 211 AKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI----RMGQ 283 (400)
T ss_dssp CEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHH----HHTC
T ss_pred ccccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHH----HcCc
Confidence 98654322 2234578999999999999999999999999999999999999986543322111 11111 1111
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 444 AVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 444 ~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
. ....+ .....+ ..+.+++.+||+.||++|||+.++++.
T Consensus 284 ~-~~~~~--~~~~~s---~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 284 Y-EFPNP--EWSEVS---EEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp C-CCCTT--TTTTSC---HHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred c-cCCCc--ccccCC---HHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 1 00000 001112 345667779999999999999999974
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-41 Score=338.00 Aligned_cols=273 Identities=23% Similarity=0.300 Sum_probs=212.2
Q ss_pred CCcChhhHHHHhcCCccccccCCCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHH--cCCCCceeEeeEE
Q 039168 204 PLFPLGLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAK--LQHKNLVRLLGCC 281 (536)
Q Consensus 204 ~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~hpniv~l~~~~ 281 (536)
...|........++|++.+.||+|+||.||+|++ +++.||||++... ....+.+|.+++.. ++||||+++++++
T Consensus 30 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~ 105 (342)
T 1b6c_B 30 SGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAAD 105 (342)
T ss_dssp SSSCHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEE
T ss_pred CCCceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeee
Confidence 3466666677788999999999999999999998 5899999998643 23567889999988 7999999999999
Q ss_pred eeCc----eEEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHh--------cCCCCCeeeCCCCCCcE
Q 039168 282 LEGQ----ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLH--------EDSRLKIIHRDLKASNV 349 (536)
Q Consensus 282 ~~~~----~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH--------~~~~~~ivH~Dikp~NI 349 (536)
.... ..++||||+++++|.+++.. ..+++..++.++.||+.||.||| +.+ |+||||||+||
T Consensus 106 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NI 178 (342)
T 1b6c_B 106 NKDNGTWTQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNI 178 (342)
T ss_dssp ECCCSSCCCEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGE
T ss_pred cccCCccceeEEEEeecCCCcHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHE
Confidence 8876 89999999999999999954 24899999999999999999999 665 99999999999
Q ss_pred EEcCCCCeEEecccCccccCCCCCcc--ccccccccccccCcchhcCCC------CCccchHHHHHHHHHHHHhC-----
Q 039168 350 LLDDDMNPKISDFGTARIFGGNQNQA--NTNIIAGTYGYMAPEYAMGGI------FSIKSDVFSFGVLLLEIISG----- 416 (536)
Q Consensus 350 ll~~~~~~kl~Dfg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwslG~il~elltg----- 416 (536)
|++.++++||+|||++.......... ......||+.|+|||++.+.. ++.++||||||+++|||++|
T Consensus 179 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~ 258 (342)
T 1b6c_B 179 LVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG 258 (342)
T ss_dssp EECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTT
T ss_pred EECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCC
Confidence 99999999999999998765433221 223457899999999998763 34789999999999999999
Q ss_pred -----CCCCCCCCccCCchhHHHHHHHhhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcc
Q 039168 417 -----RKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 491 (536)
Q Consensus 417 -----~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 491 (536)
+.||......... ... .............+.... ........+.+|+.+||+.||++|||+.+|++.|+.
T Consensus 259 ~~~~~~~p~~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~ 333 (342)
T 1b6c_B 259 IHEDYQLPYYDLVPSDPS-VEE-MRKVVCEQKLRPNIPNRW---QSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 333 (342)
T ss_dssp BCCCCCCTTTTTSCSSCC-HHH-HHHHHTTSCCCCCCCGGG---GTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred cccccccCccccCcCccc-HHH-HHHHHHHHHhCCCCcccc---cchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHH
Confidence 6666443222111 111 111111111111111111 123455678888889999999999999999999986
Q ss_pred C
Q 039168 492 D 492 (536)
Q Consensus 492 ~ 492 (536)
.
T Consensus 334 i 334 (342)
T 1b6c_B 334 L 334 (342)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=360.93 Aligned_cols=248 Identities=24% Similarity=0.280 Sum_probs=191.8
Q ss_pred hcCCccccccCCCCceeEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEE
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 290 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 290 (536)
.++|++.++||+|+||.||+|... +++.||||++... .......+.+|+.+++.++||||+++++++...+.+++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 367999999999999999999975 5899999998753 333456678899999999999999999999999999999
Q ss_pred EeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccC
Q 039168 291 YEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHE-DSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFG 369 (536)
Q Consensus 291 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 369 (536)
|||+++++|..++... ..+++..++.++.||+.||.|||+ .+ |+||||||+||||+.++.+||+|||+++...
T Consensus 227 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 227 MEYANGGELFFHLSRE---RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp ECCCSSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred EeeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence 9999999999888543 358999999999999999999998 76 9999999999999999999999999998643
Q ss_pred CCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcccccc
Q 039168 370 GNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELID 449 (536)
Q Consensus 370 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 449 (536)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ... ...... .. .
T Consensus 301 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~~---~~i~~~-~~-~--- 367 (446)
T 4ejn_A 301 KDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KLF---ELILME-EI-R--- 367 (446)
T ss_dssp C-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH---HHHHHC-CC-C---
T ss_pred CCC--cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH---HHH---HHHHhC-CC-C---
Confidence 322 2233467999999999999999999999999999999999999998543221 111 111111 10 0
Q ss_pred ccccCCCCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHH
Q 039168 450 PVLKQSCAPDELLKFIHIGLLCVQQDPADRP-----TMSSVVV 487 (536)
Q Consensus 450 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 487 (536)
..... + ..+.+++.+||+.||.+|| |+.++++
T Consensus 368 --~p~~~-~---~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 368 --FPRTL-G---PEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp --CCTTS-C---HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred --CCccC-C---HHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 11111 2 3456677799999999999 9999985
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=349.22 Aligned_cols=264 Identities=27% Similarity=0.428 Sum_probs=206.2
Q ss_pred hcCCccccccCCCCceeEEEEEe-----CCCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCc--eE
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTL-----ADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQ--EL 287 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~--~~ 287 (536)
.++|++.+.||+|+||.||+++. .+++.||||++........+.+.+|+.++++++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 35789999999999999999983 368999999998777777788999999999999999999999987654 78
Q ss_pred EEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccc
Q 039168 288 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARI 367 (536)
Q Consensus 288 ~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 367 (536)
++||||+++++|.+++.... ..+++..++.++.||++||.|||+++ |+||||||+|||++.++++||+|||++..
T Consensus 120 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV 194 (326)
T ss_dssp EEEECCCTTCBHHHHHHHST--TSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEECCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhh
Confidence 99999999999999996532 35899999999999999999999997 99999999999999999999999999987
Q ss_pred cCCCCCcc-ccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCcc---------CCchhHHHHHH
Q 039168 368 FGGNQNQA-NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSE---------HGQTLLTYTWK 437 (536)
Q Consensus 368 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~---------~~~~~~~~~~~ 437 (536)
........ ......++..|+|||.+.+..++.++||||||+++|+|++|..|+...... ...........
T Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (326)
T 2w1i_A 195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 274 (326)
T ss_dssp CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred ccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHH
Confidence 75433211 122345678899999999988999999999999999999999886432100 00011111111
Q ss_pred HhhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 438 LWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 438 ~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
....+.... . +......+.+++.+||+.||++|||+.+|++.|+..
T Consensus 275 ~~~~~~~~~-----~----~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l 320 (326)
T 2w1i_A 275 LLKNNGRLP-----R----PDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 320 (326)
T ss_dssp HHHTTCCCC-----C----CTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred HhhcCCCCC-----C----CCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 111111111 1 111123466677799999999999999999999764
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=342.90 Aligned_cols=244 Identities=23% Similarity=0.328 Sum_probs=199.9
Q ss_pred HHhcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccCh--------hhHHHHHHHHHHHHHcCCCCceeEeeEEee
Q 039168 213 EATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG--------QGLKEFKNEVNLIAKLQHKNLVRLLGCCLE 283 (536)
Q Consensus 213 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 283 (536)
...++|++.+.||+|+||.||+|.+. +++.||||++..... ...+.+.+|+.++++++||||+++++++.+
T Consensus 21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 100 (335)
T 3dls_A 21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN 100 (335)
T ss_dssp HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence 45678999999999999999999864 689999999875431 123457789999999999999999999999
Q ss_pred CceEEEEEeecCCC-ChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecc
Q 039168 284 GQELLLIYEYMPNK-SLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDF 362 (536)
Q Consensus 284 ~~~~~lv~e~~~~~-sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Df 362 (536)
.+..++||||+.++ +|..++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+||
T Consensus 101 ~~~~~lv~e~~~~g~~l~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Df 174 (335)
T 3dls_A 101 QGFFQLVMEKHGSGLDLFAFIDR---HPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDF 174 (335)
T ss_dssp SSEEEEEEECCTTSCBHHHHHHT---CCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCC
T ss_pred CCEEEEEEEeCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeec
Confidence 99999999999777 89888854 335999999999999999999999997 999999999999999999999999
Q ss_pred cCccccCCCCCccccccccccccccCcchhcCCCC-CccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhc
Q 039168 363 GTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIF-SIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCE 441 (536)
Q Consensus 363 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 441 (536)
|++........ .....||+.|+|||++.+..+ +.++||||||+++|+|++|+.||.......
T Consensus 175 g~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-------------- 237 (335)
T 3dls_A 175 GSAAYLERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV-------------- 237 (335)
T ss_dssp TTCEECCTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT--------------
T ss_pred ccceECCCCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH--------------
Confidence 99987654322 233578999999999998876 889999999999999999999975321100
Q ss_pred CCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 442 GHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 442 ~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
..... .....+. .+.+++.+||+.||++|||+.++++.
T Consensus 238 ---~~~~~---~~~~~~~---~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 238 ---EAAIH---PPYLVSK---ELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp ---TTCCC---CSSCCCH---HHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred ---hhccC---CCcccCH---HHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000 0111222 35666679999999999999999975
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=351.33 Aligned_cols=247 Identities=23% Similarity=0.258 Sum_probs=190.1
Q ss_pred hcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHH-HHHcCCCCceeEeeEEeeCceEEE
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLKEFKNEVNL-IAKLQHKNLVRLLGCCLEGQELLL 289 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~-l~~l~hpniv~l~~~~~~~~~~~l 289 (536)
.++|++.+.||+|+||.||+++.+ +++.||||++.+.. ......+.+|..+ ++.++||||+++++++.+.+.+|+
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 368999999999999999999986 48899999987543 2233456667766 577899999999999999999999
Q ss_pred EEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccC
Q 039168 290 IYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFG 369 (536)
Q Consensus 290 v~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 369 (536)
||||+++++|..++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++++||+|||+++...
T Consensus 117 v~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRE---RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp EEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred EEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence 99999999999998643 34899999999999999999999997 9999999999999999999999999998643
Q ss_pred CCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcccccc
Q 039168 370 GNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELID 449 (536)
Q Consensus 370 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 449 (536)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ........ .... .
T Consensus 191 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~------~~~~~~i~-~~~~-~--- 257 (373)
T 2r5t_A 191 EHN--STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT------AEMYDNIL-NKPL-Q--- 257 (373)
T ss_dssp CCC--CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH------HHHHHHHH-HSCC-C---
T ss_pred cCC--CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH------HHHHHHHH-hccc-C---
Confidence 222 223446899999999999999999999999999999999999999854221 11111111 1111 1
Q ss_pred ccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHH
Q 039168 450 PVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVV 486 (536)
Q Consensus 450 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl 486 (536)
+.... + ..+.+++.+||+.||.+||++.+.+
T Consensus 258 --~~~~~-~---~~~~~li~~lL~~dp~~R~~~~~~~ 288 (373)
T 2r5t_A 258 --LKPNI-T---NSARHLLEGLLQKDRTKRLGAKDDF 288 (373)
T ss_dssp --CCSSS-C---HHHHHHHHHHTCSSGGGSTTTTTTH
T ss_pred --CCCCC-C---HHHHHHHHHHcccCHHhCCCCCCCH
Confidence 11111 2 2355666799999999999985433
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=368.02 Aligned_cols=259 Identities=30% Similarity=0.461 Sum_probs=207.1
Q ss_pred HhcCCccccccCCCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEee
Q 039168 214 ATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 293 (536)
Q Consensus 214 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 293 (536)
..++|++.++||+|+||.||+|.++++..||||++.... ...+.|.+|+++|++++||||+++++++.+ +..++||||
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~ 342 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 342 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeeh
Confidence 346788899999999999999999888899999997643 335789999999999999999999999876 678999999
Q ss_pred cCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCC
Q 039168 294 MPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQN 373 (536)
Q Consensus 294 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 373 (536)
+++++|.+++.... ...+++.+++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.......
T Consensus 343 ~~~gsL~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 418 (535)
T 2h8h_A 343 MSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 418 (535)
T ss_dssp CTTEEHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHH
T ss_pred hcCCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCCce
Confidence 99999999996432 234899999999999999999999996 99999999999999999999999999987643211
Q ss_pred ccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHHHHHhhcCCccccccccc
Q 039168 374 QANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVL 452 (536)
Q Consensus 374 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l 452 (536)
.......++..|+|||++.+..++.++||||||+++|||++ |+.||...... ... .....+.... .
T Consensus 419 -~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~---~~~----~~i~~~~~~~-----~ 485 (535)
T 2h8h_A 419 -TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---EVL----DQVERGYRMP-----C 485 (535)
T ss_dssp -HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH---HHH----HHHHTTCCCC-----C
T ss_pred -ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHH----HHHHcCCCCC-----C
Confidence 11122346788999999999999999999999999999999 89997543211 111 1111221111 1
Q ss_pred cCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccCCCC
Q 039168 453 KQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSMT 495 (536)
Q Consensus 453 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 495 (536)
...+ ...+.+|+.+||+.||++|||+.+|+++|+.....
T Consensus 486 ~~~~----~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~ 524 (535)
T 2h8h_A 486 PPEC----PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524 (535)
T ss_dssp CTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred CCCC----CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence 1111 23466777799999999999999999999987443
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=358.44 Aligned_cols=255 Identities=28% Similarity=0.391 Sum_probs=204.1
Q ss_pred hcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEE
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 290 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 290 (536)
.++|++.++||+|+||.||+++++ +|+.||||++.+.. ....+.+.+|+.+|++++||||+++++++...+.+|+|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 367999999999999999999986 59999999996542 23356788999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhcccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccC
Q 039168 291 YEYMPNKSLDVHLFDATR-SVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFG 369 (536)
Q Consensus 291 ~e~~~~~sL~~~l~~~~~-~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 369 (536)
|||++|++|..++..... ...+++..++.++.||+.||.|||+++ |+||||||+||||+.+|++||+|||+++.+.
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 999999999999865432 346999999999999999999999997 9999999999999999999999999998765
Q ss_pred CCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcccccc
Q 039168 370 GNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELID 449 (536)
Q Consensus 370 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 449 (536)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ......... .... .
T Consensus 341 ~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~--~~~~~~~i~-~~~~-~--- 411 (543)
T 3c4z_A 341 AGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--NKELKQRVL-EQAV-T--- 411 (543)
T ss_dssp TTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC--HHHHHHHHH-HCCC-C---
T ss_pred CCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchh--HHHHHHHHh-hccc-C---
Confidence 4332 22345799999999999999999999999999999999999999865432211 111111111 1111 0
Q ss_pred ccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCH-----HHHHH
Q 039168 450 PVLKQSCAPDELLKFIHIGLLCVQQDPADRPTM-----SSVVV 487 (536)
Q Consensus 450 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~-----~evl~ 487 (536)
.... .+ ..+.+++.+||+.||++||++ .+|++
T Consensus 412 --~p~~-~s---~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 412 --YPDK-FS---PASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp --CCTT-SC---HHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred --CCcc-cC---HHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 1111 12 345566679999999999975 66663
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-42 Score=333.84 Aligned_cols=253 Identities=25% Similarity=0.345 Sum_probs=202.3
Q ss_pred hcCCccccccCCCCceeEEEEEeCCCcEEEEEEcccc--ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeC--ceEEEE
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRT--SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEG--QELLLI 290 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~~lv 290 (536)
.++|++.+.||+|+||.||+|+++ ++.||||++... .....+.+.+|+.++++++||||+++++++.+. ...++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 368999999999999999999985 889999998754 344567799999999999999999999999887 788999
Q ss_pred EeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCC
Q 039168 291 YEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGG 370 (536)
Q Consensus 291 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 370 (536)
|||+++++|.+++.... ...+++..++.++.||+.||.|||+++ ..++||||||+|||++.++.++|.|||+......
T Consensus 88 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~ 165 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEGT-NFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQS 165 (271)
T ss_dssp EECCTTCBHHHHHHSCS-SCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC
T ss_pred ecccCCCcHHHHHhhcc-cCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeecc
Confidence 99999999999996532 235899999999999999999999872 2399999999999999999999999998764322
Q ss_pred CCCccccccccccccccCcchhcCCCCCc---cchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcccc
Q 039168 371 NQNQANTNIIAGTYGYMAPEYAMGGIFSI---KSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVEL 447 (536)
Q Consensus 371 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 447 (536)
....||+.|+|||++.+..++. ++||||||+++|+|++|+.||..... ...............
T Consensus 166 -------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------~~~~~~~~~~~~~~~- 231 (271)
T 3kmu_A 166 -------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN------MEIGMKVALEGLRPT- 231 (271)
T ss_dssp -------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH------HHHHHHHHHSCCCCC-
T ss_pred -------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh------HHHHHHHHhcCCCCC-
Confidence 2246799999999998765544 89999999999999999999754321 111112222221111
Q ss_pred ccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 448 IDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 448 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
..... + ..+.+++.+||+.||++|||+.++++.|+..
T Consensus 232 ----~~~~~-~---~~~~~li~~~l~~~p~~Rps~~~il~~L~~l 268 (271)
T 3kmu_A 232 ----IPPGI-S---PHVSKLMKICMNEDPAKRPKFDMIVPILEKM 268 (271)
T ss_dssp ----CCTTC-C---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCCCC-C---HHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 11112 2 3466677799999999999999999999864
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=343.23 Aligned_cols=259 Identities=31% Similarity=0.450 Sum_probs=202.2
Q ss_pred hcCCccccccCCCCceeEEEEEe------CCCcEEEEEEcccc-ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceE
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTL------ADGKAIAVKRLSRT-SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQEL 287 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 287 (536)
.++|++.+.||+|+||.||+|++ .+++.||||++... .......+.+|+.++++++||||+++++++.+....
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 46899999999999999999984 24778999999754 344566789999999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhhcccC----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcC---CCCeEEe
Q 039168 288 LLIYEYMPNKSLDVHLFDATR----SVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDD---DMNPKIS 360 (536)
Q Consensus 288 ~lv~e~~~~~sL~~~l~~~~~----~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~---~~~~kl~ 360 (536)
++||||+++++|.+++..... ...+++..++.++.||+.||.|||+++ |+||||||+|||++. +..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEEC
Confidence 999999999999999976432 245899999999999999999999997 999999999999994 4469999
Q ss_pred cccCccccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHHHHHh
Q 039168 361 DFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLW 439 (536)
Q Consensus 361 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 439 (536)
|||++................|++.|+|||++.+..++.++||||||+++|+|++ |+.||...... .. ....
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~----~~~~ 258 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ---EV----LEFV 258 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HH----HHHH
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH---HH----HHHH
Confidence 9999986654433333344567899999999999999999999999999999998 88887543211 11 1111
Q ss_pred hcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 440 CEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 440 ~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
..+.... ..... + ..+.+++.+||+.||.+|||+.+|++.|...
T Consensus 259 ~~~~~~~-----~~~~~-~---~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 259 TSGGRMD-----PPKNC-P---GPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp HTTCCCC-----CCTTC-C---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hcCCCCC-----CCCCC-C---HHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 1111111 11111 2 3466677799999999999999999998764
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=332.91 Aligned_cols=247 Identities=26% Similarity=0.390 Sum_probs=197.7
Q ss_pred hcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEE
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 290 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 290 (536)
.++|++.+.||+|+||.||+|.+. +++.||+|++.... ......+.+|+.++++++||||+++++++.+.+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 468999999999999999999876 47899999986532 22356788999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCC
Q 039168 291 YEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGG 370 (536)
Q Consensus 291 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 370 (536)
|||+++++|..++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 88 ~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~ 161 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS 161 (279)
T ss_dssp ECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred EecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence 9999999999998543 34899999999999999999999986 99999999999999999999999999865432
Q ss_pred CCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccc
Q 039168 371 NQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDP 450 (536)
Q Consensus 371 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 450 (536)
.. .....|++.|+|||++.+..++.++||||||+++|+|++|+.||...... .. .........
T Consensus 162 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~-~~~~~~~~~------ 224 (279)
T 3fdn_A 162 SR----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ------ET-YKRISRVEF------ 224 (279)
T ss_dssp ----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------HH-HHHHHHTCC------
T ss_pred cc----ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHH------HH-HHHHHhCCC------
Confidence 22 23356899999999999999999999999999999999999997632211 11 111111110
Q ss_pred cccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 451 VLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 451 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
.... ..+ ..+.+++.+||+.||++|||+.++++.
T Consensus 225 ~~~~-~~~---~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 225 TFPD-FVT---EGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp CCCT-TSC---HHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred CCCC-cCC---HHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0111 112 335566779999999999999999964
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=332.32 Aligned_cols=253 Identities=22% Similarity=0.335 Sum_probs=196.7
Q ss_pred HhcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC-hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEE
Q 039168 214 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 291 (536)
Q Consensus 214 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 291 (536)
..++|.+.++||+|+||.||++... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 20 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 99 (285)
T 3is5_A 20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVM 99 (285)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEE
Confidence 3468999999999999999999975 58999999987543 334678999999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcc-cCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEE---cCCCCeEEecccCccc
Q 039168 292 EYMPNKSLDVHLFDA-TRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLL---DDDMNPKISDFGTARI 367 (536)
Q Consensus 292 e~~~~~sL~~~l~~~-~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll---~~~~~~kl~Dfg~a~~ 367 (536)
||+++++|.+++... .....+++..++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||++..
T Consensus 100 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~ 176 (285)
T 3is5_A 100 ETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAEL 176 (285)
T ss_dssp CCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC
T ss_pred EeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeeccee
Confidence 999999999888653 23356999999999999999999999997 9999999999999 4567899999999987
Q ss_pred cCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcccc
Q 039168 368 FGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVEL 447 (536)
Q Consensus 368 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 447 (536)
+..... .....||+.|+|||++. ..++.++||||||+++|+|++|+.||...... ...............
T Consensus 177 ~~~~~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~------~~~~~~~~~~~~~~~ 246 (285)
T 3is5_A 177 FKSDEH---STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLE------EVQQKATYKEPNYAV 246 (285)
T ss_dssp -------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCCCCCCC
T ss_pred cCCccc---CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHH------HHHhhhccCCccccc
Confidence 643322 23456899999999986 46899999999999999999999998643211 111111111110000
Q ss_pred ccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 448 IDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 448 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
.... .+ ..+.+++.+||+.||++|||+.++++
T Consensus 247 ----~~~~-~~---~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 247 ----ECRP-LT---PQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp ------CC-CC---HHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred ----ccCc-CC---HHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0001 12 34556777999999999999999985
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-41 Score=352.69 Aligned_cols=195 Identities=24% Similarity=0.411 Sum_probs=155.1
Q ss_pred hcCCccccccCCCCceeEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHHHcCCCCceeEeeEEee-----Cce
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLE-----GQE 286 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-----~~~ 286 (536)
.++|++.++||+|+||.||+|.+. +++.||||++... .....+.+.+|+.+|+.++||||+++++++.. ...
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 478999999999999999999875 6899999998653 34456788999999999999999999999853 357
Q ss_pred EEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCcc
Q 039168 287 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTAR 366 (536)
Q Consensus 287 ~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 366 (536)
+|+||||+ +++|..++.. ...+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++
T Consensus 132 ~~lv~e~~-~~~L~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRT---PVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLAR 204 (458)
T ss_dssp EEEEECCC-SEEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEecc-ccchhhhccc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccch
Confidence 99999998 5688888743 345999999999999999999999997 9999999999999999999999999998
Q ss_pred ccCCCCCc-------------------------cccccccccccccCcchh-cCCCCCccchHHHHHHHHHHHHhC
Q 039168 367 IFGGNQNQ-------------------------ANTNIIAGTYGYMAPEYA-MGGIFSIKSDVFSFGVLLLEIISG 416 (536)
Q Consensus 367 ~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~il~elltg 416 (536)
........ ......+||+.|+|||++ .+..++.++|||||||++|||++|
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 76432211 112335789999999986 456799999999999999999994
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=342.04 Aligned_cols=257 Identities=27% Similarity=0.455 Sum_probs=198.4
Q ss_pred hcCCccccccCCCCceeEEEEEeCC-----CcEEEEEEcccc-ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEE
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLAD-----GKAIAVKRLSRT-SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELL 288 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 288 (536)
.++|+..+.||+|+||.||+|.+.. +..||||++... .......+.+|+.++++++||||+++++++.+.+..+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 3678889999999999999998643 246999998754 3344567889999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCcccc
Q 039168 289 LIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIF 368 (536)
Q Consensus 289 lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 368 (536)
+||||+++++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 123 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 197 (333)
T 1mqb_A 123 IITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL 197 (333)
T ss_dssp EEEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhh
Confidence 999999999999998643 345899999999999999999999997 999999999999999999999999999876
Q ss_pred CCCCCcc-ccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHHHHHhhcCCccc
Q 039168 369 GGNQNQA-NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVE 446 (536)
Q Consensus 369 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 446 (536)
....... ......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||...... .. ......+....
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~---~~----~~~~~~~~~~~ 270 (333)
T 1mqb_A 198 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH---EV----MKAINDGFRLP 270 (333)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HH----HHHHHTTCCCC
T ss_pred ccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH---HH----HHHHHCCCcCC
Confidence 5432211 1222346788999999999999999999999999999999 99997533211 11 11111211111
Q ss_pred cccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 447 LIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 447 l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
. +......+.+++.+||+.||++|||+.++++.|+..
T Consensus 271 -----~----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 307 (333)
T 1mqb_A 271 -----T----PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 307 (333)
T ss_dssp -----C----CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred -----C----cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0 111123466677799999999999999999999764
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-41 Score=349.58 Aligned_cols=199 Identities=25% Similarity=0.421 Sum_probs=167.3
Q ss_pred hcCCccccccCCCCceeEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeC-----ce
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEG-----QE 286 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-----~~ 286 (536)
.++|++.+.||+|+||.||+|.+. +++.||||++... .....+.+.+|+.+|++++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 478999999999999999999975 5889999999753 334567889999999999999999999999876 67
Q ss_pred EEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCcc
Q 039168 287 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTAR 366 (536)
Q Consensus 287 ~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 366 (536)
.|+||||++ ++|..++.. ...+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++
T Consensus 105 ~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~ 177 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKT---PIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLAR 177 (432)
T ss_dssp EEEEEECCS-EEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEecCC-cCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence 999999986 589888843 345999999999999999999999997 9999999999999999999999999998
Q ss_pred ccCCCCCc--------------------cccccccccccccCcchh-cCCCCCccchHHHHHHHHHHHHhCCCCC
Q 039168 367 IFGGNQNQ--------------------ANTNIIAGTYGYMAPEYA-MGGIFSIKSDVFSFGVLLLEIISGRKNN 420 (536)
Q Consensus 367 ~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~il~elltg~~p~ 420 (536)
........ ......+||+.|+|||++ .+..++.++|||||||++|||++|..|+
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 76543221 122446789999999986 4566999999999999999999866554
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=344.03 Aligned_cols=265 Identities=24% Similarity=0.356 Sum_probs=197.3
Q ss_pred hcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC--hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEE
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 291 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 291 (536)
.++|++.+.||+|+||.||+|++. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 368999999999999999999986 48999999986543 333566789999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCC
Q 039168 292 EYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGN 371 (536)
Q Consensus 292 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 371 (536)
||+++++|..++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..+...
T Consensus 104 e~~~~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 177 (331)
T 4aaa_A 104 EFVDHTILDDLELF---PNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 177 (331)
T ss_dssp ECCSEEHHHHHHHS---TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred ecCCcchHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence 99999999887643 234899999999999999999999997 999999999999999999999999999876433
Q ss_pred CCccccccccccccccCcchhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHH--------HHHHHhhcC
Q 039168 372 QNQANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLT--------YTWKLWCEG 442 (536)
Q Consensus 372 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~--------~~~~~~~~~ 442 (536)
.. ......||+.|+|||++.+. .++.++||||||+++|+|++|+.||............. .....+...
T Consensus 178 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (331)
T 4aaa_A 178 GE--VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKN 255 (331)
T ss_dssp --------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHC
T ss_pred cc--ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhc
Confidence 22 22235689999999999876 68999999999999999999999986533211100000 000001110
Q ss_pred Cc-cccccccccCCCCH-----HHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 443 HA-VELIDPVLKQSCAP-----DELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 443 ~~-~~l~~~~l~~~~~~-----~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
.. .....+.+...... .....+.+++.+||+.||++|||+.++|+
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 256 PVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp GGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred cccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00 00000111111111 11345677778999999999999999985
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=329.49 Aligned_cols=249 Identities=22% Similarity=0.327 Sum_probs=203.2
Q ss_pred hcCCccccccCCCCceeEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEE
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 290 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 290 (536)
.++|.+.+.||+|+||.||++.+. +++.||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 468999999999999999999986 4889999998654 334567788999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCC
Q 039168 291 YEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGG 370 (536)
Q Consensus 291 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 370 (536)
|||+++++|.+++... ..+++.+++.++.||++||.|||+++ |+||||||+|||++.++++||+|||++.....
T Consensus 94 ~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 167 (294)
T 2rku_A 94 LELCRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 167 (294)
T ss_dssp EECCTTCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence 9999999999988543 35899999999999999999999997 99999999999999999999999999987643
Q ss_pred CCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccc
Q 039168 371 NQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDP 450 (536)
Q Consensus 371 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 450 (536)
... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||...... .. ......... .
T Consensus 168 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~-~~~~~~~~~-~---- 233 (294)
T 2rku_A 168 DGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK------ET-YLRIKKNEY-S---- 233 (294)
T ss_dssp TTC--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH------HH-HHHHHTTCC-C----
T ss_pred Ccc--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HH-HHHHhhccC-C----
Confidence 222 223356899999999999988999999999999999999999998543211 11 111111111 1
Q ss_pred cccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 451 VLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 451 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
+.... + ..+.+++.+||+.||++|||+.++++.
T Consensus 234 -~~~~~-~---~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 234 -IPKHI-N---PVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp -CCTTS-C---HHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred -Ccccc-C---HHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 11111 2 245667779999999999999999974
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=332.48 Aligned_cols=253 Identities=28% Similarity=0.411 Sum_probs=198.7
Q ss_pred cCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEeec
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 294 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 294 (536)
+.|.....||+|+||.||+|.+. +++.||||++........+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 34556669999999999999975 58899999998766666788999999999999999999999999999999999999
Q ss_pred CCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcC-CCCeEEecccCccccCCCCC
Q 039168 295 PNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDD-DMNPKISDFGTARIFGGNQN 373 (536)
Q Consensus 295 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~-~~~~kl~Dfg~a~~~~~~~~ 373 (536)
++++|.+++........+++..++.++.||+.||.|||+++ |+|+||||+|||++. ++.+||+|||++........
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~ 178 (295)
T 2clq_A 102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP 178 (295)
T ss_dssp SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCCC
Confidence 99999999976555556789999999999999999999997 999999999999987 89999999999987653222
Q ss_pred ccccccccccccccCcchhcCCC--CCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcccccccc
Q 039168 374 QANTNIIAGTYGYMAPEYAMGGI--FSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPV 451 (536)
Q Consensus 374 ~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 451 (536)
......|++.|+|||++.+.. ++.++||||||+++|+|++|+.||...... .... ........ .+.
T Consensus 179 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----~~~~-~~~~~~~~-----~~~ 246 (295)
T 2clq_A 179 --CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEP----QAAM-FKVGMFKV-----HPE 246 (295)
T ss_dssp ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSH----HHHH-HHHHHHCC-----CCC
T ss_pred --cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCch----hHHH-Hhhccccc-----ccc
Confidence 123356899999999997654 889999999999999999999997532111 1111 11100011 111
Q ss_pred ccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 452 LKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 452 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
+.... + ..+.+++.+||+.||++|||+.++++
T Consensus 247 ~~~~~-~---~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 247 IPESM-S---AEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp CCTTS-C---HHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred ccccC-C---HHHHHHHHHHccCChhhCCCHHHHhc
Confidence 11111 2 34566777999999999999999985
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=333.65 Aligned_cols=255 Identities=24% Similarity=0.363 Sum_probs=200.1
Q ss_pred hcCCccccccCCCCceeEEEEEeCC----CcEEEEEEcccc-ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEE
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLAD----GKAIAVKRLSRT-SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 289 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 289 (536)
.++|++.+.||+|+||.||+|.+.+ +..||+|++... .....+.+.+|+.++++++||||+++++++.++ ..++
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~ 89 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWI 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEE
Confidence 4689999999999999999998643 346999998765 344567899999999999999999999998754 5689
Q ss_pred EEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccC
Q 039168 290 IYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFG 369 (536)
Q Consensus 290 v~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 369 (536)
||||+++++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 90 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 164 (281)
T 3cc6_A 90 IMELYPYGELGHYLERN--KNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIE 164 (281)
T ss_dssp EEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred EEecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCcccc
Confidence 99999999999999643 235899999999999999999999997 9999999999999999999999999998765
Q ss_pred CCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHHHHHhhcCCccccc
Q 039168 370 GNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELI 448 (536)
Q Consensus 370 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 448 (536)
..... ......+++.|+|||++.+..++.++||||||+++|+|++ |+.||....... .... .........
T Consensus 165 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~---~~~~----~~~~~~~~~- 235 (281)
T 3cc6_A 165 DEDYY-KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD---VIGV----LEKGDRLPK- 235 (281)
T ss_dssp ---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG---HHHH----HHHTCCCCC-
T ss_pred ccccc-ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH---HHHH----HhcCCCCCC-
Confidence 43221 1223456889999999998999999999999999999998 999975432221 1111 111111110
Q ss_pred cccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 449 DPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 449 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
... .+ ..+.+++.+||+.||++|||+.++++.|+..
T Consensus 236 ----~~~-~~---~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 271 (281)
T 3cc6_A 236 ----PDL-CP---PVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 271 (281)
T ss_dssp ----CTT-CC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCC-CC---HHHHHHHHHHccCCchhCcCHHHHHHHHHHH
Confidence 111 12 3356677799999999999999999999753
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-42 Score=344.67 Aligned_cols=262 Identities=23% Similarity=0.305 Sum_probs=191.3
Q ss_pred HhcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccCh--hhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEE
Q 039168 214 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG--QGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 290 (536)
Q Consensus 214 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 290 (536)
..++|++.++||+|+||.||+|.+. +++.||||++..... ...+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI 111 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence 3478999999999999999999865 689999999975432 2345678999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEc-----CCCCeEEecccCc
Q 039168 291 YEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLD-----DDMNPKISDFGTA 365 (536)
Q Consensus 291 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~-----~~~~~kl~Dfg~a 365 (536)
|||+++ +|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++ ..+.+||+|||++
T Consensus 112 ~e~~~~-~L~~~~~~~---~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a 184 (329)
T 3gbz_A 112 FEYAEN-DLKKYMDKN---PDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLA 184 (329)
T ss_dssp EECCSE-EHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred EecCCC-CHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence 999985 888888543 34899999999999999999999997 99999999999994 4556999999999
Q ss_pred cccCCCCCccccccccccccccCcchhcCCC-CCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCc
Q 039168 366 RIFGGNQNQANTNIIAGTYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHA 444 (536)
Q Consensus 366 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 444 (536)
+.+..... ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...... ...............
T Consensus 185 ~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~~~~~~~~~~~~~~ 259 (329)
T 3gbz_A 185 RAFGIPIR--QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEI---DQLFKIFEVLGLPDD 259 (329)
T ss_dssp HHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHHCCCCT
T ss_pred cccCCccc--ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHH---HHHHHHHHHhCCCch
Confidence 87653322 223356899999999998754 899999999999999999999998643221 111111111110000
Q ss_pred ccc---------cc--ccccCCCCHH-----HHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 445 VEL---------ID--PVLKQSCAPD-----ELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 445 ~~l---------~~--~~l~~~~~~~-----~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
..+ .. +......... ....+.+++.+||+.||++|||+.++++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 260 TTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp TTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 000 00 0000000000 1235667778999999999999999996
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=342.01 Aligned_cols=247 Identities=28% Similarity=0.448 Sum_probs=197.1
Q ss_pred hcCCccccccCCCCceeEEEEEe-CCCcEEEEEEccccC---hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEE
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTS---GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 290 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 290 (536)
.+.|+..+.||+|+||.||+|++ .+++.||||++.... ....+.+.+|+.++++++||||+++++++..++..++|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 35689999999999999999996 468999999986542 33456788999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCC
Q 039168 291 YEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGG 370 (536)
Q Consensus 291 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 370 (536)
|||+. |+|.+++... ...+++..++.++.||++||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 133 ~e~~~-g~l~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 133 MEYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp EECCS-EEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EecCC-CCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 99997 5676666432 245899999999999999999999997 99999999999999999999999999986542
Q ss_pred CCCccccccccccccccCcchhc---CCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcccc
Q 039168 371 NQNQANTNIIAGTYGYMAPEYAM---GGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVEL 447 (536)
Q Consensus 371 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 447 (536)
. ....||+.|+|||++. +..++.++||||||+++|||++|+.||..... .......... ....
T Consensus 207 ~------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~------~~~~~~~~~~-~~~~- 272 (348)
T 1u5q_A 207 A------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQN-ESPA- 272 (348)
T ss_dssp B------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHS-CCCC-
T ss_pred C------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHHhc-CCCC-
Confidence 1 2357899999999985 56789999999999999999999999753321 1111111111 1111
Q ss_pred ccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 448 IDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 448 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
......++ .+.+++.+||+.||++|||+.++++.
T Consensus 273 ----~~~~~~~~---~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 273 ----LQSGHWSE---YFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp ----CCCTTSCH---HHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred ----CCCCCCCH---HHHHHHHHHcccChhhCcCHHHHhhC
Confidence 11112233 35566679999999999999999864
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-41 Score=333.49 Aligned_cols=260 Identities=22% Similarity=0.349 Sum_probs=196.9
Q ss_pred hcCCccccccCCCCceeEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEE
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 290 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 290 (536)
.++|++.+.||+|+||.||+|... +++.||||++... .....+.+.+|+.++++++||||+++++++...+..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 467999999999999999999974 6899999998753 344567789999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhccc-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccC
Q 039168 291 YEYMPNKSLDVHLFDAT-RSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFG 369 (536)
Q Consensus 291 ~e~~~~~sL~~~l~~~~-~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 369 (536)
|||+++++|.+++.... ....+++..++.++.||+.||.|||+++ ++|+||||+|||++.++.+||+|||++....
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 99999999999986432 3455899999999999999999999997 9999999999999999999999999998764
Q ss_pred CCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcccccc
Q 039168 370 GNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELID 449 (536)
Q Consensus 370 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 449 (536)
.... ......|++.|+|||++.+..++.++||||||+++|+|++|+.||..... ....... ..........
T Consensus 188 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~~~-~~~~~~~~~~-- 258 (310)
T 2wqm_A 188 SKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSLCK-KIEQCDYPPL-- 258 (310)
T ss_dssp -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---C----CHHHHHH-HHHTTCSCCC--
T ss_pred CCCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch----hHHHHHH-HhhcccCCCC--
Confidence 3322 12235689999999999999999999999999999999999999753211 1111111 1111111111
Q ss_pred ccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 450 PVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 450 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
.....++ .+.+++.+||+.||++|||+.+|++.|+..
T Consensus 259 ---~~~~~~~---~l~~li~~~l~~dp~~Rps~~~il~~l~~l 295 (310)
T 2wqm_A 259 ---PSDHYSE---ELRQLVNMCINPDPEKRPDVTYVYDVAKRM 295 (310)
T ss_dssp ---CTTTSCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---cccccCH---HHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 1111223 455666799999999999999999999876
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=338.30 Aligned_cols=263 Identities=20% Similarity=0.266 Sum_probs=204.0
Q ss_pred cChhhHHHHhcCCccc-cccCCCCceeEEEEEeC-CCcEEEEEEccccC--hhhHHHHHHHHHHHHHc-CCCCceeEeeE
Q 039168 206 FPLGLALEATNHFSDE-NKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLKEFKNEVNLIAKL-QHKNLVRLLGC 280 (536)
Q Consensus 206 ~~~~~~~~~~~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~hpniv~l~~~ 280 (536)
+.+.......++|.+. +.||+|+||.||+|.+. +++.||||++.... ......+.+|+.+++.+ +||||++++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~ 97 (327)
T 3lm5_A 18 LYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEV 97 (327)
T ss_dssp CCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred hHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence 3344556677888887 89999999999999976 58999999987542 33467889999999999 46999999999
Q ss_pred EeeCceEEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcC---CCCe
Q 039168 281 CLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDD---DMNP 357 (536)
Q Consensus 281 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~---~~~~ 357 (536)
+.+.+..++||||+.+++|.+++... ....+++..++.++.||+.||.|||+++ |+||||||+|||++. ++.+
T Consensus 98 ~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~ 173 (327)
T 3lm5_A 98 YENTSEIILILEYAAGGEIFSLCLPE-LAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDI 173 (327)
T ss_dssp EECSSEEEEEEECCTTEEGGGGGSSC-C-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCE
T ss_pred EEeCCeEEEEEEecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcE
Confidence 99999999999999999999988543 2345899999999999999999999997 999999999999997 7899
Q ss_pred EEecccCccccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHH
Q 039168 358 KISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWK 437 (536)
Q Consensus 358 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~ 437 (536)
||+|||+++....... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||....... ... .
T Consensus 174 kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~---~ 244 (327)
T 3lm5_A 174 KIVDFGMSRKIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQE---TYL---N 244 (327)
T ss_dssp EECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH---H
T ss_pred EEeeCccccccCCccc---cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH---HHH---H
Confidence 9999999987653322 223578999999999999999999999999999999999999975432211 111 1
Q ss_pred HhhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 438 LWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 438 ~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
. ..... .. . ..........+.+++.+||+.||++|||+.++++.
T Consensus 245 i-~~~~~-~~-~----~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 245 I-SQVNV-DY-S----EETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp H-HHTCC-CC-C----TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred H-Hhccc-cc-C----chhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 1 11110 00 0 00011112345667779999999999999999864
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=334.91 Aligned_cols=257 Identities=29% Similarity=0.383 Sum_probs=200.4
Q ss_pred cCCccccccCCCCceeEEEEEeCC----CcEEEEEEccccC-hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceE-EE
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLAD----GKAIAVKRLSRTS-GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQEL-LL 289 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~-~l 289 (536)
..|...++||+|+||.||+|.+.+ +..||+|++.... ....+.+.+|+.++++++||||+++++++.+.+.. ++
T Consensus 21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (298)
T 3pls_A 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHV 100 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEE
Confidence 356677899999999999998532 3379999987543 34567889999999999999999999999876655 99
Q ss_pred EEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccC
Q 039168 290 IYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFG 369 (536)
Q Consensus 290 v~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 369 (536)
||||+.+++|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 101 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 175 (298)
T 3pls_A 101 LLPYMCHGDLLQFIRS--PQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDIL 175 (298)
T ss_dssp EECCCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred EEecccCCCHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence 9999999999999964 2345899999999999999999999997 9999999999999999999999999998664
Q ss_pred CCC--CccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcccc
Q 039168 370 GNQ--NQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVEL 447 (536)
Q Consensus 370 ~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 447 (536)
... .........+++.|+|||.+.+..++.++||||||+++|+|++|..|+...... ...... ........
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~--~~~~~~----~~~~~~~~- 248 (298)
T 3pls_A 176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP--FDLTHF----LAQGRRLP- 248 (298)
T ss_dssp TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG--GGHHHH----HHTTCCCC-
T ss_pred CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCH--HHHHHH----hhcCCCCC-
Confidence 332 112223356789999999999999999999999999999999966654221111 111111 11111111
Q ss_pred ccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 448 IDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 448 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
.... .+ ..+.+++.+||+.||.+|||+.++++.|+..
T Consensus 249 ----~~~~-~~---~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~ 285 (298)
T 3pls_A 249 ----QPEY-CP---DSLYQVMQQCWEADPAVRPTFRVLVGEVEQI 285 (298)
T ss_dssp ----CCTT-CC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCcc-ch---HHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 0111 12 3466677799999999999999999999875
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=344.04 Aligned_cols=255 Identities=24% Similarity=0.316 Sum_probs=201.2
Q ss_pred hcCCccccccCCCCceeEEEEEe----CCCcEEEEEEccccC----hhhHHHHHHHHHHHHHc-CCCCceeEeeEEeeCc
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTL----ADGKAIAVKRLSRTS----GQGLKEFKNEVNLIAKL-QHKNLVRLLGCCLEGQ 285 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~ 285 (536)
.++|++.++||+|+||.||+++. .+++.||||++.... ....+.+.+|+++++.+ +||||+++++++...+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 36899999999999999999987 368999999986532 22345677899999999 6999999999999999
Q ss_pred eEEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCc
Q 039168 286 ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTA 365 (536)
Q Consensus 286 ~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 365 (536)
..++||||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++++||+|||++
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a 206 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLS 206 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eEEEEeecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCC
Confidence 999999999999999999653 34899999999999999999999997 999999999999999999999999999
Q ss_pred cccCCCCCccccccccccccccCcchhcCC--CCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCC
Q 039168 366 RIFGGNQNQANTNIIAGTYGYMAPEYAMGG--IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGH 443 (536)
Q Consensus 366 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 443 (536)
+.+..... .......||+.|+|||++.+. .++.++||||||+++|+|++|+.||........ ........... .
T Consensus 207 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~--~~~~~~~~~~~-~ 282 (355)
T 1vzo_A 207 KEFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS--QAEISRRILKS-E 282 (355)
T ss_dssp EECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC--HHHHHHHHHHC-C
T ss_pred eecccCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch--HHHHHHHHhcc-C
Confidence 86643222 222345799999999999863 478999999999999999999999865433222 11111111111 0
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHHHh
Q 039168 444 AVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRP-----TMSSVVVML 489 (536)
Q Consensus 444 ~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~L 489 (536)
+..... ....+.+++.+||+.||++|| |+.++++..
T Consensus 283 ------~~~~~~----~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 283 ------PPYPQE----MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp ------CCCCTT----SCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred ------CCCCcc----cCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 011111 123456677799999999999 999999765
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-41 Score=329.76 Aligned_cols=249 Identities=27% Similarity=0.426 Sum_probs=181.2
Q ss_pred hcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEE
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 290 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 290 (536)
.++|++.+.||+|+||.||+|++. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 467999999999999999999974 68999999986432 22356789999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCC
Q 039168 291 YEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGG 370 (536)
Q Consensus 291 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 370 (536)
|||+++++|.+++... ...+++..++.++.||++||.|||+++ |+|+||||+||+++.++.+||+|||++.....
T Consensus 90 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNR--VKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp EECCTTEEHHHHHHTC--SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred EecCCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 9999999999998643 345899999999999999999999996 99999999999999999999999999987643
Q ss_pred CCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccc
Q 039168 371 NQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDP 450 (536)
Q Consensus 371 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 450 (536)
... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||........ .. . . ... +.
T Consensus 165 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~---~-~---~~~---~~ 229 (278)
T 3cok_A 165 PHE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT---LN---K-V---VLA---DY 229 (278)
T ss_dssp -----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------------C---CSS---CC
T ss_pred CCC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH---HH---H-H---hhc---cc
Confidence 222 12235689999999999998999999999999999999999999864332211 00 0 0 000 00
Q ss_pred cccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 451 VLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 451 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
.... ..+ ..+.+++.+||+.||++|||+.++++
T Consensus 230 ~~~~-~~~---~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 230 EMPS-FLS---IEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp CCCT-TSC---HHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred CCcc-ccC---HHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 1111 112 34566777999999999999999986
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=327.72 Aligned_cols=251 Identities=24% Similarity=0.290 Sum_probs=199.5
Q ss_pred hcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccCh------hhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceE
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG------QGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQEL 287 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 287 (536)
.++|++.+.||+|+||.||++++. +++.||+|++..... ...+.+.+|+.++++++||||+++++++.+.+..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 357999999999999999999986 589999999865421 2367899999999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCC----CeEEeccc
Q 039168 288 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDM----NPKISDFG 363 (536)
Q Consensus 288 ~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~----~~kl~Dfg 363 (536)
++||||+++++|.+++... ..+++..++.++.||+.||.|||+++ ++|+||||+||+++.++ .+||+|||
T Consensus 84 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg 157 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEK---ESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFG 157 (283)
T ss_dssp EEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEeecCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEecc
Confidence 9999999999999998543 35899999999999999999999997 99999999999999877 89999999
Q ss_pred CccccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCC
Q 039168 364 TARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGH 443 (536)
Q Consensus 364 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 443 (536)
++........ .....|++.|+|||++.+..++.++||||||+++|+|++|+.||...... . .........
T Consensus 158 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~-~~~~~~~~~ 227 (283)
T 3bhy_A 158 IAHKIEAGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ------E-TLTNISAVN 227 (283)
T ss_dssp TCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH------H-HHHHHHTTC
T ss_pred cceeccCCCc---ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH------H-HHHHhHhcc
Confidence 9987643322 22346899999999999999999999999999999999999997543211 1 111111111
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 444 AVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 444 ~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
.. ......... ...+.+++.+||+.||++|||+.++++
T Consensus 228 ~~--~~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 228 YD--FDEEYFSNT----SELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp CC--CCHHHHTTC----CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cC--CcchhcccC----CHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 10 011111111 234666777999999999999999996
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=333.39 Aligned_cols=247 Identities=24% Similarity=0.361 Sum_probs=198.2
Q ss_pred HhcCCccccccCCCCceeEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHHHc-CCCCceeEeeEEeeCceEEE
Q 039168 214 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLKEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLL 289 (536)
Q Consensus 214 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~l 289 (536)
..++|++.+.||+|+||.||+|.+. +++.||||++... .......+.+|+..+..+ +||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 4578999999999999999999986 6999999998754 233456788999999999 99999999999999999999
Q ss_pred EEeecCCCChhhhhhcccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCC--------------
Q 039168 290 IYEYMPNKSLDVHLFDATR-SVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDD-------------- 354 (536)
Q Consensus 290 v~e~~~~~sL~~~l~~~~~-~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~-------------- 354 (536)
||||+++++|.+++..... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccccccccccc
Confidence 9999999999999965422 245899999999999999999999997 9999999999999844
Q ss_pred -----CCeEEecccCccccCCCCCccccccccccccccCcchhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCccCC
Q 039168 355 -----MNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHG 428 (536)
Q Consensus 355 -----~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~ 428 (536)
..+||+|||++....... ...||+.|+|||++.+. .++.++||||||+++|+|++|.+++...
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~----- 234 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG----- 234 (289)
T ss_dssp ----CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS-----
T ss_pred ccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch-----
Confidence 479999999998765322 23589999999999876 5678999999999999999998774321
Q ss_pred chhHHHHHHHhhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 429 QTLLTYTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 429 ~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
. .+.....+....+ .... + ..+.+++.+||+.||++|||+.++++.
T Consensus 235 -~----~~~~~~~~~~~~~-----~~~~-~---~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 235 -D----QWHEIRQGRLPRI-----PQVL-S---QEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp -H----HHHHHHTTCCCCC-----SSCC-C---HHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred -h----HHHHHHcCCCCCC-----Cccc-C---HHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 1 1112222222211 1112 2 345666679999999999999999864
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=331.76 Aligned_cols=258 Identities=19% Similarity=0.221 Sum_probs=196.9
Q ss_pred hcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEE
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 290 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 290 (536)
.++|++.+.||+|+||.||++.+. +++.||||++.... ....+.+.+|+.++++++||||+++++++..++..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 478999999999999999999975 68899999987542 33357789999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCC
Q 039168 291 YEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGG 370 (536)
Q Consensus 291 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 370 (536)
|||+++++|.+++... ..+++.+++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 113 ~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 186 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQ---GPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTD 186 (309)
T ss_dssp EECCCCEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred EEecCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence 9999999999998643 35899999999999999999999997 99999999999999999999999999986643
Q ss_pred CCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccc
Q 039168 371 NQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDP 450 (536)
Q Consensus 371 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 450 (536)
.... ......|++.|+|||++.+..++.++||||||+++|+|++|+.||...... ......... .... .
T Consensus 187 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~~~~~-~~~~--~ 255 (309)
T 2h34_A 187 EKLT-QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS-------VMGAHINQA-IPRP--S 255 (309)
T ss_dssp -----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-------HHHHHHHSC-CCCG--G
T ss_pred cccc-cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH-------HHHHHhccC-CCCc--c
Confidence 3221 222356899999999999999999999999999999999999997542211 111111111 1000 0
Q ss_pred cccCCCCHHHHHHHHHHHHhhcCCCCCCCC-CHHHHHHHhccCC
Q 039168 451 VLKQSCAPDELLKFIHIGLLCVQQDPADRP-TMSSVVVMLASDS 493 (536)
Q Consensus 451 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~evl~~L~~~~ 493 (536)
..... .+. .+.+++.+||+.||++|| |+.++++.|+...
T Consensus 256 ~~~~~-~~~---~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l 295 (309)
T 2h34_A 256 TVRPG-IPV---AFDAVIARGMAKNPEDRYVTCGDLSAAAHAAL 295 (309)
T ss_dssp GTSTT-CCT---HHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTC
T ss_pred ccCCC-CCH---HHHHHHHHhccCCHHHHHHhHHHHHHHHHHHH
Confidence 11111 122 355666799999999999 9999999998763
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=330.82 Aligned_cols=245 Identities=22% Similarity=0.331 Sum_probs=200.4
Q ss_pred cCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEE
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 291 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 291 (536)
++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 67999999999999999999976 57889999986432 223467889999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCC
Q 039168 292 EYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGN 371 (536)
Q Consensus 292 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 371 (536)
||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+|+||||+||+++.++.+||+|||++......
T Consensus 94 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 167 (284)
T 2vgo_A 94 EFAPRGELYKELQKH---GRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSL 167 (284)
T ss_dssp CCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred EeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence 999999999998653 34899999999999999999999996 999999999999999999999999999765432
Q ss_pred CCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcccccccc
Q 039168 372 QNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPV 451 (536)
Q Consensus 372 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 451 (536)
. .....|++.|+|||++.+..++.++||||||+++|+|++|+.||...... ... ........ .
T Consensus 168 ~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~-~~~~~~~~------~ 230 (284)
T 2vgo_A 168 R----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT------ETH-RRIVNVDL------K 230 (284)
T ss_dssp C----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------HHH-HHHHTTCC------C
T ss_pred c----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHh------HHH-HHHhcccc------C
Confidence 2 23356899999999999999999999999999999999999997543211 111 11111111 1
Q ss_pred ccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 452 LKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 452 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
.... .+ ..+.+++.+||+.||.+|||+.++++
T Consensus 231 ~~~~-~~---~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 231 FPPF-LS---DGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp CCTT-SC---HHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCc-CC---HHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 1111 12 34566777999999999999999996
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-41 Score=339.94 Aligned_cols=264 Identities=23% Similarity=0.328 Sum_probs=198.3
Q ss_pred hcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccCh--hhHHHHHHHHHHHHHcCCCCceeEeeEEee--------
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG--QGLKEFKNEVNLIAKLQHKNLVRLLGCCLE-------- 283 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-------- 283 (536)
.++|++.++||+|+||.||+|++. +++.||||++..... .....+.+|+.+++.++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 368999999999999999999984 689999999865432 234577899999999999999999999987
Q ss_pred CceEEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEeccc
Q 039168 284 GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFG 363 (536)
Q Consensus 284 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg 363 (536)
.+..++||||+++ +|...+... ...+++.+++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg 169 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG 169 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCC-CHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccch
Confidence 4568999999986 565555432 235899999999999999999999997 9999999999999999999999999
Q ss_pred CccccCCCCC--ccccccccccccccCcchhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhh
Q 039168 364 TARIFGGNQN--QANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWC 440 (536)
Q Consensus 364 ~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 440 (536)
+++.+..... ........||+.|+|||++.+. .++.++||||||+++|+|++|+.||...... ...........
T Consensus 170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~~~~i~~~~~ 246 (351)
T 3mi9_A 170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ---HQLALISQLCG 246 (351)
T ss_dssp TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHC
T ss_pred hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhC
Confidence 9987653322 2222345789999999999764 5899999999999999999999998643221 11111111111
Q ss_pred cCCccccccc------------cccCCCC-HHH------HHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 441 EGHAVELIDP------------VLKQSCA-PDE------LLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 441 ~~~~~~l~~~------------~l~~~~~-~~~------~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
. ...+.... ....... ... ...+.+|+.+||+.||++|||+.++++.
T Consensus 247 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 247 S-ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp C-CCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred C-CChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 0 00010000 0000001 111 1246778889999999999999999964
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=335.70 Aligned_cols=257 Identities=28% Similarity=0.408 Sum_probs=199.3
Q ss_pred hcCCccccccCCCCceeEEEEEeCC----CcEEEEEEcccc-ChhhHHHHHHHHHHHHHcCCCCceeEeeEEe-eCceEE
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLAD----GKAIAVKRLSRT-SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCL-EGQELL 288 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~~ 288 (536)
..+|++.++||+|+||.||+|.+.+ ...+|+|++... .....+.+.+|+.++++++||||+++++++. .++..+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 4578899999999999999998643 336899998754 3445678899999999999999999999864 556889
Q ss_pred EEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCcccc
Q 039168 289 LIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIF 368 (536)
Q Consensus 289 lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 368 (536)
+||||+++++|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 104 ~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp EEEECCTTCBHHHHHHC--TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred EEEeCCCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccccccc
Confidence 99999999999999954 2345899999999999999999999997 999999999999999999999999999876
Q ss_pred CCCCCc--cccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCC-CCCCCCCccCCchhHHHHHHHhhcCCcc
Q 039168 369 GGNQNQ--ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGR-KNNGFYFSEHGQTLLTYTWKLWCEGHAV 445 (536)
Q Consensus 369 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 445 (536)
...... .......||+.|+|||.+.+..++.++||||||+++|+|++|. +||...... ..... ...+...
T Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~---~~~~~----~~~~~~~ 251 (298)
T 3f66_A 179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF---DITVY----LLQGRRL 251 (298)
T ss_dssp SCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTT---THHHH----HHTTCCC
T ss_pred cccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHH---HHHHH----HhcCCCC
Confidence 543221 1222345788999999999999999999999999999999954 454332211 11111 1111111
Q ss_pred ccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 446 ELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 446 ~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
. . ....++ .+.+++.+||+.||++|||+.++++.|+..
T Consensus 252 ~-----~-~~~~~~---~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 289 (298)
T 3f66_A 252 L-----Q-PEYCPD---PLYEVMLKCWHPKAEMRPSFSELVSRISAI 289 (298)
T ss_dssp C-----C-CTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred C-----C-CccCCH---HHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1 0 111222 466677799999999999999999999875
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=335.48 Aligned_cols=255 Identities=29% Similarity=0.393 Sum_probs=200.8
Q ss_pred hcCCcccc-ccCCCCceeEEEEEe---CCCcEEEEEEccccC--hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEE
Q 039168 215 TNHFSDEN-KLGQGGFGPVYKGTL---ADGKAIAVKRLSRTS--GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELL 288 (536)
Q Consensus 215 ~~~~~~~~-~lg~G~~g~Vy~~~~---~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 288 (536)
.++|.+.+ .||+|+||.||+|.+ ..++.||||++.... ....+.+.+|+.+++.++||||+++++++ ..+..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 35788887 999999999999964 247889999987543 23357799999999999999999999999 667889
Q ss_pred EEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCcccc
Q 039168 289 LIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIF 368 (536)
Q Consensus 289 lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 368 (536)
+||||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 94 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 167 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKAL 167 (291)
T ss_dssp EEEECCTTEEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEeCCCCCHHHHHHhC---cCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence 999999999999999653 34899999999999999999999997 999999999999999999999999999876
Q ss_pred CCCCCcc-ccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHHHHHhhcCCccc
Q 039168 369 GGNQNQA-NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVE 446 (536)
Q Consensus 369 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 446 (536)
....... ......+++.|+|||.+.+..++.++||||||+++|+|++ |+.||...... . .......+....
T Consensus 168 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~----~~~~~~~~~~~~ 240 (291)
T 1xbb_A 168 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---E----VTAMLEKGERMG 240 (291)
T ss_dssp CTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---H----HHHHHHTTCCCC
T ss_pred ccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH---H----HHHHHHcCCCCC
Confidence 5433221 1222346788999999998889999999999999999999 99997643221 1 111122222111
Q ss_pred cccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 447 LIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 447 l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
. ... ....+.+++.+||+.||++|||+.++++.|+..
T Consensus 241 ~-----~~~----~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 277 (291)
T 1xbb_A 241 C-----PAG----CPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 277 (291)
T ss_dssp C-----CTT----CCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred C-----CCC----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1 111 123466677799999999999999999999864
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=340.74 Aligned_cols=258 Identities=24% Similarity=0.347 Sum_probs=204.2
Q ss_pred hhhHHHHhcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccCh--------hhHHHHHHHHHHHHHc-CCCCceeE
Q 039168 208 LGLALEATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG--------QGLKEFKNEVNLIAKL-QHKNLVRL 277 (536)
Q Consensus 208 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l-~hpniv~l 277 (536)
........++|++.+.||+|+||.||+|.+. +|+.||||++..... ...+.+.+|+.+++++ +||||+++
T Consensus 86 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 165 (365)
T 2y7j_A 86 WAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITL 165 (365)
T ss_dssp HHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred chhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 3444566788999999999999999999986 699999999865431 2245678999999999 89999999
Q ss_pred eeEEeeCceEEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCe
Q 039168 278 LGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNP 357 (536)
Q Consensus 278 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~ 357 (536)
++++......++||||+++++|.+++... ..+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++.+
T Consensus 166 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~i 239 (365)
T 2y7j_A 166 IDSYESSSFMFLVFDLMRKGELFDYLTEK---VALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQI 239 (365)
T ss_dssp EEEEEBSSEEEEEECCCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCE
T ss_pred EEEEeeCCEEEEEEEeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCE
Confidence 99999999999999999999999998643 35899999999999999999999997 9999999999999999999
Q ss_pred EEecccCccccCCCCCccccccccccccccCcchhcC------CCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchh
Q 039168 358 KISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMG------GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTL 431 (536)
Q Consensus 358 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~ 431 (536)
||+|||++..+..... .....||+.|+|||++.+ ..++.++||||||+++|+|++|+.||..... ...
T Consensus 240 kl~DfG~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~---~~~ 313 (365)
T 2y7j_A 240 RLSDFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ---ILM 313 (365)
T ss_dssp EECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHH
T ss_pred EEEecCcccccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH---HHH
Confidence 9999999987654322 234578999999999863 3588999999999999999999999754211 111
Q ss_pred HHHHHHHhhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 432 LTYTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 432 ~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
.. ....+.... ..+ ..... ...+.+++.+||+.||++|||+.++++
T Consensus 314 ~~----~i~~~~~~~-~~~-~~~~~----~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 314 LR----MIMEGQYQF-SSP-EWDDR----SSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp HH----HHHHTCCCC-CHH-HHSSS----CHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HH----HHHhCCCCC-CCc-ccccC----CHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11 111111100 000 00111 134667777999999999999999997
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=334.64 Aligned_cols=251 Identities=23% Similarity=0.322 Sum_probs=199.9
Q ss_pred HhcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEe
Q 039168 214 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 292 (536)
Q Consensus 214 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 292 (536)
..++|++.+.||+|+||.||++++. +++.||+|++........+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 3468999999999999999999976 689999999986655555678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEE---cCCCCeEEecccCccccC
Q 039168 293 YMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLL---DDDMNPKISDFGTARIFG 369 (536)
Q Consensus 293 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll---~~~~~~kl~Dfg~a~~~~ 369 (536)
|+++++|.+++... ..+++..++.++.||+.||.|||+++ |+|+||||+|||+ +.++.+||+|||++....
T Consensus 87 ~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 160 (304)
T 2jam_A 87 LVSGGELFDRILER---GVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ 160 (304)
T ss_dssp CCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred cCCCccHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence 99999999988543 34899999999999999999999997 9999999999999 788899999999997543
Q ss_pred CCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcccccc
Q 039168 370 GNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELID 449 (536)
Q Consensus 370 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 449 (536)
.. ......||+.|+|||++.+..++.++||||||+++|+|++|+.||..... .... .....+.. .. .
T Consensus 161 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~----~~i~~~~~-~~-~ 227 (304)
T 2jam_A 161 NG----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE---SKLF----EKIKEGYY-EF-E 227 (304)
T ss_dssp CB----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHH----HHHHHCCC-CC-C
T ss_pred CC----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHH----HHHHcCCC-CC-C
Confidence 21 22335689999999999999999999999999999999999999754221 1111 11111111 00 0
Q ss_pred ccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 450 PVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 450 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
...... ....+.+++.+||+.||++|||+.++++
T Consensus 228 ~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 228 SPFWDD----ISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp TTTTTT----SCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred cccccc----CCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111111 1234666777999999999999999996
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=342.42 Aligned_cols=199 Identities=27% Similarity=0.390 Sum_probs=175.7
Q ss_pred hcCCccccccCCCCceeEEEEEeC-CCcEEEEEEcccc-ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEe
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT-SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 292 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 292 (536)
.++|++.+.||+|+||.||++.+. +++.||+|++... .....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 468999999999999999999986 6899999998765 34456778999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCC
Q 039168 293 YMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHED-SRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGN 371 (536)
Q Consensus 293 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 371 (536)
|+++++|.+++... ..+++..++.++.||+.||.|||+. + |+||||||+|||++.++++||+|||++......
T Consensus 112 ~~~~~~L~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 185 (360)
T 3eqc_A 112 HMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 185 (360)
T ss_dssp CCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred CCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence 99999999999653 3489999999999999999999985 6 999999999999999999999999999765321
Q ss_pred CCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 039168 372 QNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFY 423 (536)
Q Consensus 372 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~ 423 (536)
......||+.|+|||++.+..++.++||||||+++|+|++|+.||...
T Consensus 186 ----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 233 (360)
T 3eqc_A 186 ----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 233 (360)
T ss_dssp ----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCC
T ss_pred ----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 122357899999999999999999999999999999999999998653
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=340.53 Aligned_cols=264 Identities=28% Similarity=0.366 Sum_probs=194.5
Q ss_pred hcCCccccccCCCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHH--HHHcCCCCceeEeeEEee-----CceE
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNL--IAKLQHKNLVRLLGCCLE-----GQEL 287 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~hpniv~l~~~~~~-----~~~~ 287 (536)
.++|++.+.||+|+||.||+|+. +++.||||++..... ..+..|.++ +..++||||+++++.+.. ....
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR---QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccch---hhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 36899999999999999999987 689999999865432 334444444 555899999999986542 3467
Q ss_pred EEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcC---------CCCCeeeCCCCCCcEEEcCCCCeE
Q 039168 288 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHED---------SRLKIIHRDLKASNVLLDDDMNPK 358 (536)
Q Consensus 288 ~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---------~~~~ivH~Dikp~NIll~~~~~~k 358 (536)
++||||+++++|.+++... ..++..++.++.||++||.|||+. + |+||||||+|||++.++.+|
T Consensus 88 ~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~k 160 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSLH----TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCV 160 (336)
T ss_dssp EEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEE
T ss_pred EEEEecCCCCcHHHHHhhc----ccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcEE
Confidence 9999999999999999542 258899999999999999999998 6 99999999999999999999
Q ss_pred EecccCccccCCCCC------ccccccccccccccCcchhcC-------CCCCccchHHHHHHHHHHHHhCCCCCCCCCc
Q 039168 359 ISDFGTARIFGGNQN------QANTNIIAGTYGYMAPEYAMG-------GIFSIKSDVFSFGVLLLEIISGRKNNGFYFS 425 (536)
Q Consensus 359 l~Dfg~a~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~il~elltg~~p~~~~~~ 425 (536)
|+|||+++.+..... ........||+.|+|||++.+ ..++.++||||||+++|||++|..|+.....
T Consensus 161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~ 240 (336)
T 3g2f_A 161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240 (336)
T ss_dssp ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence 999999987654321 112223569999999999987 3567899999999999999999877533222
Q ss_pred cCC-chhH-----------HHHHHHhhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 426 EHG-QTLL-----------TYTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 426 ~~~-~~~~-----------~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
... .... ..............+.. .. .........+.+++.+||+.||++|||+.++++.|+..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~l 316 (336)
T 3g2f_A 241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPE-AW--KENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAEL 316 (336)
T ss_dssp CCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCT-TC--CCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred hhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCc-cc--ccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHH
Confidence 111 1100 00000111111111111 00 11223455688888899999999999999999999875
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=345.61 Aligned_cols=255 Identities=24% Similarity=0.317 Sum_probs=191.3
Q ss_pred HHHhcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC--------hhhHHHHHHHHHHHHHcCCCCceeEeeEEe
Q 039168 212 LEATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--------GQGLKEFKNEVNLIAKLQHKNLVRLLGCCL 282 (536)
Q Consensus 212 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~hpniv~l~~~~~ 282 (536)
....++|.+.+.||+|+||.||+|.+. +++.||||++.... ......+.+|+.+|++++||||+++++++.
T Consensus 131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~ 210 (419)
T 3i6u_A 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD 210 (419)
T ss_dssp HHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE
T ss_pred hhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 345689999999999999999999875 58999999986532 112235789999999999999999999975
Q ss_pred eCceEEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCC---CeEE
Q 039168 283 EGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDM---NPKI 359 (536)
Q Consensus 283 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~---~~kl 359 (536)
.+..++||||+++++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++ .+||
T Consensus 211 -~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl 283 (419)
T 3i6u_A 211 -AEDYYIVLELMEGGELFDKVVG---NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKI 283 (419)
T ss_dssp -SSEEEEEEECCTTCBGGGGTSS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEE
T ss_pred -cCceEEEEEcCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEE
Confidence 4568999999999999988853 345999999999999999999999997 99999999999997544 5999
Q ss_pred ecccCccccCCCCCccccccccccccccCcchhcC---CCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHH
Q 039168 360 SDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMG---GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTW 436 (536)
Q Consensus 360 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~ 436 (536)
+|||+++...... ......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||....... .....
T Consensus 284 ~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~--~~~~~-- 356 (419)
T 3i6u_A 284 TDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKDQ-- 356 (419)
T ss_dssp CCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC--CHHHH--
T ss_pred eecccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH--HHHHH--
Confidence 9999998765322 2234679999999999864 568899999999999999999999986433221 11111
Q ss_pred HHhhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 437 KLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 437 ~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
...+.... . +..... ....+.+++.+||+.||++|||+.++++.
T Consensus 357 --i~~~~~~~-~-~~~~~~----~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 357 --ITSGKYNF-I-PEVWAE----VSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp --HHTTCCCC-C-HHHHTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred --HhcCCCCC-C-chhhcc----cCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 11111110 0 000011 12346677779999999999999999963
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=338.71 Aligned_cols=265 Identities=23% Similarity=0.322 Sum_probs=195.5
Q ss_pred HhcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccChh-----hHHHHHHHHHHHHHcCCCCceeEeeEEeeCceE
Q 039168 214 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQ-----GLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQEL 287 (536)
Q Consensus 214 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 287 (536)
..++|++.+.||+|+||.||+|++. +|+.||||++...... ..+.+.+|+.++++++||||+++++++.+.+..
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 3578999999999999999999976 5899999998753221 124678999999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccc
Q 039168 288 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARI 367 (536)
Q Consensus 288 ~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 367 (536)
++||||+++ +|..++.. ....+++..++.++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 88 ~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKS 161 (346)
T ss_dssp EEEEECCSE-EHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred EEEEEcCCC-CHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEeccccee
Confidence 999999986 77777754 2345888999999999999999999997 99999999999999999999999999987
Q ss_pred cCCCCCccccccccccccccCcchhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccc
Q 039168 368 FGGNQNQANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVE 446 (536)
Q Consensus 368 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 446 (536)
+..... ......||+.|+|||++.+. .++.++||||||+++|+|++|.+||..... ..................
T Consensus 162 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~---~~~~~~i~~~~~~~~~~~ 236 (346)
T 1ua2_A 162 FGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD---LDQLTRIFETLGTPTEEQ 236 (346)
T ss_dssp TTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHHHCCCCTTT
T ss_pred ccCCcc--cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCH---HHHHHHHHHHcCCCChhh
Confidence 653322 22335689999999999765 489999999999999999999998754321 111222222111111111
Q ss_pred cc------cccc---cCCCC-----HHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHh
Q 039168 447 LI------DPVL---KQSCA-----PDELLKFIHIGLLCVQQDPADRPTMSSVVVML 489 (536)
Q Consensus 447 l~------~~~l---~~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 489 (536)
+. +... ....+ ......+.+++.+||+.||++|||+.|+++.-
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~ 293 (346)
T 1ua2_A 237 WPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK 293 (346)
T ss_dssp SSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSG
T ss_pred hhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcCh
Confidence 00 0000 00001 11124566777799999999999999999754
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=339.59 Aligned_cols=249 Identities=22% Similarity=0.332 Sum_probs=203.3
Q ss_pred HhcCCccccccCCCCceeEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEE
Q 039168 214 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 289 (536)
Q Consensus 214 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 289 (536)
..++|.+.+.||+|+||.||++.+. +++.||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 118 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 118 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 3468999999999999999999986 4789999998654 33456778999999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccC
Q 039168 290 IYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFG 369 (536)
Q Consensus 290 v~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 369 (536)
||||+++++|.+++... ..+++.+++.++.||++||.|||+++ |+||||||+|||++.++++||+|||++....
T Consensus 119 v~e~~~~~~L~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 192 (335)
T 2owb_A 119 VLELCRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 192 (335)
T ss_dssp EECCCTTCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEecCCCCCHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence 99999999999988543 35899999999999999999999997 9999999999999999999999999998764
Q ss_pred CCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcccccc
Q 039168 370 GNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELID 449 (536)
Q Consensus 370 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 449 (536)
.... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||...... .. ......... .
T Consensus 193 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~-~~~~~~~~~-~--- 259 (335)
T 2owb_A 193 YDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK------ET-YLRIKKNEY-S--- 259 (335)
T ss_dssp STTC--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH------HH-HHHHHHTCC-C---
T ss_pred cCcc--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHH------HH-HHHHhcCCC-C---
Confidence 3322 223457899999999999999999999999999999999999998543211 11 111111111 0
Q ss_pred ccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 450 PVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 450 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
+.... + ..+.+++.+||+.||++|||+.++++
T Consensus 260 --~~~~~-~---~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 260 --IPKHI-N---PVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp --CCTTS-C---HHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred --CCccC-C---HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11111 2 23556777999999999999999996
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=329.59 Aligned_cols=249 Identities=26% Similarity=0.438 Sum_probs=203.7
Q ss_pred hcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC-hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEe
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 292 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 292 (536)
.+.|+..+.||+|+||.||+|.+. +++.||||++.... ....+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 367999999999999999999875 58999999987543 3456789999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCC
Q 039168 293 YMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQ 372 (536)
Q Consensus 293 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 372 (536)
|+++++|.+++.. ..+++..++.++.||+.||.|||+++ |+|+||||+||+++.++++||+|||++.......
T Consensus 101 ~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 173 (303)
T 3a7i_A 101 YLGGGSALDLLEP----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173 (303)
T ss_dssp CCTTEEHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred eCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCccc
Confidence 9999999998843 35899999999999999999999997 9999999999999999999999999998765432
Q ss_pred CccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccccc
Q 039168 373 NQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVL 452 (536)
Q Consensus 373 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l 452 (536)
. ......||+.|+|||++.+..++.++||||||+++|+|++|+.||...... ..... ...... +.+
T Consensus 174 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~-~~~~~~-----~~~ 239 (303)
T 3a7i_A 174 I--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM------KVLFL-IPKNNP-----PTL 239 (303)
T ss_dssp C--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHH-HHHSCC-----CCC
T ss_pred c--ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH------HHHHH-hhcCCC-----CCC
Confidence 2 223457899999999999999999999999999999999999997543211 11111 111111 111
Q ss_pred cCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 453 KQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 453 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
.... + ..+.+++.+||+.||++|||+.++++.
T Consensus 240 ~~~~-~---~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 240 EGNY-S---KPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp CSSC-C---HHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred cccc-C---HHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 1122 2 235667779999999999999999864
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=342.02 Aligned_cols=261 Identities=23% Similarity=0.342 Sum_probs=192.1
Q ss_pred cCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccChhh-HHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEee
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQG-LKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 293 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 293 (536)
++|++.++||+|+||.||+|.+. +++.||||++....... ...+.+|+.++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57999999999999999999976 68999999986543221 12355799999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCC
Q 039168 294 MPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQN 373 (536)
Q Consensus 294 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 373 (536)
+++ +|..++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 155 (324)
T 3mtl_A 82 LDK-DLKQYLDDC--GNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 155 (324)
T ss_dssp CSE-EHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred ccc-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCcc
Confidence 974 787777543 335899999999999999999999997 99999999999999999999999999986543221
Q ss_pred ccccccccccccccCcchhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCc---ccccc
Q 039168 374 QANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHA---VELID 449 (536)
Q Consensus 374 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~l~~ 449 (536)
......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||...... ............... .....
T Consensus 156 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~i~~~~~~~~~~~~~~~~~ 230 (324)
T 3mtl_A 156 --TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVE---EQLHFIFRILGTPTEETWPGILS 230 (324)
T ss_dssp ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCCCTTTSTTGGG
T ss_pred --ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCCChHhchhhhc
Confidence 2223468999999999987 56899999999999999999999998653322 112222221111110 00000
Q ss_pred c---------cccCC----CCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 450 P---------VLKQS----CAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 450 ~---------~l~~~----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
. ..... ..+.....+.+++.+||+.||++|||+.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 231 NEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp CHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred chhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 0 00000 00011234667778999999999999999997
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=343.97 Aligned_cols=262 Identities=13% Similarity=0.174 Sum_probs=202.7
Q ss_pred hcCCccccccCCCCceeEEEEEeCC---------CcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCcee---------
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLAD---------GKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVR--------- 276 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~--------- 276 (536)
.++|++.+.||+|+||.||+|++.. ++.||||++... +.+.+|++++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 4689999999999999999999763 789999998754 46789999999999999988
Q ss_pred ------EeeEEee-CceEEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcE
Q 039168 277 ------LLGCCLE-GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNV 349 (536)
Q Consensus 277 ------l~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NI 349 (536)
+++++.. +...++||||+ +++|.+++.... ...+++..++.++.||+.||.|||+++ |+||||||+||
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NI 190 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP-KHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENI 190 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGE
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHE
Confidence 6677766 78899999999 999999996532 346999999999999999999999997 99999999999
Q ss_pred EEcCCC--CeEEecccCccccCCCCCc-----cccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCC
Q 039168 350 LLDDDM--NPKISDFGTARIFGGNQNQ-----ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF 422 (536)
Q Consensus 350 ll~~~~--~~kl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~ 422 (536)
|++.++ .+||+|||+++.+...... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||..
T Consensus 191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 270 (352)
T 2jii_A 191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN 270 (352)
T ss_dssp EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 999998 8999999999876532211 112335789999999999999999999999999999999999999864
Q ss_pred CCccCCchhHHHHHHHhhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 423 YFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 423 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
..... .........+. .....+..........+. .+.+++.+||+.||++|||+.+|++.|+..
T Consensus 271 ~~~~~--~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~---~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 334 (352)
T 2jii_A 271 CLPNT--EDIMKQKQKFV-DKPGPFVGPCGHWIRPSE---TLQKYLKVVMALTYEEKPPYAMLRNNLEAL 334 (352)
T ss_dssp GTTCH--HHHHHHHHHHH-HSCCCEECTTSCEECCCH---HHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred CCcCH--HHHHHHHHhcc-CChhhhhhhccccCCCcH---HHHHHHHHHHhCChhhCCCHHHHHHHHHHH
Confidence 33211 11111111111 111222221111111233 355666699999999999999999999875
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=350.06 Aligned_cols=261 Identities=21% Similarity=0.284 Sum_probs=194.5
Q ss_pred hcCCccccccCCCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCc------eEE
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQ------ELL 288 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~------~~~ 288 (536)
..+|++.++||+|+||.||+|++..+..||+|++..... ...+|+++++.++||||+++++++.... .++
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 357999999999999999999998777799998865432 2236999999999999999999996543 388
Q ss_pred EEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEc-CCCCeEEecccCccc
Q 039168 289 LIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLD-DDMNPKISDFGTARI 367 (536)
Q Consensus 289 lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~-~~~~~kl~Dfg~a~~ 367 (536)
+||||+.++.+............+++..++.++.||+.||.|||+++ |+||||||+||||+ .++.+||+|||+++.
T Consensus 115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 99999988765544433334556999999999999999999999997 99999999999999 799999999999987
Q ss_pred cCCCCCccccccccccccccCcchhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcC----
Q 039168 368 FGGNQNQANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEG---- 442 (536)
Q Consensus 368 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---- 442 (536)
+...... ....||+.|+|||++.+. .++.++|||||||++|||++|+.||...... .............
T Consensus 192 ~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~---~~l~~i~~~~g~p~~~~ 265 (394)
T 4e7w_A 192 LIAGEPN---VSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGI---DQLVEIIKVLGTPSREQ 265 (394)
T ss_dssp CCTTCCC---CSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHHCCCCHHH
T ss_pred ccCCCCC---cccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCCCHHH
Confidence 6433322 234689999999999775 5899999999999999999999998643221 1111111111000
Q ss_pred -----------CccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 443 -----------HAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 443 -----------~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
...............+.....+.+++.+||+.||++|||+.++++.
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 266 IKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp HHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 0000000000000011112356777789999999999999999964
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=332.92 Aligned_cols=257 Identities=18% Similarity=0.259 Sum_probs=197.8
Q ss_pred hcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHHcC-CCCceeEeeEEee--CceEEEE
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQ-HKNLVRLLGCCLE--GQELLLI 290 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~--~~~~~lv 290 (536)
.++|++.++||+|+||.||+|.+. +++.||||++.... .+.+.+|+.++++++ ||||+++++++.+ ....++|
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 368999999999999999999864 68999999987543 367889999999997 9999999999987 6789999
Q ss_pred EeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCC-CeEEecccCccccC
Q 039168 291 YEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDM-NPKISDFGTARIFG 369 (536)
Q Consensus 291 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~-~~kl~Dfg~a~~~~ 369 (536)
|||+.+++|..++. .+++..++.++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||+++...
T Consensus 112 ~e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp EECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EeccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence 99999999998873 2889999999999999999999997 99999999999999777 89999999998765
Q ss_pred CCCCccccccccccccccCcchhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHh---------
Q 039168 370 GNQNQANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLW--------- 439 (536)
Q Consensus 370 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~--------- 439 (536)
.... .....|++.|+|||++.+ ..++.++||||||+++|+|++|+.||........ .........
T Consensus 183 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~--~l~~~~~~~~~~~~~~~~ 257 (330)
T 3nsz_A 183 PGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD--QLVRIAKVLGTEDLYDYI 257 (330)
T ss_dssp TTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHH--HHHHHHHHHCHHHHHHHH
T ss_pred CCCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHH--HHHHHHHhcCCchhhhHH
Confidence 3332 233468999999999987 6689999999999999999999999743222111 111000000
Q ss_pred hcC--------------CccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 440 CEG--------------HAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 440 ~~~--------------~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
... .....................+.+++.+||+.||++|||++++|+.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 258 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp HHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 000 0000000111111111123456777779999999999999999963
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=339.58 Aligned_cols=255 Identities=29% Similarity=0.448 Sum_probs=199.9
Q ss_pred cCCccccccCCCCceeEEEEEeC-CCcE--EEEEEcccc-ChhhHHHHHHHHHHHHHc-CCCCceeEeeEEeeCceEEEE
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA-DGKA--IAVKRLSRT-SGQGLKEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLI 290 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~--vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv 290 (536)
++|++.+.||+|+||.||+|++. ++.. +|+|++... .....+.+.+|+.+++++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 68999999999999999999875 4554 499988643 333456788999999999 999999999999999999999
Q ss_pred EeecCCCChhhhhhccc-------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCe
Q 039168 291 YEYMPNKSLDVHLFDAT-------------RSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNP 357 (536)
Q Consensus 291 ~e~~~~~sL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~ 357 (536)
|||+++++|.+++.... ....+++.+++.++.||+.||.|||+++ |+||||||+|||++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence 99999999999996532 2346899999999999999999999997 9999999999999999999
Q ss_pred EEecccCccccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHHH
Q 039168 358 KISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTW 436 (536)
Q Consensus 358 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~ 436 (536)
||+|||+++..... .......+++.|+|||++.+..++.++||||||+++|+|++ |+.||...... . ..
T Consensus 182 kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~------~-~~ 251 (327)
T 1fvr_A 182 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA------E-LY 251 (327)
T ss_dssp EECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------H-HH
T ss_pred EEcccCcCcccccc---ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH------H-HH
Confidence 99999999743211 11223456889999999998889999999999999999998 99997543211 1 11
Q ss_pred HHhhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 437 KLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 437 ~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
.....+.... . +......+.+++.+||+.||.+|||+.++++.|+..
T Consensus 252 ~~~~~~~~~~-----~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 298 (327)
T 1fvr_A 252 EKLPQGYRLE-----K----PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 298 (327)
T ss_dssp HHGGGTCCCC-----C----CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHhhcCCCCC-----C----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1111111111 1 111123466777799999999999999999998864
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=326.86 Aligned_cols=252 Identities=23% Similarity=0.303 Sum_probs=197.1
Q ss_pred hcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC----hhhHHHHHHHHHHHHHcCCCCceeEeeEEe--eCceE
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS----GQGLKEFKNEVNLIAKLQHKNLVRLLGCCL--EGQEL 287 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~hpniv~l~~~~~--~~~~~ 287 (536)
.++|++.+.||+|+||.||++.+. +++.||+|++.... ....+.+.+|+.++++++||||+++++++. +....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 478999999999999999999975 58999999987542 234577899999999999999999999984 45689
Q ss_pred EEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccc
Q 039168 288 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARI 367 (536)
Q Consensus 288 ~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 367 (536)
++||||++++ |.+++... ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 84 ~lv~e~~~~~-l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSV-PEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEA 158 (305)
T ss_dssp EEEEECCSEE-HHHHHHHS-TTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEehhccCC-HHHHHHhC-cccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccc
Confidence 9999999887 65565442 3346899999999999999999999997 99999999999999999999999999987
Q ss_pred cCCCCCccccccccccccccCcchhcCCC--CCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcc
Q 039168 368 FGGNQNQANTNIIAGTYGYMAPEYAMGGI--FSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAV 445 (536)
Q Consensus 368 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 445 (536)
..............||+.|+|||++.+.. ++.++||||||+++|+|++|+.||..... ... .........
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~-~~~i~~~~~- 230 (305)
T 2wtk_C 159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI------YKL-FENIGKGSY- 230 (305)
T ss_dssp CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHH-HHHHHHCCC-
T ss_pred cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH------HHH-HHHHhcCCC-
Confidence 65433333334457899999999998654 47899999999999999999999764221 111 111111111
Q ss_pred ccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 446 ELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 446 ~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
.+.... + ..+.+++.+||+.||++|||+.++++.
T Consensus 231 -----~~~~~~-~---~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 231 -----AIPGDC-G---PPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp -----CCCSSS-C---HHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred -----CCCCcc-C---HHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 111112 2 245566779999999999999999964
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=335.97 Aligned_cols=260 Identities=25% Similarity=0.396 Sum_probs=185.2
Q ss_pred HhcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC-hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEE
Q 039168 214 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 291 (536)
Q Consensus 214 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 291 (536)
..++|++.+.||+|+||.||+|.+. +++.||||++.... ....+.+.+|+.++++++||||+++++++...+..++||
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 92 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM 92 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence 3578999999999999999999875 68999999986543 334567889999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcc-----cCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCcc
Q 039168 292 EYMPNKSLDVHLFDA-----TRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTAR 366 (536)
Q Consensus 292 e~~~~~sL~~~l~~~-----~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 366 (536)
||+++++|.+++... .....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 169 (303)
T 2vwi_A 93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSA 169 (303)
T ss_dssp ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccchh
Confidence 999999999998642 12345899999999999999999999997 9999999999999999999999999998
Q ss_pred ccCCCCC---ccccccccccccccCcchhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcC
Q 039168 367 IFGGNQN---QANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEG 442 (536)
Q Consensus 367 ~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 442 (536)
....... ........||+.|+|||++.+ ..++.++||||||+++|+|++|+.||....... .. ..... .
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~---~~~~~-~ 242 (303)
T 2vwi_A 170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK---VL---MLTLQ-N 242 (303)
T ss_dssp HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGG---HH---HHHHT-S
T ss_pred eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhh---HH---HHHhc-c
Confidence 7643321 112234568999999999876 568999999999999999999999986543221 11 11111 1
Q ss_pred Cccccc----cccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 443 HAVELI----DPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 443 ~~~~l~----~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
....+. ++...... + ..+.+++.+||+.||.+|||+.++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~-~---~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 243 DPPSLETGVQDKEMLKKY-G---KSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp SCCCTTC-----CCCCCC-C---HHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CCCccccccccchhhhhh-h---HHHHHHHHHHccCChhhCcCHHHHhh
Confidence 111111 11111111 2 34566777999999999999999986
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=336.73 Aligned_cols=257 Identities=24% Similarity=0.315 Sum_probs=192.8
Q ss_pred hcCCccccccCCCCceeEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCc------
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQ------ 285 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~------ 285 (536)
.++|++.+.||+|+||.||+|.+. +|+.||||++... .....+.+.+|+.+|+.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 468999999999999999999975 6999999998653 3344677889999999999999999999998653
Q ss_pred eEEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCc
Q 039168 286 ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTA 365 (536)
Q Consensus 286 ~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 365 (536)
..++||||+ +++|..++.. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a 175 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 175 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeecc
Confidence 469999999 8899988854 34899999999999999999999997 999999999999999999999999999
Q ss_pred cccCCCCCccccccccccccccCcchhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCC-
Q 039168 366 RIFGGNQNQANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGH- 443 (536)
Q Consensus 366 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~- 443 (536)
+..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... .............
T Consensus 176 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~l~~i~~~~g~~~~ 247 (367)
T 1cm8_A 176 RQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD---QLKEIMKVTGTPPA 247 (367)
T ss_dssp EECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCCCCH
T ss_pred cccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcCCCCH
Confidence 875432 223568999999999987 679999999999999999999999986433211 1111111000000
Q ss_pred -----------------ccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 444 -----------------AVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 444 -----------------~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
........+. ...+.....+.+++.+||+.||++|||+.++++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 248 EFVQRLQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp HHHHTCSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHhhhHHHHHHHHhCCCCCCCCHH-HHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 0000000000 0011112346677779999999999999999983
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=348.36 Aligned_cols=261 Identities=21% Similarity=0.271 Sum_probs=204.3
Q ss_pred hcCCccccccCCCCceeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHHHcCC-CCceeEeeEEeeCceEEEEEe
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQH-KNLVRLLGCCLEGQELLLIYE 292 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~l~~~~~~~~~~~lv~e 292 (536)
.++|++.++||+|+||.||+|++ .+++.||||++...... ..+.+|+++++.++| +++..+..++...+..++|||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 47899999999999999999997 46899999987654322 457889999999987 566667777778889999999
Q ss_pred ecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEE---cCCCCeEEecccCccccC
Q 039168 293 YMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLL---DDDMNPKISDFGTARIFG 369 (536)
Q Consensus 293 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll---~~~~~~kl~Dfg~a~~~~ 369 (536)
|+ +++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||| +.++.+||+|||+++.+.
T Consensus 84 ~~-g~sL~~ll~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 84 LL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred CC-CCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 99 99999998643 235899999999999999999999997 9999999999999 688999999999998776
Q ss_pred CCCCcc-----ccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCc
Q 039168 370 GNQNQA-----NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHA 444 (536)
Q Consensus 370 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 444 (536)
...... ......||+.|+|||++.+..++.++|||||||+||||++|+.||........................
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSI 237 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCH
T ss_pred CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccH
Confidence 543321 122467999999999999999999999999999999999999998754433322222222111111111
Q ss_pred cccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 445 VELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 445 ~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
.. +...+ + .++.+++..||+.||++||++.+|+++|+..
T Consensus 238 ~~-----l~~~~-p---~~l~~li~~cl~~dP~~RPs~~el~~~L~~l 276 (483)
T 3sv0_A 238 EA-----LCRGY-P---TEFASYFHYCRSLRFDDKPDYSYLKRLFRDL 276 (483)
T ss_dssp HH-----HHTTS-C---HHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred HH-----HhcCC-c---HHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 11 11111 2 3466777799999999999999999988753
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=344.31 Aligned_cols=265 Identities=22% Similarity=0.250 Sum_probs=202.7
Q ss_pred HHHhcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHHcC--------CCCceeEeeEEe
Q 039168 212 LEATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQ--------HKNLVRLLGCCL 282 (536)
Q Consensus 212 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------hpniv~l~~~~~ 282 (536)
....++|++.++||+|+||.||+|++. +++.||||++... ....+.+.+|+.+++.++ ||||+++++++.
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~ 111 (397)
T 1wak_A 33 DLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFK 111 (397)
T ss_dssp CEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEE
T ss_pred hhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeeccee
Confidence 344688999999999999999999865 5889999998643 344577889999999996 788999999988
Q ss_pred ----eCceEEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCeeeCCCCCCcEEEcCCC--
Q 039168 283 ----EGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHED-SRLKIIHRDLKASNVLLDDDM-- 355 (536)
Q Consensus 283 ----~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~~~~ivH~Dikp~NIll~~~~-- 355 (536)
.....++||||+. ++|...+... ....+++..++.++.||+.||.|||++ + |+||||||+||||+.++
T Consensus 112 ~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~ 186 (397)
T 1wak_A 112 ISGVNGTHICMVFEVLG-HHLLKWIIKS-NYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQY 186 (397)
T ss_dssp EEETTEEEEEEEECCCC-CBHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHH
T ss_pred ecCCCCceEEEEEeccC-ccHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchh
Confidence 5568999999995 4555555432 224589999999999999999999998 6 99999999999999775
Q ss_pred -----------------------------------------------CeEEecccCccccCCCCCccccccccccccccC
Q 039168 356 -----------------------------------------------NPKISDFGTARIFGGNQNQANTNIIAGTYGYMA 388 (536)
Q Consensus 356 -----------------------------------------------~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a 388 (536)
.+||+|||++...... .....||+.|+|
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~a 261 (397)
T 1wak_A 187 IRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRS 261 (397)
T ss_dssp HHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCC
T ss_pred hhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccC
Confidence 7999999999876432 223468999999
Q ss_pred cchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHH---HHHHHhhc--------CCc-cccccc------
Q 039168 389 PEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLT---YTWKLWCE--------GHA-VELIDP------ 450 (536)
Q Consensus 389 PE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~---~~~~~~~~--------~~~-~~l~~~------ 450 (536)
||++.+..++.++|||||||++|+|++|+.||............. ........ ... .+.+..
T Consensus 262 PE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 341 (397)
T 1wak_A 262 LEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKH 341 (397)
T ss_dssp HHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSS
T ss_pred ChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccc
Confidence 999999999999999999999999999999987644333211111 11111000 000 000000
Q ss_pred -----------c--ccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 451 -----------V--LKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 451 -----------~--l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
. -...........+.+|+.+||+.||++|||+.++|+
T Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 342 ITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred ccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 0 001234566678889999999999999999999986
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=365.97 Aligned_cols=253 Identities=26% Similarity=0.399 Sum_probs=197.6
Q ss_pred Ccccc-ccCCCCceeEEEEEeC---CCcEEEEEEccccC-hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEe
Q 039168 218 FSDEN-KLGQGGFGPVYKGTLA---DGKAIAVKRLSRTS-GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 292 (536)
Q Consensus 218 ~~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 292 (536)
+.+.+ .||+|+||.||+|.+. ++..||||++.... ....+.+.+|+++|++++||||+++++++.. +..++|||
T Consensus 337 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E 415 (613)
T 2ozo_A 337 LLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVME 415 (613)
T ss_dssp EEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEE
T ss_pred eeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEE
Confidence 33344 7999999999999864 46779999997643 3456889999999999999999999999976 56999999
Q ss_pred ecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCC
Q 039168 293 YMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQ 372 (536)
Q Consensus 293 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 372 (536)
|+.+++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.+....
T Consensus 416 ~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~ 490 (613)
T 2ozo_A 416 MAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADD 490 (613)
T ss_dssp CCTTCBHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC---
T ss_pred eCCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCC
Confidence 99999999998543 345899999999999999999999996 9999999999999999999999999998765432
Q ss_pred Ccc-ccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHHHHHhhcCCccccccc
Q 039168 373 NQA-NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDP 450 (536)
Q Consensus 373 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 450 (536)
... ......+++.|+|||++.+..++.++|||||||++|||++ |+.||...... ... .....+.....
T Consensus 491 ~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~---~~~----~~i~~~~~~~~--- 560 (613)
T 2ozo_A 491 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVM----AFIEQGKRMEC--- 560 (613)
T ss_dssp -----------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH---HHH----HHHHTTCCCCC---
T ss_pred ceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH---HHH----HHHHcCCCCCC---
Confidence 211 1122345689999999999999999999999999999998 99998643321 111 12222222111
Q ss_pred cccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 451 VLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 451 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
+......+.+|+.+||+.||++|||+.+|++.|+..
T Consensus 561 ------p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 596 (613)
T 2ozo_A 561 ------PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 596 (613)
T ss_dssp ------CTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred ------CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 111223466777799999999999999999999874
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=346.74 Aligned_cols=256 Identities=28% Similarity=0.407 Sum_probs=191.3
Q ss_pred cCCccccccCCCCceeEEEEEeC--C--CcEEEEEEcccc-ChhhHHHHHHHHHHHHHcCCCCceeEeeEEee-CceEEE
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA--D--GKAIAVKRLSRT-SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLE-GQELLL 289 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~--~--~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~~l 289 (536)
..|++.++||+|+||.||+|++. + +..||+|.+... .....+.+.+|+.++++++||||+++++++.+ ++..++
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 35777889999999999999864 2 246899998654 33456789999999999999999999998754 567899
Q ss_pred EEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccC
Q 039168 290 IYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFG 369 (536)
Q Consensus 290 v~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 369 (536)
||||+++++|.+++... ...+++..++.++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 169 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp EEECCTTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEECCCCCCHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeecccccccc
Confidence 99999999999999543 345789999999999999999999997 9999999999999999999999999998764
Q ss_pred CCCCcc--ccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHHHHHhhcCCccc
Q 039168 370 GNQNQA--NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVE 446 (536)
Q Consensus 370 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 446 (536)
...... ......+++.|+|||++.+..++.++||||||+++|||++ |.+||...... ..... ...+....
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~---~~~~~----~~~~~~~~ 316 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF---DITVY----LLQGRRLL 316 (373)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSS---CHHHH----HHTTCCCC
T ss_pred ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHH---HHHHH----HHcCCCCC
Confidence 332211 1223456789999999999999999999999999999999 66666443221 11111 11111111
Q ss_pred cccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 447 LIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 447 l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
. ....+ ..+.+++.+||+.||++|||+.++++.|+..
T Consensus 317 -----~-p~~~~---~~l~~li~~cl~~dp~~RPs~~ell~~L~~i 353 (373)
T 3c1x_A 317 -----Q-PEYCP---DPLYEVMLKCWHPKAEMRPSFSELVSRISAI 353 (373)
T ss_dssp -----C-CTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----C-CCCCC---HHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0 11122 2456677799999999999999999999875
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=331.84 Aligned_cols=250 Identities=30% Similarity=0.413 Sum_probs=194.8
Q ss_pred hcCCccccccCCCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeC-ceEEEEEee
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEG-QELLLIYEY 293 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-~~~~lv~e~ 293 (536)
.++|++.+.||+|+||.||+++. .++.||||++.... ..+.+.+|+.++++++||||+++++++.+. +..++||||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 36899999999999999999987 48899999987543 457789999999999999999999997654 578999999
Q ss_pred cCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCC
Q 039168 294 MPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQN 373 (536)
Q Consensus 294 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 373 (536)
+++++|.+++.... ...+++..++.++.||+.||.|||+++ ++||||||+||+++.++.+||+|||++.......
T Consensus 97 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 171 (278)
T 1byg_A 97 MAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 171 (278)
T ss_dssp CTTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred CCCCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeeccccccccccc-
Confidence 99999999986432 223789999999999999999999997 9999999999999999999999999998654321
Q ss_pred ccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHHHHHhhcCCccccccccc
Q 039168 374 QANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVL 452 (536)
Q Consensus 374 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l 452 (536)
....+++.|+|||.+.+..++.++||||||+++|+|++ |+.||...... ... .....+.... .
T Consensus 172 ----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~---~~~----~~~~~~~~~~-----~ 235 (278)
T 1byg_A 172 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVV----PRVEKGYKMD-----A 235 (278)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG---GHH----HHHTTTCCCC-----C
T ss_pred ----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH---HHH----HHHhcCCCCC-----C
Confidence 12356889999999999999999999999999999998 99997643221 111 1111111111 1
Q ss_pred cCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 453 KQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 453 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
.... + ..+.+++.+||+.||++|||+.++++.|+..
T Consensus 236 ~~~~-~---~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i 271 (278)
T 1byg_A 236 PDGC-P---PAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 271 (278)
T ss_dssp CTTC-C---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cccC-C---HHHHHHHHHHhcCChhhCCCHHHHHHHHHHH
Confidence 1112 2 3456667799999999999999999999764
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=332.82 Aligned_cols=259 Identities=25% Similarity=0.335 Sum_probs=202.5
Q ss_pred hcCCccccccCCCCceeEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHHHcCCCCceeEeeEEee--CceEEE
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLE--GQELLL 289 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~--~~~~~l 289 (536)
.++|++.+.||+|+||.||++.+. +++.||+|++... .....+.+.+|+.++++++||||+++++++.. ....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 368999999999999999999976 6899999998754 33456778999999999999999999998854 578999
Q ss_pred EEeecCCCChhhhhhccc-CCCCCCHHHHHHHHHHHHHHHHHHhcCC--CCCeeeCCCCCCcEEEcCCCCeEEecccCcc
Q 039168 290 IYEYMPNKSLDVHLFDAT-RSVQLDWKRRLSIINGIARGILYLHEDS--RLKIIHRDLKASNVLLDDDMNPKISDFGTAR 366 (536)
Q Consensus 290 v~e~~~~~sL~~~l~~~~-~~~~l~~~~~~~i~~qi~~al~~LH~~~--~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 366 (536)
||||+++++|.+++.... ....+++..++.++.||+.||.|||+++ ..+|+|+||||+|||++.++.+||+|||++.
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 999999999999986533 2345899999999999999999999874 1239999999999999999999999999998
Q ss_pred ccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccc
Q 039168 367 IFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVE 446 (536)
Q Consensus 367 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 446 (536)
....... ......|++.|+|||++.+..++.++||||||+++|+|++|+.||...... .. ......+....
T Consensus 165 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~----~~~i~~~~~~~ 235 (279)
T 2w5a_A 165 ILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK---EL----AGKIREGKFRR 235 (279)
T ss_dssp HC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HH----HHHHHHTCCCC
T ss_pred eeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHH---HH----HHHHhhccccc
Confidence 7643221 122356899999999999999999999999999999999999997643211 11 11122222211
Q ss_pred cccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcc
Q 039168 447 LIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 491 (536)
Q Consensus 447 l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 491 (536)
+ .... + ..+.+++.+||+.||++|||+.+|++.+..
T Consensus 236 ~-----~~~~-~---~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 236 I-----PYRY-S---DELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp C-----CTTS-C---HHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred C-----Cccc-C---HHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 1 1111 2 345666779999999999999999987654
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=328.92 Aligned_cols=253 Identities=24% Similarity=0.402 Sum_probs=197.3
Q ss_pred HhcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEe
Q 039168 214 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 292 (536)
Q Consensus 214 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 292 (536)
..++|++.+.||+|+||.||+|.+. +++.||+|++........+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 4578999999999999999999986 489999999987766677889999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCC
Q 039168 293 YMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQ 372 (536)
Q Consensus 293 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 372 (536)
|+++++|..++... ...+++..++.++.||+.||.|||+++ ++|+||||+|||++.++.+||+|||++.......
T Consensus 97 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 171 (302)
T 2j7t_A 97 FCPGGAVDAIMLEL--DRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL 171 (302)
T ss_dssp CCTTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH
T ss_pred eCCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccccccc
Confidence 99999999988643 234899999999999999999999997 9999999999999999999999999976432111
Q ss_pred CccccccccccccccCcchh-----cCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcccc
Q 039168 373 NQANTNIIAGTYGYMAPEYA-----MGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVEL 447 (536)
Q Consensus 373 ~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 447 (536)
.......||+.|+|||++ .+..++.++||||||+++|+|++|+.||...... ....... .......
T Consensus 172 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~-~~~~~~~ 242 (302)
T 2j7t_A 172 --QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM------RVLLKIA-KSDPPTL 242 (302)
T ss_dssp --HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHH-HSCCCCC
T ss_pred --cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHH------HHHHHHh-ccCCccc
Confidence 112234689999999998 3667899999999999999999999997643221 1111111 1111111
Q ss_pred ccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 448 IDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 448 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
..+ .. . ...+.+++.+||+.||++|||+.++++
T Consensus 243 ~~~---~~-~---~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 243 LTP---SK-W---SVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp SSG---GG-S---CHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred CCc---cc-c---CHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 110 11 1 234666777999999999999999985
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=330.17 Aligned_cols=252 Identities=24% Similarity=0.389 Sum_probs=197.6
Q ss_pred HHhcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEE
Q 039168 213 EATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 291 (536)
Q Consensus 213 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 291 (536)
...++|++.+.||+|+||.||+|.+. +|+.||||++.... ..+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM 103 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence 34578999999999999999999976 48999999987543 3467889999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCC
Q 039168 292 EYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGN 371 (536)
Q Consensus 292 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 371 (536)
||+++++|.+++... ...+++..++.++.||+.||.|||+.+ ++|+||||+||+++.++.+||+|||++......
T Consensus 104 e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (314)
T 3com_A 104 EYCGAGSVSDIIRLR--NKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT 178 (314)
T ss_dssp ECCTTEEHHHHHHHH--TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred ecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence 999999999998532 345899999999999999999999997 999999999999999999999999999876543
Q ss_pred CCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcccccccc
Q 039168 372 QNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPV 451 (536)
Q Consensus 372 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 451 (536)
.. ......|++.|+|||++.+..++.++||||||+++|+|++|+.||...... ....... .........+
T Consensus 179 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~-~~~~~~~~~~- 248 (314)
T 3com_A 179 MA--KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPM------RAIFMIP-TNPPPTFRKP- 248 (314)
T ss_dssp BS--CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHH-HSCCCCCSSG-
T ss_pred cc--ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHh-cCCCcccCCc-
Confidence 22 223356899999999999999999999999999999999999997543211 1111111 1111111000
Q ss_pred ccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 452 LKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 452 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
......+.+++.+||+.||.+|||+.++++
T Consensus 249 ------~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 249 ------ELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp ------GGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ------ccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 011234666777999999999999999986
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-40 Score=347.90 Aligned_cols=252 Identities=25% Similarity=0.320 Sum_probs=199.9
Q ss_pred HhcCCccccccCCCCceeEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEE
Q 039168 214 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 290 (536)
Q Consensus 214 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 290 (536)
..++|++.++||+|+||+||++.+. +++.||||++... .......+.+|+.+|++++||||+++++++.+....++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 4578999999999999999999976 6899999998643 233457889999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEc---CCCCeEEecccCccc
Q 039168 291 YEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLD---DDMNPKISDFGTARI 367 (536)
Q Consensus 291 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~---~~~~~kl~Dfg~a~~ 367 (536)
|||+.+++|.+.+... ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+++.
T Consensus 100 ~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 173 (486)
T 3mwu_A 100 GELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (486)
T ss_dssp ECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred EEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence 9999999999888553 34899999999999999999999997 99999999999995 456799999999987
Q ss_pred cCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcccc
Q 039168 368 FGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVEL 447 (536)
Q Consensus 368 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 447 (536)
+..... .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||..... ...... ...+.....
T Consensus 174 ~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~------~~~~~~-i~~~~~~~~ 242 (486)
T 3mwu_A 174 FQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE------YDILKR-VETGKYAFD 242 (486)
T ss_dssp BCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHH-HHHTCCCSC
T ss_pred CCCCCc---cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHH-HHhCCCCCC
Confidence 653322 233579999999999876 589999999999999999999999854321 111111 111111110
Q ss_pred ccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 448 IDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 448 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
.. . ... .+ ..+.+++.+||+.||++|||+.++|+.
T Consensus 243 ~~-~-~~~-~s---~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 243 LP-Q-WRT-IS---DDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp SG-G-GGG-SC---HHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred Cc-c-cCC-CC---HHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00 0 001 12 345667779999999999999999974
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=322.59 Aligned_cols=249 Identities=24% Similarity=0.350 Sum_probs=196.6
Q ss_pred cCCccccccCCCCceeEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHHHcCCCCceeEeeEEee----CceEE
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLE----GQELL 288 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~----~~~~~ 288 (536)
..|++.+.||+|+||.||+|.+. ++..||+|++... .....+.+.+|+.++++++||||+++++++.. ....+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 45788889999999999999875 5889999998643 34456778999999999999999999999875 46789
Q ss_pred EEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEc-CCCCeEEecccCccc
Q 039168 289 LIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLD-DDMNPKISDFGTARI 367 (536)
Q Consensus 289 lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~-~~~~~kl~Dfg~a~~ 367 (536)
+||||+++++|.+++... ..+++..++.++.||+.||.|||+++ .+|+|+||||+|||++ .++.+||+|||++..
T Consensus 106 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~ 181 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEEEecCCCCHHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence 999999999999999543 34899999999999999999999873 2399999999999998 789999999999975
Q ss_pred cCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcccc
Q 039168 368 FGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVEL 447 (536)
Q Consensus 368 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 447 (536)
.... ......||+.|+|||++.+ .++.++||||||+++|+|++|+.||...... .. .......+.....
T Consensus 182 ~~~~----~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-----~~-~~~~~~~~~~~~~ 250 (290)
T 1t4h_A 182 KRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA-----AQ-IYRRVTSGVKPAS 250 (290)
T ss_dssp CCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-----HH-HHHHHTTTCCCGG
T ss_pred cccc----ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcH-----HH-HHHHHhccCCccc
Confidence 4332 2223568999999998864 5899999999999999999999998542221 11 1111111111111
Q ss_pred ccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 448 IDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 448 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
.... .+ ..+.+++.+||+.||++|||+.++++
T Consensus 251 ----~~~~-~~---~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 251 ----FDKV-AI---PEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp ----GGGC-CC---HHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ----cCCC-CC---HHHHHHHHHHccCChhhCCCHHHHhh
Confidence 1111 12 24666777999999999999999996
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=364.92 Aligned_cols=249 Identities=24% Similarity=0.288 Sum_probs=201.4
Q ss_pred HhcCCccccccCCCCceeEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHHHc-CCCCceeEeeEEeeCceEE
Q 039168 214 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLKEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELL 288 (536)
Q Consensus 214 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~ 288 (536)
..++|+++++||+|+||.||+|+++ +++.||||++.+. .....+.+..|..++..+ +||+|+++++++.+.+.+|
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 3468999999999999999999976 5889999998753 223456778899999988 7999999999999999999
Q ss_pred EEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCcccc
Q 039168 289 LIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIF 368 (536)
Q Consensus 289 lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 368 (536)
+||||+++++|..++... ..+++..++.++.||+.||.|||+++ |+||||||+||||+.++++||+|||+++..
T Consensus 419 lV~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~ 492 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 492 (674)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred EEEeCcCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeecc
Confidence 999999999999999653 34999999999999999999999997 999999999999999999999999999864
Q ss_pred CCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccc
Q 039168 369 GGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELI 448 (536)
Q Consensus 369 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 448 (536)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ....... ..... .
T Consensus 493 ~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~------~~~~~~i-~~~~~-~-- 560 (674)
T 3pfq_A 493 IWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE------DELFQSI-MEHNV-A-- 560 (674)
T ss_dssp CCTT--CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHH-HSSCC-C--
T ss_pred ccCC--cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH------HHHHHHH-HhCCC-C--
Confidence 3322 223456899999999999999999999999999999999999999864321 1111111 11111 1
Q ss_pred cccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCH-----HHHHH
Q 039168 449 DPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTM-----SSVVV 487 (536)
Q Consensus 449 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~-----~evl~ 487 (536)
+... ...++.+|+.+||+.||++||++ .+|++
T Consensus 561 ---~p~~----~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 561 ---YPKS----MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp ---CCTT----SCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred ---CCcc----CCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 1111 12346667779999999999998 77764
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=365.95 Aligned_cols=247 Identities=30% Similarity=0.418 Sum_probs=194.4
Q ss_pred cccCCCCceeEEEEEeC---CCcEEEEEEccccC--hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEeecCC
Q 039168 222 NKLGQGGFGPVYKGTLA---DGKAIAVKRLSRTS--GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPN 296 (536)
Q Consensus 222 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 296 (536)
++||+|+||.||+|.+. .++.||||++.... ....+.+.+|+++|++++|||||++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999653 46889999997543 3446789999999999999999999999864 568999999999
Q ss_pred CChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCCc-c
Q 039168 297 KSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQ-A 375 (536)
Q Consensus 297 ~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~-~ 375 (536)
++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.+...... .
T Consensus 454 g~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 527 (635)
T 4fl3_A 454 GPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 527 (635)
T ss_dssp EEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred CCHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence 9999999543 45899999999999999999999997 999999999999999999999999999877543321 2
Q ss_pred ccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHHHHHhhcCCccccccccccC
Q 039168 376 NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQ 454 (536)
Q Consensus 376 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~ 454 (536)
......+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... . .......+..... ..
T Consensus 528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~---~----~~~~i~~~~~~~~-----p~ 595 (635)
T 4fl3_A 528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---E----VTAMLEKGERMGC-----PA 595 (635)
T ss_dssp -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---H----HHHHHHTTCCCCC-----CT
T ss_pred cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH---H----HHHHHHcCCCCCC-----CC
Confidence 2223456789999999999999999999999999999998 99997543221 1 1122222222111 11
Q ss_pred CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcc
Q 039168 455 SCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 491 (536)
Q Consensus 455 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 491 (536)
.. ...+.+|+.+||+.||++|||+.+|++.|+.
T Consensus 596 ~~----~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~ 628 (635)
T 4fl3_A 596 GC----PREMYDLMNLCWTYDVENRPGFAAVELRLRN 628 (635)
T ss_dssp TC----CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred CC----CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 12 2346677779999999999999999999975
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=344.01 Aligned_cols=253 Identities=11% Similarity=0.053 Sum_probs=179.2
Q ss_pred cCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccCh---hhHHHHHHHHHHHHHc--CCCCceeEe-------eEEe
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG---QGLKEFKNEVNLIAKL--QHKNLVRLL-------GCCL 282 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l--~hpniv~l~-------~~~~ 282 (536)
..|++.+.||+|+||.||+|++. +++.||||++..... ...+.+.+|+.+++.| +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 45889999999999999999975 689999999986542 3456678886655555 599988855 4444
Q ss_pred eC-----------------ceEEEEEeecCCCChhhhhhcccCCCCCCHHHH------HHHHHHHHHHHHHHhcCCCCCe
Q 039168 283 EG-----------------QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRR------LSIINGIARGILYLHEDSRLKI 339 (536)
Q Consensus 283 ~~-----------------~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~------~~i~~qi~~al~~LH~~~~~~i 339 (536)
.. ...++||||++ ++|.+++..... .+.+..+ +.++.||++||.|||+++ |
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~---i 215 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF--VYVFRGDEGILALHILTAQLIRLAANLQSKG---L 215 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc--ccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---C
Confidence 32 34899999998 899999975432 2444555 677799999999999997 9
Q ss_pred eeCCCCCCcEEEcCCCCeEEecccCccccCCCCCccccccccccccccCcchhcC--CCCCccchHHHHHHHHHHHHhCC
Q 039168 340 IHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMG--GIFSIKSDVFSFGVLLLEIISGR 417 (536)
Q Consensus 340 vH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~ 417 (536)
+||||||+||||+.++.+||+|||+++..... .....+|+.|+|||++.+ ..++.++|||||||++|+|++|+
T Consensus 216 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~ 290 (371)
T 3q60_A 216 VHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290 (371)
T ss_dssp EETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSS
T ss_pred ccCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCC
Confidence 99999999999999999999999999865421 113456799999999987 67999999999999999999999
Q ss_pred CCCCCCCccCCchhHHHHHHHhhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 418 KNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 418 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
.||.......... +........................+.+++.+||+.||++|||+.++++
T Consensus 291 ~Pf~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 291 LPFGLVTPGIKGS--------WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp CSTTBCCTTCTTC--------CCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCCCcCcccccc--------hhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 9986543322111 0000000000000000000111234666777999999999999999974
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=326.11 Aligned_cols=248 Identities=25% Similarity=0.391 Sum_probs=193.9
Q ss_pred hcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEE
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 290 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 290 (536)
.++|++.+.||+|+||.||+|.+. +++.||||++.... ....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 368999999999999999999986 68999999986532 23456788999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCC
Q 039168 291 YEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGG 370 (536)
Q Consensus 291 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 370 (536)
|||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.+||+|||++.....
T Consensus 90 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 90 MEYVSGGELFDYICKH---GRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163 (276)
T ss_dssp EECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred EeccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCC
Confidence 9999999999998653 34899999999999999999999997 99999999999999999999999999987653
Q ss_pred CCCccccccccccccccCcchhcCCCC-CccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcccccc
Q 039168 371 NQNQANTNIIAGTYGYMAPEYAMGGIF-SIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELID 449 (536)
Q Consensus 371 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 449 (536)
... .....|++.|+|||.+.+..+ +.++||||||+++|+|++|+.||...... .. ......+.. .
T Consensus 164 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~----~~~~~~~~~-~--- 229 (276)
T 2h6d_A 164 GEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP---TL----FKKIRGGVF-Y--- 229 (276)
T ss_dssp ----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HH----HHHHHHCCC-C---
T ss_pred Ccc---eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH---HH----HHHhhcCcc-c---
Confidence 321 223468999999999988765 68999999999999999999997542211 11 111111110 0
Q ss_pred ccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 450 PVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 450 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
+... .+ ..+.+++.+||+.||++|||+.++++.
T Consensus 230 --~~~~-~~---~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 230 --IPEY-LN---RSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp --CCTT-SC---HHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred --Cchh-cC---HHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 1111 12 345667779999999999999999974
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=343.89 Aligned_cols=202 Identities=28% Similarity=0.454 Sum_probs=154.8
Q ss_pred cCCcc-ccccCCCCceeEEEEEeC---CCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEee--CceEEE
Q 039168 216 NHFSD-ENKLGQGGFGPVYKGTLA---DGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLE--GQELLL 289 (536)
Q Consensus 216 ~~~~~-~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~--~~~~~l 289 (536)
+.|++ .++||+|+||.||+|+++ +++.||||++..... ...+.+|+.+|++++||||+++++++.. ....++
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l 97 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWL 97 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence 45666 458999999999999965 578999999975432 2568899999999999999999999954 678999
Q ss_pred EEeecCCCChhhhhhccc------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEE----cCCCCeEE
Q 039168 290 IYEYMPNKSLDVHLFDAT------RSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLL----DDDMNPKI 359 (536)
Q Consensus 290 v~e~~~~~sL~~~l~~~~------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll----~~~~~~kl 359 (536)
||||+.+ +|..++.... ....+++..++.++.||+.||.|||+++ |+||||||+|||| +.++.+||
T Consensus 98 v~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 98 LFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEE
Confidence 9999975 6666664321 2234899999999999999999999997 9999999999999 67789999
Q ss_pred ecccCccccCCCCC-ccccccccccccccCcchhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCC
Q 039168 360 SDFGTARIFGGNQN-QANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFY 423 (536)
Q Consensus 360 ~Dfg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~ 423 (536)
+|||+++.+..... ........||+.|+|||++.+. .++.++|||||||++|+|++|+.||...
T Consensus 174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 239 (405)
T 3rgf_A 174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 239 (405)
T ss_dssp CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCC
T ss_pred EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCc
Confidence 99999987654321 1223346789999999999874 5899999999999999999999998653
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=331.84 Aligned_cols=258 Identities=29% Similarity=0.390 Sum_probs=195.5
Q ss_pred hcCCccccccCCCCceeEEEEEeC--CCc--EEEEEEcccc---ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceE
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA--DGK--AIAVKRLSRT---SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQEL 287 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~--~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 287 (536)
.++|++.+.||+|+||.||+|++. +++ .||||++... .....+.+.+|+.++++++||||+++++++.... .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 468999999999999999999853 233 6899998754 3345678899999999999999999999998765 8
Q ss_pred EEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccc
Q 039168 288 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARI 367 (536)
Q Consensus 288 ~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 367 (536)
++||||+.+++|.+++.... ..+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.+||+|||++..
T Consensus 96 ~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp EEEEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeEecccCCCHHHHHHhcc--CCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccccc
Confidence 99999999999999986532 45899999999999999999999997 99999999999999999999999999987
Q ss_pred cCCCCCcc-ccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHHHHHhhcCCcc
Q 039168 368 FGGNQNQA-NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGHAV 445 (536)
Q Consensus 368 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 445 (536)
........ ......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||...... .............
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~~~~~~~~~~~~~ 244 (291)
T 1u46_A 171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS------QILHKIDKEGERL 244 (291)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHHHTSCCCC
T ss_pred ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH------HHHHHHHccCCCC
Confidence 75433221 2223457889999999998889999999999999999999 99997543221 1111111111111
Q ss_pred ccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccCC
Q 039168 446 ELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDS 493 (536)
Q Consensus 446 ~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 493 (536)
. .... . ...+.+++.+||+.||++|||+.++++.|+...
T Consensus 245 ~-----~~~~-~---~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 283 (291)
T 1u46_A 245 P-----RPED-C---PQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283 (291)
T ss_dssp C-----CCTT-C---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred C-----CCcC-c---CHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence 1 1111 1 234666777999999999999999999998753
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=332.84 Aligned_cols=253 Identities=23% Similarity=0.358 Sum_probs=194.1
Q ss_pred HhcCCccccccCCCCceeEEEEEeCCCcEEEEEEcccc--ChhhHHHHHHHHHHHHHcC--CCCceeEeeEEeeCceEEE
Q 039168 214 ATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRT--SGQGLKEFKNEVNLIAKLQ--HKNLVRLLGCCLEGQELLL 289 (536)
Q Consensus 214 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--hpniv~l~~~~~~~~~~~l 289 (536)
..++|++.+.||+|+||.||++.+.+++.||||++... .....+.+.+|+.++++++ ||||+++++++...+..++
T Consensus 26 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 105 (313)
T 3cek_A 26 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 105 (313)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEE
T ss_pred ccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEE
Confidence 34689999999999999999999988999999998643 3445678899999999997 4999999999999999999
Q ss_pred EEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccC
Q 039168 290 IYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFG 369 (536)
Q Consensus 290 v~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 369 (536)
||| +.+++|.+++... ..+++..++.++.||++||.|||+++ |+||||||+|||+++ +.+||+|||++....
T Consensus 106 v~e-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~ 177 (313)
T 3cek_A 106 VME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGIANQMQ 177 (313)
T ss_dssp EEC-CCSEEHHHHHHHC---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSSSCC--
T ss_pred EEe-cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeecccccccc
Confidence 999 6688999998643 35899999999999999999999996 999999999999965 899999999998765
Q ss_pred CCCCccccccccccccccCcchhcC-----------CCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHH
Q 039168 370 GNQNQANTNIIAGTYGYMAPEYAMG-----------GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKL 438 (536)
Q Consensus 370 ~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 438 (536)
............||+.|+|||++.+ ..++.++||||||+++|+|++|+.||...... .......
T Consensus 178 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-----~~~~~~~ 252 (313)
T 3cek_A 178 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----ISKLHAI 252 (313)
T ss_dssp ------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-----HHHHHHH
T ss_pred CccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH-----HHHHHHH
Confidence 4433333344578999999999876 46889999999999999999999997543211 1111111
Q ss_pred hhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 439 WCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 439 ~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
........ .. ...+ ..+.+++.+||+.||++|||+.++++.
T Consensus 253 ~~~~~~~~-----~~-~~~~---~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 253 IDPNHEIE-----FP-DIPE---KDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp HCTTSCCC-----CC-CCSC---HHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HhcccccC-----Cc-ccch---HHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 11111111 11 1112 345666779999999999999999964
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=347.31 Aligned_cols=242 Identities=16% Similarity=0.167 Sum_probs=187.1
Q ss_pred hcCCccccccCCCCceeEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHH---HHHHHcCCCCceeEe-------eE
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLKEFKNEV---NLIAKLQHKNLVRLL-------GC 280 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~---~~l~~l~hpniv~l~-------~~ 280 (536)
.++|++.+.||+|+||.||+|++. +|+.||||++... .....+.+.+|+ +++++++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 367899999999999999999974 6999999998733 344567889999 555666899999998 66
Q ss_pred EeeCc-----------------eEEEEEeecCCCChhhhhhcccC----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCe
Q 039168 281 CLEGQ-----------------ELLLIYEYMPNKSLDVHLFDATR----SVQLDWKRRLSIINGIARGILYLHEDSRLKI 339 (536)
Q Consensus 281 ~~~~~-----------------~~~lv~e~~~~~sL~~~l~~~~~----~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i 339 (536)
+...+ ..++||||+ +|+|.+++..... ...+++..++.++.||+.||.|||+++ |
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 66553 389999999 6899999965322 112345888899999999999999997 9
Q ss_pred eeCCCCCCcEEEcCCCCeEEecccCccccCCCCCccccccccccccccCcchhcCC-----------CCCccchHHHHHH
Q 039168 340 IHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGG-----------IFSIKSDVFSFGV 408 (536)
Q Consensus 340 vH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DvwslG~ 408 (536)
+||||||+||||+.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 9999999999999999999999999986332 2234567 999999999887 8999999999999
Q ss_pred HHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 409 LLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 409 il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
++|||++|+.||.......... .+... ... .+ ..+.+++.+||+.||++|||+.++++
T Consensus 302 il~elltg~~Pf~~~~~~~~~~---------------~~~~~--~~~-~~---~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 302 VIYWIWCADLPITKDAALGGSE---------------WIFRS--CKN-IP---QPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHHSSCCC------CCSG---------------GGGSS--CCC-CC---HHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHHCCCCCcccccccchh---------------hhhhh--ccC-CC---HHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 9999999999985432211100 00000 011 22 34566677999999999999999985
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=326.95 Aligned_cols=253 Identities=24% Similarity=0.293 Sum_probs=200.8
Q ss_pred HHhcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC---------hhhHHHHHHHHHHHHHcC-CCCceeEeeEE
Q 039168 213 EATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---------GQGLKEFKNEVNLIAKLQ-HKNLVRLLGCC 281 (536)
Q Consensus 213 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-hpniv~l~~~~ 281 (536)
...++|++.+.||+|+||.||+|.++ +++.||||++.... ....+.+.+|+.+++++. ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 34578999999999999999999986 58999999986543 123456789999999995 99999999999
Q ss_pred eeCceEEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEec
Q 039168 282 LEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISD 361 (536)
Q Consensus 282 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~D 361 (536)
...+..++||||+++++|.+++... ..+++..++.++.||+.||.|||+++ ++|+||||+||+++.++.+||+|
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~d 167 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTD 167 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECC
T ss_pred ccCCeEEEEEeccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEec
Confidence 9999999999999999999998643 35899999999999999999999997 99999999999999999999999
Q ss_pred ccCccccCCCCCccccccccccccccCcchhc------CCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHH
Q 039168 362 FGTARIFGGNQNQANTNIIAGTYGYMAPEYAM------GGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYT 435 (536)
Q Consensus 362 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~ 435 (536)
||++........ .....|++.|+|||++. ...++.++||||||+++|+|++|+.||...... ...
T Consensus 168 fg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~ 238 (298)
T 1phk_A 168 FGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM------LML 238 (298)
T ss_dssp CTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHH
T ss_pred ccchhhcCCCcc---cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHH------HHH
Confidence 999987653322 23356899999999985 456889999999999999999999997542211 111
Q ss_pred HHHhhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 436 WKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 436 ~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
.....+.... ..+. .......+.+++.+||+.||++|||+.++++
T Consensus 239 -~~~~~~~~~~-~~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 239 -RMIMSGNYQF-GSPE-----WDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp -HHHHHTCCCC-CTTT-----GGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred -HHHhcCCccc-Cccc-----ccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 1111111110 0000 0111234667777999999999999999986
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-41 Score=344.15 Aligned_cols=261 Identities=23% Similarity=0.301 Sum_probs=192.6
Q ss_pred HHhcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEee--------
Q 039168 213 EATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLE-------- 283 (536)
Q Consensus 213 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-------- 283 (536)
...++|++.++||+|+||.||+|.+. +++.||||++..... ...+|+.+|+.++||||+++++++..
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 79 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP 79 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence 34578999999999999999999874 689999999865432 23479999999999999999999843
Q ss_pred ------------------------------CceEEEEEeecCCCChhhhhhcc-cCCCCCCHHHHHHHHHHHHHHHHHHh
Q 039168 284 ------------------------------GQELLLIYEYMPNKSLDVHLFDA-TRSVQLDWKRRLSIINGIARGILYLH 332 (536)
Q Consensus 284 ------------------------------~~~~~lv~e~~~~~sL~~~l~~~-~~~~~l~~~~~~~i~~qi~~al~~LH 332 (536)
....++||||+++ +|.+.+... .....+++..++.++.||++||.|||
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 158 (383)
T 3eb0_A 80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH 158 (383)
T ss_dssp ------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 3458999999984 777666542 23456999999999999999999999
Q ss_pred cCCCCCeeeCCCCCCcEEEc-CCCCeEEecccCccccCCCCCccccccccccccccCcchhcCCC-CCccchHHHHHHHH
Q 039168 333 EDSRLKIIHRDLKASNVLLD-DDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGI-FSIKSDVFSFGVLL 410 (536)
Q Consensus 333 ~~~~~~ivH~Dikp~NIll~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il 410 (536)
+++ |+||||||+|||++ .++.+||+|||+++.+..... .....||+.|+|||++.+.. ++.++|||||||++
T Consensus 159 ~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 232 (383)
T 3eb0_A 159 SLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232 (383)
T ss_dssp TTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred HCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence 997 99999999999998 688999999999987644332 22346799999999998754 89999999999999
Q ss_pred HHHHhCCCCCCCCCccCCchhHHHHHHHhhcC----------CccccccccccC-----CCCHHHHHHHHHHHHhhcCCC
Q 039168 411 LEIISGRKNNGFYFSEHGQTLLTYTWKLWCEG----------HAVELIDPVLKQ-----SCAPDELLKFIHIGLLCVQQD 475 (536)
Q Consensus 411 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~----------~~~~l~~~~l~~-----~~~~~~~~~l~~li~~cl~~d 475 (536)
|+|++|+.||....... ............ ...+..-+.... ..+......+.+++.+||+.|
T Consensus 233 ~ell~g~~pf~~~~~~~---~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 309 (383)
T 3eb0_A 233 GELILGKPLFSGETSID---QLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYE 309 (383)
T ss_dssp HHHHHSSCSSCCSSHHH---HHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSS
T ss_pred HHHHhCCCCCCCCChHH---HHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCC
Confidence 99999999986432211 111111111000 000000000000 001111234667777999999
Q ss_pred CCCCCCHHHHHH
Q 039168 476 PADRPTMSSVVV 487 (536)
Q Consensus 476 P~~RPt~~evl~ 487 (536)
|++|||+.|+++
T Consensus 310 P~~R~t~~e~l~ 321 (383)
T 3eb0_A 310 PDLRINPYEAMA 321 (383)
T ss_dssp GGGSCCHHHHHT
T ss_pred hhhCCCHHHHhc
Confidence 999999999984
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=339.90 Aligned_cols=269 Identities=20% Similarity=0.264 Sum_probs=195.6
Q ss_pred hhhHHHHhcCCccccccCCCCceeEEEEEeCCCcEEEEEEccccC-----------hhhHHHHHHHHHHHHHcCCCCcee
Q 039168 208 LGLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTS-----------GQGLKEFKNEVNLIAKLQHKNLVR 276 (536)
Q Consensus 208 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-----------~~~~~~~~~E~~~l~~l~hpniv~ 276 (536)
...+....++|++.+.||+|+||.||+|.+.+++.||||++.... ....+.+.+|+.++++++||||++
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 93 (362)
T 3pg1_A 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG 93 (362)
T ss_dssp HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence 345566789999999999999999999998889999999986432 122477899999999999999999
Q ss_pred EeeEEee-----CceEEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEE
Q 039168 277 LLGCCLE-----GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLL 351 (536)
Q Consensus 277 l~~~~~~-----~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll 351 (536)
+++++.. ....++||||+. ++|..++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||+
T Consensus 94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~ 167 (362)
T 3pg1_A 94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD--QRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILL 167 (362)
T ss_dssp CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEE
T ss_pred eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEEE
Confidence 9999854 346899999998 577777653 3345899999999999999999999997 9999999999999
Q ss_pred cCCCCeEEecccCccccCCCCCccccccccccccccCcchhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCch
Q 039168 352 DDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQT 430 (536)
Q Consensus 352 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~ 430 (536)
+.++.+||+|||+++...... ......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||...... .
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~ 241 (362)
T 3pg1_A 168 ADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY---N 241 (362)
T ss_dssp CTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---H
T ss_pred cCCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHH---H
Confidence 999999999999997543322 2233568999999999987 67899999999999999999999998643211 1
Q ss_pred hHHHHHHHhhcCCcc-----------cccccccc---CC----CCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 431 LLTYTWKLWCEGHAV-----------ELIDPVLK---QS----CAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 431 ~~~~~~~~~~~~~~~-----------~l~~~~l~---~~----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
............... ..+...+. .. ..+.....+.+++.+||+.||++|||+.++++.
T Consensus 242 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 242 QLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp HHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 111111111000000 00000000 00 001112346677789999999999999999964
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=350.59 Aligned_cols=251 Identities=25% Similarity=0.343 Sum_probs=195.7
Q ss_pred HhcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC--hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEE
Q 039168 214 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 290 (536)
Q Consensus 214 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 290 (536)
..++|++.++||+|+||.||+|+++ ++..||||++.... ......+.+|+.+++.++||||+++++++.+....++|
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 114 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3467999999999999999999986 58999999987543 33356789999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCC---CCeEEecccCccc
Q 039168 291 YEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDD---MNPKISDFGTARI 367 (536)
Q Consensus 291 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~---~~~kl~Dfg~a~~ 367 (536)
|||+.+++|.+.+... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.. +.+||+|||++..
T Consensus 115 ~e~~~~g~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~ 188 (494)
T 3lij_A 115 MECYKGGELFDEIIHR---MKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAV 188 (494)
T ss_dssp EECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence 9999999998888543 34899999999999999999999997 9999999999999764 4599999999987
Q ss_pred cCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcccc
Q 039168 368 FGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVEL 447 (536)
Q Consensus 368 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 447 (536)
+..... .....||+.|+|||++. ..++.++|||||||++|+|++|+.||...... .... . ...+....
T Consensus 189 ~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~---~-i~~~~~~~- 256 (494)
T 3lij_A 189 FENQKK---MKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ---EILR---K-VEKGKYTF- 256 (494)
T ss_dssp CBTTBC---BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH---H-HHHTCCCC-
T ss_pred CCCCcc---ccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH---HHHH---H-HHhCCCCC-
Confidence 654322 23457999999999986 46899999999999999999999998643221 1111 1 11111110
Q ss_pred ccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 448 IDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 448 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
..+ .... .+ ..+.+++.+||+.||.+|||+.++|+
T Consensus 257 ~~~-~~~~-~s---~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 257 DSP-EWKN-VS---EGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp CSG-GGTT-SC---HHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred Cch-hccc-CC---HHHHHHHHHHCCCChhhCccHHHHhc
Confidence 011 0111 12 23556677999999999999999984
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=349.21 Aligned_cols=258 Identities=25% Similarity=0.325 Sum_probs=190.3
Q ss_pred cCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeC------ceEE
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEG------QELL 288 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~------~~~~ 288 (536)
.+|++.++||+|+||.||+|++. +++.||||++..... ...+|+++|++++||||+++++++... ..++
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 47999999999999999999986 589999999865432 234799999999999999999998542 2477
Q ss_pred EEEeecCCCChhhhhhc-ccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCC-CCeEEecccCcc
Q 039168 289 LIYEYMPNKSLDVHLFD-ATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDD-MNPKISDFGTAR 366 (536)
Q Consensus 289 lv~e~~~~~sL~~~l~~-~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~-~~~kl~Dfg~a~ 366 (536)
+||||+++ +|...+.. ......+++..++.++.||++||.|||+++ |+||||||+||||+.+ +.+||+|||+++
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 99999986 45444432 233456999999999999999999999986 9999999999999965 568999999998
Q ss_pred ccCCCCCccccccccccccccCcchhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhh-----
Q 039168 367 IFGGNQNQANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWC----- 440 (536)
Q Consensus 367 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~----- 440 (536)
.+..... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||...... ..+........
T Consensus 206 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~---~~l~~i~~~lg~p~~~ 279 (420)
T 1j1b_A 206 QLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV---DQLVEIIKVLGTPTRE 279 (420)
T ss_dssp ECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHHCSCCHH
T ss_pred hcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCCCHH
Confidence 7643322 2235689999999999775 6899999999999999999999998643221 11111111110
Q ss_pred -----cCCccccccccccCC-----CCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 441 -----EGHAVELIDPVLKQS-----CAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 441 -----~~~~~~l~~~~l~~~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
.....+..-+.+... ..+.....+.+|+.+||+.||.+|||+.|+++
T Consensus 280 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 280 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp HHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 000001000000000 01111245677778999999999999999985
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-40 Score=335.61 Aligned_cols=259 Identities=25% Similarity=0.288 Sum_probs=190.4
Q ss_pred hcCCccccccCCCCceeEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCc------
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQ------ 285 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~------ 285 (536)
.++|++.+.||+|+||.||+|.+. +++.||||++... .....+.+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 468999999999999999999875 5899999998753 3345567889999999999999999999998664
Q ss_pred eEEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCc
Q 039168 286 ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTA 365 (536)
Q Consensus 286 ~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 365 (536)
..++||||+++ +|.+.+. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 174 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 174 (371)
T ss_dssp EEEEEEECCSE-EHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred ceEEEEEcCCC-CHHHHHh-----hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecc
Confidence 78999999975 5666663 23889999999999999999999997 999999999999999999999999999
Q ss_pred cccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHH--------
Q 039168 366 RIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWK-------- 437 (536)
Q Consensus 366 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~-------- 437 (536)
+...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||....... .......
T Consensus 175 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~ 248 (371)
T 2xrw_A 175 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID---QWNKVIEQLGTPCPE 248 (371)
T ss_dssp ------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHC-CCCCCHH
T ss_pred ccccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCCHH
Confidence 8654322 1223578999999999999999999999999999999999999986432211 0000000
Q ss_pred ----------HhhcCCc-------cccccccccCCC---CHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 438 ----------LWCEGHA-------VELIDPVLKQSC---APDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 438 ----------~~~~~~~-------~~l~~~~l~~~~---~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
.+..... ..++........ .......+.+++.+||+.||++|||+.++++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 249 FMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp HHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 0000000 000000000000 01124567788889999999999999999964
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=349.81 Aligned_cols=252 Identities=25% Similarity=0.335 Sum_probs=198.4
Q ss_pred HhcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccCh-------------hhHHHHHHHHHHHHHcCCCCceeEee
Q 039168 214 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG-------------QGLKEFKNEVNLIAKLQHKNLVRLLG 279 (536)
Q Consensus 214 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~hpniv~l~~ 279 (536)
..++|++.++||+|+||.||+|.+. +++.||||++..... ...+.+.+|+.+|++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 4578999999999999999999976 588999999865421 33567889999999999999999999
Q ss_pred EEeeCceEEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCC---C
Q 039168 280 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDM---N 356 (536)
Q Consensus 280 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~---~ 356 (536)
++.+....++||||+++++|.+.+... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++ .
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~ 187 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINR---HKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLN 187 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSS
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCcc
Confidence 999999999999999999999888543 34899999999999999999999997 99999999999999776 6
Q ss_pred eEEecccCccccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHH
Q 039168 357 PKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTW 436 (536)
Q Consensus 357 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~ 436 (536)
+||+|||++..+..... .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||...... ...
T Consensus 188 ~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~---- 256 (504)
T 3q5i_A 188 IKIVDFGLSSFFSKDYK---LRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ---DII---- 256 (504)
T ss_dssp EEECCCTTCEECCTTSC---BCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH----
T ss_pred EEEEECCCCEEcCCCCc---cccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHH---HHH----
Confidence 99999999987654322 233579999999999874 6899999999999999999999998643221 111
Q ss_pred HHhhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 437 KLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 437 ~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
.....+.... ....... .+ ..+.+++.+||+.||.+|||+.++|+.
T Consensus 257 ~~i~~~~~~~--~~~~~~~-~s---~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 257 KKVEKGKYYF--DFNDWKN-IS---DEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp HHHHHCCCCC--CHHHHTT-SC---HHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHcCCCCC--CccccCC-CC---HHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 1111111110 0000011 12 346667779999999999999999853
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=351.37 Aligned_cols=251 Identities=25% Similarity=0.323 Sum_probs=201.6
Q ss_pred HhcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEE
Q 039168 214 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 289 (536)
Q Consensus 214 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 289 (536)
..++|++.++||+|+||.||++... +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 3568999999999999999999986 68999999986432 3456789999999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEE---cCCCCeEEecccCcc
Q 039168 290 IYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLL---DDDMNPKISDFGTAR 366 (536)
Q Consensus 290 v~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll---~~~~~~kl~Dfg~a~ 366 (536)
||||+.+++|.+.+... ..+++..++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||++.
T Consensus 104 v~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 177 (484)
T 3nyv_A 104 VGEVYTGGELFDEIISR---KRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLST 177 (484)
T ss_dssp EECCCCSCBHHHHHHTC---SCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred EEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence 99999999999888543 45899999999999999999999997 9999999999999 567899999999998
Q ss_pred ccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccc
Q 039168 367 IFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVE 446 (536)
Q Consensus 367 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 446 (536)
.+..... .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||...... ..... ...+....
T Consensus 178 ~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~~~-i~~~~~~~ 246 (484)
T 3nyv_A 178 HFEASKK---MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEY------DILKK-VEKGKYTF 246 (484)
T ss_dssp HBCCCCS---HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHH-HHHCCCCC
T ss_pred Ecccccc---cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH------HHHHH-HHcCCCCC
Confidence 7654322 233579999999999876 6899999999999999999999998643221 11111 11111111
Q ss_pred cccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 447 LIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 447 l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
.. +. . ......+.+++.+||+.||++|||+.++|+
T Consensus 247 ~~-~~-~----~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 247 EL-PQ-W----KKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp CS-GG-G----GGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CC-cc-c----ccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 00 00 0 011234566777999999999999999995
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=335.74 Aligned_cols=257 Identities=25% Similarity=0.323 Sum_probs=182.0
Q ss_pred hcCCccccccCCCCceeEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeC------c
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEG------Q 285 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~------~ 285 (536)
.++|++.+.||+|+||.||+|.+. +|+.||||++... .....+.+.+|+.+|+.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 478999999999999999999864 6899999998653 334567788999999999999999999999754 5
Q ss_pred eEEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCc
Q 039168 286 ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTA 365 (536)
Q Consensus 286 ~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 365 (536)
..++|+|++ +++|..++.. ..+++..++.++.||++||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a 179 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA 179 (367)
T ss_dssp CCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC----
T ss_pred eEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecccc
Confidence 689999999 7889888743 35899999999999999999999997 999999999999999999999999999
Q ss_pred cccCCCCCccccccccccccccCcchhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCc
Q 039168 366 RIFGGNQNQANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHA 444 (536)
Q Consensus 366 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 444 (536)
+..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...... ..............
T Consensus 180 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~l~~i~~~~g~p~- 250 (367)
T 2fst_X 180 RHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI---DQLKLILRLVGTPG- 250 (367)
T ss_dssp ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCSCC-
T ss_pred cccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCCC-
Confidence 865422 223578999999999987 67899999999999999999999998653321 11111111110000
Q ss_pred cccccc-----------ccc--CCCCH-----HHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 445 VELIDP-----------VLK--QSCAP-----DELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 445 ~~l~~~-----------~l~--~~~~~-----~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
.+.+.. .+. ..... .....+.+|+.+||+.||++|||+.++|+.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 251 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 000000 000 00000 012346677779999999999999999964
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=331.12 Aligned_cols=262 Identities=23% Similarity=0.320 Sum_probs=192.3
Q ss_pred hcCCccccccCCCCceeEEEEEeCC-CcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEe-----------
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCL----------- 282 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~----------- 282 (536)
.++|++.+.||+|+||.||+|.+.. ++.||||++........+.+.+|+.++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 4689999999999999999999864 8999999998777777788999999999999999999999873
Q ss_pred ---eCceEEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEc-CCCCeE
Q 039168 283 ---EGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLD-DDMNPK 358 (536)
Q Consensus 283 ---~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~-~~~~~k 358 (536)
+....++||||++ ++|.+++.. ..+++..++.++.||+.||.|||+++ |+||||||+|||++ +++.+|
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k 161 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQ----GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLK 161 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEE
T ss_pred cccccCceeEEeeccC-CCHHHHhhc----CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEE
Confidence 4478999999998 589888842 35899999999999999999999997 99999999999997 567999
Q ss_pred EecccCccccCCCCC-ccccccccccccccCcchhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHH
Q 039168 359 ISDFGTARIFGGNQN-QANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTW 436 (536)
Q Consensus 359 l~Dfg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~ 436 (536)
|+|||+++....... ........+|+.|+|||.+.+ ..++.++||||||+++|+|++|+.||....... ......
T Consensus 162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~---~~~~~~ 238 (320)
T 2i6l_A 162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELE---QMQLIL 238 (320)
T ss_dssp ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHH
T ss_pred EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHH---HHHHHH
Confidence 999999987643221 122233467899999998876 678999999999999999999999986433211 111110
Q ss_pred HHhhc----------CCcccccccccc-CCCC-----HHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 437 KLWCE----------GHAVELIDPVLK-QSCA-----PDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 437 ~~~~~----------~~~~~l~~~~l~-~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
..... ......+..... .... +.....+.+++.+||+.||++|||+.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 239 ESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp HHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 00000 000000000000 0000 011234667777999999999999999986
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=330.90 Aligned_cols=252 Identities=24% Similarity=0.309 Sum_probs=194.5
Q ss_pred HhcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccCh--------hhHHHHHHHHHHHHHcCCCCceeEeeEEeeC
Q 039168 214 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG--------QGLKEFKNEVNLIAKLQHKNLVRLLGCCLEG 284 (536)
Q Consensus 214 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~ 284 (536)
..++|++.+.||+|+||.||+|.+. +++.||||++..... .....+.+|+.++++++||||+++++++..+
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 4578999999999999999999975 588999999865321 2234578999999999999999999998765
Q ss_pred ceEEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCC---eEEec
Q 039168 285 QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMN---PKISD 361 (536)
Q Consensus 285 ~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~---~kl~D 361 (536)
. .++||||+++++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++. +||+|
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~D 160 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVG---NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITD 160 (322)
T ss_dssp S-EEEEEECCTTEETHHHHST---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECC
T ss_pred c-eEEEEecCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEcc
Confidence 5 8999999999999988853 345899999999999999999999997 999999999999987664 99999
Q ss_pred ccCccccCCCCCccccccccccccccCcchhc---CCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHH
Q 039168 362 FGTARIFGGNQNQANTNIIAGTYGYMAPEYAM---GGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKL 438 (536)
Q Consensus 362 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 438 (536)
||++....... ......||+.|+|||++. ...++.++||||||+++|+|++|+.||....... .+....
T Consensus 161 fg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~--- 232 (322)
T 2ycf_A 161 FGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKDQI--- 232 (322)
T ss_dssp CTTCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS--CHHHHH---
T ss_pred Cccceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH--HHHHHH---
Confidence 99998764321 123356899999999974 4668999999999999999999999986433221 111111
Q ss_pred hhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 439 WCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 439 ~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
..+.... .+...... ...+.+++.+||+.||++|||+.++++
T Consensus 233 -~~~~~~~--~~~~~~~~----~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 233 -TSGKYNF--IPEVWAEV----SEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp -HHTCCCC--CHHHHTTS----CHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -HhCcccc--Cchhhhhc----CHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 1111110 01111111 234667777999999999999999984
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=332.31 Aligned_cols=263 Identities=21% Similarity=0.304 Sum_probs=198.6
Q ss_pred hcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC-hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeC-----ceE
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEG-----QEL 287 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-----~~~ 287 (536)
..+|++.+.||+|+||.||+|.+. +++.||||++.... ....+.+.+|++++++++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 468999999999999999999975 58899999997543 34457788999999999999999999999754 478
Q ss_pred EEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccc
Q 039168 288 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARI 367 (536)
Q Consensus 288 ~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 367 (536)
++||||+.+ +|..++.. ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 106 ~iv~e~~~~-~L~~~l~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 177 (364)
T 3qyz_A 106 YIVQDLMET-DLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 177 (364)
T ss_dssp EEEEECCSE-EHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEcccCc-CHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEe
Confidence 999999974 88887743 34899999999999999999999997 99999999999999999999999999987
Q ss_pred cCCCCCcc-ccccccccccccCcchhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcc
Q 039168 368 FGGNQNQA-NTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAV 445 (536)
Q Consensus 368 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 445 (536)
........ ......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||....... ...............
T Consensus 178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~~~i~~~~~~~~~~ 254 (364)
T 3qyz_A 178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD---QLNHILGILGSPSQE 254 (364)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGG---HHHHHHHHHCSCCHH
T ss_pred cCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHH---HHHHHHHHhCCCCHH
Confidence 65332211 1234578999999998765 458999999999999999999999986543222 111111110000000
Q ss_pred cc---c--------cc-cccCCCC-----HHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 446 EL---I--------DP-VLKQSCA-----PDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 446 ~l---~--------~~-~l~~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
.+ . .. ....... +.....+.+++.+||+.||++|||+.++++.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 255 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00 0 00 0000000 0112346777789999999999999999963
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-40 Score=333.37 Aligned_cols=268 Identities=22% Similarity=0.259 Sum_probs=187.7
Q ss_pred HHHHhcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCce---
Q 039168 211 ALEATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQE--- 286 (536)
Q Consensus 211 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~--- 286 (536)
.....++|++.+.||+|+||.||+|++. +++.||||++.... .....+.+|++.++.++||||+++++++.....
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~ 96 (360)
T 3e3p_A 18 SRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDR 96 (360)
T ss_dssp HHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCT
T ss_pred chhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccccc
Confidence 3456689999999999999999999985 58999999986543 223456778889999999999999999975433
Q ss_pred ----EEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHh--cCCCCCeeeCCCCCCcEEEcC-CCCeEE
Q 039168 287 ----LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLH--EDSRLKIIHRDLKASNVLLDD-DMNPKI 359 (536)
Q Consensus 287 ----~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH--~~~~~~ivH~Dikp~NIll~~-~~~~kl 359 (536)
.++||||++++.+..+.........+++..++.++.||+.||.||| +++ |+||||||+|||++. ++.+||
T Consensus 97 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~kl 173 (360)
T 3e3p_A 97 RDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTLKL 173 (360)
T ss_dssp TCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEEEE
T ss_pred cceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcEEE
Confidence 8999999987544333322334556899999999999999999999 776 999999999999996 899999
Q ss_pred ecccCccccCCCCCccccccccccccccCcchhcCCC-CCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHH
Q 039168 360 SDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKL 438 (536)
Q Consensus 360 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 438 (536)
+|||+++.+..... .....||+.|+|||++.+.. ++.++||||||+++|+|++|+.||....... ........
T Consensus 174 ~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~---~~~~~~~~ 247 (360)
T 3e3p_A 174 CDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAG---QLHEIVRV 247 (360)
T ss_dssp CCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHH
T ss_pred eeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHH---HHHHHHHH
Confidence 99999987654332 22346899999999997655 8999999999999999999999986532211 11111111
Q ss_pred hhcC-----------C-ccccccc------cccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 439 WCEG-----------H-AVELIDP------VLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 439 ~~~~-----------~-~~~l~~~------~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
.... . .....+. .............+.+++.+||+.||++|||+.++++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 248 LGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp HCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred cCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0000 0 0000000 00001111123467778889999999999999999963
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=330.78 Aligned_cols=253 Identities=26% Similarity=0.412 Sum_probs=194.3
Q ss_pred HHhcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHHc-CCCCceeEeeEEee------C
Q 039168 213 EATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLKEFKNEVNLIAKL-QHKNLVRLLGCCLE------G 284 (536)
Q Consensus 213 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~------~ 284 (536)
...++|++.+.||+|+||.||+|++. +++.||||++.... ...+.+.+|+.+++++ +||||+++++++.. .
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~ 99 (326)
T 2x7f_A 21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 99 (326)
T ss_dssp CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCC
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcccc
Confidence 34678999999999999999999975 68999999986543 2346788999999999 89999999999987 5
Q ss_pred ceEEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccC
Q 039168 285 QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGT 364 (536)
Q Consensus 285 ~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~ 364 (536)
+..++||||+++++|.+++.... ...+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.+||+|||+
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~ 175 (326)
T 2x7f_A 100 DQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGV 175 (326)
T ss_dssp CEEEEEEECCTTEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCTT
T ss_pred ceEEEEEEcCCCCcHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEEeeCcC
Confidence 68999999999999999986532 345899999999999999999999997 99999999999999999999999999
Q ss_pred ccccCCCCCccccccccccccccCcchhc-----CCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHh
Q 039168 365 ARIFGGNQNQANTNIIAGTYGYMAPEYAM-----GGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLW 439 (536)
Q Consensus 365 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 439 (536)
+........ ......||+.|+|||++. +..++.++||||||+++|+|++|+.||...... .......
T Consensus 176 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~ 247 (326)
T 2x7f_A 176 SAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM------RALFLIP 247 (326)
T ss_dssp TC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHH
T ss_pred ceecCcCcc--ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH------HHHHHhh
Confidence 987643221 223356899999999997 566899999999999999999999997532211 1111111
Q ss_pred hcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 440 CEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 440 ~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
. ..... +.....+. .+.+++.+||+.||.+|||+.++++
T Consensus 248 ~-~~~~~-----~~~~~~~~---~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 248 R-NPAPR-----LKSKKWSK---KFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp H-SCCCC-----CSCSCSCH---HHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred c-Ccccc-----CCccccCH---HHHHHHHHHhccChhhCCCHHHHhh
Confidence 1 11111 11111223 4556667999999999999999996
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=326.84 Aligned_cols=252 Identities=24% Similarity=0.330 Sum_probs=184.8
Q ss_pred hcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccCh--hhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEE
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG--QGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 291 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 291 (536)
.++|++.+.||+|+||.||++.+. +++.||||++..... ...+.+.++...++.++||||+++++++.+.+..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 468999999999999999999974 689999999975422 22334455666688899999999999999999999999
Q ss_pred eecCCCChhhhhhcc-cCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCeeeCCCCCCcEEEcCCCCeEEecccCccccC
Q 039168 292 EYMPNKSLDVHLFDA-TRSVQLDWKRRLSIINGIARGILYLHED-SRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFG 369 (536)
Q Consensus 292 e~~~~~sL~~~l~~~-~~~~~l~~~~~~~i~~qi~~al~~LH~~-~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 369 (536)
||+++ +|.+++... .....+++..++.++.||+.||.|||++ + |+||||||+|||++.++++||+|||++....
T Consensus 86 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 86 ELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp ECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred ehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 99975 777766432 2345699999999999999999999997 7 9999999999999999999999999998764
Q ss_pred CCCCccccccccccccccCcchh----cCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcc
Q 039168 370 GNQNQANTNIIAGTYGYMAPEYA----MGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAV 445 (536)
Q Consensus 370 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 445 (536)
.... .....||+.|+|||++ .+..++.++||||||+++|+|++|+.||...... ............ .
T Consensus 162 ~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~-~ 232 (290)
T 3fme_A 162 DDVA---KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP-----FQQLKQVVEEPS-P 232 (290)
T ss_dssp -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCH-----HHHHHHHHHSCC-C
T ss_pred cccc---ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCch-----HHHHHHHhccCC-C
Confidence 3322 2234689999999996 4567899999999999999999999998643221 111111111111 1
Q ss_pred ccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 446 ELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 446 ~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
.. .....+ ..+.+++.+||+.||++|||+.++++
T Consensus 233 ~~-----~~~~~~---~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 233 QL-----PADKFS---AEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp CC-----CTTTSC---HHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred Cc-----ccccCC---HHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 11 111122 34666777999999999999999986
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=340.72 Aligned_cols=198 Identities=21% Similarity=0.288 Sum_probs=171.5
Q ss_pred hcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHHc------CCCCceeEeeEEeeCceE
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLKEFKNEVNLIAKL------QHKNLVRLLGCCLEGQEL 287 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~hpniv~l~~~~~~~~~~ 287 (536)
..+|++.++||+|+||.||+|.+. +++.||||++... ......+.+|+.+++.+ +|+||+++++++...+..
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 468999999999999999999875 4899999998653 33456778899999888 567999999999999999
Q ss_pred EEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCC--eEEecccCc
Q 039168 288 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMN--PKISDFGTA 365 (536)
Q Consensus 288 ~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~--~kl~Dfg~a 365 (536)
++||||+. ++|.+++.... ...+++..++.++.||+.||.|||+++ |+||||||+||||+.++. +||+|||++
T Consensus 175 ~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a 249 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKNK-FQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSS 249 (429)
T ss_dssp EEEECCCC-CBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred EEEEeccC-CCHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecccc
Confidence 99999996 57888875533 234899999999999999999999996 999999999999999887 999999999
Q ss_pred cccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 039168 366 RIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFY 423 (536)
Q Consensus 366 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~ 423 (536)
...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 250 ~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~ 302 (429)
T 3kvw_A 250 CYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE 302 (429)
T ss_dssp EETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred eecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence 764322 22357899999999999999999999999999999999999998654
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=331.64 Aligned_cols=267 Identities=27% Similarity=0.412 Sum_probs=197.3
Q ss_pred hcCCccccccCCCCceeEEEEEeCCCcEEEEEEccccC--hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEe
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTS--GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 292 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 292 (536)
.++|++.+.||+|+||.||+|.+.+ .+|+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 32 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e 109 (319)
T 2y4i_B 32 FEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITS 109 (319)
T ss_dssp CSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECB
T ss_pred HHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEee
Confidence 4789999999999999999999754 59999986532 2334567789999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCC
Q 039168 293 YMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQ 372 (536)
Q Consensus 293 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 372 (536)
|+++++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++ ++.+||+|||++.......
T Consensus 110 ~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~ 183 (319)
T 2y4i_B 110 LCKGRTLYSVVRDA--KIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQ 183 (319)
T ss_dssp CCCSEEHHHHTTSS--CCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC------
T ss_pred cccCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCcccccccc
Confidence 99999999999543 345899999999999999999999997 99999999999998 6799999999987653221
Q ss_pred ---CccccccccccccccCcchhcC---------CCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhh
Q 039168 373 ---NQANTNIIAGTYGYMAPEYAMG---------GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWC 440 (536)
Q Consensus 373 ---~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 440 (536)
.........|++.|+|||++.+ ..++.++||||||+++|+|++|+.||...... ...+.. .
T Consensus 184 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~-~ 256 (319)
T 2y4i_B 184 AGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE------AIIWQM-G 256 (319)
T ss_dssp ----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH------HHHHHH-H
T ss_pred ccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHh-c
Confidence 1122233568999999999975 35789999999999999999999997542211 111111 1
Q ss_pred cCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccCCCCCCCCCCCCc
Q 039168 441 EGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSMTIPQPTEPAF 504 (536)
Q Consensus 441 ~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~p~~p~~ 504 (536)
.+....... ...+ ..+.+++.+||+.||++|||+.++++.|+.........+.|..
T Consensus 257 ~~~~~~~~~-----~~~~---~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~~~~~~ 312 (319)
T 2y4i_B 257 TGMKPNLSQ-----IGMG---KEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHPGH 312 (319)
T ss_dssp TTCCCCCCC-----SSCC---TTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC------------
T ss_pred cCCCCCCCc-----CCCC---HHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccCCCCcc
Confidence 111111111 1112 2356677799999999999999999999987655544444443
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=330.61 Aligned_cols=258 Identities=24% Similarity=0.337 Sum_probs=201.6
Q ss_pred hcCCccccccCCCCceeEEEEEeCCCcEEEEEEccccChh-----------------hHHHHHHHHHHHHHcCCCCceeE
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQ-----------------GLKEFKNEVNLIAKLQHKNLVRL 277 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------------~~~~~~~E~~~l~~l~hpniv~l 277 (536)
.++|++.+.||+|+||.||+|.+ +++.||||++...... ..+.+.+|+.++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46899999999999999999999 8999999998643221 12788999999999999999999
Q ss_pred eeEEeeCceEEEEEeecCCCChhhh------hhcccCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeeeCCCCCCcEE
Q 039168 278 LGCCLEGQELLLIYEYMPNKSLDVH------LFDATRSVQLDWKRRLSIINGIARGILYLHE-DSRLKIIHRDLKASNVL 350 (536)
Q Consensus 278 ~~~~~~~~~~~lv~e~~~~~sL~~~------l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~ivH~Dikp~NIl 350 (536)
++++.+.+..++||||+++++|.++ +.. .....+++..++.++.||+.||.|||+ ++ |+|+||||+|||
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil 184 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK-NYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNIL 184 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCS-SSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh-ccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEE
Confidence 9999999999999999999999998 432 224569999999999999999999998 76 999999999999
Q ss_pred EcCCCCeEEecccCccccCCCCCccccccccccccccCcchhcCC-CCCc-cchHHHHHHHHHHHHhCCCCCCCCCccCC
Q 039168 351 LDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGG-IFSI-KSDVFSFGVLLLEIISGRKNNGFYFSEHG 428 (536)
Q Consensus 351 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DvwslG~il~elltg~~p~~~~~~~~~ 428 (536)
++.++.+||+|||++...... ......|++.|+|||++.+. .++. ++||||||+++|+|++|+.||......
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-- 258 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL-- 258 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS--
T ss_pred EcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH--
Confidence 999999999999999876433 23345689999999999887 6666 999999999999999999998643321
Q ss_pred chhHHHHHHHhhcCCccccc------ccccc---CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 429 QTLLTYTWKLWCEGHAVELI------DPVLK---QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 429 ~~~~~~~~~~~~~~~~~~l~------~~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
... ......+...... .+... ..........+.+++.+||+.||.+|||+.++++
T Consensus 259 ~~~----~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 259 VEL----FNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp HHH----HHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHH----HHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 111 1111111111000 00000 0000112234667777999999999999999996
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-40 Score=324.81 Aligned_cols=254 Identities=28% Similarity=0.401 Sum_probs=191.7
Q ss_pred HhcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEee---------
Q 039168 214 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLE--------- 283 (536)
Q Consensus 214 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~--------- 283 (536)
..++|++.+.||+|+||.||+|++. +++.||||++... ....+.+.+|+.++++++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 3568999999999999999999975 6899999998643 3456778999999999999999999998865
Q ss_pred ----CceEEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEE
Q 039168 284 ----GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKI 359 (536)
Q Consensus 284 ----~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl 359 (536)
....++||||+++++|.+++... ...+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.+||
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl 157 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSE--NLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKI 157 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHS--CGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEE
T ss_pred ccccCCceEEEEecCCCCCHHHhhhcc--ccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEE
Confidence 45789999999999999999643 345788999999999999999999997 999999999999999999999
Q ss_pred ecccCccccCCCCC------------ccccccccccccccCcchhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCcc
Q 039168 360 SDFGTARIFGGNQN------------QANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFYFSE 426 (536)
Q Consensus 360 ~Dfg~a~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~ 426 (536)
+|||++........ ........||+.|+|||++.+. .++.++||||||+++|+|++ |+...
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~--- 231 (303)
T 1zy4_A 158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG--- 231 (303)
T ss_dssp CCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH---
T ss_pred eeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc---
Confidence 99999987643211 1122335689999999999865 68999999999999999998 33211
Q ss_pred CCchhHHHHHHHhhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 427 HGQTLLTYTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 427 ~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
...... ......... . ............+.+++.+||+.||++|||+.++++.
T Consensus 232 --~~~~~~-~~~~~~~~~-~-----~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 232 --MERVNI-LKKLRSVSI-E-----FPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp --HHHHHH-HHHHHSTTC-C-----CCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred --hhHHHH-HHhcccccc-c-----cCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 011111 111111110 1 1111222223345677779999999999999999973
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=325.94 Aligned_cols=261 Identities=20% Similarity=0.283 Sum_probs=201.9
Q ss_pred HhcCCccccccCCCCceeEEEEEe-C-CCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCC------ceeEeeEEeeCc
Q 039168 214 ATNHFSDENKLGQGGFGPVYKGTL-A-DGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKN------LVRLLGCCLEGQ 285 (536)
Q Consensus 214 ~~~~~~~~~~lg~G~~g~Vy~~~~-~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn------iv~l~~~~~~~~ 285 (536)
..++|++.+.||+|+||.||+|.+ . +++.||||++... ....+.+.+|+.+++.++|++ ++++++++...+
T Consensus 12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~ 90 (339)
T 1z57_A 12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG 90 (339)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETT
T ss_pred ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCC
Confidence 357899999999999999999986 3 5889999998643 344577889999999998765 999999999999
Q ss_pred eEEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcC------------
Q 039168 286 ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDD------------ 353 (536)
Q Consensus 286 ~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~------------ 353 (536)
..++||||+ +++|.+++.... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.
T Consensus 91 ~~~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~ 165 (339)
T 1z57_A 91 HICIVFELL-GLSTYDFIKENG-FLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIK 165 (339)
T ss_dssp EEEEEEECC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----
T ss_pred cEEEEEcCC-CCCHHHHHHhcC-CCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCccc
Confidence 999999999 889988886532 245889999999999999999999997 999999999999987
Q ss_pred -------CCCeEEecccCccccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCcc
Q 039168 354 -------DMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSE 426 (536)
Q Consensus 354 -------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~ 426 (536)
++.+||+|||++...... .....||+.|+|||++.+..++.++||||||+++|||++|+.||......
T Consensus 166 ~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 240 (339)
T 1z57_A 166 RDERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSK 240 (339)
T ss_dssp CEEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHH
T ss_pred cccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChH
Confidence 678999999999864322 22357899999999999999999999999999999999999998654322
Q ss_pred CCchhHHHHHHHhhc--------CCccccc---------------------cccc-cCCCCHHHHHHHHHHHHhhcCCCC
Q 039168 427 HGQTLLTYTWKLWCE--------GHAVELI---------------------DPVL-KQSCAPDELLKFIHIGLLCVQQDP 476 (536)
Q Consensus 427 ~~~~~~~~~~~~~~~--------~~~~~l~---------------------~~~l-~~~~~~~~~~~l~~li~~cl~~dP 476 (536)
.. .......... ....... .+.. ...........+.+++.+||+.||
T Consensus 241 ~~---~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP 317 (339)
T 1z57_A 241 EH---LAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDP 317 (339)
T ss_dssp HH---HHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSST
T ss_pred HH---HHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCc
Confidence 11 1111110000 0000000 0000 001122345667888889999999
Q ss_pred CCCCCHHHHHHH
Q 039168 477 ADRPTMSSVVVM 488 (536)
Q Consensus 477 ~~RPt~~evl~~ 488 (536)
++|||+.|+++.
T Consensus 318 ~~Rpt~~ell~h 329 (339)
T 1z57_A 318 AKRITLREALKH 329 (339)
T ss_dssp TTSCCHHHHTTS
T ss_pred ccccCHHHHhcC
Confidence 999999999853
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=328.05 Aligned_cols=263 Identities=25% Similarity=0.321 Sum_probs=196.7
Q ss_pred HhcCCccccccCCCCceeEEEEEeC-CCcEEEEEEcccc-ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeC-----ce
Q 039168 214 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT-SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEG-----QE 286 (536)
Q Consensus 214 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-----~~ 286 (536)
..++|++.+.||+|+||.||+|.+. +|+.||||++... .......+.+|+.++++++||||+++++++... ..
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 3578999999999999999999976 5899999999654 334456788999999999999999999988754 67
Q ss_pred EEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCcc
Q 039168 287 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTAR 366 (536)
Q Consensus 287 ~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 366 (536)
.++||||+. ++|..++.. ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 89 ~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLAR 160 (353)
T ss_dssp EEEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEeccccc
Confidence 999999997 588888754 35899999999999999999999997 9999999999999999999999999998
Q ss_pred ccCCCCCcc--------ccccccccccccCcchhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHH
Q 039168 367 IFGGNQNQA--------NTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWK 437 (536)
Q Consensus 367 ~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~ 437 (536)
......... ......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||....... .......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~~~~ 237 (353)
T 2b9h_A 161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRH---QLLLIFG 237 (353)
T ss_dssp ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHH
T ss_pred ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHH---HHHHHHH
Confidence 765332111 1223468999999998765 678999999999999999999999986533211 1111111
Q ss_pred HhhcCCcccccc----c-------ccc--CCCC-----HHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 438 LWCEGHAVELID----P-------VLK--QSCA-----PDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 438 ~~~~~~~~~l~~----~-------~l~--~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
............ . .+. .... +.....+.+++.+||+.||++|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 238 IIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp HHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 110000000000 0 000 0000 011234667777999999999999999997
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-39 Score=330.46 Aligned_cols=205 Identities=23% Similarity=0.329 Sum_probs=172.7
Q ss_pred hHHHHhcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHHcC-CC-----CceeEeeEEe
Q 039168 210 LALEATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQ-HK-----NLVRLLGCCL 282 (536)
Q Consensus 210 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hp-----niv~l~~~~~ 282 (536)
......++|++.+.||+|+||.||+|.+. +++.||||++... ....+.+..|+.+++.++ |+ +|+++++++.
T Consensus 48 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~ 126 (382)
T 2vx3_A 48 NGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFM 126 (382)
T ss_dssp TTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEE
T ss_pred cCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeec
Confidence 33445689999999999999999999976 5889999999743 344567788999999885 44 4999999999
Q ss_pred eCceEEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEc--CCCCeEEe
Q 039168 283 EGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLD--DDMNPKIS 360 (536)
Q Consensus 283 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~--~~~~~kl~ 360 (536)
..+..++||||+.+ +|.+++.... ...+++..++.++.||+.||.|||.+ ..+|+||||||+||||+ .++.+||+
T Consensus 127 ~~~~~~lv~e~~~~-~L~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~ 203 (382)
T 2vx3_A 127 FRNHLCLVFEMLSY-NLYDLLRNTN-FRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIV 203 (382)
T ss_dssp ETTEEEEEEECCCC-BHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEEC
T ss_pred cCCceEEEEecCCC-CHHHHHhhcC-cCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEE
Confidence 99999999999965 8888886533 23489999999999999999999953 12599999999999995 47789999
Q ss_pred cccCccccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 039168 361 DFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFY 423 (536)
Q Consensus 361 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~ 423 (536)
|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 204 DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 204 DFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA 261 (382)
T ss_dssp CCTTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred eccCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999876432 22357899999999999999999999999999999999999998643
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=329.69 Aligned_cols=263 Identities=21% Similarity=0.282 Sum_probs=199.3
Q ss_pred hcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHHcC-----------CCCceeEeeEEe
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQ-----------HKNLVRLLGCCL 282 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------hpniv~l~~~~~ 282 (536)
.++|++.+.||+|+||.||+|++. +++.||||++... ....+.+.+|+.++++++ ||||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 368999999999999999999974 6899999998743 334567889999999986 899999999998
Q ss_pred eCc----eEEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCeeeCCCCCCcEEEc-----
Q 039168 283 EGQ----ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHED-SRLKIIHRDLKASNVLLD----- 352 (536)
Q Consensus 283 ~~~----~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~~~~ivH~Dikp~NIll~----- 352 (536)
..+ ..++||||+ +++|.+++.... ...+++..++.++.||+.||.|||++ + |+||||||+|||++
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYE-HRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhh-ccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCC
Confidence 654 789999999 889999886533 34489999999999999999999998 7 99999999999994
Q ss_pred -CCCCeEEecccCccccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCch-
Q 039168 353 -DDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQT- 430 (536)
Q Consensus 353 -~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~- 430 (536)
..+.+||+|||++...... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||..........
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 246 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 246 (373)
T ss_dssp TTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred cCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence 4447999999999876432 223468999999999999999999999999999999999999986543221111
Q ss_pred --hHHHHHHHhhc--------C----------Ccccccc--------cc--ccCCCCHHHHHHHHHHHHhhcCCCCCCCC
Q 039168 431 --LLTYTWKLWCE--------G----------HAVELID--------PV--LKQSCAPDELLKFIHIGLLCVQQDPADRP 480 (536)
Q Consensus 431 --~~~~~~~~~~~--------~----------~~~~l~~--------~~--l~~~~~~~~~~~l~~li~~cl~~dP~~RP 480 (536)
........... . .....+. .. .....+......+.+++.+||+.||++||
T Consensus 247 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 326 (373)
T 1q8y_A 247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA 326 (373)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred HHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccC
Confidence 11111110000 0 0000000 00 01123456667888999999999999999
Q ss_pred CHHHHHHH
Q 039168 481 TMSSVVVM 488 (536)
Q Consensus 481 t~~evl~~ 488 (536)
|+.++++.
T Consensus 327 t~~ell~h 334 (373)
T 1q8y_A 327 DAGGLVNH 334 (373)
T ss_dssp CHHHHHTC
T ss_pred CHHHHhhC
Confidence 99999973
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-39 Score=316.67 Aligned_cols=253 Identities=25% Similarity=0.308 Sum_probs=200.9
Q ss_pred HHHhcCCccccccCCCCceeEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEE
Q 039168 212 LEATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELL 288 (536)
Q Consensus 212 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 288 (536)
....++|++.+.||+|+||.||+|++. +++.||||++... .....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence 345679999999999999999999986 6899999998643 2345678899999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCC---CCeEEecccCc
Q 039168 289 LIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDD---MNPKISDFGTA 365 (536)
Q Consensus 289 lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~---~~~kl~Dfg~a 365 (536)
+||||+.+++|.+++... ..+++..++.++.||+.||.|||+++ ++|+||||+||+++.+ +.+||+|||++
T Consensus 98 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~ 171 (287)
T 2wei_A 98 IVGELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (287)
T ss_dssp EEECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred EEEEccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcc
Confidence 999999999998888543 34899999999999999999999997 9999999999999764 46999999999
Q ss_pred cccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcc
Q 039168 366 RIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAV 445 (536)
Q Consensus 366 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 445 (536)
........ .....|++.|+|||++.+. ++.++||||||+++|+|++|+.||...... .. ......+...
T Consensus 172 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~-~~~~~~~~~~ 240 (287)
T 2wei_A 172 TCFQQNTK---MKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEY------DI-LKRVETGKYA 240 (287)
T ss_dssp GTBCCCSS---CSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HH-HHHHHHCCCC
T ss_pred eeecCCCc---cccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHH------HH-HHHHHcCCCC
Confidence 87653322 2234589999999998764 899999999999999999999997543211 11 1111112111
Q ss_pred ccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 446 ELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 446 ~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
.... .... .+ ..+.+++.+||+.||++|||+.++++
T Consensus 241 ~~~~--~~~~-~~---~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 241 FDLP--QWRT-IS---DDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp CCSG--GGTT-SC---HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCch--hhhh-cC---HHHHHHHHHHcccChhhCcCHHHHhc
Confidence 1000 0011 12 34566777999999999999999997
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=329.37 Aligned_cols=257 Identities=23% Similarity=0.328 Sum_probs=193.3
Q ss_pred HhcCCccccccCCCCceeEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceE---
Q 039168 214 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQEL--- 287 (536)
Q Consensus 214 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~--- 287 (536)
..++|.+.+.||+|+||.||+|.+. +|+.||||++... .....+.+.+|+.+++.++||||+++++++...+..
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 3478999999999999999999975 5899999999754 334467788999999999999999999999877654
Q ss_pred ---EEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccC
Q 039168 288 ---LLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGT 364 (536)
Q Consensus 288 ---~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~ 364 (536)
++||||+. ++|...+. ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 120 ~~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~ 190 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIMG-----MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGL 190 (371)
T ss_dssp CCCEEEEECCC-EEHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred eeEEEEEcccc-ccHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCc
Confidence 99999997 57776662 23899999999999999999999997 99999999999999999999999999
Q ss_pred ccccCCCCCccccccccccccccCcchhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCC
Q 039168 365 ARIFGGNQNQANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGH 443 (536)
Q Consensus 365 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 443 (536)
++..... .....||+.|+|||++.+ ..++.++||||||+++|+|++|+.||...... ............ .
T Consensus 191 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~i~~~~~~-~ 261 (371)
T 4exu_A 191 ARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL---DQLTQILKVTGV-P 261 (371)
T ss_dssp C-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCC-C
T ss_pred ccccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCC-C
Confidence 9865432 223568999999999987 67899999999999999999999998643211 111111110000 0
Q ss_pred cccccc---------------ccccCC---CCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 444 AVELID---------------PVLKQS---CAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 444 ~~~l~~---------------~~l~~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
..+... ...... ..+.....+.+++.+||+.||++|||+.++++.
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 262 GTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp CHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred cHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 000000 000000 000112456677789999999999999999864
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=327.60 Aligned_cols=255 Identities=26% Similarity=0.366 Sum_probs=175.8
Q ss_pred hcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC-hhhHHHHHHHHH-HHHHcCCCCceeEeeEEeeCceEEEEE
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLKEFKNEVN-LIAKLQHKNLVRLLGCCLEGQELLLIY 291 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~-~l~~l~hpniv~l~~~~~~~~~~~lv~ 291 (536)
.++|++.+.||+|+||.||+|.++ +++.||||++.... ......+..|+. +++.++||||+++++++...+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 368999999999999999999985 68999999997543 333445556665 777889999999999999999999999
Q ss_pred eecCCCChhhhhhcc--cCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCeeeCCCCCCcEEEcCCCCeEEecccCcccc
Q 039168 292 EYMPNKSLDVHLFDA--TRSVQLDWKRRLSIINGIARGILYLHED-SRLKIIHRDLKASNVLLDDDMNPKISDFGTARIF 368 (536)
Q Consensus 292 e~~~~~sL~~~l~~~--~~~~~l~~~~~~~i~~qi~~al~~LH~~-~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 368 (536)
||+++ +|.+++... .....+++..++.++.|++.||.|||++ + |+||||||+|||++.++.+||+|||+++..
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 99986 776666431 1245689999999999999999999998 7 999999999999999999999999999876
Q ss_pred CCCCCccccccccccccccCcchh----cCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCc
Q 039168 369 GGNQNQANTNIIAGTYGYMAPEYA----MGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHA 444 (536)
Q Consensus 369 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 444 (536)
..... .....||+.|+|||++ .+..++.++||||||+++|+|++|+.||......... . .....+..
T Consensus 177 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-----~-~~~~~~~~ 247 (327)
T 3aln_A 177 VDSIA---KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ-----L-TQVVKGDP 247 (327)
T ss_dssp --------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------------CCCCCSCC
T ss_pred ccccc---cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHH-----H-HHHhcCCC
Confidence 43322 2234689999999998 4566899999999999999999999998643221100 0 00001111
Q ss_pred cccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 445 VELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 445 ~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
.. +...........+.+++.+||+.||++|||+.++++
T Consensus 248 ~~-----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 248 PQ-----LSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CC-----CCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CC-----CCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 11 111001111234666777999999999999999974
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=338.62 Aligned_cols=253 Identities=26% Similarity=0.312 Sum_probs=186.3
Q ss_pred cCCccccccCCCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHHc-CCCCceeEeeEEeeCceEEEEEeec
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYEYM 294 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~ 294 (536)
+.|...++||+|+||+||.+...+|+.||||++.... .+.+.+|+.+|+++ +||||+++++++.+++..++||||+
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~ 91 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence 4566678999999999987777789999999986532 35678899999987 8999999999999999999999999
Q ss_pred CCCChhhhhhcccCCC----CCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCC-------------CCe
Q 039168 295 PNKSLDVHLFDATRSV----QLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDD-------------MNP 357 (536)
Q Consensus 295 ~~~sL~~~l~~~~~~~----~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~-------------~~~ 357 (536)
. ++|.+++....... ...+..++.++.||+.||.|||+++ |+||||||+|||++.+ +++
T Consensus 92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEE
Confidence 6 69999986533211 1133356789999999999999997 9999999999999754 479
Q ss_pred EEecccCccccCCCCCcc--ccccccccccccCcchhcC-------CCCCccchHHHHHHHHHHHHh-CCCCCCCCCccC
Q 039168 358 KISDFGTARIFGGNQNQA--NTNIIAGTYGYMAPEYAMG-------GIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEH 427 (536)
Q Consensus 358 kl~Dfg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~ 427 (536)
||+|||+++......... ......||+.|+|||++.+ ..++.++|||||||++|||++ |+.||.......
T Consensus 168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~ 247 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE 247 (434)
T ss_dssp EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence 999999999875433221 1234579999999999976 568999999999999999999 899975322111
Q ss_pred CchhHHHHHHHhhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 428 GQTLLTYTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 428 ~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
... ........ .............+.+++.+||+.||++|||+.+|++
T Consensus 248 ----~~i----~~~~~~~~----~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 248 ----SNI----IRGIFSLD----EMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp ----HHH----HHTCCCCC----CCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----HHH----hcCCCCcc----cccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 111 11100000 0111123344566778888999999999999999985
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=320.73 Aligned_cols=263 Identities=23% Similarity=0.330 Sum_probs=196.6
Q ss_pred HhcCCccccccCCCCceeEEEEEe--CCCcEEEEEEccccCh--hhHHHHHHHHHHHHHc---CCCCceeEeeEEe----
Q 039168 214 ATNHFSDENKLGQGGFGPVYKGTL--ADGKAIAVKRLSRTSG--QGLKEFKNEVNLIAKL---QHKNLVRLLGCCL---- 282 (536)
Q Consensus 214 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~hpniv~l~~~~~---- 282 (536)
..++|++.+.||+|+||.||+|++ .+++.||||++..... .....+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 457899999999999999999997 3588999999864322 1223566777777766 8999999999987
Q ss_pred -eCceEEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEec
Q 039168 283 -EGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISD 361 (536)
Q Consensus 283 -~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~D 361 (536)
.....++||||+. ++|.+++.... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~D 163 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD 163 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSC-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEec
Confidence 5678999999998 58988886533 234899999999999999999999997 99999999999999999999999
Q ss_pred ccCccccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhc
Q 039168 362 FGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCE 441 (536)
Q Consensus 362 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 441 (536)
||++....... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||...... ............
T Consensus 164 fg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~i~~~~~~ 237 (326)
T 1blx_A 164 FGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV---DQLGKILDVIGL 237 (326)
T ss_dssp CCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCC
T ss_pred CcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHHHHHcCC
Confidence 99998654221 223456899999999999999999999999999999999999998643221 111111111110
Q ss_pred CCccccc------cccc-------cCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 442 GHAVELI------DPVL-------KQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 442 ~~~~~l~------~~~l-------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
.....+. .... ...........+.+++.+||+.||++|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 238 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0000000 0000 00001111234566777999999999999999995
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=355.86 Aligned_cols=256 Identities=23% Similarity=0.337 Sum_probs=200.5
Q ss_pred HhcCCccccccCCCCceeEEEEEeCC----CcEEEEEEcccc-ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEE
Q 039168 214 ATNHFSDENKLGQGGFGPVYKGTLAD----GKAIAVKRLSRT-SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELL 288 (536)
Q Consensus 214 ~~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 288 (536)
..++|++.+.||+|+||.||+|.+.. +..||||++... .....+.+.+|+.++++++||||+++++++. ++..+
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 466 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 466 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceE
Confidence 45678999999999999999998642 567999998754 3444578999999999999999999999985 45689
Q ss_pred EEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCcccc
Q 039168 289 LIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIF 368 (536)
Q Consensus 289 lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 368 (536)
+||||+++++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 467 lv~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~~ 541 (656)
T 2j0j_A 467 IIMELCTLGELRSFLQVR--KFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM 541 (656)
T ss_dssp EEEECCTTCBHHHHHHHT--TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred EEEEcCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCeec
Confidence 999999999999998643 335899999999999999999999997 999999999999999999999999999876
Q ss_pred CCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHHHHHhhcCCcccc
Q 039168 369 GGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVEL 447 (536)
Q Consensus 369 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 447 (536)
...... ......+|+.|+|||++.+..++.++||||||+++|||++ |..||...... .... ....+....
T Consensus 542 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~---~~~~----~i~~~~~~~- 612 (656)
T 2j0j_A 542 EDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVIG----RIENGERLP- 612 (656)
T ss_dssp CC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHH----HHHHTCCCC-
T ss_pred CCCcce-eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH---HHHH----HHHcCCCCC-
Confidence 543221 1223456789999999999999999999999999999997 88887543221 1111 111111111
Q ss_pred ccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 448 IDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 448 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
..... ...+.+++.+||+.||++|||+.+|++.|+..
T Consensus 613 ----~~~~~----~~~l~~li~~~l~~dP~~RPs~~el~~~L~~i 649 (656)
T 2j0j_A 613 ----MPPNC----PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649 (656)
T ss_dssp ----CCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCccc----cHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 11112 23466677799999999999999999998763
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=324.46 Aligned_cols=253 Identities=21% Similarity=0.234 Sum_probs=171.6
Q ss_pred HhcCCcccc-ccCCCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEee----CceE
Q 039168 214 ATNHFSDEN-KLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLE----GQEL 287 (536)
Q Consensus 214 ~~~~~~~~~-~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~----~~~~ 287 (536)
..++|.+.+ +||+|+||.||+|.+. +++.||||++.... ....+....++.++||||+++++++.. ....
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 357888855 6999999999999986 68999999986532 222233345677899999999999876 4568
Q ss_pred EEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcC---CCCeEEecccC
Q 039168 288 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDD---DMNPKISDFGT 364 (536)
Q Consensus 288 ~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~---~~~~kl~Dfg~ 364 (536)
++||||+++++|.+++.... ...+++.+++.++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||+
T Consensus 102 ~lv~e~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~ 177 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQERG-DQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGF 177 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEeccCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEecccc
Confidence 99999999999999996533 246899999999999999999999997 999999999999986 44599999999
Q ss_pred ccccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCc
Q 039168 365 ARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHA 444 (536)
Q Consensus 365 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 444 (536)
++...... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||............. .......
T Consensus 178 ~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~---~~~~~~~- 249 (336)
T 3fhr_A 178 AKETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMK---RRIRLGQ- 249 (336)
T ss_dssp CEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------------------
T ss_pred ceeccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHH---Hhhhccc-
Confidence 98654322 223568999999999988889999999999999999999999985433221100000 0000000
Q ss_pred cccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 445 VELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 445 ~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
.. ............+.+++.+||+.||++|||+.++++
T Consensus 250 ~~-----~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 250 YG-----FPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp -C-----CCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred cc-----cCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00 000000111234566777999999999999999997
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=323.39 Aligned_cols=259 Identities=20% Similarity=0.268 Sum_probs=197.7
Q ss_pred HhcCCccccccCCCCceeEEEEEeC-CC-cEEEEEEccccChhhHHHHHHHHHHHHHcCCCC------ceeEeeEEeeCc
Q 039168 214 ATNHFSDENKLGQGGFGPVYKGTLA-DG-KAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKN------LVRLLGCCLEGQ 285 (536)
Q Consensus 214 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn------iv~l~~~~~~~~ 285 (536)
..++|++.+.||+|+||.||+|.+. ++ +.||||++... ....+.+.+|+.++++++|++ ++.+++++...+
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 95 (355)
T 2eu9_A 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHG 95 (355)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETT
T ss_pred ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCC
Confidence 4579999999999999999999975 34 68999998643 344577889999999998766 999999999999
Q ss_pred eEEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEE--------------
Q 039168 286 ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLL-------------- 351 (536)
Q Consensus 286 ~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll-------------- 351 (536)
..++||||+ +++|.+++... ....+++..++.++.||+.||.|||+++ |+||||||+|||+
T Consensus 96 ~~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~ 170 (355)
T 2eu9_A 96 HMCIAFELL-GKNTFEFLKEN-NFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKS 170 (355)
T ss_dssp EEEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred eEEEEEecc-CCChHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeccccccccccccc
Confidence 999999999 55555565442 2245899999999999999999999996 9999999999999
Q ss_pred -----cCCCCeEEecccCccccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCcc
Q 039168 352 -----DDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSE 426 (536)
Q Consensus 352 -----~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~ 426 (536)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++||||||+++|||++|+.||......
T Consensus 171 ~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 245 (355)
T 2eu9_A 171 CEEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENR 245 (355)
T ss_dssp CCEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred ccccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence 56789999999999864322 22357899999999999999999999999999999999999998643321
Q ss_pred CCchhHHHHHHHhhcCCcccc----------cc--------------------c-cccCCCCHHHHHHHHHHHHhhcCCC
Q 039168 427 HGQTLLTYTWKLWCEGHAVEL----------ID--------------------P-VLKQSCAPDELLKFIHIGLLCVQQD 475 (536)
Q Consensus 427 ~~~~~~~~~~~~~~~~~~~~l----------~~--------------------~-~l~~~~~~~~~~~l~~li~~cl~~d 475 (536)
. .......... .....+ .. + .........+...+.+++.+||+.|
T Consensus 246 ~---~~~~~~~~~~-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d 321 (355)
T 2eu9_A 246 E---HLVMMEKILG-PIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFD 321 (355)
T ss_dssp H---HHHHHHHHHC-CCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSS
T ss_pred H---HHHHHHHHcC-CCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCC
Confidence 1 1111111100 000000 00 0 0000112233456778888999999
Q ss_pred CCCCCCHHHHHH
Q 039168 476 PADRPTMSSVVV 487 (536)
Q Consensus 476 P~~RPt~~evl~ 487 (536)
|++|||+.++++
T Consensus 322 P~~Rpt~~e~l~ 333 (355)
T 2eu9_A 322 PAQRITLAEALL 333 (355)
T ss_dssp TTTSCCHHHHTT
T ss_pred hhhCcCHHHHhc
Confidence 999999999984
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=322.62 Aligned_cols=256 Identities=22% Similarity=0.303 Sum_probs=192.9
Q ss_pred hcCCccccccCCCCceeEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCce-----
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQE----- 286 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~----- 286 (536)
.++|.+.+.||+|+||.||+|.+. +|+.||||++... .....+.+.+|+.+++.++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 468999999999999999999975 5899999998754 33345678899999999999999999999987654
Q ss_pred -EEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCc
Q 039168 287 -LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTA 365 (536)
Q Consensus 287 -~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 365 (536)
.++||||+. ++|..++. ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 103 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 173 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA 173 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred eEEEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccc
Confidence 599999997 57777662 23899999999999999999999997 999999999999999999999999999
Q ss_pred cccCCCCCccccccccccccccCcchhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcC--
Q 039168 366 RIFGGNQNQANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEG-- 442 (536)
Q Consensus 366 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-- 442 (536)
+..... .....||+.|+|||++.+ ..++.++||||||+++|+|++|+.||...... .............
T Consensus 174 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~---~~~~~i~~~~~~~~~ 245 (353)
T 3coi_A 174 RHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL---DQLTQILKVTGVPGT 245 (353)
T ss_dssp TC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHH---HHHHHHHHHHCBCCH
T ss_pred cCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCCCH
Confidence 865322 223568999999999987 67899999999999999999999998643221 1111111100000
Q ss_pred ----------------CccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 443 ----------------HAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 443 ----------------~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
.........+. ...+.....+.+++.+||+.||++|||+.++++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 246 EFVQKLNDKAAKSYIQSLPQTPRKDFT-QLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp HHHTTCSCHHHHHHHHTSCBCSSCCTT-TTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHHhhHHHHHHHHhCcCCCCccHH-HhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 00000000000 0111223456677779999999999999999863
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=324.74 Aligned_cols=246 Identities=23% Similarity=0.357 Sum_probs=196.7
Q ss_pred hHHHHhcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccChh------hHHHHHHHHHHHHHcC--CCCceeEeeE
Q 039168 210 LALEATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQ------GLKEFKNEVNLIAKLQ--HKNLVRLLGC 280 (536)
Q Consensus 210 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--hpniv~l~~~ 280 (536)
......++|++.+.||+|+||.||+|.+. +++.||||++...... ..+.+.+|+.++++++ ||||++++++
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~ 116 (320)
T 3a99_A 37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 116 (320)
T ss_dssp ---CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred ccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEE
Confidence 33445678999999999999999999864 6899999998654221 2245678999999996 5999999999
Q ss_pred EeeCceEEEEEeecCC-CChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEc-CCCCeE
Q 039168 281 CLEGQELLLIYEYMPN-KSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLD-DDMNPK 358 (536)
Q Consensus 281 ~~~~~~~~lv~e~~~~-~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~-~~~~~k 358 (536)
+...+..++|||++.+ ++|.+++... ..+++..++.++.||++||.|||+++ |+||||||+|||++ +++.+|
T Consensus 117 ~~~~~~~~lv~e~~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~k 190 (320)
T 3a99_A 117 FERPDSFVLILERPEPVQDLFDFITER---GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELK 190 (320)
T ss_dssp EECSSEEEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEE
T ss_pred EecCCcEEEEEEcCCCCccHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEE
Confidence 9999999999999986 8999988543 35899999999999999999999997 99999999999999 788999
Q ss_pred EecccCccccCCCCCccccccccccccccCcchhcCCCC-CccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHH
Q 039168 359 ISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIF-SIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWK 437 (536)
Q Consensus 359 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~ 437 (536)
|+|||++....... .....||+.|+|||++.+..+ +.++||||||+++|+|++|+.||.... .
T Consensus 191 L~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~--------~---- 254 (320)
T 3a99_A 191 LIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--------E---- 254 (320)
T ss_dssp ECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--------H----
T ss_pred EeeCcccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh--------h----
Confidence 99999998765322 223568999999999987765 788999999999999999999975321 0
Q ss_pred HhhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 438 LWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 438 ~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
.. .... ...... + ..+.+++.+||+.||++|||+.+|++.
T Consensus 255 ~~-~~~~------~~~~~~-~---~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 255 II-RGQV------FFRQRV-S---SECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp HH-HCCC------CCSSCC-C---HHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hh-cccc------cccccC-C---HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 0110 011112 2 245667779999999999999999974
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=322.90 Aligned_cols=243 Identities=22% Similarity=0.367 Sum_probs=188.9
Q ss_pred HHhcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccChh------hHHHHHHHHHHHHHc----CCCCceeEeeEE
Q 039168 213 EATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQ------GLKEFKNEVNLIAKL----QHKNLVRLLGCC 281 (536)
Q Consensus 213 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l----~hpniv~l~~~~ 281 (536)
...++|++.+.||+|+||.||+|.+. +++.||||++...... ....+.+|+.+++++ +||||+++++++
T Consensus 28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~ 107 (312)
T 2iwi_A 28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF 107 (312)
T ss_dssp -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence 34578999999999999999999874 6889999999754321 223456799999999 899999999999
Q ss_pred eeCceEEEEEee-cCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEc-CCCCeEE
Q 039168 282 LEGQELLLIYEY-MPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLD-DDMNPKI 359 (536)
Q Consensus 282 ~~~~~~~lv~e~-~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~-~~~~~kl 359 (536)
...+..++|||+ +.+++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||
T Consensus 108 ~~~~~~~~v~e~~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl 181 (312)
T 2iwi_A 108 ETQEGFMLVLERPLPAQDLFDYITEK---GPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKL 181 (312)
T ss_dssp -----CEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEEE
T ss_pred ecCCeEEEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEEE
Confidence 999999999999 7899999999653 34899999999999999999999996 99999999999999 8899999
Q ss_pred ecccCccccCCCCCccccccccccccccCcchhcCCCC-CccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHH
Q 039168 360 SDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIF-SIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKL 438 (536)
Q Consensus 360 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 438 (536)
+|||++....... .....|++.|+|||++.+..+ +.++||||||+++|+|++|+.||.... . .
T Consensus 182 ~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--------~----~ 245 (312)
T 2iwi_A 182 IDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ--------E----I 245 (312)
T ss_dssp CCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--------H----H
T ss_pred EEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH--------H----H
Confidence 9999998765432 223568999999999987766 458999999999999999999975311 0 0
Q ss_pred hhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 439 WCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 439 ~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
. .... . +.... ...+.+++.+||+.||++|||+.++++.
T Consensus 246 ~-~~~~-~-----~~~~~----~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 246 L-EAEL-H-----FPAHV----SPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp H-HTCC-C-----CCTTS----CHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred h-hhcc-C-----CcccC----CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 0000 0 11111 2345667779999999999999999974
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=314.02 Aligned_cols=250 Identities=22% Similarity=0.351 Sum_probs=176.8
Q ss_pred cCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccCh-h-hHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEe
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG-Q-GLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 292 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 292 (536)
++|++.+.||+|+||.||+|.+. +++.||||++..... . ..+.+.++..+++.++||||+++++++.+.+..++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e 104 (318)
T 2dyl_A 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAME 104 (318)
T ss_dssp GGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Confidence 67899999999999999999986 689999999975432 2 23344555667888899999999999999999999999
Q ss_pred ecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCC
Q 039168 293 YMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHED-SRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGN 371 (536)
Q Consensus 293 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 371 (536)
|+ ++.+..+... ....+++..++.++.||++||.|||++ + |+|+||||+|||++.++++||+|||++......
T Consensus 105 ~~-~~~~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (318)
T 2dyl_A 105 LM-GTCAEKLKKR--MQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVDD 178 (318)
T ss_dssp CC-SEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred cc-CCcHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccCC
Confidence 99 5555544432 234589999999999999999999985 6 999999999999999999999999999766433
Q ss_pred CCccccccccccccccCcchhc-----CCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccc
Q 039168 372 QNQANTNIIAGTYGYMAPEYAM-----GGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVE 446 (536)
Q Consensus 372 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 446 (536)
.. .....||+.|+|||++. +..++.++||||||+++|+|++|+.||...... ......... .....
T Consensus 179 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~~~~~-~~~~~ 249 (318)
T 2dyl_A 179 KA---KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD-----FEVLTKVLQ-EEPPL 249 (318)
T ss_dssp -----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH-----HHHHHHHHH-SCCCC
T ss_pred cc---ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc-----HHHHHHHhc-cCCCC
Confidence 22 22346899999999994 456889999999999999999999997642211 111111111 11111
Q ss_pred cccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 447 LIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 447 l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
+.. ... .+. .+.+++.+||+.||.+|||+.++++
T Consensus 250 ~~~---~~~-~~~---~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 250 LPG---HMG-FSG---DFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp CCS---SSC-CCH---HHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCc---cCC-CCH---HHHHHHHHHccCChhHCcCHHHHhh
Confidence 100 011 122 3556667999999999999999985
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=330.75 Aligned_cols=250 Identities=22% Similarity=0.304 Sum_probs=185.1
Q ss_pred hcCCccccccCCCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHHc-CCCCceeEeeEEeeCceEEEEEee
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYEY 293 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~ 293 (536)
..+|...++||+|+||+||.....+++.||||++..... ..+.+|+.+|+++ +||||+++++++.+.+..++||||
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~ 99 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL 99 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence 356888999999999997665566899999999865432 2356899999999 899999999999999999999999
Q ss_pred cCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcC-----CCCeEEecccCcccc
Q 039168 294 MPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDD-----DMNPKISDFGTARIF 368 (536)
Q Consensus 294 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~-----~~~~kl~Dfg~a~~~ 368 (536)
+. ++|.+++.... ..+.+..++.++.||+.||.|||+++ |+||||||+|||++. ..++||+|||+++.+
T Consensus 100 ~~-g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~ 173 (432)
T 3p23_A 100 CA-ATLQEYVEQKD--FAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL 173 (432)
T ss_dssp CS-EEHHHHHHSSS--CCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred CC-CCHHHHHHhcC--CCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence 96 58888886433 23445567789999999999999997 999999999999953 335889999999876
Q ss_pred CCCCC-ccccccccccccccCcchhcC---CCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHHHHHhhcCC
Q 039168 369 GGNQN-QANTNIIAGTYGYMAPEYAMG---GIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGH 443 (536)
Q Consensus 369 ~~~~~-~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 443 (536)
..... ........||+.|+|||++.+ ..++.++|||||||++|||++ |..||...... . ..... ...
T Consensus 174 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~----~---~~~~~-~~~ 245 (432)
T 3p23_A 174 AVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR----Q---ANILL-GAC 245 (432)
T ss_dssp ------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH----H---HHHHT-TCC
T ss_pred cCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH----H---HHHHh-ccC
Confidence 53322 122334679999999999974 567889999999999999999 88887432111 1 11111 111
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 444 AVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 444 ~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
...... ........+.+|+.+||+.||++|||+.+|++
T Consensus 246 ~~~~~~------~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 246 SLDCLH------PEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp CCTTSC------TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CccccC------ccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 111111 01123344667788999999999999999994
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-39 Score=345.99 Aligned_cols=264 Identities=23% Similarity=0.263 Sum_probs=196.6
Q ss_pred hcCCccccccCCCCceeEEEEEeC-CCcEEEEEEcccc-ChhhHHHHHHHHHHHHHcCCCCceeEeeEEee------Cce
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT-SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLE------GQE 286 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~------~~~ 286 (536)
.++|++.++||+|+||.||+|.+. +|+.||||++... .....+.+.+|+.++++++||||+++++++.. .+.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 378999999999999999999975 5899999998754 44556778999999999999999999998765 678
Q ss_pred EEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCC---eEEeccc
Q 039168 287 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMN---PKISDFG 363 (536)
Q Consensus 287 ~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~---~kl~Dfg 363 (536)
.++||||+++++|.+++........+++..++.++.||+.||.|||+.+ |+||||||+|||++.++. +||+|||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEcccc
Confidence 8999999999999999976555556899999999999999999999997 999999999999997765 8999999
Q ss_pred CccccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCc--hhHHHHHHH-hh
Q 039168 364 TARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQ--TLLTYTWKL-WC 440 (536)
Q Consensus 364 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~--~~~~~~~~~-~~ 440 (536)
++........ .....||+.|+|||++.+..++.++||||||+++|+|++|+.||......... ......... ..
T Consensus 170 ~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~ 246 (676)
T 3qa8_A 170 YAKELDQGEL---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVV 246 (676)
T ss_dssp CCCBTTSCCC---CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCS
T ss_pred cccccccccc---cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhh
Confidence 9987654322 23357899999999999999999999999999999999999998542111000 000000000 00
Q ss_pred cCCccc--cccc--cccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHH
Q 039168 441 EGHAVE--LIDP--VLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSS 484 (536)
Q Consensus 441 ~~~~~~--l~~~--~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 484 (536)
...... .+.. .............+.+++.+||+.||++|||+.+
T Consensus 247 ~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~e 294 (676)
T 3qa8_A 247 YDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQ 294 (676)
T ss_dssp CCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTT
T ss_pred hhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHH
Confidence 000000 0000 0011223334556777888999999999999966
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=344.02 Aligned_cols=237 Identities=18% Similarity=0.311 Sum_probs=189.5
Q ss_pred hcCCccccccCCCCceeEEEEEeC--CCcEEEEEEcccc-ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCce-----
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA--DGKAIAVKRLSRT-SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQE----- 286 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~----- 286 (536)
.++|++.++||+|+||.||++.+. +++.||||++... .......+.+|+.++++++||||+++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 478999999999999999999975 5899999998654 34455678899999999999999999999987655
Q ss_pred EEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCcc
Q 039168 287 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTAR 366 (536)
Q Consensus 287 ~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 366 (536)
.|+||||+++++|.+++.. .+++.+++.++.||+.||.|||+++ |+||||||+|||++.+ .+||+|||+++
T Consensus 159 ~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~ 229 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVS 229 (681)
T ss_dssp EEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred eEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccch
Confidence 7999999999999887632 5899999999999999999999997 9999999999999985 99999999998
Q ss_pred ccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccc
Q 039168 367 IFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVE 446 (536)
Q Consensus 367 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 446 (536)
..... ....||+.|+|||++.+.. +.++||||||+++|+|++|..|+........ .
T Consensus 230 ~~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~----------------~- 285 (681)
T 2pzi_A 230 RINSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGL----------------P- 285 (681)
T ss_dssp ETTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSC----------------C-
T ss_pred hcccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccccc----------------c-
Confidence 76432 3356899999999997654 8999999999999999999888643211100 0
Q ss_pred cccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCC-HHHHHHHhc
Q 039168 447 LIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPT-MSSVVVMLA 490 (536)
Q Consensus 447 l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt-~~evl~~L~ 490 (536)
. ..........+.+++.+||+.||++||+ ++++...|.
T Consensus 286 --~----~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~ 324 (681)
T 2pzi_A 286 --E----DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLT 324 (681)
T ss_dssp --T----TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred --c----cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHH
Confidence 0 0000112245677888999999999995 455554443
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=301.04 Aligned_cols=229 Identities=13% Similarity=0.091 Sum_probs=180.2
Q ss_pred hcCCccccccCCCCceeEEEEEeCC-CcEEEEEEccccC---hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEE
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTS---GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 290 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 290 (536)
.++|++.+.||+|+||.||+|++.. ++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..|+|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 3689999999999999999999864 8999999997543 34457789999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCC
Q 039168 291 YEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGG 370 (536)
Q Consensus 291 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 370 (536)
|||+++++|.+++.. . ....++..++.||+.||.|||+++ |+||||||+|||++.++.+||++++
T Consensus 110 ~e~~~g~~L~~~l~~----~-~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~------- 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADT----S-PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA------- 174 (286)
T ss_dssp EECCCEEEHHHHHTT----C-CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC-------
T ss_pred EEecCCCCHHHHHhc----C-CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc-------
Confidence 999999999999842 1 355678899999999999999997 9999999999999999999998443
Q ss_pred CCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccc
Q 039168 371 NQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDP 450 (536)
Q Consensus 371 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 450 (536)
|++| ++.++||||||+++|+|++|+.||............. .........+
T Consensus 175 ---------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~-------~~~~~~~~~~ 225 (286)
T 3uqc_A 175 ---------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE-------RDTAGQPIEP 225 (286)
T ss_dssp ---------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECC-------BCTTSCBCCH
T ss_pred ---------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHH-------HHhccCCCCh
Confidence 3333 6889999999999999999999987543322100000 0000000000
Q ss_pred -cccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 451 -VLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 451 -~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
.+... .+ ..+.+++.+||+.||++| |+.++++.|+..
T Consensus 226 ~~~~~~-~~---~~l~~li~~~l~~dP~~R-s~~el~~~L~~~ 263 (286)
T 3uqc_A 226 ADIDRD-IP---FQISAVAARSVQGDGGIR-SASTLLNLMQQA 263 (286)
T ss_dssp HHHCTT-SC---HHHHHHHHHHHCTTSSCC-CHHHHHHHHHHH
T ss_pred hhcccC-CC---HHHHHHHHHHcccCCccC-CHHHHHHHHHHH
Confidence 01111 12 335667779999999999 999999999874
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-36 Score=298.50 Aligned_cols=227 Identities=21% Similarity=0.243 Sum_probs=175.9
Q ss_pred hcCCccc-cccCCCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHH-HHcCCCCceeEeeEEee----CceE
Q 039168 215 TNHFSDE-NKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLKEFKNEVNLI-AKLQHKNLVRLLGCCLE----GQEL 287 (536)
Q Consensus 215 ~~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~hpniv~l~~~~~~----~~~~ 287 (536)
.++|.+. +.||+|+||.||++.+. +++.||||++... ..+.+|+.++ +.++||||+++++++.. ....
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 3567776 78999999999999974 6899999998642 4567888887 66699999999999987 6789
Q ss_pred EEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcC---CCCeEEecccC
Q 039168 288 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDD---DMNPKISDFGT 364 (536)
Q Consensus 288 ~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~---~~~~kl~Dfg~ 364 (536)
++||||+++++|.+++.... ...+++..++.++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||+
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~ 166 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 166 (299)
T ss_dssp EEEECCCCSCBHHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEeecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEecccc
Confidence 99999999999999996533 245899999999999999999999997 999999999999998 78899999999
Q ss_pred ccccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCc
Q 039168 365 ARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHA 444 (536)
Q Consensus 365 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 444 (536)
+.... +..++.++||||||+++|+|++|+.||......... . ..
T Consensus 167 a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-----------~-~~ 210 (299)
T 3m2w_A 167 AKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-----------P-GM 210 (299)
T ss_dssp CEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------------------C-CS
T ss_pred ccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh-----------H-HH
Confidence 87532 234678999999999999999999998543221100 0 00
Q ss_pred cccccccccCCCCHH----HHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 445 VELIDPVLKQSCAPD----ELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 445 ~~l~~~~l~~~~~~~----~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
...+... ....+.. ....+.+++.+||+.||++|||+.++++
T Consensus 211 ~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 211 KTRIRMG-QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp CCSSCTT-CCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHhhc-cccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0000000 0001111 1234667777999999999999999997
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=312.74 Aligned_cols=241 Identities=15% Similarity=0.141 Sum_probs=182.5
Q ss_pred hcCCccccccCCCCceeEEEEEeCCCcEEEEEEccccC--------hhhHHHHHHHHHHHHHcC---------CCCceeE
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTS--------GQGLKEFKNEVNLIAKLQ---------HKNLVRL 277 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---------hpniv~l 277 (536)
.++|++.++||+|+||.||+|++ +|+.||||++.... ....+.+.+|+.++++++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 46799999999999999999998 68999999997542 234578899999999996 7777777
Q ss_pred eeEEe-----------------e-------------CceEEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHH
Q 039168 278 LGCCL-----------------E-------------GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARG 327 (536)
Q Consensus 278 ~~~~~-----------------~-------------~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~a 327 (536)
.+++. + .+..++||||+++|++.+.+.+ ..+++..++.++.||+.|
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHH
Confidence 66643 2 6889999999999976666632 358999999999999999
Q ss_pred HHHHh-cCCCCCeeeCCCCCCcEEEcCCC--------------------CeEEecccCccccCCCCCccccccccccccc
Q 039168 328 ILYLH-EDSRLKIIHRDLKASNVLLDDDM--------------------NPKISDFGTARIFGGNQNQANTNIIAGTYGY 386 (536)
Q Consensus 328 l~~LH-~~~~~~ivH~Dikp~NIll~~~~--------------------~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y 386 (536)
|.||| +++ |+||||||+||||+.++ .+||+|||+++..... ...||+.|
T Consensus 174 L~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~y 243 (336)
T 2vuw_A 174 LAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDVS 243 (336)
T ss_dssp HHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCCT
T ss_pred HHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeecc
Confidence 99999 886 99999999999999887 8999999999876432 34799999
Q ss_pred cCcchhcCCCCCccchHHHHHHH-HHHHHhCCCCCCCCCccCCchhHHHHHHHhh-cCCccccccccccCCCCHHHHHHH
Q 039168 387 MAPEYAMGGIFSIKSDVFSFGVL-LLEIISGRKNNGFYFSEHGQTLLTYTWKLWC-EGHAVELIDPVLKQSCAPDELLKF 464 (536)
Q Consensus 387 ~aPE~~~~~~~~~~~DvwslG~i-l~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~~~l~~~~~~~~~~~l 464 (536)
+|||++.+.. +.++|||||+++ .+++++|..||... ........... ....... ...........++
T Consensus 244 ~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~------~~~~~~~~~~~~~~~~~~~----~~~~~~~~~s~~~ 312 (336)
T 2vuw_A 244 MDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV------LWLHYLTDKMLKQMTFKTK----CNTPAMKQIKRKI 312 (336)
T ss_dssp TCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH------HHHHHHHHHHHHTCCCSSC----CCSHHHHHHHHHH
T ss_pred cChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch------hhhhHHHHhhhhhhccCcc----cchhhhhhcCHHH
Confidence 9999998776 899999998777 77888898885210 00000111111 1010000 0000122345667
Q ss_pred HHHHHhhcCCCCCCCCCHHHHH
Q 039168 465 IHIGLLCVQQDPADRPTMSSVV 486 (536)
Q Consensus 465 ~~li~~cl~~dP~~RPt~~evl 486 (536)
.+++.+||+.| |+.++|
T Consensus 313 ~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 313 QEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHGGGSS-----SHHHHH
T ss_pred HHHHHHHhccC-----CHHHHH
Confidence 88888999977 999998
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-37 Score=317.30 Aligned_cols=240 Identities=18% Similarity=0.178 Sum_probs=176.1
Q ss_pred cCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHHHcCC-CCcee--------------
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLKEFKNEVNLIAKLQH-KNLVR-------------- 276 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h-pniv~-------------- 276 (536)
..|...++||+|+||.||+|++. +|+.||||++.... ....+.+++|+.+++.++| +|...
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 45778889999999999999964 69999999987432 2335779999999999987 22111
Q ss_pred -------EeeEEee-----CceEEEEEeecCCCChhhhhhc----ccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCee
Q 039168 277 -------LLGCCLE-----GQELLLIYEYMPNKSLDVHLFD----ATRSVQLDWKRRLSIINGIARGILYLHEDSRLKII 340 (536)
Q Consensus 277 -------l~~~~~~-----~~~~~lv~e~~~~~sL~~~l~~----~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iv 340 (536)
++.++.. ....+++|+++ +++|.+++.. ......+++..++.++.||++||.|||+++ |+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ii 233 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LV 233 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cc
Confidence 1111111 22457777765 6788888742 122345788899999999999999999997 99
Q ss_pred eCCCCCCcEEEcCCCCeEEecccCccccCCCCCccccccccccccccCcchh----------cCCCCCccchHHHHHHHH
Q 039168 341 HRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYA----------MGGIFSIKSDVFSFGVLL 410 (536)
Q Consensus 341 H~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~DvwslG~il 410 (536)
||||||+||||+.++.+||+|||+++..... .....| +.|+|||++ .+..++.++|||||||++
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil 307 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI 307 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHH
T ss_pred cCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHH
Confidence 9999999999999999999999999865422 334567 999999999 555688999999999999
Q ss_pred HHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHH
Q 039168 411 LEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVV 486 (536)
Q Consensus 411 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl 486 (536)
|||++|+.||.......... ..+.. ... .+ ..+.+|+.+||+.||++|||+.+++
T Consensus 308 ~elltg~~Pf~~~~~~~~~~---------------~~~~~--~~~-~~---~~~~~li~~~l~~dP~~Rpt~~~~l 362 (413)
T 3dzo_A 308 YWIWCADLPNTDDAALGGSE---------------WIFRS--CKN-IP---QPVRALLEGFLRYPKEDRLLPLQAM 362 (413)
T ss_dssp HHHHHSSCCCCTTGGGSCSG---------------GGGSS--CCC-CC---HHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred HHHHHCCCCCCCcchhhhHH---------------HHHhh--ccc-CC---HHHHHHHHHHccCChhhCcCHHHHH
Confidence 99999999986533221111 00110 011 12 3466677799999999999976664
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=5.9e-31 Score=283.19 Aligned_cols=185 Identities=16% Similarity=0.137 Sum_probs=130.8
Q ss_pred ccCCCCceeEEEEEe-CCCcEEEEEEccccC----------hhhHHHHHHHHHHHHHc-CCCCceeEeeEEeeCceEEEE
Q 039168 223 KLGQGGFGPVYKGTL-ADGKAIAVKRLSRTS----------GQGLKEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLI 290 (536)
Q Consensus 223 ~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv 290 (536)
.++.|+.|.+..++. -.|+.|++|.+.+.. ....++|.+|+++|+++ +|+||+++++++++++..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 466777777766553 358899999986541 23356799999999999 799999999999999999999
Q ss_pred EeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCC
Q 039168 291 YEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGG 370 (536)
Q Consensus 291 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 370 (536)
|||++|++|.+.|... ..+++. +|+.||+.||+|||++| ||||||||+||||+++|++||+|||+++....
T Consensus 321 MEyv~G~~L~d~i~~~---~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAG---EEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp EECCCSEEHHHHHHTT---CCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred EecCCCCcHHHHHHhC---CCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence 9999999999999543 346654 47899999999999997 99999999999999999999999999987654
Q ss_pred CCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCC
Q 039168 371 NQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKN 419 (536)
Q Consensus 371 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p 419 (536)
... .....+||+.|||||++.+ .+..++|+||+|+++++|.++..+
T Consensus 392 ~~~--~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 392 DCS--WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp --C--CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred CCc--cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 332 2334689999999999876 467789999999998887665443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=7e-28 Score=257.83 Aligned_cols=185 Identities=17% Similarity=0.174 Sum_probs=145.3
Q ss_pred ccccccCCCCceeEEEEEeCCCcEEEEEEccccCh--------hhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEE
Q 039168 219 SDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSG--------QGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 290 (536)
Q Consensus 219 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 290 (536)
...++||+|+||.||++.. .++.+++|+...... ...+.+.+|+++|++++||||+++..++...+..++|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 4467899999999999954 578889988643221 1234589999999999999999666666677778999
Q ss_pred EeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCC
Q 039168 291 YEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGG 370 (536)
Q Consensus 291 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 370 (536)
|||+++++|.+++.. +..++.||++||.|||+++ |+||||||+|||++. ++||+|||+++....
T Consensus 418 mE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 418 MSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNL 481 (540)
T ss_dssp EECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred EECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence 999999999999853 5689999999999999997 999999999999999 999999999998754
Q ss_pred CCCcc-----ccccccccccccCcchhcC--CCCCccchHHHHHHHHHHHHhCCCCC
Q 039168 371 NQNQA-----NTNIIAGTYGYMAPEYAMG--GIFSIKSDVFSFGVLLLEIISGRKNN 420 (536)
Q Consensus 371 ~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~p~ 420 (536)
..... ......||+.|||||++.+ ..|+..+|+|+..+-.++.+.++.++
T Consensus 482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 32211 1235679999999999987 56888999999999999988877664
|
| >3a2e_A Ginkbilobin-2; domain 26 unknown function (DUF26), C-X8-C-X2-C motif, antifungal protein, embryo-abundant protein (EAP), plant protein; 2.38A {Ginkgo biloba} | Back alignment and structure |
|---|
Probab=99.91 E-value=1.8e-24 Score=178.68 Aligned_cols=107 Identities=17% Similarity=0.265 Sum_probs=97.9
Q ss_pred CCCcceEEeeccCccChhhHHHHHHHHHHHHhhccccCccccccccccccCCcceeEEEeecCCCChhhhhHHHHHHHhh
Q 039168 56 DTSTVLCMYIVRNFSVPRNVTRILAQSFNDVIAMPSLSSFRNATKGTNISNINRLETFGQCIPVLSVDDCRDCLNNTIRW 135 (536)
Q Consensus 56 ~~~~~~~~~~~~~~~~~~~f~~~~~~ll~~l~~~a~~~~~~fa~~~~~~~~~~~vyglaQC~~Dls~~~C~~Cl~~~~~~ 135 (536)
++....+.|+.++++.++.|+.+|+.||.+|...|+.+..+|+++.....+.++||||+||+|||++++|..||..++.+
T Consensus 2 ~t~~v~~~Cn~~~~t~~s~f~~nl~~ll~~L~~~a~~s~~~~~t~~~~~~~~~~vygl~qC~~Dls~~~C~~Cl~~a~~~ 81 (108)
T 3a2e_A 2 NTAFVSSACNTQKIPSGSPFNRNLRAMLADLRQNTAFSGYDYKTSRAGSGGAPTAYGRATCKQSISQSDCTACLSNLVNR 81 (108)
T ss_dssp CCCEEEEEECSSBCCTTCTHHHHHHHHHHHHHHHGGGTTSEEEEEECCSTTCCCEEEEEEECTTSCHHHHHHHHHHHHTT
T ss_pred CcceeeeecCCCccCCCChHHHHHHHHHHHHHhhCccccCCceEeeccCCCCceEEEEEEEcCCCCHHHHHHHHHHHHHH
Confidence 45666788999999999999999999999999998877788888877656678999999999999999999999999999
Q ss_pred cccccCCCCCcceEEeccccccccccCCC
Q 039168 136 IQKCFDPPGTGFGRILFPSCIMGFELHPY 164 (536)
Q Consensus 136 ~~~~c~~~~~~~~~~~~~~C~lry~~~~F 164 (536)
++++|++ ++||+|++++|+|||++++|
T Consensus 82 ~~~~C~~--~~g~~i~~~~C~lRY~~~~F 108 (108)
T 3a2e_A 82 IFSICNN--AIGARVQLVDCFIQYEQRSF 108 (108)
T ss_dssp HHHHTTS--BSSEEEEETTEEEEEESSCC
T ss_pred HHHHCCC--CceEEEECCCEEEEEeCCcC
Confidence 9999987 99999999999999999988
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=3.8e-24 Score=210.18 Aligned_cols=151 Identities=17% Similarity=0.098 Sum_probs=121.2
Q ss_pred HHHHhcCCccccccCCCCceeEEEEEeCCCcEEEEEEccccCh------------------hhHHHHHHHHHHHHHcCCC
Q 039168 211 ALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSG------------------QGLKEFKNEVNLIAKLQHK 272 (536)
Q Consensus 211 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~hp 272 (536)
.......|++.+.||+|+||.||+|.+.+|+.||||++..... .....+.+|+.+|++++
T Consensus 85 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~-- 162 (282)
T 1zar_A 85 LVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-- 162 (282)
T ss_dssp HHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--
Confidence 3344566778899999999999999997799999999864321 13466889999999999
Q ss_pred CceeEeeEEeeCceEEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEc
Q 039168 273 NLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLD 352 (536)
Q Consensus 273 niv~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~ 352 (536)
| +++.+++.. +..++||||+++++|.+ +.. .....++.||+.||.|||+++ |+||||||+|||++
T Consensus 163 ~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~ 227 (282)
T 1zar_A 163 G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS 227 (282)
T ss_dssp T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE
T ss_pred C-CCcCeEEec-cceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE
Confidence 4 555555543 55699999999999987 411 224569999999999999997 99999999999999
Q ss_pred CCCCeEEecccCccccCCCCCccccccccccccccCcchhcC
Q 039168 353 DDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMG 394 (536)
Q Consensus 353 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 394 (536)
++.+||+|||+++. +..++|||++..
T Consensus 228 -~~~vkl~DFG~a~~---------------~~~~~a~e~l~r 253 (282)
T 1zar_A 228 -EEGIWIIDFPQSVE---------------VGEEGWREILER 253 (282)
T ss_dssp -TTEEEECCCTTCEE---------------TTSTTHHHHHHH
T ss_pred -CCcEEEEECCCCeE---------------CCCCCHHHHHHH
Confidence 99999999999963 345789998753
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=3.3e-20 Score=179.72 Aligned_cols=136 Identities=18% Similarity=0.202 Sum_probs=105.8
Q ss_pred CccccccCCCCceeEEEEEe-CCCcE--EEEEEccccChh------------------------hHHHHHHHHHHHHHcC
Q 039168 218 FSDENKLGQGGFGPVYKGTL-ADGKA--IAVKRLSRTSGQ------------------------GLKEFKNEVNLIAKLQ 270 (536)
Q Consensus 218 ~~~~~~lg~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~ 270 (536)
|++.+.||+|+||.||+|.+ .+|+. ||||++...... ....+.+|+.+|++++
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 57788999999999999998 67888 999987543111 1236788999999998
Q ss_pred CCCc--eeEeeEEeeCceEEEEEeecCC-C----ChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHh-cCCCCCeeeC
Q 039168 271 HKNL--VRLLGCCLEGQELLLIYEYMPN-K----SLDVHLFDATRSVQLDWKRRLSIINGIARGILYLH-EDSRLKIIHR 342 (536)
Q Consensus 271 hpni--v~l~~~~~~~~~~~lv~e~~~~-~----sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH-~~~~~~ivH~ 342 (536)
|+++ +.++.. ...++||||+.+ | +|.++... .++..+..++.||+.||.||| +.+ |+||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~g---ivHr 195 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAE---LVHA 195 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSC---EECS
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCC---EEeC
Confidence 8854 444432 356899999942 4 55554321 224467789999999999999 886 9999
Q ss_pred CCCCCcEEEcCCCCeEEecccCcccc
Q 039168 343 DLKASNVLLDDDMNPKISDFGTARIF 368 (536)
Q Consensus 343 Dikp~NIll~~~~~~kl~Dfg~a~~~ 368 (536)
||||+|||+++ .++|+|||++...
T Consensus 196 Dlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 196 DLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SCSTTSEEESS--SEEECCCTTCEET
T ss_pred CCCHHHEEEcC--cEEEEECcccccC
Confidence 99999999998 9999999999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.71 E-value=4.2e-18 Score=171.93 Aligned_cols=139 Identities=14% Similarity=0.149 Sum_probs=101.1
Q ss_pred cCCccccccCCCCceeEEEEEeCCCcEEEEEEccccCh--------------hhH--------HHHHHHHHHHHHcCCCC
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSG--------------QGL--------KEFKNEVNLIAKLQHKN 273 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------------~~~--------~~~~~E~~~l~~l~hpn 273 (536)
.-|++.+.||+|++|.||+|...+|+.||||++..... ... -...+|...|.++.+.+
T Consensus 95 ~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 95 DVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp SCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 34899999999999999999998999999998753210 000 11245677777775544
Q ss_pred ceeEeeEEeeCceEEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcC
Q 039168 274 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDD 353 (536)
Q Consensus 274 iv~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~ 353 (536)
+.-..-+... ..+|||||++|.+|..+.. . .....++.||+.+|.+||+.| ||||||||.||||++
T Consensus 175 v~vp~p~~~~--~~~LVME~i~G~~L~~l~~-------~--~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~~ 240 (397)
T 4gyi_A 175 FPVPEPIAQS--RHTIVMSLVDALPMRQVSS-------V--PDPASLYADLIALILRLAKHG---LIHGDFNEFNILIRE 240 (397)
T ss_dssp CSCCCEEEEE--TTEEEEECCSCEEGGGCCC-------C--SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEEE
T ss_pred CCCCeeeecc--CceEEEEecCCccHhhhcc-------c--HHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeC
Confidence 3211111111 2379999999988865541 1 224567899999999999997 999999999999987
Q ss_pred CCC----------eEEecccCcccc
Q 039168 354 DMN----------PKISDFGTARIF 368 (536)
Q Consensus 354 ~~~----------~kl~Dfg~a~~~ 368 (536)
++. +.|+||+-+...
T Consensus 241 dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 241 EKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp EECSSCTTSEEEEEEECCCTTCEET
T ss_pred CCCcccccccccceEEEEeCCcccC
Confidence 763 899999987643
|
| >3a2e_A Ginkbilobin-2; domain 26 unknown function (DUF26), C-X8-C-X2-C motif, antifungal protein, embryo-abundant protein (EAP), plant protein; 2.38A {Ginkgo biloba} | Back alignment and structure |
|---|
Probab=99.65 E-value=7.3e-17 Score=133.06 Aligned_cols=52 Identities=25% Similarity=0.651 Sum_probs=51.2
Q ss_pred CEeeeccCCCChhchHHHHHHHHHHHHHhCCCCcceEEEcCeeEEEeCCCCC
Q 039168 1 FGLYLCKFDITFQSCQRCIATAVKAVMKKCNGTRKAIIWYRECMVRYSDKSL 52 (536)
Q Consensus 1 ygl~~Cr~d~~~~~C~~c~~~a~~~~~~~C~~~~~~~~~~~~C~lrys~~~f 52 (536)
|||+|||||+++++|..||+.|+.++.+.||++++|+||+|.|+||||+++|
T Consensus 57 ygl~qC~~Dls~~~C~~Cl~~a~~~~~~~C~~~~g~~i~~~~C~lRY~~~~F 108 (108)
T 3a2e_A 57 YGRATCKQSISQSDCTACLSNLVNRIFSICNNAIGARVQLVDCFIQYEQRSF 108 (108)
T ss_dssp EEEEEECTTSCHHHHHHHHHHHHTTHHHHTTSBSSEEEEETTEEEEEESSCC
T ss_pred EEEEEEcCCCCHHHHHHHHHHHHHHHHHHCCCCceEEEECCCEEEEEeCCcC
Confidence 8999999999999999999999999999999999999999999999999988
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.41 E-value=8.5e-13 Score=127.58 Aligned_cols=145 Identities=16% Similarity=0.092 Sum_probs=114.1
Q ss_pred HHhcCCccccccCCCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHHcC-CCCceeEeeEEeeCceEEEEE
Q 039168 213 EATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQ-HKNLVRLLGCCLEGQELLLIY 291 (536)
Q Consensus 213 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lv~ 291 (536)
.....|++...++.|+.+.||++... ++.+++|+...........+.+|+.+++.+. +..+.+++++....+..|+||
T Consensus 11 ~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~ 89 (263)
T 3tm0_A 11 KLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM 89 (263)
T ss_dssp HHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred HHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEE
Confidence 34467888889999999999999864 6899999986532222346889999999995 677889999999999999999
Q ss_pred eecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcC-------------------------------------
Q 039168 292 EYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHED------------------------------------- 334 (536)
Q Consensus 292 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~------------------------------------- 334 (536)
||++|.+|...+. +......++.+++++|..||+.
T Consensus 90 e~i~G~~l~~~~~--------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (263)
T 3tm0_A 90 SEADGVLCSEEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED 161 (263)
T ss_dssp ECCSSEEHHHHCC--------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTT
T ss_pred EecCCeehhhccC--------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccc
Confidence 9999999876641 1122346788999999999981
Q ss_pred -------------------CCCCeeeCCCCCCcEEEcCCCCeEEecccCcc
Q 039168 335 -------------------SRLKIIHRDLKASNVLLDDDMNPKISDFGTAR 366 (536)
Q Consensus 335 -------------------~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 366 (536)
....++|+|++|.|||++++..+.|+||+.+.
T Consensus 162 ~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp CSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 11348999999999999876556799998874
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.26 E-value=1.5e-11 Score=118.32 Aligned_cols=137 Identities=16% Similarity=0.148 Sum_probs=101.9
Q ss_pred cCCccccccCCCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCC--ceeEeeEEeeCceEEEEEee
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKN--LVRLLGCCLEGQELLLIYEY 293 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn--iv~l~~~~~~~~~~~lv~e~ 293 (536)
..+.+....+.|..+.||++...+|+.+++|+.... ....+.+|+.+++.+.+.+ +.+++.+...++..++||||
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~ 96 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE 96 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred CCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEe
Confidence 345554444466679999998777888999987654 2245778999999996544 55688888888889999999
Q ss_pred cCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCC--------------------------------------
Q 039168 294 MPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDS-------------------------------------- 335 (536)
Q Consensus 294 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~-------------------------------------- 335 (536)
++|.+|. ... .+ ...++.++++.|..||...
T Consensus 97 i~G~~l~--~~~------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (264)
T 1nd4_A 97 VPGQDLL--SSH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGL 165 (264)
T ss_dssp CSSEETT--TSC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTC
T ss_pred cCCcccC--cCc------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCc
Confidence 9999884 211 11 1256677888888888642
Q ss_pred -----------------CCCeeeCCCCCCcEEEcCCCCeEEecccCcc
Q 039168 336 -----------------RLKIIHRDLKASNVLLDDDMNPKISDFGTAR 366 (536)
Q Consensus 336 -----------------~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 366 (536)
...++|+|++|.|||+++++.+.|+||+.+.
T Consensus 166 ~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 166 APAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp CHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred cHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1139999999999999877666799999875
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.10 E-value=3.9e-10 Score=114.09 Aligned_cols=143 Identities=14% Similarity=0.243 Sum_probs=107.8
Q ss_pred ccccccCCCCceeEEEEEeCCCcEEEEEEcc--ccC-hhhHHHHHHHHHHHHHcCC--CCceeEeeEEeeC---ceEEEE
Q 039168 219 SDENKLGQGGFGPVYKGTLADGKAIAVKRLS--RTS-GQGLKEFKNEVNLIAKLQH--KNLVRLLGCCLEG---QELLLI 290 (536)
Q Consensus 219 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~h--pniv~l~~~~~~~---~~~~lv 290 (536)
...+.|+.|.++.||+.... +..+++|+.. ... ......+.+|+.+++.|.. ..+++++.++.+. +..++|
T Consensus 41 ~~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v 119 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI 119 (359)
T ss_dssp CEEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred ceEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence 34678999999999999875 4688889876 322 1234568889999999974 5678888888776 458999
Q ss_pred EeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCC-----------------------------------
Q 039168 291 YEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDS----------------------------------- 335 (536)
Q Consensus 291 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~----------------------------------- 335 (536)
|||++|..+.+.. ...++..+...++.++++.|..||...
T Consensus 120 me~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (359)
T 3dxp_A 120 MEFVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI 194 (359)
T ss_dssp EECCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred EEecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence 9999998885422 123678888899999999999999731
Q ss_pred --------------------CCCeeeCCCCCCcEEEcCCCC--eEEecccCccc
Q 039168 336 --------------------RLKIIHRDLKASNVLLDDDMN--PKISDFGTARI 367 (536)
Q Consensus 336 --------------------~~~ivH~Dikp~NIll~~~~~--~kl~Dfg~a~~ 367 (536)
...++|+|++|.|||+++++. +.|.||+.+..
T Consensus 195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 246999999999999997753 68999998863
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.00 E-value=3.4e-10 Score=111.83 Aligned_cols=186 Identities=18% Similarity=0.220 Sum_probs=121.0
Q ss_pred ccccCCCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHHcC-CCC--ceeEeeEEeeCc---eEEEEEeec
Q 039168 221 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQ-HKN--LVRLLGCCLEGQ---ELLLIYEYM 294 (536)
Q Consensus 221 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpn--iv~l~~~~~~~~---~~~lv~e~~ 294 (536)
.+.++.|....||+.. ..+++|+.... .....+.+|..+|+.+. +.. +.+++....... ..|+|||++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 4568999999999875 46889986432 44567889999999984 322 344544433332 348899999
Q ss_pred CCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcC----------------------------------------
Q 039168 295 PNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHED---------------------------------------- 334 (536)
Q Consensus 295 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---------------------------------------- 334 (536)
+|.++..... ..++..+...++.++++.|..||+.
T Consensus 99 ~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 99 KGVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp CCEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred CCeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 9998875432 2366777778888888888888851
Q ss_pred ---------------CCCCeeeCCCCCCcEEEcC--CCCeEEecccCccccCCCCCccccc------------ccccccc
Q 039168 335 ---------------SRLKIIHRDLKASNVLLDD--DMNPKISDFGTARIFGGNQNQANTN------------IIAGTYG 385 (536)
Q Consensus 335 ---------------~~~~ivH~Dikp~NIll~~--~~~~kl~Dfg~a~~~~~~~~~~~~~------------~~~gt~~ 385 (536)
....++|+|++|.||++++ ...+.|+||+.+..-.......... .+....+
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~ 253 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYK 253 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHT
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcC
Confidence 1235899999999999998 4567899999986421100000000 0000011
Q ss_pred ccC-cchhcCCCCCccchHHHHHHHHHHHHhCCCC
Q 039168 386 YMA-PEYAMGGIFSIKSDVFSFGVLLLEIISGRKN 419 (536)
Q Consensus 386 y~a-PE~~~~~~~~~~~DvwslG~il~elltg~~p 419 (536)
... |+.... .....+.|+++.++|.+.+|..+
T Consensus 254 ~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~ 286 (304)
T 3sg8_A 254 HKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMD 286 (304)
T ss_dssp CSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHH
T ss_pred CCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHH
Confidence 112 222211 12236899999999999999866
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.56 E-value=6.8e-07 Score=88.09 Aligned_cols=136 Identities=20% Similarity=0.150 Sum_probs=94.2
Q ss_pred ccccCCCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHHcCCC---CceeEeeEEe-eCceEEEEEeecCC
Q 039168 221 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHK---NLVRLLGCCL-EGQELLLIYEYMPN 296 (536)
Q Consensus 221 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp---niv~l~~~~~-~~~~~~lv~e~~~~ 296 (536)
.+.++.|....||+. +..+++|+.. .......+.+|..+|+.|.+. .+.+.+.+.. ..+..++|||+++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 456888999999988 5778888843 234456789999999999752 3556666664 44567899999999
Q ss_pred CChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcC------------------------------------------
Q 039168 297 KSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHED------------------------------------------ 334 (536)
Q Consensus 297 ~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~------------------------------------------ 334 (536)
..+...... .++..+...++.++.+.|..||+.
T Consensus 98 ~~l~~~~~~-----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 98 QILGEDGMA-----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp EECHHHHHT-----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred eECchhhhh-----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 988753211 133444444455555555555432
Q ss_pred ---------------CCCCeeeCCCCCCcEEEcC---CCCe-EEecccCccc
Q 039168 335 ---------------SRLKIIHRDLKASNVLLDD---DMNP-KISDFGTARI 367 (536)
Q Consensus 335 ---------------~~~~ivH~Dikp~NIll~~---~~~~-kl~Dfg~a~~ 367 (536)
....++|+|++|.|||+++ ++.+ .|+||+.+..
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2235799999999999997 4564 8999998864
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.47 E-value=1e-06 Score=84.87 Aligned_cols=134 Identities=16% Similarity=0.139 Sum_probs=96.0
Q ss_pred ccCCCCce-eEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHHcCC-CCceeEeeEEeeCceEEEEEeecCCCCh
Q 039168 223 KLGQGGFG-PVYKGTLA-DGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQH-KNLVRLLGCCLEGQELLLIYEYMPNKSL 299 (536)
Q Consensus 223 ~lg~G~~g-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~l~~~~~~~~~~~lv~e~~~~~sL 299 (536)
.+..|..+ .||+.... ++..+++|+-... ....+.+|...|+.+.. --+.+++.++.+.+..++|||+++|.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 34555554 68988765 4678999976432 34678889999999853 2367788899999999999999999888
Q ss_pred hhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcC---------------------------------------------
Q 039168 300 DVHLFDATRSVQLDWKRRLSIINGIARGILYLHED--------------------------------------------- 334 (536)
Q Consensus 300 ~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~--------------------------------------------- 334 (536)
....... ......+..++++.|..||..
T Consensus 108 ~~~~~~~-------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 108 FQVLEEY-------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp HHHHHHC-------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred cccccCC-------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 7654221 112234556666666666631
Q ss_pred ----------CCCCeeeCCCCCCcEEEcCCCCeEEecccCcc
Q 039168 335 ----------SRLKIIHRDLKASNVLLDDDMNPKISDFGTAR 366 (536)
Q Consensus 335 ----------~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 366 (536)
....++|+|+++.|||+++++.+-|+||+.+.
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 11237999999999999987767799999875
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.43 E-value=5e-07 Score=90.97 Aligned_cols=81 Identities=9% Similarity=0.020 Sum_probs=57.5
Q ss_pred cccc-CCCCceeEEEEEeC-------CCcEEEEEEccccC---hhhHHHHHHHHHHHHHcCC---CCceeEeeEEeeC--
Q 039168 221 ENKL-GQGGFGPVYKGTLA-------DGKAIAVKRLSRTS---GQGLKEFKNEVNLIAKLQH---KNLVRLLGCCLEG-- 284 (536)
Q Consensus 221 ~~~l-g~G~~g~Vy~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h---pniv~l~~~~~~~-- 284 (536)
.+.| +.|....+|+.... ++..+++|+..... ......+.+|+.+++.|.. -.+.+++.+..+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 4567 88999999998764 26789999765432 1012457789999988843 3567788777654
Q ss_pred -ceEEEEEeecCCCChhh
Q 039168 285 -QELLLIYEYMPNKSLDV 301 (536)
Q Consensus 285 -~~~~lv~e~~~~~sL~~ 301 (536)
+..++|||+++|..+..
T Consensus 105 ~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp TSSCEEEEECCCCBCCCB
T ss_pred cCCceEEEEecCCCChhh
Confidence 35689999999987654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.19 E-value=7.1e-06 Score=81.69 Aligned_cols=141 Identities=18% Similarity=0.263 Sum_probs=81.2
Q ss_pred ccccCCCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHHcCC--CCceeEee------EEeeCceEEEEEe
Q 039168 221 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQH--KNLVRLLG------CCLEGQELLLIYE 292 (536)
Q Consensus 221 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--pniv~l~~------~~~~~~~~~lv~e 292 (536)
.+.|+.|..+.||+....++ .+++|+.... . ..+..|..+++.|.. -.+.+++. +....+..+++||
T Consensus 37 ~~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~-~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~ 111 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTDSG-AVCLKRIHRP-E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD 111 (346)
T ss_dssp EEECC----CEEEEEEETTE-EEEEEEECSC-H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred eeeccccccCcEEEEEeCCC-CEEEEecCCC-H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence 34566677899999987554 5899988752 2 334456666665531 12333332 2234677899999
Q ss_pred ecCCCChhh--------------hhhcccCCC-----------CCCHHHH------------------------------
Q 039168 293 YMPNKSLDV--------------HLFDATRSV-----------QLDWKRR------------------------------ 317 (536)
Q Consensus 293 ~~~~~sL~~--------------~l~~~~~~~-----------~l~~~~~------------------------------ 317 (536)
|++|..+.. .++...... ...|...
T Consensus 112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 191 (346)
T 2q83_A 112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE 191 (346)
T ss_dssp CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence 999976531 111111100 0122111
Q ss_pred -HHHHHHHHHHHHHHhc----------CCCCCeeeCCCCCCcEEEcCCCCeEEecccCcc
Q 039168 318 -LSIINGIARGILYLHE----------DSRLKIIHRDLKASNVLLDDDMNPKISDFGTAR 366 (536)
Q Consensus 318 -~~i~~qi~~al~~LH~----------~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 366 (536)
..+..++..++.+|++ .....++|+|+++.|||++.++.+.|+||+.+.
T Consensus 192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 1111223445666653 013469999999999999888899999999874
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.17 E-value=6.2e-06 Score=84.24 Aligned_cols=75 Identities=11% Similarity=0.178 Sum_probs=50.4
Q ss_pred ccccCCCCceeEEEEEeC-CCcEEEEEEccccCh-------hhHHHHHHHHHHHHHcCC--CC-ceeEeeEEeeCceEEE
Q 039168 221 ENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG-------QGLKEFKNEVNLIAKLQH--KN-LVRLLGCCLEGQELLL 289 (536)
Q Consensus 221 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h--pn-iv~l~~~~~~~~~~~l 289 (536)
.+.||.|..+.||++... +++.++||....... ...+.+..|.++|+.+.. |. +.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 568999999999999764 478899997643211 123456789999988843 43 4455543 3445689
Q ss_pred EEeecCCC
Q 039168 290 IYEYMPNK 297 (536)
Q Consensus 290 v~e~~~~~ 297 (536)
|||++++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999874
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=98.00 E-value=5.9e-05 Score=74.16 Aligned_cols=139 Identities=19% Similarity=0.206 Sum_probs=93.5
Q ss_pred cccccCCCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHHcC---CCCceeEeeEEeeCceEEEEEeecCC
Q 039168 220 DENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQ---HKNLVRLLGCCLEGQELLLIYEYMPN 296 (536)
Q Consensus 220 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~l~~~~~~~~~~~lv~e~~~~ 296 (536)
..+.|+.|....+|+... ++..+++|+.... ....+..|...|+.|. ...+++++.+....+..++||||+++
T Consensus 40 ~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred eeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 356799999999999986 4678899986543 3567889999999884 35688888888878889999999999
Q ss_pred CChhh-----------hhhcccC-C------------------CCCCHHHHHH---HH----------------HHHHHH
Q 039168 297 KSLDV-----------HLFDATR-S------------------VQLDWKRRLS---II----------------NGIARG 327 (536)
Q Consensus 297 ~sL~~-----------~l~~~~~-~------------------~~l~~~~~~~---i~----------------~qi~~a 327 (536)
..+.. .|+.... . ..-+|..... +. .++++.
T Consensus 116 ~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~ 195 (312)
T 3jr1_A 116 SKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQI 195 (312)
T ss_dssp CCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHH
T ss_pred CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHH
Confidence 87532 1222111 0 0113433210 11 112222
Q ss_pred H-HHHhc-CCCCCeeeCCCCCCcEEEcCCCCeEEeccc
Q 039168 328 I-LYLHE-DSRLKIIHRDLKASNVLLDDDMNPKISDFG 363 (536)
Q Consensus 328 l-~~LH~-~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg 363 (536)
+ ..|.. .....++|+|+.+.|++++.++ +.|.||.
T Consensus 196 l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 196 VADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 2 23432 2245799999999999999887 8899974
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.97 E-value=3.4e-05 Score=74.95 Aligned_cols=81 Identities=19% Similarity=0.191 Sum_probs=59.9
Q ss_pred cCCccccccCCCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHHcCCC---CceeEeeEEeeCceEEEEEe
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHK---NLVRLLGCCLEGQELLLIYE 292 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp---niv~l~~~~~~~~~~~lv~e 292 (536)
......+.+|.|..+.||+.+..+|+.|++|+...........+..|+..|+.|... -+.+++.+. .-++|||
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e 90 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAME 90 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEE
T ss_pred CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEE
Confidence 345567789999999999999999999999987655444445688999999998532 344555442 2378999
Q ss_pred ecCCCChh
Q 039168 293 YMPNKSLD 300 (536)
Q Consensus 293 ~~~~~sL~ 300 (536)
|++++...
T Consensus 91 ~l~~~~~~ 98 (288)
T 3f7w_A 91 WVDERPPT 98 (288)
T ss_dssp CCCCCCCC
T ss_pred eecccCCC
Confidence 99876543
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.78 E-value=0.00012 Score=75.18 Aligned_cols=77 Identities=14% Similarity=0.085 Sum_probs=46.8
Q ss_pred CCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCCccccccccc--cccccCcchhcCC---CCCccchHHHHHHHHH
Q 039168 337 LKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAG--TYGYMAPEYAMGG---IFSIKSDVFSFGVLLL 411 (536)
Q Consensus 337 ~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~---~~~~~~DvwslG~il~ 411 (536)
..++|+|++|.|||+++++ ++|+||+.+..-.. ... ...... ...|++|+..... .-....++..+...+|
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p-~~D--la~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPM-GFD--IGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTW 307 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEECH-HHH--HHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccCch-HHH--HHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence 3699999999999999876 99999998864210 000 000111 1345666654321 1122345567788888
Q ss_pred HHHhCC
Q 039168 412 EIISGR 417 (536)
Q Consensus 412 elltg~ 417 (536)
+.+++.
T Consensus 308 ~~y~~~ 313 (420)
T 2pyw_A 308 NLFNKR 313 (420)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 877653
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.72 E-value=0.00016 Score=71.26 Aligned_cols=143 Identities=17% Similarity=0.135 Sum_probs=80.2
Q ss_pred ccccCCCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCC--ceeEeeE------EeeCceEEEEEe
Q 039168 221 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKN--LVRLLGC------CLEGQELLLIYE 292 (536)
Q Consensus 221 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn--iv~l~~~------~~~~~~~~lv~e 292 (536)
.+.|+.|....+|+....++ .+++|+..... ..+.+..|..+++.|.... +.+++.. ....+..+++++
T Consensus 27 ~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~ 103 (322)
T 2ppq_A 27 YKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALIS 103 (322)
T ss_dssp EEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEE
T ss_pred eeccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEE
Confidence 34677888899999987655 68899876521 1234567888887774222 2333321 223466799999
Q ss_pred ecCCCChhhh--------------hhcccCC---C---CC---CHHHHHH------------HHHHHHHHHHHHhcC---
Q 039168 293 YMPNKSLDVH--------------LFDATRS---V---QL---DWKRRLS------------IINGIARGILYLHED--- 334 (536)
Q Consensus 293 ~~~~~sL~~~--------------l~~~~~~---~---~l---~~~~~~~------------i~~qi~~al~~LH~~--- 334 (536)
|++|..+... ++..... . .. .|...+. +...+.+.+..++..
T Consensus 104 ~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~ 183 (322)
T 2ppq_A 104 FLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPK 183 (322)
T ss_dssp CCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCC
T ss_pred eCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcc
Confidence 9998765321 1111000 0 01 1211100 001133445555421
Q ss_pred -CCCCeeeCCCCCCcEEEcCCCCeEEecccCcc
Q 039168 335 -SRLKIIHRDLKASNVLLDDDMNPKISDFGTAR 366 (536)
Q Consensus 335 -~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 366 (536)
....++|+|+++.|||++++..+.|+||+.+.
T Consensus 184 ~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 184 DLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp SSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 13368999999999999987556899998875
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.63 E-value=0.00013 Score=75.23 Aligned_cols=74 Identities=15% Similarity=0.242 Sum_probs=51.5
Q ss_pred ccccCCCCceeEEEEEeCC--------CcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCc-eeEeeEEeeCceEEEEE
Q 039168 221 ENKLGQGGFGPVYKGTLAD--------GKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNL-VRLLGCCLEGQELLLIY 291 (536)
Q Consensus 221 ~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpni-v~l~~~~~~~~~~~lv~ 291 (536)
.+.|+.|....||+....+ ++.+++|+..... ..+.+.+|..+++.|...++ .++++.+.+ .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 4578889999999998653 5789999874321 12455679999998854333 566766542 3899
Q ss_pred eecCCCChh
Q 039168 292 EYMPNKSLD 300 (536)
Q Consensus 292 e~~~~~sL~ 300 (536)
||++|.++.
T Consensus 152 e~l~G~~l~ 160 (429)
T 1nw1_A 152 EYIPSRPLS 160 (429)
T ss_dssp CCCCEEECC
T ss_pred EEeCCcccC
Confidence 999875553
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.55 E-value=0.00039 Score=70.19 Aligned_cols=141 Identities=17% Similarity=0.227 Sum_probs=84.5
Q ss_pred ccccCCCCceeEEEEEeC--------CCcEEEEEEccccChhhHHHHHHHHHHHHHcCC-CCceeEeeEEeeCceEEEEE
Q 039168 221 ENKLGQGGFGPVYKGTLA--------DGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQH-KNLVRLLGCCLEGQELLLIY 291 (536)
Q Consensus 221 ~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~l~~~~~~~~~~~lv~ 291 (536)
.+.|..|-...+|+.... +++.+++|+.... ........+|..+++.|.. .-..++++.+.+ .+||
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~ 129 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE 129 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence 356777888899999864 3578999986432 2335666789999988843 333566666543 2999
Q ss_pred eecCCCChhhh-h----------------hccc--CCCCCC--HHHHHHHHHHHHH-------------------HHHH-
Q 039168 292 EYMPNKSLDVH-L----------------FDAT--RSVQLD--WKRRLSIINGIAR-------------------GILY- 330 (536)
Q Consensus 292 e~~~~~sL~~~-l----------------~~~~--~~~~l~--~~~~~~i~~qi~~-------------------al~~- 330 (536)
||++|..|..- + +... ...... +.++.+++.++.. .+..
T Consensus 130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L 209 (379)
T 3feg_A 130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL 209 (379)
T ss_dssp ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence 99998776421 1 1100 011122 3455555544322 1222
Q ss_pred ---HhcC-CCCCeeeCCCCCCcEEEcCC----CCeEEecccCcc
Q 039168 331 ---LHED-SRLKIIHRDLKASNVLLDDD----MNPKISDFGTAR 366 (536)
Q Consensus 331 ---LH~~-~~~~ivH~Dikp~NIll~~~----~~~kl~Dfg~a~ 366 (536)
|... ....++|+|+.+.|||++++ +.+.|+||..+.
T Consensus 210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 3222 23468999999999999876 789999999875
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.55 E-value=0.00094 Score=65.84 Aligned_cols=142 Identities=14% Similarity=0.170 Sum_probs=83.3
Q ss_pred cccCCCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHHcCCC--CceeEeeE-----EeeCceEEEEEeec
Q 039168 222 NKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHK--NLVRLLGC-----CLEGQELLLIYEYM 294 (536)
Q Consensus 222 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp--niv~l~~~-----~~~~~~~~lv~e~~ 294 (536)
..|+ |....||+....+|+.+++|+..... .....+..|..+++.|... .+++++.. ....+..+++||++
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 3566 88889999887778889999986321 1335677788888887422 23444432 22355678999999
Q ss_pred CCCChhh----h----------hhccc------CCCCCCHHHH----------------------HHHHHHHHHHHHHHh
Q 039168 295 PNKSLDV----H----------LFDAT------RSVQLDWKRR----------------------LSIINGIARGILYLH 332 (536)
Q Consensus 295 ~~~sL~~----~----------l~~~~------~~~~l~~~~~----------------------~~i~~qi~~al~~LH 332 (536)
+|..+.. . ++... .....++... ...+.+++..+.-+-
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 9865431 0 11100 0011221110 111222222222221
Q ss_pred c-CCCCCeeeCCCCCCcEEEcCCCCeEEecccCccc
Q 039168 333 E-DSRLKIIHRDLKASNVLLDDDMNPKISDFGTARI 367 (536)
Q Consensus 333 ~-~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 367 (536)
. .....++|+|+++.|||++ + .+.|+||+.+..
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 1 1234589999999999999 4 899999988753
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.51 E-value=0.00021 Score=69.83 Aligned_cols=75 Identities=8% Similarity=0.105 Sum_probs=47.8
Q ss_pred CccccccCCCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCc-eeEeeEEeeCceEEEEEeec-C
Q 039168 218 FSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNL-VRLLGCCLEGQELLLIYEYM-P 295 (536)
Q Consensus 218 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpni-v~l~~~~~~~~~~~lv~e~~-~ 295 (536)
+...+.|+.|....+|+. ..+++|+........ ....+|+.+++.+....+ .+++... .+.-++++||+ +
T Consensus 20 ~~~i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~ 91 (301)
T 3dxq_A 20 YTGPLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAG 91 (301)
T ss_dssp CCSCEEEESCSSEEEEEE-----TTEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTT
T ss_pred ccceeEcCCcccccccee-----eeEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCC
Confidence 344778999999999998 568888876432211 123568888887743333 4555443 33457899999 7
Q ss_pred CCChh
Q 039168 296 NKSLD 300 (536)
Q Consensus 296 ~~sL~ 300 (536)
+.++.
T Consensus 92 g~~l~ 96 (301)
T 3dxq_A 92 AQTMS 96 (301)
T ss_dssp CEECC
T ss_pred CccCC
Confidence 76654
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.41 E-value=0.001 Score=65.80 Aligned_cols=142 Identities=15% Similarity=0.150 Sum_probs=73.7
Q ss_pred ccccCCCCcee-EEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHHcCC--CCceeEeeEEeeCceEEEEEeecCCC
Q 039168 221 ENKLGQGGFGP-VYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQH--KNLVRLLGCCLEGQELLLIYEYMPNK 297 (536)
Q Consensus 221 ~~~lg~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--pniv~l~~~~~~~~~~~lv~e~~~~~ 297 (536)
.+.|+.|.... +|+....+++.+++|....... ..+..|+.+++.+.. -.+.+++.+..+.+ +++||++.+.
T Consensus 23 ~~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~ 97 (333)
T 3csv_A 23 RTPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDA 97 (333)
T ss_dssp ECC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSC
T ss_pred eeECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCc
Confidence 34566665554 6677654477788886543321 234557777777742 23455666533333 7899999876
Q ss_pred Chhhhhhccc---------------------C--CCCCCHHHHH-------HH-------------HHHHHHHHHHHh--
Q 039168 298 SLDVHLFDAT---------------------R--SVQLDWKRRL-------SI-------------INGIARGILYLH-- 332 (536)
Q Consensus 298 sL~~~l~~~~---------------------~--~~~l~~~~~~-------~i-------------~~qi~~al~~LH-- 332 (536)
.+..++.... . ...++..... .+ ...+...+..+.
T Consensus 98 ~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~ 177 (333)
T 3csv_A 98 LFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSA 177 (333)
T ss_dssp BHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred chHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHh
Confidence 6644332100 0 0112211100 00 001111222221
Q ss_pred -cCCCCCeeeCCCCCCcEEEcCC----CCeEEecccCccc
Q 039168 333 -EDSRLKIIHRDLKASNVLLDDD----MNPKISDFGTARI 367 (536)
Q Consensus 333 -~~~~~~ivH~Dikp~NIll~~~----~~~kl~Dfg~a~~ 367 (536)
......++|+|+.+.|||++.+ +.+.|+||+.+..
T Consensus 178 ~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 178 QLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp HCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred cccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 1123469999999999999874 6799999998864
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.36 E-value=0.00069 Score=70.19 Aligned_cols=75 Identities=13% Similarity=0.074 Sum_probs=49.7
Q ss_pred ccccCCCCceeEEEEEeCC-CcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCc-eeEeeEEeeCceEEEEEeecCCCC
Q 039168 221 ENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNL-VRLLGCCLEGQELLLIYEYMPNKS 298 (536)
Q Consensus 221 ~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpni-v~l~~~~~~~~~~~lv~e~~~~~s 298 (536)
.+.|+.|-...+|+....+ +..+++|+......... .-.+|..+++.|...++ .++++.+. + .+|+||++|..
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~-~---G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEII-NREREKKISCILYNKNIAKKIYVFFT-N---GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCS-CHHHHHHHHHHHTTSSSBCCEEEEET-T---EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhc-CHHHHHHHHHHHHhcCCCCCEEEEeC-C---eEEEEeeCCcc
Confidence 4578889899999998765 57888998754322111 12579999999965544 56777663 2 25999999866
Q ss_pred hh
Q 039168 299 LD 300 (536)
Q Consensus 299 L~ 300 (536)
|.
T Consensus 188 l~ 189 (458)
T 2qg7_A 188 LS 189 (458)
T ss_dssp CC
T ss_pred CC
Confidence 53
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.28 E-value=0.0018 Score=64.34 Aligned_cols=68 Identities=10% Similarity=0.100 Sum_probs=45.0
Q ss_pred CCCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHHcCC---CCceeEeeE------EeeCceEEEEEeecC
Q 039168 225 GQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQH---KNLVRLLGC------CLEGQELLLIYEYMP 295 (536)
Q Consensus 225 g~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---pniv~l~~~------~~~~~~~~lv~e~~~ 295 (536)
|.|....||+....+| .+++|+...... ..|+.+++.|.. |++++.+.. ....+..+++|+|++
T Consensus 32 G~g~~N~vy~v~~~~g-~~vLK~~~~~~~------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~ 104 (339)
T 3i1a_A 32 GADTNAFAYQADSESK-SYFIKLKYGYHD------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIH 104 (339)
T ss_dssp TSCSSCEEEEEECSSC-EEEEEEEECSSC------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCC
T ss_pred cCccccceEEEEeCCC-CEEEEEecCccc------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccC
Confidence 3444689999998777 899998765431 356666666632 224444432 234577899999999
Q ss_pred CCCh
Q 039168 296 NKSL 299 (536)
Q Consensus 296 ~~sL 299 (536)
|..+
T Consensus 105 G~~~ 108 (339)
T 3i1a_A 105 APNG 108 (339)
T ss_dssp CCBT
T ss_pred CCcC
Confidence 8766
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.23 E-value=0.00057 Score=68.78 Aligned_cols=74 Identities=12% Similarity=0.136 Sum_probs=45.9
Q ss_pred ccccCCCCceeEEEEEeCC---------CcEEEEEEccccChhhHHHHHHHHHHHHHcCCCC-ceeEeeEEeeCceEEEE
Q 039168 221 ENKLGQGGFGPVYKGTLAD---------GKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKN-LVRLLGCCLEGQELLLI 290 (536)
Q Consensus 221 ~~~lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn-iv~l~~~~~~~~~~~lv 290 (536)
.+.|+.|....+|+....+ ++.+++|+....... ......|..+++.+...+ +.++++.. . -++|
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v 112 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRI 112 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec--C--CcEE
Confidence 4568888889999998654 268888887543221 122357888888885333 44666554 2 2689
Q ss_pred EeecCCCCh
Q 039168 291 YEYMPNKSL 299 (536)
Q Consensus 291 ~e~~~~~sL 299 (536)
|||++|..+
T Consensus 113 ~e~i~G~~l 121 (369)
T 3c5i_A 113 EEWLYGDPL 121 (369)
T ss_dssp EECCCSEEC
T ss_pred EEEecCCcC
Confidence 999998654
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.08 E-value=0.0021 Score=58.71 Aligned_cols=104 Identities=12% Similarity=0.035 Sum_probs=67.4
Q ss_pred CCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCCcc
Q 039168 296 NKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQA 375 (536)
Q Consensus 296 ~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 375 (536)
.-+|.++|.. ...+++++++|.++.|.+.+|.-+-... . -..+=+.|..|++..+|.|.+.+ ..+.
T Consensus 32 ~vSL~eIL~~--~~~PlsEEqaWALc~Qc~~~L~~~~~~~-~-~~~~i~~~~~i~l~~dG~V~f~~-~~s~--------- 97 (229)
T 2yle_A 32 ALSLEEILRL--YNQPINEEQAWAVCYQCCGSLRAAARRR-Q-PRHRVRSAAQIRVWRDGAVTLAP-AADD--------- 97 (229)
T ss_dssp EEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT-C-CCCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred cccHHHHHHH--cCCCcCHHHHHHHHHHHHHHHHhhhhcc-c-CCceecCCcceEEecCCceeccc-cccc---------
Confidence 3467888854 4457999999999999999987762211 1 12333457999999999998764 1110
Q ss_pred ccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCC
Q 039168 376 NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKN 419 (536)
Q Consensus 376 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p 419 (536)
.....+.+||... ...+.+.-|||||+++|.-+--..|
T Consensus 98 -----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 -----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp --------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred -----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 0123466888763 3456788999999999999976554
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.10 E-value=0.032 Score=56.93 Aligned_cols=75 Identities=12% Similarity=0.157 Sum_probs=49.9
Q ss_pred ccccCCCCceeEEEEEeCC--------CcEEEEEEccccChhhHHHHHHHHHHHHHcCC-CCceeEeeEEeeCceEEEEE
Q 039168 221 ENKLGQGGFGPVYKGTLAD--------GKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQH-KNLVRLLGCCLEGQELLLIY 291 (536)
Q Consensus 221 ~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~l~~~~~~~~~~~lv~ 291 (536)
.+.|..|-...+|+....+ ++.+++|+....... .-...+|..+++.+.. .-..++++.+. -++|+
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADFP----EGRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEE
Confidence 4567788889999998753 588999986543321 1123578888888853 33445665432 27899
Q ss_pred eecCCCChh
Q 039168 292 EYMPNKSLD 300 (536)
Q Consensus 292 e~~~~~sL~ 300 (536)
||++|..|.
T Consensus 150 efI~G~~l~ 158 (424)
T 3mes_A 150 EFIDGEPLT 158 (424)
T ss_dssp ECCCSEECC
T ss_pred EEeCCccCC
Confidence 999997653
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=94.99 E-value=0.069 Score=54.10 Aligned_cols=29 Identities=24% Similarity=0.406 Sum_probs=24.6
Q ss_pred CeeeCCCCCCcEEE------cCCCCeEEecccCcc
Q 039168 338 KIIHRDLKASNVLL------DDDMNPKISDFGTAR 366 (536)
Q Consensus 338 ~ivH~Dikp~NIll------~~~~~~kl~Dfg~a~ 366 (536)
.++|+|+.+.|||+ +++..++++||..+.
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 35799999999999 456679999999875
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=88.71 E-value=0.86 Score=41.35 Aligned_cols=115 Identities=10% Similarity=0.080 Sum_probs=79.9
Q ss_pred CCCCceeEeeEEeeCceEEEEEeecCCC-ChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCc
Q 039168 270 QHKNLVRLLGCCLEGQELLLIYEYMPNK-SLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASN 348 (536)
Q Consensus 270 ~hpniv~l~~~~~~~~~~~lv~e~~~~~-sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~N 348 (536)
.||+++.. .+-.+++.+.+.++.-+++ ++.. + ..++...+++++.+|+....+++. -+|--|.|+|
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i------k~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~N 109 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I------KSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDE 109 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G------GGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGG
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H------HhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecce
Confidence 57888877 5666677777777654422 2322 2 237889999999999998876664 4788899999
Q ss_pred EEEcCCCCeEEecccCccccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCC
Q 039168 349 VLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNG 421 (536)
Q Consensus 349 Ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~ 421 (536)
|+++.++.+++.=.|+...+ +|. .++...=+-.+=+++..+++++..|.
T Consensus 110 L~f~~~~~p~i~~RGik~~l-------------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 110 LFFTRDGLPIAKTRGLQNVV-------------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp EEECTTSCEEESCCEETTTB-------------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred EEEcCCCCEEEEEccCccCC-------------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 99999999999877765432 121 11222224457788899999987754
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=86.90 E-value=2.5 Score=38.38 Aligned_cols=114 Identities=7% Similarity=0.049 Sum_probs=76.2
Q ss_pred CCCCceeEeeEEeeCceEEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHH-HHhcCCCCCeeeCCCCCCc
Q 039168 270 QHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGIL-YLHEDSRLKIIHRDLKASN 348 (536)
Q Consensus 270 ~hpniv~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~-~LH~~~~~~ivH~Dikp~N 348 (536)
.||++ -..+-.+++.+.+.++.-+++.-...+ ..++...+++++.+|+.... +++. -+|--|.|+|
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i------~~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~N 114 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI------RKTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPEN 114 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH------HTSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH------HhcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCce
Confidence 57877 444446777777777765343222223 23788899999999888777 6654 5788899999
Q ss_pred EEEcCCCCeEEecccCccccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCC
Q 039168 349 VLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNN 420 (536)
Q Consensus 349 Ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~ 420 (536)
|+++.++.+++.=.|+-..+ +|.- .+..-=+-++=+++..++.++..|
T Consensus 115 L~f~~~~~p~i~hRGi~~~l-------------------pP~e-----~~ee~fl~qyKali~all~~K~~F 162 (219)
T 4ano_A 115 LMFNRALEPFFLHVGVKESL-------------------PPDE-----WDDERLLREVKATVLALTEGEYRF 162 (219)
T ss_dssp EEECTTCCEEESCCEETTTB-------------------SSCS-----CCHHHHHHHHHHHHHHHTTCSSCH
T ss_pred EEEeCCCcEEEEEcCCcccC-------------------CCCC-----CCHHHHHHHHHHHHHHHHcCCCCH
Confidence 99999999999877765432 2221 111112335677888888887664
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=82.65 E-value=0.15 Score=52.54 Aligned_cols=61 Identities=8% Similarity=0.083 Sum_probs=18.5
Q ss_pred ccccccCCCCceeEEEEEeCC-CcEEEE------EEcccc--ChhhHHHHHHHHHHHHHcCCCCceeEeeEEe
Q 039168 219 SDENKLGQGGFGPVYKGTLAD-GKAIAV------KRLSRT--SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCL 282 (536)
Q Consensus 219 ~~~~~lg~G~~g~Vy~~~~~~-~~~vav------K~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~ 282 (536)
.+.+.|| ||.||+|.+.. ..+||+ |..... +.+....+.+|..+++.++|||+++.+++..
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence 3456776 99999999864 467888 655432 2233456788999999999999999988765
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 536 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 6e-79 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-73 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-69 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 6e-69 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 8e-69 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 5e-68 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 7e-68 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-67 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-67 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-67 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 5e-67 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-66 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-66 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-66 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 7e-66 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 8e-66 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-65 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-63 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-63 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-63 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 4e-63 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 5e-63 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-62 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-61 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-61 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-60 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-60 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-59 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 8e-59 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-57 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-57 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-55 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-53 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-53 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 8e-51 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 4e-50 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 8e-50 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 8e-50 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-49 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-48 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-48 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-47 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-46 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-46 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-46 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 8e-46 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 8e-46 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-45 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-45 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 6e-44 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 7e-44 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-43 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 4e-42 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-40 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-40 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 6e-39 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-37 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-35 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-35 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-34 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 5e-34 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 8e-29 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-23 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 247 bits (631), Expect = 6e-79
Identities = 71/286 (24%), Positives = 138/286 (48%), Gaps = 20/286 (6%)
Query: 216 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLV 275
+ ++G G FG VYKG A+ + ++ + Q L+ FKNEV ++ K +H N++
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 276 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDS 335
+G Q L ++ ++ SL HL + + + + I A+G+ YLH
Sbjct: 68 LFMGYSTAPQ-LAIVTQWCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLHAK- 123
Query: 336 RLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMG- 394
IIHRDLK++N+ L +D+ KI DFG A + ++G+ +MAPE
Sbjct: 124 --SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 395 --GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVL 452
+S +SDV++FG++L E+++G+ Y + + + + + G+ + V
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLP---YSNINNRDQI---IFMVGRGYLSPDLSKV- 234
Query: 453 KQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSMTIPQ 498
+S P + + + C+++ +RP ++ + + ++P+
Sbjct: 235 -RSNCPKAMKRLM---AECLKKKRDERPLFPQILASIELLARSLPK 276
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 231 bits (591), Expect = 3e-73
Identities = 86/274 (31%), Positives = 132/274 (48%), Gaps = 22/274 (8%)
Query: 216 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLV 275
+LG G FG V+ G +AVK L + S F E NL+ +LQH+ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLV 71
Query: 276 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDS 335
RL + + +I EYM N SL L ++L + L + IA G+ ++ E
Sbjct: 72 RLYAVVTQE-PIYIITEYMENGSLVDFLKT-PSGIKLTINKLLDMAAQIAEGMAFIEE-- 127
Query: 336 RLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGG 395
IHRDL+A+N+L+ D ++ KI+DFG AR+ N+ A + APE G
Sbjct: 128 -RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG-AKFPIKWTAPEAINYG 185
Query: 396 IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQS 455
F+IKSDV+SFG+LL EI++ + Y ++ + G+ ++ P
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRI--PYPGMTNPEVI----QNLERGY--RMVRP----D 233
Query: 456 CAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 489
P+EL + + LC ++ P DRPT + +L
Sbjct: 234 NCPEELYQLM---RLCWKERPEDRPTFDYLRSVL 264
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (565), Expect = 2e-69
Identities = 69/274 (25%), Positives = 115/274 (41%), Gaps = 22/274 (8%)
Query: 216 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLV 275
+ + ++G G FG V+ G + +A+K + R ++F E ++ KL H LV
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLV 63
Query: 276 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDS 335
+L G CLE + L++E+M + L +L + + L + + G +
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSDYLRT--QRGLFAAETLLGMCLDVCEG---MAYLE 118
Query: 336 RLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGG 395
+IHRDL A N L+ ++ K+SDFG R +Q ++ + +PE
Sbjct: 119 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFS 177
Query: 396 IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQS 455
+S KSDV+SFGVL+ E+ S K ++ VE I +
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGK---------------IPYENRSNSEVVEDISTGFRLY 222
Query: 456 CAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 489
I C ++ P DRP S ++ L
Sbjct: 223 KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQL 256
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 221 bits (564), Expect = 6e-69
Identities = 75/275 (27%), Positives = 126/275 (45%), Gaps = 22/275 (8%)
Query: 216 NHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNL 274
+ ++KLG G +G VY+G +AVK L + + ++EF E ++ +++H NL
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 75
Query: 275 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHED 334
V+LLG C +I E+M +L +L + R ++ L + I+ + YL
Sbjct: 76 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYLE-- 132
Query: 335 SRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMG 394
+ IHRDL A N L+ ++ K++DFG +R+ G+ A+ + APE
Sbjct: 133 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG-AKFPIKWTAPESLAY 190
Query: 395 GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQ 454
FSIKSDV++FGVLL EI + + Y + EL++ +
Sbjct: 191 NKFSIKSDVWAFGVLLWEIATYGMS--PYPGIDLSQVY-------------ELLEKDYRM 235
Query: 455 SCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 489
K + C Q +P+DRP+ + +
Sbjct: 236 ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 270
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (563), Expect = 8e-69
Identities = 77/288 (26%), Positives = 132/288 (45%), Gaps = 22/288 (7%)
Query: 216 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLV 275
E KLGQG FG V+ GT +A+K L + + F E ++ KL+H+ LV
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 75
Query: 276 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDS 335
+L + + ++ EYM SL L T + + + IA G+ Y+
Sbjct: 76 QLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYL-RLPQLVDMAAQIASGMAYVE--- 130
Query: 336 RLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGG 395
R+ +HRDL+A+N+L+ +++ K++DFG AR+ N+ A + APE A+ G
Sbjct: 131 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG-AKFPIKWTAPEAALYG 189
Query: 396 IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQS 455
F+IKSDV+SFG+LL E+ + + Y + +L + ++ +
Sbjct: 190 RFTIKSDVWSFGILLTELTTKGRV--PYPGMVNREVL-------------DQVERGYRMP 234
Query: 456 CAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSMTIPQPTEPA 503
C P+ + C +++P +RPT + L + +P
Sbjct: 235 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 282
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 220 bits (561), Expect = 5e-68
Identities = 69/304 (22%), Positives = 121/304 (39%), Gaps = 44/304 (14%)
Query: 214 ATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGL-KEFKNEVNLIAKLQH 271
+ F ++LG G G V+K + G +A K + + + E+ ++ +
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 272 KNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYL 331
+V G E+ + E+M SLD L A R + + + + +G+ YL
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYL 120
Query: 332 HEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEY 391
+ KI+HRD+K SN+L++ K+ DFG + + N GT YM+PE
Sbjct: 121 R--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----ANSFVGTRSYMSPER 174
Query: 392 AMGGIFSIKSDVFSFGVLLLEIISGR-----------------------KNNGFYFSEHG 428
G +S++SD++S G+ L+E+ GR G
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 234
Query: 429 QTLLTYTWKLWCEGHAVELID-------PVLKQSCAPDELLKFIHIGLLCVQQDPADRPT 481
+ L +Y EL+D P L E F++ C+ ++PA+R
Sbjct: 235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVN---KCLIKNPAERAD 291
Query: 482 MSSV 485
+ +
Sbjct: 292 LKQL 295
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (556), Expect = 7e-68
Identities = 71/300 (23%), Positives = 124/300 (41%), Gaps = 26/300 (8%)
Query: 210 LALEATNHFSDENKLGQGGFGPVYKGTLA---DGKAIAVKRLSRTSGQG-LKEFKNEVNL 265
L L+ N + +LG G FG V +G +A+K L + + + +E E +
Sbjct: 3 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQI 62
Query: 266 IAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIA 325
+ +L + +VRL+G C + + L+L+ E L L + ++ +++ ++
Sbjct: 63 MHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVS 119
Query: 326 RGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQAN-TNIIAGTY 384
G+ YL +HRDL A NVLL + KISDFG ++ G + + +
Sbjct: 120 MGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL 176
Query: 385 GYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHA 444
+ APE FS +SDV+S+GV + E +S + Y G ++ +G
Sbjct: 177 KWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK--PYKKMKGPEVM----AFIEQGKR 230
Query: 445 VELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSMTIPQPTEPAF 504
+E P EL + C DRP +V + + ++ E
Sbjct: 231 MECPPEC------PPELYALM---SDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGHH 281
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (553), Expect = 1e-67
Identities = 77/275 (28%), Positives = 118/275 (42%), Gaps = 28/275 (10%)
Query: 216 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLV 275
+G+G FG V G G +AVK + + + F E +++ +L+H NLV
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 63
Query: 276 RLLGCCLEGQE-LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHED 334
+LLG +E + L ++ EYM SL +L RSV L L + + YL
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLE-- 120
Query: 335 SRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMG 394
+HRDL A NVL+ +D K+SDFG + Q+ + APE
Sbjct: 121 -GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK-----LPVKWTAPEALRE 174
Query: 395 GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQ 454
FS KSDV+SFG+LL EI S + Y + ++ +G+ ++ D
Sbjct: 175 KKFSTKSDVWSFGILLWEIYSFGRV--PYPRIPLKDVV----PRVEKGYKMDAPDGC--- 225
Query: 455 SCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 489
P + + + C D A RP+ + L
Sbjct: 226 ---PPAVYEVM---KNCWHLDAAMRPSFLQLREQL 254
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (552), Expect = 1e-67
Identities = 69/274 (25%), Positives = 114/274 (41%), Gaps = 22/274 (8%)
Query: 216 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLV 275
+ +LG G FG V G +A+K + S EF E ++ L H+ LV
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLV 62
Query: 276 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDS 335
+L G C + + + +I EYM N L +L + + ++ L + + + YL
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESK- 119
Query: 336 RLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGG 395
+ +HRDL A N L++D K+SDFG +R ++ ++ + PE M
Sbjct: 120 --QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSK-FPVRWSPPEVLMYS 176
Query: 396 IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQS 455
FS KSD+++FGVL+ EI S K ++ + E I L+
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGK---------------MPYERFTNSETAEHIAQGLRLY 221
Query: 456 CAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 489
K I C + +RPT ++ +
Sbjct: 222 RPHLASEKVYTIMYSCWHEKADERPTFKILLSNI 255
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (555), Expect = 2e-67
Identities = 60/291 (20%), Positives = 114/291 (39%), Gaps = 28/291 (9%)
Query: 221 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGC 280
+ +G+G FG V++G G+ +AVK S + + E+ L+H+N++ +
Sbjct: 8 QESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIAA 65
Query: 281 CLEGQ----ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHED-- 334
+ +L L+ +Y + SL +L + + + + A G+ +LH +
Sbjct: 66 DNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIV 121
Query: 335 ---SRLKIIHRDLKASNVLLDDDMNPKISDFGTARIF--GGNQNQANTNIIAGTYGYMAP 389
+ I HRDLK+ N+L+ + I+D G A + N GT YMAP
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181
Query: 390 EYAMGGI------FSIKSDVFSFGVLLLEIISGRKNNGFYFSE----HGQTLLTYTWKLW 439
E I ++D+++ G++ EI G + + + +
Sbjct: 182 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 241
Query: 440 CEGHAVELIDPVLKQSCAPDELLKFIH-IGLLCVQQDPADRPTMSSVVVML 489
+ + + P + E L+ + I C + A R T + L
Sbjct: 242 RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 292
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (550), Expect = 5e-67
Identities = 74/276 (26%), Positives = 118/276 (42%), Gaps = 28/276 (10%)
Query: 220 DENKLGQGGFGPVYKGTLAD---GKAIAVKRLSRTSGQG--LKEFKNEVNLIAKLQHKNL 274
++ +LG G FG V KG K +AVK L + E E N++ +L + +
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 275 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHED 334
VR++G C E + +L+ E L+ +L + K + +++ ++ G+ YL
Sbjct: 71 VRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLE-- 124
Query: 335 SRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNI-IAGTYGYMAPEYAM 393
+HRDL A NVLL KISDFG ++ ++N + APE
Sbjct: 125 -ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 183
Query: 394 GGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLK 453
FS KSDV+SFGVL+ E S + Y G + + +G +
Sbjct: 184 YYKFSSKSDVWSFGVLMWEAFSYGQK--PYRGMKGSEVT----AMLEKGERMGCPAGC-- 235
Query: 454 QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 489
P E+ + LC D +RP ++V + L
Sbjct: 236 ----PREMYDLM---NLCWTYDVENRPGFAAVELRL 264
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (548), Expect = 1e-66
Identities = 70/281 (24%), Positives = 129/281 (45%), Gaps = 27/281 (9%)
Query: 216 NHFSDENKLGQGGFGPVYKGTLADG-----KAIAVKRLSRTSGQG-LKEFKNEVNLIAKL 269
+ + + +G G FG VYKG L +A+K L + +F E ++ +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 270 QHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGIL 329
H N++RL G + + +++I EYM N +LD L + + + + + ++ GIA G+
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMK 124
Query: 330 YLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNI-IAGTYGYMA 388
YL + +HRDL A N+L++ ++ K+SDFG +R+ + T + A
Sbjct: 125 YLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 181
Query: 389 PEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELI 448
PE F+ SDV+SFG+++ E+++ + + S H ++ I
Sbjct: 182 PEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH---------------EVMKAI 226
Query: 449 DPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 489
+ + D + + C QQ+ A RP + +V +L
Sbjct: 227 NDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSIL 267
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 216 bits (551), Expect = 1e-66
Identities = 75/279 (26%), Positives = 124/279 (44%), Gaps = 34/279 (12%)
Query: 215 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQG---LKEFKNEVNLIAKLQ 270
FSD ++G G FG VY + + + +A+K++S + Q ++ EV + KL+
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 271 HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILY 330
H N ++ GC L L+ EY + D+ L ++ +G +G+ Y
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP---LQEVEIAAVTHGALQGLAY 130
Query: 331 LHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPE 390
LH +IHRD+KA N+LL + K+ DFG+A I A N GT +MAPE
Sbjct: 131 LHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANSFVGTPYWMAPE 181
Query: 391 YAMG---GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVEL 447
+ G + K DV+S G+ +E+ + F+ + + L H +
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAERKP---PLFNMNAMSALY---------HIAQN 229
Query: 448 IDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVV 486
P L+ + F+ C+Q+ P DRPT ++
Sbjct: 230 ESPALQSGHWSEYFRNFV---DSCLQKIPQDRPTSEVLL 265
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 216 bits (550), Expect = 1e-66
Identities = 71/297 (23%), Positives = 128/297 (43%), Gaps = 43/297 (14%)
Query: 213 EATNHFSDE---------NKLGQGGFGPVYKGTLA----DGKAIAVKRL-SRTSGQGLKE 258
EA F+ E +G G FG V G L +A+K L S + + ++
Sbjct: 14 EAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRD 73
Query: 259 FKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRL 318
F +E +++ + H N++ L G + +++I E+M N SLD L Q + +
Sbjct: 74 FLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ--NDGQFTVIQLV 131
Query: 319 SIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTN 378
++ GIA G+ YL + +HRDL A N+L++ ++ K+SDFG +R + +
Sbjct: 132 GMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYT 188
Query: 379 I---IAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYT 435
+ APE F+ SDV+S+G+++ E +++Y
Sbjct: 189 SALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWE------------------VMSYG 230
Query: 436 WKLWCEGHAVELIDPVLKQSCAP---DELLKFIHIGLLCVQQDPADRPTMSSVVVML 489
+ + + ++I+ + + P D + L C Q+D RP +V L
Sbjct: 231 ERPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTL 287
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 213 bits (544), Expect = 7e-66
Identities = 76/302 (25%), Positives = 127/302 (42%), Gaps = 46/302 (15%)
Query: 216 NHFSDENKLGQGGFGPVYKGTL------ADGKAIAVKRLSRTSGQGL-KEFKNEVNLIAK 268
N+ +G+G FG V++ +AVK L + + +F+ E L+A+
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72
Query: 269 LQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATR-------------------- 308
+ N+V+LLG C G+ + L++EYM L+ L +
Sbjct: 73 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132
Query: 309 -SVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARI 367
L +L I +A G+ YL E K +HRDL N L+ ++M KI+DFG +R
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRN 189
Query: 368 FGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEH 427
A +M PE ++ +SDV+++GV+L EI S Y+
Sbjct: 190 IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ--PYYGMA 247
Query: 428 GQTLLTYTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 487
+ ++ +G+ + + P EL + LC + PADRP+ S+
Sbjct: 248 HEEVI----YYVRDGNILACPENC------PLELYNLM---RLCWSKLPADRPSFCSIHR 294
Query: 488 ML 489
+L
Sbjct: 295 IL 296
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (545), Expect = 8e-66
Identities = 76/281 (27%), Positives = 119/281 (42%), Gaps = 30/281 (10%)
Query: 217 HFSDENKLGQGGFGPVYKGTLADGK----AIAVKRLSRTSGQG-LKEFKNEVNLIAKLQH 271
HF +G+G FG VY GTL D AVK L+R + G + +F E ++ H
Sbjct: 30 HF--NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87
Query: 272 KNLVRLLGCCLEGQ-ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILY 330
N++ LLG CL + L++ YM + L + + T + + +
Sbjct: 88 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG----- 142
Query: 331 LHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNI--IAGTYGYMA 388
+ + K +HRDL A N +LD+ K++DFG AR + + N +MA
Sbjct: 143 MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 202
Query: 389 PEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELI 448
E F+ KSDV+SFGVLL E+++ Y + + Y + L+
Sbjct: 203 LESLQTQKFTTKSDVWSFGVLLWELMTRGAP--PYPDVNTFDITVYLLQ------GRRLL 254
Query: 449 DPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 489
P PD L + + L C RP+ S +V +
Sbjct: 255 QP----EYCPDPLYEVM---LKCWHPKAEMRPSFSELVSRI 288
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (543), Expect = 1e-65
Identities = 74/297 (24%), Positives = 112/297 (37%), Gaps = 40/297 (13%)
Query: 216 NHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRTSGQG-LKEFKNEVNLIAK 268
N S LG G FG V + T +AVK L ++ + +E+ +++
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 269 L-QHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFD---------------ATRSVQL 312
L H N+V LLG C G L+I EY L L + L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 313 DWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQ 372
D + LS +A+G+ +L IHRDL A N+LL KI DFG AR +
Sbjct: 143 DLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 373 NQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLL 432
N +MAPE +++ +SDV+S+G+ L E+ S + +
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK--- 256
Query: 433 TYTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 489
++I + + I C DP RPT +V ++
Sbjct: 257 -----------FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 302
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (530), Expect = 1e-63
Identities = 75/304 (24%), Positives = 114/304 (37%), Gaps = 45/304 (14%)
Query: 216 NHFSDENKLGQGGFGPVYKGTL------ADGKAIAVKRLSRTSGQG-LKEFKNEVNLIAK 268
+ LG G FG V T +AVK L + + +E+ ++ +
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 269 L-QHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFD--------------------AT 307
L H+N+V LLG C + LI+EY L +L
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 308 RSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARI 367
L ++ L +A+G+ +L +HRDL A NVL+ KI DFG AR
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 368 FGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEH 427
+ N +MAPE GI++IKSDV+S+G+LL EI S N +
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP-YPGIPV 272
Query: 428 GQTLLTYTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 487
+KL G ++ +E+ + C D RP+ ++
Sbjct: 273 DANF----YKLIQNGFKMDQPFYA------TEEIYIIM---QSCWAFDSRKRPSFPNLTS 319
Query: 488 MLAS 491
L
Sbjct: 320 FLGC 323
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (527), Expect = 2e-63
Identities = 66/277 (23%), Positives = 116/277 (41%), Gaps = 27/277 (9%)
Query: 215 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKN 273
+ + +LG G FG VYK A K + S + L+++ E++++A H N
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70
Query: 274 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHE 333
+V+LL L ++ E+ ++D + + R L + + + YLH+
Sbjct: 71 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP--LTESQIQVVCKQTLDALNYLHD 128
Query: 334 DSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAM 393
KIIHRDLKA N+L D + K++DFG + + ++ GT +MAPE M
Sbjct: 129 ---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPYWMAPEVVM 183
Query: 394 G-----GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELI 448
+ K+DV+S G+ L+E+ + + +L + L
Sbjct: 184 CETSKDRPYDYKADVWSLGITLIEMAEIEP---PHHELNPMRVL----LKIAKSEPPTLA 236
Query: 449 DPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSV 485
P S F+ C++++ R T S +
Sbjct: 237 QP----SRWSSNFKDFL---KKCLEKNVDARWTTSQL 266
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (528), Expect = 3e-63
Identities = 75/308 (24%), Positives = 133/308 (43%), Gaps = 41/308 (13%)
Query: 218 FSDENKLGQGGFGPVYKGT-LADGK----AIAVKRLSR-TSGQGLKEFKNEVNLIAKLQH 271
F LG G FG VYKG + +G+ +A+K L TS + KE +E ++A + +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 272 KNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYL 331
++ RLLG CL + LI + MP L ++ + + + L+ IA+G+ YL
Sbjct: 71 PHVCRLLGICLTS-TVQLITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYL 127
Query: 332 HEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEY 391
+++HRDL A NVL+ + KI+DFG A++ G + + + +MA E
Sbjct: 128 E---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 184
Query: 392 AMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPV 451
+ I++ +SDV+S+GV + E+++ Y + +++
Sbjct: 185 ILHRIYTHQSDVWSYGVTVWELMTFGSK--PYDGIPASEIS-------------SILEKG 229
Query: 452 LKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML--------------ASDSMTIP 497
+ P + I + C D RP +++ + M +P
Sbjct: 230 ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLP 289
Query: 498 QPTEPAFS 505
PT+ F
Sbjct: 290 SPTDSNFY 297
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (523), Expect = 4e-63
Identities = 65/274 (23%), Positives = 115/274 (41%), Gaps = 31/274 (11%)
Query: 221 ENKLGQGGFGPVYKGTLAD-GKAIAVKRLS--RTSGQGLKEFKNEVNLIAKLQHKNLVRL 277
+ ++G+G F VYKG + +A L + + + FK E ++ LQH N+VR
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 278 LGCCLE----GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHE 333
+ ++L+ E M + +L +L R + K S I +G+ +LH
Sbjct: 74 YDSWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHT 130
Query: 334 DSRLKIIHRDLKASNVLLDD-DMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYA 392
+ IIHRDLK N+ + + KI D G A + + + GT +MAPE
Sbjct: 131 RTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF----AKAVIGTPEFMAPEMY 185
Query: 393 MGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVL 452
+ DV++FG+ +LE+ + +SE Y + P
Sbjct: 186 EEK-YDESVDVYAFGMCMLEMATSEYP----YSECQNAAQIYR-------RVTSGVKPAS 233
Query: 453 KQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVV 486
A E+ + I C++Q+ +R ++ ++
Sbjct: 234 FDKVAIPEVKEII---EGCIRQNKDERYSIKDLL 264
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (522), Expect = 5e-63
Identities = 71/277 (25%), Positives = 116/277 (41%), Gaps = 26/277 (9%)
Query: 218 FSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTS--GQGLKEFKNEVNLIAKLQHKNL 274
+ +G G +G K +DGK + K L S + +EVNL+ +L+H N+
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 65
Query: 275 VRLLGCCLE--GQELLLIYEYMPNKSLDVHLFDATRSVQ-LDWKRRLSIINGIARGILYL 331
VR ++ L ++ EY L + T+ Q LD + L ++ + +
Sbjct: 66 VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKEC 125
Query: 332 HE--DSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAP 389
H D ++HRDLK +NV LD N K+ DFG ARI + + A GT YM+P
Sbjct: 126 HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA--FVGTPYYMSP 183
Query: 390 EYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELID 449
E ++ KSD++S G LL E+ + + + + L EG +
Sbjct: 184 EQMNRMSYNEKSDIWSLGCLLYELCALMP---PFTAFSQKELA----GKIREGKFRRIPY 236
Query: 450 PVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVV 486
DEL + I + RP++ ++
Sbjct: 237 RY------SDELNEII---TRMLNLKDYHRPSVEEIL 264
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (520), Expect = 3e-62
Identities = 76/292 (26%), Positives = 129/292 (44%), Gaps = 39/292 (13%)
Query: 216 NHFSDENKLGQGGFGPVYKGTLADG---KAIAVKRLSRT-SGQGLKEFKNEVNLIAKL-Q 270
N ++ +G+G FG V K + A+KR+ S ++F E+ ++ KL
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 271 HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHL-------------FDATRSVQLDWKRR 317
H N++ LLG C L L EY P+ +L L + + L ++
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 318 LSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANT 377
L +ARG+ YL + + IHRDL A N+L+ ++ KI+DFG +R G +
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKK 183
Query: 378 NIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWK 437
+ +MA E +++ SDV+S+GVLL EI+S Y L ++
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT--PYCGMTCAEL----YE 237
Query: 438 LWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 489
+G+ +E DE+ + C ++ P +RP+ + ++V L
Sbjct: 238 KLPQGYRLEKPLNC------DDEVYDLM---RQCWREKPYERPSFAQILVSL 280
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (512), Expect = 2e-61
Identities = 67/273 (24%), Positives = 112/273 (41%), Gaps = 23/273 (8%)
Query: 216 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLKE-FKNEVNLIAKLQHKN 273
+ LG+G +G V +A+AVK + E K E+ + L H+N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 274 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHE 333
+V+ G EG L EY L + + + + + G++YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 334 DSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAM 393
+ I HRD+K N+LLD+ N KISDFG A +F N + N + GT Y+APE
Sbjct: 122 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 394 GGIF-SIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVL 452
F + DV+S G++L +++G + + + Y+ E +
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGE----LPWDQPSDSCQEYS-------DWKEKKTYLN 227
Query: 453 KQSCAPDELLKFIHIGLLCVQQDPADRPTMSSV 485
L +H + ++P+ R T+ +
Sbjct: 228 PWKKIDSAPLALLH---KILVENPSARITIPDI 257
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 2e-61
Identities = 79/304 (25%), Positives = 130/304 (42%), Gaps = 34/304 (11%)
Query: 216 NHFSDENKLGQGGFGPVYKGTL------ADGKAIAVKRLSR-TSGQGLKEFKNEVNLIAK 268
+ +LGQG FG VY+G +A+K ++ S + EF NE +++ +
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 269 LQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLF-------DATRSVQLDWKRRLSII 321
++VRLLG +GQ L+I E M L +L + + + +
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 322 NGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIA 381
IA G+ YL+ + K +HRDL A N ++ +D KI DFG R
Sbjct: 140 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 382 GTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCE 441
+M+PE G+F+ SDV+SFGV+L EI + + Y + +L + E
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ--PYQGLSNEQVL----RFVME 250
Query: 442 GHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSMTIPQPTE 501
G ++ D PD L + + +C Q +P RP+ ++ + + P E
Sbjct: 251 GGLLDKPDNC------PDMLFELM---RMCWQYNPKMRPSFLEIISSIKEEME--PGFRE 299
Query: 502 PAFS 505
+F
Sbjct: 300 VSFY 303
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (507), Expect = 2e-60
Identities = 65/272 (23%), Positives = 122/272 (44%), Gaps = 24/272 (8%)
Query: 215 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKN 273
++ K+GQG G VY +A G+ +A+++++ + NE+ ++ + ++ N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 274 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHE 333
+V L L G EL ++ EY+ SL + + D + ++ + + +LH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM----DEGQIAAVCRECLQALEFLHS 134
Query: 334 DSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAM 393
++IHRD+K+ N+LL D + K++DFG Q++ +T + GT +MAPE
Sbjct: 135 ---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV--GTPYWMAPEVVT 189
Query: 394 GGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLK 453
+ K D++S G++ +E+I G Y +E+ L L EL +P
Sbjct: 190 RKAYGPKVDIWSLGIMAIEMIEGEP---PYLNENPLRAL----YLIATNGTPELQNP--- 239
Query: 454 QSCAPDELLKFIHIGLLCVQQDPADRPTMSSV 485
F+ C+ D R + +
Sbjct: 240 -EKLSAIFRDFL---NRCLDMDVEKRGSAKEL 267
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 2e-60
Identities = 74/276 (26%), Positives = 110/276 (39%), Gaps = 28/276 (10%)
Query: 222 NKLGQGGFGPVYKGTL----ADGKAIAVKRLSR---TSGQGLKEFKNEVNLIAKLQHKNL 274
KLG G FG V +G ++AVK L + + + +F EVN + L H+NL
Sbjct: 14 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 275 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHED 334
+RL G L + ++ E P SL L +A G+ YL
Sbjct: 74 IRLYGVVLTP-PMKMVTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGMGYLES- 129
Query: 335 SRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQ-ANTNIIAGTYGYMAPEYAM 393
+ IHRDL A N+LL KI DFG R N + + + APE
Sbjct: 130 --KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 187
Query: 394 GGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLK 453
FS SD + FGV L E+ + + + +G +L K+ EG + +
Sbjct: 188 TRTFSHASDTWMFGVTLWEMFTYGQE--PWIGLNGSQIL---HKIDKEGERLPRPEDC-- 240
Query: 454 QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 489
P ++ + + C P DRPT ++ L
Sbjct: 241 ----PQDIYNVM---VQCWAHKPEDRPTFVALRDFL 269
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (498), Expect = 1e-59
Identities = 64/275 (23%), Positives = 112/275 (40%), Gaps = 31/275 (11%)
Query: 216 NHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRT---SGQGLKEFKNEVNLIAKLQH 271
F LG+G FG VY +A+K L + + + EV + + L+H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 272 KNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYL 331
N++RL G + + LI EY P ++ L ++ D +R + I +A + Y
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYC 122
Query: 332 HEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEY 391
H ++IHRD+K N+LL KI+DFG + ++ + GT Y+ PE
Sbjct: 123 HS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPPEM 175
Query: 392 AMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPV 451
G + K D++S GVL E + G+ + + Q + ++
Sbjct: 176 IEGRMHDEKVDLWSLGVLCYEFLVGKP---PFEANTYQETY----------KRISRVEFT 222
Query: 452 LKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVV 486
+ I ++ +P+ RP + V+
Sbjct: 223 FPDFV-TEGARDLI---SRLLKHNPSQRPMLREVL 253
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 8e-59
Identities = 85/297 (28%), Positives = 124/297 (41%), Gaps = 41/297 (13%)
Query: 216 NHFSDENKLGQGGFGPVYKGTL--------ADGKAIAVKRLSR-TSGQGLKEFKNEVNLI 266
+ LG+G FG V +AVK L + + L + +E+ ++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 267 AKL-QHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLF-------------DATRSVQL 312
+ +HKN++ LLG C + L +I EY +L +L QL
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 313 DWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQ 372
K +S +ARG+ YL K IHRDL A NVL+ +D KI+DFG AR
Sbjct: 133 SSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 373 NQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLL 432
T +MAPE I++ +SDV+SFGVLL EI + + Y + L
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS--PYPGVPVEEL- 246
Query: 433 TYTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 489
+KL EGH ++ +EL + C P+ RPT +V L
Sbjct: 247 ---FKLLKEGHRMDKPSNC------TNELYMMM---RDCWHAVPSQRPTFKQLVEDL 291
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 1e-57
Identities = 77/296 (26%), Positives = 122/296 (41%), Gaps = 39/296 (13%)
Query: 216 NHFSDENKLGQGGFGPVYKGT------LADGKAIAVKRLSRTSGQG-LKEFKNEVNLIAK 268
+ LG+G FG V + A + +AVK L + + +E+ ++
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 269 -LQHKNLVRLLGCCLE-GQELLLIYEYMPNKSLDVHLF-------------DATRSVQLD 313
H N+V LLG C + G L++I E+ +L +L + L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 314 WKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQN 373
+ + +A+G+ +L K IHRDL A N+LL + KI DFG AR + +
Sbjct: 133 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 374 QANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLT 433
+MAPE +++I+SDV+SFGVLL EI S + G +
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP-----YPGVKIDE 244
Query: 434 YTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 489
+ EG + D E+ + + L C +P+ RPT S +V L
Sbjct: 245 EFCRRLKEGTRMRAPDYT------TPEMYQTM---LDCWHGEPSQRPTFSELVEHL 291
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (485), Expect = 1e-57
Identities = 60/281 (21%), Positives = 104/281 (37%), Gaps = 27/281 (9%)
Query: 216 NHFSDENKLGQGGFGPVYKGTLAD----GKAIAVKRLSRTSGQGLKE-FKNEVNLIAKLQ 270
+G+G FG V++G A+A+K + ++E F E + +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 271 HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILY 330
H ++V+L+G E + +I E L L S LD + ++ + Y
Sbjct: 67 HPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYS--LDLASLILYAYQLSTALAY 123
Query: 331 LHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPE 390
L + +HRD+ A NVL+ + K+ DFG +R + + +MAPE
Sbjct: 124 LES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK-GKLPIKWMAPE 179
Query: 391 YAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDP 450
F+ SDV+ FGV + EI+ + G + +
Sbjct: 180 SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND------VIGRIENGERLPMPPN 233
Query: 451 VLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 491
P L + C DP+ RP + + L++
Sbjct: 234 C------PPTLYSLM---TKCWAYDPSRRPRFTELKAQLST 265
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 187 bits (477), Expect = 2e-55
Identities = 64/273 (23%), Positives = 110/273 (40%), Gaps = 24/273 (8%)
Query: 216 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNL 274
+H+ +LG G FG V++ T A G A K + + + E+ ++ L+H L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 275 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHED 334
V L + E+++IYE+M L + D ++ + + + +G+ ++HE
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHE- 142
Query: 335 SRLKIIHRDLKASNVLLDDDMNP--KISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYA 392
+H DLK N++ + K+ DFG Q+ T GT + APE A
Sbjct: 143 --NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPEVA 197
Query: 393 MGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVL 452
G +D++S GVL ++SG + F +TL W + D
Sbjct: 198 EGKPVGYYTDMWSVGVLSYILLSGL--SPFGGENDDETLRNVKSCDW------NMDDSAF 249
Query: 453 KQSCAPDELLKFIHIGLLCVQQDPADRPTMSSV 485
++ FI + DP R T+
Sbjct: 250 SG--ISEDGKDFI---RKLLLADPNTRMTIHQA 277
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 182 bits (463), Expect = 2e-53
Identities = 57/273 (20%), Positives = 108/273 (39%), Gaps = 24/273 (8%)
Query: 216 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNL 274
+++ +LG G FG V++ A G+ K ++ KNE++++ +L H L
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 275 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHED 334
+ L + E++LI E++ L + A ++ ++ + G+ ++HE
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRI--AAEDYKMSEAEVINYMRQACEGLKHMHE- 145
Query: 335 SRLKIIHRDLKASNVLLDDDMNP--KISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYA 392
I+H D+K N++ + KI DFG A ++ + T + APE
Sbjct: 146 --HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE---IVKVTTATAEFAAPEIV 200
Query: 393 MGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVL 452
+D+++ GVL ++SG F + +TL +
Sbjct: 201 DREPVGFYTDMWAIGVLGYVLLSGLSP--FAGEDDLETLQNVK--------RCDWEFDED 250
Query: 453 KQSCAPDELLKFIHIGLLCVQQDPADRPTMSSV 485
S E FI +Q++P R T+
Sbjct: 251 AFSSVSPEAKDFIK---NLLQKEPRKRLTVHDA 280
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 3e-53
Identities = 59/276 (21%), Positives = 103/276 (37%), Gaps = 37/276 (13%)
Query: 217 HFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSR---TSGQGLKEFKNEVNLIAKLQHK 272
F LG+G F V LA + A+K L + + E +++++L H
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 273 NLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLH 332
V+L + ++L Y N L ++ D I + YLH
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYLH 125
Query: 333 EDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYA 392
IIHRDLK N+LL++DM+ +I+DFGTA++ QA N GT Y++PE
Sbjct: 126 G---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 182
Query: 393 MGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVL 452
SD+++ G ++ ++++G + G+ + ++
Sbjct: 183 TEKSACKSSDLWALGCIIYQLVAGL-------------------PPFRAGNEYLIFQKII 223
Query: 453 KQ-----SCAPDELLKFIHIGLLCVQQDPADRPTMS 483
K + + + D R
Sbjct: 224 KLEYDFPEKFFPKARDLV---EKLLVLDATKRLGCE 256
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (444), Expect = 8e-51
Identities = 56/295 (18%), Positives = 116/295 (39%), Gaps = 27/295 (9%)
Query: 212 LEATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQG-LKEFKNEVNLIAKL 269
+ +++ + +G+G +G V + +A+K++S Q + E+ ++ +
Sbjct: 4 FDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRF 63
Query: 270 QHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGIL 329
+H+N++ + + Y+ + L+ ++ L + I RG+
Sbjct: 64 RHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLK 123
Query: 330 YLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANT-NIIAGTYGYMA 388
Y+H ++HRDLK SN+LL+ + KI DFG AR+ + + T Y A
Sbjct: 124 YIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 180
Query: 389 PEYAMGGIFSIKS-DVFSFGVLLLEIISGR-----KNNGFYFSEHGQTLLTYTWKLWCEG 442
PE + KS D++S G +L E++S R K+ + L + + +
Sbjct: 181 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 240
Query: 443 HAVELIDPVLKQ------------SCAPDELLKFIHIGLLCVQQDPADRPTMSSV 485
++ + +L A + L + + +P R +
Sbjct: 241 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLD---KMLTFNPHKRIEVEQA 292
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 174 bits (441), Expect = 4e-50
Identities = 68/275 (24%), Positives = 108/275 (39%), Gaps = 32/275 (11%)
Query: 216 NHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSR---TSGQGLKEFKNEVNLIAKLQ- 270
N FS +G+GGFG VY AD GK A+K L + QG NE +++ +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 271 --HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGI 328
+V + +L I + M L HL + I G+
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGL 120
Query: 329 LYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMA 388
++H +++RDLK +N+LLD+ + +ISD G A F + + GT+GYMA
Sbjct: 121 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMA 173
Query: 389 PEYAMGGI-FSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVEL 447
PE G+ + +D FS G +L +++ G F +H ++
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGH----SPFRQHKTKDKHEIDRMTLTM----- 224
Query: 448 IDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTM 482
V EL + +Q+D R
Sbjct: 225 --AVELPDSFSPELRSLLE---GLLQRDVNRRLGC 254
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (436), Expect = 8e-50
Identities = 53/266 (19%), Positives = 112/266 (42%), Gaps = 25/266 (9%)
Query: 223 KLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCC 281
LG+G FG V++ + K K + + G K E++++ +H+N++ L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFV-KVKGTDQVLVKKEISILNIARHRNILHLHESF 70
Query: 282 LEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIH 341
+EL++I+E++ + + T + +L+ + +S ++ + + +LH I H
Sbjct: 71 ESMEELVMIFEFISGLDIFERI--NTSAFELNEREIVSYVHQVCEALQFLHS---HNIGH 125
Query: 342 RDLKASNVLLDDDMNP--KISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSI 399
D++ N++ + KI +FG AR N ++ Y APE + S
Sbjct: 126 FDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVST 182
Query: 400 KSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQSCAPD 459
+D++S G L+ ++SG + +E Q ++ + + K+
Sbjct: 183 ATDMWSLGTLVYVLLSGIN---PFLAETNQQII----ENIMNAE-YTFDEEAFKE--ISI 232
Query: 460 ELLKFIHIGLLCVQQDPADRPTMSSV 485
E + F+ + ++ R T S
Sbjct: 233 EAMDFVD---RLLVKERKSRMTASEA 255
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 170 bits (432), Expect = 8e-50
Identities = 60/276 (21%), Positives = 111/276 (40%), Gaps = 28/276 (10%)
Query: 215 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQG---LKEFKNEVNLIAKLQ 270
++ + LG GG V+ L + +AVK L + F+ E A L
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 271 HKNLVRLLGCCLE----GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIAR 326
H +V + G ++ EY+ +L + + KR + +I +
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQ 122
Query: 327 GILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQ-ANTNIIAGTYG 385
+ + H+ IIHRD+K +N+++ K+ DFG AR + N T + GT
Sbjct: 123 ALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179
Query: 386 YMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAV 445
Y++PE A G +SDV+S G +L E+++G + + ++ +
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEP---PFTGDSPVSVAYQHVR-------E 229
Query: 446 ELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPT 481
+ I P + +L + L + ++P +R
Sbjct: 230 DPIPPSARHEGLSADLDAVV---LKALAKNPENRYQ 262
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 170 bits (431), Expect = 2e-49
Identities = 57/284 (20%), Positives = 104/284 (36%), Gaps = 27/284 (9%)
Query: 216 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNL 274
N + K+G G FG +Y GT +A G+ +A+K + + E + +Q
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVG 64
Query: 275 VRLLG-CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHE 333
+ + C EG +++ E + D+ F + + K L + + + I Y+H
Sbjct: 65 IPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK---FSLKTVLLLADQMISRIEYIHS 121
Query: 334 DSRLKIIHRDLKASNVL---LDDDMNPKISDFGTARIFGGNQNQAN-----TNIIAGTYG 385
IHRD+K N L I DFG A+ + + + + GT
Sbjct: 122 ---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTAR 178
Query: 386 YMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAV 445
Y + +G S + D+ S G +L+ G + ++ E +
Sbjct: 179 YASINTHLGIEQSRRDDLESLGYVLMYFNLGS----LPWQGLKAATKRQKYERISEKK-M 233
Query: 446 ELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 489
VL + P E +++ C D+P S + +
Sbjct: 234 STPIEVLCKGY-PSEFATYLN---FCRSLRFDDKPDYSYLRQLF 273
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 168 bits (426), Expect = 2e-48
Identities = 57/273 (20%), Positives = 102/273 (37%), Gaps = 21/273 (7%)
Query: 215 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQG-LKEFKNEVNLIAKLQHK 272
+ + + LG G F V K +A+K +++ + +G +NE+ ++ K++H
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67
Query: 273 NLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLH 332
N+V L G L LI + + L + + + +I + + YLH
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF---YTERDASRLIFQVLDAVKYLH 124
Query: 333 EDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYA 392
+ + + LD+D ISDFG +++ + GT GY+APE
Sbjct: 125 DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLSTACGTPGYVAPEVL 181
Query: 393 MGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVL 452
+S D +S GV+ ++ G ++ E+ L K E
Sbjct: 182 AQKPYSKAVDCWSIGVIAYILLCGYP---PFYDENDAKLFEQILK-------AEYEFDSP 231
Query: 453 KQSCAPDELLKFIHIGLLCVQQDPADRPTMSSV 485
D FI +++DP R T
Sbjct: 232 YWDDISDSAKDFI---RHLMEKDPEKRFTCEQA 261
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 166 bits (420), Expect = 4e-48
Identities = 64/286 (22%), Positives = 110/286 (38%), Gaps = 39/286 (13%)
Query: 217 HFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGL---------KEFKNEVNLI 266
++ + LG+G V + K AVK + T G + EV+++
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 267 AKLQ-HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIA 325
K+ H N+++L L+++ M L +L T V L K I+ +
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMRALL 120
Query: 326 RGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYG 385
I LH+ L I+HRDLK N+LLDDDMN K++DFG + + + GT
Sbjct: 121 EVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTPS 174
Query: 386 YMAPEYAMGGI------FSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLW 439
Y+APE + + + D++S GV++ +++G ++ +L
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP---PFWHRKQMLMLRMIMS-- 229
Query: 440 CEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSV 485
+ P D + + + P R T
Sbjct: 230 ---GNYQFGSPEWDD--YSDTVKDLV---SRFLVVQPQKRYTAEEA 267
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 165 bits (419), Expect = 2e-47
Identities = 56/275 (20%), Positives = 111/275 (40%), Gaps = 42/275 (15%)
Query: 216 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSR---TSGQGLKEFKNEVNLIAKLQH 271
F LG G FG V+ +G+ A+K L + + ++ +E +++ + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 272 KNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYL 331
++R+ G + Q++ +I +Y+ L L + R K + + L L
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV------CLAL 117
Query: 332 HEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEY 391
II+RDLK N+LLD + + KI+DFG A+ + GT Y+APE
Sbjct: 118 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT-----LCGTPDYIAPEV 172
Query: 392 AMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPV 451
++ D +SFG+L+ E+++G + + + ++ + +
Sbjct: 173 VSTKPYNKSIDWWSFGILIYEMLAGY-------------------TPFYDSNTMKTYEKI 213
Query: 452 LKQ-----SCAPDELLKFIHIGLLCVQQDPADRPT 481
L +++ + + +D + R
Sbjct: 214 LNAELRFPPFFNEDVKDLLS---RLITRDLSQRLG 245
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (412), Expect = 1e-46
Identities = 70/306 (22%), Positives = 128/306 (41%), Gaps = 39/306 (12%)
Query: 222 NKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLKE-----FKNEVNLIAKLQHKNLV 275
+ LG+G F VYK + +A+K++ K+ E+ L+ +L H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 276 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDS 335
LL + L++++M + S+ L + + +G+ YLH+
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVII---KDNSLVLTPSHIKAYMLMTLQGLEYLHQH- 119
Query: 336 RLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMG- 394
I+HRDLK +N+LLD++ K++DFG A+ FG + T Y APE G
Sbjct: 120 --WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV--VTRWYRAPELLFGA 175
Query: 395 GIFSIKSDVFSFGVLLLEIISGR-----KNNGFYFSEHGQTLLTYTWKLWCEGHAVEL-- 447
++ + D+++ G +L E++ ++ + +TL T T + W + ++
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV 235
Query: 448 -------IDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM-------LASDS 493
I S A D+LL I +P R T + + M +
Sbjct: 236 TFKSFPGIPLHHIFSAAGDDLLDLIQ---GLFLFNPCARITATQALKMKYFSNRPGPTPG 292
Query: 494 MTIPQP 499
+P+P
Sbjct: 293 CQLPRP 298
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 162 bits (410), Expect = 2e-46
Identities = 47/286 (16%), Positives = 99/286 (34%), Gaps = 29/286 (10%)
Query: 216 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQH-KN 273
H+ ++G+G FG +++GT L + + +A+K R S + ++E L
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTG 62
Query: 274 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHE 333
+ + EG +L+ + + D+ + K + + +HE
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLGPSLEDLLD---LCGRKFSVKTVAMAAKQMLARVQSIHE 119
Query: 334 DSRLKIIHRDLKASNVLLDDDMNP-----KISDFGTARIF-----GGNQNQANTNIIAGT 383
+++RD+K N L+ + + DFG + + + ++GT
Sbjct: 120 ---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGT 176
Query: 384 YGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGH 443
YM+ +G S + D+ + G + + + G G T K G
Sbjct: 177 ARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPW------QGLKAATNKQKYERIGE 230
Query: 444 AVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 489
+ + P+E K++H P + +
Sbjct: 231 KKQSTPLRELCAGFPEEFYKYMH---YARNLAFDATPDYDYLQGLF 273
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (412), Expect = 2e-46
Identities = 63/274 (22%), Positives = 110/274 (40%), Gaps = 30/274 (10%)
Query: 216 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSR---TSGQGLKEFKNEVNLIAK-LQ 270
F LG+G FG V+ + A+K L + ++ E +++ +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 271 HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILY 330
H L + + L + EY+ L H+ + D R I G+ +
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQF 118
Query: 331 LHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPE 390
LH I++RDLK N+LLD D + KI+DFG + + NT GT Y+APE
Sbjct: 119 LHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTPDYIAPE 173
Query: 391 YAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDP 450
+G ++ D +SFGVLL E++ G+ + F+ + + H++ + +P
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQ--SPFHGQDEEELF-----------HSIRMDNP 220
Query: 451 VLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSS 484
+ E + ++P R +
Sbjct: 221 FYPRWL-EKEAKDLLV---KLFVREPEKRLGVRG 250
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 160 bits (405), Expect = 8e-46
Identities = 66/288 (22%), Positives = 118/288 (40%), Gaps = 29/288 (10%)
Query: 216 NHFSDENKLGQGGFGPVYKGTLADGKAIAVK--RLSRTSGQGLKEFKNEVNLIAKLQHKN 273
+ K+G+G +G VYK G+ A+K RL + E++++ +L+H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 274 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHE 333
+V+L + L+L++E++ + L+ S + + GI Y H+
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 334 DSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAM 393
+++HRDLK N+L++ + KI+DFG AR FG + I+ T Y AP+ M
Sbjct: 119 ---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV--TLWYRAPDVLM 173
Query: 394 G-GIFSIKSDVFSFGVLLLEIISGR-----KNNGFYFSEHGQTLLTYTWKLWCEGHAVEL 447
G +S D++S G + E+++G + + L T K W +
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK 233
Query: 448 IDPVLKQ----------SCAPDELLKFIHIGLLCVQQDPADRPTMSSV 485
DP + + + ++ DP R T
Sbjct: 234 YDPNFTVYEPLPWESFLKGLDESGIDLLS---KMLKLDPNQRITAKQA 278
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 8e-46
Identities = 58/292 (19%), Positives = 115/292 (39%), Gaps = 26/292 (8%)
Query: 214 ATNHFSDENKLGQGGFGPVYKGT--LADGKAIAVKRLSRTSGQG--LKEFKNEVNLIAKL 269
A + ++G+G +G V+K G+ +A+KR+ +G+ EV ++ L
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 270 ---QHKNLVRLLGCCLEGQELLLIYEYMPNKSLD---VHLFDATRSVQLDWKRRLSIING 323
+H N+VRL C + + + +D D + + ++
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 324 IARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGT 383
+ RG+ +LH +++HRDLK N+L+ K++DFG ARI+ + T
Sbjct: 125 LLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL---TSVVVT 178
Query: 384 YGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGR-----KNNGFYFSEHGQTLLTYTWKL 438
Y APE + ++ D++S G + E+ + ++ + + +
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238
Query: 439 WCEGHAVELIDPVLKQSCAPDELLKFIHIGLL-----CVQQDPADRPTMSSV 485
W A+ K + ++ + I C+ +PA R + S
Sbjct: 239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 1e-45
Identities = 66/285 (23%), Positives = 119/285 (41%), Gaps = 23/285 (8%)
Query: 217 HFSDENKLGQGGFGPVYKGT-LADGKAIAVK--RLSRTSGQGLKEFKNEVNLIAKLQHKN 273
+F K+G+G +G VYK G+ +A+K RL + E++L+ +L H N
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 274 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHE 333
+V+LL +L L++E++ DA+ + S + + +G+ + H
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLK--KFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 334 DSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPE-YA 392
+++HRDLK N+L++ + K++DFG AR FG + T Y APE
Sbjct: 121 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV--VTLWYRAPEILL 175
Query: 393 MGGIFSIKSDVFSFGVLLLEIISGR-----KNNGFYFSEHGQTLLTYTWKLWCEGHAVEL 447
+S D++S G + E+++ R + +TL T +W ++
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 235
Query: 448 IDPVLKQSCAPDELLKFIHIG-----LL--CVQQDPADRPTMSSV 485
P + D + LL + DP R + +
Sbjct: 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 1e-45
Identities = 70/292 (23%), Positives = 116/292 (39%), Gaps = 37/292 (12%)
Query: 218 FSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVR 276
++D +G G FG VY+ L D G+ +A+K++ + + E+ ++ KL H N+VR
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVR 77
Query: 277 LLGCCLEGQE------LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILY 330
L E L L+ +Y+P V + L + + R + Y
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 331 LHEDSRLKIIHRDLKASNVLLDDD-MNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAP 389
+H I HRD+K N+LLD D K+ DFG+A+ + + Y AP
Sbjct: 138 IHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICS---RYYRAP 191
Query: 390 EYAMGGI-FSIKSDVFSFGVLLLEIISGR-----KNNGFYFSEHGQTLLTYTWKLWCEG- 442
E G ++ DV+S G +L E++ G+ + E + L T T + E
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251
Query: 443 -HAVELIDPVLK--------QSCAPDELLKFIHIGLLCVQQDPADRPTMSSV 485
+ E P +K + P E + ++ P R T
Sbjct: 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCS---RLLEYTPTARLTPLEA 300
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 6e-44
Identities = 58/274 (21%), Positives = 103/274 (37%), Gaps = 30/274 (10%)
Query: 221 ENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKL-QHKNLVRLL 278
LG G G V + + A+K L + + EV L + Q ++VR++
Sbjct: 17 SQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIV 71
Query: 279 GCC----LEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHED 334
+ LL++ E + L + D + I+ I I YLH
Sbjct: 72 DVYENLYAGRKCLLIVMECLDGGELFSRIQD-RGDQAFTEREASEIMKSIGEAIQYLHS- 129
Query: 335 SRLKIIHRDLKASNVLLDDDMNP---KISDFGTARIFGGNQNQANTNIIAGTYGYMAPEY 391
+ I HRD+K N+L K++DFG A+ + + T Y+APE
Sbjct: 130 --INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY---TPYYVAPEV 184
Query: 392 AMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPV 451
+ D++S GV++ ++ G ++S HG + G + P
Sbjct: 185 LGPEKYDKSCDMWSLGVIMYILLCGYP---PFYSNHGLAISPGMKTRIRMG---QYEFPN 238
Query: 452 LKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSV 485
+ S +E+ I ++ +P R T++
Sbjct: 239 PEWSEVSEEVKMLIR---NLLKTEPTQRMTITEF 269
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 7e-44
Identities = 62/281 (22%), Positives = 106/281 (37%), Gaps = 33/281 (11%)
Query: 216 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTS------GQGLKEFKNEVNLIAK 268
+++ +LG G F V K + G A K + + G ++ + EV+++ +
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 269 LQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGI 328
+QH N++ L +++LI E + L L + L + + I G
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQILNG- 125
Query: 329 LYLHEDSRLKIIHRDLKASNVLLDDDMNP----KISDFGTARIFGGNQNQANTNIIAGTY 384
++ L+I H DLK N++L D P KI DFG A I GT
Sbjct: 126 --VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN---EFKNIFGTP 180
Query: 385 GYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHA 444
++APE +++D++S GV+ ++SG + + Q L
Sbjct: 181 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGAS---PFLGDTKQETLANVSA------- 230
Query: 445 VELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSV 485
V S FI + +DP R T+
Sbjct: 231 VNYEFEDEYFSNTSALAKDFIR---RLLVKDPKKRMTIQDS 268
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 1e-43
Identities = 58/281 (20%), Positives = 97/281 (34%), Gaps = 43/281 (15%)
Query: 216 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLKE------FKNEVNLIAK 268
+ + LG GGFG VY G ++D +A+K + + E EV L+ K
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 269 LQ--HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIAR 326
+ ++RLL +LI E T L + S +
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEELARSFFWQVLE 121
Query: 327 GILYLHEDSRLKIIHRDLKASNVLLD-DDMNPKISDFGTARIFGGNQNQANTNIIAGTYG 385
+ + H ++HRD+K N+L+D + K+ DFG+ + GT
Sbjct: 122 AVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRV 174
Query: 386 YMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHA 444
Y PE+ + V+S G+LL +++ G +
Sbjct: 175 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD-------------------IPFEHDEE 215
Query: 445 VELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSV 485
+ +Q E I C+ P+DRPT +
Sbjct: 216 IIRGQVFFRQRV-SSECQHLI---RWCLALRPSDRPTFEEI 252
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (381), Expect = 4e-42
Identities = 63/302 (20%), Positives = 116/302 (38%), Gaps = 41/302 (13%)
Query: 216 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQG--LKEFKNEVNLIAKLQHK 272
+ + K+GQG FG V+K G+ +A+K++ + + E+ ++ L+H+
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 273 NLVRLLGCCLEGQE--------LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGI 324
N+V L+ C + L++++ + + + + KR + ++
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML--- 126
Query: 325 ARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNI--IAG 382
+ L+ R KI+HRD+KA+NVL+ D K++DFG AR F +N
Sbjct: 127 ---LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183
Query: 383 TYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGR-----KNNGFYFSEHGQTLLTYTW 436
T Y PE +G + D++ G ++ E+ + + Q + T
Sbjct: 184 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 243
Query: 437 KLWCEGHAVEL-------------IDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMS 483
++W EL + LK L I + DPA R
Sbjct: 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLID---KLLVLDPAQRIDSD 300
Query: 484 SV 485
Sbjct: 301 DA 302
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 1e-40
Identities = 58/271 (21%), Positives = 101/271 (37%), Gaps = 29/271 (10%)
Query: 216 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSR---TSGQGLKEFKNEVNLIAKLQH 271
N F LG+G FG V A G+ A+K L + + + E ++ +H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 272 KNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYL 331
L L L + EY L HL +R +R I L
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGAEIVSA---L 118
Query: 332 HEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEY 391
+++RD+K N++LD D + KI+DFG + G + A GT Y+APE
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKE--GISDGATMKTFCGTPEYLAPEV 176
Query: 392 AMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPV 451
+ D + GV++ E++ GR ++++ + L + + +
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGRL---PFYNQDHERLF----------ELILMEEIR 223
Query: 452 LKQSCAPDELLKFIHIGLLCVQQDPADRPTM 482
++ E + +++DP R
Sbjct: 224 FPRTL-SPEAKSLLA---GLLKKDPKQRLGG 250
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 3e-40
Identities = 60/300 (20%), Positives = 112/300 (37%), Gaps = 43/300 (14%)
Query: 213 EATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRT--SGQGLKEFKNEVNLIAKL 269
E + D +G G +G V G +A+K+L R S K E+ L+ +
Sbjct: 15 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM 74
Query: 270 QHKNLVRLLGCCLEGQ------ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIING 323
+H+N++ LL + + L+ +M + + +L R ++
Sbjct: 75 RHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLM-----KHEKLGEDRIQFLVYQ 129
Query: 324 IARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGT 383
+ +G+ Y+H IIHRDLK N+ +++D KI DFG AR T
Sbjct: 130 MLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTG-----YVVT 181
Query: 384 YGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGR-----KNNGFYFSEHGQTLLTYTWK 437
Y APE + + ++ D++S G ++ E+I+G+ ++ E + T +
Sbjct: 182 RWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAE 241
Query: 438 LWCEGHAVELIDPVLKQ------------SCAPDELLKFIHIGLLCVQQDPADRPTMSSV 485
+ E + + + A + + + D R T
Sbjct: 242 FVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLE---KMLVLDAEQRVTAGEA 298
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (357), Expect = 6e-39
Identities = 55/286 (19%), Positives = 110/286 (38%), Gaps = 23/286 (8%)
Query: 216 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVK--RLSRTSGQGLKEFKNEVNLIAKLQHK 272
+ K+G+G +G V+K + +A+K RL E+ L+ +L+HK
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 273 NLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLH 332
N+VRL ++L L++E+ + LD + S + + +G+ + H
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCH 118
Query: 333 EDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYA 392
++HRDLK N+L++ + K+++FG AR FG + + + +
Sbjct: 119 ---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP-VRCYSAEVVTLWYRPPDVLF 174
Query: 393 MGGIFSIKSDVFSFGVLLLEIISGR------KNNGFYFSEHGQTLLTYTWKLWCEGHAVE 446
++S D++S G + E+ + + + L T T + W +
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234
Query: 447 LIDPVLKQSCAPDELLKFIHIG-----LL--CVQQDPADRPTMSSV 485
P + + LL ++ +P R +
Sbjct: 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 139 bits (351), Expect = 2e-37
Identities = 58/269 (21%), Positives = 98/269 (36%), Gaps = 32/269 (11%)
Query: 216 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSR---TSGQGLKEFKNEVNLIAKLQH 271
+ F LG G FG V G A+K L + + ++ NE ++ +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 272 KNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYL 331
LV+L + L ++ EY+ + HL R I YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYL 157
Query: 332 HEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEY 391
H L +I+RDLK N+L+D +++DFG A+ G + GT +APE
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-----LCGTPEALAPEI 209
Query: 392 AMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPV 451
+ ++ D ++ GVL+ E+ +G +F++ + V
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYP---PFFADQPIQIYEKIVS-----------GKV 255
Query: 452 LKQSCAPDELLKFIHIGLLCVQQDPADRP 480
S +L + +Q D R
Sbjct: 256 RFPSHFSSDLKDLLRN---LLQVDLTKRF 281
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 2e-35
Identities = 60/279 (21%), Positives = 108/279 (38%), Gaps = 31/279 (11%)
Query: 216 NHFSDENKLGQGGFGPVYKGTLA----DGKAIAVKRLSRTS----GQGLKEFKNEVNLIA 267
+F LG G +G V+ GK A+K L + + + + + E ++
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 268 KLQHK-NLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIAR 326
++ LV L +L LI +Y+ L HL R + + + +
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIY------VGE 137
Query: 327 GILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGY 386
+L L +L II+RD+K N+LLD + + ++DFG ++ F ++ + GT Y
Sbjct: 138 IVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RAYDFCGTIEY 196
Query: 387 MAPEYAMGGI--FSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHA 444
MAP+ GG D +S GVL+ E+++G + + + + +
Sbjct: 197 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGAS---PFTVDGEKNSQAEISRRILKS-- 251
Query: 445 VELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMS 483
+P Q I + +DP R
Sbjct: 252 ----EPPYPQEM-SALAKDLI---QRLLMKDPKKRLGCG 282
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 132 bits (333), Expect = 3e-35
Identities = 53/300 (17%), Positives = 109/300 (36%), Gaps = 48/300 (16%)
Query: 216 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQ-HKN 273
+ + KLG+G + V++ + + + + VK L K+ K E+ ++ L+ N
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPN 91
Query: 274 LVRLLGCCLE--GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYL 331
++ L + + L++E++ N L + I + + Y
Sbjct: 92 IITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYC 145
Query: 332 HEDSRLKIIHRDLKASNVLLD-DDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPE 390
H + I+HRD+K NV++D + ++ D+G A + Q N+ + + PE
Sbjct: 146 HS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY---NVRVASRYFKGPE 199
Query: 391 YAMG-GIFSIKSDVFSFGVLLLEIISGR------KNNGFYFSEHGQTLLTYTWKLWCEGH 443
+ ++ D++S G +L +I + +N + L T + + +
Sbjct: 200 LLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 259
Query: 444 AVEL------------------IDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSV 485
+EL Q E L F+ ++ D R T
Sbjct: 260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLD---KLLRYDHQSRLTAREA 316
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 2e-34
Identities = 69/304 (22%), Positives = 116/304 (38%), Gaps = 46/304 (15%)
Query: 216 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRT--SGQGLKEFKNEVNLIAKLQHK 272
+ + +G G G V + +A+K+LSR + K E+ L+ + HK
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 273 NLVRLLGCCL------EGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIAR 326
N++ LL E Q++ L+ E M V +LD +R ++ +
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM------ELDHERMSYLLYQMLC 130
Query: 327 GILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGY 386
GI +LH IIHRDLK SN+++ D KI DFG AR G + T Y
Sbjct: 131 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYY 184
Query: 387 MAPEYAMGGIFSIKSDVFSFGVLLLEIISGR-----KNNGFYFSEHGQTLLTYTWKLWCE 441
APE +G + D++S G ++ E++ + ++ +++ + L T + +
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244
Query: 442 GHAV--------ELIDPVLKQSCAPDELLKFIH----------IGLL--CVQQDPADRPT 481
+ PD L LL + DPA R +
Sbjct: 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 304
Query: 482 MSSV 485
+
Sbjct: 305 VDDA 308
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 5e-34
Identities = 68/290 (23%), Positives = 119/290 (41%), Gaps = 27/290 (9%)
Query: 213 EATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRT--SGQGLKEFKNEVNLIAKL 269
E + + + +G G +G V G +AVK+LSR S K E+ L+ +
Sbjct: 15 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 74
Query: 270 QHKNLVRLLGCCLEGQELLLI-YEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGI 328
+H+N++ LL + L Y+ + L + + +L +I I RG+
Sbjct: 75 KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 134
Query: 329 LYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMA 388
Y+H IIHRDLK SN+ +++D KI DFG AR T Y A
Sbjct: 135 KYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA-----TRWYRA 186
Query: 389 PEYAMGGI-FSIKSDVFSFGVLLLEIISGR-----KNNGFYFSEHGQTLLTYTWKLWCEG 442
PE + + ++ D++S G ++ E+++GR ++ + + T +L +
Sbjct: 187 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 246
Query: 443 HAVELIDPVLKQSCAPDELLKFIHIG-------LL--CVQQDPADRPTMS 483
+ + + + P + IG LL + D R T +
Sbjct: 247 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 296
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 115 bits (288), Expect = 8e-29
Identities = 39/212 (18%), Positives = 75/212 (35%), Gaps = 18/212 (8%)
Query: 221 ENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLG 279
KLG G F V+ + + +A+K + + ++E+ L+ ++ + +
Sbjct: 18 VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY-TEAAEDEIKLLQRVNDADNTKEDS 76
Query: 280 CCLEGQELLLIYEYMPNKSLDV-------------HLFDATRSVQLDWKRRLSIINGIAR 326
LL + + L + I +
Sbjct: 77 MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLL 136
Query: 327 GILYLHEDSRLKIIHRDLKASNVLLD-DDMNPKISDFGTARIFGGNQNQANTNIIAGTYG 385
G+ Y+H R IIH D+K NVL++ D + A + + T
Sbjct: 137 GLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTRE 194
Query: 386 YMAPEYAMGGIFSIKSDVFSFGVLLLEIISGR 417
Y +PE +G + +D++S L+ E+I+G
Sbjct: 195 YRSPEVLLGAPWGCGADIWSTACLIFELITGD 226
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 95.2 bits (236), Expect = 3e-23
Identities = 29/155 (18%), Positives = 57/155 (36%), Gaps = 20/155 (12%)
Query: 222 NKLGQGGFGPVYKGTLADGKAIAVK--RLSRTSGQGLK--------EFKNEVNLIAKLQH 271
+G+G V+ VK ++ TS + +K F A+ +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 272 KNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYL 331
+ L +L G + Y + N ++ + L DA ++ + +++ I +
Sbjct: 66 RALQKLQGLAVPKV-----YAWEGN-AVLMELIDAKELYRVRVENPDEVLDMILEEVAKF 119
Query: 332 HEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTAR 366
+ I+H DL NVL+ + I DF +
Sbjct: 120 YHR---GIVHGDLSQYNVLV-SEEGIWIIDFPQSV 150
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 536 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.9 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.65 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.14 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.76 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.41 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.28 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.73 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-53 Score=411.23 Aligned_cols=253 Identities=25% Similarity=0.331 Sum_probs=202.6
Q ss_pred hcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC-hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEe
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 292 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 292 (536)
.++|++.+.||+|+||+||+|+++ +|+.||||++.... .+..+.+.+|+.+|++++|||||++++++.+++..|+|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 468999999999999999999975 68999999987543 3345678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCC
Q 039168 293 YMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQ 372 (536)
Q Consensus 293 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 372 (536)
|+++|+|.+++.. ...+++.+++.++.||++||+|||+++ |+||||||+|||+++++++||+|||+++.+....
T Consensus 84 y~~gg~L~~~l~~---~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 84 YCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp CCTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred ccCCCcHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence 9999999999843 345999999999999999999999997 9999999999999999999999999999876544
Q ss_pred CccccccccccccccCcchhcCCCC-CccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcccccccc
Q 039168 373 NQANTNIIAGTYGYMAPEYAMGGIF-SIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPV 451 (536)
Q Consensus 373 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 451 (536)
........+||+.|||||++.+..+ +.++|||||||++|||++|+.||....... ... .............
T Consensus 158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~---~~~---~~~~~~~~~~~~~-- 229 (271)
T d1nvra_ 158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC---QEY---SDWKEKKTYLNPW-- 229 (271)
T ss_dssp EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTS---HHH---HHHHTTCTTSTTG--
T ss_pred ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHH---HHH---HHHhcCCCCCCcc--
Confidence 4444455789999999999988876 678999999999999999999986432211 111 1111111111000
Q ss_pred ccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 452 LKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 452 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
.. .+ ..+.+|+.+||+.||++|||++|+++
T Consensus 230 --~~-~s---~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 230 --KK-ID---SAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp --GG-SC---HHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --cc-CC---HHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 01 12 34556677999999999999999864
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-51 Score=404.39 Aligned_cols=249 Identities=24% Similarity=0.386 Sum_probs=205.2
Q ss_pred cCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEeec
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 294 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 294 (536)
++|++.++||+|+||+||+|++. +|+.||||++........+.+.+|+.+|++++|||||++++++.+++..|+||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 57999999999999999999975 69999999997665556678999999999999999999999999999999999999
Q ss_pred CCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCCc
Q 039168 295 PNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQ 374 (536)
Q Consensus 295 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 374 (536)
++|+|..++.. ..+++.+++.++.||+.||+|||+++ |+||||||+|||++.++++||+|||+++.+.....
T Consensus 100 ~gg~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~- 171 (293)
T d1yhwa1 100 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 171 (293)
T ss_dssp TTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred CCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeeccccc-
Confidence 99999988743 24899999999999999999999997 99999999999999999999999999997754332
Q ss_pred cccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccccccC
Q 039168 375 ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQ 454 (536)
Q Consensus 375 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~ 454 (536)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ............ .+.. ..
T Consensus 172 -~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~------~~~~~~~~~~~~-~~~~---~~ 240 (293)
T d1yhwa1 172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL------RALYLIATNGTP-ELQN---PE 240 (293)
T ss_dssp -CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHHCSC-CCSS---GG
T ss_pred -cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHH------HHHHHHHhCCCC-CCCC---cc
Confidence 233467999999999999999999999999999999999999998532211 111111111111 1100 01
Q ss_pred CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 455 SCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 455 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
. .+ ..+.+++.+||+.||++|||+.|+++
T Consensus 241 ~-~s---~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 241 K-LS---AIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp G-SC---HHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred c-CC---HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1 12 34566677999999999999999975
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-52 Score=406.84 Aligned_cols=262 Identities=27% Similarity=0.481 Sum_probs=201.0
Q ss_pred hcCCccccccCCCCceeEEEEEeCCCcEEEEEEcccc--ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEe
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRT--SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 292 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 292 (536)
.++|++.++||+|+||+||+|+.+ ..||||++... .....+.|.+|+.+|++++|||||++++++.+ ..+++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence 368999999999999999999864 36999998644 44567889999999999999999999998754 56899999
Q ss_pred ecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCC
Q 039168 293 YMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQ 372 (536)
Q Consensus 293 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 372 (536)
|+++|+|.+++... ...+++..+..++.||++||+|||+++ ||||||||+||||+.++++||+|||+++......
T Consensus 84 y~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~ 158 (276)
T d1uwha_ 84 WCEGSSLYHHLHII--ETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS 158 (276)
T ss_dssp CCCEEEHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred cCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence 99999999998643 245899999999999999999999996 9999999999999999999999999998776544
Q ss_pred CccccccccccccccCcchhcC---CCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcccccc
Q 039168 373 NQANTNIIAGTYGYMAPEYAMG---GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELID 449 (536)
Q Consensus 373 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 449 (536)
.........||+.|||||++.+ ..++.++|||||||++|||+||+.||....... . .......+.....+.
T Consensus 159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~--~----~~~~~~~~~~~p~~~ 232 (276)
T d1uwha_ 159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--Q----IIFMVGRGYLSPDLS 232 (276)
T ss_dssp -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH--H----HHHHHHHTSCCCCGG
T ss_pred CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH--H----HHHHHhcCCCCCcch
Confidence 4444455789999999999964 348999999999999999999999985432211 1 111122221111111
Q ss_pred ccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccCCCC
Q 039168 450 PVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSMT 495 (536)
Q Consensus 450 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 495 (536)
...... + ..+.+|+.+||+.||++|||+++|++.|+.....
T Consensus 233 -~~~~~~-~---~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~ 273 (276)
T d1uwha_ 233 -KVRSNC-P---KAMKRLMAECLKKKRDERPLFPQILASIELLARS 273 (276)
T ss_dssp -GSCTTC-C---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred -hccccc-h---HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence 111122 2 3456667799999999999999999999875433
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-52 Score=403.61 Aligned_cols=255 Identities=28% Similarity=0.404 Sum_probs=196.6
Q ss_pred cCCccccccCCCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEeecC
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMP 295 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 295 (536)
++|++.+.||+|+||.||+|++.+++.||||++.... ...++|.+|++++++++|||||++++++.+++..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 5789999999999999999999888999999997543 344789999999999999999999999999999999999999
Q ss_pred CCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCCcc
Q 039168 296 NKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQA 375 (536)
Q Consensus 296 ~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 375 (536)
+|+|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+||||++++++||+|||+++.........
T Consensus 84 ~g~L~~~l~~~--~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~ 158 (263)
T d1sm2a_ 84 HGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 158 (263)
T ss_dssp TCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred CCcHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCcee
Confidence 99999988543 345899999999999999999999996 9999999999999999999999999998765433222
Q ss_pred ccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccccccCC
Q 039168 376 NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQS 455 (536)
Q Consensus 376 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~ 455 (536)
.....||+.|+|||++.+..++.++|||||||++|||+|+..|+.... ....... ....+.... . ...
T Consensus 159 -~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~--~~~~~~~----~i~~~~~~~--~---p~~ 226 (263)
T d1sm2a_ 159 -STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR--SNSEVVE----DISTGFRLY--K---PRL 226 (263)
T ss_dssp -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSC--CHHHHHH----HHHHTCCCC--C---CTT
T ss_pred -ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCC--CHHHHHH----HHHhcCCCC--C---ccc
Confidence 233578999999999999999999999999999999999654432111 1111111 111221111 1 111
Q ss_pred CCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 456 CAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 456 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
.+ .++.+|+.+||+.||++|||+++|++.|+..
T Consensus 227 -~~---~~l~~li~~cl~~~p~~Rps~~~il~~L~~i 259 (263)
T d1sm2a_ 227 -AS---THVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259 (263)
T ss_dssp -SC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -cC---HHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 12 3466777799999999999999999999863
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-52 Score=400.15 Aligned_cols=245 Identities=26% Similarity=0.407 Sum_probs=202.6
Q ss_pred cCCccccccCCCCceeEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEE
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 291 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 291 (536)
++|++.+.||+|+||+||+|+++ +++.||+|++.+. .....+.+.+|+.++++++|||||++++++.+++..|+||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 57999999999999999999986 5899999998643 2234577899999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCC
Q 039168 292 EYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGN 371 (536)
Q Consensus 292 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 371 (536)
||+++|+|.+++... ..+++.+++.++.||++||+|||+++ |+||||||+|||++.++++||+|||+++.....
T Consensus 86 Ey~~~g~L~~~l~~~---~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 86 EYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp ECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred eecCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC
Confidence 999999999998643 34999999999999999999999996 999999999999999999999999999866432
Q ss_pred CCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcccccccc
Q 039168 372 QNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPV 451 (536)
Q Consensus 372 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 451 (536)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .. .......... .
T Consensus 160 ~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------~~-~~~~i~~~~~------~ 222 (263)
T d2j4za1 160 R----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY------QE-TYKRISRVEF------T 222 (263)
T ss_dssp C----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HH-HHHHHHTTCC------C
T ss_pred c----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCH------HH-HHHHHHcCCC------C
Confidence 2 2346799999999999999999999999999999999999999853221 11 1111111111 1
Q ss_pred ccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 452 LKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 452 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
+... .++ ++.+++.+||+.||++|||++|+++
T Consensus 223 ~p~~-~s~---~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 223 FPDF-VTE---GARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp CCTT-SCH---HHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCcc-CCH---HHHHHHHHHccCCHhHCcCHHHHHc
Confidence 1111 223 4556667999999999999999986
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-52 Score=403.14 Aligned_cols=254 Identities=26% Similarity=0.362 Sum_probs=193.4
Q ss_pred cCCccccccCCCCceeEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHHHcCCCCceeEeeEEee--CceEEEE
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLE--GQELLLI 290 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~--~~~~~lv 290 (536)
++|++.+.||+|+||+||+|+++ +|+.||||++... .....+.+.+|+++|++++|||||++++++.+ ++.+|+|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 67999999999999999999975 5899999998754 33456778999999999999999999999865 4668999
Q ss_pred EeecCCCChhhhhhccc-CCCCCCHHHHHHHHHHHHHHHHHHhcCC--CCCeeeCCCCCCcEEEcCCCCeEEecccCccc
Q 039168 291 YEYMPNKSLDVHLFDAT-RSVQLDWKRRLSIINGIARGILYLHEDS--RLKIIHRDLKASNVLLDDDMNPKISDFGTARI 367 (536)
Q Consensus 291 ~e~~~~~sL~~~l~~~~-~~~~l~~~~~~~i~~qi~~al~~LH~~~--~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 367 (536)
|||+++|+|.+++.... ....+++..++.++.||+.||+|||+++ ..+|+||||||+||||+.++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 99999999999986532 3456999999999999999999999864 23599999999999999999999999999998
Q ss_pred cCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcccc
Q 039168 368 FGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVEL 447 (536)
Q Consensus 368 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 447 (536)
+..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+ ......+....+
T Consensus 164 ~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~---~~----~~~i~~~~~~~~ 234 (269)
T d2java1 164 LNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK---EL----AGKIREGKFRRI 234 (269)
T ss_dssp C-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH---HH----HHHHHHTCCCCC
T ss_pred cccCCC--ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH---HH----HHHHHcCCCCCC
Confidence 754322 223467999999999999999999999999999999999999998543211 11 111222222221
Q ss_pred ccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 448 IDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 448 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
.... ++ ++.+|+.+||+.||++|||+.|+++
T Consensus 235 -----~~~~-s~---~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 235 -----PYRY-SD---ELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp -----CTTS-CH---HHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -----Cccc-CH---HHHHHHHHHcCCChhHCcCHHHHHh
Confidence 1122 23 3556667999999999999999985
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.1e-52 Score=406.26 Aligned_cols=257 Identities=29% Similarity=0.452 Sum_probs=208.9
Q ss_pred hcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEee
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 293 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 293 (536)
.++|++.++||+|+||+||+|++. +++.||||++.... ...++|.+|+.+|++++|||||++++++.+++..++||||
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 94 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 94 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence 467899999999999999999976 58899999987543 3457899999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCC
Q 039168 294 MPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQN 373 (536)
Q Consensus 294 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 373 (536)
+++|+|..++... ....+++..++.++.||++||+|||+++ |+||||||+||||++++++||+|||+++.......
T Consensus 95 ~~~g~l~~~l~~~-~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~ 170 (287)
T d1opja_ 95 MTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 170 (287)
T ss_dssp CTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS
T ss_pred ccCcchHHHhhhc-cccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCCCc
Confidence 9999999998653 3356899999999999999999999996 99999999999999999999999999987654332
Q ss_pred ccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcccccccccc
Q 039168 374 QANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLK 453 (536)
Q Consensus 374 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~ 453 (536)
. ......|++.|+|||++.+..++.++|||||||++|||++|..|+..... . .........+...+. .
T Consensus 171 ~-~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~-----~-~~~~~~i~~~~~~~~-----~ 238 (287)
T d1opja_ 171 T-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-----L-SQVYELLEKDYRMER-----P 238 (287)
T ss_dssp E-EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC-----H-HHHHHHHHTTCCCCC-----C
T ss_pred e-eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch-----H-HHHHHHHhcCCCCCC-----C
Confidence 2 22334688999999999999999999999999999999998777532111 1 111222222221111 1
Q ss_pred CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 454 QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 454 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
... + .++.+|+.+||+.||++|||+++|++.|+..
T Consensus 239 ~~~-~---~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~ 273 (287)
T d1opja_ 239 EGC-P---EKVYELMRACWQWNPSDRPSFAEIHQAFETM 273 (287)
T ss_dssp TTC-C---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred ccc-h---HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 122 2 3466677799999999999999999999865
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-51 Score=400.89 Aligned_cols=251 Identities=25% Similarity=0.389 Sum_probs=203.9
Q ss_pred cCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEeec
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 294 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 294 (536)
+.|++++.||+|+||+||+|++. +++.||||++........+.+.+|+++|++++|||||++++++.+++..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 56899999999999999999975 58999999998777777788999999999999999999999999999999999999
Q ss_pred CCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCCc
Q 039168 295 PNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQ 374 (536)
Q Consensus 295 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 374 (536)
++|+|..++.+. ...+++.++..++.||++||.|||+++ |+||||||+|||++.++++||+|||+++......
T Consensus 92 ~~g~L~~~~~~~--~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-- 164 (288)
T d2jfla1 92 AGGAVDAVMLEL--ERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-- 164 (288)
T ss_dssp TTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHH--
T ss_pred CCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCCc--
Confidence 999999987543 245999999999999999999999997 9999999999999999999999999997653221
Q ss_pred cccccccccccccCcchhc-----CCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcccccc
Q 039168 375 ANTNIIAGTYGYMAPEYAM-----GGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELID 449 (536)
Q Consensus 375 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 449 (536)
.......||+.|+|||++. +..|+.++|||||||++|||++|+.||...... .... ... ......+..
T Consensus 165 ~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~---~~~~---~i~-~~~~~~~~~ 237 (288)
T d2jfla1 165 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM---RVLL---KIA-KSEPPTLAQ 237 (288)
T ss_dssp HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGG---GHHH---HHH-HSCCCCCSS
T ss_pred ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHH---HHHH---HHH-cCCCCCCCc
Confidence 1223467999999999984 455899999999999999999999998643221 1111 111 111111111
Q ss_pred ccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 450 PVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 450 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
+ ......+.+++.+||+.||++|||+.|+++
T Consensus 238 ~-------~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 238 P-------SRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp G-------GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred c-------ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1 111234566677999999999999999986
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-51 Score=411.27 Aligned_cols=199 Identities=27% Similarity=0.390 Sum_probs=177.0
Q ss_pred hcCCccccccCCCCceeEEEEEeC-CCcEEEEEEcccc-ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEe
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT-SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 292 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 292 (536)
.++|++.++||+|+||+||+|++. +|+.||+|++... .....+.+.+|+.+|++++|||||+++++|.+++.+++|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 468999999999999999999975 6899999998754 33445788999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCC
Q 039168 293 YMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHED-SRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGN 371 (536)
Q Consensus 293 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 371 (536)
|+++|+|..++.+. ..+++..++.++.||++||.|||++ + |+||||||+||||+.++++||+|||+|+.+...
T Consensus 85 y~~gg~L~~~l~~~---~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 158 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 158 (322)
T ss_dssp CCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred cCCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCCC
Confidence 99999999999653 3489999999999999999999974 5 999999999999999999999999999876422
Q ss_pred CCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 039168 372 QNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFY 423 (536)
Q Consensus 372 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~ 423 (536)
.....+||+.|+|||++.+..|+.++|||||||++|||++|+.||...
T Consensus 159 ----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~ 206 (322)
T d1s9ja_ 159 ----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 206 (322)
T ss_dssp ----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCC
T ss_pred ----ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 223468999999999999999999999999999999999999998653
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-51 Score=400.93 Aligned_cols=255 Identities=32% Similarity=0.507 Sum_probs=204.1
Q ss_pred hcCCccccccCCCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEeec
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 294 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 294 (536)
.++|++.++||+|+||.||+|++++++.||||++.... ...+.|.+|+.+|++++|||||++++++.+ +..++||||+
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~ 89 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence 36789999999999999999999888999999997543 345789999999999999999999998765 5679999999
Q ss_pred CCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCCc
Q 039168 295 PNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQ 374 (536)
Q Consensus 295 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 374 (536)
++|+|.+++.... ...+++.+++.++.||++||.|||+++ |+||||||+||||++++.+||+|||+++.+......
T Consensus 90 ~~g~L~~~~~~~~-~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~ 165 (272)
T d1qpca_ 90 ENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT 165 (272)
T ss_dssp TTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred CCCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCccc
Confidence 9999998875433 235899999999999999999999996 999999999999999999999999999987543322
Q ss_pred cccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccccccC
Q 039168 375 ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQ 454 (536)
Q Consensus 375 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~ 454 (536)
......||+.|+|||++.+..++.++|||||||++|||+||..|+...... .. .......+.... ...
T Consensus 166 -~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~--~~----~~~~i~~~~~~~-----~p~ 233 (272)
T d1qpca_ 166 -AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN--PE----VIQNLERGYRMV-----RPD 233 (272)
T ss_dssp -CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HH----HHHHHHTTCCCC-----CCT
T ss_pred -cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCH--HH----HHHHHHhcCCCC-----Ccc
Confidence 223456899999999999999999999999999999999976654221111 11 111222222111 111
Q ss_pred CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcc
Q 039168 455 SCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 491 (536)
Q Consensus 455 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 491 (536)
.. ++ .+.+|+.+||+.||++|||+++|++.|+.
T Consensus 234 ~~-~~---~l~~li~~cl~~~P~~Rpt~~ei~~~L~~ 266 (272)
T d1qpca_ 234 NC-PE---ELYQLMRLCWKERPEDRPTFDYLRSVLED 266 (272)
T ss_dssp TC-CH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred cC-hH---HHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence 22 22 45667779999999999999999998874
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-51 Score=392.67 Aligned_cols=253 Identities=27% Similarity=0.411 Sum_probs=208.7
Q ss_pred cCCccccccCCCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEeecC
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMP 295 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 295 (536)
++|++.++||+|+||+||+|++++++.||||++..... ..++|.+|+.++++++||||+++++++.+++.+++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 68999999999999999999998889999999976443 35789999999999999999999999999999999999999
Q ss_pred CCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCCcc
Q 039168 296 NKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQA 375 (536)
Q Consensus 296 ~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 375 (536)
+|+|..++.... ..+++..++.++.||++||.|||+++ |+||||||+|||+++++.+||+|||+++.+......
T Consensus 83 ~g~l~~~~~~~~--~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~- 156 (258)
T d1k2pa_ 83 NGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT- 156 (258)
T ss_dssp TEEHHHHHHSGG--GCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC-
T ss_pred CCcHHHhhhccc--cCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCce-
Confidence 999998875433 35889999999999999999999996 999999999999999999999999999876544332
Q ss_pred ccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHHHHHhhcCCccccccccccC
Q 039168 376 NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQ 454 (536)
Q Consensus 376 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~ 454 (536)
......||+.|+|||++.+..++.++|||||||++|||+| |+.||...... ... .....+..... + .
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~---~~~----~~i~~~~~~~~--p---~ 224 (258)
T d1k2pa_ 157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS---ETA----EHIAQGLRLYR--P---H 224 (258)
T ss_dssp CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH---HHH----HHHHTTCCCCC--C---T
T ss_pred eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH---HHH----HHHHhCCCCCC--c---c
Confidence 2233568999999999999999999999999999999998 78887644321 111 11222222111 1 1
Q ss_pred CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcc
Q 039168 455 SCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 491 (536)
Q Consensus 455 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 491 (536)
. .+ ..+.+++.+||+.||++|||+++|++.|..
T Consensus 225 ~-~~---~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 225 L-AS---EKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp T-CC---HHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred c-cc---HHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 1 22 345667779999999999999999999854
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-51 Score=402.92 Aligned_cols=248 Identities=23% Similarity=0.296 Sum_probs=200.5
Q ss_pred cCCccccccCCCCceeEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEE
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 291 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 291 (536)
++|++++.||+|+||+||+|+++ +++.||||++.+. .....+.+.+|+++|++++||||+++++++.+++..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 57999999999999999999975 6899999998643 2334577899999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCC
Q 039168 292 EYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGN 371 (536)
Q Consensus 292 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 371 (536)
||+++|+|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.+...
T Consensus 88 Ey~~gg~L~~~~~~~---~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKI---GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp CCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EccCCCCHHHhhhcc---CCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccC
Confidence 999999999988543 35999999999999999999999996 999999999999999999999999999987655
Q ss_pred CCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcccccccc
Q 039168 372 QNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPV 451 (536)
Q Consensus 372 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 451 (536)
..........||+.|+|||++.+..++.++|||||||++|||++|+.||..... .... ........ .
T Consensus 162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------~~~~-~~i~~~~~-~----- 228 (288)
T d1uu3a_ 162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE------YLIF-QKIIKLEY-D----- 228 (288)
T ss_dssp --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHH-HHHHTTCC-C-----
T ss_pred CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCH------HHHH-HHHHcCCC-C-----
Confidence 444444556899999999999999999999999999999999999999864221 1111 11111111 1
Q ss_pred ccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHH
Q 039168 452 LKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVV 486 (536)
Q Consensus 452 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl 486 (536)
+.... + .++.+|+.+||+.||++|||++|++
T Consensus 229 ~p~~~-s---~~~~~li~~~L~~dP~~R~t~~e~~ 259 (288)
T d1uu3a_ 229 FPEKF-F---PKARDLVEKLLVLDATKRLGCEEME 259 (288)
T ss_dssp CCTTC-C---HHHHHHHHTTSCSSGGGSTTSGGGT
T ss_pred CCccC-C---HHHHHHHHHHccCCHhHCcCHHHHc
Confidence 11122 2 2456677799999999999999864
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.8e-51 Score=403.83 Aligned_cols=256 Identities=26% Similarity=0.412 Sum_probs=195.0
Q ss_pred cCCccccccCCCCceeEEEEEeCC-C---cEEEEEEcccc-ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEE
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLAD-G---KAIAVKRLSRT-SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 290 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 290 (536)
++|++.++||+|+||+||+|+++. + ..||||++... .....+.|.+|+++|++++|||||++++++.+++.+++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 567888999999999999998753 3 35899988654 445567899999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCC
Q 039168 291 YEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGG 370 (536)
Q Consensus 291 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 370 (536)
|||+++|+|..++... ...+++.+++.++.||++||.|||+++ |+||||||+||||+.++++||+|||+++.+..
T Consensus 106 ~Ey~~~g~L~~~~~~~--~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp EECCTTEEHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEecCCCcceeeeccc--cCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccC
Confidence 9999999999988543 345899999999999999999999996 99999999999999999999999999987754
Q ss_pred CCCccc---cccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHHHHHhhcCCccc
Q 039168 371 NQNQAN---TNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVE 446 (536)
Q Consensus 371 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 446 (536)
...... .....||+.|||||++.+..++.++|||||||++|||+| |+.||...... .... ....+....
T Consensus 181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~---~~~~----~i~~~~~~~ 253 (299)
T d1jpaa_ 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ---DVIN----AIEQDYRLP 253 (299)
T ss_dssp ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHH----HHHTTCCCC
T ss_pred CCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH---HHHH----HHHcCCCCC
Confidence 332221 222457899999999999999999999999999999998 89997543221 1111 111221111
Q ss_pred cccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 447 LIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 447 l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
. +......+.+|+.+||+.||++|||+.+|++.|+..
T Consensus 254 -----~----~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~ 290 (299)
T d1jpaa_ 254 -----P----PMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290 (299)
T ss_dssp -----C----CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred -----C----CccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1 111223466677799999999999999999998753
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-51 Score=409.14 Aligned_cols=258 Identities=30% Similarity=0.422 Sum_probs=205.0
Q ss_pred hcCCccccccCCCCceeEEEEEeCC------CcEEEEEEcccc-ChhhHHHHHHHHHHHHHc-CCCCceeEeeEEeeCce
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLAD------GKAIAVKRLSRT-SGQGLKEFKNEVNLIAKL-QHKNLVRLLGCCLEGQE 286 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~ 286 (536)
.++|++.++||+|+||+||+|++.. ...||+|++... .......+.+|+.+|.++ +|||||++++++.+.+.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence 3679999999999999999998643 236999998654 333456788999999998 89999999999999999
Q ss_pred EEEEEeecCCCChhhhhhcccC--------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCC
Q 039168 287 LLLIYEYMPNKSLDVHLFDATR--------------------SVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKA 346 (536)
Q Consensus 287 ~~lv~e~~~~~sL~~~l~~~~~--------------------~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp 346 (536)
+++||||+++|+|.++|..... ...+++..++.++.||++||+|||+++ |+||||||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp 192 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAA 192 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSG
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCch
Confidence 9999999999999999965432 235899999999999999999999996 99999999
Q ss_pred CcEEEcCCCCeEEecccCccccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCc
Q 039168 347 SNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFS 425 (536)
Q Consensus 347 ~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~ 425 (536)
+|||++.++++||+|||+++...............||+.|||||++.+..++.++|||||||++|||+| |+.||.....
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~ 272 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999987765544444445678999999999999999999999999999999998 8999754322
Q ss_pred cCCchhHHHHHHHhhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 039168 426 EHGQTLLTYTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLA 490 (536)
Q Consensus 426 ~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 490 (536)
. ..+ ......+.... .... .+ ..+.+|+.+||+.||++|||++||++.|.
T Consensus 273 ~--~~~----~~~~~~~~~~~-----~p~~-~~---~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 273 D--ANF----YKLIQNGFKMD-----QPFY-AT---EEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp S--HHH----HHHHHTTCCCC-----CCTT-CC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred H--HHH----HHHHhcCCCCC-----CCCc-CC---HHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 1 111 12222222111 1111 22 34666777999999999999999999985
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-49 Score=387.03 Aligned_cols=247 Identities=24% Similarity=0.354 Sum_probs=195.4
Q ss_pred CccccccCCCCceeEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHHHcCCCCceeEeeEEee----CceEEEE
Q 039168 218 FSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLE----GQELLLI 290 (536)
Q Consensus 218 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~----~~~~~lv 290 (536)
|++.++||+|+||+||+|++. +++.||+|++... .....+.+.+|+++|++++|||||++++++.+ +..+++|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 366778999999999999976 5889999998653 34456779999999999999999999999875 4568999
Q ss_pred EeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEc-CCCCeEEecccCccccC
Q 039168 291 YEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLD-DDMNPKISDFGTARIFG 369 (536)
Q Consensus 291 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~-~~~~~kl~Dfg~a~~~~ 369 (536)
|||+++|+|.+++... ..+++..++.++.||++||+|||+++ .+|+||||||+||||+ +++.+||+|||+++...
T Consensus 91 mE~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp EECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EeCCCCCcHHHHHhcc---ccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 9999999999999543 35899999999999999999999873 2499999999999997 57899999999998643
Q ss_pred CCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcccccc
Q 039168 370 GNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELID 449 (536)
Q Consensus 370 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 449 (536)
.. ......||+.|||||++.+ .++.++|||||||++|||++|+.||...... .........+.....
T Consensus 167 ~~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~------~~~~~~i~~~~~~~~-- 233 (270)
T d1t4ha_ 167 AS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA------AQIYRRVTSGVKPAS-- 233 (270)
T ss_dssp TT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH------HHHHHHHTTTCCCGG--
T ss_pred CC----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccH------HHHHHHHHcCCCCcc--
Confidence 22 2234679999999999875 5999999999999999999999998532211 111122222211111
Q ss_pred ccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 450 PVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 450 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
...... + ++.+++.+||++||++|||+.|+++
T Consensus 234 --~~~~~~-~---~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 234 --FDKVAI-P---EVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp --GGGCCC-H---HHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --cCccCC-H---HHHHHHHHHccCCHhHCcCHHHHhC
Confidence 111222 2 3556677999999999999999986
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-51 Score=397.59 Aligned_cols=262 Identities=29% Similarity=0.436 Sum_probs=203.2
Q ss_pred cCCccccccCCCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEeecC
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMP 295 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 295 (536)
++|++.+.||+|+||.||+|++++++.||||++.... ...+.|.+|+.+|++++|||||++++++.+ +..++||||++
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~ 94 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 94 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecC
Confidence 6799999999999999999999888899999997543 345789999999999999999999999854 56899999999
Q ss_pred CCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCCcc
Q 039168 296 NKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQA 375 (536)
Q Consensus 296 ~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 375 (536)
+|+|..++.... ...+++.+++.++.||+.||+|||+++ |+||||||+||||+.++++||+|||+++.+......
T Consensus 95 ~g~l~~~~~~~~-~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~- 169 (285)
T d1fmka3 95 KGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT- 169 (285)
T ss_dssp TCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred CCchhhhhhhcc-cccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCce-
Confidence 999998886533 235899999999999999999999997 999999999999999999999999999876543322
Q ss_pred ccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccccccCC
Q 039168 376 NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQS 455 (536)
Q Consensus 376 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~ 455 (536)
......||+.|+|||++.+..++.++|||||||++|||++|..|+...... .... .....+.... ....
T Consensus 170 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~--~~~~----~~i~~~~~~~-----~~~~ 238 (285)
T d1fmka3 170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--REVL----DQVERGYRMP-----CPPE 238 (285)
T ss_dssp ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHH----HHHHTTCCCC-----CCTT
T ss_pred eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH--HHHH----HHHHhcCCCC-----CCcc
Confidence 223356899999999999999999999999999999999977664332211 1111 1111221111 1112
Q ss_pred CCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccCCCCCCCC
Q 039168 456 CAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSMTIPQP 499 (536)
Q Consensus 456 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~p 499 (536)
. ..++.+++.+||+.||++|||+++|+++|+..-...+++
T Consensus 239 ~----~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p~ 278 (285)
T d1fmka3 239 C----PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 278 (285)
T ss_dssp S----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCC
T ss_pred c----CHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCCC
Confidence 2 234667777999999999999999999999864444433
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=4.9e-50 Score=403.80 Aligned_cols=252 Identities=23% Similarity=0.338 Sum_probs=206.3
Q ss_pred cCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEeec
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 294 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 294 (536)
++|++.+.||+|+||.||+|++. +|+.||||++........+.+.+|+.+|++++|||||++++++.+++.+|+||||+
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 105 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 105 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 58999999999999999999975 68999999998777777788999999999999999999999999999999999999
Q ss_pred CCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcC--CCCeEEecccCccccCCCC
Q 039168 295 PNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDD--DMNPKISDFGTARIFGGNQ 372 (536)
Q Consensus 295 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~--~~~~kl~Dfg~a~~~~~~~ 372 (536)
++|+|.+++.+. ...+++.+++.++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||+++.+....
T Consensus 106 ~gg~L~~~l~~~--~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 180 (350)
T d1koaa2 106 SGGELFEKVADE--HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 180 (350)
T ss_dssp CSCBHHHHHTCT--TSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred CCCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence 999999988542 345999999999999999999999997 999999999999964 6789999999998775432
Q ss_pred CccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccccc
Q 039168 373 NQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVL 452 (536)
Q Consensus 373 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l 452 (536)
. .....||+.|||||++.+..++.++|||||||++|+|++|+.||..... ..... .. ...... . ....
T Consensus 181 ~---~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~---~~~~~---~i-~~~~~~-~-~~~~ 248 (350)
T d1koaa2 181 S---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND---DETLR---NV-KSCDWN-M-DDSA 248 (350)
T ss_dssp C---EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHH---HH-HHTCCC-S-CCGG
T ss_pred c---cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH---HHHHH---HH-HhCCCC-C-Cccc
Confidence 2 3346799999999999999999999999999999999999999854321 11111 11 111110 0 0111
Q ss_pred cCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 453 KQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 453 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
... .+ ..+.+++.+||+.||++|||++|+++.
T Consensus 249 ~~~-~s---~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 249 FSG-IS---EDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp GGG-CC---HHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred ccC-CC---HHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111 12 345667779999999999999999984
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-50 Score=395.10 Aligned_cols=255 Identities=26% Similarity=0.424 Sum_probs=204.7
Q ss_pred cCCcccc-ccCCCCceeEEEEEeC---CCcEEEEEEccccC-hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEE
Q 039168 216 NHFSDEN-KLGQGGFGPVYKGTLA---DGKAIAVKRLSRTS-GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 290 (536)
Q Consensus 216 ~~~~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 290 (536)
++|.+.+ +||+|+||+||+|.++ ++..||||++.... ....+.|.+|+++|++++|||||++++++.. +.+|+|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 4566666 4999999999999764 35579999997543 4456789999999999999999999999865 568999
Q ss_pred EeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCC
Q 039168 291 YEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGG 370 (536)
Q Consensus 291 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 370 (536)
|||+++|+|.+++... ...+++..+..++.||++||+|||+++ |+||||||+||||+.++.+||+|||+++.+..
T Consensus 87 mE~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA 161 (285)
T ss_dssp EECCTTEEHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEeCCCCcHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhcccc
Confidence 9999999999987543 345899999999999999999999996 99999999999999999999999999998765
Q ss_pred CCCc-cccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHHHHHhhcCCccccc
Q 039168 371 NQNQ-ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELI 448 (536)
Q Consensus 371 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 448 (536)
.... .......||+.|+|||++.+..++.++|||||||++|||+| |+.||...... ... .....+...+.
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~---~~~----~~i~~~~~~~~- 233 (285)
T d1u59a_ 162 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVM----AFIEQGKRMEC- 233 (285)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH---HHH----HHHHTTCCCCC-
T ss_pred cccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH---HHH----HHHHcCCCCCC-
Confidence 4332 22334568999999999999999999999999999999998 89998643221 111 22223332222
Q ss_pred cccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 449 DPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 449 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
.... + .++.+|+.+||+.||++|||+.+|++.|+..
T Consensus 234 ----p~~~-~---~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~ 269 (285)
T d1u59a_ 234 ----PPEC-P---PELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269 (285)
T ss_dssp ----CTTC-C---HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCcC-C---HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1122 2 3456677799999999999999999998754
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-50 Score=395.13 Aligned_cols=257 Identities=27% Similarity=0.454 Sum_probs=197.9
Q ss_pred cCCccccccCCCCceeEEEEEeCCC-----cEEEEEEcccc-ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEE
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLADG-----KAIAVKRLSRT-SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 289 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~~~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 289 (536)
+.|+..++||+|+||+||+|.++.. ..||||++... .......|.+|+.+|++++|||||++++++.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 5688899999999999999987532 47999998754 33445678999999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccC
Q 039168 290 IYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFG 369 (536)
Q Consensus 290 v~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 369 (536)
||||+.++++...+... ...+++.++..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.+.
T Consensus 87 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 87 ITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 161 (283)
T ss_dssp EEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEEecccCcchhhhhcc--cccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhccc
Confidence 99999999998887543 345899999999999999999999996 9999999999999999999999999998775
Q ss_pred CCCCc-cccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccc
Q 039168 370 GNQNQ-ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELI 448 (536)
Q Consensus 370 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 448 (536)
..... .......||+.|+|||++.+..++.++|||||||++|||++|..|+...... ... ......+.....
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~--~~~----~~~i~~~~~~~~- 234 (283)
T d1mqba_ 162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN--HEV----MKAINDGFRLPT- 234 (283)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHH----HHHHHTTCCCCC-
T ss_pred CCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH--HHH----HHHHhccCCCCC-
Confidence 43322 2233356899999999999999999999999999999999976664322111 111 122222222111
Q ss_pred cccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 449 DPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 449 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
+......+.+|+.+||+.||++|||+.+|++.|+..
T Consensus 235 --------~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l 270 (283)
T d1mqba_ 235 --------PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 270 (283)
T ss_dssp --------CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred --------chhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHH
Confidence 111223466777899999999999999999999764
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.2e-50 Score=399.47 Aligned_cols=253 Identities=22% Similarity=0.266 Sum_probs=188.3
Q ss_pred HhcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccCh-hhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEE
Q 039168 214 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG-QGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 291 (536)
Q Consensus 214 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 291 (536)
..+.|++.+.||+|+||+||+|+++ +++.||||++..... ...+.+.+|+.+|++++|||||++++++.+++.+|+||
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 3467999999999999999999976 589999999975432 23456789999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEc---CCCCeEEecccCcccc
Q 039168 292 EYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLD---DDMNPKISDFGTARIF 368 (536)
Q Consensus 292 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~---~~~~~kl~Dfg~a~~~ 368 (536)
||++||+|.+++.. ...+++.++..++.||+.||.|||+++ |+||||||+|||+. +++.+||+|||+++..
T Consensus 87 E~~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 87 QLVSGGELFDRIVE---KGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160 (307)
T ss_dssp CCCCSCBHHHHHHT---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred eccCCCcHHHhhhc---ccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEc
Confidence 99999999999954 345999999999999999999999997 99999999999995 5789999999999866
Q ss_pred CCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccc
Q 039168 369 GGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELI 448 (536)
Q Consensus 369 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 448 (536)
.... .....+||+.|||||++.+..++.++|||||||++|||++|+.||...... ... ......... +
T Consensus 161 ~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~------~~~-~~i~~~~~~--~ 228 (307)
T d1a06a_ 161 DPGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA------KLF-EQILKAEYE--F 228 (307)
T ss_dssp ---------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHH-HHHHTTCCC--C
T ss_pred cCCC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH------HHH-HHHhccCCC--C
Confidence 4322 223467999999999999999999999999999999999999998532211 111 111111111 0
Q ss_pred cccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 449 DPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 449 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
........ ...+.+++.+||+.||++|||++|+++.
T Consensus 229 ~~~~~~~~----s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 229 DSPYWDDI----SDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp CTTTTTTS----CHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CCccccCC----CHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 11111111 2346667779999999999999999973
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-50 Score=394.17 Aligned_cols=247 Identities=30% Similarity=0.428 Sum_probs=195.9
Q ss_pred cccCCCCceeEEEEEeC---CCcEEEEEEcccc--ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEeecCC
Q 039168 222 NKLGQGGFGPVYKGTLA---DGKAIAVKRLSRT--SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPN 296 (536)
Q Consensus 222 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 296 (536)
++||+|+||+||+|.+. .++.||||++... +....+.|.+|+++|++++|||||++++++.. +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 57999999999999864 3568999998643 23345789999999999999999999999865 467899999999
Q ss_pred CChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCCcc-
Q 039168 297 KSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQA- 375 (536)
Q Consensus 297 ~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~- 375 (536)
|+|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.+.......
T Consensus 92 g~L~~~l~~~---~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 165 (277)
T d1xbba_ 92 GPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 165 (277)
T ss_dssp EEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred CcHHHHHhhc---cCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence 9999998543 45999999999999999999999996 9999999999999999999999999999775443322
Q ss_pred ccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHHHHHhhcCCccccccccccC
Q 039168 376 NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLKQ 454 (536)
Q Consensus 376 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~ 454 (536)
......||+.|+|||++.+..++.++|||||||++|||++ |+.||...... . .......+..... ..
T Consensus 166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~---~----~~~~i~~~~~~~~-----p~ 233 (277)
T d1xbba_ 166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---E----VTAMLEKGERMGC-----PA 233 (277)
T ss_dssp C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---H----HHHHHHTTCCCCC-----CT
T ss_pred cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH---H----HHHHHHcCCCCCC-----Cc
Confidence 2334578999999999999999999999999999999998 89997643211 1 1122223322221 11
Q ss_pred CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcc
Q 039168 455 SCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 491 (536)
Q Consensus 455 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 491 (536)
.. + ..+.+|+.+||+.||++|||+++|++.|+.
T Consensus 234 ~~-~---~~~~~li~~cl~~dp~~RPs~~~i~~~L~~ 266 (277)
T d1xbba_ 234 GC-P---REMYDLMNLCWTYDVENRPGFAAVELRLRN 266 (277)
T ss_dssp TC-C---HHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred cc-C---HHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence 22 2 345667779999999999999999998865
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=8.2e-50 Score=402.48 Aligned_cols=256 Identities=21% Similarity=0.278 Sum_probs=208.0
Q ss_pred cCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEeec
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 294 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 294 (536)
++|+++++||+|+||.||+|++. +|+.||||++........+.+.+|+.+|++++|||||++++++.+++.+|+||||+
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 57999999999999999999975 69999999998776666778899999999999999999999999999999999999
Q ss_pred CCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEc--CCCCeEEecccCccccCCCC
Q 039168 295 PNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLD--DDMNPKISDFGTARIFGGNQ 372 (536)
Q Consensus 295 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~--~~~~~kl~Dfg~a~~~~~~~ 372 (536)
++|+|.+.+.. ....+++.+++.++.||+.||.|||+++ |+||||||+||||+ .++++||+|||+++.+....
T Consensus 109 ~gg~L~~~~~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~ 183 (352)
T d1koba_ 109 SGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 183 (352)
T ss_dssp CCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred CCChHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCCC
Confidence 99999887743 2345999999999999999999999997 99999999999998 67899999999999875432
Q ss_pred CccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccccc
Q 039168 373 NQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVL 452 (536)
Q Consensus 373 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l 452 (536)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||...... .... ... ..... +....
T Consensus 184 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~---~~~~---~i~-~~~~~--~~~~~ 251 (352)
T d1koba_ 184 ---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL---ETLQ---NVK-RCDWE--FDEDA 251 (352)
T ss_dssp ---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHHH---HHH-HCCCC--CCSST
T ss_pred ---ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH---HHHH---HHH-hCCCC--CCccc
Confidence 233457899999999999999999999999999999999999998532211 1111 111 11110 01111
Q ss_pred cCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH--hccC
Q 039168 453 KQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM--LASD 492 (536)
Q Consensus 453 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~~ 492 (536)
... ....+.+|+.+||+.||.+|||+.|+|+. +++.
T Consensus 252 ~~~----~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 252 FSS----VSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp TTT----SCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred ccC----CCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 111 12345667779999999999999999973 5544
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.6e-50 Score=396.16 Aligned_cols=245 Identities=28% Similarity=0.470 Sum_probs=198.7
Q ss_pred cCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEE
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 291 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 291 (536)
+.|+.++.||+|+||+||+|++. +++.||||++.... ....+.+.+|+.+|++++|||||++++++.+++..|+||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 45999999999999999999975 68899999987543 334567899999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCC
Q 039168 292 EYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGN 371 (536)
Q Consensus 292 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 371 (536)
|||.+|+|..++.. ...+++.+++.++.||+.||.|||+++ |+||||||+||||+.++++||+|||+++....
T Consensus 95 E~~~~g~l~~~~~~---~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~- 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP- 167 (309)
T ss_dssp ECCSEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred EecCCCchHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC-
Confidence 99999999876643 245999999999999999999999997 99999999999999999999999999986532
Q ss_pred CCccccccccccccccCcchhcC---CCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccc
Q 039168 372 QNQANTNIIAGTYGYMAPEYAMG---GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELI 448 (536)
Q Consensus 372 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 448 (536)
.....||+.|||||++.+ ..|+.++|||||||++|||++|+.||..... ......... +....+
T Consensus 168 -----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~------~~~~~~i~~-~~~~~~- 234 (309)
T d1u5ra_ 168 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQ-NESPAL- 234 (309)
T ss_dssp -----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHH-SCCCCC-
T ss_pred -----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH------HHHHHHHHh-CCCCCC-
Confidence 223579999999999964 4589999999999999999999999753221 111111111 111111
Q ss_pred cccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 449 DPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 449 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
.....++ .+.+++.+||+.||++|||++++|+
T Consensus 235 ----~~~~~s~---~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 235 ----QSGHWSE---YFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp ----SCTTSCH---HHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ----CCCCCCH---HHHHHHHHHCcCChhHCcCHHHHHh
Confidence 1111233 3556666999999999999999986
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-49 Score=386.48 Aligned_cols=251 Identities=23% Similarity=0.273 Sum_probs=202.9
Q ss_pred hcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC------hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceE
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS------GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQEL 287 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 287 (536)
.++|++.+.||+|+||+||+|+++ +|+.||||++.+.. ....+.+.+|+.+|++++|||||++++++.+.+.+
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 468999999999999999999975 68999999986432 22367899999999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCC----CeEEeccc
Q 039168 288 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDM----NPKISDFG 363 (536)
Q Consensus 288 ~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~----~~kl~Dfg 363 (536)
|+||||+++|+|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++ ++||+|||
T Consensus 89 ~iv~E~~~gg~L~~~i~~~---~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG 162 (293)
T ss_dssp EEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCccccchhccc---cccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchh
Confidence 9999999999999998653 35999999999999999999999997 99999999999998776 59999999
Q ss_pred CccccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCC
Q 039168 364 TARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGH 443 (536)
Q Consensus 364 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 443 (536)
+++....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ... .......
T Consensus 163 ~a~~~~~~~~---~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~------~~~-~~i~~~~ 232 (293)
T d1jksa_ 163 LAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ------ETL-ANVSAVN 232 (293)
T ss_dssp TCEECTTSCB---CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHH-HHHHTTC
T ss_pred hhhhcCCCcc---ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHH------HHH-HHHHhcC
Confidence 9987653322 23457899999999999999999999999999999999999998642211 111 1111111
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 444 AVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 444 ~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
.. ......... ...+.+++.+||+.||++|||++++++
T Consensus 233 ~~--~~~~~~~~~----s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 233 YE--FEDEYFSNT----SALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp CC--CCHHHHTTS----CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CC--CCchhcCCC----CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 10 001111111 234566777999999999999999986
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-49 Score=393.99 Aligned_cols=247 Identities=23% Similarity=0.282 Sum_probs=203.3
Q ss_pred cCCccccccCCCCceeEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEE
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 291 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 291 (536)
++|++++.||+|+||.||+|+.+ +|+.||||++.+. .....+.+.+|+.+|++++||||+++++++.+.+.+|+||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 57999999999999999999975 6999999999754 2334677899999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCC
Q 039168 292 EYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGN 371 (536)
Q Consensus 292 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 371 (536)
||+++|+|..++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.+|++||+|||+++.....
T Consensus 85 ey~~gg~L~~~~~~~---~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 85 EYANGGELFFHLSRE---RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp ECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred eccCCCchhhhhhcc---cCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccC
Confidence 999999999988553 34899999999999999999999997 999999999999999999999999999876433
Q ss_pred CCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcccccccc
Q 039168 372 QNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPV 451 (536)
Q Consensus 372 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 451 (536)
.. .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||..... ..+.. ....+.. .
T Consensus 159 ~~--~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~---~~~~~----~i~~~~~-~----- 223 (337)
T d1o6la_ 159 GA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---ERLFE----LILMEEI-R----- 223 (337)
T ss_dssp TC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHH----HHHHCCC-C-----
T ss_pred Cc--ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH---HHHHH----HHhcCCC-C-----
Confidence 22 23346899999999999999999999999999999999999999764322 11111 1111111 1
Q ss_pred ccCCCCHHHHHHHHHHHHhhcCCCCCCCCC-----HHHHHH
Q 039168 452 LKQSCAPDELLKFIHIGLLCVQQDPADRPT-----MSSVVV 487 (536)
Q Consensus 452 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~ 487 (536)
+....+ .++.+++.+||++||.+||+ +.++++
T Consensus 224 ~p~~~s----~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 224 FPRTLS----PEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp CCTTSC----HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCccCC----HHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 111222 23556677999999999995 788875
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.8e-49 Score=390.41 Aligned_cols=259 Identities=29% Similarity=0.457 Sum_probs=208.4
Q ss_pred hcCCccccccCCCCceeEEEEEeC------CCcEEEEEEccccC-hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceE
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRTS-GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQEL 287 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 287 (536)
.++|++.+.||+|+||+||+|+++ +++.||||++.... .+..++|.+|+.+|++++||||+++++++...+..
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~ 91 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM 91 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCce
Confidence 468999999999999999999863 35789999997543 33466799999999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhhccc---------------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCC
Q 039168 288 LLIYEYMPNKSLDVHLFDAT---------------------RSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKA 346 (536)
Q Consensus 288 ~lv~e~~~~~sL~~~l~~~~---------------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp 346 (536)
++||||+++|+|.+++.... ....+++..++.++.||+.||+|||+++ ||||||||
T Consensus 92 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrDlKp 168 (301)
T d1lufa_ 92 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLAT 168 (301)
T ss_dssp EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSG
T ss_pred EEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEeeEEcc
Confidence 99999999999999986422 1234889999999999999999999996 99999999
Q ss_pred CcEEEcCCCCeEEecccCccccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCC-CCCCCCc
Q 039168 347 SNVLLDDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRK-NNGFYFS 425 (536)
Q Consensus 347 ~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~-p~~~~~~ 425 (536)
+||||+.++.+||+|||+++...............||+.|+|||.+.+..++.++|||||||++|||++|.. ||.....
T Consensus 169 ~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~ 248 (301)
T d1lufa_ 169 RNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH 248 (301)
T ss_dssp GGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred cceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCH
Confidence 999999999999999999987755444444445678999999999999999999999999999999999964 5443211
Q ss_pred cCCchhHHHHHHHhhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 426 EHGQTLLTYTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 426 ~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
. +.. .....+...+. ....+ .++.+|+.+||+.||++|||+.+|+++|+..
T Consensus 249 ~------e~~-~~v~~~~~~~~-----p~~~~----~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i 299 (301)
T d1lufa_ 249 E------EVI-YYVRDGNILAC-----PENCP----LELYNLMRLCWSKLPADRPSFCSIHRILQRM 299 (301)
T ss_dssp H------HHH-HHHHTTCCCCC-----CTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred H------HHH-HHHHcCCCCCC-----Cccch----HHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 1 111 12223332221 11222 3466778899999999999999999999875
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-49 Score=390.64 Aligned_cols=255 Identities=28% Similarity=0.451 Sum_probs=198.9
Q ss_pred cCCccccccCCCCceeEEEEEeC-CCc----EEEEEEcccc-ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEE
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA-DGK----AIAVKRLSRT-SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 289 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 289 (536)
++|+++++||+|+||+||+|.+. +|+ +||+|++... .....+.|.+|+.+|++++|||||++++++.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 46999999999999999999875 343 6899988643 344567899999999999999999999999865 5678
Q ss_pred EEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccC
Q 039168 290 IYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFG 369 (536)
Q Consensus 290 v~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 369 (536)
++|++.+++|.+++... ...+++..++.++.||++||.|||+++ |+||||||+||||+.++++||+|||+++.+.
T Consensus 88 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp EEECCTTCBHHHHHHHT--SSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred EEEeccCCccccccccc--ccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecc
Confidence 88999999998887543 446899999999999999999999996 9999999999999999999999999999876
Q ss_pred CCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHHHHHhhcCCccccc
Q 039168 370 GNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELI 448 (536)
Q Consensus 370 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 448 (536)
............||+.|+|||++.++.++.++|||||||++|||+| |+.||...... .+... ...+.....
T Consensus 163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~---~~~~~----i~~~~~~~~- 234 (317)
T d1xkka_ 163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---EISSI----LEKGERLPQ- 234 (317)
T ss_dssp TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG---GHHHH----HHHTCCCCC-
T ss_pred cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH---HHHHH----HHcCCCCCC-
Confidence 5554444445678999999999999999999999999999999998 78887543221 12211 122221111
Q ss_pred cccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 449 DPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 449 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
++.....+.+|+.+||+.||++|||+.+|++.|...
T Consensus 235 --------p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~ 270 (317)
T d1xkka_ 235 --------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270 (317)
T ss_dssp --------CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --------CcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence 111123466777799999999999999999887653
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-48 Score=386.16 Aligned_cols=262 Identities=22% Similarity=0.280 Sum_probs=196.3
Q ss_pred cccccCCCCceeEEEEEeC-CCcEEEEEEccccChh-----hHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEee
Q 039168 220 DENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQ-----GLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 293 (536)
Q Consensus 220 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 293 (536)
.+++||+|+||+||+|+++ +|+.||||++...... ..+.+.+|+.+|++++|||||++++++.+++..|+||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 4578999999999999975 5899999998654322 134688999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCC
Q 039168 294 MPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQN 373 (536)
Q Consensus 294 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 373 (536)
+.++++..++. ....+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~~~~~~~~~---~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~ 155 (299)
T d1ua2a_ 82 METDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 155 (299)
T ss_dssp CSEEHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred hcchHHhhhhh---cccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCcc
Confidence 99988776653 3445889999999999999999999997 99999999999999999999999999987654332
Q ss_pred ccccccccccccccCcchhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcccccc---
Q 039168 374 QANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELID--- 449 (536)
Q Consensus 374 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~--- 449 (536)
. .....||+.|+|||++.+. .++.++|||||||++|||++|+.||...... +.+..............+.+
T Consensus 156 ~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~---~~l~~i~~~~~~~~~~~~~~~~~ 230 (299)
T d1ua2a_ 156 A--YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL---DQLTRIFETLGTPTEEQWPDMCS 230 (299)
T ss_dssp C--CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHHCCCCTTTSSSTTS
T ss_pred c--ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHH---HHHHHHHHhcCCCChhhccchhc
Confidence 2 2335789999999998755 5799999999999999999999997543221 12222222111111000000
Q ss_pred ---cc---ccCCCCH-----HHHHHHHHHHHhhcCCCCCCCCCHHHHHH--HhccC
Q 039168 450 ---PV---LKQSCAP-----DELLKFIHIGLLCVQQDPADRPTMSSVVV--MLASD 492 (536)
Q Consensus 450 ---~~---l~~~~~~-----~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~~ 492 (536)
.. .....+. ....++++++.+||+.||++|||++|+|+ .++..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~ 286 (299)
T d1ua2a_ 231 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 286 (299)
T ss_dssp STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred cchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCC
Confidence 00 0000011 11235777888999999999999999997 45543
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.5e-48 Score=387.90 Aligned_cols=244 Identities=23% Similarity=0.313 Sum_probs=201.3
Q ss_pred cCCccccccCCCCceeEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEE
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 291 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 291 (536)
++|++++.||+|+||+||+|+++ +|+.||||++.+. .....+.+.+|+.+|++++|||||++++++.+++.+|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 57999999999999999999975 5999999998643 2334678899999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCC
Q 039168 292 EYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGN 371 (536)
Q Consensus 292 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 371 (536)
||++|++|..++... ..+++..++.++.||+.||+|||+++ |+||||||+||||+.+|++||+|||+++.....
T Consensus 84 E~~~gg~l~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 84 DYIEGGELFSLLRKS---QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp CCCCSCBHHHHHHHT---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred eecCCcccccccccc---ccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc
Confidence 999999999888543 34889999999999999999999996 999999999999999999999999999876432
Q ss_pred CCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcccccccc
Q 039168 372 QNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPV 451 (536)
Q Consensus 372 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 451 (536)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ........ .+.. .
T Consensus 158 -----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~------~~~~~~i~-~~~~-~----- 219 (316)
T d1fota_ 158 -----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT------MKTYEKIL-NAEL-R----- 219 (316)
T ss_dssp -----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHH-HCCC-C-----
T ss_pred -----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCH------HHHHHHHH-cCCC-C-----
Confidence 2246799999999999999999999999999999999999999854221 11111111 1111 0
Q ss_pred ccCCCCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHH
Q 039168 452 LKQSCAPDELLKFIHIGLLCVQQDPADRP-----TMSSVVV 487 (536)
Q Consensus 452 l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 487 (536)
..... + .++.+++.+||+.||.+|+ |++++++
T Consensus 220 ~p~~~-s---~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 220 FPPFF-N---EDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp CCTTS-C---HHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCCC-C---HHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 11111 2 2355667799999999996 8999986
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.1e-47 Score=375.58 Aligned_cols=258 Identities=22% Similarity=0.316 Sum_probs=198.6
Q ss_pred hcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCc----e
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQ----E 286 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~----~ 286 (536)
.++|++.+.||+|+||+||+|++. +|+.||||++.... ....+.+.+|+++|+.++||||+++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 468999999999999999999975 69999999997543 344567899999999999999999999987643 4
Q ss_pred EEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCcc
Q 039168 287 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTAR 366 (536)
Q Consensus 287 ~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 366 (536)
.|+||||++|++|..++... ..+++.+++.++.||+.||.|||+++ |+||||||+|||++.++.++|+|||.+.
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~---~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred EEEEEECCCCCEehhhhccc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhh
Confidence 89999999999999888543 35899999999999999999999996 9999999999999999999999999998
Q ss_pred ccCCCC-CccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcc
Q 039168 367 IFGGNQ-NQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAV 445 (536)
Q Consensus 367 ~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 445 (536)
...... .........||+.|+|||++.+..++.++|||||||++|||++|+.||.... ...............
T Consensus 160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~------~~~~~~~~~~~~~~~ 233 (277)
T d1o6ya_ 160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS------PVSVAYQHVREDPIP 233 (277)
T ss_dssp ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS------HHHHHHHHHHCCCCC
T ss_pred hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcC------HHHHHHHHHhcCCCC
Confidence 664332 2223344679999999999999999999999999999999999999985322 122222222222211
Q ss_pred ccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCC-CHHHHHHHhcc
Q 039168 446 ELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRP-TMSSVVVMLAS 491 (536)
Q Consensus 446 ~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~evl~~L~~ 491 (536)
. .......++ .+.+++.+||++||++|| |++++++.|..
T Consensus 234 ~----~~~~~~~s~---~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 234 P----SARHEGLSA---DLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp G----GGTSSSCCH---HHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred C----chhccCCCH---HHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 1 111111223 455666799999999999 89999887754
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9.7e-48 Score=387.18 Aligned_cols=244 Identities=23% Similarity=0.273 Sum_probs=201.9
Q ss_pred cCCccccccCCCCceeEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEE
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 291 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 291 (536)
++|++++.||+|+||.||+|+++ +|+.||||++.+. .....+.+.+|+.+|+.++|||||++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 68999999999999999999975 6999999998643 2234567899999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCC
Q 039168 292 EYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGN 371 (536)
Q Consensus 292 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 371 (536)
||+.+|+|..++... ..+++..++.++.||+.||.|||+++ ||||||||+||||+.++++||+|||+++.+...
T Consensus 121 e~~~~g~l~~~l~~~---~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred ccccccchhhhHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence 999999999998553 34999999999999999999999996 999999999999999999999999999976532
Q ss_pred CCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcccccccc
Q 039168 372 QNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPV 451 (536)
Q Consensus 372 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 451 (536)
.....||+.|||||++.+..++.++|||||||++|||++|+.||.... ......... .+...
T Consensus 195 -----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~------~~~~~~~i~-~~~~~------ 256 (350)
T d1rdqe_ 195 -----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ------PIQIYEKIV-SGKVR------ 256 (350)
T ss_dssp -----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHH-HCCCC------
T ss_pred -----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcC------HHHHHHHHh-cCCCC------
Confidence 224679999999999999999999999999999999999999985321 111111111 11110
Q ss_pred ccCCCCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHH
Q 039168 452 LKQSCAPDELLKFIHIGLLCVQQDPADRP-----TMSSVVV 487 (536)
Q Consensus 452 l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 487 (536)
..... + .++.+++.+||+.||.+|+ |++++++
T Consensus 257 ~p~~~-s---~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 257 FPSHF-S---SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp CCTTC-C---HHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CCccC-C---HHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 11112 2 2355666799999999994 8999986
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-49 Score=379.09 Aligned_cols=248 Identities=30% Similarity=0.419 Sum_probs=193.7
Q ss_pred cCCccccccCCCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEee-CceEEEEEeec
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLE-GQELLLIYEYM 294 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~~lv~e~~ 294 (536)
++|++.++||+|+||.||+|++ .|+.||||+++... ..+.+.+|++++++++||||+++++++.+ .+.+++||||+
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred HHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence 5788999999999999999998 47889999996543 44789999999999999999999999865 46689999999
Q ss_pred CCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCCc
Q 039168 295 PNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQ 374 (536)
Q Consensus 295 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 374 (536)
++|+|.+++.... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~--- 156 (262)
T d1byga_ 84 AKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--- 156 (262)
T ss_dssp TTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred CCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCC---
Confidence 9999999996532 234899999999999999999999986 999999999999999999999999999865432
Q ss_pred cccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHHHHHhhcCCcccccccccc
Q 039168 375 ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVLK 453 (536)
Q Consensus 375 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~ 453 (536)
.....+|+.|+|||++.+..++.++|||||||++|||+| |+.|+...... ..... ...+...+. .
T Consensus 157 --~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~---~~~~~----i~~~~~~~~-----~ 222 (262)
T d1byga_ 157 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPR----VEKGYKMDA-----P 222 (262)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG---GHHHH----HTTTCCCCC-----C
T ss_pred --CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH---HHHHH----HHcCCCCCC-----C
Confidence 223457889999999999999999999999999999998 67775533221 11111 222222221 1
Q ss_pred CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcc
Q 039168 454 QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 491 (536)
Q Consensus 454 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 491 (536)
... + ..+.+|+.+||+.||++|||+.+|++.|+.
T Consensus 223 ~~~-~---~~~~~li~~cl~~dP~~Rps~~~l~~~L~~ 256 (262)
T d1byga_ 223 DGC-P---PAVYEVMKNCWHLDAAMRPSFLQLREQLEH 256 (262)
T ss_dssp TTC-C---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ccC-C---HHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence 122 2 345667779999999999999999999975
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-48 Score=380.61 Aligned_cols=254 Identities=24% Similarity=0.363 Sum_probs=193.3
Q ss_pred hcCCccccccCCCCceeEEEEEeCC----CcEEEEEEcccc-ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEE
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLAD----GKAIAVKRLSRT-SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 289 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 289 (536)
.++|++.+.||+|+||.||+|++.. +..||||++... .....+.+.+|+.+|++++|||||++++++. ++..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 3689999999999999999998643 456899998654 3444677999999999999999999999996 467899
Q ss_pred EEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccC
Q 039168 290 IYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFG 369 (536)
Q Consensus 290 v~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 369 (536)
||||+++|+|..++.. ....+++..++.++.||++||.|||+++ |+||||||+||++++++.+||+|||+++.+.
T Consensus 85 v~E~~~~g~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159 (273)
T ss_dssp EEECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEEeccCCcHHhhhhc--cCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheecc
Confidence 9999999999988754 3345899999999999999999999996 9999999999999999999999999998765
Q ss_pred CCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHHHHHhhcCCccccc
Q 039168 370 GNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELI 448 (536)
Q Consensus 370 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 448 (536)
..... ......||+.|+|||++.+..++.++|||||||++|||++ |.+||...... ..... ...+.....
T Consensus 160 ~~~~~-~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~---~~~~~----i~~~~~~~~- 230 (273)
T d1mp8a_ 160 DSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVIGR----IENGERLPM- 230 (273)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHHH----HHTTCCCCC-
T ss_pred CCcce-eccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH---HHHHH----HHcCCCCCC-
Confidence 43322 2334568999999999999999999999999999999998 88887543221 12211 122222211
Q ss_pred cccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcc
Q 039168 449 DPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 491 (536)
Q Consensus 449 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 491 (536)
.... + ..+.+|+.+||+.||++|||+.+|++.|+.
T Consensus 231 ----~~~~-~---~~~~~li~~cl~~dp~~Rps~~ei~~~L~~ 265 (273)
T d1mp8a_ 231 ----PPNC-P---PTLYSLMTKCWAYDPSRRPRFTELKAQLST 265 (273)
T ss_dssp ----CTTC-C---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ----CCCC-C---HHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 1122 2 346667779999999999999999998875
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-48 Score=380.89 Aligned_cols=259 Identities=27% Similarity=0.393 Sum_probs=197.3
Q ss_pred hcCCccccccCCCCceeEEEEEeC------CCcEEEEEEcccc-ChhhHHHHHHHHHHHHHc-CCCCceeEeeEEeeC-c
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRT-SGQGLKEFKNEVNLIAKL-QHKNLVRLLGCCLEG-Q 285 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~-~ 285 (536)
.++|++.++||+|+||.||+|++. +++.||||++... .....+.+.+|..++.++ +||||+.+++++.+. .
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~ 91 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 91 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence 368999999999999999999853 3568999998754 334456778888888777 689999999998764 5
Q ss_pred eEEEEEeecCCCChhhhhhcccC-------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEc
Q 039168 286 ELLLIYEYMPNKSLDVHLFDATR-------------SVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLD 352 (536)
Q Consensus 286 ~~~lv~e~~~~~sL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~ 352 (536)
.+++||||+++|+|.+++..... ...+++.+++.++.||++||.|||+++ |+||||||+||||+
T Consensus 92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NILl~ 168 (299)
T d1ywna1 92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLS 168 (299)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEC
T ss_pred eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCccceeEC
Confidence 68999999999999999965322 335899999999999999999999996 99999999999999
Q ss_pred CCCCeEEecccCccccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCC-CCCCCCccCCchh
Q 039168 353 DDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRK-NNGFYFSEHGQTL 431 (536)
Q Consensus 353 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~-p~~~~~~~~~~~~ 431 (536)
+++++||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++|.. ||...... ..
T Consensus 169 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~--~~- 245 (299)
T d1ywna1 169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--EE- 245 (299)
T ss_dssp GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS--HH-
T ss_pred CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHH--HH-
Confidence 999999999999987765555444555689999999999999999999999999999999999754 55432211 11
Q ss_pred HHHHHHHhhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcc
Q 039168 432 LTYTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 491 (536)
Q Consensus 432 ~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 491 (536)
.......+...... ... + .++.+++.+||+.||++|||+++|++.|+.
T Consensus 246 ---~~~~~~~~~~~~~~-----~~~-~---~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ 293 (299)
T d1ywna1 246 ---FCRRLKEGTRMRAP-----DYT-T---PEMYQTMLDCWHGEPSQRPTFSELVEHLGN 293 (299)
T ss_dssp ---HHHHHHHTCCCCCC-----TTC-C---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---HHHHHhcCCCCCCC-----ccC-C---HHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 11222222222211 112 2 246677779999999999999999999875
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=7.1e-48 Score=375.71 Aligned_cols=251 Identities=25% Similarity=0.323 Sum_probs=200.9
Q ss_pred hcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccCh---------hhHHHHHHHHHHHHHcC-CCCceeEeeEEee
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG---------QGLKEFKNEVNLIAKLQ-HKNLVRLLGCCLE 283 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~ 283 (536)
.++|++.+.||+|+||+||+|++. +++.||||++.+... ...+.+.+|+.+|++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 478999999999999999999974 689999999875432 12346889999999997 9999999999999
Q ss_pred CceEEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEeccc
Q 039168 284 GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFG 363 (536)
Q Consensus 284 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg 363 (536)
++..||||||+++|+|.+++... ..+++.+++.++.||++||+|||+++ |+||||||+||||+.++.+||+|||
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~---~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG 155 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFG 155 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCT
T ss_pred CcceEEEEEcCCCchHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccch
Confidence 99999999999999999999643 35999999999999999999999997 9999999999999999999999999
Q ss_pred CccccCCCCCccccccccccccccCcchhcC------CCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHH
Q 039168 364 TARIFGGNQNQANTNIIAGTYGYMAPEYAMG------GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWK 437 (536)
Q Consensus 364 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~ 437 (536)
+++.+..... .....||+.|+|||++.+ ..++.++||||+||++|+|++|+.||..... .. ...
T Consensus 156 ~a~~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~------~~-~~~ 225 (277)
T d1phka_ 156 FSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ------ML-MLR 225 (277)
T ss_dssp TCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HH-HHH
T ss_pred heeEccCCCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH------HH-HHH
Confidence 9998754322 234579999999999853 3478899999999999999999999864321 11 111
Q ss_pred HhhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 438 LWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 438 ~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
....+... ...+. .+....++.+++.+||+.||++|||+.||++
T Consensus 226 ~i~~~~~~-~~~~~-----~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 226 MIMSGNYQ-FGSPE-----WDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp HHHHTCCC-CCTTT-----GGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHhCCCC-CCCcc-----cccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 11111111 11110 0111234666777999999999999999975
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-48 Score=383.75 Aligned_cols=259 Identities=32% Similarity=0.433 Sum_probs=207.4
Q ss_pred hcCCccccccCCCCceeEEEEEeCC--------CcEEEEEEccccCh-hhHHHHHHHHHHHHHc-CCCCceeEeeEEeeC
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLAD--------GKAIAVKRLSRTSG-QGLKEFKNEVNLIAKL-QHKNLVRLLGCCLEG 284 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~ 284 (536)
.++|++.+.||+|+||.||+|+... +..||||++..... ....++.+|...+.++ +|||||++++++.++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 3689999999999999999998532 34799999976543 4457788899999888 899999999999999
Q ss_pred ceEEEEEeecCCCChhhhhhcccC-------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEE
Q 039168 285 QELLLIYEYMPNKSLDVHLFDATR-------------SVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLL 351 (536)
Q Consensus 285 ~~~~lv~e~~~~~sL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll 351 (536)
+..++||||+++|+|.++|..... ...+++.+++.++.||+.||+|||+++ ||||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceee
Confidence 999999999999999999965432 245899999999999999999999996 9999999999999
Q ss_pred cCCCCeEEecccCccccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCch
Q 039168 352 DDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQT 430 (536)
Q Consensus 352 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~ 430 (536)
+.++.+||+|||+++...............||+.|+|||.+.++.|+.++||||||+++|||++ |+.||.....
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~----- 243 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV----- 243 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-----
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH-----
Confidence 9999999999999998876555555556778999999999999999999999999999999998 6777643221
Q ss_pred hHHHHHHHhhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 431 LLTYTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 431 ~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
......+..+..... .... + ..+.+|+.+||+.||++|||+.||++.|+..
T Consensus 244 --~~~~~~i~~~~~~~~-----p~~~-~---~~l~~li~~cl~~dP~~Rps~~eil~~L~~i 294 (299)
T d1fgka_ 244 --EELFKLLKEGHRMDK-----PSNC-T---NELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294 (299)
T ss_dssp --HHHHHHHHTTCCCCC-----CSSC-C---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --HHHHHHHHcCCCCCC-----Cccc-h---HHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 112233333333222 1122 2 3466777799999999999999999999764
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-48 Score=377.61 Aligned_cols=255 Identities=29% Similarity=0.403 Sum_probs=194.9
Q ss_pred cCCccccccCCCCceeEEEEEeCC----CcEEEEEEcccc---ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEE
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLAD----GKAIAVKRLSRT---SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELL 288 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 288 (536)
++|++.+.||+|+||.||+|+... ...||||++.+. ..+..+.|.+|+.+|++++||||+++++++.+ ...+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 679999999999999999998532 347899998654 33456789999999999999999999999976 4678
Q ss_pred EEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCcccc
Q 039168 289 LIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIF 368 (536)
Q Consensus 289 lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 368 (536)
+||||++++++.+.+... ...+++..++.++.||++||.|||+++ |+||||||+||||+.++++||+|||+++.+
T Consensus 87 lv~e~~~~~~l~~~~~~~--~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL 161 (273)
T ss_dssp EEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeeeeecCcchhhhhhcc--cCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhc
Confidence 999999999999887643 345999999999999999999999986 999999999999999999999999999987
Q ss_pred CCCCCcc-ccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccCCchhHHHHHHHhhcCCccc
Q 039168 369 GGNQNQA-NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGHAVE 446 (536)
Q Consensus 369 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 446 (536)
....... ......|+..|+|||.+.+..++.++|||||||++|||+| |+.||..... ..........+...+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~------~~~~~~i~~~~~~~~ 235 (273)
T d1u46a_ 162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG------SQILHKIDKEGERLP 235 (273)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHHHHHHTSCCCCC
T ss_pred ccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCH------HHHHHHHHhCCCCCC
Confidence 6543332 2233567889999999999999999999999999999998 8999753211 122222222222221
Q ss_pred cccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcc
Q 039168 447 LIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 491 (536)
Q Consensus 447 l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 491 (536)
. .... + ..+.+|+.+||+.||++|||+.+|+++|..
T Consensus 236 ~-----~~~~-~---~~l~~li~~cl~~dp~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 236 R-----PEDC-P---QDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271 (273)
T ss_dssp C-----CTTC-C---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred C-----cccc-c---HHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 1 1112 2 346667779999999999999999999864
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-48 Score=385.16 Aligned_cols=261 Identities=30% Similarity=0.429 Sum_probs=209.2
Q ss_pred hcCCccccccCCCCceeEEEEEe------CCCcEEEEEEccccC-hhhHHHHHHHHHHHHHc-CCCCceeEeeEEeeCce
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTL------ADGKAIAVKRLSRTS-GQGLKEFKNEVNLIAKL-QHKNLVRLLGCCLEGQE 286 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~ 286 (536)
.++|++.++||+|+||.||+|++ .+++.||||++.... ......+.+|+.+++++ +|||||++++++.+.+.
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 46889999999999999999975 246789999997643 34556789999999999 79999999999999999
Q ss_pred EEEEEeecCCCChhhhhhccc---------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEE
Q 039168 287 LLLIYEYMPNKSLDVHLFDAT---------------RSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLL 351 (536)
Q Consensus 287 ~~lv~e~~~~~sL~~~l~~~~---------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll 351 (536)
.++||||+++|+|..++.... ....+++..+..++.||++||+|||+++ ++||||||+|||+
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccccc
Confidence 999999999999999986532 2335899999999999999999999997 9999999999999
Q ss_pred cCCCCeEEecccCccccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchh
Q 039168 352 DDDMNPKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTL 431 (536)
Q Consensus 352 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~ 431 (536)
+.++.+||+|||+++...............||+.|+|||.+.+..++.++|||||||++|||+|++.|+....... ..
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~--~~ 256 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD--SK 256 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS--HH
T ss_pred cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH--HH
Confidence 9999999999999998765555444555789999999999999999999999999999999999555532222111 11
Q ss_pred HHHHHHHhhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 432 LTYTWKLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 432 ~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
.......+..... . ...+ ..+.+|+.+||+.||++|||+++|+++|++.
T Consensus 257 ---~~~~i~~~~~~~~-----~-~~~~---~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~ 305 (311)
T d1t46a_ 257 ---FYKMIKEGFRMLS-----P-EHAP---AEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (311)
T ss_dssp ---HHHHHHHTCCCCC-----C-TTSC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---HHHHHhcCCCCCC-----c-cccc---HHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 1112222221111 1 1122 3466777799999999999999999999763
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-47 Score=382.78 Aligned_cols=251 Identities=19% Similarity=0.296 Sum_probs=202.6
Q ss_pred hcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEee
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 293 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 293 (536)
.++|++++.||+|+||+||+|.++ +++.||||++..... ....+.+|+++|++++|||||++++++.+++.+|+||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 478999999999999999999976 588999999976543 345688999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCC--CCeEEecccCccccCCC
Q 039168 294 MPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDD--MNPKISDFGTARIFGGN 371 (536)
Q Consensus 294 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~--~~~kl~Dfg~a~~~~~~ 371 (536)
|+|++|.+++... ...+++.+++.++.||+.||+|||+++ |+||||||+|||++.+ .++||+|||+++.....
T Consensus 83 ~~gg~L~~~i~~~--~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~ 157 (321)
T d1tkia_ 83 ISGLDIFERINTS--AFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTSS--SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccC
Confidence 9999999998542 335899999999999999999999997 9999999999999854 47999999999876433
Q ss_pred CCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcccccccc
Q 039168 372 QNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPV 451 (536)
Q Consensus 372 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 451 (536)
. ......||+.|+|||.+.+..++.++|||||||++|+|++|+.||...... ... .... ..... ++..
T Consensus 158 ~---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~---~~~---~~i~-~~~~~--~~~~ 225 (321)
T d1tkia_ 158 D---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ---QII---ENIM-NAEYT--FDEE 225 (321)
T ss_dssp C---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHH---HHHH-HTCCC--CCHH
T ss_pred C---cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH---HHH---HHHH-hCCCC--CChh
Confidence 2 233457899999999999999999999999999999999999998643221 111 1111 11110 0111
Q ss_pred ccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 452 LKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 452 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
..... + .++.+++.+||+.||++|||+.|+++
T Consensus 226 ~~~~~-s---~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 226 AFKEI-S---IEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HHTTS-C---HHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hccCC-C---HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11111 1 23566777999999999999999997
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.9e-47 Score=385.77 Aligned_cols=248 Identities=26% Similarity=0.300 Sum_probs=195.6
Q ss_pred cCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHH---HHHHHHHcCCCCceeEeeEEeeCceEE
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLKEFKN---EVNLIAKLQHKNLVRLLGCCLEGQELL 288 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~---E~~~l~~l~hpniv~l~~~~~~~~~~~ 288 (536)
++|++.++||+|+||.||+|++. +|+.||||++.+.. ......+.+ |+.+++.++|||||++++++.+.+.+|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 68999999999999999999976 59999999986432 122233444 466677778999999999999999999
Q ss_pred EEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCcccc
Q 039168 289 LIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIF 368 (536)
Q Consensus 289 lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 368 (536)
+||||+++|+|..++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.+
T Consensus 84 ivmE~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp EEECCCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred EEEEecCCCcHHHHHHhc---ccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeec
Confidence 999999999999999653 34899999999999999999999997 999999999999999999999999999876
Q ss_pred CCCCCccccccccccccccCcchhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcccc
Q 039168 369 GGNQNQANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVEL 447 (536)
Q Consensus 369 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 447 (536)
.... .....||+.|+|||++.. ..++.++|||||||++|||++|+.||....... ......... . ..
T Consensus 158 ~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~---~~~~~~~~~-~-~~--- 225 (364)
T d1omwa3 158 SKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD---KHEIDRMTL-T-MA--- 225 (364)
T ss_dssp SSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSC---HHHHHHHSS-S-CC---
T ss_pred CCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHhcc-c-CC---
Confidence 5432 234579999999999975 568999999999999999999999986533222 111111110 0 00
Q ss_pred ccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCC-----HHHHHH
Q 039168 448 IDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPT-----MSSVVV 487 (536)
Q Consensus 448 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~ 487 (536)
....... ++ ++.+++.+||+.||++||| ++++++
T Consensus 226 --~~~~~~~-s~---~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 226 --VELPDSF-SP---ELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp --CCCCSSS-CH---HHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred --CCCCCCC-CH---HHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 0111112 22 3566677999999999999 688874
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-47 Score=383.46 Aligned_cols=251 Identities=21% Similarity=0.223 Sum_probs=195.2
Q ss_pred cCCcccc-ccCCCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHHc-CCCCceeEeeEEee----CceEE
Q 039168 216 NHFSDEN-KLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLKEFKNEVNLIAKL-QHKNLVRLLGCCLE----GQELL 288 (536)
Q Consensus 216 ~~~~~~~-~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~----~~~~~ 288 (536)
++|++.+ .||+|+||+||+|++. +++.||||++... ..+.+|+.++.++ +|||||+++++|.+ +..+|
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ 85 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 85 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence 6788875 5999999999999974 6899999998643 4677899987655 89999999999875 46799
Q ss_pred EEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcC---CCCeEEecccCc
Q 039168 289 LIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDD---DMNPKISDFGTA 365 (536)
Q Consensus 289 lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~---~~~~kl~Dfg~a 365 (536)
+|||||+||+|.++|... ....+++.+++.++.||+.||+|||+++ |+||||||+|||++. .+.+||+|||++
T Consensus 86 ivmEy~~gg~L~~~i~~~-~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 86 IVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEECCCSEEHHHHHHSC-SCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEECCCCCcHHHHHHhc-CCCCcCHHHHHHHHHHHHHHHHHHHHcC---Ccccccccccccccccccccccccccccee
Confidence 999999999999999643 2345999999999999999999999997 999999999999985 557999999999
Q ss_pred cccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcc
Q 039168 366 RIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAV 445 (536)
Q Consensus 366 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 445 (536)
+....... .....||+.|+|||++.+..|+.++|||||||++|+|++|+.||........ .............
T Consensus 162 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~---~~~~~~~i~~~~~- 234 (335)
T d2ozaa1 162 KETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI---SPGMKTRIRMGQY- 234 (335)
T ss_dssp EECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCCSCSS-
T ss_pred eeccCCCc---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHH---HHHHHHHHhcCCC-
Confidence 87654332 2345799999999999999999999999999999999999999854322111 0000000000000
Q ss_pred ccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 446 ELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 446 ~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
. +..........++.+++.+||+.||++|||+.|+++
T Consensus 235 ~-----~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 235 E-----FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp S-----CCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred C-----CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 0 000001122345777788999999999999999998
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-47 Score=375.34 Aligned_cols=267 Identities=22% Similarity=0.329 Sum_probs=200.6
Q ss_pred cCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC--hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEe
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 292 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 292 (536)
++|++++.||+|+||+||+|++. +|+.||||++.... ....+.+.+|+++|++++|||||++++++.+++.+|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 58999999999999999999974 68999999996543 2335678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCC
Q 039168 293 YMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQ 372 (536)
Q Consensus 293 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 372 (536)
|+.++.+..... .....+++..++.++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~~~~~~~~--~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 82 FLHQDLKKFMDA--SALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp CCSEEHHHHHHH--TTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred ecCCchhhhhhh--hcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCc
Confidence 997765554332 23445999999999999999999999997 9999999999999999999999999998765433
Q ss_pred CccccccccccccccCcchhcCCC-CCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcccc--c-
Q 039168 373 NQANTNIIAGTYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVEL--I- 448 (536)
Q Consensus 373 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l--~- 448 (536)
. ......||+.|+|||++.... ++.++|||||||++|+|++|+.||...... .................. .
T Consensus 157 ~--~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~---~~~~~i~~~~~~~~~~~~~~~~ 231 (298)
T d1gz8a_ 157 R--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI---DQLFRIFRTLGTPDEVVWPGVT 231 (298)
T ss_dssp B--CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCCCTTTSTTGG
T ss_pred c--cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHH---HHHHHHHHhcCCCchhhccccc
Confidence 2 233457999999999987766 588999999999999999999998643211 111111111111000000 0
Q ss_pred -----cccccC--CCC-----HHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH--hccC
Q 039168 449 -----DPVLKQ--SCA-----PDELLKFIHIGLLCVQQDPADRPTMSSVVVM--LASD 492 (536)
Q Consensus 449 -----~~~l~~--~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~~ 492 (536)
...... ... +....++.+++.+||+.||++|||+.|+++. ++..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289 (298)
T ss_dssp GSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred cccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence 000000 000 0112456777789999999999999999974 5544
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-48 Score=381.74 Aligned_cols=255 Identities=28% Similarity=0.432 Sum_probs=199.8
Q ss_pred cCCccccccCCCCceeEEEEEeCC-Cc--EEEEEEcccc-ChhhHHHHHHHHHHHHHc-CCCCceeEeeEEeeCceEEEE
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLAD-GK--AIAVKRLSRT-SGQGLKEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLI 290 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv 290 (536)
++|++.++||+|+||+||+|++++ +. .||||++... ..+..+.+.+|+++|+++ +|||||++++++.+++.+++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 688999999999999999999754 43 5788887543 334566799999999999 799999999999999999999
Q ss_pred EeecCCCChhhhhhcc-------------cCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCe
Q 039168 291 YEYMPNKSLDVHLFDA-------------TRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNP 357 (536)
Q Consensus 291 ~e~~~~~sL~~~l~~~-------------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~ 357 (536)
|||+++|+|.++|... .....+++..++.++.||++||.|||+++ |+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence 9999999999998653 23456999999999999999999999996 9999999999999999999
Q ss_pred EEecccCccccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCC-CCCCCCccCCchhHHHHH
Q 039168 358 KISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRK-NNGFYFSEHGQTLLTYTW 436 (536)
Q Consensus 358 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~-p~~~~~~~~~~~~~~~~~ 436 (536)
||+|||+++...... ......||..|+|||.+.+..++.++|||||||++|||++|.. ||.... .... .
T Consensus 167 kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~------~~~~-~ 236 (309)
T d1fvra_ 167 KIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT------CAEL-Y 236 (309)
T ss_dssp EECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC------HHHH-H
T ss_pred EEccccccccccccc---cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC------HHHH-H
Confidence 999999998654222 1223468999999999999999999999999999999999765 443221 1111 1
Q ss_pred HHhhcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 437 KLWCEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 437 ~~~~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
....++...+. ... .+ ..+.+|+.+||+.||++|||+++|++.|+..
T Consensus 237 ~~i~~~~~~~~-----~~~-~~---~~~~~li~~cl~~dP~~RPs~~eil~~L~~i 283 (309)
T d1fvra_ 237 EKLPQGYRLEK-----PLN-CD---DEVYDLMRQCWREKPYERPSFAQILVSLNRM 283 (309)
T ss_dssp HHGGGTCCCCC-----CTT-BC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHhcCCCCC-----Ccc-CC---HHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 11222222111 111 12 3466667799999999999999999998775
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-47 Score=380.05 Aligned_cols=247 Identities=25% Similarity=0.365 Sum_probs=198.9
Q ss_pred cCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHH-HcCCCCceeEeeEEeeCceEEEE
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLKEFKNEVNLIA-KLQHKNLVRLLGCCLEGQELLLI 290 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~-~l~hpniv~l~~~~~~~~~~~lv 290 (536)
++|++++.||+|+||+||+|+++ +++.||||++.+.. ....+.+..|..++. .++|||||++++++.+++.+|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57999999999999999999976 58999999997532 234456667777655 68999999999999999999999
Q ss_pred EeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCC
Q 039168 291 YEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGG 370 (536)
Q Consensus 291 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 370 (536)
|||+++|+|..++... ..+++.+++.++.||+.||+|||+++ |+||||||+|||+++++++||+|||+++....
T Consensus 82 mEy~~~g~L~~~i~~~---~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSC---HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp EECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EeecCCCcHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccc
Confidence 9999999999999643 34899999999999999999999997 99999999999999999999999999987653
Q ss_pred CCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccc
Q 039168 371 NQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDP 450 (536)
Q Consensus 371 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 450 (536)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+. .....+..
T Consensus 156 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~---~~~----~~i~~~~~------ 220 (320)
T d1xjda_ 156 GDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE---ELF----HSIRMDNP------ 220 (320)
T ss_dssp TTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH----HHHHHCCC------
T ss_pred ccc--cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH---HHH----HHHHcCCC------
Confidence 322 233467999999999999999999999999999999999999998642211 111 11111111
Q ss_pred cccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHH-HHHH
Q 039168 451 VLKQSCAPDELLKFIHIGLLCVQQDPADRPTMS-SVVV 487 (536)
Q Consensus 451 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~-evl~ 487 (536)
...... +. .+.+|+.+||+.||++|||+. ++++
T Consensus 221 ~~p~~~-s~---~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 221 FYPRWL-EK---EAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp CCCTTS-CH---HHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred CCCccC-CH---HHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 111112 22 356666799999999999995 6764
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-47 Score=375.04 Aligned_cols=252 Identities=28% Similarity=0.422 Sum_probs=199.4
Q ss_pred ccccCCCCceeEEEEEeCCC----cEEEEEEcccc-ChhhHHHHHHHHHHHHHcCCCCceeEeeEEee-CceEEEEEeec
Q 039168 221 ENKLGQGGFGPVYKGTLADG----KAIAVKRLSRT-SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLE-GQELLLIYEYM 294 (536)
Q Consensus 221 ~~~lg~G~~g~Vy~~~~~~~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~~lv~e~~ 294 (536)
.++||+|+||+||+|++.++ ..||||++... .....++|.+|+++|++++||||+++++++.+ +...++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 56899999999999997532 35899999753 45567889999999999999999999999876 56899999999
Q ss_pred CCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCCc
Q 039168 295 PNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQNQ 374 (536)
Q Consensus 295 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 374 (536)
++++|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+||||++++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~--~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 112 KHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp TTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred ecCchhhhhcc--ccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence 99999998864 3345788899999999999999999996 999999999999999999999999999876543322
Q ss_pred c--ccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccccccc
Q 039168 375 A--NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELIDPVL 452 (536)
Q Consensus 375 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l 452 (536)
. ......||+.|+|||.+.+..++.++||||||+++|||++|+.||....... ..... ...+.....
T Consensus 187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~--~~~~~----i~~g~~~~~----- 255 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITVY----LLQGRRLLQ----- 255 (311)
T ss_dssp CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHH----HHTTCCCCC-----
T ss_pred cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH--HHHHH----HHcCCCCCC-----
Confidence 2 2223568999999999999999999999999999999999888865432211 11111 112221111
Q ss_pred cCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 453 KQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 453 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
. ...+ ..+.+|+.+||+.||++|||+.||++.|++.
T Consensus 256 p-~~~~---~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i 291 (311)
T d1r0pa_ 256 P-EYCP---DPLYEVMLKCWHPKAEMRPSFSELVSRISAI 291 (311)
T ss_dssp C-TTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred c-ccCc---HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1 1122 3456677799999999999999999999876
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-47 Score=375.08 Aligned_cols=259 Identities=27% Similarity=0.425 Sum_probs=210.2
Q ss_pred hcCCccccccCCCCceeEEEEEeC------CCcEEEEEEcccc-ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceE
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRT-SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQEL 287 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 287 (536)
.++|++.++||+|+||+||+|.+. ++..||||++... .......|.+|+.++++++||||+++++++..++..
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence 368899999999999999999863 3578999999754 344456789999999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhhccc-------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEe
Q 039168 288 LLIYEYMPNKSLDVHLFDAT-------RSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKIS 360 (536)
Q Consensus 288 ~lv~e~~~~~sL~~~l~~~~-------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~ 360 (536)
++||||+++|+|..++.... ....+++..+..++.|+++||.|||+++ |+||||||+||||+.++++||+
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEEC
T ss_pred eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEe
Confidence 99999999999999886432 2234789999999999999999999996 9999999999999999999999
Q ss_pred cccCccccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCC-CCCCCCCccCCchhHHHHHHHh
Q 039168 361 DFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGR-KNNGFYFSEHGQTLLTYTWKLW 439 (536)
Q Consensus 361 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~-~p~~~~~~~~~~~~~~~~~~~~ 439 (536)
|||+++.+.............||+.|+|||.+.+..++.++||||||+++|||+||. .||..... .+. ....
T Consensus 176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~------~~~-~~~i 248 (308)
T d1p4oa_ 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN------EQV-LRFV 248 (308)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH------HHH-HHHH
T ss_pred ecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCH------HHH-HHHH
Confidence 999998776554444445567899999999999999999999999999999999985 55432211 111 1122
Q ss_pred hcCCccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 440 CEGHAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 440 ~~~~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
..+...... ...+ ..+.+|+.+||+.||++|||+++|+++|++.
T Consensus 249 ~~~~~~~~p-----~~~~----~~l~~li~~cl~~~P~~RPs~~~il~~L~~~ 292 (308)
T d1p4oa_ 249 MEGGLLDKP-----DNCP----DMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292 (308)
T ss_dssp HTTCCCCCC-----TTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred HhCCCCCCc-----ccch----HHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 223222211 1122 3466777799999999999999999999886
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-46 Score=371.54 Aligned_cols=267 Identities=23% Similarity=0.299 Sum_probs=198.0
Q ss_pred cCCccccccCCCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCc----eEEEEE
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQ----ELLLIY 291 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~----~~~lv~ 291 (536)
.+|.+.++||+|+||.||+|++ +|+.||||++...... ......|+..+.+++|||||++++++.+.+ .+++||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~-~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence 4677888999999999999997 6889999998654321 122334555566789999999999998653 689999
Q ss_pred eecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcC-----CCCCeeeCCCCCCcEEEcCCCCeEEecccCcc
Q 039168 292 EYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHED-----SRLKIIHRDLKASNVLLDDDMNPKISDFGTAR 366 (536)
Q Consensus 292 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-----~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 366 (536)
||+++|+|..++.+. .+++..++.++.|++.||.|||+. +..+|+||||||+||||+.++++||+|||+++
T Consensus 81 Ey~~~g~L~~~l~~~----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~ 156 (303)
T d1vjya_ 81 DYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp ECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred ecccCCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence 999999999999642 489999999999999999999974 12369999999999999999999999999999
Q ss_pred ccCCCCCcc--ccccccccccccCcchhcCCC------CCccchHHHHHHHHHHHHhCCCCCCCCCccCC--------ch
Q 039168 367 IFGGNQNQA--NTNIIAGTYGYMAPEYAMGGI------FSIKSDVFSFGVLLLEIISGRKNNGFYFSEHG--------QT 430 (536)
Q Consensus 367 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwslG~il~elltg~~p~~~~~~~~~--------~~ 430 (536)
......... ......||+.|+|||++.+.. ++.++|||||||++|||+||..|+........ ..
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T d1vjya_ 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccc
Confidence 775433222 233467999999999987653 67899999999999999999887643221110 01
Q ss_pred hHHHHHHHhhcCCccccccccccCC-CCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 431 LLTYTWKLWCEGHAVELIDPVLKQS-CAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 431 ~~~~~~~~~~~~~~~~l~~~~l~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
...........+.. ++.+... ...+....+.+|+.+||+.||++|||+.||++.|+..
T Consensus 237 ~~~~~~~~~~~~~~----~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i 295 (303)
T d1vjya_ 237 SVEEMRKVVCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp CHHHHHHHHTTSCC----CCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred hHHHHHHHHhcccc----CCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 11111111111111 1111111 1234456688889999999999999999999998753
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=3.4e-47 Score=373.80 Aligned_cols=261 Identities=24% Similarity=0.337 Sum_probs=199.1
Q ss_pred cCCccccccCCCCceeEEEEEeCCCcEEEEEEccccC--hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEee
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTS--GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 293 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 293 (536)
++|+++++||+|+||+||+|++++|+.||||++.... ....+.+.+|+.+|++++||||+++++++..++..+++||+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 5899999999999999999999999999999997543 23357899999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCCC
Q 039168 294 MPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQN 373 (536)
Q Consensus 294 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 373 (536)
+.++.+..+.. ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++........
T Consensus 82 ~~~~~~~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 155 (286)
T d1ob3a_ 82 LDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (286)
T ss_dssp CSEEHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred ehhhhHHHHHh---hcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCcc
Confidence 98887776663 3355999999999999999999999986 99999999999999999999999999987754332
Q ss_pred ccccccccccccccCcchhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccccc----
Q 039168 374 QANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVELI---- 448 (536)
Q Consensus 374 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~---- 448 (536)
......|++.|+|||.+.+. .++.++|||||||++|||++|+.||...... ...................
T Consensus 156 --~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~---~~~~~i~~~~~~~~~~~~~~~~~ 230 (286)
T d1ob3a_ 156 --KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA---DQLMRIFRILGTPNSKNWPNVTE 230 (286)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCCCTTTSTTGGG
T ss_pred --ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHH---HHHHHHHHhhCCCChhhccchhh
Confidence 22334689999999999765 4699999999999999999999998643211 1111111111110000000
Q ss_pred ----cccc-------cCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 449 ----DPVL-------KQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 449 ----~~~l-------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
.... ...........+.+++.+||+.||++|||++|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000 00001111235667777999999999999999984
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-47 Score=367.72 Aligned_cols=240 Identities=24% Similarity=0.372 Sum_probs=192.6
Q ss_pred hcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccCh------hhHHHHHHHHHHHHHcC--CCCceeEeeEEeeCc
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG------QGLKEFKNEVNLIAKLQ--HKNLVRLLGCCLEGQ 285 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--hpniv~l~~~~~~~~ 285 (536)
.++|++.++||+|+||+||+|++. +|+.||||++.+... .....+.+|+.+|++++ |||||++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 468999999999999999999975 689999999864321 11234678999999997 899999999999999
Q ss_pred eEEEEEeecCC-CChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcC-CCCeEEeccc
Q 039168 286 ELLLIYEYMPN-KSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDD-DMNPKISDFG 363 (536)
Q Consensus 286 ~~~lv~e~~~~-~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~-~~~~kl~Dfg 363 (536)
..++||||+.+ +++..++.. ...+++.+++.++.||++||+|||+++ |+||||||+|||++. ++.+||+|||
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~---~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG 156 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG 156 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred eEEEEEEeccCcchHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECccc
Confidence 99999999986 566666643 245999999999999999999999997 999999999999985 5799999999
Q ss_pred CccccCCCCCccccccccccccccCcchhcCCCC-CccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcC
Q 039168 364 TARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIF-SIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEG 442 (536)
Q Consensus 364 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 442 (536)
+++..... ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||.... . .. ..
T Consensus 157 ~a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--------~----i~-~~ 219 (273)
T d1xwsa_ 157 SGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--------E----II-RG 219 (273)
T ss_dssp TCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--------H----HH-HC
T ss_pred cceecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch--------H----Hh-hc
Confidence 99865432 2234679999999999987765 678999999999999999999985311 0 00 11
Q ss_pred CccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 443 HAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 443 ~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
.. ...... ++ ++.+++.+||+.||++|||++|+++
T Consensus 220 ~~------~~~~~~-s~---~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 220 QV------FFRQRV-SS---ECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp CC------CCSSCC-CH---HHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred cc------CCCCCC-CH---HHHHHHHHHccCCHhHCcCHHHHhc
Confidence 11 111122 23 3556667999999999999999986
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-46 Score=370.89 Aligned_cols=262 Identities=21% Similarity=0.296 Sum_probs=194.3
Q ss_pred hcCCccccccCCCCceeEEEEEeC-C-CcEEEEEEccccC--hhhHHHHHHHHHHHHHc---CCCCceeEeeEEee----
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA-D-GKAIAVKRLSRTS--GQGLKEFKNEVNLIAKL---QHKNLVRLLGCCLE---- 283 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~hpniv~l~~~~~~---- 283 (536)
.++|+++++||+|+||+||+|++. + ++.||||++.... ......+.+|+.+|+.| +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 478999999999999999999974 4 6679999986432 22233466777777766 79999999999863
Q ss_pred -CceEEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecc
Q 039168 284 -GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDF 362 (536)
Q Consensus 284 -~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Df 362 (536)
....+++|||+.++.+..... .....+++..++.++.||+.||+|||+++ |+||||||+|||+++++.+||+||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~df 160 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF 160 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHH--SCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred cCceEEEEEEeccCCchhhhhh--ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecch
Confidence 357899999999987765443 33456899999999999999999999997 999999999999999999999999
Q ss_pred cCccccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcC
Q 039168 363 GTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEG 442 (536)
Q Consensus 363 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 442 (536)
|+++..... .......||+.|+|||++.+..|+.++|||||||++|||++|+.||...... .............
T Consensus 161 g~~~~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~---~~~~~i~~~~~~~ 234 (305)
T d1blxa_ 161 GLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV---DQLGKILDVIGLP 234 (305)
T ss_dssp CSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCC
T ss_pred hhhhhhccc---ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHH---HHHHHHHHhhCCC
Confidence 999864322 2334567999999999999999999999999999999999999998643221 1111111111000
Q ss_pred Ccccc------ccccc-------cCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 443 HAVEL------IDPVL-------KQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 443 ~~~~l------~~~~l-------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
....+ ..... ...........+.+|+.+||+.||++|||+.|+|+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 235 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred chhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00000 00000 00001111234566777999999999999999986
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-45 Score=373.33 Aligned_cols=259 Identities=24% Similarity=0.313 Sum_probs=192.9
Q ss_pred CCccccccCCCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeC------ceEEE
Q 039168 217 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEG------QELLL 289 (536)
Q Consensus 217 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~------~~~~l 289 (536)
+|+..++||+|+||+||+|++. +|+.||||++..... .+.+|+++|++++||||+++++++... .++++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 6888899999999999999986 599999999976532 234799999999999999999998643 35899
Q ss_pred EEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCC-CeEEecccCcccc
Q 039168 290 IYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDM-NPKISDFGTARIF 368 (536)
Q Consensus 290 v~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~-~~kl~Dfg~a~~~ 368 (536)
||||++++.+..+.........+++.+++.++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+++.+
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence 9999987765555443344557999999999999999999999986 99999999999999775 8999999999876
Q ss_pred CCCCCccccccccccccccCcchhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHH----------HH
Q 039168 369 GGNQNQANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYT----------WK 437 (536)
Q Consensus 369 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~----------~~ 437 (536)
..... .....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||....... .+.... +.
T Consensus 174 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~--~l~~i~~~~g~~~~~~~~ 248 (350)
T d1q5ka_ 174 VRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD--QLVEIIKVLGTPTREQIR 248 (350)
T ss_dssp CTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH--HHHHHHHHHCCCCHHHHH
T ss_pred cCCcc---cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHH--HHHHHHHHhCCChHHhhh
Confidence 54332 223578999999998876 468999999999999999999999986433211 111110 11
Q ss_pred HhhcC----CccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 438 LWCEG----HAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 438 ~~~~~----~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
..... ...............+....++++|+.+||+.||++|||+.|+|+
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 249 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp HHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11000 000000000000011112234666777999999999999999995
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-45 Score=365.17 Aligned_cols=264 Identities=22% Similarity=0.305 Sum_probs=195.8
Q ss_pred cCCccccccCCCCceeEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHHHcCCCCceeEeeEEee--------C
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLE--------G 284 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~--------~ 284 (536)
++|+++++||+|+||+||+|++. +|+.||||++... .......+.+|+++|++++||||+++++++.. .
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 68999999999999999999975 6999999998644 23345678899999999999999999999865 3
Q ss_pred ceEEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccC
Q 039168 285 QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGT 364 (536)
Q Consensus 285 ~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~ 364 (536)
+..++||||+.++.+.... .....+++..++.++.||++||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 90 ~~~~iv~e~~~~~~~~~~~---~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~ 163 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL 163 (318)
T ss_dssp -CEEEEEECCCEEHHHHHT---CTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTT
T ss_pred ceEEEEEeccCCCccchhh---hcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecce
Confidence 4689999999888776554 33345899999999999999999999997 99999999999999999999999999
Q ss_pred ccccCCCCCc--cccccccccccccCcchhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhc
Q 039168 365 ARIFGGNQNQ--ANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCE 441 (536)
Q Consensus 365 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 441 (536)
++.+...... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||...... ............
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~---~~~~~i~~~~~~ 240 (318)
T d3blha1 164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ---HQLALISQLCGS 240 (318)
T ss_dssp CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCC
T ss_pred eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHH---HHHHHHHHhcCC
Confidence 9876543322 222335799999999999865 5899999999999999999999998543221 111111111110
Q ss_pred CC--cc-c--------cccccccCCCCHH-H------HHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 442 GH--AV-E--------LIDPVLKQSCAPD-E------LLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 442 ~~--~~-~--------l~~~~l~~~~~~~-~------~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
.. .. . .+........... . ...+++|+.+||+.||++|||++|+|+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 241 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp CCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 00 00 0 0000000011111 1 2245678889999999999999999964
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-44 Score=362.37 Aligned_cols=262 Identities=24% Similarity=0.311 Sum_probs=193.1
Q ss_pred hcCCccccccCCCCceeEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCc------
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQ------ 285 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~------ 285 (536)
.++|+++++||+|+||+||+|.+. +|+.||||++... +....+.+.+|+++|++++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 478999999999999999999975 5999999999753 3345678899999999999999999999998654
Q ss_pred eEEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCc
Q 039168 286 ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTA 365 (536)
Q Consensus 286 ~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 365 (536)
++++||||+ +.+|..++.. ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a 168 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 168 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecc-cccHHHHHHh----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccce
Confidence 579999999 5667666532 35999999999999999999999997 999999999999999999999999999
Q ss_pred cccCCCCCccccccccccccccCcchhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcC--
Q 039168 366 RIFGGNQNQANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEG-- 442 (536)
Q Consensus 366 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-- 442 (536)
+..... .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||....... ............
T Consensus 169 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~---~~~~~~~~~~~~~~ 240 (346)
T d1cm8a_ 169 RQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD---QLKEIMKVTGTPPA 240 (346)
T ss_dssp EECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCCCCH
T ss_pred eccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHH---HHHHHHhccCCCcH
Confidence 876432 2345789999999998765 46899999999999999999999986432211 111110000000
Q ss_pred ------C----------ccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH--hccCC
Q 039168 443 ------H----------AVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM--LASDS 493 (536)
Q Consensus 443 ------~----------~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~~~ 493 (536)
. ..+.....+. .........+++|+.+||+.||++|||+.|+|+. ++...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 241 EFVQRLQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp HHHHTCSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred HHHhhhcchhhhhhhccCCcccccchH-HhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 0 0000000000 0001112245677779999999999999999974 55543
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-44 Score=360.27 Aligned_cols=264 Identities=20% Similarity=0.263 Sum_probs=194.2
Q ss_pred hcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC-hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCc----eEE
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQ----ELL 288 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~----~~~ 288 (536)
..+|+++++||+|+||+||+|.++ +|+.||||++.... ....+.+.+|+.+|++++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 467999999999999999999874 69999999997543 344677899999999999999999999997643 234
Q ss_pred EEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCcccc
Q 039168 289 LIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIF 368 (536)
Q Consensus 289 lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 368 (536)
++++++.+++|.+++.. ..+++..++.++.||+.||+|||+++ |+||||||+||||++++.+||+|||+++..
T Consensus 87 ~l~~~~~~g~L~~~l~~----~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp EEEEECCCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEeecCCchhhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeec
Confidence 44556779999999853 24899999999999999999999997 999999999999999999999999999876
Q ss_pred CCCCC-ccccccccccccccCcchhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCccc
Q 039168 369 GGNQN-QANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVE 446 (536)
Q Consensus 369 ~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 446 (536)
..... ........||+.|+|||++.. ..++.++||||+||++|+|++|+.||........ ...............
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~ 236 (345)
T d1pmea_ 160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ---LNHILGILGSPSQED 236 (345)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCSCCHHH
T ss_pred cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHH---HHHHhhhccCCChhh
Confidence 43322 222344679999999999854 5679999999999999999999999864332111 111111000000000
Q ss_pred c------------ccccccCCCCH-----HHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 447 L------------IDPVLKQSCAP-----DELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 447 l------------~~~~l~~~~~~-----~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
. .........+. ....++++++.+||+.||++|||++++|+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 237 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 00000000000 011346778889999999999999999974
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.3e-44 Score=354.75 Aligned_cols=260 Identities=22% Similarity=0.265 Sum_probs=195.0
Q ss_pred cCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCC-ceeEeeEEeeCceEEEEEee
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKN-LVRLLGCCLEGQELLLIYEY 293 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn-iv~l~~~~~~~~~~~lv~e~ 293 (536)
++|++.+.||+|+||.||+|++. +|+.||||++...... +++..|+++++.++|+| |+.+..++.+++..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS--CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC--HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 57999999999999999999975 5899999988654332 45788999999998776 45556667788899999999
Q ss_pred cCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcC---CCCeEEecccCccccCC
Q 039168 294 MPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDD---DMNPKISDFGTARIFGG 370 (536)
Q Consensus 294 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~---~~~~kl~Dfg~a~~~~~ 370 (536)
+.+ +|...+.. ....+++..+..++.|++.||+|||+++ |+||||||+|||++. +..+||+|||+++.+..
T Consensus 85 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 85 LGP-SLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp CCC-BHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred cCC-chhhhhhh--ccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 955 55444432 2345899999999999999999999997 999999999999864 45799999999998764
Q ss_pred CCCc-----cccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcc
Q 039168 371 NQNQ-----ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAV 445 (536)
Q Consensus 371 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 445 (536)
.... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.......................
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~-- 236 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP-- 236 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSC--
T ss_pred cccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCC--
Confidence 4322 223446799999999999999999999999999999999999999876444332222211111110000
Q ss_pred ccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhccC
Q 039168 446 ELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 492 (536)
Q Consensus 446 ~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 492 (536)
.+.+.... ++ ++.+++..||+.||++||+++++.+.|+..
T Consensus 237 ---~~~~~~~~-p~---~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 276 (299)
T d1ckia_ 237 ---IEVLCKGY-PS---EFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276 (299)
T ss_dssp ---HHHHTTTS-CH---HHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred ---hhHhccCC-CH---HHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 01111122 23 355666699999999999999998888753
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=7.9e-44 Score=350.58 Aligned_cols=260 Identities=17% Similarity=0.227 Sum_probs=203.3
Q ss_pred hcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHHcCC-CCceeEeeEEeeCceEEEEEe
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQH-KNLVRLLGCCLEGQELLLIYE 292 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~l~~~~~~~~~~~lv~e 292 (536)
.++|++.++||+|+||+||+|++. +|+.||||++..... .+.+++|++.++.++| +|++.+++++..+...++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 468999999999999999999975 589999998865432 2457789999999976 899999999999999999999
Q ss_pred ecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcC-----CCCeEEecccCccc
Q 039168 293 YMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDD-----DMNPKISDFGTARI 367 (536)
Q Consensus 293 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~-----~~~~kl~Dfg~a~~ 367 (536)
|+ +++|..++... ...+++.++..++.|++.||+|||+++ |+||||||+|||++. .+.+||+|||+++.
T Consensus 82 ~~-~~~l~~~~~~~--~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 82 LL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHhh--ccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 99 68888887543 335899999999999999999999997 999999999999974 57899999999998
Q ss_pred cCCCCCc-----cccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcC
Q 039168 368 FGGNQNQ-----ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEG 442 (536)
Q Consensus 368 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 442 (536)
+...... .......||+.|||||++.+..++.++||||||+++|||++|+.||......................
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 235 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC
Confidence 7543222 12334679999999999999999999999999999999999999986544333222222111111111
Q ss_pred CccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcc
Q 039168 443 HAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 491 (536)
Q Consensus 443 ~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 491 (536)
... .+.... ++ ++.+++..|++.+|++||+++.+.+.|+.
T Consensus 236 ~~~-----~l~~~~-p~---~l~~ii~~~~~~~~~~rP~y~~l~~~l~~ 275 (293)
T d1csna_ 236 PLR-----ELCAGF-PE---EFYKYMHYARNLAFDATPDYDYLQGLFSK 275 (293)
T ss_dssp CHH-----HHTTTS-CH---HHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred ChH-----HhcCCC-CH---HHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence 111 111222 23 35556668999999999999998887765
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=6e-44 Score=357.56 Aligned_cols=257 Identities=18% Similarity=0.247 Sum_probs=194.7
Q ss_pred cCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHHcC-CCCceeEeeEEee--CceEEEEE
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQ-HKNLVRLLGCCLE--GQELLLIY 291 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~--~~~~~lv~ 291 (536)
++|+++++||+|+||+||+|++. +|+.||||++.... .+.+.+|+.+|++++ ||||+++++++.. ...+++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 68999999999999999999975 68999999987543 367889999999995 9999999999974 45799999
Q ss_pred eecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCC-CeEEecccCccccCC
Q 039168 292 EYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDM-NPKISDFGTARIFGG 370 (536)
Q Consensus 292 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~-~~kl~Dfg~a~~~~~ 370 (536)
||+.+++|..+. ..+++..++.++.||+.||.|||+++ |+||||||+||||+.++ .+||+|||+++....
T Consensus 112 e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 112 EHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp ECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred eecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccC
Confidence 999999997654 24899999999999999999999997 99999999999998665 599999999987654
Q ss_pred CCCccccccccccccccCcchhcCCC-CCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHH---------HHHHHhh
Q 039168 371 NQNQANTNIIAGTYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLT---------YTWKLWC 440 (536)
Q Consensus 371 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~---------~~~~~~~ 440 (536)
... .....||+.|+|||.+.+.. ++.++||||+||++|+|++|+.||............. ..+....
T Consensus 183 ~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 259 (328)
T d3bqca1 183 GQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 259 (328)
T ss_dssp TCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred CCc---ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhc
Confidence 332 23457899999999988754 7999999999999999999999986533221110000 0000000
Q ss_pred cCCcccccc------------ccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 441 EGHAVELID------------PVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 441 ~~~~~~l~~------------~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
.......+. .............++++|+.+||+.||++|||++|+|+
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp TCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000000 00000000111234667778999999999999999986
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-44 Score=359.17 Aligned_cols=252 Identities=23% Similarity=0.311 Sum_probs=198.9
Q ss_pred cCCccccccCCCCceeEEEEEeC----CCcEEEEEEccccC----hhhHHHHHHHHHHHHHcCC-CCceeEeeEEeeCce
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA----DGKAIAVKRLSRTS----GQGLKEFKNEVNLIAKLQH-KNLVRLLGCCLEGQE 286 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h-pniv~l~~~~~~~~~ 286 (536)
++|+++++||+|+||+||+|+.. +|+.||||++.+.. ....+.+.+|+++|++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 67999999999999999999852 47899999986432 2345678899999999977 899999999999999
Q ss_pred EEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCcc
Q 039168 287 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTAR 366 (536)
Q Consensus 287 ~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 366 (536)
.+++|||+.+++|..++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~---~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eeeeeecccccHHHHHHHhcc---cccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchh
Confidence 999999999999999986543 3788999999999999999999986 9999999999999999999999999998
Q ss_pred ccCCCCCccccccccccccccCcchhcCC--CCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCc
Q 039168 367 IFGGNQNQANTNIIAGTYGYMAPEYAMGG--IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHA 444 (536)
Q Consensus 367 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 444 (536)
.+...... ......|++.|+|||.+.+. .++.++|||||||+||+|++|+.||........... ..........
T Consensus 178 ~~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~---i~~~~~~~~~ 253 (322)
T d1vzoa_ 178 EFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAE---ISRRILKSEP 253 (322)
T ss_dssp ECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHH---HHHHHHHCCC
T ss_pred hhcccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHhcccCCC
Confidence 76533322 23345789999999999765 468899999999999999999999865433322211 1111111111
Q ss_pred cccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHH
Q 039168 445 VELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRP-----TMSSVVV 487 (536)
Q Consensus 445 ~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 487 (536)
.+.. .....+.+++.+||++||++|| |++|+++
T Consensus 254 ------~~~~----~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 254 ------PYPQ----EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp ------CCCT----TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred ------CCcc----cCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 1111 1223466667799999999999 4789986
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-44 Score=351.99 Aligned_cols=262 Identities=21% Similarity=0.281 Sum_probs=201.9
Q ss_pred cCCccccccCCCCceeEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHHHcCCCCceeEeeEEeeCceEEEEEe
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 292 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 292 (536)
++|+++++||+|+||+||+|++. +++.||||++... .....+.+.+|+.+|+.++||||+++++++.+....++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 58999999999999999999975 6899999998644 33456789999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCccccCCCC
Q 039168 293 YMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTARIFGGNQ 372 (536)
Q Consensus 293 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 372 (536)
++.+++|..++.. ...+++..++.++.|+++||+|||+++ |+||||||+|||++.++++||+|||.++......
T Consensus 82 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 82 FCDQDLKKYFDSC---NGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred ecccccccccccc---ccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCC
Confidence 9999998887743 345899999999999999999999996 9999999999999999999999999998775433
Q ss_pred CccccccccccccccCcchhcCCC-CCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcCCcccc----
Q 039168 373 NQANTNIIAGTYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGHAVEL---- 447 (536)
Q Consensus 373 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l---- 447 (536)
.. .....+++.|+|||.+.+.. ++.++|||||||++|||++|+.||..... ....................
T Consensus 156 ~~--~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 231 (292)
T d1unla_ 156 RC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND--VDDQLKRIFRLLGTPTEEQWPSMT 231 (292)
T ss_dssp SC--CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS--HHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred cc--ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCC--HHHHHHHHHhhcCCCChhhhhhhh
Confidence 22 22345788999999988765 68999999999999999999999643221 11122222221111100000
Q ss_pred --cc--------c-cccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 039168 448 --ID--------P-VLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 487 (536)
Q Consensus 448 --~~--------~-~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 487 (536)
.+ . .............+.+++.+||+.||++|||++|+|+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 0 0000011112234667777999999999999999986
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-43 Score=357.62 Aligned_cols=258 Identities=25% Similarity=0.286 Sum_probs=189.7
Q ss_pred cCCccccccCCCCceeEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHHHcCCCCceeEeeEEee------Cce
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLKEFKNEVNLIAKLQHKNLVRLLGCCLE------GQE 286 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~------~~~ 286 (536)
++|+++++||+|+||+||+|.+. +|+.||||++... +......+.+|+.+|++++||||++++++|.. ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 68999999999999999999976 5999999999754 34445678899999999999999999999964 468
Q ss_pred EEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCcc
Q 039168 287 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTAR 366 (536)
Q Consensus 287 ~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 366 (536)
+|+||||+.++++.... ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.+|++|||+++
T Consensus 97 ~~iv~Ey~~~~l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~ 167 (355)
T d2b1pa1 97 VYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_dssp EEEEEECCSEEHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred eEEEEeccchHHHHhhh------cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhh
Confidence 99999999877665442 24899999999999999999999997 9999999999999999999999999988
Q ss_pred ccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHH----------
Q 039168 367 IFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTW---------- 436 (536)
Q Consensus 367 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~---------- 436 (536)
...... ......||+.|+|||++.+..+++++||||+||++|+|++|+.||....... ......
T Consensus 168 ~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~---~~~~i~~~~~~~~~~~ 241 (355)
T d2b1pa1 168 TAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID---QWNKVIEQLGTPCPEF 241 (355)
T ss_dssp ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCCCCHHH
T ss_pred cccccc---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHH---HHHHHHHhccCCCHHH
Confidence 664322 2334578999999999999999999999999999999999999986432111 000000
Q ss_pred --------HHhhcCCc-------cccccccccCCC---CHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 039168 437 --------KLWCEGHA-------VELIDPVLKQSC---APDELLKFIHIGLLCVQQDPADRPTMSSVVVM 488 (536)
Q Consensus 437 --------~~~~~~~~-------~~l~~~~l~~~~---~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 488 (536)
........ ...+........ .......+++++.+||+.||++|||++|||+.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00000000 000101110111 12234567888899999999999999999854
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-43 Score=351.95 Aligned_cols=274 Identities=22% Similarity=0.274 Sum_probs=199.0
Q ss_pred hcCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccC--hhhHHHHHHHHHHHHHcCCCCceeEeeEEeeC-----ce
Q 039168 215 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLKEFKNEVNLIAKLQHKNLVRLLGCCLEG-----QE 286 (536)
Q Consensus 215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-----~~ 286 (536)
.++|+++++||+|+||+||+|++. +|+.||||++.+.. ....+.+.+|+++|++++|||||++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 478999999999999999999975 69999999997543 34456788999999999999999999998643 34
Q ss_pred EEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEecccCcc
Q 039168 287 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKISDFGTAR 366 (536)
Q Consensus 287 ~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 366 (536)
.+++++++.+++|.+++.. ..+++.+++.++.||+.||+|||+++ |+||||||+|||++.++.+|++|||++.
T Consensus 97 ~~~i~~~~~gg~L~~~~~~----~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 169 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----
T ss_pred eEEEEEeecCCchhhhccc----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhc
Confidence 4667778889999998843 34999999999999999999999997 9999999999999999999999999997
Q ss_pred ccCCCCCccccccccccccccCcchhcCCC-CCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHHHHHHhhcC---
Q 039168 367 IFGGNQNQANTNIIAGTYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEG--- 442 (536)
Q Consensus 367 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--- 442 (536)
.... ......||+.|+|||.+.+.. ++.++|||||||++|+|++|+.||....... ............
T Consensus 170 ~~~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~---~~~~i~~~~~~~~~~ 241 (348)
T d2gfsa1 170 HTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID---QLKLILRLVGTPGAE 241 (348)
T ss_dssp CCTG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCHH
T ss_pred ccCc-----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcCCCChH
Confidence 5432 223457899999999887764 6899999999999999999999986432211 111111100000
Q ss_pred ---------------CccccccccccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH--HhccCCCCCCCCCCCCc
Q 039168 443 ---------------HAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV--MLASDSMTIPQPTEPAF 504 (536)
Q Consensus 443 ---------------~~~~l~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~~~~~~~~p~~p~~ 504 (536)
.........+.. ........+++|+.+||+.||++|||++|+|+ .++....+-..|..+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~~~~~~~~~~ 319 (348)
T d2gfsa1 242 LLKKISSESARNYIQSLTQMPKMNFAN-VFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPY 319 (348)
T ss_dssp HHTTCCCHHHHHHHTTSCCCCCCCHHH-HSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSCCCCCCC
T ss_pred HhhhccchhhhhhhhhcccCCCcchhh-hcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCCccCCCCCCC
Confidence 000000000000 00001234667778999999999999999997 45554333344444433
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=7.6e-39 Score=324.72 Aligned_cols=264 Identities=20% Similarity=0.212 Sum_probs=194.3
Q ss_pred cCCccccccCCCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHHcC-----------CCCceeEeeEEee
Q 039168 216 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQ-----------HKNLVRLLGCCLE 283 (536)
Q Consensus 216 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------hpniv~l~~~~~~ 283 (536)
.+|+++++||+|+||+||+|++. +|+.||||++.+.. ...+.+.+|+.+++.++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 46999999999999999999975 69999999997543 33467788999998886 4789999988764
Q ss_pred --CceEEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeeeCCCCCCcEEEcCCCC----
Q 039168 284 --GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHE-DSRLKIIHRDLKASNVLLDDDMN---- 356 (536)
Q Consensus 284 --~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~ivH~Dikp~NIll~~~~~---- 356 (536)
....+++++++.................+++..+..++.||+.||+|||+ . +|+||||||+||||+.++.
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTTTE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCccccc
Confidence 45677778777666555454445556678999999999999999999998 5 4999999999999986653
Q ss_pred --eEEecccCccccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCccCCchhHHH
Q 039168 357 --PKISDFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTY 434 (536)
Q Consensus 357 --~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~ 434 (536)
++++|||.+...... .....||+.|+|||++.+..++.++||||+||++++|++|+.||..............
T Consensus 169 ~~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~ 243 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 243 (362)
T ss_dssp EEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred ceeeEeecccccccccc-----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHH
Confidence 999999999865322 2345789999999999999999999999999999999999999864332211111100
Q ss_pred H---HHHhhc------------------CCccccccc----------cccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHH
Q 039168 435 T---WKLWCE------------------GHAVELIDP----------VLKQSCAPDELLKFIHIGLLCVQQDPADRPTMS 483 (536)
Q Consensus 435 ~---~~~~~~------------------~~~~~l~~~----------~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 483 (536)
. ...... ......+.. .............+.+++.+||+.||.+|||++
T Consensus 244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~ 323 (362)
T d1q8ya_ 244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 323 (362)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred HHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHH
Confidence 0 000000 000000000 011223455667888999999999999999999
Q ss_pred HHHHH
Q 039168 484 SVVVM 488 (536)
Q Consensus 484 evl~~ 488 (536)
|+|+.
T Consensus 324 e~L~H 328 (362)
T d1q8ya_ 324 GLVNH 328 (362)
T ss_dssp HHHTC
T ss_pred HHhcC
Confidence 99973
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.90 E-value=1.7e-24 Score=198.04 Aligned_cols=169 Identities=17% Similarity=0.156 Sum_probs=121.2
Q ss_pred ccccccCCCCceeEEEEEeCCCcEEEEEEccccCh------------------hhHHHHHHHHHHHHHcCCCCceeEeeE
Q 039168 219 SDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSG------------------QGLKEFKNEVNLIAKLQHKNLVRLLGC 280 (536)
Q Consensus 219 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~hpniv~l~~~ 280 (536)
.+.++||+|+||+||+|++.+|+.||||++..... .....+.+|...+.++.|++++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 46789999999999999998899999998653210 112335678999999999999988866
Q ss_pred EeeCceEEEEEeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEcCCCCeEEe
Q 039168 281 CLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHEDSRLKIIHRDLKASNVLLDDDMNPKIS 360 (536)
Q Consensus 281 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~ 360 (536)
.. .+++|||+++..+.. +++.....++.|++++|.|||+++ |+||||||+|||++++ .++|+
T Consensus 83 ~~----~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~li 144 (191)
T d1zara2 83 EG----NAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWII 144 (191)
T ss_dssp ET----TEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEEC
T ss_pred cC----CEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEEE
Confidence 42 279999998876543 333445678999999999999997 9999999999999965 48999
Q ss_pred cccCccccCCCCCccccccccccccccCcchhcCCCCCccchHHHHHHHH
Q 039168 361 DFGTARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLL 410 (536)
Q Consensus 361 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il 410 (536)
|||++.....+..... ...+... -.|. ....|+.++|+||+.--+
T Consensus 145 DFG~a~~~~~~~~~~~---l~rd~~~-~~~~-f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 145 DFPQSVEVGEEGWREI---LERDVRN-IITY-FSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CCTTCEETTSTTHHHH---HHHHHHH-HHHH-HHHHHCCCCCHHHHHHHH
T ss_pred ECCCcccCCCCCcHHH---HHHHHHH-HHHH-HcCCCCCcccHHHHHHHH
Confidence 9999976542221110 0000000 0111 134578899999976444
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.65 E-value=8.1e-08 Score=89.91 Aligned_cols=146 Identities=16% Similarity=0.102 Sum_probs=100.5
Q ss_pred HHHhcCCccccccCCCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHHcC-CCCceeEeeEEeeCceEEEE
Q 039168 212 LEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQ-HKNLVRLLGCCLEGQELLLI 290 (536)
Q Consensus 212 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lv 290 (536)
....+.|+..+..+-++.+.||+... +++.++||+...........+.+|...++.+. +--+.+++.+..+++..++|
T Consensus 10 ~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv 88 (263)
T d1j7la_ 10 KKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp HHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred HHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEE
Confidence 33446777766655555678998865 56678889876554444556788999988884 33367788888888999999
Q ss_pred EeecCCCChhhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHhcC------------------------------------
Q 039168 291 YEYMPNKSLDVHLFDATRSVQLDWKRRLSIINGIARGILYLHED------------------------------------ 334 (536)
Q Consensus 291 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~------------------------------------ 334 (536)
|++++|.++....... .....++.++++.+..||+.
T Consensus 89 ~~~l~G~~~~~~~~~~--------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T d1j7la_ 89 MSEADGVLCSEEYEDE--------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp EECCSSEEHHHHTTTC--------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGST
T ss_pred EEeccccccccccccc--------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccc
Confidence 9999998876543211 11222344555555555531
Q ss_pred --------------------CCCCeeeCCCCCCcEEEcCCCCeEEecccCcc
Q 039168 335 --------------------SRLKIIHRDLKASNVLLDDDMNPKISDFGTAR 366 (536)
Q Consensus 335 --------------------~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 366 (536)
....++|+|+.|.|||+++++.+-|.||+.+.
T Consensus 161 ~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 11237899999999999977666799998875
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.14 E-value=5.7e-06 Score=76.42 Aligned_cols=130 Identities=17% Similarity=0.167 Sum_probs=87.2
Q ss_pred ccCCCCc-eeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHHcCC--CCceeEeeEEeeCceEEEEEeecCCCCh
Q 039168 223 KLGQGGF-GPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQH--KNLVRLLGCCLEGQELLLIYEYMPNKSL 299 (536)
Q Consensus 223 ~lg~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--pniv~l~~~~~~~~~~~lv~e~~~~~sL 299 (536)
.+..|.. +.||+...+++..+++|....... ..+..|...++.+.. -.+.+++.+..+++..++||++++|.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 4455554 679999988888899997654432 346778888888743 3366788888888899999999998776
Q ss_pred hhhhhcccCCCCCCHHHHHHHHHHHHHHHHHHh-----------------------------------------------
Q 039168 300 DVHLFDATRSVQLDWKRRLSIINGIARGILYLH----------------------------------------------- 332 (536)
Q Consensus 300 ~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH----------------------------------------------- 332 (536)
.... .... ..+.++.+.|.-||
T Consensus 94 ~~~~--------~~~~---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (255)
T d1nd4a_ 94 LSSH--------LAPA---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF 162 (255)
T ss_dssp TTSC--------CCHH---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred cccc--------ccHH---HHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHH
Confidence 4321 1111 11122223333333
Q ss_pred ----c----CCCCCeeeCCCCCCcEEEcCCCCeEEecccCcc
Q 039168 333 ----E----DSRLKIIHRDLKASNVLLDDDMNPKISDFGTAR 366 (536)
Q Consensus 333 ----~----~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 366 (536)
. .....++|+|+.|.|||++++..+-|+||+.+.
T Consensus 163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 1 112347999999999999987667899998875
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.76 E-value=5.5e-05 Score=74.61 Aligned_cols=77 Identities=12% Similarity=0.181 Sum_probs=50.1
Q ss_pred ccccCCCCceeEEEEEeCC-CcEEEEEEcccc-------ChhhHHHHHHHHHHHHHcC-C-C-CceeEeeEEeeCceEEE
Q 039168 221 ENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRT-------SGQGLKEFKNEVNLIAKLQ-H-K-NLVRLLGCCLEGQELLL 289 (536)
Q Consensus 221 ~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~-------~~~~~~~~~~E~~~l~~l~-h-p-niv~l~~~~~~~~~~~l 289 (536)
.+.||.|....||+....+ ++.|+||.-... -....++...|.+.|+.+. + | .+++++.+ +.+..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 4578999999999998754 678999964321 1123345667888888773 2 3 45556544 3445688
Q ss_pred EEeecCCCCh
Q 039168 290 IYEYMPNKSL 299 (536)
Q Consensus 290 v~e~~~~~sL 299 (536)
|||++.+..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999987543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.41 E-value=0.00057 Score=65.18 Aligned_cols=136 Identities=15% Similarity=0.169 Sum_probs=80.8
Q ss_pred ceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHHcCCCCc-----eeE--eeEEeeCceEEEEEeecCCCChhh
Q 039168 229 FGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKNL-----VRL--LGCCLEGQELLLIYEYMPNKSLDV 301 (536)
Q Consensus 229 ~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpni-----v~l--~~~~~~~~~~~lv~e~~~~~sL~~ 301 (536)
--.||+++..+|..|++|+.... ....+++..|...+..|....+ +.. -..+..+...+.+++++.|..+..
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~ 113 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA 113 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred cceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence 46899999999999999987543 2345678889998888853221 111 112345677899999998765432
Q ss_pred hh--------------hcc------cCCCCCCH----------------------HHHHHHHHHHHHHHHHH-hcCCCCC
Q 039168 302 HL--------------FDA------TRSVQLDW----------------------KRRLSIINGIARGILYL-HEDSRLK 338 (536)
Q Consensus 302 ~l--------------~~~------~~~~~l~~----------------------~~~~~i~~qi~~al~~L-H~~~~~~ 338 (536)
.- +.. ......+. ......+.++...+.-+ .+..+..
T Consensus 114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~ 193 (325)
T d1zyla1 114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL 193 (325)
T ss_dssp SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence 10 000 00011111 11222333333333322 1222346
Q ss_pred eeeCCCCCCcEEEcCCCCeEEecccCccc
Q 039168 339 IIHRDLKASNVLLDDDMNPKISDFGTARI 367 (536)
Q Consensus 339 ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 367 (536)
+||+|+.+.|||++++ ..+.||+-+..
T Consensus 194 liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 194 RLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp ECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred eecCCCCcccEEEeCC--ceEEechhccc
Confidence 8999999999999753 46899998863
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.28 E-value=0.00041 Score=68.12 Aligned_cols=74 Identities=14% Similarity=0.211 Sum_probs=51.0
Q ss_pred ccccCCCCceeEEEEEeCC--------CcEEEEEEccccChhhHHHHHHHHHHHHHcCCCC-ceeEeeEEeeCceEEEEE
Q 039168 221 ENKLGQGGFGPVYKGTLAD--------GKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQHKN-LVRLLGCCLEGQELLLIY 291 (536)
Q Consensus 221 ~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn-iv~l~~~~~~~~~~~lv~ 291 (536)
++.|+.|-.-.+|++...+ .+.|.+++.... .......+|..+++.+.-.+ ..++++++.+ .+|+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~--~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ 120 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 120 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc--chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence 4578889999999998643 356777765532 22345568999999885334 4467777643 6899
Q ss_pred eecCCCChh
Q 039168 292 EYMPNKSLD 300 (536)
Q Consensus 292 e~~~~~sL~ 300 (536)
||++|..+.
T Consensus 121 efi~g~~l~ 129 (395)
T d1nw1a_ 121 EYIPSRPLS 129 (395)
T ss_dssp CCCCEEECC
T ss_pred EEeccccCC
Confidence 999886654
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.73 E-value=0.0036 Score=58.88 Aligned_cols=155 Identities=12% Similarity=-0.020 Sum_probs=82.4
Q ss_pred hhHHHHhcCCcccc-----ccCCCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHHcCC-----CCceeEe
Q 039168 209 GLALEATNHFSDEN-----KLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLKEFKNEVNLIAKLQH-----KNLVRLL 278 (536)
Q Consensus 209 ~~~~~~~~~~~~~~-----~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-----pniv~l~ 278 (536)
..+.....+|.+.+ .|..|---+.|+.+..+| .+++|+..... ..+++..|.+++..|.. |..+...
T Consensus 6 ~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi~~~ 82 (316)
T d2ppqa1 6 DELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPRK 82 (316)
T ss_dssp HHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBT
T ss_pred HHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccceec
Confidence 34455556675543 355677788899987655 58999886432 22455567777777743 2222210
Q ss_pred ---eEEeeCceEEEEEeecCCCChhhhhhc--------------c------cCCC------------------CCCHHHH
Q 039168 279 ---GCCLEGQELLLIYEYMPNKSLDVHLFD--------------A------TRSV------------------QLDWKRR 317 (536)
Q Consensus 279 ---~~~~~~~~~~lv~e~~~~~sL~~~l~~--------------~------~~~~------------------~l~~~~~ 317 (536)
.+.........++.++.+......... . .... .......
T Consensus 83 ~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (316)
T d2ppqa1 83 DGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGL 162 (316)
T ss_dssp TCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTH
T ss_pred CCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhH
Confidence 112334566777777766544221100 0 0000 0001111
Q ss_pred HHHHHHHHHHHHHHhcC-CCCCeeeCCCCCCcEEEcCCCCeEEecccCcc
Q 039168 318 LSIINGIARGILYLHED-SRLKIIHRDLKASNVLLDDDMNPKISDFGTAR 366 (536)
Q Consensus 318 ~~i~~qi~~al~~LH~~-~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 366 (536)
...+..+...+.-.+.. -+.++||+|+.++||+++++...-|.||+.+.
T Consensus 163 ~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 163 REEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp HHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 22233333333333321 13359999999999999988777899999885
|